drugname,reac,freq
ABEMACICLIB,Myelosuppression,17
ABEMACICLIB,Diarrhoea,15
ABEMACICLIB,Headache,15
ABEMACICLIB,Aspartate aminotransferase increased,14
ABEMACICLIB,Alanine aminotransferase increased,13
ABEMACICLIB,Fatigue,12
ABEMACICLIB,Constipation,10
ABEMACICLIB,Muscle spasms,9
ABEMACICLIB,Tachycardia,9
ABEMACICLIB,Neutropenia,9
ABEMACICLIB,Nausea,8
ABEMACICLIB,Rash,8
ABEMACICLIB,Gait disturbance,8
ABEMACICLIB,Arthralgia,8
ABEMACICLIB,Metastases to liver,8
ABEMACICLIB,Vomiting,7
ABEMACICLIB,Pathological fracture,7
ABEMACICLIB,Dyspepsia,7
ABEMACICLIB,Myalgia,7
ABEMACICLIB,Thrombocytopenia,7
ABEMACICLIB,Arthropod bite,7
ABEMACICLIB,Gamma-glutamyltransferase increased,7
ABEMACICLIB,Hepatic echinococciasis,7
ABEMACICLIB,Transaminases increased,7
ABEMACICLIB,Aphthous ulcer,7
ABEMACICLIB,Hepatic cyst,7
ABEMACICLIB,Anaemia,7
ABEMACICLIB,Vitamin B complex deficiency,6
ABEMACICLIB,Musculoskeletal stiffness,6
ABEMACICLIB,Influenza like illness,6
ABEMACICLIB,Stomatitis,6
ABEMACICLIB,Dysuria,6
ABEMACICLIB,Dry skin,6
ABEMACICLIB,Coronavirus infection,6
ABEMACICLIB,Libido decreased,6
ABEMACICLIB,Mucosal inflammation,6
ABEMACICLIB,Rash pustular,6
ABEMACICLIB,Amenorrhoea,6
ABEMACICLIB,Back pain,6
ABEMACICLIB,Spinal pain,6
ABEMACICLIB,Disturbance in attention,6
ABEMACICLIB,Fall,6
ABEMACICLIB,Selenium deficiency,6
ABEMACICLIB,Malignant neoplasm progression,5
ABEMACICLIB,Pulmonary hypertension,5
ABEMACICLIB,Pneumonitis,5
ABEMACICLIB,Hepatic cytolysis,5
ABEMACICLIB,Interstitial lung disease,4
ABEMACICLIB,Haemoglobin decreased,4
ABEMACICLIB,Acute kidney injury,3
ABILIFY,Acute kidney injury,11
ABILIFY,Product use in unapproved indication,11
ABILIFY,Anhedonia,10
ABILIFY,Anxiety,9
ABILIFY,Depression,9
ABILIFY,Fatigue,9
ABILIFY,Tremor,9
ABILIFY,Hypotension,8
ABILIFY,Overdose,8
ABILIFY,Nausea,8
ABILIFY,International normalised ratio abnormal,7
ABILIFY,Polyuria,7
ABILIFY,Medication error,7
ABILIFY,Pain,7
ABILIFY,Restlessness,7
ABILIFY,Suicidal ideation,7
ABILIFY,Asthenia,7
ABILIFY,Dizziness,7
ABILIFY,Cognitive disorder,6
ABILIFY,Weight increased,6
ABILIFY,Diarrhoea,6
ABILIFY,Abdominal pain,6
ABILIFY,Off label use,6
ABILIFY,Gastrointestinal disorder,6
ABILIFY,Akathisia,6
ABILIFY,Disturbance in attention,6
ABILIFY,Somnolence,6
ABILIFY,Restless legs syndrome,6
ABILIFY,Dialysis,5
ABILIFY,Urinary tract infection,5
ABILIFY,Pyrexia,5
ABILIFY,Arthralgia,5
ABILIFY,Decreased appetite,5
ABILIFY,Oculogyric crisis,5
ABILIFY,Parkinsonism,5
ABILIFY,Bradyphrenia,5
ABILIFY,Neuroleptic-induced deficit syndrome,5
ABILIFY,"Hallucination, tactile",5
ABILIFY,Brain fog,5
ABILIFY,Confusional state,5
ABILIFY,Emotional disorder,5
ABILIFY,Feeling of despair,5
ABILIFY,Apathy,5
ABILIFY,Reduced facial expression,5
ABILIFY,Electric shock sensation,5
ABILIFY,Heart rate increased,5
ABILIFY,Hypoglycaemia,5
ABILIFY,Dyspnoea,4
ABILIFY,Product dose omission issue,4
ABILIFY,Inappropriate schedule of product administration,4
ABRILADA,Off label use,31
ABRILADA,Condition aggravated,18
ABRILADA,Fatigue,14
ABRILADA,Pain,11
ABRILADA,Inappropriate schedule of product administration,10
ABRILADA,Drug ineffective,8
ABRILADA,Injection site pain,7
ABRILADA,Malaise,7
ABRILADA,Arthralgia,7
ABRILADA,Diarrhoea,6
ABRILADA,Drug dose omission by device,6
ABRILADA,Pyrexia,6
ABRILADA,Haematochezia,6
ABRILADA,Nausea,6
ABRILADA,Product dose omission issue,5
ABRILADA,Insomnia,5
ABRILADA,Cough,5
ABRILADA,Asthenia,4
ABRILADA,Device difficult to use,4
ABRILADA,Therapeutic response shortened,4
ABRILADA,Stress,4
ABRILADA,COVID-19,4
ABRILADA,Injection site erythema,4
ABRILADA,Oropharyngeal pain,4
ABRILADA,Rectal haemorrhage,4
ABRILADA,Illness,4
ABRILADA,Weight increased,4
ABRILADA,Sensitivity to weather change,3
ABRILADA,Erythema,3
ABRILADA,Cellulitis,3
ABRILADA,Localised infection,3
ABRILADA,Injection site bruising,3
ABRILADA,Peripheral swelling,3
ABRILADA,Drug level decreased,3
ABRILADA,Constipation,3
ABRILADA,Maternal exposure during pregnancy,3
ABRILADA,Inflammation,3
ABRILADA,Injection site swelling,3
ABRILADA,Product dose omission in error,3
ABRILADA,Fistula,3
ABRILADA,Headache,3
ABRILADA,Anal fissure,3
ABRILADA,Influenza,3
ABRILADA,Back pain,3
ABRILADA,Dizziness,3
ABRILADA,Abdominal distension,2
ABRILADA,Flatulence,2
ABRILADA,Device defective,2
ABRILADA,Wrong technique in device usage process,2
ABRILADA,Wound,2
ACETAMINOPHEN,COVID-19,240
ACETAMINOPHEN,Fatigue,217
ACETAMINOPHEN,Sinusitis,204
ACETAMINOPHEN,Headache,192
ACETAMINOPHEN,Nausea,191
ACETAMINOPHEN,Off label use,191
ACETAMINOPHEN,Pyrexia,178
ACETAMINOPHEN,Pneumonia,173
ACETAMINOPHEN,Diarrhoea,170
ACETAMINOPHEN,Vomiting,170
ACETAMINOPHEN,Pain,165
ACETAMINOPHEN,Product dose omission issue,157
ACETAMINOPHEN,Urinary tract infection,143
ACETAMINOPHEN,Malaise,130
ACETAMINOPHEN,Fall,124
ACETAMINOPHEN,Dyspnoea,113
ACETAMINOPHEN,Arthralgia,106
ACETAMINOPHEN,Rash,101
ACETAMINOPHEN,Infusion related reaction,97
ACETAMINOPHEN,Back pain,97
ACETAMINOPHEN,Abdominal pain,97
ACETAMINOPHEN,Inappropriate schedule of product administration,97
ACETAMINOPHEN,Asthenia,94
ACETAMINOPHEN,Nasopharyngitis,94
ACETAMINOPHEN,Dizziness,94
ACETAMINOPHEN,Illness,86
ACETAMINOPHEN,Upper respiratory tract infection,85
ACETAMINOPHEN,Pruritus,84
ACETAMINOPHEN,Neutropenia,82
ACETAMINOPHEN,Infection,81
ACETAMINOPHEN,Pain in extremity,81
ACETAMINOPHEN,Anxiety,81
ACETAMINOPHEN,Cough,81
ACETAMINOPHEN,Weight decreased,76
ACETAMINOPHEN,Bronchitis,76
ACETAMINOPHEN,Influenza,76
ACETAMINOPHEN,Anaemia,72
ACETAMINOPHEN,Condition aggravated,71
ACETAMINOPHEN,Hepatic cytolysis,67
ACETAMINOPHEN,Sepsis,61
ACETAMINOPHEN,Weight increased,60
ACETAMINOPHEN,Blood pressure increased,59
ACETAMINOPHEN,Acute kidney injury,59
ACETAMINOPHEN,Product use issue,58
ACETAMINOPHEN,Drug ineffective,57
ACETAMINOPHEN,Chills,57
ACETAMINOPHEN,Respiratory tract infection,56
ACETAMINOPHEN,Febrile neutropenia,55
ACETAMINOPHEN,Gait disturbance,53
ACETAMINOPHEN,Hypotension,53
ACETAMINOPHEN\CODEINE PHOSPHATE,Nausea,17
ACETAMINOPHEN\CODEINE PHOSPHATE,Product use in unapproved indication,16
ACETAMINOPHEN\CODEINE PHOSPHATE,Anaemia,13
ACETAMINOPHEN\CODEINE PHOSPHATE,Diarrhoea,12
ACETAMINOPHEN\CODEINE PHOSPHATE,Dyspnoea,12
ACETAMINOPHEN\CODEINE PHOSPHATE,Off label use,11
ACETAMINOPHEN\CODEINE PHOSPHATE,Depression,11
ACETAMINOPHEN\CODEINE PHOSPHATE,Decreased appetite,11
ACETAMINOPHEN\CODEINE PHOSPHATE,Gait disturbance,10
ACETAMINOPHEN\CODEINE PHOSPHATE,Vomiting,10
ACETAMINOPHEN\CODEINE PHOSPHATE,Headache,10
ACETAMINOPHEN\CODEINE PHOSPHATE,Fatigue,9
ACETAMINOPHEN\CODEINE PHOSPHATE,Asthenia,9
ACETAMINOPHEN\CODEINE PHOSPHATE,Dehydration,9
ACETAMINOPHEN\CODEINE PHOSPHATE,Dysphagia,9
ACETAMINOPHEN\CODEINE PHOSPHATE,Constipation,9
ACETAMINOPHEN\CODEINE PHOSPHATE,Death,9
ACETAMINOPHEN\CODEINE PHOSPHATE,Drug ineffective,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Pain,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Hypokalaemia,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Mouth ulceration,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Mucosal inflammation,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Productive cough,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Neutropenic sepsis,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Skin candida,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Hypomagnesaemia,8
ACETAMINOPHEN\CODEINE PHOSPHATE,Nervous system disorder,7
ACETAMINOPHEN\CODEINE PHOSPHATE,Balance disorder,7
ACETAMINOPHEN\CODEINE PHOSPHATE,Neutrophil count decreased,7
ACETAMINOPHEN\CODEINE PHOSPHATE,Rash,6
ACETAMINOPHEN\CODEINE PHOSPHATE,Lung disorder,6
ACETAMINOPHEN\CODEINE PHOSPHATE,Pneumonia,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Pyrexia,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Malaise,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Infection,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Drug hypersensitivity,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Confusional state,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Dizziness,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Candida infection,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Intentional product misuse,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Hallucination,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Dermatitis,5
ACETAMINOPHEN\CODEINE PHOSPHATE,Leukopenia,5
ACETAMINOPHEN\CODEINE PHOSPHATE,General physical health deterioration,4
ACETAMINOPHEN\CODEINE PHOSPHATE,Arthropathy,4
ACETAMINOPHEN\CODEINE PHOSPHATE,Weight decreased,4
ACETAMINOPHEN\CODEINE PHOSPHATE,Condition aggravated,4
ACETAMINOPHEN\CODEINE PHOSPHATE,Arthralgia,4
ACETAMINOPHEN\CODEINE PHOSPHATE,Urinary tract infection,4
ACETAMINOPHEN\CODEINE PHOSPHATE,Inappropriate schedule of product administration,4
ACETAMINOPHEN\HYDROCODONE,Pain,29
ACETAMINOPHEN\HYDROCODONE,Fatigue,21
ACETAMINOPHEN\HYDROCODONE,Anxiety,20
ACETAMINOPHEN\HYDROCODONE,Headache,18
ACETAMINOPHEN\HYDROCODONE,Nausea,17
ACETAMINOPHEN\HYDROCODONE,COVID-19,16
ACETAMINOPHEN\HYDROCODONE,Fall,16
ACETAMINOPHEN\HYDROCODONE,Off label use,16
ACETAMINOPHEN\HYDROCODONE,Sinusitis,15
ACETAMINOPHEN\HYDROCODONE,Product dose omission issue,15
ACETAMINOPHEN\HYDROCODONE,Pneumonia,14
ACETAMINOPHEN\HYDROCODONE,Drug ineffective,14
ACETAMINOPHEN\HYDROCODONE,Diarrhoea,13
ACETAMINOPHEN\HYDROCODONE,Anhedonia,12
ACETAMINOPHEN\HYDROCODONE,Emotional distress,12
ACETAMINOPHEN\HYDROCODONE,Asthenia,12
ACETAMINOPHEN\HYDROCODONE,Dyspnoea,11
ACETAMINOPHEN\HYDROCODONE,Urinary tract infection,11
ACETAMINOPHEN\HYDROCODONE,Illness,11
ACETAMINOPHEN\HYDROCODONE,Vomiting,11
ACETAMINOPHEN\HYDROCODONE,Weight decreased,10
ACETAMINOPHEN\HYDROCODONE,Pruritus,10
ACETAMINOPHEN\HYDROCODONE,Back pain,9
ACETAMINOPHEN\HYDROCODONE,Depression,9
ACETAMINOPHEN\HYDROCODONE,Chronic kidney disease,8
ACETAMINOPHEN\HYDROCODONE,Arthralgia,8
ACETAMINOPHEN\HYDROCODONE,Decreased appetite,8
ACETAMINOPHEN\HYDROCODONE,Product use issue,8
ACETAMINOPHEN\HYDROCODONE,Insurance issue,8
ACETAMINOPHEN\HYDROCODONE,Pyrexia,8
ACETAMINOPHEN\HYDROCODONE,Blood pressure increased,8
ACETAMINOPHEN\HYDROCODONE,Feeling abnormal,8
ACETAMINOPHEN\HYDROCODONE,Multiple allergies,7
ACETAMINOPHEN\HYDROCODONE,Infection,7
ACETAMINOPHEN\HYDROCODONE,Ear infection,7
ACETAMINOPHEN\HYDROCODONE,Limb injury,7
ACETAMINOPHEN\HYDROCODONE,Alopecia,6
ACETAMINOPHEN\HYDROCODONE,Gait disturbance,6
ACETAMINOPHEN\HYDROCODONE,Bone density decreased,6
ACETAMINOPHEN\HYDROCODONE,Respiratory tract infection,6
ACETAMINOPHEN\HYDROCODONE,Asthma,6
ACETAMINOPHEN\HYDROCODONE,Contusion,6
ACETAMINOPHEN\HYDROCODONE,Inappropriate schedule of product administration,6
ACETAMINOPHEN\HYDROCODONE,Infusion site pain,6
ACETAMINOPHEN\HYDROCODONE,Malaise,6
ACETAMINOPHEN\HYDROCODONE,Drug hypersensitivity,6
ACETAMINOPHEN\HYDROCODONE,Rash,6
ACETAMINOPHEN\HYDROCODONE,Abdominal discomfort,6
ACETAMINOPHEN\HYDROCODONE,Insomnia,6
ACETAMINOPHEN\HYDROCODONE,Dizziness,6
ACYCLOVIR,Off label use,50
ACYCLOVIR,Febrile neutropenia,49
ACYCLOVIR,Pyrexia,43
ACYCLOVIR,Fatigue,42
ACYCLOVIR,Pneumonia,39
ACYCLOVIR,Diarrhoea,38
ACYCLOVIR,Neutropenia,38
ACYCLOVIR,Rash,30
ACYCLOVIR,Pain,28
ACYCLOVIR,Anxiety,26
ACYCLOVIR,COVID-19,25
ACYCLOVIR,Thrombocytopenia,24
ACYCLOVIR,Platelet count decreased,23
ACYCLOVIR,Vomiting,21
ACYCLOVIR,Nausea,20
ACYCLOVIR,Dyspnoea,20
ACYCLOVIR,Asthenia,20
ACYCLOVIR,Cytokine release syndrome,20
ACYCLOVIR,Fall,19
ACYCLOVIR,Anaemia,19
ACYCLOVIR,Decreased appetite,19
ACYCLOVIR,Emotional distress,18
ACYCLOVIR,Neutrophil count decreased,18
ACYCLOVIR,Sepsis,17
ACYCLOVIR,White blood cell count decreased,17
ACYCLOVIR,Anhedonia,16
ACYCLOVIR,Pancytopenia,16
ACYCLOVIR,Dizziness,15
ACYCLOVIR,Headache,15
ACYCLOVIR,Hypokalaemia,15
ACYCLOVIR,Insomnia,15
ACYCLOVIR,Depression,14
ACYCLOVIR,Plasma cell myeloma,14
ACYCLOVIR,Osteoporosis,14
ACYCLOVIR,Renal impairment,14
ACYCLOVIR,Osteopenia,13
ACYCLOVIR,Cough,13
ACYCLOVIR,Malaise,12
ACYCLOVIR,Back pain,12
ACYCLOVIR,Constipation,12
ACYCLOVIR,Leukopenia,12
ACYCLOVIR,General physical health deterioration,11
ACYCLOVIR,Acute kidney injury,11
ACYCLOVIR,Product dose omission issue,11
ACYCLOVIR,Dehydration,11
ACYCLOVIR,Death,10
ACYCLOVIR,Blood creatinine increased,10
ACYCLOVIR,Muscle spasms,10
ACYCLOVIR,Tremor,10
ACYCLOVIR,Septic shock,10
ADALIMUMAB,Off label use,16
ADALIMUMAB,Drug ineffective,16
ADALIMUMAB,Arthralgia,15
ADALIMUMAB,Dyspnoea,13
ADALIMUMAB,Condition aggravated,13
ADALIMUMAB,Rheumatoid arthritis,11
ADALIMUMAB,Fatigue,11
ADALIMUMAB,Drug intolerance,11
ADALIMUMAB,Diarrhoea,11
ADALIMUMAB,Rash,11
ADALIMUMAB,Pyrexia,11
ADALIMUMAB,Nausea,11
ADALIMUMAB,Therapeutic product effect decreased,10
ADALIMUMAB,Dizziness,10
ADALIMUMAB,Pain,10
ADALIMUMAB,Malaise,10
ADALIMUMAB,Respiratory failure,10
ADALIMUMAB,Musculoskeletal stiffness,9
ADALIMUMAB,Pneumonia,9
ADALIMUMAB,Musculoskeletal pain,8
ADALIMUMAB,Headache,8
ADALIMUMAB,Intentional product use issue,8
ADALIMUMAB,Joint swelling,8
ADALIMUMAB,Arthropathy,8
ADALIMUMAB,Weight decreased,8
ADALIMUMAB,Infection,8
ADALIMUMAB,Pain in extremity,8
ADALIMUMAB,Weight increased,7
ADALIMUMAB,Alopecia,7
ADALIMUMAB,Systemic lupus erythematosus,7
ADALIMUMAB,Contraindicated product administered,7
ADALIMUMAB,Synovitis,7
ADALIMUMAB,Inflammation,7
ADALIMUMAB,Nasopharyngitis,7
ADALIMUMAB,Loss of personal independence in daily activities,7
ADALIMUMAB,Drug hypersensitivity,7
ADALIMUMAB,Product use in unapproved indication,7
ADALIMUMAB,C-reactive protein increased,7
ADALIMUMAB,Psoriasis,7
ADALIMUMAB,Arthritis,7
ADALIMUMAB,Red blood cell sedimentation rate increased,7
ADALIMUMAB,Asthenia,6
ADALIMUMAB,Hand deformity,6
ADALIMUMAB,Hypersensitivity,6
ADALIMUMAB,Maternal exposure during pregnancy,6
ADALIMUMAB,Night sweats,6
ADALIMUMAB,Psoriatic arthropathy,6
ADALIMUMAB,Peripheral swelling,6
ADALIMUMAB,Vomiting,6
ADALIMUMAB,Mobility decreased,6
ADCIRCA,Diarrhoea,54
ADCIRCA,Headache,49
ADCIRCA,Nausea,28
ADCIRCA,Dyspnoea,27
ADCIRCA,Pulmonary arterial hypertension,24
ADCIRCA,Hypotension,23
ADCIRCA,Cardiac failure,22
ADCIRCA,Pyrexia,19
ADCIRCA,Cough,16
ADCIRCA,Pneumonia,15
ADCIRCA,Fatigue,13
ADCIRCA,Dizziness,13
ADCIRCA,Malaise,12
ADCIRCA,Anaemia,12
ADCIRCA,Off label use,12
ADCIRCA,Flushing,11
ADCIRCA,Brain natriuretic peptide increased,11
ADCIRCA,Fall,11
ADCIRCA,Vomiting,10
ADCIRCA,Right ventricular failure,10
ADCIRCA,Platelet count decreased,10
ADCIRCA,Chest pain,9
ADCIRCA,Pain in extremity,9
ADCIRCA,COVID-19,9
ADCIRCA,Pain in jaw,9
ADCIRCA,Infection,8
ADCIRCA,Palpitations,8
ADCIRCA,Rhinorrhoea,8
ADCIRCA,Complication associated with device,8
ADCIRCA,Oedema peripheral,8
ADCIRCA,Arthralgia,8
ADCIRCA,Feeling abnormal,7
ADCIRCA,Abdominal pain,7
ADCIRCA,Haemorrhage,7
ADCIRCA,Oxygen saturation decreased,7
ADCIRCA,Syncope,7
ADCIRCA,Pleural effusion,7
ADCIRCA,Respiratory failure,7
ADCIRCA,Oedema,7
ADCIRCA,Injection site erythema,6
ADCIRCA,Injection site pain,6
ADCIRCA,Illness,6
ADCIRCA,Abdominal pain upper,6
ADCIRCA,Device leakage,6
ADCIRCA,Weight increased,6
ADCIRCA,Nasopharyngitis,6
ADCIRCA,Dyspnoea exertional,6
ADCIRCA,Dehydration,6
ADCIRCA,Atrial fibrillation,6
ADCIRCA,Pulmonary hypertension,6
ADDERALL,Headache,12
ADDERALL,COVID-19,10
ADDERALL,Nausea,9
ADDERALL,Sinusitis,9
ADDERALL,Anxiety,8
ADDERALL,Product dose omission issue,8
ADDERALL,Nasopharyngitis,8
ADDERALL,Bronchitis,7
ADDERALL,Urinary tract infection,7
ADDERALL,Pneumonia,7
ADDERALL,Fatigue,7
ADDERALL,Arthritis,6
ADDERALL,Depression,6
ADDERALL,Off label use,6
ADDERALL,Vomiting,6
ADDERALL,Dyspnoea,6
ADDERALL,Migraine,6
ADDERALL,Condition aggravated,5
ADDERALL,Obstructive sleep apnoea syndrome,5
ADDERALL,Inappropriate schedule of product administration,5
ADDERALL,Malaise,5
ADDERALL,Dizziness,4
ADDERALL,Nephrolithiasis,4
ADDERALL,Memory impairment,4
ADDERALL,Feeling abnormal,4
ADDERALL,Hypertension,4
ADDERALL,Staphylococcal infection,4
ADDERALL,Weight increased,4
ADDERALL,Infusion site pruritus,4
ADDERALL,Illness,4
ADDERALL,Blister,4
ADDERALL,Infusion site pain,4
ADDERALL,Chest discomfort,4
ADDERALL,Product use in unapproved indication,4
ADDERALL,Erythema,4
ADDERALL,Complex regional pain syndrome,3
ADDERALL,Weight decreased,3
ADDERALL,Unevaluable event,3
ADDERALL,Blood pressure increased,3
ADDERALL,Abnormal behaviour,3
ADDERALL,Back pain,3
ADDERALL,Respiratory tract infection,3
ADDERALL,Infusion site swelling,3
ADDERALL,Influenza,3
ADDERALL,Viral infection,3
ADDERALL,Somnolence,3
ADDERALL,Dehydration,3
ADDERALL,Hypersensitivity,3
ADDERALL,Infection,3
ADDERALL,Dry mouth,3
ADEMPAS,Dyspnoea,53
ADEMPAS,Hypotension,45
ADEMPAS,Headache,41
ADEMPAS,Nausea,41
ADEMPAS,Diarrhoea,37
ADEMPAS,Death,34
ADEMPAS,Fatigue,32
ADEMPAS,Infusion site pain,24
ADEMPAS,Dizziness,23
ADEMPAS,Pneumonia,23
ADEMPAS,Fluid retention,22
ADEMPAS,Weight decreased,21
ADEMPAS,Vomiting,21
ADEMPAS,Pain,20
ADEMPAS,COVID-19,19
ADEMPAS,Malaise,18
ADEMPAS,Pain in extremity,18
ADEMPAS,Infusion site erythema,18
ADEMPAS,Peripheral swelling,17
ADEMPAS,Arthralgia,17
ADEMPAS,Oxygen saturation decreased,17
ADEMPAS,Cough,16
ADEMPAS,Asthenia,16
ADEMPAS,Weight increased,15
ADEMPAS,Chest pain,15
ADEMPAS,Oedema peripheral,14
ADEMPAS,Nasopharyngitis,14
ADEMPAS,Infection,13
ADEMPAS,Decreased appetite,13
ADEMPAS,Syncope,13
ADEMPAS,Pyrexia,12
ADEMPAS,Pulmonary hypertension,12
ADEMPAS,Epistaxis,12
ADEMPAS,Feeling abnormal,11
ADEMPAS,Pain in jaw,11
ADEMPAS,Dyspnoea exertional,11
ADEMPAS,Fall,11
ADEMPAS,Haemoptysis,11
ADEMPAS,Injection site pain,10
ADEMPAS,Cardiac failure,10
ADEMPAS,Productive cough,10
ADEMPAS,Abdominal pain,10
ADEMPAS,Dyspepsia,10
ADEMPAS,Pulmonary oedema,9
ADEMPAS,Anxiety,9
ADEMPAS,Hypervolaemia,9
ADEMPAS,Pulmonary arterial hypertension,9
ADEMPAS,Illness,9
ADEMPAS,Abdominal distension,9
ADEMPAS,Infusion site swelling,9
ADVAIR HFA,Pneumonia,34
ADVAIR HFA,Product dose omission issue,29
ADVAIR HFA,Headache,27
ADVAIR HFA,Nasopharyngitis,24
ADVAIR HFA,Dyspnoea,24
ADVAIR HFA,Asthma,24
ADVAIR HFA,Influenza,24
ADVAIR HFA,Fatigue,23
ADVAIR HFA,Cough,23
ADVAIR HFA,COVID-19,22
ADVAIR HFA,Sinusitis,21
ADVAIR HFA,Pain,20
ADVAIR HFA,Weight decreased,19
ADVAIR HFA,Pyrexia,19
ADVAIR HFA,Malaise,17
ADVAIR HFA,Weight increased,17
ADVAIR HFA,Respiratory tract infection,17
ADVAIR HFA,Illness,17
ADVAIR HFA,Arthralgia,16
ADVAIR HFA,Nausea,15
ADVAIR HFA,Blood pressure increased,15
ADVAIR HFA,Wheezing,15
ADVAIR HFA,Fall,15
ADVAIR HFA,Oropharyngeal pain,14
ADVAIR HFA,Inappropriate schedule of product administration,14
ADVAIR HFA,Urinary tract infection,14
ADVAIR HFA,Productive cough,12
ADVAIR HFA,Rash,11
ADVAIR HFA,Middle insomnia,10
ADVAIR HFA,Drug hypersensitivity,10
ADVAIR HFA,Chills,10
ADVAIR HFA,Anxiety,9
ADVAIR HFA,Upper respiratory tract infection,9
ADVAIR HFA,Infusion site pain,9
ADVAIR HFA,Seasonal allergy,8
ADVAIR HFA,Diarrhoea,8
ADVAIR HFA,Swelling,8
ADVAIR HFA,Gait disturbance,8
ADVAIR HFA,Condition aggravated,8
ADVAIR HFA,Rhinorrhoea,8
ADVAIR HFA,Infection,8
ADVAIR HFA,Anaphylactic reaction,7
ADVAIR HFA,Incorrect dose administered,7
ADVAIR HFA,Vomiting,7
ADVAIR HFA,Respiratory disorder,7
ADVAIR HFA,Bronchitis,7
ADVAIR HFA,Kidney infection,7
ADVAIR HFA,Gastroenteritis viral,7
ADVAIR HFA,Dysphonia,7
ADVAIR HFA,Nasal congestion,7
ADVATE,Haemorrhage,5
ADVATE,Haemarthrosis,4
ADVATE,Joint swelling,4
ADVATE,Arthralgia,4
ADVATE,Haematuria,4
ADVATE,Arthropathy,3
ADVATE,Fall,3
ADVATE,Joint injury,3
ADVATE,Generalised tonic-clonic seizure,3
ADVATE,Urine albumin/creatinine ratio increased,2
ADVATE,Haemophilic arthropathy,2
ADVATE,Mobility decreased,2
ADVATE,Soft tissue mass,2
ADVATE,Haemorrhage intracranial,2
ADVATE,Muscle haemorrhage,2
ADVATE,Limb injury,2
ADVATE,Head injury,2
ADVATE,Inflammation,2
ADVATE,Contusion,2
ADVATE,Pain,2
ADVATE,Renal cyst ruptured,2
ADVATE,Abdominal pain,2
ADVATE,Ligament rupture,1
ADVATE,Benign prostatic hyperplasia,1
ADVATE,Condition aggravated,1
ADVATE,Gingival bleeding,1
ADVATE,Asthenia,1
ADVATE,Loss of consciousness,1
ADVATE,Pallor,1
ADVATE,Vessel puncture site induration,1
ADVATE,Internal haemorrhage,1
ADVATE,Product impurity,1
ADVATE,Osteoarthritis,1
ADVATE,Henoch-Schonlein purpura,1
ADVATE,Humerus fracture,1
ADVATE,Suicide attempt,1
ADVATE,Major depression,1
ADVATE,Suicidal ideation,1
ADVATE,Strabismus,1
ADVATE,Wrist fracture,1
ADVATE,Poor venous access,1
ADVATE,COVID-19,1
ADVATE,Gait disturbance,1
ADVATE,Pain in extremity,1
ADVATE,Extra dose administered,1
ADVATE,Pyrexia,1
ADVATE,Swelling face,1
ADVATE,Skin laceration,1
ADVATE,Synovitis,1
ADVATE,Injury,1
ADVIL,COVID-19,14
ADVIL,Arthralgia,14
ADVIL,Pain,13
ADVIL,Vomiting,13
ADVIL,Headache,11
ADVIL,Fatigue,10
ADVIL,Inappropriate schedule of product administration,8
ADVIL,Hypertension,8
ADVIL,Nausea,8
ADVIL,Off label use,8
ADVIL,Product use issue,8
ADVIL,Fall,7
ADVIL,Sinusitis,7
ADVIL,Drug ineffective,7
ADVIL,Intentional product misuse,7
ADVIL,Chills,6
ADVIL,Product dose omission issue,6
ADVIL,Anxiety,6
ADVIL,Weight increased,6
ADVIL,Asthma,6
ADVIL,Abdominal pain,6
ADVIL,Back pain,5
ADVIL,Dyspnoea,5
ADVIL,Cough,5
ADVIL,Urinary tract infection,5
ADVIL,Weight decreased,5
ADVIL,Diarrhoea,5
ADVIL,Chest pain,5
ADVIL,Oedema peripheral,5
ADVIL,Prerenal failure,5
ADVIL,Dizziness,5
ADVIL,Asthenia,4
ADVIL,Bronchitis,4
ADVIL,Peripheral swelling,4
ADVIL,Pneumonia,4
ADVIL,Pruritus,4
ADVIL,Kidney infection,4
ADVIL,Cataract,4
ADVIL,Upper respiratory tract infection,4
ADVIL,Pain in extremity,4
ADVIL,Feeling abnormal,4
ADVIL,Wrong technique in product usage process,4
ADVIL,Anaemia,4
ADVIL,Insomnia,4
ADVIL,Disease recurrence,4
ADVIL,Decreased appetite,3
ADVIL,Illness,3
ADVIL,Rhinorrhoea,3
ADVIL,Pelvic fracture,3
ADVIL,Infusion related reaction,3
ALBUTEROL,Dyspnoea,72
ALBUTEROL,Fatigue,69
ALBUTEROL,Nausea,62
ALBUTEROL,Pneumonia,61
ALBUTEROL,Diarrhoea,58
ALBUTEROL,Headache,55
ALBUTEROL,Vomiting,53
ALBUTEROL,COVID-19,53
ALBUTEROL,Pain,52
ALBUTEROL,Product dose omission issue,51
ALBUTEROL,Dizziness,50
ALBUTEROL,Off label use,49
ALBUTEROL,Malaise,47
ALBUTEROL,Cough,35
ALBUTEROL,Pyrexia,34
ALBUTEROL,Urinary tract infection,34
ALBUTEROL,Gait disturbance,31
ALBUTEROL,Death,31
ALBUTEROL,Constipation,31
ALBUTEROL,Asthenia,29
ALBUTEROL,Sinusitis,28
ALBUTEROL,Depression,27
ALBUTEROL,Anaemia,26
ALBUTEROL,Chills,25
ALBUTEROL,Anxiety,25
ALBUTEROL,Rash,25
ALBUTEROL,Blood pressure increased,24
ALBUTEROL,Weight decreased,24
ALBUTEROL,Condition aggravated,24
ALBUTEROL,Asthma,23
ALBUTEROL,Abdominal pain,23
ALBUTEROL,Product use in unapproved indication,23
ALBUTEROL,Arthralgia,23
ALBUTEROL,Pruritus,23
ALBUTEROL,Bronchitis,22
ALBUTEROL,Migraine,22
ALBUTEROL,Productive cough,21
ALBUTEROL,Pain in extremity,21
ALBUTEROL,Inappropriate schedule of product administration,21
ALBUTEROL,Decreased appetite,21
ALBUTEROL,Emotional distress,21
ALBUTEROL,Sepsis,20
ALBUTEROL,Illness,20
ALBUTEROL,Peripheral swelling,19
ALBUTEROL,Back pain,19
ALBUTEROL,Nasopharyngitis,18
ALBUTEROL,Wheezing,18
ALBUTEROL,Fall,18
ALBUTEROL,Joint swelling,18
ALBUTEROL,Blood creatinine increased,18
ALBUTEROL SULFATE,COVID-19,84
ALBUTEROL SULFATE,Product dose omission issue,78
ALBUTEROL SULFATE,Sinusitis,66
ALBUTEROL SULFATE,Fatigue,65
ALBUTEROL SULFATE,Pneumonia,63
ALBUTEROL SULFATE,Dyspnoea,60
ALBUTEROL SULFATE,Pain,58
ALBUTEROL SULFATE,Headache,57
ALBUTEROL SULFATE,Anxiety,44
ALBUTEROL SULFATE,Nausea,43
ALBUTEROL SULFATE,Nasopharyngitis,41
ALBUTEROL SULFATE,Inappropriate schedule of product administration,38
ALBUTEROL SULFATE,Asthma,37
ALBUTEROL SULFATE,Diarrhoea,35
ALBUTEROL SULFATE,Malaise,35
ALBUTEROL SULFATE,Fall,34
ALBUTEROL SULFATE,Arthralgia,34
ALBUTEROL SULFATE,Urinary tract infection,33
ALBUTEROL SULFATE,Illness,33
ALBUTEROL SULFATE,Bronchitis,32
ALBUTEROL SULFATE,Vomiting,30
ALBUTEROL SULFATE,Weight decreased,30
ALBUTEROL SULFATE,Off label use,30
ALBUTEROL SULFATE,Cough,30
ALBUTEROL SULFATE,Condition aggravated,29
ALBUTEROL SULFATE,Asthenia,29
ALBUTEROL SULFATE,Influenza,28
ALBUTEROL SULFATE,Upper respiratory tract infection,27
ALBUTEROL SULFATE,Pyrexia,26
ALBUTEROL SULFATE,Emotional distress,26
ALBUTEROL SULFATE,Pruritus,25
ALBUTEROL SULFATE,Anhedonia,25
ALBUTEROL SULFATE,Respiratory tract infection,24
ALBUTEROL SULFATE,Infusion related reaction,23
ALBUTEROL SULFATE,Sepsis,22
ALBUTEROL SULFATE,Product use in unapproved indication,22
ALBUTEROL SULFATE,Drug ineffective,21
ALBUTEROL SULFATE,Weight increased,21
ALBUTEROL SULFATE,Constipation,21
ALBUTEROL SULFATE,Depression,20
ALBUTEROL SULFATE,Back pain,20
ALBUTEROL SULFATE,Seasonal allergy,20
ALBUTEROL SULFATE,Infection,20
ALBUTEROL SULFATE,Contusion,20
ALBUTEROL SULFATE,Feeling abnormal,20
ALBUTEROL SULFATE,Injection site pain,20
ALBUTEROL SULFATE,Ear infection,19
ALBUTEROL SULFATE,Insurance issue,19
ALBUTEROL SULFATE,Stress,18
ALBUTEROL SULFATE,Chills,18
ALBUTEROL\IPRATROPIUM,COVID-19,14
ALBUTEROL\IPRATROPIUM,Fall,10
ALBUTEROL\IPRATROPIUM,Pneumonia,10
ALBUTEROL\IPRATROPIUM,Product dose omission issue,9
ALBUTEROL\IPRATROPIUM,Headache,9
ALBUTEROL\IPRATROPIUM,Respiratory tract infection,8
ALBUTEROL\IPRATROPIUM,Dyspnoea,7
ALBUTEROL\IPRATROPIUM,Pyrexia,7
ALBUTEROL\IPRATROPIUM,Infection,6
ALBUTEROL\IPRATROPIUM,Nasopharyngitis,6
ALBUTEROL\IPRATROPIUM,Sinusitis,6
ALBUTEROL\IPRATROPIUM,Nausea,6
ALBUTEROL\IPRATROPIUM,Insurance issue,6
ALBUTEROL\IPRATROPIUM,Pain,5
ALBUTEROL\IPRATROPIUM,Inappropriate schedule of product administration,5
ALBUTEROL\IPRATROPIUM,Upper respiratory tract infection,5
ALBUTEROL\IPRATROPIUM,Productive cough,5
ALBUTEROL\IPRATROPIUM,Arthralgia,5
ALBUTEROL\IPRATROPIUM,Blood pressure increased,5
ALBUTEROL\IPRATROPIUM,Feeling abnormal,5
ALBUTEROL\IPRATROPIUM,Influenza,5
ALBUTEROL\IPRATROPIUM,Fatigue,5
ALBUTEROL\IPRATROPIUM,Limb injury,5
ALBUTEROL\IPRATROPIUM,Gastroenteritis viral,5
ALBUTEROL\IPRATROPIUM,Asthma,5
ALBUTEROL\IPRATROPIUM,Respiratory distress,4
ALBUTEROL\IPRATROPIUM,Urinary tract infection,4
ALBUTEROL\IPRATROPIUM,Weight decreased,4
ALBUTEROL\IPRATROPIUM,Cough,4
ALBUTEROL\IPRATROPIUM,Urticaria,4
ALBUTEROL\IPRATROPIUM,Illness,4
ALBUTEROL\IPRATROPIUM,Infusion site erythema,4
ALBUTEROL\IPRATROPIUM,Injection site pain,4
ALBUTEROL\IPRATROPIUM,Malaise,4
ALBUTEROL\IPRATROPIUM,Cardiac disorder,4
ALBUTEROL\IPRATROPIUM,Rash,4
ALBUTEROL\IPRATROPIUM,Sepsis,4
ALBUTEROL\IPRATROPIUM,Chronic obstructive pulmonary disease,4
ALBUTEROL\IPRATROPIUM,Nasal congestion,4
ALBUTEROL\IPRATROPIUM,Anxiety,3
ALBUTEROL\IPRATROPIUM,Death,3
ALBUTEROL\IPRATROPIUM,Cellulitis,3
ALBUTEROL\IPRATROPIUM,Dehydration,3
ALBUTEROL\IPRATROPIUM,Product use issue,3
ALBUTEROL\IPRATROPIUM,Drug hypersensitivity,3
ALBUTEROL\IPRATROPIUM,Renal disorder,3
ALBUTEROL\IPRATROPIUM,Pruritus,3
ALBUTEROL\IPRATROPIUM,Joint injury,3
ALBUTEROL\IPRATROPIUM,Oral candidiasis,3
ALBUTEROL\IPRATROPIUM,Device infusion issue,3
ALDACTONE,Acute kidney injury,10
ALDACTONE,Off label use,8
ALDACTONE,Infusion related reaction,7
ALDACTONE,Hypokalaemia,6
ALDACTONE,Anuria,5
ALDACTONE,Pain,5
ALDACTONE,Diarrhoea,5
ALDACTONE,Oedema peripheral,5
ALDACTONE,Hypophosphataemia,5
ALDACTONE,Hypomagnesaemia,5
ALDACTONE,Hypocalcaemia,5
ALDACTONE,Fall,4
ALDACTONE,Dyspnoea,4
ALDACTONE,Asthenia,4
ALDACTONE,Fatigue,4
ALDACTONE,Cardiac pacemaker evaluation,4
ALDACTONE,Coronary artery occlusion,3
ALDACTONE,Dehydration,3
ALDACTONE,Head injury,3
ALDACTONE,Anxiety,3
ALDACTONE,Pulmonary oedema,3
ALDACTONE,Syncope,3
ALDACTONE,Product dose omission issue,3
ALDACTONE,Treatment noncompliance,3
ALDACTONE,Pneumonia,3
ALDACTONE,Hyperkalaemia,3
ALDACTONE,Shock haemorrhagic,3
ALDACTONE,Gastrointestinal haemorrhage,3
ALDACTONE,Hepatic encephalopathy,3
ALDACTONE,Foot fracture,2
ALDACTONE,Malaise,2
ALDACTONE,Anhedonia,2
ALDACTONE,Emotional distress,2
ALDACTONE,Condition aggravated,2
ALDACTONE,Back pain,2
ALDACTONE,Gait disturbance,2
ALDACTONE,Nausea,2
ALDACTONE,Vomiting,2
ALDACTONE,Epistaxis,2
ALDACTONE,Respiratory tract infection,2
ALDACTONE,Urinary tract infection,2
ALDACTONE,Constipation,2
ALDACTONE,Sleep disorder,2
ALDACTONE,Ascites,2
ALDACTONE,Anaemia,2
ALDACTONE,Drug abuse,2
ALDACTONE,Left ventricular hypertrophy,2
ALDACTONE,Headache,2
ALDACTONE,Hepatic lesion,2
ALDACTONE,Confusional state,2
ALENDRONATE,Off label use,18
ALENDRONATE,Pain,15
ALENDRONATE,Fatigue,12
ALENDRONATE,Headache,11
ALENDRONATE,Anxiety,11
ALENDRONATE,Dyspnoea,10
ALENDRONATE,Dizziness,10
ALENDRONATE,Fall,10
ALENDRONATE,Anhedonia,10
ALENDRONATE,Osteoporosis,10
ALENDRONATE,Emotional distress,10
ALENDRONATE,Bone density decreased,8
ALENDRONATE,COVID-19,7
ALENDRONATE,Condition aggravated,7
ALENDRONATE,Arthralgia,7
ALENDRONATE,Pneumonia,7
ALENDRONATE,Haemoglobin decreased,6
ALENDRONATE,Diarrhoea,6
ALENDRONATE,Intentional product use issue,6
ALENDRONATE,Nausea,5
ALENDRONATE,Product dose omission issue,5
ALENDRONATE,Gait disturbance,5
ALENDRONATE,Osteopenia,5
ALENDRONATE,Influenza,5
ALENDRONATE,Drug ineffective,5
ALENDRONATE,Erythema,5
ALENDRONATE,Pyrexia,5
ALENDRONATE,Back pain,5
ALENDRONATE,Illness,5
ALENDRONATE,Nasopharyngitis,4
ALENDRONATE,Insomnia,4
ALENDRONATE,Malaise,4
ALENDRONATE,Pain in extremity,4
ALENDRONATE,Blood pressure decreased,4
ALENDRONATE,Cough,4
ALENDRONATE,Myalgia,4
ALENDRONATE,Renal impairment,4
ALENDRONATE,Neck pain,4
ALENDRONATE,Contusion,4
ALENDRONATE,Blood creatinine increased,4
ALENDRONATE,Drug hypersensitivity,4
ALENDRONATE,Weight increased,4
ALENDRONATE,Hypotension,4
ALENDRONATE,Wrist fracture,4
ALENDRONATE,Pruritus,4
ALENDRONATE,Infection,4
ALENDRONATE,Rheumatoid arthritis,4
ALENDRONATE,Blood pressure increased,3
ALENDRONATE,Peripheral swelling,3
ALENDRONATE,Weight decreased,3
ALENDRONATE SODIUM,Pain,18
ALENDRONATE SODIUM,Arthralgia,18
ALENDRONATE SODIUM,Diarrhoea,17
ALENDRONATE SODIUM,Rash,15
ALENDRONATE SODIUM,Fatigue,15
ALENDRONATE SODIUM,Dizziness,13
ALENDRONATE SODIUM,Pneumonia,12
ALENDRONATE SODIUM,Dyspnoea,12
ALENDRONATE SODIUM,Headache,12
ALENDRONATE SODIUM,Malaise,12
ALENDRONATE SODIUM,Pain in extremity,12
ALENDRONATE SODIUM,Condition aggravated,11
ALENDRONATE SODIUM,Off label use,11
ALENDRONATE SODIUM,Drug ineffective,11
ALENDRONATE SODIUM,Hypertension,10
ALENDRONATE SODIUM,Therapeutic product effect decreased,10
ALENDRONATE SODIUM,Drug intolerance,10
ALENDRONATE SODIUM,Pruritus,10
ALENDRONATE SODIUM,Nausea,10
ALENDRONATE SODIUM,Abdominal discomfort,10
ALENDRONATE SODIUM,Musculoskeletal stiffness,9
ALENDRONATE SODIUM,Weight decreased,9
ALENDRONATE SODIUM,Muscle spasms,9
ALENDRONATE SODIUM,Rheumatoid arthritis,9
ALENDRONATE SODIUM,Hypersensitivity,9
ALENDRONATE SODIUM,Vomiting,8
ALENDRONATE SODIUM,Hepatic enzyme increased,8
ALENDRONATE SODIUM,Alopecia,8
ALENDRONATE SODIUM,Contraindicated product administered,8
ALENDRONATE SODIUM,Joint swelling,8
ALENDRONATE SODIUM,Insomnia,8
ALENDRONATE SODIUM,Abdominal pain upper,8
ALENDRONATE SODIUM,Drug hypersensitivity,8
ALENDRONATE SODIUM,Anxiety,8
ALENDRONATE SODIUM,Arthropathy,7
ALENDRONATE SODIUM,Blood cholesterol increased,7
ALENDRONATE SODIUM,Nasopharyngitis,7
ALENDRONATE SODIUM,Decreased appetite,7
ALENDRONATE SODIUM,Fibromyalgia,7
ALENDRONATE SODIUM,Gait disturbance,6
ALENDRONATE SODIUM,Fall,6
ALENDRONATE SODIUM,Hand deformity,6
ALENDRONATE SODIUM,Weight increased,6
ALENDRONATE SODIUM,Wheezing,6
ALENDRONATE SODIUM,Anti-cyclic citrullinated peptide antibody positive,6
ALENDRONATE SODIUM,Maternal exposure during pregnancy,6
ALENDRONATE SODIUM,Glossodynia,6
ALENDRONATE SODIUM,Synovitis,6
ALENDRONATE SODIUM,Inflammation,6
ALENDRONATE SODIUM,Intentional product use issue,6
ALEVE,Fatigue,14
ALEVE,Product dose omission issue,13
ALEVE,Nausea,10
ALEVE,Inappropriate schedule of product administration,10
ALEVE,Anxiety,9
ALEVE,COVID-19,9
ALEVE,Fall,8
ALEVE,Diarrhoea,8
ALEVE,Pain,8
ALEVE,Rash,8
ALEVE,Dizziness,7
ALEVE,Malaise,7
ALEVE,Pneumonia,7
ALEVE,Pruritus,7
ALEVE,Vomiting,6
ALEVE,Weight decreased,6
ALEVE,Feeling abnormal,6
ALEVE,Urinary tract infection,6
ALEVE,Sinusitis,6
ALEVE,Pain in extremity,6
ALEVE,Headache,6
ALEVE,Bronchitis,5
ALEVE,Off label use,5
ALEVE,Migraine,5
ALEVE,Drug ineffective,5
ALEVE,Abdominal pain upper,5
ALEVE,Gait disturbance,5
ALEVE,Insurance issue,5
ALEVE,Asthenia,5
ALEVE,Urticaria,5
ALEVE,Condition aggravated,4
ALEVE,Illness,4
ALEVE,Infection,4
ALEVE,Nasopharyngitis,4
ALEVE,Rhinorrhoea,4
ALEVE,Hallucination,4
ALEVE,Seizure,3
ALEVE,Postural orthostatic tachycardia syndrome,3
ALEVE,Hypertension,3
ALEVE,Ligament rupture,3
ALEVE,Neck pain,3
ALEVE,Dyspnoea,3
ALEVE,Emotional distress,3
ALEVE,Upper respiratory tract infection,3
ALEVE,Skin infection,3
ALEVE,Needle issue,3
ALEVE,Constipation,3
ALEVE,Somnolence,3
ALEVE,Product use in unapproved indication,3
ALEVE,Dry skin,3
ALFACALCIDOL,Cerebrovascular accident,8
ALFACALCIDOL,Off label use,7
ALFACALCIDOL,Platelet count decreased,6
ALFACALCIDOL,Pyrexia,5
ALFACALCIDOL,Diarrhoea,4
ALFACALCIDOL,White blood cell count decreased,4
ALFACALCIDOL,Death,4
ALFACALCIDOL,Pneumonia,4
ALFACALCIDOL,Dyspnoea,3
ALFACALCIDOL,Muscle spasms,3
ALFACALCIDOL,Myocarditis,3
ALFACALCIDOL,Spinal compression fracture,3
ALFACALCIDOL,Fall,3
ALFACALCIDOL,Interstitial lung disease,3
ALFACALCIDOL,Tachycardia,3
ALFACALCIDOL,Drug eruption,3
ALFACALCIDOL,Decreased appetite,3
ALFACALCIDOL,Abdominal pain,3
ALFACALCIDOL,Vomiting,3
ALFACALCIDOL,Hepatic enzyme increased,2
ALFACALCIDOL,Body temperature increased,2
ALFACALCIDOL,Maternal exposure during pregnancy,2
ALFACALCIDOL,Discomfort,2
ALFACALCIDOL,Fatigue,2
ALFACALCIDOL,Inflammation,2
ALFACALCIDOL,Headache,2
ALFACALCIDOL,Nasopharyngitis,2
ALFACALCIDOL,Insomnia,2
ALFACALCIDOL,Atrioventricular block complete,2
ALFACALCIDOL,Malignant neoplasm progression,2
ALFACALCIDOL,Immune-mediated dermatitis,2
ALFACALCIDOL,Drug-induced liver injury,2
ALFACALCIDOL,Constipation,2
ALFACALCIDOL,Hyperglycaemia,2
ALFACALCIDOL,Haemophagocytic lymphohistiocytosis,2
ALFACALCIDOL,Lymphadenopathy,2
ALFACALCIDOL,COVID-19,2
ALFACALCIDOL,Hepatic function abnormal,2
ALFACALCIDOL,Multiple sclerosis,2
ALFACALCIDOL,Lymphocyte count decreased,2
ALFACALCIDOL,Liver disorder,2
ALFACALCIDOL,Nausea,2
ALFACALCIDOL,Inappropriate schedule of product administration,2
ALFACALCIDOL,Muscular weakness,2
ALFACALCIDOL,Depression,2
ALFACALCIDOL,Gait inability,2
ALFACALCIDOL,Chest pain,2
ALFACALCIDOL,Muscle atrophy,2
ALFACALCIDOL,Ehlers-Danlos syndrome,2
ALFACALCIDOL,Paralysis,2
ALIMTA,Tubulointerstitial nephritis,11
ALIMTA,Acute generalised exanthematous pustulosis,7
ALIMTA,Thrombocytopenia,5
ALIMTA,Interstitial lung disease,4
ALIMTA,Hepatic cytolysis,4
ALIMTA,Anaemia,3
ALIMTA,Myelosuppression,3
ALIMTA,Pyrexia,3
ALIMTA,Haemophagocytic lymphohistiocytosis,3
ALIMTA,Amylase increased,2
ALIMTA,Encephalitis,2
ALIMTA,Blood creatine phosphokinase increased,2
ALIMTA,Rash macular,2
ALIMTA,Subacute cutaneous lupus erythematosus,2
ALIMTA,Leukopenia,2
ALIMTA,Shock,2
ALIMTA,Cytokine release syndrome,2
ALIMTA,Neutropenia,2
ALIMTA,Hyperhidrosis,2
ALIMTA,White blood cell count decreased,2
ALIMTA,Mixed liver injury,2
ALIMTA,Nausea,2
ALIMTA,Death,1
ALIMTA,Constipation,1
ALIMTA,Fulminant type 1 diabetes mellitus,1
ALIMTA,Pancytopenia,1
ALIMTA,Lichenoid keratosis,1
ALIMTA,Hypoglycaemia,1
ALIMTA,Cardiac hypertrophy,1
ALIMTA,Pleural effusion,1
ALIMTA,Pneumonia,1
ALIMTA,Pulmonary embolism,1
ALIMTA,Acute kidney injury,1
ALIMTA,Rash,1
ALIMTA,Hypopituitarism,1
ALIMTA,Metastases to pleura,1
ALIMTA,Adrenal insufficiency,1
ALIMTA,Pleurisy,1
ALIMTA,Toxic epidermal necrolysis,1
ALIMTA,General physical health deterioration,1
ALIMTA,Bone marrow failure,1
ALIMTA,Erythema,1
ALIMTA,Peripheral sensory neuropathy,1
ALIMTA,Rash erythematous,1
ALIMTA,Rash pruritic,1
ALIMTA,Immune-mediated hepatic disorder,1
ALIMTA,Autoimmune hepatitis,1
ALIMTA,Irritability,1
ALIMTA,Sinus tachycardia,1
ALIMTA,Blood pressure fluctuation,1
ALLEGRA,Pain,9
ALLEGRA,Fatigue,8
ALLEGRA,Fall,8
ALLEGRA,Headache,8
ALLEGRA,Arthralgia,8
ALLEGRA,Asthenia,7
ALLEGRA,Back pain,7
ALLEGRA,Diarrhoea,7
ALLEGRA,Myalgia,7
ALLEGRA,Urticaria,7
ALLEGRA,Malaise,6
ALLEGRA,COVID-19,6
ALLEGRA,Product dose omission issue,5
ALLEGRA,Bronchitis,5
ALLEGRA,Urinary tract infection,5
ALLEGRA,Weight decreased,5
ALLEGRA,Pain in extremity,5
ALLEGRA,Nausea,5
ALLEGRA,Inappropriate schedule of product administration,4
ALLEGRA,Insurance issue,4
ALLEGRA,Product use issue,4
ALLEGRA,Erythema,4
ALLEGRA,Illness,4
ALLEGRA,Pruritus,4
ALLEGRA,Sinusitis,4
ALLEGRA,Rash,4
ALLEGRA,Off label use,4
ALLEGRA,Herpes zoster,4
ALLEGRA,Pneumonia,4
ALLEGRA,Product availability issue,4
ALLEGRA,Swelling,4
ALLEGRA,Condition aggravated,3
ALLEGRA,COVID-19 pneumonia,3
ALLEGRA,Intervertebral disc protrusion,3
ALLEGRA,Road traffic accident,3
ALLEGRA,Neck pain,3
ALLEGRA,Asthma,3
ALLEGRA,Eating disorder,3
ALLEGRA,Non-Hodgkin's lymphoma,3
ALLEGRA,Drug ineffective,3
ALLEGRA,Emotional distress,3
ALLEGRA,Chronic kidney disease,3
ALLEGRA,Anhedonia,3
ALLEGRA,Depression,3
ALLEGRA,Anxiety,3
ALLEGRA,Seasonal allergy,3
ALLEGRA,Vomiting,3
ALLEGRA,Pyrexia,3
ALLEGRA,Blood creatinine increased,3
ALLEGRA,Arthritis,3
ALLEGRA ALLERGY,Product dose omission issue,11
ALLEGRA ALLERGY,COVID-19,11
ALLEGRA ALLERGY,Sinusitis,11
ALLEGRA ALLERGY,Headache,8
ALLEGRA ALLERGY,Pruritus,8
ALLEGRA ALLERGY,Fatigue,8
ALLEGRA ALLERGY,Influenza,7
ALLEGRA ALLERGY,Rash,7
ALLEGRA ALLERGY,Inappropriate schedule of product administration,7
ALLEGRA ALLERGY,Pneumonia,6
ALLEGRA ALLERGY,Fall,6
ALLEGRA ALLERGY,Bronchitis,6
ALLEGRA ALLERGY,Urinary tract infection,6
ALLEGRA ALLERGY,Pain,6
ALLEGRA ALLERGY,Back pain,5
ALLEGRA ALLERGY,Needle issue,5
ALLEGRA ALLERGY,Nasopharyngitis,5
ALLEGRA ALLERGY,Gastroenteritis viral,4
ALLEGRA ALLERGY,COVID-19 pneumonia,4
ALLEGRA ALLERGY,Insurance issue,4
ALLEGRA ALLERGY,Erythema,4
ALLEGRA ALLERGY,Illness,4
ALLEGRA ALLERGY,Asthma,4
ALLEGRA ALLERGY,Migraine,4
ALLEGRA ALLERGY,Infusion related reaction,4
ALLEGRA ALLERGY,Seasonal allergy,4
ALLEGRA ALLERGY,Infection,4
ALLEGRA ALLERGY,Influenza like illness,4
ALLEGRA ALLERGY,Cough,4
ALLEGRA ALLERGY,Nausea,4
ALLEGRA ALLERGY,Diarrhoea,4
ALLEGRA ALLERGY,Diverticulitis,3
ALLEGRA ALLERGY,Product use issue,3
ALLEGRA ALLERGY,Infusion site erythema,3
ALLEGRA ALLERGY,Pyrexia,3
ALLEGRA ALLERGY,Arthralgia,3
ALLEGRA ALLERGY,Hypersensitivity,3
ALLEGRA ALLERGY,Condition aggravated,3
ALLEGRA ALLERGY,Infusion site pain,3
ALLEGRA ALLERGY,Nasal congestion,3
ALLEGRA ALLERGY,Asthenia,3
ALLEGRA ALLERGY,Paraesthesia,3
ALLEGRA ALLERGY,Dizziness,3
ALLEGRA ALLERGY,Dry skin,3
ALLEGRA ALLERGY,Dyspnoea,3
ALLEGRA ALLERGY,Pain in extremity,3
ALLEGRA ALLERGY,Contusion,3
ALLEGRA ALLERGY,Swelling,2
ALLEGRA ALLERGY,Injection site pruritus,2
ALLEGRA ALLERGY,Palpitations,2
ALLOPURINOL,Off label use,61
ALLOPURINOL,Neutropenia,51
ALLOPURINOL,Diarrhoea,43
ALLOPURINOL,Thrombocytopenia,42
ALLOPURINOL,Fatigue,39
ALLOPURINOL,COVID-19,39
ALLOPURINOL,Pyrexia,38
ALLOPURINOL,Anaemia,37
ALLOPURINOL,Nausea,37
ALLOPURINOL,Pain,35
ALLOPURINOL,Dyspnoea,33
ALLOPURINOL,Pneumonia,31
ALLOPURINOL,Vomiting,31
ALLOPURINOL,Acute kidney injury,30
ALLOPURINOL,Asthenia,28
ALLOPURINOL,Death,28
ALLOPURINOL,Rash,25
ALLOPURINOL,Blood creatinine increased,24
ALLOPURINOL,Febrile neutropenia,24
ALLOPURINOL,Constipation,24
ALLOPURINOL,Malaise,23
ALLOPURINOL,Emotional distress,22
ALLOPURINOL,Arthralgia,22
ALLOPURINOL,Cytokine release syndrome,22
ALLOPURINOL,General physical health deterioration,22
ALLOPURINOL,Sepsis,21
ALLOPURINOL,Dizziness,21
ALLOPURINOL,Anxiety,20
ALLOPURINOL,Fall,19
ALLOPURINOL,Product dose omission issue,18
ALLOPURINOL,Hypocalcaemia,18
ALLOPURINOL,Headache,18
ALLOPURINOL,Pruritus,18
ALLOPURINOL,Disease progression,18
ALLOPURINOL,Weight decreased,17
ALLOPURINOL,Condition aggravated,17
ALLOPURINOL,Infection,16
ALLOPURINOL,Atrial fibrillation,16
ALLOPURINOL,Abdominal pain,16
ALLOPURINOL,Hypotension,16
ALLOPURINOL,Anhedonia,15
ALLOPURINOL,Oedema peripheral,15
ALLOPURINOL,Hypertension,15
ALLOPURINOL,Chronic kidney disease,14
ALLOPURINOL,Dehydration,14
ALLOPURINOL,Decreased appetite,14
ALLOPURINOL,Intentional product misuse,14
ALLOPURINOL,Somnolence,14
ALLOPURINOL,Muscle spasms,13
ALLOPURINOL,Hyperkalaemia,13
ALPRAZOLAM,Anxiety,22
ALPRAZOLAM,Diarrhoea,22
ALPRAZOLAM,Nausea,21
ALPRAZOLAM,Pain,21
ALPRAZOLAM,Fatigue,21
ALPRAZOLAM,Off label use,20
ALPRAZOLAM,COVID-19,20
ALPRAZOLAM,Asthenia,20
ALPRAZOLAM,Product dose omission issue,18
ALPRAZOLAM,Headache,18
ALPRAZOLAM,Fall,17
ALPRAZOLAM,Drug ineffective,15
ALPRAZOLAM,Confusional state,15
ALPRAZOLAM,Product use in unapproved indication,14
ALPRAZOLAM,Dizziness,14
ALPRAZOLAM,Urinary tract infection,13
ALPRAZOLAM,Acute kidney injury,13
ALPRAZOLAM,Inappropriate schedule of product administration,13
ALPRAZOLAM,Malaise,13
ALPRAZOLAM,Pneumonia,13
ALPRAZOLAM,Pruritus,13
ALPRAZOLAM,Emotional distress,12
ALPRAZOLAM,Sinusitis,12
ALPRAZOLAM,Constipation,12
ALPRAZOLAM,Abdominal pain,12
ALPRAZOLAM,Weight decreased,11
ALPRAZOLAM,Back pain,11
ALPRAZOLAM,Condition aggravated,10
ALPRAZOLAM,Weight increased,10
ALPRAZOLAM,Vomiting,10
ALPRAZOLAM,Cough,10
ALPRAZOLAM,Illness,10
ALPRAZOLAM,Insomnia,10
ALPRAZOLAM,Arthralgia,10
ALPRAZOLAM,Hallucination,9
ALPRAZOLAM,Chronic kidney disease,9
ALPRAZOLAM,Anhedonia,9
ALPRAZOLAM,Depression,9
ALPRAZOLAM,Renal failure,9
ALPRAZOLAM,Anaemia,9
ALPRAZOLAM,Pyrexia,9
ALPRAZOLAM,Hepatic cytolysis,9
ALPRAZOLAM,Dyspnoea,9
ALPRAZOLAM,Bronchitis,8
ALPRAZOLAM,Somnolence,8
ALPRAZOLAM,Hyperkalaemia,8
ALPRAZOLAM,Neutropenia,8
ALPRAZOLAM,Intentional product misuse,8
ALPRAZOLAM,Eosinophilia,8
ALPRAZOLAM,Rash,7
ALTEPLASE,Cerebral haemorrhage,11
ALTEPLASE,Drug interaction,9
ALTEPLASE,Off label use,7
ALTEPLASE,Angioedema,7
ALTEPLASE,Vomiting,7
ALTEPLASE,Gingival bleeding,7
ALTEPLASE,Haemorrhagic transformation stroke,6
ALTEPLASE,Headache,6
ALTEPLASE,Nausea,4
ALTEPLASE,Upper gastrointestinal haemorrhage,3
ALTEPLASE,Hyperhidrosis,3
ALTEPLASE,Brain herniation,3
ALTEPLASE,Hypokalaemia,2
ALTEPLASE,Enterocutaneous fistula,2
ALTEPLASE,Coma,2
ALTEPLASE,Hypotension,2
ALTEPLASE,Haemorrhage intracranial,2
ALTEPLASE,Coagulopathy,2
ALTEPLASE,Tongue haemorrhage,2
ALTEPLASE,Chest discomfort,2
ALTEPLASE,Dyspnoea,2
ALTEPLASE,Altered state of consciousness,2
ALTEPLASE,Muscular weakness,2
ALTEPLASE,Subarachnoid haemorrhage,2
ALTEPLASE,Cytokine release syndrome,2
ALTEPLASE,Pyrexia,2
ALTEPLASE,Diarrhoea,2
ALTEPLASE,Oxygen saturation decreased,2
ALTEPLASE,Hypernatraemia,2
ALTEPLASE,Osteopenia,1
ALTEPLASE,Anhedonia,1
ALTEPLASE,Chronic kidney disease,1
ALTEPLASE,Pain,1
ALTEPLASE,Anxiety,1
ALTEPLASE,Mobility decreased,1
ALTEPLASE,Emotional distress,1
ALTEPLASE,Depression,1
ALTEPLASE,Bacteraemia,1
ALTEPLASE,Cardiac arrest,1
ALTEPLASE,Ovarian cyst,1
ALTEPLASE,Hyperpyrexia,1
ALTEPLASE,Basal ganglia haemorrhage,1
ALTEPLASE,Ischaemia,1
ALTEPLASE,Arteriosclerosis,1
ALTEPLASE,Thrombosis,1
ALTEPLASE,Aortic valve stenosis,1
ALTEPLASE,Cytotoxic oedema,1
ALTEPLASE,Cerebrovascular accident,1
ALTEPLASE,Hemianopia,1
ALTEPLASE,Bradycardia,1
AMBIEN,Fatigue,24
AMBIEN,Pain,20
AMBIEN,Sinusitis,17
AMBIEN,Nausea,14
AMBIEN,Headache,14
AMBIEN,COVID-19,14
AMBIEN,Illness,12
AMBIEN,Urinary tract infection,12
AMBIEN,Inappropriate schedule of product administration,11
AMBIEN,Product dose omission issue,11
AMBIEN,Anxiety,11
AMBIEN,Malaise,10
AMBIEN,Vomiting,10
AMBIEN,Emotional distress,10
AMBIEN,Infection,9
AMBIEN,Anhedonia,9
AMBIEN,Back pain,8
AMBIEN,Infusion site pain,8
AMBIEN,Depression,7
AMBIEN,Nasopharyngitis,7
AMBIEN,Infusion site extravasation,6
AMBIEN,Drug hypersensitivity,6
AMBIEN,Chronic kidney disease,6
AMBIEN,Rash,6
AMBIEN,Pain in extremity,6
AMBIEN,Constipation,5
AMBIEN,Asthenia,5
AMBIEN,Gait disturbance,5
AMBIEN,Pneumonia,5
AMBIEN,Fall,5
AMBIEN,Infusion related reaction,5
AMBIEN,Upper respiratory tract infection,5
AMBIEN,Weight decreased,5
AMBIEN,Osteopenia,5
AMBIEN,Osteoporosis,5
AMBIEN,Renal impairment,5
AMBIEN,Blood creatinine increased,5
AMBIEN,Diarrhoea,5
AMBIEN,Dyspnoea,5
AMBIEN,Sepsis,4
AMBIEN,Somnolence,4
AMBIEN,Ear infection,4
AMBIEN,Pollakiuria,4
AMBIEN,Product use in unapproved indication,4
AMBIEN,Feeling abnormal,4
AMBIEN,Bronchitis,4
AMBIEN,Migraine,4
AMBIEN,Gastrointestinal infection,4
AMBIEN,Anaphylactic reaction,4
AMBIEN,Memory impairment,4
AMBRISENTAN,Headache,55
AMBRISENTAN,Dyspnoea,54
AMBRISENTAN,Diarrhoea,53
AMBRISENTAN,Nausea,44
AMBRISENTAN,Fatigue,44
AMBRISENTAN,Dizziness,26
AMBRISENTAN,Hypotension,24
AMBRISENTAN,Pain in jaw,22
AMBRISENTAN,Infusion site pain,22
AMBRISENTAN,Pain,20
AMBRISENTAN,Vomiting,20
AMBRISENTAN,Pain in extremity,18
AMBRISENTAN,Cough,18
AMBRISENTAN,Pneumonia,17
AMBRISENTAN,Malaise,17
AMBRISENTAN,Flushing,17
AMBRISENTAN,Fluid retention,17
AMBRISENTAN,Oxygen saturation decreased,15
AMBRISENTAN,Infusion site erythema,15
AMBRISENTAN,Chest pain,14
AMBRISENTAN,Arthralgia,14
AMBRISENTAN,Nasopharyngitis,14
AMBRISENTAN,Myalgia,14
AMBRISENTAN,Palpitations,13
AMBRISENTAN,COVID-19,13
AMBRISENTAN,Pulmonary arterial hypertension,13
AMBRISENTAN,Injection site pain,12
AMBRISENTAN,Sinusitis,12
AMBRISENTAN,Peripheral swelling,12
AMBRISENTAN,Asthenia,12
AMBRISENTAN,Weight increased,12
AMBRISENTAN,Oedema peripheral,11
AMBRISENTAN,Pyrexia,10
AMBRISENTAN,Abdominal pain upper,10
AMBRISENTAN,Insomnia,10
AMBRISENTAN,Constipation,10
AMBRISENTAN,Vascular device infection,9
AMBRISENTAN,Illness,9
AMBRISENTAN,Feeling abnormal,9
AMBRISENTAN,Pruritus,9
AMBRISENTAN,Dyspnoea exertional,9
AMBRISENTAN,Weight decreased,9
AMBRISENTAN,Epistaxis,9
AMBRISENTAN,Infusion site haemorrhage,8
AMBRISENTAN,Back pain,8
AMBRISENTAN,Complication associated with device,8
AMBRISENTAN,Abdominal discomfort,8
AMBRISENTAN,Fall,8
AMBRISENTAN,Atrial fibrillation,8
AMBRISENTAN,Anaemia,8
AMIODARONE,Off label use,24
AMIODARONE,Hypotension,17
AMIODARONE,Drug interaction,14
AMIODARONE,Nausea,14
AMIODARONE,Dyspnoea,13
AMIODARONE,Diarrhoea,13
AMIODARONE,Condition aggravated,12
AMIODARONE,Vomiting,12
AMIODARONE,Acute kidney injury,12
AMIODARONE,Interstitial lung disease,12
AMIODARONE,Atrial fibrillation,11
AMIODARONE,Sepsis,10
AMIODARONE,Death,10
AMIODARONE,Constipation,10
AMIODARONE,Abdominal distension,10
AMIODARONE,Swelling,10
AMIODARONE,Cardiogenic shock,9
AMIODARONE,Multiple organ dysfunction syndrome,9
AMIODARONE,Ascites,9
AMIODARONE,Weight decreased,9
AMIODARONE,Pneumonia,9
AMIODARONE,Cardiac failure,9
AMIODARONE,Drug hypersensitivity,8
AMIODARONE,Stress,8
AMIODARONE,Incorrect route of product administration,8
AMIODARONE,Hyponatraemia,8
AMIODARONE,Somnolence,8
AMIODARONE,Fatigue,8
AMIODARONE,Product use in unapproved indication,7
AMIODARONE,Dry mouth,7
AMIODARONE,General physical health deterioration,7
AMIODARONE,Epistaxis,7
AMIODARONE,Hepatic cytolysis,7
AMIODARONE,Oliguria,7
AMIODARONE,Dehydration,6
AMIODARONE,Bacterial infection,6
AMIODARONE,Neuralgia,6
AMIODARONE,Fall,6
AMIODARONE,Cough,6
AMIODARONE,Anaemia,6
AMIODARONE,Syncope,6
AMIODARONE,Bradycardia,6
AMIODARONE,Lung disorder,6
AMIODARONE,Photosensitivity reaction,6
AMIODARONE,Pain,5
AMIODARONE,Feeling abnormal,5
AMIODARONE,Drug intolerance,5
AMIODARONE,Intentional product misuse,5
AMIODARONE,Appendicolith,5
AMIODARONE,Ventricular fibrillation,5
AMITRIPTYLINE,Pain,44
AMITRIPTYLINE,Fatigue,40
AMITRIPTYLINE,Anxiety,37
AMITRIPTYLINE,Vomiting,33
AMITRIPTYLINE,Headache,33
AMITRIPTYLINE,Diarrhoea,32
AMITRIPTYLINE,Arthralgia,28
AMITRIPTYLINE,Off label use,27
AMITRIPTYLINE,Dizziness,26
AMITRIPTYLINE,Depression,23
AMITRIPTYLINE,Muscle spasms,22
AMITRIPTYLINE,COVID-19,21
AMITRIPTYLINE,Dyspnoea,21
AMITRIPTYLINE,Asthenia,20
AMITRIPTYLINE,Decreased appetite,20
AMITRIPTYLINE,Drug ineffective,20
AMITRIPTYLINE,Fall,19
AMITRIPTYLINE,Pruritus,19
AMITRIPTYLINE,Nausea,17
AMITRIPTYLINE,Gait disturbance,17
AMITRIPTYLINE,Confusional state,17
AMITRIPTYLINE,Weight increased,16
AMITRIPTYLINE,Pyrexia,16
AMITRIPTYLINE,Pneumonia,15
AMITRIPTYLINE,Pain in extremity,14
AMITRIPTYLINE,Tremor,13
AMITRIPTYLINE,Migraine,13
AMITRIPTYLINE,Back pain,13
AMITRIPTYLINE,Neuropathy peripheral,12
AMITRIPTYLINE,Malaise,12
AMITRIPTYLINE,Seizure,12
AMITRIPTYLINE,Hyperhidrosis,12
AMITRIPTYLINE,Tinnitus,12
AMITRIPTYLINE,Musculoskeletal stiffness,12
AMITRIPTYLINE,Emotional distress,11
AMITRIPTYLINE,Balance disorder,11
AMITRIPTYLINE,Hypertension,11
AMITRIPTYLINE,Acute kidney injury,11
AMITRIPTYLINE,Disturbance in attention,11
AMITRIPTYLINE,Hypoaesthesia,11
AMITRIPTYLINE,Paraesthesia,11
AMITRIPTYLINE,Speech disorder,11
AMITRIPTYLINE,Eye pain,11
AMITRIPTYLINE,Vision blurred,11
AMITRIPTYLINE,Oropharyngeal pain,11
AMITRIPTYLINE,Product dose omission issue,11
AMITRIPTYLINE,Rash,11
AMITRIPTYLINE,Psychotic disorder,10
AMITRIPTYLINE,Anhedonia,10
AMITRIPTYLINE,Bronchitis,10
AMITRIPTYLINE HYDROCHLORIDE,Fatigue,103
AMITRIPTYLINE HYDROCHLORIDE,Dizziness,103
AMITRIPTYLINE HYDROCHLORIDE,Pain,102
AMITRIPTYLINE HYDROCHLORIDE,Headache,102
AMITRIPTYLINE HYDROCHLORIDE,Vomiting,100
AMITRIPTYLINE HYDROCHLORIDE,Pruritus,99
AMITRIPTYLINE HYDROCHLORIDE,Nausea,98
AMITRIPTYLINE HYDROCHLORIDE,Diarrhoea,98
AMITRIPTYLINE HYDROCHLORIDE,Anxiety,97
AMITRIPTYLINE HYDROCHLORIDE,Visual impairment,96
AMITRIPTYLINE HYDROCHLORIDE,Tachycardia,95
AMITRIPTYLINE HYDROCHLORIDE,Dyspnoea,95
AMITRIPTYLINE HYDROCHLORIDE,Arthralgia,95
AMITRIPTYLINE HYDROCHLORIDE,Hyperhidrosis,94
AMITRIPTYLINE HYDROCHLORIDE,Malaise,94
AMITRIPTYLINE HYDROCHLORIDE,Pyrexia,94
AMITRIPTYLINE HYDROCHLORIDE,Off label use,93
AMITRIPTYLINE HYDROCHLORIDE,Back pain,93
AMITRIPTYLINE HYDROCHLORIDE,Disturbance in attention,93
AMITRIPTYLINE HYDROCHLORIDE,COVID-19,93
AMITRIPTYLINE HYDROCHLORIDE,Migraine,92
AMITRIPTYLINE HYDROCHLORIDE,Heart rate increased,92
AMITRIPTYLINE HYDROCHLORIDE,Peripheral swelling,92
AMITRIPTYLINE HYDROCHLORIDE,Dry skin,91
AMITRIPTYLINE HYDROCHLORIDE,Feeling abnormal,91
AMITRIPTYLINE HYDROCHLORIDE,Insomnia,90
AMITRIPTYLINE HYDROCHLORIDE,Amnesia,90
AMITRIPTYLINE HYDROCHLORIDE,Diplopia,90
AMITRIPTYLINE HYDROCHLORIDE,Tinnitus,90
AMITRIPTYLINE HYDROCHLORIDE,Dehydration,90
AMITRIPTYLINE HYDROCHLORIDE,Memory impairment,90
AMITRIPTYLINE HYDROCHLORIDE,Hallucination,90
AMITRIPTYLINE HYDROCHLORIDE,Palpitations,90
AMITRIPTYLINE HYDROCHLORIDE,Muscular weakness,90
AMITRIPTYLINE HYDROCHLORIDE,Muscle twitching,89
AMITRIPTYLINE HYDROCHLORIDE,Cognitive disorder,89
AMITRIPTYLINE HYDROCHLORIDE,Blindness,89
AMITRIPTYLINE HYDROCHLORIDE,Alopecia,89
AMITRIPTYLINE HYDROCHLORIDE,Abdominal discomfort,89
AMITRIPTYLINE HYDROCHLORIDE,Lip swelling,89
AMITRIPTYLINE HYDROCHLORIDE,Intentional product misuse,88
AMITRIPTYLINE HYDROCHLORIDE,Abdominal pain upper,88
AMITRIPTYLINE HYDROCHLORIDE,Facial pain,88
AMITRIPTYLINE HYDROCHLORIDE,Chest pain,88
AMITRIPTYLINE HYDROCHLORIDE,Cardiospasm,88
AMITRIPTYLINE HYDROCHLORIDE,Angioedema,88
AMITRIPTYLINE HYDROCHLORIDE,Subarachnoid haemorrhage,88
AMITRIPTYLINE HYDROCHLORIDE,Anosmia,88
AMITRIPTYLINE HYDROCHLORIDE,Atrial tachycardia,88
AMITRIPTYLINE HYDROCHLORIDE,Pericarditis,88
AMLODIPINE,Fatigue,113
AMLODIPINE,Pain,111
AMLODIPINE,Nausea,101
AMLODIPINE,Dyspnoea,101
AMLODIPINE,Diarrhoea,96
AMLODIPINE,Off label use,87
AMLODIPINE,Headache,77
AMLODIPINE,Dizziness,76
AMLODIPINE,Vomiting,75
AMLODIPINE,Anxiety,73
AMLODIPINE,Asthenia,73
AMLODIPINE,Arthralgia,65
AMLODIPINE,Acute kidney injury,65
AMLODIPINE,Emotional distress,61
AMLODIPINE,Anhedonia,55
AMLODIPINE,Malaise,54
AMLODIPINE,Cough,54
AMLODIPINE,Hypertension,52
AMLODIPINE,Pneumonia,50
AMLODIPINE,Chronic kidney disease,46
AMLODIPINE,Blood creatinine increased,46
AMLODIPINE,Fall,45
AMLODIPINE,Pyrexia,43
AMLODIPINE,COVID-19,43
AMLODIPINE,Death,42
AMLODIPINE,Drug ineffective,41
AMLODIPINE,Anaemia,40
AMLODIPINE,Hypotension,39
AMLODIPINE,Oedema peripheral,38
AMLODIPINE,Decreased appetite,38
AMLODIPINE,Peripheral swelling,37
AMLODIPINE,Gait disturbance,37
AMLODIPINE,Pain in extremity,37
AMLODIPINE,Product dose omission issue,37
AMLODIPINE,Joint swelling,36
AMLODIPINE,Blood pressure increased,34
AMLODIPINE,Constipation,34
AMLODIPINE,Back pain,33
AMLODIPINE,Urinary tract infection,33
AMLODIPINE,Abdominal pain,32
AMLODIPINE,Renal impairment,32
AMLODIPINE,Weight decreased,32
AMLODIPINE,Renal failure,31
AMLODIPINE,Pruritus,31
AMLODIPINE,Rash,31
AMLODIPINE,Depression,30
AMLODIPINE,Inappropriate schedule of product administration,29
AMLODIPINE,Feeling abnormal,27
AMLODIPINE,Dehydration,25
AMLODIPINE,Nasopharyngitis,25
AMLODIPINE BESYLATE,Fatigue,49
AMLODIPINE BESYLATE,Off label use,44
AMLODIPINE BESYLATE,Diarrhoea,34
AMLODIPINE BESYLATE,COVID-19,32
AMLODIPINE BESYLATE,Pruritus,31
AMLODIPINE BESYLATE,Nausea,29
AMLODIPINE BESYLATE,Pyrexia,28
AMLODIPINE BESYLATE,Pneumonia,28
AMLODIPINE BESYLATE,Malaise,28
AMLODIPINE BESYLATE,Asthenia,27
AMLODIPINE BESYLATE,Fall,26
AMLODIPINE BESYLATE,Headache,26
AMLODIPINE BESYLATE,Pain,25
AMLODIPINE BESYLATE,Dyspnoea,24
AMLODIPINE BESYLATE,Product dose omission issue,23
AMLODIPINE BESYLATE,Rash,22
AMLODIPINE BESYLATE,Urinary tract infection,21
AMLODIPINE BESYLATE,Anaemia,21
AMLODIPINE BESYLATE,Arthralgia,19
AMLODIPINE BESYLATE,Hypertension,19
AMLODIPINE BESYLATE,Oedema peripheral,18
AMLODIPINE BESYLATE,Back pain,18
AMLODIPINE BESYLATE,Blood pressure increased,18
AMLODIPINE BESYLATE,Acute kidney injury,18
AMLODIPINE BESYLATE,Weight decreased,17
AMLODIPINE BESYLATE,Nasopharyngitis,17
AMLODIPINE BESYLATE,Decreased appetite,17
AMLODIPINE BESYLATE,Cough,17
AMLODIPINE BESYLATE,Anxiety,16
AMLODIPINE BESYLATE,Vomiting,16
AMLODIPINE BESYLATE,Sinusitis,15
AMLODIPINE BESYLATE,Illness,15
AMLODIPINE BESYLATE,Platelet count decreased,15
AMLODIPINE BESYLATE,Constipation,14
AMLODIPINE BESYLATE,Cardiac failure,14
AMLODIPINE BESYLATE,Hypotension,14
AMLODIPINE BESYLATE,Peripheral swelling,13
AMLODIPINE BESYLATE,Renal impairment,13
AMLODIPINE BESYLATE,Influenza,13
AMLODIPINE BESYLATE,Inappropriate schedule of product administration,13
AMLODIPINE BESYLATE,Joint swelling,12
AMLODIPINE BESYLATE,Drug ineffective,12
AMLODIPINE BESYLATE,Atrial fibrillation,12
AMLODIPINE BESYLATE,Infection,12
AMLODIPINE BESYLATE,Product use issue,12
AMLODIPINE BESYLATE,Depression,11
AMLODIPINE BESYLATE,Condition aggravated,11
AMLODIPINE BESYLATE,Syncope,11
AMLODIPINE BESYLATE,Product use in unapproved indication,11
AMLODIPINE BESYLATE,Abdominal pain,11
AMOXICILLIN,Pain,58
AMOXICILLIN,Diarrhoea,45
AMOXICILLIN,Off label use,39
AMOXICILLIN,Fatigue,38
AMOXICILLIN,Anxiety,35
AMOXICILLIN,Emotional distress,35
AMOXICILLIN,Rash,33
AMOXICILLIN,Nausea,32
AMOXICILLIN,Dyspnoea,32
AMOXICILLIN,Vomiting,31
AMOXICILLIN,Anhedonia,26
AMOXICILLIN,Headache,26
AMOXICILLIN,Arthralgia,23
AMOXICILLIN,Osteoporosis,22
AMOXICILLIN,Product dose omission issue,22
AMOXICILLIN,Dizziness,22
AMOXICILLIN,Acute kidney injury,21
AMOXICILLIN,Hepatic cytolysis,21
AMOXICILLIN,Product use in unapproved indication,20
AMOXICILLIN,Sinusitis,19
AMOXICILLIN,Asthenia,19
AMOXICILLIN,Back pain,18
AMOXICILLIN,Depression,18
AMOXICILLIN,Pneumonia,18
AMOXICILLIN,COVID-19,18
AMOXICILLIN,Abdominal pain,18
AMOXICILLIN,Bone density decreased,17
AMOXICILLIN,Gait disturbance,17
AMOXICILLIN,Malaise,17
AMOXICILLIN,Pyrexia,17
AMOXICILLIN,Anaemia,17
AMOXICILLIN,Condition aggravated,17
AMOXICILLIN,Constipation,17
AMOXICILLIN,Infection,16
AMOXICILLIN,Productive cough,16
AMOXICILLIN,Myalgia,16
AMOXICILLIN,Renal failure,15
AMOXICILLIN,Abdominal discomfort,15
AMOXICILLIN,Nasopharyngitis,15
AMOXICILLIN,Death,14
AMOXICILLIN,Dysphagia,14
AMOXICILLIN,Osteopenia,13
AMOXICILLIN,Erythema,13
AMOXICILLIN,Dehydration,13
AMOXICILLIN,Muscular weakness,13
AMOXICILLIN,Lower respiratory tract infection,13
AMOXICILLIN,Balance disorder,13
AMOXICILLIN,Chronic kidney disease,12
AMOXICILLIN,Insomnia,12
AMOXICILLIN,Decreased appetite,12
AMOXICILLIN\CLAVULANATE POTASSIUM,Diarrhoea,38
AMOXICILLIN\CLAVULANATE POTASSIUM,Fatigue,32
AMOXICILLIN\CLAVULANATE POTASSIUM,Alopecia,25
AMOXICILLIN\CLAVULANATE POTASSIUM,COVID-19,22
AMOXICILLIN\CLAVULANATE POTASSIUM,Mucosal inflammation,21
AMOXICILLIN\CLAVULANATE POTASSIUM,Off label use,17
AMOXICILLIN\CLAVULANATE POTASSIUM,Nausea,17
AMOXICILLIN\CLAVULANATE POTASSIUM,Anaemia,15
AMOXICILLIN\CLAVULANATE POTASSIUM,Neutropenia,15
AMOXICILLIN\CLAVULANATE POTASSIUM,Pyrexia,14
AMOXICILLIN\CLAVULANATE POTASSIUM,Neuropathy peripheral,13
AMOXICILLIN\CLAVULANATE POTASSIUM,Cellulitis,13
AMOXICILLIN\CLAVULANATE POTASSIUM,Pneumonia,13
AMOXICILLIN\CLAVULANATE POTASSIUM,Vomiting,13
AMOXICILLIN\CLAVULANATE POTASSIUM,Dyspnoea,13
AMOXICILLIN\CLAVULANATE POTASSIUM,Ejection fraction decreased,12
AMOXICILLIN\CLAVULANATE POTASSIUM,Malaise,12
AMOXICILLIN\CLAVULANATE POTASSIUM,Lymphocyte count decreased,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Leukopenia,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Influenza like illness,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Epistaxis,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Hot flush,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Rash,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Sinusitis,11
AMOXICILLIN\CLAVULANATE POTASSIUM,Vascular device infection,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Gingival swelling,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Osteonecrosis of jaw,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Lymphoedema,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Sepsis,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Gastrooesophageal reflux disease,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Incorrect dose administered,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Seizure,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Chills,10
AMOXICILLIN\CLAVULANATE POTASSIUM,Affective disorder,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Neutrophil count increased,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Platelet count decreased,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Schizophrenia,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Dyspepsia,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Overdose,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Psychotic disorder,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Disease progression,9
AMOXICILLIN\CLAVULANATE POTASSIUM,"Hallucination, auditory",9
AMOXICILLIN\CLAVULANATE POTASSIUM,Extrapyramidal disorder,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Delusion of grandeur,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Pruritus,9
AMOXICILLIN\CLAVULANATE POTASSIUM,Back pain,8
AMOXICILLIN\CLAVULANATE POTASSIUM,Arthralgia,8
AMOXICILLIN\CLAVULANATE POTASSIUM,Nasopharyngitis,8
AMOXICILLIN\CLAVULANATE POTASSIUM,Pain,8
AMOXICILLIN\CLAVULANATE POTASSIUM,Product dose omission issue,8
AMOXICILLIN\CLAVULANIC ACID,Vomiting,20
AMOXICILLIN\CLAVULANIC ACID,Diarrhoea,18
AMOXICILLIN\CLAVULANIC ACID,Pain,18
AMOXICILLIN\CLAVULANIC ACID,Pyrexia,15
AMOXICILLIN\CLAVULANIC ACID,Dyspnoea,13
AMOXICILLIN\CLAVULANIC ACID,Malaise,12
AMOXICILLIN\CLAVULANIC ACID,Chills,11
AMOXICILLIN\CLAVULANIC ACID,Back pain,10
AMOXICILLIN\CLAVULANIC ACID,Febrile neutropenia,10
AMOXICILLIN\CLAVULANIC ACID,Condition aggravated,9
AMOXICILLIN\CLAVULANIC ACID,Body temperature increased,9
AMOXICILLIN\CLAVULANIC ACID,Proctalgia,9
AMOXICILLIN\CLAVULANIC ACID,Accident,9
AMOXICILLIN\CLAVULANIC ACID,Anal inflammation,9
AMOXICILLIN\CLAVULANIC ACID,Haemorrhoids,9
AMOXICILLIN\CLAVULANIC ACID,Crohn's disease,9
AMOXICILLIN\CLAVULANIC ACID,Neutropenia,9
AMOXICILLIN\CLAVULANIC ACID,Dysphagia,7
AMOXICILLIN\CLAVULANIC ACID,Off label use,7
AMOXICILLIN\CLAVULANIC ACID,SARS-CoV-2 test negative,7
AMOXICILLIN\CLAVULANIC ACID,Anhedonia,6
AMOXICILLIN\CLAVULANIC ACID,Anxiety,6
AMOXICILLIN\CLAVULANIC ACID,Emotional distress,6
AMOXICILLIN\CLAVULANIC ACID,Fatigue,6
AMOXICILLIN\CLAVULANIC ACID,Pruritus,6
AMOXICILLIN\CLAVULANIC ACID,COVID-19,5
AMOXICILLIN\CLAVULANIC ACID,Nausea,5
AMOXICILLIN\CLAVULANIC ACID,Acute kidney injury,5
AMOXICILLIN\CLAVULANIC ACID,Pneumonia,5
AMOXICILLIN\CLAVULANIC ACID,Muscular weakness,5
AMOXICILLIN\CLAVULANIC ACID,Hepatic cytolysis,5
AMOXICILLIN\CLAVULANIC ACID,Cholestasis,5
AMOXICILLIN\CLAVULANIC ACID,Weight decreased,4
AMOXICILLIN\CLAVULANIC ACID,Headache,4
AMOXICILLIN\CLAVULANIC ACID,Pneumonia aspiration,4
AMOXICILLIN\CLAVULANIC ACID,Chronic kidney disease,4
AMOXICILLIN\CLAVULANIC ACID,Discomfort,4
AMOXICILLIN\CLAVULANIC ACID,Asthenia,4
AMOXICILLIN\CLAVULANIC ACID,Erythema,4
AMOXICILLIN\CLAVULANIC ACID,Angioedema,4
AMOXICILLIN\CLAVULANIC ACID,Skin reaction,4
AMOXICILLIN\CLAVULANIC ACID,Bronchitis,3
AMOXICILLIN\CLAVULANIC ACID,Fall,3
AMOXICILLIN\CLAVULANIC ACID,Product dose omission issue,3
AMOXICILLIN\CLAVULANIC ACID,Urinary tract infection,3
AMOXICILLIN\CLAVULANIC ACID,Arthralgia,3
AMOXICILLIN\CLAVULANIC ACID,Product use in unapproved indication,3
AMOXICILLIN\CLAVULANIC ACID,Dizziness,3
AMOXICILLIN\CLAVULANIC ACID,Seizure,3
AMOXICILLIN\CLAVULANIC ACID,Osteopenia,3
ANASTROZOLE,Fatigue,26
ANASTROZOLE,Diarrhoea,18
ANASTROZOLE,Alopecia,16
ANASTROZOLE,Pain,15
ANASTROZOLE,Malaise,14
ANASTROZOLE,White blood cell count decreased,14
ANASTROZOLE,Off label use,11
ANASTROZOLE,Headache,11
ANASTROZOLE,Anaemia,11
ANASTROZOLE,Rash,11
ANASTROZOLE,Vomiting,11
ANASTROZOLE,Nausea,10
ANASTROZOLE,Asthenia,10
ANASTROZOLE,Pain in extremity,10
ANASTROZOLE,Anxiety,9
ANASTROZOLE,Influenza like illness,9
ANASTROZOLE,Epistaxis,9
ANASTROZOLE,Hot flush,9
ANASTROZOLE,Cough,8
ANASTROZOLE,Dyspnoea,8
ANASTROZOLE,Gingival swelling,8
ANASTROZOLE,Ejection fraction decreased,8
ANASTROZOLE,Osteonecrosis of jaw,8
ANASTROZOLE,Lymphoedema,8
ANASTROZOLE,Gastrooesophageal reflux disease,8
ANASTROZOLE,Mucosal inflammation,8
ANASTROZOLE,Pyrexia,7
ANASTROZOLE,Vascular device infection,7
ANASTROZOLE,Dizziness,7
ANASTROZOLE,Metastases to bone,7
ANASTROZOLE,Feeling abnormal,7
ANASTROZOLE,Interstitial lung disease,7
ANASTROZOLE,Platelet count decreased,7
ANASTROZOLE,Weight decreased,7
ANASTROZOLE,Arthralgia,7
ANASTROZOLE,Illness,6
ANASTROZOLE,Hypersensitivity,6
ANASTROZOLE,Erythema,6
ANASTROZOLE,Insomnia,6
ANASTROZOLE,Decreased immune responsiveness,6
ANASTROZOLE,Haemoglobin decreased,6
ANASTROZOLE,Decreased appetite,6
ANASTROZOLE,COVID-19,6
ANASTROZOLE,Eating disorder,5
ANASTROZOLE,Nasopharyngitis,5
ANASTROZOLE,Weight increased,5
ANASTROZOLE,Device related infection,5
ANASTROZOLE,Sepsis,5
ANASTROZOLE,Drug ineffective,5
ANASTROZOLE,Pulmonary hypertension,5
APIXABAN,Fatigue,112
APIXABAN,Vomiting,111
APIXABAN,Malaise,107
APIXABAN,Diarrhoea,106
APIXABAN,Nausea,99
APIXABAN,Tachycardia,98
APIXABAN,Dehydration,98
APIXABAN,Pain,97
APIXABAN,Dyspnoea,96
APIXABAN,Pyrexia,95
APIXABAN,COVID-19,95
APIXABAN,Dizziness,93
APIXABAN,Chest pain,93
APIXABAN,Angioedema,93
APIXABAN,Peripheral swelling,92
APIXABAN,Arthralgia,92
APIXABAN,Anxiety,91
APIXABAN,Lip swelling,91
APIXABAN,Vasculitis,91
APIXABAN,Heart rate increased,90
APIXABAN,Off label use,90
APIXABAN,Abdominal discomfort,90
APIXABAN,Back pain,90
APIXABAN,Visual impairment,90
APIXABAN,Dry skin,90
APIXABAN,Palpitations,90
APIXABAN,Pruritus,90
APIXABAN,Insomnia,89
APIXABAN,Headache,89
APIXABAN,Abdominal pain upper,89
APIXABAN,Blood glucose increased,89
APIXABAN,Ventricular tachycardia,89
APIXABAN,Myocardial infarction,89
APIXABAN,Hallucination,89
APIXABAN,Amnesia,89
APIXABAN,Feeling abnormal,89
APIXABAN,Facial pain,89
APIXABAN,Transient ischaemic attack,89
APIXABAN,Cardiospasm,89
APIXABAN,Migraine,89
APIXABAN,Muscular weakness,89
APIXABAN,Subarachnoid haemorrhage,89
APIXABAN,Disturbance in attention,89
APIXABAN,Anosmia,89
APIXABAN,Atrial tachycardia,89
APIXABAN,Pericarditis,89
APIXABAN,Intentional product misuse,88
APIXABAN,Diplopia,88
APIXABAN,Hyperhidrosis,88
APIXABAN,Alopecia,88
APREPITANT,Off label use,18
APREPITANT,Malignant neoplasm progression,13
APREPITANT,Febrile neutropenia,8
APREPITANT,Paraesthesia,8
APREPITANT,Hypersensitivity,7
APREPITANT,Dyspepsia,7
APREPITANT,Muscle spasms,7
APREPITANT,Vitamin B12 deficiency,6
APREPITANT,Oropharyngeal discomfort,6
APREPITANT,Eructation,6
APREPITANT,Regurgitation,6
APREPITANT,Neck pain,6
APREPITANT,Abdominal distension,6
APREPITANT,Barrett's oesophagus,6
APREPITANT,Neutrophil count decreased,6
APREPITANT,Pyrexia,5
APREPITANT,Diarrhoea,5
APREPITANT,Pneumonia,4
APREPITANT,Malaise,4
APREPITANT,Decreased appetite,4
APREPITANT,Platelet count decreased,4
APREPITANT,Disseminated intravascular coagulation,4
APREPITANT,White blood cell count decreased,4
APREPITANT,Death,4
APREPITANT,Inappropriate antidiuretic hormone secretion,4
APREPITANT,Fatigue,3
APREPITANT,Asthenia,3
APREPITANT,Interstitial lung disease,3
APREPITANT,Disease progression,3
APREPITANT,Constipation,3
APREPITANT,Urinary tract infection,3
APREPITANT,Encephalopathy,3
APREPITANT,Hyponatraemia,3
APREPITANT,Treatment failure,2
APREPITANT,Urticaria,2
APREPITANT,Stomatitis,2
APREPITANT,Hypertension,2
APREPITANT,Rash,2
APREPITANT,Condition aggravated,2
APREPITANT,Lung disorder,2
APREPITANT,Hypoaesthesia,2
APREPITANT,Dizziness,2
APREPITANT,Pain,2
APREPITANT,Sinusitis,2
APREPITANT,Dyspnoea,2
APREPITANT,Cough,2
APREPITANT,Anaphylactic reaction,2
APREPITANT,Atrial thrombosis,2
APREPITANT,Cerebrovascular accident,2
APREPITANT,Thrombotic microangiopathy,2
ARANESP,Death,13
ARANESP,Multiple organ dysfunction syndrome,12
ARANESP,Sepsis,10
ARANESP,Constipation,9
ARANESP,Off label use,8
ARANESP,Stress,8
ARANESP,Cardiogenic shock,8
ARANESP,Incorrect route of product administration,8
ARANESP,Vomiting,8
ARANESP,Ascites,8
ARANESP,Nausea,8
ARANESP,Abdominal distension,8
ARANESP,Condition aggravated,8
ARANESP,Thrombocytopenia,7
ARANESP,Bacterial infection,7
ARANESP,Product use in unapproved indication,7
ARANESP,Dry mouth,7
ARANESP,Somnolence,7
ARANESP,Dyspnoea,7
ARANESP,General physical health deterioration,6
ARANESP,Abdominal pain,6
ARANESP,Neuralgia,6
ARANESP,Swelling,6
ARANESP,Neutropenia,5
ARANESP,Drug hypersensitivity,5
ARANESP,Drug intolerance,5
ARANESP,Intentional product misuse,5
ARANESP,Appendicolith,5
ARANESP,Hyponatraemia,5
ARANESP,Ventricular fibrillation,5
ARANESP,Appendicitis,5
ARANESP,Asthenia,5
ARANESP,Sleep disorder,5
ARANESP,Agranulocytosis,5
ARANESP,Anaemia,4
ARANESP,Pyrexia,4
ARANESP,Blood cholesterol increased,4
ARANESP,Blood phosphorus increased,4
ARANESP,Myasthenia gravis,4
ARANESP,Blood uric acid increased,4
ARANESP,Pneumonia,4
ARANESP,Hepatic cytolysis,4
ARANESP,Pneumonia respiratory syncytial viral,4
ARANESP,Septic shock,4
ARANESP,Febrile bone marrow aplasia,4
ARANESP,Arthralgia,3
ARANESP,Fall,3
ARANESP,Renal impairment,3
ARANESP,Cardiac failure,3
ARANESP,Pulmonary embolism,3
ARAVA,Drug ineffective,23
ARAVA,Off label use,19
ARAVA,Rheumatoid arthritis,17
ARAVA,Drug intolerance,16
ARAVA,Rash,16
ARAVA,Diarrhoea,15
ARAVA,Arthralgia,15
ARAVA,Drug hypersensitivity,14
ARAVA,Malaise,13
ARAVA,Pain in extremity,12
ARAVA,Dyspnoea,12
ARAVA,Therapeutic product effect decreased,12
ARAVA,Synovitis,12
ARAVA,Pain,12
ARAVA,Arthropathy,12
ARAVA,Nausea,12
ARAVA,Hypertension,11
ARAVA,Contraindicated product administered,11
ARAVA,Fatigue,11
ARAVA,Joint swelling,11
ARAVA,Condition aggravated,11
ARAVA,Infection,10
ARAVA,Dizziness,10
ARAVA,Headache,10
ARAVA,Peripheral swelling,10
ARAVA,Abdominal pain upper,10
ARAVA,Product use issue,10
ARAVA,C-reactive protein increased,10
ARAVA,Hypoaesthesia,9
ARAVA,Hepatic enzyme increased,9
ARAVA,Lung disorder,9
ARAVA,Treatment failure,9
ARAVA,Vomiting,9
ARAVA,Abdominal discomfort,9
ARAVA,Weight increased,8
ARAVA,Alopecia,8
ARAVA,Knee arthroplasty,8
ARAVA,Musculoskeletal stiffness,8
ARAVA,Intentional product use issue,8
ARAVA,Psoriatic arthropathy,8
ARAVA,Blood cholesterol increased,8
ARAVA,Weight decreased,8
ARAVA,Therapeutic product effect incomplete,7
ARAVA,Red blood cell sedimentation rate increased,7
ARAVA,Hand deformity,7
ARAVA,Hypersensitivity,7
ARAVA,Pruritus,7
ARAVA,Nasopharyngitis,7
ARAVA,Sinusitis,7
ARAVA,Liver disorder,7
ARIPIPRAZOLE,Overdose,19
ARIPIPRAZOLE,Off label use,17
ARIPIPRAZOLE,Diarrhoea,16
ARIPIPRAZOLE,Product use in unapproved indication,15
ARIPIPRAZOLE,Fatigue,15
ARIPIPRAZOLE,Medication error,14
ARIPIPRAZOLE,Headache,14
ARIPIPRAZOLE,Nausea,14
ARIPIPRAZOLE,Psychotic disorder,12
ARIPIPRAZOLE,Dizziness,12
ARIPIPRAZOLE,Platelet count decreased,11
ARIPIPRAZOLE,Seizure,11
ARIPIPRAZOLE,COVID-19,11
ARIPIPRAZOLE,"Hallucination, auditory",11
ARIPIPRAZOLE,Intentional product misuse,10
ARIPIPRAZOLE,Neuropathy peripheral,10
ARIPIPRAZOLE,Cellulitis,10
ARIPIPRAZOLE,Alopecia,10
ARIPIPRAZOLE,Lymphocyte count decreased,10
ARIPIPRAZOLE,Extrapyramidal disorder,10
ARIPIPRAZOLE,Hypotension,9
ARIPIPRAZOLE,Affective disorder,9
ARIPIPRAZOLE,Leukopenia,9
ARIPIPRAZOLE,Neutrophil count increased,9
ARIPIPRAZOLE,Schizophrenia,9
ARIPIPRAZOLE,Dyspepsia,9
ARIPIPRAZOLE,Incorrect dose administered,9
ARIPIPRAZOLE,Mucosal inflammation,9
ARIPIPRAZOLE,Neutropenia,9
ARIPIPRAZOLE,Delusion of grandeur,9
ARIPIPRAZOLE,Mania,9
ARIPIPRAZOLE,Suicidal ideation,9
ARIPIPRAZOLE,Weight increased,8
ARIPIPRAZOLE,Disease progression,8
ARIPIPRAZOLE,Rhinalgia,8
ARIPIPRAZOLE,Urinary retention,8
ARIPIPRAZOLE,Acute kidney injury,7
ARIPIPRAZOLE,International normalised ratio abnormal,7
ARIPIPRAZOLE,Polyuria,7
ARIPIPRAZOLE,Lymphocyte count abnormal,7
ARIPIPRAZOLE,Anxiety,7
ARIPIPRAZOLE,Hospitalisation,7
ARIPIPRAZOLE,Drug ineffective,7
ARIPIPRAZOLE,Infection,7
ARIPIPRAZOLE,Somnolence,7
ARIPIPRAZOLE,Loss of consciousness,7
ARIPIPRAZOLE,Agranulocytosis,6
ARIPIPRAZOLE,SARS-CoV-2 test positive,6
ARIPIPRAZOLE,Abdominal discomfort,6
ARIPIPRAZOLE,Insomnia,6
ASCORBIC ACID,Dyspnoea,10
ASCORBIC ACID,Abdominal distension,9
ASCORBIC ACID,Pneumonia,8
ASCORBIC ACID,Diarrhoea,8
ASCORBIC ACID,Condition aggravated,8
ASCORBIC ACID,Fatigue,8
ASCORBIC ACID,Vomiting,7
ASCORBIC ACID,Headache,7
ASCORBIC ACID,Hypersensitivity,7
ASCORBIC ACID,Dyspepsia,7
ASCORBIC ACID,Neck pain,7
ASCORBIC ACID,Weight decreased,6
ASCORBIC ACID,Nausea,6
ASCORBIC ACID,Vitamin B12 deficiency,6
ASCORBIC ACID,Oropharyngeal discomfort,6
ASCORBIC ACID,Eructation,6
ASCORBIC ACID,Regurgitation,6
ASCORBIC ACID,Barrett's oesophagus,6
ASCORBIC ACID,Arthralgia,5
ASCORBIC ACID,Urinary tract infection,5
ASCORBIC ACID,Dizziness,5
ASCORBIC ACID,Injection site pain,5
ASCORBIC ACID,Pain,5
ASCORBIC ACID,Off label use,5
ASCORBIC ACID,Candida infection,4
ASCORBIC ACID,Bronchitis,4
ASCORBIC ACID,Erythema,4
ASCORBIC ACID,Malaise,4
ASCORBIC ACID,Product dose omission issue,4
ASCORBIC ACID,Asthenia,4
ASCORBIC ACID,Gait disturbance,4
ASCORBIC ACID,Incorrect dose administered,4
ASCORBIC ACID,Sepsis,4
ASCORBIC ACID,Depression,4
ASCORBIC ACID,Dehydration,4
ASCORBIC ACID,Anaemia,4
ASCORBIC ACID,Rash macular,4
ASCORBIC ACID,Infusion site swelling,3
ASCORBIC ACID,Influenza,3
ASCORBIC ACID,Inappropriate schedule of product administration,3
ASCORBIC ACID,Pain in extremity,3
ASCORBIC ACID,Platelet count decreased,3
ASCORBIC ACID,Epistaxis,3
ASCORBIC ACID,Infection,3
ASCORBIC ACID,Sinusitis,3
ASCORBIC ACID,Rash,3
ASCORBIC ACID,Decreased appetite,3
ASCORBIC ACID,Fall,3
ASCORBIC ACID,Abdominal discomfort,3
ASCORBIC ACID,Flatulence,3
ASPIRIN,Fatigue,168
ASPIRIN,Diarrhoea,154
ASPIRIN,Pain,133
ASPIRIN,Off label use,128
ASPIRIN,Nausea,112
ASPIRIN,Product dose omission issue,111
ASPIRIN,Asthenia,102
ASPIRIN,Dyspnoea,99
ASPIRIN,Pneumonia,97
ASPIRIN,COVID-19,96
ASPIRIN,Headache,95
ASPIRIN,Weight decreased,93
ASPIRIN,Dizziness,88
ASPIRIN,Malaise,87
ASPIRIN,Fall,85
ASPIRIN,Arthralgia,84
ASPIRIN,Pyrexia,79
ASPIRIN,Vomiting,73
ASPIRIN,Acute kidney injury,67
ASPIRIN,Pain in extremity,66
ASPIRIN,Anxiety,66
ASPIRIN,Rash,66
ASPIRIN,Pruritus,64
ASPIRIN,Back pain,63
ASPIRIN,Urinary tract infection,60
ASPIRIN,Sinusitis,60
ASPIRIN,Cough,60
ASPIRIN,Anaemia,59
ASPIRIN,Chronic kidney disease,56
ASPIRIN,Inappropriate schedule of product administration,56
ASPIRIN,Nasopharyngitis,53
ASPIRIN,Emotional distress,53
ASPIRIN,Gait disturbance,52
ASPIRIN,Death,51
ASPIRIN,Hypotension,51
ASPIRIN,Drug ineffective,50
ASPIRIN,Hypertension,49
ASPIRIN,Decreased appetite,49
ASPIRIN,Illness,48
ASPIRIN,Cardiac failure,47
ASPIRIN,Weight increased,44
ASPIRIN,Bronchitis,43
ASPIRIN,Blood pressure increased,43
ASPIRIN,Insomnia,41
ASPIRIN,Constipation,41
ASPIRIN,Condition aggravated,40
ASPIRIN,General physical health deterioration,40
ASPIRIN,Chest pain,40
ASPIRIN,Atrial fibrillation,39
ASPIRIN,Renal failure,39
ASTRAZENECA COVID-19 VACCINE,Headache,84
ASTRAZENECA COVID-19 VACCINE,Pain,84
ASTRAZENECA COVID-19 VACCINE,Fatigue,84
ASTRAZENECA COVID-19 VACCINE,Pyrexia,81
ASTRAZENECA COVID-19 VACCINE,Malaise,80
ASTRAZENECA COVID-19 VACCINE,Diarrhoea,80
ASTRAZENECA COVID-19 VACCINE,Nausea,80
ASTRAZENECA COVID-19 VACCINE,Dizziness,80
ASTRAZENECA COVID-19 VACCINE,Muscular weakness,80
ASTRAZENECA COVID-19 VACCINE,Palpitations,80
ASTRAZENECA COVID-19 VACCINE,Pruritus,79
ASTRAZENECA COVID-19 VACCINE,Dry skin,79
ASTRAZENECA COVID-19 VACCINE,Anxiety,79
ASTRAZENECA COVID-19 VACCINE,Dyspnoea,79
ASTRAZENECA COVID-19 VACCINE,Chest pain,79
ASTRAZENECA COVID-19 VACCINE,COVID-19,79
ASTRAZENECA COVID-19 VACCINE,Abdominal discomfort,79
ASTRAZENECA COVID-19 VACCINE,Lip swelling,79
ASTRAZENECA COVID-19 VACCINE,Disturbance in attention,79
ASTRAZENECA COVID-19 VACCINE,Heart rate increased,79
ASTRAZENECA COVID-19 VACCINE,Insomnia,78
ASTRAZENECA COVID-19 VACCINE,Alopecia,78
ASTRAZENECA COVID-19 VACCINE,Visual impairment,78
ASTRAZENECA COVID-19 VACCINE,Hallucination,78
ASTRAZENECA COVID-19 VACCINE,Intentional product misuse,78
ASTRAZENECA COVID-19 VACCINE,Amnesia,78
ASTRAZENECA COVID-19 VACCINE,Feeling abnormal,78
ASTRAZENECA COVID-19 VACCINE,Facial pain,78
ASTRAZENECA COVID-19 VACCINE,Abdominal pain upper,78
ASTRAZENECA COVID-19 VACCINE,Dehydration,78
ASTRAZENECA COVID-19 VACCINE,Arthralgia,78
ASTRAZENECA COVID-19 VACCINE,Tachycardia,78
ASTRAZENECA COVID-19 VACCINE,Cardiospasm,78
ASTRAZENECA COVID-19 VACCINE,Peripheral swelling,78
ASTRAZENECA COVID-19 VACCINE,Memory impairment,78
ASTRAZENECA COVID-19 VACCINE,Vomiting,78
ASTRAZENECA COVID-19 VACCINE,Migraine,78
ASTRAZENECA COVID-19 VACCINE,Angioedema,78
ASTRAZENECA COVID-19 VACCINE,Subarachnoid haemorrhage,78
ASTRAZENECA COVID-19 VACCINE,Anosmia,78
ASTRAZENECA COVID-19 VACCINE,Atrial tachycardia,78
ASTRAZENECA COVID-19 VACCINE,Back pain,78
ASTRAZENECA COVID-19 VACCINE,Pericarditis,78
ASTRAZENECA COVID-19 VACCINE,Myocardial infarction,77
ASTRAZENECA COVID-19 VACCINE,Diplopia,77
ASTRAZENECA COVID-19 VACCINE,Hyperhidrosis,77
ASTRAZENECA COVID-19 VACCINE,Transient ischaemic attack,77
ASTRAZENECA COVID-19 VACCINE,Tinnitus,77
ASTRAZENECA COVID-19 VACCINE,Sleep terror,77
ASTRAZENECA COVID-19 VACCINE,Eye pruritus,77
ATARAX,Fatigue,10
ATARAX,Off label use,10
ATARAX,Nasopharyngitis,9
ATARAX,Poisoning deliberate,9
ATARAX,Cough,8
ATARAX,Weight decreased,8
ATARAX,Headache,7
ATARAX,Myalgia,7
ATARAX,Diarrhoea,7
ATARAX,Dyspnoea exertional,6
ATARAX,Nausea,6
ATARAX,Insomnia,6
ATARAX,Anaemia,6
ATARAX,Diabetes mellitus,6
ATARAX,Coma,6
ATARAX,Generalised tonic-clonic seizure,6
ATARAX,Oropharyngeal pain,5
ATARAX,Pruritus,5
ATARAX,Pyrexia,5
ATARAX,Bronchitis,5
ATARAX,Dizziness,5
ATARAX,Pain in jaw,5
ATARAX,Somnolence,5
ATARAX,Product use in unapproved indication,5
ATARAX,Abdominal pain,5
ATARAX,Abdominal distension,5
ATARAX,Blood pressure systolic increased,4
ATARAX,Incorrect dose administered,4
ATARAX,Product dose omission issue,4
ATARAX,Malaise,4
ATARAX,Weight increased,4
ATARAX,Urticaria,4
ATARAX,Swelling,4
ATARAX,Pericardial effusion,4
ATARAX,Angina pectoris,4
ATARAX,Constipation,4
ATARAX,Gastrooesophageal reflux disease,4
ATARAX,Vertigo,4
ATARAX,Gastroenteritis,4
ATARAX,Pulmonary arterial hypertension,4
ATARAX,Injection site pain,4
ATARAX,Tachycardia,4
ATARAX,Performance status decreased,4
ATARAX,Intra-abdominal fluid collection,4
ATARAX,Cardiac pacemaker evaluation,4
ATARAX,Asthenia,4
ATARAX,Pneumonia,3
ATARAX,Drug hypersensitivity,3
ATARAX,Respiratory rate increased,3
ATARAX,Blood immunoglobulin E increased,3
ATENOLOL,Pain,26
ATENOLOL,Fatigue,25
ATENOLOL,Headache,25
ATENOLOL,Off label use,25
ATENOLOL,Product dose omission issue,23
ATENOLOL,COVID-19,20
ATENOLOL,Diarrhoea,19
ATENOLOL,Anxiety,19
ATENOLOL,Nausea,17
ATENOLOL,Dyspnoea,17
ATENOLOL,Drug ineffective,15
ATENOLOL,Hypertension,14
ATENOLOL,Arthralgia,14
ATENOLOL,Asthenia,13
ATENOLOL,Drug hypersensitivity,13
ATENOLOL,Rash,12
ATENOLOL,Cough,12
ATENOLOL,Emotional distress,12
ATENOLOL,Pneumonia,12
ATENOLOL,Pain in extremity,11
ATENOLOL,Fall,11
ATENOLOL,Insomnia,11
ATENOLOL,Anhedonia,10
ATENOLOL,Coma,10
ATENOLOL,Back pain,9
ATENOLOL,Depression,9
ATENOLOL,Contusion,9
ATENOLOL,Memory impairment,9
ATENOLOL,Palpitations,9
ATENOLOL,Chronic kidney disease,9
ATENOLOL,Malaise,9
ATENOLOL,Chest pain,9
ATENOLOL,Multiple organ dysfunction syndrome,9
ATENOLOL,Nasopharyngitis,8
ATENOLOL,Thrombocytopenia,8
ATENOLOL,Alopecia,8
ATENOLOL,Peripheral swelling,8
ATENOLOL,Visual impairment,8
ATENOLOL,Sinusitis,8
ATENOLOL,Seizure,8
ATENOLOL,Haematochezia,8
ATENOLOL,Upper respiratory tract infection,8
ATENOLOL,Anaemia,8
ATENOLOL,Abdominal pain upper,8
ATENOLOL,Acute kidney injury,8
ATENOLOL,Constipation,8
ATENOLOL,Septic shock,8
ATENOLOL,Blood pressure increased,8
ATENOLOL,Cardiac failure,8
ATENOLOL,Product use issue,8
ATEZOLIZUMAB,Anaemia,57
ATEZOLIZUMAB,Death,49
ATEZOLIZUMAB,Diarrhoea,43
ATEZOLIZUMAB,Nausea,42
ATEZOLIZUMAB,Fatigue,40
ATEZOLIZUMAB,Decreased appetite,34
ATEZOLIZUMAB,Constipation,30
ATEZOLIZUMAB,White blood cell count decreased,27
ATEZOLIZUMAB,Hypothyroidism,26
ATEZOLIZUMAB,Dyspnoea,26
ATEZOLIZUMAB,Off label use,25
ATEZOLIZUMAB,Neutrophil count decreased,25
ATEZOLIZUMAB,Vomiting,24
ATEZOLIZUMAB,Pneumonia,24
ATEZOLIZUMAB,Neutropenic sepsis,21
ATEZOLIZUMAB,Febrile neutropenia,20
ATEZOLIZUMAB,Pyrexia,20
ATEZOLIZUMAB,Mucosal inflammation,17
ATEZOLIZUMAB,Platelet count decreased,17
ATEZOLIZUMAB,Hypertension,17
ATEZOLIZUMAB,Neuropathy peripheral,16
ATEZOLIZUMAB,Proteinuria,16
ATEZOLIZUMAB,Neutropenia,16
ATEZOLIZUMAB,Hypokalaemia,15
ATEZOLIZUMAB,Thrombocytopenia,15
ATEZOLIZUMAB,Malaise,15
ATEZOLIZUMAB,Interstitial lung disease,15
ATEZOLIZUMAB,Alopecia,14
ATEZOLIZUMAB,Headache,14
ATEZOLIZUMAB,Weight decreased,13
ATEZOLIZUMAB,Hyponatraemia,13
ATEZOLIZUMAB,Asthenia,13
ATEZOLIZUMAB,Dehydration,12
ATEZOLIZUMAB,Stomatitis,12
ATEZOLIZUMAB,Cough,12
ATEZOLIZUMAB,Abdominal pain,12
ATEZOLIZUMAB,Ascites,12
ATEZOLIZUMAB,Adrenal insufficiency,12
ATEZOLIZUMAB,Disease progression,11
ATEZOLIZUMAB,Lymphocyte count decreased,11
ATEZOLIZUMAB,Oedema peripheral,11
ATEZOLIZUMAB,Hypomagnesaemia,11
ATEZOLIZUMAB,Lower respiratory tract infection,10
ATEZOLIZUMAB,Urinary tract infection,10
ATEZOLIZUMAB,Hepatic function abnormal,10
ATEZOLIZUMAB,Epistaxis,10
ATEZOLIZUMAB,Arthralgia,10
ATEZOLIZUMAB,Myalgia,9
ATEZOLIZUMAB,Rash,9
ATEZOLIZUMAB,Pruritus,9
ATIVAN,Vomiting,15
ATIVAN,Headache,14
ATIVAN,Nausea,14
ATIVAN,Fatigue,11
ATIVAN,Off label use,11
ATIVAN,Weight decreased,11
ATIVAN,COVID-19,11
ATIVAN,Abdominal pain,10
ATIVAN,Seizure,10
ATIVAN,Constipation,9
ATIVAN,Nasopharyngitis,9
ATIVAN,Pain,9
ATIVAN,Inappropriate schedule of product administration,9
ATIVAN,Product dose omission issue,9
ATIVAN,Death,9
ATIVAN,Anxiety,8
ATIVAN,Drug ineffective,8
ATIVAN,Fall,8
ATIVAN,Diarrhoea,7
ATIVAN,Urinary tract infection,7
ATIVAN,Insurance issue,7
ATIVAN,Pneumonia,7
ATIVAN,Intentional product use issue,6
ATIVAN,Weight increased,6
ATIVAN,Dizziness,6
ATIVAN,Blood pressure increased,6
ATIVAN,Cellulitis,6
ATIVAN,Upper respiratory tract infection,6
ATIVAN,Malaise,6
ATIVAN,Gait disturbance,6
ATIVAN,Dyspnoea,5
ATIVAN,Pruritus,5
ATIVAN,Rash,5
ATIVAN,Gastrointestinal disorder,5
ATIVAN,Sinusitis,5
ATIVAN,Back pain,5
ATIVAN,Injection site pain,5
ATIVAN,Product use issue,5
ATIVAN,Depression,5
ATIVAN,Psychotic disorder,5
ATIVAN,Hypoaesthesia,5
ATIVAN,Migraine,5
ATIVAN,Condition aggravated,5
ATIVAN,Illness,5
ATIVAN,Arthralgia,5
ATIVAN,Pain in extremity,5
ATIVAN,Cardiac arrest,4
ATIVAN,Pneumonia aspiration,4
ATIVAN,Asthenia,4
ATIVAN,Hypertension,4
ATORVASTATIN,Pain,141
ATORVASTATIN,Fatigue,122
ATORVASTATIN,Diarrhoea,100
ATORVASTATIN,Acute kidney injury,91
ATORVASTATIN,Headache,87
ATORVASTATIN,Anxiety,82
ATORVASTATIN,Dizziness,74
ATORVASTATIN,Off label use,73
ATORVASTATIN,Dyspnoea,72
ATORVASTATIN,Nausea,70
ATORVASTATIN,Arthralgia,68
ATORVASTATIN,Emotional distress,67
ATORVASTATIN,Anhedonia,59
ATORVASTATIN,Vomiting,57
ATORVASTATIN,Malaise,57
ATORVASTATIN,Myalgia,56
ATORVASTATIN,Pruritus,55
ATORVASTATIN,Pneumonia,55
ATORVASTATIN,Fall,54
ATORVASTATIN,COVID-19,54
ATORVASTATIN,Asthenia,50
ATORVASTATIN,Chronic kidney disease,50
ATORVASTATIN,Weight decreased,49
ATORVASTATIN,Pyrexia,49
ATORVASTATIN,Pain in extremity,48
ATORVASTATIN,Anaemia,44
ATORVASTATIN,Gait disturbance,43
ATORVASTATIN,Hypertension,42
ATORVASTATIN,Product dose omission issue,42
ATORVASTATIN,Renal failure,42
ATORVASTATIN,Blood creatinine increased,41
ATORVASTATIN,Rash,40
ATORVASTATIN,Urinary tract infection,40
ATORVASTATIN,Confusional state,40
ATORVASTATIN,Cough,38
ATORVASTATIN,Back pain,38
ATORVASTATIN,Decreased appetite,38
ATORVASTATIN,Memory impairment,37
ATORVASTATIN,Peripheral swelling,36
ATORVASTATIN,Hypotension,36
ATORVASTATIN,Death,35
ATORVASTATIN,Insomnia,35
ATORVASTATIN,Drug ineffective,33
ATORVASTATIN,Blood pressure increased,32
ATORVASTATIN,Joint swelling,32
ATORVASTATIN,Medication error,32
ATORVASTATIN,Osteoporosis,32
ATORVASTATIN,Depression,30
ATORVASTATIN,Thrombocytopenia,29
ATORVASTATIN,Hepatic cytolysis,29
ATORVASTATIN CALCIUM,Fatigue,38
ATORVASTATIN CALCIUM,Diarrhoea,28
ATORVASTATIN CALCIUM,Pain,26
ATORVASTATIN CALCIUM,Off label use,25
ATORVASTATIN CALCIUM,Headache,25
ATORVASTATIN CALCIUM,Product dose omission issue,25
ATORVASTATIN CALCIUM,COVID-19,24
ATORVASTATIN CALCIUM,Nausea,24
ATORVASTATIN CALCIUM,Fall,22
ATORVASTATIN CALCIUM,Pneumonia,22
ATORVASTATIN CALCIUM,Pruritus,22
ATORVASTATIN CALCIUM,Sinusitis,20
ATORVASTATIN CALCIUM,Asthenia,20
ATORVASTATIN CALCIUM,Malaise,20
ATORVASTATIN CALCIUM,Dyspnoea,19
ATORVASTATIN CALCIUM,Cough,17
ATORVASTATIN CALCIUM,Weight decreased,17
ATORVASTATIN CALCIUM,Urinary tract infection,17
ATORVASTATIN CALCIUM,Pain in extremity,15
ATORVASTATIN CALCIUM,Arthralgia,15
ATORVASTATIN CALCIUM,Vomiting,15
ATORVASTATIN CALCIUM,Dizziness,14
ATORVASTATIN CALCIUM,Back pain,14
ATORVASTATIN CALCIUM,Blood pressure increased,13
ATORVASTATIN CALCIUM,Bronchitis,13
ATORVASTATIN CALCIUM,Influenza,12
ATORVASTATIN CALCIUM,Rash,12
ATORVASTATIN CALCIUM,Death,11
ATORVASTATIN CALCIUM,Peripheral swelling,11
ATORVASTATIN CALCIUM,Chest pain,11
ATORVASTATIN CALCIUM,Illness,11
ATORVASTATIN CALCIUM,Inappropriate schedule of product administration,11
ATORVASTATIN CALCIUM,Gait disturbance,10
ATORVASTATIN CALCIUM,Chills,10
ATORVASTATIN CALCIUM,Pyrexia,10
ATORVASTATIN CALCIUM,Upper respiratory tract infection,10
ATORVASTATIN CALCIUM,Insomnia,10
ATORVASTATIN CALCIUM,Anxiety,9
ATORVASTATIN CALCIUM,Nasopharyngitis,9
ATORVASTATIN CALCIUM,Constipation,9
ATORVASTATIN CALCIUM,Drug ineffective,9
ATORVASTATIN CALCIUM,Seasonal allergy,8
ATORVASTATIN CALCIUM,Injection site pain,8
ATORVASTATIN CALCIUM,Abdominal pain upper,8
ATORVASTATIN CALCIUM,Oropharyngeal pain,8
ATORVASTATIN CALCIUM,Ear infection,8
ATORVASTATIN CALCIUM,Weight increased,8
ATORVASTATIN CALCIUM,Feeling abnormal,8
ATORVASTATIN CALCIUM,Infection,8
ATORVASTATIN CALCIUM,Asthma,8
ATOVAQUONE,Neutropenia,9
ATOVAQUONE,Sepsis,7
ATOVAQUONE,Agranulocytosis,7
ATOVAQUONE,Hepatic cytolysis,6
ATOVAQUONE,Pneumonia,6
ATOVAQUONE,Dyspnoea,6
ATOVAQUONE,Pneumocystis jirovecii pneumonia,5
ATOVAQUONE,Acute respiratory distress syndrome,5
ATOVAQUONE,Anaemia,5
ATOVAQUONE,Anxiety,4
ATOVAQUONE,Pain,4
ATOVAQUONE,Anhedonia,4
ATOVAQUONE,Thrombocytopenia,4
ATOVAQUONE,Constipation,4
ATOVAQUONE,Off label use,4
ATOVAQUONE,Asthenia,4
ATOVAQUONE,Back pain,3
ATOVAQUONE,Acute kidney injury,3
ATOVAQUONE,Emotional distress,3
ATOVAQUONE,Neutrophil count decreased,3
ATOVAQUONE,Hypoxia,3
ATOVAQUONE,Chest pain,3
ATOVAQUONE,Pyrexia,3
ATOVAQUONE,Haemoglobin decreased,3
ATOVAQUONE,Tachycardia,3
ATOVAQUONE,Cough,3
ATOVAQUONE,Headache,3
ATOVAQUONE,Abdominal pain upper,3
ATOVAQUONE,Bronchitis,3
ATOVAQUONE,Lung disorder,3
ATOVAQUONE,Diarrhoea,3
ATOVAQUONE,Pancytopenia,3
ATOVAQUONE,Stomatitis,3
ATOVAQUONE,Congenital foot malformation,3
ATOVAQUONE,Foetal exposure during pregnancy,3
ATOVAQUONE,Phalangeal hypoplasia,3
ATOVAQUONE,Bone density decreased,2
ATOVAQUONE,Multiple fractures,2
ATOVAQUONE,Osteoporosis,2
ATOVAQUONE,Chronic kidney disease,2
ATOVAQUONE,Renal failure,2
ATOVAQUONE,Osteopenia,2
ATOVAQUONE,Pneumonia aspiration,2
ATOVAQUONE,Atrial fibrillation,2
ATOVAQUONE,Infectious pleural effusion,2
ATOVAQUONE,Nutritional condition abnormal,2
ATOVAQUONE,Pneumothorax,2
ATOVAQUONE,Cardiac failure acute,2
ATOVAQUONE,Supraventricular extrasystoles,2
ATOVAQUONE,Inflammatory marker increased,2
ATRIPLA,Emotional distress,200
ATRIPLA,Pain,200
ATRIPLA,Anxiety,191
ATRIPLA,Anhedonia,189
ATRIPLA,Chronic kidney disease,95
ATRIPLA,Osteoporosis,80
ATRIPLA,Osteopenia,70
ATRIPLA,Bone density decreased,60
ATRIPLA,Bone demineralisation,57
ATRIPLA,Renal failure,50
ATRIPLA,Depression,50
ATRIPLA,Renal impairment,43
ATRIPLA,Blood creatinine increased,41
ATRIPLA,Acute kidney injury,35
ATRIPLA,Multiple fractures,34
ATRIPLA,Fatigue,33
ATRIPLA,Economic problem,26
ATRIPLA,Gait disturbance,26
ATRIPLA,Foot fracture,23
ATRIPLA,Bone loss,18
ATRIPLA,Asthenia,18
ATRIPLA,Back pain,17
ATRIPLA,Loss of personal independence in daily activities,17
ATRIPLA,End stage renal disease,16
ATRIPLA,Decreased activity,15
ATRIPLA,Renal injury,15
ATRIPLA,Vitamin D deficiency,14
ATRIPLA,Pollakiuria,13
ATRIPLA,Quality of life decreased,13
ATRIPLA,Osteonecrosis,12
ATRIPLA,Rib fracture,11
ATRIPLA,Proteinuria,11
ATRIPLA,Mobility decreased,10
ATRIPLA,Hypertension,9
ATRIPLA,Dysstasia,9
ATRIPLA,Hand fracture,9
ATRIPLA,Drug ineffective,9
ATRIPLA,Hip fracture,8
ATRIPLA,Nephrolithiasis,8
ATRIPLA,Renal disorder,8
ATRIPLA,Wrist fracture,8
ATRIPLA,Tooth loss,8
ATRIPLA,Lower limb fracture,8
ATRIPLA,Osteoarthritis,7
ATRIPLA,Insomnia,7
ATRIPLA,Skeletal injury,7
ATRIPLA,Spinal compression fracture,6
ATRIPLA,Pain in extremity,6
ATRIPLA,Arthralgia,6
ATRIPLA,Ankle fracture,6
ATROVENT,Dyspnoea,17
ATROVENT,Constipation,10
ATROVENT,Nausea,9
ATROVENT,Condition aggravated,8
ATROVENT,Fatigue,8
ATROVENT,Vomiting,8
ATROVENT,Off label use,7
ATROVENT,Stress,7
ATROVENT,Cardiogenic shock,7
ATROVENT,Sepsis,7
ATROVENT,Incorrect route of product administration,7
ATROVENT,Death,7
ATROVENT,Multiple organ dysfunction syndrome,7
ATROVENT,Ascites,7
ATROVENT,Abdominal distension,7
ATROVENT,Pneumonia,7
ATROVENT,Drug hypersensitivity,6
ATROVENT,Bacterial infection,6
ATROVENT,Dry mouth,6
ATROVENT,Somnolence,6
ATROVENT,Blood pressure increased,6
ATROVENT,Sleep disorder,6
ATROVENT,Neuralgia,6
ATROVENT,Swelling,6
ATROVENT,Diarrhoea,5
ATROVENT,Pyrexia,5
ATROVENT,Weight decreased,5
ATROVENT,Drug intolerance,5
ATROVENT,Intentional product misuse,5
ATROVENT,General physical health deterioration,5
ATROVENT,Weight increased,5
ATROVENT,Arthralgia,5
ATROVENT,Asthma,5
ATROVENT,Wheezing,5
ATROVENT,Headache,5
ATROVENT,Appendicolith,4
ATROVENT,Hyponatraemia,4
ATROVENT,Ventricular fibrillation,4
ATROVENT,Abdominal pain,4
ATROVENT,Appendicitis,4
ATROVENT,Cough,3
ATROVENT,Pain,3
ATROVENT,Product use in unapproved indication,3
ATROVENT,Blood cholesterol increased,3
ATROVENT,Blood phosphorus increased,3
ATROVENT,Myasthenia gravis,3
ATROVENT,Blood uric acid increased,3
ATROVENT,Peripheral swelling,3
ATROVENT,Illness,3
ATROVENT,Decreased appetite,3
AUGMENTIN,COVID-19,16
AUGMENTIN,Sinusitis,14
AUGMENTIN,Asthenia,12
AUGMENTIN,Acute generalised exanthematous pustulosis,11
AUGMENTIN,Neutropenia,11
AUGMENTIN,Hepatic cytolysis,11
AUGMENTIN,Fall,10
AUGMENTIN,Nausea,10
AUGMENTIN,Cough,10
AUGMENTIN,Headache,10
AUGMENTIN,Condition aggravated,10
AUGMENTIN,Back pain,9
AUGMENTIN,Bronchitis,9
AUGMENTIN,Pyrexia,9
AUGMENTIN,Pneumonia,9
AUGMENTIN,Diarrhoea,9
AUGMENTIN,Erythema,8
AUGMENTIN,Product dose omission issue,8
AUGMENTIN,Product use issue,8
AUGMENTIN,Cholestasis,8
AUGMENTIN,Febrile neutropenia,7
AUGMENTIN,Weight increased,7
AUGMENTIN,Malaise,7
AUGMENTIN,Off label use,6
AUGMENTIN,Pain,6
AUGMENTIN,Vomiting,6
AUGMENTIN,Blood pressure increased,6
AUGMENTIN,Fatigue,6
AUGMENTIN,Upper respiratory tract infection,6
AUGMENTIN,Insurance issue,5
AUGMENTIN,Illness,5
AUGMENTIN,Weight decreased,5
AUGMENTIN,Viral infection,5
AUGMENTIN,Anxiety,5
AUGMENTIN,Inappropriate schedule of product administration,5
AUGMENTIN,Dyspnoea,5
AUGMENTIN,Pain in extremity,5
AUGMENTIN,Abdominal pain upper,5
AUGMENTIN,Hypotension,5
AUGMENTIN,Infusion related reaction,4
AUGMENTIN,Diverticulitis,4
AUGMENTIN,Balance disorder,4
AUGMENTIN,Depression,4
AUGMENTIN,Crying,4
AUGMENTIN,Skin laceration,4
AUGMENTIN,Drug hypersensitivity,4
AUGMENTIN,Infection,4
AUGMENTIN,Influenza,4
AUGMENTIN,Gastrointestinal disorder,4
AUGMENTIN,Head injury,4
AVASTIN,Cerebrovascular accident,10
AVASTIN,Off label use,7
AVASTIN,Platelet count decreased,6
AVASTIN,Diarrhoea,6
AVASTIN,Disease progression,6
AVASTIN,Nausea,6
AVASTIN,Vomiting,6
AVASTIN,Anaemia,5
AVASTIN,Tubulointerstitial nephritis,5
AVASTIN,Urinary tract infection,5
AVASTIN,Fatigue,5
AVASTIN,Dyspnoea,5
AVASTIN,Headache,5
AVASTIN,Pain,5
AVASTIN,Renal impairment,4
AVASTIN,Septic shock,4
AVASTIN,Adrenal insufficiency,4
AVASTIN,Acute kidney injury,4
AVASTIN,Varices oesophageal,4
AVASTIN,Cardiac failure,4
AVASTIN,Dizziness,4
AVASTIN,Asthenia,4
AVASTIN,Interstitial lung disease,3
AVASTIN,Constipation,3
AVASTIN,Pruritus,3
AVASTIN,Erythema multiforme,3
AVASTIN,Ascites,3
AVASTIN,Rash,3
AVASTIN,Pyrexia,3
AVASTIN,Proteinuria,3
AVASTIN,Chest pain,3
AVASTIN,Deep vein thrombosis,3
AVASTIN,Hypoalbuminaemia,3
AVASTIN,Dermatitis,3
AVASTIN,Blood creatinine increased,3
AVASTIN,Disseminated intravascular coagulation,3
AVASTIN,Oesophageal varices haemorrhage,3
AVASTIN,Dyspepsia,3
AVASTIN,Cerebral infarction,3
AVASTIN,Glioblastoma,3
AVASTIN,Ischaemic stroke,3
AVASTIN,Incorrect route of product administration,3
AVASTIN,Arthralgia,3
AVASTIN,Weight decreased,3
AVASTIN,Ileus,2
AVASTIN,Neutrophil count decreased,2
AVASTIN,Spinal compression fracture,2
AVASTIN,Liver disorder,2
AVASTIN,Feeling abnormal,2
AVASTIN,Haemoglobin decreased,2
AZACITIDINE,Febrile neutropenia,27
AZACITIDINE,Pyrexia,20
AZACITIDINE,Acute myeloid leukaemia,19
AZACITIDINE,Myelosuppression,19
AZACITIDINE,Neutropenia,16
AZACITIDINE,Neutrophil count decreased,16
AZACITIDINE,Platelet count decreased,16
AZACITIDINE,Pneumonia,15
AZACITIDINE,White blood cell count decreased,15
AZACITIDINE,Anaemia,15
AZACITIDINE,Death,12
AZACITIDINE,Off label use,11
AZACITIDINE,Thrombocytopenia,10
AZACITIDINE,Disease progression,9
AZACITIDINE,Septic shock,9
AZACITIDINE,Sepsis,7
AZACITIDINE,Tumour lysis syndrome,6
AZACITIDINE,Fatigue,6
AZACITIDINE,Nausea,6
AZACITIDINE,COVID-19,6
AZACITIDINE,Haemoglobin decreased,6
AZACITIDINE,Acute kidney injury,5
AZACITIDINE,Acute myeloid leukaemia recurrent,5
AZACITIDINE,Constipation,5
AZACITIDINE,Upper gastrointestinal haemorrhage,5
AZACITIDINE,Drug ineffective,5
AZACITIDINE,Pancytopenia,5
AZACITIDINE,Cytopenia,4
AZACITIDINE,Diarrhoea,4
AZACITIDINE,General physical health deterioration,4
AZACITIDINE,Leukopenia,4
AZACITIDINE,Cardiac failure acute,4
AZACITIDINE,Disease recurrence,3
AZACITIDINE,Blood bilirubin increased,3
AZACITIDINE,Escherichia sepsis,3
AZACITIDINE,Disseminated intravascular coagulation,3
AZACITIDINE,Infection,3
AZACITIDINE,Cerebral haemorrhage,3
AZACITIDINE,Asthenia,3
AZACITIDINE,Hypokalaemia,3
AZACITIDINE,Malaise,3
AZACITIDINE,Colitis,3
AZACITIDINE,Cerebrovascular accident,3
AZACITIDINE,Immunodeficiency,3
AZACITIDINE,Laboratory test abnormal,3
AZACITIDINE,Vomiting,3
AZACITIDINE,Agranulocytosis,3
AZACITIDINE,Bone pain,2
AZACITIDINE,Depressed level of consciousness,2
AZACITIDINE,Dyspnoea,2
AZATHIOPRINE,Off label use,30
AZATHIOPRINE,Diarrhoea,19
AZATHIOPRINE,Malaise,18
AZATHIOPRINE,Drug ineffective,18
AZATHIOPRINE,Abdominal pain,16
AZATHIOPRINE,Crohn's disease,13
AZATHIOPRINE,Pyrexia,13
AZATHIOPRINE,Fatigue,13
AZATHIOPRINE,COVID-19,13
AZATHIOPRINE,Dizziness,12
AZATHIOPRINE,Pain,12
AZATHIOPRINE,Weight increased,12
AZATHIOPRINE,Asthenia,12
AZATHIOPRINE,Weight decreased,12
AZATHIOPRINE,Inappropriate schedule of product administration,11
AZATHIOPRINE,Nausea,11
AZATHIOPRINE,Arthralgia,10
AZATHIOPRINE,Infection,9
AZATHIOPRINE,Product dose omission issue,9
AZATHIOPRINE,Cough,9
AZATHIOPRINE,Headache,9
AZATHIOPRINE,Colitis ulcerative,9
AZATHIOPRINE,Rash,8
AZATHIOPRINE,Condition aggravated,8
AZATHIOPRINE,Pneumonia,7
AZATHIOPRINE,Haematochezia,6
AZATHIOPRINE,Influenza,6
AZATHIOPRINE,Erythema,6
AZATHIOPRINE,Dyspnoea,6
AZATHIOPRINE,Decreased appetite,6
AZATHIOPRINE,Anaemia,6
AZATHIOPRINE,Pneumonia influenzal,6
AZATHIOPRINE,Hypersensitivity pneumonitis,6
AZATHIOPRINE,Respiratory failure,6
AZATHIOPRINE,Lung infiltration,6
AZATHIOPRINE,Mechanical ileus,6
AZATHIOPRINE,Photosensitivity reaction,6
AZATHIOPRINE,Frequent bowel movements,5
AZATHIOPRINE,Vomiting,5
AZATHIOPRINE,Anxiety,5
AZATHIOPRINE,Depression,5
AZATHIOPRINE,Sinusitis,5
AZATHIOPRINE,Infusion related reaction,5
AZATHIOPRINE,Urinary tract infection,5
AZATHIOPRINE,Product use issue,5
AZATHIOPRINE,Productive cough,5
AZATHIOPRINE,Abdominal discomfort,5
AZATHIOPRINE,Pruritus,5
AZATHIOPRINE,Insomnia,5
AZATHIOPRINE,Hypertension,5
AZELASTINE,Sinusitis,14
AZELASTINE,Product dose omission issue,11
AZELASTINE,Pain,10
AZELASTINE,Pneumonia,8
AZELASTINE,Fatigue,8
AZELASTINE,Upper respiratory tract infection,8
AZELASTINE,COVID-19,7
AZELASTINE,Bronchitis,6
AZELASTINE,Infection,6
AZELASTINE,Urinary tract infection,6
AZELASTINE,Inappropriate schedule of product administration,6
AZELASTINE,Nausea,5
AZELASTINE,Drug hypersensitivity,5
AZELASTINE,Vomiting,5
AZELASTINE,Herpes zoster,5
AZELASTINE,Seasonal allergy,5
AZELASTINE,Headache,5
AZELASTINE,Malaise,5
AZELASTINE,Asthma,4
AZELASTINE,Nasopharyngitis,4
AZELASTINE,Viral infection,4
AZELASTINE,Infusion site pruritus,4
AZELASTINE,Vision blurred,4
AZELASTINE,Ear infection,4
AZELASTINE,Weight decreased,4
AZELASTINE,Rash,4
AZELASTINE,Arthralgia,4
AZELASTINE,Pruritus,4
AZELASTINE,Anxiety,4
AZELASTINE,Feeling abnormal,4
AZELASTINE,Diverticulitis,3
AZELASTINE,Infusion site pain,3
AZELASTINE,Oropharyngeal pain,3
AZELASTINE,Contusion,3
AZELASTINE,Insurance issue,3
AZELASTINE,Infusion site extravasation,3
AZELASTINE,Fall,3
AZELASTINE,Pain in extremity,3
AZELASTINE,Migraine,3
AZELASTINE,Back pain,3
AZELASTINE,Diarrhoea,3
AZELASTINE,Asthenia,3
AZELASTINE,Dizziness,3
AZELASTINE,Emotional distress,3
AZELASTINE,Hypersensitivity,3
AZELASTINE,Abdominal discomfort,3
AZELASTINE,Paranasal sinus discomfort,2
AZELASTINE,Nasal discomfort,2
AZELASTINE,Vertigo,2
AZELASTINE,Scar,2
AZELASTINE HYDROCHLORIDE,Sinusitis,25
AZELASTINE HYDROCHLORIDE,Product dose omission issue,17
AZELASTINE HYDROCHLORIDE,COVID-19,16
AZELASTINE HYDROCHLORIDE,Headache,12
AZELASTINE HYDROCHLORIDE,Upper respiratory tract infection,11
AZELASTINE HYDROCHLORIDE,Pneumonia,10
AZELASTINE HYDROCHLORIDE,Nausea,9
AZELASTINE HYDROCHLORIDE,Fatigue,9
AZELASTINE HYDROCHLORIDE,Vomiting,9
AZELASTINE HYDROCHLORIDE,Bronchitis,8
AZELASTINE HYDROCHLORIDE,Ear infection,8
AZELASTINE HYDROCHLORIDE,Urinary tract infection,8
AZELASTINE HYDROCHLORIDE,Inappropriate schedule of product administration,7
AZELASTINE HYDROCHLORIDE,Infection,6
AZELASTINE HYDROCHLORIDE,Nasopharyngitis,6
AZELASTINE HYDROCHLORIDE,Diarrhoea,6
AZELASTINE HYDROCHLORIDE,Malaise,6
AZELASTINE HYDROCHLORIDE,Infusion site pain,5
AZELASTINE HYDROCHLORIDE,Seasonal allergy,5
AZELASTINE HYDROCHLORIDE,Infusion site extravasation,5
AZELASTINE HYDROCHLORIDE,Rash,5
AZELASTINE HYDROCHLORIDE,Cough,5
AZELASTINE HYDROCHLORIDE,Dyspnoea,5
AZELASTINE HYDROCHLORIDE,Nasal congestion,5
AZELASTINE HYDROCHLORIDE,Arthralgia,5
AZELASTINE HYDROCHLORIDE,Fall,5
AZELASTINE HYDROCHLORIDE,Staphylococcal infection,4
AZELASTINE HYDROCHLORIDE,Drug hypersensitivity,4
AZELASTINE HYDROCHLORIDE,Asthma,4
AZELASTINE HYDROCHLORIDE,Viral infection,4
AZELASTINE HYDROCHLORIDE,Lower respiratory tract infection,4
AZELASTINE HYDROCHLORIDE,Infusion site pruritus,4
AZELASTINE HYDROCHLORIDE,Vision blurred,4
AZELASTINE HYDROCHLORIDE,Oropharyngeal pain,4
AZELASTINE HYDROCHLORIDE,Herpes zoster,4
AZELASTINE HYDROCHLORIDE,Weight decreased,4
AZELASTINE HYDROCHLORIDE,Product use issue,4
AZELASTINE HYDROCHLORIDE,Insurance issue,4
AZELASTINE HYDROCHLORIDE,Asthenia,4
AZELASTINE HYDROCHLORIDE,Migraine,4
AZELASTINE HYDROCHLORIDE,Illness,4
AZELASTINE HYDROCHLORIDE,Infusion related reaction,4
AZELASTINE HYDROCHLORIDE,Pruritus,4
AZELASTINE HYDROCHLORIDE,Influenza,4
AZELASTINE HYDROCHLORIDE,Pain,4
AZELASTINE HYDROCHLORIDE,Conjunctivitis,3
AZELASTINE HYDROCHLORIDE,Gastrointestinal disorder,3
AZELASTINE HYDROCHLORIDE,Contusion,3
AZELASTINE HYDROCHLORIDE,Injection site erythema,3
AZELASTINE HYDROCHLORIDE,Gait disturbance,3
AZITHROMYCIN,Pain,42
AZITHROMYCIN,Dyspnoea,32
AZITHROMYCIN,Fatigue,31
AZITHROMYCIN,Anxiety,30
AZITHROMYCIN,Off label use,29
AZITHROMYCIN,Pneumonia,28
AZITHROMYCIN,Product dose omission issue,28
AZITHROMYCIN,COVID-19,27
AZITHROMYCIN,Emotional distress,26
AZITHROMYCIN,Anhedonia,25
AZITHROMYCIN,Sinusitis,25
AZITHROMYCIN,Pruritus,23
AZITHROMYCIN,Headache,23
AZITHROMYCIN,Cough,22
AZITHROMYCIN,Weight increased,16
AZITHROMYCIN,Arthralgia,16
AZITHROMYCIN,Influenza,16
AZITHROMYCIN,Nausea,16
AZITHROMYCIN,Malaise,15
AZITHROMYCIN,Weight decreased,15
AZITHROMYCIN,Pyrexia,15
AZITHROMYCIN,Chronic kidney disease,14
AZITHROMYCIN,Dizziness,14
AZITHROMYCIN,Rash,14
AZITHROMYCIN,Abdominal pain,14
AZITHROMYCIN,Upper respiratory tract infection,14
AZITHROMYCIN,Bronchitis,14
AZITHROMYCIN,Diarrhoea,13
AZITHROMYCIN,Osteoporosis,13
AZITHROMYCIN,Vomiting,13
AZITHROMYCIN,Renal failure,12
AZITHROMYCIN,Depression,12
AZITHROMYCIN,Asthenia,12
AZITHROMYCIN,Dyspepsia,12
AZITHROMYCIN,Nasopharyngitis,11
AZITHROMYCIN,Asthma,11
AZITHROMYCIN,Blood pressure increased,11
AZITHROMYCIN,Blood creatinine increased,11
AZITHROMYCIN,Drug hypersensitivity,10
AZITHROMYCIN,Palpitations,10
AZITHROMYCIN,Ear infection,10
AZITHROMYCIN,Fall,10
AZITHROMYCIN,Dyspnoea exertional,9
AZITHROMYCIN,Chills,9
AZITHROMYCIN,Renal impairment,9
AZITHROMYCIN,Illness,9
AZITHROMYCIN,Migraine,9
AZITHROMYCIN,Rhinorrhoea,8
AZITHROMYCIN,Gait disturbance,8
AZITHROMYCIN,Chest discomfort,8
AZOSEMIDE,Pneumonia,10
AZOSEMIDE,Diarrhoea,9
AZOSEMIDE,Headache,8
AZOSEMIDE,Pulmonary arterial hypertension,8
AZOSEMIDE,Cardiac failure chronic,7
AZOSEMIDE,Cardiac failure,6
AZOSEMIDE,Hypotension,6
AZOSEMIDE,Brain natriuretic peptide increased,6
AZOSEMIDE,Nausea,6
AZOSEMIDE,Oedema peripheral,6
AZOSEMIDE,Decreased appetite,5
AZOSEMIDE,Dehydration,4
AZOSEMIDE,Disease progression,4
AZOSEMIDE,Death,4
AZOSEMIDE,Iron deficiency anaemia,4
AZOSEMIDE,Pyrexia,3
AZOSEMIDE,Cerebral infarction,3
AZOSEMIDE,Platelet count decreased,3
AZOSEMIDE,Dizziness,3
AZOSEMIDE,Fall,3
AZOSEMIDE,Lymphocyte count decreased,3
AZOSEMIDE,Rash,3
AZOSEMIDE,Off label use,3
AZOSEMIDE,Pleural effusion,3
AZOSEMIDE,Hyperkalaemia,3
AZOSEMIDE,Constipation,3
AZOSEMIDE,Anaemia,3
AZOSEMIDE,Interstitial lung disease,3
AZOSEMIDE,Atrial fibrillation,3
AZOSEMIDE,Hypothyroidism,3
AZOSEMIDE,Malaise,2
AZOSEMIDE,Dyspnoea,2
AZOSEMIDE,Neutrophil percentage increased,2
AZOSEMIDE,Monocyte percentage decreased,2
AZOSEMIDE,C-reactive protein increased,2
AZOSEMIDE,Lymphocyte percentage decreased,2
AZOSEMIDE,Red blood cell count increased,2
AZOSEMIDE,Low cardiac output syndrome,2
AZOSEMIDE,Dry eye,2
AZOSEMIDE,Eye discharge,2
AZOSEMIDE,Hepatic function abnormal,2
AZOSEMIDE,Pulmonary hypertension,2
AZOSEMIDE,Right ventricular failure,2
AZOSEMIDE,Rhinitis allergic,2
AZOSEMIDE,Anaemia folate deficiency,2
AZOSEMIDE,Rheumatoid arthritis,2
AZOSEMIDE,Back pain,2
AZOSEMIDE,Large intestine polyp,2
AZOSEMIDE,Atrial septal defect,2
AZOSEMIDE,Cardiovascular disorder,2
BACLOFEN,Fatigue,26
BACLOFEN,Pain,25
BACLOFEN,Fall,18
BACLOFEN,Headache,18
BACLOFEN,Anxiety,15
BACLOFEN,Arthralgia,15
BACLOFEN,Urinary tract infection,15
BACLOFEN,Asthenia,14
BACLOFEN,Gait disturbance,14
BACLOFEN,Myalgia,12
BACLOFEN,Pneumonia,12
BACLOFEN,Product dose omission issue,12
BACLOFEN,Vomiting,12
BACLOFEN,Nausea,12
BACLOFEN,Weight decreased,12
BACLOFEN,Pain in extremity,11
BACLOFEN,Pyrexia,10
BACLOFEN,Nasopharyngitis,10
BACLOFEN,Tachycardia,9
BACLOFEN,Anhedonia,9
BACLOFEN,Emotional distress,9
BACLOFEN,Acute kidney injury,9
BACLOFEN,Muscle spasticity,9
BACLOFEN,Rash,8
BACLOFEN,Malaise,8
BACLOFEN,COVID-19,8
BACLOFEN,Chronic kidney disease,8
BACLOFEN,Blood creatinine increased,8
BACLOFEN,Cough,8
BACLOFEN,Dyspnoea,8
BACLOFEN,Dizziness,8
BACLOFEN,Respiratory failure,8
BACLOFEN,Sepsis,8
BACLOFEN,Weight increased,8
BACLOFEN,Multiple sclerosis relapse,8
BACLOFEN,Pruritus,7
BACLOFEN,Muscle spasms,7
BACLOFEN,Off label use,7
BACLOFEN,White blood cell count decreased,6
BACLOFEN,Depression,6
BACLOFEN,Infection,6
BACLOFEN,Contusion,6
BACLOFEN,Loss of consciousness,6
BACLOFEN,Diarrhoea,6
BACLOFEN,Sleep disorder,6
BACLOFEN,Back pain,6
BACLOFEN,Memory impairment,6
BACLOFEN,Metastatic malignant melanoma,6
BACLOFEN,Seizure,5
BACLOFEN,Lymphocyte count decreased,5
BACTRIM,Pyrexia,39
BACTRIM,Neutropenia,39
BACTRIM,Off label use,37
BACTRIM,Hepatic cytolysis,32
BACTRIM,Pain,30
BACTRIM,Hyperkalaemia,30
BACTRIM,Thrombocytopenia,29
BACTRIM,Acute kidney injury,26
BACTRIM,COVID-19,25
BACTRIM,Fatigue,23
BACTRIM,Diarrhoea,23
BACTRIM,Rash,21
BACTRIM,Anaemia,20
BACTRIM,Leukopenia,20
BACTRIM,Nausea,19
BACTRIM,Lymphopenia,18
BACTRIM,Product dose omission issue,18
BACTRIM,Headache,17
BACTRIM,Asthenia,17
BACTRIM,Pneumonia,17
BACTRIM,Drug reaction with eosinophilia and systemic symptoms,17
BACTRIM,Hyponatraemia,17
BACTRIM,Arthralgia,16
BACTRIM,Anxiety,16
BACTRIM,Inappropriate schedule of product administration,15
BACTRIM,Condition aggravated,15
BACTRIM,Emotional distress,14
BACTRIM,Weight decreased,14
BACTRIM,Vomiting,14
BACTRIM,Dyspnoea,13
BACTRIM,Sinusitis,13
BACTRIM,Upper respiratory tract infection,13
BACTRIM,Agranulocytosis,13
BACTRIM,Infection,13
BACTRIM,Cough,12
BACTRIM,Chronic kidney disease,12
BACTRIM,Death,12
BACTRIM,Abdominal pain,12
BACTRIM,Product use in unapproved indication,11
BACTRIM,Decreased appetite,11
BACTRIM,Septic shock,11
BACTRIM,Anhedonia,10
BACTRIM,Renal impairment,10
BACTRIM,Fall,10
BACTRIM,Candida infection,10
BACTRIM,Cytokine release syndrome,10
BACTRIM,Hyperthermia,10
BACTRIM,Toxic skin eruption,9
BACTRIM,Back pain,9
BACTRIM,Depression,9
BECLOMETHASONE DIPROPIONATE,Nightmare,10
BECLOMETHASONE DIPROPIONATE,Contusion,10
BECLOMETHASONE DIPROPIONATE,Lower respiratory tract infection,9
BECLOMETHASONE DIPROPIONATE,Abdominal pain,9
BECLOMETHASONE DIPROPIONATE,Anxiety,8
BECLOMETHASONE DIPROPIONATE,Dyspnoea,8
BECLOMETHASONE DIPROPIONATE,Condition aggravated,8
BECLOMETHASONE DIPROPIONATE,Malaise,7
BECLOMETHASONE DIPROPIONATE,Peripheral swelling,7
BECLOMETHASONE DIPROPIONATE,Diarrhoea,7
BECLOMETHASONE DIPROPIONATE,Illness,6
BECLOMETHASONE DIPROPIONATE,Mucosal inflammation,6
BECLOMETHASONE DIPROPIONATE,Genital ulceration,6
BECLOMETHASONE DIPROPIONATE,Oral pain,6
BECLOMETHASONE DIPROPIONATE,Genital pain,6
BECLOMETHASONE DIPROPIONATE,Drug interaction,6
BECLOMETHASONE DIPROPIONATE,Arthropathy,5
BECLOMETHASONE DIPROPIONATE,Aggression,5
BECLOMETHASONE DIPROPIONATE,Enuresis,5
BECLOMETHASONE DIPROPIONATE,Hyperhidrosis,5
BECLOMETHASONE DIPROPIONATE,Product dose omission issue,5
BECLOMETHASONE DIPROPIONATE,Joint swelling,5
BECLOMETHASONE DIPROPIONATE,Blood potassium decreased,5
BECLOMETHASONE DIPROPIONATE,Gastrointestinal pain,5
BECLOMETHASONE DIPROPIONATE,Irritable bowel syndrome,5
BECLOMETHASONE DIPROPIONATE,Food poisoning,5
BECLOMETHASONE DIPROPIONATE,Vomiting,5
BECLOMETHASONE DIPROPIONATE,Abdominal pain upper,5
BECLOMETHASONE DIPROPIONATE,Feeling abnormal,5
BECLOMETHASONE DIPROPIONATE,Depression,4
BECLOMETHASONE DIPROPIONATE,Dizziness,4
BECLOMETHASONE DIPROPIONATE,Fatigue,4
BECLOMETHASONE DIPROPIONATE,Decreased appetite,4
BECLOMETHASONE DIPROPIONATE,Nausea,4
BECLOMETHASONE DIPROPIONATE,COVID-19,4
BECLOMETHASONE DIPROPIONATE,Off label use,4
BECLOMETHASONE DIPROPIONATE,Rash,4
BECLOMETHASONE DIPROPIONATE,Pain in extremity,4
BECLOMETHASONE DIPROPIONATE,Amnesia,4
BECLOMETHASONE DIPROPIONATE,Disturbance in attention,4
BECLOMETHASONE DIPROPIONATE,Tendonitis,4
BECLOMETHASONE DIPROPIONATE,Gait inability,4
BECLOMETHASONE DIPROPIONATE,Dementia,4
BECLOMETHASONE DIPROPIONATE,Hypersensitivity,3
BECLOMETHASONE DIPROPIONATE,Scar,3
BECLOMETHASONE DIPROPIONATE,Haemorrhage subcutaneous,3
BECLOMETHASONE DIPROPIONATE,Sensitive skin,3
BECLOMETHASONE DIPROPIONATE,Skin wound,3
BECLOMETHASONE DIPROPIONATE,Skin injury,3
BECLOMETHASONE DIPROPIONATE,"Hallucination, visual",3
BENADRYL,Fatigue,54
BENADRYL,Off label use,36
BENADRYL,COVID-19,35
BENADRYL,Pruritus,34
BENADRYL,Nausea,34
BENADRYL,Product dose omission issue,32
BENADRYL,Malaise,32
BENADRYL,Dyspnoea,32
BENADRYL,Pain,31
BENADRYL,Headache,30
BENADRYL,Arthralgia,28
BENADRYL,Inappropriate schedule of product administration,28
BENADRYL,Rash,28
BENADRYL,Cough,28
BENADRYL,Weight decreased,25
BENADRYL,Urticaria,25
BENADRYL,Pyrexia,24
BENADRYL,Erythema,21
BENADRYL,Pneumonia,20
BENADRYL,Weight increased,19
BENADRYL,Infusion related reaction,19
BENADRYL,Vomiting,19
BENADRYL,Diarrhoea,18
BENADRYL,Asthenia,18
BENADRYL,Fall,18
BENADRYL,Blood pressure increased,17
BENADRYL,Back pain,17
BENADRYL,Pain in extremity,16
BENADRYL,Nasopharyngitis,16
BENADRYL,Sinusitis,15
BENADRYL,Somnolence,15
BENADRYL,Dizziness,15
BENADRYL,Drug ineffective,15
BENADRYL,Drug hypersensitivity,14
BENADRYL,Swelling,14
BENADRYL,Anaphylactic reaction,14
BENADRYL,Anxiety,14
BENADRYL,Asthma,13
BENADRYL,Peripheral swelling,13
BENADRYL,Incorrect dose administered,13
BENADRYL,Hypersensitivity,13
BENADRYL,Illness,13
BENADRYL,Feeling abnormal,13
BENADRYL,Chest pain,13
BENADRYL,Upper respiratory tract infection,13
BENADRYL,Injection site pain,12
BENADRYL,Intentional product use issue,12
BENADRYL,Flushing,11
BENADRYL,Hypertension,11
BENADRYL,Decreased appetite,11
BENDAMUSTINE HYDROCHLORIDE,Myelosuppression,13
BENDAMUSTINE HYDROCHLORIDE,COVID-19,11
BENDAMUSTINE HYDROCHLORIDE,Infusion related reaction,10
BENDAMUSTINE HYDROCHLORIDE,Platelet count decreased,9
BENDAMUSTINE HYDROCHLORIDE,Off label use,7
BENDAMUSTINE HYDROCHLORIDE,White blood cell count decreased,6
BENDAMUSTINE HYDROCHLORIDE,Anuria,5
BENDAMUSTINE HYDROCHLORIDE,Acute kidney injury,5
BENDAMUSTINE HYDROCHLORIDE,Disease progression,5
BENDAMUSTINE HYDROCHLORIDE,Lymphocyte count decreased,4
BENDAMUSTINE HYDROCHLORIDE,Decreased appetite,4
BENDAMUSTINE HYDROCHLORIDE,Thrombocytopenia,3
BENDAMUSTINE HYDROCHLORIDE,Diffuse large B-cell lymphoma recurrent,3
BENDAMUSTINE HYDROCHLORIDE,Pyrexia,3
BENDAMUSTINE HYDROCHLORIDE,Anaemia,3
BENDAMUSTINE HYDROCHLORIDE,Pneumonia,3
BENDAMUSTINE HYDROCHLORIDE,Neutrophil count decreased,3
BENDAMUSTINE HYDROCHLORIDE,COVID-19 pneumonia,3
BENDAMUSTINE HYDROCHLORIDE,Cytopenia,3
BENDAMUSTINE HYDROCHLORIDE,Febrile neutropenia,3
BENDAMUSTINE HYDROCHLORIDE,Hepatic function abnormal,2
BENDAMUSTINE HYDROCHLORIDE,Lymphoma,2
BENDAMUSTINE HYDROCHLORIDE,Cytomegalovirus infection,2
BENDAMUSTINE HYDROCHLORIDE,Malignant neoplasm progression,2
BENDAMUSTINE HYDROCHLORIDE,Cytomegalovirus infection reactivation,2
BENDAMUSTINE HYDROCHLORIDE,Hypogammaglobulinaemia,2
BENDAMUSTINE HYDROCHLORIDE,Tumour lysis syndrome,2
BENDAMUSTINE HYDROCHLORIDE,Pneumocystis jirovecii pneumonia,2
BENDAMUSTINE HYDROCHLORIDE,Diarrhoea,2
BENDAMUSTINE HYDROCHLORIDE,Drug ineffective,2
BENDAMUSTINE HYDROCHLORIDE,Atrial fibrillation,2
BENDAMUSTINE HYDROCHLORIDE,Mouth ulceration,2
BENDAMUSTINE HYDROCHLORIDE,Serum sickness,2
BENDAMUSTINE HYDROCHLORIDE,Blood pressure decreased,2
BENDAMUSTINE HYDROCHLORIDE,Respiratory arrest,2
BENDAMUSTINE HYDROCHLORIDE,Cardiac arrest,2
BENDAMUSTINE HYDROCHLORIDE,Hydronephrosis,2
BENDAMUSTINE HYDROCHLORIDE,Drug reaction with eosinophilia and systemic symptoms,2
BENDAMUSTINE HYDROCHLORIDE,Tumour invasion,1
BENDAMUSTINE HYDROCHLORIDE,Red blood cell count decreased,1
BENDAMUSTINE HYDROCHLORIDE,Guillain-Barre syndrome,1
BENDAMUSTINE HYDROCHLORIDE,Rash,1
BENDAMUSTINE HYDROCHLORIDE,Blood creatinine increased,1
BENDAMUSTINE HYDROCHLORIDE,Abdominal pain,1
BENDAMUSTINE HYDROCHLORIDE,Hypersensitivity,1
BENDAMUSTINE HYDROCHLORIDE,Eczema,1
BENDAMUSTINE HYDROCHLORIDE,Hypoxia,1
BENDAMUSTINE HYDROCHLORIDE,Lower limb fracture,1
BENDAMUSTINE HYDROCHLORIDE,Cardiac failure congestive,1
BENDAMUSTINE HYDROCHLORIDE,Transaminases increased,1
BENDROFLUMETHIAZIDE,Intentional product misuse,118
BENDROFLUMETHIAZIDE,Abdominal discomfort,113
BENDROFLUMETHIAZIDE,Off label use,110
BENDROFLUMETHIAZIDE,COVID-19,102
BENDROFLUMETHIAZIDE,Malaise,96
BENDROFLUMETHIAZIDE,Hallucination,95
BENDROFLUMETHIAZIDE,Diarrhoea,95
BENDROFLUMETHIAZIDE,Tachycardia,94
BENDROFLUMETHIAZIDE,Feeling abnormal,92
BENDROFLUMETHIAZIDE,Pyrexia,91
BENDROFLUMETHIAZIDE,Abdominal pain upper,91
BENDROFLUMETHIAZIDE,Chest pain,91
BENDROFLUMETHIAZIDE,Peripheral swelling,91
BENDROFLUMETHIAZIDE,Vomiting,91
BENDROFLUMETHIAZIDE,Fatigue,90
BENDROFLUMETHIAZIDE,Pruritus,90
BENDROFLUMETHIAZIDE,Dyspnoea,89
BENDROFLUMETHIAZIDE,Visual impairment,89
BENDROFLUMETHIAZIDE,Amnesia,89
BENDROFLUMETHIAZIDE,Facial pain,89
BENDROFLUMETHIAZIDE,Dry skin,89
BENDROFLUMETHIAZIDE,Dehydration,89
BENDROFLUMETHIAZIDE,Palpitations,89
BENDROFLUMETHIAZIDE,Cardiospasm,89
BENDROFLUMETHIAZIDE,Angioedema,89
BENDROFLUMETHIAZIDE,Muscular weakness,89
BENDROFLUMETHIAZIDE,Subarachnoid haemorrhage,89
BENDROFLUMETHIAZIDE,Headache,89
BENDROFLUMETHIAZIDE,Lip swelling,89
BENDROFLUMETHIAZIDE,Disturbance in attention,89
BENDROFLUMETHIAZIDE,Anosmia,89
BENDROFLUMETHIAZIDE,Atrial tachycardia,89
BENDROFLUMETHIAZIDE,Pericarditis,89
BENDROFLUMETHIAZIDE,Myocardial infarction,88
BENDROFLUMETHIAZIDE,Nausea,88
BENDROFLUMETHIAZIDE,Dizziness,88
BENDROFLUMETHIAZIDE,Insomnia,88
BENDROFLUMETHIAZIDE,Diplopia,88
BENDROFLUMETHIAZIDE,Arthralgia,88
BENDROFLUMETHIAZIDE,Pain,88
BENDROFLUMETHIAZIDE,Hyperhidrosis,88
BENDROFLUMETHIAZIDE,Alopecia,88
BENDROFLUMETHIAZIDE,Anxiety,88
BENDROFLUMETHIAZIDE,Transient ischaemic attack,88
BENDROFLUMETHIAZIDE,Memory impairment,88
BENDROFLUMETHIAZIDE,Sleep terror,88
BENDROFLUMETHIAZIDE,Tension headache,88
BENDROFLUMETHIAZIDE,Blindness,88
BENDROFLUMETHIAZIDE,Migraine,88
BENDROFLUMETHIAZIDE,Vasculitis,88
BENZONATATE,Pain,15
BENZONATATE,Emotional distress,12
BENZONATATE,COVID-19,12
BENZONATATE,Anxiety,11
BENZONATATE,Fall,11
BENZONATATE,Anhedonia,10
BENZONATATE,Osteoporosis,9
BENZONATATE,Chronic kidney disease,8
BENZONATATE,Bone density decreased,8
BENZONATATE,Pneumonia,8
BENZONATATE,Multiple fractures,8
BENZONATATE,Osteopenia,7
BENZONATATE,Renal failure,7
BENZONATATE,Malaise,7
BENZONATATE,Off label use,6
BENZONATATE,Depression,6
BENZONATATE,Nausea,6
BENZONATATE,Cough,6
BENZONATATE,Sinusitis,6
BENZONATATE,Gait disturbance,6
BENZONATATE,Dyspnoea,5
BENZONATATE,Bronchitis,5
BENZONATATE,Dehydration,5
BENZONATATE,Foot fracture,5
BENZONATATE,Fatigue,5
BENZONATATE,Headache,5
BENZONATATE,Weight decreased,5
BENZONATATE,Urinary tract infection,5
BENZONATATE,Illness,5
BENZONATATE,Product dose omission issue,5
BENZONATATE,Economic problem,4
BENZONATATE,Pain in extremity,4
BENZONATATE,Blood creatinine increased,4
BENZONATATE,Back pain,4
BENZONATATE,Influenza,4
BENZONATATE,Bone demineralisation,4
BENZONATATE,Vomiting,4
BENZONATATE,Diarrhoea,4
BENZONATATE,Hand fracture,4
BENZONATATE,Arthralgia,3
BENZONATATE,Rib fracture,3
BENZONATATE,Candida infection,3
BENZONATATE,Infusion site erythema,3
BENZONATATE,Infusion site swelling,3
BENZONATATE,Head injury,3
BENZONATATE,Dizziness,3
BENZONATATE,Seizure,3
BENZONATATE,Nasopharyngitis,3
BENZONATATE,Upper respiratory tract infection,3
BENZONATATE,Weight increased,3
BETAMETHASONE,Nausea,16
BETAMETHASONE,Constipation,16
BETAMETHASONE,Dyspnoea,12
BETAMETHASONE,Abdominal pain,11
BETAMETHASONE,Pyrexia,10
BETAMETHASONE,Off label use,10
BETAMETHASONE,Vomiting,10
BETAMETHASONE,Ascites,10
BETAMETHASONE,Stress,9
BETAMETHASONE,Cardiogenic shock,9
BETAMETHASONE,Sepsis,9
BETAMETHASONE,Incorrect route of product administration,9
BETAMETHASONE,Multiple organ dysfunction syndrome,9
BETAMETHASONE,Abdominal distension,9
BETAMETHASONE,Pain,8
BETAMETHASONE,Hyponatraemia,8
BETAMETHASONE,Dry mouth,8
BETAMETHASONE,Condition aggravated,8
BETAMETHASONE,Somnolence,8
BETAMETHASONE,Skin exfoliation,7
BETAMETHASONE,Bacterial infection,7
BETAMETHASONE,Death,7
BETAMETHASONE,General physical health deterioration,7
BETAMETHASONE,Neuralgia,7
BETAMETHASONE,Swelling,7
BETAMETHASONE,Pruritus,7
BETAMETHASONE,Headache,6
BETAMETHASONE,Drug hypersensitivity,6
BETAMETHASONE,Drug intolerance,6
BETAMETHASONE,Intentional product misuse,6
BETAMETHASONE,Appendicolith,6
BETAMETHASONE,Ventricular fibrillation,6
BETAMETHASONE,Appendicitis,6
BETAMETHASONE,Sleep disorder,6
BETAMETHASONE,Pneumonia,6
BETAMETHASONE,Pain in extremity,5
BETAMETHASONE,Product use in unapproved indication,5
BETAMETHASONE,Blood cholesterol increased,5
BETAMETHASONE,Blood phosphorus increased,5
BETAMETHASONE,Myasthenia gravis,5
BETAMETHASONE,Blood uric acid increased,5
BETAMETHASONE,Fatigue,4
BETAMETHASONE,Rash,4
BETAMETHASONE,Abdominal pain upper,4
BETAMETHASONE,Malaise,4
BETAMETHASONE,Stomatitis,4
BETAMETHASONE,Anxiety,4
BETAMETHASONE,Pulmonary embolism,4
BETAMETHASONE,Thrombosis,4
BETAMETHASONE,Diabetes mellitus,4
BEVACIZUMAB,Off label use,34
BEVACIZUMAB,Diarrhoea,32
BEVACIZUMAB,Anaemia,21
BEVACIZUMAB,Fatigue,21
BEVACIZUMAB,White blood cell count decreased,21
BEVACIZUMAB,Nausea,20
BEVACIZUMAB,Hypertension,20
BEVACIZUMAB,Decreased appetite,19
BEVACIZUMAB,Pyrexia,17
BEVACIZUMAB,Hypothyroidism,17
BEVACIZUMAB,Death,16
BEVACIZUMAB,Proteinuria,16
BEVACIZUMAB,Neuropathy peripheral,15
BEVACIZUMAB,Febrile neutropenia,15
BEVACIZUMAB,Neutropenia,13
BEVACIZUMAB,Constipation,13
BEVACIZUMAB,Pneumonia,13
BEVACIZUMAB,Weight decreased,12
BEVACIZUMAB,Vomiting,12
BEVACIZUMAB,Stomatitis,11
BEVACIZUMAB,Platelet count decreased,10
BEVACIZUMAB,Neutrophil count decreased,10
BEVACIZUMAB,Rash,10
BEVACIZUMAB,Hepatic function abnormal,10
BEVACIZUMAB,Ascites,10
BEVACIZUMAB,Adrenal insufficiency,10
BEVACIZUMAB,Cholangitis,10
BEVACIZUMAB,Abdominal pain upper,9
BEVACIZUMAB,Hepatic failure,9
BEVACIZUMAB,Hyponatraemia,9
BEVACIZUMAB,Epistaxis,9
BEVACIZUMAB,Myelosuppression,9
BEVACIZUMAB,Alopecia,8
BEVACIZUMAB,Malaise,8
BEVACIZUMAB,Abdominal pain,8
BEVACIZUMAB,Disease progression,7
BEVACIZUMAB,Pain in extremity,7
BEVACIZUMAB,Malignant neoplasm progression,7
BEVACIZUMAB,Cough,7
BEVACIZUMAB,Oedema peripheral,7
BEVACIZUMAB,Urinary tract infection,7
BEVACIZUMAB,Dyspnoea,7
BEVACIZUMAB,Mucosal inflammation,6
BEVACIZUMAB,Lymphocyte count decreased,6
BEVACIZUMAB,Pruritus,6
BEVACIZUMAB,Alanine aminotransferase increased,6
BEVACIZUMAB,Asthenia,6
BEVACIZUMAB,Pleural effusion,5
BEVACIZUMAB,Ear pain,5
BEVACIZUMAB,Haemoglobin decreased,5
BIKTARVY,Pain,126
BIKTARVY,Emotional distress,125
BIKTARVY,Anxiety,124
BIKTARVY,Anhedonia,118
BIKTARVY,Osteoporosis,61
BIKTARVY,Chronic kidney disease,49
BIKTARVY,Osteopenia,46
BIKTARVY,Bone density decreased,44
BIKTARVY,Renal failure,34
BIKTARVY,Depression,33
BIKTARVY,Bone demineralisation,33
BIKTARVY,Blood creatinine increased,29
BIKTARVY,Renal impairment,28
BIKTARVY,Fatigue,27
BIKTARVY,Multiple fractures,25
BIKTARVY,Acute kidney injury,23
BIKTARVY,Asthenia,22
BIKTARVY,Gait disturbance,19
BIKTARVY,Economic problem,14
BIKTARVY,Osteonecrosis,14
BIKTARVY,Back pain,13
BIKTARVY,Renal injury,12
BIKTARVY,Bone loss,12
BIKTARVY,Foot fracture,11
BIKTARVY,Pollakiuria,9
BIKTARVY,Arthralgia,8
BIKTARVY,Loss of personal independence in daily activities,8
BIKTARVY,Dysstasia,8
BIKTARVY,Rib fracture,7
BIKTARVY,Tooth loss,7
BIKTARVY,Decreased activity,6
BIKTARVY,Wrist fracture,6
BIKTARVY,Mobility decreased,6
BIKTARVY,Pain in extremity,5
BIKTARVY,End stage renal disease,5
BIKTARVY,Osteoarthritis,5
BIKTARVY,Fracture,5
BIKTARVY,Hip fracture,5
BIKTARVY,Skeletal injury,5
BIKTARVY,Femur fracture,5
BIKTARVY,Proteinuria,5
BIKTARVY,Drug ineffective,5
BIKTARVY,Vitamin D deficiency,5
BIKTARVY,Insomnia,5
BIKTARVY,Bone pain,5
BIKTARVY,Shoulder fracture,4
BIKTARVY,Ankle fracture,4
BIKTARVY,Hypertension,4
BIKTARVY,Dyspnoea,4
BIKTARVY,Spinal fracture,4
BIOTIN,Fatigue,23
BIOTIN,Nausea,22
BIOTIN,Headache,16
BIOTIN,Fall,16
BIOTIN,Condition aggravated,16
BIOTIN,Vomiting,14
BIOTIN,Abdominal distension,14
BIOTIN,Stress,13
BIOTIN,Malaise,12
BIOTIN,Sepsis,12
BIOTIN,COVID-19,12
BIOTIN,Product dose omission issue,12
BIOTIN,Diarrhoea,12
BIOTIN,Dyspnoea,12
BIOTIN,Alopecia,11
BIOTIN,Sinusitis,11
BIOTIN,Constipation,11
BIOTIN,Pain,10
BIOTIN,Somnolence,10
BIOTIN,Off label use,10
BIOTIN,Illness,9
BIOTIN,Dry mouth,9
BIOTIN,Dyspepsia,9
BIOTIN,Urinary tract infection,8
BIOTIN,Cardiogenic shock,8
BIOTIN,Incorrect route of product administration,8
BIOTIN,Product use in unapproved indication,8
BIOTIN,Multiple organ dysfunction syndrome,8
BIOTIN,Ascites,8
BIOTIN,Dizziness,8
BIOTIN,Neuralgia,8
BIOTIN,Ear infection,7
BIOTIN,Hypersensitivity,7
BIOTIN,Incorrect dose administered,7
BIOTIN,Infection,7
BIOTIN,Bacterial infection,7
BIOTIN,Abdominal pain,7
BIOTIN,Swelling,7
BIOTIN,Oropharyngeal discomfort,7
BIOTIN,Eructation,7
BIOTIN,Regurgitation,7
BIOTIN,Neck pain,7
BIOTIN,Drug ineffective,6
BIOTIN,Depression,6
BIOTIN,Inappropriate schedule of product administration,6
BIOTIN,Decreased appetite,6
BIOTIN,Pneumonia,6
BIOTIN,Weight increased,6
BIOTIN,Respiratory tract infection,6
BIOTIN,Contusion,6
BISACODYL,Nausea,11
BISACODYL,Dyspnoea,11
BISACODYL,Vomiting,9
BISACODYL,Ascites,9
BISACODYL,Constipation,9
BISACODYL,Off label use,8
BISACODYL,Stress,8
BISACODYL,Cardiogenic shock,8
BISACODYL,Sepsis,8
BISACODYL,Incorrect route of product administration,8
BISACODYL,Multiple organ dysfunction syndrome,8
BISACODYL,Abdominal distension,8
BISACODYL,Somnolence,8
BISACODYL,Death,7
BISACODYL,Dry mouth,7
BISACODYL,Condition aggravated,7
BISACODYL,Abdominal pain,7
BISACODYL,Fatigue,6
BISACODYL,Pyrexia,6
BISACODYL,Bacterial infection,6
BISACODYL,Neuralgia,6
BISACODYL,Swelling,6
BISACODYL,COVID-19,5
BISACODYL,Drug hypersensitivity,5
BISACODYL,Drug intolerance,5
BISACODYL,Intentional product misuse,5
BISACODYL,Appendicolith,5
BISACODYL,Hyponatraemia,5
BISACODYL,General physical health deterioration,5
BISACODYL,Ventricular fibrillation,5
BISACODYL,Appendicitis,5
BISACODYL,Sleep disorder,5
BISACODYL,Anaemia,5
BISACODYL,Asthenia,4
BISACODYL,Dehydration,4
BISACODYL,Product use in unapproved indication,4
BISACODYL,Blood cholesterol increased,4
BISACODYL,Blood phosphorus increased,4
BISACODYL,Myasthenia gravis,4
BISACODYL,Blood uric acid increased,4
BISACODYL,Fall,4
BISACODYL,Pulmonary embolism,4
BISACODYL,Anxiety,3
BISACODYL,Pain in extremity,3
BISACODYL,Pain,3
BISACODYL,Product dose omission issue,3
BISACODYL,Rib fracture,3
BISACODYL,Diarrhoea,3
BISACODYL,Pneumonia,3
BISACODYL,Weight decreased,3
BISOPROLOL,Fatigue,132
BISOPROLOL,Diarrhoea,126
BISOPROLOL,Dyspnoea,117
BISOPROLOL,Nausea,110
BISOPROLOL,Vomiting,103
BISOPROLOL,Dizziness,103
BISOPROLOL,Arthralgia,101
BISOPROLOL,Malaise,97
BISOPROLOL,Pyrexia,96
BISOPROLOL,Headache,93
BISOPROLOL,Off label use,91
BISOPROLOL,Palpitations,89
BISOPROLOL,Pain,88
BISOPROLOL,Pruritus,87
BISOPROLOL,Dehydration,83
BISOPROLOL,Back pain,83
BISOPROLOL,Diplopia,82
BISOPROLOL,Alopecia,81
BISOPROLOL,COVID-19,81
BISOPROLOL,Tachycardia,80
BISOPROLOL,Chest pain,79
BISOPROLOL,Myocardial infarction,79
BISOPROLOL,Ventricular tachycardia,79
BISOPROLOL,Migraine,78
BISOPROLOL,Anxiety,77
BISOPROLOL,Hyperhidrosis,77
BISOPROLOL,Muscular weakness,77
BISOPROLOL,Hallucination,76
BISOPROLOL,Peripheral swelling,75
BISOPROLOL,Cognitive disorder,73
BISOPROLOL,Memory impairment,73
BISOPROLOL,Insomnia,73
BISOPROLOL,Blood glucose increased,72
BISOPROLOL,Dry skin,72
BISOPROLOL,Transient ischaemic attack,72
BISOPROLOL,Abdominal pain upper,72
BISOPROLOL,Heart rate increased,72
BISOPROLOL,Feeling abnormal,72
BISOPROLOL,Visual impairment,72
BISOPROLOL,Abdominal discomfort,72
BISOPROLOL,Vasculitis,72
BISOPROLOL,Disturbance in attention,72
BISOPROLOL,Tinnitus,71
BISOPROLOL,Subarachnoid haemorrhage,71
BISOPROLOL,Atrial tachycardia,71
BISOPROLOL,Lip swelling,71
BISOPROLOL,Pericarditis,71
BISOPROLOL,Intentional product misuse,70
BISOPROLOL,Amnesia,70
BISOPROLOL,Facial pain,70
BISOPROLOL FUMARATE,Fatigue,93
BISOPROLOL FUMARATE,Nausea,89
BISOPROLOL FUMARATE,Diarrhoea,89
BISOPROLOL FUMARATE,Vomiting,88
BISOPROLOL FUMARATE,Dizziness,86
BISOPROLOL FUMARATE,Dyspnoea,86
BISOPROLOL FUMARATE,Headache,86
BISOPROLOL FUMARATE,Palpitations,86
BISOPROLOL FUMARATE,Malaise,85
BISOPROLOL FUMARATE,Pruritus,85
BISOPROLOL FUMARATE,Pyrexia,85
BISOPROLOL FUMARATE,Pain,84
BISOPROLOL FUMARATE,COVID-19,83
BISOPROLOL FUMARATE,Back pain,82
BISOPROLOL FUMARATE,Dehydration,81
BISOPROLOL FUMARATE,Ventricular tachycardia,81
BISOPROLOL FUMARATE,Arthralgia,80
BISOPROLOL FUMARATE,Anxiety,79
BISOPROLOL FUMARATE,Peripheral swelling,79
BISOPROLOL FUMARATE,Disturbance in attention,78
BISOPROLOL FUMARATE,Atrial tachycardia,78
BISOPROLOL FUMARATE,Abdominal discomfort,78
BISOPROLOL FUMARATE,Amnesia,78
BISOPROLOL FUMARATE,Visual impairment,78
BISOPROLOL FUMARATE,Heart rate increased,78
BISOPROLOL FUMARATE,Muscular weakness,77
BISOPROLOL FUMARATE,Abdominal pain upper,77
BISOPROLOL FUMARATE,Alopecia,77
BISOPROLOL FUMARATE,Lip swelling,77
BISOPROLOL FUMARATE,Myocardial infarction,77
BISOPROLOL FUMARATE,Feeling abnormal,77
BISOPROLOL FUMARATE,Insomnia,77
BISOPROLOL FUMARATE,Chest pain,77
BISOPROLOL FUMARATE,Memory impairment,77
BISOPROLOL FUMARATE,Blood glucose increased,77
BISOPROLOL FUMARATE,Pericarditis,77
BISOPROLOL FUMARATE,Tension headache,76
BISOPROLOL FUMARATE,Hallucination,76
BISOPROLOL FUMARATE,Intentional product misuse,76
BISOPROLOL FUMARATE,Facial pain,76
BISOPROLOL FUMARATE,Dry skin,76
BISOPROLOL FUMARATE,Tachycardia,76
BISOPROLOL FUMARATE,Cardiospasm,76
BISOPROLOL FUMARATE,Angioedema,76
BISOPROLOL FUMARATE,Subarachnoid haemorrhage,76
BISOPROLOL FUMARATE,Pruritus genital,76
BISOPROLOL FUMARATE,Anosmia,76
BISOPROLOL FUMARATE,Off label use,75
BISOPROLOL FUMARATE,Diplopia,75
BISOPROLOL FUMARATE,Hyperhidrosis,75
BORTEZOMIB,Off label use,28
BORTEZOMIB,Pneumonia,19
BORTEZOMIB,Infusion related reaction,15
BORTEZOMIB,Vomiting,12
BORTEZOMIB,Platelet count decreased,11
BORTEZOMIB,Plasma cell myeloma,10
BORTEZOMIB,Diarrhoea,9
BORTEZOMIB,COVID-19,9
BORTEZOMIB,Neutropenia,8
BORTEZOMIB,Anaemia,7
BORTEZOMIB,Mucosal inflammation,7
BORTEZOMIB,Headache,7
BORTEZOMIB,Electrocardiogram QT prolonged,7
BORTEZOMIB,Pruritus,7
BORTEZOMIB,Disorientation,7
BORTEZOMIB,Incorrect route of product administration,6
BORTEZOMIB,Decreased appetite,6
BORTEZOMIB,Abdominal pain upper,6
BORTEZOMIB,Septic shock,6
BORTEZOMIB,Lower respiratory tract infection,6
BORTEZOMIB,Asthenia,6
BORTEZOMIB,Drug abuse,6
BORTEZOMIB,Medication error,6
BORTEZOMIB,Abnormal behaviour,6
BORTEZOMIB,Intentional product misuse,6
BORTEZOMIB,Paranoia,6
BORTEZOMIB,Hallucination,6
BORTEZOMIB,Agitation,6
BORTEZOMIB,Disturbance in social behaviour,6
BORTEZOMIB,Emotional distress,6
BORTEZOMIB,Confusional state,6
BORTEZOMIB,White blood cell count decreased,5
BORTEZOMIB,Influenza,5
BORTEZOMIB,Thrombocytopenia,5
BORTEZOMIB,Weight decreased,5
BORTEZOMIB,Constipation,5
BORTEZOMIB,Cardiac failure,5
BORTEZOMIB,Pancytopenia,5
BORTEZOMIB,Chills,5
BORTEZOMIB,Febrile neutropenia,5
BORTEZOMIB,Diabetes mellitus,5
BORTEZOMIB,Product use in unapproved indication,5
BORTEZOMIB,Drug ineffective,4
BORTEZOMIB,Neuropathy peripheral,4
BORTEZOMIB,Insomnia,4
BORTEZOMIB,Dyspnoea,4
BORTEZOMIB,Rash,4
BORTEZOMIB,Nausea,4
BORTEZOMIB,Neutrophil count decreased,4
BORTEZOMIB,Cardiac pacemaker evaluation,4
BOSULIF,Diarrhoea,30
BOSULIF,Nausea,20
BOSULIF,Malaise,16
BOSULIF,Asthenia,12
BOSULIF,Illness,12
BOSULIF,Off label use,11
BOSULIF,Vomiting,11
BOSULIF,Rash,10
BOSULIF,Fatigue,10
BOSULIF,Weight decreased,9
BOSULIF,Product dose omission issue,7
BOSULIF,Headache,7
BOSULIF,Pleural effusion,7
BOSULIF,Arthralgia,6
BOSULIF,Abdominal pain upper,6
BOSULIF,Neoplasm progression,6
BOSULIF,Pain,6
BOSULIF,Back pain,6
BOSULIF,COVID-19,6
BOSULIF,Insomnia,6
BOSULIF,Confusional state,5
BOSULIF,Pruritus,5
BOSULIF,Loss of personal independence in daily activities,5
BOSULIF,Fluid retention,5
BOSULIF,Nasopharyngitis,5
BOSULIF,Dizziness,4
BOSULIF,Decreased appetite,4
BOSULIF,Memory impairment,4
BOSULIF,Oropharyngeal pain,4
BOSULIF,Abdominal pain,4
BOSULIF,General physical health deterioration,4
BOSULIF,Acne,4
BOSULIF,Bronchitis,4
BOSULIF,Hepatic cytolysis,4
BOSULIF,Myalgia,4
BOSULIF,Fall,4
BOSULIF,Condition aggravated,4
BOSULIF,Pain in extremity,4
BOSULIF,Feeling abnormal,4
BOSULIF,Dysphonia,4
BOSULIF,Stress,4
BOSULIF,Joint swelling,3
BOSULIF,Dyspnoea,3
BOSULIF,Chest pain,3
BOSULIF,Hypoacusis,3
BOSULIF,Haemoglobin decreased,3
BOSULIF,Venous stenosis,3
BOSULIF,Dermatitis bullous,3
BOSULIF,Thermal burn,3
BOSULIF,Haemorrhage,3
BOTOX,Headache,17
BOTOX,Migraine,14
BOTOX,Off label use,10
BOTOX,Drug ineffective,9
BOTOX,Pain,8
BOTOX,Pain in extremity,7
BOTOX,Fall,5
BOTOX,Fatigue,5
BOTOX,Neck pain,5
BOTOX,COVID-19,5
BOTOX,Abdominal pain,5
BOTOX,Arthralgia,4
BOTOX,Infection,4
BOTOX,Peripheral swelling,4
BOTOX,Rash,4
BOTOX,Product dose omission issue,4
BOTOX,Nausea,4
BOTOX,Visual impairment,4
BOTOX,Hypersensitivity,4
BOTOX,Inappropriate schedule of product administration,4
BOTOX,Dizziness,4
BOTOX,Overdose,3
BOTOX,Sinusitis,3
BOTOX,Back pain,3
BOTOX,Pruritus,3
BOTOX,Neuropathy peripheral,3
BOTOX,Discomfort,3
BOTOX,Gait disturbance,3
BOTOX,Illness,3
BOTOX,Infusion site pain,3
BOTOX,Injection site pruritus,3
BOTOX,Gastrointestinal disorder,3
BOTOX,Muscular weakness,3
BOTOX,Therapeutic product effect decreased,3
BOTOX,Condition aggravated,3
BOTOX,Dilated cardiomyopathy,2
BOTOX,Product use in unapproved indication,2
BOTOX,Product prescribing issue,2
BOTOX,Arteriosclerosis coronary artery,2
BOTOX,Ejection fraction decreased,2
BOTOX,Dysarthria,2
BOTOX,Renal failure,2
BOTOX,Dyspnoea,2
BOTOX,Infusion related reaction,2
BOTOX,Oedema peripheral,2
BOTOX,Oropharyngeal pain,2
BOTOX,Rheumatoid arthritis,2
BOTOX,Pyrexia,2
BOTOX,Gastrointestinal infection,2
BOTOX,Viral infection,2
BRAFTOVI,Serous retinal detachment,18
BRAFTOVI,Nausea,13
BRAFTOVI,Off label use,13
BRAFTOVI,Pyrexia,12
BRAFTOVI,Malaise,10
BRAFTOVI,Diarrhoea,9
BRAFTOVI,Fatigue,9
BRAFTOVI,Neoplasm progression,8
BRAFTOVI,Vomiting,7
BRAFTOVI,Decreased appetite,6
BRAFTOVI,Dyspnoea,6
BRAFTOVI,Rash,5
BRAFTOVI,Underdose,4
BRAFTOVI,Urinary tract infection,4
BRAFTOVI,Dermatitis acneiform,4
BRAFTOVI,Interstitial lung disease,4
BRAFTOVI,Alanine aminotransferase increased,4
BRAFTOVI,Death,4
BRAFTOVI,Palmar-plantar erythrodysaesthesia syndrome,3
BRAFTOVI,Drug-induced liver injury,3
BRAFTOVI,Rhabdomyolysis,3
BRAFTOVI,Constipation,3
BRAFTOVI,Ileus,3
BRAFTOVI,Blood lactate dehydrogenase increased,3
BRAFTOVI,Macular oedema,3
BRAFTOVI,Product use issue,3
BRAFTOVI,Cardiac failure,3
BRAFTOVI,Acute kidney injury,3
BRAFTOVI,Renal impairment,3
BRAFTOVI,Hypoacusis,3
BRAFTOVI,Aspartate aminotransferase increased,3
BRAFTOVI,Pain,3
BRAFTOVI,Weight decreased,3
BRAFTOVI,Pemphigoid,3
BRAFTOVI,Enterocolitis,3
BRAFTOVI,Serous retinopathy,2
BRAFTOVI,Central serous chorioretinopathy,2
BRAFTOVI,Asthenia,2
BRAFTOVI,Neuropathy peripheral,2
BRAFTOVI,Pruritus,2
BRAFTOVI,Haemophagocytic lymphohistiocytosis,2
BRAFTOVI,Pancytopenia,2
BRAFTOVI,Detachment of retinal pigment epithelium,2
BRAFTOVI,Disseminated intravascular coagulation,2
BRAFTOVI,Influenza,2
BRAFTOVI,Abdominal wall haematoma,2
BRAFTOVI,Haematuria,2
BRAFTOVI,Carcinoembryonic antigen increased,2
BRAFTOVI,Abdominal pain upper,2
BRAFTOVI,Subretinal fluid,2
BREO ELLIPTA,Pneumonia,33
BREO ELLIPTA,Sinusitis,22
BREO ELLIPTA,Product dose omission issue,22
BREO ELLIPTA,COVID-19,20
BREO ELLIPTA,Weight decreased,17
BREO ELLIPTA,Illness,17
BREO ELLIPTA,Urinary tract infection,17
BREO ELLIPTA,Bronchitis,16
BREO ELLIPTA,Headache,16
BREO ELLIPTA,Fatigue,16
BREO ELLIPTA,Nasopharyngitis,15
BREO ELLIPTA,Asthma,15
BREO ELLIPTA,Fall,13
BREO ELLIPTA,Infusion related reaction,12
BREO ELLIPTA,Cough,11
BREO ELLIPTA,Dyspnoea,11
BREO ELLIPTA,Arthralgia,11
BREO ELLIPTA,Infection,11
BREO ELLIPTA,Upper respiratory tract infection,11
BREO ELLIPTA,Respiratory tract infection,10
BREO ELLIPTA,Blood pressure increased,10
BREO ELLIPTA,Influenza,10
BREO ELLIPTA,Vomiting,10
BREO ELLIPTA,Diarrhoea,9
BREO ELLIPTA,Pain,9
BREO ELLIPTA,Inappropriate schedule of product administration,9
BREO ELLIPTA,Nausea,9
BREO ELLIPTA,Malaise,9
BREO ELLIPTA,Dehydration,9
BREO ELLIPTA,Viral infection,8
BREO ELLIPTA,Cystitis,8
BREO ELLIPTA,Condition aggravated,8
BREO ELLIPTA,Infusion site extravasation,8
BREO ELLIPTA,Infusion site pain,8
BREO ELLIPTA,Injection site erythema,8
BREO ELLIPTA,Asthenia,7
BREO ELLIPTA,Dizziness,7
BREO ELLIPTA,Injection site pain,6
BREO ELLIPTA,Feeling abnormal,6
BREO ELLIPTA,Pyrexia,6
BREO ELLIPTA,Rash,6
BREO ELLIPTA,Seasonal allergy,6
BREO ELLIPTA,Depression,6
BREO ELLIPTA,Sepsis,6
BREO ELLIPTA,Fungal infection,6
BREO ELLIPTA,Back pain,6
BREO ELLIPTA,Skin laceration,6
BREO ELLIPTA,Product use issue,6
BREO ELLIPTA,Weight increased,6
BREO ELLIPTA,Chills,5
BROMAZEPAM,Coma,13
BROMAZEPAM,Cholestasis,8
BROMAZEPAM,Acute kidney injury,7
BROMAZEPAM,Gait disturbance,7
BROMAZEPAM,Confusional state,7
BROMAZEPAM,Drug abuse,7
BROMAZEPAM,Cerebrovascular accident,7
BROMAZEPAM,General physical health deterioration,6
BROMAZEPAM,Overdose,6
BROMAZEPAM,Pulmonary oedema,6
BROMAZEPAM,Vomiting,6
BROMAZEPAM,Nausea,5
BROMAZEPAM,Diarrhoea,5
BROMAZEPAM,Dyskinesia,5
BROMAZEPAM,Extrapyramidal disorder,5
BROMAZEPAM,Mitral valve disease,5
BROMAZEPAM,Aortic valve disease,5
BROMAZEPAM,Haemodynamic instability,5
BROMAZEPAM,Depressed level of consciousness,5
BROMAZEPAM,Pneumonia aspiration,5
BROMAZEPAM,Inflammation,4
BROMAZEPAM,Lactic acidosis,4
BROMAZEPAM,Incorrect product administration duration,4
BROMAZEPAM,Ischaemic hepatitis,4
BROMAZEPAM,Fall,4
BROMAZEPAM,Malaise,4
BROMAZEPAM,Discomfort,4
BROMAZEPAM,Asphyxia,4
BROMAZEPAM,Product use in unapproved indication,4
BROMAZEPAM,Seizure,4
BROMAZEPAM,Drug interaction,4
BROMAZEPAM,Nervous system disorder,3
BROMAZEPAM,Epistaxis,3
BROMAZEPAM,Asthenia,3
BROMAZEPAM,Neutropenia,3
BROMAZEPAM,Pain,3
BROMAZEPAM,Vision blurred,3
BROMAZEPAM,Somnolence,3
BROMAZEPAM,Balance disorder,3
BROMAZEPAM,Vertigo,3
BROMAZEPAM,Weight increased,3
BROMAZEPAM,Fatigue,3
BROMAZEPAM,Headache,3
BROMAZEPAM,Diplopia,3
BROMAZEPAM,Hyperhidrosis,3
BROMAZEPAM,Tremor,3
BROMAZEPAM,Paraesthesia,3
BROMAZEPAM,"Hallucinations, mixed",3
BROMAZEPAM,Intentional product misuse,3
BROMAZEPAM,Drug detoxification,3
BUDESONIDE,Pneumonia,19
BUDESONIDE,Dyspnoea,18
BUDESONIDE,COVID-19,17
BUDESONIDE,Diarrhoea,16
BUDESONIDE,Sinusitis,15
BUDESONIDE,Product dose omission issue,15
BUDESONIDE,Fatigue,15
BUDESONIDE,Off label use,15
BUDESONIDE,Arthralgia,14
BUDESONIDE,Pyrexia,14
BUDESONIDE,Asthma,13
BUDESONIDE,Pain,12
BUDESONIDE,Influenza,12
BUDESONIDE,Nausea,12
BUDESONIDE,Weight decreased,12
BUDESONIDE,Headache,11
BUDESONIDE,Nasopharyngitis,11
BUDESONIDE,Upper respiratory tract infection,10
BUDESONIDE,Cough,10
BUDESONIDE,Illness,9
BUDESONIDE,Asthenia,9
BUDESONIDE,Condition aggravated,9
BUDESONIDE,Anxiety,8
BUDESONIDE,Contusion,8
BUDESONIDE,Vomiting,8
BUDESONIDE,Weight increased,8
BUDESONIDE,General physical health deterioration,8
BUDESONIDE,Respiratory tract infection,7
BUDESONIDE,Drug hypersensitivity,7
BUDESONIDE,Depression,7
BUDESONIDE,Drug ineffective,7
BUDESONIDE,Blood pressure increased,7
BUDESONIDE,Ear infection,7
BUDESONIDE,Inappropriate schedule of product administration,7
BUDESONIDE,Malaise,7
BUDESONIDE,Abdominal pain,6
BUDESONIDE,Fall,6
BUDESONIDE,Urinary tract infection,6
BUDESONIDE,Hyponatraemia,6
BUDESONIDE,Chest discomfort,6
BUDESONIDE,Product use in unapproved indication,6
BUDESONIDE,Wheezing,6
BUDESONIDE,Chronic obstructive pulmonary disease,5
BUDESONIDE,Hypersensitivity,5
BUDESONIDE,Hypoxia,5
BUDESONIDE,Pleural effusion,5
BUDESONIDE,Peripheral swelling,5
BUDESONIDE,Colitis ulcerative,5
BUDESONIDE,Sepsis,5
BUDESONIDE,Pruritus,5
BUPROPION,Pain,24
BUPROPION,Anxiety,23
BUPROPION,Depression,16
BUPROPION,Fatigue,15
BUPROPION,Nausea,15
BUPROPION,Emotional distress,14
BUPROPION,Anhedonia,14
BUPROPION,Diarrhoea,12
BUPROPION,Pneumonia,10
BUPROPION,Osteopenia,9
BUPROPION,Product dose omission issue,9
BUPROPION,Sinusitis,8
BUPROPION,Chronic kidney disease,8
BUPROPION,Back pain,8
BUPROPION,Vomiting,8
BUPROPION,Headache,8
BUPROPION,COVID-19,8
BUPROPION,Cough,8
BUPROPION,Dyspnoea,7
BUPROPION,Pruritus,7
BUPROPION,Malaise,7
BUPROPION,Osteoporosis,6
BUPROPION,Renal failure,6
BUPROPION,Dehydration,6
BUPROPION,Bone density decreased,6
BUPROPION,Urinary tract infection,6
BUPROPION,Arthralgia,6
BUPROPION,Joint swelling,6
BUPROPION,Migraine,6
BUPROPION,Illness,6
BUPROPION,Peripheral swelling,6
BUPROPION,Fall,6
BUPROPION,Economic problem,5
BUPROPION,Ankle fracture,5
BUPROPION,Blood creatinine increased,5
BUPROPION,Abdominal pain,5
BUPROPION,Feeling abnormal,5
BUPROPION,Memory impairment,5
BUPROPION,Rash,5
BUPROPION,Abdominal pain upper,5
BUPROPION,Quality of life decreased,4
BUPROPION,Foot fracture,4
BUPROPION,Multiple fractures,4
BUPROPION,Myocardial infarction,4
BUPROPION,Hiatus hernia,4
BUPROPION,Urticaria,4
BUPROPION,Dizziness,4
BUPROPION,Condition aggravated,4
BUPROPION,Bronchitis,4
BUPROPION,Contusion,4
BUPROPION HYDROCHLORIDE,Fatigue,11
BUPROPION HYDROCHLORIDE,Headache,10
BUPROPION HYDROCHLORIDE,Product dose omission issue,10
BUPROPION HYDROCHLORIDE,Sinusitis,8
BUPROPION HYDROCHLORIDE,COVID-19,8
BUPROPION HYDROCHLORIDE,Insomnia,6
BUPROPION HYDROCHLORIDE,Pneumonia,6
BUPROPION HYDROCHLORIDE,Depression,5
BUPROPION HYDROCHLORIDE,Off label use,5
BUPROPION HYDROCHLORIDE,Urinary tract infection,5
BUPROPION HYDROCHLORIDE,Infusion site pain,5
BUPROPION HYDROCHLORIDE,Nasopharyngitis,5
BUPROPION HYDROCHLORIDE,Inappropriate schedule of product administration,4
BUPROPION HYDROCHLORIDE,Rash,4
BUPROPION HYDROCHLORIDE,Drug ineffective,4
BUPROPION HYDROCHLORIDE,Sinus disorder,4
BUPROPION HYDROCHLORIDE,Migraine,4
BUPROPION HYDROCHLORIDE,Viral infection,4
BUPROPION HYDROCHLORIDE,Infection,4
BUPROPION HYDROCHLORIDE,Upper respiratory tract infection,4
BUPROPION HYDROCHLORIDE,Illness,4
BUPROPION HYDROCHLORIDE,Weight decreased,3
BUPROPION HYDROCHLORIDE,Dizziness,3
BUPROPION HYDROCHLORIDE,Abdominal pain upper,3
BUPROPION HYDROCHLORIDE,Dry skin,3
BUPROPION HYDROCHLORIDE,Kidney infection,3
BUPROPION HYDROCHLORIDE,Peripheral swelling,3
BUPROPION HYDROCHLORIDE,Arthralgia,3
BUPROPION HYDROCHLORIDE,Infusion site swelling,3
BUPROPION HYDROCHLORIDE,Orthostatic hypotension,3
BUPROPION HYDROCHLORIDE,Skin exfoliation,3
BUPROPION HYDROCHLORIDE,Dry eye,3
BUPROPION HYDROCHLORIDE,Lacrimation increased,3
BUPROPION HYDROCHLORIDE,Anaemia,3
BUPROPION HYDROCHLORIDE,Memory impairment,3
BUPROPION HYDROCHLORIDE,Pain,3
BUPROPION HYDROCHLORIDE,Product use in unapproved indication,3
BUPROPION HYDROCHLORIDE,Vomiting,3
BUPROPION HYDROCHLORIDE,Erythema,3
BUPROPION HYDROCHLORIDE,Pruritus,3
BUPROPION HYDROCHLORIDE,Malaise,3
BUPROPION HYDROCHLORIDE,Nausea,3
BUPROPION HYDROCHLORIDE,Dermatitis,2
BUPROPION HYDROCHLORIDE,Stress,2
BUPROPION HYDROCHLORIDE,Asthenia,2
BUPROPION HYDROCHLORIDE,Drug effective for unapproved indication,2
BUPROPION HYDROCHLORIDE,Acne,2
BUPROPION HYDROCHLORIDE,Hypertension,2
BUPROPION HYDROCHLORIDE,Dry mouth,2
BUPROPION HYDROCHLORIDE,Abdominal discomfort,2
BUSPIRONE,Fatigue,9
BUSPIRONE,Off label use,8
BUSPIRONE,Anxiety,7
BUSPIRONE,Nausea,7
BUSPIRONE,Product dose omission issue,7
BUSPIRONE,Headache,6
BUSPIRONE,Depression,5
BUSPIRONE,Pain,5
BUSPIRONE,Fall,5
BUSPIRONE,Decreased appetite,5
BUSPIRONE,Dyspnoea,5
BUSPIRONE,Vomiting,4
BUSPIRONE,Diarrhoea,4
BUSPIRONE,Tremor,4
BUSPIRONE,Condition aggravated,4
BUSPIRONE,Weight decreased,4
BUSPIRONE,Emotional distress,3
BUSPIRONE,Anhedonia,3
BUSPIRONE,Renal injury,3
BUSPIRONE,Rib fracture,3
BUSPIRONE,Gait disturbance,3
BUSPIRONE,Abdominal discomfort,3
BUSPIRONE,Chronic obstructive pulmonary disease,3
BUSPIRONE,Hypertension,3
BUSPIRONE,Palpitations,3
BUSPIRONE,Migraine,3
BUSPIRONE,Arthralgia,3
BUSPIRONE,Device breakage,3
BUSPIRONE,Insomnia,3
BUSPIRONE,Pyrexia,3
BUSPIRONE,Vision blurred,3
BUSPIRONE,Infusion related reaction,3
BUSPIRONE,Blood potassium decreased,3
BUSPIRONE,Skin discolouration,3
BUSPIRONE,Renal impairment,2
BUSPIRONE,Foot fracture,2
BUSPIRONE,Blood creatinine increased,2
BUSPIRONE,Chronic kidney disease,2
BUSPIRONE,Cardiac failure congestive,2
BUSPIRONE,Hallucination,2
BUSPIRONE,Multiple sclerosis,2
BUSPIRONE,Acute kidney injury,2
BUSPIRONE,Myalgia,2
BUSPIRONE,Memory impairment,2
BUSPIRONE,Dry mouth,2
BUSPIRONE,Muscular weakness,2
BUSPIRONE,Hypersensitivity,2
BUSPIRONE,Device kink,2
BUSPIRONE,Device placement issue,2
BUSPIRONE,Drug hypersensitivity,2
CABOMETYX,Diarrhoea,17
CABOMETYX,Nausea,12
CABOMETYX,Fatigue,11
CABOMETYX,Hypertension,9
CABOMETYX,Decreased appetite,9
CABOMETYX,Malignant neoplasm progression,9
CABOMETYX,Weight decreased,7
CABOMETYX,Hepatic cytolysis,7
CABOMETYX,Acute kidney injury,7
CABOMETYX,Stomatitis,6
CABOMETYX,Palmar-plantar erythrodysaesthesia syndrome,6
CABOMETYX,Constipation,6
CABOMETYX,Taste disorder,6
CABOMETYX,Hepatic function abnormal,6
CABOMETYX,Death,6
CABOMETYX,Pyrexia,6
CABOMETYX,Jaundice,6
CABOMETYX,Cholestasis,6
CABOMETYX,Pruritus,5
CABOMETYX,Inappropriate schedule of product administration,5
CABOMETYX,Hypothyroidism,5
CABOMETYX,Blood pressure increased,5
CABOMETYX,Asthenia,5
CABOMETYX,Pulmonary embolism,4
CABOMETYX,Cardiac failure,4
CABOMETYX,Renal impairment,4
CABOMETYX,Liver disorder,4
CABOMETYX,Illness,4
CABOMETYX,Skin ulcer,4
CABOMETYX,Abdominal pain upper,4
CABOMETYX,Abdominal discomfort,4
CABOMETYX,Dehydration,4
CABOMETYX,Dry skin,4
CABOMETYX,Off label use,4
CABOMETYX,Vomiting,4
CABOMETYX,Insomnia,4
CABOMETYX,Weight increased,3
CABOMETYX,Glossodynia,3
CABOMETYX,Dyspnoea,3
CABOMETYX,Skin exfoliation,3
CABOMETYX,Myocardial infarction,3
CABOMETYX,Platelet count decreased,3
CABOMETYX,Rash,3
CABOMETYX,Abdominal pain,3
CABOMETYX,Gastritis,3
CABOMETYX,Pleural effusion,2
CABOMETYX,Renal cell carcinoma,2
CABOMETYX,Thrombosis,2
CABOMETYX,Skin discolouration,2
CABOMETYX,Product dose omission issue,2
CALCITRIOL,Drug hypersensitivity,37
CALCITRIOL,Off label use,29
CALCITRIOL,Nausea,20
CALCITRIOL,Vomiting,18
CALCITRIOL,Dyspnoea,16
CALCITRIOL,Constipation,12
CALCITRIOL,Feeling hot,10
CALCITRIOL,Haematochezia,9
CALCITRIOL,Death,9
CALCITRIOL,Condition aggravated,9
CALCITRIOL,Pneumonia,9
CALCITRIOL,Diarrhoea,8
CALCITRIOL,Pain,8
CALCITRIOL,Stress,8
CALCITRIOL,Cardiogenic shock,8
CALCITRIOL,Sepsis,8
CALCITRIOL,Incorrect route of product administration,8
CALCITRIOL,Multiple organ dysfunction syndrome,8
CALCITRIOL,Ascites,8
CALCITRIOL,Abdominal distension,8
CALCITRIOL,Abdominal pain,8
CALCITRIOL,Neuralgia,8
CALCITRIOL,Headache,8
CALCITRIOL,Prescribed overdose,7
CALCITRIOL,Product dose omission issue,7
CALCITRIOL,Hyponatraemia,7
CALCITRIOL,Dry mouth,7
CALCITRIOL,Somnolence,7
CALCITRIOL,COVID-19,7
CALCITRIOL,Back pain,7
CALCITRIOL,Influenza,6
CALCITRIOL,Hypocalcaemia,6
CALCITRIOL,Bacterial infection,6
CALCITRIOL,Swelling,6
CALCITRIOL,End stage renal disease,5
CALCITRIOL,Chronic kidney disease,5
CALCITRIOL,Renal failure,5
CALCITRIOL,Emotional distress,5
CALCITRIOL,Urinary tract infection,5
CALCITRIOL,Drug intolerance,5
CALCITRIOL,Intentional product misuse,5
CALCITRIOL,Appendicolith,5
CALCITRIOL,General physical health deterioration,5
CALCITRIOL,Ventricular fibrillation,5
CALCITRIOL,Appendicitis,5
CALCITRIOL,Muscle spasms,5
CALCITRIOL,Pyrexia,5
CALCITRIOL,Diabetes mellitus,5
CALCITRIOL,Illness,5
CALCITRIOL,Sleep disorder,5
CALCIUM,Fatigue,76
CALCIUM,Off label use,74
CALCIUM,Diarrhoea,60
CALCIUM,Pain,52
CALCIUM,Headache,51
CALCIUM,COVID-19,46
CALCIUM,Nausea,45
CALCIUM,Rash,41
CALCIUM,Pain in extremity,39
CALCIUM,Anxiety,35
CALCIUM,Product dose omission issue,35
CALCIUM,Fall,34
CALCIUM,Dyspnoea,34
CALCIUM,Arthralgia,33
CALCIUM,Asthenia,33
CALCIUM,Back pain,33
CALCIUM,Malaise,33
CALCIUM,Vomiting,32
CALCIUM,Weight increased,32
CALCIUM,Urinary tract infection,31
CALCIUM,Pneumonia,30
CALCIUM,Sinusitis,29
CALCIUM,Weight decreased,29
CALCIUM,Condition aggravated,28
CALCIUM,Cough,28
CALCIUM,Pruritus,27
CALCIUM,Dizziness,27
CALCIUM,Pyrexia,27
CALCIUM,Hypersensitivity,26
CALCIUM,Illness,25
CALCIUM,Abdominal pain,25
CALCIUM,Anaemia,25
CALCIUM,Inappropriate schedule of product administration,25
CALCIUM,Gait disturbance,23
CALCIUM,Osteoporosis,23
CALCIUM,Nasopharyngitis,22
CALCIUM,Neck pain,22
CALCIUM,Insomnia,21
CALCIUM,Drug ineffective,21
CALCIUM,Infection,21
CALCIUM,Influenza,20
CALCIUM,Alopecia,20
CALCIUM,Anhedonia,20
CALCIUM,Emotional distress,20
CALCIUM,Blood pressure increased,20
CALCIUM,Gastrooesophageal reflux disease,19
CALCIUM,Influenza like illness,18
CALCIUM,Intentional product use issue,17
CALCIUM,Contusion,17
CALCIUM,Asthma,17
CALCIUM CARBONATE,Off label use,28
CALCIUM CARBONATE,Diarrhoea,22
CALCIUM CARBONATE,Pain,22
CALCIUM CARBONATE,Abdominal pain,21
CALCIUM CARBONATE,Fatigue,18
CALCIUM CARBONATE,Arthralgia,18
CALCIUM CARBONATE,Vomiting,17
CALCIUM CARBONATE,Pyrexia,17
CALCIUM CARBONATE,Dyspnoea,17
CALCIUM CARBONATE,Pneumonia,17
CALCIUM CARBONATE,Anxiety,16
CALCIUM CARBONATE,COVID-19,16
CALCIUM CARBONATE,Weight decreased,15
CALCIUM CARBONATE,Constipation,15
CALCIUM CARBONATE,Hypersensitivity,14
CALCIUM CARBONATE,Condition aggravated,14
CALCIUM CARBONATE,Confusional state,13
CALCIUM CARBONATE,Hypertension,12
CALCIUM CARBONATE,Nausea,12
CALCIUM CARBONATE,Decreased appetite,12
CALCIUM CARBONATE,Rash,11
CALCIUM CARBONATE,Dizziness,11
CALCIUM CARBONATE,Chest pain,11
CALCIUM CARBONATE,Anaemia,11
CALCIUM CARBONATE,Abdominal distension,11
CALCIUM CARBONATE,Weight increased,10
CALCIUM CARBONATE,Pruritus,10
CALCIUM CARBONATE,Headache,10
CALCIUM CARBONATE,Joint swelling,10
CALCIUM CARBONATE,Insomnia,10
CALCIUM CARBONATE,General physical health deterioration,10
CALCIUM CARBONATE,Arthropathy,10
CALCIUM CARBONATE,Dyspepsia,10
CALCIUM CARBONATE,Fall,10
CALCIUM CARBONATE,Lower respiratory tract infection,9
CALCIUM CARBONATE,Drug ineffective,9
CALCIUM CARBONATE,Gait disturbance,9
CALCIUM CARBONATE,Influenza,9
CALCIUM CARBONATE,Neck pain,9
CALCIUM CARBONATE,Barrett's oesophagus,9
CALCIUM CARBONATE,Death,9
CALCIUM CARBONATE,Asthenia,8
CALCIUM CARBONATE,Dry mouth,8
CALCIUM CARBONATE,Stomatitis,8
CALCIUM CARBONATE,Oedema peripheral,8
CALCIUM CARBONATE,Oropharyngeal discomfort,8
CALCIUM CARBONATE,Neutropenia,8
CALCIUM CARBONATE,Hypocalcaemia,8
CALCIUM CARBONATE,Acute kidney injury,8
CALCIUM CARBONATE,Alopecia,7
CALCIUM CARBONATE\CHOLECALCIFEROL,Off label use,11
CALCIUM CARBONATE\CHOLECALCIFEROL,Diarrhoea,11
CALCIUM CARBONATE\CHOLECALCIFEROL,Pneumonia,10
CALCIUM CARBONATE\CHOLECALCIFEROL,Headache,10
CALCIUM CARBONATE\CHOLECALCIFEROL,Dyspepsia,10
CALCIUM CARBONATE\CHOLECALCIFEROL,Fatigue,10
CALCIUM CARBONATE\CHOLECALCIFEROL,COVID-19,9
CALCIUM CARBONATE\CHOLECALCIFEROL,Back pain,8
CALCIUM CARBONATE\CHOLECALCIFEROL,Hypersensitivity,8
CALCIUM CARBONATE\CHOLECALCIFEROL,Neck pain,8
CALCIUM CARBONATE\CHOLECALCIFEROL,Arthralgia,7
CALCIUM CARBONATE\CHOLECALCIFEROL,Dyspnoea,7
CALCIUM CARBONATE\CHOLECALCIFEROL,Constipation,7
CALCIUM CARBONATE\CHOLECALCIFEROL,Abdominal distension,7
CALCIUM CARBONATE\CHOLECALCIFEROL,Pain,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Nausea,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Rash,6
CALCIUM CARBONATE\CHOLECALCIFEROL,White blood cell count decreased,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Vitamin B12 deficiency,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Oropharyngeal discomfort,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Eructation,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Regurgitation,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Barrett's oesophagus,6
CALCIUM CARBONATE\CHOLECALCIFEROL,Anxiety,5
CALCIUM CARBONATE\CHOLECALCIFEROL,Osteoporosis,5
CALCIUM CARBONATE\CHOLECALCIFEROL,Vomiting,5
CALCIUM CARBONATE\CHOLECALCIFEROL,Hypokalaemia,5
CALCIUM CARBONATE\CHOLECALCIFEROL,Dry eye,5
CALCIUM CARBONATE\CHOLECALCIFEROL,Pyrexia,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Blood pressure increased,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Osteopenia,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Sinusitis,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Malaise,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Product dose omission issue,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Aspartate aminotransferase increased,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Multiple fractures,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Seizure,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Anaemia,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Condition aggravated,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Pulmonary embolism,4
CALCIUM CARBONATE\CHOLECALCIFEROL,Swelling face,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Adverse drug reaction,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Migraine,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Asthma,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Fall,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Lethargy,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Intervertebral disc protrusion,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Epistaxis,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Blood lactate dehydrogenase increased,3
CALCIUM CARBONATE\CHOLECALCIFEROL,Hypocalcaemia,3
CALCIUM\CHOLECALCIFEROL,Fatigue,33
CALCIUM\CHOLECALCIFEROL,Diarrhoea,26
CALCIUM\CHOLECALCIFEROL,COVID-19,22
CALCIUM\CHOLECALCIFEROL,Nausea,21
CALCIUM\CHOLECALCIFEROL,Off label use,20
CALCIUM\CHOLECALCIFEROL,Dyspepsia,19
CALCIUM\CHOLECALCIFEROL,Mucosal inflammation,18
CALCIUM\CHOLECALCIFEROL,Pneumonia,16
CALCIUM\CHOLECALCIFEROL,Pyrexia,16
CALCIUM\CHOLECALCIFEROL,Neuropathy peripheral,15
CALCIUM\CHOLECALCIFEROL,Neutropenia,15
CALCIUM\CHOLECALCIFEROL,Platelet count decreased,14
CALCIUM\CHOLECALCIFEROL,Headache,13
CALCIUM\CHOLECALCIFEROL,Cellulitis,13
CALCIUM\CHOLECALCIFEROL,Fall,13
CALCIUM\CHOLECALCIFEROL,Lymphocyte count decreased,13
CALCIUM\CHOLECALCIFEROL,Anaemia,13
CALCIUM\CHOLECALCIFEROL,Dyspnoea,11
CALCIUM\CHOLECALCIFEROL,Weight decreased,11
CALCIUM\CHOLECALCIFEROL,Stomatitis,11
CALCIUM\CHOLECALCIFEROL,Leukopenia,11
CALCIUM\CHOLECALCIFEROL,Overdose,11
CALCIUM\CHOLECALCIFEROL,Incorrect dose administered,11
CALCIUM\CHOLECALCIFEROL,Alopecia,10
CALCIUM\CHOLECALCIFEROL,Arthralgia,10
CALCIUM\CHOLECALCIFEROL,Product dose omission issue,10
CALCIUM\CHOLECALCIFEROL,Vomiting,9
CALCIUM\CHOLECALCIFEROL,Back pain,9
CALCIUM\CHOLECALCIFEROL,Rash,9
CALCIUM\CHOLECALCIFEROL,Pain,9
CALCIUM\CHOLECALCIFEROL,Affective disorder,9
CALCIUM\CHOLECALCIFEROL,Neutrophil count increased,9
CALCIUM\CHOLECALCIFEROL,Schizophrenia,9
CALCIUM\CHOLECALCIFEROL,Seizure,9
CALCIUM\CHOLECALCIFEROL,Psychotic disorder,9
CALCIUM\CHOLECALCIFEROL,Disease progression,9
CALCIUM\CHOLECALCIFEROL,"Hallucination, auditory",9
CALCIUM\CHOLECALCIFEROL,Extrapyramidal disorder,9
CALCIUM\CHOLECALCIFEROL,Delusion of grandeur,9
CALCIUM\CHOLECALCIFEROL,Constipation,8
CALCIUM\CHOLECALCIFEROL,Rhinalgia,8
CALCIUM\CHOLECALCIFEROL,Thrombocytopenia,8
CALCIUM\CHOLECALCIFEROL,Urinary tract infection,7
CALCIUM\CHOLECALCIFEROL,Dysuria,7
CALCIUM\CHOLECALCIFEROL,Alanine aminotransferase increased,7
CALCIUM\CHOLECALCIFEROL,Illness,7
CALCIUM\CHOLECALCIFEROL,Lymphocyte count abnormal,7
CALCIUM\CHOLECALCIFEROL,Pruritus,7
CALCIUM\CHOLECALCIFEROL,SARS-CoV-2 test positive,7
CALCIUM\CHOLECALCIFEROL,Inappropriate schedule of product administration,7
CALCIUM\VITAMIN D,Off label use,11
CALCIUM\VITAMIN D,COVID-19,9
CALCIUM\VITAMIN D,Fatigue,9
CALCIUM\VITAMIN D,Arthralgia,8
CALCIUM\VITAMIN D,Product dose omission issue,8
CALCIUM\VITAMIN D,Fall,7
CALCIUM\VITAMIN D,Pain,7
CALCIUM\VITAMIN D,Nasopharyngitis,7
CALCIUM\VITAMIN D,Back pain,7
CALCIUM\VITAMIN D,Nausea,7
CALCIUM\VITAMIN D,Barrett's oesophagus,6
CALCIUM\VITAMIN D,Pain in extremity,6
CALCIUM\VITAMIN D,Headache,6
CALCIUM\VITAMIN D,Hypersensitivity,6
CALCIUM\VITAMIN D,Neck pain,6
CALCIUM\VITAMIN D,Influenza,5
CALCIUM\VITAMIN D,Urinary tract infection,5
CALCIUM\VITAMIN D,Illness,5
CALCIUM\VITAMIN D,Diarrhoea,5
CALCIUM\VITAMIN D,Pneumonia,5
CALCIUM\VITAMIN D,Insomnia,5
CALCIUM\VITAMIN D,Anxiety,5
CALCIUM\VITAMIN D,Constipation,5
CALCIUM\VITAMIN D,Atrial fibrillation,5
CALCIUM\VITAMIN D,Dyspepsia,5
CALCIUM\VITAMIN D,Vitamin B12 deficiency,5
CALCIUM\VITAMIN D,Oropharyngeal discomfort,5
CALCIUM\VITAMIN D,Eructation,5
CALCIUM\VITAMIN D,Regurgitation,5
CALCIUM\VITAMIN D,Abdominal distension,5
CALCIUM\VITAMIN D,Blood pressure increased,5
CALCIUM\VITAMIN D,Gait disturbance,4
CALCIUM\VITAMIN D,Body height decreased,4
CALCIUM\VITAMIN D,Neuropathy peripheral,4
CALCIUM\VITAMIN D,Feeling abnormal,4
CALCIUM\VITAMIN D,Malaise,4
CALCIUM\VITAMIN D,Weight increased,4
CALCIUM\VITAMIN D,Haemoglobin decreased,4
CALCIUM\VITAMIN D,Asthenia,4
CALCIUM\VITAMIN D,Medication error,4
CALCIUM\VITAMIN D,Dizziness,4
CALCIUM\VITAMIN D,Weight decreased,3
CALCIUM\VITAMIN D,Muscle spasms,3
CALCIUM\VITAMIN D,Pyrexia,3
CALCIUM\VITAMIN D,Hip arthroplasty,3
CALCIUM\VITAMIN D,Oropharyngeal pain,3
CALCIUM\VITAMIN D,Emotional distress,3
CALCIUM\VITAMIN D,Road traffic accident,3
CALCIUM\VITAMIN D,Head injury,3
CALCIUM\VITAMIN D,Peripheral swelling,3
CALONAL,Nausea,15
CALONAL,Diarrhoea,14
CALONAL,Pyrexia,13
CALONAL,Interstitial lung disease,8
CALONAL,Malaise,7
CALONAL,Headache,7
CALONAL,Disease progression,6
CALONAL,Anaemia,6
CALONAL,Lymphocyte count decreased,6
CALONAL,Cardiac failure,6
CALONAL,Hypertension,5
CALONAL,Decreased appetite,5
CALONAL,Abdominal pain,5
CALONAL,Vomiting,5
CALONAL,Pneumonia,5
CALONAL,Liver disorder,5
CALONAL,Off label use,5
CALONAL,Arthralgia,4
CALONAL,Weight increased,4
CALONAL,Constipation,4
CALONAL,Rash,4
CALONAL,Alopecia,4
CALONAL,Herpes zoster,4
CALONAL,Hypoaesthesia,4
CALONAL,Platelet count decreased,4
CALONAL,Infusion related reaction,4
CALONAL,Drug eruption,4
CALONAL,Insomnia,3
CALONAL,Hyperkalaemia,3
CALONAL,Neutrophil count decreased,3
CALONAL,Malignant neoplasm progression,3
CALONAL,Dizziness,3
CALONAL,Pruritus,3
CALONAL,Diabetes mellitus,3
CALONAL,Dehydration,3
CALONAL,Pain in extremity,3
CALONAL,White blood cell count decreased,3
CALONAL,Drug-induced liver injury,3
CALONAL,Blood creatine phosphokinase increased,3
CALONAL,Alanine aminotransferase increased,3
CALONAL,Aspartate aminotransferase increased,3
CALONAL,Oedema,3
CALONAL,Familial mediterranean fever,2
CALONAL,Muscular weakness,2
CALONAL,Respiratory disorder,2
CALONAL,Cerebral infarction,2
CALONAL,Hepatic function abnormal,2
CALONAL,Death,2
CALONAL,Injection site pain,2
CALONAL,Musculoskeletal pain,2
CANDESARTAN,Dyspnoea,85
CANDESARTAN,Fatigue,82
CANDESARTAN,Dizziness,80
CANDESARTAN,Nausea,79
CANDESARTAN,Arthralgia,79
CANDESARTAN,Diarrhoea,78
CANDESARTAN,Headache,77
CANDESARTAN,Malaise,76
CANDESARTAN,Pain,75
CANDESARTAN,Off label use,75
CANDESARTAN,Pyrexia,75
CANDESARTAN,Pruritus,75
CANDESARTAN,Diplopia,74
CANDESARTAN,Migraine,73
CANDESARTAN,Palpitations,73
CANDESARTAN,COVID-19,72
CANDESARTAN,Muscular weakness,71
CANDESARTAN,Vomiting,71
CANDESARTAN,Myocardial infarction,70
CANDESARTAN,Hyperhidrosis,69
CANDESARTAN,Peripheral swelling,68
CANDESARTAN,Back pain,66
CANDESARTAN,Disturbance in attention,66
CANDESARTAN,Anxiety,65
CANDESARTAN,Abdominal discomfort,65
CANDESARTAN,Alopecia,65
CANDESARTAN,Memory impairment,65
CANDESARTAN,Pericarditis,64
CANDESARTAN,Angioedema,64
CANDESARTAN,Dehydration,64
CANDESARTAN,Visual impairment,64
CANDESARTAN,Chest pain,64
CANDESARTAN,Heart rate increased,64
CANDESARTAN,Amnesia,63
CANDESARTAN,Insomnia,63
CANDESARTAN,Feeling abnormal,63
CANDESARTAN,Tachycardia,63
CANDESARTAN,Hallucination,63
CANDESARTAN,Blindness,62
CANDESARTAN,Intentional product misuse,62
CANDESARTAN,Facial pain,62
CANDESARTAN,Abdominal pain upper,62
CANDESARTAN,Dry skin,62
CANDESARTAN,Cardiospasm,62
CANDESARTAN,Tinnitus,62
CANDESARTAN,Vasculitis,62
CANDESARTAN,Subarachnoid haemorrhage,62
CANDESARTAN,Lip swelling,62
CANDESARTAN,Anosmia,62
CANDESARTAN,Atrial tachycardia,62
CANDESARTAN CILEXETIL,Dyspnoea,39
CANDESARTAN CILEXETIL,Fatigue,37
CANDESARTAN CILEXETIL,Nausea,35
CANDESARTAN CILEXETIL,Pruritus,35
CANDESARTAN CILEXETIL,Arthralgia,35
CANDESARTAN CILEXETIL,Vomiting,34
CANDESARTAN CILEXETIL,Malaise,34
CANDESARTAN CILEXETIL,Diarrhoea,33
CANDESARTAN CILEXETIL,Back pain,33
CANDESARTAN CILEXETIL,Dizziness,33
CANDESARTAN CILEXETIL,Pyrexia,32
CANDESARTAN CILEXETIL,Tachycardia,32
CANDESARTAN CILEXETIL,Chest pain,32
CANDESARTAN CILEXETIL,COVID-19,32
CANDESARTAN CILEXETIL,Headache,32
CANDESARTAN CILEXETIL,Alopecia,32
CANDESARTAN CILEXETIL,Hyperhidrosis,31
CANDESARTAN CILEXETIL,Transient ischaemic attack,31
CANDESARTAN CILEXETIL,Anxiety,31
CANDESARTAN CILEXETIL,Insomnia,31
CANDESARTAN CILEXETIL,Myocardial infarction,31
CANDESARTAN CILEXETIL,Pain,31
CANDESARTAN CILEXETIL,Memory impairment,31
CANDESARTAN CILEXETIL,Dry skin,31
CANDESARTAN CILEXETIL,Dehydration,31
CANDESARTAN CILEXETIL,Pain of skin,31
CANDESARTAN CILEXETIL,Disturbance in attention,30
CANDESARTAN CILEXETIL,Angioedema,30
CANDESARTAN CILEXETIL,Muscular weakness,30
CANDESARTAN CILEXETIL,Migraine,30
CANDESARTAN CILEXETIL,Heart rate increased,30
CANDESARTAN CILEXETIL,Blindness,30
CANDESARTAN CILEXETIL,Facial pain,30
CANDESARTAN CILEXETIL,Amnesia,30
CANDESARTAN CILEXETIL,Cognitive disorder,30
CANDESARTAN CILEXETIL,Hallucination,30
CANDESARTAN CILEXETIL,Palmoplantar keratoderma,30
CANDESARTAN CILEXETIL,Vasculitis,30
CANDESARTAN CILEXETIL,Pruritus genital,30
CANDESARTAN CILEXETIL,Tension headache,30
CANDESARTAN CILEXETIL,Subarachnoid haemorrhage,30
CANDESARTAN CILEXETIL,Feeling abnormal,30
CANDESARTAN CILEXETIL,Ventricular tachycardia,30
CANDESARTAN CILEXETIL,Carotid artery occlusion,30
CANDESARTAN CILEXETIL,Diplopia,30
CANDESARTAN CILEXETIL,Sleep terror,30
CANDESARTAN CILEXETIL,Blood glucose increased,30
CANDESARTAN CILEXETIL,Lip swelling,30
CANDESARTAN CILEXETIL,Abdominal pain upper,30
CANDESARTAN CILEXETIL,Anosmia,30
CANNABIS SATIVA SUBSP. INDICA TOP,Pain,15
CANNABIS SATIVA SUBSP. INDICA TOP,Emotional distress,12
CANNABIS SATIVA SUBSP. INDICA TOP,Anxiety,12
CANNABIS SATIVA SUBSP. INDICA TOP,Anhedonia,11
CANNABIS SATIVA SUBSP. INDICA TOP,Coma,11
CANNABIS SATIVA SUBSP. INDICA TOP,Drug abuse,8
CANNABIS SATIVA SUBSP. INDICA TOP,Osteopenia,6
CANNABIS SATIVA SUBSP. INDICA TOP,Poisoning deliberate,6
CANNABIS SATIVA SUBSP. INDICA TOP,Chronic kidney disease,5
CANNABIS SATIVA SUBSP. INDICA TOP,Fatigue,5
CANNABIS SATIVA SUBSP. INDICA TOP,Bone demineralisation,5
CANNABIS SATIVA SUBSP. INDICA TOP,Cerebrovascular accident,5
CANNABIS SATIVA SUBSP. INDICA TOP,Pollakiuria,4
CANNABIS SATIVA SUBSP. INDICA TOP,Bone density decreased,4
CANNABIS SATIVA SUBSP. INDICA TOP,Osteoporosis,4
CANNABIS SATIVA SUBSP. INDICA TOP,Irritability,4
CANNABIS SATIVA SUBSP. INDICA TOP,Pruritus,3
CANNABIS SATIVA SUBSP. INDICA TOP,Substance use,3
CANNABIS SATIVA SUBSP. INDICA TOP,Off label use,3
CANNABIS SATIVA SUBSP. INDICA TOP,Diarrhoea,3
CANNABIS SATIVA SUBSP. INDICA TOP,Depression,3
CANNABIS SATIVA SUBSP. INDICA TOP,Malaise,3
CANNABIS SATIVA SUBSP. INDICA TOP,Insomnia,3
CANNABIS SATIVA SUBSP. INDICA TOP,Back pain,3
CANNABIS SATIVA SUBSP. INDICA TOP,Blood creatinine increased,3
CANNABIS SATIVA SUBSP. INDICA TOP,Vomiting,3
CANNABIS SATIVA SUBSP. INDICA TOP,Pain in extremity,3
CANNABIS SATIVA SUBSP. INDICA TOP,Bradypnoea,3
CANNABIS SATIVA SUBSP. INDICA TOP,Tremor,3
CANNABIS SATIVA SUBSP. INDICA TOP,Apnoea,3
CANNABIS SATIVA SUBSP. INDICA TOP,Maternal drugs affecting foetus,3
CANNABIS SATIVA SUBSP. INDICA TOP,Oxygen saturation decreased,3
CANNABIS SATIVA SUBSP. INDICA TOP,Weight decreased,2
CANNABIS SATIVA SUBSP. INDICA TOP,Urticaria,2
CANNABIS SATIVA SUBSP. INDICA TOP,Disseminated varicella zoster virus infection,2
CANNABIS SATIVA SUBSP. INDICA TOP,Multiple sclerosis relapse,2
CANNABIS SATIVA SUBSP. INDICA TOP,Constipation,2
CANNABIS SATIVA SUBSP. INDICA TOP,Dermatitis allergic,2
CANNABIS SATIVA SUBSP. INDICA TOP,Pancytopenia,2
CANNABIS SATIVA SUBSP. INDICA TOP,Migraine with aura,2
CANNABIS SATIVA SUBSP. INDICA TOP,Encephalitis viral,2
CANNABIS SATIVA SUBSP. INDICA TOP,Muscle spasticity,2
CANNABIS SATIVA SUBSP. INDICA TOP,Oral candidiasis,2
CANNABIS SATIVA SUBSP. INDICA TOP,Cytomegalovirus infection,2
CANNABIS SATIVA SUBSP. INDICA TOP,Dizziness,2
CANNABIS SATIVA SUBSP. INDICA TOP,Acute kidney injury,2
CANNABIS SATIVA SUBSP. INDICA TOP,Temperature intolerance,2
CANNABIS SATIVA SUBSP. INDICA TOP,Gait disturbance,2
CANNABIS SATIVA SUBSP. INDICA TOP,Nausea,2
CANNABIS SATIVA SUBSP. INDICA TOP,Nephrolithiasis,2
CAPECITABINE,Diarrhoea,24
CAPECITABINE,Neutropenia,13
CAPECITABINE,Palmar-plantar erythrodysaesthesia syndrome,10
CAPECITABINE,Keratitis,10
CAPECITABINE,Visual acuity reduced,10
CAPECITABINE,Cerebrovascular accident,8
CAPECITABINE,Nausea,8
CAPECITABINE,Asthenia,8
CAPECITABINE,Acute kidney injury,7
CAPECITABINE,Fatigue,7
CAPECITABINE,Pyrexia,6
CAPECITABINE,Neurotoxicity,6
CAPECITABINE,Colitis,6
CAPECITABINE,Dysphagia,6
CAPECITABINE,Vomiting,6
CAPECITABINE,Dyspnoea,5
CAPECITABINE,Arthralgia,5
CAPECITABINE,Myelosuppression,5
CAPECITABINE,Adrenal insufficiency,5
CAPECITABINE,General physical health deterioration,5
CAPECITABINE,Platelet count decreased,5
CAPECITABINE,Skin exfoliation,5
CAPECITABINE,Decreased appetite,5
CAPECITABINE,Paraesthesia,5
CAPECITABINE,Stomatitis,4
CAPECITABINE,Breast cancer metastatic,4
CAPECITABINE,Neutropenic sepsis,4
CAPECITABINE,Rash,4
CAPECITABINE,Carcinoembryonic antigen increased,4
CAPECITABINE,Dyspepsia,4
CAPECITABINE,Abdominal pain upper,4
CAPECITABINE,Diarrhoea haemorrhagic,4
CAPECITABINE,Hypotension,4
CAPECITABINE,Hypoaesthesia,4
CAPECITABINE,Blood creatine decreased,4
CAPECITABINE,Back pain,4
CAPECITABINE,Anaemia,3
CAPECITABINE,Polyneuropathy,3
CAPECITABINE,Infection,3
CAPECITABINE,Off label use,3
CAPECITABINE,Urinary tract infection,3
CAPECITABINE,Rectal haemorrhage,3
CAPECITABINE,Condition aggravated,3
CAPECITABINE,Hepatic function abnormal,3
CAPECITABINE,Constipation,3
CAPECITABINE,Hypokalaemia,3
CAPECITABINE,Metastases to central nervous system,3
CAPECITABINE,Lymphopenia,3
CAPECITABINE,Aortic valve incompetence,3
CAPECITABINE,Gamma-glutamyltransferase abnormal,3
CARBAMAZEPINE,Product dose omission issue,28
CARBAMAZEPINE,Rash,28
CARBAMAZEPINE,Off label use,26
CARBAMAZEPINE,Overdose,25
CARBAMAZEPINE,Intentional product misuse,24
CARBAMAZEPINE,Pulmonary pain,24
CARBAMAZEPINE,Abdominal discomfort,24
CARBAMAZEPINE,Lower respiratory tract infection,24
CARBAMAZEPINE,Drug abuse,24
CARBAMAZEPINE,Arthropathy,23
CARBAMAZEPINE,Knee arthroplasty,22
CARBAMAZEPINE,Condition aggravated,14
CARBAMAZEPINE,Lung neoplasm malignant,13
CARBAMAZEPINE,Radiation inflammation,13
CARBAMAZEPINE,Inflammation,13
CARBAMAZEPINE,COVID-19,13
CARBAMAZEPINE,Schizophrenia,12
CARBAMAZEPINE,Obesity,11
CARBAMAZEPINE,Amyloid arthropathy,10
CARBAMAZEPINE,Vomiting,8
CARBAMAZEPINE,Fall,8
CARBAMAZEPINE,Fatigue,7
CARBAMAZEPINE,Contusion,7
CARBAMAZEPINE,Dizziness,7
CARBAMAZEPINE,Food poisoning,7
CARBAMAZEPINE,Headache,6
CARBAMAZEPINE,Pain,6
CARBAMAZEPINE,Peripheral swelling,6
CARBAMAZEPINE,Diarrhoea,6
CARBAMAZEPINE,Drug interaction,6
CARBAMAZEPINE,Hypoaesthesia,5
CARBAMAZEPINE,Somnolence,5
CARBAMAZEPINE,Gait disturbance,5
CARBAMAZEPINE,Malaise,5
CARBAMAZEPINE,Feeling abnormal,5
CARBAMAZEPINE,Illness,5
CARBAMAZEPINE,Abdominal pain upper,5
CARBAMAZEPINE,Abdominal pain,4
CARBAMAZEPINE,Anxiety,4
CARBAMAZEPINE,Pain in extremity,4
CARBAMAZEPINE,Dyspnoea,4
CARBAMAZEPINE,Hypersensitivity,4
CARBAMAZEPINE,Infection,4
CARBAMAZEPINE,Drug ineffective,4
CARBAMAZEPINE,Oral pain,4
CARBAMAZEPINE,Mucosal inflammation,4
CARBAMAZEPINE,Gastrointestinal pain,4
CARBAMAZEPINE,Dementia,4
CARBAMAZEPINE,Genital pain,4
CARBAMAZEPINE,Inappropriate schedule of product administration,3
CARBIDOPA\LEVODOPA,Fall,32
CARBIDOPA\LEVODOPA,Hallucination,20
CARBIDOPA\LEVODOPA,Malaise,17
CARBIDOPA\LEVODOPA,Dyskinesia,16
CARBIDOPA\LEVODOPA,Drug ineffective,15
CARBIDOPA\LEVODOPA,Stoma site discharge,15
CARBIDOPA\LEVODOPA,On and off phenomenon,13
CARBIDOPA\LEVODOPA,Tremor,13
CARBIDOPA\LEVODOPA,Mobility decreased,12
CARBIDOPA\LEVODOPA,Fatigue,12
CARBIDOPA\LEVODOPA,Product dose omission issue,11
CARBIDOPA\LEVODOPA,Stoma site pain,11
CARBIDOPA\LEVODOPA,Parkinson's disease,11
CARBIDOPA\LEVODOPA,Therapeutic product effect incomplete,11
CARBIDOPA\LEVODOPA,Nausea,10
CARBIDOPA\LEVODOPA,Speech disorder,10
CARBIDOPA\LEVODOPA,Inappropriate schedule of product administration,9
CARBIDOPA\LEVODOPA,Device issue,9
CARBIDOPA\LEVODOPA,Abdominal pain,9
CARBIDOPA\LEVODOPA,Stoma site erythema,9
CARBIDOPA\LEVODOPA,Dizziness,9
CARBIDOPA\LEVODOPA,Weight decreased,9
CARBIDOPA\LEVODOPA,Gait disturbance,8
CARBIDOPA\LEVODOPA,Insomnia,8
CARBIDOPA\LEVODOPA,General physical health deterioration,8
CARBIDOPA\LEVODOPA,Death,8
CARBIDOPA\LEVODOPA,Unevaluable event,8
CARBIDOPA\LEVODOPA,Device dislocation,7
CARBIDOPA\LEVODOPA,Device occlusion,7
CARBIDOPA\LEVODOPA,Musculoskeletal stiffness,7
CARBIDOPA\LEVODOPA,Dyspnoea,7
CARBIDOPA\LEVODOPA,Wrong technique in product usage process,7
CARBIDOPA\LEVODOPA,Asthenia,7
CARBIDOPA\LEVODOPA,Freezing phenomenon,7
CARBIDOPA\LEVODOPA,Muscular weakness,6
CARBIDOPA\LEVODOPA,Constipation,6
CARBIDOPA\LEVODOPA,Hypokinesia,6
CARBIDOPA\LEVODOPA,Urinary tract infection,6
CARBIDOPA\LEVODOPA,Memory impairment,6
CARBIDOPA\LEVODOPA,Bradykinesia,6
CARBIDOPA\LEVODOPA,Pyrexia,6
CARBIDOPA\LEVODOPA,Hypophagia,6
CARBIDOPA\LEVODOPA,Hip fracture,5
CARBIDOPA\LEVODOPA,Dyspepsia,5
CARBIDOPA\LEVODOPA,Balance disorder,5
CARBIDOPA\LEVODOPA,Gait inability,5
CARBIDOPA\LEVODOPA,Abnormal behaviour,5
CARBIDOPA\LEVODOPA,Head injury,5
CARBIDOPA\LEVODOPA,Oedema peripheral,5
CARBIDOPA\LEVODOPA,Pneumonia,5
CARBOCYSTEINE,Off label use,31
CARBOCYSTEINE,Product dose omission issue,24
CARBOCYSTEINE,Intentional product misuse,24
CARBOCYSTEINE,Pulmonary pain,24
CARBOCYSTEINE,Abdominal discomfort,24
CARBOCYSTEINE,Lower respiratory tract infection,24
CARBOCYSTEINE,Overdose,24
CARBOCYSTEINE,Rash,24
CARBOCYSTEINE,Drug abuse,24
CARBOCYSTEINE,Arthropathy,23
CARBOCYSTEINE,Knee arthroplasty,22
CARBOCYSTEINE,Diarrhoea,16
CARBOCYSTEINE,COVID-19,16
CARBOCYSTEINE,Condition aggravated,14
CARBOCYSTEINE,Lung neoplasm malignant,13
CARBOCYSTEINE,Radiation inflammation,13
CARBOCYSTEINE,Inflammation,13
CARBOCYSTEINE,Pneumonia,12
CARBOCYSTEINE,Schizophrenia,12
CARBOCYSTEINE,Obesity,11
CARBOCYSTEINE,Amyloid arthropathy,10
CARBOCYSTEINE,Dyspnoea,10
CARBOCYSTEINE,Vomiting,9
CARBOCYSTEINE,Pyrexia,8
CARBOCYSTEINE,Malaise,8
CARBOCYSTEINE,Food poisoning,8
CARBOCYSTEINE,Anaemia,7
CARBOCYSTEINE,Peripheral swelling,7
CARBOCYSTEINE,Abdominal pain,6
CARBOCYSTEINE,Illness,5
CARBOCYSTEINE,Mucosal inflammation,5
CARBOCYSTEINE,Drug interaction,5
CARBOCYSTEINE,Headache,4
CARBOCYSTEINE,Thrombocytopenia,4
CARBOCYSTEINE,Embolism,4
CARBOCYSTEINE,Orthostatic hypertension,4
CARBOCYSTEINE,Arthritis,4
CARBOCYSTEINE,Neutropenic sepsis,4
CARBOCYSTEINE,Chills,4
CARBOCYSTEINE,Death,4
CARBOCYSTEINE,Joint swelling,4
CARBOCYSTEINE,Abdominal pain upper,4
CARBOCYSTEINE,Oral pain,4
CARBOCYSTEINE,Gastrointestinal pain,4
CARBOCYSTEINE,Dementia,4
CARBOCYSTEINE,Genital pain,4
CARBOCYSTEINE,Weight increased,3
CARBOCYSTEINE,Constipation,3
CARBOCYSTEINE,Fatigue,3
CARBOCYSTEINE,Urinary tract infection,3
CARBOPLATIN,Diarrhoea,91
CARBOPLATIN,Anaemia,90
CARBOPLATIN,Nausea,71
CARBOPLATIN,Pyrexia,68
CARBOPLATIN,Pancytopenia,59
CARBOPLATIN,Neutrophil count decreased,55
CARBOPLATIN,Neutropenia,55
CARBOPLATIN,Vomiting,54
CARBOPLATIN,Death,53
CARBOPLATIN,White blood cell count decreased,52
CARBOPLATIN,Febrile neutropenia,49
CARBOPLATIN,Pneumonia,49
CARBOPLATIN,Dyspnoea,45
CARBOPLATIN,Thrombocytopenia,44
CARBOPLATIN,Off label use,42
CARBOPLATIN,Decreased appetite,42
CARBOPLATIN,Platelet count decreased,41
CARBOPLATIN,Asthenia,40
CARBOPLATIN,Constipation,39
CARBOPLATIN,Rash,34
CARBOPLATIN,Fatigue,32
CARBOPLATIN,Hypokalaemia,31
CARBOPLATIN,Malignant neoplasm progression,29
CARBOPLATIN,Hypothyroidism,29
CARBOPLATIN,Acute kidney injury,28
CARBOPLATIN,Mucosal inflammation,28
CARBOPLATIN,Neutropenic sepsis,28
CARBOPLATIN,Hyponatraemia,25
CARBOPLATIN,Condition aggravated,25
CARBOPLATIN,Haemoglobin decreased,24
CARBOPLATIN,Interstitial lung disease,24
CARBOPLATIN,Hypomagnesaemia,24
CARBOPLATIN,Tubulointerstitial nephritis,24
CARBOPLATIN,Dehydration,23
CARBOPLATIN,General physical health deterioration,22
CARBOPLATIN,Malaise,22
CARBOPLATIN,Alopecia,21
CARBOPLATIN,Weight decreased,21
CARBOPLATIN,Abdominal pain,21
CARBOPLATIN,Adrenal insufficiency,20
CARBOPLATIN,Lymphocyte count decreased,19
CARBOPLATIN,Non-small cell lung cancer,19
CARBOPLATIN,Pruritus,19
CARBOPLATIN,Neuropathy peripheral,18
CARBOPLATIN,Lower respiratory tract infection,18
CARBOPLATIN,Respiratory failure,18
CARBOPLATIN,Headache,17
CARBOPLATIN,Arthralgia,17
CARBOPLATIN,Chest pain,17
CARBOPLATIN,Disease progression,16
CARFILZOMIB,Pyrexia,7
CARFILZOMIB,Respiratory failure,6
CARFILZOMIB,Anaemia,6
CARFILZOMIB,Acute kidney injury,5
CARFILZOMIB,General physical health deterioration,5
CARFILZOMIB,Neutropenia,5
CARFILZOMIB,Febrile neutropenia,5
CARFILZOMIB,Lung disorder,5
CARFILZOMIB,Toxic skin eruption,5
CARFILZOMIB,COVID-19,5
CARFILZOMIB,Respiratory distress,4
CARFILZOMIB,Pulmonary embolism,4
CARFILZOMIB,Hypertension,4
CARFILZOMIB,Transaminases increased,4
CARFILZOMIB,Cardiac failure,3
CARFILZOMIB,Ejection fraction decreased,3
CARFILZOMIB,Pleural effusion,3
CARFILZOMIB,Back pain,3
CARFILZOMIB,Pneumonia,3
CARFILZOMIB,Thrombocytopenia,3
CARFILZOMIB,Tachycardia,3
CARFILZOMIB,Cough,3
CARFILZOMIB,Heart rate increased,3
CARFILZOMIB,Vomiting,3
CARFILZOMIB,Neuropathy peripheral,3
CARFILZOMIB,Cytokine release syndrome,3
CARFILZOMIB,Dyspnoea,3
CARFILZOMIB,Septic shock,3
CARFILZOMIB,Plasma cell myeloma,3
CARFILZOMIB,Urosepsis,3
CARFILZOMIB,Aspartate aminotransferase increased,2
CARFILZOMIB,Alanine aminotransferase increased,2
CARFILZOMIB,Dehydration,2
CARFILZOMIB,Decreased appetite,2
CARFILZOMIB,Liver disorder,2
CARFILZOMIB,Haematochezia,2
CARFILZOMIB,Pulpitis dental,2
CARFILZOMIB,Petechiae,2
CARFILZOMIB,Ileus paralytic,2
CARFILZOMIB,Hypovolaemic shock,2
CARFILZOMIB,Blood pressure decreased,2
CARFILZOMIB,Cerebrovascular accident,2
CARFILZOMIB,Diarrhoea,2
CARFILZOMIB,Hypokalaemia,2
CARFILZOMIB,Asthma,2
CARFILZOMIB,Constipation,2
CARFILZOMIB,Hypersensitivity,2
CARFILZOMIB,Bronchitis,2
CARFILZOMIB,Hypotension,2
CARFILZOMIB,Rash,2
CARVEDILOL,Fatigue,50
CARVEDILOL,Pain,42
CARVEDILOL,Cardiac failure,37
CARVEDILOL,Anxiety,35
CARVEDILOL,Diarrhoea,33
CARVEDILOL,Acute kidney injury,32
CARVEDILOL,Off label use,29
CARVEDILOL,Chronic kidney disease,29
CARVEDILOL,Emotional distress,28
CARVEDILOL,Asthenia,28
CARVEDILOL,Anhedonia,27
CARVEDILOL,Hypotension,27
CARVEDILOL,Dyspnoea,26
CARVEDILOL,COVID-19,24
CARVEDILOL,Fall,23
CARVEDILOL,Renal failure,23
CARVEDILOL,Nausea,21
CARVEDILOL,Syncope,20
CARVEDILOL,Pneumonia,18
CARVEDILOL,Anaemia,17
CARVEDILOL,Oedema peripheral,17
CARVEDILOL,Headache,17
CARVEDILOL,Cough,16
CARVEDILOL,Malaise,15
CARVEDILOL,Arthralgia,15
CARVEDILOL,Pyrexia,15
CARVEDILOL,Dehydration,14
CARVEDILOL,Renal impairment,14
CARVEDILOL,Vomiting,14
CARVEDILOL,Hyperkalaemia,14
CARVEDILOL,Decreased appetite,14
CARVEDILOL,Product dose omission issue,14
CARVEDILOL,Abdominal pain,13
CARVEDILOL,Hypertension,13
CARVEDILOL,Inappropriate schedule of product administration,13
CARVEDILOL,Myocardial infarction,12
CARVEDILOL,End stage renal disease,12
CARVEDILOL,Joint swelling,12
CARVEDILOL,Hyperlipidaemia,12
CARVEDILOL,Weight decreased,12
CARVEDILOL,Back pain,12
CARVEDILOL,Dizziness,12
CARVEDILOL,Ill-defined disorder,12
CARVEDILOL,Ventricular tachycardia,12
CARVEDILOL,Pericardial effusion,12
CARVEDILOL,Skin lesion,12
CARVEDILOL,Electrocardiogram QT prolonged,12
CARVEDILOL,Product use issue,11
CARVEDILOL,Blood creatinine increased,11
CARVEDILOL,Tricuspid valve incompetence,11
CEFEPIME,Febrile neutropenia,7
CEFEPIME,Anaemia,6
CEFEPIME,Pneumonia,5
CEFEPIME,Eosinophilia,5
CEFEPIME,C-reactive protein increased,5
CEFEPIME,Pyrexia,4
CEFEPIME,Immune effector cell-associated neurotoxicity syndrome,4
CEFEPIME,Atrial fibrillation,4
CEFEPIME,Agranulocytosis,4
CEFEPIME,Diarrhoea,4
CEFEPIME,Acute kidney injury,4
CEFEPIME,Hyperthermia,4
CEFEPIME,Neutrophilia,4
CEFEPIME,Hypersensitivity,4
CEFEPIME,Bacteraemia,3
CEFEPIME,Small intestinal obstruction,3
CEFEPIME,Cytokine release syndrome,3
CEFEPIME,Malignant neoplasm progression,3
CEFEPIME,Drug reaction with eosinophilia and systemic symptoms,3
CEFEPIME,Urinary tract infection,2
CEFEPIME,Death,2
CEFEPIME,Neurotoxicity,2
CEFEPIME,Blood alkaline phosphatase increased,2
CEFEPIME,White blood cell count decreased,2
CEFEPIME,Depression,2
CEFEPIME,Lymphocyte count decreased,2
CEFEPIME,Anxiety,2
CEFEPIME,Hypotension,2
CEFEPIME,Neutrophil count decreased,2
CEFEPIME,Intestinal obstruction,2
CEFEPIME,Device related sepsis,2
CEFEPIME,Anal squamous cell carcinoma,2
CEFEPIME,Weight decreased,2
CEFEPIME,Engraftment syndrome,2
CEFEPIME,Clostridium difficile colitis,2
CEFEPIME,Acute graft versus host disease,2
CEFEPIME,Aspartate aminotransferase increased,2
CEFEPIME,Neoplasm progression,2
CEFEPIME,Hepatic enzyme increased,2
CEFEPIME,Rash maculo-papular,2
CEFEPIME,Staphylococcal infection,2
CEFEPIME,Off label use,2
CEFEPIME,Sepsis,2
CEFEPIME,Mental status changes,2
CEFEPIME,Device related bacteraemia,2
CEFEPIME,Dyspnoea,1
CEFEPIME,Influenza,1
CEFEPIME,Tendonitis,1
CEFEPIME,Chronic obstructive pulmonary disease,1
CEFEPIME,Respiratory tract infection,1
CEFTRIAXONE,Off label use,10
CEFTRIAXONE,Vomiting,8
CEFTRIAXONE,Nausea,8
CEFTRIAXONE,Asthenia,7
CEFTRIAXONE,Diarrhoea,7
CEFTRIAXONE,Condition aggravated,7
CEFTRIAXONE,Tachycardia,6
CEFTRIAXONE,Confusional state,6
CEFTRIAXONE,Renal failure,6
CEFTRIAXONE,Hypokalaemia,6
CEFTRIAXONE,Pyrexia,6
CEFTRIAXONE,Constipation,6
CEFTRIAXONE,Cardiogenic shock,6
CEFTRIAXONE,Dehydration,6
CEFTRIAXONE,Dyspnoea,6
CEFTRIAXONE,Cough,6
CEFTRIAXONE,Hepatic cytolysis,6
CEFTRIAXONE,Abdominal pain,5
CEFTRIAXONE,Product use in unapproved indication,5
CEFTRIAXONE,Drug interaction,5
CEFTRIAXONE,Hypomagnesaemia,5
CEFTRIAXONE,Blood creatine phosphokinase increased,5
CEFTRIAXONE,Drug hypersensitivity,5
CEFTRIAXONE,Stress,5
CEFTRIAXONE,Sepsis,5
CEFTRIAXONE,Incorrect route of product administration,5
CEFTRIAXONE,Death,5
CEFTRIAXONE,Multiple organ dysfunction syndrome,5
CEFTRIAXONE,Ascites,5
CEFTRIAXONE,Dry mouth,5
CEFTRIAXONE,Abdominal distension,5
CEFTRIAXONE,Somnolence,5
CEFTRIAXONE,COVID-19,5
CEFTRIAXONE,Stevens-Johnson syndrome,5
CEFTRIAXONE,Fatigue,4
CEFTRIAXONE,Tachypnoea,4
CEFTRIAXONE,Rhabdomyolysis,4
CEFTRIAXONE,Clonus,4
CEFTRIAXONE,Mood altered,4
CEFTRIAXONE,Movement disorder,4
CEFTRIAXONE,Myelosuppression,4
CEFTRIAXONE,Blood creatinine increased,4
CEFTRIAXONE,Agitation,4
CEFTRIAXONE,Serotonin syndrome,4
CEFTRIAXONE,Nystagmus,4
CEFTRIAXONE,Dyskinesia,4
CEFTRIAXONE,Confabulation,4
CEFTRIAXONE,Pneumonia,4
CEFTRIAXONE,Neutropenia,4
CEFTRIAXONE,Hyponatraemia,4
CEFTRIAXONE SODIUM,Dyspnoea,7
CEFTRIAXONE SODIUM,Vomiting,6
CEFTRIAXONE SODIUM,Off label use,6
CEFTRIAXONE SODIUM,Anaemia,6
CEFTRIAXONE SODIUM,Abdominal pain,5
CEFTRIAXONE SODIUM,Pneumonia,5
CEFTRIAXONE SODIUM,General physical health deterioration,5
CEFTRIAXONE SODIUM,Nausea,4
CEFTRIAXONE SODIUM,Sepsis,4
CEFTRIAXONE SODIUM,Multiple organ dysfunction syndrome,4
CEFTRIAXONE SODIUM,Hypertriglyceridaemia,4
CEFTRIAXONE SODIUM,Pancreatitis acute,4
CEFTRIAXONE SODIUM,Asthenia,3
CEFTRIAXONE SODIUM,Constipation,3
CEFTRIAXONE SODIUM,Ascites,3
CEFTRIAXONE SODIUM,Abdominal distension,3
CEFTRIAXONE SODIUM,Appendicitis,3
CEFTRIAXONE SODIUM,Appendicolith,3
CEFTRIAXONE SODIUM,Incorrect route of product administration,3
CEFTRIAXONE SODIUM,Ventricular fibrillation,3
CEFTRIAXONE SODIUM,Swelling,3
CEFTRIAXONE SODIUM,Hyponatraemia,3
CEFTRIAXONE SODIUM,Pulmonary embolism,3
CEFTRIAXONE SODIUM,Neuralgia,3
CEFTRIAXONE SODIUM,Drug hypersensitivity,3
CEFTRIAXONE SODIUM,Bacterial infection,3
CEFTRIAXONE SODIUM,Stress,3
CEFTRIAXONE SODIUM,Diabetes mellitus,3
CEFTRIAXONE SODIUM,Cardiogenic shock,3
CEFTRIAXONE SODIUM,Diarrhoea,3
CEFTRIAXONE SODIUM,Neutropenia,3
CEFTRIAXONE SODIUM,Stevens-Johnson syndrome,3
CEFTRIAXONE SODIUM,Fatigue,2
CEFTRIAXONE SODIUM,Depression,2
CEFTRIAXONE SODIUM,Hyperhidrosis,2
CEFTRIAXONE SODIUM,Interstitial lung disease,2
CEFTRIAXONE SODIUM,Product use issue,2
CEFTRIAXONE SODIUM,Inappropriate schedule of product administration,2
CEFTRIAXONE SODIUM,Dry mouth,2
CEFTRIAXONE SODIUM,Chronic obstructive pulmonary disease,2
CEFTRIAXONE SODIUM,Blood uric acid increased,2
CEFTRIAXONE SODIUM,Condition aggravated,2
CEFTRIAXONE SODIUM,Hyperphosphataemia,2
CEFTRIAXONE SODIUM,Thrombosis,2
CEFTRIAXONE SODIUM,Somnolence,2
CEFTRIAXONE SODIUM,Drug intolerance,2
CEFTRIAXONE SODIUM,Blood cholesterol increased,2
CEFTRIAXONE SODIUM,Intentional product misuse,2
CEFTRIAXONE SODIUM,Sleep disorder,2
CEFTRIAXONE SODIUM,Myasthenia gravis,2
CELEBREX,Off label use,41
CELEBREX,Pain,25
CELEBREX,Drug ineffective,24
CELEBREX,Malaise,22
CELEBREX,Headache,21
CELEBREX,Nausea,21
CELEBREX,Arthralgia,21
CELEBREX,Fatigue,19
CELEBREX,Diarrhoea,19
CELEBREX,COVID-19,19
CELEBREX,Rash,17
CELEBREX,Infection,16
CELEBREX,Dizziness,16
CELEBREX,Drug intolerance,16
CELEBREX,Nasopharyngitis,16
CELEBREX,Pain in extremity,15
CELEBREX,Drug hypersensitivity,15
CELEBREX,Rheumatoid arthritis,14
CELEBREX,Therapeutic product effect decreased,14
CELEBREX,Pruritus,14
CELEBREX,Hypertension,13
CELEBREX,Dyspnoea,13
CELEBREX,Sinusitis,13
CELEBREX,Condition aggravated,13
CELEBREX,Abdominal discomfort,13
CELEBREX,Contraindicated product administered,11
CELEBREX,Musculoskeletal stiffness,11
CELEBREX,Joint swelling,11
CELEBREX,Psoriatic arthropathy,11
CELEBREX,Peripheral swelling,11
CELEBREX,Pneumonia,11
CELEBREX,Vomiting,11
CELEBREX,Abdominal pain upper,11
CELEBREX,Cough,11
CELEBREX,Hepatic enzyme increased,10
CELEBREX,Urinary tract infection,10
CELEBREX,Anxiety,10
CELEBREX,Hand deformity,9
CELEBREX,Hypersensitivity,9
CELEBREX,Alopecia,9
CELEBREX,Intentional product use issue,9
CELEBREX,Insomnia,9
CELEBREX,Arthropathy,9
CELEBREX,Liver disorder,9
CELEBREX,Pyrexia,9
CELEBREX,Weight decreased,9
CELEBREX,Migraine,9
CELEBREX,Upper respiratory tract infection,9
CELEBREX,Therapeutic product effect incomplete,8
CELEBREX,Weight increased,8
CELECOXIB,Nausea,20
CELECOXIB,Malaise,16
CELECOXIB,Headache,16
CELECOXIB,Pain,13
CELECOXIB,Dizziness,12
CELECOXIB,Fatigue,12
CELECOXIB,Pain in extremity,10
CELECOXIB,Infection,10
CELECOXIB,Pneumonia,10
CELECOXIB,Dyspnoea,10
CELECOXIB,Therapeutic product effect incomplete,9
CELECOXIB,Pruritus,9
CELECOXIB,Vomiting,9
CELECOXIB,Condition aggravated,9
CELECOXIB,Arthralgia,9
CELECOXIB,Diarrhoea,9
CELECOXIB,Pyrexia,8
CELECOXIB,Interstitial lung disease,8
CELECOXIB,Drug intolerance,7
CELECOXIB,Hypoaesthesia,7
CELECOXIB,Drug ineffective,7
CELECOXIB,Musculoskeletal stiffness,7
CELECOXIB,Gait disturbance,7
CELECOXIB,Decreased appetite,7
CELECOXIB,Rash,7
CELECOXIB,Nasopharyngitis,7
CELECOXIB,Muscle spasms,7
CELECOXIB,Product dose omission issue,7
CELECOXIB,COVID-19,7
CELECOXIB,Anaemia,7
CELECOXIB,Drug hypersensitivity,6
CELECOXIB,Off label use,6
CELECOXIB,Peripheral swelling,6
CELECOXIB,Therapeutic product effect decreased,6
CELECOXIB,Fibromyalgia,6
CELECOXIB,Death,6
CELECOXIB,White blood cell count decreased,6
CELECOXIB,Feeling abnormal,6
CELECOXIB,Depression,5
CELECOXIB,Weight increased,5
CELECOXIB,Anxiety,5
CELECOXIB,Bronchitis,5
CELECOXIB,Haemoglobin decreased,5
CELECOXIB,Lymphocyte count decreased,5
CELECOXIB,Back pain,5
CELECOXIB,Staphylococcal infection,4
CELECOXIB,General physical health deterioration,4
CELECOXIB,Hepatic enzyme increased,4
CELECOXIB,Arthropathy,4
CELECOXIB,Treatment failure,4
CELLCEPT,Diarrhoea,14
CELLCEPT,Off label use,12
CELLCEPT,COVID-19,8
CELLCEPT,Hypertension,7
CELLCEPT,Pneumonia,6
CELLCEPT,Septic shock,6
CELLCEPT,Hypotension,6
CELLCEPT,Arthralgia,5
CELLCEPT,Headache,5
CELLCEPT,General physical health deterioration,5
CELLCEPT,Fatigue,5
CELLCEPT,Dyspnoea,5
CELLCEPT,Renal impairment,5
CELLCEPT,Respiratory disorder,5
CELLCEPT,Product use in unapproved indication,4
CELLCEPT,Sinusitis,4
CELLCEPT,Product dose omission issue,4
CELLCEPT,Acute kidney injury,4
CELLCEPT,COVID-19 pneumonia,4
CELLCEPT,Heart transplant rejection,4
CELLCEPT,Candida infection,4
CELLCEPT,Enterobacter bacteraemia,4
CELLCEPT,Proteus infection,4
CELLCEPT,Fungaemia,4
CELLCEPT,Chronic kidney disease,4
CELLCEPT,Drug ineffective for unapproved indication,4
CELLCEPT,Neuropathy peripheral,4
CELLCEPT,Malnutrition,4
CELLCEPT,Cytomegalovirus infection,4
CELLCEPT,Localised infection,4
CELLCEPT,Cardiogenic shock,4
CELLCEPT,Neutropenia,4
CELLCEPT,Chills,3
CELLCEPT,Urinary tract infection,3
CELLCEPT,Rash,3
CELLCEPT,Migraine,3
CELLCEPT,Sepsis,3
CELLCEPT,Malaise,3
CELLCEPT,Alopecia,3
CELLCEPT,Cough,3
CELLCEPT,Pain in extremity,3
CELLCEPT,Fall,3
CELLCEPT,Toxicity to various agents,3
CELLCEPT,Weight increased,3
CELLCEPT,Erythema,3
CELLCEPT,Acute respiratory distress syndrome,3
CELLCEPT,Abdominal discomfort,3
CELLCEPT,Respiratory failure,3
CELLCEPT,Nausea,3
CELLCEPT,Respiratory distress,3
CEPHALEXIN,Pain,17
CEPHALEXIN,Anxiety,13
CEPHALEXIN,Nausea,12
CEPHALEXIN,Headache,12
CEPHALEXIN,Urinary tract infection,11
CEPHALEXIN,Emotional distress,10
CEPHALEXIN,Anhedonia,10
CEPHALEXIN,Arthralgia,10
CEPHALEXIN,COVID-19,9
CEPHALEXIN,Dyspnoea,9
CEPHALEXIN,Malaise,9
CEPHALEXIN,Diarrhoea,9
CEPHALEXIN,Vomiting,9
CEPHALEXIN,Off label use,8
CEPHALEXIN,Fatigue,8
CEPHALEXIN,Osteoporosis,7
CEPHALEXIN,Pyrexia,7
CEPHALEXIN,Abdominal pain,7
CEPHALEXIN,Dizziness,7
CEPHALEXIN,Bone density decreased,6
CEPHALEXIN,Depression,6
CEPHALEXIN,Pneumonia,6
CEPHALEXIN,Weight decreased,6
CEPHALEXIN,Rash,6
CEPHALEXIN,Cough,6
CEPHALEXIN,Pruritus,6
CEPHALEXIN,Abdominal pain upper,6
CEPHALEXIN,Peripheral swelling,5
CEPHALEXIN,Back pain,5
CEPHALEXIN,Pain in extremity,5
CEPHALEXIN,Nasopharyngitis,5
CEPHALEXIN,Gastric disorder,5
CEPHALEXIN,Chronic kidney disease,5
CEPHALEXIN,Drug ineffective,5
CEPHALEXIN,Injection site pain,5
CEPHALEXIN,C-reactive protein increased,5
CEPHALEXIN,Myalgia,5
CEPHALEXIN,Muscle spasms,5
CEPHALEXIN,Decreased appetite,5
CEPHALEXIN,Blood pressure increased,5
CEPHALEXIN,Cardiac disorder,4
CEPHALEXIN,Condition aggravated,4
CEPHALEXIN,Renal failure,4
CEPHALEXIN,Renal impairment,4
CEPHALEXIN,White blood cell count increased,4
CEPHALEXIN,Upper respiratory tract infection,4
CEPHALEXIN,Insurance issue,4
CEPHALEXIN,Blood creatinine increased,4
CEPHALEXIN,Renal disorder,4
CEPHALEXIN,Gait disturbance,4
CERTOLIZUMAB PEGOL,Drug ineffective,16
CERTOLIZUMAB PEGOL,Maternal exposure during pregnancy,14
CERTOLIZUMAB PEGOL,Rheumatoid arthritis,12
CERTOLIZUMAB PEGOL,Inappropriate schedule of product administration,11
CERTOLIZUMAB PEGOL,Nasopharyngitis,10
CERTOLIZUMAB PEGOL,Pain,10
CERTOLIZUMAB PEGOL,Product availability issue,9
CERTOLIZUMAB PEGOL,Weight increased,8
CERTOLIZUMAB PEGOL,Insomnia,8
CERTOLIZUMAB PEGOL,Pain in extremity,8
CERTOLIZUMAB PEGOL,Intentional dose omission,8
CERTOLIZUMAB PEGOL,COVID-19,8
CERTOLIZUMAB PEGOL,Therapy interrupted,8
CERTOLIZUMAB PEGOL,Maternal exposure before pregnancy,7
CERTOLIZUMAB PEGOL,Off label use,7
CERTOLIZUMAB PEGOL,Headache,7
CERTOLIZUMAB PEGOL,Rash,7
CERTOLIZUMAB PEGOL,Nausea,7
CERTOLIZUMAB PEGOL,Arthralgia,7
CERTOLIZUMAB PEGOL,Dyspnoea,6
CERTOLIZUMAB PEGOL,Fatigue,6
CERTOLIZUMAB PEGOL,Pruritus,6
CERTOLIZUMAB PEGOL,Musculoskeletal stiffness,6
CERTOLIZUMAB PEGOL,Diarrhoea,6
CERTOLIZUMAB PEGOL,Dizziness,6
CERTOLIZUMAB PEGOL,Psoriatic arthropathy,6
CERTOLIZUMAB PEGOL,Contusion,6
CERTOLIZUMAB PEGOL,Weight decreased,6
CERTOLIZUMAB PEGOL,Malaise,6
CERTOLIZUMAB PEGOL,Vomiting,6
CERTOLIZUMAB PEGOL,Hepatic enzyme increased,5
CERTOLIZUMAB PEGOL,Hypertension,5
CERTOLIZUMAB PEGOL,Alopecia,5
CERTOLIZUMAB PEGOL,Systemic lupus erythematosus,5
CERTOLIZUMAB PEGOL,Anti-cyclic citrullinated peptide antibody positive,5
CERTOLIZUMAB PEGOL,Blister,5
CERTOLIZUMAB PEGOL,Folliculitis,5
CERTOLIZUMAB PEGOL,Glossodynia,5
CERTOLIZUMAB PEGOL,Inflammation,5
CERTOLIZUMAB PEGOL,Joint swelling,5
CERTOLIZUMAB PEGOL,Back pain,5
CERTOLIZUMAB PEGOL,Dry mouth,5
CERTOLIZUMAB PEGOL,Blood cholesterol increased,5
CERTOLIZUMAB PEGOL,Arthropathy,5
CERTOLIZUMAB PEGOL,Urticaria,5
CERTOLIZUMAB PEGOL,Chest pain,5
CERTOLIZUMAB PEGOL,Abdominal discomfort,5
CERTOLIZUMAB PEGOL,Tuberculosis,5
CERTOLIZUMAB PEGOL,Asthenia,4
CERTOLIZUMAB PEGOL,Hand deformity,4
CETIRIZINE,Off label use,74
CETIRIZINE,Diarrhoea,68
CETIRIZINE,Abdominal discomfort,67
CETIRIZINE,COVID-19,66
CETIRIZINE,Pain,63
CETIRIZINE,Intentional product misuse,63
CETIRIZINE,Nausea,61
CETIRIZINE,Malaise,59
CETIRIZINE,Vomiting,59
CETIRIZINE,Fatigue,58
CETIRIZINE,Headache,57
CETIRIZINE,Dyspnoea,54
CETIRIZINE,Pruritus,53
CETIRIZINE,Back pain,53
CETIRIZINE,Anxiety,53
CETIRIZINE,Dizziness,52
CETIRIZINE,Pyrexia,52
CETIRIZINE,Alopecia,50
CETIRIZINE,Arthralgia,50
CETIRIZINE,Insomnia,49
CETIRIZINE,Abdominal pain upper,48
CETIRIZINE,Feeling abnormal,48
CETIRIZINE,Peripheral swelling,47
CETIRIZINE,Memory impairment,45
CETIRIZINE,Visual impairment,45
CETIRIZINE,Pericarditis,44
CETIRIZINE,Chest pain,44
CETIRIZINE,Blood glucose increased,44
CETIRIZINE,Tachycardia,44
CETIRIZINE,Migraine,43
CETIRIZINE,Amnesia,43
CETIRIZINE,Dehydration,43
CETIRIZINE,Angioedema,43
CETIRIZINE,Heart rate increased,42
CETIRIZINE,Muscular weakness,42
CETIRIZINE,Cognitive disorder,42
CETIRIZINE,Hyperhidrosis,42
CETIRIZINE,Palpitations,42
CETIRIZINE,Hallucination,42
CETIRIZINE,Dry skin,42
CETIRIZINE,Rash,41
CETIRIZINE,Carotid artery occlusion,41
CETIRIZINE,Facial pain,41
CETIRIZINE,Tinnitus,41
CETIRIZINE,Diplopia,41
CETIRIZINE,Vasculitis,41
CETIRIZINE,Ventricular tachycardia,41
CETIRIZINE,Anosmia,41
CETIRIZINE,Pain of skin,41
CETIRIZINE,Palmoplantar keratoderma,41
CETIRIZINE HYDROCHLORIDE,Diarrhoea,78
CETIRIZINE HYDROCHLORIDE,Malaise,77
CETIRIZINE HYDROCHLORIDE,Fatigue,77
CETIRIZINE HYDROCHLORIDE,Pain,75
CETIRIZINE HYDROCHLORIDE,Headache,70
CETIRIZINE HYDROCHLORIDE,Vomiting,70
CETIRIZINE HYDROCHLORIDE,Pyrexia,65
CETIRIZINE HYDROCHLORIDE,Arthralgia,63
CETIRIZINE HYDROCHLORIDE,Dyspnoea,63
CETIRIZINE HYDROCHLORIDE,Pruritus,62
CETIRIZINE HYDROCHLORIDE,Back pain,62
CETIRIZINE HYDROCHLORIDE,COVID-19,62
CETIRIZINE HYDROCHLORIDE,Off label use,60
CETIRIZINE HYDROCHLORIDE,Nausea,59
CETIRIZINE HYDROCHLORIDE,Dizziness,58
CETIRIZINE HYDROCHLORIDE,Anxiety,56
CETIRIZINE HYDROCHLORIDE,Peripheral swelling,55
CETIRIZINE HYDROCHLORIDE,Abdominal discomfort,55
CETIRIZINE HYDROCHLORIDE,Alopecia,54
CETIRIZINE HYDROCHLORIDE,Angioedema,54
CETIRIZINE HYDROCHLORIDE,Pericarditis,53
CETIRIZINE HYDROCHLORIDE,Heart rate increased,53
CETIRIZINE HYDROCHLORIDE,Muscular weakness,53
CETIRIZINE HYDROCHLORIDE,Feeling abnormal,53
CETIRIZINE HYDROCHLORIDE,Insomnia,52
CETIRIZINE HYDROCHLORIDE,Abdominal pain upper,52
CETIRIZINE HYDROCHLORIDE,Chest pain,52
CETIRIZINE HYDROCHLORIDE,Memory impairment,52
CETIRIZINE HYDROCHLORIDE,Palpitations,52
CETIRIZINE HYDROCHLORIDE,Migraine,51
CETIRIZINE HYDROCHLORIDE,Disturbance in attention,51
CETIRIZINE HYDROCHLORIDE,Tachycardia,51
CETIRIZINE HYDROCHLORIDE,Amnesia,50
CETIRIZINE HYDROCHLORIDE,Facial pain,50
CETIRIZINE HYDROCHLORIDE,Hallucination,50
CETIRIZINE HYDROCHLORIDE,Hyperhidrosis,49
CETIRIZINE HYDROCHLORIDE,Dry skin,49
CETIRIZINE HYDROCHLORIDE,Myocardial infarction,49
CETIRIZINE HYDROCHLORIDE,Anosmia,49
CETIRIZINE HYDROCHLORIDE,Muscle twitching,48
CETIRIZINE HYDROCHLORIDE,Blindness,48
CETIRIZINE HYDROCHLORIDE,Eye pruritus,48
CETIRIZINE HYDROCHLORIDE,Visual impairment,48
CETIRIZINE HYDROCHLORIDE,Intentional product misuse,48
CETIRIZINE HYDROCHLORIDE,Dehydration,48
CETIRIZINE HYDROCHLORIDE,Transient ischaemic attack,48
CETIRIZINE HYDROCHLORIDE,Cardiospasm,48
CETIRIZINE HYDROCHLORIDE,Subarachnoid haemorrhage,48
CETIRIZINE HYDROCHLORIDE,Lip swelling,48
CETIRIZINE HYDROCHLORIDE,Atrial tachycardia,48
CETUXIMAB,Nausea,13
CETUXIMAB,Diarrhoea,8
CETUXIMAB,Decreased appetite,7
CETUXIMAB,Pyrexia,7
CETUXIMAB,Malaise,7
CETUXIMAB,Serous retinal detachment,6
CETUXIMAB,Vomiting,5
CETUXIMAB,Folliculitis,5
CETUXIMAB,Fatigue,4
CETUXIMAB,Off label use,4
CETUXIMAB,Ileus,3
CETUXIMAB,Dermatitis acneiform,3
CETUXIMAB,Cardiac failure,3
CETUXIMAB,Weight decreased,3
CETUXIMAB,Renal impairment,3
CETUXIMAB,Alanine aminotransferase increased,3
CETUXIMAB,Aspartate aminotransferase increased,3
CETUXIMAB,Rash,3
CETUXIMAB,Cholestasis,3
CETUXIMAB,Pruritus,2
CETUXIMAB,Constipation,2
CETUXIMAB,Haematuria,2
CETUXIMAB,Carcinoembryonic antigen increased,2
CETUXIMAB,Abdominal pain upper,2
CETUXIMAB,Tumour perforation,2
CETUXIMAB,Lower gastrointestinal haemorrhage,2
CETUXIMAB,Blood creatinine increased,2
CETUXIMAB,Interstitial lung disease,2
CETUXIMAB,Malignant neoplasm progression,2
CETUXIMAB,Oedema,2
CETUXIMAB,Dyspnoea,2
CETUXIMAB,Cardiomegaly,2
CETUXIMAB,Pulmonary hypertension,2
CETUXIMAB,Pericardial effusion,2
CETUXIMAB,Insomnia,2
CETUXIMAB,Acute kidney injury,2
CETUXIMAB,Neoplasm progression,2
CETUXIMAB,Hepatic function abnormal,2
CETUXIMAB,Pain in extremity,2
CETUXIMAB,Anaemia,2
CETUXIMAB,Paronychia,2
CETUXIMAB,Myalgia,2
CETUXIMAB,Enterocolitis,2
CETUXIMAB,Ocular retrobulbar haemorrhage,2
CETUXIMAB,Colour blindness acquired,1
CETUXIMAB,Headache,1
CETUXIMAB,Neuropathy peripheral,1
CETUXIMAB,Skin ulcer,1
CETUXIMAB,Visual acuity reduced,1
CETUXIMAB,Serous retinopathy,1
CHLORPHENIRAMINE MALEATE,Nausea,28
CHLORPHENIRAMINE MALEATE,Diarrhoea,24
CHLORPHENIRAMINE MALEATE,Fatigue,22
CHLORPHENIRAMINE MALEATE,Disease progression,19
CHLORPHENIRAMINE MALEATE,Off label use,16
CHLORPHENIRAMINE MALEATE,Platelet count decreased,16
CHLORPHENIRAMINE MALEATE,Neuropathy peripheral,16
CHLORPHENIRAMINE MALEATE,Cellulitis,14
CHLORPHENIRAMINE MALEATE,Mucosal inflammation,14
CHLORPHENIRAMINE MALEATE,Anaemia,13
CHLORPHENIRAMINE MALEATE,Alopecia,13
CHLORPHENIRAMINE MALEATE,Pneumonia,13
CHLORPHENIRAMINE MALEATE,COVID-19,12
CHLORPHENIRAMINE MALEATE,Neutropenia,12
CHLORPHENIRAMINE MALEATE,Constipation,12
CHLORPHENIRAMINE MALEATE,Vomiting,12
CHLORPHENIRAMINE MALEATE,Lower respiratory tract infection,10
CHLORPHENIRAMINE MALEATE,Dyspepsia,10
CHLORPHENIRAMINE MALEATE,Lymphocyte count decreased,10
CHLORPHENIRAMINE MALEATE,Affective disorder,9
CHLORPHENIRAMINE MALEATE,Leukopenia,9
CHLORPHENIRAMINE MALEATE,Neutrophil count increased,9
CHLORPHENIRAMINE MALEATE,Schizophrenia,9
CHLORPHENIRAMINE MALEATE,Overdose,9
CHLORPHENIRAMINE MALEATE,Incorrect dose administered,9
CHLORPHENIRAMINE MALEATE,Seizure,9
CHLORPHENIRAMINE MALEATE,Psychotic disorder,9
CHLORPHENIRAMINE MALEATE,"Hallucination, auditory",9
CHLORPHENIRAMINE MALEATE,Extrapyramidal disorder,9
CHLORPHENIRAMINE MALEATE,Delusion of grandeur,9
CHLORPHENIRAMINE MALEATE,Abdominal pain,9
CHLORPHENIRAMINE MALEATE,Decreased appetite,8
CHLORPHENIRAMINE MALEATE,Rhinalgia,8
CHLORPHENIRAMINE MALEATE,Infection,7
CHLORPHENIRAMINE MALEATE,Tachycardia,7
CHLORPHENIRAMINE MALEATE,Lymphocyte count abnormal,7
CHLORPHENIRAMINE MALEATE,Thrombocytopenia,7
CHLORPHENIRAMINE MALEATE,Dyspnoea,7
CHLORPHENIRAMINE MALEATE,Haemoglobin decreased,6
CHLORPHENIRAMINE MALEATE,Abdominal pain upper,6
CHLORPHENIRAMINE MALEATE,SARS-CoV-2 test positive,6
CHLORPHENIRAMINE MALEATE,Pyrexia,6
CHLORPHENIRAMINE MALEATE,Lethargy,6
CHLORPHENIRAMINE MALEATE,Death,6
CHLORPHENIRAMINE MALEATE,Atrial fibrillation,5
CHLORPHENIRAMINE MALEATE,Product use in unapproved indication,5
CHLORPHENIRAMINE MALEATE,Ear pain,5
CHLORPHENIRAMINE MALEATE,Hepatic failure,5
CHLORPHENIRAMINE MALEATE,Weight decreased,5
CHLORPHENIRAMINE MALEATE,Blood magnesium decreased,5
CHLORTHALIDONE,Fatigue,9
CHLORTHALIDONE,Pain,9
CHLORTHALIDONE,Emotional distress,8
CHLORTHALIDONE,Anxiety,8
CHLORTHALIDONE,Anhedonia,7
CHLORTHALIDONE,Osteoporosis,7
CHLORTHALIDONE,Sinusitis,7
CHLORTHALIDONE,Pain in extremity,6
CHLORTHALIDONE,Anaemia,6
CHLORTHALIDONE,Headache,6
CHLORTHALIDONE,Nausea,6
CHLORTHALIDONE,Blood pressure increased,5
CHLORTHALIDONE,Product dose omission issue,5
CHLORTHALIDONE,Back pain,5
CHLORTHALIDONE,COVID-19,5
CHLORTHALIDONE,Off label use,5
CHLORTHALIDONE,Inappropriate schedule of product administration,4
CHLORTHALIDONE,Malaise,4
CHLORTHALIDONE,Cough,4
CHLORTHALIDONE,Dyspnoea,4
CHLORTHALIDONE,Wrong technique in product usage process,4
CHLORTHALIDONE,Weight decreased,4
CHLORTHALIDONE,Dizziness,4
CHLORTHALIDONE,Fall,4
CHLORTHALIDONE,Osteopenia,4
CHLORTHALIDONE,Chronic kidney disease,4
CHLORTHALIDONE,Diarrhoea,4
CHLORTHALIDONE,Condition aggravated,4
CHLORTHALIDONE,Drug ineffective,4
CHLORTHALIDONE,Alopecia,3
CHLORTHALIDONE,Peripheral swelling,3
CHLORTHALIDONE,Pulmonary oedema,3
CHLORTHALIDONE,Nasopharyngitis,3
CHLORTHALIDONE,Blood pressure decreased,3
CHLORTHALIDONE,Hypotension,3
CHLORTHALIDONE,Oropharyngeal pain,3
CHLORTHALIDONE,Spinal compression fracture,3
CHLORTHALIDONE,Confusional state,3
CHLORTHALIDONE,Arthralgia,3
CHLORTHALIDONE,Depression,3
CHLORTHALIDONE,Hyponatraemia,3
CHLORTHALIDONE,Upper respiratory tract infection,3
CHLORTHALIDONE,Urinary tract infection,3
CHLORTHALIDONE,Asthenia,3
CHLORTHALIDONE,Constipation,3
CHLORTHALIDONE,Lower limb fracture,2
CHLORTHALIDONE,Joint swelling,2
CHLORTHALIDONE,Gait inability,2
CHLORTHALIDONE,Hyperthyroidism,2
CHLORTHALIDONE,Iron deficiency,2
CHOLECALCIFEROL,Fatigue,61
CHOLECALCIFEROL,Off label use,60
CHOLECALCIFEROL,Diarrhoea,59
CHOLECALCIFEROL,COVID-19,57
CHOLECALCIFEROL,Nausea,51
CHOLECALCIFEROL,Pain,44
CHOLECALCIFEROL,Weight decreased,41
CHOLECALCIFEROL,Asthenia,39
CHOLECALCIFEROL,Headache,39
CHOLECALCIFEROL,Arthralgia,38
CHOLECALCIFEROL,Anaemia,38
CHOLECALCIFEROL,Vomiting,37
CHOLECALCIFEROL,General physical health deterioration,33
CHOLECALCIFEROL,Dizziness,32
CHOLECALCIFEROL,Pyrexia,32
CHOLECALCIFEROL,Neutropenia,32
CHOLECALCIFEROL,Acute kidney injury,30
CHOLECALCIFEROL,Dyspnoea,29
CHOLECALCIFEROL,Pneumonia,29
CHOLECALCIFEROL,Abdominal pain,28
CHOLECALCIFEROL,Fall,28
CHOLECALCIFEROL,Pain in extremity,26
CHOLECALCIFEROL,Hypertension,25
CHOLECALCIFEROL,Decreased appetite,25
CHOLECALCIFEROL,Malaise,23
CHOLECALCIFEROL,Myalgia,23
CHOLECALCIFEROL,Paraesthesia,22
CHOLECALCIFEROL,Gait disturbance,22
CHOLECALCIFEROL,Anxiety,22
CHOLECALCIFEROL,Leukopenia,22
CHOLECALCIFEROL,Back pain,21
CHOLECALCIFEROL,Condition aggravated,21
CHOLECALCIFEROL,Product dose omission issue,21
CHOLECALCIFEROL,Urinary tract infection,21
CHOLECALCIFEROL,Pruritus,20
CHOLECALCIFEROL,Bone pain,20
CHOLECALCIFEROL,Hyponatraemia,20
CHOLECALCIFEROL,Dehydration,20
CHOLECALCIFEROL,Neck pain,20
CHOLECALCIFEROL,Hypotension,20
CHOLECALCIFEROL,Alopecia,18
CHOLECALCIFEROL,Sepsis,18
CHOLECALCIFEROL,Nasopharyngitis,17
CHOLECALCIFEROL,Drug ineffective,17
CHOLECALCIFEROL,Dyspepsia,17
CHOLECALCIFEROL,Hypoaesthesia,17
CHOLECALCIFEROL,Constipation,17
CHOLECALCIFEROL,Chills,16
CHOLECALCIFEROL,Hypersensitivity,16
CHOLECALCIFEROL,Rash,16
CILASTATIN SODIUM\IMIPENEM,Epilepsy,19
CILASTATIN SODIUM\IMIPENEM,Delirium,9
CILASTATIN SODIUM\IMIPENEM,Seizure,6
CILASTATIN SODIUM\IMIPENEM,Pneumonia,5
CILASTATIN SODIUM\IMIPENEM,Diarrhoea,4
CILASTATIN SODIUM\IMIPENEM,Platelet count decreased,4
CILASTATIN SODIUM\IMIPENEM,Overdose,4
CILASTATIN SODIUM\IMIPENEM,Inappropriate schedule of product administration,3
CILASTATIN SODIUM\IMIPENEM,Product use in unapproved indication,3
CILASTATIN SODIUM\IMIPENEM,Dysbiosis,3
CILASTATIN SODIUM\IMIPENEM,Rash maculo-papular,3
CILASTATIN SODIUM\IMIPENEM,Mental disorder,3
CILASTATIN SODIUM\IMIPENEM,Dysphoria,3
CILASTATIN SODIUM\IMIPENEM,Sepsis,3
CILASTATIN SODIUM\IMIPENEM,Oxygen saturation decreased,3
CILASTATIN SODIUM\IMIPENEM,Labelled drug-drug interaction issue,2
CILASTATIN SODIUM\IMIPENEM,Drug eruption,2
CILASTATIN SODIUM\IMIPENEM,Adverse event,2
CILASTATIN SODIUM\IMIPENEM,Confusional state,2
CILASTATIN SODIUM\IMIPENEM,Cyanosis,2
CILASTATIN SODIUM\IMIPENEM,Rash pruritic,2
CILASTATIN SODIUM\IMIPENEM,Anxiety,2
CILASTATIN SODIUM\IMIPENEM,Disorganised speech,2
CILASTATIN SODIUM\IMIPENEM,Product use issue,2
CILASTATIN SODIUM\IMIPENEM,Heart rate increased,2
CILASTATIN SODIUM\IMIPENEM,Anaphylactic shock,2
CILASTATIN SODIUM\IMIPENEM,Drug ineffective,2
CILASTATIN SODIUM\IMIPENEM,Blood pressure decreased,2
CILASTATIN SODIUM\IMIPENEM,Blood creatinine abnormal,2
CILASTATIN SODIUM\IMIPENEM,Cerebral infarction,2
CILASTATIN SODIUM\IMIPENEM,Fatigue,1
CILASTATIN SODIUM\IMIPENEM,Dyspnoea,1
CILASTATIN SODIUM\IMIPENEM,Nodule,1
CILASTATIN SODIUM\IMIPENEM,Haemorrhage,1
CILASTATIN SODIUM\IMIPENEM,Cough,1
CILASTATIN SODIUM\IMIPENEM,Pain,1
CILASTATIN SODIUM\IMIPENEM,Tongue discolouration,1
CILASTATIN SODIUM\IMIPENEM,Lung adenocarcinoma,1
CILASTATIN SODIUM\IMIPENEM,Thoracotomy,1
CILASTATIN SODIUM\IMIPENEM,Richter's syndrome,1
CILASTATIN SODIUM\IMIPENEM,Chronic lymphocytic leukaemia,1
CILASTATIN SODIUM\IMIPENEM,Pallor,1
CILASTATIN SODIUM\IMIPENEM,Splenomegaly,1
CILASTATIN SODIUM\IMIPENEM,Anal abscess,1
CILASTATIN SODIUM\IMIPENEM,Febrile neutropenia,1
CILASTATIN SODIUM\IMIPENEM,Somnolence,1
CILASTATIN SODIUM\IMIPENEM,Nausea,1
CILASTATIN SODIUM\IMIPENEM,Abdominal distension,1
CILASTATIN SODIUM\IMIPENEM,Superinfection,1
CILASTATIN SODIUM\IMIPENEM,Septic shock,1
CIMZIA,Product dose omission issue,63
CIMZIA,Drug ineffective,56
CIMZIA,Off label use,53
CIMZIA,Maternal exposure during pregnancy,48
CIMZIA,COVID-19,46
CIMZIA,Pain,45
CIMZIA,Therapy interrupted,39
CIMZIA,Rheumatoid arthritis,36
CIMZIA,Arthralgia,32
CIMZIA,Product availability issue,27
CIMZIA,Nasopharyngitis,23
CIMZIA,Illness,23
CIMZIA,Rash,22
CIMZIA,Fatigue,21
CIMZIA,Sinusitis,21
CIMZIA,Nausea,21
CIMZIA,Headache,19
CIMZIA,Product use in unapproved indication,19
CIMZIA,Inappropriate schedule of product administration,19
CIMZIA,Psoriatic arthropathy,18
CIMZIA,Psoriasis,18
CIMZIA,Hypersensitivity,17
CIMZIA,Diarrhoea,17
CIMZIA,Malaise,17
CIMZIA,Infection,17
CIMZIA,Maternal exposure before pregnancy,17
CIMZIA,Dizziness,16
CIMZIA,Pruritus,15
CIMZIA,Condition aggravated,15
CIMZIA,Urinary tract infection,15
CIMZIA,Intentional dose omission,15
CIMZIA,Pain in extremity,14
CIMZIA,Vomiting,14
CIMZIA,Product use issue,14
CIMZIA,Crohn's disease,13
CIMZIA,Injection site pain,13
CIMZIA,Back pain,12
CIMZIA,Dyspnoea,12
CIMZIA,Joint swelling,12
CIMZIA,Alopecia,11
CIMZIA,Musculoskeletal stiffness,11
CIMZIA,Pyrexia,11
CIMZIA,Drug hypersensitivity,11
CIMZIA,Swelling,11
CIMZIA,Influenza,11
CIMZIA,Insurance issue,11
CIMZIA,Hypertension,10
CIMZIA,Weight increased,10
CIMZIA,Drug intolerance,10
CIMZIA,Synovitis,10
CIPROFLOXACIN,Fatigue,81
CIPROFLOXACIN,Anxiety,65
CIPROFLOXACIN,Arthralgia,65
CIPROFLOXACIN,Tendon pain,58
CIPROFLOXACIN,Myalgia,47
CIPROFLOXACIN,Asthenia,47
CIPROFLOXACIN,Rash,46
CIPROFLOXACIN,Pain,46
CIPROFLOXACIN,Diarrhoea,46
CIPROFLOXACIN,Depression,44
CIPROFLOXACIN,Back pain,43
CIPROFLOXACIN,Tinnitus,42
CIPROFLOXACIN,Paraesthesia,41
CIPROFLOXACIN,Pain in extremity,41
CIPROFLOXACIN,Dyspnoea,39
CIPROFLOXACIN,Neuropathy peripheral,38
CIPROFLOXACIN,Neuralgia,38
CIPROFLOXACIN,Off label use,37
CIPROFLOXACIN,Muscular weakness,35
CIPROFLOXACIN,Tendonitis,34
CIPROFLOXACIN,Hypoaesthesia,33
CIPROFLOXACIN,Insomnia,31
CIPROFLOXACIN,Condition aggravated,31
CIPROFLOXACIN,Abdominal discomfort,29
CIPROFLOXACIN,Headache,29
CIPROFLOXACIN,Muscle atrophy,29
CIPROFLOXACIN,Tendon disorder,28
CIPROFLOXACIN,Anaemia,27
CIPROFLOXACIN,Medication error,27
CIPROFLOXACIN,Abdominal pain,26
CIPROFLOXACIN,Nausea,25
CIPROFLOXACIN,Pyrexia,25
CIPROFLOXACIN,Vision blurred,24
CIPROFLOXACIN,Malaise,24
CIPROFLOXACIN,Peripheral swelling,23
CIPROFLOXACIN,Mucosal inflammation,22
CIPROFLOXACIN,Muscle twitching,22
CIPROFLOXACIN,Palpitations,20
CIPROFLOXACIN,Vomiting,20
CIPROFLOXACIN,Burning sensation,20
CIPROFLOXACIN,Product dose omission issue,20
CIPROFLOXACIN,Feeling abnormal,20
CIPROFLOXACIN,Memory impairment,19
CIPROFLOXACIN,Emotional distress,19
CIPROFLOXACIN,Lower respiratory tract infection,19
CIPROFLOXACIN,Sleep disorder,19
CIPROFLOXACIN,Alopecia,18
CIPROFLOXACIN,Balance disorder,18
CIPROFLOXACIN,Intentional product misuse,18
CIPROFLOXACIN,Dizziness,17
CIPROFLOXACIN HYDROCHLORIDE,Product dose omission issue,16
CIPROFLOXACIN HYDROCHLORIDE,Abdominal discomfort,16
CIPROFLOXACIN HYDROCHLORIDE,Rash,16
CIPROFLOXACIN HYDROCHLORIDE,Off label use,15
CIPROFLOXACIN HYDROCHLORIDE,Intentional product misuse,12
CIPROFLOXACIN HYDROCHLORIDE,Pulmonary pain,12
CIPROFLOXACIN HYDROCHLORIDE,Lower respiratory tract infection,12
CIPROFLOXACIN HYDROCHLORIDE,Overdose,12
CIPROFLOXACIN HYDROCHLORIDE,Drug abuse,12
CIPROFLOXACIN HYDROCHLORIDE,Malaise,11
CIPROFLOXACIN HYDROCHLORIDE,Arthropathy,11
CIPROFLOXACIN HYDROCHLORIDE,Fatigue,10
CIPROFLOXACIN HYDROCHLORIDE,COVID-19,10
CIPROFLOXACIN HYDROCHLORIDE,Knee arthroplasty,10
CIPROFLOXACIN HYDROCHLORIDE,Anxiety,9
CIPROFLOXACIN HYDROCHLORIDE,Diarrhoea,9
CIPROFLOXACIN HYDROCHLORIDE,Sinusitis,8
CIPROFLOXACIN HYDROCHLORIDE,Obesity,8
CIPROFLOXACIN HYDROCHLORIDE,Pneumonia,7
CIPROFLOXACIN HYDROCHLORIDE,Nasopharyngitis,7
CIPROFLOXACIN HYDROCHLORIDE,Amyloid arthropathy,7
CIPROFLOXACIN HYDROCHLORIDE,Arthralgia,7
CIPROFLOXACIN HYDROCHLORIDE,Condition aggravated,7
CIPROFLOXACIN HYDROCHLORIDE,Urinary tract infection,6
CIPROFLOXACIN HYDROCHLORIDE,Infusion site swelling,5
CIPROFLOXACIN HYDROCHLORIDE,Ear infection,5
CIPROFLOXACIN HYDROCHLORIDE,Bronchitis,5
CIPROFLOXACIN HYDROCHLORIDE,Drug ineffective,5
CIPROFLOXACIN HYDROCHLORIDE,Abdominal pain upper,5
CIPROFLOXACIN HYDROCHLORIDE,Depression,5
CIPROFLOXACIN HYDROCHLORIDE,Inflammation,5
CIPROFLOXACIN HYDROCHLORIDE,Haematochezia,4
CIPROFLOXACIN HYDROCHLORIDE,Infusion site pruritus,4
CIPROFLOXACIN HYDROCHLORIDE,Asthma,4
CIPROFLOXACIN HYDROCHLORIDE,Illness,4
CIPROFLOXACIN HYDROCHLORIDE,Abscess,4
CIPROFLOXACIN HYDROCHLORIDE,Nausea,4
CIPROFLOXACIN HYDROCHLORIDE,Vomiting,4
CIPROFLOXACIN HYDROCHLORIDE,Dyspnoea,4
CIPROFLOXACIN HYDROCHLORIDE,Dizziness,4
CIPROFLOXACIN HYDROCHLORIDE,Abdominal pain,4
CIPROFLOXACIN HYDROCHLORIDE,Gait disturbance,4
CIPROFLOXACIN HYDROCHLORIDE,Schizophrenia,4
CIPROFLOXACIN HYDROCHLORIDE,Lung neoplasm malignant,4
CIPROFLOXACIN HYDROCHLORIDE,Radiation inflammation,4
CIPROFLOXACIN HYDROCHLORIDE,Inappropriate schedule of product administration,3
CIPROFLOXACIN HYDROCHLORIDE,Crohn's disease,3
CIPROFLOXACIN HYDROCHLORIDE,Body height decreased,3
CIPROFLOXACIN HYDROCHLORIDE,Weight increased,3
CIPROFLOXACIN HYDROCHLORIDE,Back pain,3
CISPLATIN,Off label use,22
CISPLATIN,Anaemia,17
CISPLATIN,Vomiting,12
CISPLATIN,Neutropenia,12
CISPLATIN,Platelet count decreased,11
CISPLATIN,Pancytopenia,10
CISPLATIN,Pyrexia,10
CISPLATIN,Thrombocytopenia,10
CISPLATIN,Malignant neoplasm progression,9
CISPLATIN,Disease progression,9
CISPLATIN,Myelosuppression,9
CISPLATIN,Cytokine release syndrome,8
CISPLATIN,Febrile neutropenia,8
CISPLATIN,Acute kidney injury,8
CISPLATIN,White blood cell count decreased,8
CISPLATIN,Myelodysplastic syndrome,7
CISPLATIN,Neutrophil count decreased,7
CISPLATIN,Dyspepsia,7
CISPLATIN,Febrile bone marrow aplasia,7
CISPLATIN,Nausea,6
CISPLATIN,Bone marrow failure,6
CISPLATIN,Diarrhoea,6
CISPLATIN,Hypersensitivity,6
CISPLATIN,Vitamin B12 deficiency,6
CISPLATIN,Oropharyngeal discomfort,6
CISPLATIN,Eructation,6
CISPLATIN,Regurgitation,6
CISPLATIN,Neck pain,6
CISPLATIN,Abdominal distension,6
CISPLATIN,Barrett's oesophagus,6
CISPLATIN,Tubulointerstitial nephritis,6
CISPLATIN,Dizziness,6
CISPLATIN,Neoplasm progression,5
CISPLATIN,Rash,5
CISPLATIN,Blood lactate dehydrogenase increased,5
CISPLATIN,Asthenia,5
CISPLATIN,Cholangitis infective,5
CISPLATIN,Product use in unapproved indication,4
CISPLATIN,Sepsis,4
CISPLATIN,Condition aggravated,4
CISPLATIN,Hyponatraemia,4
CISPLATIN,Diffuse large B-cell lymphoma,4
CISPLATIN,Cerebral haemorrhage,4
CISPLATIN,Treatment failure,3
CISPLATIN,Drug ineffective,3
CISPLATIN,Blood HIV RNA increased,3
CISPLATIN,Dysphagia,3
CISPLATIN,Pathogen resistance,3
CISPLATIN,Oesophageal carcinoma,3
CISPLATIN,Virologic failure,3
CITALOPRAM,Fatigue,31
CITALOPRAM,Pain,26
CITALOPRAM,Nausea,26
CITALOPRAM,Depression,24
CITALOPRAM,Headache,22
CITALOPRAM,Diarrhoea,19
CITALOPRAM,Dizziness,19
CITALOPRAM,Dyspnoea,18
CITALOPRAM,Anxiety,18
CITALOPRAM,Off label use,17
CITALOPRAM,Neutropenia,17
CITALOPRAM,Weight decreased,16
CITALOPRAM,Arthralgia,16
CITALOPRAM,General physical health deterioration,15
CITALOPRAM,Pruritus,15
CITALOPRAM,Pyrexia,14
CITALOPRAM,Vomiting,14
CITALOPRAM,Product dose omission issue,14
CITALOPRAM,Fall,13
CITALOPRAM,Pneumonia,13
CITALOPRAM,Malaise,13
CITALOPRAM,COVID-19,12
CITALOPRAM,Sepsis,12
CITALOPRAM,Decreased appetite,12
CITALOPRAM,Illness,11
CITALOPRAM,Nasopharyngitis,10
CITALOPRAM,Urinary tract infection,10
CITALOPRAM,Viral infection,10
CITALOPRAM,Emotional distress,10
CITALOPRAM,Asthenia,10
CITALOPRAM,Inflammation,10
CITALOPRAM,Insomnia,10
CITALOPRAM,Condition aggravated,9
CITALOPRAM,Dehydration,9
CITALOPRAM,Muscle spasms,9
CITALOPRAM,Myalgia,9
CITALOPRAM,Muscular weakness,9
CITALOPRAM,Injection site pain,8
CITALOPRAM,Cough,8
CITALOPRAM,Tachycardia,8
CITALOPRAM,Anhedonia,8
CITALOPRAM,Acute kidney injury,8
CITALOPRAM,Pain in extremity,8
CITALOPRAM,Hyperhidrosis,8
CITALOPRAM,Tremor,8
CITALOPRAM,Paraesthesia,8
CITALOPRAM,Bronchitis,7
CITALOPRAM,Gait disturbance,7
CITALOPRAM,Inappropriate schedule of product administration,7
CITALOPRAM,Abdominal pain,7
CLARITHROMYCIN,Dyspnoea,20
CLARITHROMYCIN,Fatigue,19
CLARITHROMYCIN,Diarrhoea,19
CLARITHROMYCIN,Pneumonia,18
CLARITHROMYCIN,Anxiety,18
CLARITHROMYCIN,Nausea,16
CLARITHROMYCIN,Malaise,14
CLARITHROMYCIN,Headache,14
CLARITHROMYCIN,Pain,14
CLARITHROMYCIN,Back pain,13
CLARITHROMYCIN,Depression,13
CLARITHROMYCIN,Arthralgia,13
CLARITHROMYCIN,Rash,13
CLARITHROMYCIN,Insomnia,13
CLARITHROMYCIN,Cough,12
CLARITHROMYCIN,Sinusitis,12
CLARITHROMYCIN,Burning sensation,12
CLARITHROMYCIN,Myalgia,11
CLARITHROMYCIN,Dizziness,11
CLARITHROMYCIN,Bronchitis,10
CLARITHROMYCIN,Pyrexia,10
CLARITHROMYCIN,COVID-19,10
CLARITHROMYCIN,Confusional state,10
CLARITHROMYCIN,Off label use,10
CLARITHROMYCIN,Pain in extremity,10
CLARITHROMYCIN,Abdominal pain,9
CLARITHROMYCIN,Pruritus,9
CLARITHROMYCIN,Panic attack,9
CLARITHROMYCIN,Palpitations,9
CLARITHROMYCIN,Weight increased,8
CLARITHROMYCIN,Urinary tract infection,8
CLARITHROMYCIN,Abdominal pain upper,8
CLARITHROMYCIN,Condition aggravated,8
CLARITHROMYCIN,Muscle spasms,8
CLARITHROMYCIN,Neuralgia,8
CLARITHROMYCIN,Muscular weakness,8
CLARITHROMYCIN,Medication error,8
CLARITHROMYCIN,Drug hypersensitivity,7
CLARITHROMYCIN,Vomiting,7
CLARITHROMYCIN,Upper respiratory tract infection,7
CLARITHROMYCIN,Asthenia,7
CLARITHROMYCIN,Nightmare,7
CLARITHROMYCIN,Gastric disorder,7
CLARITHROMYCIN,Psychotic disorder,7
CLARITHROMYCIN,Heart rate irregular,7
CLARITHROMYCIN,Tendonitis,7
CLARITHROMYCIN,Chest pain,6
CLARITHROMYCIN,Product dose omission issue,6
CLARITHROMYCIN,Osteoporosis,6
CLARITHROMYCIN,Tremor,6
CLARITIN,COVID-19,14
CLARITIN,Diarrhoea,14
CLARITIN,Off label use,12
CLARITIN,Fatigue,11
CLARITIN,Pneumonia,10
CLARITIN,Sinusitis,10
CLARITIN,Product dose omission issue,9
CLARITIN,Nausea,9
CLARITIN,Pyrexia,9
CLARITIN,Headache,8
CLARITIN,Malaise,8
CLARITIN,Rash,8
CLARITIN,Illness,8
CLARITIN,Pain in extremity,8
CLARITIN,Urticaria,8
CLARITIN,Fall,7
CLARITIN,Influenza,7
CLARITIN,Pain,6
CLARITIN,Cough,6
CLARITIN,Peripheral swelling,6
CLARITIN,Nasopharyngitis,6
CLARITIN,Arthralgia,6
CLARITIN,Dyspnoea,6
CLARITIN,Pruritus,6
CLARITIN,Respiratory tract infection,5
CLARITIN,Weight increased,5
CLARITIN,Dizziness,5
CLARITIN,Blood pressure increased,5
CLARITIN,Weight decreased,5
CLARITIN,Swelling,5
CLARITIN,Myalgia,5
CLARITIN,Asthma,5
CLARITIN,Migraine,4
CLARITIN,Ear infection,4
CLARITIN,Back pain,4
CLARITIN,Vomiting,4
CLARITIN,Skin exfoliation,4
CLARITIN,Asthenia,4
CLARITIN,Bronchitis,4
CLARITIN,Somnolence,4
CLARITIN,Drug hypersensitivity,3
CLARITIN,Productive cough,3
CLARITIN,Infusion related reaction,3
CLARITIN,Dehydration,3
CLARITIN,Nasal congestion,3
CLARITIN,Arthropod bite,3
CLARITIN,Upper respiratory tract infection,3
CLARITIN,Dry skin,3
CLARITIN,Gastrooesophageal reflux disease,3
CLARITIN,Constipation,3
CLINDAMYCIN,Hepatic cytolysis,12
CLINDAMYCIN,Pain,11
CLINDAMYCIN,Off label use,9
CLINDAMYCIN,Emotional distress,9
CLINDAMYCIN,Anxiety,8
CLINDAMYCIN,Anhedonia,8
CLINDAMYCIN,Thrombocytopenia,8
CLINDAMYCIN,Headache,7
CLINDAMYCIN,Depression,6
CLINDAMYCIN,Nausea,6
CLINDAMYCIN,Diarrhoea,6
CLINDAMYCIN,Malaise,6
CLINDAMYCIN,Leukopenia,6
CLINDAMYCIN,Erythema,6
CLINDAMYCIN,Fall,5
CLINDAMYCIN,Sinusitis,5
CLINDAMYCIN,Chronic kidney disease,5
CLINDAMYCIN,Dyspnoea,5
CLINDAMYCIN,Osteopenia,5
CLINDAMYCIN,Abdominal pain upper,5
CLINDAMYCIN,Hypertension,5
CLINDAMYCIN,Arthralgia,5
CLINDAMYCIN,Nasopharyngitis,5
CLINDAMYCIN,Hyperkalaemia,5
CLINDAMYCIN,Hyponatraemia,5
CLINDAMYCIN,Lymphopenia,5
CLINDAMYCIN,Economic problem,4
CLINDAMYCIN,Fatigue,4
CLINDAMYCIN,Syncope,4
CLINDAMYCIN,Rash,4
CLINDAMYCIN,Insomnia,4
CLINDAMYCIN,Product dose omission issue,4
CLINDAMYCIN,Blister,4
CLINDAMYCIN,COVID-19,4
CLINDAMYCIN,Bronchitis,4
CLINDAMYCIN,Drug hypersensitivity,4
CLINDAMYCIN,Paraesthesia,4
CLINDAMYCIN,Cholestasis,4
CLINDAMYCIN,End stage renal disease,3
CLINDAMYCIN,Seasonal allergy,3
CLINDAMYCIN,Dizziness,3
CLINDAMYCIN,Condition aggravated,3
CLINDAMYCIN,Vomiting,3
CLINDAMYCIN,Bone density decreased,3
CLINDAMYCIN,Hypoaesthesia,3
CLINDAMYCIN,Drug ineffective,3
CLINDAMYCIN,Weight increased,3
CLINDAMYCIN,Hepatic enzyme increased,3
CLINDAMYCIN,Infusion site pruritus,3
CLINDAMYCIN,Ear infection,3
CLOBAZAM,Seizure,24
CLOBAZAM,Hepatic cytolysis,10
CLOBAZAM,Cholestasis,10
CLOBAZAM,Product preparation issue,9
CLOBAZAM,Off label use,9
CLOBAZAM,Drug ineffective,8
CLOBAZAM,General physical health deterioration,8
CLOBAZAM,Oliguria,8
CLOBAZAM,Decreased appetite,7
CLOBAZAM,Sepsis,7
CLOBAZAM,Diarrhoea haemorrhagic,7
CLOBAZAM,Fall,6
CLOBAZAM,COVID-19,5
CLOBAZAM,Condition aggravated,5
CLOBAZAM,Weight decreased,5
CLOBAZAM,Agitation,5
CLOBAZAM,Hospitalisation,4
CLOBAZAM,Product use in unapproved indication,4
CLOBAZAM,Somnolence,4
CLOBAZAM,Pyrexia,4
CLOBAZAM,Muscle spasms,4
CLOBAZAM,Type 2 diabetes mellitus,4
CLOBAZAM,Diabetic ketoacidosis,4
CLOBAZAM,Leukopenia,4
CLOBAZAM,Irritability,3
CLOBAZAM,Tricuspid valve incompetence,3
CLOBAZAM,Product use issue,3
CLOBAZAM,Echocardiogram abnormal,3
CLOBAZAM,Dyskinesia,3
CLOBAZAM,Crying,3
CLOBAZAM,Wrong technique in product usage process,3
CLOBAZAM,Dyspnoea,3
CLOBAZAM,Petechiae,3
CLOBAZAM,Confusional state,3
CLOBAZAM,Disorientation,3
CLOBAZAM,Insomnia,3
CLOBAZAM,Change in seizure presentation,3
CLOBAZAM,Fatigue,3
CLOBAZAM,Hepatitis,2
CLOBAZAM,Productive cough,2
CLOBAZAM,Mental disorder,2
CLOBAZAM,Gait inability,2
CLOBAZAM,Infection,2
CLOBAZAM,Pancytopenia,2
CLOBAZAM,Anger,2
CLOBAZAM,Overdose,2
CLOBAZAM,Anaemia,2
CLOBAZAM,Oxygen saturation decreased,2
CLOBAZAM,Aggression,2
CLOBAZAM,Tremor,2
CLOBETASOL,Psoriasis,15
CLOBETASOL,Pruritus,12
CLOBETASOL,Rash,11
CLOBETASOL,Drug ineffective,11
CLOBETASOL,Product dose omission issue,9
CLOBETASOL,Skin exfoliation,9
CLOBETASOL,Dermatitis atopic,8
CLOBETASOL,Skin lesion,7
CLOBETASOL,Erythema,7
CLOBETASOL,Pain,6
CLOBETASOL,Pain in extremity,6
CLOBETASOL,Dry skin,6
CLOBETASOL,Back pain,5
CLOBETASOL,Malaise,5
CLOBETASOL,COVID-19,5
CLOBETASOL,Weight decreased,5
CLOBETASOL,Diarrhoea,5
CLOBETASOL,Nausea,5
CLOBETASOL,Product use in unapproved indication,5
CLOBETASOL,Condition aggravated,5
CLOBETASOL,Fatigue,4
CLOBETASOL,Off label use,4
CLOBETASOL,Influenza,4
CLOBETASOL,Arthralgia,4
CLOBETASOL,Urticaria,4
CLOBETASOL,Dyspnoea,4
CLOBETASOL,Anxiety,4
CLOBETASOL,Urinary tract infection,4
CLOBETASOL,Interstitial lung disease,4
CLOBETASOL,Joint swelling,4
CLOBETASOL,Headache,4
CLOBETASOL,Pneumonia,3
CLOBETASOL,Fall,3
CLOBETASOL,Neck pain,3
CLOBETASOL,Dysphagia,3
CLOBETASOL,Osteoporosis,3
CLOBETASOL,Memory impairment,3
CLOBETASOL,Migraine,3
CLOBETASOL,Obesity,3
CLOBETASOL,Asthma,3
CLOBETASOL,Product administration interrupted,3
CLOBETASOL,Blister,3
CLOBETASOL,Abdominal pain,3
CLOBETASOL,Gait disturbance,3
CLOBETASOL,Arthritis,3
CLOBETASOL,Insomnia,3
CLOBETASOL,Discomfort,3
CLOBETASOL,Eczema,3
CLOBETASOL,Psoriatic arthropathy,3
CLOBETASOL,Treatment failure,3
CLONAZEPAM,Fatigue,48
CLONAZEPAM,Headache,40
CLONAZEPAM,Off label use,35
CLONAZEPAM,Pain,33
CLONAZEPAM,Anxiety,33
CLONAZEPAM,Dyspnoea,32
CLONAZEPAM,Seizure,32
CLONAZEPAM,Dizziness,31
CLONAZEPAM,Product dose omission issue,29
CLONAZEPAM,Diarrhoea,29
CLONAZEPAM,Vomiting,27
CLONAZEPAM,Illness,24
CLONAZEPAM,Depression,24
CLONAZEPAM,Somnolence,23
CLONAZEPAM,Drug ineffective,23
CLONAZEPAM,Arthralgia,22
CLONAZEPAM,Gait disturbance,22
CLONAZEPAM,Suicidal ideation,21
CLONAZEPAM,Fall,21
CLONAZEPAM,COVID-19,21
CLONAZEPAM,Pyrexia,20
CLONAZEPAM,Nausea,20
CLONAZEPAM,Tremor,20
CLONAZEPAM,Asthenia,19
CLONAZEPAM,Sleep disorder,19
CLONAZEPAM,Insomnia,18
CLONAZEPAM,Hypoaesthesia,18
CLONAZEPAM,Pruritus,18
CLONAZEPAM,Weight decreased,17
CLONAZEPAM,Vision blurred,17
CLONAZEPAM,Contusion,17
CLONAZEPAM,Heart rate increased,17
CLONAZEPAM,Malaise,17
CLONAZEPAM,Balance disorder,17
CLONAZEPAM,Decreased appetite,17
CLONAZEPAM,Confusional state,16
CLONAZEPAM,Speech disorder,16
CLONAZEPAM,Toxicity to various agents,16
CLONAZEPAM,Psychotic disorder,15
CLONAZEPAM,Limb injury,15
CLONAZEPAM,"Hallucinations, mixed",15
CLONAZEPAM,Muscle spasms,15
CLONAZEPAM,Mood swings,14
CLONAZEPAM,Drug interaction,14
CLONAZEPAM,Feeling abnormal,14
CLONAZEPAM,Sinusitis,14
CLONAZEPAM,Restlessness,14
CLONAZEPAM,Pneumonia,14
CLONAZEPAM,Mania,14
CLONAZEPAM,Visual impairment,14
CLONIDINE,Pain,32
CLONIDINE,Fatigue,22
CLONIDINE,Vomiting,21
CLONIDINE,Diarrhoea,21
CLONIDINE,Anxiety,18
CLONIDINE,Pyrexia,17
CLONIDINE,Emotional distress,16
CLONIDINE,Back pain,15
CLONIDINE,Anhedonia,14
CLONIDINE,Dizziness,13
CLONIDINE,Neutropenia,13
CLONIDINE,Malaise,13
CLONIDINE,Fall,12
CLONIDINE,Chronic kidney disease,12
CLONIDINE,Nausea,12
CLONIDINE,Pneumonia,12
CLONIDINE,Product dose omission issue,11
CLONIDINE,Urinary tract infection,10
CLONIDINE,Blood pressure increased,10
CLONIDINE,Febrile neutropenia,10
CLONIDINE,Body temperature increased,9
CLONIDINE,Proctalgia,9
CLONIDINE,Accident,9
CLONIDINE,Anal inflammation,9
CLONIDINE,Haemorrhoids,9
CLONIDINE,Crohn's disease,9
CLONIDINE,Pain in extremity,8
CLONIDINE,Muscle spasms,8
CLONIDINE,Condition aggravated,8
CLONIDINE,Blood creatinine increased,8
CLONIDINE,Acute kidney injury,8
CLONIDINE,Depression,8
CLONIDINE,Renal failure,8
CLONIDINE,Dyspnoea,8
CLONIDINE,Cough,8
CLONIDINE,COVID-19,8
CLONIDINE,Chills,8
CLONIDINE,Hypertension,7
CLONIDINE,Asthenia,7
CLONIDINE,Loss of consciousness,7
CLONIDINE,Decreased appetite,7
CLONIDINE,Klebsiella infection,7
CLONIDINE,Hyperhidrosis,7
CLONIDINE,Candida infection,7
CLONIDINE,Arthralgia,7
CLONIDINE,SARS-CoV-2 test negative,7
CLONIDINE,Septic shock,7
CLONIDINE,Multiple organ dysfunction syndrome,7
CLONIDINE,Off label use,6
CLONIDINE,Bone density decreased,6
CLOPIDOGREL,Diarrhoea,31
CLOPIDOGREL,Asthenia,24
CLOPIDOGREL,Fatigue,23
CLOPIDOGREL,Nausea,22
CLOPIDOGREL,Dyspnoea,20
CLOPIDOGREL,Vomiting,19
CLOPIDOGREL,Pain,17
CLOPIDOGREL,Acute kidney injury,17
CLOPIDOGREL,Pruritus,16
CLOPIDOGREL,Depression,15
CLOPIDOGREL,Dehydration,15
CLOPIDOGREL,Headache,15
CLOPIDOGREL,Chronic kidney disease,15
CLOPIDOGREL,Death,15
CLOPIDOGREL,Anaemia,15
CLOPIDOGREL,Coronary artery disease,14
CLOPIDOGREL,Constipation,14
CLOPIDOGREL,Anxiety,13
CLOPIDOGREL,Cardiac failure,13
CLOPIDOGREL,Intestinal obstruction,13
CLOPIDOGREL,Malaise,12
CLOPIDOGREL,Joint swelling,12
CLOPIDOGREL,Hypokalaemia,12
CLOPIDOGREL,Decreased appetite,12
CLOPIDOGREL,Hypotension,12
CLOPIDOGREL,Acute myocardial infarction,12
CLOPIDOGREL,Off label use,12
CLOPIDOGREL,Condition aggravated,11
CLOPIDOGREL,Palpitations,11
CLOPIDOGREL,Dysphagia,11
CLOPIDOGREL,Neutropenic sepsis,11
CLOPIDOGREL,Myocardial infarction,10
CLOPIDOGREL,Gait disturbance,10
CLOPIDOGREL,Syncope,10
CLOPIDOGREL,Oedema peripheral,10
CLOPIDOGREL,Hypomagnesaemia,10
CLOPIDOGREL,Pain in extremity,9
CLOPIDOGREL,Dizziness,9
CLOPIDOGREL,Pneumonia,9
CLOPIDOGREL,Left ventricular dysfunction,9
CLOPIDOGREL,Diastolic dysfunction,9
CLOPIDOGREL,Helicobacter gastritis,9
CLOPIDOGREL,Pericardial effusion,9
CLOPIDOGREL,Left ventricular hypertrophy,9
CLOPIDOGREL,Hyperlipidaemia,9
CLOPIDOGREL,Mitral valve incompetence,9
CLOPIDOGREL,Ejection fraction decreased,9
CLOPIDOGREL,Balance disorder,9
CLOPIDOGREL,Back pain,9
CLOPIDOGREL,Chest pain,8
CLOPIDOGREL BISULFATE,Asthenia,11
CLOPIDOGREL BISULFATE,Diarrhoea,10
CLOPIDOGREL BISULFATE,Fatigue,9
CLOPIDOGREL BISULFATE,Off label use,9
CLOPIDOGREL BISULFATE,Acute kidney injury,8
CLOPIDOGREL BISULFATE,Cardiac failure,8
CLOPIDOGREL BISULFATE,Dizziness,8
CLOPIDOGREL BISULFATE,Palpitations,7
CLOPIDOGREL BISULFATE,Vomiting,7
CLOPIDOGREL BISULFATE,Intestinal obstruction,6
CLOPIDOGREL BISULFATE,Hypotension,6
CLOPIDOGREL BISULFATE,Syncope,6
CLOPIDOGREL BISULFATE,Coronary artery disease,6
CLOPIDOGREL BISULFATE,Acute myocardial infarction,6
CLOPIDOGREL BISULFATE,Pneumonia,6
CLOPIDOGREL BISULFATE,Ventricular hypokinesia,5
CLOPIDOGREL BISULFATE,Ill-defined disorder,5
CLOPIDOGREL BISULFATE,Dyspnoea at rest,5
CLOPIDOGREL BISULFATE,Pericardial disease,5
CLOPIDOGREL BISULFATE,Anaemia macrocytic,5
CLOPIDOGREL BISULFATE,Tricuspid valve incompetence,5
CLOPIDOGREL BISULFATE,Bundle branch block left,5
CLOPIDOGREL BISULFATE,Ventricular tachycardia,5
CLOPIDOGREL BISULFATE,Supraventricular tachycardia,5
CLOPIDOGREL BISULFATE,Left ventricular dysfunction,5
CLOPIDOGREL BISULFATE,Pulmonary valve disease,5
CLOPIDOGREL BISULFATE,Diastolic dysfunction,5
CLOPIDOGREL BISULFATE,Helicobacter gastritis,5
CLOPIDOGREL BISULFATE,Stenosis,5
CLOPIDOGREL BISULFATE,Cardiomegaly,5
CLOPIDOGREL BISULFATE,Ventricular arrhythmia,5
CLOPIDOGREL BISULFATE,Pericardial effusion,5
CLOPIDOGREL BISULFATE,Cardiac discomfort,5
CLOPIDOGREL BISULFATE,Left ventricular hypertrophy,5
CLOPIDOGREL BISULFATE,Occult blood,5
CLOPIDOGREL BISULFATE,Hyperlipidaemia,5
CLOPIDOGREL BISULFATE,Chronic kidney disease,5
CLOPIDOGREL BISULFATE,Rales,5
CLOPIDOGREL BISULFATE,Carotid arteriosclerosis,5
CLOPIDOGREL BISULFATE,Mitral valve incompetence,5
CLOPIDOGREL BISULFATE,Joint swelling,5
CLOPIDOGREL BISULFATE,Skin lesion,5
CLOPIDOGREL BISULFATE,Mitral valve disease,5
CLOPIDOGREL BISULFATE,Electrocardiogram Q wave abnormal,5
CLOPIDOGREL BISULFATE,Ejection fraction decreased,5
CLOPIDOGREL BISULFATE,Hepatojugular reflux,5
CLOPIDOGREL BISULFATE,Electrocardiogram QT prolonged,5
CLOPIDOGREL BISULFATE,Carotid artery stenosis,5
CLOPIDOGREL BISULFATE,Systolic dysfunction,5
CLOPIDOGREL BISULFATE,Aortic valve incompetence,5
CLOZAPINE,Drug interaction,19
CLOZAPINE,Wrong patient received product,17
CLOZAPINE,Off label use,16
CLOZAPINE,Overdose,15
CLOZAPINE,Vomiting,14
CLOZAPINE,Condition aggravated,12
CLOZAPINE,Rash,11
CLOZAPINE,Schizophrenia,11
CLOZAPINE,Somnolence,11
CLOZAPINE,Product dose omission issue,11
CLOZAPINE,Hypoxia,10
CLOZAPINE,Sedation,10
CLOZAPINE,Neutropenia,9
CLOZAPINE,Hypothermia,9
CLOZAPINE,Hypoglycaemia,9
CLOZAPINE,Inflammation,9
CLOZAPINE,Knee arthroplasty,9
CLOZAPINE,Lung neoplasm malignant,9
CLOZAPINE,Arthropathy,9
CLOZAPINE,Intentional product misuse,9
CLOZAPINE,COVID-19,9
CLOZAPINE,Abdominal discomfort,9
CLOZAPINE,Radiation inflammation,9
CLOZAPINE,Pulmonary pain,9
CLOZAPINE,Lower respiratory tract infection,9
CLOZAPINE,Drug abuse,9
CLOZAPINE,Hepatic cytolysis,8
CLOZAPINE,Cholestasis,8
CLOZAPINE,Coma,7
CLOZAPINE,Gastrointestinal necrosis,7
CLOZAPINE,Megacolon,7
CLOZAPINE,Psychotic disorder,6
CLOZAPINE,Hospitalisation,6
CLOZAPINE,Malaise,6
CLOZAPINE,Agranulocytosis,5
CLOZAPINE,Extrapyramidal disorder,5
CLOZAPINE,Food poisoning,5
CLOZAPINE,White blood cell count decreased,4
CLOZAPINE,Neutrophil count decreased,4
CLOZAPINE,Antipsychotic drug level increased,4
CLOZAPINE,Palpitations,4
CLOZAPINE,Tachycardia,4
CLOZAPINE,Cardiac failure,4
CLOZAPINE,Anxiety,4
CLOZAPINE,Fatigue,4
CLOZAPINE,Dizziness,4
CLOZAPINE,General physical health deterioration,4
CLOZAPINE,Tonic clonic movements,4
CLOZAPINE,Toxic encephalopathy,4
CLOZAPINE,Dementia,4
CLOZARIL,Off label use,29
CLOZARIL,Schizophrenia,24
CLOZARIL,COVID-19,23
CLOZARIL,Overdose,22
CLOZARIL,Neutropenia,19
CLOZARIL,Intentional product misuse,16
CLOZARIL,Product dose omission issue,14
CLOZARIL,Condition aggravated,14
CLOZARIL,Lung neoplasm malignant,14
CLOZARIL,Rash,14
CLOZARIL,Radiation inflammation,14
CLOZARIL,Inflammation,14
CLOZARIL,Diarrhoea,13
CLOZARIL,Mucosal inflammation,13
CLOZARIL,Drug abuse,13
CLOZARIL,Abdominal discomfort,13
CLOZARIL,Lower respiratory tract infection,13
CLOZARIL,Knee arthroplasty,13
CLOZARIL,Arthropathy,13
CLOZARIL,Pulmonary pain,13
CLOZARIL,Neutrophil count increased,12
CLOZARIL,Leukopenia,11
CLOZARIL,Platelet count decreased,11
CLOZARIL,Lymphocyte count decreased,11
CLOZARIL,Thrombocytopenia,11
CLOZARIL,Psychotic disorder,10
CLOZARIL,Nausea,10
CLOZARIL,Affective disorder,9
CLOZARIL,Neuropathy peripheral,9
CLOZARIL,Cellulitis,9
CLOZARIL,Dyspepsia,9
CLOZARIL,Alopecia,9
CLOZARIL,Fatigue,9
CLOZARIL,Incorrect dose administered,9
CLOZARIL,Seizure,9
CLOZARIL,"Hallucination, auditory",9
CLOZARIL,Extrapyramidal disorder,9
CLOZARIL,Delusion of grandeur,9
CLOZARIL,Disease progression,8
CLOZARIL,Rhinalgia,8
CLOZARIL,Lymphocyte count abnormal,7
CLOZARIL,Food poisoning,7
CLOZARIL,SARS-CoV-2 test positive,6
CLOZARIL,Hospitalisation,6
CLOZARIL,White blood cell count decreased,6
CLOZARIL,Blood test abnormal,6
CLOZARIL,White blood cell count increased,5
CLOZARIL,Malaise,5
CLOZARIL,Haemoglobin decreased,5
CLOZARIL,Neoplasm progression,4
COCODAMOL,Peripheral swelling,9
COCODAMOL,Hypersensitivity,8
COCODAMOL,Dyspepsia,6
COCODAMOL,Vitamin B12 deficiency,6
COCODAMOL,Oropharyngeal discomfort,6
COCODAMOL,Eructation,6
COCODAMOL,Regurgitation,6
COCODAMOL,Neck pain,6
COCODAMOL,Abdominal distension,6
COCODAMOL,Barrett's oesophagus,6
COCODAMOL,Tachycardia,5
COCODAMOL,Rash,5
COCODAMOL,Blood creatine phosphokinase increased,4
COCODAMOL,Atrial fibrillation,4
COCODAMOL,Heart rate irregular,4
COCODAMOL,Infection,4
COCODAMOL,Disease progression,4
COCODAMOL,Off label use,4
COCODAMOL,Insomnia,4
COCODAMOL,Dyspnoea,4
COCODAMOL,Pruritus,4
COCODAMOL,Arthralgia,4
COCODAMOL,Decreased appetite,4
COCODAMOL,Fatigue,4
COCODAMOL,Depression,4
COCODAMOL,Chromaturia,4
COCODAMOL,Joint swelling,4
COCODAMOL,Disturbance in attention,4
COCODAMOL,Product used for unknown indication,3
COCODAMOL,Product use in unapproved indication,3
COCODAMOL,Palpitations,3
COCODAMOL,Death,3
COCODAMOL,Muscle spasms,3
COCODAMOL,Swelling face,3
COCODAMOL,Periorbital swelling,3
COCODAMOL,Feeling abnormal,3
COCODAMOL,Myalgia,3
COCODAMOL,Tendon pain,3
COCODAMOL,Pulmonary embolism,2
COCODAMOL,Pleural effusion,2
COCODAMOL,Condition aggravated,2
COCODAMOL,Immune-mediated nephritis,2
COCODAMOL,Blood thyroid stimulating hormone increased,2
COCODAMOL,Balance disorder,2
COCODAMOL,Deafness,2
COCODAMOL,Nausea,2
COCODAMOL,Cerebrovascular accident,2
COCODAMOL,Seizure,2
COCODAMOL,Contusion,2
COCODAMOL,Malaise,2
CODEINE,Diarrhoea,26
CODEINE,Headache,23
CODEINE,Arthralgia,22
CODEINE,Fatigue,21
CODEINE,Vomiting,21
CODEINE,Off label use,20
CODEINE,Pain,19
CODEINE,Rash,18
CODEINE,Pruritus,17
CODEINE,Dizziness,17
CODEINE,Nausea,17
CODEINE,Dyspnoea,15
CODEINE,Drug ineffective,15
CODEINE,Drug hypersensitivity,14
CODEINE,Malaise,13
CODEINE,Tachycardia,13
CODEINE,Condition aggravated,11
CODEINE,Abdominal pain,11
CODEINE,Pyrexia,11
CODEINE,Cough,11
CODEINE,Rheumatoid arthritis,10
CODEINE,Weight increased,10
CODEINE,Vision blurred,10
CODEINE,Pneumonia,10
CODEINE,Abdominal pain upper,10
CODEINE,Gait disturbance,10
CODEINE,Anxiety,10
CODEINE,Toxicity to various agents,10
CODEINE,Contraindicated product administered,9
CODEINE,Therapeutic product effect decreased,9
CODEINE,Drug intolerance,9
CODEINE,Musculoskeletal stiffness,9
CODEINE,Intentional product use issue,9
CODEINE,Back pain,9
CODEINE,COVID-19,9
CODEINE,Infection,9
CODEINE,Product use issue,9
CODEINE,Peripheral swelling,9
CODEINE,Hypoaesthesia,9
CODEINE,Abdominal discomfort,9
CODEINE,Decreased appetite,9
CODEINE,Illness,9
CODEINE,Seizure,9
CODEINE,Hypertension,8
CODEINE,Contusion,8
CODEINE,Pain in extremity,8
CODEINE,Depression,8
CODEINE,Speech disorder,8
CODEINE,Hyperhidrosis,8
CODEINE,Asthenia,7
CODEINE PHOSPHATE,Dyspnoea,17
CODEINE PHOSPHATE,Off label use,17
CODEINE PHOSPHATE,Diarrhoea,17
CODEINE PHOSPHATE,Fatigue,16
CODEINE PHOSPHATE,Pruritus,15
CODEINE PHOSPHATE,Headache,15
CODEINE PHOSPHATE,Vomiting,13
CODEINE PHOSPHATE,Dizziness,11
CODEINE PHOSPHATE,Gait disturbance,11
CODEINE PHOSPHATE,Arthralgia,10
CODEINE PHOSPHATE,Pyrexia,10
CODEINE PHOSPHATE,Drug hypersensitivity,10
CODEINE PHOSPHATE,Tachycardia,10
CODEINE PHOSPHATE,Depression,10
CODEINE PHOSPHATE,Drug ineffective,10
CODEINE PHOSPHATE,Swelling face,10
CODEINE PHOSPHATE,Agitation,10
CODEINE PHOSPHATE,Asthenia,9
CODEINE PHOSPHATE,Malaise,9
CODEINE PHOSPHATE,Anxiety,9
CODEINE PHOSPHATE,Decreased appetite,9
CODEINE PHOSPHATE,Musculoskeletal stiffness,8
CODEINE PHOSPHATE,Rash,8
CODEINE PHOSPHATE,Nausea,8
CODEINE PHOSPHATE,Cough,8
CODEINE PHOSPHATE,Pneumonia,8
CODEINE PHOSPHATE,Heart rate increased,8
CODEINE PHOSPHATE,Illness,8
CODEINE PHOSPHATE,Balance disorder,8
CODEINE PHOSPHATE,Disorientation,8
CODEINE PHOSPHATE,Hyperhidrosis,8
CODEINE PHOSPHATE,Somnolence,8
CODEINE PHOSPHATE,Tinnitus,8
CODEINE PHOSPHATE,Vision blurred,8
CODEINE PHOSPHATE,Hypersensitivity,7
CODEINE PHOSPHATE,Muscle spasms,7
CODEINE PHOSPHATE,Maternal exposure during pregnancy,7
CODEINE PHOSPHATE,Confusional state,7
CODEINE PHOSPHATE,Paraesthesia,7
CODEINE PHOSPHATE,Weight decreased,7
CODEINE PHOSPHATE,Contusion,7
CODEINE PHOSPHATE,Skin discolouration,7
CODEINE PHOSPHATE,Urticaria,7
CODEINE PHOSPHATE,Visual impairment,7
CODEINE PHOSPHATE,Paralysis,7
CODEINE PHOSPHATE,Speech disorder,7
CODEINE PHOSPHATE,Toxicity to various agents,7
CODEINE PHOSPHATE,Nasopharyngitis,6
CODEINE PHOSPHATE,Abdominal discomfort,6
CODEINE PHOSPHATE,Infection,6
COENZYME Q10,COVID-19,10
COENZYME Q10,Dyspnoea,10
COENZYME Q10,Fatigue,9
COENZYME Q10,Fall,8
COENZYME Q10,Product dose omission issue,7
COENZYME Q10,Sinusitis,7
COENZYME Q10,Headache,6
COENZYME Q10,Weight increased,6
COENZYME Q10,Peripheral swelling,5
COENZYME Q10,Dyspnoea exertional,5
COENZYME Q10,Pain,5
COENZYME Q10,Condition aggravated,5
COENZYME Q10,Malaise,5
COENZYME Q10,Urinary tract infection,5
COENZYME Q10,Arthralgia,4
COENZYME Q10,Infection,4
COENZYME Q10,Ear infection,4
COENZYME Q10,Injection site bruising,3
COENZYME Q10,Asthenia,3
COENZYME Q10,Dizziness,3
COENZYME Q10,Osteoporosis,3
COENZYME Q10,Diarrhoea,3
COENZYME Q10,Gastroenteritis viral,3
COENZYME Q10,Decreased appetite,3
COENZYME Q10,Death,3
COENZYME Q10,Abdominal pain,3
COENZYME Q10,Head injury,3
COENZYME Q10,Post procedural complication,3
COENZYME Q10,Cerebrovascular accident,3
COENZYME Q10,Blood pressure increased,3
COENZYME Q10,Contusion,3
COENZYME Q10,Pain in extremity,3
COENZYME Q10,Rash,3
COENZYME Q10,Drug ineffective,3
COENZYME Q10,Back pain,3
COENZYME Q10,Dry skin,2
COENZYME Q10,Feeling abnormal,2
COENZYME Q10,Blood pressure decreased,2
COENZYME Q10,Anxiety,2
COENZYME Q10,Pneumonia bacterial,2
COENZYME Q10,Pneumonia,2
COENZYME Q10,Depression,2
COENZYME Q10,Syncope,2
COENZYME Q10,Systemic lupus erythematosus,2
COENZYME Q10,Fibromyalgia,2
COENZYME Q10,Bite,2
COENZYME Q10,Oral viral infection,2
COENZYME Q10,Oral infection,2
COENZYME Q10,Infusion site pain,2
COENZYME Q10,Illness,2
COLACE,Fatigue,14
COLACE,Product dose omission issue,10
COLACE,Pain,8
COLACE,Headache,8
COLACE,Pneumonia,8
COLACE,Drug ineffective,7
COLACE,Dyspnoea,7
COLACE,Nausea,7
COLACE,Dizziness,7
COLACE,Fall,7
COLACE,Asthenia,7
COLACE,Arthralgia,6
COLACE,Anxiety,5
COLACE,Hypertension,5
COLACE,Pain in extremity,5
COLACE,Peripheral swelling,5
COLACE,Gait disturbance,5
COLACE,COVID-19,5
COLACE,Acute kidney injury,5
COLACE,Off label use,5
COLACE,Malaise,4
COLACE,Hypersomnia,4
COLACE,Diarrhoea,4
COLACE,Oedema peripheral,4
COLACE,Depression,3
COLACE,Blood pressure decreased,3
COLACE,Weight increased,3
COLACE,Infusion related reaction,3
COLACE,Abdominal discomfort,3
COLACE,Sinusitis,3
COLACE,Skin exfoliation,3
COLACE,Death,3
COLACE,Hyperkeratosis,3
COLACE,Contusion,3
COLACE,Syncope,3
COLACE,Therapeutic product effect incomplete,3
COLACE,Muscle spasms,3
COLACE,Rhinorrhoea,3
COLACE,Illness,3
COLACE,Staphylococcal infection,3
COLACE,Decreased appetite,3
COLACE,Back pain,3
COLACE,Hypotension,3
COLACE,Hallucination,3
COLACE,Condition aggravated,3
COLACE,Vomiting,3
COLACE,Thrombocytopenia,3
COLACE,Stress,2
COLACE,Arthritis,2
COLACE,Blood pressure increased,2
COLCHICINE,Diarrhoea,23
COLCHICINE,Pyrexia,18
COLCHICINE,Dyspnoea,16
COLCHICINE,Acute kidney injury,15
COLCHICINE,Nausea,15
COLCHICINE,Hepatic cytolysis,14
COLCHICINE,Abdominal pain,13
COLCHICINE,Arthralgia,11
COLCHICINE,Off label use,11
COLCHICINE,Headache,10
COLCHICINE,Anaemia,9
COLCHICINE,Hypertension,9
COLCHICINE,Vomiting,9
COLCHICINE,COVID-19,9
COLCHICINE,Fatigue,9
COLCHICINE,Cholestasis,9
COLCHICINE,Chest pain,8
COLCHICINE,Pain,8
COLCHICINE,Drug ineffective,8
COLCHICINE,Memory impairment,8
COLCHICINE,Rash,7
COLCHICINE,Malaise,7
COLCHICINE,Neutropenia,7
COLCHICINE,Emotional distress,6
COLCHICINE,Product dose omission issue,6
COLCHICINE,C-reactive protein increased,6
COLCHICINE,Gout,6
COLCHICINE,Condition aggravated,6
COLCHICINE,Cough,6
COLCHICINE,Product use issue,6
COLCHICINE,Cardiac failure congestive,6
COLCHICINE,Contraindicated product administered,6
COLCHICINE,Somnolence,6
COLCHICINE,Jaundice,6
COLCHICINE,Familial mediterranean fever,5
COLCHICINE,Chronic kidney disease,5
COLCHICINE,Concomitant disease aggravated,5
COLCHICINE,Anhedonia,5
COLCHICINE,Anxiety,5
COLCHICINE,Death,5
COLCHICINE,Abdominal pain upper,5
COLCHICINE,Abdominal discomfort,5
COLCHICINE,Drug intolerance,5
COLCHICINE,Liver disorder,5
COLCHICINE,Cardiac failure,5
COLCHICINE,Drug hypersensitivity,5
COLCHICINE,Toxic skin eruption,5
COLCHICINE,Balance disorder,5
COLCHICINE,Hypotension,5
COLCHICINE,Sepsis,4
COMBIVIR,Pain,59
COMBIVIR,Emotional distress,58
COMBIVIR,Anxiety,55
COMBIVIR,Anhedonia,53
COMBIVIR,Chronic kidney disease,34
COMBIVIR,Osteoporosis,26
COMBIVIR,Osteopenia,18
COMBIVIR,Bone demineralisation,18
COMBIVIR,Renal failure,16
COMBIVIR,Blood creatinine increased,15
COMBIVIR,Bone density decreased,13
COMBIVIR,Renal impairment,12
COMBIVIR,Depression,9
COMBIVIR,Acute kidney injury,9
COMBIVIR,Fatigue,9
COMBIVIR,Asthenia,8
COMBIVIR,Economic problem,7
COMBIVIR,Wrist fracture,7
COMBIVIR,Quality of life decreased,7
COMBIVIR,Multiple fractures,7
COMBIVIR,Renal injury,7
COMBIVIR,Gait disturbance,7
COMBIVIR,End stage renal disease,6
COMBIVIR,Foot fracture,5
COMBIVIR,Bone loss,5
COMBIVIR,Decreased activity,5
COMBIVIR,Back pain,4
COMBIVIR,Nephrolithiasis,4
COMBIVIR,General physical health deterioration,3
COMBIVIR,Fanconi syndrome acquired,3
COMBIVIR,Fracture,3
COMBIVIR,Pollakiuria,3
COMBIVIR,Insomnia,3
COMBIVIR,Proteinuria,3
COMBIVIR,Dysstasia,3
COMBIVIR,Renal pain,2
COMBIVIR,Ankle fracture,2
COMBIVIR,Fear,2
COMBIVIR,Osteonecrosis,2
COMBIVIR,Foetal exposure during pregnancy,2
COMBIVIR,Mobility decreased,2
COMBIVIR,Pain in extremity,2
COMBIVIR,Renal disorder,2
COMBIVIR,Arthralgia,2
COMBIVIR,Injury,2
COMBIVIR,Renal cyst,2
COMBIVIR,Gout,2
COMBIVIR,Nephropathy,2
COMBIVIR,Hip fracture,2
COMBIVIR,Lower limb fracture,2
COMIRNATY,Fatigue,23
COMIRNATY,Myalgia,13
COMIRNATY,Arthralgia,11
COMIRNATY,Pain in extremity,11
COMIRNATY,Muscular weakness,10
COMIRNATY,Headache,10
COMIRNATY,Gait disturbance,9
COMIRNATY,COVID-19,9
COMIRNATY,Vaccination failure,9
COMIRNATY,Dyspnoea,9
COMIRNATY,Foetal exposure during pregnancy,9
COMIRNATY,Drug ineffective,8
COMIRNATY,Malaise,8
COMIRNATY,Asthenia,8
COMIRNATY,Off label use,8
COMIRNATY,Chills,8
COMIRNATY,COVID-19 pneumonia,8
COMIRNATY,Lymphopenia,8
COMIRNATY,Limb discomfort,7
COMIRNATY,Nasopharyngitis,7
COMIRNATY,Pyrexia,7
COMIRNATY,Weight decreased,7
COMIRNATY,Dizziness,7
COMIRNATY,Paraesthesia,6
COMIRNATY,Influenza,6
COMIRNATY,Fall,6
COMIRNATY,Musculoskeletal stiffness,6
COMIRNATY,Small for dates baby,6
COMIRNATY,White blood cell count decreased,5
COMIRNATY,Urinary tract infection,5
COMIRNATY,Weight increased,5
COMIRNATY,Muscle spasms,5
COMIRNATY,Rash,5
COMIRNATY,Pain,5
COMIRNATY,Lymphocyte count decreased,4
COMIRNATY,Cough,4
COMIRNATY,Thrombocytopenia,4
COMIRNATY,Constipation,4
COMIRNATY,Hypoaesthesia,4
COMIRNATY,Migraine,4
COMIRNATY,Insomnia,4
COMIRNATY,Sensory disturbance,4
COMIRNATY,Confusional state,4
COMIRNATY,Muscle spasticity,4
COMIRNATY,Deep vein thrombosis,4
COMIRNATY,Pulmonary embolism,4
COMIRNATY,Swelling,4
COMIRNATY,Peripheral swelling,4
COMIRNATY,Joint swelling,4
COMIRNATY,Hypertension,4
CORTISONE,Fatigue,27
CORTISONE,Headache,25
CORTISONE,Arthralgia,22
CORTISONE,Off label use,21
CORTISONE,Pain,19
CORTISONE,Nausea,16
CORTISONE,Dyspnoea,16
CORTISONE,Asthenia,15
CORTISONE,Nasopharyngitis,15
CORTISONE,Diarrhoea,15
CORTISONE,COVID-19,15
CORTISONE,Gait disturbance,14
CORTISONE,Pruritus,14
CORTISONE,Pain in extremity,14
CORTISONE,Weight increased,13
CORTISONE,Musculoskeletal stiffness,13
CORTISONE,Drug ineffective,13
CORTISONE,Fall,12
CORTISONE,Weight decreased,12
CORTISONE,Inappropriate schedule of product administration,12
CORTISONE,Alopecia,12
CORTISONE,Malaise,12
CORTISONE,Influenza,12
CORTISONE,Intentional product use issue,11
CORTISONE,Vomiting,11
CORTISONE,Abdominal pain,11
CORTISONE,Pyrexia,10
CORTISONE,Condition aggravated,10
CORTISONE,Cough,10
CORTISONE,Dizziness,9
CORTISONE,Back pain,9
CORTISONE,Hypoaesthesia,9
CORTISONE,Oropharyngeal pain,9
CORTISONE,Myalgia,9
CORTISONE,Muscular weakness,9
CORTISONE,Hypersensitivity,8
CORTISONE,Migraine,8
CORTISONE,Psoriasis,8
CORTISONE,Erythema,8
CORTISONE,Chills,8
CORTISONE,Hypertension,7
CORTISONE,Muscle spasms,7
CORTISONE,Depression,7
CORTISONE,Mobility decreased,7
CORTISONE,Joint range of motion decreased,7
CORTISONE,Anxiety,7
CORTISONE,Heart rate increased,7
CORTISONE,Chest pain,6
CORTISONE,Urinary tract infection,6
CORTISONE,Rheumatoid arthritis,6
COSENTYX,Psoriasis,72
COSENTYX,Arthralgia,60
COSENTYX,Pain,59
COSENTYX,Pruritus,54
COSENTYX,Drug ineffective,46
COSENTYX,Pyrexia,43
COSENTYX,Rash,38
COSENTYX,Pain in extremity,38
COSENTYX,Psoriatic arthropathy,37
COSENTYX,Headache,37
COSENTYX,Malaise,34
COSENTYX,Fatigue,32
COSENTYX,Cough,32
COSENTYX,Diarrhoea,30
COSENTYX,Influenza,30
COSENTYX,Dyspnoea,29
COSENTYX,COVID-19,27
COSENTYX,Back pain,24
COSENTYX,Inflammation,23
COSENTYX,Musculoskeletal stiffness,23
COSENTYX,Inappropriate schedule of product administration,23
COSENTYX,Pneumonia,22
COSENTYX,Nasopharyngitis,22
COSENTYX,Dizziness,22
COSENTYX,Oropharyngeal pain,21
COSENTYX,Illness,21
COSENTYX,Weight decreased,20
COSENTYX,Product dose omission issue,20
COSENTYX,Joint swelling,20
COSENTYX,Skin exfoliation,20
COSENTYX,Gait disturbance,19
COSENTYX,Condition aggravated,19
COSENTYX,Arthritis,19
COSENTYX,Off label use,18
COSENTYX,Vomiting,18
COSENTYX,Erythema,18
COSENTYX,Hypertension,17
COSENTYX,Nausea,17
COSENTYX,Asthenia,16
COSENTYX,Sinusitis,15
COSENTYX,Hypersensitivity,15
COSENTYX,Skin lesion,15
COSENTYX,Insomnia,14
COSENTYX,Peripheral swelling,14
COSENTYX,Abdominal pain upper,14
COSENTYX,Product use in unapproved indication,14
COSENTYX,Maternal exposure during pregnancy,13
COSENTYX,Incorrect route of product administration,13
COSENTYX,Therapeutic product effect incomplete,13
COSENTYX,Urticaria,13
COTRIMOXAZOLE,Neutropenia,20
COTRIMOXAZOLE,Diarrhoea,19
COTRIMOXAZOLE,Febrile neutropenia,17
COTRIMOXAZOLE,Pyrexia,16
COTRIMOXAZOLE,Pain,12
COTRIMOXAZOLE,Malaise,12
COTRIMOXAZOLE,Vomiting,12
COTRIMOXAZOLE,Proctalgia,11
COTRIMOXAZOLE,Back pain,11
COTRIMOXAZOLE,Anal inflammation,11
COTRIMOXAZOLE,Accident,11
COTRIMOXAZOLE,Crohn's disease,11
COTRIMOXAZOLE,Body temperature increased,11
COTRIMOXAZOLE,Haemorrhoids,11
COTRIMOXAZOLE,Chills,10
COTRIMOXAZOLE,SARS-CoV-2 test negative,9
COTRIMOXAZOLE,Dyspnoea,7
COTRIMOXAZOLE,Anaemia,6
COTRIMOXAZOLE,Stomatitis,5
COTRIMOXAZOLE,Decreased appetite,5
COTRIMOXAZOLE,Fatigue,5
COTRIMOXAZOLE,Pneumonia,5
COTRIMOXAZOLE,Fall,4
COTRIMOXAZOLE,Rash,4
COTRIMOXAZOLE,Headache,4
COTRIMOXAZOLE,Pulmonary oedema,4
COTRIMOXAZOLE,Acute kidney injury,4
COTRIMOXAZOLE,Cytokine release syndrome,4
COTRIMOXAZOLE,Septic shock,4
COTRIMOXAZOLE,Urinary tract infection,4
COTRIMOXAZOLE,Sepsis,4
COTRIMOXAZOLE,Depression,4
COTRIMOXAZOLE,Facial paresis,3
COTRIMOXAZOLE,Facial paralysis,3
COTRIMOXAZOLE,Hemiparesis,3
COTRIMOXAZOLE,Dysarthria,3
COTRIMOXAZOLE,Aspartate aminotransferase increased,3
COTRIMOXAZOLE,Multiple organ dysfunction syndrome,3
COTRIMOXAZOLE,COVID-19,3
COTRIMOXAZOLE,General physical health deterioration,3
COTRIMOXAZOLE,Hypokalaemia,3
COTRIMOXAZOLE,Nausea,3
COTRIMOXAZOLE,Infection,3
COTRIMOXAZOLE,Constipation,3
COTRIMOXAZOLE,Abdominal pain,3
COTRIMOXAZOLE,Hyponatraemia,3
COTRIMOXAZOLE,Acute generalised exanthematous pustulosis,3
COTRIMOXAZOLE,Shock,3
COTRIMOXAZOLE,Thrombocytopenia,3
COTRIMOXAZOLE,Lung disorder,3
COVID-19 VACCINE NOS,Headache,24
COVID-19 VACCINE NOS,COVID-19,23
COVID-19 VACCINE NOS,Pain,22
COVID-19 VACCINE NOS,Fatigue,22
COVID-19 VACCINE NOS,Malaise,19
COVID-19 VACCINE NOS,Nausea,18
COVID-19 VACCINE NOS,Pyrexia,17
COVID-19 VACCINE NOS,Weight increased,16
COVID-19 VACCINE NOS,Inappropriate schedule of product administration,15
COVID-19 VACCINE NOS,Dizziness,15
COVID-19 VACCINE NOS,Diarrhoea,15
COVID-19 VACCINE NOS,Product dose omission issue,14
COVID-19 VACCINE NOS,Vomiting,12
COVID-19 VACCINE NOS,Asthenia,11
COVID-19 VACCINE NOS,Back pain,11
COVID-19 VACCINE NOS,Nasopharyngitis,10
COVID-19 VACCINE NOS,Arthralgia,10
COVID-19 VACCINE NOS,Abdominal pain,10
COVID-19 VACCINE NOS,Cough,9
COVID-19 VACCINE NOS,Palpitations,9
COVID-19 VACCINE NOS,Inflammation,9
COVID-19 VACCINE NOS,Influenza,9
COVID-19 VACCINE NOS,Illness,9
COVID-19 VACCINE NOS,Erythema,8
COVID-19 VACCINE NOS,Pain in extremity,8
COVID-19 VACCINE NOS,Heart rate increased,8
COVID-19 VACCINE NOS,Migraine,8
COVID-19 VACCINE NOS,Weight decreased,7
COVID-19 VACCINE NOS,Chills,7
COVID-19 VACCINE NOS,Gait disturbance,7
COVID-19 VACCINE NOS,Influenza like illness,7
COVID-19 VACCINE NOS,Chest pain,7
COVID-19 VACCINE NOS,Hereditary angioedema,7
COVID-19 VACCINE NOS,Dyspnoea,6
COVID-19 VACCINE NOS,Peripheral swelling,6
COVID-19 VACCINE NOS,Chest discomfort,6
COVID-19 VACCINE NOS,Pneumonia,6
COVID-19 VACCINE NOS,White blood cell count decreased,6
COVID-19 VACCINE NOS,Paraesthesia,6
COVID-19 VACCINE NOS,Infection,6
COVID-19 VACCINE NOS,Decreased appetite,6
COVID-19 VACCINE NOS,Anxiety,6
COVID-19 VACCINE NOS,Muscular weakness,6
COVID-19 VACCINE NOS,Dysphonia,6
COVID-19 VACCINE NOS,Hypersensitivity,6
COVID-19 VACCINE NOS,Drug ineffective,6
COVID-19 VACCINE NOS,Rash,5
COVID-19 VACCINE NOS,Blood pressure increased,5
COVID-19 VACCINE NOS,Bone pain,5
COVID-19 VACCINE NOS,Hyperhidrosis,5
COZAAR,Pneumonia,9
COZAAR,Hypertension,8
COZAAR,Cardiac failure,8
COZAAR,Pyrexia,8
COZAAR,Diarrhoea,6
COZAAR,Product dose omission issue,5
COZAAR,Atrial fibrillation,4
COZAAR,Palpitations,4
COZAAR,Syncope,4
COZAAR,Abdominal pain upper,3
COZAAR,Nasopharyngitis,3
COZAAR,Constipation,3
COZAAR,Liver disorder,3
COZAAR,Contusion,3
COZAAR,Condition aggravated,3
COZAAR,Sinusitis,3
COZAAR,Inappropriate schedule of product administration,3
COZAAR,Asthma,3
COZAAR,COVID-19,3
COZAAR,Hepatic enzyme increased,3
COZAAR,Cardiac failure congestive,3
COZAAR,Drug ineffective,3
COZAAR,Drug hypersensitivity,3
COZAAR,Dyspnoea,3
COZAAR,Off label use,3
COZAAR,Nausea,3
COZAAR,Chest discomfort,3
COZAAR,Insomnia,3
COZAAR,Fatigue,3
COZAAR,Memory impairment,3
COZAAR,Cellulitis,3
COZAAR,Dizziness,3
COZAAR,Gastrointestinal haemorrhage,3
COZAAR,Pulmonary embolism,3
COZAAR,Decreased appetite,3
COZAAR,Myalgia,2
COZAAR,Blood creatine phosphokinase increased,2
COZAAR,Respiratory tract infection,2
COZAAR,Muscle spasms,2
COZAAR,Radiculopathy,2
COZAAR,Fall,2
COZAAR,Pelvic fracture,2
COZAAR,Inflammation,2
COZAAR,Disease recurrence,2
COZAAR,Rash,2
COZAAR,Headache,2
COZAAR,Abdominal discomfort,2
COZAAR,Loss of employment,2
COZAAR,Drug intolerance,2
COZAAR,Cough,2
CREON,Diarrhoea,33
CREON,Asthenia,16
CREON,Weight decreased,15
CREON,Vomiting,13
CREON,Fatigue,12
CREON,Abdominal pain,12
CREON,Pain,10
CREON,Off label use,10
CREON,Nausea,9
CREON,Abdominal distension,9
CREON,Flatulence,9
CREON,Dehydration,8
CREON,Neurotoxicity,8
CREON,Product dose omission issue,7
CREON,Inappropriate schedule of product administration,7
CREON,Drug ineffective,7
CREON,Constipation,7
CREON,Dyspepsia,7
CREON,Decreased appetite,6
CREON,Urinary tract infection,6
CREON,Abdominal pain upper,6
CREON,Muscle spasms,6
CREON,Intestinal obstruction,5
CREON,Sepsis,5
CREON,Product use issue,5
CREON,Pneumonia,5
CREON,Myalgia,5
CREON,Pancreatitis,5
CREON,Fall,5
CREON,Headache,5
CREON,Steatorrhoea,5
CREON,Alopecia,5
CREON,Dysgeusia,5
CREON,Blood alkaline phosphatase increased,5
CREON,Drug hypersensitivity,4
CREON,Malnutrition,4
CREON,Sinusitis,4
CREON,Cough,4
CREON,Renal failure,4
CREON,Vascular device infection,4
CREON,Abnormal faeces,4
CREON,Back pain,4
CREON,Ascites,4
CREON,Death,4
CREON,Frequent bowel movements,4
CREON,Brain fog,3
CREON,Muscular weakness,3
CREON,Renal disorder,3
CREON,Cholelithiasis,3
CREON,Gastrointestinal stoma output increased,3
CRESTOR,Fatigue,27
CRESTOR,Pain,25
CRESTOR,COVID-19,22
CRESTOR,Fall,19
CRESTOR,Headache,16
CRESTOR,Back pain,16
CRESTOR,Diarrhoea,16
CRESTOR,Chronic kidney disease,14
CRESTOR,Anxiety,14
CRESTOR,Nausea,14
CRESTOR,Neutropenia,13
CRESTOR,Renal impairment,13
CRESTOR,Arthralgia,13
CRESTOR,Off label use,12
CRESTOR,Platelet count decreased,12
CRESTOR,Product dose omission issue,12
CRESTOR,Emotional distress,12
CRESTOR,Asthenia,12
CRESTOR,Hypertension,11
CRESTOR,Urinary tract infection,10
CRESTOR,Nephropathy toxic,10
CRESTOR,Overdose,10
CRESTOR,Oesophagitis,10
CRESTOR,Wrong product administered,10
CRESTOR,Medication error,10
CRESTOR,Discontinued product administered,10
CRESTOR,Thrombocytopenia,10
CRESTOR,Anhedonia,10
CRESTOR,Renal failure,10
CRESTOR,Sinusitis,10
CRESTOR,Depression,9
CRESTOR,Inappropriate schedule of product administration,9
CRESTOR,Dyspnoea,9
CRESTOR,Weight increased,9
CRESTOR,Malaise,8
CRESTOR,Weight decreased,8
CRESTOR,Anaemia,8
CRESTOR,Pain in extremity,7
CRESTOR,Dizziness,7
CRESTOR,Pneumonia,7
CRESTOR,Blood creatinine increased,7
CRESTOR,Decreased appetite,7
CRESTOR,Abdominal pain,7
CRESTOR,Upper respiratory tract infection,7
CRESTOR,Vomiting,7
CRESTOR,Pyrexia,6
CRESTOR,Cardiac failure,6
CRESTOR,Cough,6
CRESTOR,Rash,6
CRESTOR,Localised infection,6
CYAMEMAZINE,Somnolence,9
CYAMEMAZINE,Oxygen saturation decreased,9
CYAMEMAZINE,Coma,9
CYAMEMAZINE,Intentional overdose,8
CYAMEMAZINE,Electrocardiogram QT prolonged,8
CYAMEMAZINE,Gastrointestinal necrosis,7
CYAMEMAZINE,Drug interaction,7
CYAMEMAZINE,Megacolon,7
CYAMEMAZINE,Nervous system disorder,6
CYAMEMAZINE,Poisoning deliberate,5
CYAMEMAZINE,Transaminases increased,5
CYAMEMAZINE,Hepatic cytolysis,5
CYAMEMAZINE,Infection,5
CYAMEMAZINE,Endocarditis,5
CYAMEMAZINE,Tremor,4
CYAMEMAZINE,Irritability,4
CYAMEMAZINE,Apnoea,4
CYAMEMAZINE,Maternal drugs affecting foetus,4
CYAMEMAZINE,Vomiting,4
CYAMEMAZINE,Wrong patient received product,4
CYAMEMAZINE,Nausea,3
CYAMEMAZINE,Anxiety,3
CYAMEMAZINE,Sepsis,3
CYAMEMAZINE,Abdominal pain,3
CYAMEMAZINE,Lung disorder,3
CYAMEMAZINE,Therapeutic hypothermia,3
CYAMEMAZINE,Distal intestinal obstruction syndrome,3
CYAMEMAZINE,Pancreatitis acute,3
CYAMEMAZINE,Product use in unapproved indication,3
CYAMEMAZINE,Drug reaction with eosinophilia and systemic symptoms,3
CYAMEMAZINE,Hypotension,3
CYAMEMAZINE,Cytokine release syndrome,2
CYAMEMAZINE,Tachycardia,2
CYAMEMAZINE,Medullary compression syndrome,2
CYAMEMAZINE,Pericardial effusion,2
CYAMEMAZINE,Pyrexia,2
CYAMEMAZINE,Myalgia,2
CYAMEMAZINE,Cardiac tamponade,2
CYAMEMAZINE,Altered state of consciousness,2
CYAMEMAZINE,Acute kidney injury,2
CYAMEMAZINE,Hyperthermia malignant,2
CYAMEMAZINE,Acute respiratory distress syndrome,2
CYAMEMAZINE,Hallucination,1
CYAMEMAZINE,Cerebral venous thrombosis,1
CYAMEMAZINE,Fall,1
CYAMEMAZINE,Acute lymphocytic leukaemia,1
CYAMEMAZINE,Neoplasm progression,1
CYAMEMAZINE,Dyspnoea,1
CYAMEMAZINE,Toxicity to various agents,1
CYAMEMAZINE,Dyskinesia,1
CYANOCOBALAMIN,Off label use,26
CYANOCOBALAMIN,Product dose omission issue,22
CYANOCOBALAMIN,Fatigue,22
CYANOCOBALAMIN,Diarrhoea,21
CYANOCOBALAMIN,COVID-19,20
CYANOCOBALAMIN,Pneumonia,18
CYANOCOBALAMIN,Nausea,17
CYANOCOBALAMIN,Fall,17
CYANOCOBALAMIN,Anaemia,16
CYANOCOBALAMIN,Pain,15
CYANOCOBALAMIN,Inappropriate schedule of product administration,15
CYANOCOBALAMIN,Weight decreased,15
CYANOCOBALAMIN,Urinary tract infection,14
CYANOCOBALAMIN,Dyspnoea,14
CYANOCOBALAMIN,Sepsis,12
CYANOCOBALAMIN,Pruritus,12
CYANOCOBALAMIN,Abdominal distension,11
CYANOCOBALAMIN,Upper respiratory tract infection,10
CYANOCOBALAMIN,Sinusitis,10
CYANOCOBALAMIN,Illness,10
CYANOCOBALAMIN,Hypersensitivity,10
CYANOCOBALAMIN,Malaise,10
CYANOCOBALAMIN,Pyrexia,10
CYANOCOBALAMIN,Infusion related reaction,10
CYANOCOBALAMIN,Intentional product use issue,9
CYANOCOBALAMIN,Maternal exposure during pregnancy,9
CYANOCOBALAMIN,Abortion spontaneous,9
CYANOCOBALAMIN,Alanine aminotransferase increased,9
CYANOCOBALAMIN,Aspartate aminotransferase increased,9
CYANOCOBALAMIN,Anxiety,9
CYANOCOBALAMIN,Condition aggravated,9
CYANOCOBALAMIN,Hepatic cytolysis,8
CYANOCOBALAMIN,Nasopharyngitis,8
CYANOCOBALAMIN,Asthenia,8
CYANOCOBALAMIN,Headache,8
CYANOCOBALAMIN,Dizziness,8
CYANOCOBALAMIN,Hypoglycaemia,8
CYANOCOBALAMIN,Hypotension,8
CYANOCOBALAMIN,Drug abuse,7
CYANOCOBALAMIN,Oropharyngeal discomfort,7
CYANOCOBALAMIN,Viral infection,7
CYANOCOBALAMIN,Peripheral swelling,7
CYANOCOBALAMIN,Cough,7
CYANOCOBALAMIN,Arthritis,7
CYANOCOBALAMIN,Poor venous access,7
CYANOCOBALAMIN,Dyspepsia,7
CYANOCOBALAMIN,Transient aphasia,7
CYANOCOBALAMIN,Caesarean section,6
CYANOCOBALAMIN,Ultrasound antenatal screen,6
CYANOCOBALAMIN,Decreased appetite,6
CYCLOBENZAPRINE,Pain,34
CYCLOBENZAPRINE,Anxiety,24
CYCLOBENZAPRINE,Anhedonia,21
CYCLOBENZAPRINE,Headache,20
CYCLOBENZAPRINE,Emotional distress,20
CYCLOBENZAPRINE,Product dose omission issue,17
CYCLOBENZAPRINE,Fall,16
CYCLOBENZAPRINE,Urinary tract infection,14
CYCLOBENZAPRINE,Nausea,14
CYCLOBENZAPRINE,Osteoporosis,13
CYCLOBENZAPRINE,COVID-19,13
CYCLOBENZAPRINE,Chronic kidney disease,13
CYCLOBENZAPRINE,Fatigue,13
CYCLOBENZAPRINE,Depression,12
CYCLOBENZAPRINE,Malaise,12
CYCLOBENZAPRINE,Arthralgia,12
CYCLOBENZAPRINE,Pneumonia,12
CYCLOBENZAPRINE,Dyspnoea,11
CYCLOBENZAPRINE,Weight decreased,11
CYCLOBENZAPRINE,Bronchitis,11
CYCLOBENZAPRINE,Pyrexia,11
CYCLOBENZAPRINE,Influenza,10
CYCLOBENZAPRINE,Osteopenia,10
CYCLOBENZAPRINE,Blood creatinine increased,10
CYCLOBENZAPRINE,Vomiting,10
CYCLOBENZAPRINE,Off label use,10
CYCLOBENZAPRINE,Blood pressure increased,9
CYCLOBENZAPRINE,Sinusitis,9
CYCLOBENZAPRINE,Renal impairment,9
CYCLOBENZAPRINE,Renal failure,9
CYCLOBENZAPRINE,Bone density decreased,9
CYCLOBENZAPRINE,Nasopharyngitis,8
CYCLOBENZAPRINE,Weight increased,8
CYCLOBENZAPRINE,Upper respiratory tract infection,8
CYCLOBENZAPRINE,Limb injury,8
CYCLOBENZAPRINE,Hypersensitivity,8
CYCLOBENZAPRINE,Back pain,8
CYCLOBENZAPRINE,Migraine,8
CYCLOBENZAPRINE,Diarrhoea,7
CYCLOBENZAPRINE,Cough,7
CYCLOBENZAPRINE,Infection,7
CYCLOBENZAPRINE,Dehydration,7
CYCLOBENZAPRINE,Asthenia,7
CYCLOBENZAPRINE,Acute kidney injury,7
CYCLOBENZAPRINE,Feeling abnormal,6
CYCLOBENZAPRINE,Illness,6
CYCLOBENZAPRINE,Foot fracture,6
CYCLOBENZAPRINE,Multiple fractures,6
CYCLOBENZAPRINE,Rash,6
CYCLOBENZAPRINE,Injection site pain,5
CYCLOBENZAPRINE HYDROCHLORIDE,Product dose omission issue,15
CYCLOBENZAPRINE HYDROCHLORIDE,Fatigue,9
CYCLOBENZAPRINE HYDROCHLORIDE,Malaise,9
CYCLOBENZAPRINE HYDROCHLORIDE,Sinusitis,9
CYCLOBENZAPRINE HYDROCHLORIDE,Pain,8
CYCLOBENZAPRINE HYDROCHLORIDE,Back pain,8
CYCLOBENZAPRINE HYDROCHLORIDE,COVID-19,8
CYCLOBENZAPRINE HYDROCHLORIDE,Illness,7
CYCLOBENZAPRINE HYDROCHLORIDE,Upper respiratory tract infection,7
CYCLOBENZAPRINE HYDROCHLORIDE,Weight decreased,7
CYCLOBENZAPRINE HYDROCHLORIDE,Headache,6
CYCLOBENZAPRINE HYDROCHLORIDE,Weight increased,6
CYCLOBENZAPRINE HYDROCHLORIDE,Bronchitis,6
CYCLOBENZAPRINE HYDROCHLORIDE,Urinary tract infection,6
CYCLOBENZAPRINE HYDROCHLORIDE,Pneumonia,6
CYCLOBENZAPRINE HYDROCHLORIDE,Migraine,6
CYCLOBENZAPRINE HYDROCHLORIDE,Condition aggravated,6
CYCLOBENZAPRINE HYDROCHLORIDE,Fall,6
CYCLOBENZAPRINE HYDROCHLORIDE,Arthralgia,5
CYCLOBENZAPRINE HYDROCHLORIDE,Pain in extremity,5
CYCLOBENZAPRINE HYDROCHLORIDE,Influenza,5
CYCLOBENZAPRINE HYDROCHLORIDE,Oropharyngeal pain,5
CYCLOBENZAPRINE HYDROCHLORIDE,Cough,5
CYCLOBENZAPRINE HYDROCHLORIDE,Product use issue,5
CYCLOBENZAPRINE HYDROCHLORIDE,Off label use,5
CYCLOBENZAPRINE HYDROCHLORIDE,Pruritus,5
CYCLOBENZAPRINE HYDROCHLORIDE,Diarrhoea,4
CYCLOBENZAPRINE HYDROCHLORIDE,Nausea,4
CYCLOBENZAPRINE HYDROCHLORIDE,Dizziness,4
CYCLOBENZAPRINE HYDROCHLORIDE,Dyspnoea,4
CYCLOBENZAPRINE HYDROCHLORIDE,Nasopharyngitis,4
CYCLOBENZAPRINE HYDROCHLORIDE,Pyrexia,4
CYCLOBENZAPRINE HYDROCHLORIDE,Respiratory tract infection,4
CYCLOBENZAPRINE HYDROCHLORIDE,Infection,4
CYCLOBENZAPRINE HYDROCHLORIDE,Needle issue,4
CYCLOBENZAPRINE HYDROCHLORIDE,Vomiting,4
CYCLOBENZAPRINE HYDROCHLORIDE,Device related infection,4
CYCLOBENZAPRINE HYDROCHLORIDE,Rash,3
CYCLOBENZAPRINE HYDROCHLORIDE,Death,3
CYCLOBENZAPRINE HYDROCHLORIDE,Pleural effusion,3
CYCLOBENZAPRINE HYDROCHLORIDE,Feeling abnormal,3
CYCLOBENZAPRINE HYDROCHLORIDE,Anxiety,3
CYCLOBENZAPRINE HYDROCHLORIDE,Asthenia,3
CYCLOBENZAPRINE HYDROCHLORIDE,Abdominal pain,3
CYCLOBENZAPRINE HYDROCHLORIDE,Influenza like illness,3
CYCLOBENZAPRINE HYDROCHLORIDE,Inappropriate schedule of product administration,3
CYCLOBENZAPRINE HYDROCHLORIDE,Cerebrovascular accident,3
CYCLOBENZAPRINE HYDROCHLORIDE,Decreased appetite,3
CYCLOBENZAPRINE HYDROCHLORIDE,Incorrect dose administered,3
CYCLOBENZAPRINE HYDROCHLORIDE,Joint swelling,2
CYCLOPHOSPHAMIDE,Myelosuppression,112
CYCLOPHOSPHAMIDE,Febrile neutropenia,94
CYCLOPHOSPHAMIDE,White blood cell count decreased,82
CYCLOPHOSPHAMIDE,Pyrexia,78
CYCLOPHOSPHAMIDE,Off label use,68
CYCLOPHOSPHAMIDE,Neutropenia,66
CYCLOPHOSPHAMIDE,Vomiting,64
CYCLOPHOSPHAMIDE,Nausea,53
CYCLOPHOSPHAMIDE,Cytokine release syndrome,44
CYCLOPHOSPHAMIDE,Platelet count decreased,42
CYCLOPHOSPHAMIDE,Diarrhoea,41
CYCLOPHOSPHAMIDE,Pancytopenia,40
CYCLOPHOSPHAMIDE,Neutrophil count decreased,40
CYCLOPHOSPHAMIDE,Anaemia,39
CYCLOPHOSPHAMIDE,Sepsis,30
CYCLOPHOSPHAMIDE,Agranulocytosis,30
CYCLOPHOSPHAMIDE,Pneumonia,26
CYCLOPHOSPHAMIDE,Fatigue,24
CYCLOPHOSPHAMIDE,Dyspnoea,24
CYCLOPHOSPHAMIDE,Mucosal inflammation,22
CYCLOPHOSPHAMIDE,Thrombocytopenia,22
CYCLOPHOSPHAMIDE,Hepatic function abnormal,22
CYCLOPHOSPHAMIDE,Malaise,22
CYCLOPHOSPHAMIDE,Headache,21
CYCLOPHOSPHAMIDE,Malignant neoplasm progression,21
CYCLOPHOSPHAMIDE,Disease progression,19
CYCLOPHOSPHAMIDE,Back pain,19
CYCLOPHOSPHAMIDE,COVID-19,19
CYCLOPHOSPHAMIDE,Respiratory failure,18
CYCLOPHOSPHAMIDE,Pain,18
CYCLOPHOSPHAMIDE,Chills,18
CYCLOPHOSPHAMIDE,Acute kidney injury,17
CYCLOPHOSPHAMIDE,Immune effector cell-associated neurotoxicity syndrome,17
CYCLOPHOSPHAMIDE,Asthenia,17
CYCLOPHOSPHAMIDE,Cough,16
CYCLOPHOSPHAMIDE,Haemoglobin decreased,16
CYCLOPHOSPHAMIDE,Condition aggravated,16
CYCLOPHOSPHAMIDE,Dysphagia,15
CYCLOPHOSPHAMIDE,Myelodysplastic syndrome,15
CYCLOPHOSPHAMIDE,Decreased appetite,15
CYCLOPHOSPHAMIDE,Hypogammaglobulinaemia,15
CYCLOPHOSPHAMIDE,Hypotension,15
CYCLOPHOSPHAMIDE,Stomatitis,14
CYCLOPHOSPHAMIDE,Urinary tract infection,14
CYCLOPHOSPHAMIDE,Pruritus,14
CYCLOPHOSPHAMIDE,Hypoxia,13
CYCLOPHOSPHAMIDE,Tachycardia,13
CYCLOPHOSPHAMIDE,Septic shock,13
CYCLOPHOSPHAMIDE,Lower respiratory tract infection,13
CYCLOPHOSPHAMIDE,Gastrointestinal disorder,12
CYCLOSPORINE,Pyrexia,20
CYCLOSPORINE,Off label use,17
CYCLOSPORINE,Rash,13
CYCLOSPORINE,Pleural effusion,13
CYCLOSPORINE,Anaemia,12
CYCLOSPORINE,Pain in extremity,11
CYCLOSPORINE,Product use in unapproved indication,11
CYCLOSPORINE,Diarrhoea,11
CYCLOSPORINE,Weight increased,11
CYCLOSPORINE,Arthralgia,10
CYCLOSPORINE,Platelet count decreased,10
CYCLOSPORINE,Dizziness,10
CYCLOSPORINE,Blood bilirubin increased,10
CYCLOSPORINE,Acute kidney injury,10
CYCLOSPORINE,Pain,9
CYCLOSPORINE,Drug ineffective,9
CYCLOSPORINE,C-reactive protein increased,9
CYCLOSPORINE,Dyspnoea,9
CYCLOSPORINE,Ascites,9
CYCLOSPORINE,Fatigue,8
CYCLOSPORINE,Pneumonia,8
CYCLOSPORINE,Chronic kidney disease,8
CYCLOSPORINE,Headache,7
CYCLOSPORINE,Inappropriate schedule of product administration,7
CYCLOSPORINE,Blood pressure increased,7
CYCLOSPORINE,Haemoglobin decreased,7
CYCLOSPORINE,Malaise,7
CYCLOSPORINE,Epstein-Barr virus infection,7
CYCLOSPORINE,Pruritus,6
CYCLOSPORINE,Mobility decreased,6
CYCLOSPORINE,Condition aggravated,6
CYCLOSPORINE,Cough,6
CYCLOSPORINE,Asthenia,6
CYCLOSPORINE,Oedema,6
CYCLOSPORINE,Encephalitis fungal,6
CYCLOSPORINE,Hodgkin's disease,6
CYCLOSPORINE,Urticaria,5
CYCLOSPORINE,Back pain,5
CYCLOSPORINE,Drug hypersensitivity,5
CYCLOSPORINE,Product use issue,5
CYCLOSPORINE,Arthritis,5
CYCLOSPORINE,White blood cell count decreased,5
CYCLOSPORINE,Therapeutic product effect incomplete,5
CYCLOSPORINE,Psoriasis,5
CYCLOSPORINE,Cardiac failure,5
CYCLOSPORINE,Abdominal distension,5
CYCLOSPORINE,Blood albumin decreased,5
CYCLOSPORINE,Product dose omission issue,5
CYCLOSPORINE,Renal failure,5
CYCLOSPORINE,Cardiomegaly,5
CYMBALTA,Fatigue,25
CYMBALTA,Headache,18
CYMBALTA,COVID-19,18
CYMBALTA,Nausea,17
CYMBALTA,Fall,17
CYMBALTA,Malaise,17
CYMBALTA,Product dose omission issue,17
CYMBALTA,Sinusitis,17
CYMBALTA,Urinary tract infection,16
CYMBALTA,Off label use,15
CYMBALTA,Pain,15
CYMBALTA,Bronchitis,14
CYMBALTA,Dizziness,14
CYMBALTA,Asthenia,14
CYMBALTA,Dyspnoea,13
CYMBALTA,Anxiety,13
CYMBALTA,Arthralgia,13
CYMBALTA,Gait disturbance,13
CYMBALTA,Pain in extremity,13
CYMBALTA,Nasopharyngitis,11
CYMBALTA,Weight increased,10
CYMBALTA,Confusional state,10
CYMBALTA,Condition aggravated,10
CYMBALTA,Drug ineffective,9
CYMBALTA,Back pain,9
CYMBALTA,Needle issue,9
CYMBALTA,Weight decreased,9
CYMBALTA,Rash,9
CYMBALTA,Vomiting,9
CYMBALTA,Inappropriate schedule of product administration,9
CYMBALTA,Tremor,9
CYMBALTA,Migraine,8
CYMBALTA,Influenza,8
CYMBALTA,Pruritus,8
CYMBALTA,Pneumonia,8
CYMBALTA,Abdominal pain,8
CYMBALTA,Depression,7
CYMBALTA,Diarrhoea,7
CYMBALTA,Illness,7
CYMBALTA,Infection,7
CYMBALTA,Dehydration,7
CYMBALTA,Feeling abnormal,7
CYMBALTA,Memory impairment,6
CYMBALTA,Myalgia,6
CYMBALTA,Product use issue,6
CYMBALTA,Upper respiratory tract infection,6
CYMBALTA,Diabetes mellitus,6
CYMBALTA,Oedema peripheral,6
CYMBALTA,Peripheral swelling,6
CYMBALTA,Seasonal allergy,6
CYTARABINE,Febrile neutropenia,57
CYTARABINE,Pyrexia,37
CYTARABINE,Myelosuppression,37
CYTARABINE,Off label use,30
CYTARABINE,Platelet count decreased,22
CYTARABINE,White blood cell count decreased,19
CYTARABINE,Neutrophil count decreased,18
CYTARABINE,Neutropenia,16
CYTARABINE,Nausea,16
CYTARABINE,Pruritus,15
CYTARABINE,Thrombocytopenia,14
CYTARABINE,Pancytopenia,14
CYTARABINE,Pneumonia,12
CYTARABINE,Disease progression,12
CYTARABINE,Vomiting,11
CYTARABINE,Anaemia,11
CYTARABINE,Rash,10
CYTARABINE,Drug-induced liver injury,10
CYTARABINE,Stomatitis,9
CYTARABINE,Neoplasm progression,9
CYTARABINE,Sepsis,9
CYTARABINE,Cytokine release syndrome,9
CYTARABINE,Cellulitis,9
CYTARABINE,Cytopenia,9
CYTARABINE,Myelodysplastic syndrome,8
CYTARABINE,Respiratory failure,8
CYTARABINE,Alanine aminotransferase increased,8
CYTARABINE,Mucosal inflammation,7
CYTARABINE,Decreased appetite,7
CYTARABINE,Blood lactate dehydrogenase increased,7
CYTARABINE,Neuropathy peripheral,7
CYTARABINE,Acute myeloid leukaemia,7
CYTARABINE,Cough,7
CYTARABINE,Asthenia,7
CYTARABINE,Haemoglobin decreased,7
CYTARABINE,Septic shock,7
CYTARABINE,Diarrhoea,7
CYTARABINE,Erythema,7
CYTARABINE,Shock,6
CYTARABINE,Tumour lysis syndrome,6
CYTARABINE,Malignant neoplasm progression,6
CYTARABINE,Aspartate aminotransferase increased,6
CYTARABINE,Granulocyte count decreased,6
CYTARABINE,Pain,6
CYTARABINE,COVID-19,6
CYTARABINE,Blood creatinine increased,6
CYTARABINE,Second primary malignancy,5
CYTARABINE,Abdominal pain,5
CYTARABINE,Dehydration,5
CYTARABINE,Constipation,5
DABRAFENIB,Pyrexia,20
DABRAFENIB,Chills,9
DABRAFENIB,Fatigue,7
DABRAFENIB,Headache,7
DABRAFENIB,Vomiting,7
DABRAFENIB,Aspartate aminotransferase increased,6
DABRAFENIB,General physical health deterioration,6
DABRAFENIB,Asthenia,6
DABRAFENIB,Gamma-glutamyltransferase increased,5
DABRAFENIB,Alanine aminotransferase increased,5
DABRAFENIB,Malignant neoplasm progression,5
DABRAFENIB,Chromaturia,5
DABRAFENIB,Diarrhoea,5
DABRAFENIB,Dyspnoea,4
DABRAFENIB,Acute kidney injury,4
DABRAFENIB,Nausea,4
DABRAFENIB,Anaemia,4
DABRAFENIB,C-reactive protein increased,3
DABRAFENIB,Pain,3
DABRAFENIB,Hypotension,3
DABRAFENIB,Rash,3
DABRAFENIB,Platelet count decreased,3
DABRAFENIB,Thrombocytopenia,3
DABRAFENIB,Blood alkaline phosphatase increased,3
DABRAFENIB,Leukopenia,3
DABRAFENIB,Weight decreased,3
DABRAFENIB,Blood creatinine increased,3
DABRAFENIB,Abdominal pain,3
DABRAFENIB,Decreased appetite,3
DABRAFENIB,Confusional state,3
DABRAFENIB,Erythema nodosum,3
DABRAFENIB,Sepsis,3
DABRAFENIB,Ejection fraction decreased,2
DABRAFENIB,Constipation,2
DABRAFENIB,Infection,2
DABRAFENIB,Syncope,2
DABRAFENIB,Rash erythematous,2
DABRAFENIB,Hepatic enzyme increased,2
DABRAFENIB,C-reactive protein decreased,2
DABRAFENIB,Hyperhidrosis,2
DABRAFENIB,Transaminases increased,2
DABRAFENIB,Protein urine present,2
DABRAFENIB,White blood cell count decreased,2
DABRAFENIB,Blood creatine phosphokinase increased,2
DABRAFENIB,Influenza like illness,2
DABRAFENIB,Drug-induced liver injury,2
DABRAFENIB,COVID-19,2
DABRAFENIB,Renal pain,2
DABRAFENIB,Dehydration,2
DABRAFENIB,Hypercalcaemia,2
DAPAGLIFLOZIN,Diarrhoea,98
DAPAGLIFLOZIN,Fatigue,94
DAPAGLIFLOZIN,Pruritus,94
DAPAGLIFLOZIN,Back pain,93
DAPAGLIFLOZIN,Dyspnoea,93
DAPAGLIFLOZIN,Vomiting,93
DAPAGLIFLOZIN,Dehydration,93
DAPAGLIFLOZIN,Disturbance in attention,93
DAPAGLIFLOZIN,Nausea,92
DAPAGLIFLOZIN,COVID-19,92
DAPAGLIFLOZIN,Pyrexia,92
DAPAGLIFLOZIN,Abdominal discomfort,92
DAPAGLIFLOZIN,Blood glucose increased,91
DAPAGLIFLOZIN,Malaise,91
DAPAGLIFLOZIN,Palpitations,91
DAPAGLIFLOZIN,Headache,91
DAPAGLIFLOZIN,Tachycardia,90
DAPAGLIFLOZIN,Chest pain,90
DAPAGLIFLOZIN,Ventricular tachycardia,89
DAPAGLIFLOZIN,Peripheral swelling,89
DAPAGLIFLOZIN,Intentional product misuse,89
DAPAGLIFLOZIN,Myocardial infarction,89
DAPAGLIFLOZIN,Visual impairment,89
DAPAGLIFLOZIN,Hallucination,89
DAPAGLIFLOZIN,Amnesia,89
DAPAGLIFLOZIN,Feeling abnormal,89
DAPAGLIFLOZIN,Facial pain,89
DAPAGLIFLOZIN,Dry skin,89
DAPAGLIFLOZIN,Dizziness,89
DAPAGLIFLOZIN,Insomnia,89
DAPAGLIFLOZIN,Diplopia,89
DAPAGLIFLOZIN,Pain,89
DAPAGLIFLOZIN,Cardiospasm,89
DAPAGLIFLOZIN,Migraine,89
DAPAGLIFLOZIN,Angioedema,89
DAPAGLIFLOZIN,Muscular weakness,89
DAPAGLIFLOZIN,Subarachnoid haemorrhage,89
DAPAGLIFLOZIN,Lip swelling,89
DAPAGLIFLOZIN,Anosmia,89
DAPAGLIFLOZIN,Atrial tachycardia,89
DAPAGLIFLOZIN,Pericarditis,89
DAPAGLIFLOZIN,Arthralgia,88
DAPAGLIFLOZIN,Hyperhidrosis,88
DAPAGLIFLOZIN,Alopecia,88
DAPAGLIFLOZIN,Anxiety,88
DAPAGLIFLOZIN,Transient ischaemic attack,88
DAPAGLIFLOZIN,Tinnitus,88
DAPAGLIFLOZIN,Memory impairment,88
DAPAGLIFLOZIN,Sleep terror,88
DAPAGLIFLOZIN,Tension headache,88
DAPTOMYCIN,Hepatic cytolysis,14
DAPTOMYCIN,Acute kidney injury,11
DAPTOMYCIN,Off label use,10
DAPTOMYCIN,Cholestasis,9
DAPTOMYCIN,Agranulocytosis,8
DAPTOMYCIN,Oliguria,8
DAPTOMYCIN,Rhabdomyolysis,7
DAPTOMYCIN,Eosinophilia,6
DAPTOMYCIN,Interstitial lung disease,6
DAPTOMYCIN,Device related sepsis,5
DAPTOMYCIN,Cytokine release syndrome,4
DAPTOMYCIN,Hyponatraemia,4
DAPTOMYCIN,Neutropenia,4
DAPTOMYCIN,Mixed anxiety and depressive disorder,4
DAPTOMYCIN,Confusional state,4
DAPTOMYCIN,Immune effector cell-associated neurotoxicity syndrome,4
DAPTOMYCIN,Hyperthermia,4
DAPTOMYCIN,Neutrophilia,4
DAPTOMYCIN,Hypersensitivity,4
DAPTOMYCIN,C-reactive protein increased,4
DAPTOMYCIN,End stage renal disease,3
DAPTOMYCIN,Arthritis bacterial,3
DAPTOMYCIN,Disease progression,3
DAPTOMYCIN,Product use in unapproved indication,3
DAPTOMYCIN,Fungaemia,3
DAPTOMYCIN,Aplasia pure red cell,3
DAPTOMYCIN,Thrombocytopenia,3
DAPTOMYCIN,Purpura,3
DAPTOMYCIN,Diarrhoea,2
DAPTOMYCIN,Candida endophthalmitis,2
DAPTOMYCIN,Macular degeneration,2
DAPTOMYCIN,Heart rate irregular,2
DAPTOMYCIN,Atrial fibrillation,2
DAPTOMYCIN,Infection,2
DAPTOMYCIN,Tachycardia,2
DAPTOMYCIN,Blood creatine phosphokinase increased,2
DAPTOMYCIN,Product used for unknown indication,2
DAPTOMYCIN,Cellulitis,2
DAPTOMYCIN,Dehydration,2
DAPTOMYCIN,Cardiac arrest,2
DAPTOMYCIN,Drug interaction,2
DAPTOMYCIN,Rash papular,2
DAPTOMYCIN,Rash,2
DAPTOMYCIN,Rash maculo-papular,2
DAPTOMYCIN,Vomiting,2
DAPTOMYCIN,Sepsis,2
DAPTOMYCIN,Transaminases increased,2
DAPTOMYCIN,Pyrexia,2
DAPTOMYCIN,Decreased activity,1
DAPTOMYCIN,Quality of life decreased,1
DARATUMUMAB,Febrile neutropenia,24
DARATUMUMAB,Plasma cell myeloma,14
DARATUMUMAB,Off label use,14
DARATUMUMAB,Pneumonia,13
DARATUMUMAB,Anaemia,13
DARATUMUMAB,COVID-19,13
DARATUMUMAB,Pyrexia,11
DARATUMUMAB,Leukopenia,11
DARATUMUMAB,Infusion related reaction,8
DARATUMUMAB,Cardiac failure,8
DARATUMUMAB,Sepsis,7
DARATUMUMAB,Acute kidney injury,7
DARATUMUMAB,COVID-19 pneumonia,7
DARATUMUMAB,Hypokalaemia,6
DARATUMUMAB,Dyspnoea,6
DARATUMUMAB,Chills,6
DARATUMUMAB,Lower respiratory tract infection,6
DARATUMUMAB,Neutrophil count decreased,6
DARATUMUMAB,Asthenia,6
DARATUMUMAB,Diarrhoea,5
DARATUMUMAB,Thrombocytopenia,5
DARATUMUMAB,White blood cell count decreased,5
DARATUMUMAB,Pancytopenia,5
DARATUMUMAB,Atrial fibrillation,5
DARATUMUMAB,Neuropathy peripheral,4
DARATUMUMAB,Vomiting,4
DARATUMUMAB,Fatigue,4
DARATUMUMAB,Nausea,4
DARATUMUMAB,Tumour lysis syndrome,4
DARATUMUMAB,Death,4
DARATUMUMAB,Pneumonia pneumococcal,4
DARATUMUMAB,Cardiac pacemaker evaluation,4
DARATUMUMAB,Parainfluenzae virus infection,4
DARATUMUMAB,Dysphonia,4
DARATUMUMAB,Oral pruritus,4
DARATUMUMAB,Rash pruritic,4
DARATUMUMAB,Neutropenia,4
DARATUMUMAB,Abdominal pain upper,4
DARATUMUMAB,Hypotension,3
DARATUMUMAB,Decreased appetite,3
DARATUMUMAB,Product dose omission issue,3
DARATUMUMAB,Platelet count decreased,3
DARATUMUMAB,Rash,3
DARATUMUMAB,Cytokine release syndrome,3
DARATUMUMAB,Pneumonia aspiration,3
DARATUMUMAB,Pneumonitis,3
DARATUMUMAB,Renal impairment,3
DARATUMUMAB,Rib fracture,3
DARATUMUMAB,Oesophageal candidiasis,3
DARATUMUMAB,Transaminases increased,3
DARZALEX,Off label use,26
DARZALEX,Infusion related reaction,24
DARZALEX,Diarrhoea,9
DARZALEX,Plasma cell myeloma,9
DARZALEX,Pneumonia,8
DARZALEX,Pancytopenia,8
DARZALEX,Leukopenia,8
DARZALEX,Dyspnoea,8
DARZALEX,Fatigue,7
DARZALEX,White blood cell count decreased,7
DARZALEX,Hepatic cytolysis,7
DARZALEX,Cholestasis,7
DARZALEX,Eosinophilia,7
DARZALEX,Blood bilirubin increased,7
DARZALEX,Diabetes mellitus,7
DARZALEX,Pyrexia,6
DARZALEX,Back pain,6
DARZALEX,Myelosuppression,6
DARZALEX,Chest pain,5
DARZALEX,Anaemia,5
DARZALEX,Vomiting,5
DARZALEX,Thrombosis,5
DARZALEX,Asthenia,5
DARZALEX,Malaise,5
DARZALEX,Chills,5
DARZALEX,Death,5
DARZALEX,Bone pain,4
DARZALEX,Intentional product use issue,4
DARZALEX,Platelet count decreased,4
DARZALEX,Rash,4
DARZALEX,Febrile neutropenia,4
DARZALEX,Drug ineffective,4
DARZALEX,Nausea,4
DARZALEX,Thrombocytopenia,4
DARZALEX,Pain,4
DARZALEX,Tremor,4
DARZALEX,Hyperpyrexia,4
DARZALEX,Temperature intolerance,4
DARZALEX,Neutrophil count decreased,3
DARZALEX,Oedema peripheral,3
DARZALEX,Cough,3
DARZALEX,Constipation,3
DARZALEX,Pleural effusion,3
DARZALEX,Pulmonary embolism,3
DARZALEX,Rash pruritic,3
DARZALEX,Hypotension,3
DARZALEX,Myelodysplastic syndrome,3
DARZALEX,Septic shock,3
DARZALEX,Inappropriate schedule of product administration,3
DARZALEX,Neuropathy peripheral,3
DECADRON,Nausea,9
DECADRON,Off label use,9
DECADRON,Diarrhoea,8
DECADRON,Febrile neutropenia,7
DECADRON,Vomiting,7
DECADRON,Decreased appetite,6
DECADRON,Fatigue,6
DECADRON,Pyrexia,5
DECADRON,Rash,5
DECADRON,Disease progression,5
DECADRON,Neutrophil count decreased,5
DECADRON,Thrombocytopenia,5
DECADRON,Neutropenia,5
DECADRON,Sepsis,4
DECADRON,Pneumonia,4
DECADRON,White blood cell count decreased,4
DECADRON,Platelet count decreased,4
DECADRON,Taste disorder,4
DECADRON,Pain,4
DECADRON,Urinary tract infection,4
DECADRON,Death,4
DECADRON,Septic shock,4
DECADRON,Interstitial lung disease,4
DECADRON,Hyponatraemia,4
DECADRON,Abdominal pain,4
DECADRON,Madarosis,3
DECADRON,Haemophagocytic lymphohistiocytosis,3
DECADRON,Acute kidney injury,3
DECADRON,Blood creatinine increased,3
DECADRON,Anaemia,3
DECADRON,Stomatitis,3
DECADRON,Herpes zoster,3
DECADRON,Malaise,3
DECADRON,Liver disorder,3
DECADRON,Hypertension,3
DECADRON,Asthenia,3
DECADRON,Pruritus,3
DECADRON,Renal failure,3
DECADRON,Hypothyroidism,3
DECADRON,Cytokine release syndrome,3
DECADRON,Back pain,3
DECADRON,Dehydration,3
DECADRON,Insomnia,3
DECADRON,Weight decreased,3
DECADRON,Alopecia areata,2
DECADRON,Alopecia totalis,2
DECADRON,Pulmonary oedema,2
DECADRON,Arthralgia,2
DECADRON,Constipation,2
DECADRON,Product dose omission issue,2
DEFITELIO,Hypotension,15
DEFITELIO,Venoocclusive liver disease,12
DEFITELIO,Multiple organ dysfunction syndrome,7
DEFITELIO,Pulmonary alveolar haemorrhage,5
DEFITELIO,Graft versus host disease,4
DEFITELIO,Haematuria,4
DEFITELIO,Gastrointestinal haemorrhage,4
DEFITELIO,Acute myeloid leukaemia,4
DEFITELIO,Upper gastrointestinal haemorrhage,4
DEFITELIO,Acute kidney injury,4
DEFITELIO,Pleural effusion,3
DEFITELIO,Ascites,3
DEFITELIO,Off label use,3
DEFITELIO,Sepsis,3
DEFITELIO,Renal failure,3
DEFITELIO,Acute lymphocytic leukaemia,3
DEFITELIO,Thrombotic microangiopathy,3
DEFITELIO,Melaena,3
DEFITELIO,Blood bilirubin increased,2
DEFITELIO,Rash,2
DEFITELIO,Subdural haematoma,2
DEFITELIO,Diarrhoea,2
DEFITELIO,Epistaxis,2
DEFITELIO,Platelet count decreased,2
DEFITELIO,Mouth haemorrhage,2
DEFITELIO,Respiratory disorder,2
DEFITELIO,Purpura,2
DEFITELIO,Idiopathic pneumonia syndrome,2
DEFITELIO,Pancreatitis,2
DEFITELIO,Lymphoma,2
DEFITELIO,Acute graft versus host disease,2
DEFITELIO,Thrombocytopenia,2
DEFITELIO,Febrile neutropenia,2
DEFITELIO,BK virus infection,2
DEFITELIO,Pulmonary haemorrhage,2
DEFITELIO,Cystitis haemorrhagic,2
DEFITELIO,Cytomegalovirus test positive,1
DEFITELIO,Corynebacterium sepsis,1
DEFITELIO,Cardiac dysfunction,1
DEFITELIO,Haemothorax,1
DEFITELIO,Pericardial effusion,1
DEFITELIO,Cerebral haemorrhage,1
DEFITELIO,Ear haemorrhage,1
DEFITELIO,Asphyxia,1
DEFITELIO,Infection,1
DEFITELIO,Graft versus host disease in skin,1
DEFITELIO,Graft versus host disease in liver,1
DEFITELIO,Graft versus host disease in gastrointestinal tract,1
DEFITELIO,Post transplant lymphoproliferative disorder,1
DEFITELIO,Acidosis,1
DENOSUMAB,Diarrhoea,35
DENOSUMAB,Fatigue,30
DENOSUMAB,Anaemia,25
DENOSUMAB,Nausea,25
DENOSUMAB,Mucosal inflammation,24
DENOSUMAB,Alopecia,20
DENOSUMAB,Off label use,19
DENOSUMAB,Osteonecrosis of jaw,18
DENOSUMAB,White blood cell count decreased,15
DENOSUMAB,Neutropenia,15
DENOSUMAB,Platelet count decreased,15
DENOSUMAB,Rash,14
DENOSUMAB,COVID-19,13
DENOSUMAB,Leukopenia,13
DENOSUMAB,Neuropathy peripheral,13
DENOSUMAB,Disease progression,13
DENOSUMAB,Hot flush,11
DENOSUMAB,Vomiting,11
DENOSUMAB,Dyspepsia,11
DENOSUMAB,Lymphocyte count decreased,11
DENOSUMAB,Gingival swelling,10
DENOSUMAB,Influenza like illness,10
DENOSUMAB,Ejection fraction decreased,10
DENOSUMAB,Lymphoedema,10
DENOSUMAB,Epistaxis,10
DENOSUMAB,Gastrooesophageal reflux disease,10
DENOSUMAB,Seizure,10
DENOSUMAB,Malignant neoplasm progression,9
DENOSUMAB,Sepsis,9
DENOSUMAB,Vascular device infection,9
DENOSUMAB,Affective disorder,9
DENOSUMAB,Neutrophil count increased,9
DENOSUMAB,Cellulitis,9
DENOSUMAB,Schizophrenia,9
DENOSUMAB,Overdose,9
DENOSUMAB,Incorrect dose administered,9
DENOSUMAB,Psychotic disorder,9
DENOSUMAB,"Hallucination, auditory",9
DENOSUMAB,Extrapyramidal disorder,9
DENOSUMAB,Delusion of grandeur,9
DENOSUMAB,Device related infection,8
DENOSUMAB,Rhinalgia,8
DENOSUMAB,Neoplasm progression,8
DENOSUMAB,Hypocalcaemia,7
DENOSUMAB,Lymphocyte count abnormal,7
DENOSUMAB,Decreased appetite,7
DENOSUMAB,Haemoglobin decreased,7
DENOSUMAB,Pain,6
DENOSUMAB,SARS-CoV-2 test positive,6
DENOSUMAB,Pneumonia,6
DEPAKOTE,Seizure,15
DEPAKOTE,Off label use,10
DEPAKOTE,Hypothermia,9
DEPAKOTE,Sedation,9
DEPAKOTE,Hypoxia,9
DEPAKOTE,Hypoglycaemia,9
DEPAKOTE,Wrong patient received product,9
DEPAKOTE,Anxiety,8
DEPAKOTE,Tremor,7
DEPAKOTE,Depression,6
DEPAKOTE,Rash,6
DEPAKOTE,Condition aggravated,5
DEPAKOTE,Vomiting,5
DEPAKOTE,Diarrhoea,5
DEPAKOTE,Cardiac disorder,4
DEPAKOTE,Pain,4
DEPAKOTE,Chronic kidney disease,4
DEPAKOTE,Fall,4
DEPAKOTE,Insomnia,4
DEPAKOTE,Headache,4
DEPAKOTE,Decreased appetite,4
DEPAKOTE,Osteoporosis,3
DEPAKOTE,Renal failure,3
DEPAKOTE,Bone density decreased,3
DEPAKOTE,Pruritus,3
DEPAKOTE,Product dose omission issue,3
DEPAKOTE,Inappropriate schedule of product administration,3
DEPAKOTE,COVID-19,3
DEPAKOTE,Chest pain,3
DEPAKOTE,Blood pressure increased,3
DEPAKOTE,Anhedonia,3
DEPAKOTE,Emotional distress,3
DEPAKOTE,Cardiac arrest,3
DEPAKOTE,Acute respiratory failure,3
DEPAKOTE,Leukocytosis,3
DEPAKOTE,Constipation,3
DEPAKOTE,Drug interaction,3
DEPAKOTE,Hospitalisation,3
DEPAKOTE,Hypersensitivity,3
DEPAKOTE,Agitation,3
DEPAKOTE,Abnormal behaviour,3
DEPAKOTE,Immune system disorder,3
DEPAKOTE,Product administration interrupted,3
DEPAKOTE,Product use issue,3
DEPAKOTE,Somnolence,3
DEPAKOTE,Fatigue,3
DEPAKOTE,Rib fracture,2
DEPAKOTE,Renal impairment,2
DEPAKOTE,Multiple fractures,2
DEPAKOTE,Gait disturbance,2
DESCOVY,Pain,103
DESCOVY,Emotional distress,101
DESCOVY,Anxiety,97
DESCOVY,Anhedonia,95
DESCOVY,Osteoporosis,48
DESCOVY,Chronic kidney disease,46
DESCOVY,Osteopenia,40
DESCOVY,Bone density decreased,33
DESCOVY,Bone demineralisation,32
DESCOVY,Blood creatinine increased,25
DESCOVY,Depression,24
DESCOVY,Renal failure,20
DESCOVY,Multiple fractures,16
DESCOVY,Renal impairment,14
DESCOVY,Fatigue,13
DESCOVY,Acute kidney injury,13
DESCOVY,Gait disturbance,13
DESCOVY,Bone loss,12
DESCOVY,Renal injury,10
DESCOVY,Asthenia,10
DESCOVY,Economic problem,9
DESCOVY,Osteonecrosis,9
DESCOVY,Foot fracture,9
DESCOVY,Skeletal injury,8
DESCOVY,Vitamin D deficiency,8
DESCOVY,Arthralgia,7
DESCOVY,Decreased activity,7
DESCOVY,Pollakiuria,6
DESCOVY,Back pain,6
DESCOVY,Hip fracture,6
DESCOVY,Rib fracture,5
DESCOVY,Quality of life decreased,5
DESCOVY,Mobility decreased,5
DESCOVY,Loss of personal independence in daily activities,5
DESCOVY,Nephrolithiasis,5
DESCOVY,Hypertension,5
DESCOVY,Insomnia,5
DESCOVY,Ankle fracture,4
DESCOVY,Nephropathy,4
DESCOVY,Anaemia,4
DESCOVY,Dysstasia,4
DESCOVY,Tooth loss,4
DESCOVY,Pain in extremity,3
DESCOVY,Gait inability,3
DESCOVY,Proteinuria,3
DESCOVY,End stage renal disease,3
DESCOVY,Renal pain,3
DESCOVY,Lower limb fracture,3
DESCOVY,Weight decreased,3
DESCOVY,Hand fracture,3
DESLORATADINE,Intentional overdose,9
DESLORATADINE,Disturbance in attention,7
DESLORATADINE,Palpitations,6
DESLORATADINE,Toxicity to various agents,6
DESLORATADINE,Shock,6
DESLORATADINE,Coma,6
DESLORATADINE,Dizziness,5
DESLORATADINE,Headache,5
DESLORATADINE,Acute kidney injury,5
DESLORATADINE,Arrhythmia,5
DESLORATADINE,Fatigue,4
DESLORATADINE,Insomnia,4
DESLORATADINE,Nausea,4
DESLORATADINE,Pruritus,4
DESLORATADINE,Depressed level of consciousness,4
DESLORATADINE,Off label use,4
DESLORATADINE,Thrombocytopenia,4
DESLORATADINE,Suicide attempt,4
DESLORATADINE,Drug ineffective,4
DESLORATADINE,Liver disorder,4
DESLORATADINE,Constipation,4
DESLORATADINE,Confusional state,4
DESLORATADINE,Asthenia,3
DESLORATADINE,Pain,3
DESLORATADINE,Tinnitus,3
DESLORATADINE,Dyspnoea,3
DESLORATADINE,Asthmatic crisis,3
DESLORATADINE,Abdominal pain,3
DESLORATADINE,Pyrexia,3
DESLORATADINE,Vomiting,3
DESLORATADINE,Extrasystoles,3
DESLORATADINE,Cholestasis,3
DESLORATADINE,Drug interaction,3
DESLORATADINE,Hypertensive crisis,3
DESLORATADINE,Sepsis,3
DESLORATADINE,Humerus fracture,3
DESLORATADINE,Fracture,3
DESLORATADINE,Leukopenia,3
DESLORATADINE,Cerebral haemorrhage,2
DESLORATADINE,Illness,2
DESLORATADINE,Anxiety,2
DESLORATADINE,Feeling abnormal,2
DESLORATADINE,Discouragement,2
DESLORATADINE,Loss of consciousness,2
DESLORATADINE,Blood pressure increased,2
DESLORATADINE,Erythema,2
DESLORATADINE,Chest pain,2
DESLORATADINE,Urticaria,2
DESLORATADINE,Hereditary angioedema,2
DESLORATADINE,Arthralgia,2
DEXAMETHASONE,Off label use,195
DEXAMETHASONE,Diarrhoea,114
DEXAMETHASONE,Fatigue,101
DEXAMETHASONE,Anaemia,98
DEXAMETHASONE,Vomiting,90
DEXAMETHASONE,Nausea,89
DEXAMETHASONE,Pneumonia,85
DEXAMETHASONE,Death,77
DEXAMETHASONE,Pyrexia,72
DEXAMETHASONE,Rash,71
DEXAMETHASONE,Neutropenia,69
DEXAMETHASONE,COVID-19,67
DEXAMETHASONE,Febrile neutropenia,64
DEXAMETHASONE,Decreased appetite,58
DEXAMETHASONE,Dyspnoea,55
DEXAMETHASONE,Thrombocytopenia,49
DEXAMETHASONE,Asthenia,49
DEXAMETHASONE,Platelet count decreased,46
DEXAMETHASONE,Neutrophil count decreased,44
DEXAMETHASONE,Constipation,41
DEXAMETHASONE,Malaise,40
DEXAMETHASONE,Neuropathy peripheral,39
DEXAMETHASONE,Mucosal inflammation,38
DEXAMETHASONE,White blood cell count decreased,38
DEXAMETHASONE,Malignant neoplasm progression,36
DEXAMETHASONE,Pain,35
DEXAMETHASONE,Product dose omission issue,35
DEXAMETHASONE,Headache,34
DEXAMETHASONE,Condition aggravated,34
DEXAMETHASONE,Lower respiratory tract infection,34
DEXAMETHASONE,Infusion related reaction,33
DEXAMETHASONE,Sepsis,33
DEXAMETHASONE,Plasma cell myeloma,32
DEXAMETHASONE,Abdominal pain,30
DEXAMETHASONE,Dehydration,30
DEXAMETHASONE,Pancytopenia,30
DEXAMETHASONE,Cough,29
DEXAMETHASONE,Weight decreased,27
DEXAMETHASONE,Pruritus,27
DEXAMETHASONE,Arthralgia,27
DEXAMETHASONE,Dizziness,26
DEXAMETHASONE,Abdominal pain upper,25
DEXAMETHASONE,Septic shock,25
DEXAMETHASONE,Drug ineffective,24
DEXAMETHASONE,Alopecia,24
DEXAMETHASONE,Insomnia,24
DEXAMETHASONE,Abdominal discomfort,24
DEXAMETHASONE,Product use in unapproved indication,24
DEXAMETHASONE,Acute kidney injury,24
DEXAMETHASONE,Leukopenia,23
DEXAMETHASONE SODIUM PHOSPHATE,Off label use,27
DEXAMETHASONE SODIUM PHOSPHATE,Myelosuppression,14
DEXAMETHASONE SODIUM PHOSPHATE,Diarrhoea,11
DEXAMETHASONE SODIUM PHOSPHATE,Vomiting,10
DEXAMETHASONE SODIUM PHOSPHATE,Pyrexia,7
DEXAMETHASONE SODIUM PHOSPHATE,Nausea,7
DEXAMETHASONE SODIUM PHOSPHATE,Hypokalaemia,7
DEXAMETHASONE SODIUM PHOSPHATE,Hypoaesthesia,7
DEXAMETHASONE SODIUM PHOSPHATE,White blood cell count decreased,6
DEXAMETHASONE SODIUM PHOSPHATE,Disease progression,6
DEXAMETHASONE SODIUM PHOSPHATE,Thrombocytopenia,6
DEXAMETHASONE SODIUM PHOSPHATE,Hepatic function abnormal,6
DEXAMETHASONE SODIUM PHOSPHATE,Neutrophil count decreased,6
DEXAMETHASONE SODIUM PHOSPHATE,Anaemia,5
DEXAMETHASONE SODIUM PHOSPHATE,Febrile neutropenia,5
DEXAMETHASONE SODIUM PHOSPHATE,Liver injury,5
DEXAMETHASONE SODIUM PHOSPHATE,Hepatic failure,5
DEXAMETHASONE SODIUM PHOSPHATE,COVID-19,5
DEXAMETHASONE SODIUM PHOSPHATE,Neuropathy peripheral,5
DEXAMETHASONE SODIUM PHOSPHATE,Platelet count decreased,4
DEXAMETHASONE SODIUM PHOSPHATE,Rash,4
DEXAMETHASONE SODIUM PHOSPHATE,Hypocalcaemia,4
DEXAMETHASONE SODIUM PHOSPHATE,Arthralgia,4
DEXAMETHASONE SODIUM PHOSPHATE,Decreased appetite,4
DEXAMETHASONE SODIUM PHOSPHATE,Drug-induced liver injury,4
DEXAMETHASONE SODIUM PHOSPHATE,Neutropenia,4
DEXAMETHASONE SODIUM PHOSPHATE,Pneumonia,4
DEXAMETHASONE SODIUM PHOSPHATE,Pain in extremity,4
DEXAMETHASONE SODIUM PHOSPHATE,Pain,4
DEXAMETHASONE SODIUM PHOSPHATE,Pancytopenia,3
DEXAMETHASONE SODIUM PHOSPHATE,Drug eruption,3
DEXAMETHASONE SODIUM PHOSPHATE,Malignant neoplasm progression,3
DEXAMETHASONE SODIUM PHOSPHATE,Cough,3
DEXAMETHASONE SODIUM PHOSPHATE,Interstitial lung disease,3
DEXAMETHASONE SODIUM PHOSPHATE,Insomnia,3
DEXAMETHASONE SODIUM PHOSPHATE,Hyperglycaemia,3
DEXAMETHASONE SODIUM PHOSPHATE,Hyperuricaemia,3
DEXAMETHASONE SODIUM PHOSPHATE,Underdose,3
DEXAMETHASONE SODIUM PHOSPHATE,Pruritus,3
DEXAMETHASONE SODIUM PHOSPHATE,Erythema,3
DEXAMETHASONE SODIUM PHOSPHATE,Cytokine release syndrome,3
DEXAMETHASONE SODIUM PHOSPHATE,Asthenia,3
DEXAMETHASONE SODIUM PHOSPHATE,Death,3
DEXAMETHASONE SODIUM PHOSPHATE,Hypoproteinaemia,3
DEXAMETHASONE SODIUM PHOSPHATE,Stomatitis,3
DEXAMETHASONE SODIUM PHOSPHATE,Hyponatraemia,3
DEXAMETHASONE SODIUM PHOSPHATE,Small intestinal perforation,2
DEXAMETHASONE SODIUM PHOSPHATE,Haemophagocytic lymphohistiocytosis,2
DEXAMETHASONE SODIUM PHOSPHATE,Somnolence,2
DEXAMETHASONE SODIUM PHOSPHATE,Loss of consciousness,2
DEXILANT,Nausea,19
DEXILANT,Dyspnoea,16
DEXILANT,Off label use,15
DEXILANT,Fatigue,14
DEXILANT,Abdominal pain,14
DEXILANT,Pain,13
DEXILANT,Condition aggravated,13
DEXILANT,Headache,12
DEXILANT,Vomiting,12
DEXILANT,Malaise,11
DEXILANT,Dizziness,10
DEXILANT,Constipation,10
DEXILANT,Abdominal distension,10
DEXILANT,COVID-19,9
DEXILANT,Drug ineffective,9
DEXILANT,Diarrhoea,9
DEXILANT,Stress,9
DEXILANT,Sepsis,9
DEXILANT,Swelling,9
DEXILANT,Sinusitis,8
DEXILANT,Arthralgia,8
DEXILANT,Asthenia,8
DEXILANT,Drug hypersensitivity,8
DEXILANT,Cardiogenic shock,8
DEXILANT,Incorrect route of product administration,8
DEXILANT,Drug intolerance,8
DEXILANT,Multiple organ dysfunction syndrome,8
DEXILANT,Ascites,8
DEXILANT,Dry mouth,8
DEXILANT,Somnolence,8
DEXILANT,Product dose omission issue,7
DEXILANT,Bacterial infection,7
DEXILANT,Bronchitis,7
DEXILANT,Death,7
DEXILANT,Feeling abnormal,7
DEXILANT,Pneumonia,6
DEXILANT,Intentional product misuse,6
DEXILANT,General physical health deterioration,6
DEXILANT,Neuralgia,6
DEXILANT,Blood pressure increased,6
DEXILANT,Peripheral swelling,6
DEXILANT,Infection,5
DEXILANT,Decreased appetite,5
DEXILANT,Weight decreased,5
DEXILANT,Myalgia,5
DEXILANT,Erythema,5
DEXILANT,Fall,5
DEXILANT,Nasopharyngitis,5
DEXILANT,Anaemia,5
DEXILANT,Appendicolith,5
DEXTROSE,Myelosuppression,27
DEXTROSE,Nausea,26
DEXTROSE,Vomiting,24
DEXTROSE,Off label use,20
DEXTROSE,Abdominal pain,16
DEXTROSE,Dyspnoea,15
DEXTROSE,White blood cell count decreased,14
DEXTROSE,Pyrexia,14
DEXTROSE,Condition aggravated,13
DEXTROSE,Pruritus,11
DEXTROSE,Product use in unapproved indication,10
DEXTROSE,Ascites,10
DEXTROSE,Constipation,10
DEXTROSE,Abdominal distension,10
DEXTROSE,Pain,9
DEXTROSE,Diarrhoea,9
DEXTROSE,Platelet count decreased,9
DEXTROSE,Stress,8
DEXTROSE,Multiple organ dysfunction syndrome,8
DEXTROSE,Hyponatraemia,8
DEXTROSE,Neuralgia,8
DEXTROSE,COVID-19,7
DEXTROSE,Pneumonia,7
DEXTROSE,Aspartate aminotransferase increased,7
DEXTROSE,Cardiogenic shock,7
DEXTROSE,Sepsis,7
DEXTROSE,Incorrect route of product administration,7
DEXTROSE,Dry mouth,7
DEXTROSE,General physical health deterioration,7
DEXTROSE,Headache,7
DEXTROSE,Fatigue,7
DEXTROSE,Malaise,7
DEXTROSE,Dizziness,7
DEXTROSE,Swelling,7
DEXTROSE,Neutrophil count decreased,7
DEXTROSE,Rash,7
DEXTROSE,Asthenia,7
DEXTROSE,Arthralgia,6
DEXTROSE,Back pain,6
DEXTROSE,Alanine aminotransferase increased,6
DEXTROSE,Drug hypersensitivity,6
DEXTROSE,Bacterial infection,6
DEXTROSE,Drug intolerance,6
DEXTROSE,Somnolence,6
DEXTROSE,Product dose omission issue,6
DEXTROSE,Dehydration,6
DEXTROSE,Haemoglobin decreased,6
DEXTROSE,Palpitations,6
DEXTROSE,Hyperhidrosis,6
DEXTROSE,Granulocyte count decreased,6
DIAZEPAM,Anxiety,27
DIAZEPAM,Fatigue,27
DIAZEPAM,Dizziness,27
DIAZEPAM,Drug interaction,27
DIAZEPAM,Toxicity to various agents,26
DIAZEPAM,Headache,24
DIAZEPAM,Pyrexia,23
DIAZEPAM,Vomiting,23
DIAZEPAM,Illness,20
DIAZEPAM,Coma,20
DIAZEPAM,Tachycardia,20
DIAZEPAM,Depression,19
DIAZEPAM,Arthralgia,19
DIAZEPAM,Off label use,18
DIAZEPAM,Asthenia,18
DIAZEPAM,Seizure,18
DIAZEPAM,Pain,17
DIAZEPAM,Drug abuse,17
DIAZEPAM,Dyspnoea,17
DIAZEPAM,Somnolence,17
DIAZEPAM,Mania,17
DIAZEPAM,Urinary retention,17
DIAZEPAM,Hyperhidrosis,16
DIAZEPAM,Diarrhoea,16
DIAZEPAM,Nausea,16
DIAZEPAM,Gait disturbance,16
DIAZEPAM,Mydriasis,16
DIAZEPAM,Tremor,16
DIAZEPAM,Confusional state,15
DIAZEPAM,Hypoaesthesia,15
DIAZEPAM,Sleep disorder,15
DIAZEPAM,Speech disorder,15
DIAZEPAM,Paraesthesia,15
DIAZEPAM,Neuroleptic malignant syndrome,15
DIAZEPAM,Pruritus,14
DIAZEPAM,Suicidal ideation,14
DIAZEPAM,Decreased appetite,14
DIAZEPAM,Dyskinesia,14
DIAZEPAM,Suicide attempt,14
DIAZEPAM,Serotonin syndrome,13
DIAZEPAM,Disturbance in attention,13
DIAZEPAM,Nightmare,13
DIAZEPAM,Drug withdrawal syndrome,13
DIAZEPAM,Restlessness,13
DIAZEPAM,Muscle spasms,13
DIAZEPAM,Restless legs syndrome,13
DIAZEPAM,Drug ineffective,12
DIAZEPAM,Heart rate increased,12
DIAZEPAM,Skin discolouration,12
DIAZEPAM,Incontinence,12
DICLOFENAC,Pain,27
DICLOFENAC,Fatigue,23
DICLOFENAC,Headache,19
DICLOFENAC,Pain in extremity,19
DICLOFENAC,Nausea,18
DICLOFENAC,Arthralgia,18
DICLOFENAC,Off label use,14
DICLOFENAC,Nasopharyngitis,14
DICLOFENAC,Drug ineffective,14
DICLOFENAC,Dizziness,13
DICLOFENAC,Pneumonia,13
DICLOFENAC,Diarrhoea,12
DICLOFENAC,Back pain,12
DICLOFENAC,Malaise,12
DICLOFENAC,Dyspnoea,11
DICLOFENAC,Drug intolerance,11
DICLOFENAC,Rash,11
DICLOFENAC,Pyrexia,11
DICLOFENAC,Rheumatoid arthritis,10
DICLOFENAC,Mobility decreased,10
DICLOFENAC,Cough,10
DICLOFENAC,Fall,10
DICLOFENAC,Acute kidney injury,10
DICLOFENAC,Hypertension,9
DICLOFENAC,Weight increased,9
DICLOFENAC,Inflammation,9
DICLOFENAC,Sinusitis,9
DICLOFENAC,Arthropathy,9
DICLOFENAC,Peripheral swelling,9
DICLOFENAC,Weight decreased,9
DICLOFENAC,Vomiting,9
DICLOFENAC,Drug hypersensitivity,9
DICLOFENAC,Abdominal pain,9
DICLOFENAC,Anxiety,9
DICLOFENAC,Product dose omission issue,9
DICLOFENAC,Urinary tract infection,9
DICLOFENAC,Hypersensitivity,8
DICLOFENAC,Pruritus,8
DICLOFENAC,Musculoskeletal stiffness,8
DICLOFENAC,Lung disorder,8
DICLOFENAC,Depression,8
DICLOFENAC,Sleep disorder,8
DICLOFENAC,Hypoaesthesia,8
DICLOFENAC,Muscular weakness,8
DICLOFENAC,Hyperkalaemia,8
DICLOFENAC,Infusion related reaction,7
DICLOFENAC,Asthenia,7
DICLOFENAC,Obesity,7
DICLOFENAC,Therapeutic product effect decreased,7
DICLOFENAC,Joint swelling,7
DICLOFENAC SODIUM,Product administered at inappropriate site,23
DICLOFENAC SODIUM,Wrong technique in product usage process,20
DICLOFENAC SODIUM,Off label use,19
DICLOFENAC SODIUM,Drug ineffective,15
DICLOFENAC SODIUM,Underdose,14
DICLOFENAC SODIUM,Headache,11
DICLOFENAC SODIUM,Diarrhoea,10
DICLOFENAC SODIUM,Pain,10
DICLOFENAC SODIUM,Arthralgia,10
DICLOFENAC SODIUM,Inappropriate schedule of product administration,9
DICLOFENAC SODIUM,Incorrect product administration duration,9
DICLOFENAC SODIUM,Fatigue,8
DICLOFENAC SODIUM,Pruritus,8
DICLOFENAC SODIUM,Dizziness,8
DICLOFENAC SODIUM,Insomnia,8
DICLOFENAC SODIUM,Contusion,8
DICLOFENAC SODIUM,Nausea,8
DICLOFENAC SODIUM,Condition aggravated,8
DICLOFENAC SODIUM,COVID-19,8
DICLOFENAC SODIUM,Hypertension,7
DICLOFENAC SODIUM,Dyspnoea,7
DICLOFENAC SODIUM,Rash,7
DICLOFENAC SODIUM,Sinusitis,7
DICLOFENAC SODIUM,Asthenia,6
DICLOFENAC SODIUM,Rheumatoid arthritis,6
DICLOFENAC SODIUM,Hepatic enzyme increased,6
DICLOFENAC SODIUM,Alopecia,6
DICLOFENAC SODIUM,Wheezing,6
DICLOFENAC SODIUM,Anti-cyclic citrullinated peptide antibody positive,6
DICLOFENAC SODIUM,Maternal exposure during pregnancy,6
DICLOFENAC SODIUM,Blister,6
DICLOFENAC SODIUM,Glossodynia,6
DICLOFENAC SODIUM,Confusional state,6
DICLOFENAC SODIUM,Joint swelling,6
DICLOFENAC SODIUM,Psoriatic arthropathy,6
DICLOFENAC SODIUM,Pericarditis,6
DICLOFENAC SODIUM,Blood cholesterol increased,6
DICLOFENAC SODIUM,Liver injury,6
DICLOFENAC SODIUM,Pneumonia,6
DICLOFENAC SODIUM,Urticaria,6
DICLOFENAC SODIUM,Depression,6
DICLOFENAC SODIUM,Infection,6
DICLOFENAC SODIUM,Fall,6
DICLOFENAC SODIUM,Hand deformity,5
DICLOFENAC SODIUM,Hypersensitivity,5
DICLOFENAC SODIUM,Helicobacter infection,5
DICLOFENAC SODIUM,Systemic lupus erythematosus,5
DICLOFENAC SODIUM,Infusion related reaction,5
DICLOFENAC SODIUM,Pemphigus,5
DICLOFENAC SODIUM,Drug intolerance,5
DIETARY SUPPLEMENT,Nausea,16
DIETARY SUPPLEMENT,Off label use,11
DIETARY SUPPLEMENT,Headache,11
DIETARY SUPPLEMENT,Asthenia,10
DIETARY SUPPLEMENT,Fatigue,10
DIETARY SUPPLEMENT,Incorrect route of product administration,9
DIETARY SUPPLEMENT,Weight decreased,9
DIETARY SUPPLEMENT,Vomiting,9
DIETARY SUPPLEMENT,Malaise,9
DIETARY SUPPLEMENT,Dyspnoea,8
DIETARY SUPPLEMENT,Diarrhoea,8
DIETARY SUPPLEMENT,Dry mouth,8
DIETARY SUPPLEMENT,Swelling,8
DIETARY SUPPLEMENT,Condition aggravated,8
DIETARY SUPPLEMENT,General physical health deterioration,8
DIETARY SUPPLEMENT,Abdominal pain,8
DIETARY SUPPLEMENT,Constipation,8
DIETARY SUPPLEMENT,Stress,8
DIETARY SUPPLEMENT,Ascites,8
DIETARY SUPPLEMENT,Abdominal distension,8
DIETARY SUPPLEMENT,Drug intolerance,7
DIETARY SUPPLEMENT,Pruritus,7
DIETARY SUPPLEMENT,Nasopharyngitis,7
DIETARY SUPPLEMENT,Sinusitis,7
DIETARY SUPPLEMENT,Migraine,7
DIETARY SUPPLEMENT,Product dose omission issue,7
DIETARY SUPPLEMENT,Cardiogenic shock,7
DIETARY SUPPLEMENT,Sepsis,7
DIETARY SUPPLEMENT,Death,7
DIETARY SUPPLEMENT,Multiple organ dysfunction syndrome,7
DIETARY SUPPLEMENT,Rash,6
DIETARY SUPPLEMENT,Pain,6
DIETARY SUPPLEMENT,Drug hypersensitivity,6
DIETARY SUPPLEMENT,COVID-19,6
DIETARY SUPPLEMENT,Somnolence,6
DIETARY SUPPLEMENT,Hypersensitivity,5
DIETARY SUPPLEMENT,Weight increased,5
DIETARY SUPPLEMENT,Discomfort,5
DIETARY SUPPLEMENT,Dizziness,5
DIETARY SUPPLEMENT,Blood cholesterol increased,5
DIETARY SUPPLEMENT,Arthralgia,5
DIETARY SUPPLEMENT,Decreased appetite,5
DIETARY SUPPLEMENT,Sleep disorder,5
DIETARY SUPPLEMENT,Pneumonia,5
DIETARY SUPPLEMENT,Fall,5
DIETARY SUPPLEMENT,Urinary tract infection,5
DIETARY SUPPLEMENT,Bacterial infection,5
DIETARY SUPPLEMENT,Hyponatraemia,5
DIETARY SUPPLEMENT,Neuralgia,5
DIETARY SUPPLEMENT,Hypertension,4
DIGOXIN,Diarrhoea,103
DIGOXIN,Dyspnoea,102
DIGOXIN,Vomiting,100
DIGOXIN,Pyrexia,97
DIGOXIN,Fatigue,95
DIGOXIN,Nausea,94
DIGOXIN,Malaise,93
DIGOXIN,Dehydration,92
DIGOXIN,COVID-19,92
DIGOXIN,Headache,92
DIGOXIN,Palpitations,92
DIGOXIN,Chest pain,91
DIGOXIN,Anxiety,90
DIGOXIN,Tachycardia,90
DIGOXIN,Dry skin,90
DIGOXIN,Dizziness,90
DIGOXIN,Myocardial infarction,90
DIGOXIN,Arthralgia,90
DIGOXIN,Visual impairment,90
DIGOXIN,Amnesia,90
DIGOXIN,Feeling abnormal,90
DIGOXIN,Facial pain,90
DIGOXIN,Memory impairment,90
DIGOXIN,Pruritus,90
DIGOXIN,Pericarditis,90
DIGOXIN,Off label use,89
DIGOXIN,Pain,89
DIGOXIN,Heart rate increased,89
DIGOXIN,Hallucination,89
DIGOXIN,Insomnia,89
DIGOXIN,Cardiospasm,89
DIGOXIN,Migraine,89
DIGOXIN,Angioedema,89
DIGOXIN,Muscular weakness,89
DIGOXIN,Abdominal discomfort,89
DIGOXIN,Subarachnoid haemorrhage,89
DIGOXIN,Lip swelling,89
DIGOXIN,Disturbance in attention,89
DIGOXIN,Anosmia,89
DIGOXIN,Atrial tachycardia,89
DIGOXIN,Ventricular tachycardia,89
DIGOXIN,Back pain,89
DIGOXIN,Intentional product misuse,88
DIGOXIN,Diplopia,88
DIGOXIN,Hyperhidrosis,88
DIGOXIN,Alopecia,88
DIGOXIN,Transient ischaemic attack,88
DIGOXIN,Peripheral swelling,88
DIGOXIN,Sleep terror,88
DIGOXIN,Tension headache,88
DILTIAZEM,Diarrhoea,20
DILTIAZEM,Fatigue,16
DILTIAZEM,Nausea,15
DILTIAZEM,Pain,14
DILTIAZEM,Dyspnoea,14
DILTIAZEM,Cough,13
DILTIAZEM,COVID-19,13
DILTIAZEM,Pain in extremity,12
DILTIAZEM,Malaise,12
DILTIAZEM,Dizziness,12
DILTIAZEM,Product dose omission issue,12
DILTIAZEM,Fall,11
DILTIAZEM,Pneumonia,11
DILTIAZEM,Vomiting,11
DILTIAZEM,Headache,10
DILTIAZEM,Upper respiratory tract infection,9
DILTIAZEM,Atrial fibrillation,9
DILTIAZEM,Asthenia,8
DILTIAZEM,Insomnia,8
DILTIAZEM,Influenza,7
DILTIAZEM,Off label use,7
DILTIAZEM,Anxiety,7
DILTIAZEM,Illness,7
DILTIAZEM,Nasopharyngitis,7
DILTIAZEM,Anaemia,7
DILTIAZEM,Epistaxis,7
DILTIAZEM,Sinusitis,7
DILTIAZEM,Inappropriate schedule of product administration,7
DILTIAZEM,Arthralgia,6
DILTIAZEM,Peripheral swelling,6
DILTIAZEM,Contusion,6
DILTIAZEM,Hypertension,6
DILTIAZEM,Hypotension,6
DILTIAZEM,Dyspepsia,5
DILTIAZEM,Gait inability,5
DILTIAZEM,Urinary tract infection,5
DILTIAZEM,Condition aggravated,5
DILTIAZEM,Cerebrovascular accident,5
DILTIAZEM,Weight decreased,5
DILTIAZEM,Abdominal pain,5
DILTIAZEM,Pyrexia,5
DILTIAZEM,Oedema,5
DILTIAZEM,Oxygen saturation decreased,5
DILTIAZEM,Heart rate increased,5
DILTIAZEM,Blood pressure decreased,5
DILTIAZEM,Abdominal discomfort,5
DILTIAZEM,Cardiac failure congestive,5
DILTIAZEM,Amnesia,5
DILTIAZEM,Fluid retention,5
DILTIAZEM,Memory impairment,4
DIPHENHYDRAMINE,COVID-19,195
DIPHENHYDRAMINE,Sinusitis,195
DIPHENHYDRAMINE,Product dose omission issue,170
DIPHENHYDRAMINE,Fatigue,125
DIPHENHYDRAMINE,Pneumonia,123
DIPHENHYDRAMINE,Headache,116
DIPHENHYDRAMINE,Urinary tract infection,100
DIPHENHYDRAMINE,Nausea,92
DIPHENHYDRAMINE,Fall,90
DIPHENHYDRAMINE,Off label use,90
DIPHENHYDRAMINE,Inappropriate schedule of product administration,86
DIPHENHYDRAMINE,Malaise,81
DIPHENHYDRAMINE,Upper respiratory tract infection,81
DIPHENHYDRAMINE,Nasopharyngitis,80
DIPHENHYDRAMINE,Bronchitis,79
DIPHENHYDRAMINE,Pain,76
DIPHENHYDRAMINE,Illness,73
DIPHENHYDRAMINE,Infusion related reaction,69
DIPHENHYDRAMINE,Infection,64
DIPHENHYDRAMINE,Pyrexia,63
DIPHENHYDRAMINE,Dyspnoea,61
DIPHENHYDRAMINE,Cough,60
DIPHENHYDRAMINE,Respiratory tract infection,57
DIPHENHYDRAMINE,Influenza,56
DIPHENHYDRAMINE,Insurance issue,56
DIPHENHYDRAMINE,Ear infection,51
DIPHENHYDRAMINE,Weight decreased,48
DIPHENHYDRAMINE,Seasonal allergy,48
DIPHENHYDRAMINE,Infusion site pain,48
DIPHENHYDRAMINE,Blood pressure increased,48
DIPHENHYDRAMINE,Weight increased,46
DIPHENHYDRAMINE,Vomiting,42
DIPHENHYDRAMINE,Back pain,42
DIPHENHYDRAMINE,Product use issue,42
DIPHENHYDRAMINE,Asthenia,41
DIPHENHYDRAMINE,Diarrhoea,41
DIPHENHYDRAMINE,Pruritus,41
DIPHENHYDRAMINE,Rash,38
DIPHENHYDRAMINE,Infusion site extravasation,38
DIPHENHYDRAMINE,Dizziness,38
DIPHENHYDRAMINE,Asthma,37
DIPHENHYDRAMINE,Infusion site swelling,36
DIPHENHYDRAMINE,Erythema,34
DIPHENHYDRAMINE,Viral infection,34
DIPHENHYDRAMINE,Arthralgia,34
DIPHENHYDRAMINE,Migraine,33
DIPHENHYDRAMINE,Drug hypersensitivity,33
DIPHENHYDRAMINE,Infusion site pruritus,32
DIPHENHYDRAMINE,Condition aggravated,32
DIPHENHYDRAMINE,Intentional product use issue,31
DIPHENHYDRAMINE HYDROCHLORIDE,Sinusitis,41
DIPHENHYDRAMINE HYDROCHLORIDE,COVID-19,40
DIPHENHYDRAMINE HYDROCHLORIDE,Headache,37
DIPHENHYDRAMINE HYDROCHLORIDE,Product dose omission issue,37
DIPHENHYDRAMINE HYDROCHLORIDE,Fall,35
DIPHENHYDRAMINE HYDROCHLORIDE,Fatigue,31
DIPHENHYDRAMINE HYDROCHLORIDE,Pneumonia,28
DIPHENHYDRAMINE HYDROCHLORIDE,Urinary tract infection,24
DIPHENHYDRAMINE HYDROCHLORIDE,Dyspnoea,24
DIPHENHYDRAMINE HYDROCHLORIDE,Pain,23
DIPHENHYDRAMINE HYDROCHLORIDE,Nasopharyngitis,23
DIPHENHYDRAMINE HYDROCHLORIDE,Nausea,20
DIPHENHYDRAMINE HYDROCHLORIDE,Pyrexia,19
DIPHENHYDRAMINE HYDROCHLORIDE,Illness,19
DIPHENHYDRAMINE HYDROCHLORIDE,Upper respiratory tract infection,18
DIPHENHYDRAMINE HYDROCHLORIDE,Malaise,17
DIPHENHYDRAMINE HYDROCHLORIDE,Cough,17
DIPHENHYDRAMINE HYDROCHLORIDE,Back pain,17
DIPHENHYDRAMINE HYDROCHLORIDE,Inappropriate schedule of product administration,16
DIPHENHYDRAMINE HYDROCHLORIDE,Bronchitis,16
DIPHENHYDRAMINE HYDROCHLORIDE,Infusion related reaction,16
DIPHENHYDRAMINE HYDROCHLORIDE,Anxiety,15
DIPHENHYDRAMINE HYDROCHLORIDE,Pain in extremity,15
DIPHENHYDRAMINE HYDROCHLORIDE,Insurance issue,15
DIPHENHYDRAMINE HYDROCHLORIDE,Vomiting,13
DIPHENHYDRAMINE HYDROCHLORIDE,Seasonal allergy,12
DIPHENHYDRAMINE HYDROCHLORIDE,Infusion site extravasation,12
DIPHENHYDRAMINE HYDROCHLORIDE,Ear infection,12
DIPHENHYDRAMINE HYDROCHLORIDE,Influenza,12
DIPHENHYDRAMINE HYDROCHLORIDE,Weight decreased,12
DIPHENHYDRAMINE HYDROCHLORIDE,Rash,12
DIPHENHYDRAMINE HYDROCHLORIDE,Infection,12
DIPHENHYDRAMINE HYDROCHLORIDE,Viral infection,11
DIPHENHYDRAMINE HYDROCHLORIDE,Contusion,11
DIPHENHYDRAMINE HYDROCHLORIDE,Limb injury,11
DIPHENHYDRAMINE HYDROCHLORIDE,Dizziness,11
DIPHENHYDRAMINE HYDROCHLORIDE,Product use issue,11
DIPHENHYDRAMINE HYDROCHLORIDE,Migraine,11
DIPHENHYDRAMINE HYDROCHLORIDE,Infusion site pain,10
DIPHENHYDRAMINE HYDROCHLORIDE,Arthralgia,10
DIPHENHYDRAMINE HYDROCHLORIDE,Diarrhoea,10
DIPHENHYDRAMINE HYDROCHLORIDE,Gastroenteritis viral,10
DIPHENHYDRAMINE HYDROCHLORIDE,Skin infection,9
DIPHENHYDRAMINE HYDROCHLORIDE,Respiratory tract infection,9
DIPHENHYDRAMINE HYDROCHLORIDE,Peripheral swelling,9
DIPHENHYDRAMINE HYDROCHLORIDE,Blood pressure decreased,9
DIPHENHYDRAMINE HYDROCHLORIDE,Erythema,9
DIPHENHYDRAMINE HYDROCHLORIDE,Asthenia,9
DIPHENHYDRAMINE HYDROCHLORIDE,Cellulitis,9
DIPHENHYDRAMINE HYDROCHLORIDE,Weight increased,9
DOCETAXEL,Diarrhoea,61
DOCETAXEL,Alopecia,41
DOCETAXEL,Fatigue,41
DOCETAXEL,Nausea,33
DOCETAXEL,Mucosal inflammation,31
DOCETAXEL,Off label use,23
DOCETAXEL,White blood cell count decreased,23
DOCETAXEL,Hair texture abnormal,22
DOCETAXEL,Hair colour changes,22
DOCETAXEL,Anaemia,21
DOCETAXEL,Madarosis,20
DOCETAXEL,Neutropenia,18
DOCETAXEL,Epistaxis,16
DOCETAXEL,Neuropathy peripheral,15
DOCETAXEL,Ejection fraction decreased,15
DOCETAXEL,Rash,15
DOCETAXEL,Disease progression,15
DOCETAXEL,Hair disorder,14
DOCETAXEL,Osteonecrosis of jaw,14
DOCETAXEL,Hot flush,14
DOCETAXEL,Pain in extremity,14
DOCETAXEL,Leukopenia,13
DOCETAXEL,Platelet count decreased,13
DOCETAXEL,Vomiting,13
DOCETAXEL,Myelosuppression,13
DOCETAXEL,Vascular device infection,12
DOCETAXEL,Gingival swelling,12
DOCETAXEL,Influenza like illness,12
DOCETAXEL,Lymphoedema,12
DOCETAXEL,Gastrooesophageal reflux disease,12
DOCETAXEL,Dyspnoea,12
DOCETAXEL,Sepsis,11
DOCETAXEL,Neutrophil count increased,11
DOCETAXEL,Neutrophil count decreased,11
DOCETAXEL,Febrile neutropenia,10
DOCETAXEL,Dyspepsia,10
DOCETAXEL,COVID-19,10
DOCETAXEL,Stomatitis,10
DOCETAXEL,Alopecia areata,9
DOCETAXEL,Affective disorder,9
DOCETAXEL,Cellulitis,9
DOCETAXEL,Schizophrenia,9
DOCETAXEL,Overdose,9
DOCETAXEL,Incorrect dose administered,9
DOCETAXEL,Seizure,9
DOCETAXEL,Psychotic disorder,9
DOCETAXEL,Lymphocyte count decreased,9
DOCETAXEL,"Hallucination, auditory",9
DOCETAXEL,Extrapyramidal disorder,9
DOCETAXEL,Delusion of grandeur,9
DOCUSATE,Pain,11
DOCUSATE,Anhedonia,8
DOCUSATE,Anxiety,8
DOCUSATE,Emotional distress,8
DOCUSATE,Neutropenia,7
DOCUSATE,Blood test abnormal,6
DOCUSATE,Urinary tract infection,5
DOCUSATE,Osteoporosis,5
DOCUSATE,Fatigue,5
DOCUSATE,Diarrhoea,5
DOCUSATE,Death,5
DOCUSATE,Pyrexia,5
DOCUSATE,Chronic kidney disease,4
DOCUSATE,Renal impairment,3
DOCUSATE,Malaise,3
DOCUSATE,Illness,3
DOCUSATE,Arthralgia,3
DOCUSATE,Pain in extremity,3
DOCUSATE,Dyspnoea,3
DOCUSATE,Febrile neutropenia,3
DOCUSATE,Abdominal pain,3
DOCUSATE,End stage renal disease,2
DOCUSATE,Bone density decreased,2
DOCUSATE,Gout,2
DOCUSATE,Acute kidney injury,2
DOCUSATE,COVID-19,2
DOCUSATE,Prostatomegaly,2
DOCUSATE,Disorientation,2
DOCUSATE,Pulmonary thrombosis,2
DOCUSATE,Pneumonia,2
DOCUSATE,Hereditary angioedema,2
DOCUSATE,Nausea,2
DOCUSATE,Nasopharyngitis,2
DOCUSATE,Hepatic fibrosis,2
DOCUSATE,Product dose omission issue,2
DOCUSATE,Depression,2
DOCUSATE,Osteopenia,2
DOCUSATE,Back pain,2
DOCUSATE,Hypothyroidism,2
DOCUSATE,Cough,2
DOCUSATE,Pneumonitis,2
DOCUSATE,Ascites,2
DOCUSATE,Oedema,2
DOCUSATE,Cytokine release syndrome,2
DOCUSATE,Gait disturbance,2
DOCUSATE,Vomiting,2
DOCUSATE,Decreased activity,1
DOCUSATE,Quality of life decreased,1
DOCUSATE,Renal failure,1
DOCUSATE,Economic problem,1
DOCUSATE SODIUM,Vomiting,22
DOCUSATE SODIUM,Constipation,16
DOCUSATE SODIUM,Pain,16
DOCUSATE SODIUM,Nausea,15
DOCUSATE SODIUM,Off label use,15
DOCUSATE SODIUM,Diarrhoea,14
DOCUSATE SODIUM,Pyrexia,13
DOCUSATE SODIUM,Accident,13
DOCUSATE SODIUM,Febrile neutropenia,12
DOCUSATE SODIUM,Death,11
DOCUSATE SODIUM,Condition aggravated,11
DOCUSATE SODIUM,Proctalgia,11
DOCUSATE SODIUM,Back pain,11
DOCUSATE SODIUM,Anal inflammation,11
DOCUSATE SODIUM,Malaise,11
DOCUSATE SODIUM,Crohn's disease,11
DOCUSATE SODIUM,Body temperature increased,11
DOCUSATE SODIUM,Neutropenia,11
DOCUSATE SODIUM,Haemorrhoids,11
DOCUSATE SODIUM,Sepsis,10
DOCUSATE SODIUM,Chills,10
DOCUSATE SODIUM,Dyspnoea,9
DOCUSATE SODIUM,SARS-CoV-2 test negative,9
DOCUSATE SODIUM,Abdominal distension,8
DOCUSATE SODIUM,Stress,7
DOCUSATE SODIUM,Cardiogenic shock,7
DOCUSATE SODIUM,Incorrect route of product administration,7
DOCUSATE SODIUM,Multiple organ dysfunction syndrome,7
DOCUSATE SODIUM,Ascites,7
DOCUSATE SODIUM,Somnolence,7
DOCUSATE SODIUM,Abdominal pain,7
DOCUSATE SODIUM,Anaemia,7
DOCUSATE SODIUM,Hyponatraemia,6
DOCUSATE SODIUM,Dry mouth,6
DOCUSATE SODIUM,Drug hypersensitivity,5
DOCUSATE SODIUM,Bacterial infection,5
DOCUSATE SODIUM,Seizure,5
DOCUSATE SODIUM,Fall,5
DOCUSATE SODIUM,Neuralgia,5
DOCUSATE SODIUM,Swelling,5
DOCUSATE SODIUM,Drug intolerance,4
DOCUSATE SODIUM,Intentional product misuse,4
DOCUSATE SODIUM,Appendicolith,4
DOCUSATE SODIUM,General physical health deterioration,4
DOCUSATE SODIUM,Ventricular fibrillation,4
DOCUSATE SODIUM,Appendicitis,4
DOCUSATE SODIUM,Intentional product use issue,4
DOCUSATE SODIUM,COVID-19,4
DOCUSATE SODIUM,Sleep disorder,4
DOCUSATE SODIUM,Pneumonia,3
DOLIPRANE,Coma,10
DOLIPRANE,Acute kidney injury,8
DOLIPRANE,Lung disorder,7
DOLIPRANE,Abdominal pain,7
DOLIPRANE,Anaemia,7
DOLIPRANE,Hypotension,6
DOLIPRANE,Infection,6
DOLIPRANE,Fatigue,5
DOLIPRANE,Fall,5
DOLIPRANE,Back pain,5
DOLIPRANE,Malaise,5
DOLIPRANE,Asthenia,5
DOLIPRANE,Vomiting,5
DOLIPRANE,Product use issue,5
DOLIPRANE,Prerenal failure,5
DOLIPRANE,Intentional product misuse,5
DOLIPRANE,Hepatic cytolysis,5
DOLIPRANE,Dermatitis,5
DOLIPRANE,Leukopenia,5
DOLIPRANE,Diarrhoea,4
DOLIPRANE,General physical health deterioration,4
DOLIPRANE,Somnolence,4
DOLIPRANE,Vertigo,4
DOLIPRANE,Headache,4
DOLIPRANE,Hyperhidrosis,4
DOLIPRANE,Nausea,4
DOLIPRANE,Musculoskeletal pain,4
DOLIPRANE,Rash vesicular,4
DOLIPRANE,Poisoning deliberate,4
DOLIPRANE,Toxicity to various agents,4
DOLIPRANE,Tubulointerstitial nephritis,4
DOLIPRANE,Erythema,3
DOLIPRANE,Visual impairment,3
DOLIPRANE,Nervous system disorder,3
DOLIPRANE,Night sweats,3
DOLIPRANE,Dizziness,3
DOLIPRANE,Tachycardia,3
DOLIPRANE,Facial paralysis,3
DOLIPRANE,Bell's palsy,3
DOLIPRANE,Guillain-Barre syndrome,3
DOLIPRANE,Pyrexia,3
DOLIPRANE,Fixed eruption,3
DOLIPRANE,Dermatitis bullous,3
DOLIPRANE,Cardio-respiratory arrest,3
DOLIPRANE,Occipital neuralgia,2
DOLIPRANE,Communication disorder,2
DOLIPRANE,Asthenopia,2
DOLIPRANE,Eye pain,2
DOLIPRANE,Intermenstrual bleeding,2
DOLIPRANE,Hypocalcaemia,2
DOMPERIDONE,Diarrhoea,27
DOMPERIDONE,Vomiting,25
DOMPERIDONE,Pyrexia,22
DOMPERIDONE,Off label use,20
DOMPERIDONE,Fatigue,19
DOMPERIDONE,Headache,18
DOMPERIDONE,Arthralgia,17
DOMPERIDONE,Decreased appetite,17
DOMPERIDONE,Contusion,17
DOMPERIDONE,Drug interaction,16
DOMPERIDONE,Nightmare,16
DOMPERIDONE,Illness,16
DOMPERIDONE,Blood sodium decreased,15
DOMPERIDONE,Pruritus,14
DOMPERIDONE,Nausea,14
DOMPERIDONE,Swelling face,14
DOMPERIDONE,Hypoaesthesia,14
DOMPERIDONE,Premature labour,13
DOMPERIDONE,Psychotic disorder,13
DOMPERIDONE,Hyperhidrosis,13
DOMPERIDONE,Tremor,13
DOMPERIDONE,Asthenia,13
DOMPERIDONE,Heart rate increased,13
DOMPERIDONE,Muscle spasms,13
DOMPERIDONE,Seizure,13
DOMPERIDONE,Paraesthesia,13
DOMPERIDONE,Schizophrenia,13
DOMPERIDONE,Dyspnoea,13
DOMPERIDONE,Abdominal pain,12
DOMPERIDONE,Musculoskeletal stiffness,12
DOMPERIDONE,Emotional disorder,12
DOMPERIDONE,Serotonin syndrome,12
DOMPERIDONE,Anxiety,12
DOMPERIDONE,Drug withdrawal syndrome,12
DOMPERIDONE,Sleep disorder,12
DOMPERIDONE,Paralysis,12
DOMPERIDONE,Dizziness,12
DOMPERIDONE,Dystonia,12
DOMPERIDONE,Gait disturbance,12
DOMPERIDONE,Speech disorder,12
DOMPERIDONE,Tachycardia,12
DOMPERIDONE,Dyskinesia,12
DOMPERIDONE,Condition aggravated,12
DOMPERIDONE,Exposure during pregnancy,11
DOMPERIDONE,COVID-19,11
DOMPERIDONE,Malaise,11
DOMPERIDONE,Parosmia,11
DOMPERIDONE,Mania,11
DOMPERIDONE,Disturbance in attention,11
DOMPERIDONE,Hypoaesthesia oral,11
DOXAZOSIN,Anxiety,10
DOXAZOSIN,Fatigue,8
DOXAZOSIN,Emotional distress,7
DOXAZOSIN,Anhedonia,7
DOXAZOSIN,Pain,7
DOXAZOSIN,Dyspnoea,7
DOXAZOSIN,Off label use,6
DOXAZOSIN,Nausea,6
DOXAZOSIN,Abdominal pain,5
DOXAZOSIN,Malaise,5
DOXAZOSIN,Peripheral swelling,5
DOXAZOSIN,Medication error,5
DOXAZOSIN,Joint swelling,5
DOXAZOSIN,Blood creatinine increased,4
DOXAZOSIN,Chronic kidney disease,4
DOXAZOSIN,Hyperbilirubinaemia,4
DOXAZOSIN,Hypertension,4
DOXAZOSIN,Confusional state,4
DOXAZOSIN,Mouth ulceration,4
DOXAZOSIN,Lethargy,3
DOXAZOSIN,End stage renal disease,3
DOXAZOSIN,Decreased activity,3
DOXAZOSIN,Depression,3
DOXAZOSIN,Nephrolithiasis,3
DOXAZOSIN,Hepatocellular injury,3
DOXAZOSIN,Headache,3
DOXAZOSIN,Chest pain,3
DOXAZOSIN,Neutropenic sepsis,3
DOXAZOSIN,Pyrexia,3
DOXAZOSIN,Paraesthesia,3
DOXAZOSIN,Insomnia,3
DOXAZOSIN,Rosacea,3
DOXAZOSIN,Gingival discomfort,3
DOXAZOSIN,Anaemia,3
DOXAZOSIN,Renal tubular necrosis,2
DOXAZOSIN,Somnolence,2
DOXAZOSIN,Pain in extremity,2
DOXAZOSIN,Quality of life decreased,2
DOXAZOSIN,Liver injury,2
DOXAZOSIN,Osteoporosis,2
DOXAZOSIN,Multiple fractures,2
DOXAZOSIN,Acute kidney injury,2
DOXAZOSIN,Death,2
DOXAZOSIN,Cough,2
DOXAZOSIN,Blood pressure ambulatory increased,2
DOXAZOSIN,Cardiac autonomic neuropathy,2
DOXAZOSIN,Back pain,2
DOXAZOSIN,Supine hypertension,2
DOXAZOSIN,Renal impairment,2
DOXAZOSIN,Renal failure,2
DOXORUBICIN,Febrile neutropenia,30
DOXORUBICIN,Pyrexia,18
DOXORUBICIN,Neutropenia,17
DOXORUBICIN,Pancytopenia,16
DOXORUBICIN,Anaemia,15
DOXORUBICIN,Off label use,14
DOXORUBICIN,Fatigue,13
DOXORUBICIN,Nausea,13
DOXORUBICIN,Pneumonia,13
DOXORUBICIN,Vomiting,13
DOXORUBICIN,Respiratory failure,10
DOXORUBICIN,Hypothyroidism,10
DOXORUBICIN,Disease progression,10
DOXORUBICIN,Cough,9
DOXORUBICIN,Urinary tract infection,9
DOXORUBICIN,Tachycardia,9
DOXORUBICIN,Sepsis,9
DOXORUBICIN,Back pain,9
DOXORUBICIN,Mucosal inflammation,9
DOXORUBICIN,Dyspnoea,8
DOXORUBICIN,Condition aggravated,8
DOXORUBICIN,Arthralgia,7
DOXORUBICIN,Thrombocytopenia,7
DOXORUBICIN,Troponin increased,7
DOXORUBICIN,Fall,6
DOXORUBICIN,Myalgia,6
DOXORUBICIN,General physical health deterioration,6
DOXORUBICIN,Device malfunction,6
DOXORUBICIN,Diarrhoea,6
DOXORUBICIN,Decreased appetite,6
DOXORUBICIN,Hypotension,6
DOXORUBICIN,Pleural effusion,6
DOXORUBICIN,Myocarditis,6
DOXORUBICIN,Lower respiratory tract infection,6
DOXORUBICIN,Dysphagia,5
DOXORUBICIN,Myelodysplastic syndrome,5
DOXORUBICIN,Dizziness,5
DOXORUBICIN,Hepatic steatosis,5
DOXORUBICIN,Inflammation,5
DOXORUBICIN,Splenomegaly,5
DOXORUBICIN,Pain,5
DOXORUBICIN,Bone pain,5
DOXORUBICIN,Candida infection,5
DOXORUBICIN,Hodgkin's disease,5
DOXORUBICIN,COVID-19 pneumonia,5
DOXORUBICIN,Malignant neoplasm progression,5
DOXORUBICIN,Malaise,5
DOXORUBICIN,Inappropriate antidiuretic hormone secretion,5
DOXORUBICIN,Ascites,5
DOXORUBICIN,Hypokalaemia,5
DOXORUBICIN HYDROCHLORIDE,Febrile neutropenia,29
DOXORUBICIN HYDROCHLORIDE,Off label use,25
DOXORUBICIN HYDROCHLORIDE,Pyrexia,23
DOXORUBICIN HYDROCHLORIDE,Myelosuppression,22
DOXORUBICIN HYDROCHLORIDE,Diarrhoea,18
DOXORUBICIN HYDROCHLORIDE,Neutropenia,18
DOXORUBICIN HYDROCHLORIDE,Vomiting,17
DOXORUBICIN HYDROCHLORIDE,Neutrophil count decreased,12
DOXORUBICIN HYDROCHLORIDE,Pain,11
DOXORUBICIN HYDROCHLORIDE,Chills,10
DOXORUBICIN HYDROCHLORIDE,Proctalgia,10
DOXORUBICIN HYDROCHLORIDE,Back pain,10
DOXORUBICIN HYDROCHLORIDE,Anal inflammation,10
DOXORUBICIN HYDROCHLORIDE,Malaise,10
DOXORUBICIN HYDROCHLORIDE,Accident,10
DOXORUBICIN HYDROCHLORIDE,Crohn's disease,10
DOXORUBICIN HYDROCHLORIDE,Body temperature increased,10
DOXORUBICIN HYDROCHLORIDE,Haemorrhoids,10
DOXORUBICIN HYDROCHLORIDE,White blood cell count decreased,9
DOXORUBICIN HYDROCHLORIDE,Platelet count decreased,8
DOXORUBICIN HYDROCHLORIDE,Pancytopenia,8
DOXORUBICIN HYDROCHLORIDE,Anaemia,8
DOXORUBICIN HYDROCHLORIDE,SARS-CoV-2 test negative,8
DOXORUBICIN HYDROCHLORIDE,Product use in unapproved indication,8
DOXORUBICIN HYDROCHLORIDE,Nausea,6
DOXORUBICIN HYDROCHLORIDE,Malignant neoplasm progression,6
DOXORUBICIN HYDROCHLORIDE,Cytokine release syndrome,6
DOXORUBICIN HYDROCHLORIDE,Drug ineffective,6
DOXORUBICIN HYDROCHLORIDE,Hypokalaemia,6
DOXORUBICIN HYDROCHLORIDE,Atrial fibrillation,6
DOXORUBICIN HYDROCHLORIDE,Mucosal inflammation,5
DOXORUBICIN HYDROCHLORIDE,Neuropathy peripheral,5
DOXORUBICIN HYDROCHLORIDE,Cardiac failure,5
DOXORUBICIN HYDROCHLORIDE,Neoplasm progression,5
DOXORUBICIN HYDROCHLORIDE,Disease progression,5
DOXORUBICIN HYDROCHLORIDE,Fatigue,4
DOXORUBICIN HYDROCHLORIDE,Acute kidney injury,4
DOXORUBICIN HYDROCHLORIDE,Dyspnoea,4
DOXORUBICIN HYDROCHLORIDE,Rash,4
DOXORUBICIN HYDROCHLORIDE,Hypoxia,4
DOXORUBICIN HYDROCHLORIDE,Hepatic function abnormal,4
DOXORUBICIN HYDROCHLORIDE,Hypertension,4
DOXORUBICIN HYDROCHLORIDE,Asthenia,4
DOXORUBICIN HYDROCHLORIDE,Lymphocyte count decreased,3
DOXORUBICIN HYDROCHLORIDE,Gastrointestinal disorder,3
DOXORUBICIN HYDROCHLORIDE,COVID-19 pneumonia,3
DOXORUBICIN HYDROCHLORIDE,Vaccination failure,3
DOXORUBICIN HYDROCHLORIDE,Liver injury,3
DOXORUBICIN HYDROCHLORIDE,Dyspepsia,3
DOXORUBICIN HYDROCHLORIDE,Hepatic failure,3
DOXYCYCLINE,Nausea,23
DOXYCYCLINE,Headache,23
DOXYCYCLINE,Pain,23
DOXYCYCLINE,Off label use,22
DOXYCYCLINE,Anxiety,22
DOXYCYCLINE,COVID-19,22
DOXYCYCLINE,Dyspnoea,20
DOXYCYCLINE,Rash,19
DOXYCYCLINE,Lower respiratory tract infection,18
DOXYCYCLINE,Back pain,18
DOXYCYCLINE,Pneumonia,17
DOXYCYCLINE,Depression,17
DOXYCYCLINE,Arthralgia,17
DOXYCYCLINE,Diarrhoea,17
DOXYCYCLINE,Sinusitis,17
DOXYCYCLINE,Fatigue,16
DOXYCYCLINE,Malaise,16
DOXYCYCLINE,Product dose omission issue,16
DOXYCYCLINE,Condition aggravated,15
DOXYCYCLINE,Emotional distress,15
DOXYCYCLINE,Pruritus,12
DOXYCYCLINE,Abdominal discomfort,12
DOXYCYCLINE,Pain in extremity,12
DOXYCYCLINE,Anhedonia,12
DOXYCYCLINE,Pyrexia,11
DOXYCYCLINE,Weight decreased,11
DOXYCYCLINE,Vomiting,11
DOXYCYCLINE,Nasopharyngitis,11
DOXYCYCLINE,Abdominal pain,11
DOXYCYCLINE,Dizziness,11
DOXYCYCLINE,Bronchitis,11
DOXYCYCLINE,Arthropathy,10
DOXYCYCLINE,Osteoporosis,10
DOXYCYCLINE,Upper respiratory tract infection,10
DOXYCYCLINE,Cholestasis,10
DOXYCYCLINE,Peripheral swelling,9
DOXYCYCLINE,Decreased appetite,9
DOXYCYCLINE,Infection,9
DOXYCYCLINE,Drug hypersensitivity,9
DOXYCYCLINE,Hypoaesthesia,9
DOXYCYCLINE,Knee arthroplasty,9
DOXYCYCLINE,Illness,9
DOXYCYCLINE,Cough,9
DOXYCYCLINE,Gait disturbance,8
DOXYCYCLINE,Abdominal pain upper,8
DOXYCYCLINE,Confusional state,8
DOXYCYCLINE,Neuropathy peripheral,8
DOXYCYCLINE,Swelling face,8
DOXYCYCLINE,Chills,8
DOXYCYCLINE,Fall,8
DOXYCYCLINE HYCLATE,Sinusitis,24
DOXYCYCLINE HYCLATE,COVID-19,22
DOXYCYCLINE HYCLATE,Product dose omission issue,18
DOXYCYCLINE HYCLATE,Infection,12
DOXYCYCLINE HYCLATE,Pneumonia,11
DOXYCYCLINE HYCLATE,Urinary tract infection,11
DOXYCYCLINE HYCLATE,Upper respiratory tract infection,11
DOXYCYCLINE HYCLATE,Respiratory tract infection,11
DOXYCYCLINE HYCLATE,Headache,10
DOXYCYCLINE HYCLATE,Pain,10
DOXYCYCLINE HYCLATE,Bronchitis,10
DOXYCYCLINE HYCLATE,Nausea,9
DOXYCYCLINE HYCLATE,Fatigue,8
DOXYCYCLINE HYCLATE,Anxiety,8
DOXYCYCLINE HYCLATE,Ear infection,8
DOXYCYCLINE HYCLATE,Contusion,7
DOXYCYCLINE HYCLATE,Malaise,7
DOXYCYCLINE HYCLATE,Asthma,7
DOXYCYCLINE HYCLATE,Multiple allergies,7
DOXYCYCLINE HYCLATE,Influenza,7
DOXYCYCLINE HYCLATE,Infusion site extravasation,7
DOXYCYCLINE HYCLATE,Illness,7
DOXYCYCLINE HYCLATE,Pruritus,6
DOXYCYCLINE HYCLATE,Migraine,6
DOXYCYCLINE HYCLATE,Inappropriate schedule of product administration,6
DOXYCYCLINE HYCLATE,Insurance issue,6
DOXYCYCLINE HYCLATE,Infusion related reaction,5
DOXYCYCLINE HYCLATE,Weight decreased,5
DOXYCYCLINE HYCLATE,Rash,5
DOXYCYCLINE HYCLATE,Weight increased,5
DOXYCYCLINE HYCLATE,Arthralgia,5
DOXYCYCLINE HYCLATE,Eye infection,5
DOXYCYCLINE HYCLATE,Anhedonia,5
DOXYCYCLINE HYCLATE,Emotional distress,5
DOXYCYCLINE HYCLATE,Fall,5
DOXYCYCLINE HYCLATE,Infusion site pain,5
DOXYCYCLINE HYCLATE,Vomiting,4
DOXYCYCLINE HYCLATE,Insomnia,4
DOXYCYCLINE HYCLATE,Dyspnoea,4
DOXYCYCLINE HYCLATE,Influenza like illness,4
DOXYCYCLINE HYCLATE,Staphylococcal infection,4
DOXYCYCLINE HYCLATE,Product availability issue,4
DOXYCYCLINE HYCLATE,Dehydration,4
DOXYCYCLINE HYCLATE,Nephrolithiasis,4
DOXYCYCLINE HYCLATE,Kidney infection,4
DOXYCYCLINE HYCLATE,Renal impairment,4
DOXYCYCLINE HYCLATE,Back pain,4
DOXYCYCLINE HYCLATE,Oropharyngeal pain,4
DOXYCYCLINE HYCLATE,Acute kidney injury,4
DOXYCYCLINE HYCLATE,Weight fluctuation,4
DULOXETINE,Fatigue,36
DULOXETINE,Nausea,32
DULOXETINE,Diarrhoea,31
DULOXETINE,Pain,30
DULOXETINE,COVID-19,25
DULOXETINE,Off label use,24
DULOXETINE,Headache,19
DULOXETINE,Anxiety,18
DULOXETINE,Vomiting,18
DULOXETINE,Pain in extremity,16
DULOXETINE,Product dose omission issue,16
DULOXETINE,Asthenia,15
DULOXETINE,Mucosal inflammation,15
DULOXETINE,Dyspnoea,15
DULOXETINE,Malaise,14
DULOXETINE,Overdose,14
DULOXETINE,Alopecia,13
DULOXETINE,Condition aggravated,13
DULOXETINE,Anhedonia,12
DULOXETINE,Back pain,12
DULOXETINE,Drug ineffective,12
DULOXETINE,Arthralgia,11
DULOXETINE,Depression,11
DULOXETINE,Gait disturbance,11
DULOXETINE,Schizophrenia,11
DULOXETINE,Seizure,11
DULOXETINE,Emotional distress,11
DULOXETINE,Dizziness,11
DULOXETINE,Abdominal pain,11
DULOXETINE,Urinary tract infection,10
DULOXETINE,Pneumonia,10
DULOXETINE,Neuropathy peripheral,10
DULOXETINE,Cellulitis,10
DULOXETINE,Illness,10
DULOXETINE,Intentional product misuse,10
DULOXETINE,Pyrexia,9
DULOXETINE,Platelet count decreased,9
DULOXETINE,Incorrect dose administered,9
DULOXETINE,"Hallucination, auditory",9
DULOXETINE,Neutropenia,9
DULOXETINE,Abdominal discomfort,9
DULOXETINE,Rash,9
DULOXETINE,Weight decreased,9
DULOXETINE,Muscular weakness,9
DULOXETINE,Oral pain,9
DULOXETINE,Fall,9
DULOXETINE,Drug interaction,9
DULOXETINE,Sinusitis,8
DULOXETINE,Affective disorder,8
DULOXETINE,Leukopenia,8
DULOXETINE HYDROCHLORIDE,Product dose omission issue,21
DULOXETINE HYDROCHLORIDE,Nausea,16
DULOXETINE HYDROCHLORIDE,COVID-19,16
DULOXETINE HYDROCHLORIDE,Headache,15
DULOXETINE HYDROCHLORIDE,Fatigue,13
DULOXETINE HYDROCHLORIDE,Sinusitis,12
DULOXETINE HYDROCHLORIDE,Malaise,12
DULOXETINE HYDROCHLORIDE,Arthralgia,10
DULOXETINE HYDROCHLORIDE,Illness,9
DULOXETINE HYDROCHLORIDE,Urinary tract infection,8
DULOXETINE HYDROCHLORIDE,Weight decreased,8
DULOXETINE HYDROCHLORIDE,Dyspnoea,8
DULOXETINE HYDROCHLORIDE,Pyrexia,7
DULOXETINE HYDROCHLORIDE,Fall,7
DULOXETINE HYDROCHLORIDE,Hyponatraemia,7
DULOXETINE HYDROCHLORIDE,Condition aggravated,7
DULOXETINE HYDROCHLORIDE,Suicide attempt,7
DULOXETINE HYDROCHLORIDE,Tachycardia,6
DULOXETINE HYDROCHLORIDE,Cough,6
DULOXETINE HYDROCHLORIDE,Infection,6
DULOXETINE HYDROCHLORIDE,Upper respiratory tract infection,6
DULOXETINE HYDROCHLORIDE,Abdominal pain,6
DULOXETINE HYDROCHLORIDE,Influenza like illness,6
DULOXETINE HYDROCHLORIDE,Pain,6
DULOXETINE HYDROCHLORIDE,Asthenia,6
DULOXETINE HYDROCHLORIDE,Hyperkalaemia,6
DULOXETINE HYDROCHLORIDE,Pneumonia,5
DULOXETINE HYDROCHLORIDE,Nasopharyngitis,5
DULOXETINE HYDROCHLORIDE,Migraine,5
DULOXETINE HYDROCHLORIDE,Weight increased,5
DULOXETINE HYDROCHLORIDE,Gastrointestinal haemorrhage,5
DULOXETINE HYDROCHLORIDE,Inappropriate schedule of product administration,5
DULOXETINE HYDROCHLORIDE,Diarrhoea,5
DULOXETINE HYDROCHLORIDE,Back pain,5
DULOXETINE HYDROCHLORIDE,Feeling abnormal,5
DULOXETINE HYDROCHLORIDE,Chills,5
DULOXETINE HYDROCHLORIDE,Off label use,5
DULOXETINE HYDROCHLORIDE,Hyperhidrosis,5
DULOXETINE HYDROCHLORIDE,Dizziness,5
DULOXETINE HYDROCHLORIDE,Bronchitis,4
DULOXETINE HYDROCHLORIDE,Confusional state,4
DULOXETINE HYDROCHLORIDE,Product use issue,4
DULOXETINE HYDROCHLORIDE,Needle issue,4
DULOXETINE HYDROCHLORIDE,Vomiting,4
DULOXETINE HYDROCHLORIDE,Somnolence,4
DULOXETINE HYDROCHLORIDE,Interstitial lung disease,4
DULOXETINE HYDROCHLORIDE,Blood pressure increased,4
DULOXETINE HYDROCHLORIDE,Pain in extremity,4
DULOXETINE HYDROCHLORIDE,Cerebrovascular accident,4
DULOXETINE HYDROCHLORIDE,Palpitations,4
DUPIXENT,Pruritus,189
DUPIXENT,Dermatitis atopic,126
DUPIXENT,Dry skin,108
DUPIXENT,Product use in unapproved indication,107
DUPIXENT,Injection site pain,97
DUPIXENT,Rash,86
DUPIXENT,Eczema,77
DUPIXENT,Skin exfoliation,74
DUPIXENT,Condition aggravated,65
DUPIXENT,Product dose omission issue,64
DUPIXENT,Inappropriate schedule of product administration,56
DUPIXENT,Accidental exposure to product,50
DUPIXENT,Asthma,49
DUPIXENT,Arthralgia,49
DUPIXENT,Skin fissures,47
DUPIXENT,Injection site erythema,46
DUPIXENT,Injection site swelling,46
DUPIXENT,Erythema,45
DUPIXENT,Incorrect dose administered,44
DUPIXENT,Cough,43
DUPIXENT,Headache,42
DUPIXENT,Drug ineffective,40
DUPIXENT,Injection site pruritus,33
DUPIXENT,Pain,33
DUPIXENT,Therapeutic response decreased,32
DUPIXENT,Dry eye,31
DUPIXENT,Dyspnoea,30
DUPIXENT,Sinusitis,29
DUPIXENT,Ocular hyperaemia,29
DUPIXENT,Eye pruritus,29
DUPIXENT,Therapeutic response shortened,28
DUPIXENT,Skin haemorrhage,27
DUPIXENT,Fatigue,26
DUPIXENT,Off label use,26
DUPIXENT,COVID-19,25
DUPIXENT,Pyrexia,24
DUPIXENT,Pain in extremity,24
DUPIXENT,Sleep disorder,22
DUPIXENT,Product preparation error,22
DUPIXENT,Urticaria,21
DUPIXENT,Vision blurred,21
DUPIXENT,Nausea,21
DUPIXENT,Conjunctivitis,20
DUPIXENT,Rash erythematous,20
DUPIXENT,Skin swelling,19
DUPIXENT,Hypersensitivity,19
DUPIXENT,Rash macular,18
DUPIXENT,Injection site urticaria,17
DUPIXENT,Nasal congestion,17
DUPIXENT,Insomnia,17
EBASTINE,Off label use,8
EBASTINE,Arthralgia,7
EBASTINE,Acute kidney injury,7
EBASTINE,Pruritus,6
EBASTINE,Neutropenia,6
EBASTINE,Pyrexia,6
EBASTINE,Asthenia,6
EBASTINE,Toxic skin eruption,6
EBASTINE,Haemodynamic instability,6
EBASTINE,Depressed level of consciousness,6
EBASTINE,Pneumonia aspiration,6
EBASTINE,Back pain,5
EBASTINE,Fatigue,5
EBASTINE,Diarrhoea,5
EBASTINE,Lymphopenia,5
EBASTINE,Thrombocytopenia,5
EBASTINE,Malaise,5
EBASTINE,Nasopharyngitis,4
EBASTINE,Rash,4
EBASTINE,Weight decreased,4
EBASTINE,Inappropriate schedule of product administration,4
EBASTINE,Blood lactate dehydrogenase increased,4
EBASTINE,Dyspepsia,4
EBASTINE,Urinary tract infection,4
EBASTINE,Myalgia,4
EBASTINE,Hyponatraemia,4
EBASTINE,Blood pressure increased,3
EBASTINE,Injection site pain,3
EBASTINE,Product dose omission issue,3
EBASTINE,Peripheral swelling,3
EBASTINE,Pain,3
EBASTINE,Swelling,3
EBASTINE,Hypersensitivity,3
EBASTINE,Angioedema,3
EBASTINE,Contusion,3
EBASTINE,Urticaria,3
EBASTINE,Leukopenia,3
EBASTINE,Tumour lysis syndrome,3
EBASTINE,Skin lesion,3
EBASTINE,Hepatic cytolysis,3
EBASTINE,Bronchitis,3
EBASTINE,Richter's syndrome,3
EBASTINE,Cough,3
EBASTINE,COVID-19,3
EBASTINE,Headache,3
EBASTINE,Erythema,3
EBASTINE,Seizure,3
EBASTINE,Pancytopenia,3
EBASTINE,Epidermolysis,3
EBASTINE,Drug interaction,3
EDOXABAN,Neutropenia,6
EDOXABAN,Blood test abnormal,6
EDOXABAN,Cardiac failure,4
EDOXABAN,Hypertension,4
EDOXABAN,Pain in extremity,4
EDOXABAN,Amnesia,4
EDOXABAN,Disturbance in attention,4
EDOXABAN,Tendonitis,4
EDOXABAN,Gait inability,4
EDOXABAN,Anaemia,4
EDOXABAN,Hypotension,4
EDOXABAN,Atrial fibrillation,4
EDOXABAN,Abdominal pain,3
EDOXABAN,Fatigue,3
EDOXABAN,Arthralgia,3
EDOXABAN,Diarrhoea,3
EDOXABAN,Renal impairment,3
EDOXABAN,Left ventricular dysfunction,3
EDOXABAN,Ventricular tachycardia,3
EDOXABAN,Ventricular extrasystoles,3
EDOXABAN,Mitral valve incompetence,3
EDOXABAN,Product use in unapproved indication,3
EDOXABAN,Feeling cold,3
EDOXABAN,Cough,3
EDOXABAN,Cardiovascular disorder,3
EDOXABAN,Coronary artery disease,3
EDOXABAN,Ejection fraction decreased,3
EDOXABAN,Peripheral coldness,3
EDOXABAN,Death,2
EDOXABAN,Vomiting,2
EDOXABAN,Dyspnoea,2
EDOXABAN,Decreased appetite,2
EDOXABAN,Gastritis,2
EDOXABAN,Acute kidney injury,2
EDOXABAN,Epistaxis,2
EDOXABAN,Oesophageal varices haemorrhage,2
EDOXABAN,Neck pain,2
EDOXABAN,Constipation,2
EDOXABAN,Medication error,2
EDOXABAN,Vasculitic rash,2
EDOXABAN,Vasculitis,2
EDOXABAN,Hyperhidrosis,2
EDOXABAN,Sepsis,2
EDOXABAN,Upper gastrointestinal haemorrhage,2
EDOXABAN,Gastroenteritis,1
EDOXABAN,Cholestasis,1
EDOXABAN,Occult blood,1
EDOXABAN,Pulmonary mass,1
EDOXABAN,Drug hypersensitivity,1
EDOXABAN,Intervertebral disc protrusion,1
EDOXABAN TOSYLATE,Renal impairment,7
EDOXABAN TOSYLATE,Cerebral infarction,5
EDOXABAN TOSYLATE,Anaemia,5
EDOXABAN TOSYLATE,Interstitial lung disease,5
EDOXABAN TOSYLATE,Decreased appetite,4
EDOXABAN TOSYLATE,Malaise,4
EDOXABAN TOSYLATE,Atrial fibrillation,4
EDOXABAN TOSYLATE,Haematuria,4
EDOXABAN TOSYLATE,Cerebrovascular accident,4
EDOXABAN TOSYLATE,Pancytopenia,4
EDOXABAN TOSYLATE,Stomatitis,3
EDOXABAN TOSYLATE,Fall,3
EDOXABAN TOSYLATE,Shock haemorrhagic,3
EDOXABAN TOSYLATE,Malignant neoplasm progression,3
EDOXABAN TOSYLATE,Diarrhoea,3
EDOXABAN TOSYLATE,Dehydration,3
EDOXABAN TOSYLATE,Pleural effusion,3
EDOXABAN TOSYLATE,Pain in extremity,3
EDOXABAN TOSYLATE,Epistaxis,3
EDOXABAN TOSYLATE,Melaena,2
EDOXABAN TOSYLATE,Infection,2
EDOXABAN TOSYLATE,Haemophagocytic lymphohistiocytosis,2
EDOXABAN TOSYLATE,General physical health deterioration,2
EDOXABAN TOSYLATE,Upper gastrointestinal haemorrhage,2
EDOXABAN TOSYLATE,Taste disorder,2
EDOXABAN TOSYLATE,Underdose,2
EDOXABAN TOSYLATE,Platelet count decreased,2
EDOXABAN TOSYLATE,Nausea,2
EDOXABAN TOSYLATE,Spinal compression fracture,2
EDOXABAN TOSYLATE,Haemorrhage,2
EDOXABAN TOSYLATE,Dyspnoea,2
EDOXABAN TOSYLATE,Death,2
EDOXABAN TOSYLATE,Tubulointerstitial nephritis,2
EDOXABAN TOSYLATE,Alanine aminotransferase increased,2
EDOXABAN TOSYLATE,Intra-abdominal haemorrhage,2
EDOXABAN TOSYLATE,Sepsis,2
EDOXABAN TOSYLATE,Hypotension,2
EDOXABAN TOSYLATE,Cardiomegaly,2
EDOXABAN TOSYLATE,Deep vein thrombosis,2
EDOXABAN TOSYLATE,Hypertension,2
EDOXABAN TOSYLATE,Incorrect dose administered,2
EDOXABAN TOSYLATE,Cardiac tamponade,2
EDOXABAN TOSYLATE,Asthenia,2
EDOXABAN TOSYLATE,Microcytic anaemia,2
EDOXABAN TOSYLATE,Pericardial effusion,2
EDOXABAN TOSYLATE,White blood cell count decreased,1
EDOXABAN TOSYLATE,Bacteraemia,1
EDOXABAN TOSYLATE,Cytomegalovirus test positive,1
EDOXABAN TOSYLATE,Respiratory failure,1
EDOXABAN TOSYLATE,Implant site infection,1
EFFEXOR,COVID-19,11
EFFEXOR,Pain,8
EFFEXOR,Arthralgia,8
EFFEXOR,Fatigue,8
EFFEXOR,Nausea,8
EFFEXOR,Weight increased,7
EFFEXOR,Urinary tract infection,7
EFFEXOR,Anxiety,7
EFFEXOR,Vomiting,7
EFFEXOR,Product dose omission issue,6
EFFEXOR,Peripheral swelling,6
EFFEXOR,Malaise,6
EFFEXOR,Dizziness,6
EFFEXOR,Nasopharyngitis,5
EFFEXOR,Depression,5
EFFEXOR,Dehydration,5
EFFEXOR,Weight decreased,5
EFFEXOR,Seizure,5
EFFEXOR,Hyponatraemia,5
EFFEXOR,Fluid retention,4
EFFEXOR,Neuropathy peripheral,4
EFFEXOR,Diarrhoea,4
EFFEXOR,Blood glucose increased,4
EFFEXOR,Sinusitis,4
EFFEXOR,Cough,4
EFFEXOR,Injection site pain,4
EFFEXOR,Hypotension,4
EFFEXOR,Fall,4
EFFEXOR,Inappropriate schedule of product administration,3
EFFEXOR,Abdominal pain,3
EFFEXOR,Burning sensation,3
EFFEXOR,Sinus disorder,3
EFFEXOR,Emotional distress,3
EFFEXOR,Anhedonia,3
EFFEXOR,Myalgia,3
EFFEXOR,Crying,3
EFFEXOR,Insomnia,3
EFFEXOR,Blood creatinine increased,3
EFFEXOR,Pyrexia,3
EFFEXOR,Nasal congestion,3
EFFEXOR,Decreased appetite,3
EFFEXOR,Pruritus,3
EFFEXOR,Head injury,3
EFFEXOR,Stress,3
EFFEXOR,Dry skin,3
EFFEXOR,Hypertension,3
EFFEXOR,Chest pain,3
EFFEXOR,Neuralgia,3
EFFEXOR,Bone pain,3
EFFEXOR,Aortic aneurysm,2
ELDECALCITOL,Interstitial lung disease,7
ELDECALCITOL,Headache,6
ELDECALCITOL,Malaise,5
ELDECALCITOL,COVID-19,4
ELDECALCITOL,Pneumonia,4
ELDECALCITOL,Urinary tract infection,3
ELDECALCITOL,Dyspnoea,3
ELDECALCITOL,Faeces discoloured,3
ELDECALCITOL,Epistaxis,3
ELDECALCITOL,Herpes zoster,3
ELDECALCITOL,Concomitant disease aggravated,3
ELDECALCITOL,Lymphocyte count decreased,3
ELDECALCITOL,Fall,3
ELDECALCITOL,Serous retinal detachment,3
ELDECALCITOL,Osteonecrosis,3
ELDECALCITOL,Colitis ischaemic,3
ELDECALCITOL,Diarrhoea,3
ELDECALCITOL,Lung neoplasm malignant,2
ELDECALCITOL,Hyperuricaemia,2
ELDECALCITOL,Meningitis,2
ELDECALCITOL,Abdominal pain upper,2
ELDECALCITOL,Decubitus ulcer,2
ELDECALCITOL,Altered state of consciousness,2
ELDECALCITOL,Gastrointestinal haemorrhage,2
ELDECALCITOL,Meningitis bacterial,2
ELDECALCITOL,Anaemia,2
ELDECALCITOL,Mixed connective tissue disease,2
ELDECALCITOL,Hypotension,2
ELDECALCITOL,Shock haemorrhagic,2
ELDECALCITOL,Oedema peripheral,2
ELDECALCITOL,White blood cell count decreased,2
ELDECALCITOL,Aspartate aminotransferase increased,2
ELDECALCITOL,Nausea,2
ELDECALCITOL,Dermatitis psoriasiform,2
ELDECALCITOL,Pemphigoid,2
ELDECALCITOL,Sinus node dysfunction,2
ELDECALCITOL,Deep vein thrombosis,2
ELDECALCITOL,Osteoporosis,2
ELDECALCITOL,Pleural effusion,2
ELDECALCITOL,Renal impairment,2
ELDECALCITOL,Arthralgia,2
ELDECALCITOL,Cardiac failure congestive,2
ELDECALCITOL,Haematuria,2
ELDECALCITOL,Pyrexia,2
ELDECALCITOL,Febrile neutropenia,2
ELDECALCITOL,Large cell lung cancer stage IV,1
ELDECALCITOL,Neuroendocrine carcinoma,1
ELDECALCITOL,Nephrolithiasis,1
ELDECALCITOL,Pyelonephritis,1
ELDECALCITOL,Bacteraemia,1
ELIGARD,Hot flush,16
ELIGARD,Intentional product use issue,13
ELIGARD,Prostatic specific antigen increased,7
ELIGARD,Injection site pain,7
ELIGARD,Drug ineffective,5
ELIGARD,Second primary malignancy,5
ELIGARD,Fatigue,5
ELIGARD,Weight increased,5
ELIGARD,Asthenia,4
ELIGARD,Blood testosterone increased,3
ELIGARD,Muscle atrophy,3
ELIGARD,Insurance issue,3
ELIGARD,Diarrhoea,3
ELIGARD,Fat tissue increased,2
ELIGARD,Injection site mass,2
ELIGARD,Hypotonia,2
ELIGARD,Protein urine,2
ELIGARD,Injection site haematoma,2
ELIGARD,Amnesia,2
ELIGARD,Fall,2
ELIGARD,Intentional dose omission,2
ELIGARD,Syncope,2
ELIGARD,Loss of consciousness,2
ELIGARD,Malaise,2
ELIGARD,Dizziness,2
ELIGARD,Femur fracture,2
ELIGARD,Mobility decreased,2
ELIGARD,Oropharyngeal pain,2
ELIGARD,Productive cough,2
ELIGARD,Pyrexia,2
ELIGARD,Pneumonia,2
ELIGARD,Prostatic specific antigen abnormal,2
ELIGARD,Malignant neoplasm progression,2
ELIGARD,Haematuria,2
ELIGARD,Cardiac failure,2
ELIGARD,Myelodysplastic syndrome,1
ELIGARD,Prostate cancer,1
ELIGARD,Chills,1
ELIGARD,Increased appetite,1
ELIGARD,Depression,1
ELIGARD,Suicidal ideation,1
ELIGARD,Adult failure to thrive,1
ELIGARD,Enterovesical fistula,1
ELIGARD,Colon cancer metastatic,1
ELIGARD,Hypotension,1
ELIGARD,Electrocardiogram abnormal,1
ELIGARD,Aspiration,1
ELIGARD,Non-small cell lung cancer,1
ELIGARD,Mood altered,1
ELIGARD,Hip fracture,1
ELIQUIS,Dyspnoea,90
ELIQUIS,Fatigue,82
ELIQUIS,Diarrhoea,75
ELIQUIS,Off label use,68
ELIQUIS,Nausea,61
ELIQUIS,Headache,59
ELIQUIS,Dizziness,57
ELIQUIS,Fall,54
ELIQUIS,Atrial fibrillation,51
ELIQUIS,Product dose omission issue,50
ELIQUIS,Asthenia,50
ELIQUIS,Cough,48
ELIQUIS,COVID-19,46
ELIQUIS,Pneumonia,45
ELIQUIS,Pain,43
ELIQUIS,Hypotension,40
ELIQUIS,Weight decreased,40
ELIQUIS,Death,39
ELIQUIS,Anaemia,38
ELIQUIS,Arthralgia,36
ELIQUIS,Malaise,34
ELIQUIS,Peripheral swelling,32
ELIQUIS,Vomiting,31
ELIQUIS,Oxygen saturation decreased,29
ELIQUIS,Epistaxis,28
ELIQUIS,Feeling abnormal,27
ELIQUIS,Pruritus,27
ELIQUIS,Pain in extremity,27
ELIQUIS,Urinary tract infection,26
ELIQUIS,Contusion,24
ELIQUIS,Back pain,24
ELIQUIS,Rash,23
ELIQUIS,Anxiety,23
ELIQUIS,Drug ineffective,22
ELIQUIS,Blood pressure decreased,22
ELIQUIS,Cerebrovascular accident,22
ELIQUIS,Chest pain,22
ELIQUIS,Condition aggravated,21
ELIQUIS,Nasopharyngitis,20
ELIQUIS,Inappropriate schedule of product administration,20
ELIQUIS,Acute kidney injury,20
ELIQUIS,Fluid retention,20
ELIQUIS,Illness,20
ELIQUIS,Oedema peripheral,20
ELIQUIS,Hypertension,20
ELIQUIS,Abdominal pain upper,19
ELIQUIS,Cardiac disorder,19
ELIQUIS,Pyrexia,18
ELIQUIS,Neutropenia,18
ELIQUIS,Muscle spasms,18
ELTROMBOPAG OLAMINE,Platelet count decreased,51
ELTROMBOPAG OLAMINE,Malaise,17
ELTROMBOPAG OLAMINE,Platelet count increased,16
ELTROMBOPAG OLAMINE,Contusion,13
ELTROMBOPAG OLAMINE,Petechiae,11
ELTROMBOPAG OLAMINE,Inappropriate schedule of product administration,11
ELTROMBOPAG OLAMINE,Diarrhoea,11
ELTROMBOPAG OLAMINE,Haemorrhage,11
ELTROMBOPAG OLAMINE,Illness,11
ELTROMBOPAG OLAMINE,Anaemia,11
ELTROMBOPAG OLAMINE,Pyrexia,11
ELTROMBOPAG OLAMINE,Incorrect dose administered,10
ELTROMBOPAG OLAMINE,Product dose omission issue,10
ELTROMBOPAG OLAMINE,Headache,10
ELTROMBOPAG OLAMINE,Asthenia,9
ELTROMBOPAG OLAMINE,Pain,9
ELTROMBOPAG OLAMINE,Influenza,8
ELTROMBOPAG OLAMINE,Anxiety,8
ELTROMBOPAG OLAMINE,Haemoglobin decreased,8
ELTROMBOPAG OLAMINE,Epistaxis,8
ELTROMBOPAG OLAMINE,Disease recurrence,8
ELTROMBOPAG OLAMINE,Off label use,8
ELTROMBOPAG OLAMINE,Arthralgia,7
ELTROMBOPAG OLAMINE,Fatigue,7
ELTROMBOPAG OLAMINE,Dizziness,7
ELTROMBOPAG OLAMINE,Product supply issue,7
ELTROMBOPAG OLAMINE,Feeling abnormal,6
ELTROMBOPAG OLAMINE,Pain in extremity,6
ELTROMBOPAG OLAMINE,Discouragement,6
ELTROMBOPAG OLAMINE,General physical health deterioration,6
ELTROMBOPAG OLAMINE,Platelet count abnormal,6
ELTROMBOPAG OLAMINE,Haematoma,5
ELTROMBOPAG OLAMINE,Drug ineffective,5
ELTROMBOPAG OLAMINE,Intentional product use issue,4
ELTROMBOPAG OLAMINE,Stress,4
ELTROMBOPAG OLAMINE,Wrong technique in product usage process,4
ELTROMBOPAG OLAMINE,Mouth haemorrhage,4
ELTROMBOPAG OLAMINE,Nausea,4
ELTROMBOPAG OLAMINE,Depressed mood,4
ELTROMBOPAG OLAMINE,Product prescribing error,4
ELTROMBOPAG OLAMINE,Chest pain,4
ELTROMBOPAG OLAMINE,Tachycardia,4
ELTROMBOPAG OLAMINE,Somnolence,4
ELTROMBOPAG OLAMINE,Infection,4
ELTROMBOPAG OLAMINE,Vomiting,4
ELTROMBOPAG OLAMINE,Abdominal discomfort,4
ELTROMBOPAG OLAMINE,Death,4
ELTROMBOPAG OLAMINE,Gingival bleeding,4
ELTROMBOPAG OLAMINE,White blood cell count decreased,3
ELTROMBOPAG OLAMINE,Product availability issue,3
EMEND,Off label use,8
EMEND,Asthenia,7
EMEND,Pyrexia,7
EMEND,Acute generalised exanthematous pustulosis,7
EMEND,Rash,6
EMEND,Dyspnoea,5
EMEND,Diarrhoea,5
EMEND,Nausea,5
EMEND,Thrombocytopenia,5
EMEND,Hepatic cytolysis,5
EMEND,Fatigue,4
EMEND,Gastrointestinal disorder,4
EMEND,Neutropenia,4
EMEND,Death,4
EMEND,Back pain,3
EMEND,Hypoxia,3
EMEND,Cough,3
EMEND,Atelectasis,3
EMEND,Anaemia,3
EMEND,Tumour lysis syndrome,3
EMEND,Neuralgia,3
EMEND,Cataract,3
EMEND,Arthralgia,3
EMEND,Glaucoma,3
EMEND,Oedema peripheral,3
EMEND,Acute kidney injury,3
EMEND,Bronchitis,3
EMEND,Richter's syndrome,3
EMEND,Lung opacity,3
EMEND,Alopecia,2
EMEND,Infusion related reaction,2
EMEND,Night sweats,2
EMEND,Pruritus,2
EMEND,Dry mouth,2
EMEND,Computerised tomogram thorax,2
EMEND,Computerised tomogram thorax abnormal,2
EMEND,Leukopenia,2
EMEND,Mucormycosis,2
EMEND,Pulmonary mucormycosis,2
EMEND,Skin lesion,2
EMEND,Optic nerve cupping,2
EMEND,Rhinovirus infection,2
EMEND,Facial paralysis,2
EMEND,Hyperphosphataemia,2
EMEND,Sciatica,2
EMEND,Escherichia infection,2
EMEND,Aspergillus infection,2
EMEND,Blood lactate dehydrogenase increased,2
EMEND,Lymphopenia,2
EMEND,Aplasia pure red cell,2
EMPAGLIFLOZIN,Diarrhoea,10
EMPAGLIFLOZIN,Vomiting,7
EMPAGLIFLOZIN,Off label use,6
EMPAGLIFLOZIN,Intentional product use issue,6
EMPAGLIFLOZIN,Headache,6
EMPAGLIFLOZIN,Dizziness,6
EMPAGLIFLOZIN,Ventricular tachycardia,6
EMPAGLIFLOZIN,Pyrexia,5
EMPAGLIFLOZIN,Hypotension,5
EMPAGLIFLOZIN,COVID-19,5
EMPAGLIFLOZIN,Dry skin,5
EMPAGLIFLOZIN,Nausea,5
EMPAGLIFLOZIN,Fatigue,5
EMPAGLIFLOZIN,Weight decreased,4
EMPAGLIFLOZIN,Back pain,4
EMPAGLIFLOZIN,Cognitive disorder,4
EMPAGLIFLOZIN,Coronary artery disease,4
EMPAGLIFLOZIN,Atrial fibrillation,4
EMPAGLIFLOZIN,Tachycardia,4
EMPAGLIFLOZIN,Dehydration,4
EMPAGLIFLOZIN,Palpitations,4
EMPAGLIFLOZIN,Abdominal discomfort,4
EMPAGLIFLOZIN,Product use in unapproved indication,4
EMPAGLIFLOZIN,Tinnitus,4
EMPAGLIFLOZIN,Migraine,4
EMPAGLIFLOZIN,Pain,4
EMPAGLIFLOZIN,Cardiac failure,4
EMPAGLIFLOZIN,Renal impairment,4
EMPAGLIFLOZIN,Blood glucose increased,4
EMPAGLIFLOZIN,Pruritus,4
EMPAGLIFLOZIN,Abdominal pain upper,4
EMPAGLIFLOZIN,Cough,4
EMPAGLIFLOZIN,Drug interaction,3
EMPAGLIFLOZIN,Decreased appetite,3
EMPAGLIFLOZIN,Cerebrovascular accident,3
EMPAGLIFLOZIN,Medication error,3
EMPAGLIFLOZIN,Inappropriate schedule of product administration,3
EMPAGLIFLOZIN,Adverse drug reaction,3
EMPAGLIFLOZIN,Pericarditis,3
EMPAGLIFLOZIN,Hallucination,3
EMPAGLIFLOZIN,Facial pain,3
EMPAGLIFLOZIN,Myocardial infarction,3
EMPAGLIFLOZIN,Dyspnoea,3
EMPAGLIFLOZIN,Chest pain,3
EMPAGLIFLOZIN,Palmoplantar keratoderma,3
EMPAGLIFLOZIN,Amnesia,3
EMPAGLIFLOZIN,Anxiety,3
EMPAGLIFLOZIN,Sleep terror,3
EMPAGLIFLOZIN,Rash papular,3
EMPAGLIFLOZIN,Lip swelling,3
ENALAPRIL,Diarrhoea,16
ENALAPRIL,Malaise,11
ENALAPRIL,Fatigue,11
ENALAPRIL,Inappropriate schedule of product administration,10
ENALAPRIL,Dyspnoea,9
ENALAPRIL,Anxiety,8
ENALAPRIL,Pyrexia,8
ENALAPRIL,Asthenia,8
ENALAPRIL,Decreased appetite,8
ENALAPRIL,Off label use,8
ENALAPRIL,Anaemia,8
ENALAPRIL,Death,8
ENALAPRIL,Pain in extremity,7
ENALAPRIL,Abdominal pain,7
ENALAPRIL,Pain,7
ENALAPRIL,Weight increased,7
ENALAPRIL,Product dose omission issue,7
ENALAPRIL,Blood pressure increased,7
ENALAPRIL,Headache,6
ENALAPRIL,Platelet count decreased,6
ENALAPRIL,Seizure,6
ENALAPRIL,Nasopharyngitis,6
ENALAPRIL,Gait disturbance,6
ENALAPRIL,Pneumonia,6
ENALAPRIL,Weight decreased,6
ENALAPRIL,Nausea,6
ENALAPRIL,Hyponatraemia,6
ENALAPRIL,Somnolence,5
ENALAPRIL,Vomiting,5
ENALAPRIL,Condition aggravated,5
ENALAPRIL,Leukopenia,5
ENALAPRIL,Incorrect dose administered,4
ENALAPRIL,Mobility decreased,4
ENALAPRIL,Hypoacusis,4
ENALAPRIL,Tremor,4
ENALAPRIL,Peripheral swelling,4
ENALAPRIL,Syncope,4
ENALAPRIL,Cough,4
ENALAPRIL,Drug ineffective,4
ENALAPRIL,Hypoaesthesia,4
ENALAPRIL,Arthralgia,4
ENALAPRIL,Hypotension,4
ENALAPRIL,Hypertension,4
ENALAPRIL,Dizziness,4
ENALAPRIL,Illness,4
ENALAPRIL,Fall,4
ENALAPRIL,Urinary tract infection,4
ENALAPRIL,Hypokalaemia,4
ENALAPRIL,Stress,4
ENALAPRIL,Acute kidney injury,4
ENALAPRIL MALEATE,Off label use,8
ENALAPRIL MALEATE,Diarrhoea,8
ENALAPRIL MALEATE,Pyrexia,8
ENALAPRIL MALEATE,Vomiting,8
ENALAPRIL MALEATE,Cardiac failure,6
ENALAPRIL MALEATE,Infection,5
ENALAPRIL MALEATE,Product dose omission issue,5
ENALAPRIL MALEATE,Cough,5
ENALAPRIL MALEATE,Hypotension,5
ENALAPRIL MALEATE,Renal impairment,5
ENALAPRIL MALEATE,Thyroiditis,5
ENALAPRIL MALEATE,Headache,4
ENALAPRIL MALEATE,Sinusitis,4
ENALAPRIL MALEATE,Hyponatraemia,4
ENALAPRIL MALEATE,Urinary tract infection,4
ENALAPRIL MALEATE,Dehydration,4
ENALAPRIL MALEATE,Pneumonia,4
ENALAPRIL MALEATE,Circulatory collapse,4
ENALAPRIL MALEATE,Muscle haemorrhage,4
ENALAPRIL MALEATE,Tendon rupture,4
ENALAPRIL MALEATE,Azoospermia,4
ENALAPRIL MALEATE,Seizure,3
ENALAPRIL MALEATE,Hypoaesthesia,3
ENALAPRIL MALEATE,Gastroenteritis,3
ENALAPRIL MALEATE,Pain,3
ENALAPRIL MALEATE,Asthma,3
ENALAPRIL MALEATE,Fatigue,3
ENALAPRIL MALEATE,Sepsis,3
ENALAPRIL MALEATE,Pleural effusion,3
ENALAPRIL MALEATE,Tachypnoea,3
ENALAPRIL MALEATE,Haemorrhage,3
ENALAPRIL MALEATE,Respiratory failure,3
ENALAPRIL MALEATE,Pancreatitis,3
ENALAPRIL MALEATE,Nausea,3
ENALAPRIL MALEATE,Arthralgia,3
ENALAPRIL MALEATE,Product use issue,3
ENALAPRIL MALEATE,Decreased appetite,3
ENALAPRIL MALEATE,Bronchitis,3
ENALAPRIL MALEATE,Chest pain,2
ENALAPRIL MALEATE,Ischaemic stroke,2
ENALAPRIL MALEATE,Herpes zoster,2
ENALAPRIL MALEATE,Injection site erythema,2
ENALAPRIL MALEATE,Eye abrasion,2
ENALAPRIL MALEATE,Upper respiratory tract infection,2
ENALAPRIL MALEATE,Drug ineffective,2
ENALAPRIL MALEATE,Drug hypersensitivity,2
ENALAPRIL MALEATE,Prerenal failure,2
ENALAPRIL MALEATE,Pneumonia viral,2
ENALAPRIL MALEATE,Viral upper respiratory tract infection,2
ENALAPRIL MALEATE,Productive cough,2
ENBREL,Off label use,53
ENBREL,Rash,43
ENBREL,Arthropathy,36
ENBREL,Abdominal discomfort,36
ENBREL,Overdose,33
ENBREL,Lower respiratory tract infection,31
ENBREL,Arthralgia,30
ENBREL,Product dose omission issue,29
ENBREL,Knee arthroplasty,28
ENBREL,Rheumatoid arthritis,27
ENBREL,Drug ineffective,27
ENBREL,Condition aggravated,27
ENBREL,Intentional product misuse,27
ENBREL,Pulmonary pain,24
ENBREL,Drug abuse,24
ENBREL,Inflammation,22
ENBREL,Diarrhoea,22
ENBREL,Obesity,17
ENBREL,Drug intolerance,17
ENBREL,Joint swelling,17
ENBREL,Drug hypersensitivity,17
ENBREL,Hypertension,16
ENBREL,Therapeutic product effect decreased,16
ENBREL,Pain,16
ENBREL,Contraindicated product administered,15
ENBREL,Malaise,15
ENBREL,COVID-19,15
ENBREL,Musculoskeletal stiffness,14
ENBREL,Vomiting,14
ENBREL,Product use issue,14
ENBREL,Dyspnoea,13
ENBREL,Fatigue,13
ENBREL,Headache,13
ENBREL,Dizziness,13
ENBREL,Back pain,13
ENBREL,Peripheral swelling,13
ENBREL,Nausea,13
ENBREL,Lung neoplasm malignant,13
ENBREL,Radiation inflammation,13
ENBREL,Hepatic enzyme increased,12
ENBREL,Synovitis,12
ENBREL,Abdominal pain upper,12
ENBREL,C-reactive protein increased,12
ENBREL,Platelet count decreased,12
ENBREL,Schizophrenia,12
ENBREL,Medication error,11
ENBREL,Psoriatic arthropathy,11
ENBREL,Infection,10
ENBREL,Mobility decreased,10
ENBREL,Abdominal pain,10
ENCORAFENIB,Nausea,6
ENCORAFENIB,Colitis,5
ENCORAFENIB,Myalgia,4
ENCORAFENIB,Lipase increased,4
ENCORAFENIB,Alanine aminotransferase increased,4
ENCORAFENIB,Anaemia,4
ENCORAFENIB,Diarrhoea,4
ENCORAFENIB,Drug-induced liver injury,3
ENCORAFENIB,Fatigue,3
ENCORAFENIB,Aspartate aminotransferase increased,3
ENCORAFENIB,Blood creatine phosphokinase increased,3
ENCORAFENIB,Pyrexia,3
ENCORAFENIB,Vomiting,3
ENCORAFENIB,Hepatic cytolysis,2
ENCORAFENIB,Immune-mediated pancreatitis,2
ENCORAFENIB,Gastroenteritis,2
ENCORAFENIB,Osteoarthritis,2
ENCORAFENIB,Gamma-glutamyltransferase increased,2
ENCORAFENIB,Duodenal ulcer,2
ENCORAFENIB,Second primary malignancy,2
ENCORAFENIB,Renal impairment,2
ENCORAFENIB,Dyspnoea,2
ENCORAFENIB,Ocular retrobulbar haemorrhage,2
ENCORAFENIB,General physical health deterioration,2
ENCORAFENIB,Urinary tract infection,2
ENCORAFENIB,Constipation,2
ENCORAFENIB,Hypokalaemia,2
ENCORAFENIB,Disseminated intravascular coagulation,1
ENCORAFENIB,Haemorrhage intracranial,1
ENCORAFENIB,Confusional state,1
ENCORAFENIB,Hemiparesis,1
ENCORAFENIB,Cerebrovascular accident,1
ENCORAFENIB,Immune-mediated enterocolitis,1
ENCORAFENIB,Autoimmune hepatitis,1
ENCORAFENIB,Blood alkaline phosphatase increased,1
ENCORAFENIB,Gastrointestinal pain,1
ENCORAFENIB,Pharyngitis,1
ENCORAFENIB,Muscle spasms,1
ENCORAFENIB,Neuralgia,1
ENCORAFENIB,Neutrophil count decreased,1
ENCORAFENIB,Pneumothorax,1
ENCORAFENIB,Adrenocorticotropic hormone deficiency,1
ENCORAFENIB,Polyserositis,1
ENCORAFENIB,Basal cell carcinoma,1
ENCORAFENIB,Pain in extremity,1
ENCORAFENIB,Palpitations,1
ENCORAFENIB,Cholestasis,1
ENCORAFENIB,Cellulitis,1
ENCORAFENIB,Lower respiratory tract infection,1
ENCORAFENIB,Pulmonary embolism,1
ENFORTUMAB VEDOTIN,Diarrhoea,16
ENFORTUMAB VEDOTIN,Decreased appetite,15
ENFORTUMAB VEDOTIN,Rash,14
ENFORTUMAB VEDOTIN,Pyrexia,13
ENFORTUMAB VEDOTIN,Inappropriate schedule of product administration,13
ENFORTUMAB VEDOTIN,Nausea,12
ENFORTUMAB VEDOTIN,Pruritus,11
ENFORTUMAB VEDOTIN,Malaise,11
ENFORTUMAB VEDOTIN,Alopecia,10
ENFORTUMAB VEDOTIN,Taste disorder,9
ENFORTUMAB VEDOTIN,Vomiting,9
ENFORTUMAB VEDOTIN,Myelosuppression,7
ENFORTUMAB VEDOTIN,Hepatic function abnormal,5
ENFORTUMAB VEDOTIN,Interstitial lung disease,5
ENFORTUMAB VEDOTIN,Anaemia,5
ENFORTUMAB VEDOTIN,Hyperglycaemia,5
ENFORTUMAB VEDOTIN,Peripheral sensory neuropathy,5
ENFORTUMAB VEDOTIN,Febrile neutropenia,5
ENFORTUMAB VEDOTIN,Vision blurred,5
ENFORTUMAB VEDOTIN,Skin disorder,5
ENFORTUMAB VEDOTIN,Hypoaesthesia,4
ENFORTUMAB VEDOTIN,Constipation,4
ENFORTUMAB VEDOTIN,Neutropenia,4
ENFORTUMAB VEDOTIN,Off label use,4
ENFORTUMAB VEDOTIN,Neutrophil count decreased,4
ENFORTUMAB VEDOTIN,Neuropathy peripheral,4
ENFORTUMAB VEDOTIN,Malignant neoplasm progression,3
ENFORTUMAB VEDOTIN,Pneumonia,3
ENFORTUMAB VEDOTIN,Dizziness,3
ENFORTUMAB VEDOTIN,Delirium,3
ENFORTUMAB VEDOTIN,Leukopenia,3
ENFORTUMAB VEDOTIN,Dehydration,3
ENFORTUMAB VEDOTIN,Liver disorder,3
ENFORTUMAB VEDOTIN,Cataract,3
ENFORTUMAB VEDOTIN,Product use issue,3
ENFORTUMAB VEDOTIN,Pulmonary toxicity,3
ENFORTUMAB VEDOTIN,Abdominal pain,2
ENFORTUMAB VEDOTIN,Pharyngeal inflammation,2
ENFORTUMAB VEDOTIN,Transitional cell carcinoma,2
ENFORTUMAB VEDOTIN,Rash papular,2
ENFORTUMAB VEDOTIN,Thrombocytopenia,2
ENFORTUMAB VEDOTIN,Skin exfoliation,2
ENFORTUMAB VEDOTIN,Pain of skin,2
ENFORTUMAB VEDOTIN,Mucosal inflammation,2
ENFORTUMAB VEDOTIN,Pain in extremity,2
ENFORTUMAB VEDOTIN,Cardiac failure,2
ENFORTUMAB VEDOTIN,Malignant pericardial neoplasm,2
ENFORTUMAB VEDOTIN,Fatigue,2
ENFORTUMAB VEDOTIN,COVID-19,2
ENFORTUMAB VEDOTIN,Hyperkalaemia,2
ENHERTU,Disease progression,29
ENHERTU,Interstitial lung disease,19
ENHERTU,Nausea,14
ENHERTU,Malaise,12
ENHERTU,Anaemia,12
ENHERTU,Diarrhoea,12
ENHERTU,Intentional product use issue,12
ENHERTU,Decreased appetite,11
ENHERTU,Underdose,11
ENHERTU,Vomiting,9
ENHERTU,General physical health deterioration,9
ENHERTU,Neutrophil count decreased,7
ENHERTU,Death,6
ENHERTU,Febrile neutropenia,6
ENHERTU,Thrombocytopenia,6
ENHERTU,Acute kidney injury,6
ENHERTU,Pyrexia,5
ENHERTU,Septic shock,5
ENHERTU,Disseminated intravascular coagulation,5
ENHERTU,Dyspnoea,5
ENHERTU,Off label use,5
ENHERTU,Hyponatraemia,5
ENHERTU,Asthenia,5
ENHERTU,Cough,4
ENHERTU,Lung opacity,4
ENHERTU,Blood lactate dehydrogenase increased,4
ENHERTU,Hepatic function abnormal,4
ENHERTU,Constipation,4
ENHERTU,Somnolence,4
ENHERTU,Fatigue,4
ENHERTU,Blood bilirubin increased,4
ENHERTU,Pneumonia,4
ENHERTU,Hypokalaemia,4
ENHERTU,Sepsis,4
ENHERTU,Neutropenia,4
ENHERTU,Pulmonary toxicity,4
ENHERTU,Platelet count decreased,4
ENHERTU,Stomatitis,3
ENHERTU,Lung disorder,3
ENHERTU,Anxiety,3
ENHERTU,Gamma-glutamyltransferase increased,3
ENHERTU,Neuropathy peripheral,3
ENHERTU,Pleural effusion,3
ENHERTU,Blood alkaline phosphatase increased,3
ENHERTU,COVID-19,3
ENHERTU,Hypotension,3
ENHERTU,Cerebral haemorrhage,3
ENHERTU,Hepatic failure,3
ENHERTU,Pancytopenia,3
ENHERTU,Oedema peripheral,3
ENOXAPARIN,Diarrhoea,12
ENOXAPARIN,Fatigue,10
ENOXAPARIN,Pyrexia,9
ENOXAPARIN,Pneumonia,9
ENOXAPARIN,Nausea,8
ENOXAPARIN,Off label use,8
ENOXAPARIN,Abdominal pain,8
ENOXAPARIN,COVID-19,8
ENOXAPARIN,Vomiting,8
ENOXAPARIN,Febrile neutropenia,8
ENOXAPARIN,Pain,7
ENOXAPARIN,Decreased appetite,7
ENOXAPARIN,Sepsis,6
ENOXAPARIN,Thrombocytopenia,6
ENOXAPARIN,Dyspnoea,5
ENOXAPARIN,Cough,5
ENOXAPARIN,Weight decreased,5
ENOXAPARIN,Death,5
ENOXAPARIN,Asthenia,5
ENOXAPARIN,Neutropenia,5
ENOXAPARIN,Cerebrovascular accident,5
ENOXAPARIN,Hypoxia,4
ENOXAPARIN,Plasma cell myeloma,4
ENOXAPARIN,Acute kidney injury,4
ENOXAPARIN,Septic shock,4
ENOXAPARIN,Urinary tract infection,4
ENOXAPARIN,Tachycardia,4
ENOXAPARIN,Anaemia,4
ENOXAPARIN,Alopecia,4
ENOXAPARIN,Agranulocytosis,4
ENOXAPARIN,Multiple organ dysfunction syndrome,4
ENOXAPARIN,Transaminases increased,4
ENOXAPARIN,Stevens-Johnson syndrome,4
ENOXAPARIN,Anxiety,3
ENOXAPARIN,Renal failure,3
ENOXAPARIN,Constipation,3
ENOXAPARIN,Hypophagia,3
ENOXAPARIN,Abnormal faeces,3
ENOXAPARIN,Weight increased,3
ENOXAPARIN,Malaise,3
ENOXAPARIN,Hereditary angioedema,3
ENOXAPARIN,Hypervolaemia,3
ENOXAPARIN,Neutrophil count decreased,3
ENOXAPARIN,Atrial fibrillation,3
ENOXAPARIN,Cytokine release syndrome,3
ENOXAPARIN,Headache,3
ENOXAPARIN,Gastrointestinal disorder,2
ENOXAPARIN,Emotional distress,2
ENOXAPARIN,Anhedonia,2
ENOXAPARIN,Product dose omission issue,2
ENOXAPARIN SODIUM,Sepsis,11
ENOXAPARIN SODIUM,Fatigue,11
ENOXAPARIN SODIUM,Nausea,11
ENOXAPARIN SODIUM,Pneumonia,11
ENOXAPARIN SODIUM,Dyspnoea,10
ENOXAPARIN SODIUM,Vomiting,10
ENOXAPARIN SODIUM,Tachycardia,9
ENOXAPARIN SODIUM,Pyrexia,9
ENOXAPARIN SODIUM,Headache,9
ENOXAPARIN SODIUM,Infusion related reaction,9
ENOXAPARIN SODIUM,Cerebrovascular accident,8
ENOXAPARIN SODIUM,Off label use,8
ENOXAPARIN SODIUM,Septic shock,8
ENOXAPARIN SODIUM,Neutropenia,8
ENOXAPARIN SODIUM,Fall,8
ENOXAPARIN SODIUM,Arthralgia,8
ENOXAPARIN SODIUM,Pancytopenia,7
ENOXAPARIN SODIUM,Anaemia,7
ENOXAPARIN SODIUM,Haematoma,7
ENOXAPARIN SODIUM,Pain,7
ENOXAPARIN SODIUM,Asthenia,7
ENOXAPARIN SODIUM,Thrombocytopenia,7
ENOXAPARIN SODIUM,Hepatic cytolysis,7
ENOXAPARIN SODIUM,Disease progression,6
ENOXAPARIN SODIUM,Cough,6
ENOXAPARIN SODIUM,General physical health deterioration,6
ENOXAPARIN SODIUM,Febrile neutropenia,6
ENOXAPARIN SODIUM,Agranulocytosis,6
ENOXAPARIN SODIUM,Acute kidney injury,6
ENOXAPARIN SODIUM,Atrial fibrillation,5
ENOXAPARIN SODIUM,Muscle spasticity,5
ENOXAPARIN SODIUM,Dizziness,5
ENOXAPARIN SODIUM,Hepatic steatosis,5
ENOXAPARIN SODIUM,Lung disorder,5
ENOXAPARIN SODIUM,Inflammation,5
ENOXAPARIN SODIUM,Respiratory failure,5
ENOXAPARIN SODIUM,Klebsiella infection,5
ENOXAPARIN SODIUM,Dysphagia,5
ENOXAPARIN SODIUM,Cholestasis,5
ENOXAPARIN SODIUM,Blood creatine phosphokinase increased,4
ENOXAPARIN SODIUM,Heart rate irregular,4
ENOXAPARIN SODIUM,Infection,4
ENOXAPARIN SODIUM,Product use in unapproved indication,4
ENOXAPARIN SODIUM,Platelet count decreased,4
ENOXAPARIN SODIUM,Rash,4
ENOXAPARIN SODIUM,Viral infection,4
ENOXAPARIN SODIUM,Drug abuse,4
ENOXAPARIN SODIUM,Hypochromic anaemia,4
ENOXAPARIN SODIUM,Inguinal hernia,4
ENOXAPARIN SODIUM,Renal cyst,4
ENTECAVIR,Off label use,8
ENTECAVIR,Pyrexia,6
ENTECAVIR,Neutropenia,6
ENTECAVIR,Febrile neutropenia,6
ENTECAVIR,Dyspnoea,5
ENTECAVIR,Pain,4
ENTECAVIR,Hypokalaemia,4
ENTECAVIR,Rash,4
ENTECAVIR,Nausea,4
ENTECAVIR,Platelet count decreased,4
ENTECAVIR,Diarrhoea,4
ENTECAVIR,Emotional distress,3
ENTECAVIR,Anxiety,3
ENTECAVIR,Chronic kidney disease,3
ENTECAVIR,Anhedonia,3
ENTECAVIR,Fatigue,3
ENTECAVIR,Asthenia,3
ENTECAVIR,Pneumonia,3
ENTECAVIR,Malaise,3
ENTECAVIR,Decreased appetite,3
ENTECAVIR,Pain in extremity,3
ENTECAVIR,Pneumocystis jirovecii pneumonia,3
ENTECAVIR,Acute kidney injury,2
ENTECAVIR,Vitamin D deficiency,2
ENTECAVIR,Hyperkalaemia,2
ENTECAVIR,Proteinuria,2
ENTECAVIR,Leukopenia,2
ENTECAVIR,Thrombocytopenia,2
ENTECAVIR,COVID-19,2
ENTECAVIR,Septic shock,2
ENTECAVIR,Pulmonary embolism,2
ENTECAVIR,Pleural effusion,2
ENTECAVIR,Death,2
ENTECAVIR,Hypoaesthesia,2
ENTECAVIR,Hyperglycaemia,2
ENTECAVIR,Pruritus,2
ENTECAVIR,Constipation,2
ENTECAVIR,Dehydration,2
ENTECAVIR,Alopecia,2
ENTECAVIR,Skin exfoliation,2
ENTECAVIR,Peripheral sensory neuropathy,2
ENTECAVIR,Pain of skin,2
ENTECAVIR,Mucosal inflammation,2
ENTECAVIR,Taste disorder,2
ENTECAVIR,Clostridium difficile colitis,2
ENTECAVIR,Colitis ulcerative,2
ENTECAVIR,White blood cell count decreased,2
ENTECAVIR,Ascites,2
ENTECAVIR,Tachycardia,2
ENTECAVIR,Cytokine release syndrome,2
ENTRESTO,Dyspnoea,35
ENTRESTO,Cardiac failure,27
ENTRESTO,Cough,26
ENTRESTO,Fatigue,23
ENTRESTO,Hypotension,23
ENTRESTO,Wrong technique in product usage process,19
ENTRESTO,Dizziness,17
ENTRESTO,Off label use,17
ENTRESTO,Hyperkalaemia,16
ENTRESTO,Acute kidney injury,16
ENTRESTO,Product use in unapproved indication,16
ENTRESTO,Chest discomfort,13
ENTRESTO,Product use issue,13
ENTRESTO,Nausea,12
ENTRESTO,Peripheral swelling,12
ENTRESTO,Inappropriate schedule of product administration,12
ENTRESTO,Dehydration,11
ENTRESTO,Prescribed underdose,11
ENTRESTO,Weight decreased,10
ENTRESTO,Diarrhoea,10
ENTRESTO,Renal failure,10
ENTRESTO,Oedema peripheral,9
ENTRESTO,Productive cough,9
ENTRESTO,Fall,9
ENTRESTO,Blood pressure decreased,9
ENTRESTO,Chest pain,9
ENTRESTO,Asthenia,9
ENTRESTO,Throat clearing,9
ENTRESTO,Back pain,8
ENTRESTO,COVID-19,8
ENTRESTO,Cardiac failure chronic,8
ENTRESTO,Palpitations,8
ENTRESTO,Fluid retention,8
ENTRESTO,Nasopharyngitis,7
ENTRESTO,Pruritus,7
ENTRESTO,Cardiac failure congestive,7
ENTRESTO,Death,7
ENTRESTO,Decreased appetite,7
ENTRESTO,Headache,7
ENTRESTO,Malaise,7
ENTRESTO,Renal impairment,7
ENTRESTO,Arthralgia,7
ENTRESTO,Pyrexia,7
ENTRESTO,Hepatic cytolysis,7
ENTRESTO,Ejection fraction decreased,6
ENTRESTO,Swelling,6
ENTRESTO,Myocardial infarction,6
ENTRESTO,Syncope,6
ENTRESTO,Weight increased,6
ENTRESTO,Insomnia,6
ENTYVIO,Colitis ulcerative,11
ENTYVIO,Therapeutic reaction time decreased,10
ENTYVIO,Pyrexia,6
ENTYVIO,Capillary leak syndrome,6
ENTYVIO,Thrombocytopenia,6
ENTYVIO,Anaemia,6
ENTYVIO,Drug ineffective,5
ENTYVIO,Fatigue,5
ENTYVIO,Off label use,4
ENTYVIO,Colectomy,4
ENTYVIO,Intestinal obstruction,4
ENTYVIO,Haematochezia,4
ENTYVIO,Weight decreased,4
ENTYVIO,Clostridium difficile infection,3
ENTYVIO,Rectal haemorrhage,3
ENTYVIO,Pneumonia,3
ENTYVIO,Weight increased,3
ENTYVIO,Dyspnoea,3
ENTYVIO,Abdominal pain,3
ENTYVIO,Nausea,3
ENTYVIO,Diarrhoea,3
ENTYVIO,Drug level decreased,2
ENTYVIO,Crohn's disease,2
ENTYVIO,Ileal stenosis,2
ENTYVIO,Intestinal stenosis,2
ENTYVIO,Cytomegalovirus enterocolitis,2
ENTYVIO,Injection site pain,2
ENTYVIO,Musculoskeletal pain,2
ENTYVIO,Stoma site pain,2
ENTYVIO,Abdominal distension,2
ENTYVIO,Gastrointestinal stoma output abnormal,2
ENTYVIO,Stoma site haemorrhage,2
ENTYVIO,Catheter site hypoaesthesia,2
ENTYVIO,Stoma complication,2
ENTYVIO,Product dose omission issue,2
ENTYVIO,Rheumatoid arthritis,2
ENTYVIO,Mammoplasty,2
ENTYVIO,Salpingectomy,2
ENTYVIO,Cholecystectomy,2
ENTYVIO,Hypothyroidism,2
ENTYVIO,Small intestinal resection,2
ENTYVIO,Fistula,2
ENTYVIO,Tubulointerstitial nephritis,2
ENTYVIO,Vomiting,2
ENTYVIO,Frequent bowel movements,2
ENTYVIO,Mechanical ileus,2
ENTYVIO,Drug-induced liver injury,2
ENTYVIO,Hepatic cytolysis,2
ENTYVIO,Pain in extremity,2
ENTYVIO,Abdominal discomfort,2
ENZALUTAMIDE,Fatigue,6
ENZALUTAMIDE,Second primary malignancy,6
ENZALUTAMIDE,Product availability issue,3
ENZALUTAMIDE,Back pain,3
ENZALUTAMIDE,Pain in extremity,3
ENZALUTAMIDE,Malignant neoplasm progression,2
ENZALUTAMIDE,Atrial fibrillation,2
ENZALUTAMIDE,Arthritis,2
ENZALUTAMIDE,Nervous system disorder,2
ENZALUTAMIDE,Neuropathy peripheral,2
ENZALUTAMIDE,Acute myocardial infarction,2
ENZALUTAMIDE,Platelet count decreased,2
ENZALUTAMIDE,Pancytopenia,2
ENZALUTAMIDE,Haematuria,2
ENZALUTAMIDE,Off label use,2
ENZALUTAMIDE,Dyspnoea,2
ENZALUTAMIDE,Pulmonary embolism,2
ENZALUTAMIDE,Drug interaction,2
ENZALUTAMIDE,Myelodysplastic syndrome,2
ENZALUTAMIDE,Syncope,2
ENZALUTAMIDE,Liver injury,2
ENZALUTAMIDE,Prostatic specific antigen increased,1
ENZALUTAMIDE,Arthralgia,1
ENZALUTAMIDE,Ankle fracture,1
ENZALUTAMIDE,COVID-19 pneumonia,1
ENZALUTAMIDE,Chest pain,1
ENZALUTAMIDE,Gait inability,1
ENZALUTAMIDE,Drug ineffective,1
ENZALUTAMIDE,Joint swelling,1
ENZALUTAMIDE,Osteoporotic fracture,1
ENZALUTAMIDE,Product dose omission in error,1
ENZALUTAMIDE,Insurance issue,1
ENZALUTAMIDE,Asthenia,1
ENZALUTAMIDE,Hot flush,1
ENZALUTAMIDE,Flatulence,1
ENZALUTAMIDE,Colon cancer metastatic,1
ENZALUTAMIDE,Aspiration,1
ENZALUTAMIDE,Non-small cell lung cancer,1
ENZALUTAMIDE,Osteomyelitis,1
ENZALUTAMIDE,Prostate cancer stage IV,1
ENZALUTAMIDE,Prostate cancer metastatic,1
ENZALUTAMIDE,Dizziness,1
ENZALUTAMIDE,Gait disturbance,1
ENZALUTAMIDE,Anaemia,1
ENZALUTAMIDE,Somnolence,1
ENZALUTAMIDE,Apathy,1
ENZALUTAMIDE,Confusional state,1
ENZALUTAMIDE,Lethargy,1
ENZALUTAMIDE,Encephalitis,1
ENZALUTAMIDE,Subarachnoid haemorrhage,1
EPCORITAMAB,Cytokine release syndrome,15
EPCORITAMAB,Pneumonia,10
EPCORITAMAB,Pyrexia,10
EPCORITAMAB,Febrile neutropenia,7
EPCORITAMAB,Diarrhoea,7
EPCORITAMAB,Thrombocytopenia,6
EPCORITAMAB,Neutropenia,6
EPCORITAMAB,Cellulitis,5
EPCORITAMAB,Sepsis,4
EPCORITAMAB,Rhinovirus infection,4
EPCORITAMAB,Asthenia,4
EPCORITAMAB,Neutropenic infection,3
EPCORITAMAB,COVID-19,3
EPCORITAMAB,Atrial fibrillation,3
EPCORITAMAB,Fatigue,3
EPCORITAMAB,Hypotension,3
EPCORITAMAB,Pneumonitis,3
EPCORITAMAB,Anaemia,3
EPCORITAMAB,Bronchopulmonary aspergillosis,3
EPCORITAMAB,Infusion related reaction,3
EPCORITAMAB,Conjunctivitis,3
EPCORITAMAB,Rash,3
EPCORITAMAB,Pulmonary sepsis,3
EPCORITAMAB,Odynophagia,3
EPCORITAMAB,Renal impairment,3
EPCORITAMAB,Product use issue,2
EPCORITAMAB,Dyspnoea,2
EPCORITAMAB,Gastrointestinal perforation,2
EPCORITAMAB,Back pain,2
EPCORITAMAB,Abdominal pain,2
EPCORITAMAB,Urinary tract infection,2
EPCORITAMAB,Hypoxia,2
EPCORITAMAB,Bacteraemia,2
EPCORITAMAB,Endotracheal intubation,2
EPCORITAMAB,Septic shock,2
EPCORITAMAB,Fungal sepsis,2
EPCORITAMAB,Condition aggravated,2
EPCORITAMAB,Pneumocystis jirovecii pneumonia,2
EPCORITAMAB,Constipation,1
EPCORITAMAB,Oedema peripheral,1
EPCORITAMAB,Haematuria,1
EPCORITAMAB,Urinary retention,1
EPCORITAMAB,Immune effector cell-associated neurotoxicity syndrome,1
EPCORITAMAB,Confusional state,1
EPCORITAMAB,Cytomegalovirus infection reactivation,1
EPCORITAMAB,Tachycardia,1
EPCORITAMAB,Productive cough,1
EPCORITAMAB,Decreased appetite,1
EPCORITAMAB,Pneumonia viral,1
EPCORITAMAB,Sputum discoloured,1
EPIDIOLEX,Seizure,102
EPIDIOLEX,Off label use,33
EPIDIOLEX,Hospitalisation,27
EPIDIOLEX,Product administration interrupted,23
EPIDIOLEX,Product dose omission issue,21
EPIDIOLEX,Death,21
EPIDIOLEX,Diarrhoea,13
EPIDIOLEX,Weight decreased,10
EPIDIOLEX,Product use in unapproved indication,9
EPIDIOLEX,Illness,8
EPIDIOLEX,Fall,8
EPIDIOLEX,COVID-19,7
EPIDIOLEX,Rash,7
EPIDIOLEX,Vomiting,7
EPIDIOLEX,Generalised tonic-clonic seizure,6
EPIDIOLEX,Decreased appetite,6
EPIDIOLEX,Somnolence,5
EPIDIOLEX,Abdominal discomfort,5
EPIDIOLEX,Pyrexia,5
EPIDIOLEX,Drug ineffective,5
EPIDIOLEX,Intentional product use issue,5
EPIDIOLEX,Condition aggravated,5
EPIDIOLEX,Cough,4
EPIDIOLEX,Nasopharyngitis,4
EPIDIOLEX,Prescribed overdose,4
EPIDIOLEX,Emergency care,4
EPIDIOLEX,Product supply issue,4
EPIDIOLEX,Unevaluable event,4
EPIDIOLEX,Epilepsy,4
EPIDIOLEX,Head injury,4
EPIDIOLEX,Drug hypersensitivity,4
EPIDIOLEX,Infection,4
EPIDIOLEX,Fatigue,4
EPIDIOLEX,Weight increased,4
EPIDIOLEX,Nausea,4
EPIDIOLEX,Surgery,4
EPIDIOLEX,Therapy change,4
EPIDIOLEX,Product preparation issue,4
EPIDIOLEX,Aspiration,3
EPIDIOLEX,Dizziness,3
EPIDIOLEX,Accidental overdose,3
EPIDIOLEX,Incorrect dose administered,3
EPIDIOLEX,Musculoskeletal discomfort,3
EPIDIOLEX,Blister,3
EPIDIOLEX,Dyspnoea,3
EPIDIOLEX,Respiratory disorder,3
EPIDIOLEX,Pneumonia,3
EPIDIOLEX,Urinary tract infection,3
EPIDIOLEX,Headache,3
EPIDIOLEX,Anger,3
EPINEPHRINE,Sinusitis,211
EPINEPHRINE,COVID-19,200
EPINEPHRINE,Product dose omission issue,185
EPINEPHRINE,Pneumonia,128
EPINEPHRINE,Headache,119
EPINEPHRINE,Fatigue,118
EPINEPHRINE,Urinary tract infection,109
EPINEPHRINE,Fall,94
EPINEPHRINE,Nausea,88
EPINEPHRINE,Upper respiratory tract infection,88
EPINEPHRINE,Nasopharyngitis,87
EPINEPHRINE,Inappropriate schedule of product administration,84
EPINEPHRINE,Bronchitis,81
EPINEPHRINE,Illness,79
EPINEPHRINE,Malaise,72
EPINEPHRINE,Pain,69
EPINEPHRINE,Infusion related reaction,63
EPINEPHRINE,Infection,62
EPINEPHRINE,Respiratory tract infection,60
EPINEPHRINE,Insurance issue,59
EPINEPHRINE,Influenza,56
EPINEPHRINE,Infusion site pain,53
EPINEPHRINE,Cough,51
EPINEPHRINE,Dyspnoea,51
EPINEPHRINE,Pyrexia,51
EPINEPHRINE,Ear infection,50
EPINEPHRINE,Seasonal allergy,50
EPINEPHRINE,Weight decreased,47
EPINEPHRINE,Asthma,41
EPINEPHRINE,Vomiting,40
EPINEPHRINE,Weight increased,40
EPINEPHRINE,Infusion site extravasation,40
EPINEPHRINE,Infusion site swelling,40
EPINEPHRINE,Back pain,40
EPINEPHRINE,Migraine,40
EPINEPHRINE,Diarrhoea,39
EPINEPHRINE,Viral infection,37
EPINEPHRINE,Rash,34
EPINEPHRINE,Pruritus,34
EPINEPHRINE,Infusion site pruritus,33
EPINEPHRINE,Gastroenteritis viral,33
EPINEPHRINE,Dizziness,33
EPINEPHRINE,Arthralgia,33
EPINEPHRINE,Asthenia,32
EPINEPHRINE,Infusion site erythema,31
EPINEPHRINE,Multiple allergies,31
EPINEPHRINE,Pain in extremity,30
EPINEPHRINE,Blood pressure increased,30
EPINEPHRINE,Cellulitis,29
EPINEPHRINE,Contusion,28
EPIPEN,Fatigue,12
EPIPEN,Headache,11
EPIPEN,COVID-19,10
EPIPEN,Product dose omission issue,10
EPIPEN,Pneumonia,10
EPIPEN,Arthralgia,10
EPIPEN,Sinusitis,9
EPIPEN,Nasopharyngitis,8
EPIPEN,Injection site pain,8
EPIPEN,Pain,8
EPIPEN,Nausea,7
EPIPEN,Dyspnoea,7
EPIPEN,Asthma,7
EPIPEN,Vomiting,7
EPIPEN,Hereditary angioedema,7
EPIPEN,Fall,7
EPIPEN,Product use issue,6
EPIPEN,Memory impairment,6
EPIPEN,Muscle spasms,6
EPIPEN,Pruritus,6
EPIPEN,Weight decreased,5
EPIPEN,Malaise,5
EPIPEN,Pain in extremity,5
EPIPEN,Ear infection,5
EPIPEN,Infusion site pain,5
EPIPEN,Bronchitis,5
EPIPEN,Upper respiratory tract infection,5
EPIPEN,Cough,5
EPIPEN,Vision blurred,4
EPIPEN,Influenza,4
EPIPEN,Drug ineffective,4
EPIPEN,Weight increased,4
EPIPEN,Anxiety,4
EPIPEN,Pyrexia,4
EPIPEN,Hypertension,4
EPIPEN,Swelling,4
EPIPEN,Urticaria,4
EPIPEN,Insurance issue,4
EPIPEN,Inappropriate schedule of product administration,4
EPIPEN,Wrong technique in product usage process,4
EPIPEN,Anaphylactic reaction,3
EPIPEN,Blood pressure increased,3
EPIPEN,Peripheral swelling,3
EPIPEN,Wheezing,3
EPIPEN,Skin burning sensation,3
EPIPEN,Sinus disorder,3
EPIPEN,Oropharyngeal pain,3
EPIPEN,Infusion site scar,3
EPIPEN,Gastrointestinal disorder,3
EPIPEN,Migraine,3
EPIRUBICIN,Myelosuppression,24
EPIRUBICIN,White blood cell count decreased,23
EPIRUBICIN,Agranulocytosis,18
EPIRUBICIN,Vomiting,11
EPIRUBICIN,Nausea,10
EPIRUBICIN,Neutrophil count decreased,8
EPIRUBICIN,Pyrexia,7
EPIRUBICIN,Neutropenia,6
EPIRUBICIN,Pancytopenia,4
EPIRUBICIN,Neutropenic sepsis,4
EPIRUBICIN,Thrombocytopenia,4
EPIRUBICIN,Disturbance in attention,4
EPIRUBICIN,Cognitive disorder,4
EPIRUBICIN,Memory impairment,4
EPIRUBICIN,Ejection fraction decreased,4
EPIRUBICIN,Dilated cardiomyopathy,4
EPIRUBICIN,Discomfort,4
EPIRUBICIN,Hepatic function abnormal,3
EPIRUBICIN,Dysphagia,3
EPIRUBICIN,Cardiac failure,3
EPIRUBICIN,Liver injury,3
EPIRUBICIN,Oedema,3
EPIRUBICIN,Hyponatraemia,3
EPIRUBICIN,Seizure,3
EPIRUBICIN,Acute myeloid leukaemia,2
EPIRUBICIN,Hepatic failure,2
EPIRUBICIN,Leukopenia,2
EPIRUBICIN,Granulocyte count decreased,2
EPIRUBICIN,Pneumonia,2
EPIRUBICIN,Febrile neutropenia,2
EPIRUBICIN,Anaemia,2
EPIRUBICIN,Diarrhoea,2
EPIRUBICIN,Aspartate aminotransferase increased,2
EPIRUBICIN,Alanine aminotransferase increased,2
EPIRUBICIN,Chest discomfort,2
EPIRUBICIN,Haemoglobin decreased,2
EPIRUBICIN,Lymphadenitis,2
EPIRUBICIN,Deep vein thrombosis,2
EPIRUBICIN,Oedematous pancreatitis,2
EPIRUBICIN,Dizziness,2
EPIRUBICIN,Insomnia,2
EPIRUBICIN,Upper gastrointestinal haemorrhage,2
EPIRUBICIN,Left ventricular dysfunction,2
EPIRUBICIN,Electrocardiogram abnormal,2
EPIRUBICIN,Left atrial hypertrophy,2
EPIRUBICIN,Hair texture abnormal,1
EPIRUBICIN,Hair disorder,1
EPIRUBICIN,Alopecia,1
EPIRUBICIN,Hair colour changes,1
EPIRUBICIN,Hypothyroidism,1
EPIRUBICIN HYDROCHLORIDE,White blood cell count decreased,24
EPIRUBICIN HYDROCHLORIDE,Myelosuppression,23
EPIRUBICIN HYDROCHLORIDE,Vomiting,13
EPIRUBICIN HYDROCHLORIDE,Hepatic function abnormal,12
EPIRUBICIN HYDROCHLORIDE,Asthenia,9
EPIRUBICIN HYDROCHLORIDE,Nausea,9
EPIRUBICIN HYDROCHLORIDE,Agranulocytosis,6
EPIRUBICIN HYDROCHLORIDE,Pyrexia,5
EPIRUBICIN HYDROCHLORIDE,Granulocyte count decreased,4
EPIRUBICIN HYDROCHLORIDE,Decreased appetite,4
EPIRUBICIN HYDROCHLORIDE,Febrile neutropenia,3
EPIRUBICIN HYDROCHLORIDE,Neutrophil count decreased,3
EPIRUBICIN HYDROCHLORIDE,Platelet count decreased,3
EPIRUBICIN HYDROCHLORIDE,Abdominal pain,3
EPIRUBICIN HYDROCHLORIDE,Discomfort,3
EPIRUBICIN HYDROCHLORIDE,Dysphagia,3
EPIRUBICIN HYDROCHLORIDE,Drug-induced liver injury,3
EPIRUBICIN HYDROCHLORIDE,Aspartate aminotransferase increased,2
EPIRUBICIN HYDROCHLORIDE,Pancytopenia,2
EPIRUBICIN HYDROCHLORIDE,Diarrhoea,2
EPIRUBICIN HYDROCHLORIDE,Hyperthyroidism,2
EPIRUBICIN HYDROCHLORIDE,Feeding disorder,2
EPIRUBICIN HYDROCHLORIDE,Off label use,2
EPIRUBICIN HYDROCHLORIDE,Depressed level of consciousness,2
EPIRUBICIN HYDROCHLORIDE,Cold sweat,2
EPIRUBICIN HYDROCHLORIDE,Dizziness,2
EPIRUBICIN HYDROCHLORIDE,Fatigue,2
EPIRUBICIN HYDROCHLORIDE,Condition aggravated,2
EPIRUBICIN HYDROCHLORIDE,Hepatic failure,2
EPIRUBICIN HYDROCHLORIDE,Septic shock,2
EPIRUBICIN HYDROCHLORIDE,Febrile bone marrow aplasia,2
EPIRUBICIN HYDROCHLORIDE,Necrotising fasciitis,2
EPIRUBICIN HYDROCHLORIDE,Breast cancer,2
EPIRUBICIN HYDROCHLORIDE,Liver injury,2
EPIRUBICIN HYDROCHLORIDE,Urinary tract infection,2
EPIRUBICIN HYDROCHLORIDE,Anal abscess,1
EPIRUBICIN HYDROCHLORIDE,C-reactive protein increased,1
EPIRUBICIN HYDROCHLORIDE,Maternal exposure during pregnancy,1
EPIRUBICIN HYDROCHLORIDE,Oligohydramnios,1
EPIRUBICIN HYDROCHLORIDE,Contraindicated product administered,1
EPIRUBICIN HYDROCHLORIDE,Abortion induced,1
EPIRUBICIN HYDROCHLORIDE,Neoplasm progression,1
EPIRUBICIN HYDROCHLORIDE,Merycism,1
EPIRUBICIN HYDROCHLORIDE,Dehydration,1
EPIRUBICIN HYDROCHLORIDE,Dyspnoea,1
EPIRUBICIN HYDROCHLORIDE,Hypoacusis,1
EPIRUBICIN HYDROCHLORIDE,Central hypothyroidism,1
EPIRUBICIN HYDROCHLORIDE,Thyroiditis,1
EPIRUBICIN HYDROCHLORIDE,Electrolyte imbalance,1
EPIRUBICIN HYDROCHLORIDE,Speech disorder,1
EPIVIR,Pain,76
EPIVIR,Emotional distress,75
EPIVIR,Anxiety,69
EPIVIR,Anhedonia,68
EPIVIR,Chronic kidney disease,44
EPIVIR,Osteoporosis,34
EPIVIR,Osteopenia,25
EPIVIR,Renal failure,22
EPIVIR,Bone density decreased,20
EPIVIR,Depression,19
EPIVIR,Bone demineralisation,19
EPIVIR,Fatigue,18
EPIVIR,Blood creatinine increased,16
EPIVIR,End stage renal disease,16
EPIVIR,Acute kidney injury,15
EPIVIR,Renal impairment,14
EPIVIR,Asthenia,14
EPIVIR,Economic problem,13
EPIVIR,Gait disturbance,10
EPIVIR,Foot fracture,9
EPIVIR,Decreased activity,9
EPIVIR,Multiple fractures,8
EPIVIR,Back pain,7
EPIVIR,Quality of life decreased,6
EPIVIR,Loss of personal independence in daily activities,6
EPIVIR,Mobility decreased,6
EPIVIR,Renal injury,6
EPIVIR,Proteinuria,6
EPIVIR,Nephropathy,5
EPIVIR,Fanconi syndrome acquired,5
EPIVIR,Bone loss,5
EPIVIR,Skeletal injury,5
EPIVIR,Hip fracture,4
EPIVIR,Wrist fracture,4
EPIVIR,Osteonecrosis,4
EPIVIR,Hyperkalaemia,4
EPIVIR,Anaemia,4
EPIVIR,Hypothyroidism,4
EPIVIR,Nephrolithiasis,3
EPIVIR,Rib fracture,3
EPIVIR,Insomnia,3
EPIVIR,Renal disorder,3
EPIVIR,Hypertension,3
EPIVIR,Vitamin D deficiency,3
EPIVIR,Spinal compression fracture,2
EPIVIR,Glomerular filtration rate decreased,2
EPIVIR,Osteomalacia,2
EPIVIR,General physical health deterioration,2
EPIVIR,Ankle fracture,2
EPIVIR,Weight decreased,2
ERBITUX,White blood cell count decreased,12
ERBITUX,Myelosuppression,9
ERBITUX,Granulocyte count decreased,8
ERBITUX,Neutrophil count decreased,6
ERBITUX,Off label use,4
ERBITUX,Palmar-plantar erythrodysaesthesia syndrome,4
ERBITUX,Dyspnoea,4
ERBITUX,Haemoglobin decreased,4
ERBITUX,Platelet count decreased,4
ERBITUX,Vomiting,4
ERBITUX,Diarrhoea,4
ERBITUX,Serous retinal detachment,3
ERBITUX,Haematotoxicity,3
ERBITUX,Neurotoxicity,3
ERBITUX,Asthenia,3
ERBITUX,Mucosal inflammation,3
ERBITUX,Chest discomfort,3
ERBITUX,Palpitations,3
ERBITUX,Pruritus,3
ERBITUX,Rash,3
ERBITUX,Cardiac arrest,2
ERBITUX,Underdose,2
ERBITUX,Macular oedema,2
ERBITUX,Nausea,2
ERBITUX,Pyrexia,2
ERBITUX,Portal venous gas,2
ERBITUX,Pneumatosis intestinalis,2
ERBITUX,Stomatitis,2
ERBITUX,Hyperthermia,2
ERBITUX,Abdominal pain,2
ERBITUX,Febrile neutropenia,2
ERBITUX,Hyperhidrosis,2
ERBITUX,Chills,2
ERBITUX,Flushing,2
ERBITUX,Heart rate increased,2
ERBITUX,Hypotension,2
ERBITUX,Erythema,2
ERBITUX,Myocardial ischaemia,1
ERBITUX,Hypertension,1
ERBITUX,Tachycardia,1
ERBITUX,Neuropathy peripheral,1
ERBITUX,Inappropriate schedule of product administration,1
ERBITUX,Dysgeusia,1
ERBITUX,Neoplasm progression,1
ERBITUX,Product use issue,1
ERBITUX,Infusion related reaction,1
ERBITUX,Eye symptom,1
ERBITUX,Central serous chorioretinopathy,1
ERBITUX,Blister,1
ERBITUX,Constipation,1
ERGOCALCIFEROL,Off label use,26
ERGOCALCIFEROL,Fatigue,18
ERGOCALCIFEROL,Pain,14
ERGOCALCIFEROL,Hypersensitivity,13
ERGOCALCIFEROL,Diarrhoea,13
ERGOCALCIFEROL,Weight decreased,12
ERGOCALCIFEROL,Rash,11
ERGOCALCIFEROL,Dizziness,11
ERGOCALCIFEROL,Urinary tract infection,11
ERGOCALCIFEROL,Anxiety,11
ERGOCALCIFEROL,Headache,10
ERGOCALCIFEROL,Nausea,10
ERGOCALCIFEROL,COVID-19,10
ERGOCALCIFEROL,Condition aggravated,9
ERGOCALCIFEROL,Product dose omission issue,9
ERGOCALCIFEROL,Dyspnoea,8
ERGOCALCIFEROL,Abdominal pain,8
ERGOCALCIFEROL,Depression,8
ERGOCALCIFEROL,Emotional distress,8
ERGOCALCIFEROL,Anhedonia,8
ERGOCALCIFEROL,Dyspepsia,8
ERGOCALCIFEROL,Abdominal distension,8
ERGOCALCIFEROL,Weight increased,7
ERGOCALCIFEROL,Arthralgia,7
ERGOCALCIFEROL,Multiple fractures,7
ERGOCALCIFEROL,Myalgia,7
ERGOCALCIFEROL,Chronic kidney disease,7
ERGOCALCIFEROL,Joint swelling,6
ERGOCALCIFEROL,Sinusitis,6
ERGOCALCIFEROL,Insomnia,6
ERGOCALCIFEROL,Tachycardia,6
ERGOCALCIFEROL,Drug ineffective,6
ERGOCALCIFEROL,Hepatic cirrhosis,6
ERGOCALCIFEROL,Decreased appetite,6
ERGOCALCIFEROL,Malaise,6
ERGOCALCIFEROL,Vitamin B12 deficiency,6
ERGOCALCIFEROL,Oropharyngeal discomfort,6
ERGOCALCIFEROL,Eructation,6
ERGOCALCIFEROL,Regurgitation,6
ERGOCALCIFEROL,Neck pain,6
ERGOCALCIFEROL,Barrett's oesophagus,6
ERGOCALCIFEROL,Abdominal discomfort,6
ERGOCALCIFEROL,Chest pain,6
ERGOCALCIFEROL,Asthenia,5
ERGOCALCIFEROL,Hypertension,5
ERGOCALCIFEROL,Bronchitis,5
ERGOCALCIFEROL,Peripheral swelling,5
ERGOCALCIFEROL,Viral infection,5
ERGOCALCIFEROL,Vomiting,5
ERGOCALCIFEROL,Hypotension,5
ESCITALOPRAM,Pain,19
ESCITALOPRAM,Nausea,17
ESCITALOPRAM,Anxiety,15
ESCITALOPRAM,Off label use,14
ESCITALOPRAM,Pyrexia,13
ESCITALOPRAM,Dyspnoea,13
ESCITALOPRAM,COVID-19,13
ESCITALOPRAM,Vomiting,12
ESCITALOPRAM,Emotional distress,12
ESCITALOPRAM,Confusional state,12
ESCITALOPRAM,Depression,12
ESCITALOPRAM,Illness,12
ESCITALOPRAM,Pruritus,12
ESCITALOPRAM,Headache,11
ESCITALOPRAM,Medication error,11
ESCITALOPRAM,Fatigue,10
ESCITALOPRAM,Inappropriate schedule of product administration,9
ESCITALOPRAM,Diarrhoea,9
ESCITALOPRAM,Insomnia,9
ESCITALOPRAM,Weight decreased,9
ESCITALOPRAM,Palpitations,9
ESCITALOPRAM,Product dose omission issue,8
ESCITALOPRAM,Chronic kidney disease,8
ESCITALOPRAM,Anhedonia,8
ESCITALOPRAM,Malaise,8
ESCITALOPRAM,Pain in extremity,8
ESCITALOPRAM,Fall,8
ESCITALOPRAM,Constipation,8
ESCITALOPRAM,Gait disturbance,8
ESCITALOPRAM,Dehydration,8
ESCITALOPRAM,Pneumonia,8
ESCITALOPRAM,Rash,8
ESCITALOPRAM,Leukopenia,8
ESCITALOPRAM,Suicidal ideation,8
ESCITALOPRAM,Dizziness,7
ESCITALOPRAM,Abdominal pain,7
ESCITALOPRAM,Back pain,7
ESCITALOPRAM,General physical health deterioration,7
ESCITALOPRAM,Tremor,7
ESCITALOPRAM,Dry mouth,7
ESCITALOPRAM,Somnolence,7
ESCITALOPRAM,Contusion,6
ESCITALOPRAM,Suicide attempt,6
ESCITALOPRAM,Withdrawal syndrome,6
ESCITALOPRAM,Cholestasis,6
ESCITALOPRAM,Toxic skin eruption,6
ESCITALOPRAM,Periorbital inflammation,6
ESCITALOPRAM,Orbital swelling,6
ESCITALOPRAM,Diplopia,6
ESCITALOPRAM,Idiopathic orbital inflammation,6
ESCITALOPRAM OXALATE,Nausea,11
ESCITALOPRAM OXALATE,Asthenia,10
ESCITALOPRAM OXALATE,Fatigue,10
ESCITALOPRAM OXALATE,Tremor,9
ESCITALOPRAM OXALATE,Product dose omission issue,8
ESCITALOPRAM OXALATE,Somnolence,8
ESCITALOPRAM OXALATE,Cognitive disorder,8
ESCITALOPRAM OXALATE,Pneumonia,7
ESCITALOPRAM OXALATE,Apathy,7
ESCITALOPRAM OXALATE,Dizziness,7
ESCITALOPRAM OXALATE,Dyspnoea,6
ESCITALOPRAM OXALATE,Fall,6
ESCITALOPRAM OXALATE,Brain fog,6
ESCITALOPRAM OXALATE,Heart rate increased,6
ESCITALOPRAM OXALATE,Diarrhoea,5
ESCITALOPRAM OXALATE,Pruritus,5
ESCITALOPRAM OXALATE,Malaise,5
ESCITALOPRAM OXALATE,Pain,5
ESCITALOPRAM OXALATE,Dry skin,5
ESCITALOPRAM OXALATE,Restlessness,5
ESCITALOPRAM OXALATE,Oculogyric crisis,5
ESCITALOPRAM OXALATE,Parkinsonism,5
ESCITALOPRAM OXALATE,Anhedonia,5
ESCITALOPRAM OXALATE,Suicidal ideation,5
ESCITALOPRAM OXALATE,Gastrointestinal disorder,5
ESCITALOPRAM OXALATE,Bradyphrenia,5
ESCITALOPRAM OXALATE,Neuroleptic-induced deficit syndrome,5
ESCITALOPRAM OXALATE,"Hallucination, tactile",5
ESCITALOPRAM OXALATE,Confusional state,5
ESCITALOPRAM OXALATE,Akathisia,5
ESCITALOPRAM OXALATE,Emotional disorder,5
ESCITALOPRAM OXALATE,Disturbance in attention,5
ESCITALOPRAM OXALATE,Feeling of despair,5
ESCITALOPRAM OXALATE,Reduced facial expression,5
ESCITALOPRAM OXALATE,Restless legs syndrome,5
ESCITALOPRAM OXALATE,Electric shock sensation,5
ESCITALOPRAM OXALATE,Hypoglycaemia,5
ESCITALOPRAM OXALATE,Respiratory disorder,5
ESCITALOPRAM OXALATE,Bronchitis,4
ESCITALOPRAM OXALATE,Sinusitis,4
ESCITALOPRAM OXALATE,COVID-19,4
ESCITALOPRAM OXALATE,Illness,4
ESCITALOPRAM OXALATE,Back pain,4
ESCITALOPRAM OXALATE,Headache,4
ESCITALOPRAM OXALATE,Discomfort,4
ESCITALOPRAM OXALATE,Muscle haemorrhage,4
ESCITALOPRAM OXALATE,Tendon rupture,4
ESCITALOPRAM OXALATE,Deep vein thrombosis,4
ESCITALOPRAM OXALATE,Respiratory tract infection,3
ESCITALOPRAM OXALATE,Influenza,3
ESOMEPRAZOLE,Fatigue,71
ESOMEPRAZOLE,Off label use,66
ESOMEPRAZOLE,Diarrhoea,64
ESOMEPRAZOLE,Pyrexia,63
ESOMEPRAZOLE,Anxiety,62
ESOMEPRAZOLE,Headache,62
ESOMEPRAZOLE,Pain,61
ESOMEPRAZOLE,Back pain,60
ESOMEPRAZOLE,Malaise,60
ESOMEPRAZOLE,Abdominal pain upper,60
ESOMEPRAZOLE,Nausea,59
ESOMEPRAZOLE,Palpitations,59
ESOMEPRAZOLE,Dyspnoea,59
ESOMEPRAZOLE,Vomiting,58
ESOMEPRAZOLE,COVID-19,58
ESOMEPRAZOLE,Arthralgia,56
ESOMEPRAZOLE,Insomnia,56
ESOMEPRAZOLE,Dehydration,56
ESOMEPRAZOLE,Abdominal discomfort,55
ESOMEPRAZOLE,Ventricular tachycardia,54
ESOMEPRAZOLE,Dizziness,53
ESOMEPRAZOLE,Muscular weakness,53
ESOMEPRAZOLE,Feeling abnormal,53
ESOMEPRAZOLE,Muscle twitching,52
ESOMEPRAZOLE,Hyperhidrosis,52
ESOMEPRAZOLE,Heart rate increased,52
ESOMEPRAZOLE,Tachycardia,51
ESOMEPRAZOLE,Pruritus,51
ESOMEPRAZOLE,Myocardial infarction,50
ESOMEPRAZOLE,Blood glucose increased,50
ESOMEPRAZOLE,Chest pain,50
ESOMEPRAZOLE,Tinnitus,49
ESOMEPRAZOLE,Dry skin,48
ESOMEPRAZOLE,Amnesia,48
ESOMEPRAZOLE,Diplopia,48
ESOMEPRAZOLE,Alopecia,48
ESOMEPRAZOLE,Transient ischaemic attack,48
ESOMEPRAZOLE,Peripheral swelling,48
ESOMEPRAZOLE,Blindness,48
ESOMEPRAZOLE,Angioedema,48
ESOMEPRAZOLE,Lip swelling,48
ESOMEPRAZOLE,Visual impairment,47
ESOMEPRAZOLE,Hallucination,47
ESOMEPRAZOLE,Intentional product misuse,47
ESOMEPRAZOLE,Facial pain,47
ESOMEPRAZOLE,Cardiospasm,47
ESOMEPRAZOLE,Memory impairment,47
ESOMEPRAZOLE,Sleep terror,47
ESOMEPRAZOLE,Tension headache,47
ESOMEPRAZOLE,Migraine,47
ESOMEPRAZOLE MAGNESIUM,Fatigue,57
ESOMEPRAZOLE MAGNESIUM,Diarrhoea,57
ESOMEPRAZOLE MAGNESIUM,Headache,56
ESOMEPRAZOLE MAGNESIUM,Nausea,54
ESOMEPRAZOLE MAGNESIUM,Malaise,53
ESOMEPRAZOLE MAGNESIUM,Dyspnoea,53
ESOMEPRAZOLE MAGNESIUM,Palpitations,52
ESOMEPRAZOLE MAGNESIUM,Abdominal discomfort,51
ESOMEPRAZOLE MAGNESIUM,Back pain,51
ESOMEPRAZOLE MAGNESIUM,Arthralgia,51
ESOMEPRAZOLE MAGNESIUM,Ventricular tachycardia,50
ESOMEPRAZOLE MAGNESIUM,Pain,49
ESOMEPRAZOLE MAGNESIUM,Anxiety,49
ESOMEPRAZOLE MAGNESIUM,Abdominal pain upper,49
ESOMEPRAZOLE MAGNESIUM,Dizziness,48
ESOMEPRAZOLE MAGNESIUM,Pruritus,48
ESOMEPRAZOLE MAGNESIUM,Memory impairment,47
ESOMEPRAZOLE MAGNESIUM,Off label use,47
ESOMEPRAZOLE MAGNESIUM,COVID-19,47
ESOMEPRAZOLE MAGNESIUM,Dry skin,47
ESOMEPRAZOLE MAGNESIUM,Muscular weakness,47
ESOMEPRAZOLE MAGNESIUM,Feeling abnormal,47
ESOMEPRAZOLE MAGNESIUM,Peripheral swelling,47
ESOMEPRAZOLE MAGNESIUM,Pyrexia,46
ESOMEPRAZOLE MAGNESIUM,Visual impairment,46
ESOMEPRAZOLE MAGNESIUM,Insomnia,45
ESOMEPRAZOLE MAGNESIUM,Myocardial infarction,45
ESOMEPRAZOLE MAGNESIUM,Vomiting,45
ESOMEPRAZOLE MAGNESIUM,Disturbance in attention,45
ESOMEPRAZOLE MAGNESIUM,Angioedema,45
ESOMEPRAZOLE MAGNESIUM,Migraine,45
ESOMEPRAZOLE MAGNESIUM,Intentional product misuse,45
ESOMEPRAZOLE MAGNESIUM,Facial pain,45
ESOMEPRAZOLE MAGNESIUM,Amnesia,45
ESOMEPRAZOLE MAGNESIUM,Hallucination,45
ESOMEPRAZOLE MAGNESIUM,Chest pain,45
ESOMEPRAZOLE MAGNESIUM,Subarachnoid haemorrhage,45
ESOMEPRAZOLE MAGNESIUM,Dehydration,45
ESOMEPRAZOLE MAGNESIUM,Lip swelling,45
ESOMEPRAZOLE MAGNESIUM,Anosmia,45
ESOMEPRAZOLE MAGNESIUM,Tachycardia,45
ESOMEPRAZOLE MAGNESIUM,Pericarditis,45
ESOMEPRAZOLE MAGNESIUM,Cardiospasm,45
ESOMEPRAZOLE MAGNESIUM,Atrial tachycardia,45
ESOMEPRAZOLE MAGNESIUM,Heart rate increased,44
ESOMEPRAZOLE MAGNESIUM,Blindness,44
ESOMEPRAZOLE MAGNESIUM,Cognitive disorder,44
ESOMEPRAZOLE MAGNESIUM,Palmoplantar keratoderma,44
ESOMEPRAZOLE MAGNESIUM,Vasculitis,44
ESOMEPRAZOLE MAGNESIUM,Alopecia,44
ESTRADIOL,Nausea,23
ESTRADIOL,Sinusitis,20
ESTRADIOL,COVID-19,19
ESTRADIOL,Headache,18
ESTRADIOL,Fatigue,17
ESTRADIOL,Dizziness,16
ESTRADIOL,Malaise,16
ESTRADIOL,Inappropriate schedule of product administration,14
ESTRADIOL,Off label use,14
ESTRADIOL,Product dose omission issue,14
ESTRADIOL,Pain,14
ESTRADIOL,Back pain,12
ESTRADIOL,Diarrhoea,11
ESTRADIOL,Bronchitis,10
ESTRADIOL,Asthenia,9
ESTRADIOL,Feeling abnormal,9
ESTRADIOL,Urinary tract infection,9
ESTRADIOL,Pneumonia,9
ESTRADIOL,Vomiting,9
ESTRADIOL,Pruritus,9
ESTRADIOL,Drug ineffective,8
ESTRADIOL,Anxiety,8
ESTRADIOL,Cough,8
ESTRADIOL,Arthralgia,8
ESTRADIOL,Rash,8
ESTRADIOL,Illness,7
ESTRADIOL,Depression,7
ESTRADIOL,Fall,7
ESTRADIOL,Respiratory tract infection,7
ESTRADIOL,Pyrexia,7
ESTRADIOL,Alopecia,7
ESTRADIOL,Ear infection,6
ESTRADIOL,Abdominal pain upper,6
ESTRADIOL,Infusion related reaction,6
ESTRADIOL,Nasopharyngitis,6
ESTRADIOL,Weight decreased,6
ESTRADIOL,Upper respiratory tract infection,6
ESTRADIOL,Weight increased,6
ESTRADIOL,Pain in extremity,6
ESTRADIOL,Insomnia,5
ESTRADIOL,Decreased appetite,5
ESTRADIOL,Wrong technique in product usage process,5
ESTRADIOL,Influenza like illness,5
ESTRADIOL,Dyspnoea,5
ESTRADIOL,Seasonal allergy,5
ESTRADIOL,Gait disturbance,5
ESTRADIOL,Muscle spasms,5
ESTRADIOL,Somnolence,5
ESTRADIOL,Chills,5
ESTRADIOL,Hypotension,5
ESTRIOL,Hyperhidrosis,90
ESTRIOL,Headache,90
ESTRIOL,Arthralgia,90
ESTRIOL,COVID-19,90
ESTRIOL,Dyspnoea,89
ESTRIOL,Visual impairment,89
ESTRIOL,Hallucination,89
ESTRIOL,Amnesia,89
ESTRIOL,Feeling abnormal,89
ESTRIOL,Facial pain,89
ESTRIOL,Dry skin,89
ESTRIOL,Dehydration,89
ESTRIOL,Tachycardia,89
ESTRIOL,Anxiety,89
ESTRIOL,Fatigue,89
ESTRIOL,Chest pain,89
ESTRIOL,Palpitations,89
ESTRIOL,Cardiospasm,89
ESTRIOL,Diarrhoea,89
ESTRIOL,Angioedema,89
ESTRIOL,Muscular weakness,89
ESTRIOL,Malaise,89
ESTRIOL,Abdominal discomfort,89
ESTRIOL,Subarachnoid haemorrhage,89
ESTRIOL,Lip swelling,89
ESTRIOL,Pruritus,89
ESTRIOL,Disturbance in attention,89
ESTRIOL,Anosmia,89
ESTRIOL,Atrial tachycardia,89
ESTRIOL,Pericarditis,89
ESTRIOL,Intentional product misuse,88
ESTRIOL,Myocardial infarction,88
ESTRIOL,Nausea,88
ESTRIOL,Dizziness,88
ESTRIOL,Insomnia,88
ESTRIOL,Diplopia,88
ESTRIOL,Pain,88
ESTRIOL,Alopecia,88
ESTRIOL,Transient ischaemic attack,88
ESTRIOL,Peripheral swelling,88
ESTRIOL,Memory impairment,88
ESTRIOL,Sleep terror,88
ESTRIOL,Vomiting,88
ESTRIOL,Tension headache,88
ESTRIOL,Blindness,88
ESTRIOL,Migraine,88
ESTRIOL,Pyrexia,88
ESTRIOL,Vasculitis,88
ESTRIOL,Pruritus genital,88
ESTRIOL,Cognitive disorder,88
ETOPOSIDE,Anaemia,39
ETOPOSIDE,Death,36
ETOPOSIDE,Nausea,34
ETOPOSIDE,Off label use,31
ETOPOSIDE,Fatigue,30
ETOPOSIDE,Diarrhoea,30
ETOPOSIDE,Pancytopenia,29
ETOPOSIDE,Vomiting,27
ETOPOSIDE,Pyrexia,27
ETOPOSIDE,Dyspnoea,25
ETOPOSIDE,Thrombocytopenia,25
ETOPOSIDE,Platelet count decreased,23
ETOPOSIDE,White blood cell count decreased,23
ETOPOSIDE,Neutropenic sepsis,22
ETOPOSIDE,Neutrophil count decreased,22
ETOPOSIDE,Febrile neutropenia,21
ETOPOSIDE,Mucosal inflammation,20
ETOPOSIDE,Decreased appetite,20
ETOPOSIDE,Pneumonia,19
ETOPOSIDE,Neutropenia,17
ETOPOSIDE,Dysphagia,16
ETOPOSIDE,Constipation,16
ETOPOSIDE,Disease progression,15
ETOPOSIDE,Headache,15
ETOPOSIDE,Myelosuppression,15
ETOPOSIDE,Hypokalaemia,14
ETOPOSIDE,Asthenia,13
ETOPOSIDE,Haemoglobin decreased,12
ETOPOSIDE,Malignant neoplasm progression,12
ETOPOSIDE,Respiratory failure,12
ETOPOSIDE,Hypothyroidism,12
ETOPOSIDE,Cough,11
ETOPOSIDE,Hypomagnesaemia,11
ETOPOSIDE,Abdominal distension,11
ETOPOSIDE,Bone pain,10
ETOPOSIDE,Candida infection,10
ETOPOSIDE,Lower respiratory tract infection,9
ETOPOSIDE,Balance disorder,9
ETOPOSIDE,Product use in unapproved indication,9
ETOPOSIDE,Neuropathy peripheral,8
ETOPOSIDE,Pain in extremity,8
ETOPOSIDE,Cytokine release syndrome,8
ETOPOSIDE,Myalgia,8
ETOPOSIDE,Arthralgia,8
ETOPOSIDE,Anaphylactic reaction,8
ETOPOSIDE,Back pain,8
ETOPOSIDE,Gait disturbance,8
ETOPOSIDE,Dehydration,8
ETOPOSIDE,Mouth ulceration,8
ETOPOSIDE,Depression,8
EUTHYROX,Diarrhoea,8
EUTHYROX,Palpitations,8
EUTHYROX,Pyrexia,7
EUTHYROX,Periorbital inflammation,6
EUTHYROX,Orbital swelling,6
EUTHYROX,Diplopia,6
EUTHYROX,Idiopathic orbital inflammation,6
EUTHYROX,Periorbital swelling,6
EUTHYROX,Headache,5
EUTHYROX,Off label use,5
EUTHYROX,Rash,5
EUTHYROX,Arthralgia,5
EUTHYROX,Malaise,4
EUTHYROX,Urticaria,4
EUTHYROX,Fatigue,4
EUTHYROX,Pain,3
EUTHYROX,Vomiting,3
EUTHYROX,Muscle spasms,3
EUTHYROX,Blood lactate dehydrogenase increased,3
EUTHYROX,Cytokine release syndrome,3
EUTHYROX,Nasopharyngitis,3
EUTHYROX,Dyspnoea,3
EUTHYROX,Weight decreased,3
EUTHYROX,Fall,3
EUTHYROX,Abdominal pain,3
EUTHYROX,Atrial fibrillation,3
EUTHYROX,Product dose omission issue,3
EUTHYROX,Paronychia,3
EUTHYROX,General physical health deterioration,3
EUTHYROX,Anaemia,3
EUTHYROX,Maternal exposure during pregnancy,3
EUTHYROX,Hypothyroidism,3
EUTHYROX,Depressed mood,3
EUTHYROX,Pulmonary fibrosis,3
EUTHYROX,Febrile neutropenia,3
EUTHYROX,Anxiety,3
EUTHYROX,Stress,3
EUTHYROX,Neutropenia,3
EUTHYROX,Gait inability,2
EUTHYROX,Dizziness,2
EUTHYROX,Nausea,2
EUTHYROX,Thyroid cancer,2
EUTHYROX,Oedema peripheral,2
EUTHYROX,Alopecia,2
EUTHYROX,Lymphadenopathy,2
EUTHYROX,COVID-19,2
EUTHYROX,Swelling face,2
EUTHYROX,Chills,2
EUTHYROX,Cerebrovascular accident,2
EUTHYROX,Platelet count decreased,2
EXEMESTANE,Diarrhoea,20
EXEMESTANE,Alopecia,15
EXEMESTANE,Fatigue,15
EXEMESTANE,Hot flush,15
EXEMESTANE,Gastrooesophageal reflux disease,15
EXEMESTANE,Anaemia,15
EXEMESTANE,Ejection fraction decreased,13
EXEMESTANE,Mucosal inflammation,13
EXEMESTANE,Rash,13
EXEMESTANE,Gingival swelling,12
EXEMESTANE,Influenza like illness,12
EXEMESTANE,Osteonecrosis of jaw,12
EXEMESTANE,Lymphoedema,12
EXEMESTANE,Epistaxis,12
EXEMESTANE,Vascular device infection,11
EXEMESTANE,Sepsis,9
EXEMESTANE,White blood cell count decreased,8
EXEMESTANE,Device related infection,8
EXEMESTANE,Off label use,8
EXEMESTANE,Nausea,5
EXEMESTANE,Neutropenia,5
EXEMESTANE,Pain in extremity,5
EXEMESTANE,Malaise,5
EXEMESTANE,Hypoaesthesia,5
EXEMESTANE,Pyrexia,4
EXEMESTANE,Asthenia,4
EXEMESTANE,Arthralgia,4
EXEMESTANE,Gait disturbance,4
EXEMESTANE,Vomiting,4
EXEMESTANE,Stomatitis,4
EXEMESTANE,Neutropenic sepsis,4
EXEMESTANE,Oedema peripheral,3
EXEMESTANE,Insomnia,3
EXEMESTANE,Dry skin,3
EXEMESTANE,COVID-19,3
EXEMESTANE,Neutrophil count decreased,3
EXEMESTANE,Feeling abnormal,3
EXEMESTANE,Abdominal pain upper,3
EXEMESTANE,Dizziness,3
EXEMESTANE,Headache,3
EXEMESTANE,Cough,3
EXEMESTANE,Myelosuppression,3
EXEMESTANE,Diverticulitis,2
EXEMESTANE,Glossitis,2
EXEMESTANE,Thrombosis,2
EXEMESTANE,Nail infection,2
EXEMESTANE,Memory impairment,2
EXEMESTANE,Pain,2
EXEMESTANE,Myalgia,2
EXEMESTANE,Visual impairment,2
EZETIMIBE,Off label use,42
EZETIMIBE,Rash,37
EZETIMIBE,Product dose omission issue,30
EZETIMIBE,Diarrhoea,28
EZETIMIBE,Abdominal discomfort,27
EZETIMIBE,COVID-19,27
EZETIMIBE,Nausea,27
EZETIMIBE,Vomiting,26
EZETIMIBE,Asthenia,24
EZETIMIBE,Intentional product misuse,24
EZETIMIBE,Pulmonary pain,24
EZETIMIBE,Arthropathy,24
EZETIMIBE,Lower respiratory tract infection,24
EZETIMIBE,Overdose,24
EZETIMIBE,Drug abuse,24
EZETIMIBE,Fatigue,22
EZETIMIBE,Knee arthroplasty,22
EZETIMIBE,Headache,22
EZETIMIBE,Myalgia,21
EZETIMIBE,Dyspnoea,19
EZETIMIBE,Condition aggravated,18
EZETIMIBE,Pain,17
EZETIMIBE,Malaise,17
EZETIMIBE,Hypoaesthesia,16
EZETIMIBE,Dizziness,16
EZETIMIBE,Inflammation,16
EZETIMIBE,Arthralgia,15
EZETIMIBE,Vertigo,15
EZETIMIBE,Anxiety,14
EZETIMIBE,Blood pressure increased,14
EZETIMIBE,Lung neoplasm malignant,14
EZETIMIBE,Back pain,13
EZETIMIBE,Radiation inflammation,13
EZETIMIBE,Coronary artery disease,12
EZETIMIBE,Schizophrenia,12
EZETIMIBE,Obesity,11
EZETIMIBE,Pyrexia,11
EZETIMIBE,Amyloid arthropathy,10
EZETIMIBE,Gait disturbance,10
EZETIMIBE,Myocardial infarction,9
EZETIMIBE,Drug ineffective,9
EZETIMIBE,Pruritus,9
EZETIMIBE,Oedema,9
EZETIMIBE,Drug intolerance,9
EZETIMIBE,Hyperhidrosis,9
EZETIMIBE,Hypertension,9
EZETIMIBE,Weight decreased,9
EZETIMIBE,Abdominal pain upper,9
EZETIMIBE,Fall,8
EZETIMIBE,Migraine,8
FAMOTIDINE,Fatigue,53
FAMOTIDINE,Diarrhoea,45
FAMOTIDINE,Pain,42
FAMOTIDINE,Nausea,41
FAMOTIDINE,COVID-19,38
FAMOTIDINE,Headache,36
FAMOTIDINE,Dyspnoea,35
FAMOTIDINE,Off label use,33
FAMOTIDINE,Pneumonia,32
FAMOTIDINE,Product dose omission issue,28
FAMOTIDINE,Pyrexia,28
FAMOTIDINE,Vomiting,27
FAMOTIDINE,Anaemia,27
FAMOTIDINE,Decreased appetite,26
FAMOTIDINE,Asthenia,24
FAMOTIDINE,Platelet count decreased,24
FAMOTIDINE,Inappropriate schedule of product administration,22
FAMOTIDINE,Sinusitis,21
FAMOTIDINE,Pain in extremity,20
FAMOTIDINE,Fall,19
FAMOTIDINE,Malaise,19
FAMOTIDINE,Dizziness,19
FAMOTIDINE,Illness,18
FAMOTIDINE,Urinary tract infection,18
FAMOTIDINE,Weight decreased,18
FAMOTIDINE,Abdominal pain upper,18
FAMOTIDINE,Acute kidney injury,17
FAMOTIDINE,Anxiety,16
FAMOTIDINE,Back pain,16
FAMOTIDINE,Arthralgia,16
FAMOTIDINE,Renal failure,15
FAMOTIDINE,Hypertension,15
FAMOTIDINE,Abdominal pain,15
FAMOTIDINE,Neuropathy peripheral,15
FAMOTIDINE,Alanine aminotransferase increased,15
FAMOTIDINE,Influenza,14
FAMOTIDINE,Upper respiratory tract infection,14
FAMOTIDINE,Weight increased,14
FAMOTIDINE,Rash,14
FAMOTIDINE,Constipation,14
FAMOTIDINE,Aspartate aminotransferase increased,14
FAMOTIDINE,Blood creatinine increased,13
FAMOTIDINE,Emotional distress,13
FAMOTIDINE,Pruritus,13
FAMOTIDINE,Drug ineffective,13
FAMOTIDINE,Feeling abnormal,12
FAMOTIDINE,Anhedonia,12
FAMOTIDINE,Dehydration,12
FAMOTIDINE,Cough,12
FAMOTIDINE,Product use in unapproved indication,12
FASLODEX,Fatigue,18
FASLODEX,White blood cell count decreased,17
FASLODEX,Alopecia,14
FASLODEX,Neoplasm progression,13
FASLODEX,Cough,11
FASLODEX,Diarrhoea,11
FASLODEX,Pain,8
FASLODEX,Full blood count abnormal,8
FASLODEX,Asthenia,8
FASLODEX,Illness,7
FASLODEX,Malaise,7
FASLODEX,Anaemia,7
FASLODEX,Neutropenia,7
FASLODEX,Headache,7
FASLODEX,Anxiety,7
FASLODEX,Stomatitis,6
FASLODEX,Off label use,6
FASLODEX,Feeling abnormal,6
FASLODEX,General physical health deterioration,6
FASLODEX,Rash,5
FASLODEX,Product dose omission issue,5
FASLODEX,Fall,5
FASLODEX,Decreased appetite,5
FASLODEX,Dyspepsia,5
FASLODEX,Weight decreased,5
FASLODEX,Dyspnoea,5
FASLODEX,Abdominal pain upper,5
FASLODEX,Nausea,5
FASLODEX,Vomiting,4
FASLODEX,Rhinorrhoea,4
FASLODEX,Full blood count decreased,4
FASLODEX,Nasal congestion,4
FASLODEX,Nasopharyngitis,4
FASLODEX,Abdominal pain,4
FASLODEX,Back pain,4
FASLODEX,COVID-19,4
FASLODEX,Interstitial lung disease,4
FASLODEX,Haemoglobin decreased,4
FASLODEX,Insomnia,4
FASLODEX,Pyrexia,3
FASLODEX,Dysphagia,3
FASLODEX,Bronchitis,3
FASLODEX,Red blood cell count decreased,3
FASLODEX,Epistaxis,3
FASLODEX,Dizziness,3
FASLODEX,Aspartate aminotransferase increased,3
FASLODEX,Liver disorder,3
FASLODEX,Alanine aminotransferase increased,3
FASLODEX,Nervousness,3
FASLODEX,Muscle spasms,3
FEBUXOSTAT,Diarrhoea,18
FEBUXOSTAT,Decreased appetite,12
FEBUXOSTAT,Platelet count decreased,11
FEBUXOSTAT,Neutrophil count decreased,11
FEBUXOSTAT,Pyrexia,10
FEBUXOSTAT,Rash,10
FEBUXOSTAT,White blood cell count decreased,9
FEBUXOSTAT,Anaemia,9
FEBUXOSTAT,Myelosuppression,8
FEBUXOSTAT,Febrile neutropenia,8
FEBUXOSTAT,Interstitial lung disease,8
FEBUXOSTAT,Cardiac failure,7
FEBUXOSTAT,Acute myeloid leukaemia,7
FEBUXOSTAT,Acute kidney injury,7
FEBUXOSTAT,Renal impairment,7
FEBUXOSTAT,Hypotension,6
FEBUXOSTAT,Pulmonary arterial hypertension,6
FEBUXOSTAT,Pneumonia,6
FEBUXOSTAT,Disseminated intravascular coagulation,6
FEBUXOSTAT,Drug interaction,6
FEBUXOSTAT,Tumour lysis syndrome,6
FEBUXOSTAT,Nausea,6
FEBUXOSTAT,Dehydration,5
FEBUXOSTAT,Atrial fibrillation,5
FEBUXOSTAT,Condition aggravated,5
FEBUXOSTAT,Neutropenia,5
FEBUXOSTAT,Vomiting,5
FEBUXOSTAT,C-reactive protein increased,4
FEBUXOSTAT,Malaise,4
FEBUXOSTAT,Hypertension,4
FEBUXOSTAT,Hepatic function abnormal,4
FEBUXOSTAT,Fall,4
FEBUXOSTAT,Erythema multiforme,4
FEBUXOSTAT,Weight decreased,4
FEBUXOSTAT,Hypothyroidism,4
FEBUXOSTAT,Adrenal insufficiency,4
FEBUXOSTAT,Oedema peripheral,4
FEBUXOSTAT,Cardiac failure chronic,3
FEBUXOSTAT,Cerebral infarction,3
FEBUXOSTAT,Tachycardia,3
FEBUXOSTAT,Dyspnoea,3
FEBUXOSTAT,Chest pain,3
FEBUXOSTAT,Pneumothorax,3
FEBUXOSTAT,Taste disorder,3
FEBUXOSTAT,Epistaxis,3
FEBUXOSTAT,Liver disorder,3
FEBUXOSTAT,Stevens-Johnson syndrome,3
FEBUXOSTAT,Pulmonary toxicity,3
FEBUXOSTAT,Oedema,3
FEBUXOSTAT,Headache,3
FELODIPINE,Fatigue,99
FELODIPINE,Nausea,96
FELODIPINE,Dyspnoea,93
FELODIPINE,Palpitations,93
FELODIPINE,Malaise,92
FELODIPINE,Insomnia,92
FELODIPINE,Headache,92
FELODIPINE,Heart rate increased,91
FELODIPINE,Pyrexia,91
FELODIPINE,Abdominal discomfort,91
FELODIPINE,Visual impairment,91
FELODIPINE,Amnesia,91
FELODIPINE,Pain,91
FELODIPINE,Anxiety,91
FELODIPINE,Chest pain,91
FELODIPINE,Pruritus,91
FELODIPINE,Dry skin,90
FELODIPINE,Arthralgia,90
FELODIPINE,Peripheral swelling,90
FELODIPINE,COVID-19,90
FELODIPINE,Subarachnoid haemorrhage,90
FELODIPINE,Disturbance in attention,90
FELODIPINE,Hallucination,89
FELODIPINE,Feeling abnormal,89
FELODIPINE,Facial pain,89
FELODIPINE,Dizziness,89
FELODIPINE,Dehydration,89
FELODIPINE,Hyperhidrosis,89
FELODIPINE,Tachycardia,89
FELODIPINE,Cardiospasm,89
FELODIPINE,Tinnitus,89
FELODIPINE,Memory impairment,89
FELODIPINE,Vomiting,89
FELODIPINE,Migraine,89
FELODIPINE,Diarrhoea,89
FELODIPINE,Angioedema,89
FELODIPINE,Muscular weakness,89
FELODIPINE,Blood glucose increased,89
FELODIPINE,Lip swelling,89
FELODIPINE,Anosmia,89
FELODIPINE,Atrial tachycardia,89
FELODIPINE,Back pain,89
FELODIPINE,Pericarditis,89
FELODIPINE,Intentional product misuse,88
FELODIPINE,Myocardial infarction,88
FELODIPINE,Diplopia,88
FELODIPINE,Alopecia,88
FELODIPINE,Transient ischaemic attack,88
FELODIPINE,Sleep terror,88
FELODIPINE,Tension headache,88
FEMARA,Pain,12
FEMARA,Vomiting,11
FEMARA,Nausea,11
FEMARA,Diarrhoea,10
FEMARA,White blood cell count decreased,10
FEMARA,Weight increased,9
FEMARA,Fatigue,9
FEMARA,Asthenia,8
FEMARA,Headache,8
FEMARA,Haemoglobin decreased,7
FEMARA,Malaise,7
FEMARA,Anaemia,7
FEMARA,Pyrexia,7
FEMARA,Illness,7
FEMARA,Back pain,7
FEMARA,Dyspnoea,6
FEMARA,Arthralgia,6
FEMARA,Decreased appetite,6
FEMARA,Off label use,5
FEMARA,Dry skin,5
FEMARA,Lymphocyte count decreased,5
FEMARA,Cough,5
FEMARA,Neutropenia,5
FEMARA,General physical health deterioration,5
FEMARA,Pulmonary embolism,5
FEMARA,Pneumonia,5
FEMARA,Gait disturbance,5
FEMARA,Anxiety,4
FEMARA,Malignant neoplasm progression,4
FEMARA,Somnolence,4
FEMARA,Breast cancer,4
FEMARA,Platelet count decreased,4
FEMARA,Cellulitis,4
FEMARA,Discouragement,4
FEMARA,Drug ineffective,4
FEMARA,Inflammation,4
FEMARA,Pruritus,4
FEMARA,Rash,4
FEMARA,Decreased immune responsiveness,4
FEMARA,Muscle spasms,4
FEMARA,Neutrophil count decreased,4
FEMARA,Dyspepsia,4
FEMARA,Erythema,4
FEMARA,Urinary tract infection,4
FEMARA,Abdominal pain upper,4
FEMARA,Weight decreased,4
FEMARA,Madarosis,3
FEMARA,Alopecia,3
FEMARA,Pleural effusion,3
FEMARA,Hypotension,3
FENOFIBRATE,Acute kidney injury,20
FENOFIBRATE,Chronic kidney disease,18
FENOFIBRATE,Pain,17
FENOFIBRATE,Anxiety,16
FENOFIBRATE,Asthenia,14
FENOFIBRATE,Emotional distress,13
FENOFIBRATE,Anhedonia,13
FENOFIBRATE,Renal failure,12
FENOFIBRATE,Sinusitis,12
FENOFIBRATE,Pneumonia,11
FENOFIBRATE,Fatigue,11
FENOFIBRATE,COVID-19,11
FENOFIBRATE,Product dose omission issue,11
FENOFIBRATE,Urinary tract infection,11
FENOFIBRATE,Diarrhoea,11
FENOFIBRATE,Nausea,10
FENOFIBRATE,Vomiting,10
FENOFIBRATE,Rhabdomyolysis,9
FENOFIBRATE,Pyrexia,9
FENOFIBRATE,Bronchitis,9
FENOFIBRATE,Hepatic function abnormal,9
FENOFIBRATE,Hepatic cytolysis,8
FENOFIBRATE,Hypokalaemia,7
FENOFIBRATE,Renal impairment,7
FENOFIBRATE,Osteopenia,7
FENOFIBRATE,Syncope,7
FENOFIBRATE,Jaundice,7
FENOFIBRATE,Confusional state,6
FENOFIBRATE,Drug interaction,6
FENOFIBRATE,Blood creatinine increased,6
FENOFIBRATE,Dyskinesia,6
FENOFIBRATE,Upper respiratory tract infection,6
FENOFIBRATE,Fall,6
FENOFIBRATE,Hypotension,6
FENOFIBRATE,Gait disturbance,6
FENOFIBRATE,Atrial fibrillation,6
FENOFIBRATE,Abdominal discomfort,6
FENOFIBRATE,Economic problem,5
FENOFIBRATE,Product use in unapproved indication,5
FENOFIBRATE,Movement disorder,5
FENOFIBRATE,Myelosuppression,5
FENOFIBRATE,Blood creatine phosphokinase increased,5
FENOFIBRATE,Multiple fractures,5
FENOFIBRATE,Back pain,5
FENOFIBRATE,Somnolence,5
FENOFIBRATE,Thrombosis,5
FENOFIBRATE,Cough,5
FENOFIBRATE,Septic shock,5
FENOFIBRATE,Myalgia,5
FENOFIBRATE,Hepatitis cholestatic,5
FENTANYL,Vomiting,25
FENTANYL,Off label use,23
FENTANYL,Diarrhoea,23
FENTANYL,Pain,22
FENTANYL,Malaise,18
FENTANYL,Febrile neutropenia,17
FENTANYL,Nausea,16
FENTANYL,Back pain,15
FENTANYL,Pyrexia,15
FENTANYL,Fatigue,13
FENTANYL,Dehydration,13
FENTANYL,Neutropenia,12
FENTANYL,Body temperature increased,11
FENTANYL,Condition aggravated,11
FENTANYL,Death,11
FENTANYL,Confusional state,10
FENTANYL,General physical health deterioration,10
FENTANYL,Tachycardia,9
FENTANYL,Abdominal pain,9
FENTANYL,Chills,9
FENTANYL,Proctalgia,9
FENTANYL,Accident,9
FENTANYL,Anal inflammation,9
FENTANYL,Haemorrhoids,9
FENTANYL,Crohn's disease,9
FENTANYL,Anaemia,9
FENTANYL,Stevens-Johnson syndrome,9
FENTANYL,Emotional distress,8
FENTANYL,Dyspnoea,8
FENTANYL,Agitation,8
FENTANYL,Headache,7
FENTANYL,Tenderness,7
FENTANYL,Muscular weakness,7
FENTANYL,Pneumonia,7
FENTANYL,Product use in unapproved indication,7
FENTANYL,SARS-CoV-2 test negative,7
FENTANYL,Clostridium difficile infection,7
FENTANYL,Asthenia,7
FENTANYL,Depressed level of consciousness,7
FENTANYL,Hyperglycaemia,7
FENTANYL,Medication error,7
FENTANYL,Blood pressure increased,6
FENTANYL,Fall,6
FENTANYL,COVID-19,6
FENTANYL,Decreased appetite,6
FENTANYL,Sepsis,6
FENTANYL,Systemic infection,6
FENTANYL,Haematochezia,6
FENTANYL,Cachexia,6
FENTANYL,Drug abuse,6
FERROUS SULFATE,Diarrhoea,29
FERROUS SULFATE,Off label use,25
FERROUS SULFATE,Product dose omission issue,23
FERROUS SULFATE,Pain,22
FERROUS SULFATE,Fatigue,22
FERROUS SULFATE,Weight decreased,20
FERROUS SULFATE,Anaemia,18
FERROUS SULFATE,COVID-19,17
FERROUS SULFATE,Urinary tract infection,17
FERROUS SULFATE,Malaise,16
FERROUS SULFATE,Pneumonia,16
FERROUS SULFATE,Acute kidney injury,14
FERROUS SULFATE,Dizziness,13
FERROUS SULFATE,Dyspnoea,12
FERROUS SULFATE,Fall,11
FERROUS SULFATE,Pruritus,11
FERROUS SULFATE,Oedema,11
FERROUS SULFATE,Pyrexia,11
FERROUS SULFATE,Nasopharyngitis,11
FERROUS SULFATE,Headache,10
FERROUS SULFATE,Anxiety,10
FERROUS SULFATE,Chronic kidney disease,10
FERROUS SULFATE,Nausea,10
FERROUS SULFATE,Abdominal pain,10
FERROUS SULFATE,Oropharyngeal discomfort,9
FERROUS SULFATE,Product use issue,9
FERROUS SULFATE,Illness,9
FERROUS SULFATE,Erythema,9
FERROUS SULFATE,Emotional distress,9
FERROUS SULFATE,Atrial fibrillation,9
FERROUS SULFATE,Asthenia,9
FERROUS SULFATE,Vomiting,9
FERROUS SULFATE,Memory impairment,8
FERROUS SULFATE,Skin exfoliation,8
FERROUS SULFATE,Anhedonia,8
FERROUS SULFATE,Renal failure,8
FERROUS SULFATE,Sinusitis,8
FERROUS SULFATE,Hypersensitivity,8
FERROUS SULFATE,Dyspepsia,8
FERROUS SULFATE,Condition aggravated,7
FERROUS SULFATE,Rash,7
FERROUS SULFATE,Arthralgia,7
FERROUS SULFATE,Cough,7
FERROUS SULFATE,Inappropriate schedule of product administration,7
FERROUS SULFATE,Weight increased,7
FERROUS SULFATE,Gait disturbance,7
FERROUS SULFATE,Pain in extremity,6
FERROUS SULFATE,Infection,6
FERROUS SULFATE,Drug reaction with eosinophilia and systemic symptoms,6
FERROUS SULFATE,Agranulocytosis,6
FEXOFENADINE,Fatigue,14
FEXOFENADINE,Pruritus,10
FEXOFENADINE,Pain,9
FEXOFENADINE,Arthralgia,9
FEXOFENADINE,Nausea,9
FEXOFENADINE,Dizziness,8
FEXOFENADINE,Lip swelling,8
FEXOFENADINE,Diarrhoea,7
FEXOFENADINE,Arthritis,7
FEXOFENADINE,Headache,7
FEXOFENADINE,Malaise,7
FEXOFENADINE,Swelling face,7
FEXOFENADINE,Anxiety,6
FEXOFENADINE,Muscle spasms,6
FEXOFENADINE,Pyrexia,5
FEXOFENADINE,Inappropriate schedule of product administration,5
FEXOFENADINE,Myalgia,5
FEXOFENADINE,Pneumonia,4
FEXOFENADINE,Constipation,4
FEXOFENADINE,Pancytopenia,4
FEXOFENADINE,Emotional distress,4
FEXOFENADINE,Anhedonia,4
FEXOFENADINE,Stress,4
FEXOFENADINE,Eating disorder,4
FEXOFENADINE,Cough,4
FEXOFENADINE,Dyspnoea,4
FEXOFENADINE,Decreased appetite,4
FEXOFENADINE,Asthma,3
FEXOFENADINE,Chronic kidney disease,3
FEXOFENADINE,Weight increased,3
FEXOFENADINE,Asthenia,3
FEXOFENADINE,Product use issue,3
FEXOFENADINE,Peripheral swelling,3
FEXOFENADINE,Vomiting,3
FEXOFENADINE,Upper respiratory tract infection,3
FEXOFENADINE,Sinusitis,3
FEXOFENADINE,Feeling abnormal,3
FEXOFENADINE,Rash,3
FEXOFENADINE,Abdominal pain,3
FEXOFENADINE,Drug ineffective,3
FEXOFENADINE,Blood glucose increased,3
FEXOFENADINE,Swelling,3
FEXOFENADINE,Medication error,3
FEXOFENADINE,Neuralgia,3
FEXOFENADINE,Peripheral coldness,3
FEXOFENADINE,Photosensitivity reaction,3
FEXOFENADINE,Disseminated varicella zoster virus infection,2
FEXOFENADINE,Multiple sclerosis relapse,2
FEXOFENADINE,Dermatitis allergic,2
FEXOFENADINE,Migraine with aura,2
FEXOFENADINE HYDROCHLORIDE,Fatigue,8
FEXOFENADINE HYDROCHLORIDE,Rash,6
FEXOFENADINE HYDROCHLORIDE,Nausea,5
FEXOFENADINE HYDROCHLORIDE,Vomiting,5
FEXOFENADINE HYDROCHLORIDE,Oropharyngeal pain,5
FEXOFENADINE HYDROCHLORIDE,Arthralgia,5
FEXOFENADINE HYDROCHLORIDE,Pyrexia,5
FEXOFENADINE HYDROCHLORIDE,Muscular weakness,5
FEXOFENADINE HYDROCHLORIDE,Hypotension,5
FEXOFENADINE HYDROCHLORIDE,Neuralgia,5
FEXOFENADINE HYDROCHLORIDE,COVID-19,4
FEXOFENADINE HYDROCHLORIDE,Pneumonia,4
FEXOFENADINE HYDROCHLORIDE,Drug hypersensitivity,4
FEXOFENADINE HYDROCHLORIDE,Upper respiratory tract infection,4
FEXOFENADINE HYDROCHLORIDE,Pruritus,4
FEXOFENADINE HYDROCHLORIDE,Hallucination,4
FEXOFENADINE HYDROCHLORIDE,Malaise,4
FEXOFENADINE HYDROCHLORIDE,Atrial fibrillation,4
FEXOFENADINE HYDROCHLORIDE,Migraine,4
FEXOFENADINE HYDROCHLORIDE,Myalgia,4
FEXOFENADINE HYDROCHLORIDE,Abdominal pain,4
FEXOFENADINE HYDROCHLORIDE,Hypoaesthesia,4
FEXOFENADINE HYDROCHLORIDE,Tinnitus,4
FEXOFENADINE HYDROCHLORIDE,Nasopharyngitis,3
FEXOFENADINE HYDROCHLORIDE,Gastrointestinal disorder,3
FEXOFENADINE HYDROCHLORIDE,Fall,3
FEXOFENADINE HYDROCHLORIDE,Pain,3
FEXOFENADINE HYDROCHLORIDE,Urinary tract infection,3
FEXOFENADINE HYDROCHLORIDE,Weight decreased,3
FEXOFENADINE HYDROCHLORIDE,Alopecia,3
FEXOFENADINE HYDROCHLORIDE,Hepatic function abnormal,3
FEXOFENADINE HYDROCHLORIDE,Diarrhoea,3
FEXOFENADINE HYDROCHLORIDE,Interstitial lung disease,3
FEXOFENADINE HYDROCHLORIDE,Tendon pain,3
FEXOFENADINE HYDROCHLORIDE,Medication error,3
FEXOFENADINE HYDROCHLORIDE,Hyperventilation,3
FEXOFENADINE HYDROCHLORIDE,Tremor,3
FEXOFENADINE HYDROCHLORIDE,Dyspnoea,3
FEXOFENADINE HYDROCHLORIDE,Apnoea,3
FEXOFENADINE HYDROCHLORIDE,Somnolence,3
FEXOFENADINE HYDROCHLORIDE,Headache,3
FEXOFENADINE HYDROCHLORIDE,Mood swings,3
FEXOFENADINE HYDROCHLORIDE,Respiratory depression,3
FEXOFENADINE HYDROCHLORIDE,Feeling abnormal,3
FEXOFENADINE HYDROCHLORIDE,Neuropsychiatric symptoms,3
FEXOFENADINE HYDROCHLORIDE,Diverticulitis,2
FEXOFENADINE HYDROCHLORIDE,Asthma,2
FEXOFENADINE HYDROCHLORIDE,Scar,2
FEXOFENADINE HYDROCHLORIDE,Renal mass,2
FEXOFENADINE HYDROCHLORIDE,Infusion site pain,2
FILGRASTIM,Pyrexia,33
FILGRASTIM,Anaemia,27
FILGRASTIM,Neutrophil count decreased,21
FILGRASTIM,Febrile neutropenia,21
FILGRASTIM,Fatigue,20
FILGRASTIM,Neutropenia,20
FILGRASTIM,Thrombocytopenia,20
FILGRASTIM,Diarrhoea,19
FILGRASTIM,Vomiting,19
FILGRASTIM,Nausea,19
FILGRASTIM,Pancytopenia,17
FILGRASTIM,Platelet count decreased,16
FILGRASTIM,Pneumonia,16
FILGRASTIM,Off label use,14
FILGRASTIM,Dyspnoea,12
FILGRASTIM,Cytokine release syndrome,12
FILGRASTIM,Abdominal pain,12
FILGRASTIM,Drug reaction with eosinophilia and systemic symptoms,11
FILGRASTIM,Death,11
FILGRASTIM,Pruritus,10
FILGRASTIM,Neuropathy peripheral,10
FILGRASTIM,Decreased appetite,10
FILGRASTIM,Alanine aminotransferase increased,10
FILGRASTIM,Aspartate aminotransferase increased,10
FILGRASTIM,Asthenia,10
FILGRASTIM,Rash,9
FILGRASTIM,Oedema,9
FILGRASTIM,Neurotoxicity,9
FILGRASTIM,White blood cell count decreased,9
FILGRASTIM,Lower respiratory tract infection,9
FILGRASTIM,Cough,8
FILGRASTIM,Disease progression,8
FILGRASTIM,Pain in extremity,8
FILGRASTIM,Sepsis,8
FILGRASTIM,Hypoxia,8
FILGRASTIM,Weight decreased,7
FILGRASTIM,Haemoglobin decreased,7
FILGRASTIM,Cellulitis,7
FILGRASTIM,Neutropenic sepsis,7
FILGRASTIM,Urinary tract infection,7
FILGRASTIM,C-reactive protein increased,7
FILGRASTIM,Malignant neoplasm progression,6
FILGRASTIM,Mucosal inflammation,6
FILGRASTIM,Face oedema,6
FILGRASTIM,Malaise,6
FILGRASTIM,Hypokalaemia,6
FILGRASTIM,Back pain,6
FILGRASTIM,Myalgia,6
FILGRASTIM,Skin exfoliation,5
FILGRASTIM,Erythema,5
FINASTERIDE,Anxiety,28
FINASTERIDE,Erectile dysfunction,20
FINASTERIDE,Fatigue,19
FINASTERIDE,Insomnia,16
FINASTERIDE,Loss of libido,15
FINASTERIDE,Depression,14
FINASTERIDE,Arthralgia,13
FINASTERIDE,Disturbance in attention,12
FINASTERIDE,Pain,11
FINASTERIDE,Anhedonia,11
FINASTERIDE,Dizziness,11
FINASTERIDE,Off label use,11
FINASTERIDE,Asthenia,11
FINASTERIDE,Nausea,10
FINASTERIDE,Genital hypoaesthesia,9
FINASTERIDE,Back pain,9
FINASTERIDE,Myalgia,9
FINASTERIDE,Dry skin,9
FINASTERIDE,Emotional distress,8
FINASTERIDE,Memory impairment,8
FINASTERIDE,Suicidal ideation,8
FINASTERIDE,Amnesia,8
FINASTERIDE,Dyspnoea,8
FINASTERIDE,Bone pain,7
FINASTERIDE,Anaemia,7
FINASTERIDE,Inappropriate schedule of product administration,7
FINASTERIDE,Vision blurred,7
FINASTERIDE,Diarrhoea,7
FINASTERIDE,Aphonia,7
FINASTERIDE,Tremor,7
FINASTERIDE,Hypoaesthesia,7
FINASTERIDE,Chronic kidney disease,6
FINASTERIDE,Headache,6
FINASTERIDE,Vertigo,6
FINASTERIDE,Cognitive disorder,6
FINASTERIDE,Palpitations,6
FINASTERIDE,Rash,6
FINASTERIDE,Product dose omission issue,6
FINASTERIDE,Chest pain,6
FINASTERIDE,Micturition urgency,6
FINASTERIDE,Muscle twitching,6
FINASTERIDE,Head discomfort,6
FINASTERIDE,Misophonia,6
FINASTERIDE,Dark circles under eyes,6
FINASTERIDE,Application site pain,6
FINASTERIDE,Hypertension,6
FINASTERIDE,Bone density decreased,5
FINASTERIDE,Osteoporosis,5
FINASTERIDE,Mobility decreased,5
FINASTERIDE,Fall,5
FINGOLIMOD,Lymphopenia,27
FINGOLIMOD,Malignant melanoma,4
FINGOLIMOD,Gait disturbance,4
FINGOLIMOD,Anxiety,4
FINGOLIMOD,COVID-19,3
FINGOLIMOD,Hepatic lesion,3
FINGOLIMOD,Liposarcoma,3
FINGOLIMOD,Stress,3
FINGOLIMOD,Lymphocyte count decreased,3
FINGOLIMOD,Motor dysfunction,2
FINGOLIMOD,Multiple sclerosis,2
FINGOLIMOD,Gait inability,2
FINGOLIMOD,Lymphoedema,2
FINGOLIMOD,Cough,2
FINGOLIMOD,Aspartate aminotransferase increased,2
FINGOLIMOD,Gamma-glutamyltransferase increased,2
FINGOLIMOD,Alanine aminotransferase increased,2
FINGOLIMOD,Fatigue,2
FINGOLIMOD,Non-small cell lung cancer,2
FINGOLIMOD,Breast cancer,1
FINGOLIMOD,Cervix carcinoma,1
FINGOLIMOD,Transaminases increased,1
FINGOLIMOD,Panic attack,1
FINGOLIMOD,T-lymphocyte count decreased,1
FINGOLIMOD,Blood alkaline phosphatase increased,1
FINGOLIMOD,White blood cell count decreased,1
FINGOLIMOD,Joint swelling,1
FINGOLIMOD,Aphthous ulcer,1
FINGOLIMOD,Blood bilirubin increased,1
FINGOLIMOD,Pollakiuria,1
FINGOLIMOD,Mean cell haemoglobin concentration increased,1
FINGOLIMOD,Urinary tract infection,1
FINGOLIMOD,Intermenstrual bleeding,1
FINGOLIMOD,Herpes zoster,1
FINGOLIMOD,Nasopharyngitis,1
FINGOLIMOD,Polycythaemia vera,1
FINGOLIMOD,Impaired quality of life,1
FINGOLIMOD,Paraesthesia,1
FINGOLIMOD,Pain in extremity,1
FINGOLIMOD,Product substitution issue,1
FINGOLIMOD,Arthralgia,1
FINGOLIMOD,Nausea,1
FINGOLIMOD,Asthenia,1
FINGOLIMOD,Dysgeusia,1
FINGOLIMOD,Incorrect dose administered,1
FINGOLIMOD,Visual impairment,1
FINGOLIMOD,Blindness,1
FINGOLIMOD,Optic neuritis,1
FISH OIL,Product dose omission issue,26
FISH OIL,Fatigue,25
FISH OIL,Sinusitis,23
FISH OIL,Headache,22
FISH OIL,COVID-19,22
FISH OIL,Diarrhoea,20
FISH OIL,Fall,19
FISH OIL,Dyspnoea,18
FISH OIL,Weight increased,16
FISH OIL,Pain,16
FISH OIL,Off label use,15
FISH OIL,Pain in extremity,15
FISH OIL,Pruritus,14
FISH OIL,Arthralgia,14
FISH OIL,Nausea,14
FISH OIL,Rash,13
FISH OIL,Bronchitis,13
FISH OIL,Blood pressure increased,12
FISH OIL,Pneumonia,12
FISH OIL,Urinary tract infection,12
FISH OIL,Nasopharyngitis,11
FISH OIL,Malaise,11
FISH OIL,Anxiety,11
FISH OIL,Drug ineffective,11
FISH OIL,Peripheral swelling,10
FISH OIL,Weight decreased,10
FISH OIL,Gait disturbance,10
FISH OIL,Condition aggravated,10
FISH OIL,Back pain,9
FISH OIL,Cough,9
FISH OIL,Osteoporosis,9
FISH OIL,Vomiting,9
FISH OIL,Dizziness,8
FISH OIL,Insomnia,8
FISH OIL,Inappropriate schedule of product administration,8
FISH OIL,Illness,8
FISH OIL,Upper respiratory tract infection,8
FISH OIL,Rheumatoid arthritis,7
FISH OIL,Infusion related reaction,7
FISH OIL,Joint swelling,7
FISH OIL,Muscular weakness,7
FISH OIL,Infection,7
FISH OIL,Neuropathy peripheral,7
FISH OIL,Constipation,7
FISH OIL,Swelling,6
FISH OIL,Abdominal pain,6
FISH OIL,Stress,6
FISH OIL,Death,6
FISH OIL,Anhedonia,6
FISH OIL,Emotional distress,6
FLOMAX,COVID-19,11
FLOMAX,Dizziness,9
FLOMAX,Pneumonia,7
FLOMAX,Fatigue,7
FLOMAX,Off label use,7
FLOMAX,Urinary tract infection,6
FLOMAX,Pain,5
FLOMAX,Fall,5
FLOMAX,Product dose omission issue,4
FLOMAX,Cystitis,4
FLOMAX,Arthralgia,4
FLOMAX,Death,4
FLOMAX,Dyspnoea,4
FLOMAX,Asthenia,4
FLOMAX,Diarrhoea,4
FLOMAX,Anxiety,3
FLOMAX,Chronic kidney disease,3
FLOMAX,Ear infection,3
FLOMAX,Sinusitis,3
FLOMAX,Weight decreased,3
FLOMAX,Loss of consciousness,3
FLOMAX,Chest discomfort,3
FLOMAX,Feeling abnormal,3
FLOMAX,Confusional state,3
FLOMAX,Nasopharyngitis,3
FLOMAX,Anaemia,3
FLOMAX,Gait disturbance,3
FLOMAX,Abdominal discomfort,3
FLOMAX,Constipation,3
FLOMAX,Tremor,3
FLOMAX,Disease recurrence,3
FLOMAX,Cough,3
FLOMAX,Bronchitis,3
FLOMAX,Depression,2
FLOMAX,Unevaluable event,2
FLOMAX,Nephrolithiasis,2
FLOMAX,Weight increased,2
FLOMAX,COVID-19 pneumonia,2
FLOMAX,Seasonal allergy,2
FLOMAX,Needle issue,2
FLOMAX,Spinal fracture,2
FLOMAX,Illness,2
FLOMAX,Herpes zoster,2
FLOMAX,Small intestinal obstruction,2
FLOMAX,Product leakage,2
FLOMAX,Head injury,2
FLOMAX,Pulmonary oedema,2
FLOMAX,Influenza,2
FLOMAX,Suicidal ideation,2
FLOMAX,Paranoia,2
FLONASE,Product dose omission issue,25
FLONASE,COVID-19,23
FLONASE,Sinusitis,21
FLONASE,Fatigue,19
FLONASE,Pneumonia,18
FLONASE,Upper respiratory tract infection,16
FLONASE,Headache,14
FLONASE,Nausea,12
FLONASE,Malaise,12
FLONASE,Pain,12
FLONASE,Arthralgia,10
FLONASE,Diarrhoea,10
FLONASE,Inappropriate schedule of product administration,10
FLONASE,Dyspnoea,9
FLONASE,Fall,9
FLONASE,Feeling abnormal,9
FLONASE,Urinary tract infection,8
FLONASE,Bronchitis,8
FLONASE,Insurance issue,8
FLONASE,Pain in extremity,8
FLONASE,Rash,7
FLONASE,Dizziness,7
FLONASE,Cough,7
FLONASE,Asthma,7
FLONASE,Asthenia,7
FLONASE,Joint swelling,6
FLONASE,Urticaria,6
FLONASE,Ear infection,6
FLONASE,Anxiety,6
FLONASE,Respiratory tract infection,6
FLONASE,Influenza,6
FLONASE,Pyrexia,6
FLONASE,Migraine,6
FLONASE,Illness,6
FLONASE,Off label use,6
FLONASE,Erythema,5
FLONASE,Weight decreased,5
FLONASE,Seasonal allergy,5
FLONASE,Swelling,5
FLONASE,Back pain,5
FLONASE,Nasopharyngitis,5
FLONASE,Memory impairment,5
FLONASE,Death,4
FLONASE,Vomiting,4
FLONASE,Weight increased,4
FLONASE,Infusion site pruritus,4
FLONASE,Infusion site pain,4
FLONASE,Infusion site erythema,4
FLONASE,Infusion site swelling,4
FLONASE,Blood pressure increased,4
FLONASE ALLERGY RELIEF,Sinusitis,12
FLONASE ALLERGY RELIEF,Illness,8
FLONASE ALLERGY RELIEF,Product dose omission issue,8
FLONASE ALLERGY RELIEF,Headache,7
FLONASE ALLERGY RELIEF,Nausea,7
FLONASE ALLERGY RELIEF,COVID-19,6
FLONASE ALLERGY RELIEF,Nasopharyngitis,6
FLONASE ALLERGY RELIEF,Upper respiratory tract infection,6
FLONASE ALLERGY RELIEF,Asthma,6
FLONASE ALLERGY RELIEF,Pyrexia,5
FLONASE ALLERGY RELIEF,Rash,5
FLONASE ALLERGY RELIEF,Pain,5
FLONASE ALLERGY RELIEF,Pneumonia,5
FLONASE ALLERGY RELIEF,Bronchitis,5
FLONASE ALLERGY RELIEF,Gastroenteritis viral,4
FLONASE ALLERGY RELIEF,Infusion related reaction,4
FLONASE ALLERGY RELIEF,Influenza,4
FLONASE ALLERGY RELIEF,Fatigue,4
FLONASE ALLERGY RELIEF,Pruritus,4
FLONASE ALLERGY RELIEF,Respiratory tract infection,4
FLONASE ALLERGY RELIEF,Arthralgia,4
FLONASE ALLERGY RELIEF,Herpes zoster,3
FLONASE ALLERGY RELIEF,Urinary tract infection,3
FLONASE ALLERGY RELIEF,Syncope,3
FLONASE ALLERGY RELIEF,Cough,3
FLONASE ALLERGY RELIEF,Inappropriate schedule of product administration,3
FLONASE ALLERGY RELIEF,Chest discomfort,3
FLONASE ALLERGY RELIEF,Flank pain,3
FLONASE ALLERGY RELIEF,Injection site pain,3
FLONASE ALLERGY RELIEF,Rhinorrhoea,3
FLONASE ALLERGY RELIEF,Sputum discoloured,3
FLONASE ALLERGY RELIEF,Lower respiratory tract infection,3
FLONASE ALLERGY RELIEF,Constipation,3
FLONASE ALLERGY RELIEF,Dry skin,3
FLONASE ALLERGY RELIEF,Condition aggravated,3
FLONASE ALLERGY RELIEF,Diarrhoea,3
FLONASE ALLERGY RELIEF,Abdominal pain upper,3
FLONASE ALLERGY RELIEF,Injection site pruritus,3
FLONASE ALLERGY RELIEF,Vomiting,3
FLONASE ALLERGY RELIEF,Obstructive sleep apnoea syndrome,2
FLONASE ALLERGY RELIEF,Nephrolithiasis,2
FLONASE ALLERGY RELIEF,Root canal infection,2
FLONASE ALLERGY RELIEF,Allergic respiratory symptom,2
FLONASE ALLERGY RELIEF,Infusion site haemorrhage,2
FLONASE ALLERGY RELIEF,Diverticulitis,2
FLONASE ALLERGY RELIEF,Tooth infection,2
FLONASE ALLERGY RELIEF,Pharyngitis,2
FLONASE ALLERGY RELIEF,Prostate infection,2
FLONASE ALLERGY RELIEF,Prostate cancer,2
FLONASE ALLERGY RELIEF,Fungal infection,2
FLUCONAZOLE,Pain,31
FLUCONAZOLE,Diarrhoea,28
FLUCONAZOLE,Anxiety,26
FLUCONAZOLE,Fatigue,25
FLUCONAZOLE,Nausea,25
FLUCONAZOLE,Headache,24
FLUCONAZOLE,Vomiting,24
FLUCONAZOLE,Emotional distress,21
FLUCONAZOLE,Anaemia,21
FLUCONAZOLE,Product dose omission issue,21
FLUCONAZOLE,Off label use,20
FLUCONAZOLE,Pyrexia,20
FLUCONAZOLE,Dyspnoea,19
FLUCONAZOLE,Anhedonia,19
FLUCONAZOLE,Depression,19
FLUCONAZOLE,Neutrophil count decreased,17
FLUCONAZOLE,Death,16
FLUCONAZOLE,Decreased appetite,15
FLUCONAZOLE,Gait disturbance,15
FLUCONAZOLE,Constipation,15
FLUCONAZOLE,Febrile neutropenia,15
FLUCONAZOLE,Arthralgia,14
FLUCONAZOLE,Rash,14
FLUCONAZOLE,Renal failure,14
FLUCONAZOLE,COVID-19,14
FLUCONAZOLE,Thrombocytopenia,14
FLUCONAZOLE,White blood cell count decreased,13
FLUCONAZOLE,Platelet count decreased,13
FLUCONAZOLE,Weight decreased,13
FLUCONAZOLE,Back pain,13
FLUCONAZOLE,Asthenia,13
FLUCONAZOLE,Dehydration,13
FLUCONAZOLE,Sinusitis,12
FLUCONAZOLE,Chronic kidney disease,12
FLUCONAZOLE,Hypokalaemia,12
FLUCONAZOLE,Dysphagia,12
FLUCONAZOLE,Cytokine release syndrome,12
FLUCONAZOLE,Product use in unapproved indication,11
FLUCONAZOLE,Acute kidney injury,11
FLUCONAZOLE,Malaise,11
FLUCONAZOLE,Pneumonia,11
FLUCONAZOLE,Blood pressure increased,10
FLUCONAZOLE,Fall,10
FLUCONAZOLE,Productive cough,10
FLUCONAZOLE,Neutropenic sepsis,10
FLUCONAZOLE,Osteoporosis,9
FLUCONAZOLE,Bone density decreased,9
FLUCONAZOLE,Drug ineffective,9
FLUCONAZOLE,Infection,9
FLUCONAZOLE,Multiple fractures,9
FLUDARABINE,Cytokine release syndrome,28
FLUDARABINE,Pyrexia,27
FLUDARABINE,Platelet count decreased,11
FLUDARABINE,Febrile neutropenia,11
FLUDARABINE,Myelodysplastic syndrome,9
FLUDARABINE,Hypogammaglobulinaemia,9
FLUDARABINE,Second primary malignancy,8
FLUDARABINE,Sepsis,8
FLUDARABINE,Immune effector cell-associated neurotoxicity syndrome,8
FLUDARABINE,Neutropenia,8
FLUDARABINE,Respiratory failure,7
FLUDARABINE,Acute kidney injury,7
FLUDARABINE,Malignant neoplasm progression,7
FLUDARABINE,Neurotoxicity,6
FLUDARABINE,Neutrophil count decreased,6
FLUDARABINE,Anaemia,6
FLUDARABINE,Pneumonia,5
FLUDARABINE,Pancytopenia,5
FLUDARABINE,Septic shock,5
FLUDARABINE,White blood cell count decreased,5
FLUDARABINE,Hypoxia,5
FLUDARABINE,Tachycardia,5
FLUDARABINE,Haemoglobin decreased,4
FLUDARABINE,Lymphocyte count decreased,4
FLUDARABINE,Hypotension,4
FLUDARABINE,Diffuse large B-cell lymphoma,4
FLUDARABINE,Diffuse large B-cell lymphoma recurrent,4
FLUDARABINE,Dyspnoea,4
FLUDARABINE,Generalised tonic-clonic seizure,3
FLUDARABINE,Bone marrow failure,3
FLUDARABINE,Cardiac failure,3
FLUDARABINE,Thrombocytopenia,3
FLUDARABINE,Confusional state,3
FLUDARABINE,Off label use,3
FLUDARABINE,Plasma cell myeloma,2
FLUDARABINE,Pulmonary oedema,2
FLUDARABINE,Capillary leak syndrome,2
FLUDARABINE,C-reactive protein increased,2
FLUDARABINE,Candida infection,2
FLUDARABINE,Tumour lysis syndrome,2
FLUDARABINE,Acute lymphocytic leukaemia recurrent,2
FLUDARABINE,Blood pressure decreased,2
FLUDARABINE,Acute lymphocytic leukaemia,2
FLUDARABINE,Pericardial effusion,2
FLUDARABINE,Haemophagocytic lymphohistiocytosis,2
FLUDARABINE,Cerebral infarction,2
FLUDARABINE,Nervous system disorder,2
FLUDARABINE,Hepatic enzyme increased,2
FLUDARABINE,Hepatic failure,2
FLUDARABINE,Multiple organ dysfunction syndrome,2
FLUDARABINE PHOSPHATE,Cytokine release syndrome,21
FLUDARABINE PHOSPHATE,Platelet count decreased,13
FLUDARABINE PHOSPHATE,Malignant neoplasm progression,10
FLUDARABINE PHOSPHATE,Pyrexia,9
FLUDARABINE PHOSPHATE,Neutrophil count decreased,8
FLUDARABINE PHOSPHATE,Febrile neutropenia,8
FLUDARABINE PHOSPHATE,White blood cell count decreased,8
FLUDARABINE PHOSPHATE,Sepsis,6
FLUDARABINE PHOSPHATE,Haemoglobin decreased,6
FLUDARABINE PHOSPHATE,Hypogammaglobulinaemia,6
FLUDARABINE PHOSPHATE,Immune effector cell-associated neurotoxicity syndrome,5
FLUDARABINE PHOSPHATE,Diffuse large B-cell lymphoma,5
FLUDARABINE PHOSPHATE,Lymphocyte count decreased,5
FLUDARABINE PHOSPHATE,Hypotension,5
FLUDARABINE PHOSPHATE,Hypoxia,4
FLUDARABINE PHOSPHATE,Neutropenia,4
FLUDARABINE PHOSPHATE,Acute kidney injury,4
FLUDARABINE PHOSPHATE,Small intestinal perforation,4
FLUDARABINE PHOSPHATE,Pulmonary arterial hypertension,4
FLUDARABINE PHOSPHATE,Blood pressure decreased,3
FLUDARABINE PHOSPHATE,Lymphadenopathy,3
FLUDARABINE PHOSPHATE,Pancytopenia,3
FLUDARABINE PHOSPHATE,Bone marrow failure,3
FLUDARABINE PHOSPHATE,Diffuse large B-cell lymphoma recurrent,3
FLUDARABINE PHOSPHATE,Tachycardia,3
FLUDARABINE PHOSPHATE,Thrombocytopenia,3
FLUDARABINE PHOSPHATE,Cardiac arrest,3
FLUDARABINE PHOSPHATE,Diarrhoea,3
FLUDARABINE PHOSPHATE,Herpes zoster reactivation,3
FLUDARABINE PHOSPHATE,Campylobacter infection,3
FLUDARABINE PHOSPHATE,Chills,3
FLUDARABINE PHOSPHATE,Gait disturbance,2
FLUDARABINE PHOSPHATE,Headache,2
FLUDARABINE PHOSPHATE,Diffuse large B-cell lymphoma stage III,2
FLUDARABINE PHOSPHATE,Bacterial infection,2
FLUDARABINE PHOSPHATE,Septic shock,2
FLUDARABINE PHOSPHATE,Haemophagocytic lymphohistiocytosis,2
FLUDARABINE PHOSPHATE,Pleural effusion,2
FLUDARABINE PHOSPHATE,Dysarthria,2
FLUDARABINE PHOSPHATE,Amylase increased,2
FLUDARABINE PHOSPHATE,Hepatic failure,2
FLUDARABINE PHOSPHATE,Hepatotoxicity,2
FLUDARABINE PHOSPHATE,Cellulitis staphylococcal,2
FLUDARABINE PHOSPHATE,Disease progression,2
FLUDARABINE PHOSPHATE,Cellulitis,2
FLUDARABINE PHOSPHATE,Hypervolaemia,2
FLUDARABINE PHOSPHATE,Dyspnoea,2
FLUDARABINE PHOSPHATE,Dizziness,2
FLUDARABINE PHOSPHATE,Cardiac failure,2
FLUDARABINE PHOSPHATE,Respiratory failure,2
FLUOROURACIL,Off label use,46
FLUOROURACIL,Diarrhoea,35
FLUOROURACIL,Neurotoxicity,33
FLUOROURACIL,Asthenia,30
FLUOROURACIL,Neutropenia,29
FLUOROURACIL,Malignant neoplasm progression,29
FLUOROURACIL,General physical health deterioration,24
FLUOROURACIL,Paraesthesia,19
FLUOROURACIL,Nausea,19
FLUOROURACIL,Vomiting,18
FLUOROURACIL,Thrombocytopenia,17
FLUOROURACIL,Acute kidney injury,17
FLUOROURACIL,Dysgeusia,17
FLUOROURACIL,Mucosal inflammation,16
FLUOROURACIL,Febrile neutropenia,15
FLUOROURACIL,Hypokalaemia,15
FLUOROURACIL,Sepsis,14
FLUOROURACIL,Myelosuppression,14
FLUOROURACIL,Anaemia,13
FLUOROURACIL,Hypotension,13
FLUOROURACIL,Pyrexia,12
FLUOROURACIL,Neutrophil count decreased,12
FLUOROURACIL,Decreased appetite,11
FLUOROURACIL,Death,11
FLUOROURACIL,Transient aphasia,10
FLUOROURACIL,Hypoglycaemia,10
FLUOROURACIL,Renal failure,10
FLUOROURACIL,White blood cell count decreased,10
FLUOROURACIL,Rash,9
FLUOROURACIL,Cerebrovascular accident,9
FLUOROURACIL,Muscle spasms,9
FLUOROURACIL,Strabismus,9
FLUOROURACIL,Diplopia,9
FLUOROURACIL,VIth nerve paralysis,9
FLUOROURACIL,Leukopenia,8
FLUOROURACIL,Dyspnoea,8
FLUOROURACIL,Hyponatraemia,8
FLUOROURACIL,Cholestasis,8
FLUOROURACIL,Haematemesis,8
FLUOROURACIL,Melaena,8
FLUOROURACIL,Ischaemic stroke,8
FLUOROURACIL,Pneumonia,7
FLUOROURACIL,Interstitial lung disease,7
FLUOROURACIL,Abdominal pain,7
FLUOROURACIL,Folliculitis,7
FLUOROURACIL,Diarrhoea haemorrhagic,7
FLUOROURACIL,Alopecia,6
FLUOROURACIL,Palmar-plantar erythrodysaesthesia syndrome,6
FLUOROURACIL,Dehydration,6
FLUOROURACIL,Colitis,6
FLUOXETINE,Suicidal ideation,18
FLUOXETINE,Fatigue,13
FLUOXETINE,Suicide attempt,13
FLUOXETINE,Pain,11
FLUOXETINE,Weight increased,10
FLUOXETINE,Headache,9
FLUOXETINE,Medication error,9
FLUOXETINE,Off label use,9
FLUOXETINE,COVID-19,9
FLUOXETINE,Anxiety,8
FLUOXETINE,Asthenia,8
FLUOXETINE,Product dose omission issue,8
FLUOXETINE,Arthralgia,8
FLUOXETINE,Pyrexia,8
FLUOXETINE,Disturbance in attention,8
FLUOXETINE,Tremor,7
FLUOXETINE,Fall,7
FLUOXETINE,Pruritus,7
FLUOXETINE,Pneumonia,7
FLUOXETINE,Urinary tract infection,7
FLUOXETINE,Anhedonia,6
FLUOXETINE,Depression,6
FLUOXETINE,Dizziness,6
FLUOXETINE,Dyspnoea,6
FLUOXETINE,Disturbance in sexual arousal,6
FLUOXETINE,Anorgasmia,6
FLUOXETINE,Feeling of despair,6
FLUOXETINE,Genital hypoaesthesia,6
FLUOXETINE,Somnolence,6
FLUOXETINE,Heart rate increased,6
FLUOXETINE,Confusional state,6
FLUOXETINE,Insomnia,6
FLUOXETINE,Hypoaesthesia,6
FLUOXETINE,Blood pressure increased,5
FLUOXETINE,Depressed mood,5
FLUOXETINE,Nausea,5
FLUOXETINE,Muscular weakness,5
FLUOXETINE,Mobility decreased,5
FLUOXETINE,Cellulitis,5
FLUOXETINE,Thrombocytopenia,5
FLUOXETINE,Constipation,5
FLUOXETINE,Loss of libido,5
FLUOXETINE,Sinusitis,5
FLUOXETINE,Nasopharyngitis,5
FLUOXETINE,Dysgeusia,5
FLUOXETINE,Intentional overdose,5
FLUOXETINE,Musculoskeletal stiffness,4
FLUOXETINE,Inappropriate schedule of product administration,4
FLUOXETINE,Abdominal pain upper,4
FLUOXETINE,Weight decreased,4
FLUOXETINE HYDROCHLORIDE,Fatigue,17
FLUOXETINE HYDROCHLORIDE,Tremor,11
FLUOXETINE HYDROCHLORIDE,Dizziness,9
FLUOXETINE HYDROCHLORIDE,Confusional state,9
FLUOXETINE HYDROCHLORIDE,COVID-19,8
FLUOXETINE HYDROCHLORIDE,Epilepsy,8
FLUOXETINE HYDROCHLORIDE,Hallucination,8
FLUOXETINE HYDROCHLORIDE,Vomiting,7
FLUOXETINE HYDROCHLORIDE,Dyspnoea,7
FLUOXETINE HYDROCHLORIDE,Pain,7
FLUOXETINE HYDROCHLORIDE,Mental disorder,7
FLUOXETINE HYDROCHLORIDE,Depressed mood,7
FLUOXETINE HYDROCHLORIDE,Fear,7
FLUOXETINE HYDROCHLORIDE,Amnesia,7
FLUOXETINE HYDROCHLORIDE,Headache,6
FLUOXETINE HYDROCHLORIDE,Fall,6
FLUOXETINE HYDROCHLORIDE,Somnolence,6
FLUOXETINE HYDROCHLORIDE,Urinary tract infection,6
FLUOXETINE HYDROCHLORIDE,Product dose omission issue,6
FLUOXETINE HYDROCHLORIDE,Sinusitis,6
FLUOXETINE HYDROCHLORIDE,Oropharyngeal pain,6
FLUOXETINE HYDROCHLORIDE,Behaviour disorder,6
FLUOXETINE HYDROCHLORIDE,Diarrhoea,6
FLUOXETINE HYDROCHLORIDE,Disturbance in attention,6
FLUOXETINE HYDROCHLORIDE,Intentional overdose,6
FLUOXETINE HYDROCHLORIDE,Peripheral swelling,5
FLUOXETINE HYDROCHLORIDE,Anxiety,5
FLUOXETINE HYDROCHLORIDE,Nausea,5
FLUOXETINE HYDROCHLORIDE,Contusion,4
FLUOXETINE HYDROCHLORIDE,Heart rate increased,4
FLUOXETINE HYDROCHLORIDE,Rash macular,4
FLUOXETINE HYDROCHLORIDE,Weight increased,4
FLUOXETINE HYDROCHLORIDE,Respiratory tract infection,4
FLUOXETINE HYDROCHLORIDE,Bronchitis,4
FLUOXETINE HYDROCHLORIDE,Pneumonia,4
FLUOXETINE HYDROCHLORIDE,Influenza,4
FLUOXETINE HYDROCHLORIDE,Gastrointestinal disorder,4
FLUOXETINE HYDROCHLORIDE,Condition aggravated,4
FLUOXETINE HYDROCHLORIDE,Suicidal ideation,4
FLUOXETINE HYDROCHLORIDE,Asthenia,4
FLUOXETINE HYDROCHLORIDE,Hypoaesthesia,3
FLUOXETINE HYDROCHLORIDE,Head discomfort,3
FLUOXETINE HYDROCHLORIDE,Pain in extremity,3
FLUOXETINE HYDROCHLORIDE,Infection,3
FLUOXETINE HYDROCHLORIDE,Respiratory disorder,3
FLUOXETINE HYDROCHLORIDE,Pneumonia aspiration,3
FLUOXETINE HYDROCHLORIDE,Abdominal pain,3
FLUOXETINE HYDROCHLORIDE,Illness,3
FLUOXETINE HYDROCHLORIDE,Off label use,3
FLUOXETINE HYDROCHLORIDE,Cognitive disorder,3
FLUTICASONE,Pain,25
FLUTICASONE,Nausea,23
FLUTICASONE,COVID-19,22
FLUTICASONE,Fatigue,21
FLUTICASONE,Sinusitis,20
FLUTICASONE,Vomiting,18
FLUTICASONE,Pneumonia,17
FLUTICASONE,Anxiety,17
FLUTICASONE,Emotional distress,16
FLUTICASONE,Anhedonia,16
FLUTICASONE,Product dose omission issue,16
FLUTICASONE,Fall,15
FLUTICASONE,Headache,14
FLUTICASONE,Dyspnoea,14
FLUTICASONE,Off label use,13
FLUTICASONE,Somnolence,13
FLUTICASONE,Bronchitis,13
FLUTICASONE,Drug hypersensitivity,12
FLUTICASONE,Arthralgia,11
FLUTICASONE,Condition aggravated,11
FLUTICASONE,Sepsis,11
FLUTICASONE,Stress,11
FLUTICASONE,Abdominal distension,11
FLUTICASONE,Depression,10
FLUTICASONE,Cough,10
FLUTICASONE,Back pain,10
FLUTICASONE,Diarrhoea,10
FLUTICASONE,Abdominal pain,10
FLUTICASONE,Malaise,9
FLUTICASONE,Pruritus,9
FLUTICASONE,Pyrexia,9
FLUTICASONE,Chronic kidney disease,9
FLUTICASONE,Death,9
FLUTICASONE,Osteoporosis,9
FLUTICASONE,Cardiogenic shock,9
FLUTICASONE,Ascites,9
FLUTICASONE,Constipation,9
FLUTICASONE,Asthma,8
FLUTICASONE,Osteopenia,8
FLUTICASONE,Dehydration,8
FLUTICASONE,Urinary tract infection,8
FLUTICASONE,Incorrect route of product administration,8
FLUTICASONE,Multiple organ dysfunction syndrome,8
FLUTICASONE,Dry mouth,8
FLUTICASONE,Influenza,7
FLUTICASONE,Infection,7
FLUTICASONE,Infusion site pain,7
FLUTICASONE,Ear infection,7
FLUTICASONE,Weight decreased,7
FLUTICASONE,Sleep disorder,7
FLUTICASONE PROPIONATE,Sinusitis,44
FLUTICASONE PROPIONATE,COVID-19,35
FLUTICASONE PROPIONATE,Product dose omission issue,29
FLUTICASONE PROPIONATE,Pain,26
FLUTICASONE PROPIONATE,Pneumonia,24
FLUTICASONE PROPIONATE,Nausea,23
FLUTICASONE PROPIONATE,Fall,21
FLUTICASONE PROPIONATE,Bronchitis,21
FLUTICASONE PROPIONATE,Urinary tract infection,19
FLUTICASONE PROPIONATE,Fatigue,19
FLUTICASONE PROPIONATE,Vomiting,17
FLUTICASONE PROPIONATE,Nasopharyngitis,16
FLUTICASONE PROPIONATE,Headache,16
FLUTICASONE PROPIONATE,Upper respiratory tract infection,15
FLUTICASONE PROPIONATE,Rash,14
FLUTICASONE PROPIONATE,Weight decreased,13
FLUTICASONE PROPIONATE,Illness,13
FLUTICASONE PROPIONATE,Influenza,13
FLUTICASONE PROPIONATE,Malaise,13
FLUTICASONE PROPIONATE,Asthma,13
FLUTICASONE PROPIONATE,Inappropriate schedule of product administration,12
FLUTICASONE PROPIONATE,Dyspnoea,12
FLUTICASONE PROPIONATE,Drug hypersensitivity,12
FLUTICASONE PROPIONATE,Pruritus,12
FLUTICASONE PROPIONATE,Cough,12
FLUTICASONE PROPIONATE,Arthralgia,11
FLUTICASONE PROPIONATE,Seasonal allergy,11
FLUTICASONE PROPIONATE,Ear infection,11
FLUTICASONE PROPIONATE,Weight increased,11
FLUTICASONE PROPIONATE,Infusion site pruritus,10
FLUTICASONE PROPIONATE,Pyrexia,10
FLUTICASONE PROPIONATE,Dizziness,10
FLUTICASONE PROPIONATE,Migraine,9
FLUTICASONE PROPIONATE,Feeling abnormal,9
FLUTICASONE PROPIONATE,Diarrhoea,9
FLUTICASONE PROPIONATE,Infusion site pain,9
FLUTICASONE PROPIONATE,Asthenia,9
FLUTICASONE PROPIONATE,Infusion site erythema,8
FLUTICASONE PROPIONATE,Infection,8
FLUTICASONE PROPIONATE,Injection site pain,8
FLUTICASONE PROPIONATE,Back pain,8
FLUTICASONE PROPIONATE,Pain in extremity,8
FLUTICASONE PROPIONATE,Insomnia,7
FLUTICASONE PROPIONATE,Somnolence,7
FLUTICASONE PROPIONATE,Gait disturbance,7
FLUTICASONE PROPIONATE,Diverticulitis,7
FLUTICASONE PROPIONATE,Condition aggravated,7
FLUTICASONE PROPIONATE,Viral infection,7
FLUTICASONE PROPIONATE,Stress,7
FLUTICASONE PROPIONATE,Infusion site extravasation,7
FOLIC ACID,Off label use,138
FOLIC ACID,COVID-19,90
FOLIC ACID,Pain,81
FOLIC ACID,Diarrhoea,76
FOLIC ACID,Fatigue,72
FOLIC ACID,Product dose omission issue,70
FOLIC ACID,Condition aggravated,65
FOLIC ACID,Rash,61
FOLIC ACID,Malaise,55
FOLIC ACID,Fall,54
FOLIC ACID,Headache,54
FOLIC ACID,Arthralgia,51
FOLIC ACID,Dyspnoea,50
FOLIC ACID,Pain in extremity,49
FOLIC ACID,Nausea,48
FOLIC ACID,Arthropathy,45
FOLIC ACID,Pyrexia,45
FOLIC ACID,Asthenia,44
FOLIC ACID,Dizziness,44
FOLIC ACID,Abdominal discomfort,43
FOLIC ACID,Vomiting,42
FOLIC ACID,Illness,42
FOLIC ACID,Pneumonia,41
FOLIC ACID,Maternal exposure during pregnancy,40
FOLIC ACID,Anaemia,40
FOLIC ACID,Sinusitis,39
FOLIC ACID,Abdominal pain,39
FOLIC ACID,Inflammation,38
FOLIC ACID,Cough,38
FOLIC ACID,Drug ineffective,37
FOLIC ACID,Weight decreased,37
FOLIC ACID,Urinary tract infection,36
FOLIC ACID,Decreased appetite,34
FOLIC ACID,Knee arthroplasty,33
FOLIC ACID,Hypotension,33
FOLIC ACID,Rheumatoid arthritis,32
FOLIC ACID,Intentional product use issue,32
FOLIC ACID,Intentional product misuse,32
FOLIC ACID,Lower respiratory tract infection,31
FOLIC ACID,Drug abuse,31
FOLIC ACID,Peripheral swelling,30
FOLIC ACID,Inappropriate schedule of product administration,30
FOLIC ACID,Neutropenia,29
FOLIC ACID,Nasopharyngitis,28
FOLIC ACID,Hypersensitivity,28
FOLIC ACID,Hypertension,28
FOLIC ACID,Gait disturbance,27
FOLIC ACID,Weight increased,27
FOLIC ACID,General physical health deterioration,27
FOLIC ACID,Overdose,27
FOSAMAX,Diarrhoea,17
FOSAMAX,Pain,17
FOSAMAX,Off label use,14
FOSAMAX,Drug ineffective,13
FOSAMAX,Arthralgia,13
FOSAMAX,Dyspnoea,12
FOSAMAX,Drug intolerance,12
FOSAMAX,Rash,12
FOSAMAX,Abdominal discomfort,12
FOSAMAX,Therapeutic product effect decreased,11
FOSAMAX,Fatigue,11
FOSAMAX,Drug hypersensitivity,11
FOSAMAX,Hypertension,10
FOSAMAX,Headache,10
FOSAMAX,Nausea,10
FOSAMAX,Malaise,10
FOSAMAX,Product use issue,10
FOSAMAX,Anxiety,10
FOSAMAX,Hepatic enzyme increased,9
FOSAMAX,Contraindicated product administered,9
FOSAMAX,Infusion related reaction,9
FOSAMAX,Nasopharyngitis,9
FOSAMAX,Sinusitis,9
FOSAMAX,Rheumatoid arthritis,8
FOSAMAX,Musculoskeletal stiffness,8
FOSAMAX,Liver disorder,8
FOSAMAX,Abdominal pain upper,8
FOSAMAX,Hypersensitivity,7
FOSAMAX,Alopecia,7
FOSAMAX,Dizziness,7
FOSAMAX,Condition aggravated,7
FOSAMAX,Cough,7
FOSAMAX,Hand deformity,6
FOSAMAX,Wheezing,6
FOSAMAX,Anti-cyclic citrullinated peptide antibody positive,6
FOSAMAX,Maternal exposure during pregnancy,6
FOSAMAX,Glossodynia,6
FOSAMAX,Synovitis,6
FOSAMAX,Intentional product use issue,6
FOSAMAX,Joint swelling,6
FOSAMAX,Psoriatic arthropathy,6
FOSAMAX,Back pain,6
FOSAMAX,Blood cholesterol increased,6
FOSAMAX,Arthropathy,6
FOSAMAX,Mobility decreased,6
FOSAMAX,Abdominal pain,6
FOSAMAX,Swelling,6
FOSAMAX,Fibromyalgia,6
FOSAMAX,Anhedonia,6
FOSAMAX,Osteoporosis,6
FOSFOMYCIN,Pruritus,93
FOSFOMYCIN,Diarrhoea,91
FOSFOMYCIN,Malaise,89
FOSFOMYCIN,Tachycardia,89
FOSFOMYCIN,Abdominal pain upper,87
FOSFOMYCIN,Dyspnoea,87
FOSFOMYCIN,Visual impairment,87
FOSFOMYCIN,Hallucination,87
FOSFOMYCIN,Amnesia,87
FOSFOMYCIN,Feeling abnormal,87
FOSFOMYCIN,Facial pain,87
FOSFOMYCIN,Dry skin,87
FOSFOMYCIN,Dehydration,87
FOSFOMYCIN,Fatigue,87
FOSFOMYCIN,Chest pain,87
FOSFOMYCIN,Palpitations,87
FOSFOMYCIN,Cardiospasm,87
FOSFOMYCIN,Angioedema,87
FOSFOMYCIN,Muscular weakness,87
FOSFOMYCIN,COVID-19,87
FOSFOMYCIN,Abdominal discomfort,87
FOSFOMYCIN,Subarachnoid haemorrhage,87
FOSFOMYCIN,Lip swelling,87
FOSFOMYCIN,Disturbance in attention,87
FOSFOMYCIN,Anosmia,87
FOSFOMYCIN,Atrial tachycardia,87
FOSFOMYCIN,Pericarditis,87
FOSFOMYCIN,Intentional product misuse,86
FOSFOMYCIN,Myocardial infarction,86
FOSFOMYCIN,Nausea,86
FOSFOMYCIN,Dizziness,86
FOSFOMYCIN,Insomnia,86
FOSFOMYCIN,Diplopia,86
FOSFOMYCIN,Arthralgia,86
FOSFOMYCIN,Pain,86
FOSFOMYCIN,Hyperhidrosis,86
FOSFOMYCIN,Alopecia,86
FOSFOMYCIN,Anxiety,86
FOSFOMYCIN,Transient ischaemic attack,86
FOSFOMYCIN,Peripheral swelling,86
FOSFOMYCIN,Memory impairment,86
FOSFOMYCIN,Sleep terror,86
FOSFOMYCIN,Vomiting,86
FOSFOMYCIN,Tension headache,86
FOSFOMYCIN,Blindness,86
FOSFOMYCIN,Migraine,86
FOSFOMYCIN,Pyrexia,86
FOSFOMYCIN,Vasculitis,86
FOSFOMYCIN,Pruritus genital,86
FOSFOMYCIN,Cognitive disorder,86
FULVESTRANT,Fatigue,19
FULVESTRANT,White blood cell count decreased,16
FULVESTRANT,Arthralgia,14
FULVESTRANT,Headache,14
FULVESTRANT,Pain,14
FULVESTRANT,Malaise,12
FULVESTRANT,Diarrhoea,11
FULVESTRANT,Neutropenia,11
FULVESTRANT,Pruritus,11
FULVESTRANT,Neoplasm progression,11
FULVESTRANT,Metastases to bone,10
FULVESTRANT,Back pain,10
FULVESTRANT,Alopecia,9
FULVESTRANT,Alanine aminotransferase increased,9
FULVESTRANT,Muscle spasms,9
FULVESTRANT,Gamma-glutamyltransferase increased,9
FULVESTRANT,Aspartate aminotransferase increased,9
FULVESTRANT,Asthenia,9
FULVESTRANT,Haemoglobin decreased,9
FULVESTRANT,Decreased appetite,9
FULVESTRANT,Cough,9
FULVESTRANT,Tachycardia,8
FULVESTRANT,Vomiting,8
FULVESTRANT,Neutrophil count decreased,8
FULVESTRANT,Weight decreased,8
FULVESTRANT,Thrombocytopenia,7
FULVESTRANT,Metastases to liver,7
FULVESTRANT,Aphthous ulcer,7
FULVESTRANT,Constipation,7
FULVESTRANT,Rash,7
FULVESTRANT,Anxiety,7
FULVESTRANT,Memory impairment,7
FULVESTRANT,Dyspnoea,7
FULVESTRANT,Red blood cell count decreased,7
FULVESTRANT,Arthropod bite,6
FULVESTRANT,Hepatic echinococciasis,6
FULVESTRANT,Transaminases increased,6
FULVESTRANT,Hepatic cyst,6
FULVESTRANT,Nausea,6
FULVESTRANT,Hypoaesthesia,6
FULVESTRANT,Interstitial lung disease,6
FULVESTRANT,Illness,6
FULVESTRANT,Malignant neoplasm progression,6
FULVESTRANT,Abdominal discomfort,5
FULVESTRANT,Anaemia,5
FULVESTRANT,Dizziness,5
FULVESTRANT,Blood glucose increased,5
FULVESTRANT,Feeling abnormal,5
FULVESTRANT,Somnolence,5
FULVESTRANT,Stress,5
FUROSEMIDE,Diarrhoea,83
FUROSEMIDE,Acute kidney injury,82
FUROSEMIDE,Off label use,81
FUROSEMIDE,Dyspnoea,76
FUROSEMIDE,Fatigue,68
FUROSEMIDE,Pneumonia,68
FUROSEMIDE,Hypotension,59
FUROSEMIDE,Nausea,58
FUROSEMIDE,Headache,53
FUROSEMIDE,Cardiac failure,53
FUROSEMIDE,Pyrexia,52
FUROSEMIDE,Vomiting,45
FUROSEMIDE,Product dose omission issue,44
FUROSEMIDE,Pain,43
FUROSEMIDE,Asthenia,42
FUROSEMIDE,Death,41
FUROSEMIDE,Dizziness,39
FUROSEMIDE,Fall,39
FUROSEMIDE,Anaemia,37
FUROSEMIDE,COVID-19,37
FUROSEMIDE,Hyponatraemia,36
FUROSEMIDE,Urinary tract infection,35
FUROSEMIDE,Thrombocytopenia,34
FUROSEMIDE,Pruritus,34
FUROSEMIDE,Hyperkalaemia,34
FUROSEMIDE,Anxiety,33
FUROSEMIDE,Hypokalaemia,33
FUROSEMIDE,Cough,32
FUROSEMIDE,Decreased appetite,31
FUROSEMIDE,Arthralgia,30
FUROSEMIDE,Malaise,30
FUROSEMIDE,Hypocalcaemia,29
FUROSEMIDE,Atrial fibrillation,28
FUROSEMIDE,Rash,26
FUROSEMIDE,Weight increased,25
FUROSEMIDE,Abdominal pain,24
FUROSEMIDE,Inappropriate schedule of product administration,24
FUROSEMIDE,Constipation,24
FUROSEMIDE,Renal impairment,24
FUROSEMIDE,Oedema peripheral,23
FUROSEMIDE,Peripheral swelling,22
FUROSEMIDE,Cardiac failure congestive,22
FUROSEMIDE,Weight decreased,22
FUROSEMIDE,Septic shock,21
FUROSEMIDE,Hypomagnesaemia,21
FUROSEMIDE,Hypoglycaemia,21
FUROSEMIDE,Confusional state,20
FUROSEMIDE,Neutropenia,20
FUROSEMIDE,Contusion,20
FUROSEMIDE,Illness,20
GABAPENTIN,Pain,156
GABAPENTIN,Fatigue,108
GABAPENTIN,Anxiety,89
GABAPENTIN,Headache,89
GABAPENTIN,Off label use,80
GABAPENTIN,Nausea,79
GABAPENTIN,Product dose omission issue,73
GABAPENTIN,Emotional distress,69
GABAPENTIN,Pain in extremity,67
GABAPENTIN,Dyspnoea,66
GABAPENTIN,Pneumonia,66
GABAPENTIN,Diarrhoea,66
GABAPENTIN,COVID-19,65
GABAPENTIN,Back pain,63
GABAPENTIN,Anhedonia,63
GABAPENTIN,Fall,59
GABAPENTIN,Arthralgia,56
GABAPENTIN,Urinary tract infection,52
GABAPENTIN,Asthenia,52
GABAPENTIN,Condition aggravated,51
GABAPENTIN,Vomiting,49
GABAPENTIN,Inappropriate schedule of product administration,46
GABAPENTIN,Chronic kidney disease,45
GABAPENTIN,Osteoporosis,44
GABAPENTIN,Dizziness,44
GABAPENTIN,Sinusitis,43
GABAPENTIN,Drug ineffective,42
GABAPENTIN,Malaise,42
GABAPENTIN,Depression,41
GABAPENTIN,Abdominal pain,41
GABAPENTIN,Illness,41
GABAPENTIN,Rash,40
GABAPENTIN,Pyrexia,39
GABAPENTIN,Gait disturbance,39
GABAPENTIN,Nasopharyngitis,38
GABAPENTIN,Pruritus,37
GABAPENTIN,Somnolence,34
GABAPENTIN,Feeling abnormal,33
GABAPENTIN,Erythema,33
GABAPENTIN,Weight decreased,32
GABAPENTIN,Peripheral swelling,32
GABAPENTIN,Weight increased,31
GABAPENTIN,Contusion,31
GABAPENTIN,Hypoaesthesia,30
GABAPENTIN,Renal failure,29
GABAPENTIN,Cough,28
GABAPENTIN,Influenza,28
GABAPENTIN,Osteopenia,28
GABAPENTIN,Upper respiratory tract infection,28
GABAPENTIN,Sepsis,27
GEMCITABINE,Neutropenia,25
GEMCITABINE,Thrombocytopenia,24
GEMCITABINE,Malignant neoplasm progression,15
GEMCITABINE,Pyrexia,13
GEMCITABINE,Anaemia,13
GEMCITABINE,Vomiting,13
GEMCITABINE,Pancytopenia,12
GEMCITABINE,Off label use,12
GEMCITABINE,Diarrhoea,11
GEMCITABINE,Neutrophil count decreased,10
GEMCITABINE,Platelet count decreased,10
GEMCITABINE,Cytokine release syndrome,10
GEMCITABINE,Disease progression,8
GEMCITABINE,Constipation,8
GEMCITABINE,White blood cell count decreased,8
GEMCITABINE,Ascites,8
GEMCITABINE,Acute kidney injury,8
GEMCITABINE,Sepsis,7
GEMCITABINE,Febrile neutropenia,7
GEMCITABINE,Hyponatraemia,7
GEMCITABINE,Dizziness,7
GEMCITABINE,Nausea,6
GEMCITABINE,Hypotension,6
GEMCITABINE,Dyspnoea,6
GEMCITABINE,Product use in unapproved indication,6
GEMCITABINE,Abdominal pain,5
GEMCITABINE,Pneumonitis,5
GEMCITABINE,Bone marrow failure,5
GEMCITABINE,Respiratory failure,5
GEMCITABINE,Pneumonia,5
GEMCITABINE,Somnolence,5
GEMCITABINE,Septic shock,4
GEMCITABINE,Oedema peripheral,4
GEMCITABINE,Paraesthesia,4
GEMCITABINE,Neutropenic sepsis,4
GEMCITABINE,Metastases to peritoneum,4
GEMCITABINE,Haematotoxicity,4
GEMCITABINE,Metastases to lymph nodes,4
GEMCITABINE,Diffuse large B-cell lymphoma,4
GEMCITABINE,Decreased appetite,4
GEMCITABINE,Death,4
GEMCITABINE,Asthenia,4
GEMCITABINE,Hypoxia,4
GEMCITABINE,Cardiac failure,4
GEMCITABINE,Fall,4
GEMCITABINE,Generalised oedema,4
GEMCITABINE,Leukopenia,4
GEMCITABINE,Drug ineffective,4
GEMCITABINE,Cerebral haemorrhage,4
GEMCITABINE,Cholangitis infective,4
GEMCITABINE HYDROCHLORIDE,Myelosuppression,12
GEMCITABINE HYDROCHLORIDE,Off label use,8
GEMCITABINE HYDROCHLORIDE,Platelet count decreased,6
GEMCITABINE HYDROCHLORIDE,Diarrhoea,6
GEMCITABINE HYDROCHLORIDE,White blood cell count decreased,5
GEMCITABINE HYDROCHLORIDE,Febrile neutropenia,5
GEMCITABINE HYDROCHLORIDE,Malignant neoplasm progression,5
GEMCITABINE HYDROCHLORIDE,Cough,4
GEMCITABINE HYDROCHLORIDE,Hyponatraemia,4
GEMCITABINE HYDROCHLORIDE,Anaemia,4
GEMCITABINE HYDROCHLORIDE,Dyspnoea,4
GEMCITABINE HYDROCHLORIDE,Neutrophil count decreased,4
GEMCITABINE HYDROCHLORIDE,Constipation,3
GEMCITABINE HYDROCHLORIDE,Death,3
GEMCITABINE HYDROCHLORIDE,Hypokalaemia,3
GEMCITABINE HYDROCHLORIDE,Sepsis,3
GEMCITABINE HYDROCHLORIDE,Pyrexia,3
GEMCITABINE HYDROCHLORIDE,Asthenia,3
GEMCITABINE HYDROCHLORIDE,Vomiting,3
GEMCITABINE HYDROCHLORIDE,Thrombocytopenia,3
GEMCITABINE HYDROCHLORIDE,Urinary tract infection,2
GEMCITABINE HYDROCHLORIDE,Pneumonia bacterial,2
GEMCITABINE HYDROCHLORIDE,Abdominal infection,2
GEMCITABINE HYDROCHLORIDE,Bronchopulmonary aspergillosis,2
GEMCITABINE HYDROCHLORIDE,Hypersensitivity,2
GEMCITABINE HYDROCHLORIDE,Hypoglycaemia,2
GEMCITABINE HYDROCHLORIDE,Lymphocyte count decreased,2
GEMCITABINE HYDROCHLORIDE,Coagulopathy,2
GEMCITABINE HYDROCHLORIDE,Upper gastrointestinal haemorrhage,2
GEMCITABINE HYDROCHLORIDE,Oral infection,2
GEMCITABINE HYDROCHLORIDE,Neutropenic sepsis,2
GEMCITABINE HYDROCHLORIDE,Disease progression,2
GEMCITABINE HYDROCHLORIDE,Weight decreased,2
GEMCITABINE HYDROCHLORIDE,Decreased appetite,2
GEMCITABINE HYDROCHLORIDE,Dizziness,2
GEMCITABINE HYDROCHLORIDE,Ischaemic stroke,2
GEMCITABINE HYDROCHLORIDE,Alanine aminotransferase increased,2
GEMCITABINE HYDROCHLORIDE,Lung disorder,2
GEMCITABINE HYDROCHLORIDE,Hypothyroidism,2
GEMCITABINE HYDROCHLORIDE,Pulmonary toxicity,2
GEMCITABINE HYDROCHLORIDE,Exposure to SARS-CoV-2,2
GEMCITABINE HYDROCHLORIDE,Chest pain,2
GEMCITABINE HYDROCHLORIDE,Enterocolitis,2
GEMCITABINE HYDROCHLORIDE,Peripheral artery thrombosis,2
GEMCITABINE HYDROCHLORIDE,Atrial thrombosis,2
GEMCITABINE HYDROCHLORIDE,Gastrointestinal disorder,2
GEMCITABINE HYDROCHLORIDE,Urinary tract infection bacterial,1
GEMCITABINE HYDROCHLORIDE,Cytokine release syndrome,1
GEMCITABINE HYDROCHLORIDE,Oedema peripheral,1
GEMCITABINE HYDROCHLORIDE,Haematuria,1
GENOTROPIN,Drug dose omission by device,174
GENOTROPIN,Device leakage,101
GENOTROPIN,Device breakage,94
GENOTROPIN,Device mechanical issue,74
GENOTROPIN,Poor quality device used,52
GENOTROPIN,Wrong technique in device usage process,50
GENOTROPIN,Device information output issue,42
GENOTROPIN,Device issue,42
GENOTROPIN,Device use issue,31
GENOTROPIN,Device malfunction,24
GENOTROPIN,Device use error,21
GENOTROPIN,Incorrect dose administered by device,21
GENOTROPIN,Device difficult to use,19
GENOTROPIN,Expired device used,18
GENOTROPIN,Injection site pain,18
GENOTROPIN,Device delivery system issue,18
GENOTROPIN,Product dose omission issue,17
GENOTROPIN,Device physical property issue,16
GENOTROPIN,Off label use,16
GENOTROPIN,Device defective,13
GENOTROPIN,Device failure,12
GENOTROPIN,Device power source issue,10
GENOTROPIN,Product prescribing error,10
GENOTROPIN,Needle issue,9
GENOTROPIN,Liquid product physical issue,7
GENOTROPIN,Accidental exposure to product,7
GENOTROPIN,Exposure via skin contact,6
GENOTROPIN,Overdose,5
GENOTROPIN,Product storage error,5
GENOTROPIN,Malaise,5
GENOTROPIN,Device operational issue,4
GENOTROPIN,Incorrect dose administered,4
GENOTROPIN,Injection site bruising,4
GENOTROPIN,Pain,3
GENOTROPIN,Product physical issue,3
GENOTROPIN,Product quality issue,3
GENOTROPIN,Device dispensing error,3
GENOTROPIN,Product odour abnormal,3
GENOTROPIN,Intentional product misuse,3
GENOTROPIN,Expired product administered,3
GENOTROPIN,Product solubility abnormal,3
GENOTROPIN,Fatigue,3
GENOTROPIN,Hypoacusis,2
GENOTROPIN,Circumstance or information capable of leading to medication error,2
GENOTROPIN,Product contamination physical,2
GENOTROPIN,Product communication issue,2
GENOTROPIN,Product prescribing issue,2
GENOTROPIN,Product supply issue,2
GENOTROPIN,Circumstance or information capable of leading to device use error,2
GENOTROPIN,Diarrhoea,2
GENTAMICIN,Diarrhoea,24
GENTAMICIN,Alopecia,21
GENTAMICIN,Fatigue,21
GENTAMICIN,Mucosal inflammation,21
GENTAMICIN,Off label use,20
GENTAMICIN,Disease progression,12
GENTAMICIN,Anaemia,12
GENTAMICIN,Nausea,12
GENTAMICIN,Ejection fraction decreased,11
GENTAMICIN,Rash,11
GENTAMICIN,COVID-19,11
GENTAMICIN,Vascular device infection,10
GENTAMICIN,Gingival swelling,10
GENTAMICIN,Influenza like illness,10
GENTAMICIN,Osteonecrosis of jaw,10
GENTAMICIN,Lymphoedema,10
GENTAMICIN,Epistaxis,10
GENTAMICIN,Hot flush,10
GENTAMICIN,Gastrooesophageal reflux disease,10
GENTAMICIN,Dyspepsia,10
GENTAMICIN,Lymphocyte count decreased,10
GENTAMICIN,Affective disorder,9
GENTAMICIN,Leukopenia,9
GENTAMICIN,Neutrophil count increased,9
GENTAMICIN,Platelet count decreased,9
GENTAMICIN,Neuropathy peripheral,9
GENTAMICIN,Cellulitis,9
GENTAMICIN,Schizophrenia,9
GENTAMICIN,Overdose,9
GENTAMICIN,Incorrect dose administered,9
GENTAMICIN,Seizure,9
GENTAMICIN,Psychotic disorder,9
GENTAMICIN,"Hallucination, auditory",9
GENTAMICIN,Extrapyramidal disorder,9
GENTAMICIN,Neutropenia,9
GENTAMICIN,Delusion of grandeur,9
GENTAMICIN,Sepsis,8
GENTAMICIN,Rhinalgia,8
GENTAMICIN,Device related infection,7
GENTAMICIN,Lymphocyte count abnormal,7
GENTAMICIN,SARS-CoV-2 test positive,6
GENTAMICIN,Product use in unapproved indication,5
GENTAMICIN,Neoplasm progression,5
GENTAMICIN,Pyrexia,5
GENTAMICIN,Pneumonia,5
GENTAMICIN,Blood creatine phosphokinase increased,4
GENTAMICIN,Atrial fibrillation,4
GENTAMICIN,Heart rate irregular,4
GENTAMICIN,Infection,4
GENTAMICIN,Tachycardia,4
GENVOYA,Emotional distress,84
GENVOYA,Pain,84
GENVOYA,Anxiety,81
GENVOYA,Anhedonia,80
GENVOYA,Chronic kidney disease,38
GENVOYA,Osteoporosis,34
GENVOYA,Osteopenia,27
GENVOYA,Bone demineralisation,26
GENVOYA,Depression,24
GENVOYA,Bone density decreased,21
GENVOYA,Economic problem,17
GENVOYA,Acute kidney injury,16
GENVOYA,Multiple fractures,15
GENVOYA,Renal failure,14
GENVOYA,Renal impairment,14
GENVOYA,Blood creatinine increased,12
GENVOYA,Asthenia,11
GENVOYA,Fatigue,10
GENVOYA,Gait disturbance,9
GENVOYA,Bone loss,9
GENVOYA,Loss of personal independence in daily activities,9
GENVOYA,Vitamin D deficiency,8
GENVOYA,Renal injury,8
GENVOYA,Ankle fracture,7
GENVOYA,End stage renal disease,7
GENVOYA,Foot fracture,6
GENVOYA,Osteonecrosis,6
GENVOYA,Decreased activity,6
GENVOYA,Back pain,5
GENVOYA,Quality of life decreased,5
GENVOYA,Rib fracture,5
GENVOYA,Mobility decreased,5
GENVOYA,Nephropathy,5
GENVOYA,Hand fracture,5
GENVOYA,Hip fracture,5
GENVOYA,Spinal fracture,5
GENVOYA,Bone pain,5
GENVOYA,Osteoarthritis,4
GENVOYA,Hypertension,4
GENVOYA,Arthralgia,4
GENVOYA,Drug ineffective,4
GENVOYA,Pain in extremity,3
GENVOYA,Skeletal injury,3
GENVOYA,Nephrolithiasis,3
GENVOYA,Pathological fracture,3
GENVOYA,Fall,3
GENVOYA,Fracture,3
GENVOYA,Lower limb fracture,3
GENVOYA,Chronic kidney disease-mineral and bone disorder,3
GENVOYA,Hyperkalaemia,3
GILENYA,Multiple sclerosis relapse,19
GILENYA,Headache,16
GILENYA,Dizziness,16
GILENYA,Fatigue,16
GILENYA,Pain in extremity,14
GILENYA,Asthenia,13
GILENYA,Nausea,13
GILENYA,Gait disturbance,13
GILENYA,Pain,12
GILENYA,Malaise,10
GILENYA,Decreased appetite,10
GILENYA,Insomnia,10
GILENYA,Hypoaesthesia,9
GILENYA,Seizure,8
GILENYA,Stress,8
GILENYA,Anxiety,8
GILENYA,Depression,8
GILENYA,Maternal exposure during pregnancy,8
GILENYA,Vomiting,7
GILENYA,Fall,7
GILENYA,Feeling abnormal,7
GILENYA,Pyrexia,6
GILENYA,Weight decreased,6
GILENYA,Mood altered,6
GILENYA,Somnolence,6
GILENYA,Influenza,5
GILENYA,Product dose omission issue,5
GILENYA,Tonsillitis,5
GILENYA,Lymphocyte count decreased,5
GILENYA,Muscle spasms,5
GILENYA,Arthralgia,5
GILENYA,COVID-19,5
GILENYA,Weight increased,5
GILENYA,Tremor,5
GILENYA,White blood cell count decreased,5
GILENYA,Cough,4
GILENYA,Diarrhoea,4
GILENYA,Speech disorder,4
GILENYA,Sleep disorder,4
GILENYA,Depressive symptom,4
GILENYA,Oropharyngeal pain,4
GILENYA,Memory impairment,4
GILENYA,Vision blurred,4
GILENYA,Visual impairment,4
GILENYA,Depressed mood,4
GILENYA,Trigeminal neuralgia,4
GILENYA,Vertigo,4
GILENYA,Drug ineffective,4
GILENYA,Muscular weakness,4
GILENYA,Foetal exposure during pregnancy,4
GLICLAZIDE,Nausea,16
GLICLAZIDE,Diarrhoea,14
GLICLAZIDE,Acute kidney injury,13
GLICLAZIDE,Hyperkalaemia,13
GLICLAZIDE,Hyponatraemia,13
GLICLAZIDE,Off label use,12
GLICLAZIDE,Asthenia,12
GLICLAZIDE,Inappropriate antidiuretic hormone secretion,11
GLICLAZIDE,Malaise,10
GLICLAZIDE,Headache,8
GLICLAZIDE,Arthralgia,8
GLICLAZIDE,Vomiting,7
GLICLAZIDE,Fatigue,7
GLICLAZIDE,Peripheral swelling,7
GLICLAZIDE,Pneumonitis,7
GLICLAZIDE,Rash,7
GLICLAZIDE,Abdominal pain upper,7
GLICLAZIDE,Drug ineffective,7
GLICLAZIDE,Pain,6
GLICLAZIDE,Interstitial lung disease,6
GLICLAZIDE,Product use issue,6
GLICLAZIDE,Hypertension,6
GLICLAZIDE,Drug hypersensitivity,6
GLICLAZIDE,Dyspnoea,6
GLICLAZIDE,Decreased appetite,6
GLICLAZIDE,Disorientation,6
GLICLAZIDE,Hypomagnesaemia,6
GLICLAZIDE,Hypocalcaemia,6
GLICLAZIDE,Weight decreased,5
GLICLAZIDE,Diabetes mellitus inadequate control,5
GLICLAZIDE,Pulmonary hypertension,5
GLICLAZIDE,Cough,5
GLICLAZIDE,Cardiac failure,5
GLICLAZIDE,Dizziness,5
GLICLAZIDE,Neutropenia,5
GLICLAZIDE,Renal failure,5
GLICLAZIDE,Pyelonephritis,5
GLICLAZIDE,Hypokalaemia,5
GLICLAZIDE,Hypophosphataemia,5
GLICLAZIDE,Abdominal pain,4
GLICLAZIDE,Oedema peripheral,4
GLICLAZIDE,Pneumonia,4
GLICLAZIDE,Abdominal discomfort,4
GLICLAZIDE,Loss of employment,4
GLICLAZIDE,Drug intolerance,4
GLICLAZIDE,Liver disorder,4
GLICLAZIDE,Gastric disorder,4
GLICLAZIDE,Hepatic steatosis,4
GLICLAZIDE,Cardiac failure congestive,4
GLICLAZIDE,Contraindicated product administered,4
GLIMEPIRIDE,COVID-19,13
GLIMEPIRIDE,Diarrhoea,11
GLIMEPIRIDE,Fatigue,10
GLIMEPIRIDE,Hypertension,9
GLIMEPIRIDE,Pain,8
GLIMEPIRIDE,Hypoglycaemia,8
GLIMEPIRIDE,Lactic acidosis,8
GLIMEPIRIDE,Dyspnoea,7
GLIMEPIRIDE,Acute kidney injury,7
GLIMEPIRIDE,Product dose omission issue,7
GLIMEPIRIDE,Sinusitis,7
GLIMEPIRIDE,Diabetes mellitus,7
GLIMEPIRIDE,Atrial fibrillation,7
GLIMEPIRIDE,Pruritus,7
GLIMEPIRIDE,Abdominal discomfort,6
GLIMEPIRIDE,Malaise,6
GLIMEPIRIDE,Hyperammonaemic encephalopathy,6
GLIMEPIRIDE,Off label use,5
GLIMEPIRIDE,Back pain,5
GLIMEPIRIDE,Anxiety,5
GLIMEPIRIDE,Fall,5
GLIMEPIRIDE,Chronic kidney disease,5
GLIMEPIRIDE,Urinary tract infection,5
GLIMEPIRIDE,Nausea,5
GLIMEPIRIDE,Nasopharyngitis,4
GLIMEPIRIDE,Emotional distress,4
GLIMEPIRIDE,Pneumonia,4
GLIMEPIRIDE,Dizziness,4
GLIMEPIRIDE,Pyrexia,4
GLIMEPIRIDE,Hyperkalaemia,4
GLIMEPIRIDE,Constipation,4
GLIMEPIRIDE,Rash,4
GLIMEPIRIDE,Arthralgia,4
GLIMEPIRIDE,Blood glucose increased,4
GLIMEPIRIDE,Decreased appetite,4
GLIMEPIRIDE,Peripheral swelling,4
GLIMEPIRIDE,Condition aggravated,3
GLIMEPIRIDE,Depression,3
GLIMEPIRIDE,Gait disturbance,3
GLIMEPIRIDE,Anhedonia,3
GLIMEPIRIDE,Renal failure,3
GLIMEPIRIDE,Localised infection,3
GLIMEPIRIDE,Bronchitis,3
GLIMEPIRIDE,COVID-19 pneumonia,3
GLIMEPIRIDE,Oropharyngeal pain,3
GLIMEPIRIDE,Cough,3
GLIMEPIRIDE,Asthenia,3
GLIMEPIRIDE,Weight decreased,3
GLIMEPIRIDE,Hallucination,3
GLIMEPIRIDE,Product packaging issue,3
GLIPIZIDE,Pain,17
GLIPIZIDE,Off label use,14
GLIPIZIDE,Chronic kidney disease,13
GLIPIZIDE,Anxiety,12
GLIPIZIDE,Emotional distress,12
GLIPIZIDE,Anhedonia,11
GLIPIZIDE,Product dose omission issue,10
GLIPIZIDE,Diarrhoea,10
GLIPIZIDE,Renal failure,8
GLIPIZIDE,Insomnia,8
GLIPIZIDE,Fatigue,8
GLIPIZIDE,Asthenia,8
GLIPIZIDE,Illness,7
GLIPIZIDE,Depression,6
GLIPIZIDE,Glycosylated haemoglobin increased,5
GLIPIZIDE,Acute kidney injury,5
GLIPIZIDE,Back pain,5
GLIPIZIDE,Nausea,5
GLIPIZIDE,Rash,5
GLIPIZIDE,Nasopharyngitis,5
GLIPIZIDE,Diabetes mellitus,4
GLIPIZIDE,COVID-19,4
GLIPIZIDE,Headache,4
GLIPIZIDE,Fall,4
GLIPIZIDE,Mobility decreased,4
GLIPIZIDE,Death,4
GLIPIZIDE,Sinusitis,4
GLIPIZIDE,Bronchitis,4
GLIPIZIDE,Gait disturbance,4
GLIPIZIDE,Dizziness,4
GLIPIZIDE,Pruritus,4
GLIPIZIDE,Cough,4
GLIPIZIDE,Blood glucose increased,3
GLIPIZIDE,Skeletal injury,3
GLIPIZIDE,Renal impairment,3
GLIPIZIDE,Tremor,3
GLIPIZIDE,Therapeutic product effect decreased,3
GLIPIZIDE,Somnolence,3
GLIPIZIDE,Vomiting,3
GLIPIZIDE,Angina pectoris,3
GLIPIZIDE,Lacrimation increased,3
GLIPIZIDE,Retinal detachment,3
GLIPIZIDE,Dyspnoea,3
GLIPIZIDE,Stress,2
GLIPIZIDE,Arthralgia,2
GLIPIZIDE,Taste disorder,2
GLIPIZIDE,Oral pain,2
GLIPIZIDE,Eating disorder,2
GLIPIZIDE,Blood cholesterol abnormal,2
GLIPIZIDE,Glossitis,2
GRANISETRON,Nausea,9
GRANISETRON,Anaemia,9
GRANISETRON,Off label use,8
GRANISETRON,Fatigue,8
GRANISETRON,Thrombocytopenia,8
GRANISETRON,Vomiting,6
GRANISETRON,Febrile neutropenia,6
GRANISETRON,Platelet count decreased,6
GRANISETRON,Hypokalaemia,5
GRANISETRON,Lymphocyte count decreased,5
GRANISETRON,Diarrhoea,5
GRANISETRON,Somnolence,5
GRANISETRON,Pyrexia,5
GRANISETRON,White blood cell count decreased,4
GRANISETRON,Hypothyroidism,4
GRANISETRON,Dyspnoea,4
GRANISETRON,Myalgia,4
GRANISETRON,Pneumonia,4
GRANISETRON,Lethargy,4
GRANISETRON,Malaise,4
GRANISETRON,Neutropenia,4
GRANISETRON,Leukopenia,4
GRANISETRON,Pancytopenia,4
GRANISETRON,Rash,4
GRANISETRON,Sepsis,4
GRANISETRON,Malignant neoplasm progression,3
GRANISETRON,Neuropathy peripheral,3
GRANISETRON,Hyperglycaemia,3
GRANISETRON,Alopecia,3
GRANISETRON,Pruritus,3
GRANISETRON,Back pain,3
GRANISETRON,Alanine aminotransferase increased,3
GRANISETRON,Arthralgia,3
GRANISETRON,Pulmonary sepsis,3
GRANISETRON,Hepatic function abnormal,3
GRANISETRON,General physical health deterioration,3
GRANISETRON,Oral candidiasis,3
GRANISETRON,Urinary tract infection,3
GRANISETRON,Fall,3
GRANISETRON,Hypotension,3
GRANISETRON,Dehydration,3
GRANISETRON,Osteoarthritis,3
GRANISETRON,Chronic hepatitis B,3
GRANISETRON,Fungal infection,3
GRANISETRON,Spinal fracture,3
GRANISETRON,Lower respiratory tract infection,3
GRANISETRON,Decreased appetite,3
GRANISETRON,Product use in unapproved indication,2
GRANISETRON,Blood pressure systolic increased,2
GRANISETRON,Blood pressure diastolic increased,2
HAEGARDA,Hereditary angioedema,63
HAEGARDA,No adverse event,37
HAEGARDA,Weight decreased,21
HAEGARDA,Weight increased,19
HAEGARDA,Product dose omission issue,18
HAEGARDA,Off label use,12
HAEGARDA,Insurance issue,11
HAEGARDA,Stress,10
HAEGARDA,Drug ineffective,9
HAEGARDA,COVID-19,9
HAEGARDA,Pain,8
HAEGARDA,Therapy interrupted,8
HAEGARDA,Product preparation issue,7
HAEGARDA,Maternal exposure during pregnancy,7
HAEGARDA,Vomiting,6
HAEGARDA,Device issue,6
HAEGARDA,Product use issue,6
HAEGARDA,Fall,5
HAEGARDA,Incorrect dose administered,5
HAEGARDA,Product supply issue,5
HAEGARDA,Inappropriate schedule of product administration,4
HAEGARDA,Product dose omission in error,4
HAEGARDA,Anxiety,4
HAEGARDA,Pain in extremity,4
HAEGARDA,Abdominal distension,4
HAEGARDA,Nausea,4
HAEGARDA,Illness,4
HAEGARDA,Dizziness,4
HAEGARDA,Injury,3
HAEGARDA,Product distribution issue,3
HAEGARDA,Rib fracture,3
HAEGARDA,Arthralgia,3
HAEGARDA,Injection site pain,3
HAEGARDA,Constipation,3
HAEGARDA,Diarrhoea,3
HAEGARDA,Device breakage,3
HAEGARDA,Dyspnoea,3
HAEGARDA,Abdominal pain,3
HAEGARDA,Injection site bruising,3
HAEGARDA,Product container seal issue,2
HAEGARDA,Duodenogastric reflux,2
HAEGARDA,Dysphagia,2
HAEGARDA,Needle issue,2
HAEGARDA,Concussion,2
HAEGARDA,Bowel movement irregularity,2
HAEGARDA,Contusion,2
HAEGARDA,Injection site discharge,2
HAEGARDA,Hypersomnia,2
HAEGARDA,Accidental exposure to product,2
HAEGARDA,Disturbance in attention,2
HALOPERIDOL,Fatigue,10
HALOPERIDOL,Nausea,9
HALOPERIDOL,Affective disorder,8
HALOPERIDOL,Leukopenia,8
HALOPERIDOL,Neutrophil count increased,8
HALOPERIDOL,Platelet count decreased,8
HALOPERIDOL,Neuropathy peripheral,8
HALOPERIDOL,Cellulitis,8
HALOPERIDOL,Schizophrenia,8
HALOPERIDOL,Diarrhoea,8
HALOPERIDOL,Dyspepsia,8
HALOPERIDOL,Overdose,8
HALOPERIDOL,Alopecia,8
HALOPERIDOL,Incorrect dose administered,8
HALOPERIDOL,Seizure,8
HALOPERIDOL,Psychotic disorder,8
HALOPERIDOL,COVID-19,8
HALOPERIDOL,Mucosal inflammation,8
HALOPERIDOL,Lymphocyte count decreased,8
HALOPERIDOL,"Hallucination, auditory",8
HALOPERIDOL,Extrapyramidal disorder,8
HALOPERIDOL,Neutropenia,8
HALOPERIDOL,Delusion of grandeur,8
HALOPERIDOL,Off label use,8
HALOPERIDOL,Lymphocyte count abnormal,7
HALOPERIDOL,Disease progression,7
HALOPERIDOL,Rhinalgia,7
HALOPERIDOL,SARS-CoV-2 test positive,6
HALOPERIDOL,Hospitalisation,6
HALOPERIDOL,Hepatic cytolysis,5
HALOPERIDOL,Neoplasm progression,4
HALOPERIDOL,Urinary retention,4
HALOPERIDOL,Coma,4
HALOPERIDOL,Drug interaction,4
HALOPERIDOL,Post-traumatic stress disorder,3
HALOPERIDOL,Blood pressure increased,3
HALOPERIDOL,Anxiety,3
HALOPERIDOL,Anhedonia,3
HALOPERIDOL,Pain,3
HALOPERIDOL,Intentional product misuse,3
HALOPERIDOL,Apathy,3
HALOPERIDOL,Clostridium difficile infection,3
HALOPERIDOL,Urinary tract infection,2
HALOPERIDOL,Victim of sexual abuse,2
HALOPERIDOL,Staphylococcal infection,2
HALOPERIDOL,Weight decreased,2
HALOPERIDOL,Enuresis,2
HALOPERIDOL,Obstructive sleep apnoea syndrome,2
HALOPERIDOL,Abnormal behaviour,2
HALOPERIDOL,Intentional product use issue,2
HEPARIN,COVID-19,38
HEPARIN,Product dose omission issue,35
HEPARIN,Pneumonia,35
HEPARIN,Fatigue,33
HEPARIN,Headache,33
HEPARIN,Nausea,29
HEPARIN,Sinusitis,27
HEPARIN,Fall,27
HEPARIN,Dyspnoea,25
HEPARIN,Inappropriate schedule of product administration,22
HEPARIN,Pyrexia,21
HEPARIN,Pain,21
HEPARIN,Urinary tract infection,19
HEPARIN,Malaise,19
HEPARIN,Off label use,18
HEPARIN,Vomiting,17
HEPARIN,Back pain,16
HEPARIN,Upper respiratory tract infection,16
HEPARIN,Pain in extremity,15
HEPARIN,Cough,15
HEPARIN,Infusion related reaction,15
HEPARIN,Arthralgia,15
HEPARIN,Respiratory tract infection,14
HEPARIN,Product use in unapproved indication,14
HEPARIN,Nasopharyngitis,14
HEPARIN,Blood pressure increased,13
HEPARIN,Rash,12
HEPARIN,Weight decreased,12
HEPARIN,Sepsis,12
HEPARIN,Asthenia,12
HEPARIN,Hereditary angioedema,11
HEPARIN,Productive cough,11
HEPARIN,Insurance issue,11
HEPARIN,Infection,11
HEPARIN,Illness,11
HEPARIN,Contusion,10
HEPARIN,Dizziness,10
HEPARIN,Skin laceration,10
HEPARIN,Diarrhoea,10
HEPARIN,Migraine,10
HEPARIN,Condition aggravated,10
HEPARIN,Ear infection,9
HEPARIN,Bronchitis,9
HEPARIN,Atrial fibrillation,7
HEPARIN,Weight increased,7
HEPARIN,Poor venous access,7
HEPARIN,Respiratory distress,7
HEPARIN,Pruritus,7
HEPARIN,Seasonal allergy,7
HEPARIN,Localised infection,7
HEPARIN SODIUM,Off label use,13
HEPARIN SODIUM,Sepsis,11
HEPARIN SODIUM,Dyspnoea,10
HEPARIN SODIUM,Vomiting,10
HEPARIN SODIUM,Ascites,9
HEPARIN SODIUM,Drug hypersensitivity,8
HEPARIN SODIUM,Stress,8
HEPARIN SODIUM,Nausea,8
HEPARIN SODIUM,Cardiogenic shock,7
HEPARIN SODIUM,Incorrect route of product administration,7
HEPARIN SODIUM,Death,7
HEPARIN SODIUM,Multiple organ dysfunction syndrome,7
HEPARIN SODIUM,Constipation,7
HEPARIN SODIUM,Abdominal distension,7
HEPARIN SODIUM,Dry mouth,6
HEPARIN SODIUM,Condition aggravated,6
HEPARIN SODIUM,Somnolence,6
HEPARIN SODIUM,Diarrhoea,6
HEPARIN SODIUM,Hyponatraemia,5
HEPARIN SODIUM,Bacterial infection,5
HEPARIN SODIUM,Neuralgia,5
HEPARIN SODIUM,Swelling,5
HEPARIN SODIUM,Heparin-induced thrombocytopenia,5
HEPARIN SODIUM,Deep vein thrombosis,4
HEPARIN SODIUM,Drug intolerance,4
HEPARIN SODIUM,Intentional product misuse,4
HEPARIN SODIUM,Appendicolith,4
HEPARIN SODIUM,General physical health deterioration,4
HEPARIN SODIUM,Ventricular fibrillation,4
HEPARIN SODIUM,Abdominal pain,4
HEPARIN SODIUM,Appendicitis,4
HEPARIN SODIUM,Sleep disorder,4
HEPARIN SODIUM,Myelosuppression,4
HEPARIN SODIUM,Anaemia,4
HEPARIN SODIUM,Liver function test abnormal,4
HEPARIN SODIUM,Malaise,3
HEPARIN SODIUM,Nasopharyngitis,3
HEPARIN SODIUM,Blood cholesterol increased,3
HEPARIN SODIUM,Blood phosphorus increased,3
HEPARIN SODIUM,Myasthenia gravis,3
HEPARIN SODIUM,Blood uric acid increased,3
HEPARIN SODIUM,Hypokalaemia,3
HEPARIN SODIUM,Thrombosis,3
HEPARIN SODIUM,Jaundice cholestatic,3
HEPARIN SODIUM,Platelet count decreased,2
HEPARIN SODIUM,Urinary tract infection,2
HEPARIN SODIUM,Gastric fistula,2
HEPARIN SODIUM,Abdominal abscess,2
HEPARIN SODIUM,Vaginal fistula,2
HEPARIN SODIUM,Fistula,2
HERBALS,Vomiting,12
HERBALS,Nausea,11
HERBALS,Headache,8
HERBALS,Condition aggravated,8
HERBALS,Fatigue,7
HERBALS,Constipation,7
HERBALS,Abdominal pain,7
HERBALS,Malaise,6
HERBALS,Dyspnoea,6
HERBALS,Off label use,6
HERBALS,Platelet count decreased,6
HERBALS,Diabetes mellitus,6
HERBALS,Stress,5
HERBALS,Sepsis,5
HERBALS,Myasthenia gravis,5
HERBALS,Hyponatraemia,5
HERBALS,Death,5
HERBALS,White blood cell count decreased,5
HERBALS,Depression,4
HERBALS,COVID-19,4
HERBALS,Somnolence,4
HERBALS,Diarrhoea,4
HERBALS,Pain,4
HERBALS,Muscular weakness,4
HERBALS,Weight decreased,4
HERBALS,Multiple organ dysfunction syndrome,4
HERBALS,Ascites,4
HERBALS,Appendicolith,4
HERBALS,Incorrect route of product administration,4
HERBALS,General physical health deterioration,4
HERBALS,Abdominal distension,4
HERBALS,Ventricular fibrillation,4
HERBALS,Cardiogenic shock,4
HERBALS,Appendicitis,4
HERBALS,Anaemia,4
HERBALS,Dizziness,4
HERBALS,Cough,3
HERBALS,Drug hypersensitivity,3
HERBALS,Blood cholesterol increased,3
HERBALS,Dry mouth,3
HERBALS,Blood phosphorus increased,3
HERBALS,Blood uric acid increased,3
HERBALS,Renal impairment,3
HERBALS,Lymphocyte count decreased,3
HERBALS,Pyrexia,3
HERBALS,Arthralgia,3
HERBALS,Muscle spasms,3
HERBALS,Decreased appetite,3
HERBALS,Neuralgia,3
HERBALS,Gait disturbance,2
HERBALS\TURMERIC,COVID-19,15
HERBALS\TURMERIC,Headache,12
HERBALS\TURMERIC,Fatigue,11
HERBALS\TURMERIC,Sinusitis,11
HERBALS\TURMERIC,Product dose omission issue,8
HERBALS\TURMERIC,Fall,8
HERBALS\TURMERIC,Weight decreased,8
HERBALS\TURMERIC,Off label use,8
HERBALS\TURMERIC,Nasopharyngitis,7
HERBALS\TURMERIC,Pain,7
HERBALS\TURMERIC,Arthralgia,7
HERBALS\TURMERIC,Nausea,7
HERBALS\TURMERIC,Diarrhoea,7
HERBALS\TURMERIC,Pain in extremity,6
HERBALS\TURMERIC,Product use issue,6
HERBALS\TURMERIC,Vomiting,6
HERBALS\TURMERIC,Muscular weakness,5
HERBALS\TURMERIC,Asthenia,5
HERBALS\TURMERIC,Gait disturbance,5
HERBALS\TURMERIC,Arthropathy,5
HERBALS\TURMERIC,Illness,5
HERBALS\TURMERIC,Rash,5
HERBALS\TURMERIC,Seasonal allergy,5
HERBALS\TURMERIC,Feeling abnormal,4
HERBALS\TURMERIC,Rheumatoid arthritis,4
HERBALS\TURMERIC,Muscle tightness,4
HERBALS\TURMERIC,White blood cell count decreased,4
HERBALS\TURMERIC,Musculoskeletal stiffness,4
HERBALS\TURMERIC,Influenza,4
HERBALS\TURMERIC,Pneumonia,4
HERBALS\TURMERIC,Weight increased,4
HERBALS\TURMERIC,Skin infection,4
HERBALS\TURMERIC,Hypersensitivity,4
HERBALS\TURMERIC,Infusion related reaction,4
HERBALS\TURMERIC,Cerebrovascular accident,4
HERBALS\TURMERIC,Insurance issue,4
HERBALS\TURMERIC,Pruritus,4
HERBALS\TURMERIC,Abdominal pain,4
HERBALS\TURMERIC,Dizziness,4
HERBALS\TURMERIC,Product use in unapproved indication,4
HERBALS\TURMERIC,Blood HIV RNA increased,4
HERBALS\TURMERIC,Treatment failure,4
HERBALS\TURMERIC,Disease recurrence,4
HERBALS\TURMERIC,Pathogen resistance,4
HERBALS\TURMERIC,Swelling,3
HERBALS\TURMERIC,Gait inability,3
HERBALS\TURMERIC,Erythema,3
HERBALS\TURMERIC,Peripheral swelling,3
HERBALS\TURMERIC,Therapeutic response decreased,3
HERBALS\TURMERIC,Myalgia,3
HIZENTRA,Fatigue,25
HIZENTRA,No adverse event,21
HIZENTRA,Malaise,17
HIZENTRA,Headache,17
HIZENTRA,Asthenia,11
HIZENTRA,Pyrexia,10
HIZENTRA,COVID-19,10
HIZENTRA,Pneumonia,10
HIZENTRA,Death,10
HIZENTRA,Product dose omission issue,9
HIZENTRA,Infusion site swelling,9
HIZENTRA,Nausea,9
HIZENTRA,Insurance issue,8
HIZENTRA,Infusion site pain,8
HIZENTRA,Dizziness,8
HIZENTRA,Dyspnoea,8
HIZENTRA,Rash,8
HIZENTRA,Inappropriate schedule of product administration,7
HIZENTRA,Muscular weakness,7
HIZENTRA,Off label use,7
HIZENTRA,Cough,6
HIZENTRA,Drug ineffective,6
HIZENTRA,Feeling abnormal,6
HIZENTRA,Infusion site bruising,6
HIZENTRA,Diarrhoea,5
HIZENTRA,Weight increased,5
HIZENTRA,Viral infection,5
HIZENTRA,Pain,5
HIZENTRA,Arthralgia,5
HIZENTRA,Migraine,5
HIZENTRA,Swelling,5
HIZENTRA,Sinusitis,5
HIZENTRA,Tremor,5
HIZENTRA,Vomiting,5
HIZENTRA,Blood pressure increased,5
HIZENTRA,Abdominal discomfort,5
HIZENTRA,Injection site erythema,5
HIZENTRA,Infusion site extravasation,5
HIZENTRA,Infusion site erythema,5
HIZENTRA,Chronic inflammatory demyelinating polyradiculoneuropathy,5
HIZENTRA,Therapy interrupted,5
HIZENTRA,Pruritus,5
HIZENTRA,Bronchitis,4
HIZENTRA,Influenza,4
HIZENTRA,Ear infection,4
HIZENTRA,Infusion site warmth,4
HIZENTRA,Meningitis aseptic,4
HIZENTRA,Infusion site pruritus,4
HIZENTRA,Hypoaesthesia,4
HIZENTRA,Dehydration,4
HUMALOG,COVID-19,14
HUMALOG,Off label use,10
HUMALOG,Fatigue,10
HUMALOG,Fall,9
HUMALOG,Pain,9
HUMALOG,Urinary tract infection,9
HUMALOG,Anaemia,9
HUMALOG,Acute kidney injury,9
HUMALOG,Anxiety,8
HUMALOG,Dyspnoea,8
HUMALOG,Diarrhoea,8
HUMALOG,Product dose omission issue,8
HUMALOG,Nausea,8
HUMALOG,Pyrexia,7
HUMALOG,Headache,7
HUMALOG,Emotional distress,7
HUMALOG,Hypoglycaemia,7
HUMALOG,Asthenia,6
HUMALOG,Chronic kidney disease,6
HUMALOG,Anhedonia,6
HUMALOG,Pancytopenia,6
HUMALOG,Thrombocytopenia,6
HUMALOG,Back pain,5
HUMALOG,Sinusitis,5
HUMALOG,Dehydration,5
HUMALOG,Foot fracture,5
HUMALOG,Malaise,5
HUMALOG,Hyperglycaemia,5
HUMALOG,Pneumonia,4
HUMALOG,Productive cough,4
HUMALOG,Arthralgia,4
HUMALOG,Weight increased,4
HUMALOG,Diabetes mellitus,4
HUMALOG,Hypertension,4
HUMALOG,Hyperkalaemia,4
HUMALOG,Renal failure,4
HUMALOG,Decreased appetite,4
HUMALOG,Blood glucose increased,4
HUMALOG,Hypotension,4
HUMALOG,Drug interaction,4
HUMALOG,Pain in extremity,4
HUMALOG,Alopecia,3
HUMALOG,Depression,3
HUMALOG,Upper respiratory tract infection,3
HUMALOG,Chills,3
HUMALOG,Atrial fibrillation,3
HUMALOG,Septic shock,3
HUMALOG,Neutropenia,3
HUMALOG,Nasopharyngitis,3
HUMALOG,Osteoporosis,3
HUMAN IMMUNOGLOBULIN G,Sinusitis,161
HUMAN IMMUNOGLOBULIN G,COVID-19,158
HUMAN IMMUNOGLOBULIN G,Product dose omission issue,121
HUMAN IMMUNOGLOBULIN G,Fatigue,106
HUMAN IMMUNOGLOBULIN G,Headache,103
HUMAN IMMUNOGLOBULIN G,Pneumonia,93
HUMAN IMMUNOGLOBULIN G,Urinary tract infection,89
HUMAN IMMUNOGLOBULIN G,Nausea,84
HUMAN IMMUNOGLOBULIN G,Malaise,70
HUMAN IMMUNOGLOBULIN G,Fall,69
HUMAN IMMUNOGLOBULIN G,Upper respiratory tract infection,68
HUMAN IMMUNOGLOBULIN G,Inappropriate schedule of product administration,63
HUMAN IMMUNOGLOBULIN G,Illness,63
HUMAN IMMUNOGLOBULIN G,Nasopharyngitis,60
HUMAN IMMUNOGLOBULIN G,Pain,59
HUMAN IMMUNOGLOBULIN G,Bronchitis,58
HUMAN IMMUNOGLOBULIN G,Pyrexia,55
HUMAN IMMUNOGLOBULIN G,Infusion related reaction,55
HUMAN IMMUNOGLOBULIN G,Infection,52
HUMAN IMMUNOGLOBULIN G,Influenza,51
HUMAN IMMUNOGLOBULIN G,Dyspnoea,50
HUMAN IMMUNOGLOBULIN G,Respiratory tract infection,48
HUMAN IMMUNOGLOBULIN G,Infusion site pain,44
HUMAN IMMUNOGLOBULIN G,Ear infection,43
HUMAN IMMUNOGLOBULIN G,Weight decreased,43
HUMAN IMMUNOGLOBULIN G,Cough,42
HUMAN IMMUNOGLOBULIN G,Insurance issue,42
HUMAN IMMUNOGLOBULIN G,Off label use,41
HUMAN IMMUNOGLOBULIN G,Infusion site swelling,40
HUMAN IMMUNOGLOBULIN G,Asthma,40
HUMAN IMMUNOGLOBULIN G,Diarrhoea,38
HUMAN IMMUNOGLOBULIN G,Migraine,37
HUMAN IMMUNOGLOBULIN G,Back pain,37
HUMAN IMMUNOGLOBULIN G,Arthralgia,35
HUMAN IMMUNOGLOBULIN G,Dizziness,34
HUMAN IMMUNOGLOBULIN G,Asthenia,34
HUMAN IMMUNOGLOBULIN G,Rash,34
HUMAN IMMUNOGLOBULIN G,Seasonal allergy,33
HUMAN IMMUNOGLOBULIN G,Pain in extremity,31
HUMAN IMMUNOGLOBULIN G,Vomiting,31
HUMAN IMMUNOGLOBULIN G,Blood pressure increased,31
HUMAN IMMUNOGLOBULIN G,Viral infection,30
HUMAN IMMUNOGLOBULIN G,Weight increased,30
HUMAN IMMUNOGLOBULIN G,Gastroenteritis viral,29
HUMAN IMMUNOGLOBULIN G,Infusion site pruritus,28
HUMAN IMMUNOGLOBULIN G,Oropharyngeal pain,28
HUMAN IMMUNOGLOBULIN G,Pruritus,27
HUMAN IMMUNOGLOBULIN G,Infusion site extravasation,25
HUMAN IMMUNOGLOBULIN G,Contusion,25
HUMAN IMMUNOGLOBULIN G,Infusion site bruising,23
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Sinusitis,47
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,COVID-19,38
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Pneumonia,35
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Pyrexia,30
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Weight increased,29
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Product dose omission issue,28
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Malaise,25
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Urinary tract infection,21
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Bronchitis,18
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Cough,17
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Vomiting,17
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site pain,17
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Inappropriate schedule of product administration,16
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infection,15
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site erythema,15
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site extravasation,15
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Upper respiratory tract infection,15
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Fatigue,15
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Fall,15
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Influenza,14
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Nasopharyngitis,14
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Seasonal allergy,13
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Weight decreased,12
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Diarrhoea,12
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion related reaction,12
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Product availability issue,12
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Headache,11
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Pain,10
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Pain in extremity,9
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Rash,9
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site pruritus,9
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Insurance issue,9
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Illness,9
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site swelling,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Ear infection,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Gastrointestinal disorder,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Nausea,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Nasal congestion,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Abdominal pain,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Body height increased,8
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Infusion site rash,7
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Feeling abnormal,7
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Incorrect dose administered,7
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Multiple allergies,7
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Viral infection,6
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Dizziness,6
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Oropharyngeal pain,6
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Asthma,6
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Erythema,6
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN,Inflammation,6
HUMIRA,Arthralgia,92
HUMIRA,Drug ineffective,80
HUMIRA,Pain,79
HUMIRA,Pain in extremity,68
HUMIRA,Off label use,57
HUMIRA,Diarrhoea,49
HUMIRA,Rheumatoid arthritis,47
HUMIRA,Fatigue,46
HUMIRA,Peripheral swelling,44
HUMIRA,Malaise,43
HUMIRA,Rash,42
HUMIRA,Headache,40
HUMIRA,COVID-19,40
HUMIRA,Back pain,38
HUMIRA,Dyspnoea,37
HUMIRA,Therapeutic product effect decreased,35
HUMIRA,Fall,35
HUMIRA,Musculoskeletal stiffness,34
HUMIRA,Psoriasis,34
HUMIRA,Injection site haemorrhage,34
HUMIRA,Weight decreased,31
HUMIRA,Nausea,31
HUMIRA,Crohn's disease,30
HUMIRA,Wrong technique in product usage process,30
HUMIRA,Arthritis,29
HUMIRA,Unevaluable event,29
HUMIRA,Pruritus,28
HUMIRA,Device issue,28
HUMIRA,Inflammation,27
HUMIRA,Pyrexia,27
HUMIRA,Condition aggravated,27
HUMIRA,Osteoarthritis,27
HUMIRA,Injection site pain,27
HUMIRA,Dizziness,26
HUMIRA,Nasopharyngitis,26
HUMIRA,Joint swelling,25
HUMIRA,Mobility decreased,25
HUMIRA,Drug hypersensitivity,24
HUMIRA,Sinusitis,24
HUMIRA,Vomiting,24
HUMIRA,Infection,23
HUMIRA,Asthenia,23
HUMIRA,Hypertension,23
HUMIRA,Drug intolerance,21
HUMIRA,Psoriatic arthropathy,21
HUMIRA,Abdominal pain upper,21
HUMIRA,Abdominal pain,21
HUMIRA,Hypoaesthesia,20
HUMIRA,Maternal exposure during pregnancy,20
HUMIRA,Pneumonia,20
HYDRALAZINE,Pain,14
HYDRALAZINE,Fatigue,13
HYDRALAZINE,Anxiety,9
HYDRALAZINE,Emotional distress,9
HYDRALAZINE,Depression,9
HYDRALAZINE,Anhedonia,8
HYDRALAZINE,Chronic kidney disease,8
HYDRALAZINE,Arthritis,8
HYDRALAZINE,Off label use,7
HYDRALAZINE,Arthralgia,7
HYDRALAZINE,End stage renal disease,6
HYDRALAZINE,Illness,6
HYDRALAZINE,Hypertension,6
HYDRALAZINE,Atrial fibrillation,6
HYDRALAZINE,Infection,6
HYDRALAZINE,Diarrhoea,5
HYDRALAZINE,Nausea,5
HYDRALAZINE,Acute kidney injury,5
HYDRALAZINE,Renal failure,5
HYDRALAZINE,Dizziness,5
HYDRALAZINE,Death,5
HYDRALAZINE,Vomiting,4
HYDRALAZINE,Asthenia,4
HYDRALAZINE,Cough,4
HYDRALAZINE,Decreased appetite,4
HYDRALAZINE,Weight decreased,4
HYDRALAZINE,Condition aggravated,4
HYDRALAZINE,Peripheral swelling,4
HYDRALAZINE,Dyspnoea,4
HYDRALAZINE,Cerebrovascular accident,4
HYDRALAZINE,Myalgia,4
HYDRALAZINE,Pleural effusion,4
HYDRALAZINE,Premature menopause,4
HYDRALAZINE,Venous thrombosis limb,4
HYDRALAZINE,Lupus-like syndrome,4
HYDRALAZINE,Live birth,4
HYDRALAZINE,Antiphospholipid syndrome,4
HYDRALAZINE,Polyserositis,4
HYDRALAZINE,Respiratory failure,4
HYDRALAZINE,Ascites,4
HYDRALAZINE,Cardiac tamponade,4
HYDRALAZINE,Peritonitis,4
HYDRALAZINE,Maternal exposure during pregnancy,4
HYDRALAZINE,Somatic symptom disorder,4
HYDRALAZINE,Ovarian failure,4
HYDRALAZINE,Frequent bowel movements,4
HYDRALAZINE,Photosensitivity reaction,4
HYDRALAZINE,Pouchitis,4
HYDRALAZINE,Hair colour changes,3
HYDRALAZINE,Neuropathy peripheral,3
HYDROCHLOROTHIAZIDE,Pain,153
HYDROCHLOROTHIAZIDE,Fatigue,150
HYDROCHLOROTHIAZIDE,Anxiety,134
HYDROCHLOROTHIAZIDE,Headache,128
HYDROCHLOROTHIAZIDE,COVID-19,128
HYDROCHLOROTHIAZIDE,Diarrhoea,126
HYDROCHLOROTHIAZIDE,Nausea,122
HYDROCHLOROTHIAZIDE,Malaise,120
HYDROCHLOROTHIAZIDE,Dyspnoea,119
HYDROCHLOROTHIAZIDE,Off label use,119
HYDROCHLOROTHIAZIDE,Pruritus,118
HYDROCHLOROTHIAZIDE,Arthralgia,116
HYDROCHLOROTHIAZIDE,Back pain,109
HYDROCHLOROTHIAZIDE,Dizziness,109
HYDROCHLOROTHIAZIDE,Memory impairment,106
HYDROCHLOROTHIAZIDE,Peripheral swelling,106
HYDROCHLOROTHIAZIDE,Pyrexia,104
HYDROCHLOROTHIAZIDE,Palpitations,104
HYDROCHLOROTHIAZIDE,Insomnia,103
HYDROCHLOROTHIAZIDE,Abdominal pain upper,100
HYDROCHLOROTHIAZIDE,Feeling abnormal,99
HYDROCHLOROTHIAZIDE,Vomiting,99
HYDROCHLOROTHIAZIDE,Abdominal discomfort,98
HYDROCHLOROTHIAZIDE,Ventricular tachycardia,98
HYDROCHLOROTHIAZIDE,Dehydration,96
HYDROCHLOROTHIAZIDE,Dry skin,95
HYDROCHLOROTHIAZIDE,Alopecia,94
HYDROCHLOROTHIAZIDE,Heart rate increased,94
HYDROCHLOROTHIAZIDE,Blood glucose increased,93
HYDROCHLOROTHIAZIDE,Migraine,93
HYDROCHLOROTHIAZIDE,Disturbance in attention,93
HYDROCHLOROTHIAZIDE,Chest pain,93
HYDROCHLOROTHIAZIDE,Intentional product misuse,92
HYDROCHLOROTHIAZIDE,Pericarditis,92
HYDROCHLOROTHIAZIDE,Tinnitus,92
HYDROCHLOROTHIAZIDE,Tachycardia,92
HYDROCHLOROTHIAZIDE,Eye pruritus,92
HYDROCHLOROTHIAZIDE,Muscular weakness,92
HYDROCHLOROTHIAZIDE,Myocardial infarction,92
HYDROCHLOROTHIAZIDE,Hallucination,91
HYDROCHLOROTHIAZIDE,Cognitive disorder,91
HYDROCHLOROTHIAZIDE,Amnesia,91
HYDROCHLOROTHIAZIDE,Hyperhidrosis,91
HYDROCHLOROTHIAZIDE,Visual impairment,91
HYDROCHLOROTHIAZIDE,Lip swelling,91
HYDROCHLOROTHIAZIDE,Anosmia,90
HYDROCHLOROTHIAZIDE,Atrial tachycardia,90
HYDROCHLOROTHIAZIDE,Vasculitis,89
HYDROCHLOROTHIAZIDE,Transient ischaemic attack,89
HYDROCHLOROTHIAZIDE,Facial pain,89
HYDROCODONE,Pain,27
HYDROCODONE,Emotional distress,18
HYDROCODONE,Anxiety,17
HYDROCODONE,Anhedonia,16
HYDROCODONE,Depression,11
HYDROCODONE,Fatigue,11
HYDROCODONE,Osteoporosis,10
HYDROCODONE,Nausea,9
HYDROCODONE,Osteopenia,8
HYDROCODONE,Malaise,8
HYDROCODONE,Fall,7
HYDROCODONE,Chronic kidney disease,7
HYDROCODONE,Renal failure,7
HYDROCODONE,Asthenia,7
HYDROCODONE,Product dose omission issue,6
HYDROCODONE,COVID-19,6
HYDROCODONE,Economic problem,5
HYDROCODONE,Acute kidney injury,5
HYDROCODONE,Bone density decreased,5
HYDROCODONE,Pruritus,5
HYDROCODONE,Pneumonia,5
HYDROCODONE,Gait disturbance,5
HYDROCODONE,Drug ineffective,5
HYDROCODONE,Headache,5
HYDROCODONE,Back pain,5
HYDROCODONE,Off label use,5
HYDROCODONE,Foot fracture,4
HYDROCODONE,End stage renal disease,4
HYDROCODONE,Urinary tract infection,4
HYDROCODONE,Bone demineralisation,4
HYDROCODONE,Illness,4
HYDROCODONE,Diarrhoea,4
HYDROCODONE,Anaemia,3
HYDROCODONE,General physical health deterioration,3
HYDROCODONE,Ankle fracture,3
HYDROCODONE,Wrist fracture,3
HYDROCODONE,Quality of life decreased,3
HYDROCODONE,Renal injury,3
HYDROCODONE,Fracture,3
HYDROCODONE,Cough,3
HYDROCODONE,Sciatica,3
HYDROCODONE,Muscular weakness,3
HYDROCODONE,Hypertension,3
HYDROCODONE,Hereditary angioedema,3
HYDROCODONE,Urticaria,3
HYDROCODONE,Somnolence,3
HYDROCODONE,Confusional state,3
HYDROCODONE,Back disorder,3
HYDROCODONE,Sinusitis,3
HYDROCODONE,Infection,3
HYDROCORTISONE,Off label use,46
HYDROCORTISONE,Fatigue,40
HYDROCORTISONE,Pain,33
HYDROCORTISONE,Diarrhoea,27
HYDROCORTISONE,Pyrexia,27
HYDROCORTISONE,Headache,25
HYDROCORTISONE,Rash,25
HYDROCORTISONE,Arthralgia,24
HYDROCORTISONE,Dyspnoea,23
HYDROCORTISONE,Malaise,23
HYDROCORTISONE,Nausea,21
HYDROCORTISONE,Vomiting,21
HYDROCORTISONE,Pruritus,20
HYDROCORTISONE,Abdominal pain,19
HYDROCORTISONE,COVID-19,18
HYDROCORTISONE,Infusion related reaction,17
HYDROCORTISONE,Weight increased,16
HYDROCORTISONE,Alopecia,16
HYDROCORTISONE,Asthenia,15
HYDROCORTISONE,Dizziness,15
HYDROCORTISONE,Drug ineffective,15
HYDROCORTISONE,Weight decreased,15
HYDROCORTISONE,Pain in extremity,15
HYDROCORTISONE,Back pain,14
HYDROCORTISONE,Depression,14
HYDROCORTISONE,Neutropenia,14
HYDROCORTISONE,Hypertension,13
HYDROCORTISONE,Pneumonia,13
HYDROCORTISONE,Condition aggravated,13
HYDROCORTISONE,Urinary tract infection,13
HYDROCORTISONE,Musculoskeletal stiffness,12
HYDROCORTISONE,Insomnia,12
HYDROCORTISONE,Abdominal discomfort,12
HYDROCORTISONE,Product dose omission issue,12
HYDROCORTISONE,Cough,12
HYDROCORTISONE,Muscle spasms,11
HYDROCORTISONE,Intentional product use issue,11
HYDROCORTISONE,Chest pain,11
HYDROCORTISONE,Product use in unapproved indication,11
HYDROCORTISONE,Anaemia,11
HYDROCORTISONE,Confusional state,10
HYDROCORTISONE,Anxiety,10
HYDROCORTISONE,Crohn's disease,10
HYDROCORTISONE,Constipation,10
HYDROCORTISONE,Hepatic enzyme increased,9
HYDROCORTISONE,Medication error,9
HYDROCORTISONE,Psoriatic arthropathy,9
HYDROCORTISONE,Type 2 diabetes mellitus,9
HYDROCORTISONE,Decreased appetite,9
HYDROCORTISONE,Muscular weakness,9
HYDROMORPHONE,Vomiting,24
HYDROMORPHONE,Nausea,24
HYDROMORPHONE,Pain,17
HYDROMORPHONE,Fatigue,17
HYDROMORPHONE,Off label use,17
HYDROMORPHONE,Sepsis,15
HYDROMORPHONE,Death,12
HYDROMORPHONE,Pain in extremity,11
HYDROMORPHONE,Dyspnoea,11
HYDROMORPHONE,Pneumonia,10
HYDROMORPHONE,Drug ineffective,10
HYDROMORPHONE,Drug hypersensitivity,10
HYDROMORPHONE,Arthralgia,10
HYDROMORPHONE,Constipation,10
HYDROMORPHONE,Anxiety,9
HYDROMORPHONE,Fall,9
HYDROMORPHONE,Diarrhoea,9
HYDROMORPHONE,Dizziness,8
HYDROMORPHONE,Anaemia,8
HYDROMORPHONE,Headache,8
HYDROMORPHONE,Drug intolerance,8
HYDROMORPHONE,Somnolence,8
HYDROMORPHONE,Sleep disorder,8
HYDROMORPHONE,Stress,8
HYDROMORPHONE,Pyrexia,7
HYDROMORPHONE,Back pain,7
HYDROMORPHONE,General physical health deterioration,7
HYDROMORPHONE,Abdominal distension,7
HYDROMORPHONE,Swelling,7
HYDROMORPHONE,Abdominal pain,6
HYDROMORPHONE,Contusion,6
HYDROMORPHONE,Cough,6
HYDROMORPHONE,Hypoaesthesia,6
HYDROMORPHONE,Loss of consciousness,6
HYDROMORPHONE,Dysphagia,6
HYDROMORPHONE,Rib fracture,6
HYDROMORPHONE,Ascites,6
HYDROMORPHONE,Condition aggravated,6
HYDROMORPHONE,Respiratory failure,5
HYDROMORPHONE,Nasopharyngitis,5
HYDROMORPHONE,COVID-19,5
HYDROMORPHONE,Malaise,5
HYDROMORPHONE,Lung disorder,5
HYDROMORPHONE,Neutropenia,5
HYDROMORPHONE,Haematoma,5
HYDROMORPHONE,Inflammation,5
HYDROMORPHONE,Tachycardia,5
HYDROMORPHONE,Hyperhidrosis,5
HYDROMORPHONE,Cardiogenic shock,5
HYDROMORPHONE,Bacterial infection,5
HYDROXYCHLOROQUINE,Off label use,29
HYDROXYCHLOROQUINE,Arthralgia,26
HYDROXYCHLOROQUINE,Headache,26
HYDROXYCHLOROQUINE,Drug ineffective,26
HYDROXYCHLOROQUINE,Diarrhoea,24
HYDROXYCHLOROQUINE,Rash,23
HYDROXYCHLOROQUINE,Nausea,22
HYDROXYCHLOROQUINE,Rheumatoid arthritis,20
HYDROXYCHLOROQUINE,Fatigue,20
HYDROXYCHLOROQUINE,Condition aggravated,20
HYDROXYCHLOROQUINE,Peripheral swelling,19
HYDROXYCHLOROQUINE,Pain,18
HYDROXYCHLOROQUINE,Hypertension,17
HYDROXYCHLOROQUINE,Pyrexia,16
HYDROXYCHLOROQUINE,Malaise,16
HYDROXYCHLOROQUINE,Product use issue,15
HYDROXYCHLOROQUINE,Drug intolerance,15
HYDROXYCHLOROQUINE,Dyspnoea,14
HYDROXYCHLOROQUINE,Nasopharyngitis,14
HYDROXYCHLOROQUINE,Arthropathy,14
HYDROXYCHLOROQUINE,Pain in extremity,14
HYDROXYCHLOROQUINE,Joint swelling,13
HYDROXYCHLOROQUINE,Therapeutic product effect decreased,13
HYDROXYCHLOROQUINE,Pneumonia,13
HYDROXYCHLOROQUINE,Vomiting,13
HYDROXYCHLOROQUINE,Abdominal discomfort,13
HYDROXYCHLOROQUINE,COVID-19,13
HYDROXYCHLOROQUINE,Musculoskeletal stiffness,12
HYDROXYCHLOROQUINE,Hepatic enzyme increased,12
HYDROXYCHLOROQUINE,Contraindicated product administered,12
HYDROXYCHLOROQUINE,Weight decreased,12
HYDROXYCHLOROQUINE,Urinary tract infection,12
HYDROXYCHLOROQUINE,Product dose omission issue,12
HYDROXYCHLOROQUINE,Infection,11
HYDROXYCHLOROQUINE,Intentional product use issue,11
HYDROXYCHLOROQUINE,Mobility decreased,11
HYDROXYCHLOROQUINE,Drug hypersensitivity,11
HYDROXYCHLOROQUINE,Fall,11
HYDROXYCHLOROQUINE,Weight increased,10
HYDROXYCHLOROQUINE,Synovitis,10
HYDROXYCHLOROQUINE,Insomnia,10
HYDROXYCHLOROQUINE,Abdominal pain upper,10
HYDROXYCHLOROQUINE,Swelling,10
HYDROXYCHLOROQUINE,Herpes zoster,10
HYDROXYCHLOROQUINE,Asthenia,9
HYDROXYCHLOROQUINE,Alopecia,9
HYDROXYCHLOROQUINE,Dizziness,9
HYDROXYCHLOROQUINE,Psoriatic arthropathy,9
HYDROXYCHLOROQUINE,Sinusitis,9
HYDROXYCHLOROQUINE,C-reactive protein increased,9
HYDROXYCHLOROQUINE SULFATE,Arthralgia,25
HYDROXYCHLOROQUINE SULFATE,Nausea,20
HYDROXYCHLOROQUINE SULFATE,Drug ineffective,19
HYDROXYCHLOROQUINE SULFATE,Off label use,19
HYDROXYCHLOROQUINE SULFATE,Rheumatoid arthritis,18
HYDROXYCHLOROQUINE SULFATE,Fatigue,17
HYDROXYCHLOROQUINE SULFATE,Diarrhoea,17
HYDROXYCHLOROQUINE SULFATE,Pneumonia,16
HYDROXYCHLOROQUINE SULFATE,Malaise,16
HYDROXYCHLOROQUINE SULFATE,Condition aggravated,16
HYDROXYCHLOROQUINE SULFATE,Pain,16
HYDROXYCHLOROQUINE SULFATE,Drug intolerance,15
HYDROXYCHLOROQUINE SULFATE,Pain in extremity,15
HYDROXYCHLOROQUINE SULFATE,Sinusitis,15
HYDROXYCHLOROQUINE SULFATE,Rash,14
HYDROXYCHLOROQUINE SULFATE,Headache,14
HYDROXYCHLOROQUINE SULFATE,Drug hypersensitivity,14
HYDROXYCHLOROQUINE SULFATE,Musculoskeletal stiffness,13
HYDROXYCHLOROQUINE SULFATE,Infection,13
HYDROXYCHLOROQUINE SULFATE,Therapeutic product effect decreased,12
HYDROXYCHLOROQUINE SULFATE,Product use issue,12
HYDROXYCHLOROQUINE SULFATE,Contraindicated product administered,12
HYDROXYCHLOROQUINE SULFATE,Arthropathy,11
HYDROXYCHLOROQUINE SULFATE,Peripheral swelling,11
HYDROXYCHLOROQUINE SULFATE,Joint swelling,11
HYDROXYCHLOROQUINE SULFATE,Vomiting,11
HYDROXYCHLOROQUINE SULFATE,Abdominal discomfort,11
HYDROXYCHLOROQUINE SULFATE,Dizziness,11
HYDROXYCHLOROQUINE SULFATE,C-reactive protein increased,11
HYDROXYCHLOROQUINE SULFATE,Product dose omission issue,11
HYDROXYCHLOROQUINE SULFATE,Insomnia,10
HYDROXYCHLOROQUINE SULFATE,Mobility decreased,10
HYDROXYCHLOROQUINE SULFATE,COVID-19,10
HYDROXYCHLOROQUINE SULFATE,Synovitis,9
HYDROXYCHLOROQUINE SULFATE,Loss of personal independence in daily activities,9
HYDROXYCHLOROQUINE SULFATE,Nasopharyngitis,9
HYDROXYCHLOROQUINE SULFATE,Hypoaesthesia,9
HYDROXYCHLOROQUINE SULFATE,Blood pressure increased,9
HYDROXYCHLOROQUINE SULFATE,Red blood cell sedimentation rate increased,9
HYDROXYCHLOROQUINE SULFATE,Hepatic enzyme increased,8
HYDROXYCHLOROQUINE SULFATE,Treatment failure,8
HYDROXYCHLOROQUINE SULFATE,C-reactive protein abnormal,8
HYDROXYCHLOROQUINE SULFATE,Weight decreased,8
HYDROXYCHLOROQUINE SULFATE,Hypertension,8
HYDROXYCHLOROQUINE SULFATE,Dyspnoea,8
HYDROXYCHLOROQUINE SULFATE,Arthritis,8
HYDROXYCHLOROQUINE SULFATE,Influenza,8
HYDROXYCHLOROQUINE SULFATE,Psoriatic arthropathy,7
HYDROXYCHLOROQUINE SULFATE,Pyrexia,7
HYDROXYCHLOROQUINE SULFATE,Contusion,7
HYDROXYUREA,Off label use,19
HYDROXYUREA,Sickle cell anaemia with crisis,12
HYDROXYUREA,Diarrhoea,10
HYDROXYUREA,Nausea,8
HYDROXYUREA,Fatigue,6
HYDROXYUREA,Pain,6
HYDROXYUREA,Acute chest syndrome,6
HYDROXYUREA,Asthenia,5
HYDROXYUREA,Pyrexia,5
HYDROXYUREA,Vomiting,4
HYDROXYUREA,Abdominal discomfort,4
HYDROXYUREA,Malaise,3
HYDROXYUREA,Disease progression,3
HYDROXYUREA,Abdominal pain,3
HYDROXYUREA,Headache,3
HYDROXYUREA,Upper gastrointestinal haemorrhage,3
HYDROXYUREA,Back pain,3
HYDROXYUREA,Product use issue,3
HYDROXYUREA,Muscle spasms,2
HYDROXYUREA,Constipation,2
HYDROXYUREA,Peripheral swelling,2
HYDROXYUREA,Product dose omission issue,2
HYDROXYUREA,Anxiety,2
HYDROXYUREA,Death,2
HYDROXYUREA,COVID-19,2
HYDROXYUREA,Sinus pain,2
HYDROXYUREA,Dizziness,2
HYDROXYUREA,Rash pruritic,2
HYDROXYUREA,Pneumonia klebsiella,2
HYDROXYUREA,Sepsis,2
HYDROXYUREA,SARS-CoV-2 test positive,2
HYDROXYUREA,Therapeutic response unexpected,2
HYDROXYUREA,Palpitations,2
HYDROXYUREA,Chest discomfort,2
HYDROXYUREA,Sinusitis,2
HYDROXYUREA,Condition aggravated,2
HYDROXYUREA,Fall,2
HYDROXYUREA,Full blood count decreased,2
HYDROXYUREA,Pulmonary hypertension,2
HYDROXYUREA,Pain in extremity,2
HYDROXYUREA,Drug ineffective,2
HYDROXYUREA,Cytopenia,2
HYDROXYUREA,Incorrect dose administered,2
HYDROXYUREA,Eye pain,2
HYDROXYUREA,Chills,1
HYDROXYUREA,Feeling abnormal,1
HYDROXYUREA,Toxicity to various agents,1
HYDROXYUREA,Vitamin B12 decreased,1
HYDROXYUREA,Joint swelling,1
HYDROXYUREA,Poor quality sleep,1
HYDROXYZINE,Pain,26
HYDROXYZINE,Anxiety,19
HYDROXYZINE,Anhedonia,15
HYDROXYZINE,Emotional distress,15
HYDROXYZINE,Pyrexia,15
HYDROXYZINE,Headache,13
HYDROXYZINE,Product dose omission issue,13
HYDROXYZINE,Pruritus,13
HYDROXYZINE,Fatigue,11
HYDROXYZINE,Diarrhoea,10
HYDROXYZINE,Chronic kidney disease,9
HYDROXYZINE,Pain in extremity,9
HYDROXYZINE,Urticaria,9
HYDROXYZINE,Off label use,8
HYDROXYZINE,Weight increased,8
HYDROXYZINE,Rash,8
HYDROXYZINE,Vomiting,8
HYDROXYZINE,Inappropriate schedule of product administration,7
HYDROXYZINE,Asthenia,7
HYDROXYZINE,Osteopenia,7
HYDROXYZINE,Renal impairment,7
HYDROXYZINE,Insomnia,7
HYDROXYZINE,Osteoporosis,7
HYDROXYZINE,Nasopharyngitis,7
HYDROXYZINE,Drug ineffective,7
HYDROXYZINE,Arthralgia,7
HYDROXYZINE,Abdominal pain,7
HYDROXYZINE,Weight decreased,6
HYDROXYZINE,Malaise,6
HYDROXYZINE,Depression,5
HYDROXYZINE,Nausea,5
HYDROXYZINE,Blood creatinine increased,5
HYDROXYZINE,Stress,5
HYDROXYZINE,Hypersensitivity,5
HYDROXYZINE,Migraine,5
HYDROXYZINE,Acute kidney injury,5
HYDROXYZINE,Toxicity to various agents,5
HYDROXYZINE,C-reactive protein increased,5
HYDROXYZINE,Aspartate aminotransferase increased,5
HYDROXYZINE,Dyspnoea,5
HYDROXYZINE,Fall,5
HYDROXYZINE,End stage renal disease,4
HYDROXYZINE,Dizziness,4
HYDROXYZINE,Incorrect dose administered,4
HYDROXYZINE,Cough,4
HYDROXYZINE,Gait disturbance,4
HYDROXYZINE,Muscle spasms,4
HYDROXYZINE,Injection site pain,4
HYDROXYZINE,Neuroblastoma,4
HYDROXYZINE,Blood lactate dehydrogenase increased,4
HYDROXYZINE HYDROCHLORIDE,Pain,14
HYDROXYZINE HYDROCHLORIDE,Headache,14
HYDROXYZINE HYDROCHLORIDE,Fatigue,14
HYDROXYZINE HYDROCHLORIDE,Nausea,12
HYDROXYZINE HYDROCHLORIDE,Pruritus,12
HYDROXYZINE HYDROCHLORIDE,Product dose omission issue,12
HYDROXYZINE HYDROCHLORIDE,Pyrexia,12
HYDROXYZINE HYDROCHLORIDE,Weight decreased,10
HYDROXYZINE HYDROCHLORIDE,Vomiting,10
HYDROXYZINE HYDROCHLORIDE,Sinusitis,9
HYDROXYZINE HYDROCHLORIDE,COVID-19,8
HYDROXYZINE HYDROCHLORIDE,Inappropriate schedule of product administration,8
HYDROXYZINE HYDROCHLORIDE,Hypersensitivity,8
HYDROXYZINE HYDROCHLORIDE,Rash,8
HYDROXYZINE HYDROCHLORIDE,Urinary tract infection,7
HYDROXYZINE HYDROCHLORIDE,Influenza,7
HYDROXYZINE HYDROCHLORIDE,Drug ineffective,7
HYDROXYZINE HYDROCHLORIDE,Dizziness,7
HYDROXYZINE HYDROCHLORIDE,Pain in extremity,7
HYDROXYZINE HYDROCHLORIDE,Diarrhoea,7
HYDROXYZINE HYDROCHLORIDE,Arthralgia,7
HYDROXYZINE HYDROCHLORIDE,Urticaria,7
HYDROXYZINE HYDROCHLORIDE,Weight increased,7
HYDROXYZINE HYDROCHLORIDE,Nasopharyngitis,6
HYDROXYZINE HYDROCHLORIDE,Asthma,6
HYDROXYZINE HYDROCHLORIDE,Anxiety,6
HYDROXYZINE HYDROCHLORIDE,Illness,6
HYDROXYZINE HYDROCHLORIDE,Fall,6
HYDROXYZINE HYDROCHLORIDE,Off label use,6
HYDROXYZINE HYDROCHLORIDE,Abdominal pain,6
HYDROXYZINE HYDROCHLORIDE,Injection site pain,6
HYDROXYZINE HYDROCHLORIDE,Anaemia,6
HYDROXYZINE HYDROCHLORIDE,Product use in unapproved indication,6
HYDROXYZINE HYDROCHLORIDE,Dermatitis atopic,6
HYDROXYZINE HYDROCHLORIDE,Pneumonia,6
HYDROXYZINE HYDROCHLORIDE,Chest pain,5
HYDROXYZINE HYDROCHLORIDE,Asthenia,5
HYDROXYZINE HYDROCHLORIDE,Muscle spasms,5
HYDROXYZINE HYDROCHLORIDE,Platelet count decreased,5
HYDROXYZINE HYDROCHLORIDE,Dyspnoea,5
HYDROXYZINE HYDROCHLORIDE,Malaise,5
HYDROXYZINE HYDROCHLORIDE,Condition aggravated,4
HYDROXYZINE HYDROCHLORIDE,Blood pressure increased,4
HYDROXYZINE HYDROCHLORIDE,Seasonal allergy,4
HYDROXYZINE HYDROCHLORIDE,Ear infection,4
HYDROXYZINE HYDROCHLORIDE,Injection site mass,4
HYDROXYZINE HYDROCHLORIDE,Respiratory tract infection,4
HYDROXYZINE HYDROCHLORIDE,Infusion site pain,4
HYDROXYZINE HYDROCHLORIDE,Abdominal pain upper,4
HYDROXYZINE HYDROCHLORIDE,Erythema,4
IBRANCE,Fatigue,117
IBRANCE,White blood cell count decreased,111
IBRANCE,Neoplasm progression,91
IBRANCE,Diarrhoea,67
IBRANCE,Neutropenia,66
IBRANCE,Alopecia,65
IBRANCE,Off label use,64
IBRANCE,Pain,53
IBRANCE,Nausea,52
IBRANCE,Asthenia,46
IBRANCE,COVID-19,43
IBRANCE,Malaise,40
IBRANCE,Weight decreased,40
IBRANCE,Product dose omission issue,39
IBRANCE,Urinary tract infection,34
IBRANCE,Anaemia,33
IBRANCE,Full blood count abnormal,33
IBRANCE,Vomiting,31
IBRANCE,Stomatitis,29
IBRANCE,Arthralgia,29
IBRANCE,Illness,28
IBRANCE,Feeling abnormal,28
IBRANCE,Decreased appetite,27
IBRANCE,Dizziness,27
IBRANCE,Pruritus,26
IBRANCE,Dyspnoea,26
IBRANCE,Cough,24
IBRANCE,Anxiety,24
IBRANCE,Memory impairment,24
IBRANCE,Nasopharyngitis,23
IBRANCE,Neutrophil count decreased,23
IBRANCE,Weight increased,23
IBRANCE,Headache,21
IBRANCE,Full blood count decreased,21
IBRANCE,Leukopenia,21
IBRANCE,Thrombocytopenia,20
IBRANCE,Rash,19
IBRANCE,Fall,19
IBRANCE,Insomnia,19
IBRANCE,Confusional state,19
IBRANCE,Hypoacusis,18
IBRANCE,Epistaxis,18
IBRANCE,Back pain,18
IBRANCE,General physical health deterioration,18
IBRANCE,Pyrexia,17
IBRANCE,Red blood cell count decreased,17
IBRANCE,Pain in extremity,17
IBRANCE,Dry skin,16
IBRANCE,Pneumonia,16
IBRANCE,Depression,16
IBRUTINIB,Neutropenia,9
IBRUTINIB,COVID-19,8
IBRUTINIB,Fatigue,5
IBRUTINIB,Weight decreased,4
IBRUTINIB,Nausea,4
IBRUTINIB,Vomiting,4
IBRUTINIB,Death,4
IBRUTINIB,Cough,4
IBRUTINIB,Thrombocytopenia,4
IBRUTINIB,Off label use,4
IBRUTINIB,Febrile neutropenia,4
IBRUTINIB,Atrial fibrillation,4
IBRUTINIB,Oedema peripheral,3
IBRUTINIB,Nasopharyngitis,3
IBRUTINIB,Rash papular,3
IBRUTINIB,Sepsis,3
IBRUTINIB,Decreased appetite,3
IBRUTINIB,Richter's syndrome,3
IBRUTINIB,Lymphopenia,3
IBRUTINIB,Hyperkalaemia,3
IBRUTINIB,Hypotension,3
IBRUTINIB,Acute kidney injury,3
IBRUTINIB,Hepatitis acute,3
IBRUTINIB,Pneumonia,3
IBRUTINIB,Diarrhoea,3
IBRUTINIB,Left ventricular dysfunction,3
IBRUTINIB,Hypocalcaemia,3
IBRUTINIB,Cognitive disorder,2
IBRUTINIB,Arthralgia,2
IBRUTINIB,Epistaxis,2
IBRUTINIB,Inguinal hernia,2
IBRUTINIB,Hypoglycaemia,2
IBRUTINIB,Ear pain,2
IBRUTINIB,Incorrect dose administered,2
IBRUTINIB,Sinus disorder,2
IBRUTINIB,Cheilitis,2
IBRUTINIB,Conjunctivitis,2
IBRUTINIB,Rhinorrhoea,2
IBRUTINIB,Ear infection,2
IBRUTINIB,Cystitis,2
IBRUTINIB,Ocular hyperaemia,2
IBRUTINIB,Lacrimation increased,2
IBRUTINIB,Needle issue,2
IBRUTINIB,Oropharyngeal pain,2
IBRUTINIB,Mass,2
IBRUTINIB,Hypoacusis,2
IBRUTINIB,Swelling face,2
IBRUTINIB,Viral infection,2
IBRUTINIB,COVID-19 pneumonia,2
IBRUTINIB,Septic shock,2
IBUPROFEN,Pain,86
IBUPROFEN,Fatigue,85
IBUPROFEN,Headache,71
IBUPROFEN,Nausea,61
IBUPROFEN,Diarrhoea,54
IBUPROFEN,Arthralgia,52
IBUPROFEN,COVID-19,52
IBUPROFEN,Rash,51
IBUPROFEN,Vomiting,49
IBUPROFEN,Anxiety,46
IBUPROFEN,Back pain,45
IBUPROFEN,Pyrexia,44
IBUPROFEN,Pneumonia,41
IBUPROFEN,Infection,41
IBUPROFEN,Condition aggravated,41
IBUPROFEN,Product dose omission issue,39
IBUPROFEN,Dizziness,37
IBUPROFEN,Sinusitis,37
IBUPROFEN,Fall,36
IBUPROFEN,Acute kidney injury,35
IBUPROFEN,Dyspnoea,34
IBUPROFEN,Off label use,33
IBUPROFEN,Nasopharyngitis,32
IBUPROFEN,Myalgia,31
IBUPROFEN,Pain in extremity,30
IBUPROFEN,Asthenia,29
IBUPROFEN,Emotional distress,29
IBUPROFEN,Infusion related reaction,27
IBUPROFEN,Malaise,26
IBUPROFEN,Anhedonia,26
IBUPROFEN,Urinary tract infection,26
IBUPROFEN,Inappropriate schedule of product administration,26
IBUPROFEN,Insomnia,25
IBUPROFEN,Abdominal pain,25
IBUPROFEN,Constipation,23
IBUPROFEN,Sepsis,23
IBUPROFEN,Musculoskeletal stiffness,22
IBUPROFEN,Gait disturbance,22
IBUPROFEN,Hypoaesthesia,22
IBUPROFEN,Upper respiratory tract infection,22
IBUPROFEN,Paraesthesia,21
IBUPROFEN,Hypersensitivity,20
IBUPROFEN,Pruritus,20
IBUPROFEN,Decreased appetite,20
IBUPROFEN,Neutropenia,20
IBUPROFEN,Illness,20
IBUPROFEN,Influenza,20
IBUPROFEN,Weight decreased,19
IBUPROFEN,Depression,19
IBUPROFEN,Cough,19
ICATIBANT,Hereditary angioedema,63
ICATIBANT,Weight increased,42
ICATIBANT,Weight decreased,38
ICATIBANT,Malaise,36
ICATIBANT,Headache,28
ICATIBANT,Pain,28
ICATIBANT,COVID-19,22
ICATIBANT,Product prescribing error,21
ICATIBANT,Pyrexia,19
ICATIBANT,Dizziness,17
ICATIBANT,Diarrhoea,17
ICATIBANT,Inappropriate schedule of product administration,16
ICATIBANT,Influenza,16
ICATIBANT,Cough,16
ICATIBANT,Nausea,16
ICATIBANT,Oropharyngeal pain,15
ICATIBANT,Anxiety,14
ICATIBANT,Stress,14
ICATIBANT,Vomiting,13
ICATIBANT,Off label use,13
ICATIBANT,Product dose omission issue,12
ICATIBANT,Depression,12
ICATIBANT,Arthralgia,12
ICATIBANT,Fatigue,12
ICATIBANT,Product availability issue,12
ICATIBANT,Nasal congestion,12
ICATIBANT,Chest pain,12
ICATIBANT,Body height decreased,12
ICATIBANT,Asthenia,12
ICATIBANT,Abdominal pain,12
ICATIBANT,Dyspnoea,11
ICATIBANT,Discouragement,11
ICATIBANT,Fall,11
ICATIBANT,Dysphonia,11
ICATIBANT,Urinary tract infection,10
ICATIBANT,Pregnancy,10
ICATIBANT,Crying,9
ICATIBANT,Influenza like illness,9
ICATIBANT,Pruritus,9
ICATIBANT,Pneumonia,9
ICATIBANT,Body height increased,9
ICATIBANT,Discomfort,8
ICATIBANT,Blood pressure increased,8
ICATIBANT,Back pain,8
ICATIBANT,Decreased appetite,8
ICATIBANT,Drug ineffective,8
ICATIBANT,Pain in extremity,8
ICATIBANT,Product use issue,7
ICATIBANT,Body height abnormal,7
ICATIBANT,Gait disturbance,7
IDURSULFASE,Pyrexia,62
IDURSULFASE,Product dose omission issue,55
IDURSULFASE,Cough,45
IDURSULFASE,Inappropriate schedule of product administration,44
IDURSULFASE,Influenza,27
IDURSULFASE,COVID-19,25
IDURSULFASE,Weight increased,25
IDURSULFASE,Malaise,24
IDURSULFASE,Poor venous access,23
IDURSULFASE,Incorrect dose administered,23
IDURSULFASE,Pain,22
IDURSULFASE,Infusion related reaction,21
IDURSULFASE,Nasal congestion,21
IDURSULFASE,Product availability issue,20
IDURSULFASE,Diarrhoea,20
IDURSULFASE,Vomiting,19
IDURSULFASE,Fatigue,18
IDURSULFASE,Nasopharyngitis,16
IDURSULFASE,Seizure,16
IDURSULFASE,Pneumonia,16
IDURSULFASE,Rhinorrhoea,16
IDURSULFASE,Restlessness,15
IDURSULFASE,Dyspnoea,15
IDURSULFASE,Productive cough,15
IDURSULFASE,Weight decreased,14
IDURSULFASE,Blood pressure increased,14
IDURSULFASE,Oxygen saturation decreased,14
IDURSULFASE,Off label use,14
IDURSULFASE,Gait disturbance,13
IDURSULFASE,Illness,13
IDURSULFASE,Body height increased,12
IDURSULFASE,Erythema,12
IDURSULFASE,Urticaria,12
IDURSULFASE,Crying,12
IDURSULFASE,Device issue,12
IDURSULFASE,Product prescribing error,11
IDURSULFASE,Ear infection,11
IDURSULFASE,Somnolence,11
IDURSULFASE,Mobility decreased,10
IDURSULFASE,Tremor,10
IDURSULFASE,Headache,10
IDURSULFASE,Rash,9
IDURSULFASE,Asthenia,9
IDURSULFASE,Respiratory disorder,9
IDURSULFASE,Blood pressure decreased,9
IDURSULFASE,Irritability,9
IDURSULFASE,Fall,9
IDURSULFASE,Pain in extremity,8
IDURSULFASE,Insomnia,8
IDURSULFASE,Heart rate increased,8
IFOSFAMIDE,Febrile neutropenia,21
IFOSFAMIDE,Pyrexia,15
IFOSFAMIDE,Pancytopenia,14
IFOSFAMIDE,Vomiting,13
IFOSFAMIDE,Neutropenia,12
IFOSFAMIDE,Off label use,12
IFOSFAMIDE,Diarrhoea,11
IFOSFAMIDE,Proctalgia,11
IFOSFAMIDE,Back pain,11
IFOSFAMIDE,Pain,11
IFOSFAMIDE,Anal inflammation,11
IFOSFAMIDE,Malaise,11
IFOSFAMIDE,Accident,11
IFOSFAMIDE,Crohn's disease,11
IFOSFAMIDE,Body temperature increased,11
IFOSFAMIDE,Haemorrhoids,11
IFOSFAMIDE,Chills,10
IFOSFAMIDE,SARS-CoV-2 test negative,9
IFOSFAMIDE,Malignant neoplasm progression,8
IFOSFAMIDE,Platelet count decreased,7
IFOSFAMIDE,Product use in unapproved indication,7
IFOSFAMIDE,Neutrophil count decreased,6
IFOSFAMIDE,Disease progression,6
IFOSFAMIDE,Cytokine release syndrome,5
IFOSFAMIDE,Drug ineffective,5
IFOSFAMIDE,White blood cell count decreased,4
IFOSFAMIDE,Thrombocytopenia,4
IFOSFAMIDE,Abdominal pain,4
IFOSFAMIDE,Nausea,4
IFOSFAMIDE,Diffuse large B-cell lymphoma,3
IFOSFAMIDE,Haemoglobin decreased,3
IFOSFAMIDE,Hypoxia,3
IFOSFAMIDE,Hypogammaglobulinaemia,3
IFOSFAMIDE,Mucosal inflammation,3
IFOSFAMIDE,Blood lactate dehydrogenase increased,3
IFOSFAMIDE,Anaemia,3
IFOSFAMIDE,Acne pustular,3
IFOSFAMIDE,Progressive multifocal leukoencephalopathy,3
IFOSFAMIDE,Metastases to liver,3
IFOSFAMIDE,Therapeutic product effect incomplete,3
IFOSFAMIDE,Desmoplastic small round cell tumour,3
IFOSFAMIDE,Ascites,3
IFOSFAMIDE,Metastases to peritoneum,3
IFOSFAMIDE,Metastases to lymph nodes,3
IFOSFAMIDE,Myelodysplastic syndrome,2
IFOSFAMIDE,Second primary malignancy,2
IFOSFAMIDE,Bone marrow failure,2
IFOSFAMIDE,Rash,2
IFOSFAMIDE,Amylase increased,2
IFOSFAMIDE,Hepatic failure,2
ILARIS,Pyrexia,30
ILARIS,Abdominal pain,15
ILARIS,COVID-19,15
ILARIS,Inappropriate schedule of product administration,14
ILARIS,Diarrhoea,13
ILARIS,Condition aggravated,11
ILARIS,Rash,10
ILARIS,White blood cell count decreased,9
ILARIS,Familial mediterranean fever,8
ILARIS,Vomiting,8
ILARIS,C-reactive protein increased,8
ILARIS,Malaise,7
ILARIS,Headache,7
ILARIS,Product use in unapproved indication,7
ILARIS,Cough,7
ILARIS,Neutropenia,7
ILARIS,Haemophagocytic lymphohistiocytosis,6
ILARIS,Hepatic function abnormal,6
ILARIS,Pain,6
ILARIS,Leukopenia,6
ILARIS,Sepsis,5
ILARIS,Pneumonia,5
ILARIS,Arthralgia,5
ILARIS,Anaemia,5
ILARIS,Neutrophil count decreased,5
ILARIS,Still's disease,5
ILARIS,Fatigue,5
ILARIS,Haematochezia,5
ILARIS,Concomitant disease aggravated,5
ILARIS,Lymphocyte count decreased,5
ILARIS,Oropharyngeal pain,5
ILARIS,Disease recurrence,4
ILARIS,Therapeutic response decreased,4
ILARIS,Gastrointestinal haemorrhage,4
ILARIS,Infection,4
ILARIS,Ascites,4
ILARIS,Peritonitis,4
ILARIS,Pneumonitis,4
ILARIS,Feeling abnormal,4
ILARIS,Urticaria,4
ILARIS,Lymphadenopathy,4
ILARIS,Asthenia,4
ILARIS,Coronavirus infection,4
ILARIS,Blood lactate dehydrogenase increased,3
ILARIS,Haemorrhage,3
ILARIS,Disseminated intravascular coagulation,3
ILARIS,Dyspnoea,3
ILARIS,Pleural effusion,3
ILARIS,Respiratory disorder,3
ILARIS,Pharyngitis,3
IMBRUVICA,Fatigue,16
IMBRUVICA,Death,13
IMBRUVICA,Atrial fibrillation,10
IMBRUVICA,Off label use,10
IMBRUVICA,Chronic lymphocytic leukaemia,10
IMBRUVICA,Diarrhoea,9
IMBRUVICA,Contusion,8
IMBRUVICA,Fall,8
IMBRUVICA,Pneumonia,8
IMBRUVICA,Hypertension,7
IMBRUVICA,Arthralgia,7
IMBRUVICA,Headache,7
IMBRUVICA,Dizziness,6
IMBRUVICA,Gait disturbance,6
IMBRUVICA,Dyspnoea,6
IMBRUVICA,Lymphadenopathy,6
IMBRUVICA,White blood cell count abnormal,5
IMBRUVICA,Nasopharyngitis,5
IMBRUVICA,Decreased appetite,5
IMBRUVICA,Cellulitis,5
IMBRUVICA,Platelet count decreased,5
IMBRUVICA,COVID-19,5
IMBRUVICA,Muscle spasms,5
IMBRUVICA,Pain,5
IMBRUVICA,Back pain,5
IMBRUVICA,Pyrexia,5
IMBRUVICA,Rash,5
IMBRUVICA,Chest discomfort,4
IMBRUVICA,Insomnia,4
IMBRUVICA,Renal impairment,4
IMBRUVICA,Nausea,4
IMBRUVICA,Asthenia,4
IMBRUVICA,Anaemia,4
IMBRUVICA,Pleural effusion,4
IMBRUVICA,Oxygen saturation decreased,4
IMBRUVICA,Influenza,4
IMBRUVICA,Malaise,4
IMBRUVICA,Chest pain,3
IMBRUVICA,Heart rate increased,3
IMBRUVICA,Palpitations,3
IMBRUVICA,Haemorrhage,3
IMBRUVICA,Onychoclasis,3
IMBRUVICA,Swelling,3
IMBRUVICA,Prostate cancer,3
IMBRUVICA,Neutrophil count decreased,3
IMBRUVICA,Therapeutic product effect decreased,3
IMBRUVICA,Bedridden,3
IMBRUVICA,Renal disorder,3
IMBRUVICA,Cardiac disorder,3
IMBRUVICA,Hospitalisation,3
IMDUR,Chest pain,91
IMDUR,Fatigue,90
IMDUR,Diarrhoea,90
IMDUR,Muscular weakness,89
IMDUR,Hallucination,89
IMDUR,Dry skin,89
IMDUR,Malaise,89
IMDUR,Dyspnoea,89
IMDUR,Pain,88
IMDUR,Anxiety,88
IMDUR,Memory impairment,88
IMDUR,Alopecia,88
IMDUR,Visual impairment,88
IMDUR,Amnesia,88
IMDUR,Feeling abnormal,88
IMDUR,Facial pain,88
IMDUR,Nausea,88
IMDUR,Dehydration,88
IMDUR,Tachycardia,88
IMDUR,Palpitations,88
IMDUR,Cardiospasm,88
IMDUR,Vomiting,88
IMDUR,Angioedema,88
IMDUR,COVID-19,88
IMDUR,Abdominal discomfort,88
IMDUR,Subarachnoid haemorrhage,88
IMDUR,Headache,88
IMDUR,Lip swelling,88
IMDUR,Pruritus,88
IMDUR,Disturbance in attention,88
IMDUR,Anosmia,88
IMDUR,Atrial tachycardia,88
IMDUR,Heart rate increased,88
IMDUR,Pericarditis,88
IMDUR,Intentional product misuse,87
IMDUR,Myocardial infarction,87
IMDUR,Dizziness,87
IMDUR,Insomnia,87
IMDUR,Diplopia,87
IMDUR,Arthralgia,87
IMDUR,Hyperhidrosis,87
IMDUR,Transient ischaemic attack,87
IMDUR,Peripheral swelling,87
IMDUR,Sleep terror,87
IMDUR,Tension headache,87
IMDUR,Blindness,87
IMDUR,Migraine,87
IMDUR,Pyrexia,87
IMDUR,Vasculitis,87
IMDUR,Pruritus genital,87
IMODIUM,Diarrhoea,34
IMODIUM,Fatigue,14
IMODIUM,Abdominal pain,13
IMODIUM,Dehydration,11
IMODIUM,Nausea,11
IMODIUM,Weight decreased,11
IMODIUM,Product dose omission issue,10
IMODIUM,Abdominal pain upper,10
IMODIUM,COVID-19,9
IMODIUM,Pain,9
IMODIUM,Asthenia,9
IMODIUM,Vomiting,9
IMODIUM,Urinary tract infection,8
IMODIUM,Abdominal distension,7
IMODIUM,Pneumonia,7
IMODIUM,Decreased appetite,7
IMODIUM,Off label use,7
IMODIUM,Hyponatraemia,6
IMODIUM,Anxiety,6
IMODIUM,Drug ineffective,6
IMODIUM,Arthralgia,6
IMODIUM,Flatulence,6
IMODIUM,Dizziness,6
IMODIUM,Back pain,6
IMODIUM,Dyspnoea,6
IMODIUM,Pyrexia,6
IMODIUM,Peripheral swelling,5
IMODIUM,Vascular device infection,5
IMODIUM,Blood creatinine increased,5
IMODIUM,Headache,5
IMODIUM,Muscle spasms,5
IMODIUM,Stomatitis,5
IMODIUM,Fall,5
IMODIUM,Weight increased,4
IMODIUM,Oedema peripheral,4
IMODIUM,Hypokalaemia,4
IMODIUM,Pain in extremity,4
IMODIUM,Oropharyngeal pain,4
IMODIUM,Abdominal discomfort,4
IMODIUM,Product use issue,4
IMODIUM,Acute kidney injury,4
IMODIUM,Joint swelling,4
IMODIUM,Constipation,4
IMODIUM,Colitis ulcerative,4
IMODIUM,Cough,4
IMODIUM,Gait disturbance,4
IMODIUM,Rash,4
IMODIUM,Intestinal obstruction,4
IMODIUM,Memory impairment,4
IMODIUM,General physical health deterioration,3
IMURAN,Off label use,20
IMURAN,Fatigue,9
IMURAN,Drug ineffective,9
IMURAN,Nausea,8
IMURAN,Pain,8
IMURAN,Pneumonia,7
IMURAN,Arthralgia,7
IMURAN,Pyrexia,6
IMURAN,Intentional product use issue,6
IMURAN,Rash,6
IMURAN,Condition aggravated,6
IMURAN,Diarrhoea,6
IMURAN,Pain in extremity,6
IMURAN,Malaise,5
IMURAN,White blood cell count decreased,5
IMURAN,Peripheral swelling,5
IMURAN,Dyspnoea,5
IMURAN,Drug hypersensitivity,4
IMURAN,Abdominal pain,4
IMURAN,Headache,4
IMURAN,Colitis ulcerative,4
IMURAN,Abdominal distension,4
IMURAN,Tenosynovitis,4
IMURAN,Dizziness,4
IMURAN,Weight increased,4
IMURAN,Rheumatoid arthritis,4
IMURAN,Influenza,3
IMURAN,Blood pressure decreased,3
IMURAN,Tachycardia,3
IMURAN,Urinary tract infection,3
IMURAN,Cough,3
IMURAN,Hypothyroidism,3
IMURAN,Crohn's disease,3
IMURAN,Product dose omission issue,3
IMURAN,Anxiety,3
IMURAN,C-reactive protein increased,3
IMURAN,Haemoglobin decreased,3
IMURAN,Upper respiratory tract infection,3
IMURAN,Asthenia,3
IMURAN,Synovitis,3
IMURAN,Hypertension,3
IMURAN,Therapeutic product effect incomplete,3
IMURAN,Back pain,3
IMURAN,Muscular weakness,3
IMURAN,Colectomy,3
IMURAN,Treatment failure,3
IMURAN,Weight decreased,3
IMURAN,Myalgia,3
IMURAN,Joint swelling,3
IMURAN,Decreased appetite,3
INDAPAMIDE,Blood creatinine increased,11
INDAPAMIDE,Vomiting,10
INDAPAMIDE,Urinary retention,9
INDAPAMIDE,Malaise,9
INDAPAMIDE,Diabetes mellitus,8
INDAPAMIDE,Lip swelling,7
INDAPAMIDE,Oedema peripheral,6
INDAPAMIDE,Fatigue,6
INDAPAMIDE,Inappropriate antidiuretic hormone secretion,6
INDAPAMIDE,Bradycardia,5
INDAPAMIDE,Pruritus,5
INDAPAMIDE,Nausea,5
INDAPAMIDE,Hyponatraemia,5
INDAPAMIDE,Myalgia,5
INDAPAMIDE,Arthralgia,4
INDAPAMIDE,Dizziness,4
INDAPAMIDE,Swelling face,4
INDAPAMIDE,Somnolence,4
INDAPAMIDE,Hypotension,4
INDAPAMIDE,Product administration error,4
INDAPAMIDE,Lethargy,4
INDAPAMIDE,Tachycardia,3
INDAPAMIDE,COVID-19,3
INDAPAMIDE,Cough,3
INDAPAMIDE,Dyspnoea,3
INDAPAMIDE,Peripheral swelling,3
INDAPAMIDE,Fluid retention,3
INDAPAMIDE,Spur cell anaemia,3
INDAPAMIDE,Rash,3
INDAPAMIDE,Rosacea,3
INDAPAMIDE,Weight decreased,2
INDAPAMIDE,Enlarged uvula,2
INDAPAMIDE,Joint swelling,2
INDAPAMIDE,Cellulitis,2
INDAPAMIDE,Drug hypersensitivity,2
INDAPAMIDE,Dry mouth,2
INDAPAMIDE,Palpitations,2
INDAPAMIDE,Muscular weakness,2
INDAPAMIDE,Chromaturia,2
INDAPAMIDE,Asthenia,2
INDAPAMIDE,Epistaxis,2
INDAPAMIDE,Hypoglycaemia,2
INDAPAMIDE,Off label use,2
INDAPAMIDE,Swollen tongue,2
INDAPAMIDE,Deep vein thrombosis,2
INDAPAMIDE,Chest pain,2
INDAPAMIDE,Weight increased,2
INDAPAMIDE,Hypertension,2
INDAPAMIDE,Syncope,2
INDAPAMIDE,Illness,2
INFLIXIMAB,Off label use,47
INFLIXIMAB,Drug ineffective,25
INFLIXIMAB,COVID-19,20
INFLIXIMAB,Crohn's disease,19
INFLIXIMAB,Arthralgia,18
INFLIXIMAB,Rheumatoid arthritis,16
INFLIXIMAB,Malaise,15
INFLIXIMAB,Diarrhoea,14
INFLIXIMAB,Condition aggravated,14
INFLIXIMAB,Pyrexia,13
INFLIXIMAB,Intentional product use issue,11
INFLIXIMAB,Pain,11
INFLIXIMAB,Tuberculosis,11
INFLIXIMAB,Colitis ulcerative,11
INFLIXIMAB,Hypersensitivity,10
INFLIXIMAB,Weight increased,10
INFLIXIMAB,Dyspnoea,10
INFLIXIMAB,Infusion related reaction,10
INFLIXIMAB,Fatigue,10
INFLIXIMAB,Headache,10
INFLIXIMAB,Rash,10
INFLIXIMAB,Weight decreased,10
INFLIXIMAB,Vomiting,10
INFLIXIMAB,Drug intolerance,9
INFLIXIMAB,Synovitis,9
INFLIXIMAB,Nausea,9
INFLIXIMAB,Abdominal pain,9
INFLIXIMAB,Asthenia,8
INFLIXIMAB,Alopecia,8
INFLIXIMAB,Systemic lupus erythematosus,8
INFLIXIMAB,Therapeutic product effect decreased,8
INFLIXIMAB,Dizziness,8
INFLIXIMAB,Joint swelling,8
INFLIXIMAB,Product use issue,8
INFLIXIMAB,Product use in unapproved indication,8
INFLIXIMAB,Ankylosing spondylitis,8
INFLIXIMAB,Erythema,8
INFLIXIMAB,Impaired healing,7
INFLIXIMAB,Hepatic enzyme increased,7
INFLIXIMAB,Pruritus,7
INFLIXIMAB,Musculoskeletal stiffness,7
INFLIXIMAB,Nasopharyngitis,7
INFLIXIMAB,Arthropathy,7
INFLIXIMAB,Depression,7
INFLIXIMAB,Decreased appetite,7
INFLIXIMAB,Abdominal pain upper,7
INFLIXIMAB,Loss of personal independence in daily activities,7
INFLIXIMAB,Mobility decreased,7
INFLIXIMAB,Abdominal discomfort,7
INFLIXIMAB,Pain in extremity,7
INLYTA,Off label use,10
INLYTA,Diarrhoea,10
INLYTA,Fatigue,9
INLYTA,Weight decreased,9
INLYTA,Pain in extremity,7
INLYTA,Asthenia,6
INLYTA,Neoplasm progression,6
INLYTA,Blood pressure increased,6
INLYTA,Oral pain,6
INLYTA,Pain,5
INLYTA,Arthralgia,5
INLYTA,Weight increased,5
INLYTA,Dysphonia,4
INLYTA,Product dose omission issue,4
INLYTA,COVID-19,4
INLYTA,Malaise,4
INLYTA,Decreased appetite,4
INLYTA,Dry mouth,4
INLYTA,Brain fog,3
INLYTA,Pneumonia,3
INLYTA,Hyperkeratosis,3
INLYTA,Gait disturbance,3
INLYTA,Hypertension,3
INLYTA,Rash,3
INLYTA,Body surface area decreased,3
INLYTA,Localised infection,3
INLYTA,Palmar-plantar erythrodysaesthesia syndrome,3
INLYTA,Stomatitis,3
INLYTA,Abdominal pain,3
INLYTA,Renal impairment,3
INLYTA,Arthritis,2
INLYTA,Myocardial infarction,2
INLYTA,Back pain,2
INLYTA,Ulcer,2
INLYTA,Dysphagia,2
INLYTA,Eating disorder,2
INLYTA,Body surface area increased,2
INLYTA,Blood creatinine increased,2
INLYTA,Glossodynia,2
INLYTA,Hypotension,2
INLYTA,Taste disorder,2
INLYTA,Musculoskeletal stiffness,2
INLYTA,Joint stiffness,2
INLYTA,Oesophagomediastinal fistula,2
INLYTA,Interstitial lung disease,2
INLYTA,Tubulointerstitial nephritis,2
INLYTA,Pneumocystis jirovecii pneumonia,2
INLYTA,Pyrexia,2
INLYTA,Hepatic cytolysis,2
INLYTA,Discomfort,2
INNOHEP,General physical health deterioration,13
INNOHEP,Anaemia,8
INNOHEP,Sepsis,7
INNOHEP,Diarrhoea haemorrhagic,7
INNOHEP,Diarrhoea,6
INNOHEP,Inflammation,6
INNOHEP,Acute kidney injury,5
INNOHEP,Weight decreased,5
INNOHEP,Lactic acidosis,4
INNOHEP,Incorrect product administration duration,4
INNOHEP,Ischaemic hepatitis,4
INNOHEP,Thrombocytopenia,4
INNOHEP,Malnutrition,3
INNOHEP,Abdominal pain,3
INNOHEP,Dehydration,3
INNOHEP,Infection,3
INNOHEP,Lung disorder,3
INNOHEP,Dyspnoea,3
INNOHEP,Electrocardiogram QT prolonged,3
INNOHEP,Leukopenia,3
INNOHEP,Decreased appetite,3
INNOHEP,Hepatic cytolysis,3
INNOHEP,Rectal haemorrhage,3
INNOHEP,Renal failure,3
INNOHEP,Vascular device infection,2
INNOHEP,Hypokalaemia,2
INNOHEP,Gastrointestinal stoma output increased,2
INNOHEP,Blood magnesium decreased,2
INNOHEP,Bladder cancer,2
INNOHEP,Blood magnesium abnormal,2
INNOHEP,Kidney infection,2
INNOHEP,Neoplasm malignant,2
INNOHEP,Blood magnesium increased,2
INNOHEP,Abdominal discomfort,2
INNOHEP,Cystitis,2
INNOHEP,Stoma site oedema,2
INNOHEP,Bladder neoplasm,2
INNOHEP,Oral fungal infection,2
INNOHEP,SARS-CoV-2 test positive,2
INNOHEP,Hyperglobulinaemia,2
INNOHEP,Disease progression,2
INNOHEP,Haemorrhage,2
INNOHEP,Haematoma,2
INNOHEP,Asthenia,2
INNOHEP,Gamma-glutamyltransferase increased,2
INNOHEP,Blood pressure abnormal,2
INNOHEP,Myopathy,2
INNOHEP,Post thrombotic syndrome,2
INNOHEP,Lymphoedema,2
INNOHEP,Ocular retrobulbar haemorrhage,2
INSULIN ASPART,Off label use,19
INSULIN ASPART,Sepsis,12
INSULIN ASPART,Vomiting,12
INSULIN ASPART,Aspartate aminotransferase increased,11
INSULIN ASPART,Intentional product use issue,10
INSULIN ASPART,Maternal exposure during pregnancy,10
INSULIN ASPART,Abortion spontaneous,10
INSULIN ASPART,Alanine aminotransferase increased,10
INSULIN ASPART,Abdominal distension,10
INSULIN ASPART,Condition aggravated,10
INSULIN ASPART,Hepatic cytolysis,9
INSULIN ASPART,Nausea,9
INSULIN ASPART,Somnolence,9
INSULIN ASPART,Drug abuse,8
INSULIN ASPART,Stress,8
INSULIN ASPART,Cardiogenic shock,8
INSULIN ASPART,Incorrect route of product administration,8
INSULIN ASPART,Multiple organ dysfunction syndrome,8
INSULIN ASPART,Ascites,8
INSULIN ASPART,Constipation,8
INSULIN ASPART,Dyspnoea,8
INSULIN ASPART,Caesarean section,7
INSULIN ASPART,Dry mouth,7
INSULIN ASPART,Abdominal pain,7
INSULIN ASPART,Ultrasound antenatal screen,6
INSULIN ASPART,Bacterial infection,6
INSULIN ASPART,Death,6
INSULIN ASPART,Intentional product misuse,6
INSULIN ASPART,Hyponatraemia,6
INSULIN ASPART,Neuralgia,6
INSULIN ASPART,Swelling,6
INSULIN ASPART,Hyperkalaemia,6
INSULIN ASPART,Anaemia,6
INSULIN ASPART,Hydrops foetalis,5
INSULIN ASPART,Drug hypersensitivity,5
INSULIN ASPART,Drug intolerance,5
INSULIN ASPART,Appendicolith,5
INSULIN ASPART,General physical health deterioration,5
INSULIN ASPART,Ventricular fibrillation,5
INSULIN ASPART,Appendicitis,5
INSULIN ASPART,Sleep disorder,5
INSULIN ASPART,Diarrhoea,5
INSULIN ASPART,Trisomy 18,4
INSULIN ASPART,Cleft lip and palate,4
INSULIN ASPART,Blood cholesterol increased,4
INSULIN ASPART,Blood phosphorus increased,4
INSULIN ASPART,Myasthenia gravis,4
INSULIN ASPART,Blood uric acid increased,4
INSULIN ASPART,Blood glucose increased,4
INSULIN ASPART,Pneumonia,4
INSULIN GLARGINE,Diarrhoea,14
INSULIN GLARGINE,Nausea,12
INSULIN GLARGINE,Vomiting,10
INSULIN GLARGINE,Acute kidney injury,10
INSULIN GLARGINE,Dehydration,9
INSULIN GLARGINE,Constipation,8
INSULIN GLARGINE,Anaemia,8
INSULIN GLARGINE,Blood glucose increased,7
INSULIN GLARGINE,Hyponatraemia,7
INSULIN GLARGINE,Diabetes mellitus,6
INSULIN GLARGINE,Pneumonia,6
INSULIN GLARGINE,Pyrexia,6
INSULIN GLARGINE,Hyperglycaemia,6
INSULIN GLARGINE,Hypoglycaemia,6
INSULIN GLARGINE,Hepatic cytolysis,6
INSULIN GLARGINE,Inappropriate antidiuretic hormone secretion,6
INSULIN GLARGINE,Pancreatic carcinoma,6
INSULIN GLARGINE,Hypoaesthesia,5
INSULIN GLARGINE,Cholestasis,5
INSULIN GLARGINE,Alopecia,4
INSULIN GLARGINE,Off label use,4
INSULIN GLARGINE,Fatigue,4
INSULIN GLARGINE,Asthenia,4
INSULIN GLARGINE,Malaise,4
INSULIN GLARGINE,Haemoglobin decreased,4
INSULIN GLARGINE,Drug interaction,4
INSULIN GLARGINE,Oesophagitis,4
INSULIN GLARGINE,Confusional state,4
INSULIN GLARGINE,Oedema peripheral,3
INSULIN GLARGINE,Pleural effusion,3
INSULIN GLARGINE,Pain,3
INSULIN GLARGINE,Abdominal pain upper,3
INSULIN GLARGINE,Hyperkalaemia,3
INSULIN GLARGINE,Rash,3
INSULIN GLARGINE,Pruritus,3
INSULIN GLARGINE,Pain in extremity,3
INSULIN GLARGINE,Taste disorder,3
INSULIN GLARGINE,Rash maculo-papular,3
INSULIN GLARGINE,Neuropathy peripheral,3
INSULIN GLARGINE,Neutrophil count decreased,3
INSULIN GLARGINE,Thrombocytopenia,3
INSULIN GLARGINE,Headache,3
INSULIN GLARGINE,Fixed eruption,3
INSULIN GLARGINE,Dermatitis bullous,3
INSULIN GLARGINE,Cellulitis,2
INSULIN GLARGINE,Breast cellulitis,2
INSULIN GLARGINE,Ureterolithiasis,2
INSULIN GLARGINE,Chronic kidney disease,2
INSULIN GLARGINE,Hypokalaemia,2
INSULIN GLARGINE,Renal impairment,2
INSULIN LISPRO,Hyperglycaemia,13
INSULIN LISPRO,Fatigue,12
INSULIN LISPRO,Vomiting,9
INSULIN LISPRO,Nausea,9
INSULIN LISPRO,Pain,8
INSULIN LISPRO,Anaemia,8
INSULIN LISPRO,General physical health deterioration,7
INSULIN LISPRO,Haematochezia,7
INSULIN LISPRO,Dehydration,7
INSULIN LISPRO,Diarrhoea,7
INSULIN LISPRO,Death,7
INSULIN LISPRO,Tachycardia,7
INSULIN LISPRO,Blood glucose increased,6
INSULIN LISPRO,Asthenia,6
INSULIN LISPRO,Off label use,6
INSULIN LISPRO,Condition aggravated,6
INSULIN LISPRO,Depressed level of consciousness,6
INSULIN LISPRO,Systemic infection,6
INSULIN LISPRO,Cachexia,6
INSULIN LISPRO,Tenderness,6
INSULIN LISPRO,Drug ineffective,5
INSULIN LISPRO,COVID-19,5
INSULIN LISPRO,Abdominal pain,5
INSULIN LISPRO,Abdominal pain upper,4
INSULIN LISPRO,Sepsis,4
INSULIN LISPRO,Headache,4
INSULIN LISPRO,Diabetes mellitus inadequate control,3
INSULIN LISPRO,Weight increased,3
INSULIN LISPRO,Cytokine release syndrome,3
INSULIN LISPRO,Dyspnoea,3
INSULIN LISPRO,Product dose omission issue,3
INSULIN LISPRO,Hypoglycaemia,3
INSULIN LISPRO,Neurotoxicity,3
INSULIN LISPRO,Mucosal inflammation,3
INSULIN LISPRO,Transaminases increased,3
INSULIN LISPRO,Hypertension,2
INSULIN LISPRO,Laboratory test abnormal,2
INSULIN LISPRO,Influenza,2
INSULIN LISPRO,Autoimmune hepatitis,2
INSULIN LISPRO,Therapy interrupted,2
INSULIN LISPRO,Jaundice,2
INSULIN LISPRO,Weight decreased,2
INSULIN LISPRO,Steatohepatitis,2
INSULIN LISPRO,Hepatic cirrhosis,2
INSULIN LISPRO,Blood bilirubin increased,2
INSULIN LISPRO,Menstrual disorder,2
INSULIN LISPRO,Treatment noncompliance,2
INSULIN LISPRO,Viral infection,2
INSULIN LISPRO,Product use issue,2
INSULIN LISPRO,Decreased appetite,2
INSULIN NOS,Diarrhoea,27
INSULIN NOS,Fatigue,20
INSULIN NOS,Pain,18
INSULIN NOS,Nausea,18
INSULIN NOS,Dyspnoea,16
INSULIN NOS,Asthenia,16
INSULIN NOS,Vomiting,16
INSULIN NOS,Off label use,14
INSULIN NOS,Hyperglycaemia,13
INSULIN NOS,COVID-19,13
INSULIN NOS,Headache,13
INSULIN NOS,Pyrexia,11
INSULIN NOS,Urinary tract infection,11
INSULIN NOS,Malaise,11
INSULIN NOS,Anaemia,11
INSULIN NOS,Abdominal pain,11
INSULIN NOS,Pruritus,10
INSULIN NOS,Anxiety,10
INSULIN NOS,Pain in extremity,9
INSULIN NOS,Emotional distress,9
INSULIN NOS,Abdominal discomfort,9
INSULIN NOS,Drug ineffective,9
INSULIN NOS,Gait disturbance,8
INSULIN NOS,Arthralgia,8
INSULIN NOS,Blood pressure increased,8
INSULIN NOS,Gait inability,8
INSULIN NOS,Chronic kidney disease,8
INSULIN NOS,Renal failure,8
INSULIN NOS,Cough,8
INSULIN NOS,Dizziness,8
INSULIN NOS,Psoriatic arthropathy,8
INSULIN NOS,Abdominal pain upper,8
INSULIN NOS,Weight increased,8
INSULIN NOS,Fall,8
INSULIN NOS,Weight decreased,7
INSULIN NOS,Device issue,7
INSULIN NOS,Device related infection,7
INSULIN NOS,Anhedonia,7
INSULIN NOS,Back pain,7
INSULIN NOS,Inappropriate schedule of product administration,7
INSULIN NOS,Blood glucose increased,7
INSULIN NOS,Pneumonia,6
INSULIN NOS,Abnormal faeces,6
INSULIN NOS,Faeces hard,6
INSULIN NOS,Renal impairment,6
INSULIN NOS,Flatulence,6
INSULIN NOS,Type 1 diabetes mellitus,6
INSULIN NOS,Post procedural complication,6
INSULIN NOS,Rheumatoid arthritis,6
INSULIN NOS,General physical health deterioration,6
INVESTIGATIONAL PRODUCT,Platelet count decreased,4
INVESTIGATIONAL PRODUCT,Pyrexia,4
INVESTIGATIONAL PRODUCT,Pneumonia,4
INVESTIGATIONAL PRODUCT,Febrile neutropenia,3
INVESTIGATIONAL PRODUCT,Neutrophil count decreased,3
INVESTIGATIONAL PRODUCT,C-reactive protein increased,3
INVESTIGATIONAL PRODUCT,White blood cell count decreased,3
INVESTIGATIONAL PRODUCT,Vomiting,3
INVESTIGATIONAL PRODUCT,Gastritis,3
INVESTIGATIONAL PRODUCT,Sepsis,2
INVESTIGATIONAL PRODUCT,Cytokine release syndrome,2
INVESTIGATIONAL PRODUCT,Diarrhoea,2
INVESTIGATIONAL PRODUCT,Endocarditis,2
INVESTIGATIONAL PRODUCT,Wound infection,2
INVESTIGATIONAL PRODUCT,Fungating wound,2
INVESTIGATIONAL PRODUCT,Dehydration,2
INVESTIGATIONAL PRODUCT,Constipation,2
INVESTIGATIONAL PRODUCT,Acute kidney injury,2
INVESTIGATIONAL PRODUCT,COVID-19,2
INVESTIGATIONAL PRODUCT,Dyspnoea,2
INVESTIGATIONAL PRODUCT,Cardiac pacemaker evaluation,2
INVESTIGATIONAL PRODUCT,Myocardial infarction,2
INVESTIGATIONAL PRODUCT,Septic shock,2
INVESTIGATIONAL PRODUCT,Malnutrition,1
INVESTIGATIONAL PRODUCT,Pseudomonas infection,1
INVESTIGATIONAL PRODUCT,Gastric haemorrhage,1
INVESTIGATIONAL PRODUCT,Helicobacter infection,1
INVESTIGATIONAL PRODUCT,Dizziness,1
INVESTIGATIONAL PRODUCT,Fall,1
INVESTIGATIONAL PRODUCT,Staphylococcal sepsis,1
INVESTIGATIONAL PRODUCT,Cerebral infarction,1
INVESTIGATIONAL PRODUCT,Peripheral arterial occlusive disease,1
INVESTIGATIONAL PRODUCT,Infusion related reaction,1
INVESTIGATIONAL PRODUCT,Neutropenic sepsis,1
INVESTIGATIONAL PRODUCT,Neurotoxicity,1
INVESTIGATIONAL PRODUCT,Fatigue,1
INVESTIGATIONAL PRODUCT,Pyelonephritis,1
INVESTIGATIONAL PRODUCT,Haemoglobin decreased,1
INVESTIGATIONAL PRODUCT,Pleural effusion,1
INVESTIGATIONAL PRODUCT,Blood albumin decreased,1
INVESTIGATIONAL PRODUCT,Red blood cell count decreased,1
INVESTIGATIONAL PRODUCT,Neutropenia,1
INVESTIGATIONAL PRODUCT,Lymphocyte count decreased,1
INVESTIGATIONAL PRODUCT,Monocyte count decreased,1
INVESTIGATIONAL PRODUCT,Catheter site infection,1
INVESTIGATIONAL PRODUCT,Staphylococcal infection,1
INVESTIGATIONAL PRODUCT,Lower respiratory tract infection,1
INVESTIGATIONAL PRODUCT,Rhinorrhoea,1
INVESTIGATIONAL PRODUCT,Blood potassium decreased,1
INVESTIGATIONAL PRODUCT,Hypomagnesaemia,1
IPILIMUMAB,Anaemia,13
IPILIMUMAB,Diarrhoea,11
IPILIMUMAB,Pyrexia,10
IPILIMUMAB,Malignant neoplasm progression,8
IPILIMUMAB,Vomiting,7
IPILIMUMAB,Thrombocytopenia,7
IPILIMUMAB,Asthenia,7
IPILIMUMAB,Immune-mediated enterocolitis,6
IPILIMUMAB,Pneumonia,6
IPILIMUMAB,Capillary leak syndrome,6
IPILIMUMAB,Nausea,5
IPILIMUMAB,Neutropenia,5
IPILIMUMAB,Atrial fibrillation,5
IPILIMUMAB,Colitis,5
IPILIMUMAB,Pneumonitis,5
IPILIMUMAB,Confusional state,5
IPILIMUMAB,Somnolence,5
IPILIMUMAB,Off label use,4
IPILIMUMAB,Blood bilirubin increased,4
IPILIMUMAB,Hydrothorax,4
IPILIMUMAB,Pelvic abscess,4
IPILIMUMAB,Chest pain,4
IPILIMUMAB,Vertigo,4
IPILIMUMAB,Lymphangiosis carcinomatosa,4
IPILIMUMAB,Arthralgia,4
IPILIMUMAB,Decreased appetite,4
IPILIMUMAB,Sudden death,4
IPILIMUMAB,Radiation associated pain,4
IPILIMUMAB,Paraparesis,4
IPILIMUMAB,General physical health deterioration,4
IPILIMUMAB,Blood corticotrophin decreased,4
IPILIMUMAB,Hypophagia,4
IPILIMUMAB,Delusion,4
IPILIMUMAB,Klebsiella test positive,4
IPILIMUMAB,Staring,4
IPILIMUMAB,Hallucination,4
IPILIMUMAB,Communication disorder,4
IPILIMUMAB,Fluid intake reduced,4
IPILIMUMAB,Condition aggravated,4
IPILIMUMAB,Thyroiditis,3
IPILIMUMAB,Dehydration,3
IPILIMUMAB,Hypoacusis,3
IPILIMUMAB,Hyponatraemia,3
IPILIMUMAB,Sepsis,3
IPILIMUMAB,Hyperthyroidism,3
IPILIMUMAB,Dyspnoea,3
IPILIMUMAB,Aspartate aminotransferase increased,3
IPILIMUMAB,Hypophysitis,3
IPILIMUMAB,Adrenal insufficiency,3
IPILIMUMAB,Erysipelas,2
IPRATROPIUM BROMIDE,Product dose omission issue,18
IPRATROPIUM BROMIDE,Nausea,17
IPRATROPIUM BROMIDE,Dyspnoea,16
IPRATROPIUM BROMIDE,Pneumonia,15
IPRATROPIUM BROMIDE,Sinusitis,15
IPRATROPIUM BROMIDE,Vomiting,15
IPRATROPIUM BROMIDE,Stress,12
IPRATROPIUM BROMIDE,Hyponatraemia,11
IPRATROPIUM BROMIDE,Off label use,11
IPRATROPIUM BROMIDE,Cardiogenic shock,11
IPRATROPIUM BROMIDE,Abdominal distension,11
IPRATROPIUM BROMIDE,Pain,11
IPRATROPIUM BROMIDE,Asthma,10
IPRATROPIUM BROMIDE,Drug hypersensitivity,10
IPRATROPIUM BROMIDE,Sepsis,10
IPRATROPIUM BROMIDE,Incorrect route of product administration,10
IPRATROPIUM BROMIDE,Multiple organ dysfunction syndrome,10
IPRATROPIUM BROMIDE,Ascites,10
IPRATROPIUM BROMIDE,Constipation,10
IPRATROPIUM BROMIDE,Condition aggravated,10
IPRATROPIUM BROMIDE,Bronchitis,9
IPRATROPIUM BROMIDE,Illness,9
IPRATROPIUM BROMIDE,Upper respiratory tract infection,9
IPRATROPIUM BROMIDE,Death,9
IPRATROPIUM BROMIDE,Dry mouth,9
IPRATROPIUM BROMIDE,Somnolence,9
IPRATROPIUM BROMIDE,Neuralgia,9
IPRATROPIUM BROMIDE,Swelling,9
IPRATROPIUM BROMIDE,COVID-19,9
IPRATROPIUM BROMIDE,Pyrexia,8
IPRATROPIUM BROMIDE,Bacterial infection,8
IPRATROPIUM BROMIDE,Intentional product misuse,8
IPRATROPIUM BROMIDE,Abdominal pain,8
IPRATROPIUM BROMIDE,Headache,8
IPRATROPIUM BROMIDE,Pruritus,8
IPRATROPIUM BROMIDE,Sleep disorder,8
IPRATROPIUM BROMIDE,Fatigue,8
IPRATROPIUM BROMIDE,Drug intolerance,7
IPRATROPIUM BROMIDE,Appendicolith,7
IPRATROPIUM BROMIDE,General physical health deterioration,7
IPRATROPIUM BROMIDE,Ventricular fibrillation,7
IPRATROPIUM BROMIDE,Appendicitis,7
IPRATROPIUM BROMIDE,Contusion,6
IPRATROPIUM BROMIDE,Product use in unapproved indication,6
IPRATROPIUM BROMIDE,Blood cholesterol increased,6
IPRATROPIUM BROMIDE,Blood phosphorus increased,6
IPRATROPIUM BROMIDE,Myasthenia gravis,6
IPRATROPIUM BROMIDE,Blood uric acid increased,6
IPRATROPIUM BROMIDE,Arthralgia,6
IPRATROPIUM BROMIDE,Lower respiratory tract infection,6
IRBESARTAN,Off label use,39
IRBESARTAN,Overdose,33
IRBESARTAN,Rash,27
IRBESARTAN,Product dose omission issue,26
IRBESARTAN,Lower respiratory tract infection,26
IRBESARTAN,Pulmonary pain,25
IRBESARTAN,Abdominal discomfort,25
IRBESARTAN,Intentional product misuse,24
IRBESARTAN,Arthropathy,24
IRBESARTAN,Drug abuse,24
IRBESARTAN,Hyperkalaemia,24
IRBESARTAN,Knee arthroplasty,22
IRBESARTAN,COVID-19,21
IRBESARTAN,Hyponatraemia,21
IRBESARTAN,Acute kidney injury,20
IRBESARTAN,Diarrhoea,16
IRBESARTAN,Drug interaction,16
IRBESARTAN,Condition aggravated,15
IRBESARTAN,Lung neoplasm malignant,14
IRBESARTAN,Radiation inflammation,13
IRBESARTAN,Inflammation,13
IRBESARTAN,Nausea,12
IRBESARTAN,Obesity,12
IRBESARTAN,Schizophrenia,12
IRBESARTAN,Fatigue,11
IRBESARTAN,Vomiting,11
IRBESARTAN,Malaise,11
IRBESARTAN,Renal failure,11
IRBESARTAN,Constipation,10
IRBESARTAN,Amyloid arthropathy,10
IRBESARTAN,Hypokalaemia,10
IRBESARTAN,Interstitial lung disease,8
IRBESARTAN,Neutropenia,8
IRBESARTAN,Illness,8
IRBESARTAN,Feeling abnormal,7
IRBESARTAN,Asthenia,7
IRBESARTAN,Dizziness,7
IRBESARTAN,Dyspnoea,7
IRBESARTAN,Cardiac failure,7
IRBESARTAN,Lipase increased,7
IRBESARTAN,Food poisoning,7
IRBESARTAN,Pain in extremity,6
IRBESARTAN,Inappropriate schedule of product administration,6
IRBESARTAN,Cough,6
IRBESARTAN,Headache,6
IRBESARTAN,Pneumonitis,6
IRBESARTAN,Hepatic cytolysis,6
IRBESARTAN,Confusional state,6
IRBESARTAN,Arthralgia,6
IRBESARTAN,Sinus node dysfunction,6
IRINOTECAN,Neurotoxicity,24
IRINOTECAN,Diarrhoea,18
IRINOTECAN,General physical health deterioration,16
IRINOTECAN,Asthenia,16
IRINOTECAN,Dysgeusia,16
IRINOTECAN,Neutropenia,13
IRINOTECAN,Cerebrovascular accident,8
IRINOTECAN,Thrombocytopenia,8
IRINOTECAN,Sepsis,7
IRINOTECAN,Vomiting,7
IRINOTECAN,Diarrhoea haemorrhagic,6
IRINOTECAN,Accidental overdose,5
IRINOTECAN,Hypokalaemia,5
IRINOTECAN,Paraesthesia,5
IRINOTECAN,Nausea,5
IRINOTECAN,Alopecia,5
IRINOTECAN,Mucosal inflammation,5
IRINOTECAN,Off label use,5
IRINOTECAN,Dry skin,5
IRINOTECAN,Colitis,4
IRINOTECAN,Acute kidney injury,4
IRINOTECAN,Glossitis,4
IRINOTECAN,Haematuria,4
IRINOTECAN,Cholestasis,4
IRINOTECAN,Hypocalcaemia,4
IRINOTECAN,Xerosis,4
IRINOTECAN,Electrocardiogram QT prolonged,4
IRINOTECAN,Drug interaction,4
IRINOTECAN,Oesophagitis,4
IRINOTECAN,Metastases to liver,4
IRINOTECAN,Malignant neoplasm progression,4
IRINOTECAN,Pyrexia,3
IRINOTECAN,Rash,3
IRINOTECAN,Pancreatitis,3
IRINOTECAN,Dehydration,3
IRINOTECAN,Decreased appetite,3
IRINOTECAN,Dry mouth,3
IRINOTECAN,Transaminases increased,3
IRINOTECAN,Anaemia,3
IRINOTECAN,Haemoglobin decreased,3
IRINOTECAN,Product use in unapproved indication,3
IRINOTECAN,Therapeutic product effect incomplete,3
IRINOTECAN,Desmoplastic small round cell tumour,3
IRINOTECAN,Ascites,3
IRINOTECAN,Metastases to peritoneum,3
IRINOTECAN,Drug ineffective,3
IRINOTECAN,Disease progression,3
IRINOTECAN,Metastases to lymph nodes,3
IRINOTECAN,Hypotension,2
IRINOTECAN,Epiglottitis,2
IRON,Diarrhoea,47
IRON,Fatigue,36
IRON,Nausea,32
IRON,Off label use,29
IRON,Anaemia,24
IRON,Product dose omission issue,20
IRON,Rash,20
IRON,COVID-19,20
IRON,Headache,19
IRON,Pain,19
IRON,Weight decreased,19
IRON,Alopecia,18
IRON,Fall,17
IRON,Pain in extremity,16
IRON,Arthralgia,16
IRON,Gastrooesophageal reflux disease,16
IRON,Cough,15
IRON,Dizziness,15
IRON,Drug ineffective,15
IRON,Hot flush,15
IRON,Pruritus,15
IRON,Lymphoedema,14
IRON,Epistaxis,14
IRON,Decreased appetite,14
IRON,Illness,14
IRON,Vascular device infection,13
IRON,Influenza like illness,13
IRON,Ejection fraction decreased,13
IRON,Dyspnoea,13
IRON,Pneumonia,13
IRON,Condition aggravated,12
IRON,Asthenia,12
IRON,Gingival swelling,12
IRON,Osteonecrosis of jaw,12
IRON,Mucosal inflammation,12
IRON,Vomiting,12
IRON,Abdominal pain,12
IRON,Nasopharyngitis,12
IRON,Dehydration,11
IRON,Abdominal distension,10
IRON,Gait disturbance,10
IRON,Sepsis,10
IRON,Influenza,10
IRON,Sinusitis,10
IRON,Inappropriate schedule of product administration,10
IRON,Abdominal pain upper,10
IRON,Peripheral swelling,9
IRON,Feeling abnormal,9
IRON,Device related infection,9
IRON,Product use issue,9
ISATUXIMAB,Neutropenia,23
ISATUXIMAB,COVID-19,8
ISATUXIMAB,Pneumonia,6
ISATUXIMAB,Pyrexia,6
ISATUXIMAB,Infusion related reaction,6
ISATUXIMAB,Thrombocytopenia,6
ISATUXIMAB,Lymphopenia,6
ISATUXIMAB,Lung disorder,6
ISATUXIMAB,Anaemia,5
ISATUXIMAB,General physical health deterioration,5
ISATUXIMAB,Renal failure,5
ISATUXIMAB,Toxic skin eruption,5
ISATUXIMAB,Respiratory distress,4
ISATUXIMAB,Febrile neutropenia,4
ISATUXIMAB,Asthenia,4
ISATUXIMAB,Bronchitis,4
ISATUXIMAB,Acute kidney injury,4
ISATUXIMAB,Septic shock,4
ISATUXIMAB,Back pain,3
ISATUXIMAB,Cough,3
ISATUXIMAB,Heart rate increased,3
ISATUXIMAB,Vomiting,3
ISATUXIMAB,Rhinitis,3
ISATUXIMAB,Neutrophil count decreased,3
ISATUXIMAB,Hypertension,3
ISATUXIMAB,Constipation,3
ISATUXIMAB,Femoral neck fracture,3
ISATUXIMAB,Pulmonary embolism,3
ISATUXIMAB,Atrial flutter,3
ISATUXIMAB,Urosepsis,3
ISATUXIMAB,Respiratory failure,2
ISATUXIMAB,Haematochezia,2
ISATUXIMAB,Tachycardia,2
ISATUXIMAB,Pulpitis dental,2
ISATUXIMAB,Petechiae,2
ISATUXIMAB,Abdominal pain upper,2
ISATUXIMAB,Cystitis escherichia,2
ISATUXIMAB,Cytokine release syndrome,2
ISATUXIMAB,Hypersensitivity,2
ISATUXIMAB,Hypotension,2
ISATUXIMAB,Rash,2
ISATUXIMAB,Pneumocystis jirovecii pneumonia,2
ISATUXIMAB,Bone pain,2
ISATUXIMAB,Pseudomonas infection,2
ISATUXIMAB,Infection,2
ISATUXIMAB,Acute respiratory distress syndrome,2
ISATUXIMAB,COVID-19 pneumonia,2
ISATUXIMAB,Deep vein thrombosis,2
ISATUXIMAB,Anaphylactic reaction,2
ISATUXIMAB,Lower respiratory tract infection,2
ISENTRESS,Emotional distress,83
ISENTRESS,Pain,83
ISENTRESS,Anxiety,78
ISENTRESS,Anhedonia,77
ISENTRESS,Chronic kidney disease,44
ISENTRESS,Osteoporosis,38
ISENTRESS,Osteopenia,33
ISENTRESS,Bone density decreased,24
ISENTRESS,Bone demineralisation,24
ISENTRESS,Renal failure,23
ISENTRESS,Depression,17
ISENTRESS,Economic problem,16
ISENTRESS,Foetal exposure during pregnancy,15
ISENTRESS,End stage renal disease,14
ISENTRESS,Blood creatinine increased,13
ISENTRESS,Acute kidney injury,13
ISENTRESS,Renal impairment,13
ISENTRESS,Off label use,12
ISENTRESS,Gait disturbance,12
ISENTRESS,Asthenia,12
ISENTRESS,Alanine aminotransferase increased,11
ISENTRESS,Aspartate aminotransferase increased,11
ISENTRESS,Fatigue,11
ISENTRESS,Hepatic cytolysis,10
ISENTRESS,Bone loss,10
ISENTRESS,Intentional product use issue,9
ISENTRESS,Maternal exposure during pregnancy,9
ISENTRESS,Caesarean section,9
ISENTRESS,Abortion spontaneous,9
ISENTRESS,Foot fracture,9
ISENTRESS,Back pain,9
ISENTRESS,Multiple fractures,9
ISENTRESS,Renal injury,9
ISENTRESS,Drug abuse,8
ISENTRESS,Drug ineffective,7
ISENTRESS,Vitamin D deficiency,7
ISENTRESS,Ultrasound antenatal screen,6
ISENTRESS,Volvulus,6
ISENTRESS,Wrist fracture,6
ISENTRESS,Pain in extremity,6
ISENTRESS,Arthralgia,6
ISENTRESS,Proteinuria,6
ISENTRESS,Hip fracture,6
ISENTRESS,Hydrops foetalis,5
ISENTRESS,Quality of life decreased,5
ISENTRESS,Fanconi syndrome acquired,5
ISENTRESS,Pollakiuria,5
ISENTRESS,Osteonecrosis,5
ISENTRESS,Decreased activity,5
ISENTRESS,Mobility decreased,5
ISOSORBIDE DINITRATE,Diarrhoea,88
ISOSORBIDE DINITRATE,Fatigue,88
ISOSORBIDE DINITRATE,COVID-19,87
ISOSORBIDE DINITRATE,Nausea,87
ISOSORBIDE DINITRATE,Malaise,87
ISOSORBIDE DINITRATE,Pain,86
ISOSORBIDE DINITRATE,Anxiety,86
ISOSORBIDE DINITRATE,Dry skin,86
ISOSORBIDE DINITRATE,Chest pain,86
ISOSORBIDE DINITRATE,Pruritus,86
ISOSORBIDE DINITRATE,Dyspnoea,85
ISOSORBIDE DINITRATE,Visual impairment,85
ISOSORBIDE DINITRATE,Hallucination,85
ISOSORBIDE DINITRATE,Amnesia,85
ISOSORBIDE DINITRATE,Feeling abnormal,85
ISOSORBIDE DINITRATE,Facial pain,85
ISOSORBIDE DINITRATE,Myocardial infarction,85
ISOSORBIDE DINITRATE,Dizziness,85
ISOSORBIDE DINITRATE,Dehydration,85
ISOSORBIDE DINITRATE,Alopecia,85
ISOSORBIDE DINITRATE,Tachycardia,85
ISOSORBIDE DINITRATE,Palpitations,85
ISOSORBIDE DINITRATE,Cardiospasm,85
ISOSORBIDE DINITRATE,Peripheral swelling,85
ISOSORBIDE DINITRATE,Vomiting,85
ISOSORBIDE DINITRATE,Angioedema,85
ISOSORBIDE DINITRATE,Muscular weakness,85
ISOSORBIDE DINITRATE,Abdominal discomfort,85
ISOSORBIDE DINITRATE,Subarachnoid haemorrhage,85
ISOSORBIDE DINITRATE,Lip swelling,85
ISOSORBIDE DINITRATE,Disturbance in attention,85
ISOSORBIDE DINITRATE,Anosmia,85
ISOSORBIDE DINITRATE,Pain of skin,85
ISOSORBIDE DINITRATE,Atrial tachycardia,85
ISOSORBIDE DINITRATE,Heart rate increased,85
ISOSORBIDE DINITRATE,Pericarditis,85
ISOSORBIDE DINITRATE,Intentional product misuse,84
ISOSORBIDE DINITRATE,Insomnia,84
ISOSORBIDE DINITRATE,Diplopia,84
ISOSORBIDE DINITRATE,Arthralgia,84
ISOSORBIDE DINITRATE,Hyperhidrosis,84
ISOSORBIDE DINITRATE,Transient ischaemic attack,84
ISOSORBIDE DINITRATE,Tinnitus,84
ISOSORBIDE DINITRATE,Memory impairment,84
ISOSORBIDE DINITRATE,Sleep terror,84
ISOSORBIDE DINITRATE,Tension headache,84
ISOSORBIDE DINITRATE,Blindness,84
ISOSORBIDE DINITRATE,Migraine,84
ISOSORBIDE DINITRATE,Pyrexia,84
ISOSORBIDE DINITRATE,Vasculitis,84
ISOSORBIDE MONONITRATE,Pain,93
ISOSORBIDE MONONITRATE,Diarrhoea,91
ISOSORBIDE MONONITRATE,Anxiety,91
ISOSORBIDE MONONITRATE,Nausea,89
ISOSORBIDE MONONITRATE,Pruritus,89
ISOSORBIDE MONONITRATE,Arthralgia,89
ISOSORBIDE MONONITRATE,Vomiting,89
ISOSORBIDE MONONITRATE,Dizziness,88
ISOSORBIDE MONONITRATE,Fatigue,88
ISOSORBIDE MONONITRATE,Cognitive disorder,87
ISOSORBIDE MONONITRATE,Palpitations,86
ISOSORBIDE MONONITRATE,Memory impairment,86
ISOSORBIDE MONONITRATE,Dyspnoea,86
ISOSORBIDE MONONITRATE,COVID-19,85
ISOSORBIDE MONONITRATE,Myocardial infarction,85
ISOSORBIDE MONONITRATE,Dry skin,85
ISOSORBIDE MONONITRATE,Chest pain,85
ISOSORBIDE MONONITRATE,Angioedema,85
ISOSORBIDE MONONITRATE,Headache,84
ISOSORBIDE MONONITRATE,Pyrexia,84
ISOSORBIDE MONONITRATE,Heart rate increased,84
ISOSORBIDE MONONITRATE,Peripheral swelling,84
ISOSORBIDE MONONITRATE,Visual impairment,84
ISOSORBIDE MONONITRATE,Hallucination,84
ISOSORBIDE MONONITRATE,Amnesia,84
ISOSORBIDE MONONITRATE,Feeling abnormal,84
ISOSORBIDE MONONITRATE,Facial pain,84
ISOSORBIDE MONONITRATE,Abdominal pain upper,84
ISOSORBIDE MONONITRATE,Insomnia,84
ISOSORBIDE MONONITRATE,Dehydration,84
ISOSORBIDE MONONITRATE,Tachycardia,84
ISOSORBIDE MONONITRATE,Cardiospasm,84
ISOSORBIDE MONONITRATE,Blindness,84
ISOSORBIDE MONONITRATE,Muscular weakness,84
ISOSORBIDE MONONITRATE,Malaise,84
ISOSORBIDE MONONITRATE,Abdominal discomfort,84
ISOSORBIDE MONONITRATE,Subarachnoid haemorrhage,84
ISOSORBIDE MONONITRATE,Blood glucose increased,84
ISOSORBIDE MONONITRATE,Lip swelling,84
ISOSORBIDE MONONITRATE,Disturbance in attention,84
ISOSORBIDE MONONITRATE,Anosmia,84
ISOSORBIDE MONONITRATE,Atrial tachycardia,84
ISOSORBIDE MONONITRATE,Pericarditis,84
ISOSORBIDE MONONITRATE,Intentional product misuse,83
ISOSORBIDE MONONITRATE,Diplopia,83
ISOSORBIDE MONONITRATE,Hyperhidrosis,83
ISOSORBIDE MONONITRATE,Alopecia,83
ISOSORBIDE MONONITRATE,Transient ischaemic attack,83
ISOSORBIDE MONONITRATE,Sleep terror,83
ISOSORBIDE MONONITRATE,Eye pruritus,83
IXAZOMIB,Off label use,53
IXAZOMIB,Hypokalaemia,27
IXAZOMIB,Vomiting,22
IXAZOMIB,Diarrhoea,18
IXAZOMIB,White blood cell count decreased,17
IXAZOMIB,Product dose omission issue,16
IXAZOMIB,Platelet count decreased,16
IXAZOMIB,Pneumonia,15
IXAZOMIB,Malaise,13
IXAZOMIB,Blood creatinine increased,11
IXAZOMIB,Neuropathy peripheral,10
IXAZOMIB,Decreased appetite,10
IXAZOMIB,Asthenia,10
IXAZOMIB,Myelosuppression,9
IXAZOMIB,Plasma cell myeloma,9
IXAZOMIB,Urinary retention,9
IXAZOMIB,Nausea,8
IXAZOMIB,Anaemia,8
IXAZOMIB,COVID-19,7
IXAZOMIB,Pain in extremity,7
IXAZOMIB,Hypocalcaemia,7
IXAZOMIB,Fatigue,7
IXAZOMIB,Constipation,7
IXAZOMIB,Cough,7
IXAZOMIB,Nasopharyngitis,6
IXAZOMIB,Fall,6
IXAZOMIB,Rash,6
IXAZOMIB,Death,6
IXAZOMIB,Lymphocyte count decreased,6
IXAZOMIB,Hepatic failure,6
IXAZOMIB,Neutrophil count decreased,6
IXAZOMIB,Pyrexia,6
IXAZOMIB,Back pain,5
IXAZOMIB,Insomnia,5
IXAZOMIB,Upper respiratory tract infection,5
IXAZOMIB,Dizziness,5
IXAZOMIB,Somnolence,4
IXAZOMIB,Arthralgia,4
IXAZOMIB,Product physical issue,4
IXAZOMIB,Hepatic function abnormal,4
IXAZOMIB,Abdominal discomfort,4
IXAZOMIB,Dyspnoea,4
IXAZOMIB,Respiratory tract infection,4
IXAZOMIB,Urinary tract infection,4
IXAZOMIB,Osteomyelitis,3
IXAZOMIB,Blood glucose increased,3
IXAZOMIB,Product packaging quantity issue,3
IXAZOMIB,Loss of consciousness,3
IXAZOMIB,Peripheral swelling,3
IXAZOMIB,Pruritus,3
JANUVIA,Pain,14
JANUVIA,Fatigue,12
JANUVIA,Cough,11
JANUVIA,Diarrhoea,10
JANUVIA,Pneumonia,9
JANUVIA,Acute kidney injury,9
JANUVIA,Emotional distress,9
JANUVIA,Pyrexia,9
JANUVIA,Back pain,8
JANUVIA,Anxiety,8
JANUVIA,Nausea,8
JANUVIA,Malaise,8
JANUVIA,Asthenia,8
JANUVIA,Constipation,8
JANUVIA,Anhedonia,7
JANUVIA,Chronic kidney disease,7
JANUVIA,Headache,7
JANUVIA,Product dose omission issue,7
JANUVIA,Pain in extremity,7
JANUVIA,COVID-19,7
JANUVIA,Hypertension,7
JANUVIA,Confusional state,7
JANUVIA,Somnolence,7
JANUVIA,Platelet count decreased,7
JANUVIA,Dizziness,6
JANUVIA,Hypocalcaemia,6
JANUVIA,Nasopharyngitis,6
JANUVIA,Diabetes mellitus,6
JANUVIA,Rash,6
JANUVIA,Condition aggravated,6
JANUVIA,Hypoglycaemia,6
JANUVIA,Lactic acidosis,6
JANUVIA,Hypomagnesaemia,6
JANUVIA,Influenza,5
JANUVIA,Pruritus,5
JANUVIA,Bronchitis,5
JANUVIA,Urinary tract infection,5
JANUVIA,Fall,5
JANUVIA,Drug ineffective,5
JANUVIA,Blood pressure increased,5
JANUVIA,Overdose,5
JANUVIA,Pancreatitis necrotising,5
JANUVIA,Hypokalaemia,5
JANUVIA,Hypophosphataemia,5
JANUVIA,Arthralgia,4
JANUVIA,Peripheral swelling,4
JANUVIA,Septic shock,4
JANUVIA,Alopecia,4
JANUVIA,Sinusitis,4
JANUVIA,Infusion related reaction,4
JARDIANCE,Vomiting,13
JARDIANCE,Nausea,12
JARDIANCE,Headache,11
JARDIANCE,Asthenia,11
JARDIANCE,Fall,11
JARDIANCE,Diarrhoea,11
JARDIANCE,Fatigue,10
JARDIANCE,Dyspnoea,9
JARDIANCE,Sepsis,9
JARDIANCE,Decreased appetite,9
JARDIANCE,Off label use,9
JARDIANCE,Weight decreased,8
JARDIANCE,COVID-19,8
JARDIANCE,Pain,8
JARDIANCE,Pneumonia,8
JARDIANCE,Pruritus,8
JARDIANCE,Cough,7
JARDIANCE,Anaemia,6
JARDIANCE,Blood pressure increased,6
JARDIANCE,Infusion related reaction,6
JARDIANCE,Arthralgia,6
JARDIANCE,Dizziness,6
JARDIANCE,Death,6
JARDIANCE,Diabetic ketoacidosis,6
JARDIANCE,Malaise,5
JARDIANCE,Pyrexia,5
JARDIANCE,Depression,5
JARDIANCE,Hypertension,5
JARDIANCE,Acute kidney injury,5
JARDIANCE,Back pain,5
JARDIANCE,Condition aggravated,5
JARDIANCE,Somnolence,5
JARDIANCE,Cardio-respiratory arrest,5
JARDIANCE,Blood glucose increased,5
JARDIANCE,Fournier's gangrene,5
JARDIANCE,Gastrooesophageal reflux disease,5
JARDIANCE,Drug reaction with eosinophilia and systemic symptoms,5
JARDIANCE,Eosinophilia,5
JARDIANCE,Urinary tract infection,4
JARDIANCE,Product use in unapproved indication,4
JARDIANCE,Blood glucose abnormal,4
JARDIANCE,Limb injury,4
JARDIANCE,Hypersensitivity,4
JARDIANCE,Skin laceration,4
JARDIANCE,Diverticulitis,4
JARDIANCE,Loss of consciousness,4
JARDIANCE,Anxiety,4
JARDIANCE,Emotional distress,4
JARDIANCE,Anhedonia,4
JARDIANCE,Chronic kidney disease,4
KALETRA,Emotional distress,54
KALETRA,Pain,54
KALETRA,Anxiety,53
KALETRA,Anhedonia,51
KALETRA,Chronic kidney disease,29
KALETRA,Osteoporosis,18
KALETRA,Osteopenia,18
KALETRA,Renal failure,16
KALETRA,Depression,15
KALETRA,Bone density decreased,13
KALETRA,Renal impairment,13
KALETRA,Bone demineralisation,13
KALETRA,Alanine aminotransferase increased,12
KALETRA,Aspartate aminotransferase increased,12
KALETRA,Fatigue,12
KALETRA,Hepatic cytolysis,11
KALETRA,Intentional product use issue,10
KALETRA,Maternal exposure during pregnancy,10
KALETRA,Off label use,10
KALETRA,Abortion spontaneous,10
KALETRA,Economic problem,10
KALETRA,Blood creatinine increased,10
KALETRA,End stage renal disease,10
KALETRA,Foetal exposure during pregnancy,9
KALETRA,Caesarean section,9
KALETRA,Asthenia,9
KALETRA,Gait disturbance,9
KALETRA,Drug abuse,8
KALETRA,Ultrasound antenatal screen,6
KALETRA,Volvulus,6
KALETRA,Wrist fracture,6
KALETRA,Acute kidney injury,6
KALETRA,Decreased activity,6
KALETRA,Hydrops foetalis,5
KALETRA,Renal injury,5
KALETRA,Bone loss,5
KALETRA,Dyslipidaemia,5
KALETRA,Trisomy 18,4
KALETRA,Cleft lip and palate,4
KALETRA,Foot fracture,4
KALETRA,Back pain,4
KALETRA,Quality of life decreased,4
KALETRA,Fanconi syndrome acquired,4
KALETRA,Mobility decreased,4
KALETRA,Loss of personal independence in daily activities,4
KALETRA,Multiple fractures,4
KALETRA,Dysstasia,4
KALETRA,Insomnia,4
KALETRA,Exposure during pregnancy,3
KALETRA,General physical health deterioration,3
KARDEGIC,Neutropenia,28
KARDEGIC,Acute kidney injury,26
KARDEGIC,Thrombocytopenia,20
KARDEGIC,Hypocalcaemia,16
KARDEGIC,Asthenia,16
KARDEGIC,Off label use,16
KARDEGIC,Toxic skin eruption,15
KARDEGIC,Renal impairment,14
KARDEGIC,Hepatic cytolysis,13
KARDEGIC,Drug interaction,12
KARDEGIC,Back pain,11
KARDEGIC,Anaemia,11
KARDEGIC,Confusional state,11
KARDEGIC,Septic shock,10
KARDEGIC,Nephropathy toxic,10
KARDEGIC,Overdose,10
KARDEGIC,Platelet count decreased,10
KARDEGIC,Oesophagitis,10
KARDEGIC,Wrong product administered,10
KARDEGIC,Medication error,10
KARDEGIC,Discontinued product administered,10
KARDEGIC,Diarrhoea,10
KARDEGIC,Hypomagnesaemia,10
KARDEGIC,Hyponatraemia,10
KARDEGIC,Encephalopathy,10
KARDEGIC,Cholestasis,9
KARDEGIC,Stevens-Johnson syndrome,9
KARDEGIC,Lactic acidosis,8
KARDEGIC,Rash maculo-papular,8
KARDEGIC,Eosinophilia,8
KARDEGIC,Circulatory collapse,8
KARDEGIC,Vomiting,7
KARDEGIC,Lymphopenia,7
KARDEGIC,Hyperkalaemia,7
KARDEGIC,COVID-19,7
KARDEGIC,Pyrexia,6
KARDEGIC,General physical health deterioration,6
KARDEGIC,Cerebral haematoma,6
KARDEGIC,Inappropriate antidiuretic hormone secretion,6
KARDEGIC,Hyperammonaemic encephalopathy,6
KARDEGIC,Vertigo,5
KARDEGIC,Pain in extremity,5
KARDEGIC,Haematotoxicity,5
KARDEGIC,Weight decreased,5
KARDEGIC,Inflammation,5
KARDEGIC,Agranulocytosis,5
KARDEGIC,Anaphylactic shock,5
KARDEGIC,Chronic kidney disease,5
KARDEGIC,Rash,5
KARDEGIC,Pancreatitis acute,5
KEPPRA,Seizure,37
KEPPRA,Fatigue,22
KEPPRA,Off label use,22
KEPPRA,Asthenia,18
KEPPRA,Diarrhoea,14
KEPPRA,Pyrexia,13
KEPPRA,Somnolence,13
KEPPRA,Dizziness,12
KEPPRA,Product dose omission issue,12
KEPPRA,Headache,11
KEPPRA,Pain,10
KEPPRA,Urinary tract infection,10
KEPPRA,Rash,10
KEPPRA,Anxiety,9
KEPPRA,Fall,9
KEPPRA,Memory impairment,9
KEPPRA,Gait disturbance,9
KEPPRA,Nausea,9
KEPPRA,Dyspnoea,9
KEPPRA,Epilepsy,8
KEPPRA,Constipation,7
KEPPRA,Weight increased,7
KEPPRA,Back pain,7
KEPPRA,Malaise,7
KEPPRA,Depression,7
KEPPRA,Infection,6
KEPPRA,Vomiting,6
KEPPRA,Illness,6
KEPPRA,Inappropriate schedule of product administration,6
KEPPRA,Nasopharyngitis,6
KEPPRA,Product use issue,6
KEPPRA,Pruritus,6
KEPPRA,Condition aggravated,6
KEPPRA,Arthralgia,6
KEPPRA,Cytokine release syndrome,6
KEPPRA,Emotional distress,5
KEPPRA,Syncope,5
KEPPRA,Weight decreased,5
KEPPRA,Feeling abnormal,5
KEPPRA,Cough,5
KEPPRA,Tremor,5
KEPPRA,Crying,5
KEPPRA,Insomnia,5
KEPPRA,Anhedonia,4
KEPPRA,Gastrointestinal disorder,4
KEPPRA,Viral infection,4
KEPPRA,Hot flush,4
KEPPRA,Poor venous access,4
KEPPRA,Decreased appetite,4
KEPPRA,Abnormal behaviour,4
KESIMPTA,Pyrexia,13
KESIMPTA,Headache,12
KESIMPTA,Chills,12
KESIMPTA,Pain,11
KESIMPTA,Nausea,9
KESIMPTA,Fatigue,9
KESIMPTA,Muscle spasms,9
KESIMPTA,Myalgia,8
KESIMPTA,Gait disturbance,7
KESIMPTA,Muscular weakness,7
KESIMPTA,Feeling abnormal,6
KESIMPTA,Hypoaesthesia,6
KESIMPTA,Accidental exposure to product,6
KESIMPTA,Malaise,6
KESIMPTA,Influenza like illness,6
KESIMPTA,Vomiting,5
KESIMPTA,Pain in extremity,5
KESIMPTA,Injection site pain,5
KESIMPTA,COVID-19,5
KESIMPTA,Abdominal discomfort,5
KESIMPTA,Feeling hot,5
KESIMPTA,Lethargy,5
KESIMPTA,Multiple sclerosis relapse,5
KESIMPTA,Tremor,5
KESIMPTA,Multiple sclerosis,4
KESIMPTA,Asthenia,4
KESIMPTA,Wrong technique in device usage process,4
KESIMPTA,Dizziness,4
KESIMPTA,Maternal exposure during pregnancy,4
KESIMPTA,Lymphocyte count decreased,4
KESIMPTA,Condition aggravated,3
KESIMPTA,Nasal congestion,3
KESIMPTA,Oropharyngeal pain,3
KESIMPTA,Urinary tract infection,3
KESIMPTA,Injection site reaction,3
KESIMPTA,Fall,3
KESIMPTA,Arthralgia,3
KESIMPTA,Temperature intolerance,3
KESIMPTA,Inappropriate schedule of product administration,3
KESIMPTA,Blood pressure increased,3
KESIMPTA,Incorrect dose administered by device,3
KESIMPTA,Disturbance in attention,3
KESIMPTA,Injection site bruising,3
KESIMPTA,Device malfunction,3
KESIMPTA,Musculoskeletal stiffness,3
KESIMPTA,Somnolence,3
KESIMPTA,Limb discomfort,3
KESIMPTA,Nasopharyngitis,3
KESIMPTA,Dyspnoea,3
KESIMPTA,Mobility decreased,2
KETAMINE,Anaphylactic shock,18
KETAMINE,Neutropenia,13
KETAMINE,Vomiting,12
KETAMINE,Malaise,12
KETAMINE,Diarrhoea,11
KETAMINE,Back pain,10
KETAMINE,Acute generalised exanthematous pustulosis,10
KETAMINE,Body temperature increased,9
KETAMINE,Chills,9
KETAMINE,Proctalgia,9
KETAMINE,Pain,9
KETAMINE,Accident,9
KETAMINE,Anal inflammation,9
KETAMINE,Febrile neutropenia,9
KETAMINE,Haemorrhoids,9
KETAMINE,Crohn's disease,9
KETAMINE,Pyrexia,9
KETAMINE,SARS-CoV-2 test negative,7
KETAMINE,Lactic acidosis,6
KETAMINE,Off label use,5
KETAMINE,Bradycardia,5
KETAMINE,Cardiogenic shock,5
KETAMINE,Hypotension,4
KETAMINE,Leukopenia,4
KETAMINE,Withdrawal syndrome,3
KETAMINE,Laryngeal obstruction,3
KETAMINE,Rash,3
KETAMINE,Pruritus,3
KETAMINE,Extravasation,3
KETAMINE,Cystitis,2
KETAMINE,Lymphoedema,2
KETAMINE,Migraine,2
KETAMINE,Myocardial infarction,2
KETAMINE,Hallucination,2
KETAMINE,Fibromyalgia,2
KETAMINE,Pneumonia,2
KETAMINE,Fluid retention,2
KETAMINE,Urticaria,2
KETAMINE,Oesophageal spasm,2
KETAMINE,Obstructive sleep apnoea syndrome,2
KETAMINE,Anxiety,2
KETAMINE,Dizziness,2
KETAMINE,Sleep apnoea syndrome,2
KETAMINE,Condition aggravated,2
KETAMINE,Tinnitus,2
KETAMINE,Agitation,2
KETAMINE,Abdominal pain,2
KETAMINE,Hyperhidrosis,2
KETAMINE,Abdominal pain upper,2
KETAMINE,Oesophageal pain,2
KETOPROFEN,Intentional product misuse,10
KETOPROFEN,Rash,7
KETOPROFEN,Overdose,7
KETOPROFEN,Drug abuse,7
KETOPROFEN,Condition aggravated,6
KETOPROFEN,Drug reaction with eosinophilia and systemic symptoms,6
KETOPROFEN,Lactic acidosis,6
KETOPROFEN,Off label use,5
KETOPROFEN,Lower respiratory tract infection,5
KETOPROFEN,Arthropathy,5
KETOPROFEN,Pulmonary pain,5
KETOPROFEN,Abdominal discomfort,5
KETOPROFEN,Product dose omission issue,5
KETOPROFEN,Knee arthroplasty,5
KETOPROFEN,Hyperhidrosis,5
KETOPROFEN,Neutropenia,5
KETOPROFEN,Severe invasive streptococcal infection,5
KETOPROFEN,Acute generalised exanthematous pustulosis,5
KETOPROFEN,Vomiting,5
KETOPROFEN,Abdominal pain,5
KETOPROFEN,Product use issue,5
KETOPROFEN,Prerenal failure,5
KETOPROFEN,Suicide attempt,5
KETOPROFEN,Renal failure,4
KETOPROFEN,Anaphylactic reaction,4
KETOPROFEN,Leukopenia,4
KETOPROFEN,Cholestasis,4
KETOPROFEN,Lung neoplasm malignant,3
KETOPROFEN,Stomatitis,3
KETOPROFEN,Anaemia,3
KETOPROFEN,Obesity,3
KETOPROFEN,Amyloid arthropathy,3
KETOPROFEN,Somnolence,3
KETOPROFEN,Dizziness,3
KETOPROFEN,Nausea,3
KETOPROFEN,Angioedema,3
KETOPROFEN,Agitation,3
KETOPROFEN,Confusional state,3
KETOPROFEN,Hypotension,3
KETOPROFEN,Coma,3
KETOPROFEN,Poisoning deliberate,3
KETOPROFEN,Sepsis,2
KETOPROFEN,Thrombosis,2
KETOPROFEN,Osteonecrosis of jaw,2
KETOPROFEN,Visual impairment,2
KETOPROFEN,Occipital neuralgia,2
KETOPROFEN,Communication disorder,2
KETOPROFEN,Asthenopia,2
KETOPROFEN,Eye pain,2
KETOPROFEN,Intermenstrual bleeding,2
KEYTRUDA,Malignant neoplasm progression,43
KEYTRUDA,Pyrexia,38
KEYTRUDA,Diarrhoea,34
KEYTRUDA,Hypertension,25
KEYTRUDA,Hypothyroidism,24
KEYTRUDA,Myocarditis,21
KEYTRUDA,Inappropriate schedule of product administration,20
KEYTRUDA,Platelet count decreased,20
KEYTRUDA,Myelosuppression,20
KEYTRUDA,Tubulointerstitial nephritis,20
KEYTRUDA,Interstitial lung disease,18
KEYTRUDA,Weight decreased,18
KEYTRUDA,Rash,18
KEYTRUDA,Anaemia,18
KEYTRUDA,Hepatic cytolysis,18
KEYTRUDA,Pancytopenia,17
KEYTRUDA,Product use issue,17
KEYTRUDA,Product use in unapproved indication,16
KEYTRUDA,Off label use,15
KEYTRUDA,Thrombocytopenia,14
KEYTRUDA,Pain in extremity,14
KEYTRUDA,Asthenia,14
KEYTRUDA,Decreased appetite,14
KEYTRUDA,Vomiting,14
KEYTRUDA,Nausea,14
KEYTRUDA,Pruritus,14
KEYTRUDA,Palmar-plantar erythrodysaesthesia syndrome,14
KEYTRUDA,Fatigue,13
KEYTRUDA,Malaise,13
KEYTRUDA,Adrenal insufficiency,13
KEYTRUDA,Acute kidney injury,12
KEYTRUDA,Condition aggravated,12
KEYTRUDA,Pneumonia,11
KEYTRUDA,Pleural effusion,11
KEYTRUDA,Mucosal inflammation,11
KEYTRUDA,White blood cell count decreased,10
KEYTRUDA,Cholangitis,10
KEYTRUDA,Neutropenia,10
KEYTRUDA,Subacute cutaneous lupus erythematosus,10
KEYTRUDA,Hyponatraemia,9
KEYTRUDA,Arthralgia,9
KEYTRUDA,Confusional state,9
KEYTRUDA,Lung disorder,9
KEYTRUDA,Troponin increased,9
KEYTRUDA,Lichenoid keratosis,9
KEYTRUDA,Pulmonary toxicity,8
KEYTRUDA,Diabetic ketoacidosis,8
KEYTRUDA,Encephalopathy,8
KEYTRUDA,Circulatory collapse,8
KEYTRUDA,Hyperglycaemia,7
KISQALI,Fatigue,49
KISQALI,Headache,46
KISQALI,Nausea,45
KISQALI,Vomiting,45
KISQALI,Pain,42
KISQALI,Neutropenia,39
KISQALI,Diarrhoea,36
KISQALI,Anaemia,33
KISQALI,Malaise,30
KISQALI,Electrocardiogram QT prolonged,27
KISQALI,Back pain,27
KISQALI,Arthralgia,27
KISQALI,Leukopenia,24
KISQALI,Pruritus,24
KISQALI,Aspartate aminotransferase increased,23
KISQALI,Alanine aminotransferase increased,23
KISQALI,Dry skin,23
KISQALI,Dyspnoea,20
KISQALI,COVID-19,20
KISQALI,Metastases to bone,20
KISQALI,Decreased immune responsiveness,20
KISQALI,Death,20
KISQALI,Dyspepsia,19
KISQALI,Constipation,19
KISQALI,Weight decreased,19
KISQALI,Dizziness,18
KISQALI,White blood cell count decreased,18
KISQALI,Decreased appetite,18
KISQALI,Alopecia,17
KISQALI,Asthenia,17
KISQALI,Cough,16
KISQALI,Spinal pain,16
KISQALI,Pain in extremity,16
KISQALI,Fall,15
KISQALI,Gait disturbance,15
KISQALI,Abdominal pain upper,15
KISQALI,General physical health deterioration,14
KISQALI,Bone pain,14
KISQALI,Anxiety,14
KISQALI,Haemoglobin decreased,13
KISQALI,Thrombocytopenia,13
KISQALI,Rash,13
KISQALI,Chest pain,13
KISQALI,Hypersensitivity,13
KISQALI,Weight increased,13
KISQALI,Illness,13
KISQALI,Gamma-glutamyltransferase increased,11
KISQALI,Urinary tract infection,11
KISQALI,Oedema peripheral,11
KISQALI,Malignant neoplasm progression,11
KLONOPIN,Malaise,9
KLONOPIN,Nausea,7
KLONOPIN,Headache,7
KLONOPIN,Inappropriate schedule of product administration,6
KLONOPIN,Illness,6
KLONOPIN,Abdominal distension,6
KLONOPIN,Drug ineffective,5
KLONOPIN,Pain,5
KLONOPIN,Fatigue,5
KLONOPIN,Urinary tract infection,5
KLONOPIN,Fall,5
KLONOPIN,Dyspnoea,5
KLONOPIN,Off label use,5
KLONOPIN,Constipation,4
KLONOPIN,Anxiety,4
KLONOPIN,Seasonal allergy,4
KLONOPIN,Pneumonia,4
KLONOPIN,COVID-19,4
KLONOPIN,Influenza,4
KLONOPIN,Sinusitis,4
KLONOPIN,Weight decreased,4
KLONOPIN,Cough,4
KLONOPIN,Product dose omission issue,4
KLONOPIN,Feeling abnormal,4
KLONOPIN,Depression,3
KLONOPIN,Pulmonary embolism,3
KLONOPIN,Bronchitis,3
KLONOPIN,Insurance issue,3
KLONOPIN,Rash,3
KLONOPIN,Insomnia,3
KLONOPIN,Hernia,3
KLONOPIN,Myalgia,3
KLONOPIN,Flatulence,3
KLONOPIN,Muscle spasms,3
KLONOPIN,Dehydration,3
KLONOPIN,Platelet count decreased,3
KLONOPIN,Pyrexia,3
KLONOPIN,Dry skin,3
KLONOPIN,Blood pressure increased,3
KLONOPIN,Product use in unapproved indication,3
KLONOPIN,Skin exfoliation,3
KLONOPIN,Decreased appetite,3
KLONOPIN,Injection site pain,3
KLONOPIN,Arthralgia,3
KLONOPIN,Drug dependence,2
KLONOPIN,Stress,2
KLONOPIN,Arthritis,2
KLONOPIN,General physical health deterioration,2
KLONOPIN,Oxygen saturation decreased,2
KLONOPIN,Infusion site extravasation,2
KYMRIAH,Cytokine release syndrome,41
KYMRIAH,Pyrexia,34
KYMRIAH,Platelet count decreased,24
KYMRIAH,Malignant neoplasm progression,20
KYMRIAH,Hypogammaglobulinaemia,18
KYMRIAH,White blood cell count decreased,17
KYMRIAH,Neutrophil count decreased,14
KYMRIAH,Second primary malignancy,12
KYMRIAH,Diffuse large B-cell lymphoma recurrent,12
KYMRIAH,Immune effector cell-associated neurotoxicity syndrome,11
KYMRIAH,Lymphocyte count decreased,11
KYMRIAH,Diffuse large B-cell lymphoma,9
KYMRIAH,Haemoglobin decreased,9
KYMRIAH,Sepsis,8
KYMRIAH,Hypoxia,8
KYMRIAH,Hypotension,8
KYMRIAH,Myelodysplastic syndrome,6
KYMRIAH,Pancytopenia,6
KYMRIAH,Pneumonia,6
KYMRIAH,Multiple organ dysfunction syndrome,6
KYMRIAH,Acute kidney injury,5
KYMRIAH,Bone marrow failure,5
KYMRIAH,Febrile neutropenia,5
KYMRIAH,Haemophagocytic lymphohistiocytosis,5
KYMRIAH,C-reactive protein increased,5
KYMRIAH,Anaemia,5
KYMRIAH,Cough,4
KYMRIAH,Blood pressure decreased,4
KYMRIAH,Cellulitis,4
KYMRIAH,Septic shock,4
KYMRIAH,Hepatic failure,4
KYMRIAH,Acute lymphocytic leukaemia recurrent,4
KYMRIAH,Diarrhoea,4
KYMRIAH,Tachypnoea,4
KYMRIAH,COVID-19,3
KYMRIAH,Red blood cell count decreased,3
KYMRIAH,Headache,3
KYMRIAH,Lymphadenopathy,3
KYMRIAH,Drug ineffective,3
KYMRIAH,Blood fibrinogen decreased,3
KYMRIAH,Hepatotoxicity,3
KYMRIAH,Serum ferritin increased,3
KYMRIAH,Neutropenia,3
KYMRIAH,Hepatic enzyme increased,3
KYMRIAH,Off label use,3
KYMRIAH,Somnolence,3
KYMRIAH,Weight decreased,2
KYMRIAH,Invasive ductal breast carcinoma,2
KYMRIAH,Fatigue,2
KYMRIAH,Chest pain,2
LACTULOSE,Constipation,21
LACTULOSE,Dyspnoea,16
LACTULOSE,Nausea,16
LACTULOSE,Diarrhoea,16
LACTULOSE,Vomiting,16
LACTULOSE,Anaemia,15
LACTULOSE,Asthenia,14
LACTULOSE,Hypokalaemia,14
LACTULOSE,Death,14
LACTULOSE,Fall,13
LACTULOSE,Headache,13
LACTULOSE,Product use issue,12
LACTULOSE,Decreased appetite,11
LACTULOSE,Condition aggravated,11
LACTULOSE,Off label use,11
LACTULOSE,Depression,10
LACTULOSE,Productive cough,10
LACTULOSE,Urinary tract infection,9
LACTULOSE,Weight decreased,9
LACTULOSE,Dysphagia,9
LACTULOSE,Mucosal inflammation,9
LACTULOSE,Hypomagnesaemia,9
LACTULOSE,Pneumonia,9
LACTULOSE,Confusional state,9
LACTULOSE,Acute kidney injury,8
LACTULOSE,Nervous system disorder,8
LACTULOSE,Balance disorder,8
LACTULOSE,Fatigue,8
LACTULOSE,Gait disturbance,8
LACTULOSE,Dehydration,8
LACTULOSE,Mouth ulceration,8
LACTULOSE,Neutropenic sepsis,8
LACTULOSE,Skin candida,8
LACTULOSE,Neutrophil count decreased,8
LACTULOSE,Insurance issue,8
LACTULOSE,Leukopenia,8
LACTULOSE,Product use in unapproved indication,7
LACTULOSE,Hypertension,7
LACTULOSE,Neutropenia,7
LACTULOSE,Hyperammonaemic encephalopathy,7
LACTULOSE,Pain,6
LACTULOSE,Arthralgia,6
LACTULOSE,Hospitalisation,6
LACTULOSE,Pyrexia,6
LACTULOSE,Haemolytic anaemia,6
LACTULOSE,Renal failure,5
LACTULOSE,Lactic acidosis,5
LACTULOSE,Somnolence,5
LACTULOSE,General physical health deterioration,5
LACTULOSE,Oedema peripheral,5
LAMICTAL,Off label use,12
LAMICTAL,Nausea,10
LAMICTAL,Product dose omission issue,10
LAMICTAL,Vomiting,9
LAMICTAL,Headache,8
LAMICTAL,Urinary tract infection,7
LAMICTAL,Fatigue,6
LAMICTAL,Muscle spasms,6
LAMICTAL,Death,6
LAMICTAL,Staphylococcal infection,5
LAMICTAL,Asthenia,5
LAMICTAL,Weight decreased,4
LAMICTAL,Eye infection,4
LAMICTAL,Dizziness,4
LAMICTAL,Tooth abscess,4
LAMICTAL,Mouth ulceration,4
LAMICTAL,Drug reaction with eosinophilia and systemic symptoms,4
LAMICTAL,Memory impairment,4
LAMICTAL,Diarrhoea,4
LAMICTAL,Seizure,4
LAMICTAL,Enuresis,3
LAMICTAL,Abnormal behaviour,3
LAMICTAL,Drug intolerance,3
LAMICTAL,Anxiety,3
LAMICTAL,COVID-19,3
LAMICTAL,Escherichia infection,3
LAMICTAL,Pain,3
LAMICTAL,Syncope,3
LAMICTAL,Abdominal distension,3
LAMICTAL,Arthralgia,3
LAMICTAL,Cardiac disorder,3
LAMICTAL,Suicide attempt,3
LAMICTAL,Gastrointestinal disorder,3
LAMICTAL,Decreased appetite,3
LAMICTAL,Sinusitis,3
LAMICTAL,Illness,3
LAMICTAL,Post-traumatic stress disorder,2
LAMICTAL,Victim of sexual abuse,2
LAMICTAL,Obstructive sleep apnoea syndrome,2
LAMICTAL,Blood pressure increased,2
LAMICTAL,Intentional product use issue,2
LAMICTAL,Mental disability,2
LAMICTAL,Weight increased,2
LAMICTAL,Nephrolithiasis,2
LAMICTAL,Attention deficit hyperactivity disorder,2
LAMICTAL,Infection,2
LAMICTAL,Eyelid infection,2
LAMICTAL,Inappropriate schedule of product administration,2
LAMICTAL,Dehydration,2
LAMICTAL,Bowel movement irregularity,2
LAMIVUDINE,Hepatic cytolysis,14
LAMIVUDINE,Pain,13
LAMIVUDINE,Dyslipidaemia,13
LAMIVUDINE,Alanine aminotransferase increased,12
LAMIVUDINE,Aspartate aminotransferase increased,12
LAMIVUDINE,Anxiety,12
LAMIVUDINE,Anhedonia,12
LAMIVUDINE,Foetal exposure during pregnancy,11
LAMIVUDINE,Off label use,11
LAMIVUDINE,Emotional distress,11
LAMIVUDINE,Intentional product use issue,10
LAMIVUDINE,Maternal exposure during pregnancy,10
LAMIVUDINE,Abortion spontaneous,10
LAMIVUDINE,Chronic kidney disease,10
LAMIVUDINE,Caesarean section,9
LAMIVUDINE,Drug abuse,8
LAMIVUDINE,Ultrasound antenatal screen,6
LAMIVUDINE,Volvulus,6
LAMIVUDINE,Optic atrophy,6
LAMIVUDINE,Hydrops foetalis,5
LAMIVUDINE,Osteopenia,5
LAMIVUDINE,Acute kidney injury,5
LAMIVUDINE,Febrile neutropenia,5
LAMIVUDINE,Trisomy 18,4
LAMIVUDINE,Cleft lip and palate,4
LAMIVUDINE,Renal impairment,4
LAMIVUDINE,Osteoporosis,4
LAMIVUDINE,Renal failure,4
LAMIVUDINE,Hyperkalaemia,4
LAMIVUDINE,Dyspnoea,4
LAMIVUDINE,Exposure during pregnancy,3
LAMIVUDINE,Depression,3
LAMIVUDINE,Metabolic acidosis,3
LAMIVUDINE,Post procedural infection,3
LAMIVUDINE,Urinary tract infection,3
LAMIVUDINE,Cystostomy,3
LAMIVUDINE,Staphylococcal sepsis,3
LAMIVUDINE,Mucosal inflammation,3
LAMIVUDINE,Nausea,3
LAMIVUDINE,Proteinuria,2
LAMIVUDINE,Renal tubular dysfunction,2
LAMIVUDINE,Renal disorder,2
LAMIVUDINE,Bone density decreased,2
LAMIVUDINE,Renal injury,2
LAMIVUDINE,End stage renal disease,2
LAMIVUDINE,Gout,2
LAMIVUDINE,Asthenia,2
LAMIVUDINE,Infection,2
LAMIVUDINE,Tachycardia,2
LAMIVUDINE,Pyrexia,2
LAMOTRIGINE,Pain,19
LAMOTRIGINE,Fatigue,17
LAMOTRIGINE,Seizure,17
LAMOTRIGINE,Nausea,16
LAMOTRIGINE,Anxiety,13
LAMOTRIGINE,Tremor,12
LAMOTRIGINE,Insomnia,11
LAMOTRIGINE,Product dose omission issue,11
LAMOTRIGINE,Epilepsy,10
LAMOTRIGINE,Somnolence,10
LAMOTRIGINE,Dizziness,9
LAMOTRIGINE,Suicidal ideation,9
LAMOTRIGINE,Inappropriate schedule of product administration,9
LAMOTRIGINE,Decreased appetite,9
LAMOTRIGINE,Intentional overdose,9
LAMOTRIGINE,Disturbance in attention,9
LAMOTRIGINE,Dyspnoea,8
LAMOTRIGINE,Headache,8
LAMOTRIGINE,Depression,8
LAMOTRIGINE,Pyrexia,8
LAMOTRIGINE,Back pain,8
LAMOTRIGINE,Product use in unapproved indication,8
LAMOTRIGINE,Foetal exposure during pregnancy,8
LAMOTRIGINE,Agitation,8
LAMOTRIGINE,Maternal exposure during pregnancy,8
LAMOTRIGINE,Heart rate increased,7
LAMOTRIGINE,Pain in extremity,7
LAMOTRIGINE,Diarrhoea,7
LAMOTRIGINE,Osteoporosis,7
LAMOTRIGINE,Gait disturbance,7
LAMOTRIGINE,Mobility decreased,7
LAMOTRIGINE,Dry mouth,7
LAMOTRIGINE,Vision blurred,7
LAMOTRIGINE,Visual impairment,7
LAMOTRIGINE,Weight decreased,6
LAMOTRIGINE,Blood pressure decreased,6
LAMOTRIGINE,Product administration interrupted,6
LAMOTRIGINE,Dysarthria,6
LAMOTRIGINE,Off label use,6
LAMOTRIGINE,Cough,6
LAMOTRIGINE,Constipation,6
LAMOTRIGINE,Drug ineffective,6
LAMOTRIGINE,Anhedonia,6
LAMOTRIGINE,Emotional distress,6
LAMOTRIGINE,Muscle spasms,6
LAMOTRIGINE,Psychomotor hyperactivity,6
LAMOTRIGINE,Peripheral swelling,5
LAMOTRIGINE,Vomiting,5
LAMOTRIGINE,Erythema,5
LAMOTRIGINE,Acute kidney injury,5
LANADELUMAB,Hereditary angioedema,55
LANADELUMAB,Product dose omission issue,28
LANADELUMAB,Inappropriate schedule of product administration,21
LANADELUMAB,Weight decreased,19
LANADELUMAB,COVID-19,15
LANADELUMAB,Weight increased,10
LANADELUMAB,Pneumonia,9
LANADELUMAB,Insurance issue,8
LANADELUMAB,Malaise,8
LANADELUMAB,Headache,7
LANADELUMAB,Product use issue,7
LANADELUMAB,Stress,6
LANADELUMAB,Sinusitis,6
LANADELUMAB,Product availability issue,6
LANADELUMAB,Injection site erythema,6
LANADELUMAB,Injection site pain,6
LANADELUMAB,Migraine,5
LANADELUMAB,Dizziness,5
LANADELUMAB,Nausea,5
LANADELUMAB,Arthralgia,4
LANADELUMAB,Fall,4
LANADELUMAB,Vomiting,4
LANADELUMAB,Fatigue,4
LANADELUMAB,Injection site bruising,3
LANADELUMAB,Sinus disorder,3
LANADELUMAB,Urinary tract infection,3
LANADELUMAB,Dyspnoea,3
LANADELUMAB,Decreased appetite,3
LANADELUMAB,Injection site paraesthesia,3
LANADELUMAB,Cellulitis,3
LANADELUMAB,Upper respiratory tract infection,3
LANADELUMAB,Chest pain,3
LANADELUMAB,Injection site swelling,3
LANADELUMAB,Road traffic accident,3
LANADELUMAB,Pain,3
LANADELUMAB,General physical health deterioration,3
LANADELUMAB,Respiratory tract infection,3
LANADELUMAB,Systemic lupus erythematosus,3
LANADELUMAB,Rash,2
LANADELUMAB,Injection site reaction,2
LANADELUMAB,Haemorrhage,2
LANADELUMAB,Drug hypersensitivity,2
LANADELUMAB,Anxiety,2
LANADELUMAB,Drug abuse,2
LANADELUMAB,Pyrexia,2
LANADELUMAB,Necrotising fasciitis,2
LANADELUMAB,Cataract,2
LANADELUMAB,Drug ineffective,2
LANADELUMAB,Procedural complication,2
LANADELUMAB,Sepsis,2
LANSOPRAZOLE,Vomiting,141
LANSOPRAZOLE,Diarrhoea,138
LANSOPRAZOLE,Nausea,131
LANSOPRAZOLE,Dyspnoea,126
LANSOPRAZOLE,Malaise,120
LANSOPRAZOLE,Fatigue,119
LANSOPRAZOLE,Off label use,117
LANSOPRAZOLE,Pain,113
LANSOPRAZOLE,Headache,113
LANSOPRAZOLE,Pruritus,109
LANSOPRAZOLE,Pyrexia,109
LANSOPRAZOLE,Arthralgia,108
LANSOPRAZOLE,Dehydration,106
LANSOPRAZOLE,Anxiety,105
LANSOPRAZOLE,Feeling abnormal,102
LANSOPRAZOLE,COVID-19,102
LANSOPRAZOLE,Dizziness,101
LANSOPRAZOLE,Back pain,101
LANSOPRAZOLE,Muscular weakness,99
LANSOPRAZOLE,Dry skin,98
LANSOPRAZOLE,Abdominal discomfort,98
LANSOPRAZOLE,Memory impairment,97
LANSOPRAZOLE,Peripheral swelling,97
LANSOPRAZOLE,Insomnia,96
LANSOPRAZOLE,Migraine,96
LANSOPRAZOLE,Abdominal pain upper,96
LANSOPRAZOLE,Angioedema,96
LANSOPRAZOLE,Alopecia,94
LANSOPRAZOLE,Lip swelling,94
LANSOPRAZOLE,Disturbance in attention,94
LANSOPRAZOLE,Intentional product misuse,93
LANSOPRAZOLE,Palpitations,93
LANSOPRAZOLE,Tinnitus,93
LANSOPRAZOLE,Hallucination,92
LANSOPRAZOLE,Hyperhidrosis,92
LANSOPRAZOLE,Chest pain,92
LANSOPRAZOLE,Amnesia,91
LANSOPRAZOLE,Tachycardia,91
LANSOPRAZOLE,Blood glucose increased,91
LANSOPRAZOLE,Pericarditis,90
LANSOPRAZOLE,Facial pain,90
LANSOPRAZOLE,Muscle twitching,90
LANSOPRAZOLE,Transient ischaemic attack,90
LANSOPRAZOLE,Visual impairment,90
LANSOPRAZOLE,Myocardial infarction,90
LANSOPRAZOLE,Ventricular tachycardia,89
LANSOPRAZOLE,Diplopia,89
LANSOPRAZOLE,Cardiospasm,89
LANSOPRAZOLE,Subarachnoid haemorrhage,89
LANSOPRAZOLE,Anosmia,89
LANTUS,Acute kidney injury,18
LANTUS,Fatigue,17
LANTUS,Off label use,15
LANTUS,COVID-19,13
LANTUS,Product dose omission issue,13
LANTUS,Fall,12
LANTUS,Diarrhoea,12
LANTUS,Pain,11
LANTUS,Hypotension,10
LANTUS,Dyspnoea,10
LANTUS,Nausea,10
LANTUS,Headache,10
LANTUS,International normalised ratio abnormal,9
LANTUS,Polyuria,9
LANTUS,Overdose,9
LANTUS,Medication error,9
LANTUS,Emotional distress,9
LANTUS,Anxiety,9
LANTUS,Urinary tract infection,8
LANTUS,Dialysis,7
LANTUS,Depression,7
LANTUS,Cough,7
LANTUS,Chronic kidney disease,7
LANTUS,Anhedonia,7
LANTUS,Renal failure,6
LANTUS,Asthenia,6
LANTUS,Decreased appetite,6
LANTUS,Product storage error,6
LANTUS,Blood glucose increased,6
LANTUS,Hyperglycaemia,6
LANTUS,Vomiting,6
LANTUS,Sinusitis,6
LANTUS,Pyrexia,6
LANTUS,Productive cough,5
LANTUS,Hypertension,5
LANTUS,Rhinorrhoea,5
LANTUS,Weight decreased,5
LANTUS,Insomnia,5
LANTUS,Malaise,5
LANTUS,Inappropriate schedule of product administration,5
LANTUS,Hypocalcaemia,5
LANTUS,Xerosis,5
LANTUS,Electrocardiogram QT prolonged,5
LANTUS,Upper respiratory tract infection,4
LANTUS,Blood glucose abnormal,4
LANTUS,Blood pressure increased,4
LANTUS,Dizziness,4
LANTUS,Loss of consciousness,4
LANTUS,Back pain,4
LANTUS,Osteoporosis,4
LASIX,Diarrhoea,34
LASIX,Pain,32
LASIX,Dyspnoea,27
LASIX,Fatigue,27
LASIX,Off label use,26
LASIX,Asthenia,26
LASIX,Fall,21
LASIX,Arthralgia,20
LASIX,Product dose omission issue,20
LASIX,Headache,19
LASIX,Nausea,19
LASIX,Anxiety,18
LASIX,Weight decreased,17
LASIX,Chronic kidney disease,16
LASIX,Weight increased,15
LASIX,Hypotension,15
LASIX,Emotional distress,15
LASIX,Oedema peripheral,15
LASIX,Dizziness,15
LASIX,Drug ineffective,15
LASIX,Pneumonia,14
LASIX,Vomiting,14
LASIX,Malaise,13
LASIX,Peripheral swelling,13
LASIX,Cough,13
LASIX,Anaemia,13
LASIX,Cardiac failure,13
LASIX,Hypertension,12
LASIX,Pyrexia,12
LASIX,Renal failure,12
LASIX,Condition aggravated,12
LASIX,Cardiac failure congestive,12
LASIX,Urinary tract infection,11
LASIX,Dehydration,11
LASIX,Acute kidney injury,11
LASIX,Abdominal pain upper,11
LASIX,Oedema,11
LASIX,Pain in extremity,10
LASIX,Abdominal distension,10
LASIX,Swelling,10
LASIX,Renal impairment,10
LASIX,Anhedonia,10
LASIX,Fluid retention,10
LASIX,Atrial fibrillation,10
LASIX,Generalised oedema,10
LASIX,Blood pressure increased,9
LASIX,Nasopharyngitis,9
LASIX,Insomnia,9
LASIX,Inappropriate schedule of product administration,9
LASIX,Constipation,9
LATANOPROST,Diarrhoea,10
LATANOPROST,Off label use,8
LATANOPROST,Fatigue,7
LATANOPROST,Nausea,7
LATANOPROST,Asthenia,6
LATANOPROST,Depression,6
LATANOPROST,Pain,5
LATANOPROST,COVID-19,5
LATANOPROST,Drug ineffective,5
LATANOPROST,Rash,5
LATANOPROST,Decreased appetite,5
LATANOPROST,Malaise,5
LATANOPROST,Abdominal pain upper,5
LATANOPROST,Pneumonia,5
LATANOPROST,Eye irritation,5
LATANOPROST,Anxiety,4
LATANOPROST,Fall,4
LATANOPROST,Peripheral swelling,4
LATANOPROST,Pyrexia,4
LATANOPROST,Condition aggravated,4
LATANOPROST,Cough,4
LATANOPROST,Abdominal discomfort,4
LATANOPROST,Musculoskeletal pain,4
LATANOPROST,Product dose omission issue,4
LATANOPROST,Constipation,4
LATANOPROST,Weight decreased,4
LATANOPROST,Anhedonia,3
LATANOPROST,Emotional distress,3
LATANOPROST,Dyspnoea,3
LATANOPROST,Pruritus,3
LATANOPROST,Dysgeusia,3
LATANOPROST,Neutropenia,3
LATANOPROST,Heart rate increased,3
LATANOPROST,Urinary tract infection,3
LATANOPROST,Dyspepsia,3
LATANOPROST,Systemic lupus erythematosus,3
LATANOPROST,Arthralgia,3
LATANOPROST,Product packaging quantity issue,3
LATANOPROST,Ocular hyperaemia,3
LATANOPROST,Pain in extremity,3
LATANOPROST,Inappropriate schedule of product administration,3
LATANOPROST,Headache,3
LATANOPROST,Cerebrovascular accident,3
LATANOPROST,Nasopharyngitis,3
LATANOPROST,Epistaxis,3
LATANOPROST,Malignant melanoma,2
LATANOPROST,Osteonecrosis,2
LATANOPROST,Chronic kidney disease,2
LATANOPROST,Renal failure,2
LATANOPROST,Renal injury,2
LEFLUNOMIDE,Arthralgia,31
LEFLUNOMIDE,Rheumatoid arthritis,27
LEFLUNOMIDE,Pain in extremity,26
LEFLUNOMIDE,Drug ineffective,26
LEFLUNOMIDE,Pain,25
LEFLUNOMIDE,Fatigue,23
LEFLUNOMIDE,Condition aggravated,20
LEFLUNOMIDE,Rash,19
LEFLUNOMIDE,Off label use,18
LEFLUNOMIDE,Malaise,17
LEFLUNOMIDE,Peripheral swelling,16
LEFLUNOMIDE,Dyspnoea,15
LEFLUNOMIDE,Headache,15
LEFLUNOMIDE,Musculoskeletal stiffness,15
LEFLUNOMIDE,Sinusitis,15
LEFLUNOMIDE,Nausea,15
LEFLUNOMIDE,Drug intolerance,14
LEFLUNOMIDE,Nasopharyngitis,14
LEFLUNOMIDE,Diarrhoea,14
LEFLUNOMIDE,Psoriatic arthropathy,14
LEFLUNOMIDE,Pyrexia,14
LEFLUNOMIDE,C-reactive protein increased,14
LEFLUNOMIDE,Arthritis,14
LEFLUNOMIDE,Infection,13
LEFLUNOMIDE,Drug hypersensitivity,13
LEFLUNOMIDE,Joint swelling,13
LEFLUNOMIDE,Arthropathy,13
LEFLUNOMIDE,Swelling,12
LEFLUNOMIDE,COVID-19,12
LEFLUNOMIDE,Dizziness,11
LEFLUNOMIDE,Weight increased,11
LEFLUNOMIDE,Synovitis,11
LEFLUNOMIDE,Gait disturbance,11
LEFLUNOMIDE,Hypoaesthesia,10
LEFLUNOMIDE,Asthenia,10
LEFLUNOMIDE,Therapeutic product effect decreased,10
LEFLUNOMIDE,Treatment failure,10
LEFLUNOMIDE,Abdominal discomfort,10
LEFLUNOMIDE,Product dose omission issue,10
LEFLUNOMIDE,Red blood cell sedimentation rate increased,9
LEFLUNOMIDE,Hypertension,9
LEFLUNOMIDE,Inflammation,9
LEFLUNOMIDE,Pruritus,9
LEFLUNOMIDE,Intentional product use issue,9
LEFLUNOMIDE,Blood cholesterol increased,9
LEFLUNOMIDE,Pneumonia,9
LEFLUNOMIDE,Weight decreased,9
LEFLUNOMIDE,Vomiting,9
LEFLUNOMIDE,Mobility decreased,9
LEFLUNOMIDE,Therapeutic product effect incomplete,8
LENALIDOMIDE,Off label use,46
LENALIDOMIDE,Pneumonia,35
LENALIDOMIDE,Neutropenia,26
LENALIDOMIDE,Diarrhoea,24
LENALIDOMIDE,Vomiting,23
LENALIDOMIDE,COVID-19,18
LENALIDOMIDE,Febrile neutropenia,18
LENALIDOMIDE,Thrombocytopenia,17
LENALIDOMIDE,Pyrexia,16
LENALIDOMIDE,Anaemia,16
LENALIDOMIDE,Asthenia,15
LENALIDOMIDE,Malaise,15
LENALIDOMIDE,Leukopenia,14
LENALIDOMIDE,Cytokine release syndrome,13
LENALIDOMIDE,Death,12
LENALIDOMIDE,Platelet count decreased,11
LENALIDOMIDE,Acute kidney injury,11
LENALIDOMIDE,Blood creatinine increased,10
LENALIDOMIDE,White blood cell count decreased,10
LENALIDOMIDE,Urinary retention,10
LENALIDOMIDE,Hyperthermia,10
LENALIDOMIDE,Hypokalaemia,9
LENALIDOMIDE,Dyspnoea,9
LENALIDOMIDE,Rash,9
LENALIDOMIDE,General physical health deterioration,9
LENALIDOMIDE,Neutrophil count decreased,8
LENALIDOMIDE,Sepsis,8
LENALIDOMIDE,Disease progression,8
LENALIDOMIDE,Nausea,8
LENALIDOMIDE,Fatigue,8
LENALIDOMIDE,Pulmonary embolism,7
LENALIDOMIDE,Septic shock,7
LENALIDOMIDE,Diabetes mellitus,7
LENALIDOMIDE,Infusion related reaction,7
LENALIDOMIDE,Respiratory failure,6
LENALIDOMIDE,Pneumonitis,6
LENALIDOMIDE,Atrial fibrillation,6
LENALIDOMIDE,Neuropathy peripheral,6
LENALIDOMIDE,Weight decreased,6
LENALIDOMIDE,C-reactive protein increased,6
LENALIDOMIDE,Plasma cell myeloma,6
LENALIDOMIDE,Toxic skin eruption,6
LENALIDOMIDE,Pancytopenia,5
LENALIDOMIDE,Renal failure,5
LENALIDOMIDE,Respiratory distress,5
LENALIDOMIDE,Deep vein thrombosis,5
LENALIDOMIDE,COVID-19 pneumonia,5
LENALIDOMIDE,Hypotension,5
LENALIDOMIDE,Urinary tract infection,5
LENALIDOMIDE,Lymphopenia,5
LENVATINIB MESYLATE,Hypertension,13
LENVATINIB MESYLATE,Platelet count decreased,12
LENVATINIB MESYLATE,Hypothyroidism,11
LENVATINIB MESYLATE,Product use issue,8
LENVATINIB MESYLATE,Pyrexia,7
LENVATINIB MESYLATE,Palmar-plantar erythrodysaesthesia syndrome,7
LENVATINIB MESYLATE,Malignant neoplasm progression,6
LENVATINIB MESYLATE,Inappropriate schedule of product administration,6
LENVATINIB MESYLATE,Diarrhoea,6
LENVATINIB MESYLATE,Proteinuria,6
LENVATINIB MESYLATE,Fatigue,6
LENVATINIB MESYLATE,Arthralgia,5
LENVATINIB MESYLATE,Pleural effusion,4
LENVATINIB MESYLATE,Alanine aminotransferase increased,4
LENVATINIB MESYLATE,Cardiac failure,4
LENVATINIB MESYLATE,Stomatitis,4
LENVATINIB MESYLATE,Asthenia,4
LENVATINIB MESYLATE,Large intestine perforation,3
LENVATINIB MESYLATE,Aspartate aminotransferase increased,3
LENVATINIB MESYLATE,C-reactive protein increased,3
LENVATINIB MESYLATE,Malaise,3
LENVATINIB MESYLATE,Rash,3
LENVATINIB MESYLATE,Pain in extremity,3
LENVATINIB MESYLATE,Vomiting,3
LENVATINIB MESYLATE,Weight decreased,3
LENVATINIB MESYLATE,Neuropathy peripheral,3
LENVATINIB MESYLATE,Anaemia,2
LENVATINIB MESYLATE,Thrombocytopenia,2
LENVATINIB MESYLATE,Abdominal discomfort,2
LENVATINIB MESYLATE,Dysphonia,2
LENVATINIB MESYLATE,Immune-mediated myocarditis,2
LENVATINIB MESYLATE,Acute kidney injury,2
LENVATINIB MESYLATE,Hyponatraemia,2
LENVATINIB MESYLATE,Cholecystitis,2
LENVATINIB MESYLATE,General physical health deterioration,2
LENVATINIB MESYLATE,Interstitial lung disease,2
LENVATINIB MESYLATE,Renal impairment,2
LENVATINIB MESYLATE,Adrenal insufficiency,2
LENVATINIB MESYLATE,Decreased appetite,2
LENVATINIB MESYLATE,Immune-mediated hypothyroidism,2
LENVATINIB MESYLATE,Renal disorder,2
LENVATINIB MESYLATE,Altered state of consciousness,2
LENVATINIB MESYLATE,Hepatic function abnormal,2
LENVATINIB MESYLATE,Myelosuppression,2
LENVATINIB MESYLATE,Pain,2
LENVATINIB MESYLATE,Hyperglycaemia,2
LENVATINIB MESYLATE,Haemoglobin decreased,2
LENVATINIB MESYLATE,Rash pruritic,2
LENVATINIB MESYLATE,Myalgia,2
LENVATINIB MESYLATE,Product use in unapproved indication,2
LENVIMA,Hypertension,11
LENVIMA,Pyrexia,8
LENVIMA,Decreased appetite,6
LENVIMA,Hypothyroidism,5
LENVIMA,Platelet count decreased,5
LENVIMA,Diarrhoea,5
LENVIMA,Malignant neoplasm progression,4
LENVIMA,Interstitial lung disease,4
LENVIMA,Weight decreased,4
LENVIMA,Nausea,4
LENVIMA,Cardiac failure,3
LENVIMA,Abdominal pain,3
LENVIMA,Fatigue,3
LENVIMA,Mucosal inflammation,3
LENVIMA,Drug-induced liver injury,3
LENVIMA,Proteinuria,3
LENVIMA,Pleural effusion,2
LENVIMA,Myocarditis,2
LENVIMA,Palmar-plantar erythrodysaesthesia syndrome,2
LENVIMA,Nephrotic syndrome,2
LENVIMA,Hypokalaemia,2
LENVIMA,Tumour haemorrhage,2
LENVIMA,Pruritus,2
LENVIMA,Anaemia,2
LENVIMA,Renal failure,2
LENVIMA,Myelosuppression,2
LENVIMA,Pneumonia,2
LENVIMA,Aspartate aminotransferase increased,2
LENVIMA,Alanine aminotransferase increased,2
LENVIMA,Asthenia,2
LENVIMA,Ischaemic stroke,2
LENVIMA,Cortisol increased,1
LENVIMA,General physical health deterioration,1
LENVIMA,Shock,1
LENVIMA,Arthralgia,1
LENVIMA,Acute abdomen,1
LENVIMA,Uterine perforation,1
LENVIMA,Respiratory failure,1
LENVIMA,Peritonitis,1
LENVIMA,Female genital tract fistula,1
LENVIMA,Hyponatraemia,1
LENVIMA,Acute kidney injury,1
LENVIMA,Gingivitis,1
LENVIMA,Haemoptysis,1
LENVIMA,Liver function test increased,1
LENVIMA,Malaise,1
LENVIMA,Hyperhidrosis,1
LENVIMA,Transient ischaemic attack,1
LENVIMA,Intra-abdominal haemorrhage,1
LENVIMA,Atrial fibrillation,1
LERCANIDIPINE,Hypotension,16
LERCANIDIPINE,Hypoglycaemia,11
LERCANIDIPINE,Neutropenia,10
LERCANIDIPINE,Transient aphasia,10
LERCANIDIPINE,Anaemia,8
LERCANIDIPINE,Neuropathy peripheral,7
LERCANIDIPINE,Rash,7
LERCANIDIPINE,Off label use,6
LERCANIDIPINE,Septic shock,6
LERCANIDIPINE,Acute kidney injury,6
LERCANIDIPINE,Asthenia,5
LERCANIDIPINE,Cardiogenic shock,5
LERCANIDIPINE,Erythema,5
LERCANIDIPINE,Chest discomfort,5
LERCANIDIPINE,Pruritus,5
LERCANIDIPINE,Hyperkalaemia,4
LERCANIDIPINE,Thrombocytopenia,4
LERCANIDIPINE,Oedema peripheral,4
LERCANIDIPINE,Fatigue,4
LERCANIDIPINE,Epistaxis,4
LERCANIDIPINE,Malaise,4
LERCANIDIPINE,Heart transplant rejection,4
LERCANIDIPINE,Candida infection,4
LERCANIDIPINE,General physical health deterioration,4
LERCANIDIPINE,Enterobacter bacteraemia,4
LERCANIDIPINE,Proteus infection,4
LERCANIDIPINE,Fungaemia,4
LERCANIDIPINE,Chronic kidney disease,4
LERCANIDIPINE,Drug ineffective for unapproved indication,4
LERCANIDIPINE,Malnutrition,4
LERCANIDIPINE,Respiratory disorder,4
LERCANIDIPINE,Cytomegalovirus infection,4
LERCANIDIPINE,Localised infection,4
LERCANIDIPINE,Condition aggravated,4
LERCANIDIPINE,Pleural effusion,3
LERCANIDIPINE,Arthralgia,3
LERCANIDIPINE,Diarrhoea,3
LERCANIDIPINE,Anaphylactic shock,3
LERCANIDIPINE,Peripheral coldness,3
LERCANIDIPINE,Peripheral arterial occlusive disease,3
LERCANIDIPINE,Pulmonary embolism,2
LERCANIDIPINE,Thrombosis,2
LERCANIDIPINE,Cardiac failure chronic,2
LERCANIDIPINE,Coronary artery stenosis,2
LERCANIDIPINE,COVID-19 pneumonia,2
LERCANIDIPINE,Procedural haemorrhage,2
LERCANIDIPINE,Gastrointestinal haemorrhage,2
LERCANIDIPINE,Cardiac aneurysm,2
LERCANIDIPINE,Erosive oesophagitis,2
LERCANIDIPINE,Abdominal distension,2
LERCANIDIPINE HYDROCHLORIDE,Hypocalcaemia,8
LERCANIDIPINE HYDROCHLORIDE,Vision blurred,5
LERCANIDIPINE HYDROCHLORIDE,Muscle spasms,5
LERCANIDIPINE HYDROCHLORIDE,Gait disturbance,5
LERCANIDIPINE HYDROCHLORIDE,Toxic skin eruption,5
LERCANIDIPINE HYDROCHLORIDE,Nausea,5
LERCANIDIPINE HYDROCHLORIDE,Acute kidney injury,5
LERCANIDIPINE HYDROCHLORIDE,Oedema peripheral,5
LERCANIDIPINE HYDROCHLORIDE,Dyskinesia,4
LERCANIDIPINE HYDROCHLORIDE,Extrapyramidal disorder,4
LERCANIDIPINE HYDROCHLORIDE,Hypomagnesaemia,4
LERCANIDIPINE HYDROCHLORIDE,Dizziness,4
LERCANIDIPINE HYDROCHLORIDE,Xerosis,4
LERCANIDIPINE HYDROCHLORIDE,Electrocardiogram QT prolonged,4
LERCANIDIPINE HYDROCHLORIDE,Atrioventricular block complete,4
LERCANIDIPINE HYDROCHLORIDE,Fatigue,3
LERCANIDIPINE HYDROCHLORIDE,Fluid retention,3
LERCANIDIPINE HYDROCHLORIDE,Metabolic acidosis,3
LERCANIDIPINE HYDROCHLORIDE,Ischaemic stroke,3
LERCANIDIPINE HYDROCHLORIDE,Thrombocytopenia,2
LERCANIDIPINE HYDROCHLORIDE,Hyperhidrosis,2
LERCANIDIPINE HYDROCHLORIDE,Decreased appetite,2
LERCANIDIPINE HYDROCHLORIDE,Paraesthesia,2
LERCANIDIPINE HYDROCHLORIDE,Renal cyst ruptured,2
LERCANIDIPINE HYDROCHLORIDE,Haematuria,2
LERCANIDIPINE HYDROCHLORIDE,Anaphylactic shock,2
LERCANIDIPINE HYDROCHLORIDE,Adverse drug reaction,2
LERCANIDIPINE HYDROCHLORIDE,Dysuria,2
LERCANIDIPINE HYDROCHLORIDE,Pain in extremity,2
LERCANIDIPINE HYDROCHLORIDE,Neutropenia,2
LERCANIDIPINE HYDROCHLORIDE,Lymphopenia,2
LERCANIDIPINE HYDROCHLORIDE,Off label use,2
LERCANIDIPINE HYDROCHLORIDE,Pyrexia,2
LERCANIDIPINE HYDROCHLORIDE,Rhabdomyolysis,2
LERCANIDIPINE HYDROCHLORIDE,Hepatic cytolysis,2
LERCANIDIPINE HYDROCHLORIDE,Dyspnoea,2
LERCANIDIPINE HYDROCHLORIDE,Atrial fibrillation,2
LERCANIDIPINE HYDROCHLORIDE,Pneumonia fungal,1
LERCANIDIPINE HYDROCHLORIDE,Gingivitis,1
LERCANIDIPINE HYDROCHLORIDE,Transient ischaemic attack,1
LERCANIDIPINE HYDROCHLORIDE,Abdominal pain,1
LERCANIDIPINE HYDROCHLORIDE,Mucosal inflammation,1
LERCANIDIPINE HYDROCHLORIDE,Feeling hot,1
LERCANIDIPINE HYDROCHLORIDE,Burning sensation,1
LERCANIDIPINE HYDROCHLORIDE,Rash,1
LERCANIDIPINE HYDROCHLORIDE,Pancreatitis acute,1
LERCANIDIPINE HYDROCHLORIDE,Myopericarditis,1
LERCANIDIPINE HYDROCHLORIDE,Liver disorder,1
LERCANIDIPINE HYDROCHLORIDE,Prescribed overdose,1
LERCANIDIPINE HYDROCHLORIDE,Tendon rupture,1
LETAIRIS,Headache,21
LETAIRIS,Diarrhoea,16
LETAIRIS,Nausea,15
LETAIRIS,Dyspnoea,15
LETAIRIS,Fatigue,11
LETAIRIS,Vomiting,10
LETAIRIS,Chest pain,9
LETAIRIS,Malaise,8
LETAIRIS,Infusion site pain,8
LETAIRIS,Feeling abnormal,7
LETAIRIS,Dizziness,6
LETAIRIS,Chest discomfort,6
LETAIRIS,Device leakage,5
LETAIRIS,Infection,5
LETAIRIS,Sinusitis,5
LETAIRIS,Complication associated with device,5
LETAIRIS,Abdominal pain,5
LETAIRIS,Pneumonia,5
LETAIRIS,Back pain,5
LETAIRIS,Erythema,5
LETAIRIS,Flushing,5
LETAIRIS,Device occlusion,5
LETAIRIS,Hypotension,5
LETAIRIS,Myalgia,5
LETAIRIS,Weight decreased,5
LETAIRIS,Decreased appetite,5
LETAIRIS,Fluid retention,5
LETAIRIS,Infusion site erythema,5
LETAIRIS,Device failure,5
LETAIRIS,Infusion site infection,5
LETAIRIS,COVID-19,4
LETAIRIS,Injection site pruritus,4
LETAIRIS,Catheter site erythema,4
LETAIRIS,Injection site erythema,4
LETAIRIS,Drug hypersensitivity,4
LETAIRIS,Injection site pain,4
LETAIRIS,Device issue,4
LETAIRIS,Pain in jaw,4
LETAIRIS,Gastrooesophageal reflux disease,4
LETAIRIS,Pyrexia,4
LETAIRIS,Syncope,4
LETAIRIS,Dyspnoea exertional,4
LETAIRIS,Fall,4
LETAIRIS,Abdominal discomfort,4
LETAIRIS,Productive cough,4
LETAIRIS,Pain in extremity,4
LETAIRIS,Underdose,4
LETAIRIS,Pain,4
LETAIRIS,Chills,3
LETAIRIS,Nasal congestion,3
LETROZOLE,Fatigue,88
LETROZOLE,Neutropenia,74
LETROZOLE,Diarrhoea,67
LETROZOLE,White blood cell count decreased,62
LETROZOLE,Anaemia,49
LETROZOLE,Neoplasm progression,48
LETROZOLE,Nausea,48
LETROZOLE,Arthralgia,46
LETROZOLE,Pain,45
LETROZOLE,Headache,38
LETROZOLE,Vomiting,35
LETROZOLE,Alopecia,33
LETROZOLE,Urinary tract infection,31
LETROZOLE,Off label use,30
LETROZOLE,COVID-19,30
LETROZOLE,Dyspnoea,29
LETROZOLE,Back pain,29
LETROZOLE,Leukopenia,28
LETROZOLE,Constipation,28
LETROZOLE,Asthenia,28
LETROZOLE,Weight decreased,27
LETROZOLE,Malaise,26
LETROZOLE,Thrombocytopenia,26
LETROZOLE,Dry skin,25
LETROZOLE,Pruritus,25
LETROZOLE,Fall,24
LETROZOLE,Feeling abnormal,22
LETROZOLE,Neutrophil count decreased,22
LETROZOLE,General physical health deterioration,22
LETROZOLE,Electrocardiogram QT prolonged,22
LETROZOLE,Pain in extremity,21
LETROZOLE,Weight increased,20
LETROZOLE,Dizziness,20
LETROZOLE,Nasopharyngitis,19
LETROZOLE,Stomatitis,19
LETROZOLE,Depressed mood,19
LETROZOLE,Illness,18
LETROZOLE,Cough,18
LETROZOLE,Pneumonia,18
LETROZOLE,Aspartate aminotransferase increased,18
LETROZOLE,Alanine aminotransferase increased,18
LETROZOLE,Gait disturbance,18
LETROZOLE,Bone pain,18
LETROZOLE,Pyrexia,17
LETROZOLE,Decreased appetite,17
LETROZOLE,Myalgia,17
LETROZOLE,Abdominal pain,17
LETROZOLE,Rash,16
LETROZOLE,Product dose omission issue,16
LETROZOLE,Depression,15
LEUCOVORIN,Diarrhoea,17
LEUCOVORIN,General physical health deterioration,14
LEUCOVORIN,Nausea,14
LEUCOVORIN,Pyrexia,12
LEUCOVORIN,Rash,11
LEUCOVORIN,Off label use,11
LEUCOVORIN,Neutropenia,10
LEUCOVORIN,Headache,9
LEUCOVORIN,Cough,9
LEUCOVORIN,Hypertension,8
LEUCOVORIN,Dyspnoea,8
LEUCOVORIN,Abdominal pain upper,7
LEUCOVORIN,Malaise,7
LEUCOVORIN,Arthralgia,6
LEUCOVORIN,Fatigue,6
LEUCOVORIN,Febrile neutropenia,6
LEUCOVORIN,Insomnia,5
LEUCOVORIN,Drug ineffective,5
LEUCOVORIN,Product use issue,5
LEUCOVORIN,Hepatic steatosis,5
LEUCOVORIN,Vomiting,5
LEUCOVORIN,Neutrophil count decreased,5
LEUCOVORIN,COVID-19,4
LEUCOVORIN,Oropharyngeal pain,4
LEUCOVORIN,Abdominal discomfort,4
LEUCOVORIN,Loss of employment,4
LEUCOVORIN,Drug intolerance,4
LEUCOVORIN,Liver disorder,4
LEUCOVORIN,Gastric disorder,4
LEUCOVORIN,Cardiac failure congestive,4
LEUCOVORIN,Cardiac failure,4
LEUCOVORIN,Drug hypersensitivity,4
LEUCOVORIN,Contraindicated product administered,4
LEUCOVORIN,Therapeutic product effect decreased,4
LEUCOVORIN,Intentional product use issue,4
LEUCOVORIN,Asthenia,4
LEUCOVORIN,Pneumonia fungal,4
LEUCOVORIN,Dry mouth,4
LEUCOVORIN,Dehydration,4
LEUCOVORIN,Leukopenia,3
LEUCOVORIN,Anaemia,3
LEUCOVORIN,Pleural effusion,3
LEUCOVORIN,Accidental overdose,3
LEUCOVORIN,Back pain,3
LEUCOVORIN,White blood cell count decreased,3
LEUCOVORIN,Chills,3
LEUCOVORIN,Throat irritation,3
LEUCOVORIN,Weight decreased,3
LEUCOVORIN,Disease recurrence,3
LEUCOVORIN,Hepatic enzyme increased,3
LEUCOVORIN CALCIUM,Neutropenia,14
LEUCOVORIN CALCIUM,Thrombocytopenia,11
LEUCOVORIN CALCIUM,Diarrhoea,9
LEUCOVORIN CALCIUM,Hypocalcaemia,7
LEUCOVORIN CALCIUM,Off label use,7
LEUCOVORIN CALCIUM,Anaemia,6
LEUCOVORIN CALCIUM,Nausea,6
LEUCOVORIN CALCIUM,Drug reaction with eosinophilia and systemic symptoms,6
LEUCOVORIN CALCIUM,General physical health deterioration,5
LEUCOVORIN CALCIUM,Asthenia,5
LEUCOVORIN CALCIUM,Pneumonia,5
LEUCOVORIN CALCIUM,Pyrexia,5
LEUCOVORIN CALCIUM,COVID-19,5
LEUCOVORIN CALCIUM,Granulocyte count decreased,5
LEUCOVORIN CALCIUM,Drug hypersensitivity,4
LEUCOVORIN CALCIUM,Haemorrhage,4
LEUCOVORIN CALCIUM,Hyperuricaemia,4
LEUCOVORIN CALCIUM,Dyspnoea,4
LEUCOVORIN CALCIUM,Cardiac pacemaker evaluation,4
LEUCOVORIN CALCIUM,Lymphopenia,4
LEUCOVORIN CALCIUM,Myelosuppression,4
LEUCOVORIN CALCIUM,White blood cell count decreased,4
LEUCOVORIN CALCIUM,Hepatic cytolysis,4
LEUCOVORIN CALCIUM,Tooth disorder,3
LEUCOVORIN CALCIUM,Rectal haemorrhage,3
LEUCOVORIN CALCIUM,Richter's syndrome,3
LEUCOVORIN CALCIUM,Neuropathy peripheral,3
LEUCOVORIN CALCIUM,Arthralgia,3
LEUCOVORIN CALCIUM,Vomiting,3
LEUCOVORIN CALCIUM,Weight decreased,3
LEUCOVORIN CALCIUM,Malaise,3
LEUCOVORIN CALCIUM,Cytokine release syndrome,3
LEUCOVORIN CALCIUM,Ischaemic cardiomyopathy,3
LEUCOVORIN CALCIUM,Death,3
LEUCOVORIN CALCIUM,Pruritus,3
LEUCOVORIN CALCIUM,Hyperkalaemia,3
LEUCOVORIN CALCIUM,Hyperphosphataemia,2
LEUCOVORIN CALCIUM,Bladder disorder,2
LEUCOVORIN CALCIUM,Peripheral venous disease,2
LEUCOVORIN CALCIUM,Bacterial infection,2
LEUCOVORIN CALCIUM,Renal failure,2
LEUCOVORIN CALCIUM,Tumour lysis syndrome,2
LEUCOVORIN CALCIUM,Hypovitaminosis,2
LEUCOVORIN CALCIUM,Cough,2
LEUCOVORIN CALCIUM,Nasopharyngitis,2
LEUCOVORIN CALCIUM,Hypotension,2
LEUCOVORIN CALCIUM,Sepsis,2
LEUCOVORIN CALCIUM,Oral fungal infection,2
LEUCOVORIN CALCIUM,SARS-CoV-2 test positive,2
LEUCOVORIN CALCIUM,Lung disorder,2
LEUPROLIDE ACETATE,Diabetes mellitus,23
LEUPROLIDE ACETATE,Hypertension,5
LEUPROLIDE ACETATE,Pneumonia aspiration,5
LEUPROLIDE ACETATE,Muscular weakness,5
LEUPROLIDE ACETATE,Pneumonia,5
LEUPROLIDE ACETATE,Condition aggravated,4
LEUPROLIDE ACETATE,Hepatic function abnormal,4
LEUPROLIDE ACETATE,Lower limb fracture,4
LEUPROLIDE ACETATE,Fall,4
LEUPROLIDE ACETATE,Blood glucose increased,3
LEUPROLIDE ACETATE,Bronchitis,3
LEUPROLIDE ACETATE,Bulbospinal muscular atrophy congenital,3
LEUPROLIDE ACETATE,Dysphagia,3
LEUPROLIDE ACETATE,Pyrexia,3
LEUPROLIDE ACETATE,Malaise,3
LEUPROLIDE ACETATE,Pain,3
LEUPROLIDE ACETATE,Hyperlipidaemia,3
LEUPROLIDE ACETATE,Depression,3
LEUPROLIDE ACETATE,Foot fracture,2
LEUPROLIDE ACETATE,Glycosylated haemoglobin increased,2
LEUPROLIDE ACETATE,Cardiac failure,2
LEUPROLIDE ACETATE,Ankle fracture,2
LEUPROLIDE ACETATE,Erectile dysfunction,2
LEUPROLIDE ACETATE,Male sexual dysfunction,2
LEUPROLIDE ACETATE,Hypercholesterolaemia,2
LEUPROLIDE ACETATE,Dyspnoea,2
LEUPROLIDE ACETATE,Alanine aminotransferase increased,2
LEUPROLIDE ACETATE,Aspartate aminotransferase increased,2
LEUPROLIDE ACETATE,Respiratory failure,2
LEUPROLIDE ACETATE,Prostatic specific antigen abnormal,2
LEUPROLIDE ACETATE,Asthenia,2
LEUPROLIDE ACETATE,Drug ineffective,2
LEUPROLIDE ACETATE,Malignant neoplasm progression,2
LEUPROLIDE ACETATE,Blood bilirubin increased,2
LEUPROLIDE ACETATE,Death,2
LEUPROLIDE ACETATE,Herpes zoster,2
LEUPROLIDE ACETATE,Sepsis,2
LEUPROLIDE ACETATE,Anaemia,2
LEUPROLIDE ACETATE,Spinal compression fracture,2
LEUPROLIDE ACETATE,Myelosuppression,2
LEUPROLIDE ACETATE,Weight decreased,2
LEUPROLIDE ACETATE,COVID-19,2
LEUPROLIDE ACETATE,Injection site reaction,1
LEUPROLIDE ACETATE,Hypoaesthesia,1
LEUPROLIDE ACETATE,Oesophageal varices haemorrhage,1
LEUPROLIDE ACETATE,Infectious pleural effusion,1
LEUPROLIDE ACETATE,Aspiration,1
LEUPROLIDE ACETATE,Pleural effusion,1
LEUPROLIDE ACETATE,Immobilisation syndrome,1
LEUPROLIDE ACETATE,Respiratory tract infection,1
LEVEMIR,Cerebrovascular accident,8
LEVEMIR,Chronic kidney disease,5
LEVEMIR,Pain,5
LEVEMIR,Dizziness,5
LEVEMIR,Blood glucose increased,5
LEVEMIR,Emotional distress,4
LEVEMIR,Nausea,4
LEVEMIR,Vomiting,4
LEVEMIR,Off label use,4
LEVEMIR,Product dose omission issue,4
LEVEMIR,Maternal exposure during pregnancy,4
LEVEMIR,Anaemia,4
LEVEMIR,Anhedonia,3
LEVEMIR,Anxiety,3
LEVEMIR,Depression,3
LEVEMIR,Acute kidney injury,3
LEVEMIR,Urinary tract infection,3
LEVEMIR,Abdominal distension,3
LEVEMIR,Blood glucose decreased,3
LEVEMIR,Death,3
LEVEMIR,Drug reaction with eosinophilia and systemic symptoms,3
LEVEMIR,Neutropenia,2
LEVEMIR,Insomnia,2
LEVEMIR,Pollakiuria,2
LEVEMIR,Back pain,2
LEVEMIR,Hyperglycaemia,2
LEVEMIR,Fatigue,2
LEVEMIR,Asthenia,2
LEVEMIR,Renal failure,2
LEVEMIR,Squamous cell carcinoma,2
LEVEMIR,Bowel movement irregularity,2
LEVEMIR,Escherichia infection,2
LEVEMIR,Eructation,2
LEVEMIR,Fungal infection,2
LEVEMIR,Kidney infection,2
LEVEMIR,Eye infection,2
LEVEMIR,Vein rupture,2
LEVEMIR,Sweat gland infection,2
LEVEMIR,Therapy interrupted,2
LEVEMIR,Weight increased,2
LEVEMIR,Pre-eclampsia,2
LEVEMIR,Dyspnoea,2
LEVEMIR,Intestinal obstruction,2
LEVEMIR,Arthralgia,2
LEVEMIR,Hypoglycaemia,2
LEVEMIR,Foetal exposure during pregnancy,2
LEVEMIR,COVID-19 pneumonia,2
LEVEMIR,Blood pressure increased,2
LEVEMIR,Blood potassium decreased,2
LEVEMIR,Metabolic acidosis,2
LEVETIRACETAM,Pyrexia,26
LEVETIRACETAM,Seizure,25
LEVETIRACETAM,Thrombocytopenia,19
LEVETIRACETAM,Off label use,18
LEVETIRACETAM,Cytokine release syndrome,16
LEVETIRACETAM,Epilepsy,14
LEVETIRACETAM,Neutropenia,14
LEVETIRACETAM,Malaise,13
LEVETIRACETAM,Pain,12
LEVETIRACETAM,Fatigue,11
LEVETIRACETAM,Product dose omission issue,11
LEVETIRACETAM,Asthenia,10
LEVETIRACETAM,Pneumonia,10
LEVETIRACETAM,Inappropriate schedule of product administration,10
LEVETIRACETAM,Cough,10
LEVETIRACETAM,Immune effector cell-associated neurotoxicity syndrome,10
LEVETIRACETAM,Arthralgia,9
LEVETIRACETAM,Somnolence,9
LEVETIRACETAM,Acute kidney injury,9
LEVETIRACETAM,Headache,8
LEVETIRACETAM,Nasopharyngitis,8
LEVETIRACETAM,Diarrhoea,8
LEVETIRACETAM,Erythema,8
LEVETIRACETAM,Dyspnoea,7
LEVETIRACETAM,Weight decreased,7
LEVETIRACETAM,Tremor,7
LEVETIRACETAM,COVID-19,7
LEVETIRACETAM,Gait disturbance,7
LEVETIRACETAM,Hyponatraemia,7
LEVETIRACETAM,Vomiting,6
LEVETIRACETAM,Chills,6
LEVETIRACETAM,Influenza,6
LEVETIRACETAM,Anxiety,6
LEVETIRACETAM,Type 2 diabetes mellitus,6
LEVETIRACETAM,Pain in extremity,6
LEVETIRACETAM,Fall,6
LEVETIRACETAM,Nausea,6
LEVETIRACETAM,Dizziness,6
LEVETIRACETAM,Device issue,6
LEVETIRACETAM,Condition aggravated,6
LEVETIRACETAM,Platelet count decreased,6
LEVETIRACETAM,White blood cell count decreased,6
LEVETIRACETAM,Leukopenia,6
LEVETIRACETAM,Insomnia,5
LEVETIRACETAM,Hyperhidrosis,5
LEVETIRACETAM,Productive cough,5
LEVETIRACETAM,Illness,5
LEVETIRACETAM,Rash,5
LEVETIRACETAM,Product availability issue,5
LEVETIRACETAM,Crying,5
LEVOFLOXACIN,Fatigue,58
LEVOFLOXACIN,Nausea,38
LEVOFLOXACIN,Neuropathy peripheral,30
LEVOFLOXACIN,Diarrhoea,30
LEVOFLOXACIN,Myalgia,30
LEVOFLOXACIN,Pain,28
LEVOFLOXACIN,Pneumonia,27
LEVOFLOXACIN,Anxiety,27
LEVOFLOXACIN,Vomiting,25
LEVOFLOXACIN,Arthralgia,24
LEVOFLOXACIN,Headache,23
LEVOFLOXACIN,COVID-19,23
LEVOFLOXACIN,Malaise,22
LEVOFLOXACIN,Pyrexia,22
LEVOFLOXACIN,Off label use,20
LEVOFLOXACIN,Neutropenia,20
LEVOFLOXACIN,Depression,19
LEVOFLOXACIN,Asthenia,19
LEVOFLOXACIN,Blood creatinine increased,18
LEVOFLOXACIN,Tendon pain,18
LEVOFLOXACIN,Sleep disorder,18
LEVOFLOXACIN,Dizziness,17
LEVOFLOXACIN,Back pain,17
LEVOFLOXACIN,Emotional distress,16
LEVOFLOXACIN,Fall,15
LEVOFLOXACIN,Leukopenia,15
LEVOFLOXACIN,Alopecia,14
LEVOFLOXACIN,Dyspnoea,14
LEVOFLOXACIN,Febrile neutropenia,14
LEVOFLOXACIN,Anhedonia,14
LEVOFLOXACIN,Sinusitis,14
LEVOFLOXACIN,Memory impairment,13
LEVOFLOXACIN,Skin burning sensation,13
LEVOFLOXACIN,Pain in extremity,12
LEVOFLOXACIN,Platelet count decreased,12
LEVOFLOXACIN,Incorrect dose administered,12
LEVOFLOXACIN,Seizure,12
LEVOFLOXACIN,Lymphocyte count decreased,12
LEVOFLOXACIN,Visual impairment,12
LEVOFLOXACIN,Condition aggravated,12
LEVOFLOXACIN,Musculoskeletal discomfort,12
LEVOFLOXACIN,Cough,11
LEVOFLOXACIN,Anaemia,11
LEVOFLOXACIN,Cellulitis,11
LEVOFLOXACIN,Muscle contractions involuntary,11
LEVOFLOXACIN,Infection,10
LEVOFLOXACIN,Bronchitis,10
LEVOFLOXACIN,Chronic kidney disease,10
LEVOFLOXACIN,Tachycardia,10
LEVOFLOXACIN,Weight decreased,10
LEVOLEUCOVORIN CALCIUM,Off label use,30
LEVOLEUCOVORIN CALCIUM,Malignant neoplasm progression,25
LEVOLEUCOVORIN CALCIUM,Hypotension,11
LEVOLEUCOVORIN CALCIUM,Death,11
LEVOLEUCOVORIN CALCIUM,Sepsis,11
LEVOLEUCOVORIN CALCIUM,Transient aphasia,10
LEVOLEUCOVORIN CALCIUM,Hypoglycaemia,10
LEVOLEUCOVORIN CALCIUM,Febrile neutropenia,9
LEVOLEUCOVORIN CALCIUM,Mucosal inflammation,8
LEVOLEUCOVORIN CALCIUM,Haematemesis,8
LEVOLEUCOVORIN CALCIUM,Melaena,8
LEVOLEUCOVORIN CALCIUM,Renal failure,8
LEVOLEUCOVORIN CALCIUM,General physical health deterioration,7
LEVOLEUCOVORIN CALCIUM,Neutrophil count decreased,6
LEVOLEUCOVORIN CALCIUM,Decreased appetite,6
LEVOLEUCOVORIN CALCIUM,Diarrhoea,6
LEVOLEUCOVORIN CALCIUM,Drug interaction,6
LEVOLEUCOVORIN CALCIUM,Acute kidney injury,6
LEVOLEUCOVORIN CALCIUM,Hyponatraemia,6
LEVOLEUCOVORIN CALCIUM,Diarrhoea haemorrhagic,6
LEVOLEUCOVORIN CALCIUM,Rash pustular,6
LEVOLEUCOVORIN CALCIUM,Staphylococcal bacteraemia,6
LEVOLEUCOVORIN CALCIUM,Vomiting,5
LEVOLEUCOVORIN CALCIUM,Hypokalaemia,5
LEVOLEUCOVORIN CALCIUM,Underdose,4
LEVOLEUCOVORIN CALCIUM,Neutropenia,4
LEVOLEUCOVORIN CALCIUM,Anaemia,4
LEVOLEUCOVORIN CALCIUM,Pulmonary arterial hypertension,4
LEVOLEUCOVORIN CALCIUM,Oesophagitis,4
LEVOLEUCOVORIN CALCIUM,Myelosuppression,3
LEVOLEUCOVORIN CALCIUM,Hyperthermia,3
LEVOLEUCOVORIN CALCIUM,Nausea,3
LEVOLEUCOVORIN CALCIUM,Rectal haemorrhage,3
LEVOLEUCOVORIN CALCIUM,Atrial flutter,2
LEVOLEUCOVORIN CALCIUM,Malaise,2
LEVOLEUCOVORIN CALCIUM,Interstitial lung disease,2
LEVOLEUCOVORIN CALCIUM,Cholangitis infective,2
LEVOLEUCOVORIN CALCIUM,Cough,2
LEVOLEUCOVORIN CALCIUM,Asthenia,2
LEVOLEUCOVORIN CALCIUM,Constipation,2
LEVOLEUCOVORIN CALCIUM,Gait disturbance,2
LEVOLEUCOVORIN CALCIUM,Leukopenia,2
LEVOLEUCOVORIN CALCIUM,Anaphylactic reaction,2
LEVOLEUCOVORIN CALCIUM,Rash,2
LEVOLEUCOVORIN CALCIUM,Folliculitis,2
LEVOLEUCOVORIN CALCIUM,White blood cell count decreased,2
LEVOLEUCOVORIN CALCIUM,Accidental overdose,1
LEVOLEUCOVORIN CALCIUM,Dehydration,1
LEVOLEUCOVORIN CALCIUM,Pneumonitis,1
LEVOLEUCOVORIN CALCIUM,Cerebellar infarction,1
LEVOTHYROXINE,Fatigue,188
LEVOTHYROXINE,Off label use,175
LEVOTHYROXINE,Diarrhoea,169
LEVOTHYROXINE,Pain,169
LEVOTHYROXINE,Nausea,165
LEVOTHYROXINE,COVID-19,159
LEVOTHYROXINE,Headache,147
LEVOTHYROXINE,Dyspnoea,146
LEVOTHYROXINE,Malaise,140
LEVOTHYROXINE,Vomiting,136
LEVOTHYROXINE,Arthralgia,133
LEVOTHYROXINE,Pyrexia,132
LEVOTHYROXINE,Dizziness,128
LEVOTHYROXINE,Anxiety,113
LEVOTHYROXINE,Pruritus,113
LEVOTHYROXINE,Back pain,109
LEVOTHYROXINE,Feeling abnormal,107
LEVOTHYROXINE,Abdominal discomfort,106
LEVOTHYROXINE,Abdominal pain upper,105
LEVOTHYROXINE,Peripheral swelling,104
LEVOTHYROXINE,Alopecia,101
LEVOTHYROXINE,Product dose omission issue,101
LEVOTHYROXINE,Insomnia,98
LEVOTHYROXINE,Intentional product misuse,96
LEVOTHYROXINE,Rash,92
LEVOTHYROXINE,Dehydration,92
LEVOTHYROXINE,Chest pain,92
LEVOTHYROXINE,Memory impairment,91
LEVOTHYROXINE,Palpitations,89
LEVOTHYROXINE,Tachycardia,85
LEVOTHYROXINE,Migraine,83
LEVOTHYROXINE,Visual impairment,80
LEVOTHYROXINE,Muscular weakness,80
LEVOTHYROXINE,Hyperhidrosis,79
LEVOTHYROXINE,Dry skin,79
LEVOTHYROXINE,Blood glucose increased,79
LEVOTHYROXINE,Myocardial infarction,79
LEVOTHYROXINE,Heart rate increased,78
LEVOTHYROXINE,Amnesia,77
LEVOTHYROXINE,Disturbance in attention,75
LEVOTHYROXINE,Cognitive disorder,74
LEVOTHYROXINE,Tinnitus,74
LEVOTHYROXINE,Hallucination,72
LEVOTHYROXINE,Anosmia,72
LEVOTHYROXINE,Lip swelling,72
LEVOTHYROXINE,Diplopia,71
LEVOTHYROXINE,Transient ischaemic attack,71
LEVOTHYROXINE,Muscle twitching,71
LEVOTHYROXINE,Eye pruritus,71
LEVOTHYROXINE,Asthenia,70
LEVOTHYROXINE SODIUM,Diarrhoea,135
LEVOTHYROXINE SODIUM,Malaise,125
LEVOTHYROXINE SODIUM,Nausea,123
LEVOTHYROXINE SODIUM,Dyspnoea,122
LEVOTHYROXINE SODIUM,Fatigue,122
LEVOTHYROXINE SODIUM,Pain,120
LEVOTHYROXINE SODIUM,COVID-19,120
LEVOTHYROXINE SODIUM,Headache,118
LEVOTHYROXINE SODIUM,Arthralgia,118
LEVOTHYROXINE SODIUM,Pyrexia,115
LEVOTHYROXINE SODIUM,Vomiting,113
LEVOTHYROXINE SODIUM,Dehydration,106
LEVOTHYROXINE SODIUM,Off label use,105
LEVOTHYROXINE SODIUM,Pruritus,103
LEVOTHYROXINE SODIUM,Insomnia,98
LEVOTHYROXINE SODIUM,Feeling abnormal,98
LEVOTHYROXINE SODIUM,Dizziness,97
LEVOTHYROXINE SODIUM,Back pain,97
LEVOTHYROXINE SODIUM,Peripheral swelling,97
LEVOTHYROXINE SODIUM,Migraine,97
LEVOTHYROXINE SODIUM,Abdominal pain upper,96
LEVOTHYROXINE SODIUM,Abdominal discomfort,95
LEVOTHYROXINE SODIUM,Alopecia,94
LEVOTHYROXINE SODIUM,Chest pain,94
LEVOTHYROXINE SODIUM,Memory impairment,94
LEVOTHYROXINE SODIUM,Muscular weakness,94
LEVOTHYROXINE SODIUM,Anxiety,91
LEVOTHYROXINE SODIUM,Tachycardia,91
LEVOTHYROXINE SODIUM,Dry skin,90
LEVOTHYROXINE SODIUM,Palpitations,90
LEVOTHYROXINE SODIUM,Myocardial infarction,89
LEVOTHYROXINE SODIUM,Visual impairment,89
LEVOTHYROXINE SODIUM,Pericarditis,88
LEVOTHYROXINE SODIUM,Heart rate increased,88
LEVOTHYROXINE SODIUM,Amnesia,87
LEVOTHYROXINE SODIUM,Disturbance in attention,87
LEVOTHYROXINE SODIUM,Blood glucose increased,86
LEVOTHYROXINE SODIUM,Eye pruritus,86
LEVOTHYROXINE SODIUM,Lip swelling,86
LEVOTHYROXINE SODIUM,Transient ischaemic attack,86
LEVOTHYROXINE SODIUM,Cognitive disorder,85
LEVOTHYROXINE SODIUM,Hyperhidrosis,85
LEVOTHYROXINE SODIUM,Hallucination,85
LEVOTHYROXINE SODIUM,Facial pain,85
LEVOTHYROXINE SODIUM,Cardiospasm,85
LEVOTHYROXINE SODIUM,Tinnitus,85
LEVOTHYROXINE SODIUM,Angioedema,85
LEVOTHYROXINE SODIUM,Subarachnoid haemorrhage,85
LEVOTHYROXINE SODIUM,Anosmia,85
LEVOTHYROXINE SODIUM,Pain of skin,85
LEXAPRO,Product dose omission issue,20
LEXAPRO,Fatigue,20
LEXAPRO,COVID-19,19
LEXAPRO,Nausea,17
LEXAPRO,Off label use,16
LEXAPRO,Inappropriate schedule of product administration,15
LEXAPRO,Sinusitis,13
LEXAPRO,Diarrhoea,13
LEXAPRO,Headache,12
LEXAPRO,Pneumonia,11
LEXAPRO,Anxiety,11
LEXAPRO,Fall,10
LEXAPRO,Anaemia,10
LEXAPRO,Pain,10
LEXAPRO,Dizziness,10
LEXAPRO,Cough,9
LEXAPRO,Dyspnoea,9
LEXAPRO,Pruritus,9
LEXAPRO,Weight decreased,8
LEXAPRO,Contusion,8
LEXAPRO,Dehydration,8
LEXAPRO,Vomiting,8
LEXAPRO,Tremor,8
LEXAPRO,Asthenia,8
LEXAPRO,Urinary tract infection,8
LEXAPRO,Rash,7
LEXAPRO,Condition aggravated,6
LEXAPRO,Feeling abnormal,6
LEXAPRO,Malaise,5
LEXAPRO,Back pain,5
LEXAPRO,Upper respiratory tract infection,5
LEXAPRO,Weight increased,5
LEXAPRO,Illness,5
LEXAPRO,Chest pain,5
LEXAPRO,Seasonal allergy,5
LEXAPRO,Muscle spasms,5
LEXAPRO,Arthralgia,5
LEXAPRO,Memory impairment,5
LEXAPRO,Seizure,5
LEXAPRO,Hallucination,5
LEXAPRO,Constipation,5
LEXAPRO,Insomnia,4
LEXAPRO,Influenza,4
LEXAPRO,Nasopharyngitis,4
LEXAPRO,Cardiac failure congestive,4
LEXAPRO,Sepsis,4
LEXAPRO,Renal failure,4
LEXAPRO,Depressed mood,4
LEXAPRO,Myalgia,4
LEXAPRO,Blood pressure increased,4
LIDOCAINE,Sinusitis,142
LIDOCAINE,COVID-19,126
LIDOCAINE,Product dose omission issue,111
LIDOCAINE,Pneumonia,90
LIDOCAINE,Fatigue,79
LIDOCAINE,Urinary tract infection,73
LIDOCAINE,Headache,68
LIDOCAINE,Upper respiratory tract infection,65
LIDOCAINE,Pain,64
LIDOCAINE,Malaise,62
LIDOCAINE,Nausea,60
LIDOCAINE,Bronchitis,53
LIDOCAINE,Fall,52
LIDOCAINE,Illness,51
LIDOCAINE,Nasopharyngitis,51
LIDOCAINE,Inappropriate schedule of product administration,48
LIDOCAINE,Dyspnoea,47
LIDOCAINE,Pyrexia,45
LIDOCAINE,Vomiting,42
LIDOCAINE,Respiratory tract infection,42
LIDOCAINE,Cough,39
LIDOCAINE,Infusion related reaction,39
LIDOCAINE,Influenza,38
LIDOCAINE,Diarrhoea,38
LIDOCAINE,Insurance issue,37
LIDOCAINE,Back pain,36
LIDOCAINE,Ear infection,33
LIDOCAINE,Seasonal allergy,33
LIDOCAINE,Infusion site extravasation,33
LIDOCAINE,Infusion site pain,33
LIDOCAINE,Infection,33
LIDOCAINE,Weight decreased,28
LIDOCAINE,Infusion site swelling,27
LIDOCAINE,Viral infection,27
LIDOCAINE,Migraine,27
LIDOCAINE,Asthenia,27
LIDOCAINE,Rash,26
LIDOCAINE,Infusion site pruritus,25
LIDOCAINE,Asthma,25
LIDOCAINE,Pruritus,24
LIDOCAINE,Dizziness,24
LIDOCAINE,Weight increased,22
LIDOCAINE,Anxiety,22
LIDOCAINE,Infusion site erythema,21
LIDOCAINE,Gastroenteritis viral,21
LIDOCAINE,Multiple allergies,20
LIDOCAINE,Kidney infection,20
LIDOCAINE,Off label use,20
LIDOCAINE,Chills,19
LIDOCAINE,Feeling abnormal,19
LIDOCAINE\PRILOCAINE,Product dose omission issue,20
LIDOCAINE\PRILOCAINE,COVID-19,18
LIDOCAINE\PRILOCAINE,Sinusitis,18
LIDOCAINE\PRILOCAINE,Headache,17
LIDOCAINE\PRILOCAINE,Inappropriate schedule of product administration,13
LIDOCAINE\PRILOCAINE,Fall,13
LIDOCAINE\PRILOCAINE,Upper respiratory tract infection,13
LIDOCAINE\PRILOCAINE,Infection,13
LIDOCAINE\PRILOCAINE,Fatigue,12
LIDOCAINE\PRILOCAINE,Urinary tract infection,10
LIDOCAINE\PRILOCAINE,Nasopharyngitis,10
LIDOCAINE\PRILOCAINE,Pneumonia,9
LIDOCAINE\PRILOCAINE,Weight decreased,8
LIDOCAINE\PRILOCAINE,Insurance issue,8
LIDOCAINE\PRILOCAINE,Illness,8
LIDOCAINE\PRILOCAINE,Pain,8
LIDOCAINE\PRILOCAINE,Pyrexia,8
LIDOCAINE\PRILOCAINE,Infusion site pain,8
LIDOCAINE\PRILOCAINE,Dyspnoea,7
LIDOCAINE\PRILOCAINE,Vomiting,7
LIDOCAINE\PRILOCAINE,Ear infection,7
LIDOCAINE\PRILOCAINE,Contusion,7
LIDOCAINE\PRILOCAINE,Nausea,7
LIDOCAINE\PRILOCAINE,Diarrhoea,7
LIDOCAINE\PRILOCAINE,Herpes zoster,6
LIDOCAINE\PRILOCAINE,Seasonal allergy,6
LIDOCAINE\PRILOCAINE,Gastrointestinal disorder,6
LIDOCAINE\PRILOCAINE,Needle issue,6
LIDOCAINE\PRILOCAINE,Rash,5
LIDOCAINE\PRILOCAINE,Infusion related reaction,5
LIDOCAINE\PRILOCAINE,Viral infection,5
LIDOCAINE\PRILOCAINE,Respiratory tract infection,5
LIDOCAINE\PRILOCAINE,Arthralgia,5
LIDOCAINE\PRILOCAINE,Renal disorder,5
LIDOCAINE\PRILOCAINE,Bronchitis,5
LIDOCAINE\PRILOCAINE,Oropharyngeal pain,5
LIDOCAINE\PRILOCAINE,Migraine,5
LIDOCAINE\PRILOCAINE,Gastroenteritis viral,5
LIDOCAINE\PRILOCAINE,Infusion site erythema,5
LIDOCAINE\PRILOCAINE,Infusion site swelling,5
LIDOCAINE\PRILOCAINE,Erythema,4
LIDOCAINE\PRILOCAINE,Urticaria,4
LIDOCAINE\PRILOCAINE,Peripheral swelling,4
LIDOCAINE\PRILOCAINE,Respiratory distress,4
LIDOCAINE\PRILOCAINE,Productive cough,4
LIDOCAINE\PRILOCAINE,Sepsis,4
LIDOCAINE\PRILOCAINE,Product use issue,4
LIDOCAINE\PRILOCAINE,Pain in extremity,4
LIDOCAINE\PRILOCAINE,Back pain,4
LIDOCAINE\PRILOCAINE,Cystitis,4
LILETTA,Device expulsion,38
LILETTA,Procedural pain,18
LILETTA,Off label use,10
LILETTA,Unintentional medical device removal,5
LILETTA,Device dislocation,4
LILETTA,Embedded device,4
LILETTA,Presyncope,4
LILETTA,Uterine spasm,3
LILETTA,Uterine perforation,3
LILETTA,Device deployment issue,3
LILETTA,Cough,1
LILETTA,Depression,1
LILETTA,Eczema,1
LILETTA,Rash erythematous,1
LILETTA,Initial insomnia,1
LILETTA,Dermatitis atopic,1
LILETTA,Skin exfoliation,1
LILETTA,Therapeutic product effect decreased,1
LILETTA,Skin fissures,1
LILETTA,Dry skin,1
LILETTA,Pruritus,1
LILETTA,Device breakage,1
LILETTA,Loss of consciousness,1
LILETTA,Anxiety,1
LILETTA,Ovarian cyst,1
LILETTA,Menometrorrhagia,1
LILETTA,Complication of device insertion,1
LILETTA,Device malfunction,1
LILETTA,Device issue,1
LILETTA,Dizziness,1
LILETTA,Abdominal pain,1
LINAGLIPTIN,Palpitations,98
LINAGLIPTIN,Fatigue,98
LINAGLIPTIN,Ventricular tachycardia,97
LINAGLIPTIN,Pruritus,91
LINAGLIPTIN,Diarrhoea,91
LINAGLIPTIN,Dehydration,90
LINAGLIPTIN,Hallucination,90
LINAGLIPTIN,Malaise,90
LINAGLIPTIN,Pyrexia,89
LINAGLIPTIN,COVID-19,89
LINAGLIPTIN,Dyspnoea,89
LINAGLIPTIN,Pain,88
LINAGLIPTIN,Anxiety,88
LINAGLIPTIN,Alopecia,88
LINAGLIPTIN,Visual impairment,88
LINAGLIPTIN,Amnesia,88
LINAGLIPTIN,Feeling abnormal,88
LINAGLIPTIN,Facial pain,88
LINAGLIPTIN,Myocardial infarction,88
LINAGLIPTIN,Dry skin,88
LINAGLIPTIN,Dizziness,88
LINAGLIPTIN,Tachycardia,88
LINAGLIPTIN,Chest pain,88
LINAGLIPTIN,Cardiospasm,88
LINAGLIPTIN,Vomiting,88
LINAGLIPTIN,Angioedema,88
LINAGLIPTIN,Muscular weakness,88
LINAGLIPTIN,Abdominal discomfort,88
LINAGLIPTIN,Subarachnoid haemorrhage,88
LINAGLIPTIN,Blood glucose increased,88
LINAGLIPTIN,Lip swelling,88
LINAGLIPTIN,Disturbance in attention,88
LINAGLIPTIN,Anosmia,88
LINAGLIPTIN,Atrial tachycardia,88
LINAGLIPTIN,Pericarditis,88
LINAGLIPTIN,Intentional product misuse,87
LINAGLIPTIN,Nausea,87
LINAGLIPTIN,Insomnia,87
LINAGLIPTIN,Diplopia,87
LINAGLIPTIN,Arthralgia,87
LINAGLIPTIN,Hyperhidrosis,87
LINAGLIPTIN,Transient ischaemic attack,87
LINAGLIPTIN,Peripheral swelling,87
LINAGLIPTIN,Memory impairment,87
LINAGLIPTIN,Sleep terror,87
LINAGLIPTIN,Tension headache,87
LINAGLIPTIN,Blindness,87
LINAGLIPTIN,Migraine,87
LINAGLIPTIN,Vasculitis,87
LINAGLIPTIN,Pruritus genital,87
LINEZOLID,Thrombocytopenia,26
LINEZOLID,Anaemia,23
LINEZOLID,Off label use,20
LINEZOLID,Nausea,18
LINEZOLID,Vomiting,15
LINEZOLID,Decreased appetite,14
LINEZOLID,Diarrhoea,13
LINEZOLID,Neuropathy peripheral,13
LINEZOLID,Dyspnoea,12
LINEZOLID,Death,12
LINEZOLID,Headache,11
LINEZOLID,Dehydration,10
LINEZOLID,Asthenia,10
LINEZOLID,Depression,9
LINEZOLID,Dysphagia,9
LINEZOLID,Mucosal inflammation,9
LINEZOLID,Neutropenic sepsis,9
LINEZOLID,Constipation,9
LINEZOLID,Gait disturbance,8
LINEZOLID,Hypokalaemia,8
LINEZOLID,Mouth ulceration,8
LINEZOLID,Productive cough,8
LINEZOLID,Product use in unapproved indication,8
LINEZOLID,Skin candida,8
LINEZOLID,Neutrophil count decreased,8
LINEZOLID,Hypomagnesaemia,8
LINEZOLID,Clostridium difficile infection,8
LINEZOLID,Renal failure,8
LINEZOLID,Leukopenia,8
LINEZOLID,Cholestasis,8
LINEZOLID,Nervous system disorder,7
LINEZOLID,Balance disorder,7
LINEZOLID,Pruritus,7
LINEZOLID,Electrocardiogram QT prolonged,6
LINEZOLID,Platelet count decreased,6
LINEZOLID,Blood potassium decreased,6
LINEZOLID,Blood bilirubin increased,6
LINEZOLID,Candida infection,5
LINEZOLID,Acute kidney injury,5
LINEZOLID,Pyrexia,5
LINEZOLID,Cardio-respiratory arrest,5
LINEZOLID,Serotonin syndrome,5
LINEZOLID,Venoocclusive liver disease,5
LINEZOLID,Skin burning sensation,5
LINEZOLID,Sleep disorder,5
LINEZOLID,Chills,5
LINEZOLID,Dysgeusia,5
LINEZOLID,Paraesthesia,5
LINEZOLID,Acute generalised exanthematous pustulosis,5
LINEZOLID,BK virus infection,5
LINZESS,Headache,12
LINZESS,Decreased appetite,10
LINZESS,Fall,9
LINZESS,Drug ineffective,9
LINZESS,Pain,9
LINZESS,Product dose omission issue,9
LINZESS,Pneumonia,9
LINZESS,Diarrhoea,8
LINZESS,Nausea,8
LINZESS,Anxiety,7
LINZESS,Malaise,7
LINZESS,Inappropriate schedule of product administration,6
LINZESS,Asthenia,6
LINZESS,Sinusitis,6
LINZESS,Pain in extremity,5
LINZESS,Depression,5
LINZESS,Fatigue,5
LINZESS,Palpitations,5
LINZESS,Condition aggravated,5
LINZESS,Weight decreased,5
LINZESS,Off label use,5
LINZESS,Dizziness,4
LINZESS,Dyspnoea,4
LINZESS,Feeling abnormal,4
LINZESS,Arthralgia,4
LINZESS,Syncope,4
LINZESS,Urinary tract infection,3
LINZESS,Hypoaesthesia,3
LINZESS,Hypertension,3
LINZESS,Tooth infection,3
LINZESS,Emotional distress,3
LINZESS,Anhedonia,3
LINZESS,Depressed mood,3
LINZESS,Hereditary angioedema,3
LINZESS,Muscle spasms,3
LINZESS,Product availability issue,3
LINZESS,Vomiting,3
LINZESS,Upper respiratory tract infection,3
LINZESS,Pruritus,3
LINZESS,Nasopharyngitis,3
LINZESS,Product quality issue,3
LINZESS,COVID-19,3
LINZESS,Somnolence,2
LINZESS,Paraesthesia,2
LINZESS,Epistaxis,2
LINZESS,Chronic kidney disease,2
LINZESS,Injury,2
LINZESS,Face injury,2
LINZESS,Angina pectoris,2
LINZESS,Bradyphrenia,2
LIPITOR,Fatigue,34
LIPITOR,Pain,33
LIPITOR,Headache,23
LIPITOR,Anxiety,22
LIPITOR,Pneumonia,21
LIPITOR,Nausea,20
LIPITOR,Fall,20
LIPITOR,Product dose omission issue,20
LIPITOR,Asthenia,18
LIPITOR,Arthralgia,17
LIPITOR,Diarrhoea,17
LIPITOR,Dyspnoea,17
LIPITOR,Off label use,16
LIPITOR,Weight decreased,16
LIPITOR,Anhedonia,16
LIPITOR,COVID-19,16
LIPITOR,Emotional distress,15
LIPITOR,Malaise,15
LIPITOR,Dizziness,14
LIPITOR,Back pain,12
LIPITOR,Chronic kidney disease,12
LIPITOR,Illness,12
LIPITOR,Vomiting,12
LIPITOR,Weight increased,12
LIPITOR,Peripheral swelling,11
LIPITOR,Gait disturbance,11
LIPITOR,Atrial fibrillation,11
LIPITOR,Urinary tract infection,11
LIPITOR,Pain in extremity,11
LIPITOR,Cerebrovascular accident,11
LIPITOR,Condition aggravated,10
LIPITOR,Blood creatinine increased,10
LIPITOR,Drug ineffective,10
LIPITOR,Anaemia,10
LIPITOR,Rash,9
LIPITOR,Death,9
LIPITOR,Muscle spasms,9
LIPITOR,Cough,9
LIPITOR,Osteoporosis,9
LIPITOR,Product use issue,9
LIPITOR,Bronchitis,9
LIPITOR,Nasopharyngitis,9
LIPITOR,Inappropriate schedule of product administration,9
LIPITOR,Insomnia,8
LIPITOR,Chest pain,8
LIPITOR,Pyrexia,8
LIPITOR,Hypertension,8
LIPITOR,Memory impairment,8
LIPITOR,Renal failure,7
LIPITOR,Sinusitis,7
LIPTRUZET,Condition aggravated,9
LIPTRUZET,Hepatic cytolysis,9
LIPTRUZET,Drug interaction,8
LIPTRUZET,Sudden death,8
LIPTRUZET,Hyponatraemia,7
LIPTRUZET,Hyperkalaemia,7
LIPTRUZET,Prescription drug used without a prescription,7
LIPTRUZET,Vertigo,4
LIPTRUZET,Pain in extremity,4
LIPTRUZET,Musculoskeletal pain,4
LIPTRUZET,Cholestasis,4
LIPTRUZET,Facial paralysis,3
LIPTRUZET,Bell's palsy,3
LIPTRUZET,Guillain-Barre syndrome,3
LIPTRUZET,Back pain,3
LIPTRUZET,Rhabdomyolysis,3
LIPTRUZET,Vascular stent stenosis,3
LIPTRUZET,Fatigue,2
LIPTRUZET,Acute kidney injury,2
LIPTRUZET,Rash papulosquamous,2
LIPTRUZET,Eczema,2
LIPTRUZET,Pruritus,2
LIPTRUZET,Haemorrhagic stroke,2
LIPTRUZET,Urinary tract infection,1
LIPTRUZET,Thrombocytopenia,1
LIPTRUZET,Agranulocytosis,1
LIPTRUZET,Constipation,1
LIPTRUZET,Cerebrovascular accident,1
LIPTRUZET,Anxiety,1
LIPTRUZET,Immune thrombocytopenia,1
LIPTRUZET,Ligament sprain,1
LIPTRUZET,Neutropenia,1
LIPTRUZET,Hypocalcaemia,1
LIPTRUZET,Hyperuricaemia,1
LIPTRUZET,Nasopharyngitis,1
LIPTRUZET,Influenza,1
LIPTRUZET,Obstructive pancreatitis,1
LIPTRUZET,Encephalitis,1
LIPTRUZET,Necrotising myositis,1
LIPTRUZET,Interstitial lung disease,1
LIPTRUZET,Dizziness postural,1
LIPTRUZET,Colitis,1
LIPTRUZET,Shock haemorrhagic,1
LIPTRUZET,Sleep disorder,1
LIPTRUZET,Restlessness,1
LIPTRUZET,Pharyngeal abscess,1
LIPTRUZET,Injection site erythema,1
LIPTRUZET,Off label use,1
LISINOPRIL,Pain,122
LISINOPRIL,Fatigue,91
LISINOPRIL,Anxiety,87
LISINOPRIL,Emotional distress,77
LISINOPRIL,Anhedonia,72
LISINOPRIL,Diarrhoea,64
LISINOPRIL,Off label use,58
LISINOPRIL,Headache,53
LISINOPRIL,Nausea,50
LISINOPRIL,Chronic kidney disease,44
LISINOPRIL,Dyspnoea,42
LISINOPRIL,Asthenia,41
LISINOPRIL,Back pain,41
LISINOPRIL,Arthralgia,41
LISINOPRIL,COVID-19,41
LISINOPRIL,Product dose omission issue,41
LISINOPRIL,Cough,38
LISINOPRIL,Osteoporosis,37
LISINOPRIL,Depression,36
LISINOPRIL,Drug ineffective,35
LISINOPRIL,Illness,35
LISINOPRIL,Fall,35
LISINOPRIL,Pruritus,34
LISINOPRIL,Pneumonia,34
LISINOPRIL,Pain in extremity,34
LISINOPRIL,Malaise,32
LISINOPRIL,Acute kidney injury,32
LISINOPRIL,Dizziness,31
LISINOPRIL,Renal failure,31
LISINOPRIL,Vomiting,30
LISINOPRIL,Hypertension,28
LISINOPRIL,Sinusitis,28
LISINOPRIL,Osteopenia,28
LISINOPRIL,Pyrexia,27
LISINOPRIL,Bone density decreased,27
LISINOPRIL,Nasopharyngitis,25
LISINOPRIL,Blood creatinine increased,25
LISINOPRIL,Weight decreased,24
LISINOPRIL,Rash,24
LISINOPRIL,Decreased appetite,24
LISINOPRIL,Gait disturbance,23
LISINOPRIL,Blood pressure increased,22
LISINOPRIL,Condition aggravated,21
LISINOPRIL,Inappropriate schedule of product administration,21
LISINOPRIL,Abdominal pain upper,20
LISINOPRIL,Urinary tract infection,19
LISINOPRIL,Renal impairment,19
LISINOPRIL,Anaemia,19
LISINOPRIL,Weight increased,18
LISINOPRIL,Peripheral swelling,18
LOMOTIL,Diarrhoea,12
LOMOTIL,Fatigue,8
LOMOTIL,COVID-19,7
LOMOTIL,Dehydration,7
LOMOTIL,Product dose omission issue,6
LOMOTIL,Urinary tract infection,6
LOMOTIL,Nausea,6
LOMOTIL,Oedema peripheral,5
LOMOTIL,Fistula,5
LOMOTIL,Vomiting,5
LOMOTIL,Weight increased,4
LOMOTIL,Peripheral swelling,4
LOMOTIL,Abdominal abscess,4
LOMOTIL,Abdominal pain,4
LOMOTIL,Sepsis,4
LOMOTIL,Contusion,4
LOMOTIL,Dizziness,4
LOMOTIL,Weight decreased,4
LOMOTIL,Pyrexia,4
LOMOTIL,Off label use,4
LOMOTIL,Upper respiratory tract infection,4
LOMOTIL,Fall,4
LOMOTIL,Inappropriate schedule of product administration,3
LOMOTIL,Back pain,3
LOMOTIL,Dyspnoea,3
LOMOTIL,Asthenia,3
LOMOTIL,Hypertension,3
LOMOTIL,Insomnia,3
LOMOTIL,Acute kidney injury,3
LOMOTIL,Stress,3
LOMOTIL,Arthritis,3
LOMOTIL,Decreased appetite,3
LOMOTIL,Illness,3
LOMOTIL,Drug ineffective,3
LOMOTIL,Intentional product use issue,2
LOMOTIL,Fluid retention,2
LOMOTIL,Aortic aneurysm,2
LOMOTIL,Abscess limb,2
LOMOTIL,Pain,2
LOMOTIL,Anal fistula,2
LOMOTIL,Post procedural erythema,2
LOMOTIL,Herpes zoster,2
LOMOTIL,Ulcer,2
LOMOTIL,Fistula discharge,2
LOMOTIL,Fear of surgery,2
LOMOTIL,Myalgia,2
LOMOTIL,Foot deformity,2
LOMOTIL,Sinusitis,2
LOMOTIL,Therapeutic product effect incomplete,2
LOMOTIL,Headache,2
LOPERAMIDE,Diarrhoea,48
LOPERAMIDE,Vomiting,26
LOPERAMIDE,Nausea,24
LOPERAMIDE,Fatigue,22
LOPERAMIDE,Weight decreased,21
LOPERAMIDE,Decreased appetite,20
LOPERAMIDE,Abdominal pain,19
LOPERAMIDE,Pyrexia,17
LOPERAMIDE,Dehydration,16
LOPERAMIDE,Off label use,12
LOPERAMIDE,Abdominal pain upper,12
LOPERAMIDE,Pain in extremity,10
LOPERAMIDE,Anaemia,10
LOPERAMIDE,Product dose omission issue,10
LOPERAMIDE,Weight increased,10
LOPERAMIDE,Acute kidney injury,9
LOPERAMIDE,Vascular device infection,9
LOPERAMIDE,Abnormal faeces,9
LOPERAMIDE,Pneumonia,9
LOPERAMIDE,Malaise,8
LOPERAMIDE,Arthralgia,8
LOPERAMIDE,Constipation,8
LOPERAMIDE,Neutropenia,8
LOPERAMIDE,Intentional product use issue,8
LOPERAMIDE,Nasopharyngitis,7
LOPERAMIDE,Back pain,7
LOPERAMIDE,Neuropathy peripheral,7
LOPERAMIDE,Pain,7
LOPERAMIDE,Blood magnesium decreased,7
LOPERAMIDE,Urinary tract infection,7
LOPERAMIDE,Abdominal distension,7
LOPERAMIDE,Flatulence,7
LOPERAMIDE,Muscle spasms,7
LOPERAMIDE,Weight fluctuation,6
LOPERAMIDE,Dyspnoea,6
LOPERAMIDE,Alopecia,6
LOPERAMIDE,Anxiety,6
LOPERAMIDE,Disease progression,6
LOPERAMIDE,White blood cell count decreased,6
LOPERAMIDE,Rash,6
LOPERAMIDE,Hypokalaemia,6
LOPERAMIDE,COVID-19,6
LOPERAMIDE,Neutropenic sepsis,6
LOPERAMIDE,Headache,5
LOPERAMIDE,Inappropriate schedule of product administration,5
LOPERAMIDE,Autoimmune haemolytic anaemia,5
LOPERAMIDE,Ear pain,5
LOPERAMIDE,Mucosal inflammation,5
LOPERAMIDE,Haemoglobin decreased,5
LOPERAMIDE,Hepatic failure,5
LOPERAMIDE HYDROCHLORIDE,Diarrhoea,15
LOPERAMIDE HYDROCHLORIDE,Off label use,9
LOPERAMIDE HYDROCHLORIDE,Anaemia,8
LOPERAMIDE HYDROCHLORIDE,Dyspnoea,7
LOPERAMIDE HYDROCHLORIDE,Fatigue,7
LOPERAMIDE HYDROCHLORIDE,Stomatitis,5
LOPERAMIDE HYDROCHLORIDE,Weight decreased,5
LOPERAMIDE HYDROCHLORIDE,Decreased appetite,5
LOPERAMIDE HYDROCHLORIDE,Death,4
LOPERAMIDE HYDROCHLORIDE,Hyperglycaemia,4
LOPERAMIDE HYDROCHLORIDE,Palpitations,4
LOPERAMIDE HYDROCHLORIDE,Abdominal pain,4
LOPERAMIDE HYDROCHLORIDE,Dizziness,4
LOPERAMIDE HYDROCHLORIDE,Dermatitis,4
LOPERAMIDE HYDROCHLORIDE,Lung disorder,4
LOPERAMIDE HYDROCHLORIDE,Leukopenia,4
LOPERAMIDE HYDROCHLORIDE,Immune-mediated hypophysitis,3
LOPERAMIDE HYDROCHLORIDE,Immune-mediated enterocolitis,3
LOPERAMIDE HYDROCHLORIDE,Febrile neutropenia,3
LOPERAMIDE HYDROCHLORIDE,C-reactive protein increased,3
LOPERAMIDE HYDROCHLORIDE,Tumour pain,3
LOPERAMIDE HYDROCHLORIDE,Insomnia,3
LOPERAMIDE HYDROCHLORIDE,Dry eye,3
LOPERAMIDE HYDROCHLORIDE,Liver injury,3
LOPERAMIDE HYDROCHLORIDE,Hepatic function abnormal,3
LOPERAMIDE HYDROCHLORIDE,Dyspepsia,3
LOPERAMIDE HYDROCHLORIDE,Hepatic failure,3
LOPERAMIDE HYDROCHLORIDE,Hypoaesthesia,3
LOPERAMIDE HYDROCHLORIDE,Rash,3
LOPERAMIDE HYDROCHLORIDE,Product dose omission issue,3
LOPERAMIDE HYDROCHLORIDE,Atrial fibrillation,3
LOPERAMIDE HYDROCHLORIDE,Dehydration,3
LOPERAMIDE HYDROCHLORIDE,Septic shock,3
LOPERAMIDE HYDROCHLORIDE,Urinary tract infection,3
LOPERAMIDE HYDROCHLORIDE,Hypopituitarism,2
LOPERAMIDE HYDROCHLORIDE,Secondary adrenocortical insufficiency,2
LOPERAMIDE HYDROCHLORIDE,Thyroiditis,2
LOPERAMIDE HYDROCHLORIDE,Intentional product use issue,2
LOPERAMIDE HYDROCHLORIDE,Acute kidney injury,2
LOPERAMIDE HYDROCHLORIDE,Seizure,2
LOPERAMIDE HYDROCHLORIDE,General physical health deterioration,2
LOPERAMIDE HYDROCHLORIDE,Myelosuppression,2
LOPERAMIDE HYDROCHLORIDE,Hyperuricaemia,2
LOPERAMIDE HYDROCHLORIDE,Hypokalaemia,2
LOPERAMIDE HYDROCHLORIDE,Immunodeficiency,2
LOPERAMIDE HYDROCHLORIDE,Sepsis,2
LOPERAMIDE HYDROCHLORIDE,Weight increased,2
LOPERAMIDE HYDROCHLORIDE,Oral pain,2
LOPERAMIDE HYDROCHLORIDE,Alopecia,2
LOPERAMIDE HYDROCHLORIDE,Impaired healing,2
LORATADINE,Fatigue,35
LORATADINE,COVID-19,28
LORATADINE,Headache,27
LORATADINE,Pain,25
LORATADINE,Anxiety,23
LORATADINE,Pyrexia,20
LORATADINE,Product dose omission issue,19
LORATADINE,Pruritus,19
LORATADINE,Nausea,18
LORATADINE,Pneumonia,18
LORATADINE,Diarrhoea,17
LORATADINE,Arthralgia,16
LORATADINE,Dizziness,14
LORATADINE,Cough,14
LORATADINE,Vomiting,13
LORATADINE,Pain in extremity,12
LORATADINE,Sinusitis,12
LORATADINE,Inappropriate schedule of product administration,12
LORATADINE,White blood cell count decreased,11
LORATADINE,Depression,11
LORATADINE,Dyspnoea,11
LORATADINE,Weight increased,11
LORATADINE,Anhedonia,11
LORATADINE,Emotional distress,11
LORATADINE,Urinary tract infection,11
LORATADINE,Rash,11
LORATADINE,Feeling abnormal,10
LORATADINE,Influenza,10
LORATADINE,Heart rate increased,10
LORATADINE,Off label use,10
LORATADINE,Erythema,10
LORATADINE,Paraesthesia,10
LORATADINE,Back pain,10
LORATADINE,Insomnia,10
LORATADINE,Palpitations,9
LORATADINE,Illness,9
LORATADINE,Blood pressure increased,9
LORATADINE,Chills,8
LORATADINE,Bone pain,8
LORATADINE,Asthenia,8
LORATADINE,Nasopharyngitis,8
LORATADINE,Urticaria,8
LORATADINE,Abdominal pain,8
LORATADINE,Inflammation,7
LORATADINE,Gait disturbance,7
LORATADINE,Lower respiratory tract infection,7
LORATADINE,Bronchitis,7
LORATADINE,Chronic kidney disease,7
LORATADINE,Malaise,7
LORATADINE,Flushing,7
LORAZEPAM,Fatigue,55
LORAZEPAM,Nausea,47
LORAZEPAM,Off label use,46
LORAZEPAM,Diarrhoea,40
LORAZEPAM,Vomiting,38
LORAZEPAM,Dyspnoea,36
LORAZEPAM,Anxiety,33
LORAZEPAM,Pyrexia,31
LORAZEPAM,Headache,29
LORAZEPAM,Dizziness,29
LORAZEPAM,Asthenia,27
LORAZEPAM,Pruritus,27
LORAZEPAM,Seizure,27
LORAZEPAM,Pain,26
LORAZEPAM,Drug ineffective,25
LORAZEPAM,Depression,24
LORAZEPAM,COVID-19,23
LORAZEPAM,Fall,21
LORAZEPAM,Decreased appetite,21
LORAZEPAM,Malaise,20
LORAZEPAM,Schizophrenia,20
LORAZEPAM,Psychotic disorder,20
LORAZEPAM,Arthralgia,20
LORAZEPAM,Product dose omission issue,19
LORAZEPAM,Tremor,19
LORAZEPAM,Platelet count decreased,18
LORAZEPAM,Drug interaction,18
LORAZEPAM,Muscle spasms,17
LORAZEPAM,Gait disturbance,17
LORAZEPAM,Illness,17
LORAZEPAM,Confusional state,16
LORAZEPAM,Rash,16
LORAZEPAM,Blood pressure increased,16
LORAZEPAM,Pneumonia,16
LORAZEPAM,Suicidal ideation,16
LORAZEPAM,Sleep disorder,16
LORAZEPAM,Cellulitis,16
LORAZEPAM,Somnolence,16
LORAZEPAM,Alopecia,15
LORAZEPAM,Paraesthesia,15
LORAZEPAM,Weight decreased,15
LORAZEPAM,Neuropathy peripheral,15
LORAZEPAM,Urinary tract infection,15
LORAZEPAM,Skin discolouration,15
LORAZEPAM,Balance disorder,15
LORAZEPAM,Agitation,15
LORAZEPAM,Toxicity to various agents,15
LORAZEPAM,Urinary retention,15
LORAZEPAM,Visual impairment,15
LORAZEPAM,Sepsis,14
LORMETAZEPAM,Intentional overdose,9
LORMETAZEPAM,Anaemia,7
LORMETAZEPAM,Disturbance in attention,7
LORMETAZEPAM,Poisoning deliberate,6
LORMETAZEPAM,Epistaxis,5
LORMETAZEPAM,Asthenia,5
LORMETAZEPAM,Gingival bleeding,5
LORMETAZEPAM,Hypomagnesaemia,5
LORMETAZEPAM,Hypocalcaemia,5
LORMETAZEPAM,Muscle spasms,5
LORMETAZEPAM,Hepatic cytolysis,5
LORMETAZEPAM,Mitral valve incompetence,5
LORMETAZEPAM,Atrioventricular block complete,5
LORMETAZEPAM,Lipase increased,5
LORMETAZEPAM,Pancreatic carcinoma,5
LORMETAZEPAM,Arthralgia,4
LORMETAZEPAM,Hypotension,4
LORMETAZEPAM,Diarrhoea,3
LORMETAZEPAM,Coma,3
LORMETAZEPAM,Nausea,3
LORMETAZEPAM,Mucosal inflammation,3
LORMETAZEPAM,Acute kidney injury,3
LORMETAZEPAM,Somnolence,3
LORMETAZEPAM,Therapeutic hypothermia,3
LORMETAZEPAM,Distal intestinal obstruction syndrome,3
LORMETAZEPAM,Pancreatitis acute,3
LORMETAZEPAM,Shock,2
LORMETAZEPAM,Pyrexia,2
LORMETAZEPAM,Respiratory failure,2
LORMETAZEPAM,Hypertension,2
LORMETAZEPAM,Hypothyroidism,2
LORMETAZEPAM,Pleural effusion,2
LORMETAZEPAM,Cortisol increased,2
LORMETAZEPAM,Uterine perforation,2
LORMETAZEPAM,Leukopenia,2
LORMETAZEPAM,Faeces discoloured,2
LORMETAZEPAM,Cystitis,2
LORMETAZEPAM,Neutropenia,2
LORMETAZEPAM,Malaise,2
LORMETAZEPAM,Constipation,2
LORMETAZEPAM,Abdominal pain upper,2
LORMETAZEPAM,Hyperferritinaemia,2
LORMETAZEPAM,Tachycardia,2
LORMETAZEPAM,Drug abuse,2
LORMETAZEPAM,Agitation,2
LORMETAZEPAM,Renal cyst ruptured,2
LORMETAZEPAM,Lung adenocarcinoma,2
LORMETAZEPAM,Off label use,2
LORMETAZEPAM,Suicide attempt,2
LORMETAZEPAM,Treatment delayed,2
LOSARTAN,Pain,149
LOSARTAN,Diarrhoea,126
LOSARTAN,COVID-19,126
LOSARTAN,Fatigue,124
LOSARTAN,Anxiety,123
LOSARTAN,Headache,122
LOSARTAN,Malaise,114
LOSARTAN,Off label use,114
LOSARTAN,Dizziness,106
LOSARTAN,Dyspnoea,105
LOSARTAN,Arthralgia,104
LOSARTAN,Nausea,100
LOSARTAN,Peripheral swelling,97
LOSARTAN,Pruritus,97
LOSARTAN,Chest pain,94
LOSARTAN,Vomiting,92
LOSARTAN,Memory impairment,91
LOSARTAN,Back pain,91
LOSARTAN,Feeling abnormal,89
LOSARTAN,Insomnia,89
LOSARTAN,Pyrexia,86
LOSARTAN,Alopecia,82
LOSARTAN,Abdominal pain upper,81
LOSARTAN,Abdominal discomfort,80
LOSARTAN,Dehydration,80
LOSARTAN,Visual impairment,79
LOSARTAN,Migraine,78
LOSARTAN,Muscular weakness,77
LOSARTAN,Blood glucose increased,77
LOSARTAN,Amnesia,76
LOSARTAN,Myocardial infarction,76
LOSARTAN,Heart rate increased,76
LOSARTAN,Lip swelling,76
LOSARTAN,Palpitations,75
LOSARTAN,Hyperhidrosis,75
LOSARTAN,Dry skin,74
LOSARTAN,Intentional product misuse,74
LOSARTAN,Tachycardia,73
LOSARTAN,Transient ischaemic attack,73
LOSARTAN,Anosmia,72
LOSARTAN,Hallucination,72
LOSARTAN,Disturbance in attention,72
LOSARTAN,Subarachnoid haemorrhage,72
LOSARTAN,Angioedema,72
LOSARTAN,Cognitive disorder,72
LOSARTAN,Pericarditis,72
LOSARTAN,Diplopia,71
LOSARTAN,Blindness,71
LOSARTAN,Facial pain,71
LOSARTAN,Cardiospasm,71
LOSARTAN POTASSIUM,Fatigue,52
LOSARTAN POTASSIUM,COVID-19,49
LOSARTAN POTASSIUM,Pruritus,47
LOSARTAN POTASSIUM,Diarrhoea,43
LOSARTAN POTASSIUM,Pain,42
LOSARTAN POTASSIUM,Malaise,41
LOSARTAN POTASSIUM,Headache,40
LOSARTAN POTASSIUM,Dyspnoea,39
LOSARTAN POTASSIUM,Nausea,37
LOSARTAN POTASSIUM,Sinusitis,33
LOSARTAN POTASSIUM,Off label use,30
LOSARTAN POTASSIUM,Pyrexia,30
LOSARTAN POTASSIUM,Back pain,29
LOSARTAN POTASSIUM,Arthralgia,29
LOSARTAN POTASSIUM,Anxiety,28
LOSARTAN POTASSIUM,Product dose omission issue,28
LOSARTAN POTASSIUM,Dizziness,27
LOSARTAN POTASSIUM,Vomiting,27
LOSARTAN POTASSIUM,Feeling abnormal,26
LOSARTAN POTASSIUM,Rash,26
LOSARTAN POTASSIUM,Peripheral swelling,26
LOSARTAN POTASSIUM,Dehydration,25
LOSARTAN POTASSIUM,Chest pain,24
LOSARTAN POTASSIUM,Alopecia,23
LOSARTAN POTASSIUM,Abdominal pain upper,23
LOSARTAN POTASSIUM,Memory impairment,23
LOSARTAN POTASSIUM,Pneumonia,22
LOSARTAN POTASSIUM,Palpitations,22
LOSARTAN POTASSIUM,Abdominal discomfort,22
LOSARTAN POTASSIUM,Muscular weakness,22
LOSARTAN POTASSIUM,Pain in extremity,21
LOSARTAN POTASSIUM,Dry skin,21
LOSARTAN POTASSIUM,Eye pruritus,21
LOSARTAN POTASSIUM,Insomnia,21
LOSARTAN POTASSIUM,Intentional product misuse,21
LOSARTAN POTASSIUM,Tinnitus,20
LOSARTAN POTASSIUM,Visual impairment,20
LOSARTAN POTASSIUM,Urinary tract infection,19
LOSARTAN POTASSIUM,Inappropriate schedule of product administration,19
LOSARTAN POTASSIUM,Tachycardia,19
LOSARTAN POTASSIUM,Transient ischaemic attack,19
LOSARTAN POTASSIUM,Anosmia,19
LOSARTAN POTASSIUM,Lip swelling,19
LOSARTAN POTASSIUM,Cognitive disorder,19
LOSARTAN POTASSIUM,Angioedema,19
LOSARTAN POTASSIUM,Ventricular tachycardia,19
LOSARTAN POTASSIUM,Amnesia,19
LOSARTAN POTASSIUM,Facial pain,19
LOSARTAN POTASSIUM,Myocardial infarction,19
LOSARTAN POTASSIUM,Migraine,18
LOVENOX,Hepatic cytolysis,19
LOVENOX,Anaemia,15
LOVENOX,Thrombocytopenia,11
LOVENOX,Cholestasis,11
LOVENOX,Drug reaction with eosinophilia and systemic symptoms,10
LOVENOX,Rash maculo-papular,9
LOVENOX,Stevens-Johnson syndrome,9
LOVENOX,Acute kidney injury,8
LOVENOX,Nausea,8
LOVENOX,Acute generalised exanthematous pustulosis,8
LOVENOX,Dyspnoea,8
LOVENOX,Haematoma,7
LOVENOX,Asthenia,7
LOVENOX,Weight decreased,7
LOVENOX,Diarrhoea,7
LOVENOX,Eosinophilia,7
LOVENOX,Agranulocytosis,7
LOVENOX,Neutropenia,6
LOVENOX,Leukopenia,6
LOVENOX,Haemolytic anaemia,6
LOVENOX,Condition aggravated,6
LOVENOX,Muscle haemorrhage,6
LOVENOX,Tendon rupture,6
LOVENOX,Inappropriate antidiuretic hormone secretion,6
LOVENOX,Capillary leak syndrome,6
LOVENOX,Subarachnoid haemorrhage,6
LOVENOX,Chronic kidney disease,5
LOVENOX,Off label use,5
LOVENOX,Weight increased,5
LOVENOX,Pneumonia,5
LOVENOX,Abdominal pain upper,5
LOVENOX,Heparin-induced thrombocytopenia,5
LOVENOX,Vomiting,5
LOVENOX,Mixed liver injury,5
LOVENOX,Atrial fibrillation,4
LOVENOX,Lung disorder,4
LOVENOX,Fatigue,4
LOVENOX,COVID-19,4
LOVENOX,Small intestinal obstruction,4
LOVENOX,Device related sepsis,4
LOVENOX,Vascular device infection,4
LOVENOX,Anaphylactic shock,4
LOVENOX,Neuroleptic malignant syndrome,4
LOVENOX,Hepatitis,4
LOVENOX,General physical health deterioration,3
LOVENOX,Hypocalcaemia,3
LOVENOX,Muscle spasms,3
LOVENOX,Lactic acidosis,3
LOVENOX,Pyrexia,3
LOVENOX,Pain,3
LOXAPINE,Coma,20
LOXAPINE,Wrong patient received product,13
LOXAPINE,Sedation,9
LOXAPINE,Hypoxia,8
LOXAPINE,Hypothermia,8
LOXAPINE,Hypoglycaemia,8
LOXAPINE,Respiratory distress,7
LOXAPINE,Hepatic cytolysis,7
LOXAPINE,Somnolence,6
LOXAPINE,Vomiting,5
LOXAPINE,Poisoning deliberate,5
LOXAPINE,Neuroleptic malignant syndrome,4
LOXAPINE,Suicide attempt,4
LOXAPINE,Drug ineffective,4
LOXAPINE,Dissociative disorder,4
LOXAPINE,Urinary retention,4
LOXAPINE,Dyspnoea,3
LOXAPINE,Dysphagia,3
LOXAPINE,Urinary tract infection,2
LOXAPINE,Cough,2
LOXAPINE,Lung disorder,2
LOXAPINE,Extrapyramidal disorder,2
LOXAPINE,Off label use,2
LOXAPINE,Anxiety,2
LOXAPINE,Agranulocytosis,2
LOXAPINE,Drug interaction,2
LOXAPINE,Injection site pain,1
LOXAPINE,Nasopharyngitis,1
LOXAPINE,Acute respiratory failure,1
LOXAPINE,Diarrhoea,1
LOXAPINE,Intestinal obstruction,1
LOXAPINE,Asthma,1
LOXAPINE,Acne,1
LOXAPINE,Weight decreased,1
LOXAPINE,Feeling abnormal,1
LOXAPINE,General physical health deterioration,1
LOXAPINE,Blood iron abnormal,1
LOXAPINE,Wrong technique in product usage process,1
LOXAPINE,Pulmonary congestion,1
LOXAPINE,Pulmonary function test decreased,1
LOXAPINE,Blood pressure systolic increased,1
LOXAPINE,Injection site bruising,1
LOXAPINE,Tooth abscess,1
LOXAPINE,Skin haemorrhage,1
LOXAPINE,Viral infection,1
LOXAPINE,Dementia,1
LOXAPINE,Headache,1
LOXAPINE,Anger,1
LOXAPINE,Abdominal hernia obstructive,1
LOXAPINE,Bronchitis,1
LOXOPROFEN SODIUM,Interstitial lung disease,14
LOXOPROFEN SODIUM,Pyrexia,12
LOXOPROFEN SODIUM,Lymphocyte count decreased,6
LOXOPROFEN SODIUM,Diarrhoea,6
LOXOPROFEN SODIUM,White blood cell count decreased,6
LOXOPROFEN SODIUM,Hepatic function abnormal,5
LOXOPROFEN SODIUM,Nausea,5
LOXOPROFEN SODIUM,Anaemia,5
LOXOPROFEN SODIUM,Back pain,5
LOXOPROFEN SODIUM,Febrile neutropenia,5
LOXOPROFEN SODIUM,Herpes zoster,4
LOXOPROFEN SODIUM,Malaise,4
LOXOPROFEN SODIUM,Hypertension,4
LOXOPROFEN SODIUM,Decreased appetite,4
LOXOPROFEN SODIUM,Arthralgia,4
LOXOPROFEN SODIUM,Neutrophil count decreased,4
LOXOPROFEN SODIUM,Pain,4
LOXOPROFEN SODIUM,Pneumonia,4
LOXOPROFEN SODIUM,Skin disorder,3
LOXOPROFEN SODIUM,Off label use,3
LOXOPROFEN SODIUM,Vomiting,3
LOXOPROFEN SODIUM,Rash,3
LOXOPROFEN SODIUM,Stomatitis,3
LOXOPROFEN SODIUM,Dizziness,3
LOXOPROFEN SODIUM,Urinary tract infection,3
LOXOPROFEN SODIUM,Fulminant type 1 diabetes mellitus,3
LOXOPROFEN SODIUM,Amylase increased,3
LOXOPROFEN SODIUM,Pleural effusion,3
LOXOPROFEN SODIUM,Adrenal insufficiency,3
LOXOPROFEN SODIUM,Dyspnoea,3
LOXOPROFEN SODIUM,Headache,3
LOXOPROFEN SODIUM,Acute kidney injury,3
LOXOPROFEN SODIUM,Pulmonary toxicity,3
LOXOPROFEN SODIUM,Diabetic ketoacidosis,3
LOXOPROFEN SODIUM,Malignant neoplasm progression,3
LOXOPROFEN SODIUM,Alanine aminotransferase increased,3
LOXOPROFEN SODIUM,Product use in unapproved indication,2
LOXOPROFEN SODIUM,Pruritus,2
LOXOPROFEN SODIUM,Fall,2
LOXOPROFEN SODIUM,Secondary adrenocortical insufficiency,2
LOXOPROFEN SODIUM,Diverticulum intestinal haemorrhagic,2
LOXOPROFEN SODIUM,Hypercholesterolaemia,2
LOXOPROFEN SODIUM,Diabetes mellitus,2
LOXOPROFEN SODIUM,Breast cancer,2
LOXOPROFEN SODIUM,Oedema peripheral,2
LOXOPROFEN SODIUM,Pyelonephritis acute,2
LOXOPROFEN SODIUM,Renal abscess,2
LOXOPROFEN SODIUM,Blood creatinine increased,2
LOXOPROFEN SODIUM,Immune-mediated hepatic disorder,2
LOXOPROFEN SODIUM,Platelet count decreased,2
LYRICA,Fatigue,47
LYRICA,Pain,41
LYRICA,Nausea,35
LYRICA,Fall,32
LYRICA,Dyspnoea,31
LYRICA,Arthralgia,30
LYRICA,Dizziness,29
LYRICA,Headache,27
LYRICA,Pneumonia,26
LYRICA,Diarrhoea,23
LYRICA,Malaise,22
LYRICA,Off label use,22
LYRICA,COVID-19,22
LYRICA,Pain in extremity,21
LYRICA,Weight decreased,20
LYRICA,Urinary tract infection,19
LYRICA,Pyrexia,19
LYRICA,Illness,19
LYRICA,Asthenia,19
LYRICA,Sinusitis,19
LYRICA,Vomiting,19
LYRICA,Infection,18
LYRICA,Decreased appetite,18
LYRICA,Cough,17
LYRICA,Confusional state,17
LYRICA,Back pain,17
LYRICA,Condition aggravated,16
LYRICA,Gait disturbance,16
LYRICA,Pruritus,16
LYRICA,Hypoaesthesia,15
LYRICA,Nasopharyngitis,15
LYRICA,Rash,15
LYRICA,Anxiety,15
LYRICA,Anaemia,15
LYRICA,Drug intolerance,14
LYRICA,Lung disorder,14
LYRICA,Depression,14
LYRICA,Drug hypersensitivity,13
LYRICA,Hypertension,13
LYRICA,Drug ineffective,13
LYRICA,Product dose omission issue,13
LYRICA,Hypersensitivity,12
LYRICA,Intentional product use issue,12
LYRICA,Loss of consciousness,12
LYRICA,Myalgia,12
LYRICA,Somnolence,12
LYRICA,Feeling abnormal,11
LYRICA,General physical health deterioration,11
LYRICA,Weight increased,11
LYRICA,Muscle spasms,11
MAGNESIUM,Fatigue,57
MAGNESIUM,Nausea,56
MAGNESIUM,Headache,54
MAGNESIUM,Sinusitis,48
MAGNESIUM,Diarrhoea,47
MAGNESIUM,COVID-19,45
MAGNESIUM,Off label use,43
MAGNESIUM,Asthenia,41
MAGNESIUM,Product dose omission issue,40
MAGNESIUM,Vomiting,38
MAGNESIUM,Fall,37
MAGNESIUM,Dyspnoea,36
MAGNESIUM,Pneumonia,36
MAGNESIUM,Nasopharyngitis,34
MAGNESIUM,Pain,34
MAGNESIUM,Weight decreased,32
MAGNESIUM,Arthralgia,30
MAGNESIUM,Malaise,29
MAGNESIUM,Inappropriate schedule of product administration,29
MAGNESIUM,Pain in extremity,28
MAGNESIUM,Pyrexia,26
MAGNESIUM,Decreased appetite,26
MAGNESIUM,Illness,26
MAGNESIUM,Cough,25
MAGNESIUM,Urinary tract infection,25
MAGNESIUM,Gait disturbance,24
MAGNESIUM,Weight increased,22
MAGNESIUM,Pruritus,22
MAGNESIUM,Dehydration,22
MAGNESIUM,Constipation,21
MAGNESIUM,Dizziness,21
MAGNESIUM,Product use issue,21
MAGNESIUM,Infection,20
MAGNESIUM,Anxiety,20
MAGNESIUM,Rash,19
MAGNESIUM,Back pain,19
MAGNESIUM,Drug ineffective,19
MAGNESIUM,Condition aggravated,19
MAGNESIUM,Bronchitis,19
MAGNESIUM,Muscle spasms,17
MAGNESIUM,Intentional product use issue,16
MAGNESIUM,Alopecia,16
MAGNESIUM,Insomnia,16
MAGNESIUM,Product use in unapproved indication,16
MAGNESIUM,Upper respiratory tract infection,16
MAGNESIUM,Insurance issue,16
MAGNESIUM,Hypersensitivity,15
MAGNESIUM,Gastrointestinal disorder,15
MAGNESIUM,Depression,15
MAGNESIUM,Asthma,15
MAGNESIUM OXIDE,Off label use,21
MAGNESIUM OXIDE,Diarrhoea,20
MAGNESIUM OXIDE,Dyspnoea,19
MAGNESIUM OXIDE,Pneumonia,19
MAGNESIUM OXIDE,Constipation,19
MAGNESIUM OXIDE,Nausea,18
MAGNESIUM OXIDE,Condition aggravated,15
MAGNESIUM OXIDE,Anaemia,15
MAGNESIUM OXIDE,Vomiting,15
MAGNESIUM OXIDE,Pyrexia,13
MAGNESIUM OXIDE,Abdominal pain,11
MAGNESIUM OXIDE,Interstitial lung disease,11
MAGNESIUM OXIDE,Hepatic function abnormal,11
MAGNESIUM OXIDE,Product dose omission issue,10
MAGNESIUM OXIDE,Fall,9
MAGNESIUM OXIDE,Hyponatraemia,9
MAGNESIUM OXIDE,Fatigue,9
MAGNESIUM OXIDE,Ascites,9
MAGNESIUM OXIDE,Drug hypersensitivity,8
MAGNESIUM OXIDE,Somnolence,8
MAGNESIUM OXIDE,Oedema peripheral,8
MAGNESIUM OXIDE,Acute kidney injury,8
MAGNESIUM OXIDE,Urinary tract infection,8
MAGNESIUM OXIDE,Malaise,8
MAGNESIUM OXIDE,Death,8
MAGNESIUM OXIDE,Neutrophil count decreased,8
MAGNESIUM OXIDE,Sepsis,8
MAGNESIUM OXIDE,Product use issue,7
MAGNESIUM OXIDE,COVID-19,7
MAGNESIUM OXIDE,Diabetes mellitus,7
MAGNESIUM OXIDE,Headache,7
MAGNESIUM OXIDE,Stress,7
MAGNESIUM OXIDE,White blood cell count decreased,7
MAGNESIUM OXIDE,Cardiogenic shock,7
MAGNESIUM OXIDE,Bacterial infection,7
MAGNESIUM OXIDE,Incorrect route of product administration,7
MAGNESIUM OXIDE,Multiple organ dysfunction syndrome,7
MAGNESIUM OXIDE,Platelet count decreased,7
MAGNESIUM OXIDE,Abdominal distension,7
MAGNESIUM OXIDE,Dry mouth,7
MAGNESIUM OXIDE,Weight decreased,7
MAGNESIUM OXIDE,Decreased appetite,7
MAGNESIUM OXIDE,Malignant neoplasm progression,7
MAGNESIUM OXIDE,Intentional product misuse,6
MAGNESIUM OXIDE,Pain,6
MAGNESIUM OXIDE,Dehydration,6
MAGNESIUM OXIDE,Pneumonia aspiration,6
MAGNESIUM OXIDE,Cough,6
MAGNESIUM OXIDE,Hypokalaemia,6
MAGNESIUM OXIDE,Febrile neutropenia,6
MAGNESIUM SULFATE,Pyrexia,6
MAGNESIUM SULFATE,Dehydration,6
MAGNESIUM SULFATE,Cytokine release syndrome,5
MAGNESIUM SULFATE,Diarrhoea,5
MAGNESIUM SULFATE,Rash,4
MAGNESIUM SULFATE,Febrile neutropenia,4
MAGNESIUM SULFATE,Fatigue,4
MAGNESIUM SULFATE,Blood alkaline phosphatase increased,3
MAGNESIUM SULFATE,Neuropathy peripheral,3
MAGNESIUM SULFATE,Immune effector cell-associated neurotoxicity syndrome,3
MAGNESIUM SULFATE,Acute kidney injury,3
MAGNESIUM SULFATE,COVID-19,3
MAGNESIUM SULFATE,Septic shock,2
MAGNESIUM SULFATE,Neurotoxicity,2
MAGNESIUM SULFATE,White blood cell count decreased,2
MAGNESIUM SULFATE,Depression,2
MAGNESIUM SULFATE,Lymphocyte count decreased,2
MAGNESIUM SULFATE,Anaemia,2
MAGNESIUM SULFATE,Anxiety,2
MAGNESIUM SULFATE,Neutrophil count decreased,2
MAGNESIUM SULFATE,Abdominal pain upper,2
MAGNESIUM SULFATE,Cellulitis,2
MAGNESIUM SULFATE,Sepsis,2
MAGNESIUM SULFATE,Skin disorder,2
MAGNESIUM SULFATE,Peripheral swelling,2
MAGNESIUM SULFATE,Deep vein thrombosis,2
MAGNESIUM SULFATE,Arthralgia,2
MAGNESIUM SULFATE,Liver function test abnormal,2
MAGNESIUM SULFATE,Pneumonia,2
MAGNESIUM SULFATE,Constipation,2
MAGNESIUM SULFATE,Urinary tract infection,2
MAGNESIUM SULFATE,Blood bilirubin increased,2
MAGNESIUM SULFATE,Aspartate aminotransferase increased,2
MAGNESIUM SULFATE,Stomatitis,2
MAGNESIUM SULFATE,Mood altered,2
MAGNESIUM SULFATE,Nasal congestion,2
MAGNESIUM SULFATE,Nausea,2
MAGNESIUM SULFATE,Illness,2
MAGNESIUM SULFATE,Asthenia,2
MAGNESIUM SULFATE,Malaise,2
MAGNESIUM SULFATE,Cholelithiasis,2
MAGNESIUM SULFATE,Alanine aminotransferase increased,2
MAGNESIUM SULFATE,Blood creatinine increased,2
MAGNESIUM SULFATE,Blood urea increased,2
MAGNESIUM SULFATE,Drug eruption,2
MAGNESIUM SULFATE,Blood potassium increased,2
MAGNESIUM SULFATE,Feeling cold,2
MAGNESIUM SULFATE,Influenza like illness,2
MAGNESIUM SULFATE,Tremor,2
MAGNESIUM SULFATE,Decreased appetite,2
MAYZENT,Lymphocyte count decreased,23
MAYZENT,White blood cell count decreased,7
MAYZENT,Urinary tract infection,6
MAYZENT,Concomitant disease aggravated,5
MAYZENT,Expanded disability status scale score increased,5
MAYZENT,Lymphopenia,5
MAYZENT,Pyrexia,5
MAYZENT,Fatigue,4
MAYZENT,Multiple sclerosis relapse,4
MAYZENT,Hepatic function abnormal,4
MAYZENT,Product use in unapproved indication,3
MAYZENT,COVID-19,3
MAYZENT,Multiple sclerosis,3
MAYZENT,Malignant melanoma,3
MAYZENT,Hypertension,3
MAYZENT,Muscle spasticity,3
MAYZENT,Peripheral swelling,3
MAYZENT,Drug level increased,2
MAYZENT,Prothrombin time ratio increased,2
MAYZENT,Back pain,2
MAYZENT,Inflammation,2
MAYZENT,Strabismus,2
MAYZENT,Ocular dysmetria,2
MAYZENT,Urge incontinence,2
MAYZENT,Bone neoplasm,2
MAYZENT,Normal newborn,2
MAYZENT,Maternal exposure during pregnancy,2
MAYZENT,Infection,2
MAYZENT,Squamous cell carcinoma,2
MAYZENT,Herpes zoster,2
MAYZENT,Breast cancer,2
MAYZENT,Oedema peripheral,2
MAYZENT,Muscular weakness,2
MAYZENT,Invasive ductal breast carcinoma,2
MAYZENT,Venous angioma of brain,2
MAYZENT,Hallucination,2
MAYZENT,Hypothyroidism,2
MAYZENT,Secondary progressive multiple sclerosis,2
MAYZENT,Renal cyst,2
MAYZENT,Hepatic cyst,2
MAYZENT,Relapsing multiple sclerosis,2
MAYZENT,Liver disorder,2
MAYZENT,Cellulitis,2
MAYZENT,Basal cell carcinoma,2
MAYZENT,Fall,2
MAYZENT,Uhthoff's phenomenon,1
MAYZENT,Suicide attempt,1
MAYZENT,Loss of consciousness,1
MAYZENT,Cardio-respiratory arrest,1
MAYZENT,Treatment failure,1
MEDROL,Paraesthesia,7
MEDROL,Nausea,7
MEDROL,Asthenia,7
MEDROL,Decreased appetite,7
MEDROL,Anxiety,6
MEDROL,Product dose omission issue,6
MEDROL,Dizziness,6
MEDROL,Headache,6
MEDROL,Vertigo,6
MEDROL,Condition aggravated,6
MEDROL,Off label use,5
MEDROL,Weight decreased,5
MEDROL,Nasopharyngitis,5
MEDROL,Diarrhoea,5
MEDROL,Pneumonitis,5
MEDROL,Confusional state,5
MEDROL,Feeling abnormal,5
MEDROL,Pain,4
MEDROL,Sinusitis,4
MEDROL,Oropharyngeal pain,4
MEDROL,Fall,4
MEDROL,Vomiting,4
MEDROL,Alanine aminotransferase increased,4
MEDROL,Death,4
MEDROL,Aspartate aminotransferase increased,4
MEDROL,Muscular weakness,4
MEDROL,Movement disorder,4
MEDROL,Hyperhidrosis,4
MEDROL,Dyspnoea,4
MEDROL,Nervousness,4
MEDROL,Blood pressure increased,4
MEDROL,Infection,3
MEDROL,Arthralgia,3
MEDROL,Product use issue,3
MEDROL,Peripheral swelling,3
MEDROL,COVID-19,3
MEDROL,Cough,3
MEDROL,Fatigue,3
MEDROL,Back pain,3
MEDROL,Rheumatoid arthritis,3
MEDROL,Dry skin,3
MEDROL,Adverse drug reaction,3
MEDROL,Hepatic enzyme increased,3
MEDROL,Pain in extremity,3
MEDROL,Pyrexia,3
MEDROL,Osteoporosis,3
MEDROL,Kaposi's sarcoma,3
MEDROL,Metastasis,3
MEDROL,Paralysis,3
MEDROL,Throat tightness,3
MEKINIST,Pyrexia,17
MEKINIST,Fatigue,6
MEKINIST,Blood creatine phosphokinase increased,6
MEKINIST,Vomiting,6
MEKINIST,Pneumonia,6
MEKINIST,Malignant neoplasm progression,6
MEKINIST,Diarrhoea,5
MEKINIST,Rash,5
MEKINIST,Product use in unapproved indication,5
MEKINIST,Headache,5
MEKINIST,Nausea,4
MEKINIST,Visual impairment,4
MEKINIST,Hypothyroidism,3
MEKINIST,Hyponatraemia,3
MEKINIST,Alanine aminotransferase increased,3
MEKINIST,Aspartate aminotransferase increased,3
MEKINIST,Chills,3
MEKINIST,Cardiac failure,3
MEKINIST,Pleural effusion,3
MEKINIST,Pain,3
MEKINIST,Asthenia,3
MEKINIST,Pain in extremity,3
MEKINIST,Insomnia,3
MEKINIST,Anaemia,3
MEKINIST,Drug intolerance,2
MEKINIST,Skin toxicity,2
MEKINIST,Malaise,2
MEKINIST,Gastrointestinal haemorrhage,2
MEKINIST,Urinary tract infection,2
MEKINIST,Hepatic enzyme increased,2
MEKINIST,Hyperhidrosis,2
MEKINIST,Thrombocytopenia,2
MEKINIST,Lymphocyte count decreased,2
MEKINIST,Dyspnoea,2
MEKINIST,Condition aggravated,2
MEKINIST,Decreased appetite,2
MEKINIST,COVID-19,2
MEKINIST,Acne,2
MEKINIST,Skin lesion,2
MEKINIST,Pruritus,2
MEKINIST,Agitation,2
MEKINIST,Seizure,2
MEKINIST,Erysipelas,2
MEKINIST,Product use issue,2
MEKINIST,Confusional state,2
MEKINIST,Feeding disorder,2
MEKINIST,Pulmonary mass,2
MEKINIST,Abdominal discomfort,2
MEKINIST,Swelling,2
MEKINIST,Dysphonia,2
MEKTOVI,Serous retinal detachment,18
MEKTOVI,Pyrexia,12
MEKTOVI,Nausea,10
MEKTOVI,Off label use,10
MEKTOVI,Fatigue,10
MEKTOVI,Diarrhoea,9
MEKTOVI,Malaise,7
MEKTOVI,Neoplasm progression,7
MEKTOVI,Vomiting,7
MEKTOVI,Rash,6
MEKTOVI,Decreased appetite,5
MEKTOVI,Alanine aminotransferase increased,5
MEKTOVI,Drug-induced liver injury,4
MEKTOVI,Underdose,4
MEKTOVI,Urinary tract infection,4
MEKTOVI,Dermatitis acneiform,4
MEKTOVI,Interstitial lung disease,4
MEKTOVI,Weight decreased,4
MEKTOVI,Palmar-plantar erythrodysaesthesia syndrome,3
MEKTOVI,Rhabdomyolysis,3
MEKTOVI,Blood lactate dehydrogenase increased,3
MEKTOVI,Macular oedema,3
MEKTOVI,Anaemia,3
MEKTOVI,Dyspnoea,3
MEKTOVI,Acute kidney injury,3
MEKTOVI,Renal impairment,3
MEKTOVI,Aspartate aminotransferase increased,3
MEKTOVI,Death,3
MEKTOVI,Pemphigoid,3
MEKTOVI,Enterocolitis,3
MEKTOVI,Serous retinopathy,2
MEKTOVI,Central serous chorioretinopathy,2
MEKTOVI,Asthenia,2
MEKTOVI,Haemophagocytic lymphohistiocytosis,2
MEKTOVI,Pancytopenia,2
MEKTOVI,Detachment of retinal pigment epithelium,2
MEKTOVI,Disseminated intravascular coagulation,2
MEKTOVI,Influenza,2
MEKTOVI,Abdominal wall haematoma,2
MEKTOVI,Haematuria,2
MEKTOVI,Abdominal pain upper,2
MEKTOVI,Subretinal fluid,2
MEKTOVI,Dizziness,2
MEKTOVI,Ileus,2
MEKTOVI,Tumour perforation,2
MEKTOVI,Lower gastrointestinal haemorrhage,2
MEKTOVI,Blood creatinine increased,2
MEKTOVI,Malignant neoplasm progression,2
MEKTOVI,Product use issue,2
MEKTOVI,Peripheral swelling,2
MELATONIN,Fatigue,39
MELATONIN,Off label use,30
MELATONIN,Vomiting,27
MELATONIN,Product dose omission issue,27
MELATONIN,Nausea,25
MELATONIN,COVID-19,20
MELATONIN,Pain,20
MELATONIN,Somnolence,19
MELATONIN,Dyspnoea,18
MELATONIN,Inappropriate schedule of product administration,18
MELATONIN,Fall,18
MELATONIN,Condition aggravated,17
MELATONIN,Diarrhoea,17
MELATONIN,Sepsis,16
MELATONIN,Seizure,16
MELATONIN,Dry mouth,15
MELATONIN,Pyrexia,14
MELATONIN,Decreased appetite,14
MELATONIN,Tremor,14
MELATONIN,Drug ineffective,14
MELATONIN,Stress,13
MELATONIN,Malaise,13
MELATONIN,Headache,13
MELATONIN,Asthenia,13
MELATONIN,Constipation,13
MELATONIN,Cough,12
MELATONIN,Urinary tract infection,12
MELATONIN,Sinusitis,12
MELATONIN,Epilepsy,12
MELATONIN,Product use in unapproved indication,12
MELATONIN,Ascites,12
MELATONIN,Abdominal distension,12
MELATONIN,Confusional state,12
MELATONIN,Nasopharyngitis,11
MELATONIN,Dizziness,11
MELATONIN,Illness,11
MELATONIN,Anaemia,11
MELATONIN,Ear infection,10
MELATONIN,Gait disturbance,10
MELATONIN,Abdominal pain,10
MELATONIN,Death,10
MELATONIN,Multiple organ dysfunction syndrome,10
MELATONIN,Mental disorder,10
MELATONIN,Hallucination,10
MELATONIN,Insomnia,10
MELATONIN,Weight increased,9
MELATONIN,Pneumonia,9
MELATONIN,Suicidal ideation,9
MELATONIN,Arthralgia,9
MELATONIN,Drug hypersensitivity,9
MELOXICAM,Pain,34
MELOXICAM,Fatigue,24
MELOXICAM,Arthralgia,22
MELOXICAM,COVID-19,21
MELOXICAM,Anxiety,20
MELOXICAM,Back pain,17
MELOXICAM,Pain in extremity,17
MELOXICAM,Headache,15
MELOXICAM,Sinusitis,15
MELOXICAM,Pneumonia,15
MELOXICAM,Nausea,15
MELOXICAM,Gait disturbance,15
MELOXICAM,Emotional distress,15
MELOXICAM,Product dose omission issue,14
MELOXICAM,Fall,13
MELOXICAM,Anhedonia,13
MELOXICAM,Asthenia,12
MELOXICAM,Rash,12
MELOXICAM,Drug ineffective,12
MELOXICAM,Malaise,12
MELOXICAM,Nasopharyngitis,11
MELOXICAM,Joint swelling,11
MELOXICAM,Condition aggravated,11
MELOXICAM,Rheumatoid arthritis,10
MELOXICAM,Dyspnoea,10
MELOXICAM,Off label use,10
MELOXICAM,Dizziness,10
MELOXICAM,Peripheral swelling,10
MELOXICAM,Depression,10
MELOXICAM,Infection,10
MELOXICAM,Therapeutic product effect decreased,9
MELOXICAM,Musculoskeletal stiffness,9
MELOXICAM,Diarrhoea,9
MELOXICAM,Pyrexia,9
MELOXICAM,Weight decreased,9
MELOXICAM,Osteopenia,9
MELOXICAM,Urinary tract infection,9
MELOXICAM,Pruritus,8
MELOXICAM,Loss of personal independence in daily activities,8
MELOXICAM,Mobility decreased,8
MELOXICAM,Abdominal pain,8
MELOXICAM,Swelling,8
MELOXICAM,Upper respiratory tract infection,8
MELOXICAM,Bone density decreased,8
MELOXICAM,Drug intolerance,7
MELOXICAM,Bronchitis,7
MELOXICAM,Weight increased,6
MELOXICAM,Injury,6
MELOXICAM,Infusion related reaction,6
MELOXICAM,Discomfort,6
MERCAPTOPURINE,Febrile neutropenia,19
MERCAPTOPURINE,Pyrexia,12
MERCAPTOPURINE,Sepsis,10
MERCAPTOPURINE,Cough,6
MERCAPTOPURINE,Pneumonia fungal,5
MERCAPTOPURINE,Pneumonia,5
MERCAPTOPURINE,Pneumocystis jirovecii pneumonia,5
MERCAPTOPURINE,Acute respiratory distress syndrome,5
MERCAPTOPURINE,Vomiting,5
MERCAPTOPURINE,Pancytopenia,4
MERCAPTOPURINE,Drug hypersensitivity,4
MERCAPTOPURINE,Platelet count decreased,4
MERCAPTOPURINE,Haemoglobin decreased,4
MERCAPTOPURINE,Nausea,4
MERCAPTOPURINE,White blood cell count decreased,4
MERCAPTOPURINE,Diarrhoea,4
MERCAPTOPURINE,Alanine aminotransferase increased,4
MERCAPTOPURINE,Rhinitis,4
MERCAPTOPURINE,Enterocolitis infectious,4
MERCAPTOPURINE,Liver function test abnormal,3
MERCAPTOPURINE,Neutrophil count decreased,3
MERCAPTOPURINE,Tachycardia,3
MERCAPTOPURINE,Parainfluenzae virus infection,3
MERCAPTOPURINE,Myalgia,3
MERCAPTOPURINE,Dehydration,3
MERCAPTOPURINE,Myelosuppression,3
MERCAPTOPURINE,Hyperthermia,2
MERCAPTOPURINE,Respiratory disorder,2
MERCAPTOPURINE,Pleural effusion,2
MERCAPTOPURINE,Seizure,2
MERCAPTOPURINE,Depersonalisation/derealisation disorder,2
MERCAPTOPURINE,Dyskinesia,2
MERCAPTOPURINE,Chest pain,2
MERCAPTOPURINE,Chills,2
MERCAPTOPURINE,Red blood cell count decreased,2
MERCAPTOPURINE,Neutropenia,2
MERCAPTOPURINE,Gastrointestinal wall thickening,2
MERCAPTOPURINE,Hypophagia,2
MERCAPTOPURINE,Rhinorrhoea,2
MERCAPTOPURINE,Haematochezia,2
MERCAPTOPURINE,COVID-19,2
MERCAPTOPURINE,Neuropathy peripheral,2
MERCAPTOPURINE,Influenza,2
MERCAPTOPURINE,Sinus tachycardia,2
MERCAPTOPURINE,Colitis,2
MERCAPTOPURINE,Hypotension,2
MERCAPTOPURINE,Renal impairment,2
MERCAPTOPURINE,Liver injury,2
MERCAPTOPURINE,Off label use,2
MERCAPTOPURINE,Product dose omission issue,2
MEROPENEM,Diarrhoea,27
MEROPENEM,Pyrexia,25
MEROPENEM,Rash,20
MEROPENEM,Anaemia,19
MEROPENEM,Febrile neutropenia,18
MEROPENEM,Off label use,16
MEROPENEM,Fatigue,14
MEROPENEM,Neutropenia,14
MEROPENEM,Neutrophil count decreased,13
MEROPENEM,Pneumonia,13
MEROPENEM,Vascular device infection,12
MEROPENEM,Ejection fraction decreased,12
MEROPENEM,Alopecia,12
MEROPENEM,Sepsis,12
MEROPENEM,Epistaxis,12
MEROPENEM,Gastrooesophageal reflux disease,12
MEROPENEM,Vomiting,12
MEROPENEM,Malaise,12
MEROPENEM,Gingival swelling,11
MEROPENEM,Influenza like illness,11
MEROPENEM,Osteonecrosis of jaw,11
MEROPENEM,Lymphoedema,11
MEROPENEM,Hot flush,11
MEROPENEM,Mucosal inflammation,11
MEROPENEM,Cytokine release syndrome,11
MEROPENEM,Pain,10
MEROPENEM,Chills,9
MEROPENEM,Oliguria,9
MEROPENEM,Pruritus,9
MEROPENEM,Device related infection,9
MEROPENEM,Thrombocytopenia,9
MEROPENEM,Body temperature increased,9
MEROPENEM,Back pain,9
MEROPENEM,Proctalgia,9
MEROPENEM,Accident,9
MEROPENEM,Anal inflammation,9
MEROPENEM,Haemorrhoids,9
MEROPENEM,Crohn's disease,9
MEROPENEM,Drug reaction with eosinophilia and systemic symptoms,8
MEROPENEM,Erythema,8
MEROPENEM,Agranulocytosis,8
MEROPENEM,Oedema,7
MEROPENEM,Eosinophilia,7
MEROPENEM,Condition aggravated,7
MEROPENEM,SARS-CoV-2 test negative,7
MEROPENEM,Skin exfoliation,6
MEROPENEM,Immune effector cell-associated neurotoxicity syndrome,6
MEROPENEM,Death,6
MEROPENEM,Platelet count decreased,5
MEROPENEM,Malignant neoplasm progression,5
MESALAMINE,Colitis ulcerative,29
MESALAMINE,Off label use,28
MESALAMINE,Abdominal pain,24
MESALAMINE,Diarrhoea,23
MESALAMINE,Haematochezia,21
MESALAMINE,Drug ineffective,21
MESALAMINE,Pyrexia,17
MESALAMINE,Headache,16
MESALAMINE,Malaise,16
MESALAMINE,Weight decreased,16
MESALAMINE,COVID-19,15
MESALAMINE,Condition aggravated,14
MESALAMINE,Cough,13
MESALAMINE,Crohn's disease,12
MESALAMINE,Pain,12
MESALAMINE,Fatigue,12
MESALAMINE,Frequent bowel movements,11
MESALAMINE,Weight increased,11
MESALAMINE,Product dose omission issue,10
MESALAMINE,Asthenia,9
MESALAMINE,Dizziness,8
MESALAMINE,Abdominal discomfort,8
MESALAMINE,Influenza,8
MESALAMINE,Nasal congestion,8
MESALAMINE,Rectal haemorrhage,7
MESALAMINE,Nausea,7
MESALAMINE,Constipation,7
MESALAMINE,Abdominal distension,7
MESALAMINE,Inappropriate schedule of product administration,6
MESALAMINE,Arthralgia,6
MESALAMINE,Influenza like illness,6
MESALAMINE,Back pain,6
MESALAMINE,Productive cough,6
MESALAMINE,Anaemia,6
MESALAMINE,Vomiting,5
MESALAMINE,Clostridium difficile infection,5
MESALAMINE,Muscle spasms,5
MESALAMINE,Pregnancy,5
MESALAMINE,Product use issue,5
MESALAMINE,Faeces soft,5
MESALAMINE,Diarrhoea haemorrhagic,5
MESALAMINE,Rhinorrhoea,5
MESALAMINE,Peripheral swelling,5
MESALAMINE,Pruritus,5
MESALAMINE,Discomfort,5
MESALAMINE,Decreased appetite,5
MESALAMINE,Oropharyngeal pain,5
MESALAMINE,Dyspnoea,5
MESALAMINE,Stress,5
MESALAMINE,Drug hypersensitivity,4
MESNA,Pyrexia,16
MESNA,Febrile neutropenia,16
MESNA,Neutropenia,16
MESNA,Diarrhoea,15
MESNA,Vomiting,13
MESNA,Pain,12
MESNA,Proctalgia,11
MESNA,Back pain,11
MESNA,Anal inflammation,11
MESNA,Malaise,11
MESNA,Accident,11
MESNA,Crohn's disease,11
MESNA,Body temperature increased,11
MESNA,Haemorrhoids,11
MESNA,Chills,10
MESNA,SARS-CoV-2 test negative,9
MESNA,Hypokalaemia,6
MESNA,Anaemia,6
MESNA,Stomatitis,5
MESNA,Off label use,5
MESNA,Dysarthria,4
MESNA,Myelosuppression,4
MESNA,Sepsis,4
MESNA,Hypotension,4
MESNA,Thrombocytopenia,4
MESNA,Leukopenia,4
MESNA,Facial paresis,3
MESNA,Facial paralysis,3
MESNA,Hemiparesis,3
MESNA,Insomnia,3
MESNA,Liver injury,3
MESNA,Tachycardia,3
MESNA,Product use in unapproved indication,3
MESNA,Pancytopenia,3
MESNA,General physical health deterioration,3
MESNA,Oral candidiasis,3
MESNA,Urinary tract infection,3
MESNA,Rash,3
MESNA,Fall,3
MESNA,Dehydration,3
MESNA,Osteoarthritis,3
MESNA,Chronic hepatitis B,3
MESNA,Fungal infection,3
MESNA,Spinal fracture,3
MESNA,Pneumonia,2
MESNA,Depersonalisation/derealisation disorder,2
MESNA,Dyskinesia,2
MESNA,Nausea,2
MESNA,Hypocalcaemia,2
MESNA,White blood cell count decreased,2
METAMIZOLE,Headache,10
METAMIZOLE,Nausea,10
METAMIZOLE,Pneumonia,10
METAMIZOLE,Fatigue,9
METAMIZOLE,Arthralgia,9
METAMIZOLE,Off label use,9
METAMIZOLE,Acute kidney injury,9
METAMIZOLE,Vomiting,9
METAMIZOLE,Pleural effusion,8
METAMIZOLE,Fall,8
METAMIZOLE,Constipation,8
METAMIZOLE,COVID-19,8
METAMIZOLE,Neutropenia,7
METAMIZOLE,Anaemia,7
METAMIZOLE,Respiratory failure,7
METAMIZOLE,Muscle spasms,7
METAMIZOLE,Pain in extremity,7
METAMIZOLE,General physical health deterioration,7
METAMIZOLE,Pyrexia,5
METAMIZOLE,Disturbance in attention,5
METAMIZOLE,Back pain,5
METAMIZOLE,Cardiac failure,5
METAMIZOLE,Cholelithiasis,5
METAMIZOLE,Muscular weakness,5
METAMIZOLE,Productive cough,5
METAMIZOLE,Pain,5
METAMIZOLE,Leukopenia,4
METAMIZOLE,Cholecystitis,4
METAMIZOLE,Abdominal pain,4
METAMIZOLE,Asthenia,4
METAMIZOLE,Hypocalcaemia,4
METAMIZOLE,Pruritus,4
METAMIZOLE,Dysphagia,4
METAMIZOLE,Urinary tract infection,4
METAMIZOLE,Sleep apnoea syndrome,4
METAMIZOLE,Muscle spasticity,4
METAMIZOLE,Weight decreased,4
METAMIZOLE,Diarrhoea,4
METAMIZOLE,Burning sensation,4
METAMIZOLE,Pulmonary embolism,4
METAMIZOLE,Aortic arteriosclerosis,4
METAMIZOLE,Hyperventilation,4
METAMIZOLE,Dyspnoea,4
METAMIZOLE,Bone pain,4
METAMIZOLE,Liver function test increased,4
METAMIZOLE,Feeling cold,4
METAMIZOLE,Infection,3
METAMIZOLE,Decreased appetite,3
METAMIZOLE,Hypokalaemia,3
METAMIZOLE,Product dose omission issue,3
METFORMIN,Fatigue,82
METFORMIN,Pain,77
METFORMIN,Off label use,75
METFORMIN,Diarrhoea,71
METFORMIN,Nausea,62
METFORMIN,Asthenia,59
METFORMIN,Acute kidney injury,57
METFORMIN,Headache,57
METFORMIN,Malaise,53
METFORMIN,Arthralgia,53
METFORMIN,Pain in extremity,51
METFORMIN,COVID-19,51
METFORMIN,Anxiety,46
METFORMIN,Dyspnoea,44
METFORMIN,Vomiting,43
METFORMIN,Weight decreased,42
METFORMIN,Hypotension,42
METFORMIN,Chronic kidney disease,42
METFORMIN,Fall,41
METFORMIN,Product dose omission issue,39
METFORMIN,Pneumonia,38
METFORMIN,Emotional distress,38
METFORMIN,Cough,36
METFORMIN,Anhedonia,34
METFORMIN,Pyrexia,33
METFORMIN,Nasopharyngitis,32
METFORMIN,Dizziness,32
METFORMIN,Drug ineffective,32
METFORMIN,Lactic acidosis,32
METFORMIN,Urinary tract infection,31
METFORMIN,Weight increased,29
METFORMIN,Rash,29
METFORMIN,Blood creatinine increased,29
METFORMIN,Pruritus,29
METFORMIN,Condition aggravated,26
METFORMIN,Blood pressure increased,26
METFORMIN,Sinusitis,26
METFORMIN,Blood glucose increased,24
METFORMIN,Back pain,24
METFORMIN,Depression,24
METFORMIN,Joint swelling,24
METFORMIN,Decreased appetite,23
METFORMIN,Hyperkalaemia,23
METFORMIN,Influenza,22
METFORMIN,Illness,22
METFORMIN,Renal failure,22
METFORMIN,Death,22
METFORMIN,Overdose,21
METFORMIN,Arthritis,21
METFORMIN,Palpitations,20
METFORMIN HYDROCHLORIDE,Acute kidney injury,35
METFORMIN HYDROCHLORIDE,Nausea,31
METFORMIN HYDROCHLORIDE,Asthenia,30
METFORMIN HYDROCHLORIDE,Diarrhoea,30
METFORMIN HYDROCHLORIDE,Off label use,27
METFORMIN HYDROCHLORIDE,Fatigue,26
METFORMIN HYDROCHLORIDE,Pneumonia,26
METFORMIN HYDROCHLORIDE,Product dose omission issue,25
METFORMIN HYDROCHLORIDE,COVID-19,24
METFORMIN HYDROCHLORIDE,Sinusitis,24
METFORMIN HYDROCHLORIDE,Malaise,22
METFORMIN HYDROCHLORIDE,Fall,22
METFORMIN HYDROCHLORIDE,Dyspnoea,22
METFORMIN HYDROCHLORIDE,Pain,21
METFORMIN HYDROCHLORIDE,Pyrexia,21
METFORMIN HYDROCHLORIDE,Headache,20
METFORMIN HYDROCHLORIDE,Cough,20
METFORMIN HYDROCHLORIDE,Urinary tract infection,19
METFORMIN HYDROCHLORIDE,Vomiting,19
METFORMIN HYDROCHLORIDE,Pruritus,17
METFORMIN HYDROCHLORIDE,Hypotension,17
METFORMIN HYDROCHLORIDE,Illness,16
METFORMIN HYDROCHLORIDE,Inappropriate schedule of product administration,14
METFORMIN HYDROCHLORIDE,Nasopharyngitis,14
METFORMIN HYDROCHLORIDE,Hyperkalaemia,14
METFORMIN HYDROCHLORIDE,Condition aggravated,14
METFORMIN HYDROCHLORIDE,Back pain,13
METFORMIN HYDROCHLORIDE,Bronchitis,13
METFORMIN HYDROCHLORIDE,Upper respiratory tract infection,13
METFORMIN HYDROCHLORIDE,Lactic acidosis,13
METFORMIN HYDROCHLORIDE,Arthralgia,12
METFORMIN HYDROCHLORIDE,Dizziness,12
METFORMIN HYDROCHLORIDE,Decreased appetite,12
METFORMIN HYDROCHLORIDE,Infusion related reaction,11
METFORMIN HYDROCHLORIDE,Weight decreased,11
METFORMIN HYDROCHLORIDE,Rash,11
METFORMIN HYDROCHLORIDE,Asthma,11
METFORMIN HYDROCHLORIDE,Death,10
METFORMIN HYDROCHLORIDE,Pain in extremity,10
METFORMIN HYDROCHLORIDE,Hypoglycaemia,10
METFORMIN HYDROCHLORIDE,Intentional product use issue,9
METFORMIN HYDROCHLORIDE,Seasonal allergy,9
METFORMIN HYDROCHLORIDE,Chronic kidney disease,9
METFORMIN HYDROCHLORIDE,Chest discomfort,9
METFORMIN HYDROCHLORIDE,Anaemia,9
METFORMIN HYDROCHLORIDE,Blood pressure increased,9
METFORMIN HYDROCHLORIDE,General physical health deterioration,9
METFORMIN HYDROCHLORIDE,Hypoaesthesia,9
METFORMIN HYDROCHLORIDE,Syncope,9
METFORMIN HYDROCHLORIDE,Oedema peripheral,9
METHOCARBAMOL,Pain,15
METHOCARBAMOL,Fall,10
METHOCARBAMOL,Upper respiratory tract infection,10
METHOCARBAMOL,Nausea,10
METHOCARBAMOL,Fatigue,10
METHOCARBAMOL,COVID-19,9
METHOCARBAMOL,Sinusitis,9
METHOCARBAMOL,Headache,8
METHOCARBAMOL,Urinary tract infection,7
METHOCARBAMOL,Product dose omission issue,7
METHOCARBAMOL,Emotional distress,6
METHOCARBAMOL,Acute kidney injury,6
METHOCARBAMOL,Dyspnoea,5
METHOCARBAMOL,Productive cough,5
METHOCARBAMOL,Contusion,5
METHOCARBAMOL,Anxiety,5
METHOCARBAMOL,Anhedonia,5
METHOCARBAMOL,Osteoporosis,5
METHOCARBAMOL,Illness,5
METHOCARBAMOL,Bronchitis,5
METHOCARBAMOL,Infection,5
METHOCARBAMOL,Weight decreased,5
METHOCARBAMOL,Pneumonia,5
METHOCARBAMOL,Vomiting,5
METHOCARBAMOL,Diarrhoea,5
METHOCARBAMOL,Pain in extremity,5
METHOCARBAMOL,Off label use,5
METHOCARBAMOL,Blood pressure increased,5
METHOCARBAMOL,Arthralgia,4
METHOCARBAMOL,Renal failure,4
METHOCARBAMOL,Ear infection,4
METHOCARBAMOL,Malaise,4
METHOCARBAMOL,Abdominal pain,4
METHOCARBAMOL,Back pain,4
METHOCARBAMOL,Bone density decreased,3
METHOCARBAMOL,Migraine,3
METHOCARBAMOL,Anaphylactic reaction,3
METHOCARBAMOL,Sepsis,3
METHOCARBAMOL,Hypersensitivity,3
METHOCARBAMOL,Infusion site swelling,3
METHOCARBAMOL,Seizure,3
METHOCARBAMOL,Procedural pain,3
METHOCARBAMOL,Dehydration,3
METHOCARBAMOL,Abdominal distension,3
METHOCARBAMOL,Nasopharyngitis,3
METHOCARBAMOL,Pyrexia,3
METHOCARBAMOL,Foot fracture,3
METHOCARBAMOL,Gait disturbance,3
METHOCARBAMOL,Muscular weakness,3
METHOCARBAMOL,Asthenia,3
METHOTREXATE,Off label use,135
METHOTREXATE,Drug ineffective,83
METHOTREXATE,Pain,83
METHOTREXATE,Arthralgia,82
METHOTREXATE,COVID-19,78
METHOTREXATE,Fatigue,66
METHOTREXATE,Condition aggravated,60
METHOTREXATE,Headache,57
METHOTREXATE,Malaise,56
METHOTREXATE,Rash,54
METHOTREXATE,Pain in extremity,54
METHOTREXATE,Pyrexia,52
METHOTREXATE,Diarrhoea,51
METHOTREXATE,Nausea,51
METHOTREXATE,Rheumatoid arthritis,45
METHOTREXATE,Dyspnoea,45
METHOTREXATE,Pneumonia,44
METHOTREXATE,Cough,44
METHOTREXATE,Nasopharyngitis,43
METHOTREXATE,Inappropriate schedule of product administration,40
METHOTREXATE,Product dose omission issue,38
METHOTREXATE,Sinusitis,36
METHOTREXATE,Illness,36
METHOTREXATE,Vomiting,35
METHOTREXATE,Intentional product use issue,35
METHOTREXATE,Back pain,35
METHOTREXATE,Peripheral swelling,34
METHOTREXATE,Fall,34
METHOTREXATE,Musculoskeletal stiffness,33
METHOTREXATE,Joint swelling,32
METHOTREXATE,Weight decreased,32
METHOTREXATE,Asthenia,32
METHOTREXATE,Gait disturbance,31
METHOTREXATE,Pruritus,31
METHOTREXATE,Infection,30
METHOTREXATE,Arthritis,30
METHOTREXATE,Weight increased,30
METHOTREXATE,Pancytopenia,30
METHOTREXATE,Drug hypersensitivity,28
METHOTREXATE,Psoriasis,27
METHOTREXATE,Hypertension,25
METHOTREXATE,Abdominal discomfort,25
METHOTREXATE,Dizziness,25
METHOTREXATE,Influenza,24
METHOTREXATE,Arthropathy,24
METHOTREXATE,Psoriatic arthropathy,24
METHOTREXATE,Osteoarthritis,24
METHOTREXATE,Erythema,24
METHOTREXATE,Intentional product misuse,23
METHOTREXATE,Urinary tract infection,23
METHOTREXATE SODIUM,Off label use,67
METHOTREXATE SODIUM,Rash,40
METHOTREXATE SODIUM,Condition aggravated,33
METHOTREXATE SODIUM,Drug ineffective,31
METHOTREXATE SODIUM,Overdose,28
METHOTREXATE SODIUM,Arthropathy,27
METHOTREXATE SODIUM,Pyrexia,26
METHOTREXATE SODIUM,Abdominal discomfort,26
METHOTREXATE SODIUM,Nausea,25
METHOTREXATE SODIUM,Arthralgia,24
METHOTREXATE SODIUM,Dyspnoea,22
METHOTREXATE SODIUM,Knee arthroplasty,22
METHOTREXATE SODIUM,Back pain,22
METHOTREXATE SODIUM,Lower respiratory tract infection,21
METHOTREXATE SODIUM,Vomiting,21
METHOTREXATE SODIUM,Dizziness,20
METHOTREXATE SODIUM,Malaise,20
METHOTREXATE SODIUM,Intentional product misuse,20
METHOTREXATE SODIUM,Diarrhoea,20
METHOTREXATE SODIUM,Pain,20
METHOTREXATE SODIUM,Rheumatoid arthritis,19
METHOTREXATE SODIUM,COVID-19,19
METHOTREXATE SODIUM,Drug hypersensitivity,18
METHOTREXATE SODIUM,Product dose omission issue,18
METHOTREXATE SODIUM,Inflammation,17
METHOTREXATE SODIUM,Liver injury,17
METHOTREXATE SODIUM,Thrombocytopenia,17
METHOTREXATE SODIUM,Pulmonary pain,17
METHOTREXATE SODIUM,Drug abuse,17
METHOTREXATE SODIUM,Pain in extremity,16
METHOTREXATE SODIUM,Headache,16
METHOTREXATE SODIUM,Neutropenia,16
METHOTREXATE SODIUM,Musculoskeletal stiffness,15
METHOTREXATE SODIUM,Pneumonia,15
METHOTREXATE SODIUM,Abdominal pain,15
METHOTREXATE SODIUM,Drug intolerance,14
METHOTREXATE SODIUM,Pruritus,14
METHOTREXATE SODIUM,Cough,14
METHOTREXATE SODIUM,Renal impairment,14
METHOTREXATE SODIUM,Obesity,13
METHOTREXATE SODIUM,Fatigue,13
METHOTREXATE SODIUM,Synovitis,13
METHOTREXATE SODIUM,Febrile neutropenia,13
METHOTREXATE SODIUM,Platelet count decreased,13
METHOTREXATE SODIUM,Joint swelling,12
METHOTREXATE SODIUM,Peripheral swelling,12
METHOTREXATE SODIUM,Therapeutic product effect decreased,12
METHOTREXATE SODIUM,Medication error,12
METHOTREXATE SODIUM,Infection,11
METHOTREXATE SODIUM,Hypertension,11
METHYLCOBALAMIN,Off label use,16
METHYLCOBALAMIN,Pneumonia,10
METHYLCOBALAMIN,Diabetes mellitus,9
METHYLCOBALAMIN,Diarrhoea,8
METHYLCOBALAMIN,Lymphocyte count decreased,7
METHYLCOBALAMIN,Platelet count decreased,7
METHYLCOBALAMIN,Hepatic function abnormal,6
METHYLCOBALAMIN,White blood cell count decreased,6
METHYLCOBALAMIN,Nausea,6
METHYLCOBALAMIN,Dehydration,5
METHYLCOBALAMIN,Headache,5
METHYLCOBALAMIN,Anaemia,5
METHYLCOBALAMIN,Decreased appetite,5
METHYLCOBALAMIN,Constipation,4
METHYLCOBALAMIN,Cerebral infarction,4
METHYLCOBALAMIN,Concomitant disease aggravated,4
METHYLCOBALAMIN,Hypokalaemia,4
METHYLCOBALAMIN,COVID-19,4
METHYLCOBALAMIN,Vomiting,4
METHYLCOBALAMIN,Adrenal insufficiency,4
METHYLCOBALAMIN,Hypopituitarism,3
METHYLCOBALAMIN,Insomnia,3
METHYLCOBALAMIN,C-reactive protein increased,3
METHYLCOBALAMIN,Meningitis,3
METHYLCOBALAMIN,Hyperglycaemia,3
METHYLCOBALAMIN,Myelosuppression,3
METHYLCOBALAMIN,Atrial fibrillation,3
METHYLCOBALAMIN,Acute kidney injury,3
METHYLCOBALAMIN,Hypertension,3
METHYLCOBALAMIN,Neutrophil count decreased,3
METHYLCOBALAMIN,Secondary adrenocortical insufficiency,2
METHYLCOBALAMIN,Immune-mediated hypophysitis,2
METHYLCOBALAMIN,Immune-mediated enterocolitis,2
METHYLCOBALAMIN,Thyroiditis,2
METHYLCOBALAMIN,Depression,2
METHYLCOBALAMIN,Muscular weakness,2
METHYLCOBALAMIN,Weight increased,2
METHYLCOBALAMIN,Cardiac failure chronic,2
METHYLCOBALAMIN,Neutrophil percentage increased,2
METHYLCOBALAMIN,Disease progression,2
METHYLCOBALAMIN,Monocyte percentage decreased,2
METHYLCOBALAMIN,Lymphocyte percentage decreased,2
METHYLCOBALAMIN,Red blood cell count increased,2
METHYLCOBALAMIN,Low cardiac output syndrome,2
METHYLCOBALAMIN,Hypotension,2
METHYLCOBALAMIN,Loss of consciousness,2
METHYLCOBALAMIN,Cardio-respiratory arrest,2
METHYLCOBALAMIN,Neuropathy peripheral,2
METHYLCOBALAMIN,Blood glucose abnormal,2
METHYLCOBALAMIN,Abdominal pain upper,2
METHYLPREDNISOLONE,Off label use,89
METHYLPREDNISOLONE,Pyrexia,41
METHYLPREDNISOLONE,Fatigue,33
METHYLPREDNISOLONE,Pain,31
METHYLPREDNISOLONE,Malaise,26
METHYLPREDNISOLONE,COVID-19,26
METHYLPREDNISOLONE,Headache,24
METHYLPREDNISOLONE,Anxiety,24
METHYLPREDNISOLONE,Condition aggravated,24
METHYLPREDNISOLONE,Asthenia,23
METHYLPREDNISOLONE,Arthralgia,22
METHYLPREDNISOLONE,Product use issue,22
METHYLPREDNISOLONE,Diarrhoea,22
METHYLPREDNISOLONE,Pneumonia,22
METHYLPREDNISOLONE,Inappropriate schedule of product administration,22
METHYLPREDNISOLONE,Intentional product use issue,21
METHYLPREDNISOLONE,Fall,20
METHYLPREDNISOLONE,Dyspnoea,19
METHYLPREDNISOLONE,Blood pressure increased,18
METHYLPREDNISOLONE,Acute kidney injury,18
METHYLPREDNISOLONE,Hypertension,17
METHYLPREDNISOLONE,Cough,17
METHYLPREDNISOLONE,Nausea,17
METHYLPREDNISOLONE,Anaemia,17
METHYLPREDNISOLONE,Vomiting,14
METHYLPREDNISOLONE,Rash,14
METHYLPREDNISOLONE,Dizziness,14
METHYLPREDNISOLONE,Emotional distress,14
METHYLPREDNISOLONE,Anhedonia,14
METHYLPREDNISOLONE,Urinary tract infection,14
METHYLPREDNISOLONE,Nasopharyngitis,13
METHYLPREDNISOLONE,Pleural effusion,13
METHYLPREDNISOLONE,Pruritus,12
METHYLPREDNISOLONE,C-reactive protein increased,12
METHYLPREDNISOLONE,Abdominal pain,12
METHYLPREDNISOLONE,Renal impairment,12
METHYLPREDNISOLONE,Pain in extremity,12
METHYLPREDNISOLONE,Blood pressure fluctuation,12
METHYLPREDNISOLONE,Thrombocytopenia,12
METHYLPREDNISOLONE,Hepatic cytolysis,12
METHYLPREDNISOLONE,Infection,11
METHYLPREDNISOLONE,Depression,11
METHYLPREDNISOLONE,Osteoporosis,11
METHYLPREDNISOLONE,Ascites,11
METHYLPREDNISOLONE,Gait disturbance,11
METHYLPREDNISOLONE,Chronic kidney disease,11
METHYLPREDNISOLONE,Drug ineffective,10
METHYLPREDNISOLONE,Blood pressure systolic increased,10
METHYLPREDNISOLONE,Cytokine release syndrome,10
METHYLPREDNISOLONE,Product dose omission issue,10
METOCLOPRAMIDE,Vomiting,49
METOCLOPRAMIDE,Nausea,48
METOCLOPRAMIDE,Fatigue,38
METOCLOPRAMIDE,Death,32
METOCLOPRAMIDE,Diarrhoea,30
METOCLOPRAMIDE,Anaemia,28
METOCLOPRAMIDE,Off label use,26
METOCLOPRAMIDE,Decreased appetite,25
METOCLOPRAMIDE,Dyspnoea,23
METOCLOPRAMIDE,Constipation,23
METOCLOPRAMIDE,Pyrexia,20
METOCLOPRAMIDE,Mucosal inflammation,15
METOCLOPRAMIDE,Depression,15
METOCLOPRAMIDE,Dehydration,15
METOCLOPRAMIDE,Confusional state,14
METOCLOPRAMIDE,Product use in unapproved indication,14
METOCLOPRAMIDE,Pain,13
METOCLOPRAMIDE,Headache,13
METOCLOPRAMIDE,Neutropenic sepsis,13
METOCLOPRAMIDE,Pneumonia,13
METOCLOPRAMIDE,Weight decreased,11
METOCLOPRAMIDE,Condition aggravated,11
METOCLOPRAMIDE,Dysphagia,11
METOCLOPRAMIDE,Abdominal pain,11
METOCLOPRAMIDE,Thrombocytopenia,11
METOCLOPRAMIDE,Hypokalaemia,11
METOCLOPRAMIDE,Neutrophil count decreased,11
METOCLOPRAMIDE,Febrile neutropenia,11
METOCLOPRAMIDE,Asthenia,10
METOCLOPRAMIDE,Emotional distress,10
METOCLOPRAMIDE,Abdominal pain upper,10
METOCLOPRAMIDE,White blood cell count decreased,10
METOCLOPRAMIDE,Malaise,10
METOCLOPRAMIDE,Mouth ulceration,10
METOCLOPRAMIDE,Neuropathy peripheral,9
METOCLOPRAMIDE,Neutropenia,9
METOCLOPRAMIDE,Dizziness,9
METOCLOPRAMIDE,Haemoglobin decreased,9
METOCLOPRAMIDE,Balance disorder,9
METOCLOPRAMIDE,COVID-19,9
METOCLOPRAMIDE,General physical health deterioration,9
METOCLOPRAMIDE,Tachycardia,9
METOCLOPRAMIDE,Hyperglycaemia,9
METOCLOPRAMIDE,Hypotension,9
METOCLOPRAMIDE,Disease progression,8
METOCLOPRAMIDE,Malignant neoplasm progression,8
METOCLOPRAMIDE,Productive cough,8
METOCLOPRAMIDE,Hypoxia,7
METOCLOPRAMIDE,Cough,7
METOCLOPRAMIDE,Rash,7
METOPROLOL,Off label use,65
METOPROLOL,Diarrhoea,58
METOPROLOL,Pain,57
METOPROLOL,Fatigue,55
METOPROLOL,Dyspnoea,48
METOPROLOL,Headache,41
METOPROLOL,COVID-19,40
METOPROLOL,Product dose omission issue,38
METOPROLOL,Anxiety,35
METOPROLOL,Weight decreased,34
METOPROLOL,Nausea,34
METOPROLOL,Asthenia,33
METOPROLOL,Malaise,32
METOPROLOL,Dizziness,32
METOPROLOL,Fall,32
METOPROLOL,Arthralgia,29
METOPROLOL,Emotional distress,28
METOPROLOL,Drug ineffective,27
METOPROLOL,Cough,26
METOPROLOL,Urinary tract infection,25
METOPROLOL,Anhedonia,25
METOPROLOL,Atrial fibrillation,25
METOPROLOL,Anaemia,24
METOPROLOL,Pain in extremity,23
METOPROLOL,Pneumonia,23
METOPROLOL,Chronic kidney disease,23
METOPROLOL,Feeling abnormal,22
METOPROLOL,Gait disturbance,22
METOPROLOL,Condition aggravated,22
METOPROLOL,Depression,21
METOPROLOL,Nasopharyngitis,21
METOPROLOL,Weight increased,21
METOPROLOL,Death,20
METOPROLOL,Peripheral swelling,20
METOPROLOL,Vomiting,19
METOPROLOL,Pyrexia,17
METOPROLOL,Inappropriate schedule of product administration,17
METOPROLOL,Blood pressure increased,16
METOPROLOL,Pruritus,16
METOPROLOL,Hypotension,16
METOPROLOL,Chest pain,16
METOPROLOL,Hypertension,15
METOPROLOL,Abdominal pain upper,15
METOPROLOL,Abdominal discomfort,15
METOPROLOL,Memory impairment,14
METOPROLOL,Osteoporosis,14
METOPROLOL,Swelling,14
METOPROLOL,Decreased appetite,13
METOPROLOL,Influenza,13
METOPROLOL,Sinusitis,13
METOPROLOL SUCCINATE,Fatigue,33
METOPROLOL SUCCINATE,Diarrhoea,28
METOPROLOL SUCCINATE,Dizziness,25
METOPROLOL SUCCINATE,Nausea,25
METOPROLOL SUCCINATE,COVID-19,25
METOPROLOL SUCCINATE,Dyspnoea,25
METOPROLOL SUCCINATE,Pruritus,24
METOPROLOL SUCCINATE,Pain,23
METOPROLOL SUCCINATE,Headache,22
METOPROLOL SUCCINATE,Product dose omission issue,20
METOPROLOL SUCCINATE,Off label use,20
METOPROLOL SUCCINATE,Pneumonia,19
METOPROLOL SUCCINATE,Urinary tract infection,17
METOPROLOL SUCCINATE,Weight decreased,17
METOPROLOL SUCCINATE,Atrial fibrillation,17
METOPROLOL SUCCINATE,Cough,17
METOPROLOL SUCCINATE,Chest pain,15
METOPROLOL SUCCINATE,Pain in extremity,14
METOPROLOL SUCCINATE,Fall,13
METOPROLOL SUCCINATE,Cardiac failure,13
METOPROLOL SUCCINATE,Malaise,13
METOPROLOL SUCCINATE,Inappropriate schedule of product administration,13
METOPROLOL SUCCINATE,Product use in unapproved indication,13
METOPROLOL SUCCINATE,Sinusitis,13
METOPROLOL SUCCINATE,Hypotension,13
METOPROLOL SUCCINATE,Illness,13
METOPROLOL SUCCINATE,Asthenia,12
METOPROLOL SUCCINATE,Chest discomfort,12
METOPROLOL SUCCINATE,Palpitations,12
METOPROLOL SUCCINATE,Rash,12
METOPROLOL SUCCINATE,Vomiting,12
METOPROLOL SUCCINATE,Nasopharyngitis,12
METOPROLOL SUCCINATE,Condition aggravated,11
METOPROLOL SUCCINATE,Pyrexia,11
METOPROLOL SUCCINATE,Drug ineffective,11
METOPROLOL SUCCINATE,Abdominal pain,10
METOPROLOL SUCCINATE,Back pain,10
METOPROLOL SUCCINATE,Arthralgia,9
METOPROLOL SUCCINATE,Somnolence,8
METOPROLOL SUCCINATE,Hypoaesthesia,8
METOPROLOL SUCCINATE,Chills,8
METOPROLOL SUCCINATE,Decreased appetite,8
METOPROLOL SUCCINATE,Bronchitis,8
METOPROLOL SUCCINATE,Gait disturbance,8
METOPROLOL SUCCINATE,Erythema,8
METOPROLOL SUCCINATE,Weight increased,8
METOPROLOL SUCCINATE,Peripheral swelling,8
METOPROLOL SUCCINATE,Anaemia,8
METOPROLOL SUCCINATE,Epistaxis,7
METOPROLOL SUCCINATE,Product use issue,7
METOPROLOL TARTRATE,Diarrhoea,21
METOPROLOL TARTRATE,COVID-19,20
METOPROLOL TARTRATE,Fatigue,20
METOPROLOL TARTRATE,Off label use,19
METOPROLOL TARTRATE,Pain,18
METOPROLOL TARTRATE,Dyspnoea,16
METOPROLOL TARTRATE,Product dose omission issue,16
METOPROLOL TARTRATE,Weight decreased,16
METOPROLOL TARTRATE,Rash,16
METOPROLOL TARTRATE,Nausea,15
METOPROLOL TARTRATE,Product use issue,14
METOPROLOL TARTRATE,Headache,14
METOPROLOL TARTRATE,Urinary tract infection,14
METOPROLOL TARTRATE,Arthralgia,13
METOPROLOL TARTRATE,Pruritus,12
METOPROLOL TARTRATE,Malaise,12
METOPROLOL TARTRATE,Atrial fibrillation,11
METOPROLOL TARTRATE,Drug ineffective,11
METOPROLOL TARTRATE,Asthenia,10
METOPROLOL TARTRATE,Drug hypersensitivity,9
METOPROLOL TARTRATE,Illness,9
METOPROLOL TARTRATE,Cerebrovascular accident,9
METOPROLOL TARTRATE,Upper respiratory tract infection,9
METOPROLOL TARTRATE,Abdominal pain upper,9
METOPROLOL TARTRATE,Cough,9
METOPROLOL TARTRATE,Condition aggravated,8
METOPROLOL TARTRATE,Sinusitis,8
METOPROLOL TARTRATE,Pneumonia,8
METOPROLOL TARTRATE,Alopecia,8
METOPROLOL TARTRATE,Pyrexia,7
METOPROLOL TARTRATE,Decreased appetite,7
METOPROLOL TARTRATE,Chest pain,7
METOPROLOL TARTRATE,Anaemia,7
METOPROLOL TARTRATE,Back pain,7
METOPROLOL TARTRATE,Abdominal discomfort,7
METOPROLOL TARTRATE,Feeling abnormal,6
METOPROLOL TARTRATE,Dizziness,6
METOPROLOL TARTRATE,Anxiety,6
METOPROLOL TARTRATE,Inappropriate schedule of product administration,6
METOPROLOL TARTRATE,Insurance issue,6
METOPROLOL TARTRATE,Cardiac failure,6
METOPROLOL TARTRATE,Blood pressure increased,6
METOPROLOL TARTRATE,Neuropathy peripheral,6
METOPROLOL TARTRATE,Fall,6
METOPROLOL TARTRATE,Weight increased,5
METOPROLOL TARTRATE,Peripheral swelling,5
METOPROLOL TARTRATE,Migraine,5
METOPROLOL TARTRATE,Renal impairment,5
METOPROLOL TARTRATE,Sepsis,5
METOPROLOL TARTRATE,Bronchitis,5
METRONIDAZOLE,Nausea,29
METRONIDAZOLE,Dyspnoea,20
METRONIDAZOLE,Pain,19
METRONIDAZOLE,Anxiety,18
METRONIDAZOLE,Fatigue,16
METRONIDAZOLE,Vomiting,16
METRONIDAZOLE,Off label use,16
METRONIDAZOLE,Headache,15
METRONIDAZOLE,Abdominal pain,15
METRONIDAZOLE,Dizziness,14
METRONIDAZOLE,Diarrhoea,14
METRONIDAZOLE,Sepsis,14
METRONIDAZOLE,Multiple organ dysfunction syndrome,13
METRONIDAZOLE,Depression,12
METRONIDAZOLE,COVID-19,12
METRONIDAZOLE,Drug hypersensitivity,11
METRONIDAZOLE,Malaise,11
METRONIDAZOLE,Weight decreased,11
METRONIDAZOLE,Condition aggravated,11
METRONIDAZOLE,Abdominal distension,11
METRONIDAZOLE,Pain in extremity,10
METRONIDAZOLE,Infection,10
METRONIDAZOLE,Drug intolerance,10
METRONIDAZOLE,Death,10
METRONIDAZOLE,Emotional distress,10
METRONIDAZOLE,Ascites,10
METRONIDAZOLE,Abdominal pain upper,9
METRONIDAZOLE,Tremor,9
METRONIDAZOLE,Anhedonia,9
METRONIDAZOLE,Urinary tract infection,9
METRONIDAZOLE,Hyponatraemia,9
METRONIDAZOLE,Stress,9
METRONIDAZOLE,Cardiogenic shock,9
METRONIDAZOLE,Incorrect route of product administration,9
METRONIDAZOLE,Dry mouth,9
METRONIDAZOLE,Constipation,9
METRONIDAZOLE,Somnolence,9
METRONIDAZOLE,Stevens-Johnson syndrome,9
METRONIDAZOLE,Arthralgia,8
METRONIDAZOLE,Rash,8
METRONIDAZOLE,Insomnia,8
METRONIDAZOLE,Asthenia,8
METRONIDAZOLE,Pyrexia,8
METRONIDAZOLE,Inappropriate schedule of product administration,8
METRONIDAZOLE,Swelling,8
METRONIDAZOLE,Anaemia,8
METRONIDAZOLE,Drug ineffective,7
METRONIDAZOLE,General physical health deterioration,7
METRONIDAZOLE,Renal disorder,7
METRONIDAZOLE,Pneumonia,7
MIDAZOLAM,Off label use,6
MIDAZOLAM,Lactic acidosis,6
MIDAZOLAM,Thrombocytopenia,5
MIDAZOLAM,Pyrexia,5
MIDAZOLAM,Multiple organ dysfunction syndrome,5
MIDAZOLAM,Hypotension,4
MIDAZOLAM,Cardiac arrest,4
MIDAZOLAM,Hyponatraemia,4
MIDAZOLAM,Pulmonary oedema,4
MIDAZOLAM,Platelet count decreased,4
MIDAZOLAM,Renal failure,4
MIDAZOLAM,Abdominal pain,4
MIDAZOLAM,Diarrhoea,4
MIDAZOLAM,Liver disorder,3
MIDAZOLAM,Drug interaction,3
MIDAZOLAM,Dizziness,3
MIDAZOLAM,Withdrawal syndrome,3
MIDAZOLAM,Laryngeal obstruction,3
MIDAZOLAM,Aspartate aminotransferase increased,3
MIDAZOLAM,Septic shock,3
MIDAZOLAM,Acute hepatic failure,3
MIDAZOLAM,Dyspnoea,3
MIDAZOLAM,Chest pain,3
MIDAZOLAM,Sudden death,3
MIDAZOLAM,Respiratory depression,3
MIDAZOLAM,Suicidal ideation,3
MIDAZOLAM,Anaphylactic shock,3
MIDAZOLAM,Abdominal pain upper,3
MIDAZOLAM,Posterior reversible encephalopathy syndrome,3
MIDAZOLAM,Renal impairment,3
MIDAZOLAM,Hepatitis acute,3
MIDAZOLAM,Pseudomonas infection,3
MIDAZOLAM,Pneumonia,3
MIDAZOLAM,Malignant neoplasm progression,2
MIDAZOLAM,Seizure,2
MIDAZOLAM,Gait inability,2
MIDAZOLAM,Vomiting,2
MIDAZOLAM,Malaise,2
MIDAZOLAM,Haemorrhage,2
MIDAZOLAM,Arterial injury,2
MIDAZOLAM,Oxygen saturation decreased,2
MIDAZOLAM,Bacteraemia,2
MIDAZOLAM,Cardiac failure,2
MIDAZOLAM,Hyperpyrexia,2
MIDAZOLAM,Intestinal ischaemia,2
MIDAZOLAM,Sepsis,2
MIDAZOLAM,Erythema,2
MIDAZOLAM,Alanine aminotransferase increased,2
MIDAZOLAM,Haematemesis,2
MIDAZOLAM,Labile blood pressure,2
MINERALS\VITAMINS,COVID-19,19
MINERALS\VITAMINS,Nausea,19
MINERALS\VITAMINS,Diarrhoea,16
MINERALS\VITAMINS,Pain,14
MINERALS\VITAMINS,Fatigue,14
MINERALS\VITAMINS,Weight decreased,13
MINERALS\VITAMINS,Off label use,13
MINERALS\VITAMINS,Maternal exposure during pregnancy,11
MINERALS\VITAMINS,Product dose omission issue,11
MINERALS\VITAMINS,Sinusitis,9
MINERALS\VITAMINS,Illness,9
MINERALS\VITAMINS,Nasopharyngitis,9
MINERALS\VITAMINS,Dyspnoea,9
MINERALS\VITAMINS,Back pain,9
MINERALS\VITAMINS,Pain in extremity,9
MINERALS\VITAMINS,Vomiting,8
MINERALS\VITAMINS,Fall,8
MINERALS\VITAMINS,Pneumonia,8
MINERALS\VITAMINS,Arthralgia,8
MINERALS\VITAMINS,Malaise,8
MINERALS\VITAMINS,Asthenia,8
MINERALS\VITAMINS,Drug ineffective,7
MINERALS\VITAMINS,Urinary tract infection,7
MINERALS\VITAMINS,Condition aggravated,7
MINERALS\VITAMINS,Dizziness,7
MINERALS\VITAMINS,Constipation,7
MINERALS\VITAMINS,Death,7
MINERALS\VITAMINS,Pruritus,7
MINERALS\VITAMINS,Dry skin,7
MINERALS\VITAMINS,Infusion site pain,6
MINERALS\VITAMINS,Upper respiratory tract infection,6
MINERALS\VITAMINS,Localised infection,6
MINERALS\VITAMINS,Maternal exposure before pregnancy,6
MINERALS\VITAMINS,Decreased appetite,6
MINERALS\VITAMINS,Anxiety,5
MINERALS\VITAMINS,Dry mouth,5
MINERALS\VITAMINS,Headache,5
MINERALS\VITAMINS,Memory impairment,5
MINERALS\VITAMINS,Skin exfoliation,5
MINERALS\VITAMINS,Stress,4
MINERALS\VITAMINS,Gait disturbance,4
MINERALS\VITAMINS,Blood cholesterol increased,4
MINERALS\VITAMINS,Rash,4
MINERALS\VITAMINS,Diverticulitis,4
MINERALS\VITAMINS,Epistaxis,4
MINERALS\VITAMINS,Viral infection,4
MINERALS\VITAMINS,Limb injury,4
MINERALS\VITAMINS,Muscle spasms,4
MINERALS\VITAMINS,Weight increased,4
MINERALS\VITAMINS,Inappropriate schedule of product administration,4
MINOXIDIL,Inappropriate schedule of product administration,36
MINOXIDIL,Application site pain,29
MINOXIDIL,Incorrect dose administered,24
MINOXIDIL,Application site pruritus,21
MINOXIDIL,Application site erythema,15
MINOXIDIL,Application site exfoliation,15
MINOXIDIL,Wrong technique in product usage process,14
MINOXIDIL,Product administered at inappropriate site,12
MINOXIDIL,Condition aggravated,11
MINOXIDIL,Drug ineffective,11
MINOXIDIL,Application site irritation,10
MINOXIDIL,Application site rash,8
MINOXIDIL,Application site dryness,8
MINOXIDIL,Application site papules,8
MINOXIDIL,Accidental exposure to product,8
MINOXIDIL,Rash,8
MINOXIDIL,Hypersensitivity,7
MINOXIDIL,Application site scab,7
MINOXIDIL,Alopecia,6
MINOXIDIL,Application site vesicles,6
MINOXIDIL,Underdose,6
MINOXIDIL,Erythema,6
MINOXIDIL,Skin exfoliation,6
MINOXIDIL,Pruritus,6
MINOXIDIL,Hair texture abnormal,5
MINOXIDIL,Erectile dysfunction,4
MINOXIDIL,Hyperhidrosis,4
MINOXIDIL,Application site haemorrhage,4
MINOXIDIL,Application site ulcer,4
MINOXIDIL,Papule,4
MINOXIDIL,Off label use,4
MINOXIDIL,Swelling face,4
MINOXIDIL,Photosensitivity reaction,3
MINOXIDIL,Non-24-hour sleep-wake disorder,3
MINOXIDIL,Disturbance in attention,3
MINOXIDIL,Fatigue,3
MINOXIDIL,Anxiety,3
MINOXIDIL,Penile size reduced,3
MINOXIDIL,Epididymitis,3
MINOXIDIL,Cognitive disorder,3
MINOXIDIL,Idiopathic environmental intolerance,3
MINOXIDIL,Arthralgia,3
MINOXIDIL,Insomnia,3
MINOXIDIL,Autonomic nervous system imbalance,3
MINOXIDIL,Testicular pain,3
MINOXIDIL,Myalgia,3
MINOXIDIL,Loss of libido,3
MINOXIDIL,Dizziness postural,3
MINOXIDIL,Muscular dystrophy,3
MINOXIDIL,Weight abnormal,3
MIRALAX,COVID-19,20
MIRALAX,Fatigue,15
MIRALAX,Diarrhoea,14
MIRALAX,Headache,14
MIRALAX,Dyspnoea,14
MIRALAX,Asthenia,13
MIRALAX,Pain,12
MIRALAX,Product dose omission issue,12
MIRALAX,Fall,12
MIRALAX,Constipation,12
MIRALAX,Pyrexia,11
MIRALAX,Off label use,10
MIRALAX,Nausea,10
MIRALAX,Pneumonia,10
MIRALAX,Urinary tract infection,10
MIRALAX,Back pain,9
MIRALAX,Dizziness,7
MIRALAX,Emotional distress,7
MIRALAX,Seizure,7
MIRALAX,Arthralgia,7
MIRALAX,Death,7
MIRALAX,Infection,7
MIRALAX,Weight decreased,6
MIRALAX,Vomiting,6
MIRALAX,Insomnia,6
MIRALAX,Chest pain,6
MIRALAX,Decreased appetite,6
MIRALAX,Drug ineffective,5
MIRALAX,Pain in extremity,5
MIRALAX,Head injury,5
MIRALAX,Skin laceration,5
MIRALAX,Weight increased,5
MIRALAX,Anxiety,5
MIRALAX,Upper respiratory tract infection,5
MIRALAX,Acute respiratory failure,5
MIRALAX,Sinusitis,5
MIRALAX,Oedema,5
MIRALAX,Septic shock,5
MIRALAX,Cough,5
MIRALAX,Inappropriate schedule of product administration,4
MIRALAX,Road traffic accident,4
MIRALAX,Malaise,4
MIRALAX,Confusional state,4
MIRALAX,Gait disturbance,4
MIRALAX,Condition aggravated,4
MIRALAX,Cerebrovascular accident,4
MIRALAX,Anhedonia,4
MIRALAX,Chronic kidney disease,4
MIRALAX,Sepsis,4
MIRALAX,Infusion site pain,4
MIRCERA,Drug hypersensitivity,108
MIRCERA,Dyspnoea,32
MIRCERA,Nausea,24
MIRCERA,Flushing,19
MIRCERA,Feeling hot,19
MIRCERA,Pruritus,18
MIRCERA,Vomiting,18
MIRCERA,Unresponsive to stimuli,15
MIRCERA,Erythema,15
MIRCERA,Hypotension,12
MIRCERA,Dizziness,11
MIRCERA,Chest pain,10
MIRCERA,Back pain,9
MIRCERA,Hyperhidrosis,9
MIRCERA,Malaise,9
MIRCERA,Blood pressure increased,8
MIRCERA,Urticaria,8
MIRCERA,Blood pressure decreased,7
MIRCERA,Loss of consciousness,6
MIRCERA,Feeling abnormal,6
MIRCERA,Headache,5
MIRCERA,Fatigue,4
MIRCERA,Rash,4
MIRCERA,Pain,4
MIRCERA,Hypertension,4
MIRCERA,Haemoglobin decreased,4
MIRCERA,Abdominal pain,4
MIRCERA,Heart rate increased,4
MIRCERA,Tachycardia,4
MIRCERA,Hypersensitivity,4
MIRCERA,Diarrhoea,3
MIRCERA,Cardiac arrest,3
MIRCERA,Seizure,3
MIRCERA,Renal disorder,3
MIRCERA,Blood pressure abnormal,3
MIRCERA,COVID-19,3
MIRCERA,Off label use,3
MIRCERA,Cerebrovascular accident,3
MIRCERA,Haematocrit decreased,2
MIRCERA,Paraesthesia,2
MIRCERA,Syncope,2
MIRCERA,Respiratory distress,2
MIRCERA,Hyperventilation,2
MIRCERA,Dysphonia,2
MIRCERA,Confusional state,2
MIRCERA,Fall,2
MIRCERA,Mental status changes,2
MIRCERA,Cough,2
MIRCERA,Pulse absent,2
MIRCERA,Anaphylactic reaction,2
MIRENA,Embedded device,10
MIRENA,Headache,9
MIRENA,Fatigue,7
MIRENA,Product dose omission issue,7
MIRENA,Weight increased,7
MIRENA,Uterine perforation,7
MIRENA,Complication of device insertion,6
MIRENA,Depression,6
MIRENA,Ovarian cyst,5
MIRENA,Device dislocation,5
MIRENA,Device expulsion,5
MIRENA,Heavy menstrual bleeding,4
MIRENA,Device difficult to use,4
MIRENA,Abdominal pain lower,4
MIRENA,Malaise,3
MIRENA,COVID-19,3
MIRENA,Pregnancy with contraceptive device,3
MIRENA,Abdominal distension,3
MIRENA,Pyrexia,3
MIRENA,Nausea,3
MIRENA,Stress,3
MIRENA,Depressed mood,3
MIRENA,Anxiety,3
MIRENA,Device use issue,3
MIRENA,Pelvic pain,3
MIRENA,Drug ineffective,3
MIRENA,Suicidal ideation,3
MIRENA,Back pain,3
MIRENA,Insurance issue,2
MIRENA,Pneumonia,2
MIRENA,Alopecia,2
MIRENA,Pleurisy,2
MIRENA,Chills,2
MIRENA,Dyspnoea,2
MIRENA,Influenza,2
MIRENA,Laryngitis,2
MIRENA,Respiratory tract infection,2
MIRENA,Cough,2
MIRENA,Gastrooesophageal reflux disease,2
MIRENA,Neuropathy peripheral,2
MIRENA,Gestational diabetes,2
MIRENA,Gastroenteritis viral,2
MIRENA,Mental disorder,2
MIRENA,Intermenstrual bleeding,2
MIRENA,Insomnia,2
MIRENA,Cognitive disorder,2
MIRENA,Illness,2
MIRENA,Amenorrhoea,2
MIRENA,Genital haemorrhage,2
MIRENA,Vaginal haemorrhage,2
MIRTAZAPINE,Fatigue,48
MIRTAZAPINE,Diarrhoea,43
MIRTAZAPINE,Vomiting,39
MIRTAZAPINE,Asthenia,36
MIRTAZAPINE,Nausea,35
MIRTAZAPINE,Anxiety,33
MIRTAZAPINE,Off label use,30
MIRTAZAPINE,Dyspnoea,29
MIRTAZAPINE,Arthralgia,27
MIRTAZAPINE,Depression,26
MIRTAZAPINE,Seizure,25
MIRTAZAPINE,Decreased appetite,25
MIRTAZAPINE,Muscle spasms,25
MIRTAZAPINE,Somnolence,24
MIRTAZAPINE,Confusional state,24
MIRTAZAPINE,Pain,23
MIRTAZAPINE,Dizziness,23
MIRTAZAPINE,Coma,23
MIRTAZAPINE,Suicidal ideation,22
MIRTAZAPINE,Headache,22
MIRTAZAPINE,Psychotic disorder,21
MIRTAZAPINE,Drug interaction,21
MIRTAZAPINE,Toxicity to various agents,21
MIRTAZAPINE,COVID-19,20
MIRTAZAPINE,Schizophrenia,20
MIRTAZAPINE,Drug ineffective,19
MIRTAZAPINE,Tachycardia,18
MIRTAZAPINE,Tinnitus,18
MIRTAZAPINE,Pyrexia,18
MIRTAZAPINE,Gait disturbance,17
MIRTAZAPINE,Pruritus,17
MIRTAZAPINE,Serotonin syndrome,17
MIRTAZAPINE,Hypoaesthesia,16
MIRTAZAPINE,"Hallucinations, mixed",16
MIRTAZAPINE,Speech disorder,16
MIRTAZAPINE,Dyskinesia,16
MIRTAZAPINE,Visual impairment,16
MIRTAZAPINE,Tremor,16
MIRTAZAPINE,Paraesthesia,15
MIRTAZAPINE,Alopecia,15
MIRTAZAPINE,Muscle disorder,15
MIRTAZAPINE,Musculoskeletal stiffness,15
MIRTAZAPINE,Agitation,14
MIRTAZAPINE,Dyspepsia,14
MIRTAZAPINE,Vision blurred,14
MIRTAZAPINE,Mood swings,14
MIRTAZAPINE,Sleep disorder,14
MIRTAZAPINE,Eye pain,14
MIRTAZAPINE,Contusion,14
MIRTAZAPINE,Back pain,13
MIYA-BM,Diarrhoea,15
MIYA-BM,Pneumonia,8
MIYA-BM,Anaemia,8
MIYA-BM,Nausea,6
MIYA-BM,Decreased appetite,6
MIYA-BM,Interstitial lung disease,6
MIYA-BM,Hypertension,5
MIYA-BM,Platelet count decreased,5
MIYA-BM,Hepatic function abnormal,5
MIYA-BM,Urinary tract infection,5
MIYA-BM,Off label use,5
MIYA-BM,Malaise,4
MIYA-BM,Renal impairment,4
MIYA-BM,Epistaxis,4
MIYA-BM,Vomiting,4
MIYA-BM,Hypotension,4
MIYA-BM,Rash,3
MIYA-BM,Pyrexia,3
MIYA-BM,Herpes zoster,3
MIYA-BM,Pruritus,3
MIYA-BM,Death,3
MIYA-BM,Headache,3
MIYA-BM,Pulmonary arterial hypertension,3
MIYA-BM,Oedema,3
MIYA-BM,Diabetes mellitus,2
MIYA-BM,Hypoaesthesia,2
MIYA-BM,Obstructive airways disorder,2
MIYA-BM,Lung neoplasm malignant,2
MIYA-BM,White blood cell count decreased,2
MIYA-BM,Alopecia,2
MIYA-BM,Stomatitis,2
MIYA-BM,Dizziness,2
MIYA-BM,Neuropathy peripheral,2
MIYA-BM,Constipation,2
MIYA-BM,Rotator cuff syndrome,2
MIYA-BM,Pharyngeal inflammation,2
MIYA-BM,Inappropriate schedule of product administration,2
MIYA-BM,Product use issue,2
MIYA-BM,Mixed connective tissue disease,2
MIYA-BM,COVID-19,2
MIYA-BM,Oedema peripheral,2
MIYA-BM,Hot flush,2
MIYA-BM,Gastroenteritis,2
MIYA-BM,Disease progression,2
MIYA-BM,Tumour haemorrhage,2
MIYA-BM,Immune-mediated enterocolitis,2
MIYA-BM,Cough,2
MIYA-BM,Toxic epidermal necrolysis,2
MIYA-BM,Encephalitis,2
MIYA-BM,Bacteraemia,2
MODERNA COVID-19 VACCINE,COVID-19,27
MODERNA COVID-19 VACCINE,Fall,23
MODERNA COVID-19 VACCINE,Fatigue,20
MODERNA COVID-19 VACCINE,Back pain,17
MODERNA COVID-19 VACCINE,Peripheral swelling,16
MODERNA COVID-19 VACCINE,Pain,16
MODERNA COVID-19 VACCINE,Pain in extremity,14
MODERNA COVID-19 VACCINE,Nasopharyngitis,12
MODERNA COVID-19 VACCINE,Arthralgia,12
MODERNA COVID-19 VACCINE,Diarrhoea,12
MODERNA COVID-19 VACCINE,Condition aggravated,12
MODERNA COVID-19 VACCINE,Off label use,11
MODERNA COVID-19 VACCINE,Nausea,10
MODERNA COVID-19 VACCINE,Illness,10
MODERNA COVID-19 VACCINE,Sinusitis,10
MODERNA COVID-19 VACCINE,Vomiting,10
MODERNA COVID-19 VACCINE,Malaise,9
MODERNA COVID-19 VACCINE,Headache,9
MODERNA COVID-19 VACCINE,Product dose omission issue,9
MODERNA COVID-19 VACCINE,Contusion,9
MODERNA COVID-19 VACCINE,Gait disturbance,8
MODERNA COVID-19 VACCINE,Bronchitis,8
MODERNA COVID-19 VACCINE,Pruritus,8
MODERNA COVID-19 VACCINE,Feeling abnormal,8
MODERNA COVID-19 VACCINE,Pneumonia,7
MODERNA COVID-19 VACCINE,Urinary tract infection,7
MODERNA COVID-19 VACCINE,Pyrexia,7
MODERNA COVID-19 VACCINE,Psoriasis,7
MODERNA COVID-19 VACCINE,Abdominal pain,7
MODERNA COVID-19 VACCINE,Seasonal allergy,6
MODERNA COVID-19 VACCINE,Gastrointestinal disorder,6
MODERNA COVID-19 VACCINE,Insurance issue,6
MODERNA COVID-19 VACCINE,Upper respiratory tract infection,6
MODERNA COVID-19 VACCINE,Drug ineffective,6
MODERNA COVID-19 VACCINE,Rash,6
MODERNA COVID-19 VACCINE,Hypertension,6
MODERNA COVID-19 VACCINE,Dyspnoea,6
MODERNA COVID-19 VACCINE,Osteoarthritis,6
MODERNA COVID-19 VACCINE,Abdominal pain upper,6
MODERNA COVID-19 VACCINE,Drug interaction,6
MODERNA COVID-19 VACCINE,Oral pain,6
MODERNA COVID-19 VACCINE,Inappropriate schedule of product administration,5
MODERNA COVID-19 VACCINE,Depression,5
MODERNA COVID-19 VACCINE,Ear infection,5
MODERNA COVID-19 VACCINE,Diverticulitis,5
MODERNA COVID-19 VACCINE,Back injury,5
MODERNA COVID-19 VACCINE,Bone pain,5
MODERNA COVID-19 VACCINE,Cataract,5
MODERNA COVID-19 VACCINE,Cough,5
MODERNA COVID-19 VACCINE,Lower respiratory tract infection,5
MOMETASONE FUROATE,Pain,11
MOMETASONE FUROATE,Product dose omission issue,11
MOMETASONE FUROATE,Off label use,8
MOMETASONE FUROATE,Headache,8
MOMETASONE FUROATE,Pneumonia,8
MOMETASONE FUROATE,Fatigue,8
MOMETASONE FUROATE,Pruritus,8
MOMETASONE FUROATE,Nausea,7
MOMETASONE FUROATE,Illness,5
MOMETASONE FUROATE,Dry skin,5
MOMETASONE FUROATE,Blood creatine phosphokinase increased,5
MOMETASONE FUROATE,Heart rate irregular,5
MOMETASONE FUROATE,Infection,5
MOMETASONE FUROATE,Product use in unapproved indication,5
MOMETASONE FUROATE,Urticaria,5
MOMETASONE FUROATE,Dyspnoea,5
MOMETASONE FUROATE,Inappropriate schedule of product administration,5
MOMETASONE FUROATE,Rash,5
MOMETASONE FUROATE,Alopecia,4
MOMETASONE FUROATE,Insomnia,4
MOMETASONE FUROATE,Somnolence,4
MOMETASONE FUROATE,Drug ineffective,4
MOMETASONE FUROATE,Anxiety,4
MOMETASONE FUROATE,Depression,4
MOMETASONE FUROATE,Atrial fibrillation,4
MOMETASONE FUROATE,Disease progression,4
MOMETASONE FUROATE,Tachycardia,4
MOMETASONE FUROATE,Swelling,4
MOMETASONE FUROATE,Seasonal allergy,4
MOMETASONE FUROATE,Ear infection,4
MOMETASONE FUROATE,Infusion site pain,4
MOMETASONE FUROATE,Back pain,4
MOMETASONE FUROATE,Sinusitis,4
MOMETASONE FUROATE,Skin exfoliation,4
MOMETASONE FUROATE,Injection site erythema,4
MOMETASONE FUROATE,Gait disturbance,4
MOMETASONE FUROATE,Blood creatinine increased,4
MOMETASONE FUROATE,Arthralgia,4
MOMETASONE FUROATE,Fall,4
MOMETASONE FUROATE,Condition aggravated,4
MOMETASONE FUROATE,Weight decreased,3
MOMETASONE FUROATE,Pollakiuria,3
MOMETASONE FUROATE,Product used for unknown indication,3
MOMETASONE FUROATE,Injection site pruritus,3
MOMETASONE FUROATE,Influenza,3
MOMETASONE FUROATE,Diarrhoea,3
MOMETASONE FUROATE,Pyrexia,3
MOMETASONE FUROATE,Pain in extremity,3
MOMETASONE FUROATE,Staphylococcal infection,3
MOMETASONE FUROATE,Vomiting,3
MONTELUKAST,Dyspnoea,31
MONTELUKAST,Pain,28
MONTELUKAST,Product dose omission issue,26
MONTELUKAST,Headache,26
MONTELUKAST,Fatigue,24
MONTELUKAST,Arthralgia,24
MONTELUKAST,Pneumonia,23
MONTELUKAST,Illness,21
MONTELUKAST,Cough,21
MONTELUKAST,Nausea,20
MONTELUKAST,Nasopharyngitis,19
MONTELUKAST,COVID-19,19
MONTELUKAST,Anxiety,18
MONTELUKAST,Weight increased,18
MONTELUKAST,Malaise,17
MONTELUKAST,Pyrexia,17
MONTELUKAST,Rash,16
MONTELUKAST,Vomiting,16
MONTELUKAST,Drug ineffective,15
MONTELUKAST,Asthma,15
MONTELUKAST,Pruritus,15
MONTELUKAST,Diarrhoea,14
MONTELUKAST,Dizziness,14
MONTELUKAST,Hypersensitivity,13
MONTELUKAST,Sinusitis,13
MONTELUKAST,Urticaria,13
MONTELUKAST,Aggression,12
MONTELUKAST,Weight decreased,11
MONTELUKAST,Urinary tract infection,10
MONTELUKAST,Fall,10
MONTELUKAST,Contusion,10
MONTELUKAST,Off label use,10
MONTELUKAST,Productive cough,9
MONTELUKAST,Wheezing,9
MONTELUKAST,General physical health deterioration,9
MONTELUKAST,Asthenia,9
MONTELUKAST,Emotional distress,9
MONTELUKAST,Influenza,8
MONTELUKAST,Nasal congestion,8
MONTELUKAST,Inappropriate schedule of product administration,8
MONTELUKAST,Upper respiratory tract infection,8
MONTELUKAST,Anhedonia,8
MONTELUKAST,Bronchitis,8
MONTELUKAST,Tremor,8
MONTELUKAST,Muscle spasms,7
MONTELUKAST,Rhinorrhoea,7
MONTELUKAST,Injection site pain,7
MONTELUKAST,Swelling,7
MONTELUKAST,Feeling abnormal,7
MONTELUKAST,Abdominal pain,7
MONTELUKAST SODIUM,Product dose omission issue,22
MONTELUKAST SODIUM,Sinusitis,21
MONTELUKAST SODIUM,Fatigue,21
MONTELUKAST SODIUM,COVID-19,18
MONTELUKAST SODIUM,Pruritus,18
MONTELUKAST SODIUM,Pneumonia,16
MONTELUKAST SODIUM,Dyspnoea,14
MONTELUKAST SODIUM,Nasopharyngitis,13
MONTELUKAST SODIUM,Urinary tract infection,13
MONTELUKAST SODIUM,Headache,13
MONTELUKAST SODIUM,Fall,12
MONTELUKAST SODIUM,Upper respiratory tract infection,12
MONTELUKAST SODIUM,Malaise,12
MONTELUKAST SODIUM,Asthma,12
MONTELUKAST SODIUM,Pain,11
MONTELUKAST SODIUM,Nausea,11
MONTELUKAST SODIUM,Bronchitis,10
MONTELUKAST SODIUM,Cough,10
MONTELUKAST SODIUM,Illness,10
MONTELUKAST SODIUM,Pyrexia,10
MONTELUKAST SODIUM,Somnolence,10
MONTELUKAST SODIUM,Infection,9
MONTELUKAST SODIUM,Arthralgia,9
MONTELUKAST SODIUM,Seasonal allergy,9
MONTELUKAST SODIUM,Condition aggravated,8
MONTELUKAST SODIUM,Respiratory tract infection,8
MONTELUKAST SODIUM,Vomiting,8
MONTELUKAST SODIUM,Infusion related reaction,7
MONTELUKAST SODIUM,Rash,7
MONTELUKAST SODIUM,Weight increased,7
MONTELUKAST SODIUM,Dizziness,7
MONTELUKAST SODIUM,Hypoglycaemia,7
MONTELUKAST SODIUM,Product use in unapproved indication,7
MONTELUKAST SODIUM,Gait disturbance,6
MONTELUKAST SODIUM,Influenza,6
MONTELUKAST SODIUM,Feeling abnormal,6
MONTELUKAST SODIUM,Viral infection,6
MONTELUKAST SODIUM,Infusion site swelling,6
MONTELUKAST SODIUM,Migraine,6
MONTELUKAST SODIUM,Ear infection,6
MONTELUKAST SODIUM,Infusion site erythema,6
MONTELUKAST SODIUM,Infusion site pain,6
MONTELUKAST SODIUM,Sepsis,6
MONTELUKAST SODIUM,Muscular weakness,6
MONTELUKAST SODIUM,Injection site pain,6
MONTELUKAST SODIUM,Hallucination,6
MONTELUKAST SODIUM,Tremor,6
MONTELUKAST SODIUM,Diarrhoea,6
MONTELUKAST SODIUM,Asthmatic crisis,5
MONTELUKAST SODIUM,Inappropriate schedule of product administration,5
MORPHINE,Diarrhoea,42
MORPHINE,Nausea,34
MORPHINE,Vomiting,32
MORPHINE,Fatigue,31
MORPHINE,Pyrexia,24
MORPHINE,Dyspnoea,22
MORPHINE,Off label use,22
MORPHINE,Pain,21
MORPHINE,Headache,20
MORPHINE,Platelet count decreased,20
MORPHINE,Neuropathy peripheral,19
MORPHINE,Abdominal pain,19
MORPHINE,Weight decreased,17
MORPHINE,Pain in extremity,16
MORPHINE,Mucosal inflammation,16
MORPHINE,Neutropenia,16
MORPHINE,Anaemia,15
MORPHINE,Leukopenia,15
MORPHINE,COVID-19,15
MORPHINE,Back pain,14
MORPHINE,Malaise,14
MORPHINE,Disease progression,14
MORPHINE,Cough,13
MORPHINE,Alopecia,12
MORPHINE,Dizziness,12
MORPHINE,Drug hypersensitivity,12
MORPHINE,White blood cell count decreased,11
MORPHINE,Arthralgia,11
MORPHINE,Lymphocyte count decreased,11
MORPHINE,Seizure,11
MORPHINE,Decreased appetite,11
MORPHINE,Asthenia,10
MORPHINE,Pruritus,10
MORPHINE,Inappropriate schedule of product administration,10
MORPHINE,Myalgia,10
MORPHINE,Affective disorder,10
MORPHINE,Schizophrenia,10
MORPHINE,Overdose,10
MORPHINE,Incorrect dose administered,10
MORPHINE,Bone pain,10
MORPHINE,Tachycardia,10
MORPHINE,Pneumonia,10
MORPHINE,Weight increased,9
MORPHINE,Drug intolerance,9
MORPHINE,Rash,9
MORPHINE,Blood pressure increased,9
MORPHINE,Anxiety,9
MORPHINE,Neutrophil count increased,9
MORPHINE,Cellulitis,9
MORPHINE,Dyspepsia,9
MORPHINE SULFATE,Diarrhoea,36
MORPHINE SULFATE,Vomiting,29
MORPHINE SULFATE,Nausea,21
MORPHINE SULFATE,Headache,20
MORPHINE SULFATE,Pain,20
MORPHINE SULFATE,Pyrexia,19
MORPHINE SULFATE,Malaise,18
MORPHINE SULFATE,Neutropenia,18
MORPHINE SULFATE,Death,18
MORPHINE SULFATE,Neutropenic sepsis,17
MORPHINE SULFATE,Back pain,17
MORPHINE SULFATE,Dyspnoea,16
MORPHINE SULFATE,Off label use,15
MORPHINE SULFATE,Fatigue,14
MORPHINE SULFATE,Mucosal inflammation,14
MORPHINE SULFATE,Disease progression,13
MORPHINE SULFATE,COVID-19,13
MORPHINE SULFATE,Dehydration,13
MORPHINE SULFATE,Febrile neutropenia,13
MORPHINE SULFATE,Constipation,13
MORPHINE SULFATE,Product use in unapproved indication,11
MORPHINE SULFATE,Decreased appetite,11
MORPHINE SULFATE,Keratitis,11
MORPHINE SULFATE,Asthenia,10
MORPHINE SULFATE,Dysphagia,10
MORPHINE SULFATE,Anaemia,10
MORPHINE SULFATE,Body temperature increased,10
MORPHINE SULFATE,Proctalgia,10
MORPHINE SULFATE,Accident,10
MORPHINE SULFATE,Anal inflammation,10
MORPHINE SULFATE,Haemorrhoids,10
MORPHINE SULFATE,Crohn's disease,10
MORPHINE SULFATE,Visual acuity reduced,10
MORPHINE SULFATE,Tachycardia,9
MORPHINE SULFATE,Depression,9
MORPHINE SULFATE,Neutrophil count decreased,9
MORPHINE SULFATE,Chills,9
MORPHINE SULFATE,Stevens-Johnson syndrome,9
MORPHINE SULFATE,Abdominal pain,8
MORPHINE SULFATE,Neuropathy peripheral,8
MORPHINE SULFATE,Lymphocyte count decreased,8
MORPHINE SULFATE,Platelet count decreased,8
MORPHINE SULFATE,Incorrect dose administered,8
MORPHINE SULFATE,Hypokalaemia,8
MORPHINE SULFATE,Gait disturbance,8
MORPHINE SULFATE,Mouth ulceration,8
MORPHINE SULFATE,Productive cough,8
MORPHINE SULFATE,Balance disorder,8
MORPHINE SULFATE,Skin candida,8
MORPHINE SULFATE,Hypomagnesaemia,8
MOVICOL,Vomiting,13
MOVICOL,Nausea,12
MOVICOL,Asthenia,11
MOVICOL,Arthralgia,9
MOVICOL,Dyspnoea,9
MOVICOL,Fall,9
MOVICOL,Hypoaesthesia,9
MOVICOL,Constipation,8
MOVICOL,Pyrexia,8
MOVICOL,Fatigue,8
MOVICOL,Back pain,7
MOVICOL,Headache,7
MOVICOL,Loss of consciousness,7
MOVICOL,Speech disorder,7
MOVICOL,Sleep apnoea syndrome,7
MOVICOL,Dysphagia,7
MOVICOL,Off label use,7
MOVICOL,General physical health deterioration,6
MOVICOL,Neutropenia,6
MOVICOL,Pain,6
MOVICOL,Muscle spasticity,6
MOVICOL,Pain in extremity,6
MOVICOL,Vertigo,6
MOVICOL,Throat irritation,6
MOVICOL,Autoscopy,6
MOVICOL,Respiratory failure,5
MOVICOL,Pneumonia,5
MOVICOL,Hepatic steatosis,5
MOVICOL,Haematoma,5
MOVICOL,Myalgia,5
MOVICOL,Anaemia,5
MOVICOL,Ankyloglossia congenital,5
MOVICOL,Confusional state,5
MOVICOL,Alopecia,4
MOVICOL,Dry skin,4
MOVICOL,Viral infection,4
MOVICOL,Drug abuse,4
MOVICOL,Hypochromic anaemia,4
MOVICOL,Inguinal hernia,4
MOVICOL,Dizziness,4
MOVICOL,Renal cyst,4
MOVICOL,Neurological decompensation,4
MOVICOL,Urinary tract infection,4
MOVICOL,Uterine enlargement,4
MOVICOL,Lung disorder,4
MOVICOL,Monoplegia,4
MOVICOL,Tissue infiltration,4
MOVICOL,Inflammation,4
MOVICOL,Psychogenic seizure,4
MOVICOL,Klebsiella infection,4
MOXIFLOXACIN,Decreased appetite,6
MOXIFLOXACIN,Nausea,6
MOXIFLOXACIN,Diarrhoea,6
MOXIFLOXACIN,Asthenia,5
MOXIFLOXACIN,Dyspnoea,5
MOXIFLOXACIN,Anaemia,5
MOXIFLOXACIN,Clostridium difficile infection,5
MOXIFLOXACIN,Pulmonary embolism,4
MOXIFLOXACIN,Acute kidney injury,4
MOXIFLOXACIN,Electrocardiogram QT prolonged,4
MOXIFLOXACIN,Abdominal pain upper,4
MOXIFLOXACIN,Fatigue,4
MOXIFLOXACIN,Chest discomfort,3
MOXIFLOXACIN,Lower respiratory tract infection,3
MOXIFLOXACIN,Fall,3
MOXIFLOXACIN,Productive cough,3
MOXIFLOXACIN,Aspartate aminotransferase increased,3
MOXIFLOXACIN,Pancreatitis chronic,3
MOXIFLOXACIN,Hepatitis C,3
MOXIFLOXACIN,Hepatitis toxic,3
MOXIFLOXACIN,Oedema peripheral,3
MOXIFLOXACIN,Death,3
MOXIFLOXACIN,Pneumonia,3
MOXIFLOXACIN,Viral infection,2
MOXIFLOXACIN,Nasal congestion,2
MOXIFLOXACIN,Cough,2
MOXIFLOXACIN,Oral candidiasis,2
MOXIFLOXACIN,Sputum discoloured,2
MOXIFLOXACIN,Asthma,2
MOXIFLOXACIN,Middle insomnia,2
MOXIFLOXACIN,Drug hypersensitivity,2
MOXIFLOXACIN,Sleep disorder,2
MOXIFLOXACIN,Deep vein thrombosis,2
MOXIFLOXACIN,Blood pressure increased,2
MOXIFLOXACIN,Sensitivity to weather change,2
MOXIFLOXACIN,Hypertension,2
MOXIFLOXACIN,Respiratory disorder,2
MOXIFLOXACIN,Oropharyngeal pain,2
MOXIFLOXACIN,Hypoacusis,2
MOXIFLOXACIN,Breath sounds abnormal,2
MOXIFLOXACIN,Body temperature decreased,2
MOXIFLOXACIN,Eye contusion,2
MOXIFLOXACIN,Swelling face,2
MOXIFLOXACIN,Ear congestion,2
MOXIFLOXACIN,Forced expiratory volume decreased,2
MOXIFLOXACIN,Skin laceration,2
MOXIFLOXACIN,Rales,2
MOXIFLOXACIN,Blood pressure systolic increased,2
MOXIFLOXACIN,Wheezing,2
MOXIFLOXACIN,Heart rate increased,2
MUCINEX,COVID-19,21
MUCINEX,Sinusitis,20
MUCINEX,Pneumonia,17
MUCINEX,Dyspnoea,15
MUCINEX,Headache,15
MUCINEX,Product dose omission issue,14
MUCINEX,Cough,11
MUCINEX,Bronchitis,10
MUCINEX,Fatigue,9
MUCINEX,Dizziness,8
MUCINEX,Upper respiratory tract infection,8
MUCINEX,Nausea,8
MUCINEX,Depression,7
MUCINEX,Fall,7
MUCINEX,Migraine,7
MUCINEX,Vomiting,7
MUCINEX,Diarrhoea,7
MUCINEX,Malaise,6
MUCINEX,Nasopharyngitis,6
MUCINEX,Multiple allergies,6
MUCINEX,Back pain,6
MUCINEX,Weight increased,6
MUCINEX,Influenza,5
MUCINEX,Product use issue,5
MUCINEX,Productive cough,5
MUCINEX,Insurance issue,5
MUCINEX,Limb injury,5
MUCINEX,Asthenia,5
MUCINEX,Rhinorrhoea,5
MUCINEX,Nasal congestion,5
MUCINEX,Arthralgia,5
MUCINEX,Pyrexia,5
MUCINEX,Anxiety,5
MUCINEX,Pain,5
MUCINEX,Disease recurrence,5
MUCINEX,Infusion site swelling,4
MUCINEX,Infusion related reaction,4
MUCINEX,Contusion,4
MUCINEX,Infection,4
MUCINEX,Ear infection,4
MUCINEX,Blood pressure increased,4
MUCINEX,Hypertension,4
MUCINEX,Skin laceration,4
MUCINEX,Off label use,4
MUCINEX,Respiratory disorder,4
MUCINEX,Gait disturbance,4
MUCINEX,Oedema,4
MUCINEX,Hospitalisation,4
MUCINEX,Respiratory tract infection,3
MUCINEX,Viral infection,3
MUPIROCIN,COVID-19,9
MUPIROCIN,Nausea,9
MUPIROCIN,Fatigue,8
MUPIROCIN,Erythema,7
MUPIROCIN,Sinusitis,6
MUPIROCIN,Product dose omission issue,6
MUPIROCIN,Bronchitis,6
MUPIROCIN,Asthma,6
MUPIROCIN,Anxiety,6
MUPIROCIN,Vomiting,5
MUPIROCIN,Fall,5
MUPIROCIN,Weight decreased,5
MUPIROCIN,Diarrhoea,5
MUPIROCIN,Nasopharyngitis,5
MUPIROCIN,Infusion site pruritus,5
MUPIROCIN,Ear infection,5
MUPIROCIN,Pruritus,5
MUPIROCIN,Gait disturbance,4
MUPIROCIN,Urinary tract infection,4
MUPIROCIN,Diverticulitis,4
MUPIROCIN,Condition aggravated,4
MUPIROCIN,Pneumonia,4
MUPIROCIN,Pain,4
MUPIROCIN,Viral infection,4
MUPIROCIN,Malaise,4
MUPIROCIN,Infusion site pain,4
MUPIROCIN,Intervertebral disc protrusion,4
MUPIROCIN,Back pain,4
MUPIROCIN,Product use issue,4
MUPIROCIN,Scar,4
MUPIROCIN,Vision blurred,4
MUPIROCIN,Blister,4
MUPIROCIN,Dehydration,4
MUPIROCIN,Dermatitis atopic,4
MUPIROCIN,Product use in unapproved indication,4
MUPIROCIN,Influenza,3
MUPIROCIN,Illness,3
MUPIROCIN,Conjunctivitis,3
MUPIROCIN,Arthralgia,3
MUPIROCIN,Skin cancer,3
MUPIROCIN,Pulmonary mass,3
MUPIROCIN,Stress,3
MUPIROCIN,Headache,3
MUPIROCIN,Gastrointestinal disorder,3
MUPIROCIN,Skin infection,3
MUPIROCIN,Joint swelling,3
MUPIROCIN,COVID-19 pneumonia,3
MUPIROCIN,Insurance issue,3
MUPIROCIN,Neck pain,3
MUPIROCIN,Oropharyngeal pain,3
MYCOPHENOLATE MOFETIL,Pyrexia,16
MYCOPHENOLATE MOFETIL,Off label use,12
MYCOPHENOLATE MOFETIL,Pneumonia,10
MYCOPHENOLATE MOFETIL,Acute kidney injury,10
MYCOPHENOLATE MOFETIL,Anaemia,8
MYCOPHENOLATE MOFETIL,Pleural effusion,8
MYCOPHENOLATE MOFETIL,Fatigue,7
MYCOPHENOLATE MOFETIL,Rash,7
MYCOPHENOLATE MOFETIL,Headache,7
MYCOPHENOLATE MOFETIL,Diarrhoea,7
MYCOPHENOLATE MOFETIL,Dizziness,7
MYCOPHENOLATE MOFETIL,Oedema,6
MYCOPHENOLATE MOFETIL,C-reactive protein increased,6
MYCOPHENOLATE MOFETIL,Cytomegalovirus infection,6
MYCOPHENOLATE MOFETIL,Epstein-Barr virus infection,6
MYCOPHENOLATE MOFETIL,Encephalitis fungal,6
MYCOPHENOLATE MOFETIL,Hodgkin's disease,6
MYCOPHENOLATE MOFETIL,Tachycardia,6
MYCOPHENOLATE MOFETIL,Staphylococcal infection,6
MYCOPHENOLATE MOFETIL,Systemic lupus erythematosus,5
MYCOPHENOLATE MOFETIL,Weight decreased,5
MYCOPHENOLATE MOFETIL,Hypertension,5
MYCOPHENOLATE MOFETIL,Decreased appetite,5
MYCOPHENOLATE MOFETIL,Asthenia,5
MYCOPHENOLATE MOFETIL,Pain in extremity,5
MYCOPHENOLATE MOFETIL,Sinusitis,5
MYCOPHENOLATE MOFETIL,Dyspnoea,5
MYCOPHENOLATE MOFETIL,Aortic valve disease mixed,5
MYCOPHENOLATE MOFETIL,Orthopnoea,5
MYCOPHENOLATE MOFETIL,Aortic stenosis,5
MYCOPHENOLATE MOFETIL,Leukocytosis,5
MYCOPHENOLATE MOFETIL,Hyperkinetic heart syndrome,5
MYCOPHENOLATE MOFETIL,Endocarditis,5
MYCOPHENOLATE MOFETIL,Transplant failure,5
MYCOPHENOLATE MOFETIL,Staphylococcal sepsis,5
MYCOPHENOLATE MOFETIL,Splenomegaly,5
MYCOPHENOLATE MOFETIL,Aortic valve incompetence,5
MYCOPHENOLATE MOFETIL,Oral herpes,5
MYCOPHENOLATE MOFETIL,Blood bilirubin increased,5
MYCOPHENOLATE MOFETIL,Bronchitis bacterial,5
MYCOPHENOLATE MOFETIL,Pulmonary hypertension,5
MYCOPHENOLATE MOFETIL,Emphysema,5
MYCOPHENOLATE MOFETIL,Ascites,5
MYCOPHENOLATE MOFETIL,Lung abscess,5
MYCOPHENOLATE MOFETIL,Cardiac failure chronic,5
MYCOPHENOLATE MOFETIL,Chronic kidney disease,5
MYCOPHENOLATE MOFETIL,Type 2 diabetes mellitus,4
MYCOPHENOLATE MOFETIL,General physical health deterioration,4
MYCOPHENOLATE MOFETIL,Infusion related reaction,4
MYCOPHENOLATE MOFETIL,Nausea,4
MYCOPHENOLIC ACID,Off label use,11
MYCOPHENOLIC ACID,Diarrhoea,8
MYCOPHENOLIC ACID,Blood pressure increased,6
MYCOPHENOLIC ACID,Arthralgia,6
MYCOPHENOLIC ACID,Pain,6
MYCOPHENOLIC ACID,Drug ineffective,5
MYCOPHENOLIC ACID,Herpes zoster,5
MYCOPHENOLIC ACID,Rash,5
MYCOPHENOLIC ACID,Fall,5
MYCOPHENOLIC ACID,Pyrexia,5
MYCOPHENOLIC ACID,Rheumatoid arthritis,4
MYCOPHENOLIC ACID,Hernia,4
MYCOPHENOLIC ACID,Weight increased,4
MYCOPHENOLIC ACID,Acute kidney injury,4
MYCOPHENOLIC ACID,Cough,4
MYCOPHENOLIC ACID,Chest discomfort,4
MYCOPHENOLIC ACID,Product use issue,3
MYCOPHENOLIC ACID,Insomnia,3
MYCOPHENOLIC ACID,Blood glucose increased,3
MYCOPHENOLIC ACID,White blood cell count decreased,3
MYCOPHENOLIC ACID,Pain in extremity,3
MYCOPHENOLIC ACID,C-reactive protein increased,3
MYCOPHENOLIC ACID,Immunodeficiency,3
MYCOPHENOLIC ACID,Infection,3
MYCOPHENOLIC ACID,Hypoaesthesia,3
MYCOPHENOLIC ACID,Joint swelling,3
MYCOPHENOLIC ACID,Condition aggravated,3
MYCOPHENOLIC ACID,Nasopharyngitis,3
MYCOPHENOLIC ACID,Back pain,3
MYCOPHENOLIC ACID,Infusion site swelling,3
MYCOPHENOLIC ACID,Influenza like illness,3
MYCOPHENOLIC ACID,Intentional product use issue,3
MYCOPHENOLIC ACID,Feeling abnormal,3
MYCOPHENOLIC ACID,Vomiting,3
MYCOPHENOLIC ACID,Blood pressure fluctuation,3
MYCOPHENOLIC ACID,Decreased appetite,3
MYCOPHENOLIC ACID,Dyspnoea,3
MYCOPHENOLIC ACID,Somnolence,3
MYCOPHENOLIC ACID,Abdominal discomfort,3
MYCOPHENOLIC ACID,Asthenia,3
MYCOPHENOLIC ACID,Dizziness,3
MYCOPHENOLIC ACID,Headache,3
MYCOPHENOLIC ACID,Contraindicated product administered,2
MYCOPHENOLIC ACID,Anaphylactic reaction,2
MYCOPHENOLIC ACID,Rheumatic disorder,2
MYCOPHENOLIC ACID,Drug resistance,2
MYCOPHENOLIC ACID,C-reactive protein abnormal,2
MYCOPHENOLIC ACID,Arthritis,2
MYCOPHENOLIC ACID,Skin reaction,2
MYCOPHENOLIC ACID,Prescribed underdose,2
MYRBETRIQ,Fatigue,12
MYRBETRIQ,Pain,11
MYRBETRIQ,Fall,9
MYRBETRIQ,Off label use,8
MYRBETRIQ,Depression,7
MYRBETRIQ,Asthenia,7
MYRBETRIQ,Headache,7
MYRBETRIQ,Seasonal allergy,7
MYRBETRIQ,Pneumonia,7
MYRBETRIQ,Product dose omission issue,7
MYRBETRIQ,Arthralgia,7
MYRBETRIQ,COVID-19,7
MYRBETRIQ,Hypertension,6
MYRBETRIQ,Nausea,6
MYRBETRIQ,Urinary tract infection,6
MYRBETRIQ,Anxiety,6
MYRBETRIQ,Blood pressure increased,5
MYRBETRIQ,Dizziness,5
MYRBETRIQ,Weight decreased,5
MYRBETRIQ,Sinusitis,5
MYRBETRIQ,Back pain,5
MYRBETRIQ,Chronic kidney disease,5
MYRBETRIQ,Anhedonia,5
MYRBETRIQ,Emotional distress,5
MYRBETRIQ,Gait disturbance,5
MYRBETRIQ,Diarrhoea,5
MYRBETRIQ,Rash,5
MYRBETRIQ,Illness,4
MYRBETRIQ,Balance disorder,4
MYRBETRIQ,Mobility decreased,4
MYRBETRIQ,Rhinorrhoea,4
MYRBETRIQ,Cough,4
MYRBETRIQ,Arthritis,4
MYRBETRIQ,Decreased appetite,4
MYRBETRIQ,Foot fracture,4
MYRBETRIQ,Death,4
MYRBETRIQ,Sinus disorder,3
MYRBETRIQ,Drug ineffective,3
MYRBETRIQ,Loss of consciousness,3
MYRBETRIQ,Arthropathy,3
MYRBETRIQ,Limb injury,3
MYRBETRIQ,Hypersensitivity,3
MYRBETRIQ,Limb discomfort,3
MYRBETRIQ,Cystitis,3
MYRBETRIQ,Asthma,3
MYRBETRIQ,Weight increased,3
MYRBETRIQ,Multiple allergies,3
MYRBETRIQ,Infusion site pain,3
MYRBETRIQ,Infusion site erythema,3
MYRBETRIQ,Osteopenia,3
NAPROXEN,Pain,119
NAPROXEN,Anxiety,118
NAPROXEN,Fatigue,117
NAPROXEN,Headache,108
NAPROXEN,Arthralgia,108
NAPROXEN,COVID-19,106
NAPROXEN,Nausea,105
NAPROXEN,Insomnia,105
NAPROXEN,Dizziness,105
NAPROXEN,Feeling abnormal,105
NAPROXEN,Abdominal pain upper,103
NAPROXEN,Diarrhoea,102
NAPROXEN,Dyspnoea,102
NAPROXEN,Muscular weakness,101
NAPROXEN,Peripheral swelling,100
NAPROXEN,Pruritus,100
NAPROXEN,Vomiting,100
NAPROXEN,Malaise,99
NAPROXEN,Back pain,99
NAPROXEN,Hyperhidrosis,99
NAPROXEN,Pyrexia,98
NAPROXEN,Dehydration,98
NAPROXEN,Muscle twitching,98
NAPROXEN,Heart rate increased,98
NAPROXEN,Chest pain,97
NAPROXEN,Abdominal discomfort,96
NAPROXEN,Alopecia,94
NAPROXEN,Migraine,94
NAPROXEN,Lip swelling,94
NAPROXEN,Hallucination,94
NAPROXEN,Subarachnoid haemorrhage,93
NAPROXEN,Pericarditis,91
NAPROXEN,Memory impairment,91
NAPROXEN,Dry skin,91
NAPROXEN,Myocardial infarction,91
NAPROXEN,Visual impairment,91
NAPROXEN,Off label use,90
NAPROXEN,Tinnitus,90
NAPROXEN,Facial pain,89
NAPROXEN,Tachycardia,89
NAPROXEN,Palpitations,89
NAPROXEN,Angioedema,89
NAPROXEN,Disturbance in attention,89
NAPROXEN,Blindness,88
NAPROXEN,Amnesia,88
NAPROXEN,Cardiospasm,88
NAPROXEN,Anosmia,88
NAPROXEN,Atrial tachycardia,88
NAPROXEN,Ventricular tachycardia,88
NAPROXEN,Intentional product misuse,87
NEBIVOLOL,Hypomagnesaemia,10
NEBIVOLOL,Cholestasis,10
NEBIVOLOL,Hypocalcaemia,9
NEBIVOLOL,Fatigue,8
NEBIVOLOL,Anaemia,6
NEBIVOLOL,Constipation,6
NEBIVOLOL,Drug interaction,6
NEBIVOLOL,Lung disorder,6
NEBIVOLOL,Hyperammonaemic encephalopathy,6
NEBIVOLOL,Nausea,5
NEBIVOLOL,Neutropenia,5
NEBIVOLOL,Red blood cell count decreased,5
NEBIVOLOL,Hypertension,5
NEBIVOLOL,Dizziness,5
NEBIVOLOL,Hypokalaemia,5
NEBIVOLOL,Muscle spasms,5
NEBIVOLOL,Dermatitis,5
NEBIVOLOL,Leukopenia,5
NEBIVOLOL,Dyspnoea,4
NEBIVOLOL,Acute kidney injury,4
NEBIVOLOL,Pyrexia,4
NEBIVOLOL,Off label use,4
NEBIVOLOL,Syncope,4
NEBIVOLOL,Vomiting,3
NEBIVOLOL,Thrombocytopenia,3
NEBIVOLOL,Asthenia,3
NEBIVOLOL,Abdominal pain upper,3
NEBIVOLOL,Concomitant disease aggravated,3
NEBIVOLOL,Polyneuropathy,3
NEBIVOLOL,Incorrect dose administered,3
NEBIVOLOL,Diarrhoea,3
NEBIVOLOL,Palpitations,3
NEBIVOLOL,Dry mouth,3
NEBIVOLOL,Haemoglobin decreased,3
NEBIVOLOL,Melaena,3
NEBIVOLOL,Gastrointestinal haemorrhage,3
NEBIVOLOL,Haematocrit decreased,3
NEBIVOLOL,Weight decreased,2
NEBIVOLOL,Blood test abnormal,2
NEBIVOLOL,Alopecia,2
NEBIVOLOL,Thyroid disorder,2
NEBIVOLOL,White blood cell count decreased,2
NEBIVOLOL,Oral pain,2
NEBIVOLOL,COVID-19,2
NEBIVOLOL,Cough,2
NEBIVOLOL,Gingivitis,2
NEBIVOLOL,Urinary tract infection,2
NEBIVOLOL,Cystitis escherichia,2
NEBIVOLOL,Chromaturia,2
NEBIVOLOL,Decreased appetite,2
NEULASTA,Device adhesion issue,253
NEULASTA,Device malfunction,177
NEULASTA,Unintentional medical device removal,119
NEULASTA,Device occlusion,92
NEULASTA,Wrong technique in product usage process,64
NEULASTA,Device use error,62
NEULASTA,Device issue,53
NEULASTA,Accidental exposure to product,43
NEULASTA,Drug dose omission by device,40
NEULASTA,Intercepted product preparation error,39
NEULASTA,Device physical property issue,26
NEULASTA,Product communication issue,12
NEULASTA,Device leakage,11
NEULASTA,Pyrexia,10
NEULASTA,Off label use,10
NEULASTA,Intercepted product administration error,10
NEULASTA,Vomiting,9
NEULASTA,Application site haemorrhage,9
NEULASTA,Fatigue,8
NEULASTA,Dyspnoea,8
NEULASTA,Nausea,8
NEULASTA,Bone pain,8
NEULASTA,Incorrect dose administered by device,7
NEULASTA,Myalgia,7
NEULASTA,Hyperhidrosis,7
NEULASTA,Device power source issue,7
NEULASTA,Device placement issue,7
NEULASTA,Application site pain,7
NEULASTA,Cough,6
NEULASTA,Neutropenia,6
NEULASTA,Inflammation,6
NEULASTA,Tachycardia,6
NEULASTA,Pneumonia,6
NEULASTA,Headache,5
NEULASTA,Fall,5
NEULASTA,Respiratory failure,5
NEULASTA,Sepsis,5
NEULASTA,Hypothyroidism,5
NEULASTA,Arthralgia,5
NEULASTA,Hyponatraemia,5
NEULASTA,Device electrical finding,5
NEULASTA,Needle issue,5
NEULASTA,Device delivery system issue,5
NEULASTA,Device failure,5
NEULASTA,Viral infection,4
NEULASTA,Drug abuse,4
NEULASTA,Inguinal hernia,4
NEULASTA,Dizziness,4
NEULASTA,Hepatic steatosis,4
NEULASTA,Renal cyst,4
NEURONTIN,Pain,10
NEURONTIN,Fatigue,8
NEURONTIN,Product dose omission issue,8
NEURONTIN,Pneumonia,8
NEURONTIN,Headache,7
NEURONTIN,Off label use,7
NEURONTIN,Anxiety,6
NEURONTIN,Malaise,6
NEURONTIN,Nausea,6
NEURONTIN,Anhedonia,5
NEURONTIN,Emotional distress,5
NEURONTIN,Arthralgia,5
NEURONTIN,Gait disturbance,5
NEURONTIN,Pyrexia,4
NEURONTIN,Inappropriate schedule of product administration,4
NEURONTIN,Illness,4
NEURONTIN,Insomnia,4
NEURONTIN,Diarrhoea,4
NEURONTIN,Vomiting,4
NEURONTIN,Fall,4
NEURONTIN,Cough,4
NEURONTIN,Asthenia,4
NEURONTIN,Seizure,4
NEURONTIN,Multiple sclerosis relapse,4
NEURONTIN,Urinary tract infection,3
NEURONTIN,COVID-19,3
NEURONTIN,Sinusitis,3
NEURONTIN,Upper respiratory tract infection,3
NEURONTIN,Bronchitis,3
NEURONTIN,Migraine,3
NEURONTIN,Anaphylactic reaction,3
NEURONTIN,Sepsis,3
NEURONTIN,Chest pain,3
NEURONTIN,Bone demineralisation,3
NEURONTIN,Back pain,3
NEURONTIN,Dyspnoea,3
NEURONTIN,Osteoporosis,3
NEURONTIN,Somnolence,3
NEURONTIN,Drug ineffective,3
NEURONTIN,Myalgia,3
NEURONTIN,Dizziness,3
NEURONTIN,Blood pressure increased,2
NEURONTIN,Nephrolithiasis,2
NEURONTIN,Chronic kidney disease,2
NEURONTIN,Product prescribing error,2
NEURONTIN,Product use issue,2
NEURONTIN,Feeling abnormal,2
NEURONTIN,Product use in unapproved indication,2
NEURONTIN,Body temperature abnormal,2
NEURONTIN,Hernia,2
NEXIUM,Diarrhoea,25
NEXIUM,Malaise,21
NEXIUM,Nausea,21
NEXIUM,Pneumonia,18
NEXIUM,Dyspnoea,15
NEXIUM,Fall,14
NEXIUM,Headache,13
NEXIUM,COVID-19,11
NEXIUM,Pyrexia,11
NEXIUM,Fatigue,10
NEXIUM,Urinary tract infection,10
NEXIUM,Cough,10
NEXIUM,Anaemia,10
NEXIUM,Arthralgia,10
NEXIUM,Nasopharyngitis,9
NEXIUM,Pain,9
NEXIUM,Infusion related reaction,9
NEXIUM,Product dose omission issue,8
NEXIUM,Pruritus,8
NEXIUM,Hypertension,8
NEXIUM,Platelet count decreased,8
NEXIUM,Interstitial lung disease,8
NEXIUM,Weight increased,7
NEXIUM,Sinusitis,7
NEXIUM,Inappropriate schedule of product administration,7
NEXIUM,Back pain,7
NEXIUM,Rash,7
NEXIUM,Off label use,6
NEXIUM,Asthma,6
NEXIUM,C-reactive protein increased,6
NEXIUM,Cardiac failure,6
NEXIUM,Chest pain,6
NEXIUM,Cardiothoracic ratio increased,6
NEXIUM,Dizziness,6
NEXIUM,Weight decreased,5
NEXIUM,Anxiety,5
NEXIUM,Death,5
NEXIUM,Cellulitis,5
NEXIUM,Illness,5
NEXIUM,Lymphocyte count decreased,5
NEXIUM,Clostridium difficile colitis,5
NEXIUM,Hepatic function abnormal,5
NEXIUM,Erythema,5
NEXIUM,Condition aggravated,5
NEXIUM,Feeling abnormal,4
NEXIUM,Oedema peripheral,4
NEXIUM,White blood cell count decreased,4
NEXIUM,Infection,4
NEXIUM,Bronchitis,4
NEXIUM,Dehydration,4
NEXPLANON,Device expulsion,22
NEXPLANON,Device dislocation,22
NEXPLANON,Unintended pregnancy,17
NEXPLANON,Complication associated with device,17
NEXPLANON,No adverse event,17
NEXPLANON,Pregnancy with implant contraceptive,16
NEXPLANON,Complication of device removal,12
NEXPLANON,Device placement issue,11
NEXPLANON,Device breakage,9
NEXPLANON,Device issue,9
NEXPLANON,Vaginal haemorrhage,6
NEXPLANON,Implant site pain,6
NEXPLANON,Incorrect product administration duration,6
NEXPLANON,Device kink,5
NEXPLANON,Heavy menstrual bleeding,5
NEXPLANON,Pain,5
NEXPLANON,Fatigue,5
NEXPLANON,Product use in unapproved indication,4
NEXPLANON,Abortion induced,4
NEXPLANON,Menstruation irregular,4
NEXPLANON,Impaired healing,3
NEXPLANON,Dysmenorrhoea,3
NEXPLANON,Intermenstrual bleeding,3
NEXPLANON,Product dose omission issue,3
NEXPLANON,Weight increased,3
NEXPLANON,Wrong technique in product usage process,3
NEXPLANON,Device deployment issue,3
NEXPLANON,Headache,3
NEXPLANON,Pain in extremity,3
NEXPLANON,Implant site bruising,2
NEXPLANON,Stress,2
NEXPLANON,Anxiety,2
NEXPLANON,Inappropriate schedule of product administration,2
NEXPLANON,Implant site pruritus,2
NEXPLANON,Device use issue,2
NEXPLANON,Overdose,2
NEXPLANON,Implant site infection,2
NEXPLANON,Implant site fibrosis,2
NEXPLANON,Product quality issue,2
NEXPLANON,Pruritus,2
NEXPLANON,Complication of device insertion,2
NEXPLANON,Paraesthesia,2
NEXPLANON,Peripheral swelling,2
NEXPLANON,Dizziness,2
NEXPLANON,Amenorrhoea,2
NEXPLANON,Medical device site scab,1
NEXPLANON,Skin striae,1
NEXPLANON,Implant site necrosis,1
NEXPLANON,Medical device site laceration,1
NEXPLANON,Implant site urticaria,1
NIFEDIPINE,Diarrhoea,21
NIFEDIPINE,Pain,17
NIFEDIPINE,Headache,16
NIFEDIPINE,Dyspnoea,14
NIFEDIPINE,Hypertension,14
NIFEDIPINE,Dizziness,13
NIFEDIPINE,Fatigue,12
NIFEDIPINE,Emotional distress,12
NIFEDIPINE,Anxiety,12
NIFEDIPINE,Chronic kidney disease,11
NIFEDIPINE,Off label use,11
NIFEDIPINE,Death,10
NIFEDIPINE,Condition aggravated,10
NIFEDIPINE,Cough,10
NIFEDIPINE,Anhedonia,10
NIFEDIPINE,Influenza,9
NIFEDIPINE,Acute kidney injury,9
NIFEDIPINE,Pneumonia,9
NIFEDIPINE,Nausea,8
NIFEDIPINE,Product dose omission issue,8
NIFEDIPINE,Pain in extremity,7
NIFEDIPINE,Fall,7
NIFEDIPINE,Oedema peripheral,7
NIFEDIPINE,Blood creatinine increased,6
NIFEDIPINE,Renal impairment,6
NIFEDIPINE,Depression,6
NIFEDIPINE,Renal failure,6
NIFEDIPINE,End stage renal disease,6
NIFEDIPINE,Asthenia,6
NIFEDIPINE,Pyrexia,6
NIFEDIPINE,Decreased appetite,6
NIFEDIPINE,Malaise,6
NIFEDIPINE,Mobility decreased,6
NIFEDIPINE,Inappropriate schedule of product administration,5
NIFEDIPINE,Proteinuria,5
NIFEDIPINE,Platelet count decreased,5
NIFEDIPINE,Cerebrovascular accident,5
NIFEDIPINE,Gait inability,5
NIFEDIPINE,White blood cell count decreased,5
NIFEDIPINE,Nasopharyngitis,5
NIFEDIPINE,Fluid retention,5
NIFEDIPINE,Drug ineffective,5
NIFEDIPINE,Rash,4
NIFEDIPINE,Pulmonary arterial hypertension,4
NIFEDIPINE,Blood glucose increased,4
NIFEDIPINE,Bone density decreased,4
NIFEDIPINE,Quality of life decreased,4
NIFEDIPINE,Loss of personal independence in daily activities,4
NIFEDIPINE,Osteoporosis,4
NIFEDIPINE,Sinusitis,4
NIRMATRELVIR\RITONAVIR,Off label use,25
NIRMATRELVIR\RITONAVIR,Hepatic function abnormal,24
NIRMATRELVIR\RITONAVIR,Diarrhoea,12
NIRMATRELVIR\RITONAVIR,Nausea,9
NIRMATRELVIR\RITONAVIR,Incorrect dose administered,8
NIRMATRELVIR\RITONAVIR,Inappropriate schedule of product administration,8
NIRMATRELVIR\RITONAVIR,Aspartate aminotransferase increased,7
NIRMATRELVIR\RITONAVIR,Alanine aminotransferase increased,7
NIRMATRELVIR\RITONAVIR,Rash,7
NIRMATRELVIR\RITONAVIR,Hepatic enzyme increased,7
NIRMATRELVIR\RITONAVIR,Liver injury,6
NIRMATRELVIR\RITONAVIR,Abdominal distension,6
NIRMATRELVIR\RITONAVIR,Drug-induced liver injury,6
NIRMATRELVIR\RITONAVIR,Dizziness,5
NIRMATRELVIR\RITONAVIR,Transaminases increased,5
NIRMATRELVIR\RITONAVIR,Vomiting,4
NIRMATRELVIR\RITONAVIR,Renal impairment,4
NIRMATRELVIR\RITONAVIR,Hallucination,4
NIRMATRELVIR\RITONAVIR,Decreased appetite,3
NIRMATRELVIR\RITONAVIR,Condition aggravated,3
NIRMATRELVIR\RITONAVIR,Dysgeusia,3
NIRMATRELVIR\RITONAVIR,Chest discomfort,3
NIRMATRELVIR\RITONAVIR,Blood pressure increased,3
NIRMATRELVIR\RITONAVIR,Pruritus,3
NIRMATRELVIR\RITONAVIR,Product prescribing error,2
NIRMATRELVIR\RITONAVIR,Headache,2
NIRMATRELVIR\RITONAVIR,Taste disorder,2
NIRMATRELVIR\RITONAVIR,Somnolence,2
NIRMATRELVIR\RITONAVIR,Abdominal pain,2
NIRMATRELVIR\RITONAVIR,Asthenia,2
NIRMATRELVIR\RITONAVIR,Oedema peripheral,2
NIRMATRELVIR\RITONAVIR,Bradycardia,2
NIRMATRELVIR\RITONAVIR,Contraindicated product administered,2
NIRMATRELVIR\RITONAVIR,Hypotension,2
NIRMATRELVIR\RITONAVIR,Discomfort,2
NIRMATRELVIR\RITONAVIR,Mental disorder,2
NIRMATRELVIR\RITONAVIR,Heart rate decreased,2
NIRMATRELVIR\RITONAVIR,Palpitations,2
NIRMATRELVIR\RITONAVIR,Hiccups,2
NIRMATRELVIR\RITONAVIR,Klebsiella infection,1
NIRMATRELVIR\RITONAVIR,Marasmus,1
NIRMATRELVIR\RITONAVIR,Melaena,1
NIRMATRELVIR\RITONAVIR,Hepatic failure,1
NIRMATRELVIR\RITONAVIR,Blood creatinine increased,1
NIRMATRELVIR\RITONAVIR,Hypertension,1
NIRMATRELVIR\RITONAVIR,Maternal exposure during pregnancy,1
NIRMATRELVIR\RITONAVIR,Listless,1
NIRMATRELVIR\RITONAVIR,Dysphoria,1
NIRMATRELVIR\RITONAVIR,Mania,1
NIRMATRELVIR\RITONAVIR,Communication disorder,1
NITROFURANTOIN,Urinary tract infection,12
NITROFURANTOIN,Myalgia,12
NITROFURANTOIN,Pain,11
NITROFURANTOIN,Arthralgia,11
NITROFURANTOIN,Fatigue,10
NITROFURANTOIN,Abdominal pain,9
NITROFURANTOIN,Dizziness,8
NITROFURANTOIN,Migraine,8
NITROFURANTOIN,Anxiety,7
NITROFURANTOIN,Cystitis,7
NITROFURANTOIN,Tinnitus,7
NITROFURANTOIN,Back pain,6
NITROFURANTOIN,Diarrhoea,6
NITROFURANTOIN,Atrial fibrillation,6
NITROFURANTOIN,Insomnia,5
NITROFURANTOIN,Nausea,5
NITROFURANTOIN,Product dose omission issue,5
NITROFURANTOIN,Weight decreased,5
NITROFURANTOIN,Off label use,5
NITROFURANTOIN,Malaise,5
NITROFURANTOIN,Abdominal pain upper,5
NITROFURANTOIN,Vomiting,5
NITROFURANTOIN,Feeling abnormal,5
NITROFURANTOIN,Adverse drug reaction,5
NITROFURANTOIN,Tendon pain,5
NITROFURANTOIN,Muscular weakness,5
NITROFURANTOIN,Neuralgia,5
NITROFURANTOIN,Hypoaesthesia,5
NITROFURANTOIN,Depression,4
NITROFURANTOIN,Osteoporosis,4
NITROFURANTOIN,Acute kidney injury,4
NITROFURANTOIN,Fall,4
NITROFURANTOIN,Visual impairment,4
NITROFURANTOIN,Rash pruritic,4
NITROFURANTOIN,Sleep disorder,4
NITROFURANTOIN,Dyspnoea,4
NITROFURANTOIN,Anhedonia,3
NITROFURANTOIN,Emotional distress,3
NITROFURANTOIN,Fungal infection,3
NITROFURANTOIN,Decreased appetite,3
NITROFURANTOIN,Insurance issue,3
NITROFURANTOIN,Pneumonia,3
NITROFURANTOIN,Illness,3
NITROFURANTOIN,Chills,3
NITROFURANTOIN,Hallucination,3
NITROFURANTOIN,Condition aggravated,3
NITROFURANTOIN,Agitation,3
NITROFURANTOIN,Stomatitis,3
NITROFURANTOIN,Vision blurred,3
NITROFURANTOIN,Confusional state,3
NITROGLYCERIN,Asthenia,20
NITROGLYCERIN,Fatigue,18
NITROGLYCERIN,Diarrhoea,14
NITROGLYCERIN,Anxiety,13
NITROGLYCERIN,Pain,13
NITROGLYCERIN,Pneumonia,12
NITROGLYCERIN,Chronic kidney disease,12
NITROGLYCERIN,Nausea,12
NITROGLYCERIN,Renal impairment,10
NITROGLYCERIN,Myocardial infarction,10
NITROGLYCERIN,Dizziness,10
NITROGLYCERIN,Anhedonia,9
NITROGLYCERIN,Emotional distress,9
NITROGLYCERIN,Dyspnoea,9
NITROGLYCERIN,Condition aggravated,9
NITROGLYCERIN,Gait disturbance,8
NITROGLYCERIN,Vomiting,8
NITROGLYCERIN,Abdominal pain,8
NITROGLYCERIN,Off label use,8
NITROGLYCERIN,Headache,8
NITROGLYCERIN,Depression,7
NITROGLYCERIN,Pain in extremity,7
NITROGLYCERIN,Sepsis,7
NITROGLYCERIN,Stevens-Johnson syndrome,7
NITROGLYCERIN,Malaise,6
NITROGLYCERIN,Pyrexia,6
NITROGLYCERIN,Urinary tract infection,6
NITROGLYCERIN,Back pain,6
NITROGLYCERIN,Product dose omission issue,6
NITROGLYCERIN,Abdominal pain upper,6
NITROGLYCERIN,Drug intolerance,6
NITROGLYCERIN,Constipation,6
NITROGLYCERIN,Death,6
NITROGLYCERIN,Thrombosis,6
NITROGLYCERIN,Chest pain,5
NITROGLYCERIN,Anaemia,5
NITROGLYCERIN,Fall,5
NITROGLYCERIN,Weight decreased,5
NITROGLYCERIN,Inappropriate schedule of product administration,5
NITROGLYCERIN,Blood pressure increased,5
NITROGLYCERIN,COVID-19,5
NITROGLYCERIN,Rash,5
NITROGLYCERIN,Bronchitis,5
NITROGLYCERIN,Myalgia,5
NITROGLYCERIN,Drug interaction,5
NITROGLYCERIN,Odynophagia,5
NITROGLYCERIN,Liver disorder,5
NITROGLYCERIN,Atrial fibrillation,5
NITROGLYCERIN,Abdominal discomfort,5
NITROGLYCERIN,Chest discomfort,4
NIVOLUMAB,Diarrhoea,18
NIVOLUMAB,Anaemia,16
NIVOLUMAB,Pyrexia,14
NIVOLUMAB,Vomiting,14
NIVOLUMAB,Malignant neoplasm progression,13
NIVOLUMAB,Thrombocytopenia,12
NIVOLUMAB,Pneumonia,11
NIVOLUMAB,Off label use,10
NIVOLUMAB,Nausea,10
NIVOLUMAB,Asthenia,9
NIVOLUMAB,Alanine aminotransferase increased,8
NIVOLUMAB,Aspartate aminotransferase increased,8
NIVOLUMAB,Pneumonitis,8
NIVOLUMAB,Somnolence,7
NIVOLUMAB,Dyspnoea,6
NIVOLUMAB,Myocarditis,6
NIVOLUMAB,Colitis,6
NIVOLUMAB,Acute kidney injury,6
NIVOLUMAB,Hypokalaemia,6
NIVOLUMAB,Febrile neutropenia,6
NIVOLUMAB,Neutropenia,6
NIVOLUMAB,Hyponatraemia,6
NIVOLUMAB,Capillary leak syndrome,6
NIVOLUMAB,Myositis,5
NIVOLUMAB,Platelet count decreased,5
NIVOLUMAB,Immune-mediated enterocolitis,5
NIVOLUMAB,Hypothyroidism,5
NIVOLUMAB,Paraparesis,5
NIVOLUMAB,Rash maculo-papular,5
NIVOLUMAB,Hepatic cytolysis,5
NIVOLUMAB,Type 2 diabetes mellitus,5
NIVOLUMAB,Weight decreased,5
NIVOLUMAB,Arthralgia,5
NIVOLUMAB,Adrenal insufficiency,5
NIVOLUMAB,General physical health deterioration,5
NIVOLUMAB,Chest pain,5
NIVOLUMAB,Confusional state,5
NIVOLUMAB,Decreased appetite,5
NIVOLUMAB,Thyroiditis,4
NIVOLUMAB,Myasthenia gravis,4
NIVOLUMAB,Prescribed overdose,4
NIVOLUMAB,Cardiac failure,4
NIVOLUMAB,Atrial fibrillation,4
NIVOLUMAB,Hyperthyroidism,4
NIVOLUMAB,White blood cell count decreased,4
NIVOLUMAB,Blood bilirubin increased,4
NIVOLUMAB,Hypophysitis,4
NIVOLUMAB,Diabetic ketoacidosis,4
NIVOLUMAB,Hydrothorax,4
NIVOLUMAB,Pelvic abscess,4
NORCO,Fatigue,15
NORCO,Pain,15
NORCO,Product dose omission issue,12
NORCO,Weight decreased,10
NORCO,Diarrhoea,10
NORCO,Anxiety,9
NORCO,COVID-19,9
NORCO,Malaise,9
NORCO,Asthenia,9
NORCO,Headache,8
NORCO,Sinusitis,8
NORCO,Illness,8
NORCO,Pneumonia,8
NORCO,Arthralgia,7
NORCO,Feeling abnormal,7
NORCO,Emotional distress,7
NORCO,Anhedonia,7
NORCO,Bronchitis,7
NORCO,Decreased appetite,7
NORCO,Vomiting,7
NORCO,Fall,7
NORCO,Off label use,6
NORCO,Depression,6
NORCO,Urinary tract infection,6
NORCO,Nasopharyngitis,6
NORCO,Nausea,6
NORCO,Cough,6
NORCO,Condition aggravated,6
NORCO,Infection,5
NORCO,Dizziness,5
NORCO,Blood pressure increased,5
NORCO,Constipation,5
NORCO,Migraine,5
NORCO,Pruritus,5
NORCO,Drug ineffective,5
NORCO,Pyrexia,5
NORCO,Peripheral swelling,4
NORCO,Nephrolithiasis,4
NORCO,Intentional product use issue,4
NORCO,Upper respiratory tract infection,4
NORCO,Ear infection,4
NORCO,Muscle spasms,4
NORCO,Alopecia,4
NORCO,Chronic kidney disease,4
NORCO,Dyspnoea,4
NORCO,Seizure,4
NORCO,Hypophosphataemia,4
NORCO,Death,4
NORCO,Anaemia,4
NORCO,Pain in extremity,4
NOREPINEPHRINE,Acute generalised exanthematous pustulosis,14
NOREPINEPHRINE,Multiple organ dysfunction syndrome,12
NOREPINEPHRINE,Off label use,10
NOREPINEPHRINE,Cardiogenic shock,9
NOREPINEPHRINE,Sepsis,9
NOREPINEPHRINE,Death,9
NOREPINEPHRINE,Nausea,9
NOREPINEPHRINE,Stress,8
NOREPINEPHRINE,Incorrect route of product administration,8
NOREPINEPHRINE,Vomiting,8
NOREPINEPHRINE,Ascites,8
NOREPINEPHRINE,Constipation,8
NOREPINEPHRINE,Abdominal distension,8
NOREPINEPHRINE,Dyspnoea,8
NOREPINEPHRINE,Dry mouth,7
NOREPINEPHRINE,Condition aggravated,7
NOREPINEPHRINE,Somnolence,7
NOREPINEPHRINE,Abdominal pain,7
NOREPINEPHRINE,Bradycardia,7
NOREPINEPHRINE,Bacterial infection,6
NOREPINEPHRINE,Neuralgia,6
NOREPINEPHRINE,Swelling,6
NOREPINEPHRINE,Hypotension,6
NOREPINEPHRINE,Drug hypersensitivity,5
NOREPINEPHRINE,Drug intolerance,5
NOREPINEPHRINE,Intentional product misuse,5
NOREPINEPHRINE,Appendicolith,5
NOREPINEPHRINE,Hyponatraemia,5
NOREPINEPHRINE,General physical health deterioration,5
NOREPINEPHRINE,Ventricular fibrillation,5
NOREPINEPHRINE,Appendicitis,5
NOREPINEPHRINE,Sleep disorder,5
NOREPINEPHRINE,Product use in unapproved indication,4
NOREPINEPHRINE,Blood cholesterol increased,4
NOREPINEPHRINE,Blood phosphorus increased,4
NOREPINEPHRINE,Myasthenia gravis,4
NOREPINEPHRINE,Blood uric acid increased,4
NOREPINEPHRINE,Pyrexia,4
NOREPINEPHRINE,Septic shock,4
NOREPINEPHRINE,Anaphylactic shock,4
NOREPINEPHRINE,Anaemia,4
NOREPINEPHRINE,Drug reaction with eosinophilia and systemic symptoms,4
NOREPINEPHRINE,Pulmonary embolism,3
NOREPINEPHRINE,Diabetes mellitus,3
NOREPINEPHRINE,Haemorrhage,3
NOREPINEPHRINE,Platelet count decreased,3
NOREPINEPHRINE,Respiratory failure,3
NOREPINEPHRINE,Shock,3
NOREPINEPHRINE,Acute kidney injury,2
NOREPINEPHRINE,Pleural effusion,2
NORVASC,Malaise,11
NORVASC,Pain,11
NORVASC,Fatigue,11
NORVASC,Product dose omission issue,10
NORVASC,Headache,10
NORVASC,Nausea,10
NORVASC,Inappropriate schedule of product administration,9
NORVASC,Off label use,9
NORVASC,COVID-19,9
NORVASC,Dyspnoea,9
NORVASC,Pneumonia,8
NORVASC,Dizziness,8
NORVASC,Cough,8
NORVASC,Fall,7
NORVASC,Anxiety,7
NORVASC,Sinusitis,7
NORVASC,Urinary tract infection,7
NORVASC,Weight decreased,7
NORVASC,Prescribed overdose,6
NORVASC,Emotional distress,6
NORVASC,Blood pressure increased,6
NORVASC,Decreased appetite,6
NORVASC,Vomiting,6
NORVASC,Rash,6
NORVASC,Balance disorder,5
NORVASC,Weight increased,5
NORVASC,Viral infection,5
NORVASC,Nasopharyngitis,5
NORVASC,Haematochezia,5
NORVASC,Depression,5
NORVASC,Anhedonia,5
NORVASC,Blood creatinine increased,5
NORVASC,Hypertension,5
NORVASC,Asthenia,5
NORVASC,Chronic kidney disease,5
NORVASC,Illness,5
NORVASC,Condition aggravated,5
NORVASC,Upper respiratory tract infection,5
NORVASC,Psoriasis,4
NORVASC,Diarrhoea,4
NORVASC,Limb injury,4
NORVASC,Mobility decreased,4
NORVASC,C-reactive protein increased,4
NORVASC,Haemoglobin decreased,4
NORVASC,Asthma,4
NORVASC,Back pain,4
NORVASC,Alanine aminotransferase increased,4
NORVASC,Drug ineffective,4
NORVASC,Chest pain,4
NORVASC,Peripheral swelling,3
NORVIR,Pain,136
NORVIR,Emotional distress,135
NORVIR,Anxiety,127
NORVIR,Anhedonia,126
NORVIR,Chronic kidney disease,75
NORVIR,Osteoporosis,59
NORVIR,Renal failure,48
NORVIR,Osteopenia,43
NORVIR,Bone density decreased,36
NORVIR,Bone demineralisation,35
NORVIR,Depression,33
NORVIR,Multiple fractures,27
NORVIR,Renal impairment,27
NORVIR,Acute kidney injury,25
NORVIR,Fatigue,23
NORVIR,Blood creatinine increased,22
NORVIR,Economic problem,21
NORVIR,Asthenia,20
NORVIR,Gait disturbance,18
NORVIR,End stage renal disease,17
NORVIR,Bone loss,15
NORVIR,Renal injury,14
NORVIR,Foot fracture,13
NORVIR,Decreased activity,12
NORVIR,Loss of personal independence in daily activities,12
NORVIR,Back pain,12
NORVIR,Nephropathy,11
NORVIR,Quality of life decreased,11
NORVIR,Insomnia,11
NORVIR,Skeletal injury,10
NORVIR,Osteonecrosis,9
NORVIR,Proteinuria,8
NORVIR,Ankle fracture,8
NORVIR,Hypertension,8
NORVIR,Mobility decreased,7
NORVIR,Anaemia,7
NORVIR,Fracture,6
NORVIR,Tooth loss,6
NORVIR,Rib fracture,6
NORVIR,Vitamin D deficiency,6
NORVIR,Drug ineffective,6
NORVIR,Wrist fracture,5
NORVIR,Nephrolithiasis,5
NORVIR,Hip fracture,5
NORVIR,Pollakiuria,5
NORVIR,Pain in extremity,4
NORVIR,Pathological fracture,4
NORVIR,Fanconi syndrome acquired,4
NORVIR,Osteoarthritis,4
NORVIR,Chronic kidney disease-mineral and bone disorder,4
NOVOLOG,Pain,13
NOVOLOG,Product dose omission issue,10
NOVOLOG,Anxiety,10
NOVOLOG,Fatigue,10
NOVOLOG,Depression,9
NOVOLOG,Fall,7
NOVOLOG,Anhedonia,7
NOVOLOG,Emotional distress,7
NOVOLOG,Acute kidney injury,7
NOVOLOG,Hypertension,6
NOVOLOG,Chronic kidney disease,6
NOVOLOG,Asthenia,5
NOVOLOG,Urinary tract infection,5
NOVOLOG,Sinusitis,5
NOVOLOG,Off label use,5
NOVOLOG,Arthropathy,4
NOVOLOG,COVID-19,4
NOVOLOG,Foot fracture,4
NOVOLOG,Cough,4
NOVOLOG,Renal failure,4
NOVOLOG,Nausea,4
NOVOLOG,Vomiting,4
NOVOLOG,Bronchitis,4
NOVOLOG,Headache,4
NOVOLOG,Chills,3
NOVOLOG,Rhinorrhoea,3
NOVOLOG,Blood glucose increased,3
NOVOLOG,Blood potassium decreased,3
NOVOLOG,Balance disorder,3
NOVOLOG,Blood pressure increased,3
NOVOLOG,Mobility decreased,3
NOVOLOG,Dizziness,3
NOVOLOG,Decreased appetite,3
NOVOLOG,Bone density decreased,3
NOVOLOG,Renal injury,3
NOVOLOG,Dyspnoea,3
NOVOLOG,Malaise,3
NOVOLOG,Pneumonia,3
NOVOLOG,Diarrhoea,3
NOVOLOG,Pelvic fracture,2
NOVOLOG,Infusion related reaction,2
NOVOLOG,Liquid product physical issue,2
NOVOLOG,Inappropriate schedule of product administration,2
NOVOLOG,Foot deformity,2
NOVOLOG,Condition aggravated,2
NOVOLOG,Blood glucose abnormal,2
NOVOLOG,Wound haemorrhage,2
NOVOLOG,Limb injury,2
NOVOLOG,Chest injury,2
NOVOLOG,Hypersensitivity,2
NOVORAPID,Acute kidney injury,12
NOVORAPID,Diarrhoea,11
NOVORAPID,International normalised ratio abnormal,9
NOVORAPID,Hypotension,9
NOVORAPID,Polyuria,9
NOVORAPID,Overdose,9
NOVORAPID,Medication error,9
NOVORAPID,Hyponatraemia,9
NOVORAPID,Dialysis,7
NOVORAPID,Vomiting,7
NOVORAPID,Nausea,7
NOVORAPID,Diabetic ketoacidosis,7
NOVORAPID,Pyrexia,6
NOVORAPID,Blood glucose increased,6
NOVORAPID,Inappropriate antidiuretic hormone secretion,6
NOVORAPID,Abdominal pain,5
NOVORAPID,Dizziness,5
NOVORAPID,Hypoglycaemia,5
NOVORAPID,Asthenia,5
NOVORAPID,Malaise,4
NOVORAPID,Oropharyngeal pain,4
NOVORAPID,COVID-19,4
NOVORAPID,Weight decreased,4
NOVORAPID,Myocardial infarction,4
NOVORAPID,Off label use,4
NOVORAPID,Decreased appetite,4
NOVORAPID,General physical health deterioration,4
NOVORAPID,Ascites,3
NOVORAPID,Chest pain,3
NOVORAPID,Cystitis,3
NOVORAPID,Rash,3
NOVORAPID,Pneumonia,3
NOVORAPID,Pruritus,3
NOVORAPID,Condition aggravated,3
NOVORAPID,Hyperhidrosis,3
NOVORAPID,Depression,3
NOVORAPID,Fatigue,3
NOVORAPID,Drug ineffective,3
NOVORAPID,Dyspnoea,3
NOVORAPID,Death,3
NOVORAPID,Stress,3
NOVORAPID,Pleurisy,3
NOVORAPID,Hyperkalaemia,3
NOVORAPID,Palpitations,3
NOVORAPID,Odynophagia,3
NOVORAPID,Renal impairment,3
NOVORAPID,Intentional product misuse,2
NOVORAPID,Drug abuse,2
NOVORAPID,Constipation,2
NOVORAPID,Abdominal distension,2
NUPLAZID,Hallucination,36
NUPLAZID,Product dose omission issue,34
NUPLAZID,Death,16
NUPLAZID,Fall,15
NUPLAZID,Delusion,11
NUPLAZID,Drug ineffective,10
NUPLAZID,Insomnia,9
NUPLAZID,Peripheral swelling,9
NUPLAZID,Nonspecific reaction,8
NUPLAZID,Inappropriate schedule of product administration,8
NUPLAZID,Confusional state,8
NUPLAZID,"Hallucination, visual",8
NUPLAZID,Memory impairment,8
NUPLAZID,Aggression,7
NUPLAZID,Abnormal behaviour,7
NUPLAZID,Condition aggravated,7
NUPLAZID,Gait disturbance,6
NUPLAZID,Nausea,6
NUPLAZID,Dysarthria,6
NUPLAZID,Urinary tract infection,6
NUPLAZID,Amnesia,5
NUPLAZID,Head injury,5
NUPLAZID,Suicidal ideation,5
NUPLAZID,Dyspnoea,5
NUPLAZID,Therapeutic product effect decreased,5
NUPLAZID,Agitation,5
NUPLAZID,Somnolence,5
NUPLAZID,Tremor,5
NUPLAZID,Fatigue,5
NUPLAZID,Feeling abnormal,5
NUPLAZID,Disorientation,4
NUPLAZID,Balance disorder,4
NUPLAZID,General physical health deterioration,4
NUPLAZID,Sleep talking,4
NUPLAZID,Sleep disorder,4
NUPLAZID,COVID-19,4
NUPLAZID,Asthenia,4
NUPLAZID,Dizziness,4
NUPLAZID,Palpitations,4
NUPLAZID,Depression,3
NUPLAZID,Dyspepsia,3
NUPLAZID,Chest discomfort,3
NUPLAZID,Speech disorder,3
NUPLAZID,Oedema peripheral,3
NUPLAZID,Dementia,3
NUPLAZID,Herpes zoster,3
NUPLAZID,Hypokinesia,3
NUPLAZID,Drooling,3
NUPLAZID,Contusion,3
NUPLAZID,Therapeutic response unexpected,3
NURTEC ODT,Drug ineffective,15
NURTEC ODT,Off label use,10
NURTEC ODT,Nausea,7
NURTEC ODT,Fatigue,6
NURTEC ODT,Migraine,6
NURTEC ODT,Headache,5
NURTEC ODT,Inappropriate schedule of product administration,5
NURTEC ODT,Vomiting,5
NURTEC ODT,Dizziness,5
NURTEC ODT,Malaise,4
NURTEC ODT,COVID-19,4
NURTEC ODT,Illness,4
NURTEC ODT,Dyspepsia,4
NURTEC ODT,Nasopharyngitis,3
NURTEC ODT,Cough,3
NURTEC ODT,Chest discomfort,3
NURTEC ODT,Pain,3
NURTEC ODT,Feeling abnormal,3
NURTEC ODT,Anxiety,3
NURTEC ODT,Throat irritation,2
NURTEC ODT,Back pain,2
NURTEC ODT,Contusion,2
NURTEC ODT,Sinusitis,2
NURTEC ODT,Abdominal discomfort,2
NURTEC ODT,Oropharyngeal pain,2
NURTEC ODT,Fall,2
NURTEC ODT,Product dose omission issue,2
NURTEC ODT,Insomnia,2
NURTEC ODT,Arthralgia,2
NURTEC ODT,Pain in extremity,2
NURTEC ODT,Chest pain,2
NURTEC ODT,Hypersensitivity,2
NURTEC ODT,Depression,2
NURTEC ODT,Incorrect dose administered,2
NURTEC ODT,Influenza like illness,1
NURTEC ODT,Thirst,1
NURTEC ODT,Dysuria,1
NURTEC ODT,Skin irritation,1
NURTEC ODT,Renal pain,1
NURTEC ODT,Adenovirus infection,1
NURTEC ODT,Myocardial infarction,1
NURTEC ODT,COVID-19 immunisation,1
NURTEC ODT,Influenza,1
NURTEC ODT,Skin reaction,1
NURTEC ODT,Infusion site extravasation,1
NURTEC ODT,Prolapse,1
NURTEC ODT,Back injury,1
NURTEC ODT,Upper respiratory tract infection,1
NURTEC ODT,Flank pain,1
NURTEC ODT,Hiccups,1
NYSTATIN,Fatigue,26
NYSTATIN,Nausea,21
NYSTATIN,Diarrhoea,18
NYSTATIN,Product dose omission issue,16
NYSTATIN,Vomiting,16
NYSTATIN,Pain,15
NYSTATIN,Weight decreased,15
NYSTATIN,Headache,15
NYSTATIN,Dyspnoea,13
NYSTATIN,Pyrexia,12
NYSTATIN,Arthralgia,11
NYSTATIN,Anxiety,10
NYSTATIN,Off label use,10
NYSTATIN,Malaise,10
NYSTATIN,COVID-19,10
NYSTATIN,Inappropriate schedule of product administration,9
NYSTATIN,Illness,9
NYSTATIN,Pneumonia,9
NYSTATIN,Decreased appetite,9
NYSTATIN,Muscle spasms,9
NYSTATIN,Rash,8
NYSTATIN,Sepsis,7
NYSTATIN,Asthenia,7
NYSTATIN,Back pain,6
NYSTATIN,Asthma,6
NYSTATIN,Candida infection,6
NYSTATIN,Pruritus,6
NYSTATIN,Influenza like illness,6
NYSTATIN,Bronchitis,6
NYSTATIN,General physical health deterioration,6
NYSTATIN,Product use issue,6
NYSTATIN,Erythema,6
NYSTATIN,Fall,6
NYSTATIN,Cough,6
NYSTATIN,Abdominal pain,6
NYSTATIN,Constipation,6
NYSTATIN,Abdominal discomfort,6
NYSTATIN,Abdominal distension,6
NYSTATIN,Hypertension,6
NYSTATIN,Upper respiratory tract infection,6
NYSTATIN,Sinusitis,6
NYSTATIN,Feeling abnormal,6
NYSTATIN,Dysphagia,6
NYSTATIN,Injection site pain,5
NYSTATIN,Swelling,5
NYSTATIN,Hypersensitivity,5
NYSTATIN,Weight increased,5
NYSTATIN,Insurance issue,5
NYSTATIN,Myalgia,5
NYSTATIN,Dehydration,5
OBINUTUZUMAB,Myelosuppression,14
OBINUTUZUMAB,COVID-19,12
OBINUTUZUMAB,COVID-19 pneumonia,11
OBINUTUZUMAB,Infusion related reaction,10
OBINUTUZUMAB,Vaccination failure,7
OBINUTUZUMAB,Pyrexia,6
OBINUTUZUMAB,Weight decreased,5
OBINUTUZUMAB,Dyspnoea,5
OBINUTUZUMAB,Thrombocytopenia,4
OBINUTUZUMAB,Platelet count decreased,4
OBINUTUZUMAB,Neutropenia,4
OBINUTUZUMAB,Hyperkalaemia,4
OBINUTUZUMAB,Hypersensitivity pneumonitis,4
OBINUTUZUMAB,Disease progression,3
OBINUTUZUMAB,Hepatic function abnormal,3
OBINUTUZUMAB,Lymphoma,3
OBINUTUZUMAB,White blood cell count decreased,3
OBINUTUZUMAB,Off label use,3
OBINUTUZUMAB,Respiratory failure,3
OBINUTUZUMAB,Pneumonitis,3
OBINUTUZUMAB,Lung infiltration,3
OBINUTUZUMAB,Pleurisy,3
OBINUTUZUMAB,Febrile neutropenia,3
OBINUTUZUMAB,Cytomegalovirus infection reactivation,2
OBINUTUZUMAB,Leukopenia,2
OBINUTUZUMAB,Lymphopenia,2
OBINUTUZUMAB,Anaemia,2
OBINUTUZUMAB,Cytomegalovirus chorioretinitis,2
OBINUTUZUMAB,Myelodysplastic syndrome,2
OBINUTUZUMAB,Neutrophil count decreased,2
OBINUTUZUMAB,Pneumocystis jirovecii infection,2
OBINUTUZUMAB,Interstitial lung disease,2
OBINUTUZUMAB,Cytopenia,2
OBINUTUZUMAB,Atrial fibrillation,2
OBINUTUZUMAB,Pyelonephritis,2
OBINUTUZUMAB,Hepatic cytolysis,2
OBINUTUZUMAB,Ovarian failure,2
OBINUTUZUMAB,Tumour invasion,1
OBINUTUZUMAB,Fluid intake reduced,1
OBINUTUZUMAB,Malnutrition,1
OBINUTUZUMAB,Faecaloma,1
OBINUTUZUMAB,Hyperuricaemia,1
OBINUTUZUMAB,Hypokalaemia,1
OBINUTUZUMAB,Vitamin D deficiency,1
OBINUTUZUMAB,Sciatica,1
OBINUTUZUMAB,Fall,1
OBINUTUZUMAB,Myocardial ischaemia,1
OBINUTUZUMAB,Slipping rib syndrome,1
OBINUTUZUMAB,Hypoglycaemia,1
OBINUTUZUMAB,Hypophagia,1
OCREVUS,COVID-19,23
OCREVUS,Fatigue,22
OCREVUS,Pain in extremity,22
OCREVUS,Asthenia,20
OCREVUS,Headache,18
OCREVUS,Arthralgia,16
OCREVUS,Gait disturbance,15
OCREVUS,Nausea,13
OCREVUS,Off label use,13
OCREVUS,Paraesthesia,12
OCREVUS,Musculoskeletal stiffness,12
OCREVUS,Hypoaesthesia,11
OCREVUS,Nasopharyngitis,10
OCREVUS,Urinary incontinence,10
OCREVUS,Multiple sclerosis relapse,9
OCREVUS,Dizziness,9
OCREVUS,Weight increased,9
OCREVUS,Back pain,9
OCREVUS,Somnolence,9
OCREVUS,Chills,8
OCREVUS,Muscular weakness,8
OCREVUS,Fall,8
OCREVUS,Myalgia,8
OCREVUS,White blood cell count decreased,8
OCREVUS,Influenza,7
OCREVUS,Erythema,7
OCREVUS,Blood pressure increased,7
OCREVUS,Vision blurred,7
OCREVUS,Multiple sclerosis,6
OCREVUS,Dyspnoea,6
OCREVUS,Muscle spasticity,6
OCREVUS,Pain,6
OCREVUS,Urinary tract infection,6
OCREVUS,Diplopia,6
OCREVUS,Maternal exposure before pregnancy,6
OCREVUS,Neutrophilia,6
OCREVUS,Decreased vibratory sense,6
OCREVUS,Urinary retention,6
OCREVUS,Micturition urgency,6
OCREVUS,Drug ineffective,5
OCREVUS,Body temperature increased,5
OCREVUS,Diarrhoea,5
OCREVUS,Heart rate increased,5
OCREVUS,Weight decreased,5
OCREVUS,Constipation,5
OCREVUS,Pruritus,5
OCREVUS,Bronchitis,4
OCREVUS,Uhthoff's phenomenon,4
OCREVUS,Depressed mood,4
OCREVUS,Sensory disturbance,4
OFEV,Diarrhoea,48
OFEV,Dyspnoea,36
OFEV,Cough,24
OFEV,Nausea,24
OFEV,Oxygen saturation decreased,21
OFEV,Headache,17
OFEV,Weight decreased,15
OFEV,Fatigue,15
OFEV,Decreased appetite,15
OFEV,Idiopathic pulmonary fibrosis,13
OFEV,Dizziness,11
OFEV,Vomiting,11
OFEV,Asthenia,11
OFEV,Peripheral swelling,10
OFEV,Dyspnoea exertional,10
OFEV,Abdominal pain,9
OFEV,Abdominal discomfort,9
OFEV,Hypotension,8
OFEV,Oedema peripheral,8
OFEV,Urinary tract infection,8
OFEV,Pain,8
OFEV,Nasopharyngitis,7
OFEV,Pneumonia,7
OFEV,Anxiety,7
OFEV,Hypertension,7
OFEV,Constipation,7
OFEV,Dehydration,6
OFEV,Interstitial lung disease,6
OFEV,Abdominal pain upper,6
OFEV,Death,6
OFEV,COVID-19,5
OFEV,Productive cough,5
OFEV,Fall,5
OFEV,Anaemia,5
OFEV,Rectal haemorrhage,5
OFEV,Chest discomfort,5
OFEV,Feeling abnormal,5
OFEV,Taste disorder,5
OFEV,Illness,5
OFEV,Throat irritation,5
OFEV,Infection,5
OFEV,Dyspepsia,4
OFEV,Atrial fibrillation,4
OFEV,Diabetes mellitus,4
OFEV,Flushing,4
OFEV,Alopecia,4
OFEV,Abdominal distension,4
OFEV,Epistaxis,4
OFEV,Pain in extremity,4
OFEV,Back pain,4
OFLOXACIN,Back pain,15
OFLOXACIN,Insomnia,13
OFLOXACIN,Anxiety,13
OFLOXACIN,Dyspnoea,13
OFLOXACIN,Fatigue,12
OFLOXACIN,Arthralgia,12
OFLOXACIN,Memory impairment,12
OFLOXACIN,Tendon pain,12
OFLOXACIN,Tinnitus,11
OFLOXACIN,Visual impairment,10
OFLOXACIN,Asthenia,10
OFLOXACIN,Tendonitis,9
OFLOXACIN,Muscle twitching,9
OFLOXACIN,Hypoaesthesia,8
OFLOXACIN,Abdominal pain,7
OFLOXACIN,Pain,7
OFLOXACIN,Neuralgia,7
OFLOXACIN,Vision blurred,7
OFLOXACIN,Paraesthesia,7
OFLOXACIN,Pain in extremity,6
OFLOXACIN,Depression,6
OFLOXACIN,Myalgia,6
OFLOXACIN,Muscle atrophy,6
OFLOXACIN,Palpitations,6
OFLOXACIN,Medication error,6
OFLOXACIN,Feeling abnormal,6
OFLOXACIN,Nervous system disorder,5
OFLOXACIN,Bladder pain,5
OFLOXACIN,Nausea,5
OFLOXACIN,Neck pain,5
OFLOXACIN,Sleep disorder,5
OFLOXACIN,Inappropriate antidiuretic hormone secretion,5
OFLOXACIN,Peripheral swelling,5
OFLOXACIN,Confusional state,5
OFLOXACIN,Urinary incontinence,5
OFLOXACIN,Renal pain,5
OFLOXACIN,Bladder irritation,5
OFLOXACIN,Abnormal loss of weight,5
OFLOXACIN,Tremor,5
OFLOXACIN,COVID-19,4
OFLOXACIN,Neuroleptic malignant syndrome,4
OFLOXACIN,"Hallucinations, mixed",4
OFLOXACIN,Syncope,4
OFLOXACIN,Electric shock sensation,4
OFLOXACIN,Rectal spasm,4
OFLOXACIN,Head discomfort,4
OFLOXACIN,Muscle disorder,4
OFLOXACIN,Burning sensation,4
OFLOXACIN,Penile pain,4
OFLOXACIN,Vomiting,3
OLANZAPINE,Fatigue,24
OLANZAPINE,Nausea,24
OLANZAPINE,Overdose,19
OLANZAPINE,Off label use,18
OLANZAPINE,Medication error,16
OLANZAPINE,Acute kidney injury,14
OLANZAPINE,Diarrhoea,14
OLANZAPINE,Seizure,14
OLANZAPINE,Platelet count decreased,13
OLANZAPINE,Psychotic disorder,13
OLANZAPINE,COVID-19,12
OLANZAPINE,Extrapyramidal disorder,12
OLANZAPINE,Neutropenia,12
OLANZAPINE,Coma,12
OLANZAPINE,Lymphocyte count decreased,11
OLANZAPINE,Incorrect dose administered,11
OLANZAPINE,Disease progression,11
OLANZAPINE,"Hallucination, auditory",11
OLANZAPINE,Weight decreased,11
OLANZAPINE,Dyspnoea,11
OLANZAPINE,Hypotension,10
OLANZAPINE,Pain,10
OLANZAPINE,Neuropathy peripheral,10
OLANZAPINE,Affective disorder,10
OLANZAPINE,Leukopenia,10
OLANZAPINE,Cellulitis,10
OLANZAPINE,Alopecia,10
OLANZAPINE,Intentional overdose,10
OLANZAPINE,International normalised ratio abnormal,9
OLANZAPINE,Polyuria,9
OLANZAPINE,Neutrophil count increased,9
OLANZAPINE,Schizophrenia,9
OLANZAPINE,Dyspepsia,9
OLANZAPINE,Mucosal inflammation,9
OLANZAPINE,Delusion of grandeur,9
OLANZAPINE,Drug ineffective,9
OLANZAPINE,Somnolence,9
OLANZAPINE,Intentional product misuse,8
OLANZAPINE,Depression,8
OLANZAPINE,Headache,8
OLANZAPINE,Rhinalgia,8
OLANZAPINE,Hypoaesthesia,8
OLANZAPINE,Product use in unapproved indication,8
OLANZAPINE,Electrocardiogram QT prolonged,8
OLANZAPINE,Hallucination,7
OLANZAPINE,Anxiety,7
OLANZAPINE,Pain in extremity,7
OLANZAPINE,Lymphocyte count abnormal,7
OLANZAPINE,Completed suicide,7
OLANZAPINE,Toxic skin eruption,7
OLMESARTAN,Diarrhoea,10
OLMESARTAN,Headache,7
OLMESARTAN,Fatigue,7
OLMESARTAN,Weight decreased,7
OLMESARTAN,Hypertension,6
OLMESARTAN,Condition aggravated,6
OLMESARTAN,Muscle spasms,6
OLMESARTAN,Product dose omission issue,6
OLMESARTAN,Drug ineffective,6
OLMESARTAN,Pyrexia,5
OLMESARTAN,Vision blurred,5
OLMESARTAN,Arthralgia,5
OLMESARTAN,Pain,5
OLMESARTAN,Pain in extremity,4
OLMESARTAN,Migraine,4
OLMESARTAN,Asthenia,4
OLMESARTAN,Swelling,4
OLMESARTAN,Acute kidney injury,4
OLMESARTAN,Back pain,3
OLMESARTAN,Urinary tract infection,3
OLMESARTAN,Infection,3
OLMESARTAN,Nasopharyngitis,3
OLMESARTAN,Movement disorder,3
OLMESARTAN,Pneumonia,3
OLMESARTAN,Malaise,3
OLMESARTAN,Inappropriate schedule of product administration,3
OLMESARTAN,Sinusitis,3
OLMESARTAN,Product availability issue,3
OLMESARTAN,Vomiting,3
OLMESARTAN,Joint swelling,3
OLMESARTAN,Arthritis,3
OLMESARTAN,Lymphocyte count decreased,3
OLMESARTAN,Decreased appetite,3
OLMESARTAN,Nausea,3
OLMESARTAN,Dizziness,3
OLMESARTAN,Dysgeusia,3
OLMESARTAN,Dyspnoea,3
OLMESARTAN,Dehydration,3
OLMESARTAN,General physical health deterioration,2
OLMESARTAN,Speech disorder,2
OLMESARTAN,Peripheral swelling,2
OLMESARTAN,Chest pain,2
OLMESARTAN,Rheumatoid arthritis,2
OLMESARTAN,Confusional state,2
OLMESARTAN,Renal failure,2
OLMESARTAN,Product use in unapproved indication,2
OLMESARTAN,Blood creatine phosphokinase increased,2
OLMESARTAN,Depressed mood,2
OLMESARTAN,Hereditary angioedema,2
OLMESARTAN,Eye infection,2
OLMESARTAN MEDOXOMIL,Diarrhoea,9
OLMESARTAN MEDOXOMIL,Decreased appetite,8
OLMESARTAN MEDOXOMIL,Nausea,7
OLMESARTAN MEDOXOMIL,Weight decreased,7
OLMESARTAN MEDOXOMIL,Headache,6
OLMESARTAN MEDOXOMIL,Urinary tract infection,5
OLMESARTAN MEDOXOMIL,Off label use,5
OLMESARTAN MEDOXOMIL,Pyrexia,4
OLMESARTAN MEDOXOMIL,Peripheral swelling,4
OLMESARTAN MEDOXOMIL,Pain in extremity,4
OLMESARTAN MEDOXOMIL,Condition aggravated,4
OLMESARTAN MEDOXOMIL,Diabetes mellitus,4
OLMESARTAN MEDOXOMIL,Blood pressure increased,4
OLMESARTAN MEDOXOMIL,White blood cell count decreased,4
OLMESARTAN MEDOXOMIL,Arthralgia,4
OLMESARTAN MEDOXOMIL,Cystitis,4
OLMESARTAN MEDOXOMIL,Myelosuppression,4
OLMESARTAN MEDOXOMIL,Rash,4
OLMESARTAN MEDOXOMIL,Fall,4
OLMESARTAN MEDOXOMIL,Hypokalaemia,4
OLMESARTAN MEDOXOMIL,Vomiting,4
OLMESARTAN MEDOXOMIL,Influenza,3
OLMESARTAN MEDOXOMIL,Pneumonia,3
OLMESARTAN MEDOXOMIL,Mobility decreased,3
OLMESARTAN MEDOXOMIL,Kidney infection,3
OLMESARTAN MEDOXOMIL,Hypertension,3
OLMESARTAN MEDOXOMIL,Infection,3
OLMESARTAN MEDOXOMIL,Rheumatoid arthritis,3
OLMESARTAN MEDOXOMIL,Nasopharyngitis,3
OLMESARTAN MEDOXOMIL,Prescribed underdose,3
OLMESARTAN MEDOXOMIL,Insomnia,3
OLMESARTAN MEDOXOMIL,Blood glucose increased,3
OLMESARTAN MEDOXOMIL,Platelet count decreased,3
OLMESARTAN MEDOXOMIL,Weight increased,3
OLMESARTAN MEDOXOMIL,Colitis microscopic,3
OLMESARTAN MEDOXOMIL,Sinusitis,3
OLMESARTAN MEDOXOMIL,Joint swelling,3
OLMESARTAN MEDOXOMIL,Dyspnoea,3
OLMESARTAN MEDOXOMIL,Renal pain,3
OLMESARTAN MEDOXOMIL,Rhabdomyolysis,3
OLMESARTAN MEDOXOMIL,Drug interaction,3
OLMESARTAN MEDOXOMIL,Blood creatine phosphokinase increased,3
OLMESARTAN MEDOXOMIL,Movement disorder,3
OLMESARTAN MEDOXOMIL,Underdose,3
OLMESARTAN MEDOXOMIL,Renal impairment,3
OLMESARTAN MEDOXOMIL,Acute kidney injury,3
OLMESARTAN MEDOXOMIL,Malaise,2
OLMESARTAN MEDOXOMIL,Fatigue,2
OLMESARTAN MEDOXOMIL,Chest pain,2
OLMESARTAN MEDOXOMIL,Decreased immune responsiveness,2
OMEPRAZOLE,Fatigue,253
OMEPRAZOLE,Pain,222
OMEPRAZOLE,Diarrhoea,218
OMEPRAZOLE,Headache,209
OMEPRAZOLE,Off label use,201
OMEPRAZOLE,Vomiting,200
OMEPRAZOLE,Anxiety,194
OMEPRAZOLE,Nausea,193
OMEPRAZOLE,COVID-19,187
OMEPRAZOLE,Pyrexia,185
OMEPRAZOLE,Dyspnoea,173
OMEPRAZOLE,Arthralgia,169
OMEPRAZOLE,Malaise,167
OMEPRAZOLE,Dizziness,165
OMEPRAZOLE,Pruritus,157
OMEPRAZOLE,Back pain,148
OMEPRAZOLE,Peripheral swelling,138
OMEPRAZOLE,Feeling abnormal,133
OMEPRAZOLE,Abdominal pain upper,132
OMEPRAZOLE,Abdominal discomfort,131
OMEPRAZOLE,Intentional product misuse,126
OMEPRAZOLE,Dehydration,125
OMEPRAZOLE,Insomnia,124
OMEPRAZOLE,Muscular weakness,124
OMEPRAZOLE,Hyperhidrosis,123
OMEPRAZOLE,Chest pain,121
OMEPRAZOLE,Visual impairment,115
OMEPRAZOLE,Tachycardia,114
OMEPRAZOLE,Hallucination,114
OMEPRAZOLE,Heart rate increased,114
OMEPRAZOLE,Disturbance in attention,109
OMEPRAZOLE,Migraine,108
OMEPRAZOLE,Tinnitus,108
OMEPRAZOLE,Memory impairment,107
OMEPRAZOLE,Dry skin,107
OMEPRAZOLE,Rash,106
OMEPRAZOLE,Alopecia,106
OMEPRAZOLE,Myocardial infarction,106
OMEPRAZOLE,Amnesia,103
OMEPRAZOLE,Product dose omission issue,100
OMEPRAZOLE,Palpitations,99
OMEPRAZOLE,Muscle twitching,99
OMEPRAZOLE,Diplopia,98
OMEPRAZOLE,Lip swelling,98
OMEPRAZOLE,Cognitive disorder,98
OMEPRAZOLE,Eye pruritus,96
OMEPRAZOLE,Blood glucose increased,93
OMEPRAZOLE,Pain of skin,92
OMEPRAZOLE,Carotid artery occlusion,91
OMEPRAZOLE,Facial pain,90
OMNIPAQUE,Pruritus,14
OMNIPAQUE,Sneezing,12
OMNIPAQUE,Dyspnoea,10
OMNIPAQUE,Urticaria,9
OMNIPAQUE,Anaphylactic reaction,6
OMNIPAQUE,Rash,5
OMNIPAQUE,Blood pressure decreased,5
OMNIPAQUE,Vomiting,5
OMNIPAQUE,Nausea,4
OMNIPAQUE,Chest discomfort,4
OMNIPAQUE,Cough,3
OMNIPAQUE,Tachypnoea,3
OMNIPAQUE,Hypotension,3
OMNIPAQUE,Erythema,3
OMNIPAQUE,Chills,3
OMNIPAQUE,Hypertension,2
OMNIPAQUE,Altered state of consciousness,2
OMNIPAQUE,Off label use,2
OMNIPAQUE,Hypersensitivity,2
OMNIPAQUE,Acute kidney injury,2
OMNIPAQUE,Sensation of foreign body,2
OMNIPAQUE,Flushing,2
OMNIPAQUE,Eye swelling,2
OMNIPAQUE,Eye pruritus,2
OMNIPAQUE,Urinary incontinence,2
OMNIPAQUE,Cyanosis,2
OMNIPAQUE,Headache,2
OMNIPAQUE,Throat tightness,2
OMNIPAQUE,Fatigue,2
OMNIPAQUE,Nasal congestion,2
OMNIPAQUE,Temperature intolerance,2
OMNIPAQUE,Dizziness,2
OMNIPAQUE,Hyperhidrosis,2
OMNIPAQUE,Blood pressure increased,2
OMNIPAQUE,Decreased appetite,1
OMNIPAQUE,Hepatic function abnormal,1
OMNIPAQUE,Pneumonia aspiration,1
OMNIPAQUE,Arteriosclerosis,1
OMNIPAQUE,Malignant neoplasm progression,1
OMNIPAQUE,Drug eruption,1
OMNIPAQUE,Immune-mediated encephalitis,1
OMNIPAQUE,Condition aggravated,1
OMNIPAQUE,C-reactive protein increased,1
OMNIPAQUE,Pain,1
OMNIPAQUE,Coronary artery stenosis,1
OMNIPAQUE,Hyponatraemia,1
OMNIPAQUE,Pyrexia,1
OMNIPAQUE,Myocardial infarction,1
OMNIPAQUE,Diarrhoea,1
OMNIPAQUE,Anaemia,1
ONDANSETRON,Nausea,92
ONDANSETRON,Diarrhoea,89
ONDANSETRON,Vomiting,79
ONDANSETRON,Off label use,72
ONDANSETRON,Fatigue,56
ONDANSETRON,Pain,54
ONDANSETRON,Dyspnoea,49
ONDANSETRON,Pyrexia,49
ONDANSETRON,Anaemia,49
ONDANSETRON,Constipation,44
ONDANSETRON,Death,42
ONDANSETRON,Decreased appetite,41
ONDANSETRON,Febrile neutropenia,40
ONDANSETRON,Asthenia,38
ONDANSETRON,Headache,36
ONDANSETRON,Neutropenia,34
ONDANSETRON,COVID-19,33
ONDANSETRON,Rash,31
ONDANSETRON,Malaise,31
ONDANSETRON,Pneumonia,31
ONDANSETRON,Sepsis,31
ONDANSETRON,Dehydration,30
ONDANSETRON,Anxiety,28
ONDANSETRON,Abdominal pain,28
ONDANSETRON,Urinary tract infection,27
ONDANSETRON,Weight decreased,27
ONDANSETRON,Thrombocytopenia,26
ONDANSETRON,Back pain,24
ONDANSETRON,Product use in unapproved indication,23
ONDANSETRON,Chills,23
ONDANSETRON,Acute kidney injury,23
ONDANSETRON,Depression,21
ONDANSETRON,Neutrophil count decreased,21
ONDANSETRON,Product dose omission issue,20
ONDANSETRON,Mucosal inflammation,20
ONDANSETRON,Abdominal distension,20
ONDANSETRON,Hypotension,19
ONDANSETRON,Hypokalaemia,19
ONDANSETRON,Fall,18
ONDANSETRON,White blood cell count decreased,18
ONDANSETRON,Platelet count decreased,18
ONDANSETRON,Emotional distress,18
ONDANSETRON,Renal failure,18
ONDANSETRON,Condition aggravated,18
ONDANSETRON,Neutropenic sepsis,18
ONDANSETRON,Arthralgia,17
ONDANSETRON,Neuropathy peripheral,17
ONDANSETRON,Cough,16
ONDANSETRON,Anhedonia,16
ONDANSETRON,Malignant neoplasm progression,16
ONDANSETRON HYDROCHLORIDE,Nausea,23
ONDANSETRON HYDROCHLORIDE,Vomiting,19
ONDANSETRON HYDROCHLORIDE,Fatigue,17
ONDANSETRON HYDROCHLORIDE,Off label use,17
ONDANSETRON HYDROCHLORIDE,Diarrhoea,15
ONDANSETRON HYDROCHLORIDE,Pneumonia,15
ONDANSETRON HYDROCHLORIDE,COVID-19,12
ONDANSETRON HYDROCHLORIDE,Cough,10
ONDANSETRON HYDROCHLORIDE,Headache,9
ONDANSETRON HYDROCHLORIDE,Product dose omission issue,9
ONDANSETRON HYDROCHLORIDE,Pyrexia,9
ONDANSETRON HYDROCHLORIDE,Dyspnoea,9
ONDANSETRON HYDROCHLORIDE,Malaise,9
ONDANSETRON HYDROCHLORIDE,Inappropriate schedule of product administration,8
ONDANSETRON HYDROCHLORIDE,Fall,8
ONDANSETRON HYDROCHLORIDE,Weight decreased,8
ONDANSETRON HYDROCHLORIDE,Pain,7
ONDANSETRON HYDROCHLORIDE,Dizziness,7
ONDANSETRON HYDROCHLORIDE,Asthenia,7
ONDANSETRON HYDROCHLORIDE,Sinusitis,7
ONDANSETRON HYDROCHLORIDE,Illness,7
ONDANSETRON HYDROCHLORIDE,Condition aggravated,6
ONDANSETRON HYDROCHLORIDE,Gastrointestinal disorder,6
ONDANSETRON HYDROCHLORIDE,Viral infection,5
ONDANSETRON HYDROCHLORIDE,Rash,5
ONDANSETRON HYDROCHLORIDE,Decreased appetite,5
ONDANSETRON HYDROCHLORIDE,Migraine,5
ONDANSETRON HYDROCHLORIDE,Pruritus,5
ONDANSETRON HYDROCHLORIDE,Myelosuppression,5
ONDANSETRON HYDROCHLORIDE,Ear infection,4
ONDANSETRON HYDROCHLORIDE,Infection,4
ONDANSETRON HYDROCHLORIDE,Respiratory tract infection,4
ONDANSETRON HYDROCHLORIDE,Arthralgia,4
ONDANSETRON HYDROCHLORIDE,Urinary tract infection,4
ONDANSETRON HYDROCHLORIDE,Gait disturbance,4
ONDANSETRON HYDROCHLORIDE,Abdominal pain,4
ONDANSETRON HYDROCHLORIDE,Abdominal discomfort,4
ONDANSETRON HYDROCHLORIDE,Abdominal distension,4
ONDANSETRON HYDROCHLORIDE,Feeling abnormal,4
ONDANSETRON HYDROCHLORIDE,Cerebrovascular accident,4
ONDANSETRON HYDROCHLORIDE,Peripheral swelling,4
ONDANSETRON HYDROCHLORIDE,Taste disorder,4
ONDANSETRON HYDROCHLORIDE,Oedema peripheral,4
ONDANSETRON HYDROCHLORIDE,Constipation,4
ONDANSETRON HYDROCHLORIDE,Neoplasm progression,4
ONDANSETRON HYDROCHLORIDE,Pain in extremity,3
ONDANSETRON HYDROCHLORIDE,Road traffic accident,3
ONDANSETRON HYDROCHLORIDE,Infusion related reaction,3
ONDANSETRON HYDROCHLORIDE,Hypoaesthesia,3
ONDANSETRON HYDROCHLORIDE,Influenza like illness,3
ONIVYDE,Off label use,29
ONIVYDE,Malignant neoplasm progression,28
ONIVYDE,Death,11
ONIVYDE,Neutrophil count decreased,5
ONIVYDE,Nausea,5
ONIVYDE,Abdominal pain,5
ONIVYDE,Metastases to liver,4
ONIVYDE,Underdose,4
ONIVYDE,Vomiting,4
ONIVYDE,Diarrhoea,4
ONIVYDE,Product use in unapproved indication,4
ONIVYDE,Myelosuppression,3
ONIVYDE,Therapeutic product effect incomplete,3
ONIVYDE,Desmoplastic small round cell tumour,3
ONIVYDE,Ascites,3
ONIVYDE,Metastases to peritoneum,3
ONIVYDE,Drug ineffective,3
ONIVYDE,Disease progression,3
ONIVYDE,Metastases to lymph nodes,3
ONIVYDE,Decreased appetite,2
ONIVYDE,Malaise,2
ONIVYDE,Hypokalaemia,2
ONIVYDE,Fatigue,2
ONIVYDE,Dehydration,2
ONIVYDE,Acute kidney injury,2
ONIVYDE,Anaemia,2
ONIVYDE,Asthenia,2
ONIVYDE,Cholangitis infective,2
ONIVYDE,Weight decreased,2
ONIVYDE,Leukopenia,2
ONIVYDE,General physical health deterioration,2
ONIVYDE,Aspartate aminotransferase increased,1
ONIVYDE,Alanine aminotransferase increased,1
ONIVYDE,Malignant ascites,1
ONIVYDE,Oesophageal obstruction,1
ONIVYDE,Dizziness,1
ONIVYDE,Peripheral sensory neuropathy,1
ONIVYDE,Upper respiratory tract infection,1
ONIVYDE,Blood creatinine increased,1
ONIVYDE,COVID-19,1
ONIVYDE,Back pain,1
ONIVYDE,Skin ulcer,1
ONIVYDE,Ileus,1
ONIVYDE,Enterocolitis,1
ONIVYDE,Confusional state,1
ONIVYDE,Stomatitis,1
ONIVYDE,Delirium,1
ONIVYDE,Cytopenia,1
ONIVYDE,Device related infection,1
ONIVYDE,Disseminated intravascular coagulation,1
OPDIVO,Malignant neoplasm progression,43
OPDIVO,Off label use,37
OPDIVO,Decreased appetite,27
OPDIVO,Hypothyroidism,26
OPDIVO,Rash,24
OPDIVO,Diarrhoea,23
OPDIVO,Non-small cell lung cancer,22
OPDIVO,Pyrexia,22
OPDIVO,Death,21
OPDIVO,Secondary adrenocortical insufficiency,18
OPDIVO,Immune-mediated enterocolitis,18
OPDIVO,Interstitial lung disease,18
OPDIVO,Hepatic function abnormal,17
OPDIVO,Hepatic cytolysis,17
OPDIVO,Fulminant type 1 diabetes mellitus,15
OPDIVO,Malaise,15
OPDIVO,Prescribed overdose,15
OPDIVO,Nausea,14
OPDIVO,Acute kidney injury,14
OPDIVO,Hypopituitarism,13
OPDIVO,Pruritus,13
OPDIVO,Fatigue,12
OPDIVO,Arthralgia,12
OPDIVO,Intentional product use issue,12
OPDIVO,Constipation,12
OPDIVO,Pulmonary toxicity,12
OPDIVO,Pneumonia,12
OPDIVO,Adrenocorticotropic hormone deficiency,11
OPDIVO,Cytokine release syndrome,11
OPDIVO,Weight decreased,11
OPDIVO,Pemphigoid,11
OPDIVO,Cholestasis,11
OPDIVO,Immune-mediated lung disease,10
OPDIVO,Dehydration,10
OPDIVO,Liver disorder,10
OPDIVO,Adrenal insufficiency,10
OPDIVO,Drug-induced liver injury,9
OPDIVO,Headache,9
OPDIVO,Disseminated intravascular coagulation,8
OPDIVO,Thyroiditis,8
OPDIVO,Anaemia,8
OPDIVO,Back pain,8
OPDIVO,Hypertension,8
OPDIVO,Taste disorder,8
OPDIVO,Neutropenia,8
OPDIVO,Pneumothorax,7
OPDIVO,Diabetic ketoacidosis,7
OPDIVO,Type 1 diabetes mellitus,7
OPDIVO,Hyperthyroidism,7
OPDIVO,Haemophagocytic lymphohistiocytosis,7
OPSUMIT,Headache,106
OPSUMIT,Diarrhoea,99
OPSUMIT,Dyspnoea,89
OPSUMIT,Nausea,75
OPSUMIT,Hypotension,63
OPSUMIT,Fatigue,56
OPSUMIT,Cough,49
OPSUMIT,Infusion site pain,40
OPSUMIT,Dizziness,39
OPSUMIT,Vomiting,39
OPSUMIT,Pneumonia,38
OPSUMIT,Pulmonary arterial hypertension,33
OPSUMIT,Malaise,31
OPSUMIT,Pain,31
OPSUMIT,Cardiac failure,31
OPSUMIT,Pain in extremity,29
OPSUMIT,Pain in jaw,29
OPSUMIT,Oxygen saturation decreased,29
OPSUMIT,COVID-19,28
OPSUMIT,Dyspnoea exertional,28
OPSUMIT,Pyrexia,28
OPSUMIT,Weight decreased,28
OPSUMIT,Off label use,27
OPSUMIT,Asthenia,26
OPSUMIT,Chest pain,26
OPSUMIT,Infusion site erythema,24
OPSUMIT,Arthralgia,23
OPSUMIT,Death,22
OPSUMIT,Fluid retention,22
OPSUMIT,Peripheral swelling,21
OPSUMIT,Weight increased,21
OPSUMIT,Anaemia,20
OPSUMIT,Feeling abnormal,19
OPSUMIT,Nasopharyngitis,18
OPSUMIT,Infection,17
OPSUMIT,Decreased appetite,17
OPSUMIT,Infusion site swelling,17
OPSUMIT,Flushing,16
OPSUMIT,Device dislocation,16
OPSUMIT,Oedema,16
OPSUMIT,Nasal congestion,15
OPSUMIT,Pulmonary hypertension,15
OPSUMIT,Abdominal pain,15
OPSUMIT,Fall,15
OPSUMIT,Palpitations,15
OPSUMIT,Oedema peripheral,14
OPSUMIT,Device malfunction,14
OPSUMIT,Abdominal discomfort,14
OPSUMIT,Epistaxis,14
OPSUMIT,Rash,13
ORENCIA,Arthralgia,21
ORENCIA,Rheumatoid arthritis,20
ORENCIA,Rash,20
ORENCIA,Drug ineffective,20
ORENCIA,Off label use,19
ORENCIA,Pain,19
ORENCIA,Headache,17
ORENCIA,Diarrhoea,17
ORENCIA,Drug intolerance,16
ORENCIA,Therapeutic product effect decreased,15
ORENCIA,Malaise,15
ORENCIA,Contraindicated product administered,14
ORENCIA,Arthropathy,14
ORENCIA,Peripheral swelling,14
ORENCIA,Nausea,14
ORENCIA,Fatigue,13
ORENCIA,Dizziness,13
ORENCIA,Joint swelling,13
ORENCIA,Drug hypersensitivity,13
ORENCIA,Product use issue,13
ORENCIA,Nasopharyngitis,12
ORENCIA,Condition aggravated,12
ORENCIA,Pain in extremity,12
ORENCIA,Hypertension,11
ORENCIA,Dyspnoea,11
ORENCIA,Synovitis,11
ORENCIA,Pneumonia,11
ORENCIA,Infection,11
ORENCIA,Abdominal discomfort,11
ORENCIA,Hepatic enzyme increased,10
ORENCIA,Pyrexia,10
ORENCIA,C-reactive protein increased,10
ORENCIA,Hypersensitivity,9
ORENCIA,Pruritus,9
ORENCIA,Musculoskeletal stiffness,9
ORENCIA,Psoriatic arthropathy,9
ORENCIA,Insomnia,9
ORENCIA,Treatment failure,9
ORENCIA,Liver disorder,9
ORENCIA,Weight decreased,9
ORENCIA,Abdominal pain upper,9
ORENCIA,Loss of personal independence in daily activities,9
ORENCIA,Mobility decreased,9
ORENCIA,Arthritis,9
ORENCIA,Weight increased,8
ORENCIA,Alopecia,8
ORENCIA,Infusion related reaction,8
ORENCIA,Sinusitis,8
ORENCIA,Back pain,8
ORENCIA,C-reactive protein abnormal,8
ORENITRAM,Headache,29
ORENITRAM,Nausea,27
ORENITRAM,Diarrhoea,25
ORENITRAM,Dyspnoea,24
ORENITRAM,Dizziness,16
ORENITRAM,Vomiting,15
ORENITRAM,Fatigue,15
ORENITRAM,Arthralgia,14
ORENITRAM,Hypotension,13
ORENITRAM,Pain,12
ORENITRAM,Pain in extremity,11
ORENITRAM,Oxygen saturation decreased,11
ORENITRAM,Peripheral swelling,9
ORENITRAM,Fall,8
ORENITRAM,Product dose omission issue,8
ORENITRAM,Pulmonary hypertension,8
ORENITRAM,Weight decreased,7
ORENITRAM,Abdominal pain upper,7
ORENITRAM,Pruritus,7
ORENITRAM,Flushing,7
ORENITRAM,Feeling abnormal,7
ORENITRAM,Constipation,7
ORENITRAM,Dyspepsia,7
ORENITRAM,Pain in jaw,7
ORENITRAM,Cardiac failure congestive,7
ORENITRAM,Fluid retention,7
ORENITRAM,Therapy non-responder,7
ORENITRAM,Chest pain,7
ORENITRAM,Pneumonia,7
ORENITRAM,Cough,6
ORENITRAM,Loss of consciousness,6
ORENITRAM,Asthenia,6
ORENITRAM,COVID-19,6
ORENITRAM,Hypervolaemia,6
ORENITRAM,Palpitations,6
ORENITRAM,Muscle spasms,6
ORENITRAM,Dyspnoea exertional,6
ORENITRAM,Migraine,5
ORENITRAM,Nasopharyngitis,5
ORENITRAM,Myalgia,5
ORENITRAM,Chest discomfort,5
ORENITRAM,Infusion site erythema,5
ORENITRAM,Back pain,5
ORENITRAM,Urinary tract infection,5
ORENITRAM,Weight increased,5
ORENITRAM,Abdominal discomfort,5
ORENITRAM,Syncope,5
ORENITRAM,Sinusitis,4
ORENITRAM,Rash,4
ORENITRAM,Decreased appetite,4
OXALIPLATIN,Neurotoxicity,41
OXALIPLATIN,Diarrhoea,41
OXALIPLATIN,Off label use,38
OXALIPLATIN,Neutropenia,33
OXALIPLATIN,Nausea,32
OXALIPLATIN,Asthenia,29
OXALIPLATIN,Vomiting,23
OXALIPLATIN,Thrombocytopenia,20
OXALIPLATIN,Paraesthesia,20
OXALIPLATIN,Dysgeusia,17
OXALIPLATIN,Hypotension,17
OXALIPLATIN,Sepsis,16
OXALIPLATIN,Hypokalaemia,16
OXALIPLATIN,White blood cell count decreased,15
OXALIPLATIN,Myelosuppression,15
OXALIPLATIN,Pyrexia,14
OXALIPLATIN,General physical health deterioration,14
OXALIPLATIN,Acute kidney injury,14
OXALIPLATIN,Febrile neutropenia,13
OXALIPLATIN,Anaemia,12
OXALIPLATIN,Hyponatraemia,12
OXALIPLATIN,Hypoglycaemia,12
OXALIPLATIN,Decreased appetite,12
OXALIPLATIN,Hyperhidrosis,11
OXALIPLATIN,Abdominal pain,11
OXALIPLATIN,Disease progression,11
OXALIPLATIN,Dyspnoea,11
OXALIPLATIN,Transient aphasia,10
OXALIPLATIN,Folliculitis,10
OXALIPLATIN,Haematemesis,10
OXALIPLATIN,Mucosal inflammation,10
OXALIPLATIN,Neuropathy peripheral,9
OXALIPLATIN,Platelet count decreased,9
OXALIPLATIN,Neutrophil count decreased,9
OXALIPLATIN,Muscle spasms,9
OXALIPLATIN,Strabismus,9
OXALIPLATIN,Diplopia,9
OXALIPLATIN,VIth nerve paralysis,9
OXALIPLATIN,Renal failure,9
OXALIPLATIN,Cholestasis,8
OXALIPLATIN,Melaena,8
OXALIPLATIN,Loss of consciousness,8
OXALIPLATIN,Rash,8
OXALIPLATIN,Cytokine release syndrome,7
OXALIPLATIN,Urinary tract infection,7
OXALIPLATIN,Malaise,7
OXALIPLATIN,Interstitial lung disease,7
OXALIPLATIN,Dysphagia,7
OXALIPLATIN,Diarrhoea haemorrhagic,7
OXALIPLATIN,Product use in unapproved indication,6
OXAZEPAM,Coma,35
OXAZEPAM,Poisoning deliberate,22
OXAZEPAM,Somnolence,16
OXAZEPAM,Toxicity to various agents,14
OXAZEPAM,Vomiting,13
OXAZEPAM,Bradycardia,11
OXAZEPAM,Respiratory depression,9
OXAZEPAM,Drug abuse,9
OXAZEPAM,Drug interaction,8
OXAZEPAM,Pancreatitis acute,8
OXAZEPAM,Anaemia,7
OXAZEPAM,Overdose,7
OXAZEPAM,Respiratory distress,7
OXAZEPAM,Interstitial lung disease,7
OXAZEPAM,Cerebrovascular accident,7
OXAZEPAM,Seizure,7
OXAZEPAM,Confusional state,7
OXAZEPAM,Hypocalcaemia,6
OXAZEPAM,Acute kidney injury,6
OXAZEPAM,Off label use,6
OXAZEPAM,Hypotension,6
OXAZEPAM,Serotonin syndrome,6
OXAZEPAM,Electrocardiogram QT prolonged,6
OXAZEPAM,Muscle spasms,6
OXAZEPAM,Pulmonary oedema,6
OXAZEPAM,Shock,6
OXAZEPAM,Asthenia,5
OXAZEPAM,Nausea,5
OXAZEPAM,Hypomagnesaemia,5
OXAZEPAM,Shock haemorrhagic,5
OXAZEPAM,Cardiac failure,5
OXAZEPAM,Wrong patient received product,5
OXAZEPAM,Pancreatic carcinoma,5
OXAZEPAM,Epistaxis,4
OXAZEPAM,Lung disorder,4
OXAZEPAM,Fall,4
OXAZEPAM,White blood cell count decreased,4
OXAZEPAM,Cardiac pacemaker evaluation,4
OXAZEPAM,Ischaemic cardiomyopathy,4
OXAZEPAM,Inappropriate antidiuretic hormone secretion,4
OXAZEPAM,Cardio-respiratory arrest,4
OXAZEPAM,Suicidal ideation,4
OXAZEPAM,Erythema multiforme,4
OXAZEPAM,Contusion,4
OXAZEPAM,Product administration error,4
OXAZEPAM,Hypoxia,4
OXAZEPAM,Tachycardia,4
OXAZEPAM,Hepatic cytolysis,4
OXAZEPAM,Atrial fibrillation,3
OXAZEPAM,Diarrhoea,3
OXBRYTA,Sickle cell anaemia with crisis,19
OXBRYTA,Diarrhoea,18
OXBRYTA,Off label use,17
OXBRYTA,Nausea,10
OXBRYTA,Headache,9
OXBRYTA,Pain,8
OXBRYTA,Haemoglobin decreased,8
OXBRYTA,Fatigue,7
OXBRYTA,Abdominal discomfort,7
OXBRYTA,Abdominal pain,6
OXBRYTA,Constipation,4
OXBRYTA,COVID-19,3
OXBRYTA,Acute chest syndrome,3
OXBRYTA,Asthenia,3
OXBRYTA,Dizziness,3
OXBRYTA,Vomiting,3
OXBRYTA,Pneumonia,3
OXBRYTA,Product dose omission issue,3
OXBRYTA,Abdominal pain upper,3
OXBRYTA,Malaise,3
OXBRYTA,Pyrexia,3
OXBRYTA,Sinus pain,2
OXBRYTA,Rash pruritic,2
OXBRYTA,Therapy interrupted,2
OXBRYTA,Palpitations,2
OXBRYTA,Chest discomfort,2
OXBRYTA,Full blood count decreased,2
OXBRYTA,Taste disorder,2
OXBRYTA,Wrong technique in product usage process,2
OXBRYTA,Pain in extremity,2
OXBRYTA,Product use complaint,2
OXBRYTA,Rash,2
OXBRYTA,Back pain,2
OXBRYTA,Illness,2
OXBRYTA,Peripheral swelling,2
OXBRYTA,Tonsillectomy,2
OXBRYTA,Bowel movement irregularity,2
OXBRYTA,Gastroenteritis viral,1
OXBRYTA,Urinary tract infection,1
OXBRYTA,Multiple organ dysfunction syndrome,1
OXBRYTA,Inappropriate schedule of product administration,1
OXBRYTA,Gastroenteritis Escherichia coli,1
OXBRYTA,Pulmonary hypertension,1
OXBRYTA,Pre-eclampsia,1
OXBRYTA,Foetal death,1
OXBRYTA,Exposure during pregnancy,1
OXBRYTA,Pruritus,1
OXBRYTA,Cellulitis,1
OXBRYTA,Plantar fasciitis,1
OXBRYTA,Anxiety,1
OXCARBAZEPINE,Pruritus,11
OXCARBAZEPINE,Rash,8
OXCARBAZEPINE,Off label use,7
OXCARBAZEPINE,Pain in extremity,6
OXCARBAZEPINE,Seizure,6
OXCARBAZEPINE,COVID-19,5
OXCARBAZEPINE,Headache,5
OXCARBAZEPINE,Product dose omission issue,5
OXCARBAZEPINE,Pyrexia,5
OXCARBAZEPINE,Fatigue,4
OXCARBAZEPINE,Cough,4
OXCARBAZEPINE,Insomnia,4
OXCARBAZEPINE,Tonsillitis,4
OXCARBAZEPINE,Diarrhoea,3
OXCARBAZEPINE,Epistaxis,3
OXCARBAZEPINE,Nasopharyngitis,3
OXCARBAZEPINE,Erythema,3
OXCARBAZEPINE,Paraesthesia,3
OXCARBAZEPINE,Arthralgia,3
OXCARBAZEPINE,Illness,3
OXCARBAZEPINE,Asthenia,3
OXCARBAZEPINE,Blood cholesterol increased,3
OXCARBAZEPINE,Pneumonia,3
OXCARBAZEPINE,Inappropriate schedule of product administration,3
OXCARBAZEPINE,Weight decreased,3
OXCARBAZEPINE,Anxiety,3
OXCARBAZEPINE,Constipation,3
OXCARBAZEPINE,Drug ineffective,3
OXCARBAZEPINE,Peripheral swelling,3
OXCARBAZEPINE,Hyponatraemia,3
OXCARBAZEPINE,Dizziness,3
OXCARBAZEPINE,Hepatic function abnormal,3
OXCARBAZEPINE,Uhthoff's phenomenon,2
OXCARBAZEPINE,Herpes zoster,2
OXCARBAZEPINE,Intervertebral disc protrusion,2
OXCARBAZEPINE,Lymph node pain,2
OXCARBAZEPINE,Chills,2
OXCARBAZEPINE,Basal cell carcinoma,2
OXCARBAZEPINE,Bronchitis,2
OXCARBAZEPINE,Injection site swelling,2
OXCARBAZEPINE,Muscular weakness,2
OXCARBAZEPINE,Blood glucose increased,2
OXCARBAZEPINE,B-lymphocyte count decreased,2
OXCARBAZEPINE,Type 2 diabetes mellitus,2
OXCARBAZEPINE,Cardiovascular disorder,2
OXCARBAZEPINE,Lyme disease,2
OXCARBAZEPINE,Product administration error,2
OXCARBAZEPINE,Fall,2
OXCARBAZEPINE,Urticaria,2
OXCARBAZEPINE,Granuloma annulare,2
OXYBUTYNIN,Pain,16
OXYBUTYNIN,Emotional distress,10
OXYBUTYNIN,Anxiety,9
OXYBUTYNIN,Anhedonia,8
OXYBUTYNIN,Sinusitis,7
OXYBUTYNIN,Nausea,7
OXYBUTYNIN,Feeling abnormal,7
OXYBUTYNIN,Diarrhoea,6
OXYBUTYNIN,Arthralgia,6
OXYBUTYNIN,Chronic kidney disease,6
OXYBUTYNIN,Fatigue,6
OXYBUTYNIN,Headache,6
OXYBUTYNIN,Product dose omission issue,6
OXYBUTYNIN,Weight decreased,5
OXYBUTYNIN,Osteopenia,5
OXYBUTYNIN,Influenza,4
OXYBUTYNIN,COVID-19,4
OXYBUTYNIN,Urinary tract infection,4
OXYBUTYNIN,Bone density decreased,4
OXYBUTYNIN,Back pain,4
OXYBUTYNIN,Gait disturbance,3
OXYBUTYNIN,Illness,3
OXYBUTYNIN,Fall,3
OXYBUTYNIN,Body height decreased,3
OXYBUTYNIN,Chills,3
OXYBUTYNIN,Nasopharyngitis,3
OXYBUTYNIN,Movement disorder,3
OXYBUTYNIN,Depression,3
OXYBUTYNIN,Cough,3
OXYBUTYNIN,Inappropriate schedule of product administration,3
OXYBUTYNIN,Dizziness,3
OXYBUTYNIN,Acute kidney injury,3
OXYBUTYNIN,Osteoporosis,3
OXYBUTYNIN,Herpes zoster,3
OXYBUTYNIN,Memory impairment,3
OXYBUTYNIN,Mouth ulceration,3
OXYBUTYNIN,Gingival discomfort,3
OXYBUTYNIN,Vomiting,2
OXYBUTYNIN,Diverticulitis,2
OXYBUTYNIN,Cystitis,2
OXYBUTYNIN,Balance disorder,2
OXYBUTYNIN,Pneumonia,2
OXYBUTYNIN,Muscle spasms,2
OXYBUTYNIN,Dyspnoea,2
OXYBUTYNIN,Peripheral swelling,2
OXYBUTYNIN,Cardiac disorder,2
OXYBUTYNIN,Intentional product misuse,2
OXYBUTYNIN,Fear,2
OXYBUTYNIN,Economic problem,2
OXYBUTYNIN,Fracture,2
OXYCODONE,Diarrhoea,42
OXYCODONE,Pain,40
OXYCODONE,Fatigue,36
OXYCODONE,Nausea,35
OXYCODONE,Off label use,33
OXYCODONE,Headache,28
OXYCODONE,Vomiting,24
OXYCODONE,COVID-19,24
OXYCODONE,Arthralgia,23
OXYCODONE,Dyspnoea,22
OXYCODONE,Weight decreased,21
OXYCODONE,Pneumonia,20
OXYCODONE,Confusional state,19
OXYCODONE,Decreased appetite,18
OXYCODONE,Anxiety,18
OXYCODONE,Asthenia,17
OXYCODONE,Sinusitis,17
OXYCODONE,Back pain,17
OXYCODONE,Pyrexia,17
OXYCODONE,Rash,16
OXYCODONE,Abdominal pain,16
OXYCODONE,Product dose omission issue,16
OXYCODONE,Sepsis,16
OXYCODONE,Fall,15
OXYCODONE,Dehydration,15
OXYCODONE,Anaemia,15
OXYCODONE,Death,14
OXYCODONE,Alopecia,14
OXYCODONE,Somnolence,14
OXYCODONE,Emotional distress,14
OXYCODONE,Febrile neutropenia,14
OXYCODONE,Malaise,13
OXYCODONE,Anhedonia,13
OXYCODONE,Constipation,13
OXYCODONE,Hypertension,12
OXYCODONE,Drug intolerance,12
OXYCODONE,Depression,12
OXYCODONE,Pain in extremity,12
OXYCODONE,Acute kidney injury,12
OXYCODONE,Infusion related reaction,11
OXYCODONE,Pruritus,11
OXYCODONE,Insomnia,11
OXYCODONE,Chest pain,11
OXYCODONE,Abdominal discomfort,11
OXYCODONE,Illness,11
OXYCODONE,Weight increased,10
OXYCODONE,Drug ineffective,10
OXYCODONE,Peripheral swelling,10
OXYCODONE,Hypoaesthesia,10
OXYCODONE,Joint swelling,9
OXYCODONE HYDROCHLORIDE,Nausea,22
OXYCODONE HYDROCHLORIDE,Pain,20
OXYCODONE HYDROCHLORIDE,Fatigue,19
OXYCODONE HYDROCHLORIDE,Headache,19
OXYCODONE HYDROCHLORIDE,Pyrexia,16
OXYCODONE HYDROCHLORIDE,Diarrhoea,15
OXYCODONE HYDROCHLORIDE,Vomiting,14
OXYCODONE HYDROCHLORIDE,Off label use,13
OXYCODONE HYDROCHLORIDE,Arthralgia,13
OXYCODONE HYDROCHLORIDE,Urinary tract infection,13
OXYCODONE HYDROCHLORIDE,Pneumonia,12
OXYCODONE HYDROCHLORIDE,Malaise,12
OXYCODONE HYDROCHLORIDE,Asthenia,12
OXYCODONE HYDROCHLORIDE,Pain in extremity,12
OXYCODONE HYDROCHLORIDE,Drug ineffective,11
OXYCODONE HYDROCHLORIDE,Abdominal pain,11
OXYCODONE HYDROCHLORIDE,Dizziness,11
OXYCODONE HYDROCHLORIDE,Product dose omission issue,11
OXYCODONE HYDROCHLORIDE,Illness,11
OXYCODONE HYDROCHLORIDE,Weight decreased,10
OXYCODONE HYDROCHLORIDE,Back pain,10
OXYCODONE HYDROCHLORIDE,Constipation,9
OXYCODONE HYDROCHLORIDE,Pruritus,9
OXYCODONE HYDROCHLORIDE,Infection,9
OXYCODONE HYDROCHLORIDE,Nasopharyngitis,9
OXYCODONE HYDROCHLORIDE,Blood pressure increased,9
OXYCODONE HYDROCHLORIDE,COVID-19,9
OXYCODONE HYDROCHLORIDE,Depression,8
OXYCODONE HYDROCHLORIDE,Decreased appetite,8
OXYCODONE HYDROCHLORIDE,Encephalopathy,8
OXYCODONE HYDROCHLORIDE,Interstitial lung disease,8
OXYCODONE HYDROCHLORIDE,Rash,7
OXYCODONE HYDROCHLORIDE,Dyspnoea,7
OXYCODONE HYDROCHLORIDE,Sepsis,7
OXYCODONE HYDROCHLORIDE,Anxiety,7
OXYCODONE HYDROCHLORIDE,Muscle spasms,7
OXYCODONE HYDROCHLORIDE,Paraesthesia,7
OXYCODONE HYDROCHLORIDE,Intentional product use issue,6
OXYCODONE HYDROCHLORIDE,General physical health deterioration,6
OXYCODONE HYDROCHLORIDE,Liver disorder,6
OXYCODONE HYDROCHLORIDE,Musculoskeletal stiffness,6
OXYCODONE HYDROCHLORIDE,Hypertension,6
OXYCODONE HYDROCHLORIDE,Insomnia,6
OXYCODONE HYDROCHLORIDE,Condition aggravated,6
OXYCODONE HYDROCHLORIDE,Abdominal pain upper,6
OXYCODONE HYDROCHLORIDE,Drug hypersensitivity,6
OXYCODONE HYDROCHLORIDE,Therapeutic product effect decreased,6
OXYCODONE HYDROCHLORIDE,Hypoaesthesia,6
OXYCODONE HYDROCHLORIDE,Confusional state,6
OXYCODONE HYDROCHLORIDE,Inappropriate schedule of product administration,6
OXYCONTIN,Pain,10
OXYCONTIN,Fall,7
OXYCONTIN,Confusional state,7
OXYCONTIN,Urinary tract infection,6
OXYCONTIN,Nausea,6
OXYCONTIN,Diarrhoea,6
OXYCONTIN,Poisoning deliberate,6
OXYCONTIN,Respiratory depression,6
OXYCONTIN,Electrocardiogram QT prolonged,6
OXYCONTIN,Bradycardia,6
OXYCONTIN,Coma,6
OXYCONTIN,Asthenia,5
OXYCONTIN,Vomiting,5
OXYCONTIN,Emotional distress,5
OXYCONTIN,Anxiety,5
OXYCONTIN,Dyspnoea,4
OXYCONTIN,Oedema peripheral,4
OXYCONTIN,Illness,4
OXYCONTIN,Anhedonia,4
OXYCONTIN,Death,4
OXYCONTIN,Constipation,4
OXYCONTIN,Off label use,4
OXYCONTIN,Dizziness,4
OXYCONTIN,Pyrexia,4
OXYCONTIN,Insomnia,4
OXYCONTIN,Headache,4
OXYCONTIN,Tubulointerstitial nephritis,4
OXYCONTIN,Cardiac failure,3
OXYCONTIN,Chronic kidney disease,3
OXYCONTIN,Decreased appetite,3
OXYCONTIN,Abdominal distension,3
OXYCONTIN,Weight decreased,3
OXYCONTIN,Stomatitis,3
OXYCONTIN,Abdominal pain,3
OXYCONTIN,Arthralgia,3
OXYCONTIN,Peripheral swelling,3
OXYCONTIN,Malaise,3
OXYCONTIN,COVID-19,3
OXYCONTIN,Pneumonia,3
OXYCONTIN,Drug ineffective,3
OXYCONTIN,Anaemia,3
OXYCONTIN,Hyperkalaemia,3
OXYCONTIN,Pulmonary embolism,2
OXYCONTIN,Malignant neoplasm progression,2
OXYCONTIN,Depression,2
OXYCONTIN,Toxicity to various agents,2
OXYCONTIN,Drug withdrawal syndrome,2
OXYCONTIN,Drug dependence,2
OXYCONTIN,Impaired driving ability,2
OXYCONTIN,Product use in unapproved indication,2
OXYGEN,Pneumonia,40
OXYGEN,Product dose omission issue,38
OXYGEN,Dyspnoea,37
OXYGEN,COVID-19,35
OXYGEN,Headache,31
OXYGEN,Fall,27
OXYGEN,Fatigue,25
OXYGEN,Sinusitis,19
OXYGEN,Cough,18
OXYGEN,Inappropriate schedule of product administration,18
OXYGEN,Malaise,18
OXYGEN,Nasopharyngitis,17
OXYGEN,Diarrhoea,17
OXYGEN,Asthenia,16
OXYGEN,Pyrexia,16
OXYGEN,Respiratory tract infection,15
OXYGEN,Influenza,15
OXYGEN,Oxygen saturation decreased,14
OXYGEN,Weight decreased,13
OXYGEN,Nausea,13
OXYGEN,Urinary tract infection,13
OXYGEN,Dizziness,12
OXYGEN,Productive cough,12
OXYGEN,Pain,12
OXYGEN,Epistaxis,12
OXYGEN,Upper respiratory tract infection,11
OXYGEN,Arthralgia,11
OXYGEN,Illness,11
OXYGEN,Sepsis,10
OXYGEN,Contusion,10
OXYGEN,Blood pressure increased,10
OXYGEN,Peripheral swelling,9
OXYGEN,Weight increased,9
OXYGEN,Limb injury,9
OXYGEN,Asthma,9
OXYGEN,Feeling abnormal,9
OXYGEN,Off label use,9
OXYGEN,Condition aggravated,9
OXYGEN,Oedema peripheral,9
OXYGEN,Dyspnoea exertional,9
OXYGEN,Gait disturbance,8
OXYGEN,Seasonal allergy,8
OXYGEN,Chest pain,8
OXYGEN,Respiratory distress,8
OXYGEN,Bronchitis,8
OXYGEN,Insurance issue,8
OXYGEN,Infusion related reaction,7
OXYGEN,Vomiting,7
OXYGEN,Ear infection,7
OXYGEN,Cellulitis,7
OZEMPIC,Nausea,32
OZEMPIC,Diarrhoea,27
OZEMPIC,Vomiting,24
OZEMPIC,Off label use,24
OZEMPIC,COVID-19,20
OZEMPIC,Decreased appetite,19
OZEMPIC,Weight decreased,18
OZEMPIC,Dyspnoea,15
OZEMPIC,Pain,15
OZEMPIC,Headache,15
OZEMPIC,Asthenia,12
OZEMPIC,Fatigue,11
OZEMPIC,Dizziness,11
OZEMPIC,Abdominal pain upper,11
OZEMPIC,Malaise,10
OZEMPIC,Dehydration,10
OZEMPIC,Rash,10
OZEMPIC,Fall,8
OZEMPIC,Anxiety,8
OZEMPIC,Hypokalaemia,8
OZEMPIC,Product dose omission issue,8
OZEMPIC,Pyrexia,8
OZEMPIC,Inappropriate schedule of product administration,8
OZEMPIC,Acute kidney injury,8
OZEMPIC,Confusional state,8
OZEMPIC,Product use in unapproved indication,8
OZEMPIC,Neuropathy peripheral,7
OZEMPIC,Nasopharyngitis,7
OZEMPIC,Arthralgia,7
OZEMPIC,Chronic kidney disease,7
OZEMPIC,Urinary tract infection,7
OZEMPIC,Localised infection,7
OZEMPIC,Pneumonia,7
OZEMPIC,Cough,7
OZEMPIC,Weight increased,6
OZEMPIC,Blood glucose increased,6
OZEMPIC,Sinusitis,6
OZEMPIC,Pruritus,6
OZEMPIC,Bronchitis,6
OZEMPIC,Back pain,6
OZEMPIC,Constipation,6
OZEMPIC,Hypotension,6
OZEMPIC,Hyponatraemia,6
OZEMPIC,Glycosylated haemoglobin increased,5
OZEMPIC,Upper respiratory tract infection,5
OZEMPIC,Respiratory tract infection,5
OZEMPIC,Infusion site erythema,5
OZEMPIC,Injection site pain,5
OZEMPIC,Gastrointestinal disorder,5
OZEMPIC,Illness,5
PACLITAXEL,Diarrhoea,74
PACLITAXEL,Anaemia,56
PACLITAXEL,Neutropenia,52
PACLITAXEL,Nausea,51
PACLITAXEL,White blood cell count decreased,42
PACLITAXEL,Neutrophil count decreased,39
PACLITAXEL,Platelet count decreased,35
PACLITAXEL,Pyrexia,33
PACLITAXEL,Febrile neutropenia,33
PACLITAXEL,Off label use,32
PACLITAXEL,Neuropathy peripheral,31
PACLITAXEL,Dyspnoea,29
PACLITAXEL,Asthenia,29
PACLITAXEL,Vomiting,28
PACLITAXEL,Fatigue,26
PACLITAXEL,Pneumonia,25
PACLITAXEL,Lymphocyte count decreased,23
PACLITAXEL,Hypokalaemia,23
PACLITAXEL,Adrenal insufficiency,23
PACLITAXEL,Rash,22
PACLITAXEL,Alopecia,22
PACLITAXEL,Mucosal inflammation,22
PACLITAXEL,Hyponatraemia,21
PACLITAXEL,Weight decreased,20
PACLITAXEL,Malaise,20
PACLITAXEL,Constipation,20
PACLITAXEL,Disease progression,19
PACLITAXEL,Decreased appetite,19
PACLITAXEL,Condition aggravated,19
PACLITAXEL,Inappropriate schedule of product administration,19
PACLITAXEL,Malignant neoplasm progression,18
PACLITAXEL,Stomatitis,18
PACLITAXEL,Oedema peripheral,17
PACLITAXEL,Pancytopenia,17
PACLITAXEL,Myelosuppression,17
PACLITAXEL,Cough,16
PACLITAXEL,COVID-19,16
PACLITAXEL,Haemoglobin decreased,16
PACLITAXEL,Dehydration,15
PACLITAXEL,Infusion related reaction,15
PACLITAXEL,Dizziness,15
PACLITAXEL,Acute kidney injury,15
PACLITAXEL,Leukopenia,14
PACLITAXEL,Neutropenic sepsis,14
PACLITAXEL,Thrombocytopenia,14
PACLITAXEL,Death,13
PACLITAXEL,Hepatic function abnormal,13
PACLITAXEL,Pruritus,13
PACLITAXEL,Abdominal pain,13
PACLITAXEL,Interstitial lung disease,13
PALBOCICLIB,White blood cell count decreased,18
PALBOCICLIB,Diarrhoea,13
PALBOCICLIB,Haemoglobin decreased,13
PALBOCICLIB,Pain,12
PALBOCICLIB,Vomiting,12
PALBOCICLIB,Asthenia,11
PALBOCICLIB,Blood pressure increased,11
PALBOCICLIB,Neoplasm progression,11
PALBOCICLIB,Neutropenia,10
PALBOCICLIB,Dyspnoea exertional,9
PALBOCICLIB,Anaemia,9
PALBOCICLIB,Neutrophil count decreased,9
PALBOCICLIB,Heart rate increased,9
PALBOCICLIB,Weight decreased,9
PALBOCICLIB,Platelet count decreased,8
PALBOCICLIB,Dyspnoea,8
PALBOCICLIB,General physical health deterioration,8
PALBOCICLIB,Oedema peripheral,7
PALBOCICLIB,Fatigue,7
PALBOCICLIB,Arthralgia,7
PALBOCICLIB,Cough,7
PALBOCICLIB,Red blood cell count decreased,7
PALBOCICLIB,Blood creatinine increased,6
PALBOCICLIB,COVID-19,6
PALBOCICLIB,Pruritus,6
PALBOCICLIB,Nausea,6
PALBOCICLIB,Electrocardiogram QT prolonged,6
PALBOCICLIB,Back pain,6
PALBOCICLIB,White blood cell count abnormal,6
PALBOCICLIB,Acute kidney injury,6
PALBOCICLIB,Dizziness,5
PALBOCICLIB,Leukopenia,5
PALBOCICLIB,Urinary tract infection,5
PALBOCICLIB,Osteonecrosis of jaw,5
PALBOCICLIB,Hypokalaemia,5
PALBOCICLIB,Bronchitis,5
PALBOCICLIB,Pyrexia,5
PALBOCICLIB,Haematocrit decreased,5
PALBOCICLIB,Pain in extremity,5
PALBOCICLIB,Body mass index increased,5
PALBOCICLIB,Body surface area increased,5
PALBOCICLIB,Death,5
PALBOCICLIB,Interstitial lung disease,5
PALBOCICLIB,Depressed mood,4
PALBOCICLIB,Hypocalcaemia,4
PALBOCICLIB,Intervertebral disc protrusion,4
PALBOCICLIB,Diverticulitis,4
PALBOCICLIB,Blood calcium increased,4
PALBOCICLIB,Fall,4
PALBOCICLIB,Viral infection,4
PALONOSETRON HYDROCHLORIDE,Malignant neoplasm progression,22
PALONOSETRON HYDROCHLORIDE,Off label use,21
PALONOSETRON HYDROCHLORIDE,Death,7
PALONOSETRON HYDROCHLORIDE,Nausea,6
PALONOSETRON HYDROCHLORIDE,Vomiting,6
PALONOSETRON HYDROCHLORIDE,Neutrophil count decreased,5
PALONOSETRON HYDROCHLORIDE,Neutropenia,4
PALONOSETRON HYDROCHLORIDE,Rash vesicular,4
PALONOSETRON HYDROCHLORIDE,Diarrhoea,3
PALONOSETRON HYDROCHLORIDE,White blood cell count decreased,3
PALONOSETRON HYDROCHLORIDE,Decreased appetite,3
PALONOSETRON HYDROCHLORIDE,Leukopenia,3
PALONOSETRON HYDROCHLORIDE,Neuropathy peripheral,2
PALONOSETRON HYDROCHLORIDE,Disease progression,2
PALONOSETRON HYDROCHLORIDE,Myelosuppression,2
PALONOSETRON HYDROCHLORIDE,Anaemia,2
PALONOSETRON HYDROCHLORIDE,Malaise,2
PALONOSETRON HYDROCHLORIDE,Underdose,2
PALONOSETRON HYDROCHLORIDE,Interstitial lung disease,2
PALONOSETRON HYDROCHLORIDE,Disseminated intravascular coagulation,2
PALONOSETRON HYDROCHLORIDE,Cholangitis infective,2
PALONOSETRON HYDROCHLORIDE,Liver injury,2
PALONOSETRON HYDROCHLORIDE,Hair texture abnormal,1
PALONOSETRON HYDROCHLORIDE,Hair colour changes,1
PALONOSETRON HYDROCHLORIDE,Madarosis,1
PALONOSETRON HYDROCHLORIDE,Alopecia areata,1
PALONOSETRON HYDROCHLORIDE,Mucosal inflammation,1
PALONOSETRON HYDROCHLORIDE,Alopecia totalis,1
PALONOSETRON HYDROCHLORIDE,Fatigue,1
PALONOSETRON HYDROCHLORIDE,Headache,1
PALONOSETRON HYDROCHLORIDE,Immune-mediated lung disease,1
PALONOSETRON HYDROCHLORIDE,Hypocalcaemia,1
PALONOSETRON HYDROCHLORIDE,Laryngeal pain,1
PALONOSETRON HYDROCHLORIDE,Abdominal pain upper,1
PALONOSETRON HYDROCHLORIDE,Hypokalaemia,1
PALONOSETRON HYDROCHLORIDE,Hepatic function abnormal,1
PALONOSETRON HYDROCHLORIDE,Renal impairment,1
PALONOSETRON HYDROCHLORIDE,KL-6 increased,1
PALONOSETRON HYDROCHLORIDE,Aspartate aminotransferase increased,1
PALONOSETRON HYDROCHLORIDE,Alanine aminotransferase increased,1
PALONOSETRON HYDROCHLORIDE,Inflammation,1
PALONOSETRON HYDROCHLORIDE,Constipation,1
PALONOSETRON HYDROCHLORIDE,Blood pressure systolic increased,1
PALONOSETRON HYDROCHLORIDE,Metastases to kidney,1
PALONOSETRON HYDROCHLORIDE,Neuroendocrine tumour of the rectum,1
PALONOSETRON HYDROCHLORIDE,Lymphocyte percentage decreased,1
PALONOSETRON HYDROCHLORIDE,Hepatic failure,1
PALONOSETRON HYDROCHLORIDE,Malignant ascites,1
PALONOSETRON HYDROCHLORIDE,Metastases to liver,1
PALONOSETRON HYDROCHLORIDE,Thrombocytopenia,1
PANTOPRAZOLE,Off label use,90
PANTOPRAZOLE,Diarrhoea,86
PANTOPRAZOLE,Fatigue,85
PANTOPRAZOLE,Pain,65
PANTOPRAZOLE,Nausea,61
PANTOPRAZOLE,Vomiting,59
PANTOPRAZOLE,Dyspnoea,59
PANTOPRAZOLE,Acute kidney injury,58
PANTOPRAZOLE,Asthenia,57
PANTOPRAZOLE,Neutropenia,50
PANTOPRAZOLE,Pneumonia,49
PANTOPRAZOLE,Arthralgia,48
PANTOPRAZOLE,Headache,47
PANTOPRAZOLE,Dizziness,46
PANTOPRAZOLE,Pyrexia,43
PANTOPRAZOLE,Anaemia,41
PANTOPRAZOLE,Abdominal pain,40
PANTOPRAZOLE,Pain in extremity,40
PANTOPRAZOLE,COVID-19,40
PANTOPRAZOLE,Drug ineffective,39
PANTOPRAZOLE,Pruritus,38
PANTOPRAZOLE,Fall,38
PANTOPRAZOLE,Hypotension,38
PANTOPRAZOLE,Hypomagnesaemia,37
PANTOPRAZOLE,Weight decreased,35
PANTOPRAZOLE,Hypocalcaemia,35
PANTOPRAZOLE,Anxiety,34
PANTOPRAZOLE,Thrombocytopenia,34
PANTOPRAZOLE,Back pain,33
PANTOPRAZOLE,Oedema peripheral,33
PANTOPRAZOLE,Chronic kidney disease,32
PANTOPRAZOLE,Rash,31
PANTOPRAZOLE,Product dose omission issue,31
PANTOPRAZOLE,Cough,31
PANTOPRAZOLE,Cardiac failure,29
PANTOPRAZOLE,Joint swelling,28
PANTOPRAZOLE,Renal failure,28
PANTOPRAZOLE,Product use in unapproved indication,27
PANTOPRAZOLE,Leukopenia,26
PANTOPRAZOLE,Drug reaction with eosinophilia and systemic symptoms,26
PANTOPRAZOLE,Peripheral swelling,25
PANTOPRAZOLE,Condition aggravated,25
PANTOPRAZOLE,Emotional distress,25
PANTOPRAZOLE,Depression,24
PANTOPRAZOLE,Abdominal pain upper,24
PANTOPRAZOLE,Hypokalaemia,24
PANTOPRAZOLE,General physical health deterioration,23
PANTOPRAZOLE,Hypertension,23
PANTOPRAZOLE,Erythema,23
PANTOPRAZOLE,Tachycardia,23
PANTOPRAZOLE SODIUM,Diarrhoea,65
PANTOPRAZOLE SODIUM,Fatigue,55
PANTOPRAZOLE SODIUM,Off label use,50
PANTOPRAZOLE SODIUM,Nausea,49
PANTOPRAZOLE SODIUM,Headache,40
PANTOPRAZOLE SODIUM,Pain,38
PANTOPRAZOLE SODIUM,COVID-19,36
PANTOPRAZOLE SODIUM,Pneumonia,32
PANTOPRAZOLE SODIUM,Vomiting,31
PANTOPRAZOLE SODIUM,Dyspnoea,29
PANTOPRAZOLE SODIUM,Weight decreased,29
PANTOPRAZOLE SODIUM,Pyrexia,28
PANTOPRAZOLE SODIUM,Asthenia,28
PANTOPRAZOLE SODIUM,Malaise,28
PANTOPRAZOLE SODIUM,Sinusitis,25
PANTOPRAZOLE SODIUM,Abdominal pain,25
PANTOPRAZOLE SODIUM,Cough,24
PANTOPRAZOLE SODIUM,Product dose omission issue,23
PANTOPRAZOLE SODIUM,Arthralgia,22
PANTOPRAZOLE SODIUM,Fall,22
PANTOPRAZOLE SODIUM,Pruritus,21
PANTOPRAZOLE SODIUM,Dizziness,21
PANTOPRAZOLE SODIUM,Rash,20
PANTOPRAZOLE SODIUM,Urinary tract infection,19
PANTOPRAZOLE SODIUM,Abdominal pain upper,19
PANTOPRAZOLE SODIUM,Illness,18
PANTOPRAZOLE SODIUM,Weight increased,18
PANTOPRAZOLE SODIUM,Anaemia,18
PANTOPRAZOLE SODIUM,Pain in extremity,17
PANTOPRAZOLE SODIUM,Back pain,16
PANTOPRAZOLE SODIUM,Drug ineffective,16
PANTOPRAZOLE SODIUM,Abdominal discomfort,16
PANTOPRAZOLE SODIUM,Inappropriate schedule of product administration,16
PANTOPRAZOLE SODIUM,Nasopharyngitis,15
PANTOPRAZOLE SODIUM,Decreased appetite,15
PANTOPRAZOLE SODIUM,Dehydration,15
PANTOPRAZOLE SODIUM,Upper respiratory tract infection,15
PANTOPRAZOLE SODIUM,Acute kidney injury,15
PANTOPRAZOLE SODIUM,Injection site pain,14
PANTOPRAZOLE SODIUM,Bronchitis,14
PANTOPRAZOLE SODIUM,Peripheral swelling,14
PANTOPRAZOLE SODIUM,Anxiety,14
PANTOPRAZOLE SODIUM,Feeling abnormal,13
PANTOPRAZOLE SODIUM,Influenza,13
PANTOPRAZOLE SODIUM,Joint swelling,13
PANTOPRAZOLE SODIUM,Contusion,13
PANTOPRAZOLE SODIUM,Condition aggravated,13
PANTOPRAZOLE SODIUM,Sepsis,13
PANTOPRAZOLE SODIUM,Hypokalaemia,13
PANTOPRAZOLE SODIUM,Insomnia,12
PARAGARD T 380A,Device dislocation,23
PARAGARD T 380A,Device expulsion,19
PARAGARD T 380A,Complication of device removal,17
PARAGARD T 380A,Foreign body in reproductive tract,17
PARAGARD T 380A,Device breakage,15
PARAGARD T 380A,Embedded device,10
PARAGARD T 380A,Complication of device insertion,10
PARAGARD T 380A,Ovarian cyst,9
PARAGARD T 380A,Pain,8
PARAGARD T 380A,Injury associated with device,8
PARAGARD T 380A,Off label use,8
PARAGARD T 380A,Abnormal uterine bleeding,7
PARAGARD T 380A,Anxiety,6
PARAGARD T 380A,Deformity,6
PARAGARD T 380A,Muscle spasms,6
PARAGARD T 380A,Sensation of foreign body,6
PARAGARD T 380A,Reproductive complication associated with device,5
PARAGARD T 380A,Procedural pain,5
PARAGARD T 380A,Pelvic pain,5
PARAGARD T 380A,Device use issue,4
PARAGARD T 380A,Device material issue,4
PARAGARD T 380A,Device issue,4
PARAGARD T 380A,Dyspareunia,4
PARAGARD T 380A,Complication associated with device,4
PARAGARD T 380A,Discomfort,4
PARAGARD T 380A,Pregnancy with contraceptive device,4
PARAGARD T 380A,Heavy menstrual bleeding,4
PARAGARD T 380A,Economic problem,3
PARAGARD T 380A,Uterine leiomyoma,3
PARAGARD T 380A,Cervical dysplasia,3
PARAGARD T 380A,Intermenstrual bleeding,3
PARAGARD T 380A,Abdominal distension,2
PARAGARD T 380A,Procedural haemorrhage,2
PARAGARD T 380A,Smear cervix abnormal,2
PARAGARD T 380A,Dysmenorrhoea,2
PARAGARD T 380A,Uterine polyp,2
PARAGARD T 380A,Emotional distress,2
PARAGARD T 380A,Drug ineffective,2
PARAGARD T 380A,Device placement issue,2
PARAGARD T 380A,Uterine perforation,2
PARAGARD T 380A,Menstruation irregular,2
PARAGARD T 380A,Anhedonia,1
PARAGARD T 380A,Amenorrhoea,1
PARAGARD T 380A,Abdominal pain,1
PARAGARD T 380A,Food poisoning,1
PARAGARD T 380A,Uterine haemorrhage,1
PARAGARD T 380A,Papilloma viral infection,1
PARAGARD T 380A,Uterine obstruction,1
PARAGARD T 380A,Phlebolith,1
PARAGARD T 380A,Device allergy,1
PAROXETINE,Fatigue,29
PAROXETINE,Asthenia,24
PAROXETINE,Somnolence,20
PAROXETINE,Anxiety,20
PAROXETINE,Confusional state,20
PAROXETINE,Dizziness,18
PAROXETINE,Dyspnoea,17
PAROXETINE,Suicidal ideation,16
PAROXETINE,Tremor,16
PAROXETINE,Arthralgia,15
PAROXETINE,Disturbance in attention,15
PAROXETINE,Off label use,15
PAROXETINE,Heart rate increased,15
PAROXETINE,Emotional disorder,15
PAROXETINE,Feeling of despair,15
PAROXETINE,Restlessness,15
PAROXETINE,Restless legs syndrome,15
PAROXETINE,Diarrhoea,15
PAROXETINE,Nausea,14
PAROXETINE,Depression,14
PAROXETINE,Headache,14
PAROXETINE,Toxicity to various agents,14
PAROXETINE,Drug ineffective,14
PAROXETINE,Illness,14
PAROXETINE,Hypoaesthesia,14
PAROXETINE,Pyrexia,14
PAROXETINE,Disorientation,13
PAROXETINE,Drug interaction,13
PAROXETINE,Agitation,13
PAROXETINE,Vomiting,13
PAROXETINE,Serotonin syndrome,13
PAROXETINE,Gait disturbance,12
PAROXETINE,Nightmare,12
PAROXETINE,Dyskinesia,12
PAROXETINE,Premature labour,11
PAROXETINE,Sleep disorder,11
PAROXETINE,Vision blurred,11
PAROXETINE,Pain,11
PAROXETINE,Pruritus,11
PAROXETINE,Blood sodium decreased,11
PAROXETINE,Seizure,11
PAROXETINE,Drug withdrawal syndrome,11
PAROXETINE,Paralysis,11
PAROXETINE,Paraesthesia,11
PAROXETINE,Dystonia,11
PAROXETINE,Neuroleptic malignant syndrome,11
PAROXETINE,Psychotic disorder,11
PAROXETINE,Tachycardia,11
PAROXETINE,Cyanosis,11
PAROXETINE,Contusion,11
PAROXETINE HYDROCHLORIDE,Fatigue,16
PAROXETINE HYDROCHLORIDE,Asthenia,16
PAROXETINE HYDROCHLORIDE,Gait disturbance,15
PAROXETINE HYDROCHLORIDE,Depression,15
PAROXETINE HYDROCHLORIDE,Headache,15
PAROXETINE HYDROCHLORIDE,Vomiting,15
PAROXETINE HYDROCHLORIDE,Dizziness,15
PAROXETINE HYDROCHLORIDE,Somnolence,14
PAROXETINE HYDROCHLORIDE,Off label use,14
PAROXETINE HYDROCHLORIDE,Serotonin syndrome,14
PAROXETINE HYDROCHLORIDE,Paraesthesia,14
PAROXETINE HYDROCHLORIDE,Anxiety,13
PAROXETINE HYDROCHLORIDE,Hyperhidrosis,13
PAROXETINE HYDROCHLORIDE,Sleep disorder,13
PAROXETINE HYDROCHLORIDE,Mydriasis,13
PAROXETINE HYDROCHLORIDE,Eye pain,13
PAROXETINE HYDROCHLORIDE,Tachycardia,13
PAROXETINE HYDROCHLORIDE,Dyskinesia,13
PAROXETINE HYDROCHLORIDE,Visual impairment,13
PAROXETINE HYDROCHLORIDE,Tremor,13
PAROXETINE HYDROCHLORIDE,Vision blurred,13
PAROXETINE HYDROCHLORIDE,Contusion,13
PAROXETINE HYDROCHLORIDE,Pruritus,12
PAROXETINE HYDROCHLORIDE,Drug interaction,12
PAROXETINE HYDROCHLORIDE,Blood sodium decreased,12
PAROXETINE HYDROCHLORIDE,Seizure,12
PAROXETINE HYDROCHLORIDE,Drooling,12
PAROXETINE HYDROCHLORIDE,Balance disorder,12
PAROXETINE HYDROCHLORIDE,Confusional state,12
PAROXETINE HYDROCHLORIDE,Drug withdrawal syndrome,12
PAROXETINE HYDROCHLORIDE,Paralysis,12
PAROXETINE HYDROCHLORIDE,Suicidal ideation,12
PAROXETINE HYDROCHLORIDE,Muscle spasms,12
PAROXETINE HYDROCHLORIDE,Dystonia,12
PAROXETINE HYDROCHLORIDE,Decreased appetite,12
PAROXETINE HYDROCHLORIDE,Pyrexia,12
PAROXETINE HYDROCHLORIDE,Delirium,12
PAROXETINE HYDROCHLORIDE,Diarrhoea,12
PAROXETINE HYDROCHLORIDE,Dyspnoea,12
PAROXETINE HYDROCHLORIDE,Parosmia,11
PAROXETINE HYDROCHLORIDE,Mania,11
PAROXETINE HYDROCHLORIDE,Disturbance in attention,11
PAROXETINE HYDROCHLORIDE,Hypoaesthesia oral,11
PAROXETINE HYDROCHLORIDE,Depersonalisation/derealisation disorder,11
PAROXETINE HYDROCHLORIDE,Agitation,11
PAROXETINE HYDROCHLORIDE,Toxicity to various agents,11
PAROXETINE HYDROCHLORIDE,Heart rate increased,11
PAROXETINE HYDROCHLORIDE,Therapeutic product ineffective,11
PAROXETINE HYDROCHLORIDE,Emotional disorder,11
PAROXETINE HYDROCHLORIDE,Mood swings,11
PAXLOVID,COVID-19,245
PAXLOVID,Disease recurrence,227
PAXLOVID,Dysgeusia,125
PAXLOVID,Diarrhoea,70
PAXLOVID,Nausea,38
PAXLOVID,Incorrect dose administered,34
PAXLOVID,Fatigue,32
PAXLOVID,Headache,28
PAXLOVID,Cough,25
PAXLOVID,Off label use,21
PAXLOVID,Dizziness,20
PAXLOVID,Insomnia,20
PAXLOVID,Asthenia,18
PAXLOVID,Decreased appetite,17
PAXLOVID,Malaise,17
PAXLOVID,Abdominal discomfort,16
PAXLOVID,Vomiting,16
PAXLOVID,Abdominal pain upper,15
PAXLOVID,Oropharyngeal pain,15
PAXLOVID,Pruritus,14
PAXLOVID,Therapeutic product effect incomplete,14
PAXLOVID,Dyspnoea,13
PAXLOVID,Myalgia,13
PAXLOVID,Feeling abnormal,13
PAXLOVID,Rash,12
PAXLOVID,Taste disorder,12
PAXLOVID,Inappropriate schedule of product administration,12
PAXLOVID,Arthralgia,11
PAXLOVID,Rhinorrhoea,11
PAXLOVID,Weight decreased,11
PAXLOVID,Incorrect product administration duration,11
PAXLOVID,Illness,10
PAXLOVID,Drug interaction,10
PAXLOVID,Pain in extremity,9
PAXLOVID,Pyrexia,9
PAXLOVID,Pain,9
PAXLOVID,Product prescribing error,9
PAXLOVID,Chills,8
PAXLOVID,Dry mouth,8
PAXLOVID,Nasal congestion,8
PAXLOVID,Dysphonia,8
PAXLOVID,Abdominal pain,8
PAXLOVID,Contraindicated product administered,8
PAXLOVID,Sinusitis,7
PAXLOVID,Wrong technique in product usage process,7
PAXLOVID,Brain fog,7
PAXLOVID,Back pain,7
PAXLOVID,Dyspepsia,6
PAXLOVID,Muscle spasms,6
PAXLOVID,Intentional product misuse,6
PEGFILGRASTIM,Pyrexia,8
PEGFILGRASTIM,Nausea,7
PEGFILGRASTIM,Pneumonia,6
PEGFILGRASTIM,Decreased appetite,6
PEGFILGRASTIM,Anaemia,6
PEGFILGRASTIM,Diarrhoea,5
PEGFILGRASTIM,Fatigue,5
PEGFILGRASTIM,Arthralgia,5
PEGFILGRASTIM,Febrile neutropenia,5
PEGFILGRASTIM,Off label use,5
PEGFILGRASTIM,Bone pain,5
PEGFILGRASTIM,Drug interaction,5
PEGFILGRASTIM,Neutropenia,5
PEGFILGRASTIM,Neutrophil count decreased,4
PEGFILGRASTIM,Platelet count decreased,4
PEGFILGRASTIM,Myalgia,4
PEGFILGRASTIM,Laryngeal oedema,4
PEGFILGRASTIM,Sensation of foreign body,4
PEGFILGRASTIM,Hydrothorax,4
PEGFILGRASTIM,Pelvic abscess,4
PEGFILGRASTIM,Chest pain,4
PEGFILGRASTIM,Vertigo,4
PEGFILGRASTIM,Lymphangiosis carcinomatosa,4
PEGFILGRASTIM,Confusional state,4
PEGFILGRASTIM,Sudden death,4
PEGFILGRASTIM,Asthenia,4
PEGFILGRASTIM,Radiation associated pain,4
PEGFILGRASTIM,Paraparesis,4
PEGFILGRASTIM,General physical health deterioration,4
PEGFILGRASTIM,Blood corticotrophin decreased,4
PEGFILGRASTIM,Somnolence,4
PEGFILGRASTIM,Hypophagia,4
PEGFILGRASTIM,Delusion,4
PEGFILGRASTIM,Klebsiella test positive,4
PEGFILGRASTIM,Malignant neoplasm progression,4
PEGFILGRASTIM,Staring,4
PEGFILGRASTIM,Vomiting,4
PEGFILGRASTIM,Hallucination,4
PEGFILGRASTIM,Communication disorder,4
PEGFILGRASTIM,Fluid intake reduced,4
PEGFILGRASTIM,Condition aggravated,4
PEGFILGRASTIM,Hepatic function abnormal,4
PEGFILGRASTIM,Oesophagitis,4
PEGFILGRASTIM,Neuropathy peripheral,3
PEGFILGRASTIM,Dyspnoea,3
PEGFILGRASTIM,Rash,3
PEGFILGRASTIM,Hair texture abnormal,2
PEGFILGRASTIM,Hair colour changes,2
PEGFILGRASTIM,Madarosis,2
PEGFILGRASTIM,Alopecia areata,2
PEMBROLIZUMAB,Diarrhoea,23
PEMBROLIZUMAB,Pancytopenia,19
PEMBROLIZUMAB,Pneumonia,18
PEMBROLIZUMAB,Rash,14
PEMBROLIZUMAB,General physical health deterioration,13
PEMBROLIZUMAB,Respiratory failure,13
PEMBROLIZUMAB,Pyrexia,13
PEMBROLIZUMAB,Off label use,11
PEMBROLIZUMAB,Tubulointerstitial nephritis,11
PEMBROLIZUMAB,Inappropriate schedule of product administration,10
PEMBROLIZUMAB,Anaemia,9
PEMBROLIZUMAB,Addison's disease,9
PEMBROLIZUMAB,Hepatic cytolysis,8
PEMBROLIZUMAB,Haemophagocytic lymphohistiocytosis,7
PEMBROLIZUMAB,Immune-mediated lung disease,7
PEMBROLIZUMAB,Alopecia,7
PEMBROLIZUMAB,Periarticular thenar erythema with onycholysis,7
PEMBROLIZUMAB,Mouth ulceration,7
PEMBROLIZUMAB,Hypersensitivity pneumonitis,6
PEMBROLIZUMAB,Acute kidney injury,6
PEMBROLIZUMAB,Hypothyroidism,6
PEMBROLIZUMAB,Hypertension,6
PEMBROLIZUMAB,Dyspnoea,6
PEMBROLIZUMAB,Colitis,6
PEMBROLIZUMAB,Neutropenia,6
PEMBROLIZUMAB,Febrile neutropenia,5
PEMBROLIZUMAB,Sepsis,5
PEMBROLIZUMAB,Hypokalaemia,5
PEMBROLIZUMAB,Alanine aminotransferase increased,5
PEMBROLIZUMAB,Thrombocytopenia,5
PEMBROLIZUMAB,Malignant neoplasm progression,5
PEMBROLIZUMAB,Asthenia,5
PEMBROLIZUMAB,Platelet count decreased,5
PEMBROLIZUMAB,Vomiting,5
PEMBROLIZUMAB,Septic shock,4
PEMBROLIZUMAB,Arthralgia,4
PEMBROLIZUMAB,Pain in extremity,4
PEMBROLIZUMAB,Pulmonary embolism,4
PEMBROLIZUMAB,Interstitial lung disease,4
PEMBROLIZUMAB,Stomatitis,4
PEMBROLIZUMAB,Death,4
PEMBROLIZUMAB,Hyponatraemia,4
PEMBROLIZUMAB,Immune-mediated hepatitis,4
PEMBROLIZUMAB,Liver injury,4
PEMBROLIZUMAB,Hepatitis,4
PEMBROLIZUMAB,Dysphagia,3
PEMBROLIZUMAB,Abdominal pain,3
PEMBROLIZUMAB,Product use in unapproved indication,3
PEMBROLIZUMAB,Product use issue,3
PEMBROLIZUMAB,Aspartate aminotransferase increased,3
PEMETREXED,Pyrexia,26
PEMETREXED,Pancytopenia,21
PEMETREXED,Pneumonia,16
PEMETREXED,Vomiting,15
PEMETREXED,Anaemia,13
PEMETREXED,Diarrhoea,13
PEMETREXED,General physical health deterioration,13
PEMETREXED,Tubulointerstitial nephritis,12
PEMETREXED,Rash,12
PEMETREXED,Non-small cell lung cancer,10
PEMETREXED,Neutropenia,10
PEMETREXED,Respiratory failure,10
PEMETREXED,Malignant neoplasm progression,9
PEMETREXED,Myocarditis,9
PEMETREXED,Lichenoid keratosis,9
PEMETREXED,Diabetic ketoacidosis,9
PEMETREXED,Subacute cutaneous lupus erythematosus,9
PEMETREXED,Confusional state,9
PEMETREXED,Addison's disease,9
PEMETREXED,Encephalopathy,8
PEMETREXED,Circulatory collapse,8
PEMETREXED,Off label use,7
PEMETREXED,Glomerulonephritis rapidly progressive,7
PEMETREXED,Febrile bone marrow aplasia,7
PEMETREXED,Oedema peripheral,6
PEMETREXED,Asthenia,6
PEMETREXED,Condition aggravated,6
PEMETREXED,Nausea,6
PEMETREXED,Mouth ulceration,6
PEMETREXED,Death,5
PEMETREXED,Febrile neutropenia,5
PEMETREXED,White blood cell count decreased,5
PEMETREXED,Arthralgia,5
PEMETREXED,Myelosuppression,5
PEMETREXED,Chest pain,5
PEMETREXED,Hallucination,5
PEMETREXED,Aspartate aminotransferase increased,4
PEMETREXED,Liver injury,4
PEMETREXED,Alopecia,4
PEMETREXED,Hydrothorax,4
PEMETREXED,Pelvic abscess,4
PEMETREXED,Vertigo,4
PEMETREXED,Lymphangiosis carcinomatosa,4
PEMETREXED,Decreased appetite,4
PEMETREXED,Sudden death,4
PEMETREXED,Radiation associated pain,4
PEMETREXED,Paraparesis,4
PEMETREXED,Blood corticotrophin decreased,4
PEMETREXED,Somnolence,4
PEMETREXED,Hypophagia,4
PEPCID,Fatigue,21
PEPCID,Pain,18
PEPCID,Pneumonia,15
PEPCID,Diarrhoea,15
PEPCID,COVID-19,13
PEPCID,Anxiety,11
PEPCID,Inappropriate schedule of product administration,10
PEPCID,Dyspnoea,10
PEPCID,Off label use,10
PEPCID,Urinary tract infection,9
PEPCID,Nasopharyngitis,9
PEPCID,Sinusitis,9
PEPCID,Anaemia,9
PEPCID,Headache,8
PEPCID,Nausea,7
PEPCID,Vomiting,7
PEPCID,Pain in extremity,7
PEPCID,Back pain,7
PEPCID,Malaise,6
PEPCID,Depression,6
PEPCID,Sepsis,6
PEPCID,Influenza,6
PEPCID,Anhedonia,6
PEPCID,Emotional distress,6
PEPCID,Chronic kidney disease,6
PEPCID,Dizziness,6
PEPCID,Infusion related reaction,6
PEPCID,Hypoaesthesia,6
PEPCID,Product dose omission issue,6
PEPCID,Acute kidney injury,6
PEPCID,Pruritus,6
PEPCID,Fall,5
PEPCID,Infusion site pain,5
PEPCID,Somnolence,5
PEPCID,Renal failure,5
PEPCID,Dehydration,5
PEPCID,Multiple allergies,5
PEPCID,Abdominal discomfort,5
PEPCID,Constipation,5
PEPCID,Pyrexia,5
PEPCID,Asthma,5
PEPCID,Weight decreased,5
PEPCID,Upper respiratory tract infection,5
PEPCID,Abdominal pain upper,5
PEPCID,Infusion site extravasation,4
PEPCID,Respiratory tract infection,4
PEPCID,Death,4
PEPCID,Drug hypersensitivity,4
PEPCID,Arthralgia,4
PEPCID,Illness,4
PERCOCET,Pain,12
PERCOCET,COVID-19,11
PERCOCET,Fatigue,10
PERCOCET,Urinary tract infection,10
PERCOCET,Product dose omission issue,8
PERCOCET,Fall,8
PERCOCET,Pneumonia,7
PERCOCET,Dyspnoea,7
PERCOCET,Sinusitis,7
PERCOCET,Headache,6
PERCOCET,Anxiety,6
PERCOCET,Nausea,6
PERCOCET,Feeling abnormal,6
PERCOCET,Pain in extremity,6
PERCOCET,Incorrect dose administered,6
PERCOCET,Diarrhoea,6
PERCOCET,Arthralgia,6
PERCOCET,Peripheral swelling,6
PERCOCET,Off label use,6
PERCOCET,Contusion,5
PERCOCET,Infusion related reaction,5
PERCOCET,Death,4
PERCOCET,Gait disturbance,4
PERCOCET,Dizziness,4
PERCOCET,Cystitis,4
PERCOCET,Emotional distress,4
PERCOCET,Anhedonia,4
PERCOCET,Infusion site pain,4
PERCOCET,Seasonal allergy,4
PERCOCET,Malaise,4
PERCOCET,Nasopharyngitis,4
PERCOCET,Pyrexia,4
PERCOCET,Upper respiratory tract infection,4
PERCOCET,Illness,4
PERCOCET,Arthritis,4
PERCOCET,Rash,4
PERCOCET,Infusion site rash,4
PERCOCET,Drug hypersensitivity,4
PERCOCET,Joint swelling,4
PERCOCET,Vomiting,4
PERCOCET,Drug ineffective,4
PERCOCET,Neck pain,3
PERCOCET,Depression,3
PERCOCET,Osteopenia,3
PERCOCET,Bone density decreased,3
PERCOCET,Renal failure,3
PERCOCET,Acute kidney injury,3
PERCOCET,Inappropriate schedule of product administration,3
PERCOCET,Back pain,3
PERCOCET,Anaemia,3
PERINDOPRIL,Off label use,22
PERINDOPRIL,Diarrhoea,11
PERINDOPRIL,Drug interaction,11
PERINDOPRIL,Acute kidney injury,10
PERINDOPRIL,Anaemia,10
PERINDOPRIL,Pneumonia,10
PERINDOPRIL,Nausea,9
PERINDOPRIL,Abdominal pain,8
PERINDOPRIL,Hypotension,8
PERINDOPRIL,Fatigue,8
PERINDOPRIL,Haematochezia,7
PERINDOPRIL,Prescribed overdose,7
PERINDOPRIL,Weight decreased,7
PERINDOPRIL,Malaise,7
PERINDOPRIL,Pain,6
PERINDOPRIL,Headache,6
PERINDOPRIL,Pyrexia,6
PERINDOPRIL,Drug ineffective,6
PERINDOPRIL,COVID-19,6
PERINDOPRIL,Neutropenia,6
PERINDOPRIL,Leukopenia,6
PERINDOPRIL,Diabetes mellitus,6
PERINDOPRIL,Photosensitivity reaction,6
PERINDOPRIL,Vomiting,5
PERINDOPRIL,Confusional state,5
PERINDOPRIL,Urticaria,5
PERINDOPRIL,Hypertension,5
PERINDOPRIL,Pruritus,5
PERINDOPRIL,Dyspnoea,5
PERINDOPRIL,Condition aggravated,5
PERINDOPRIL,Blood pressure increased,5
PERINDOPRIL,Dizziness,5
PERINDOPRIL,Abdominal pain upper,5
PERINDOPRIL,Dermatitis,5
PERINDOPRIL,Lung disorder,5
PERINDOPRIL,Pain in extremity,4
PERINDOPRIL,Asthenia,4
PERINDOPRIL,Anxiety,4
PERINDOPRIL,Arthralgia,4
PERINDOPRIL,Erythema,4
PERINDOPRIL,Tinnitus,4
PERINDOPRIL,Stomatitis,4
PERINDOPRIL,Overdose,4
PERINDOPRIL,Death,4
PERINDOPRIL,Syncope,4
PERINDOPRIL,Oedema peripheral,4
PERINDOPRIL,Inappropriate antidiuretic hormone secretion,4
PERINDOPRIL,Euglycaemic diabetic ketoacidosis,4
PERINDOPRIL,Mixed liver injury,4
PERINDOPRIL,Incorrect dose administered,4
PERTUZUMAB,Diarrhoea,44
PERTUZUMAB,Mucosal inflammation,27
PERTUZUMAB,Anaemia,27
PERTUZUMAB,Fatigue,24
PERTUZUMAB,Alopecia,22
PERTUZUMAB,Off label use,19
PERTUZUMAB,Neutropenia,18
PERTUZUMAB,Nausea,16
PERTUZUMAB,Gastrooesophageal reflux disease,14
PERTUZUMAB,Rash,14
PERTUZUMAB,Neuropathy peripheral,13
PERTUZUMAB,Osteonecrosis of jaw,13
PERTUZUMAB,Vascular device infection,12
PERTUZUMAB,Influenza like illness,12
PERTUZUMAB,Ejection fraction decreased,12
PERTUZUMAB,COVID-19,12
PERTUZUMAB,Hypokalaemia,12
PERTUZUMAB,Gingival swelling,11
PERTUZUMAB,Lymphoedema,11
PERTUZUMAB,Epistaxis,11
PERTUZUMAB,Hot flush,11
PERTUZUMAB,Platelet count decreased,11
PERTUZUMAB,Thrombocytopenia,11
PERTUZUMAB,Febrile neutropenia,10
PERTUZUMAB,Overdose,10
PERTUZUMAB,Dyspepsia,10
PERTUZUMAB,Disease progression,10
PERTUZUMAB,Keratitis,10
PERTUZUMAB,Visual acuity reduced,10
PERTUZUMAB,Affective disorder,9
PERTUZUMAB,Leukopenia,9
PERTUZUMAB,Neutrophil count increased,9
PERTUZUMAB,Cellulitis,9
PERTUZUMAB,Schizophrenia,9
PERTUZUMAB,Incorrect dose administered,9
PERTUZUMAB,Seizure,9
PERTUZUMAB,Psychotic disorder,9
PERTUZUMAB,Lymphocyte count decreased,9
PERTUZUMAB,"Hallucination, auditory",9
PERTUZUMAB,Extrapyramidal disorder,9
PERTUZUMAB,Delusion of grandeur,9
PERTUZUMAB,Sepsis,8
PERTUZUMAB,Rhinalgia,8
PERTUZUMAB,Device related infection,7
PERTUZUMAB,Lymphocyte count abnormal,7
PERTUZUMAB,General physical health deterioration,7
PERTUZUMAB,Respiratory tract infection,7
PERTUZUMAB,Vomiting,6
PERTUZUMAB,SARS-CoV-2 test positive,6
PERTUZUMAB,Muscle spasms,6
PFIZER-BIONTECH COVID-19 VACCINE,COVID-19,34
PFIZER-BIONTECH COVID-19 VACCINE,Fatigue,28
PFIZER-BIONTECH COVID-19 VACCINE,Pain,26
PFIZER-BIONTECH COVID-19 VACCINE,Fall,23
PFIZER-BIONTECH COVID-19 VACCINE,Headache,19
PFIZER-BIONTECH COVID-19 VACCINE,Urinary tract infection,18
PFIZER-BIONTECH COVID-19 VACCINE,Pain in extremity,18
PFIZER-BIONTECH COVID-19 VACCINE,Arthralgia,18
PFIZER-BIONTECH COVID-19 VACCINE,Pneumonia,17
PFIZER-BIONTECH COVID-19 VACCINE,Dyspnoea,17
PFIZER-BIONTECH COVID-19 VACCINE,Nausea,16
PFIZER-BIONTECH COVID-19 VACCINE,Off label use,16
PFIZER-BIONTECH COVID-19 VACCINE,Back pain,15
PFIZER-BIONTECH COVID-19 VACCINE,Product dose omission issue,14
PFIZER-BIONTECH COVID-19 VACCINE,Inappropriate schedule of product administration,13
PFIZER-BIONTECH COVID-19 VACCINE,Pyrexia,12
PFIZER-BIONTECH COVID-19 VACCINE,Asthenia,12
PFIZER-BIONTECH COVID-19 VACCINE,Diarrhoea,11
PFIZER-BIONTECH COVID-19 VACCINE,Dizziness,11
PFIZER-BIONTECH COVID-19 VACCINE,Hypertension,10
PFIZER-BIONTECH COVID-19 VACCINE,Malaise,9
PFIZER-BIONTECH COVID-19 VACCINE,Sinusitis,9
PFIZER-BIONTECH COVID-19 VACCINE,Psoriasis,9
PFIZER-BIONTECH COVID-19 VACCINE,Cough,8
PFIZER-BIONTECH COVID-19 VACCINE,Influenza like illness,8
PFIZER-BIONTECH COVID-19 VACCINE,Infusion related reaction,8
PFIZER-BIONTECH COVID-19 VACCINE,Anxiety,8
PFIZER-BIONTECH COVID-19 VACCINE,Weight decreased,8
PFIZER-BIONTECH COVID-19 VACCINE,Neutropenia,8
PFIZER-BIONTECH COVID-19 VACCINE,Pruritus,8
PFIZER-BIONTECH COVID-19 VACCINE,Weight increased,8
PFIZER-BIONTECH COVID-19 VACCINE,Rash,7
PFIZER-BIONTECH COVID-19 VACCINE,Decreased appetite,7
PFIZER-BIONTECH COVID-19 VACCINE,Arthritis,7
PFIZER-BIONTECH COVID-19 VACCINE,Contusion,7
PFIZER-BIONTECH COVID-19 VACCINE,Musculoskeletal stiffness,7
PFIZER-BIONTECH COVID-19 VACCINE,Gait disturbance,6
PFIZER-BIONTECH COVID-19 VACCINE,Depression,6
PFIZER-BIONTECH COVID-19 VACCINE,Infusion site pain,6
PFIZER-BIONTECH COVID-19 VACCINE,Nasopharyngitis,6
PFIZER-BIONTECH COVID-19 VACCINE,Skin laceration,6
PFIZER-BIONTECH COVID-19 VACCINE,Blood pressure increased,6
PFIZER-BIONTECH COVID-19 VACCINE,Vomiting,6
PFIZER-BIONTECH COVID-19 VACCINE,Cataract,6
PFIZER-BIONTECH COVID-19 VACCINE,Peripheral swelling,6
PFIZER-BIONTECH COVID-19 VACCINE,Infection,6
PFIZER-BIONTECH COVID-19 VACCINE,Chest pain,6
PFIZER-BIONTECH COVID-19 VACCINE,Oedema peripheral,6
PFIZER-BIONTECH COVID-19 VACCINE,Muscular weakness,6
PFIZER-BIONTECH COVID-19 VACCINE,Abdominal pain upper,6
PIPERACILLIN AND TAZOBACTAM,Stevens-Johnson syndrome,6
PIPERACILLIN AND TAZOBACTAM,Platelet count decreased,5
PIPERACILLIN AND TAZOBACTAM,Pneumonia,5
PIPERACILLIN AND TAZOBACTAM,Febrile neutropenia,5
PIPERACILLIN AND TAZOBACTAM,White blood cell count decreased,4
PIPERACILLIN AND TAZOBACTAM,Lymphocyte count decreased,4
PIPERACILLIN AND TAZOBACTAM,Anaemia,4
PIPERACILLIN AND TAZOBACTAM,Off label use,4
PIPERACILLIN AND TAZOBACTAM,COVID-19,4
PIPERACILLIN AND TAZOBACTAM,Hypersensitivity,4
PIPERACILLIN AND TAZOBACTAM,Pyrexia,3
PIPERACILLIN AND TAZOBACTAM,Hypotension,3
PIPERACILLIN AND TAZOBACTAM,Acute kidney injury,3
PIPERACILLIN AND TAZOBACTAM,Diarrhoea,3
PIPERACILLIN AND TAZOBACTAM,Malaise,3
PIPERACILLIN AND TAZOBACTAM,Dyspnoea,3
PIPERACILLIN AND TAZOBACTAM,Myelosuppression,3
PIPERACILLIN AND TAZOBACTAM,Coagulopathy,3
PIPERACILLIN AND TAZOBACTAM,Hepatic cytolysis,3
PIPERACILLIN AND TAZOBACTAM,Anaphylactic shock,3
PIPERACILLIN AND TAZOBACTAM,Neurotoxicity,2
PIPERACILLIN AND TAZOBACTAM,Neutrophil count decreased,2
PIPERACILLIN AND TAZOBACTAM,Tachypnoea,2
PIPERACILLIN AND TAZOBACTAM,Pneumonia aspiration,2
PIPERACILLIN AND TAZOBACTAM,Dysphagia,2
PIPERACILLIN AND TAZOBACTAM,Condition aggravated,2
PIPERACILLIN AND TAZOBACTAM,Septic shock,2
PIPERACILLIN AND TAZOBACTAM,Pneumonia bacterial,2
PIPERACILLIN AND TAZOBACTAM,Abdominal infection,2
PIPERACILLIN AND TAZOBACTAM,Bronchopulmonary aspergillosis,2
PIPERACILLIN AND TAZOBACTAM,Cough,2
PIPERACILLIN AND TAZOBACTAM,Hyponatraemia,2
PIPERACILLIN AND TAZOBACTAM,Hypoglycaemia,2
PIPERACILLIN AND TAZOBACTAM,Death,2
PIPERACILLIN AND TAZOBACTAM,Hypokalaemia,2
PIPERACILLIN AND TAZOBACTAM,Upper gastrointestinal haemorrhage,2
PIPERACILLIN AND TAZOBACTAM,Oral infection,2
PIPERACILLIN AND TAZOBACTAM,Decreased appetite,2
PIPERACILLIN AND TAZOBACTAM,Hepatic function abnormal,2
PIPERACILLIN AND TAZOBACTAM,Visual impairment,2
PIPERACILLIN AND TAZOBACTAM,Thrombocytopenia,2
PIPERACILLIN AND TAZOBACTAM,Tremor,2
PIPERACILLIN AND TAZOBACTAM,Syncope,2
PIPERACILLIN AND TAZOBACTAM,Vision blurred,2
PIPERACILLIN AND TAZOBACTAM,Hypocalcaemia,2
PIPERACILLIN AND TAZOBACTAM,Respiratory failure,1
PIPERACILLIN AND TAZOBACTAM,Hypothermia,1
PIPERACILLIN AND TAZOBACTAM,Blood alkaline phosphatase increased,1
PIPERACILLIN AND TAZOBACTAM,Genital pain,1
PIPERACILLIN AND TAZOBACTAM,Paraesthesia,1
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Diarrhoea,47
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Off label use,30
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Pyrexia,29
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Neutropenia,23
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Fatigue,21
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Febrile neutropenia,21
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Anaemia,20
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Vomiting,20
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Alopecia,19
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Mucosal inflammation,19
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Acute kidney injury,16
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Rash,16
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Malaise,16
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Nausea,15
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Dyspnoea,15
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Back pain,14
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Chills,13
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Pain,13
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Epistaxis,13
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Thrombocytopenia,13
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Rash maculo-papular,13
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Hepatic cytolysis,12
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Vascular device infection,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Ejection fraction decreased,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Sepsis,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Leukopenia,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Platelet count decreased,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Neuropathy peripheral,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,COVID-19,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Proctalgia,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Anal inflammation,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Accident,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Crohn's disease,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Body temperature increased,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Haemorrhoids,11
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Gingival swelling,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Influenza like illness,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Osteonecrosis of jaw,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Lymphoedema,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Hot flush,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Gastrooesophageal reflux disease,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Dyspepsia,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Lymphocyte count decreased,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Pneumonia,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Renal failure,10
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Device related infection,9
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Neutrophil count increased,9
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,SARS-CoV-2 test negative,9
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Cholestasis,9
PIPERACILLIN SODIUM\TAZOBACTAM SODIUM,Affective disorder,8
PLACEBO,Suicide attempt,24
PLACEBO,Suicidal ideation,23
PLACEBO,Pneumonia,7
PLACEBO,Anaemia,5
PLACEBO,Intentional self-injury,5
PLACEBO,Depression suicidal,5
PLACEBO,Platelet count decreased,4
PLACEBO,Sepsis,4
PLACEBO,Septic shock,3
PLACEBO,White blood cell count decreased,3
PLACEBO,Condition aggravated,3
PLACEBO,Depression,3
PLACEBO,Pleural effusion,2
PLACEBO,Cardiac failure,2
PLACEBO,Second primary malignancy,2
PLACEBO,Malignant melanoma,2
PLACEBO,Respiratory failure,2
PLACEBO,COVID-19,2
PLACEBO,Rectal cancer metastatic,2
PLACEBO,Wound infection,2
PLACEBO,Neutrophil count decreased,2
PLACEBO,Haemoglobin decreased,2
PLACEBO,Infusion related reaction,2
PLACEBO,Epilepsy,2
PLACEBO,Acute kidney injury,2
PLACEBO,Dysphagia,2
PLACEBO,Myocardial infarction,2
PLACEBO,Lacunar infarction,2
PLACEBO,Drug-induced liver injury,2
PLACEBO,Anxiety,2
PLACEBO,Major depression,2
PLACEBO,Dehydration,2
PLACEBO,Neutropenia,2
PLACEBO,Syncope,2
PLACEBO,Basal cell carcinoma,2
PLACEBO,Bronchitis,1
PLACEBO,Blast crisis in myelogenous leukaemia,1
PLACEBO,Cellulitis,1
PLACEBO,Gastric haemorrhage,1
PLACEBO,Helicobacter infection,1
PLACEBO,COVID-19 pneumonia,1
PLACEBO,Inflammatory bowel disease,1
PLACEBO,Skin graft scar contracture,1
PLACEBO,B-cell lymphoma,1
PLACEBO,Peripheral arterial occlusive disease,1
PLACEBO,Somnolence,1
PLACEBO,Abdominal pain,1
PLACEBO,Disease progression,1
PLACEBO,Chest pain,1
PLACEBO,Inappropriate schedule of product administration,1
PLAQUENIL,Off label use,34
PLAQUENIL,Nausea,28
PLAQUENIL,Drug ineffective,25
PLAQUENIL,Fatigue,25
PLAQUENIL,Arthralgia,24
PLAQUENIL,Dyspnoea,23
PLAQUENIL,Headache,23
PLAQUENIL,Sinusitis,22
PLAQUENIL,Malaise,21
PLAQUENIL,COVID-19,21
PLAQUENIL,Drug hypersensitivity,20
PLAQUENIL,Rheumatoid arthritis,20
PLAQUENIL,Diarrhoea,19
PLAQUENIL,Pain,18
PLAQUENIL,Condition aggravated,18
PLAQUENIL,Pain in extremity,17
PLAQUENIL,Drug intolerance,17
PLAQUENIL,Rash,17
PLAQUENIL,Dizziness,16
PLAQUENIL,Nasopharyngitis,16
PLAQUENIL,Infection,15
PLAQUENIL,Joint swelling,15
PLAQUENIL,Product use issue,15
PLAQUENIL,Hypertension,14
PLAQUENIL,Therapeutic product effect decreased,14
PLAQUENIL,Vomiting,13
PLAQUENIL,Abdominal discomfort,13
PLAQUENIL,Musculoskeletal stiffness,12
PLAQUENIL,Peripheral swelling,12
PLAQUENIL,Hepatic enzyme increased,12
PLAQUENIL,Weight increased,12
PLAQUENIL,Intentional product use issue,12
PLAQUENIL,Pneumonia,12
PLAQUENIL,Fall,12
PLAQUENIL,Systemic lupus erythematosus,11
PLAQUENIL,Contraindicated product administered,11
PLAQUENIL,Hypoaesthesia,10
PLAQUENIL,Asthenia,10
PLAQUENIL,Insomnia,10
PLAQUENIL,Product dose omission issue,10
PLAQUENIL,Cough,10
PLAQUENIL,Therapeutic product effect incomplete,9
PLAQUENIL,Red blood cell sedimentation rate increased,9
PLAQUENIL,Alopecia,9
PLAQUENIL,Maternal exposure during pregnancy,9
PLAQUENIL,Pyrexia,9
PLAQUENIL,Contusion,9
PLAQUENIL,Abdominal pain upper,9
PLAQUENIL,Upper respiratory tract infection,9
PLAQUENIL,Urinary tract infection,9
PLAVIX,Fatigue,13
PLAVIX,COVID-19,12
PLAVIX,Diarrhoea,11
PLAVIX,Urinary tract infection,10
PLAVIX,Hypertension,10
PLAVIX,Off label use,10
PLAVIX,Weight decreased,10
PLAVIX,Pain,9
PLAVIX,Fall,8
PLAVIX,Malaise,8
PLAVIX,Pruritus,8
PLAVIX,Condition aggravated,8
PLAVIX,Chest pain,7
PLAVIX,Nausea,7
PLAVIX,Product dose omission issue,7
PLAVIX,Dizziness,7
PLAVIX,Neutropenia,6
PLAVIX,Musculoskeletal pain,6
PLAVIX,Death,6
PLAVIX,Nasopharyngitis,6
PLAVIX,Gait disturbance,6
PLAVIX,Arthralgia,6
PLAVIX,Headache,6
PLAVIX,Pain in extremity,5
PLAVIX,Chronic kidney disease,5
PLAVIX,Decreased appetite,5
PLAVIX,Asthenia,5
PLAVIX,Sinusitis,5
PLAVIX,Chest discomfort,5
PLAVIX,Heart rate increased,5
PLAVIX,Palpitations,5
PLAVIX,Cerebrovascular accident,5
PLAVIX,Cardiac disorder,5
PLAVIX,Drug interaction,5
PLAVIX,Rash maculo-papular,5
PLAVIX,Dyspnoea,4
PLAVIX,Foot fracture,4
PLAVIX,Coronary artery occlusion,4
PLAVIX,Anxiety,4
PLAVIX,Vomiting,4
PLAVIX,Atrial fibrillation,4
PLAVIX,Abdominal pain upper,4
PLAVIX,Influenza,4
PLAVIX,Cardiac failure congestive,4
PLAVIX,Weight increased,4
PLAVIX,Rash,4
PLAVIX,Muscular weakness,4
PLAVIX,Insomnia,4
PLAVIX,Febrile neutropenia,4
PLAVIX,Gastrointestinal haemorrhage,4
POLARAMINE,Pyrexia,9
POLARAMINE,Asthenia,9
POLARAMINE,Neutropenia,8
POLARAMINE,Rash,7
POLARAMINE,Infusion related reaction,7
POLARAMINE,Pneumonia,5
POLARAMINE,Hepatic function abnormal,5
POLARAMINE,Anaemia,5
POLARAMINE,Rash pruritic,5
POLARAMINE,Dysphonia,5
POLARAMINE,Oral pruritus,5
POLARAMINE,Nausea,4
POLARAMINE,Diarrhoea,4
POLARAMINE,Pancytopenia,4
POLARAMINE,Cytokine release syndrome,4
POLARAMINE,Off label use,4
POLARAMINE,Blood pressure decreased,3
POLARAMINE,Lymphocyte count decreased,3
POLARAMINE,Platelet count decreased,3
POLARAMINE,Myasthenia gravis,3
POLARAMINE,Bronchitis,3
POLARAMINE,Oedema peripheral,3
POLARAMINE,Back pain,3
POLARAMINE,Anaphylactic shock,3
POLARAMINE,COVID-19,3
POLARAMINE,Conjunctivitis,3
POLARAMINE,Drug interaction,3
POLARAMINE,Subcapsular splenic haematoma,3
POLARAMINE,Agranulocytosis,3
POLARAMINE,Mucosal inflammation,3
POLARAMINE,Liver disorder,3
POLARAMINE,Toxic skin eruption,2
POLARAMINE,Acne,2
POLARAMINE,Renal disorder,2
POLARAMINE,Pruritus,2
POLARAMINE,Urinary tract infection,2
POLARAMINE,Vomiting,2
POLARAMINE,Thrombocytopenia,2
POLARAMINE,Abdominal pain upper,2
POLARAMINE,Cystitis escherichia,2
POLARAMINE,Engraft failure,2
POLARAMINE,Cytomegalovirus infection reactivation,2
POLARAMINE,Hypotension,2
POLARAMINE,Dyspnoea,2
POLARAMINE,Interstitial lung disease,2
POLARAMINE,Pulmonary toxicity,2
POLARAMINE,Neuralgia,2
POLARAMINE,Eczema,2
POLARAMINE,Death,2
POLARAMINE,Flushing,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Neutropenia,6
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Blood test abnormal,6
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Insomnia,5
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Swollen tongue,5
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Agitation,5
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Abnormal behaviour,5
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Pneumonia,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Death,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Vomiting,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Abdominal pain,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Hypersensitivity,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Constipation,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Fatigue,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Hyponatraemia,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Neuropathy peripheral,4
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Pyrexia,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Hypothyroidism,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Dizziness,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Chest pain,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Urinary tract infection,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Dyspnoea,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Hostility,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Aggression,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Personality disorder,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Diarrhoea,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Coronary artery disease,3
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Headache,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Confusional state,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Ascites,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Oedema,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Abdominal distension,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Blood bilirubin increased,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Disorientation,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Psychomotor hyperactivity,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Renal failure,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Hyperpyrexia,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Multiple organ dysfunction syndrome,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Abdominal pain upper,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Rash maculo-papular,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Stomatitis,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Hypomagnesaemia,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Oedema peripheral,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Lung adenocarcinoma,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Blood creatinine increased,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Decubitus ulcer,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Lower respiratory tract infection,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Dysuria,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Respiratory tract infection,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Panic reaction,2
POLYETHYLENE GLYCOL 3350\POTASSIUM CHLORIDE\SODIUM BICARBONATE\SODIUM CHLORIDE,Medication error,2
POLYETHYLENE GLYCOLS,Pyrexia,20
POLYETHYLENE GLYCOLS,Vomiting,20
POLYETHYLENE GLYCOLS,Off label use,19
POLYETHYLENE GLYCOLS,Neutropenia,15
POLYETHYLENE GLYCOLS,Confusional state,13
POLYETHYLENE GLYCOLS,Nausea,13
POLYETHYLENE GLYCOLS,Constipation,13
POLYETHYLENE GLYCOLS,Diarrhoea,13
POLYETHYLENE GLYCOLS,Dyspnoea,12
POLYETHYLENE GLYCOLS,Febrile neutropenia,12
POLYETHYLENE GLYCOLS,Body temperature increased,12
POLYETHYLENE GLYCOLS,Anaemia,11
POLYETHYLENE GLYCOLS,Malaise,10
POLYETHYLENE GLYCOLS,Back pain,10
POLYETHYLENE GLYCOLS,Pain,10
POLYETHYLENE GLYCOLS,Somnolence,9
POLYETHYLENE GLYCOLS,Neuralgia,9
POLYETHYLENE GLYCOLS,Proctalgia,9
POLYETHYLENE GLYCOLS,Accident,9
POLYETHYLENE GLYCOLS,Anal inflammation,9
POLYETHYLENE GLYCOLS,Haemorrhoids,9
POLYETHYLENE GLYCOLS,Crohn's disease,9
POLYETHYLENE GLYCOLS,Tachycardia,8
POLYETHYLENE GLYCOLS,Thrombocytopenia,8
POLYETHYLENE GLYCOLS,Sepsis,8
POLYETHYLENE GLYCOLS,Death,8
POLYETHYLENE GLYCOLS,Ascites,8
POLYETHYLENE GLYCOLS,Abdominal distension,8
POLYETHYLENE GLYCOLS,Chills,8
POLYETHYLENE GLYCOLS,Fall,8
POLYETHYLENE GLYCOLS,Stress,7
POLYETHYLENE GLYCOLS,Cardiogenic shock,7
POLYETHYLENE GLYCOLS,Incorrect route of product administration,7
POLYETHYLENE GLYCOLS,Multiple organ dysfunction syndrome,7
POLYETHYLENE GLYCOLS,Condition aggravated,7
POLYETHYLENE GLYCOLS,Dry mouth,7
POLYETHYLENE GLYCOLS,General physical health deterioration,7
POLYETHYLENE GLYCOLS,SARS-CoV-2 test negative,7
POLYETHYLENE GLYCOLS,COVID-19,7
POLYETHYLENE GLYCOLS,Rhabdomyolysis,6
POLYETHYLENE GLYCOLS,Product use in unapproved indication,6
POLYETHYLENE GLYCOLS,Hypokalaemia,6
POLYETHYLENE GLYCOLS,Drug interaction,6
POLYETHYLENE GLYCOLS,Blood creatinine increased,6
POLYETHYLENE GLYCOLS,Blood creatine phosphokinase increased,6
POLYETHYLENE GLYCOLS,Dyskinesia,6
POLYETHYLENE GLYCOLS,Bacterial infection,6
POLYETHYLENE GLYCOLS,Drug intolerance,6
POLYETHYLENE GLYCOLS,Swelling,6
POLYETHYLENE GLYCOLS,Abdominal pain,6
POMALIDOMIDE,Neutropenia,20
POMALIDOMIDE,Thrombocytopenia,14
POMALIDOMIDE,Pneumonia,8
POMALIDOMIDE,Death,7
POMALIDOMIDE,Off label use,6
POMALIDOMIDE,Febrile neutropenia,5
POMALIDOMIDE,Asthenia,5
POMALIDOMIDE,Infusion related reaction,5
POMALIDOMIDE,Plasma cell myeloma,5
POMALIDOMIDE,Hypokalaemia,4
POMALIDOMIDE,Cough,3
POMALIDOMIDE,Heart rate increased,3
POMALIDOMIDE,Vomiting,3
POMALIDOMIDE,Abdominal pain upper,3
POMALIDOMIDE,Rhinitis,3
POMALIDOMIDE,Acute kidney injury,3
POMALIDOMIDE,Bronchitis,3
POMALIDOMIDE,Diarrhoea,3
POMALIDOMIDE,Myelosuppression,3
POMALIDOMIDE,Rash,3
POMALIDOMIDE,Lung disorder,3
POMALIDOMIDE,Colon cancer,3
POMALIDOMIDE,COVID-19,3
POMALIDOMIDE,Haematochezia,2
POMALIDOMIDE,General physical health deterioration,2
POMALIDOMIDE,Tachycardia,2
POMALIDOMIDE,Pulpitis dental,2
POMALIDOMIDE,Petechiae,2
POMALIDOMIDE,Cystitis escherichia,2
POMALIDOMIDE,White blood cell count decreased,2
POMALIDOMIDE,Neutrophil count decreased,2
POMALIDOMIDE,Hypertension,2
POMALIDOMIDE,Anaemia,2
POMALIDOMIDE,Pneumonia pneumococcal,2
POMALIDOMIDE,Cardiac failure,2
POMALIDOMIDE,Myelodysplastic syndrome,2
POMALIDOMIDE,Prostate cancer,2
POMALIDOMIDE,Hyperglycaemia,2
POMALIDOMIDE,Meningitis,2
POMALIDOMIDE,Cerebrovascular accident,2
POMALIDOMIDE,Second primary malignancy,2
POMALIDOMIDE,Thrombosis,2
POMALIDOMIDE,COVID-19 pneumonia,2
POMALIDOMIDE,Platelet count decreased,2
POMALIDOMIDE,Lymphocyte count increased,1
POMALIDOMIDE,Plasma cell leukaemia,1
POMALIDOMIDE,Oedema mucosal,1
POMALIDOMIDE,Viral diarrhoea,1
POMALIDOMIDE,Renal failure,1
POMALIDOMIDE,Gingivitis,1
POMALYST,Off label use,23
POMALYST,Fatigue,21
POMALYST,Rash,13
POMALYST,Death,12
POMALYST,Constipation,9
POMALYST,Diarrhoea,9
POMALYST,Plasma cell myeloma,9
POMALYST,Dizziness,8
POMALYST,Decreased appetite,7
POMALYST,Dyspnoea,7
POMALYST,Pneumonia,7
POMALYST,Asthenia,7
POMALYST,Pruritus,7
POMALYST,Neutropenia,7
POMALYST,Neuropathy peripheral,6
POMALYST,White blood cell count decreased,6
POMALYST,Muscle spasms,6
POMALYST,Hypoaesthesia,6
POMALYST,Neutrophil count decreased,6
POMALYST,Peripheral swelling,6
POMALYST,Platelet count decreased,6
POMALYST,Brain fog,5
POMALYST,Thrombosis,5
POMALYST,Drug ineffective,4
POMALYST,Nervousness,4
POMALYST,Back pain,4
POMALYST,Coronavirus infection,4
POMALYST,COVID-19,4
POMALYST,Full blood count decreased,4
POMALYST,Nausea,4
POMALYST,Taste disorder,4
POMALYST,Pyrexia,4
POMALYST,Cough,4
POMALYST,Haemoglobin decreased,4
POMALYST,Nasopharyngitis,3
POMALYST,Erectile dysfunction,3
POMALYST,Bone pain,3
POMALYST,Tremor,3
POMALYST,Memory impairment,3
POMALYST,Acute kidney injury,3
POMALYST,Vomiting,3
POMALYST,Blister,3
POMALYST,Headache,3
POMALYST,Weight decreased,3
POMALYST,Dysphonia,3
POMALYST,Urinary tract infection,3
POMALYST,Upper respiratory tract infection,3
POMALYST,Malaise,3
POMALYST,Atrial fibrillation,3
POMALYST,Rash macular,3
PONATINIB,Product dose omission issue,24
PONATINIB,Death,8
PONATINIB,Fatigue,7
PONATINIB,Off label use,7
PONATINIB,Dry skin,6
PONATINIB,Nausea,5
PONATINIB,Pyrexia,5
PONATINIB,Malaise,5
PONATINIB,COVID-19,5
PONATINIB,Illness,5
PONATINIB,Thrombocytopenia,5
PONATINIB,Rash,5
PONATINIB,Headache,4
PONATINIB,Arthralgia,4
PONATINIB,Chest pain,4
PONATINIB,Neuropathy peripheral,4
PONATINIB,Memory impairment,4
PONATINIB,Cough,4
PONATINIB,Vomiting,3
PONATINIB,Pain,3
PONATINIB,Nasopharyngitis,3
PONATINIB,Acute lymphocytic leukaemia recurrent,3
PONATINIB,Fluid retention,3
PONATINIB,Abdominal pain upper,3
PONATINIB,Product storage error,3
PONATINIB,Multiple allergies,3
PONATINIB,Atrial fibrillation,3
PONATINIB,Influenza,3
PONATINIB,Fall,3
PONATINIB,Diabetes mellitus,3
PONATINIB,Drug ineffective,3
PONATINIB,Pancreatitis,3
PONATINIB,Platelet count decreased,3
PONATINIB,Hepatic enzyme increased,3
PONATINIB,Hyperhidrosis,2
PONATINIB,Vertigo,2
PONATINIB,Tremor,2
PONATINIB,Asthenia,2
PONATINIB,Diarrhoea,2
PONATINIB,Staphylococcal infection,2
PONATINIB,Anxiety,2
PONATINIB,Herpes zoster,2
PONATINIB,Nephrolithiasis,2
PONATINIB,Muscle spasms,2
PONATINIB,Blood pressure increased,2
PONATINIB,Dizziness,2
PONATINIB,Laboratory test abnormal,2
PONATINIB,Product use issue,2
PONATINIB,Visual impairment,2
PONATINIB,Rash erythematous,2
POSACONAZOLE,Febrile neutropenia,12
POSACONAZOLE,Thrombocytopenia,9
POSACONAZOLE,Neutropenia,8
POSACONAZOLE,Pyrexia,5
POSACONAZOLE,Pneumonia,5
POSACONAZOLE,Product use issue,5
POSACONAZOLE,Cellulitis,5
POSACONAZOLE,Cytokine release syndrome,5
POSACONAZOLE,Acute kidney injury,5
POSACONAZOLE,Neutropenic infection,4
POSACONAZOLE,Off label use,4
POSACONAZOLE,Cardiac failure acute,4
POSACONAZOLE,Diarrhoea,3
POSACONAZOLE,Septic shock,3
POSACONAZOLE,Rash maculo-papular,3
POSACONAZOLE,COVID-19,3
POSACONAZOLE,Platelet count decreased,3
POSACONAZOLE,Neutrophil count decreased,3
POSACONAZOLE,Chills,3
POSACONAZOLE,Constipation,3
POSACONAZOLE,Disease progression,3
POSACONAZOLE,Adenovirus infection,2
POSACONAZOLE,Drug interaction,2
POSACONAZOLE,Neuropathy peripheral,2
POSACONAZOLE,White blood cell count decreased,2
POSACONAZOLE,Haemoglobin decreased,2
POSACONAZOLE,Hepatic cytolysis,2
POSACONAZOLE,Cholestasis,2
POSACONAZOLE,Rash,2
POSACONAZOLE,Cystitis,2
POSACONAZOLE,Gastrointestinal haemorrhage,2
POSACONAZOLE,Hypofibrinogenaemia,2
POSACONAZOLE,Hypotension,2
POSACONAZOLE,Dizziness,2
POSACONAZOLE,Hypoxia,2
POSACONAZOLE,Leukopenia,2
POSACONAZOLE,Drug ineffective,2
POSACONAZOLE,Cytopenia,2
POSACONAZOLE,Incorrect dose administered,2
POSACONAZOLE,Hepatitis acute,2
POSACONAZOLE,Pancreatic disorder,1
POSACONAZOLE,Hair colour changes,1
POSACONAZOLE,Hepatitis cholestatic,1
POSACONAZOLE,Hypertriglyceridaemia,1
POSACONAZOLE,Product administered to patient of inappropriate age,1
POSACONAZOLE,Bone marrow failure,1
POSACONAZOLE,Abscess,1
POSACONAZOLE,Immune effector cell-associated neurotoxicity syndrome,1
POSACONAZOLE,Back pain,1
POSACONAZOLE,Escherichia urinary tract infection,1
POTASSIUM,Fatigue,27
POTASSIUM,Diarrhoea,23
POTASSIUM,Nausea,22
POTASSIUM,Product dose omission issue,22
POTASSIUM,COVID-19,21
POTASSIUM,Off label use,20
POTASSIUM,Pain,18
POTASSIUM,Sinusitis,17
POTASSIUM,Malaise,17
POTASSIUM,Fall,16
POTASSIUM,Urinary tract infection,15
POTASSIUM,Weight decreased,15
POTASSIUM,Pneumonia,14
POTASSIUM,Headache,14
POTASSIUM,Asthenia,14
POTASSIUM,Pyrexia,14
POTASSIUM,Anxiety,12
POTASSIUM,Infection,12
POTASSIUM,Inappropriate schedule of product administration,12
POTASSIUM,Vomiting,11
POTASSIUM,Nasopharyngitis,11
POTASSIUM,Cough,11
POTASSIUM,Abdominal pain,11
POTASSIUM,Arthralgia,10
POTASSIUM,Back pain,10
POTASSIUM,Pain in extremity,10
POTASSIUM,Dyspnoea,10
POTASSIUM,Gait disturbance,9
POTASSIUM,Dehydration,9
POTASSIUM,Blood pressure increased,9
POTASSIUM,Abdominal pain upper,9
POTASSIUM,Constipation,9
POTASSIUM,Illness,8
POTASSIUM,Infusion site pain,8
POTASSIUM,Chest pain,8
POTASSIUM,Feeling abnormal,8
POTASSIUM,Bronchitis,8
POTASSIUM,Upper respiratory tract infection,8
POTASSIUM,Dizziness,8
POTASSIUM,Chronic obstructive pulmonary disease,8
POTASSIUM,Product use issue,8
POTASSIUM,Drug ineffective,7
POTASSIUM,Depression,7
POTASSIUM,Influenza,7
POTASSIUM,Cystitis,7
POTASSIUM,Atrial fibrillation,7
POTASSIUM,Sepsis,7
POTASSIUM,Weight increased,7
POTASSIUM,Memory impairment,7
POTASSIUM,Decreased appetite,7
POTASSIUM CHLORIDE,Diarrhoea,57
POTASSIUM CHLORIDE,Off label use,50
POTASSIUM CHLORIDE,Pneumonia,43
POTASSIUM CHLORIDE,Dyspnoea,39
POTASSIUM CHLORIDE,Fatigue,39
POTASSIUM CHLORIDE,Nausea,35
POTASSIUM CHLORIDE,Headache,34
POTASSIUM CHLORIDE,Pyrexia,34
POTASSIUM CHLORIDE,Vomiting,34
POTASSIUM CHLORIDE,Condition aggravated,32
POTASSIUM CHLORIDE,COVID-19,31
POTASSIUM CHLORIDE,Weight decreased,29
POTASSIUM CHLORIDE,Asthenia,28
POTASSIUM CHLORIDE,Pain,28
POTASSIUM CHLORIDE,Product dose omission issue,28
POTASSIUM CHLORIDE,Fall,27
POTASSIUM CHLORIDE,Arthralgia,25
POTASSIUM CHLORIDE,Sepsis,25
POTASSIUM CHLORIDE,Anaemia,25
POTASSIUM CHLORIDE,Constipation,24
POTASSIUM CHLORIDE,Urinary tract infection,22
POTASSIUM CHLORIDE,Malaise,22
POTASSIUM CHLORIDE,Inappropriate schedule of product administration,22
POTASSIUM CHLORIDE,Abdominal distension,22
POTASSIUM CHLORIDE,Pruritus,21
POTASSIUM CHLORIDE,Anxiety,21
POTASSIUM CHLORIDE,Hypokalaemia,20
POTASSIUM CHLORIDE,Decreased appetite,20
POTASSIUM CHLORIDE,Rash,19
POTASSIUM CHLORIDE,Dehydration,19
POTASSIUM CHLORIDE,Dizziness,19
POTASSIUM CHLORIDE,Acute kidney injury,19
POTASSIUM CHLORIDE,Hypotension,19
POTASSIUM CHLORIDE,Weight increased,18
POTASSIUM CHLORIDE,Abdominal pain,18
POTASSIUM CHLORIDE,Product use issue,17
POTASSIUM CHLORIDE,Illness,17
POTASSIUM CHLORIDE,Drug hypersensitivity,16
POTASSIUM CHLORIDE,Nasopharyngitis,16
POTASSIUM CHLORIDE,Sinusitis,15
POTASSIUM CHLORIDE,Atrial fibrillation,15
POTASSIUM CHLORIDE,Death,15
POTASSIUM CHLORIDE,Cardiac failure,15
POTASSIUM CHLORIDE,Hyperkalaemia,15
POTASSIUM CHLORIDE,Renal failure,14
POTASSIUM CHLORIDE,Product use in unapproved indication,13
POTASSIUM CHLORIDE,Upper respiratory tract infection,13
POTASSIUM CHLORIDE,Gait disturbance,13
POTASSIUM CHLORIDE,Cough,13
POTASSIUM CHLORIDE,Ascites,13
PRAVASTATIN,Pain,43
PRAVASTATIN,Emotional distress,31
PRAVASTATIN,Anxiety,29
PRAVASTATIN,Anhedonia,27
PRAVASTATIN,Fatigue,23
PRAVASTATIN,Chronic kidney disease,21
PRAVASTATIN,Off label use,21
PRAVASTATIN,Diarrhoea,17
PRAVASTATIN,Acute kidney injury,16
PRAVASTATIN,Osteoporosis,16
PRAVASTATIN,Dyspnoea,14
PRAVASTATIN,Depression,12
PRAVASTATIN,Osteopenia,12
PRAVASTATIN,Dizziness,11
PRAVASTATIN,Renal impairment,11
PRAVASTATIN,Headache,11
PRAVASTATIN,Bone density decreased,11
PRAVASTATIN,Renal failure,10
PRAVASTATIN,Fall,10
PRAVASTATIN,Urinary tract infection,10
PRAVASTATIN,Nausea,10
PRAVASTATIN,Pyrexia,10
PRAVASTATIN,COVID-19,9
PRAVASTATIN,Illness,9
PRAVASTATIN,Malaise,9
PRAVASTATIN,Hypertension,8
PRAVASTATIN,Pruritus,8
PRAVASTATIN,Drug ineffective,7
PRAVASTATIN,Arthralgia,7
PRAVASTATIN,Cough,7
PRAVASTATIN,Asthenia,7
PRAVASTATIN,End stage renal disease,7
PRAVASTATIN,Product dose omission issue,7
PRAVASTATIN,Bone demineralisation,7
PRAVASTATIN,Anaemia,7
PRAVASTATIN,Back pain,7
PRAVASTATIN,Rash,7
PRAVASTATIN,Vomiting,7
PRAVASTATIN,Pain in extremity,6
PRAVASTATIN,Intentional product use issue,6
PRAVASTATIN,Myalgia,6
PRAVASTATIN,Infection,6
PRAVASTATIN,Insomnia,6
PRAVASTATIN,Multiple fractures,6
PRAVASTATIN,Hyperkalaemia,6
PRAVASTATIN,Gait disturbance,6
PRAVASTATIN,Weight decreased,6
PRAVASTATIN,Cerebrovascular accident,6
PRAVASTATIN,Peripheral swelling,5
PRAVASTATIN,White blood cell count decreased,5
PRAVASTATIN SODIUM,Diarrhoea,13
PRAVASTATIN SODIUM,Fatigue,9
PRAVASTATIN SODIUM,Hyponatraemia,9
PRAVASTATIN SODIUM,Fall,7
PRAVASTATIN SODIUM,Product dose omission issue,7
PRAVASTATIN SODIUM,COVID-19,7
PRAVASTATIN SODIUM,Urinary tract infection,7
PRAVASTATIN SODIUM,Off label use,6
PRAVASTATIN SODIUM,Coma,6
PRAVASTATIN SODIUM,Shock haemorrhagic,6
PRAVASTATIN SODIUM,Inappropriate antidiuretic hormone secretion,6
PRAVASTATIN SODIUM,Arthralgia,5
PRAVASTATIN SODIUM,Headache,5
PRAVASTATIN SODIUM,Dyspnoea,5
PRAVASTATIN SODIUM,Muscle spasms,5
PRAVASTATIN SODIUM,Sinusitis,5
PRAVASTATIN SODIUM,Acute kidney injury,5
PRAVASTATIN SODIUM,Hypokalaemia,5
PRAVASTATIN SODIUM,Memory impairment,4
PRAVASTATIN SODIUM,Pruritus,4
PRAVASTATIN SODIUM,Abdominal pain upper,4
PRAVASTATIN SODIUM,Pyrexia,4
PRAVASTATIN SODIUM,Pulmonary embolism,4
PRAVASTATIN SODIUM,Malaise,4
PRAVASTATIN SODIUM,Breast cancer,4
PRAVASTATIN SODIUM,Hepatitis,4
PRAVASTATIN SODIUM,Abdominal discomfort,3
PRAVASTATIN SODIUM,Nausea,3
PRAVASTATIN SODIUM,Asthenia,3
PRAVASTATIN SODIUM,Peripheral swelling,3
PRAVASTATIN SODIUM,Dizziness,3
PRAVASTATIN SODIUM,Depression,3
PRAVASTATIN SODIUM,Nasal congestion,3
PRAVASTATIN SODIUM,Therapeutic product effect incomplete,3
PRAVASTATIN SODIUM,Visual impairment,3
PRAVASTATIN SODIUM,Pain in extremity,3
PRAVASTATIN SODIUM,Skin disorder,3
PRAVASTATIN SODIUM,Rhinorrhoea,3
PRAVASTATIN SODIUM,Influenza like illness,3
PRAVASTATIN SODIUM,Infusion site pain,3
PRAVASTATIN SODIUM,Feeling abnormal,3
PRAVASTATIN SODIUM,Cerebral haemorrhage,3
PRAVASTATIN SODIUM,Platelet count decreased,3
PRAVASTATIN SODIUM,Anaemia,3
PRAVASTATIN SODIUM,Eczema,3
PRAVASTATIN SODIUM,Asthma,3
PRAVASTATIN SODIUM,Hepatic cytolysis,3
PRAVASTATIN SODIUM,Oedema peripheral,3
PRAVASTATIN SODIUM,Rhabdomyolysis,3
PRAVASTATIN SODIUM,Vomiting,3
PREDNISOLONE,Pyrexia,80
PREDNISOLONE,Off label use,60
PREDNISOLONE,Vomiting,48
PREDNISOLONE,Diarrhoea,47
PREDNISOLONE,Fatigue,41
PREDNISOLONE,Nausea,39
PREDNISOLONE,Pain,38
PREDNISOLONE,Decreased appetite,35
PREDNISOLONE,Arthralgia,35
PREDNISOLONE,Platelet count decreased,35
PREDNISOLONE,Dyspnoea,34
PREDNISOLONE,Pneumonia,34
PREDNISOLONE,Headache,32
PREDNISOLONE,Dizziness,31
PREDNISOLONE,Anaemia,31
PREDNISOLONE,Malaise,30
PREDNISOLONE,Aspartate aminotransferase increased,28
PREDNISOLONE,Pain in extremity,27
PREDNISOLONE,Alanine aminotransferase increased,27
PREDNISOLONE,Urinary tract infection,27
PREDNISOLONE,General physical health deterioration,26
PREDNISOLONE,COVID-19,25
PREDNISOLONE,Abdominal pain,24
PREDNISOLONE,Febrile neutropenia,23
PREDNISOLONE,Fall,23
PREDNISOLONE,Rash,22
PREDNISOLONE,Thrombocytopenia,22
PREDNISOLONE,Sepsis,22
PREDNISOLONE,Drug ineffective,21
PREDNISOLONE,Weight decreased,21
PREDNISOLONE,Hepatic function abnormal,21
PREDNISOLONE,Hypertension,20
PREDNISOLONE,Weight increased,20
PREDNISOLONE,Depression,20
PREDNISOLONE,Death,20
PREDNISOLONE,Cough,18
PREDNISOLONE,Influenza,18
PREDNISOLONE,Inappropriate schedule of product administration,18
PREDNISOLONE,White blood cell count decreased,17
PREDNISOLONE,Neuropathy peripheral,17
PREDNISOLONE,Constipation,17
PREDNISOLONE,Asthenia,16
PREDNISOLONE,Tachycardia,16
PREDNISOLONE,Myalgia,16
PREDNISOLONE,Neutropenia,15
PREDNISOLONE,Hypotension,15
PREDNISOLONE,Pruritus,14
PREDNISOLONE,Back pain,14
PREDNISOLONE,Urticaria,14
PREDNISOLONE,Interstitial lung disease,14
PREDNISONE,Off label use,259
PREDNISONE,Fatigue,156
PREDNISONE,Dyspnoea,149
PREDNISONE,Pain,142
PREDNISONE,Arthralgia,138
PREDNISONE,COVID-19,134
PREDNISONE,Headache,129
PREDNISONE,Diarrhoea,127
PREDNISONE,Pyrexia,117
PREDNISONE,Nausea,111
PREDNISONE,Condition aggravated,111
PREDNISONE,Drug ineffective,110
PREDNISONE,Pneumonia,108
PREDNISONE,Malaise,106
PREDNISONE,Weight decreased,103
PREDNISONE,Product dose omission issue,95
PREDNISONE,Rash,89
PREDNISONE,Cough,88
PREDNISONE,Sinusitis,78
PREDNISONE,Asthenia,78
PREDNISONE,Weight increased,78
PREDNISONE,Nasopharyngitis,75
PREDNISONE,Dizziness,70
PREDNISONE,Vomiting,70
PREDNISONE,Pain in extremity,70
PREDNISONE,Fall,69
PREDNISONE,Inappropriate schedule of product administration,69
PREDNISONE,Pruritus,67
PREDNISONE,Intentional product use issue,66
PREDNISONE,Illness,64
PREDNISONE,Anxiety,64
PREDNISONE,Peripheral swelling,62
PREDNISONE,Back pain,62
PREDNISONE,Product use in unapproved indication,57
PREDNISONE,Hypertension,56
PREDNISONE,Infection,55
PREDNISONE,Rheumatoid arthritis,55
PREDNISONE,Blood pressure increased,53
PREDNISONE,Gait disturbance,51
PREDNISONE,Product use issue,49
PREDNISONE,Drug hypersensitivity,46
PREDNISONE,Asthma,45
PREDNISONE,Influenza,45
PREDNISONE,Hypotension,44
PREDNISONE,Anaemia,42
PREDNISONE,Acute kidney injury,42
PREDNISONE,Bronchitis,41
PREDNISONE,Joint swelling,41
PREDNISONE,Decreased appetite,40
PREDNISONE,Abdominal discomfort,39
PREDONINE,Pyrexia,18
PREDONINE,Pneumonia,14
PREDONINE,Pneumonia aspiration,14
PREDONINE,Decreased appetite,13
PREDONINE,Diarrhoea,10
PREDONINE,Rash,9
PREDONINE,Platelet count decreased,9
PREDONINE,Nausea,9
PREDONINE,Hypertension,9
PREDONINE,Renal impairment,9
PREDONINE,Respiratory disorder,8
PREDONINE,Hyperkalaemia,8
PREDONINE,Constipation,7
PREDONINE,Hepatic function abnormal,7
PREDONINE,Haematuria,7
PREDONINE,Anaemia,7
PREDONINE,Disseminated intravascular coagulation,7
PREDONINE,White blood cell count decreased,6
PREDONINE,Urinary tract infection,6
PREDONINE,Oliguria,6
PREDONINE,Medical device site haemorrhage,6
PREDONINE,Drug withdrawal syndrome,6
PREDONINE,Faecaloma,6
PREDONINE,Cerebral atrophy,6
PREDONINE,Proteinuria,6
PREDONINE,Tremor,6
PREDONINE,Abdominal distension,6
PREDONINE,Atypical haemolytic uraemic syndrome,6
PREDONINE,Thrombosis,6
PREDONINE,Generalised oedema,6
PREDONINE,Thrombotic microangiopathy,6
PREDONINE,Serratia infection,6
PREDONINE,Ascites,6
PREDONINE,Interstitial lung disease,6
PREDONINE,COVID-19,6
PREDONINE,Chest pain,5
PREDONINE,Alanine aminotransferase increased,5
PREDONINE,Neutrophil count decreased,5
PREDONINE,Hypotension,5
PREDONINE,Dyspnoea,5
PREDONINE,Lymphocyte count decreased,5
PREDONINE,Taste disorder,5
PREDONINE,Metastases to liver,5
PREDONINE,Symptom recurrence,5
PREDONINE,Headache,5
PREDONINE,Hyperglycaemia,4
PREDONINE,Condition aggravated,4
PREDONINE,Blood lactate dehydrogenase increased,4
PREDONINE,Aspartate aminotransferase increased,4
PREDONINE,Dehydration,4
PREGABALIN,Fatigue,56
PREGABALIN,Nausea,47
PREGABALIN,Off label use,43
PREGABALIN,Pain,43
PREGABALIN,Dizziness,39
PREGABALIN,Headache,33
PREGABALIN,Arthralgia,31
PREGABALIN,Pain in extremity,28
PREGABALIN,Diarrhoea,28
PREGABALIN,COVID-19,28
PREGABALIN,Vomiting,27
PREGABALIN,Asthenia,26
PREGABALIN,Malaise,23
PREGABALIN,Drug ineffective,23
PREGABALIN,Pruritus,21
PREGABALIN,Fall,21
PREGABALIN,General physical health deterioration,20
PREGABALIN,Pyrexia,20
PREGABALIN,Condition aggravated,20
PREGABALIN,Peripheral swelling,19
PREGABALIN,Nasopharyngitis,19
PREGABALIN,Death,19
PREGABALIN,Weight increased,19
PREGABALIN,Neutropenia,19
PREGABALIN,Insomnia,18
PREGABALIN,Rash,18
PREGABALIN,Hypoaesthesia,17
PREGABALIN,Gait disturbance,17
PREGABALIN,Hypertension,17
PREGABALIN,Tachycardia,17
PREGABALIN,Weight decreased,16
PREGABALIN,Alopecia,16
PREGABALIN,Cough,16
PREGABALIN,Anxiety,16
PREGABALIN,Dyspnoea,15
PREGABALIN,Platelet count decreased,15
PREGABALIN,Lymphocyte count decreased,15
PREGABALIN,Seizure,15
PREGABALIN,Muscular weakness,14
PREGABALIN,Neuropathy peripheral,14
PREGABALIN,Product dose omission issue,14
PREGABALIN,Dyspepsia,13
PREGABALIN,Illness,13
PREGABALIN,Leukopenia,13
PREGABALIN,Paraesthesia,13
PREGABALIN,Back pain,13
PREGABALIN,Blood pressure increased,12
PREGABALIN,Infection,12
PREGABALIN,Pneumonia,12
PREGABALIN,Decreased appetite,12
PREMARIN,Off label use,57
PREMARIN,Illness,24
PREMARIN,Pain,18
PREMARIN,Malaise,17
PREMARIN,Feeling abnormal,16
PREMARIN,Insomnia,16
PREMARIN,Fatigue,16
PREMARIN,Drug ineffective,15
PREMARIN,Headache,14
PREMARIN,Intentional product misuse,14
PREMARIN,Product dispensing error,14
PREMARIN,Weight decreased,13
PREMARIN,Product dose omission issue,11
PREMARIN,Asthenia,11
PREMARIN,Fall,11
PREMARIN,Product use issue,11
PREMARIN,Product prescribing error,11
PREMARIN,Migraine,10
PREMARIN,Dizziness,10
PREMARIN,Urinary tract infection,10
PREMARIN,Memory impairment,9
PREMARIN,Expired product administered,9
PREMARIN,Hypertension,9
PREMARIN,Hot flush,9
PREMARIN,COVID-19,9
PREMARIN,Pruritus,9
PREMARIN,Nausea,9
PREMARIN,Crying,8
PREMARIN,Night sweats,8
PREMARIN,Weight increased,8
PREMARIN,Hyperhidrosis,8
PREMARIN,Anxiety,7
PREMARIN,Drug effective for unapproved indication,7
PREMARIN,Pyrexia,7
PREMARIN,Nasopharyngitis,7
PREMARIN,Mood swings,6
PREMARIN,Stress,6
PREMARIN,Gait disturbance,6
PREMARIN,Depressed mood,6
PREMARIN,Intentional product use issue,6
PREMARIN,Sinusitis,6
PREMARIN,Arthralgia,6
PREMARIN,Condition aggravated,6
PREMARIN,Wrong technique in product usage process,6
PREMARIN,Hypoacusis,5
PREMARIN,Mental disorder,5
PREMARIN,Frustration tolerance decreased,5
PREMARIN,Alopecia,5
PREMARIN,Contraindicated product administered,5
PREMARIN,Vulvovaginal dryness,5
PREVACID,Vomiting,13
PREVACID,Off label use,11
PREVACID,Nausea,11
PREVACID,Dyspnoea,10
PREVACID,Incorrect route of product administration,10
PREVACID,Pain,10
PREVACID,Constipation,10
PREVACID,Drug hypersensitivity,9
PREVACID,Abdominal pain,9
PREVACID,Sepsis,9
PREVACID,Dry mouth,8
PREVACID,Death,8
PREVACID,Stress,8
PREVACID,Cardiogenic shock,8
PREVACID,Multiple organ dysfunction syndrome,8
PREVACID,Ascites,8
PREVACID,Abdominal distension,8
PREVACID,Condition aggravated,8
PREVACID,Fatigue,7
PREVACID,Diarrhoea,7
PREVACID,Pyrexia,7
PREVACID,Abdominal discomfort,7
PREVACID,Somnolence,7
PREVACID,Weight increased,6
PREVACID,Drug intolerance,6
PREVACID,General physical health deterioration,6
PREVACID,Fall,6
PREVACID,Weight decreased,6
PREVACID,Intentional product misuse,6
PREVACID,Bacterial infection,6
PREVACID,Product use in unapproved indication,6
PREVACID,Neuralgia,6
PREVACID,Swelling,6
PREVACID,Infusion related reaction,5
PREVACID,Blood cholesterol increased,5
PREVACID,Bronchitis,5
PREVACID,Product dose omission issue,5
PREVACID,Malaise,5
PREVACID,Asthma,5
PREVACID,Appendicolith,5
PREVACID,Hyponatraemia,5
PREVACID,Ventricular fibrillation,5
PREVACID,Appendicitis,5
PREVACID,Sleep disorder,5
PREVACID,Nasopharyngitis,4
PREVACID,Back pain,4
PREVACID,Pulmonary embolism,4
PREVACID,Pneumonia,4
PREVACID,Chills,4
PREVACID,COVID-19,4
PREZCOBIX,Emotional distress,47
PREZCOBIX,Pain,47
PREZCOBIX,Anxiety,42
PREZCOBIX,Anhedonia,40
PREZCOBIX,Chronic kidney disease,27
PREZCOBIX,Renal failure,21
PREZCOBIX,Bone density decreased,20
PREZCOBIX,Osteopenia,18
PREZCOBIX,Osteoporosis,18
PREZCOBIX,Depression,13
PREZCOBIX,Acute kidney injury,13
PREZCOBIX,Multiple fractures,11
PREZCOBIX,Bone demineralisation,11
PREZCOBIX,Renal impairment,10
PREZCOBIX,Fatigue,8
PREZCOBIX,Blood creatinine increased,7
PREZCOBIX,Gait disturbance,7
PREZCOBIX,Asthenia,7
PREZCOBIX,Bone loss,6
PREZCOBIX,Economic problem,6
PREZCOBIX,Foot fracture,6
PREZCOBIX,End stage renal disease,6
PREZCOBIX,Renal injury,6
PREZCOBIX,Osteonecrosis,5
PREZCOBIX,Drug ineffective,5
PREZCOBIX,Back pain,5
PREZCOBIX,Pollakiuria,4
PREZCOBIX,Proteinuria,4
PREZCOBIX,Hyperkalaemia,4
PREZCOBIX,Mobility decreased,4
PREZCOBIX,Anaemia,4
PREZCOBIX,Loss of personal independence in daily activities,4
PREZCOBIX,Insomnia,3
PREZCOBIX,Rib fracture,3
PREZCOBIX,Nephropathy,3
PREZCOBIX,Ankle fracture,3
PREZCOBIX,Vitamin D deficiency,3
PREZCOBIX,Nephrolithiasis,3
PREZCOBIX,Protein urine present,3
PREZCOBIX,Fanconi syndrome acquired,2
PREZCOBIX,Renal disorder,2
PREZCOBIX,Renal tubular disorder,2
PREZCOBIX,Hypertension,2
PREZCOBIX,Osteoporotic fracture,2
PREZCOBIX,Facial bones fracture,2
PREZCOBIX,Renal cyst,2
PREZCOBIX,Nephrogenic anaemia,2
PREZCOBIX,Seizure,2
PREZCOBIX,Weight increased,2
PREZCOBIX,Hip fracture,2
PREZISTA,Emotional distress,82
PREZISTA,Pain,82
PREZISTA,Anxiety,78
PREZISTA,Anhedonia,77
PREZISTA,Chronic kidney disease,49
PREZISTA,Renal failure,34
PREZISTA,Osteoporosis,33
PREZISTA,Osteopenia,23
PREZISTA,Acute kidney injury,21
PREZISTA,Depression,19
PREZISTA,Bone density decreased,18
PREZISTA,Bone demineralisation,18
PREZISTA,Economic problem,17
PREZISTA,Blood creatinine increased,16
PREZISTA,Fatigue,15
PREZISTA,Renal impairment,15
PREZISTA,Multiple fractures,12
PREZISTA,Foot fracture,11
PREZISTA,End stage renal disease,10
PREZISTA,Renal injury,10
PREZISTA,Asthenia,9
PREZISTA,Back pain,8
PREZISTA,Bone loss,8
PREZISTA,Decreased activity,8
PREZISTA,Gait disturbance,8
PREZISTA,Quality of life decreased,7
PREZISTA,Skeletal injury,7
PREZISTA,Loss of personal independence in daily activities,7
PREZISTA,Vitamin D deficiency,7
PREZISTA,Nephropathy,6
PREZISTA,Osteonecrosis,6
PREZISTA,Pollakiuria,6
PREZISTA,Ankle fracture,5
PREZISTA,Fanconi syndrome acquired,5
PREZISTA,Rib fracture,5
PREZISTA,Mobility decreased,4
PREZISTA,Nephrolithiasis,4
PREZISTA,Proteinuria,4
PREZISTA,Tooth loss,4
PREZISTA,Insomnia,4
PREZISTA,Hypertension,4
PREZISTA,Anaemia,4
PREZISTA,Hypothyroidism,4
PREZISTA,Wrist fracture,3
PREZISTA,Fear,3
PREZISTA,Osteoarthritis,3
PREZISTA,Chronic kidney disease-mineral and bone disorder,3
PREZISTA,Gait inability,3
PREZISTA,Hip fracture,3
PREZISTA,Drug ineffective,3
PRILOSEC,COVID-19,21
PRILOSEC,Fatigue,16
PRILOSEC,Headache,15
PRILOSEC,Sinusitis,14
PRILOSEC,Nausea,12
PRILOSEC,Pain,12
PRILOSEC,Product dose omission issue,11
PRILOSEC,Influenza,11
PRILOSEC,Arthralgia,9
PRILOSEC,Diarrhoea,9
PRILOSEC,Abdominal pain upper,9
PRILOSEC,Urinary tract infection,9
PRILOSEC,Bronchitis,9
PRILOSEC,Dizziness,8
PRILOSEC,Pyrexia,8
PRILOSEC,Seasonal allergy,8
PRILOSEC,Weight increased,8
PRILOSEC,Fall,8
PRILOSEC,Upper respiratory tract infection,7
PRILOSEC,Cough,7
PRILOSEC,Weight decreased,7
PRILOSEC,Dyspnoea,6
PRILOSEC,Off label use,6
PRILOSEC,Pneumonia,6
PRILOSEC,Respiratory tract infection,6
PRILOSEC,Ear infection,6
PRILOSEC,Inappropriate schedule of product administration,6
PRILOSEC,Drug ineffective,6
PRILOSEC,Malaise,6
PRILOSEC,Feeling abnormal,5
PRILOSEC,Constipation,5
PRILOSEC,Back pain,5
PRILOSEC,Memory impairment,5
PRILOSEC,Multiple allergies,5
PRILOSEC,Nasopharyngitis,5
PRILOSEC,Oropharyngeal pain,5
PRILOSEC,Insomnia,5
PRILOSEC,Rash,4
PRILOSEC,Infection,4
PRILOSEC,Gait disturbance,4
PRILOSEC,Anaemia,4
PRILOSEC,Cyst,4
PRILOSEC,Nephrolithiasis,4
PRILOSEC,Asthma,4
PRILOSEC,Infusion related reaction,4
PRILOSEC,Product use in unapproved indication,4
PRILOSEC,Syncope,4
PRILOSEC,Gastroenteritis viral,4
PRILOSEC,Herpes zoster,4
PRILOSEC,Epistaxis,4
PRIMPERAN,Anaemia,9
PRIMPERAN,Neutropenia,9
PRIMPERAN,Nausea,8
PRIMPERAN,Diarrhoea,7
PRIMPERAN,Vomiting,7
PRIMPERAN,Cholestasis,7
PRIMPERAN,Pyrexia,5
PRIMPERAN,Oedema peripheral,5
PRIMPERAN,Asthenia,5
PRIMPERAN,Tumour lysis syndrome,4
PRIMPERAN,Back pain,4
PRIMPERAN,Lymphopenia,4
PRIMPERAN,Thrombocytopenia,4
PRIMPERAN,Hepatic cytolysis,4
PRIMPERAN,Off label use,4
PRIMPERAN,Confusional state,4
PRIMPERAN,Sciatica,3
PRIMPERAN,Arthralgia,3
PRIMPERAN,Death,3
PRIMPERAN,Acute kidney injury,3
PRIMPERAN,Bronchitis,3
PRIMPERAN,White blood cell count decreased,3
PRIMPERAN,Paraesthesia,3
PRIMPERAN,Dizziness,3
PRIMPERAN,Pancytopenia,3
PRIMPERAN,Renal impairment,3
PRIMPERAN,Rash,3
PRIMPERAN,Tongue injury,3
PRIMPERAN,Cardiac failure,3
PRIMPERAN,Facial bones fracture,3
PRIMPERAN,Pulmonary oedema,3
PRIMPERAN,Asphyxia,3
PRIMPERAN,Contusion,3
PRIMPERAN,Seizure,3
PRIMPERAN,Arteriosclerosis,3
PRIMPERAN,Overdose,3
PRIMPERAN,General physical health deterioration,2
PRIMPERAN,Leukopenia,2
PRIMPERAN,Mucormycosis,2
PRIMPERAN,Pulmonary mucormycosis,2
PRIMPERAN,Skin lesion,2
PRIMPERAN,Optic nerve cupping,2
PRIMPERAN,Rhinovirus infection,2
PRIMPERAN,Facial paralysis,2
PRIMPERAN,Neuralgia,2
PRIMPERAN,Hyperphosphataemia,2
PRIMPERAN,Cataract,2
PRIMPERAN,Escherichia infection,2
PRIMPERAN,Aspergillus infection,2
PRIMPERAN,Blood lactate dehydrogenase increased,2
PRIVIGEN,Off label use,16
PRIVIGEN,No adverse event,13
PRIVIGEN,Dyspnoea,10
PRIVIGEN,Chills,10
PRIVIGEN,Headache,6
PRIVIGEN,Pyrexia,6
PRIVIGEN,Malaise,5
PRIVIGEN,Nausea,4
PRIVIGEN,Anaphylactic reaction,4
PRIVIGEN,Dizziness,4
PRIVIGEN,Pneumonia,4
PRIVIGEN,Gait disturbance,4
PRIVIGEN,Septic shock,4
PRIVIGEN,Drug ineffective for unapproved indication,4
PRIVIGEN,Neuropathy peripheral,4
PRIVIGEN,Hypotension,4
PRIVIGEN,Throat tightness,4
PRIVIGEN,Chest pain,4
PRIVIGEN,Erythema,4
PRIVIGEN,Cough,4
PRIVIGEN,Tremor,4
PRIVIGEN,Hypertension,4
PRIVIGEN,Arthralgia,4
PRIVIGEN,Neutropenia,4
PRIVIGEN,Asthenia,4
PRIVIGEN,Heart rate increased,3
PRIVIGEN,Vomiting,3
PRIVIGEN,Pain in extremity,3
PRIVIGEN,Flushing,3
PRIVIGEN,Back pain,3
PRIVIGEN,Fall,3
PRIVIGEN,Mobility decreased,3
PRIVIGEN,Heart transplant rejection,3
PRIVIGEN,Candida infection,3
PRIVIGEN,General physical health deterioration,3
PRIVIGEN,Enterobacter bacteraemia,3
PRIVIGEN,Proteus infection,3
PRIVIGEN,Fungaemia,3
PRIVIGEN,Chronic kidney disease,3
PRIVIGEN,Malnutrition,3
PRIVIGEN,Respiratory disorder,3
PRIVIGEN,Cytomegalovirus infection,3
PRIVIGEN,Localised infection,3
PRIVIGEN,Cardiogenic shock,3
PRIVIGEN,C-reactive protein abnormal,3
PRIVIGEN,Rash,3
PRIVIGEN,Drug intolerance,3
PRIVIGEN,Ischaemic stroke,3
PRIVIGEN,Diarrhoea,3
PRIVIGEN,COVID-19,3
PROAIR HFA,COVID-19,39
PROAIR HFA,Product dose omission issue,35
PROAIR HFA,Pain,31
PROAIR HFA,Fatigue,29
PROAIR HFA,Sinusitis,28
PROAIR HFA,Urinary tract infection,26
PROAIR HFA,Headache,24
PROAIR HFA,Fall,22
PROAIR HFA,Pneumonia,21
PROAIR HFA,Influenza,18
PROAIR HFA,Illness,17
PROAIR HFA,Bronchitis,17
PROAIR HFA,Anxiety,16
PROAIR HFA,Nasopharyngitis,15
PROAIR HFA,Anhedonia,15
PROAIR HFA,Emotional distress,15
PROAIR HFA,Inappropriate schedule of product administration,14
PROAIR HFA,Respiratory tract infection,14
PROAIR HFA,Upper respiratory tract infection,14
PROAIR HFA,Nausea,13
PROAIR HFA,Ear infection,13
PROAIR HFA,Dyspnoea,13
PROAIR HFA,Asthma,13
PROAIR HFA,Rash,12
PROAIR HFA,Malaise,12
PROAIR HFA,Insurance issue,12
PROAIR HFA,Arthralgia,11
PROAIR HFA,Seasonal allergy,11
PROAIR HFA,Weight increased,11
PROAIR HFA,Asthenia,11
PROAIR HFA,Depression,10
PROAIR HFA,Osteoporosis,10
PROAIR HFA,Back pain,10
PROAIR HFA,Pruritus,10
PROAIR HFA,Pyrexia,10
PROAIR HFA,Cystitis,9
PROAIR HFA,Pain in extremity,9
PROAIR HFA,Infusion site erythema,9
PROAIR HFA,Weight decreased,8
PROAIR HFA,Infusion site pain,8
PROAIR HFA,Gastroenteritis viral,8
PROAIR HFA,Product use issue,8
PROAIR HFA,Needle issue,8
PROAIR HFA,Infusion site swelling,8
PROAIR HFA,Migraine,8
PROAIR HFA,Muscle spasms,7
PROAIR HFA,Drug ineffective,7
PROAIR HFA,Dizziness,7
PROAIR HFA,Foot fracture,7
PROAIR HFA,Infusion site extravasation,7
PROBIOTICS NOS,Off label use,12
PROBIOTICS NOS,Product dose omission issue,10
PROBIOTICS NOS,Diarrhoea,10
PROBIOTICS NOS,Rash,10
PROBIOTICS NOS,Weight decreased,8
PROBIOTICS NOS,Lower respiratory tract infection,8
PROBIOTICS NOS,Pulmonary pain,8
PROBIOTICS NOS,Knee arthroplasty,8
PROBIOTICS NOS,Abdominal discomfort,8
PROBIOTICS NOS,Overdose,8
PROBIOTICS NOS,Intentional product misuse,8
PROBIOTICS NOS,Obesity,8
PROBIOTICS NOS,Drug abuse,8
PROBIOTICS NOS,Arthropathy,7
PROBIOTICS NOS,Amyloid arthropathy,7
PROBIOTICS NOS,Nausea,6
PROBIOTICS NOS,Pruritus,6
PROBIOTICS NOS,Insomnia,5
PROBIOTICS NOS,Fatigue,5
PROBIOTICS NOS,Dizziness,5
PROBIOTICS NOS,Sinusitis,4
PROBIOTICS NOS,COVID-19,4
PROBIOTICS NOS,Pneumonia,4
PROBIOTICS NOS,Hypersensitivity,4
PROBIOTICS NOS,Fall,4
PROBIOTICS NOS,Pyrexia,3
PROBIOTICS NOS,Asthma,3
PROBIOTICS NOS,Pain,3
PROBIOTICS NOS,Feeling abnormal,3
PROBIOTICS NOS,Back pain,3
PROBIOTICS NOS,Pain in extremity,3
PROBIOTICS NOS,Asthenia,3
PROBIOTICS NOS,Constipation,3
PROBIOTICS NOS,Malaise,3
PROBIOTICS NOS,Urinary tract infection,3
PROBIOTICS NOS,Bronchitis,3
PROBIOTICS NOS,Infection,3
PROBIOTICS NOS,Dyspnoea,3
PROBIOTICS NOS,Hypoxia,3
PROBIOTICS NOS,Dry skin,3
PROBIOTICS NOS,Drug ineffective,3
PROBIOTICS NOS,Inappropriate schedule of product administration,3
PROBIOTICS NOS,Conjunctivitis,2
PROBIOTICS NOS,Swelling,2
PROBIOTICS NOS,Muscular weakness,2
PROBIOTICS NOS,Rheumatoid arthritis,2
PROBIOTICS NOS,Erythema,2
PROBIOTICS NOS,Arthralgia,2
PROBIOTICS NOS,Atrial fibrillation,2
PROBIOTICS NOS,Muscle spasms,2
PROCHLORPERAZINE,Nausea,11
PROCHLORPERAZINE,Fatigue,10
PROCHLORPERAZINE,Diarrhoea,10
PROCHLORPERAZINE,Febrile neutropenia,9
PROCHLORPERAZINE,Pain,7
PROCHLORPERAZINE,Vomiting,7
PROCHLORPERAZINE,Asthenia,6
PROCHLORPERAZINE,Decreased appetite,6
PROCHLORPERAZINE,Dehydration,6
PROCHLORPERAZINE,Pyrexia,5
PROCHLORPERAZINE,Constipation,5
PROCHLORPERAZINE,COVID-19,5
PROCHLORPERAZINE,White blood cell count decreased,5
PROCHLORPERAZINE,Neutrophil count decreased,5
PROCHLORPERAZINE,Pneumonia,4
PROCHLORPERAZINE,Platelet count decreased,4
PROCHLORPERAZINE,Headache,4
PROCHLORPERAZINE,Abdominal discomfort,4
PROCHLORPERAZINE,Weight decreased,4
PROCHLORPERAZINE,Abdominal pain,4
PROCHLORPERAZINE,Death,4
PROCHLORPERAZINE,Malignant neoplasm progression,4
PROCHLORPERAZINE,Alanine aminotransferase increased,4
PROCHLORPERAZINE,Cytokine release syndrome,4
PROCHLORPERAZINE,Dizziness,3
PROCHLORPERAZINE,Oropharyngeal pain,3
PROCHLORPERAZINE,Red blood cell count decreased,3
PROCHLORPERAZINE,Arthralgia,3
PROCHLORPERAZINE,Product use issue,3
PROCHLORPERAZINE,Aspartate aminotransferase increased,3
PROCHLORPERAZINE,Bronchitis,3
PROCHLORPERAZINE,Gastrointestinal disorder,3
PROCHLORPERAZINE,Anxiety,2
PROCHLORPERAZINE,Blood creatinine increased,2
PROCHLORPERAZINE,Malaise,2
PROCHLORPERAZINE,Thrombocytopenia,2
PROCHLORPERAZINE,Sinusitis,2
PROCHLORPERAZINE,Abdominal distension,2
PROCHLORPERAZINE,Neuropathy peripheral,2
PROCHLORPERAZINE,Haemophagocytic lymphohistiocytosis,2
PROCHLORPERAZINE,Skin disorder,2
PROCHLORPERAZINE,Gait disturbance,2
PROCHLORPERAZINE,Septic shock,2
PROCHLORPERAZINE,Bacteraemia,2
PROCHLORPERAZINE,Abdominal pain upper,2
PROCHLORPERAZINE,Liver abscess,2
PROCHLORPERAZINE,Thrombosis,2
PROCHLORPERAZINE,Dyspnoea,2
PROCHLORPERAZINE,Syncope,2
PROCHLORPERAZINE,Hyperphosphataemia,2
PROGESTERONE,Nausea,8
PROGESTERONE,COVID-19,8
PROGESTERONE,Sinusitis,8
PROGESTERONE,Headache,8
PROGESTERONE,Dizziness,7
PROGESTERONE,Diarrhoea,6
PROGESTERONE,Product dose omission issue,6
PROGESTERONE,Fatigue,6
PROGESTERONE,Pain in extremity,6
PROGESTERONE,Drug hypersensitivity,5
PROGESTERONE,Oropharyngeal pain,5
PROGESTERONE,Influenza,5
PROGESTERONE,Nasopharyngitis,5
PROGESTERONE,Dyspnoea,5
PROGESTERONE,Urinary tract infection,4
PROGESTERONE,Seasonal allergy,4
PROGESTERONE,Weight decreased,4
PROGESTERONE,Upper respiratory tract infection,4
PROGESTERONE,Off label use,4
PROGESTERONE,Inappropriate schedule of product administration,4
PROGESTERONE,Feeling abnormal,4
PROGESTERONE,Foetal exposure during pregnancy,4
PROGESTERONE,Exposure during pregnancy,3
PROGESTERONE,Pruritus,3
PROGESTERONE,Depression,3
PROGESTERONE,Bronchitis,3
PROGESTERONE,Respiratory tract infection,3
PROGESTERONE,Cough,3
PROGESTERONE,Heart rate increased,3
PROGESTERONE,Pneumonia,3
PROGESTERONE,Pain,3
PROGESTERONE,Syncope,3
PROGESTERONE,Anxiety,3
PROGESTERONE,Drug ineffective,3
PROGESTERONE,Hot flush,3
PROGESTERONE,Malaise,3
PROGESTERONE,Vaginal haemorrhage,3
PROGESTERONE,Maternal exposure during pregnancy,3
PROGESTERONE,Vomiting,3
PROGESTERONE,Frenulum breve,3
PROGESTERONE,Congenital genital malformation,3
PROGESTERONE,Burning sensation,3
PROGESTERONE,Monoplegia,3
PROGESTERONE,Premature labour,2
PROGESTERONE,Polyp,2
PROGESTERONE,Needle issue,2
PROGESTERONE,Infusion site erythema,2
PROGESTERONE,Injection site pain,2
PROGESTERONE,Pyrexia,2
PROGESTERONE,Insomnia,2
PROGRAF,Nausea,6
PROGRAF,Off label use,6
PROGRAF,Sepsis,5
PROGRAF,Anaemia,4
PROGRAF,Platelet count decreased,4
PROGRAF,Pyrexia,4
PROGRAF,Headache,4
PROGRAF,Interstitial lung disease,4
PROGRAF,Maternal exposure during pregnancy,4
PROGRAF,Lung neoplasm malignant,3
PROGRAF,Seizure,3
PROGRAF,Altered state of consciousness,3
PROGRAF,Hepatic function abnormal,3
PROGRAF,Malaise,3
PROGRAF,Dyspnoea,3
PROGRAF,Symptom recurrence,3
PROGRAF,Exposure via breast milk,3
PROGRAF,Low birth weight baby,3
PROGRAF,Product use in unapproved indication,3
PROGRAF,Diarrhoea,3
PROGRAF,Vomiting,3
PROGRAF,Inappropriate schedule of product administration,3
PROGRAF,Neutropenia,3
PROGRAF,Oesophageal candidiasis,3
PROGRAF,Product dose omission issue,2
PROGRAF,Renal impairment,2
PROGRAF,Obstructive airways disorder,2
PROGRAF,White blood cell count decreased,2
PROGRAF,Haemophagocytic lymphohistiocytosis,2
PROGRAF,Lymphadenopathy,2
PROGRAF,Decubitus ulcer,2
PROGRAF,Gastrointestinal haemorrhage,2
PROGRAF,Meningitis bacterial,2
PROGRAF,Faeces discoloured,2
PROGRAF,Acute kidney injury,2
PROGRAF,Diverticulum intestinal haemorrhagic,2
PROGRAF,Hypertension,2
PROGRAF,Hypercholesterolaemia,2
PROGRAF,Diabetes mellitus,2
PROGRAF,Tumour rupture,2
PROGRAF,Metastases to liver,2
PROGRAF,Breast cancer metastatic,2
PROGRAF,Maternal exposure during breast feeding,2
PROGRAF,Therapeutic product effect incomplete,2
PROGRAF,Myasthenia gravis crisis,2
PROGRAF,Fatigue,2
PROGRAF,Apgar score low,2
PROGRAF,Premature baby,2
PROGRAF,Abdominal pain,2
PROGRAF,Asthenia,2
PROLIA,Fatigue,24
PROLIA,Off label use,18
PROLIA,Diarrhoea,17
PROLIA,Pain,14
PROLIA,Fall,13
PROLIA,Pain in extremity,13
PROLIA,Nausea,13
PROLIA,Urinary tract infection,12
PROLIA,COVID-19,12
PROLIA,Anaemia,11
PROLIA,Hypocalcaemia,11
PROLIA,Back pain,10
PROLIA,Dyspnoea,10
PROLIA,Headache,9
PROLIA,Vomiting,9
PROLIA,Arthralgia,9
PROLIA,Weight increased,8
PROLIA,Osteonecrosis of jaw,8
PROLIA,Decreased appetite,8
PROLIA,Product dose omission issue,8
PROLIA,Weight decreased,8
PROLIA,Osteoporosis,7
PROLIA,Rash,7
PROLIA,Mucosal inflammation,6
PROLIA,Sinusitis,6
PROLIA,Emotional distress,6
PROLIA,Gait disturbance,6
PROLIA,Abdominal pain upper,6
PROLIA,Bone pain,6
PROLIA,Asthenia,6
PROLIA,Hypomagnesaemia,6
PROLIA,Hypophosphataemia,6
PROLIA,Peripheral swelling,5
PROLIA,Malaise,5
PROLIA,Skin laceration,5
PROLIA,Illness,5
PROLIA,Neuropathy peripheral,5
PROLIA,Inappropriate schedule of product administration,5
PROLIA,Abdominal discomfort,5
PROLIA,Diverticulitis,5
PROLIA,Hypokalaemia,5
PROLIA,Blood creatinine increased,5
PROLIA,Dizziness,5
PROLIA,Arthritis,5
PROLIA,Osteoarthritis,4
PROLIA,Hot flush,4
PROLIA,Influenza like illness,4
PROLIA,Cerebrovascular accident,4
PROLIA,Road traffic accident,4
PROLIA,Head injury,4
PROMETHAZINE,Pain,17
PROMETHAZINE,Nausea,13
PROMETHAZINE,Anxiety,13
PROMETHAZINE,Anhedonia,13
PROMETHAZINE,Emotional distress,12
PROMETHAZINE,Headache,8
PROMETHAZINE,Depression,8
PROMETHAZINE,Sinusitis,8
PROMETHAZINE,Osteoporosis,7
PROMETHAZINE,Chronic kidney disease,7
PROMETHAZINE,Pneumonia,7
PROMETHAZINE,Fatigue,7
PROMETHAZINE,Neutrophil count decreased,7
PROMETHAZINE,COVID-19,7
PROMETHAZINE,Dizziness,6
PROMETHAZINE,Upper respiratory tract infection,6
PROMETHAZINE,Fall,5
PROMETHAZINE,Vomiting,5
PROMETHAZINE,Osteopenia,5
PROMETHAZINE,Renal failure,5
PROMETHAZINE,Diarrhoea,5
PROMETHAZINE,Dyspnoea,5
PROMETHAZINE,Pyrexia,5
PROMETHAZINE,Neutropenia,5
PROMETHAZINE,Rash,4
PROMETHAZINE,Herpes zoster,4
PROMETHAZINE,Hyponatraemia,4
PROMETHAZINE,Urinary tract infection,4
PROMETHAZINE,Bone demineralisation,4
PROMETHAZINE,Acute kidney injury,4
PROMETHAZINE,Disease progression,4
PROMETHAZINE,Anaemia,4
PROMETHAZINE,Pain in extremity,4
PROMETHAZINE,Hypersensitivity,4
PROMETHAZINE,Nephrolithiasis,3
PROMETHAZINE,Memory impairment,3
PROMETHAZINE,Multiple sclerosis relapse,3
PROMETHAZINE,Weight increased,3
PROMETHAZINE,Economic problem,3
PROMETHAZINE,Bone loss,3
PROMETHAZINE,Quality of life decreased,3
PROMETHAZINE,Infection,3
PROMETHAZINE,Product dose omission issue,3
PROMETHAZINE,Oropharyngeal pain,3
PROMETHAZINE,Mobility decreased,3
PROMETHAZINE,Small intestinal obstruction,3
PROMETHAZINE,Gait disturbance,3
PROMETHAZINE,Bone pain,3
PROMETHAZINE,Alopecia,3
PROMETHAZINE,Pruritus,3
PROPOFOL,Anaphylactic shock,34
PROPOFOL,Acute generalised exanthematous pustulosis,15
PROPOFOL,Hypotension,10
PROPOFOL,Off label use,9
PROPOFOL,Drug reaction with eosinophilia and systemic symptoms,7
PROPOFOL,Pyrexia,6
PROPOFOL,Multiple organ dysfunction syndrome,6
PROPOFOL,Bradycardia,6
PROPOFOL,Cardiogenic shock,6
PROPOFOL,Lactic acidosis,6
PROPOFOL,Diarrhoea,5
PROPOFOL,Vomiting,5
PROPOFOL,Ascites,5
PROPOFOL,Cardiac arrest,5
PROPOFOL,Tachypnoea,4
PROPOFOL,Pneumonia aspiration,4
PROPOFOL,Pneumonia,4
PROPOFOL,Intestinal ischaemia,4
PROPOFOL,Increased bronchial secretion,4
PROPOFOL,Dyspnoea,4
PROPOFOL,Rhabdomyolysis,4
PROPOFOL,Hepatic cytolysis,4
PROPOFOL,Urticaria,4
PROPOFOL,Leukopenia,4
PROPOFOL,Neutropenia,4
PROPOFOL,Renal failure,4
PROPOFOL,Septic shock,3
PROPOFOL,Liver disorder,3
PROPOFOL,Stoma closure,3
PROPOFOL,Interstitial lung disease,3
PROPOFOL,Bronchial disorder,3
PROPOFOL,Secretion discharge,3
PROPOFOL,Pneumococcal sepsis,3
PROPOFOL,Disease complication,3
PROPOFOL,Demyelination,3
PROPOFOL,Injury,3
PROPOFOL,Chest X-ray abnormal,3
PROPOFOL,Atelectasis,3
PROPOFOL,Circulatory collapse,3
PROPOFOL,Motor neurone disease,3
PROPOFOL,Muscular weakness,3
PROPOFOL,Ischaemic cerebral infarction,3
PROPOFOL,Inflammation,3
PROPOFOL,Respiratory arrest,3
PROPOFOL,Mechanical ventilation,3
PROPOFOL,Respiratory tract infection bacterial,3
PROPOFOL,Lung consolidation,3
PROPOFOL,Dysphagia,3
PROPOFOL,Brain injury,3
PROPOFOL,Dehydration,3
PROPRANOLOL,Off label use,15
PROPRANOLOL,Nausea,15
PROPRANOLOL,COVID-19,12
PROPRANOLOL,Product use issue,11
PROPRANOLOL,Product use in unapproved indication,10
PROPRANOLOL,Pain,8
PROPRANOLOL,Fatigue,8
PROPRANOLOL,Headache,8
PROPRANOLOL,Dyspnoea,8
PROPRANOLOL,Diarrhoea,8
PROPRANOLOL,Gait disturbance,8
PROPRANOLOL,Feeling abnormal,7
PROPRANOLOL,Rash,7
PROPRANOLOL,Fall,7
PROPRANOLOL,Illness,7
PROPRANOLOL,Insomnia,7
PROPRANOLOL,Hyperkalaemia,7
PROPRANOLOL,Acute kidney injury,7
PROPRANOLOL,Arthralgia,6
PROPRANOLOL,Anxiety,6
PROPRANOLOL,Vomiting,6
PROPRANOLOL,Product dose omission issue,6
PROPRANOLOL,Condition aggravated,5
PROPRANOLOL,Dizziness,5
PROPRANOLOL,Bradycardia,5
PROPRANOLOL,Peripheral swelling,5
PROPRANOLOL,Tremor,5
PROPRANOLOL,Abdominal discomfort,5
PROPRANOLOL,Sepsis,5
PROPRANOLOL,Dyskinesia,5
PROPRANOLOL,Extrapyramidal disorder,5
PROPRANOLOL,Anaphylactic shock,5
PROPRANOLOL,Cardiogenic shock,5
PROPRANOLOL,Foetal death,5
PROPRANOLOL,Meconium in amniotic fluid,5
PROPRANOLOL,Malaise,4
PROPRANOLOL,Pneumonia,4
PROPRANOLOL,Hypertension,4
PROPRANOLOL,Pruritus,4
PROPRANOLOL,Urinary tract infection,4
PROPRANOLOL,Hyperhidrosis,4
PROPRANOLOL,Pyrexia,4
PROPRANOLOL,Muscle spasms,4
PROPRANOLOL,Completed suicide,4
PROPRANOLOL,Gastrointestinal disorder,4
PROPRANOLOL,Confusional state,4
PROPRANOLOL,Contusion,3
PROPRANOLOL,Infusion related reaction,3
PROPRANOLOL,Skin fissures,3
PROPRANOLOL,Somnolence,3
PROPRANOLOL HYDROCHLORIDE,Off label use,17
PROPRANOLOL HYDROCHLORIDE,Sinusitis,7
PROPRANOLOL HYDROCHLORIDE,Diarrhoea,7
PROPRANOLOL HYDROCHLORIDE,Dyspnoea,6
PROPRANOLOL HYDROCHLORIDE,Cystitis,6
PROPRANOLOL HYDROCHLORIDE,Drug ineffective,5
PROPRANOLOL HYDROCHLORIDE,Pain,5
PROPRANOLOL HYDROCHLORIDE,Urinary tract infection,5
PROPRANOLOL HYDROCHLORIDE,Hypoaesthesia,5
PROPRANOLOL HYDROCHLORIDE,COVID-19,5
PROPRANOLOL HYDROCHLORIDE,Nausea,5
PROPRANOLOL HYDROCHLORIDE,Product use issue,5
PROPRANOLOL HYDROCHLORIDE,Fall,4
PROPRANOLOL HYDROCHLORIDE,Seasonal allergy,4
PROPRANOLOL HYDROCHLORIDE,Upper respiratory tract infection,4
PROPRANOLOL HYDROCHLORIDE,Infusion site pain,4
PROPRANOLOL HYDROCHLORIDE,Influenza,4
PROPRANOLOL HYDROCHLORIDE,Fatigue,4
PROPRANOLOL HYDROCHLORIDE,Headache,4
PROPRANOLOL HYDROCHLORIDE,Injection site pain,4
PROPRANOLOL HYDROCHLORIDE,Kidney infection,3
PROPRANOLOL HYDROCHLORIDE,Staphylococcal infection,3
PROPRANOLOL HYDROCHLORIDE,Blood pressure abnormal,3
PROPRANOLOL HYDROCHLORIDE,Peripheral swelling,3
PROPRANOLOL HYDROCHLORIDE,Hereditary angioedema,3
PROPRANOLOL HYDROCHLORIDE,Injection site erythema,3
PROPRANOLOL HYDROCHLORIDE,Rash,3
PROPRANOLOL HYDROCHLORIDE,Infusion related reaction,3
PROPRANOLOL HYDROCHLORIDE,Migraine,3
PROPRANOLOL HYDROCHLORIDE,Illness,3
PROPRANOLOL HYDROCHLORIDE,COVID-19 immunisation,3
PROPRANOLOL HYDROCHLORIDE,Pruritus,3
PROPRANOLOL HYDROCHLORIDE,Vomiting,3
PROPRANOLOL HYDROCHLORIDE,Dizziness,3
PROPRANOLOL HYDROCHLORIDE,General physical health deterioration,3
PROPRANOLOL HYDROCHLORIDE,Malaise,3
PROPRANOLOL HYDROCHLORIDE,Condition aggravated,3
PROPRANOLOL HYDROCHLORIDE,Overdose,3
PROPRANOLOL HYDROCHLORIDE,Blood pressure increased,3
PROPRANOLOL HYDROCHLORIDE,Pneumonia,3
PROPRANOLOL HYDROCHLORIDE,Hypertension,3
PROPRANOLOL HYDROCHLORIDE,Blood pressure decreased,3
PROPRANOLOL HYDROCHLORIDE,Insomnia,2
PROPRANOLOL HYDROCHLORIDE,Multiple allergies,2
PROPRANOLOL HYDROCHLORIDE,Cerebrovascular accident,2
PROPRANOLOL HYDROCHLORIDE,Wrist fracture,2
PROPRANOLOL HYDROCHLORIDE,Rosacea,2
PROPRANOLOL HYDROCHLORIDE,Infusion site pruritus,2
PROPRANOLOL HYDROCHLORIDE,Diabetes mellitus,2
PROPRANOLOL HYDROCHLORIDE,Infusion site discomfort,2
PROTONIX,COVID-19,19
PROTONIX,Urinary tract infection,15
PROTONIX,Product dose omission issue,13
PROTONIX,Pain,12
PROTONIX,Weight decreased,12
PROTONIX,Off label use,10
PROTONIX,Diarrhoea,9
PROTONIX,Product use issue,9
PROTONIX,Illness,8
PROTONIX,Upper respiratory tract infection,8
PROTONIX,Nausea,8
PROTONIX,Pneumonia,8
PROTONIX,Headache,7
PROTONIX,Abdominal pain,7
PROTONIX,Sinusitis,7
PROTONIX,Vomiting,7
PROTONIX,Anxiety,6
PROTONIX,Migraine,6
PROTONIX,Fatigue,6
PROTONIX,Malaise,6
PROTONIX,Insurance issue,6
PROTONIX,Back pain,6
PROTONIX,Dyspnoea,6
PROTONIX,Fall,5
PROTONIX,Intestinal obstruction,5
PROTONIX,Asthenia,5
PROTONIX,Respiratory tract infection,5
PROTONIX,Small intestinal obstruction,5
PROTONIX,Influenza,5
PROTONIX,Inappropriate schedule of product administration,5
PROTONIX,Arthralgia,5
PROTONIX,Dizziness,5
PROTONIX,Anaemia,5
PROTONIX,Drug ineffective,4
PROTONIX,Infection,4
PROTONIX,Syncope,4
PROTONIX,Eye infection,4
PROTONIX,Infusion related reaction,4
PROTONIX,Cellulitis,4
PROTONIX,Needle issue,4
PROTONIX,Decreased appetite,4
PROTONIX,Confusional state,4
PROTONIX,Blood pressure increased,4
PROTONIX,Oropharyngeal pain,4
PROTONIX,Depression,3
PROTONIX,Epilepsy,3
PROTONIX,Gastric disorder,3
PROTONIX,Chronic kidney disease,3
PROTONIX,Emotional distress,3
PROTONIX,Gastrointestinal bacterial overgrowth,3
PROZAC,Fatigue,10
PROZAC,Fall,10
PROZAC,Weight decreased,9
PROZAC,Nasopharyngitis,9
PROZAC,Nausea,9
PROZAC,COVID-19,7
PROZAC,Anxiety,7
PROZAC,Pain,7
PROZAC,Sinusitis,6
PROZAC,Upper respiratory tract infection,6
PROZAC,Erythema,6
PROZAC,Headache,6
PROZAC,Product dose omission issue,6
PROZAC,Feeling abnormal,6
PROZAC,Diarrhoea,6
PROZAC,Emotional distress,5
PROZAC,Cough,5
PROZAC,Weight increased,5
PROZAC,Infusion site swelling,5
PROZAC,Gait disturbance,5
PROZAC,Suicidal ideation,5
PROZAC,Bronchitis,5
PROZAC,Asthenia,5
PROZAC,Epistaxis,5
PROZAC,Illness,4
PROZAC,Pneumonia,4
PROZAC,Arthralgia,4
PROZAC,Depression,4
PROZAC,Stress,4
PROZAC,Product use in unapproved indication,4
PROZAC,Pain in extremity,4
PROZAC,Anaemia,4
PROZAC,Cellulitis,3
PROZAC,Hypoaesthesia,3
PROZAC,Sinus congestion,3
PROZAC,Rash pruritic,3
PROZAC,Insurance issue,3
PROZAC,Malaise,3
PROZAC,Back pain,3
PROZAC,Multiple allergies,3
PROZAC,Eating disorder,3
PROZAC,Constipation,3
PROZAC,Drug ineffective,3
PROZAC,Withdrawal syndrome,3
PROZAC,Insomnia,3
PROZAC,Infusion site erythema,3
PROZAC,Gingival bleeding,3
PROZAC,Mucosal inflammation,3
PROZAC,Injection site pruritus,3
PROZAC,Off label use,3
PULMICORT TURBUHALER,Asthma,11
PULMICORT TURBUHALER,Nasopharyngitis,10
PULMICORT TURBUHALER,Vomiting,9
PULMICORT TURBUHALER,Pneumonia,8
PULMICORT TURBUHALER,Sinusitis,8
PULMICORT TURBUHALER,Headache,8
PULMICORT TURBUHALER,COVID-19,8
PULMICORT TURBUHALER,Dyspnoea,7
PULMICORT TURBUHALER,Weight decreased,7
PULMICORT TURBUHALER,Fatigue,7
PULMICORT TURBUHALER,Oropharyngeal pain,6
PULMICORT TURBUHALER,Influenza,6
PULMICORT TURBUHALER,Nausea,6
PULMICORT TURBUHALER,Cough,5
PULMICORT TURBUHALER,Drug hypersensitivity,5
PULMICORT TURBUHALER,Dizziness,5
PULMICORT TURBUHALER,Diarrhoea,5
PULMICORT TURBUHALER,Malaise,5
PULMICORT TURBUHALER,Weight increased,5
PULMICORT TURBUHALER,Pyrexia,4
PULMICORT TURBUHALER,Productive cough,4
PULMICORT TURBUHALER,Bronchitis,4
PULMICORT TURBUHALER,Chills,4
PULMICORT TURBUHALER,Ear infection,4
PULMICORT TURBUHALER,General physical health deterioration,4
PULMICORT TURBUHALER,Asthenia,4
PULMICORT TURBUHALER,Illness,4
PULMICORT TURBUHALER,Dilated cardiomyopathy,4
PULMICORT TURBUHALER,Overdose,4
PULMICORT TURBUHALER,Arteriosclerosis coronary artery,4
PULMICORT TURBUHALER,Viral infection,4
PULMICORT TURBUHALER,Lower respiratory tract infection,4
PULMICORT TURBUHALER,Infusion site pruritus,4
PULMICORT TURBUHALER,Condition aggravated,4
PULMICORT TURBUHALER,Hyperhidrosis,4
PULMICORT TURBUHALER,Product dose omission issue,4
PULMICORT TURBUHALER,Arthralgia,4
PULMICORT TURBUHALER,Injection site pain,4
PULMICORT TURBUHALER,Visual impairment,4
PULMICORT TURBUHALER,Blindness,4
PULMICORT TURBUHALER,Gait disturbance,3
PULMICORT TURBUHALER,Limb discomfort,3
PULMICORT TURBUHALER,Upper respiratory tract infection,3
PULMICORT TURBUHALER,Eczema,3
PULMICORT TURBUHALER,Nasal congestion,3
PULMICORT TURBUHALER,Aphonia,3
PULMICORT TURBUHALER,Product use in unapproved indication,3
PULMICORT TURBUHALER,Infusion site pain,3
PULMICORT TURBUHALER,Vision blurred,3
PULMICORT TURBUHALER,Gastrointestinal disorder,3
QUETIAPINE,Headache,26
QUETIAPINE,Off label use,21
QUETIAPINE,Depression,21
QUETIAPINE,Anxiety,21
QUETIAPINE,Dizziness,20
QUETIAPINE,Pain,20
QUETIAPINE,Gait disturbance,20
QUETIAPINE,Pyrexia,18
QUETIAPINE,Nausea,18
QUETIAPINE,Arthralgia,18
QUETIAPINE,Dyskinesia,17
QUETIAPINE,Fatigue,16
QUETIAPINE,Confusional state,16
QUETIAPINE,Vomiting,16
QUETIAPINE,Diarrhoea,15
QUETIAPINE,Somnolence,15
QUETIAPINE,Suicide attempt,15
QUETIAPINE,Musculoskeletal stiffness,14
QUETIAPINE,Abdominal pain,14
QUETIAPINE,Toxicity to various agents,14
QUETIAPINE,Asthenia,13
QUETIAPINE,Dyspnoea,13
QUETIAPINE,Muscle spasms,13
QUETIAPINE,Pruritus,13
QUETIAPINE,Pain in extremity,13
QUETIAPINE,Hyperhidrosis,13
QUETIAPINE,Seizure,13
QUETIAPINE,Maternal exposure during pregnancy,12
QUETIAPINE,Drug ineffective,12
QUETIAPINE,Suicidal ideation,12
QUETIAPINE,Rash,11
QUETIAPINE,Back pain,11
QUETIAPINE,Insomnia,11
QUETIAPINE,Condition aggravated,11
QUETIAPINE,Restlessness,11
QUETIAPINE,Paraesthesia,10
QUETIAPINE,Delirium,10
QUETIAPINE,Decreased appetite,10
QUETIAPINE,Illness,10
QUETIAPINE,Menstrual disorder,10
QUETIAPINE,Agitation,10
QUETIAPINE,Drug interaction,10
QUETIAPINE,Thrombocytopenia,10
QUETIAPINE,Medication error,9
QUETIAPINE,Contusion,9
QUETIAPINE,Sleep disorder,9
QUETIAPINE,Hypoaesthesia,9
QUETIAPINE,Psychotic disorder,9
QUETIAPINE,Tremor,9
QUETIAPINE,Dystonia,9
QUETIAPINE FUMARATE,Headache,14
QUETIAPINE FUMARATE,Dizziness,14
QUETIAPINE FUMARATE,Vomiting,13
QUETIAPINE FUMARATE,Off label use,12
QUETIAPINE FUMARATE,Dyspnoea,11
QUETIAPINE FUMARATE,Musculoskeletal stiffness,10
QUETIAPINE FUMARATE,Depression,10
QUETIAPINE FUMARATE,Nausea,10
QUETIAPINE FUMARATE,Decreased appetite,10
QUETIAPINE FUMARATE,Asthenia,10
QUETIAPINE FUMARATE,Arthralgia,10
QUETIAPINE FUMARATE,Diarrhoea,10
QUETIAPINE FUMARATE,Anxiety,10
QUETIAPINE FUMARATE,Muscle spasms,10
QUETIAPINE FUMARATE,Drug interaction,10
QUETIAPINE FUMARATE,Somnolence,10
QUETIAPINE FUMARATE,Drug ineffective,9
QUETIAPINE FUMARATE,Pyrexia,9
QUETIAPINE FUMARATE,Fatigue,9
QUETIAPINE FUMARATE,Pruritus,9
QUETIAPINE FUMARATE,Dyskinesia,9
QUETIAPINE FUMARATE,Illness,9
QUETIAPINE FUMARATE,Contusion,8
QUETIAPINE FUMARATE,Delirium,8
QUETIAPINE FUMARATE,Gait disturbance,8
QUETIAPINE FUMARATE,Maternal exposure during pregnancy,8
QUETIAPINE FUMARATE,Sleep disorder,8
QUETIAPINE FUMARATE,Hypoaesthesia,8
QUETIAPINE FUMARATE,Confusional state,8
QUETIAPINE FUMARATE,Exposure during pregnancy,8
QUETIAPINE FUMARATE,Vision blurred,8
QUETIAPINE FUMARATE,Paraesthesia,7
QUETIAPINE FUMARATE,Swelling face,7
QUETIAPINE FUMARATE,Tremor,7
QUETIAPINE FUMARATE,Toxicity to various agents,7
QUETIAPINE FUMARATE,Nightmare,7
QUETIAPINE FUMARATE,Incontinence,7
QUETIAPINE FUMARATE,Suicidal ideation,7
QUETIAPINE FUMARATE,Restless legs syndrome,7
QUETIAPINE FUMARATE,Urinary retention,7
QUETIAPINE FUMARATE,Muscle rigidity,7
QUETIAPINE FUMARATE,Seizure,7
QUETIAPINE FUMARATE,Mania,7
QUETIAPINE FUMARATE,Pneumonia,6
QUETIAPINE FUMARATE,Pain,6
QUETIAPINE FUMARATE,Tachycardia,6
QUETIAPINE FUMARATE,Derealisation,6
QUETIAPINE FUMARATE,Muscle disorder,6
QUETIAPINE FUMARATE,Dissociation,6
QUETIAPINE FUMARATE,Feeling of despair,6
RABEPRAZOLE SODIUM,Off label use,14
RABEPRAZOLE SODIUM,Diarrhoea,13
RABEPRAZOLE SODIUM,Cardiac failure,11
RABEPRAZOLE SODIUM,Pyrexia,10
RABEPRAZOLE SODIUM,Hypertension,9
RABEPRAZOLE SODIUM,Pneumonia,8
RABEPRAZOLE SODIUM,Headache,8
RABEPRAZOLE SODIUM,Dyspnoea,8
RABEPRAZOLE SODIUM,Arthralgia,8
RABEPRAZOLE SODIUM,Nausea,7
RABEPRAZOLE SODIUM,Hepatic function abnormal,7
RABEPRAZOLE SODIUM,Rash,7
RABEPRAZOLE SODIUM,Malaise,6
RABEPRAZOLE SODIUM,Cough,6
RABEPRAZOLE SODIUM,Interstitial lung disease,6
RABEPRAZOLE SODIUM,COVID-19,5
RABEPRAZOLE SODIUM,Anaemia,5
RABEPRAZOLE SODIUM,Hypokalaemia,5
RABEPRAZOLE SODIUM,Abdominal pain upper,5
RABEPRAZOLE SODIUM,Product use issue,5
RABEPRAZOLE SODIUM,Cardiac failure congestive,5
RABEPRAZOLE SODIUM,Vomiting,5
RABEPRAZOLE SODIUM,Decreased appetite,5
RABEPRAZOLE SODIUM,Inappropriate schedule of product administration,4
RABEPRAZOLE SODIUM,Pulmonary arterial hypertension,4
RABEPRAZOLE SODIUM,White blood cell count decreased,4
RABEPRAZOLE SODIUM,Febrile neutropenia,4
RABEPRAZOLE SODIUM,Abdominal discomfort,4
RABEPRAZOLE SODIUM,Loss of employment,4
RABEPRAZOLE SODIUM,Drug intolerance,4
RABEPRAZOLE SODIUM,Liver disorder,4
RABEPRAZOLE SODIUM,Hepatic enzyme increased,4
RABEPRAZOLE SODIUM,Gastric disorder,4
RABEPRAZOLE SODIUM,Hepatic steatosis,4
RABEPRAZOLE SODIUM,Drug ineffective,4
RABEPRAZOLE SODIUM,Drug hypersensitivity,4
RABEPRAZOLE SODIUM,Contraindicated product administered,4
RABEPRAZOLE SODIUM,Therapeutic product effect decreased,4
RABEPRAZOLE SODIUM,Herpes zoster,4
RABEPRAZOLE SODIUM,Urinary tract infection,4
RABEPRAZOLE SODIUM,Hypotension,3
RABEPRAZOLE SODIUM,Sinusitis,3
RABEPRAZOLE SODIUM,Myocardial infarction,3
RABEPRAZOLE SODIUM,Bronchitis,3
RABEPRAZOLE SODIUM,Pruritus,3
RABEPRAZOLE SODIUM,Dysphonia,3
RABEPRAZOLE SODIUM,Weight decreased,3
RABEPRAZOLE SODIUM,Erythema,2
RABEPRAZOLE SODIUM,Myelodysplastic syndrome,2
RABEPRAZOLE SODIUM,Second primary malignancy,2
RAMIPRIL,Fatigue,49
RAMIPRIL,Diarrhoea,45
RAMIPRIL,Acute kidney injury,41
RAMIPRIL,Arthralgia,40
RAMIPRIL,Dizziness,35
RAMIPRIL,Hypotension,34
RAMIPRIL,Off label use,33
RAMIPRIL,Pyrexia,31
RAMIPRIL,Nausea,31
RAMIPRIL,Asthenia,29
RAMIPRIL,Headache,26
RAMIPRIL,Pain,25
RAMIPRIL,Hypertension,24
RAMIPRIL,Joint swelling,24
RAMIPRIL,Condition aggravated,24
RAMIPRIL,Sepsis,24
RAMIPRIL,Syncope,24
RAMIPRIL,Rash,23
RAMIPRIL,Vomiting,23
RAMIPRIL,Ejection fraction decreased,23
RAMIPRIL,Pruritus,22
RAMIPRIL,Hyponatraemia,22
RAMIPRIL,Dyspnoea,21
RAMIPRIL,Cough,21
RAMIPRIL,Constipation,21
RAMIPRIL,Epistaxis,20
RAMIPRIL,Alopecia,19
RAMIPRIL,Confusional state,19
RAMIPRIL,Pain in extremity,18
RAMIPRIL,Death,18
RAMIPRIL,Pneumonia,17
RAMIPRIL,Anaemia,17
RAMIPRIL,Cardiac failure,17
RAMIPRIL,Influenza like illness,16
RAMIPRIL,Mucosal inflammation,16
RAMIPRIL,Oedema peripheral,16
RAMIPRIL,Palpitations,16
RAMIPRIL,Paraesthesia,15
RAMIPRIL,General physical health deterioration,15
RAMIPRIL,Weight decreased,15
RAMIPRIL,Malaise,15
RAMIPRIL,Neutropenia,15
RAMIPRIL,Medication error,14
RAMIPRIL,Back pain,14
RAMIPRIL,Decreased appetite,14
RAMIPRIL,Abdominal pain,14
RAMIPRIL,Myalgia,14
RAMIPRIL,Hypomagnesaemia,14
RAMIPRIL,Lower respiratory tract infection,13
RAMIPRIL,Ill-defined disorder,13
RANITIDINE,Diarrhoea,37
RANITIDINE,Nausea,34
RANITIDINE,Fatigue,34
RANITIDINE,Pain,29
RANITIDINE,Off label use,26
RANITIDINE,Arthralgia,22
RANITIDINE,Dyspnoea,19
RANITIDINE,Neuropathy peripheral,19
RANITIDINE,COVID-19,17
RANITIDINE,Mucosal inflammation,16
RANITIDINE,Vomiting,15
RANITIDINE,Anxiety,15
RANITIDINE,Platelet count decreased,15
RANITIDINE,Pain in extremity,14
RANITIDINE,Pneumonia,13
RANITIDINE,Urinary tract infection,13
RANITIDINE,Neutropenia,13
RANITIDINE,Rash,13
RANITIDINE,Sinusitis,12
RANITIDINE,Upper respiratory tract infection,12
RANITIDINE,Emotional distress,12
RANITIDINE,Leukopenia,12
RANITIDINE,Disease progression,12
RANITIDINE,Incorrect dose administered,11
RANITIDINE,Malaise,11
RANITIDINE,Drug hypersensitivity,11
RANITIDINE,Pyrexia,11
RANITIDINE,Product dose omission issue,11
RANITIDINE,Illness,11
RANITIDINE,Anhedonia,11
RANITIDINE,Anaemia,11
RANITIDINE,Alopecia,11
RANITIDINE,Cough,11
RANITIDINE,Acute kidney injury,11
RANITIDINE,Decreased appetite,11
RANITIDINE,Headache,10
RANITIDINE,Pruritus,10
RANITIDINE,Drug ineffective,10
RANITIDINE,Lower respiratory tract infection,10
RANITIDINE,Bone density decreased,10
RANITIDINE,Cellulitis,10
RANITIDINE,Dyspepsia,10
RANITIDINE,Abdominal pain upper,10
RANITIDINE,Back pain,9
RANITIDINE,Fall,9
RANITIDINE,Affective disorder,9
RANITIDINE,Neutrophil count increased,9
RANITIDINE,Schizophrenia,9
RANITIDINE,Overdose,9
RANITIDINE,Seizure,9
REBAMIPIDE,Interstitial lung disease,11
REBAMIPIDE,Nausea,8
REBAMIPIDE,Hypertension,7
REBAMIPIDE,Herpes zoster,6
REBAMIPIDE,Dyspnoea,6
REBAMIPIDE,Headache,5
REBAMIPIDE,Liver disorder,5
REBAMIPIDE,Diarrhoea,5
REBAMIPIDE,Pneumonia,5
REBAMIPIDE,Disease progression,4
REBAMIPIDE,White blood cell count decreased,4
REBAMIPIDE,Death,4
REBAMIPIDE,Drug-induced liver injury,4
REBAMIPIDE,Oedema peripheral,4
REBAMIPIDE,Acute kidney injury,4
REBAMIPIDE,Pyrexia,4
REBAMIPIDE,Blood creatine phosphokinase increased,4
REBAMIPIDE,Off label use,3
REBAMIPIDE,Platelet count decreased,3
REBAMIPIDE,Febrile neutropenia,3
REBAMIPIDE,Malaise,3
REBAMIPIDE,Altered state of consciousness,3
REBAMIPIDE,Anaemia,3
REBAMIPIDE,Maternal exposure during pregnancy,3
REBAMIPIDE,Fall,3
REBAMIPIDE,Cardiac failure,3
REBAMIPIDE,Dizziness,3
REBAMIPIDE,Suicide attempt,3
REBAMIPIDE,Septic shock,3
REBAMIPIDE,Abdominal discomfort,3
REBAMIPIDE,Hepatic function abnormal,2
REBAMIPIDE,Chest pain,2
REBAMIPIDE,Arthralgia,2
REBAMIPIDE,Fulminant type 1 diabetes mellitus,2
REBAMIPIDE,Decubitus ulcer,2
REBAMIPIDE,Gastrointestinal haemorrhage,2
REBAMIPIDE,Meningitis bacterial,2
REBAMIPIDE,Faeces discoloured,2
REBAMIPIDE,Diverticulum intestinal haemorrhagic,2
REBAMIPIDE,Hypercholesterolaemia,2
REBAMIPIDE,Diabetes mellitus,2
REBAMIPIDE,Breast cancer,2
REBAMIPIDE,Lymphocyte count decreased,2
REBAMIPIDE,Aspartate aminotransferase increased,2
REBAMIPIDE,Alanine aminotransferase increased,2
REBAMIPIDE,Tumour haemorrhage,2
REBAMIPIDE,Cough,2
REBAMIPIDE,Apgar score low,2
REBAMIPIDE,Low birth weight baby,2
REBAMIPIDE,Premature baby,2
REMICADE,Off label use,201
REMICADE,Crohn's disease,66
REMICADE,COVID-19,51
REMICADE,Infusion related reaction,47
REMICADE,Drug ineffective,42
REMICADE,Diarrhoea,42
REMICADE,Colitis ulcerative,38
REMICADE,Abdominal pain,37
REMICADE,Pain,27
REMICADE,Nausea,27
REMICADE,Haematochezia,27
REMICADE,Inappropriate schedule of product administration,26
REMICADE,Dyspnoea,25
REMICADE,Weight decreased,25
REMICADE,Fatigue,23
REMICADE,Rash,23
REMICADE,Arthralgia,23
REMICADE,Product use issue,23
REMICADE,Frequent bowel movements,23
REMICADE,Malaise,21
REMICADE,Rheumatoid arthritis,20
REMICADE,Nasopharyngitis,20
REMICADE,Vomiting,20
REMICADE,Pneumonia,19
REMICADE,Product dose omission issue,19
REMICADE,Weight increased,17
REMICADE,Pain in extremity,17
REMICADE,Drug level decreased,17
REMICADE,Peripheral swelling,16
REMICADE,Drug hypersensitivity,16
REMICADE,Exposure during pregnancy,16
REMICADE,Asthenia,15
REMICADE,Hypersensitivity,15
REMICADE,General physical health deterioration,15
REMICADE,Influenza,15
REMICADE,Therapeutic product effect decreased,14
REMICADE,Headache,14
REMICADE,Treatment failure,14
REMICADE,Nephrolithiasis,14
REMICADE,Inflammation,13
REMICADE,Drug intolerance,13
REMICADE,Musculoskeletal stiffness,13
REMICADE,Dizziness,13
REMICADE,Infection,13
REMICADE,Condition aggravated,13
REMICADE,Urinary tract infection,13
REMICADE,Constipation,13
REMICADE,Alopecia,12
REMICADE,Joint swelling,12
REMICADE,Intestinal resection,12
REMODULIN,Dyspnoea,89
REMODULIN,Infusion site pain,88
REMODULIN,Headache,74
REMODULIN,Nausea,68
REMODULIN,Diarrhoea,67
REMODULIN,Infusion site erythema,53
REMODULIN,Vomiting,45
REMODULIN,Device failure,45
REMODULIN,Fatigue,38
REMODULIN,Hypotension,31
REMODULIN,Pain in extremity,30
REMODULIN,Weight decreased,30
REMODULIN,Pneumonia,29
REMODULIN,Dizziness,28
REMODULIN,Pain,27
REMODULIN,Device dislocation,27
REMODULIN,Malaise,26
REMODULIN,Oxygen saturation decreased,26
REMODULIN,Infusion site swelling,25
REMODULIN,Infusion site haemorrhage,24
REMODULIN,Peripheral swelling,24
REMODULIN,Device leakage,23
REMODULIN,Chest pain,22
REMODULIN,Fluid retention,22
REMODULIN,Device malfunction,21
REMODULIN,Pain in jaw,21
REMODULIN,Infusion site infection,21
REMODULIN,Death,20
REMODULIN,Device infusion issue,20
REMODULIN,Fall,19
REMODULIN,Oedema peripheral,19
REMODULIN,Pulmonary arterial hypertension,18
REMODULIN,Decreased appetite,18
REMODULIN,Injection site erythema,17
REMODULIN,Chest discomfort,17
REMODULIN,Feeling abnormal,16
REMODULIN,Cough,16
REMODULIN,Pulmonary hypertension,16
REMODULIN,Asthenia,16
REMODULIN,Palpitations,15
REMODULIN,Nasopharyngitis,15
REMODULIN,Dyspnoea exertional,15
REMODULIN,Illness,14
REMODULIN,Flushing,14
REMODULIN,Device issue,14
REMODULIN,Arthralgia,14
REMODULIN,Therapy non-responder,14
REMODULIN,Vascular device infection,13
REMODULIN,Weight increased,13
REMODULIN,Device wireless communication issue,13
REPAGLINIDE,Septic shock,11
REPAGLINIDE,Hypocalcaemia,10
REPAGLINIDE,Candida infection,7
REPAGLINIDE,Multiple organ dysfunction syndrome,7
REPAGLINIDE,Hypoglycaemia,7
REPAGLINIDE,Hypotension,6
REPAGLINIDE,Off label use,6
REPAGLINIDE,Hypomagnesaemia,5
REPAGLINIDE,Muscle spasms,5
REPAGLINIDE,Xerosis,5
REPAGLINIDE,Electrocardiogram QT prolonged,5
REPAGLINIDE,Malaise,4
REPAGLINIDE,Confusional state,4
REPAGLINIDE,Heart transplant rejection,4
REPAGLINIDE,General physical health deterioration,4
REPAGLINIDE,Enterobacter bacteraemia,4
REPAGLINIDE,Proteus infection,4
REPAGLINIDE,Fungaemia,4
REPAGLINIDE,Chronic kidney disease,4
REPAGLINIDE,Drug ineffective for unapproved indication,4
REPAGLINIDE,Neuropathy peripheral,4
REPAGLINIDE,Malnutrition,4
REPAGLINIDE,Respiratory disorder,4
REPAGLINIDE,Cytomegalovirus infection,4
REPAGLINIDE,Localised infection,4
REPAGLINIDE,Cardiogenic shock,4
REPAGLINIDE,Pneumonia respiratory syncytial viral,4
REPAGLINIDE,Febrile bone marrow aplasia,4
REPAGLINIDE,Product use in unapproved indication,4
REPAGLINIDE,Altered state of consciousness,4
REPAGLINIDE,Fatigue,3
REPAGLINIDE,Pyrexia,3
REPAGLINIDE,Rash,3
REPAGLINIDE,Bone marrow failure,3
REPAGLINIDE,Staphylococcal infection,3
REPAGLINIDE,Klebsiella infection,3
REPAGLINIDE,Generalised tonic-clonic seizure,3
REPAGLINIDE,Accidental overdose,3
REPAGLINIDE,Incorrect dosage administered,3
REPAGLINIDE,Arthralgia,2
REPAGLINIDE,Pneumonia,2
REPAGLINIDE,Asthma,2
REPAGLINIDE,C-reactive protein increased,2
REPAGLINIDE,Urinary tract infection,2
REPAGLINIDE,Diarrhoea,2
REPAGLINIDE,Aspartate aminotransferase increased,2
REPAGLINIDE,Alanine aminotransferase increased,2
REPAGLINIDE,Decreased appetite,2
REPAGLINIDE,Chest discomfort,2
REPAGLINIDE,Hypothyroidism,2
REPATHA,Device difficult to use,71
REPATHA,Drug dose omission by device,47
REPATHA,Accidental exposure to product,31
REPATHA,Wrong technique in product usage process,31
REPATHA,Incorrect dose administered by device,13
REPATHA,Off label use,9
REPATHA,Fatigue,8
REPATHA,Pruritus,7
REPATHA,Device use error,7
REPATHA,Injection site pain,6
REPATHA,Product dose omission issue,5
REPATHA,Dyspnoea,5
REPATHA,Fall,5
REPATHA,COVID-19,5
REPATHA,Diarrhoea,5
REPATHA,Product communication issue,5
REPATHA,Pain in extremity,5
REPATHA,Pain,4
REPATHA,Inappropriate schedule of product administration,4
REPATHA,Nausea,4
REPATHA,Injection site swelling,4
REPATHA,Asthenia,4
REPATHA,Tremor,4
REPATHA,Intercepted product administration error,4
REPATHA,Product storage error,4
REPATHA,Hypertension,4
REPATHA,Back pain,3
REPATHA,Nasopharyngitis,3
REPATHA,Peripheral swelling,3
REPATHA,Rash,3
REPATHA,Weight decreased,3
REPATHA,Blood pressure increased,3
REPATHA,Anxiety,3
REPATHA,Muscle spasms,3
REPATHA,Limb discomfort,3
REPATHA,Dizziness,3
REPATHA,Incorrect dose administered,3
REPATHA,Skin exfoliation,3
REPATHA,Drug hypersensitivity,2
REPATHA,Heart rate increased,2
REPATHA,Brain fog,2
REPATHA,Rash erythematous,2
REPATHA,Contusion,2
REPATHA,Urticaria,2
REPATHA,Arthritis,2
REPATHA,Injection site extravasation,2
REPATHA,Post procedural swelling,2
REPATHA,Pulmonary embolism,2
REPATHA,Actinic keratosis,2
REPATHA,Post herpetic neuralgia,2
RESTASIS,Eye irritation,21
RESTASIS,Headache,11
RESTASIS,Drug ineffective,11
RESTASIS,COVID-19,10
RESTASIS,Product dose omission issue,10
RESTASIS,Vision blurred,10
RESTASIS,Eye pain,10
RESTASIS,Ocular hyperaemia,9
RESTASIS,Malaise,8
RESTASIS,Fatigue,7
RESTASIS,Fall,6
RESTASIS,Hypersensitivity,6
RESTASIS,Weight increased,6
RESTASIS,Sinusitis,6
RESTASIS,Dyspnoea,6
RESTASIS,Off label use,6
RESTASIS,Visual impairment,6
RESTASIS,Pruritus,6
RESTASIS,Urinary tract infection,5
RESTASIS,Pain,5
RESTASIS,Blood pressure increased,5
RESTASIS,Weight decreased,5
RESTASIS,Dry eye,5
RESTASIS,Limb injury,4
RESTASIS,Infection,4
RESTASIS,Abdominal pain upper,4
RESTASIS,Product storage error,4
RESTASIS,Pneumonia,4
RESTASIS,Burning sensation,4
RESTASIS,Dizziness,4
RESTASIS,Arthritis,4
RESTASIS,Migraine,4
RESTASIS,Inappropriate schedule of product administration,4
RESTASIS,Discomfort,4
RESTASIS,Nausea,4
RESTASIS,Diarrhoea,4
RESTASIS,Photophobia,4
RESTASIS,Respiratory tract infection,3
RESTASIS,Back pain,3
RESTASIS,Arthropathy,3
RESTASIS,Depression,3
RESTASIS,Asthenia,3
RESTASIS,Skin laceration,3
RESTASIS,Incorrect dose administered,3
RESTASIS,Muscle spasms,3
RESTASIS,Eye infection,3
RESTASIS,Vomiting,3
RESTASIS,Condition aggravated,3
RESTASIS,Pain in extremity,3
RESTASIS,Blister,3
REVATIO,Headache,20
REVATIO,Dyspnoea,17
REVATIO,Diarrhoea,14
REVATIO,Nausea,14
REVATIO,Fatigue,9
REVATIO,Arthralgia,9
REVATIO,Pain,9
REVATIO,Malaise,8
REVATIO,Oxygen saturation decreased,7
REVATIO,Hypotension,6
REVATIO,Urinary tract infection,6
REVATIO,Anaemia,6
REVATIO,Pyrexia,6
REVATIO,Chest pain,5
REVATIO,Off label use,5
REVATIO,Pulmonary arterial hypertension,5
REVATIO,Oral candidiasis,5
REVATIO,Rash,5
REVATIO,Cough,5
REVATIO,Dizziness,5
REVATIO,Palpitations,4
REVATIO,Device occlusion,4
REVATIO,Product dose omission issue,4
REVATIO,Gallbladder enlargement,4
REVATIO,Limb discomfort,4
REVATIO,Cardiothoracic ratio increased,4
REVATIO,Pain in jaw,4
REVATIO,Product administration interrupted,4
REVATIO,Device breakage,4
REVATIO,Infusion site pain,4
REVATIO,Pneumonia,4
REVATIO,Vomiting,4
REVATIO,Spinal fracture,4
REVATIO,Hypokalaemia,4
REVATIO,Weight decreased,4
REVATIO,Sinusitis,3
REVATIO,Dyspnoea exertional,3
REVATIO,Gastrointestinal haemorrhage,3
REVATIO,Catheter site erythema,3
REVATIO,Cardiac failure congestive,3
REVATIO,Tachycardia,3
REVATIO,Cardiac failure,3
REVATIO,Oropharyngeal pain,3
REVATIO,Abdominal discomfort,3
REVATIO,Decreased appetite,3
REVATIO,Feeling abnormal,3
REVATIO,Drug hypersensitivity,3
REVATIO,Systemic lupus erythematosus,3
REVATIO,Pancytopenia,3
REVATIO,General physical health deterioration,3
REVLIMID,Off label use,188
REVLIMID,Diarrhoea,105
REVLIMID,Fatigue,79
REVLIMID,Rash,63
REVLIMID,Pruritus,42
REVLIMID,Death,40
REVLIMID,Nausea,35
REVLIMID,Platelet count decreased,33
REVLIMID,Constipation,32
REVLIMID,Neuropathy peripheral,32
REVLIMID,White blood cell count decreased,32
REVLIMID,Pneumonia,31
REVLIMID,Vomiting,28
REVLIMID,Peripheral swelling,27
REVLIMID,Haemoglobin decreased,26
REVLIMID,COVID-19,25
REVLIMID,Neutropenia,25
REVLIMID,Anaemia,23
REVLIMID,Product dose omission issue,23
REVLIMID,Decreased appetite,23
REVLIMID,Asthenia,23
REVLIMID,Arthralgia,22
REVLIMID,Back pain,21
REVLIMID,Dizziness,20
REVLIMID,Plasma cell myeloma,19
REVLIMID,Muscle spasms,18
REVLIMID,Abdominal discomfort,18
REVLIMID,Dyspnoea,18
REVLIMID,Weight decreased,18
REVLIMID,Fall,18
REVLIMID,Blood potassium decreased,17
REVLIMID,Cough,16
REVLIMID,Abdominal pain upper,16
REVLIMID,Thrombosis,15
REVLIMID,Thrombocytopenia,15
REVLIMID,Tremor,14
REVLIMID,Pain,14
REVLIMID,Laboratory test abnormal,14
REVLIMID,Nasopharyngitis,14
REVLIMID,Malaise,13
REVLIMID,Insomnia,13
REVLIMID,Drug ineffective,13
REVLIMID,Oedema peripheral,12
REVLIMID,Influenza,12
REVLIMID,Urticaria,12
REVLIMID,Full blood count decreased,11
REVLIMID,Memory impairment,11
REVLIMID,Urinary tract infection,11
REVLIMID,Contusion,10
REVLIMID,Red blood cell count decreased,10
REYATAZ,Pain,73
REYATAZ,Emotional distress,72
REYATAZ,Anxiety,69
REYATAZ,Anhedonia,68
REYATAZ,Chronic kidney disease,43
REYATAZ,Osteoporosis,33
REYATAZ,Renal failure,24
REYATAZ,Osteopenia,22
REYATAZ,Depression,22
REYATAZ,Bone demineralisation,21
REYATAZ,Bone density decreased,18
REYATAZ,Multiple fractures,14
REYATAZ,Renal impairment,14
REYATAZ,Blood creatinine increased,13
REYATAZ,Economic problem,12
REYATAZ,Acute kidney injury,12
REYATAZ,Asthenia,12
REYATAZ,Fatigue,10
REYATAZ,Gait disturbance,8
REYATAZ,Bone loss,7
REYATAZ,Back pain,7
REYATAZ,Proteinuria,7
REYATAZ,Insomnia,7
REYATAZ,End stage renal disease,6
REYATAZ,Renal injury,6
REYATAZ,Hip fracture,5
REYATAZ,Anaemia,5
REYATAZ,Fracture,4
REYATAZ,Osteonecrosis,4
REYATAZ,Tooth loss,4
REYATAZ,Loss of personal independence in daily activities,4
REYATAZ,Nephropathy,4
REYATAZ,Ankle fracture,4
REYATAZ,Pollakiuria,4
REYATAZ,Hypertension,4
REYATAZ,Wrist fracture,4
REYATAZ,Quality of life decreased,3
REYATAZ,Skeletal injury,3
REYATAZ,Decreased activity,3
REYATAZ,Nephrolithiasis,3
REYATAZ,Chronic kidney disease-mineral and bone disorder,3
REYATAZ,Pathological fracture,3
REYATAZ,Vitamin D deficiency,3
REYATAZ,Fanconi syndrome acquired,3
REYATAZ,Osteoarthritis,2
REYATAZ,Rib fracture,2
REYATAZ,Mobility decreased,2
REYATAZ,Fall,2
REYATAZ,Foot fracture,2
REYATAZ,Arthralgia,2
RIFAMPIN,Atrial fibrillation,7
RIFAMPIN,Off label use,7
RIFAMPIN,Asthenia,6
RIFAMPIN,Tachycardia,6
RIFAMPIN,Product use in unapproved indication,6
RIFAMPIN,Cough,6
RIFAMPIN,Decreased appetite,6
RIFAMPIN,Hepatic cytolysis,6
RIFAMPIN,Depression,5
RIFAMPIN,Arthralgia,5
RIFAMPIN,Blood creatine phosphokinase increased,4
RIFAMPIN,Heart rate irregular,4
RIFAMPIN,Infection,4
RIFAMPIN,Disease progression,4
RIFAMPIN,Drug reaction with eosinophilia and systemic symptoms,4
RIFAMPIN,Pneumonia,4
RIFAMPIN,Neuroleptic malignant syndrome,4
RIFAMPIN,Weight decreased,4
RIFAMPIN,Vascular purpura,4
RIFAMPIN,Alanine aminotransferase increased,4
RIFAMPIN,Mania,4
RIFAMPIN,Pain in extremity,3
RIFAMPIN,Insomnia,3
RIFAMPIN,Fatigue,3
RIFAMPIN,Abdominal pain upper,3
RIFAMPIN,Product used for unknown indication,3
RIFAMPIN,Anxiety,3
RIFAMPIN,Pain,3
RIFAMPIN,Headache,3
RIFAMPIN,Influenza,3
RIFAMPIN,Gait disturbance,3
RIFAMPIN,Nausea,3
RIFAMPIN,Dyspnoea,3
RIFAMPIN,Drug interaction,3
RIFAMPIN,Aspartate aminotransferase increased,3
RIFAMPIN,Haemophagocytic lymphohistiocytosis,3
RIFAMPIN,Vomiting,2
RIFAMPIN,Visual impairment,2
RIFAMPIN,Abdominal pain,2
RIFAMPIN,Back pain,2
RIFAMPIN,Hyperhidrosis,2
RIFAMPIN,Haemorrhoids,2
RIFAMPIN,Hepatitis C,2
RIFAMPIN,Crying,2
RIFAMPIN,Therapeutic product effect incomplete,2
RIFAMPIN,Dysstasia,2
RIFAMPIN,Discouragement,2
RIFAMPIN,Nerve injury,2
RIFAMPIN,Tremor,2
RIFAMPIN,Condition aggravated,2
RINVOQ,Arthralgia,35
RINVOQ,Pain,35
RINVOQ,COVID-19,26
RINVOQ,Fall,19
RINVOQ,Pain in extremity,17
RINVOQ,Fatigue,16
RINVOQ,Drug ineffective,16
RINVOQ,Rheumatoid arthritis,14
RINVOQ,Pneumonia,14
RINVOQ,Urinary tract infection,13
RINVOQ,Peripheral swelling,13
RINVOQ,Malaise,12
RINVOQ,Herpes zoster,12
RINVOQ,Osteoarthritis,11
RINVOQ,Musculoskeletal stiffness,11
RINVOQ,Arthritis,11
RINVOQ,Insomnia,10
RINVOQ,Interstitial lung disease,10
RINVOQ,Joint swelling,10
RINVOQ,Pruritus,10
RINVOQ,Therapeutic product effect incomplete,9
RINVOQ,Nausea,9
RINVOQ,Pyrexia,9
RINVOQ,Back pain,9
RINVOQ,Gait disturbance,9
RINVOQ,Mobility decreased,9
RINVOQ,Sinusitis,8
RINVOQ,Abdominal pain upper,8
RINVOQ,Headache,8
RINVOQ,Weight decreased,8
RINVOQ,Loss of personal independence in daily activities,8
RINVOQ,Joint range of motion decreased,8
RINVOQ,Diarrhoea,8
RINVOQ,Erythema,8
RINVOQ,Influenza,7
RINVOQ,Unevaluable event,7
RINVOQ,Dyspnoea,7
RINVOQ,Hypertension,7
RINVOQ,Dizziness,6
RINVOQ,Sepsis,6
RINVOQ,Vomiting,6
RINVOQ,Joint stiffness,6
RINVOQ,Swelling,6
RINVOQ,Haemoglobin decreased,6
RINVOQ,Upper respiratory tract infection,6
RINVOQ,Hypoaesthesia,6
RINVOQ,Blister,6
RINVOQ,Acne,6
RINVOQ,Gait inability,6
RINVOQ,Off label use,6
RISPERDAL,Off label use,13
RISPERDAL,Fatigue,12
RISPERDAL,Seizure,11
RISPERDAL,Gynaecomastia,10
RISPERDAL,Alopecia,10
RISPERDAL,Schizophrenia,10
RISPERDAL,Incorrect dose administered,10
RISPERDAL,COVID-19,10
RISPERDAL,Neutropenia,10
RISPERDAL,Affective disorder,9
RISPERDAL,Leukopenia,9
RISPERDAL,Neutrophil count increased,9
RISPERDAL,Platelet count decreased,9
RISPERDAL,Neuropathy peripheral,9
RISPERDAL,Cellulitis,9
RISPERDAL,Diarrhoea,9
RISPERDAL,Dyspepsia,9
RISPERDAL,Overdose,9
RISPERDAL,Psychotic disorder,9
RISPERDAL,Mucosal inflammation,9
RISPERDAL,Lymphocyte count decreased,9
RISPERDAL,"Hallucination, auditory",9
RISPERDAL,Extrapyramidal disorder,9
RISPERDAL,Delusion of grandeur,9
RISPERDAL,Nausea,9
RISPERDAL,Disease progression,8
RISPERDAL,Rhinalgia,8
RISPERDAL,Obesity,7
RISPERDAL,Lymphocyte count abnormal,7
RISPERDAL,Depression,6
RISPERDAL,Weight increased,6
RISPERDAL,SARS-CoV-2 test positive,6
RISPERDAL,Hepatic cytolysis,6
RISPERDAL,Cholestasis,6
RISPERDAL,Hospitalisation,5
RISPERDAL,Anxiety,5
RISPERDAL,Cardiac disorder,4
RISPERDAL,Neoplasm progression,4
RISPERDAL,Tremor,4
RISPERDAL,Somnolence,4
RISPERDAL,Erectile dysfunction,4
RISPERDAL,Emotional disorder,3
RISPERDAL,Lung disorder,3
RISPERDAL,Blood oestrogen increased,3
RISPERDAL,Hypometabolism,3
RISPERDAL,Blood testosterone decreased,3
RISPERDAL,Dental caries,3
RISPERDAL,Blood testosterone abnormal,3
RISPERDAL,Hypoaesthesia,3
RISPERDAL,Fall,3
RISPERIDONE,Anxiety,17
RISPERIDONE,COVID-19,14
RISPERIDONE,Fatigue,14
RISPERIDONE,Somnolence,14
RISPERIDONE,Depression,13
RISPERIDONE,Diarrhoea,13
RISPERIDONE,Off label use,13
RISPERIDONE,Gynaecomastia,10
RISPERIDONE,Headache,10
RISPERIDONE,Weight increased,10
RISPERIDONE,Medication error,10
RISPERIDONE,Incorrect dose administered,9
RISPERIDONE,Sedation,9
RISPERIDONE,Nausea,8
RISPERIDONE,Pain,8
RISPERIDONE,Leukopenia,8
RISPERIDONE,Seizure,8
RISPERIDONE,Pyrexia,8
RISPERIDONE,Wrong patient received product,8
RISPERIDONE,Hypoxia,8
RISPERIDONE,Hypothermia,8
RISPERIDONE,Hypoglycaemia,8
RISPERIDONE,Emotional distress,7
RISPERIDONE,"Hallucination, auditory",7
RISPERIDONE,Dyspnoea,7
RISPERIDONE,Abnormal weight gain,6
RISPERIDONE,Alopecia,6
RISPERIDONE,Vomiting,6
RISPERIDONE,Anhedonia,6
RISPERIDONE,Platelet count decreased,6
RISPERIDONE,Schizophrenia,6
RISPERIDONE,Dyspepsia,6
RISPERIDONE,Overdose,6
RISPERIDONE,Psychotic disorder,6
RISPERIDONE,Extrapyramidal disorder,6
RISPERIDONE,Dry mouth,6
RISPERIDONE,Suicidal ideation,6
RISPERIDONE,Inappropriate schedule of product administration,6
RISPERIDONE,Product dose omission issue,6
RISPERIDONE,Gastrointestinal necrosis,6
RISPERIDONE,Drug interaction,6
RISPERIDONE,Megacolon,6
RISPERIDONE,Infusion related reaction,5
RISPERIDONE,Obesity,5
RISPERIDONE,Affective disorder,5
RISPERIDONE,Neutrophil count increased,5
RISPERIDONE,Neuropathy peripheral,5
RISPERIDONE,Cellulitis,5
RISPERIDONE,Mucosal inflammation,5
RISPERIDONE,Lymphocyte count decreased,5
RITUXIMAB,Off label use,62
RITUXIMAB,Neutropenia,55
RITUXIMAB,Febrile neutropenia,44
RITUXIMAB,Pyrexia,41
RITUXIMAB,Diarrhoea,39
RITUXIMAB,Pneumonia,38
RITUXIMAB,Anaemia,34
RITUXIMAB,Thrombocytopenia,33
RITUXIMAB,COVID-19,27
RITUXIMAB,Agranulocytosis,26
RITUXIMAB,Asthenia,25
RITUXIMAB,Rash,25
RITUXIMAB,Neutrophil count decreased,25
RITUXIMAB,Arthralgia,24
RITUXIMAB,Nausea,23
RITUXIMAB,Platelet count decreased,23
RITUXIMAB,Disease progression,22
RITUXIMAB,Fatigue,21
RITUXIMAB,Drug ineffective,21
RITUXIMAB,Cytokine release syndrome,21
RITUXIMAB,Sepsis,21
RITUXIMAB,C-reactive protein increased,19
RITUXIMAB,Dyspnoea,18
RITUXIMAB,White blood cell count decreased,17
RITUXIMAB,Septic shock,17
RITUXIMAB,Hypertension,16
RITUXIMAB,Headache,16
RITUXIMAB,General physical health deterioration,16
RITUXIMAB,Myelosuppression,16
RITUXIMAB,Acute kidney injury,16
RITUXIMAB,Infection,15
RITUXIMAB,Drug hypersensitivity,15
RITUXIMAB,Abdominal pain,15
RITUXIMAB,Product use issue,15
RITUXIMAB,Pancytopenia,15
RITUXIMAB,Weight decreased,14
RITUXIMAB,Decreased appetite,14
RITUXIMAB,Vomiting,14
RITUXIMAB,Condition aggravated,14
RITUXIMAB,Hepatic enzyme increased,13
RITUXIMAB,Therapeutic product effect decreased,13
RITUXIMAB,Drug intolerance,13
RITUXIMAB,Malaise,13
RITUXIMAB,Product use in unapproved indication,13
RITUXIMAB,Tumour lysis syndrome,13
RITUXIMAB,Blood lactate dehydrogenase increased,13
RITUXIMAB,Leukopenia,13
RITUXIMAB,Hepatic cytolysis,13
RITUXIMAB,Infusion related reaction,12
RITUXIMAB,Death,12
RIVAROXABAN,Off label use,12
RIVAROXABAN,Pneumonia,8
RIVAROXABAN,Vomiting,8
RIVAROXABAN,Abdominal pain,7
RIVAROXABAN,Malaise,7
RIVAROXABAN,Dyspnoea,7
RIVAROXABAN,Nausea,6
RIVAROXABAN,Mania,6
RIVAROXABAN,General physical health deterioration,6
RIVAROXABAN,Dizziness,5
RIVAROXABAN,Hypertension,5
RIVAROXABAN,Diarrhoea,5
RIVAROXABAN,Weight increased,5
RIVAROXABAN,Pain,5
RIVAROXABAN,Pyrexia,5
RIVAROXABAN,Decreased appetite,5
RIVAROXABAN,Pneumonia aspiration,5
RIVAROXABAN,Anaemia,5
RIVAROXABAN,Fatigue,5
RIVAROXABAN,Hypotension,5
RIVAROXABAN,Dehydration,4
RIVAROXABAN,Intentional product use issue,4
RIVAROXABAN,COVID-19,4
RIVAROXABAN,Neuropathy peripheral,4
RIVAROXABAN,Atrial fibrillation,4
RIVAROXABAN,Depression,4
RIVAROXABAN,Palpitations,4
RIVAROXABAN,Rash,4
RIVAROXABAN,Tendon rupture,4
RIVAROXABAN,Intraventricular haemorrhage,4
RIVAROXABAN,Cerebral haemorrhage,4
RIVAROXABAN,Disturbance in attention,4
RIVAROXABAN,Hypoglycaemia,4
RIVAROXABAN,Blood pressure decreased,3
RIVAROXABAN,Pulmonary embolism,3
RIVAROXABAN,Weight decreased,3
RIVAROXABAN,Arthralgia,3
RIVAROXABAN,Product dose omission issue,3
RIVAROXABAN,Respiratory failure,3
RIVAROXABAN,Nephrolithiasis,3
RIVAROXABAN,Dysphagia,3
RIVAROXABAN,Abdominal pain upper,3
RIVAROXABAN,Cardiac failure,3
RIVAROXABAN,Haematemesis,3
RIVAROXABAN,Prothrombin time prolonged,3
RIVAROXABAN,Administration related reaction,3
RIVAROXABAN,Febrile neutropenia,3
RIVAROXABAN,Medication error,3
RIVAROXABAN,Pruritus,3
RIVAROXABAN,Burning sensation,3
ROSUVASTATIN,Pain,44
ROSUVASTATIN,COVID-19,38
ROSUVASTATIN,Fatigue,37
ROSUVASTATIN,Anxiety,32
ROSUVASTATIN,Off label use,32
ROSUVASTATIN,Asthenia,31
ROSUVASTATIN,Dizziness,31
ROSUVASTATIN,Arthralgia,30
ROSUVASTATIN,Myalgia,30
ROSUVASTATIN,Nausea,28
ROSUVASTATIN,Diarrhoea,27
ROSUVASTATIN,Emotional distress,25
ROSUVASTATIN,Chronic kidney disease,25
ROSUVASTATIN,Anhedonia,24
ROSUVASTATIN,Acute kidney injury,24
ROSUVASTATIN,Vomiting,21
ROSUVASTATIN,Drug ineffective,21
ROSUVASTATIN,Pruritus,20
ROSUVASTATIN,Joint swelling,19
ROSUVASTATIN,Rash,19
ROSUVASTATIN,Weight decreased,18
ROSUVASTATIN,Back pain,18
ROSUVASTATIN,Dyspnoea,18
ROSUVASTATIN,Malaise,17
ROSUVASTATIN,Hypotension,17
ROSUVASTATIN,Oedema peripheral,17
ROSUVASTATIN,Product dose omission issue,16
ROSUVASTATIN,Pyrexia,15
ROSUVASTATIN,Pneumonia,15
ROSUVASTATIN,Fall,14
ROSUVASTATIN,Depression,14
ROSUVASTATIN,Condition aggravated,14
ROSUVASTATIN,Gait disturbance,14
ROSUVASTATIN,Syncope,14
ROSUVASTATIN,Acute myocardial infarction,14
ROSUVASTATIN,Cardiac failure,13
ROSUVASTATIN,Osteoporosis,13
ROSUVASTATIN,Blood creatinine increased,13
ROSUVASTATIN,Intentional product use issue,13
ROSUVASTATIN,Weight increased,13
ROSUVASTATIN,Disease recurrence,13
ROSUVASTATIN,Pain in extremity,12
ROSUVASTATIN,Headache,12
ROSUVASTATIN,Osteopenia,12
ROSUVASTATIN,Drug interaction,12
ROSUVASTATIN,Sinusitis,12
ROSUVASTATIN,Intestinal obstruction,12
ROSUVASTATIN,Diastolic dysfunction,12
ROSUVASTATIN,Palpitations,12
ROSUVASTATIN,Hyperlipidaemia,12
ROSUVASTATIN CALCIUM,Sinusitis,25
ROSUVASTATIN CALCIUM,Product dose omission issue,22
ROSUVASTATIN CALCIUM,Diarrhoea,19
ROSUVASTATIN CALCIUM,Pneumonia,18
ROSUVASTATIN CALCIUM,Fatigue,17
ROSUVASTATIN CALCIUM,Arthralgia,15
ROSUVASTATIN CALCIUM,Headache,15
ROSUVASTATIN CALCIUM,Vomiting,14
ROSUVASTATIN CALCIUM,Pruritus,14
ROSUVASTATIN CALCIUM,Bronchitis,13
ROSUVASTATIN CALCIUM,Pain,13
ROSUVASTATIN CALCIUM,Nausea,13
ROSUVASTATIN CALCIUM,Illness,13
ROSUVASTATIN CALCIUM,Weight increased,12
ROSUVASTATIN CALCIUM,Rash,12
ROSUVASTATIN CALCIUM,Dyspnoea,12
ROSUVASTATIN CALCIUM,Pyrexia,12
ROSUVASTATIN CALCIUM,Malaise,12
ROSUVASTATIN CALCIUM,COVID-19,12
ROSUVASTATIN CALCIUM,Decreased appetite,12
ROSUVASTATIN CALCIUM,Dizziness,11
ROSUVASTATIN CALCIUM,Asthenia,11
ROSUVASTATIN CALCIUM,Pain in extremity,10
ROSUVASTATIN CALCIUM,Off label use,10
ROSUVASTATIN CALCIUM,Upper respiratory tract infection,10
ROSUVASTATIN CALCIUM,Cough,10
ROSUVASTATIN CALCIUM,Infection,9
ROSUVASTATIN CALCIUM,Condition aggravated,9
ROSUVASTATIN CALCIUM,Blood pressure increased,8
ROSUVASTATIN CALCIUM,Urinary tract infection,8
ROSUVASTATIN CALCIUM,Fall,8
ROSUVASTATIN CALCIUM,Interstitial lung disease,8
ROSUVASTATIN CALCIUM,Myalgia,8
ROSUVASTATIN CALCIUM,Inappropriate schedule of product administration,7
ROSUVASTATIN CALCIUM,Anxiety,7
ROSUVASTATIN CALCIUM,Abdominal pain upper,7
ROSUVASTATIN CALCIUM,Hypersensitivity,7
ROSUVASTATIN CALCIUM,Drug ineffective,6
ROSUVASTATIN CALCIUM,Multiple allergies,6
ROSUVASTATIN CALCIUM,Joint swelling,6
ROSUVASTATIN CALCIUM,Nasopharyngitis,6
ROSUVASTATIN CALCIUM,Respiratory tract infection,6
ROSUVASTATIN CALCIUM,Gastroenteritis viral,6
ROSUVASTATIN CALCIUM,Eye infection,6
ROSUVASTATIN CALCIUM,Muscular weakness,6
ROSUVASTATIN CALCIUM,Neuropathy peripheral,6
ROSUVASTATIN CALCIUM,Migraine,6
ROSUVASTATIN CALCIUM,Hepatic function abnormal,6
ROSUVASTATIN CALCIUM,Feeling abnormal,6
ROSUVASTATIN CALCIUM,Chest pain,6
RUXIENCE,Off label use,193
RUXIENCE,Intentional product use issue,99
RUXIENCE,COVID-19,43
RUXIENCE,Condition aggravated,42
RUXIENCE,Malaise,36
RUXIENCE,Inappropriate schedule of product administration,32
RUXIENCE,Blood pressure fluctuation,31
RUXIENCE,Fatigue,30
RUXIENCE,Dyspnoea,28
RUXIENCE,Product use issue,27
RUXIENCE,Pruritus,26
RUXIENCE,Throat irritation,24
RUXIENCE,Pain,24
RUXIENCE,Headache,22
RUXIENCE,Nausea,22
RUXIENCE,Cough,21
RUXIENCE,Weight increased,21
RUXIENCE,Blood pressure increased,20
RUXIENCE,Erythema,19
RUXIENCE,Arthralgia,19
RUXIENCE,Hypertension,19
RUXIENCE,Weight decreased,18
RUXIENCE,Rash,17
RUXIENCE,Heart rate increased,15
RUXIENCE,Asthenia,15
RUXIENCE,Oxygen saturation decreased,15
RUXIENCE,Fall,14
RUXIENCE,Ear pruritus,14
RUXIENCE,Anxiety,13
RUXIENCE,Drug ineffective,13
RUXIENCE,Pneumonia,13
RUXIENCE,Nasopharyngitis,12
RUXIENCE,Dizziness,11
RUXIENCE,Rheumatoid arthritis,11
RUXIENCE,Blood pressure systolic increased,11
RUXIENCE,Oropharyngeal pain,11
RUXIENCE,C-reactive protein increased,10
RUXIENCE,Illness,10
RUXIENCE,Pain in extremity,10
RUXIENCE,Throat tightness,9
RUXIENCE,Therapeutic product effect incomplete,9
RUXIENCE,Gait disturbance,9
RUXIENCE,Nasal congestion,9
RUXIENCE,Loss of personal independence in daily activities,9
RUXIENCE,Diarrhoea,9
RUXIENCE,Renal disorder,8
RUXIENCE,Back pain,8
RUXIENCE,Poor venous access,8
RUXIENCE,Chills,8
RUXIENCE,Pyrexia,8
RUXOLITINIB,Febrile neutropenia,17
RUXOLITINIB,Haemoglobin decreased,9
RUXOLITINIB,Platelet count decreased,7
RUXOLITINIB,Sepsis,7
RUXOLITINIB,Inappropriate schedule of product administration,6
RUXOLITINIB,Pyrexia,6
RUXOLITINIB,Acute respiratory distress syndrome,6
RUXOLITINIB,Cough,6
RUXOLITINIB,Tachycardia,5
RUXOLITINIB,Acute kidney injury,5
RUXOLITINIB,Pneumocystis jirovecii pneumonia,5
RUXOLITINIB,White blood cell count decreased,5
RUXOLITINIB,Drug hypersensitivity,4
RUXOLITINIB,Dehydration,4
RUXOLITINIB,Vomiting,4
RUXOLITINIB,Death,4
RUXOLITINIB,Chest pain,4
RUXOLITINIB,Hypotension,4
RUXOLITINIB,Pulmonary arterial hypertension,4
RUXOLITINIB,Enterocolitis infectious,4
RUXOLITINIB,Lethargy,3
RUXOLITINIB,Platelet count increased,3
RUXOLITINIB,Asthenia,3
RUXOLITINIB,Feeling abnormal,3
RUXOLITINIB,Neutrophil count decreased,3
RUXOLITINIB,Malaise,3
RUXOLITINIB,Pain,3
RUXOLITINIB,Headache,3
RUXOLITINIB,Product use in unapproved indication,3
RUXOLITINIB,Pneumonia,3
RUXOLITINIB,Dyspnoea,3
RUXOLITINIB,Fatigue,3
RUXOLITINIB,Influenza,3
RUXOLITINIB,Diarrhoea,3
RUXOLITINIB,Pneumonia fungal,3
RUXOLITINIB,Parainfluenzae virus infection,3
RUXOLITINIB,Upper respiratory tract infection,3
RUXOLITINIB,Neutropenia,3
RUXOLITINIB,Nausea,3
RUXOLITINIB,Myalgia,3
RUXOLITINIB,Seizure,2
RUXOLITINIB,Abdominal pain,2
RUXOLITINIB,Hypoglycaemia,2
RUXOLITINIB,Decreased appetite,2
RUXOLITINIB,Stomatitis,2
RUXOLITINIB,Constipation,2
RUXOLITINIB,Red blood cell count decreased,2
RUXOLITINIB,Anaemia,2
RUXOLITINIB,General physical health deterioration,2
RUXOLITINIB,Polycythaemia vera,2
SACUBITRIL\VALSARTAN,Hypotension,30
SACUBITRIL\VALSARTAN,Product use in unapproved indication,14
SACUBITRIL\VALSARTAN,Inappropriate schedule of product administration,9
SACUBITRIL\VALSARTAN,Blood pressure decreased,9
SACUBITRIL\VALSARTAN,Dizziness,9
SACUBITRIL\VALSARTAN,Asthenia,8
SACUBITRIL\VALSARTAN,Hyperkalaemia,7
SACUBITRIL\VALSARTAN,Cough,7
SACUBITRIL\VALSARTAN,Prescribed underdose,6
SACUBITRIL\VALSARTAN,Ventricular tachycardia,5
SACUBITRIL\VALSARTAN,Cardiac failure,5
SACUBITRIL\VALSARTAN,Fatigue,4
SACUBITRIL\VALSARTAN,Acute kidney injury,4
SACUBITRIL\VALSARTAN,Dyspnoea,4
SACUBITRIL\VALSARTAN,Chest pain,4
SACUBITRIL\VALSARTAN,Blood potassium increased,4
SACUBITRIL\VALSARTAN,Palpitations,4
SACUBITRIL\VALSARTAN,Blood creatinine increased,4
SACUBITRIL\VALSARTAN,Wrong technique in product usage process,4
SACUBITRIL\VALSARTAN,Atrial fibrillation,4
SACUBITRIL\VALSARTAN,Oedema peripheral,3
SACUBITRIL\VALSARTAN,Abdominal pain,3
SACUBITRIL\VALSARTAN,Decreased appetite,3
SACUBITRIL\VALSARTAN,Loss of consciousness,3
SACUBITRIL\VALSARTAN,Pruritus,3
SACUBITRIL\VALSARTAN,Peripheral swelling,3
SACUBITRIL\VALSARTAN,Oedema,3
SACUBITRIL\VALSARTAN,Underdose,3
SACUBITRIL\VALSARTAN,Product use issue,3
SACUBITRIL\VALSARTAN,Syncope,3
SACUBITRIL\VALSARTAN,Renal impairment,3
SACUBITRIL\VALSARTAN,Left ventricular dysfunction,3
SACUBITRIL\VALSARTAN,Ventricular extrasystoles,3
SACUBITRIL\VALSARTAN,Mitral valve incompetence,3
SACUBITRIL\VALSARTAN,Feeling cold,3
SACUBITRIL\VALSARTAN,Cardiovascular disorder,3
SACUBITRIL\VALSARTAN,Coronary artery disease,3
SACUBITRIL\VALSARTAN,Ejection fraction decreased,3
SACUBITRIL\VALSARTAN,Peripheral coldness,3
SACUBITRIL\VALSARTAN,Blood glucose increased,2
SACUBITRIL\VALSARTAN,Lethargy,2
SACUBITRIL\VALSARTAN,Somnolence,2
SACUBITRIL\VALSARTAN,Blood pressure fluctuation,2
SACUBITRIL\VALSARTAN,Angioedema,2
SACUBITRIL\VALSARTAN,Hypertension,2
SACUBITRIL\VALSARTAN,Chest discomfort,2
SACUBITRIL\VALSARTAN,Limb discomfort,2
SACUBITRIL\VALSARTAN,Abdominal distension,2
SACUBITRIL\VALSARTAN,Pain in extremity,2
SACUBITRIL\VALSARTAN,Headache,2
SELEXIPAG,Diarrhoea,22
SELEXIPAG,Headache,21
SELEXIPAG,Nausea,20
SELEXIPAG,Pain in jaw,17
SELEXIPAG,Fatigue,16
SELEXIPAG,Abdominal pain,15
SELEXIPAG,Dyspnoea,13
SELEXIPAG,Myalgia,13
SELEXIPAG,Nasopharyngitis,12
SELEXIPAG,Pulmonary arterial hypertension,11
SELEXIPAG,Dizziness,9
SELEXIPAG,Vomiting,9
SELEXIPAG,Somnolence,8
SELEXIPAG,Dyspnoea exertional,8
SELEXIPAG,Vertigo,8
SELEXIPAG,Abdominal distension,8
SELEXIPAG,Arthralgia,8
SELEXIPAG,Pain,8
SELEXIPAG,Bronchitis,7
SELEXIPAG,Product dose omission issue,7
SELEXIPAG,Epistaxis,7
SELEXIPAG,Oxygen saturation decreased,7
SELEXIPAG,Abdominal pain upper,7
SELEXIPAG,Pneumonia,6
SELEXIPAG,Hypotension,6
SELEXIPAG,Gastrooesophageal reflux disease,6
SELEXIPAG,Vision blurred,6
SELEXIPAG,Injection site pain,5
SELEXIPAG,Decreased appetite,5
SELEXIPAG,Hypoaesthesia,5
SELEXIPAG,Loss of consciousness,5
SELEXIPAG,Constipation,5
SELEXIPAG,Anaemia,5
SELEXIPAG,Insomnia,5
SELEXIPAG,Off label use,5
SELEXIPAG,Tachycardia,5
SELEXIPAG,Abdominal discomfort,5
SELEXIPAG,Cough,4
SELEXIPAG,Pericardial effusion,4
SELEXIPAG,Angina pectoris,4
SELEXIPAG,Product use in unapproved indication,4
SELEXIPAG,Gastroenteritis,4
SELEXIPAG,Performance status decreased,4
SELEXIPAG,Intra-abdominal fluid collection,4
SELEXIPAG,Oedema peripheral,4
SELEXIPAG,Oropharyngeal pain,4
SELEXIPAG,Weight increased,4
SELEXIPAG,Pyrexia,4
SELEXIPAG,Chills,4
SELEXIPAG,Malaise,3
SELINEXOR,Pneumonia,12
SELINEXOR,Platelet count decreased,9
SELINEXOR,Anaemia,6
SELINEXOR,Febrile neutropenia,6
SELINEXOR,White blood cell count decreased,4
SELINEXOR,Neutrophil count decreased,4
SELINEXOR,Decreased appetite,3
SELINEXOR,Sepsis,3
SELINEXOR,Dyspnoea,3
SELINEXOR,Syncope,2
SELINEXOR,Dehydration,2
SELINEXOR,Nausea,2
SELINEXOR,Diarrhoea,2
SELINEXOR,Dizziness,2
SELINEXOR,Death,2
SELINEXOR,Thrombocytopenia,2
SELINEXOR,Hyponatraemia,2
SELINEXOR,Respiratory distress,1
SELINEXOR,Ejection fraction decreased,1
SELINEXOR,Pleural effusion,1
SELINEXOR,Acute kidney injury,1
SELINEXOR,Mental status changes,1
SELINEXOR,Respiratory failure,1
SELINEXOR,COVID-19 pneumonia,1
SELINEXOR,Orthostatic hypotension,1
SELINEXOR,Immune thrombocytopenia,1
SELINEXOR,Vomiting,1
SELINEXOR,Bronchitis,1
SELINEXOR,Tachycardia,1
SELINEXOR,Pyrexia,1
SELINEXOR,Cytokine release syndrome,1
SELINEXOR,Somnolence,1
SELINEXOR,Haemophagocytic lymphohistiocytosis,1
SELINEXOR,Pneumonia aspiration,1
SELINEXOR,Cerebral infarction,1
SELINEXOR,Headache,1
SELINEXOR,Atelectasis,1
SELINEXOR,Hypoxia,1
SELINEXOR,Embolism,1
SELINEXOR,Anxiety,1
SELINEXOR,Pulmonary infarction,1
SELINEXOR,Pleuritic pain,1
SELINEXOR,Upper respiratory tract infection,1
SELINEXOR,Intracranial mass,1
SELINEXOR,Encephalitis viral,1
SELINEXOR,Peripheral nerve injury,1
SELINEXOR,Accidental overdose,1
SELINEXOR,Septic shock,1
SELINEXOR,Atrial fibrillation,1
SELINEXOR,Pneumonitis,1
SENNA,Fatigue,11
SENNA,Urinary tract infection,10
SENNA,Dyspnoea,9
SENNA,Constipation,9
SENNA,Diarrhoea,9
SENNA,Vomiting,8
SENNA,Seizure,8
SENNA,Nausea,6
SENNA,COVID-19,6
SENNA,Headache,6
SENNA,Pneumonia,5
SENNA,Fall,5
SENNA,Hyponatraemia,5
SENNA,Chest pain,5
SENNA,Hypoxia,4
SENNA,Rash,4
SENNA,Cough,4
SENNA,Condition aggravated,4
SENNA,Tachycardia,4
SENNA,Hypertension,4
SENNA,Decreased appetite,4
SENNA,Death,4
SENNA,Pyrexia,4
SENNA,Product dose omission issue,3
SENNA,Acute respiratory failure,3
SENNA,Rhinovirus infection,3
SENNA,Hypothyroidism,3
SENNA,Pruritus,3
SENNA,Autoimmune hepatitis,3
SENNA,Liver function test abnormal,3
SENNA,Rhabdomyolysis,3
SENNA,Loss of consciousness,3
SENNA,Psychotic disorder,3
SENNA,Lethargy,3
SENNA,Dysuria,3
SENNA,Oedema peripheral,3
SENNA,Abdominal pain,3
SENNA,Confusional state,3
SENNA,Dizziness,3
SENNA,Lower respiratory tract infection,3
SENNA,Respiratory tract infection,3
SENNA,Coronary artery disease,3
SENNA,Infusion related reaction,2
SENNA,Inappropriate schedule of product administration,2
SENNA,Weight decreased,2
SENNA,Peripheral swelling,2
SENNA,Supraventricular tachycardia,2
SENNA,Urinary retention,2
SENNA,Pseudomonas infection,2
SENNA,Human metapneumovirus test positive,2
SEROQUEL,Anxiety,17
SEROQUEL,Depression,15
SEROQUEL,Pain,12
SEROQUEL,Hallucination,12
SEROQUEL,Product dose omission issue,11
SEROQUEL,Fall,10
SEROQUEL,COVID-19,8
SEROQUEL,Off label use,8
SEROQUEL,Vomiting,8
SEROQUEL,Confusional state,8
SEROQUEL,Emotional distress,7
SEROQUEL,Anhedonia,7
SEROQUEL,Fatigue,7
SEROQUEL,Pneumonia,7
SEROQUEL,Sinusitis,7
SEROQUEL,Dyspnoea,7
SEROQUEL,Inappropriate schedule of product administration,6
SEROQUEL,Dizziness,6
SEROQUEL,Nausea,6
SEROQUEL,Back pain,6
SEROQUEL,Insomnia,6
SEROQUEL,Drug ineffective,5
SEROQUEL,Somnolence,5
SEROQUEL,Hypertension,5
SEROQUEL,Blood creatinine increased,5
SEROQUEL,Headache,5
SEROQUEL,Asthenia,5
SEROQUEL,Agitation,5
SEROQUEL,Muscle spasms,5
SEROQUEL,Tremor,5
SEROQUEL,Death,5
SEROQUEL,Illness,4
SEROQUEL,Nasopharyngitis,4
SEROQUEL,Contusion,4
SEROQUEL,Bronchitis,4
SEROQUEL,Chronic kidney disease,4
SEROQUEL,Gait disturbance,4
SEROQUEL,Disturbance in attention,4
SEROQUEL,Seizure,4
SEROQUEL,Suicidal ideation,4
SEROQUEL,Decreased appetite,4
SEROQUEL,Pyrexia,4
SEROQUEL,Disorientation,4
SEROQUEL,Vision blurred,4
SEROQUEL,Migraine,4
SEROQUEL,Memory impairment,4
SEROQUEL,Peripheral swelling,4
SEROQUEL,Obesity,3
SEROQUEL,Chills,3
SEROQUEL,Blood potassium decreased,3
SERTRALINE,Fatigue,34
SERTRALINE,Nausea,30
SERTRALINE,Confusional state,30
SERTRALINE,Pain,27
SERTRALINE,Headache,23
SERTRALINE,Anxiety,23
SERTRALINE,Off label use,22
SERTRALINE,Suicidal ideation,22
SERTRALINE,Dizziness,20
SERTRALINE,Emotional distress,18
SERTRALINE,Back pain,18
SERTRALINE,Vomiting,18
SERTRALINE,COVID-19,17
SERTRALINE,Asthenia,17
SERTRALINE,Medication error,17
SERTRALINE,Anhedonia,16
SERTRALINE,Pain in extremity,16
SERTRALINE,Suicide attempt,16
SERTRALINE,Hyperhidrosis,16
SERTRALINE,Foetal exposure during pregnancy,16
SERTRALINE,Arthralgia,15
SERTRALINE,Diarrhoea,15
SERTRALINE,Dyspnoea,15
SERTRALINE,Depression,15
SERTRALINE,Pyrexia,15
SERTRALINE,Agitation,15
SERTRALINE,Serotonin syndrome,15
SERTRALINE,Inappropriate schedule of product administration,15
SERTRALINE,Restlessness,15
SERTRALINE,Pruritus,14
SERTRALINE,Fall,14
SERTRALINE,Product use in unapproved indication,14
SERTRALINE,Drug ineffective,14
SERTRALINE,Urinary tract infection,13
SERTRALINE,Abdominal pain,13
SERTRALINE,Cough,12
SERTRALINE,Malaise,12
SERTRALINE,Somnolence,12
SERTRALINE,Renal failure,11
SERTRALINE,Tremor,11
SERTRALINE,Brain fog,11
SERTRALINE,Feeling abnormal,10
SERTRALINE,Tachycardia,10
SERTRALINE,Blood creatinine increased,10
SERTRALINE,Gastrointestinal disorder,10
SERTRALINE,Hallucination,10
SERTRALINE,Flushing,10
SERTRALINE,Pulmonary artery stenosis,10
SERTRALINE,Drug abuse,10
SERTRALINE,Drug interaction,9
SERTRALINE HYDROCHLORIDE,Headache,13
SERTRALINE HYDROCHLORIDE,Pain,13
SERTRALINE HYDROCHLORIDE,Nausea,12
SERTRALINE HYDROCHLORIDE,COVID-19,11
SERTRALINE HYDROCHLORIDE,Sinusitis,10
SERTRALINE HYDROCHLORIDE,Vomiting,9
SERTRALINE HYDROCHLORIDE,Fall,9
SERTRALINE HYDROCHLORIDE,Anxiety,9
SERTRALINE HYDROCHLORIDE,Fatigue,9
SERTRALINE HYDROCHLORIDE,Abdominal pain upper,8
SERTRALINE HYDROCHLORIDE,Diarrhoea,8
SERTRALINE HYDROCHLORIDE,Product dose omission issue,7
SERTRALINE HYDROCHLORIDE,Urinary tract infection,7
SERTRALINE HYDROCHLORIDE,Pain in extremity,7
SERTRALINE HYDROCHLORIDE,Insomnia,6
SERTRALINE HYDROCHLORIDE,Weight decreased,6
SERTRALINE HYDROCHLORIDE,Upper respiratory tract infection,6
SERTRALINE HYDROCHLORIDE,Malaise,6
SERTRALINE HYDROCHLORIDE,Dyspnoea,6
SERTRALINE HYDROCHLORIDE,Somnolence,5
SERTRALINE HYDROCHLORIDE,Pneumonia,5
SERTRALINE HYDROCHLORIDE,Nasopharyngitis,5
SERTRALINE HYDROCHLORIDE,Depression,5
SERTRALINE HYDROCHLORIDE,Off label use,5
SERTRALINE HYDROCHLORIDE,Pyrexia,5
SERTRALINE HYDROCHLORIDE,Bronchitis,5
SERTRALINE HYDROCHLORIDE,Illness,5
SERTRALINE HYDROCHLORIDE,Cough,5
SERTRALINE HYDROCHLORIDE,Dizziness,5
SERTRALINE HYDROCHLORIDE,Contusion,5
SERTRALINE HYDROCHLORIDE,Hereditary angioedema,4
SERTRALINE HYDROCHLORIDE,Weight increased,4
SERTRALINE HYDROCHLORIDE,Chronic kidney disease,4
SERTRALINE HYDROCHLORIDE,Seasonal allergy,4
SERTRALINE HYDROCHLORIDE,Asthma,4
SERTRALINE HYDROCHLORIDE,Arthralgia,4
SERTRALINE HYDROCHLORIDE,Peripheral swelling,4
SERTRALINE HYDROCHLORIDE,Infusion site pain,4
SERTRALINE HYDROCHLORIDE,Chronic obstructive pulmonary disease,4
SERTRALINE HYDROCHLORIDE,Gastroenteritis viral,4
SERTRALINE HYDROCHLORIDE,Decreased appetite,4
SERTRALINE HYDROCHLORIDE,Product use in unapproved indication,4
SERTRALINE HYDROCHLORIDE,Medication error,4
SERTRALINE HYDROCHLORIDE,Suicide attempt,4
SERTRALINE HYDROCHLORIDE,Hepatic cytolysis,4
SERTRALINE HYDROCHLORIDE,Nephrolithiasis,3
SERTRALINE HYDROCHLORIDE,Abdominal distension,3
SERTRALINE HYDROCHLORIDE,Blood pressure increased,3
SERTRALINE HYDROCHLORIDE,Limb injury,3
SERTRALINE HYDROCHLORIDE,Pruritus,3
SILDENAFIL,Infusion site pain,27
SILDENAFIL,Headache,26
SILDENAFIL,Nausea,24
SILDENAFIL,Weight decreased,24
SILDENAFIL,Diarrhoea,21
SILDENAFIL,Dyspnoea,19
SILDENAFIL,Vomiting,19
SILDENAFIL,Pain,16
SILDENAFIL,Dizziness,13
SILDENAFIL,Infusion site erythema,12
SILDENAFIL,Decreased appetite,12
SILDENAFIL,Tachycardia,12
SILDENAFIL,Pulmonary arterial hypertension,11
SILDENAFIL,Fatigue,11
SILDENAFIL,Device dislocation,10
SILDENAFIL,Hypotension,10
SILDENAFIL,Device failure,10
SILDENAFIL,Anxiety,9
SILDENAFIL,Pneumonia,9
SILDENAFIL,Infusion site swelling,9
SILDENAFIL,Suspected counterfeit product,9
SILDENAFIL,Weight increased,8
SILDENAFIL,Arthralgia,8
SILDENAFIL,Acute kidney injury,8
SILDENAFIL,Pyrexia,8
SILDENAFIL,Chest discomfort,8
SILDENAFIL,Oedema peripheral,8
SILDENAFIL,Myalgia,8
SILDENAFIL,Cough,8
SILDENAFIL,Emotional distress,7
SILDENAFIL,Peripheral swelling,7
SILDENAFIL,Pain in jaw,7
SILDENAFIL,Oxygen saturation decreased,7
SILDENAFIL,Infusion site haemorrhage,7
SILDENAFIL,Anhedonia,6
SILDENAFIL,Right ventricular failure,6
SILDENAFIL,Dyspepsia,6
SILDENAFIL,Dyspnoea exertional,6
SILDENAFIL,Hypoxia,6
SILDENAFIL,Infusion site discharge,6
SILDENAFIL,Infusion site infection,6
SILDENAFIL,Constipation,6
SILDENAFIL,Abdominal pain,6
SILDENAFIL,Palpitations,6
SILDENAFIL,Hypertension,5
SILDENAFIL,Fluid retention,5
SILDENAFIL,Sleep disorder,5
SILDENAFIL,Abdominal discomfort,5
SILDENAFIL,Abdominal pain upper,5
SILDENAFIL,Asthenia,5
SILDENAFIL CITRATE,Dyspnoea,58
SILDENAFIL CITRATE,Headache,52
SILDENAFIL CITRATE,Diarrhoea,47
SILDENAFIL CITRATE,Cough,41
SILDENAFIL CITRATE,Dizziness,36
SILDENAFIL CITRATE,Nausea,35
SILDENAFIL CITRATE,Fatigue,32
SILDENAFIL CITRATE,Pain,28
SILDENAFIL CITRATE,Oxygen saturation decreased,28
SILDENAFIL CITRATE,Hypotension,23
SILDENAFIL CITRATE,Asthenia,23
SILDENAFIL CITRATE,Pain in extremity,21
SILDENAFIL CITRATE,Malaise,20
SILDENAFIL CITRATE,Peripheral swelling,20
SILDENAFIL CITRATE,Vomiting,19
SILDENAFIL CITRATE,Fluid retention,19
SILDENAFIL CITRATE,Arthralgia,18
SILDENAFIL CITRATE,Pneumonia,16
SILDENAFIL CITRATE,Pain in jaw,15
SILDENAFIL CITRATE,Infusion site pain,15
SILDENAFIL CITRATE,Pyrexia,14
SILDENAFIL CITRATE,Flushing,13
SILDENAFIL CITRATE,Weight decreased,13
SILDENAFIL CITRATE,Weight increased,13
SILDENAFIL CITRATE,Decreased appetite,13
SILDENAFIL CITRATE,Rash,12
SILDENAFIL CITRATE,Feeling abnormal,12
SILDENAFIL CITRATE,Dyspnoea exertional,12
SILDENAFIL CITRATE,Sinusitis,11
SILDENAFIL CITRATE,Syncope,11
SILDENAFIL CITRATE,Oedema peripheral,11
SILDENAFIL CITRATE,Chest discomfort,11
SILDENAFIL CITRATE,COVID-19,11
SILDENAFIL CITRATE,Injection site erythema,11
SILDENAFIL CITRATE,Death,11
SILDENAFIL CITRATE,Anxiety,10
SILDENAFIL CITRATE,Catheter site erythema,10
SILDENAFIL CITRATE,Chest pain,10
SILDENAFIL CITRATE,Migraine,10
SILDENAFIL CITRATE,Pruritus,10
SILDENAFIL CITRATE,Erythema,10
SILDENAFIL CITRATE,Oedema,10
SILDENAFIL CITRATE,Nasal congestion,10
SILDENAFIL CITRATE,Back pain,9
SILDENAFIL CITRATE,Nasopharyngitis,9
SILDENAFIL CITRATE,Swelling,9
SILDENAFIL CITRATE,Therapy non-responder,9
SILDENAFIL CITRATE,Urinary tract infection,8
SILDENAFIL CITRATE,Atrial fibrillation,8
SILDENAFIL CITRATE,Infusion site erythema,8
SIMPONI,Rheumatoid arthritis,27
SIMPONI,Product dose omission issue,26
SIMPONI,Pneumonia,25
SIMPONI,Drug ineffective,23
SIMPONI,Off label use,20
SIMPONI,Arthralgia,20
SIMPONI,Pain,19
SIMPONI,COVID-19,18
SIMPONI,Headache,15
SIMPONI,Psoriatic arthropathy,13
SIMPONI,Influenza,13
SIMPONI,Fatigue,12
SIMPONI,Musculoskeletal stiffness,12
SIMPONI,Dyspnoea,11
SIMPONI,Peripheral swelling,11
SIMPONI,Nausea,11
SIMPONI,Device issue,11
SIMPONI,Diarrhoea,10
SIMPONI,Rash,10
SIMPONI,Joint swelling,10
SIMPONI,Sinusitis,10
SIMPONI,Arthropathy,10
SIMPONI,Weight decreased,10
SIMPONI,Pain in extremity,10
SIMPONI,Urinary tract infection,10
SIMPONI,Alopecia,9
SIMPONI,Drug intolerance,9
SIMPONI,Needle issue,9
SIMPONI,Hypersensitivity,8
SIMPONI,Hypertension,8
SIMPONI,Therapeutic product effect decreased,8
SIMPONI,Inflammation,8
SIMPONI,Dizziness,8
SIMPONI,Treatment failure,8
SIMPONI,Infection,8
SIMPONI,Memory impairment,8
SIMPONI,Hepatic enzyme increased,7
SIMPONI,Synovitis,7
SIMPONI,Pruritus,7
SIMPONI,Wound,7
SIMPONI,Back pain,7
SIMPONI,Blood cholesterol increased,7
SIMPONI,Condition aggravated,7
SIMPONI,Abdominal pain upper,7
SIMPONI,Drug hypersensitivity,7
SIMPONI,Abdominal discomfort,7
SIMPONI,Hypoaesthesia,7
SIMPONI,Inappropriate schedule of product administration,7
SIMPONI,Asthenia,6
SIMPONI,Hand deformity,6
SIMVASTATIN,Off label use,142
SIMVASTATIN,COVID-19,131
SIMVASTATIN,Diarrhoea,128
SIMVASTATIN,Pain,119
SIMVASTATIN,Fatigue,117
SIMVASTATIN,Vomiting,117
SIMVASTATIN,Nausea,115
SIMVASTATIN,Arthralgia,112
SIMVASTATIN,Dyspnoea,112
SIMVASTATIN,Malaise,110
SIMVASTATIN,Headache,110
SIMVASTATIN,Pruritus,109
SIMVASTATIN,Intentional product misuse,109
SIMVASTATIN,Pyrexia,108
SIMVASTATIN,Abdominal discomfort,108
SIMVASTATIN,Dizziness,105
SIMVASTATIN,Feeling abnormal,104
SIMVASTATIN,Muscular weakness,102
SIMVASTATIN,Dehydration,102
SIMVASTATIN,Palpitations,101
SIMVASTATIN,Back pain,101
SIMVASTATIN,Peripheral swelling,100
SIMVASTATIN,Anxiety,100
SIMVASTATIN,Insomnia,99
SIMVASTATIN,Disturbance in attention,98
SIMVASTATIN,Tachycardia,97
SIMVASTATIN,Abdominal pain upper,97
SIMVASTATIN,Lip swelling,96
SIMVASTATIN,Blood glucose increased,94
SIMVASTATIN,Memory impairment,94
SIMVASTATIN,Diplopia,94
SIMVASTATIN,Migraine,93
SIMVASTATIN,Chest pain,92
SIMVASTATIN,Dry skin,92
SIMVASTATIN,Hyperhidrosis,92
SIMVASTATIN,Visual impairment,91
SIMVASTATIN,Myocardial infarction,91
SIMVASTATIN,Amnesia,91
SIMVASTATIN,Alopecia,90
SIMVASTATIN,Atrial tachycardia,90
SIMVASTATIN,Heart rate increased,89
SIMVASTATIN,Cognitive disorder,89
SIMVASTATIN,Hallucination,89
SIMVASTATIN,Facial pain,89
SIMVASTATIN,Cardiospasm,89
SIMVASTATIN,Angioedema,89
SIMVASTATIN,Subarachnoid haemorrhage,89
SIMVASTATIN,Anosmia,89
SIMVASTATIN,Pericarditis,89
SIMVASTATIN,Transient ischaemic attack,88
SINGULAIR,Product dose omission issue,63
SINGULAIR,Sinusitis,57
SINGULAIR,Fatigue,52
SINGULAIR,COVID-19,51
SINGULAIR,Asthma,48
SINGULAIR,Weight decreased,42
SINGULAIR,Headache,42
SINGULAIR,Pneumonia,40
SINGULAIR,Dyspnoea,40
SINGULAIR,Illness,37
SINGULAIR,Cough,37
SINGULAIR,Bronchitis,36
SINGULAIR,Weight increased,35
SINGULAIR,Nasopharyngitis,35
SINGULAIR,Malaise,34
SINGULAIR,Influenza,29
SINGULAIR,Nausea,29
SINGULAIR,Inappropriate schedule of product administration,29
SINGULAIR,Diarrhoea,26
SINGULAIR,Blood pressure increased,26
SINGULAIR,Drug hypersensitivity,25
SINGULAIR,Arthralgia,24
SINGULAIR,Pain,24
SINGULAIR,Fall,24
SINGULAIR,Oropharyngeal pain,23
SINGULAIR,Infection,23
SINGULAIR,Urinary tract infection,22
SINGULAIR,Seasonal allergy,21
SINGULAIR,Upper respiratory tract infection,21
SINGULAIR,Vomiting,20
SINGULAIR,Asthenia,20
SINGULAIR,Urticaria,20
SINGULAIR,Pyrexia,19
SINGULAIR,Wheezing,19
SINGULAIR,Drug ineffective,19
SINGULAIR,Nasal congestion,18
SINGULAIR,Ear infection,18
SINGULAIR,Off label use,18
SINGULAIR,Dizziness,18
SINGULAIR,Infusion related reaction,17
SINGULAIR,Hypersensitivity,17
SINGULAIR,Back pain,17
SINGULAIR,Pruritus,17
SINGULAIR,Pain in extremity,16
SINGULAIR,Chest discomfort,16
SINGULAIR,Anxiety,16
SINGULAIR,Heart rate increased,16
SINGULAIR,Respiratory tract infection,15
SINGULAIR,Feeling abnormal,15
SINGULAIR,Erythema,15
SITAGLIPTIN,Hyperkalaemia,8
SITAGLIPTIN,Intestinal obstruction,7
SITAGLIPTIN,Acute kidney injury,7
SITAGLIPTIN,Pneumonia,6
SITAGLIPTIN,Lactic acidosis,5
SITAGLIPTIN,Diarrhoea,4
SITAGLIPTIN,Vomiting,4
SITAGLIPTIN,Nausea,4
SITAGLIPTIN,Hypoglycaemia,4
SITAGLIPTIN,Condition aggravated,4
SITAGLIPTIN,COVID-19,3
SITAGLIPTIN,Decreased appetite,3
SITAGLIPTIN,Cerebrovascular accident,3
SITAGLIPTIN,Intentional product use issue,3
SITAGLIPTIN,Anaemia,3
SITAGLIPTIN,Pancreatitis acute,3
SITAGLIPTIN,Hyperthyroidism,3
SITAGLIPTIN,Pain,3
SITAGLIPTIN,Peripheral arterial occlusive disease,3
SITAGLIPTIN,Drug-induced liver injury,2
SITAGLIPTIN,Dehydration,2
SITAGLIPTIN,Cough,2
SITAGLIPTIN,Asthenia,2
SITAGLIPTIN,Off label use,2
SITAGLIPTIN,Proteinuria,2
SITAGLIPTIN,Pneumonitis,2
SITAGLIPTIN,Pharyngeal inflammation,2
SITAGLIPTIN,Hyponatraemia,2
SITAGLIPTIN,Hepatic enzyme increased,2
SITAGLIPTIN,Prescribed underdose,2
SITAGLIPTIN,Neutrophil count decreased,2
SITAGLIPTIN,Thrombocytopenia,2
SITAGLIPTIN,Memory impairment,2
SITAGLIPTIN,Hypertension,2
SITAGLIPTIN,Arthralgia,2
SITAGLIPTIN,Cardiac discomfort,2
SITAGLIPTIN,Dry eye,2
SITAGLIPTIN,Ischaemic enteritis,1
SITAGLIPTIN,Peripheral coldness,1
SITAGLIPTIN,General physical health deterioration,1
SITAGLIPTIN,Abdominal distension,1
SITAGLIPTIN,Bacterial infection,1
SITAGLIPTIN,Weight increased,1
SITAGLIPTIN,Gastrointestinal inflammation,1
SITAGLIPTIN,Diarrhoea haemorrhagic,1
SITAGLIPTIN,Hyperhidrosis,1
SITAGLIPTIN,Proctalgia,1
SITAGLIPTIN,Rectal tenesmus,1
SITAGLIPTIN,Haematochezia,1
SITAGLIPTIN,Abdominal pain upper,1
SKYRIZI,Psoriasis,32
SKYRIZI,Pain,14
SKYRIZI,Fatigue,10
SKYRIZI,Injection site haemorrhage,10
SKYRIZI,Arthralgia,9
SKYRIZI,Headache,9
SKYRIZI,Unevaluable event,9
SKYRIZI,Crohn's disease,8
SKYRIZI,Fall,8
SKYRIZI,Pyrexia,8
SKYRIZI,Therapeutic response shortened,8
SKYRIZI,Weight decreased,8
SKYRIZI,Device issue,8
SKYRIZI,Skin exfoliation,7
SKYRIZI,Skin disorder,7
SKYRIZI,Dyspnoea,7
SKYRIZI,Dizziness,7
SKYRIZI,Pain in extremity,6
SKYRIZI,Decreased appetite,6
SKYRIZI,Basal cell carcinoma,6
SKYRIZI,Nasopharyngitis,6
SKYRIZI,Diarrhoea,6
SKYRIZI,Drug ineffective,6
SKYRIZI,COVID-19,6
SKYRIZI,Urinary tract infection,6
SKYRIZI,Hypotension,5
SKYRIZI,Blood pressure increased,5
SKYRIZI,Hypertension,5
SKYRIZI,Skin cancer,5
SKYRIZI,Nausea,5
SKYRIZI,Therapeutic product effect incomplete,5
SKYRIZI,Pneumonia,5
SKYRIZI,Injection site papule,5
SKYRIZI,Injection site pain,5
SKYRIZI,Condition aggravated,5
SKYRIZI,Knee arthroplasty,5
SKYRIZI,Malaise,5
SKYRIZI,Asthenia,5
SKYRIZI,Myocardial infarction,5
SKYRIZI,Breast cancer,5
SKYRIZI,Injection site swelling,5
SKYRIZI,Swelling,4
SKYRIZI,Heart rate increased,4
SKYRIZI,Discomfort,4
SKYRIZI,Illness,4
SKYRIZI,Upper respiratory tract infection,4
SKYRIZI,Chills,4
SKYRIZI,Dysphonia,4
SKYRIZI,Gait inability,4
SKYRIZI,Off label use,4
SODIUM BICARBONATE,Vomiting,25
SODIUM BICARBONATE,Off label use,23
SODIUM BICARBONATE,Nausea,14
SODIUM BICARBONATE,Malaise,13
SODIUM BICARBONATE,Pyrexia,12
SODIUM BICARBONATE,Urinary retention,10
SODIUM BICARBONATE,Condition aggravated,9
SODIUM BICARBONATE,Blood creatinine increased,9
SODIUM BICARBONATE,Cerebrovascular accident,8
SODIUM BICARBONATE,Hypokalaemia,8
SODIUM BICARBONATE,Anxiety,8
SODIUM BICARBONATE,Fatigue,8
SODIUM BICARBONATE,Diarrhoea,8
SODIUM BICARBONATE,Dyspnoea,8
SODIUM BICARBONATE,Abdominal distension,8
SODIUM BICARBONATE,Neuralgia,8
SODIUM BICARBONATE,Vascular device infection,7
SODIUM BICARBONATE,Pain,7
SODIUM BICARBONATE,Chronic kidney disease,7
SODIUM BICARBONATE,Hepatic cytolysis,7
SODIUM BICARBONATE,White blood cell count decreased,7
SODIUM BICARBONATE,Constipation,7
SODIUM BICARBONATE,Emotional distress,6
SODIUM BICARBONATE,Mobility decreased,6
SODIUM BICARBONATE,Renal failure,6
SODIUM BICARBONATE,Drug hypersensitivity,6
SODIUM BICARBONATE,Stress,6
SODIUM BICARBONATE,Sepsis,6
SODIUM BICARBONATE,Death,6
SODIUM BICARBONATE,Multiple organ dysfunction syndrome,6
SODIUM BICARBONATE,Decreased appetite,6
SODIUM BICARBONATE,Somnolence,6
SODIUM BICARBONATE,Ascites,6
SODIUM BICARBONATE,Abdominal pain,5
SODIUM BICARBONATE,Dehydration,5
SODIUM BICARBONATE,Anhedonia,5
SODIUM BICARBONATE,Pain in extremity,5
SODIUM BICARBONATE,Cardiogenic shock,5
SODIUM BICARBONATE,Bacterial infection,5
SODIUM BICARBONATE,Incorrect route of product administration,5
SODIUM BICARBONATE,Drug intolerance,5
SODIUM BICARBONATE,Pneumonia,5
SODIUM BICARBONATE,Swelling,5
SODIUM BICARBONATE,Myelosuppression,5
SODIUM BICARBONATE,Depression,4
SODIUM BICARBONATE,Illness,4
SODIUM BICARBONATE,Intentional product misuse,4
SODIUM BICARBONATE,COVID-19,4
SODIUM BICARBONATE,Product dose omission issue,4
SODIUM BICARBONATE,Rash,4
SODIUM CHLORIDE,COVID-19,123
SODIUM CHLORIDE,Myelosuppression,119
SODIUM CHLORIDE,Sinusitis,118
SODIUM CHLORIDE,Product dose omission issue,108
SODIUM CHLORIDE,Fatigue,103
SODIUM CHLORIDE,Nausea,99
SODIUM CHLORIDE,Pneumonia,93
SODIUM CHLORIDE,Pyrexia,91
SODIUM CHLORIDE,White blood cell count decreased,85
SODIUM CHLORIDE,Diarrhoea,84
SODIUM CHLORIDE,Headache,83
SODIUM CHLORIDE,Dyspnoea,81
SODIUM CHLORIDE,Off label use,79
SODIUM CHLORIDE,Vomiting,78
SODIUM CHLORIDE,Fall,78
SODIUM CHLORIDE,Pain,66
SODIUM CHLORIDE,Inappropriate schedule of product administration,64
SODIUM CHLORIDE,Urinary tract infection,61
SODIUM CHLORIDE,Nasopharyngitis,58
SODIUM CHLORIDE,Abdominal pain,51
SODIUM CHLORIDE,Malaise,50
SODIUM CHLORIDE,Infusion related reaction,48
SODIUM CHLORIDE,Illness,48
SODIUM CHLORIDE,Asthenia,47
SODIUM CHLORIDE,Weight decreased,46
SODIUM CHLORIDE,Upper respiratory tract infection,46
SODIUM CHLORIDE,Back pain,45
SODIUM CHLORIDE,Dizziness,45
SODIUM CHLORIDE,Cough,44
SODIUM CHLORIDE,Rash,43
SODIUM CHLORIDE,Product use in unapproved indication,42
SODIUM CHLORIDE,Arthralgia,39
SODIUM CHLORIDE,Pruritus,37
SODIUM CHLORIDE,Bronchitis,36
SODIUM CHLORIDE,Pain in extremity,36
SODIUM CHLORIDE,Infection,36
SODIUM CHLORIDE,Respiratory tract infection,36
SODIUM CHLORIDE,Insurance issue,35
SODIUM CHLORIDE,Decreased appetite,34
SODIUM CHLORIDE,Neutrophil count decreased,34
SODIUM CHLORIDE,Influenza,33
SODIUM CHLORIDE,Abdominal distension,33
SODIUM CHLORIDE,Weight increased,32
SODIUM CHLORIDE,Productive cough,31
SODIUM CHLORIDE,Chest discomfort,30
SODIUM CHLORIDE,Seasonal allergy,29
SODIUM CHLORIDE,Platelet count decreased,29
SODIUM CHLORIDE,Erythema,28
SODIUM CHLORIDE,Ear infection,28
SODIUM CHLORIDE,Condition aggravated,28
SOLU-MEDROL,Off label use,31
SOLU-MEDROL,Nausea,23
SOLU-MEDROL,Headache,17
SOLU-MEDROL,Dyspnoea,15
SOLU-MEDROL,Malaise,13
SOLU-MEDROL,Fatigue,13
SOLU-MEDROL,Asthenia,13
SOLU-MEDROL,Rash,12
SOLU-MEDROL,COVID-19,12
SOLU-MEDROL,Vomiting,12
SOLU-MEDROL,Pruritus,12
SOLU-MEDROL,Urinary tract infection,11
SOLU-MEDROL,Inappropriate schedule of product administration,11
SOLU-MEDROL,Intentional product use issue,11
SOLU-MEDROL,Pneumonia,10
SOLU-MEDROL,Pyrexia,10
SOLU-MEDROL,Blood pressure fluctuation,10
SOLU-MEDROL,Hypertension,10
SOLU-MEDROL,Product dose omission issue,9
SOLU-MEDROL,Weight decreased,9
SOLU-MEDROL,Fall,8
SOLU-MEDROL,Cough,8
SOLU-MEDROL,Pain,8
SOLU-MEDROL,Arthralgia,8
SOLU-MEDROL,Erythema,8
SOLU-MEDROL,Diarrhoea,8
SOLU-MEDROL,Product use in unapproved indication,7
SOLU-MEDROL,Dizziness,7
SOLU-MEDROL,Back pain,7
SOLU-MEDROL,Blood pressure increased,7
SOLU-MEDROL,Sinusitis,6
SOLU-MEDROL,Illness,6
SOLU-MEDROL,Insomnia,6
SOLU-MEDROL,Respiratory failure,6
SOLU-MEDROL,Weight increased,5
SOLU-MEDROL,Dehydration,5
SOLU-MEDROL,Loss of consciousness,5
SOLU-MEDROL,Throat irritation,5
SOLU-MEDROL,Chills,5
SOLU-MEDROL,Condition aggravated,5
SOLU-MEDROL,Decreased appetite,5
SOLU-MEDROL,Infusion related reaction,5
SOLU-MEDROL,Anaphylactic shock,5
SOLU-MEDROL,Anxiety,4
SOLU-MEDROL,Depression,4
SOLU-MEDROL,Multiple sclerosis relapse,4
SOLU-MEDROL,Constipation,4
SOLU-MEDROL,Migraine,4
SOLU-MEDROL,Respiratory tract infection,4
SOLU-MEDROL,Abdominal discomfort,4
SPIRIVA,Asthma,34
SPIRIVA,Dyspnoea,32
SPIRIVA,Fatigue,26
SPIRIVA,Nasopharyngitis,25
SPIRIVA,Bronchitis,24
SPIRIVA,Diarrhoea,24
SPIRIVA,Headache,23
SPIRIVA,Pain,22
SPIRIVA,COVID-19,22
SPIRIVA,Weight decreased,21
SPIRIVA,Cough,21
SPIRIVA,Vomiting,20
SPIRIVA,Nausea,20
SPIRIVA,Pneumonia,20
SPIRIVA,Fall,19
SPIRIVA,Productive cough,18
SPIRIVA,Anaemia,18
SPIRIVA,Gait disturbance,17
SPIRIVA,Malaise,16
SPIRIVA,Depression,16
SPIRIVA,Sinusitis,15
SPIRIVA,Product dose omission issue,15
SPIRIVA,Anxiety,13
SPIRIVA,Pruritus,13
SPIRIVA,Dizziness,13
SPIRIVA,Pyrexia,12
SPIRIVA,Urinary tract infection,12
SPIRIVA,Illness,11
SPIRIVA,Influenza,11
SPIRIVA,Back pain,11
SPIRIVA,Chest discomfort,11
SPIRIVA,Weight increased,11
SPIRIVA,Hypocalcaemia,11
SPIRIVA,Hypokalaemia,11
SPIRIVA,Seasonal allergy,11
SPIRIVA,Asthenia,11
SPIRIVA,Hypomagnesaemia,11
SPIRIVA,Feeling abnormal,10
SPIRIVA,Viral infection,10
SPIRIVA,Wheezing,10
SPIRIVA,Inappropriate schedule of product administration,10
SPIRIVA,Sputum discoloured,9
SPIRIVA,Blood pressure increased,9
SPIRIVA,Blood pressure systolic increased,9
SPIRIVA,Arthralgia,9
SPIRIVA,Decreased appetite,9
SPIRIVA,Chronic obstructive pulmonary disease,8
SPIRIVA,Intervertebral disc protrusion,8
SPIRIVA,Blood creatinine increased,8
SPIRIVA,Diverticulitis,8
SPIRONOLACTONE,Cardiac failure,52
SPIRONOLACTONE,Dyspnoea,49
SPIRONOLACTONE,Acute kidney injury,48
SPIRONOLACTONE,Diarrhoea,47
SPIRONOLACTONE,Hypotension,44
SPIRONOLACTONE,Headache,41
SPIRONOLACTONE,Off label use,40
SPIRONOLACTONE,Fatigue,40
SPIRONOLACTONE,Nausea,40
SPIRONOLACTONE,Dizziness,37
SPIRONOLACTONE,Asthenia,31
SPIRONOLACTONE,Pneumonia,30
SPIRONOLACTONE,Hyperkalaemia,30
SPIRONOLACTONE,Fall,28
SPIRONOLACTONE,Vomiting,28
SPIRONOLACTONE,Decreased appetite,28
SPIRONOLACTONE,Pain,26
SPIRONOLACTONE,Pyrexia,26
SPIRONOLACTONE,Death,26
SPIRONOLACTONE,Anaemia,24
SPIRONOLACTONE,Weight decreased,23
SPIRONOLACTONE,Cough,22
SPIRONOLACTONE,COVID-19,20
SPIRONOLACTONE,Condition aggravated,19
SPIRONOLACTONE,Malaise,19
SPIRONOLACTONE,Pulmonary arterial hypertension,19
SPIRONOLACTONE,Drug ineffective,18
SPIRONOLACTONE,Arthralgia,18
SPIRONOLACTONE,Illness,18
SPIRONOLACTONE,Atrial fibrillation,18
SPIRONOLACTONE,Hyponatraemia,17
SPIRONOLACTONE,Product use issue,16
SPIRONOLACTONE,Dehydration,16
SPIRONOLACTONE,Product dose omission issue,16
SPIRONOLACTONE,Oedema peripheral,16
SPIRONOLACTONE,Anxiety,15
SPIRONOLACTONE,Feeling abnormal,15
SPIRONOLACTONE,Pleural effusion,15
SPIRONOLACTONE,Urinary tract infection,15
SPIRONOLACTONE,Confusional state,15
SPIRONOLACTONE,Infection,14
SPIRONOLACTONE,Weight increased,14
SPIRONOLACTONE,Renal impairment,14
SPIRONOLACTONE,Chest pain,13
SPIRONOLACTONE,Sepsis,13
SPIRONOLACTONE,Renal failure,13
SPIRONOLACTONE,Product use in unapproved indication,13
SPIRONOLACTONE,Contusion,12
SPIRONOLACTONE,Rash,12
SPIRONOLACTONE,General physical health deterioration,12
STELARA,Product dose omission issue,74
STELARA,Off label use,61
STELARA,Syringe issue,25
STELARA,Drug ineffective,24
STELARA,Crohn's disease,24
STELARA,Diarrhoea,23
STELARA,Headache,21
STELARA,Arthralgia,21
STELARA,Needle issue,21
STELARA,Inappropriate schedule of product administration,20
STELARA,Fatigue,19
STELARA,Pyrexia,18
STELARA,Infusion related reaction,17
STELARA,Abdominal pain,16
STELARA,Rash,14
STELARA,Pain,14
STELARA,Dyspnoea,13
STELARA,Nausea,13
STELARA,Pain in extremity,13
STELARA,Product use issue,13
STELARA,COVID-19,13
STELARA,Haematochezia,13
STELARA,Dizziness,12
STELARA,Malaise,12
STELARA,Condition aggravated,12
STELARA,Accidental exposure to product,12
STELARA,Asthenia,11
STELARA,Weight decreased,11
STELARA,Muscle spasms,10
STELARA,Psoriatic arthropathy,10
STELARA,Decreased appetite,10
STELARA,Device issue,10
STELARA,Rheumatoid arthritis,9
STELARA,Weight increased,9
STELARA,Alopecia,9
STELARA,Drug intolerance,9
STELARA,Inflammation,9
STELARA,Nasopharyngitis,9
STELARA,General physical health deterioration,9
STELARA,Gait disturbance,9
STELARA,Vomiting,9
STELARA,Underdose,9
STELARA,Hypersensitivity,8
STELARA,Hypertension,8
STELARA,Peripheral swelling,8
STELARA,Therapeutic response decreased,8
STELARA,Abdominal discomfort,8
STELARA,Abdominal distension,8
STELARA,Hepatic enzyme increased,7
STELARA,Synovitis,7
STERILE WATER,Hereditary angioedema,15
STERILE WATER,Inappropriate schedule of product administration,15
STERILE WATER,Product dose omission issue,13
STERILE WATER,COVID-19,11
STERILE WATER,Pneumonia,9
STERILE WATER,Fall,8
STERILE WATER,Fatigue,7
STERILE WATER,Sinusitis,6
STERILE WATER,Arthralgia,6
STERILE WATER,Headache,6
STERILE WATER,Pruritus,6
STERILE WATER,Weight decreased,5
STERILE WATER,Insurance issue,5
STERILE WATER,Pain,5
STERILE WATER,Back pain,5
STERILE WATER,Vomiting,5
STERILE WATER,Illness,5
STERILE WATER,Nasopharyngitis,5
STERILE WATER,Urinary tract infection,5
STERILE WATER,Nausea,5
STERILE WATER,Product use issue,4
STERILE WATER,Cough,4
STERILE WATER,Dizziness,4
STERILE WATER,Cellulitis,4
STERILE WATER,Chest discomfort,4
STERILE WATER,Diarrhoea,4
STERILE WATER,Product use in unapproved indication,3
STERILE WATER,Pain in extremity,3
STERILE WATER,Lymphadenopathy,3
STERILE WATER,Migraine,3
STERILE WATER,Pyrexia,3
STERILE WATER,Arthritis,3
STERILE WATER,Anaemia,3
STERILE WATER,Drug ineffective,3
STERILE WATER,Abdominal distension,3
STERILE WATER,Gastroenteritis viral,3
STERILE WATER,Off label use,3
STERILE WATER,Condition aggravated,3
STERILE WATER,Abdominal pain,3
STERILE WATER,Hypoaesthesia,3
STERILE WATER,Influenza,2
STERILE WATER,Exposure during pregnancy,2
STERILE WATER,Sinus disorder,2
STERILE WATER,Limb injury,2
STERILE WATER,Productive cough,2
STERILE WATER,Oedema peripheral,2
STERILE WATER,Oropharyngeal pain,2
STERILE WATER,Infection,2
STERILE WATER,Rheumatoid arthritis,2
STERILE WATER,Contusion,2
STRIBILD,Pain,57
STRIBILD,Emotional distress,55
STRIBILD,Anxiety,55
STRIBILD,Anhedonia,54
STRIBILD,Chronic kidney disease,31
STRIBILD,Osteoporosis,21
STRIBILD,Economic problem,15
STRIBILD,Depression,15
STRIBILD,Blood creatinine increased,15
STRIBILD,Renal failure,15
STRIBILD,Bone density decreased,14
STRIBILD,Acute kidney injury,13
STRIBILD,Osteopenia,13
STRIBILD,Renal impairment,12
STRIBILD,Bone demineralisation,12
STRIBILD,Fatigue,11
STRIBILD,Multiple fractures,10
STRIBILD,Asthenia,10
STRIBILD,Osteonecrosis,9
STRIBILD,Bone loss,9
STRIBILD,Decreased activity,7
STRIBILD,Renal injury,7
STRIBILD,Back pain,6
STRIBILD,Rib fracture,6
STRIBILD,Gait disturbance,6
STRIBILD,Loss of personal independence in daily activities,6
STRIBILD,Foot fracture,5
STRIBILD,End stage renal disease,5
STRIBILD,Vitamin D deficiency,4
STRIBILD,Quality of life decreased,4
STRIBILD,Pollakiuria,4
STRIBILD,Bone pain,4
STRIBILD,Renal pain,3
STRIBILD,Hypokalaemia,3
STRIBILD,Renal disorder,3
STRIBILD,Osteoarthritis,3
STRIBILD,Hypokinesia,3
STRIBILD,Skeletal injury,3
STRIBILD,Dysstasia,3
STRIBILD,Hand fracture,3
STRIBILD,Spinal compression fracture,2
STRIBILD,Tooth injury,2
STRIBILD,Hypertension,2
STRIBILD,Arthralgia,2
STRIBILD,Post-traumatic stress disorder,2
STRIBILD,Impaired work ability,2
STRIBILD,Pain in extremity,2
STRIBILD,Hip fracture,2
STRIBILD,Diarrhoea,2
STRIBILD,Gynaecomastia,2
SUCRALFATE,Nausea,9
SUCRALFATE,Dyspnoea,9
SUCRALFATE,Pain,9
SUCRALFATE,Headache,7
SUCRALFATE,COVID-19,7
SUCRALFATE,Urinary tract infection,7
SUCRALFATE,Hypertension,6
SUCRALFATE,Fall,5
SUCRALFATE,Dizziness,5
SUCRALFATE,Fatigue,5
SUCRALFATE,Pneumonia,5
SUCRALFATE,Illness,5
SUCRALFATE,Weight decreased,5
SUCRALFATE,Pulmonary embolism,5
SUCRALFATE,Diarrhoea,5
SUCRALFATE,Back pain,4
SUCRALFATE,Emotional distress,4
SUCRALFATE,Anhedonia,4
SUCRALFATE,Anxiety,4
SUCRALFATE,Abdominal pain,4
SUCRALFATE,Pyrexia,4
SUCRALFATE,Osteoporosis,4
SUCRALFATE,Cough,4
SUCRALFATE,Gastrointestinal disorder,4
SUCRALFATE,Vomiting,4
SUCRALFATE,Abdominal pain upper,4
SUCRALFATE,Weight increased,4
SUCRALFATE,Arthralgia,3
SUCRALFATE,Renal failure,3
SUCRALFATE,Depression,3
SUCRALFATE,Needle issue,3
SUCRALFATE,Small intestinal obstruction,3
SUCRALFATE,Sinusitis,3
SUCRALFATE,Abdominal discomfort,3
SUCRALFATE,Pruritus,3
SUCRALFATE,Chest discomfort,3
SUCRALFATE,Acute kidney injury,3
SUCRALFATE,Blood pressure increased,3
SUCRALFATE,Chest pain,3
SUCRALFATE,Chills,3
SUCRALFATE,Asthenia,3
SUCRALFATE,Infusion related reaction,3
SUCRALFATE,Migraine,3
SUCRALFATE,Dyspepsia,2
SUCRALFATE,Bone pain,2
SUCRALFATE,Drug hypersensitivity,2
SUCRALFATE,Malaise,2
SUCRALFATE,Tooth infection,2
SUCRALFATE,Blood pressure abnormal,2
SUCRALFATE,Glomerular filtration rate abnormal,2
SUFENTANIL,Anaphylactic shock,21
SUFENTANIL,Acute generalised exanthematous pustulosis,17
SUFENTANIL,Drug reaction with eosinophilia and systemic symptoms,6
SUFENTANIL,Lactic acidosis,6
SUFENTANIL,Cardiac arrest,5
SUFENTANIL,Cardiogenic shock,5
SUFENTANIL,Leukopenia,4
SUFENTANIL,Neutropenia,4
SUFENTANIL,Off label use,3
SUFENTANIL,Anaphylactic reaction,2
SUFENTANIL,Erythema,2
SUFENTANIL,Pancytopenia,2
SUFENTANIL,Cardio-respiratory arrest,1
SUFENTANIL,Acute respiratory distress syndrome,1
SUFENTANIL,Multiple organ dysfunction syndrome,1
SUFENTANIL,Abdominal pain,1
SUFENTANIL,Haemodynamic instability,1
SUFENTANIL,Bronchospasm,1
SUFENTANIL,Papule,1
SUFENTANIL,Hypotension,1
SUFENTANIL,Propofol infusion syndrome,1
SUFENTANIL,Product use in unapproved indication,1
SUFENTANIL,Hypertransaminasaemia,1
SUFENTANIL,COVID-19 pneumonia,1
SUFENTANIL,COVID-19,1
SUFENTANIL,Rhabdomyolysis,1
SUFENTANIL,Respiratory distress,1
SUFENTANIL,Septic shock,1
SULFAMETHOXAZOLE,Pain,22
SULFAMETHOXAZOLE,Pyrexia,19
SULFAMETHOXAZOLE,Febrile neutropenia,15
SULFAMETHOXAZOLE,Diarrhoea,14
SULFAMETHOXAZOLE,Back pain,14
SULFAMETHOXAZOLE,Malaise,14
SULFAMETHOXAZOLE,Vomiting,14
SULFAMETHOXAZOLE,Body temperature increased,12
SULFAMETHOXAZOLE,Accident,12
SULFAMETHOXAZOLE,Proctalgia,11
SULFAMETHOXAZOLE,Anal inflammation,11
SULFAMETHOXAZOLE,Crohn's disease,11
SULFAMETHOXAZOLE,Neutropenia,11
SULFAMETHOXAZOLE,Haemorrhoids,11
SULFAMETHOXAZOLE,Chills,10
SULFAMETHOXAZOLE,Off label use,9
SULFAMETHOXAZOLE,Anxiety,9
SULFAMETHOXAZOLE,SARS-CoV-2 test negative,9
SULFAMETHOXAZOLE,Pneumonia,8
SULFAMETHOXAZOLE,Emotional distress,8
SULFAMETHOXAZOLE,Anhedonia,8
SULFAMETHOXAZOLE,Dyspnoea,6
SULFAMETHOXAZOLE,Osteoporosis,6
SULFAMETHOXAZOLE,Headache,5
SULFAMETHOXAZOLE,Rash,5
SULFAMETHOXAZOLE,Lung disorder,5
SULFAMETHOXAZOLE,Depression,5
SULFAMETHOXAZOLE,Nausea,5
SULFAMETHOXAZOLE,Infection,5
SULFAMETHOXAZOLE,Hypertension,4
SULFAMETHOXAZOLE,Nasopharyngitis,4
SULFAMETHOXAZOLE,Wound,4
SULFAMETHOXAZOLE,Sinusitis,4
SULFAMETHOXAZOLE,Stomatitis,4
SULFAMETHOXAZOLE,Peripheral swelling,4
SULFAMETHOXAZOLE,Liver disorder,4
SULFAMETHOXAZOLE,Urticaria,4
SULFAMETHOXAZOLE,Weight decreased,4
SULFAMETHOXAZOLE,Pain in extremity,4
SULFAMETHOXAZOLE,Osteopenia,4
SULFAMETHOXAZOLE,Renal impairment,4
SULFAMETHOXAZOLE,Bone demineralisation,4
SULFAMETHOXAZOLE,Sepsis,4
SULFAMETHOXAZOLE,Septic shock,4
SULFAMETHOXAZOLE,Orbital haemorrhage,4
SULFAMETHOXAZOLE,Asthenia,3
SULFAMETHOXAZOLE,Hand deformity,3
SULFAMETHOXAZOLE,Rheumatoid factor positive,3
SULFAMETHOXAZOLE,Impaired healing,3
SULFAMETHOXAZOLE,Rheumatoid arthritis,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Dyspnoea,9
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Headache,9
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Pyrexia,9
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Pneumonia,9
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Fatigue,7
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Off label use,7
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Pain,7
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Nausea,7
SULFAMETHOXAZOLE AND TRIMETHOPRIM,COVID-19,7
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Febrile neutropenia,6
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Anaemia,6
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Rheumatoid arthritis,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Diarrhoea,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Anxiety,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Infection,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,White blood cell count decreased,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Sepsis,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Cough,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Platelet count decreased,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Neutrophil count decreased,5
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Weight increased,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Alopecia,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Intentional product use issue,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Rash,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Dizziness,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Lung disorder,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Drug hypersensitivity,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Product dose omission issue,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Chills,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Anhedonia,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Renal failure,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Emotional distress,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Urticaria,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Malaise,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Condition aggravated,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Cerebral haemorrhage,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Immune effector cell-associated neurotoxicity syndrome,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Disseminated intravascular coagulation,4
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Asthenia,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Hypertension,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Infusion related reaction,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Inflammation,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Pruritus,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Nasopharyngitis,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Gastrointestinal disorder,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Sinusitis,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Back pain,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Insomnia,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Vision blurred,3
SULFAMETHOXAZOLE AND TRIMETHOPRIM,Cardiac disorder,3
SULFAMETHOXAZOLE\TRIMETHOPRIM,Pyrexia,49
SULFAMETHOXAZOLE\TRIMETHOPRIM,Pneumonia,34
SULFAMETHOXAZOLE\TRIMETHOPRIM,Febrile neutropenia,32
SULFAMETHOXAZOLE\TRIMETHOPRIM,Vomiting,26
SULFAMETHOXAZOLE\TRIMETHOPRIM,Diarrhoea,25
SULFAMETHOXAZOLE\TRIMETHOPRIM,Rash,23
SULFAMETHOXAZOLE\TRIMETHOPRIM,Dyspnoea,22
SULFAMETHOXAZOLE\TRIMETHOPRIM,Fatigue,21
SULFAMETHOXAZOLE\TRIMETHOPRIM,Dizziness,21
SULFAMETHOXAZOLE\TRIMETHOPRIM,Off label use,19
SULFAMETHOXAZOLE\TRIMETHOPRIM,Nausea,19
SULFAMETHOXAZOLE\TRIMETHOPRIM,Malaise,17
SULFAMETHOXAZOLE\TRIMETHOPRIM,Anaemia,17
SULFAMETHOXAZOLE\TRIMETHOPRIM,Headache,16
SULFAMETHOXAZOLE\TRIMETHOPRIM,Platelet count decreased,16
SULFAMETHOXAZOLE\TRIMETHOPRIM,COVID-19,16
SULFAMETHOXAZOLE\TRIMETHOPRIM,Neutropenia,16
SULFAMETHOXAZOLE\TRIMETHOPRIM,Sepsis,16
SULFAMETHOXAZOLE\TRIMETHOPRIM,Decreased appetite,15
SULFAMETHOXAZOLE\TRIMETHOPRIM,Arthralgia,14
SULFAMETHOXAZOLE\TRIMETHOPRIM,Abdominal pain,14
SULFAMETHOXAZOLE\TRIMETHOPRIM,Acute kidney injury,13
SULFAMETHOXAZOLE\TRIMETHOPRIM,Interstitial lung disease,13
SULFAMETHOXAZOLE\TRIMETHOPRIM,Liver disorder,12
SULFAMETHOXAZOLE\TRIMETHOPRIM,Pain,12
SULFAMETHOXAZOLE\TRIMETHOPRIM,White blood cell count decreased,12
SULFAMETHOXAZOLE\TRIMETHOPRIM,Urinary tract infection,12
SULFAMETHOXAZOLE\TRIMETHOPRIM,Hypertension,11
SULFAMETHOXAZOLE\TRIMETHOPRIM,Thrombocytopenia,11
SULFAMETHOXAZOLE\TRIMETHOPRIM,Neutrophil count decreased,11
SULFAMETHOXAZOLE\TRIMETHOPRIM,Pancytopenia,11
SULFAMETHOXAZOLE\TRIMETHOPRIM,Abdominal discomfort,10
SULFAMETHOXAZOLE\TRIMETHOPRIM,Tachycardia,10
SULFAMETHOXAZOLE\TRIMETHOPRIM,Cytokine release syndrome,10
SULFAMETHOXAZOLE\TRIMETHOPRIM,Septic shock,10
SULFAMETHOXAZOLE\TRIMETHOPRIM,General physical health deterioration,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Condition aggravated,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,C-reactive protein increased,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Tremor,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Fall,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Back pain,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Cough,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Myalgia,9
SULFAMETHOXAZOLE\TRIMETHOPRIM,Drug ineffective,8
SULFAMETHOXAZOLE\TRIMETHOPRIM,Pruritus,8
SULFAMETHOXAZOLE\TRIMETHOPRIM,Drug intolerance,8
SULFAMETHOXAZOLE\TRIMETHOPRIM,Lung disorder,8
SULFAMETHOXAZOLE\TRIMETHOPRIM,Drug hypersensitivity,8
SULFAMETHOXAZOLE\TRIMETHOPRIM,Hypotension,8
SULFAMETHOXAZOLE\TRIMETHOPRIM,Respiratory failure,8
SULFASALAZINE,Drug ineffective,37
SULFASALAZINE,Off label use,35
SULFASALAZINE,Arthralgia,35
SULFASALAZINE,Pain,29
SULFASALAZINE,Pain in extremity,28
SULFASALAZINE,Condition aggravated,28
SULFASALAZINE,Diarrhoea,25
SULFASALAZINE,Rheumatoid arthritis,24
SULFASALAZINE,Musculoskeletal stiffness,22
SULFASALAZINE,Joint swelling,22
SULFASALAZINE,Fatigue,21
SULFASALAZINE,Pyrexia,20
SULFASALAZINE,Nausea,20
SULFASALAZINE,COVID-19,20
SULFASALAZINE,Malaise,19
SULFASALAZINE,Drug intolerance,17
SULFASALAZINE,Rash,17
SULFASALAZINE,Dizziness,16
SULFASALAZINE,Dyspnoea,16
SULFASALAZINE,Headache,16
SULFASALAZINE,Psoriatic arthropathy,16
SULFASALAZINE,Therapeutic product effect incomplete,15
SULFASALAZINE,Synovitis,15
SULFASALAZINE,Nasopharyngitis,15
SULFASALAZINE,Peripheral swelling,15
SULFASALAZINE,Drug hypersensitivity,14
SULFASALAZINE,Hypertension,14
SULFASALAZINE,Inflammation,14
SULFASALAZINE,Intentional product use issue,14
SULFASALAZINE,Back pain,14
SULFASALAZINE,Vomiting,14
SULFASALAZINE,C-reactive protein increased,14
SULFASALAZINE,Arthritis,14
SULFASALAZINE,Therapeutic product effect decreased,13
SULFASALAZINE,Arthropathy,13
SULFASALAZINE,Treatment failure,13
SULFASALAZINE,Weight decreased,13
SULFASALAZINE,Infection,12
SULFASALAZINE,Weight increased,12
SULFASALAZINE,Pneumonia,12
SULFASALAZINE,Mobility decreased,12
SULFASALAZINE,Cough,12
SULFASALAZINE,Red blood cell sedimentation rate increased,11
SULFASALAZINE,Asthenia,11
SULFASALAZINE,Contraindicated product administered,11
SULFASALAZINE,Insomnia,11
SULFASALAZINE,Gait disturbance,11
SULFASALAZINE,Loss of personal independence in daily activities,11
SULFASALAZINE,Product use issue,11
SULFASALAZINE,Hypoaesthesia,10
SUMATRIPTAN,Migraine,10
SUMATRIPTAN,Headache,7
SUMATRIPTAN,Abdominal pain,7
SUMATRIPTAN,Product dose omission issue,6
SUMATRIPTAN,Vomiting,5
SUMATRIPTAN,Nausea,5
SUMATRIPTAN,COVID-19,5
SUMATRIPTAN,Malaise,5
SUMATRIPTAN,Pruritus,5
SUMATRIPTAN,Foetal death,5
SUMATRIPTAN,Meconium in amniotic fluid,5
SUMATRIPTAN,Depression,4
SUMATRIPTAN,Pain,4
SUMATRIPTAN,Diarrhoea,4
SUMATRIPTAN,Sinusitis,4
SUMATRIPTAN,Myocardial infarction,4
SUMATRIPTAN,Dizziness,4
SUMATRIPTAN,Fatigue,4
SUMATRIPTAN,Vision blurred,4
SUMATRIPTAN,Illness,4
SUMATRIPTAN,Foetal exposure during pregnancy,4
SUMATRIPTAN,Anxiety,3
SUMATRIPTAN,Small intestinal obstruction,3
SUMATRIPTAN,Urinary tract infection,3
SUMATRIPTAN,Infusion site pruritus,3
SUMATRIPTAN,Rash,3
SUMATRIPTAN,Pneumonia,3
SUMATRIPTAN,Fluid retention,3
SUMATRIPTAN,Sleep apnoea syndrome,3
SUMATRIPTAN,Condition aggravated,3
SUMATRIPTAN,Death,3
SUMATRIPTAN,Adverse drug reaction,3
SUMATRIPTAN,Bradycardia neonatal,3
SUMATRIPTAN,Small for dates baby,3
SUMATRIPTAN,Oropharyngeal pain,2
SUMATRIPTAN,Abdominal discomfort,2
SUMATRIPTAN,Clostridium difficile colitis,2
SUMATRIPTAN,Dehydration,2
SUMATRIPTAN,Abdominal distension,2
SUMATRIPTAN,Infusion site swelling,2
SUMATRIPTAN,Weight increased,2
SUMATRIPTAN,Tinea pedis,2
SUMATRIPTAN,Bacterial vulvovaginitis,2
SUMATRIPTAN,Insurance issue,2
SUMATRIPTAN,Vaginal infection,2
SUMATRIPTAN,Liquid product physical issue,2
SUMATRIPTAN,Incorrect drug administration rate,2
SUMATRIPTAN,Infusion site pain,2
SUMATRIPTAN,Drug hypersensitivity,2
SUMATRIPTAN,Cystitis,2
SUSTIVA,Pain,83
SUSTIVA,Emotional distress,82
SUSTIVA,Anxiety,77
SUSTIVA,Anhedonia,75
SUSTIVA,Chronic kidney disease,42
SUSTIVA,Osteoporosis,37
SUSTIVA,Osteopenia,28
SUSTIVA,Renal failure,23
SUSTIVA,Bone density decreased,22
SUSTIVA,Bone demineralisation,21
SUSTIVA,Depression,19
SUSTIVA,Blood creatinine increased,15
SUSTIVA,Economic problem,14
SUSTIVA,Renal impairment,14
SUSTIVA,Acute kidney injury,14
SUSTIVA,Multiple fractures,11
SUSTIVA,Gait disturbance,11
SUSTIVA,Fatigue,10
SUSTIVA,Back pain,8
SUSTIVA,Bone loss,8
SUSTIVA,End stage renal disease,8
SUSTIVA,Asthenia,8
SUSTIVA,Foot fracture,7
SUSTIVA,Proteinuria,7
SUSTIVA,Insomnia,6
SUSTIVA,Mobility decreased,6
SUSTIVA,Hip fracture,6
SUSTIVA,Renal injury,6
SUSTIVA,Quality of life decreased,5
SUSTIVA,Pollakiuria,5
SUSTIVA,Decreased activity,4
SUSTIVA,Fanconi syndrome acquired,4
SUSTIVA,Dysstasia,4
SUSTIVA,Wrist fracture,4
SUSTIVA,General physical health deterioration,3
SUSTIVA,Renal disorder,3
SUSTIVA,Pathological fracture,3
SUSTIVA,Weight decreased,3
SUSTIVA,Nephrolithiasis,3
SUSTIVA,Osteonecrosis,3
SUSTIVA,Lower limb fracture,3
SUSTIVA,Hand fracture,3
SUSTIVA,Tooth loss,3
SUSTIVA,Hypertension,3
SUSTIVA,Spinal compression fracture,2
SUSTIVA,Renal pain,2
SUSTIVA,Loss of personal independence in daily activities,2
SUSTIVA,Fall,2
SUSTIVA,Ankle fracture,2
SUSTIVA,Malaise,2
SYMBICORT,Asthma,62
SYMBICORT,Dyspnoea,58
SYMBICORT,Fatigue,43
SYMBICORT,Sinusitis,43
SYMBICORT,COVID-19,43
SYMBICORT,Pneumonia,42
SYMBICORT,Nasopharyngitis,39
SYMBICORT,Product dose omission issue,35
SYMBICORT,Headache,35
SYMBICORT,Cough,34
SYMBICORT,Weight decreased,32
SYMBICORT,Inappropriate schedule of product administration,32
SYMBICORT,Pain,31
SYMBICORT,Nausea,30
SYMBICORT,Malaise,29
SYMBICORT,Fall,29
SYMBICORT,Bronchitis,28
SYMBICORT,Diarrhoea,28
SYMBICORT,Dizziness,27
SYMBICORT,Urinary tract infection,26
SYMBICORT,Influenza,25
SYMBICORT,Anxiety,25
SYMBICORT,Illness,24
SYMBICORT,Pain in extremity,24
SYMBICORT,Wheezing,22
SYMBICORT,Blood pressure increased,22
SYMBICORT,Pyrexia,22
SYMBICORT,Hypersensitivity,21
SYMBICORT,Weight increased,21
SYMBICORT,Drug hypersensitivity,21
SYMBICORT,Arthralgia,20
SYMBICORT,Off label use,20
SYMBICORT,Upper respiratory tract infection,18
SYMBICORT,Seasonal allergy,18
SYMBICORT,Pruritus,18
SYMBICORT,Productive cough,17
SYMBICORT,Chest discomfort,17
SYMBICORT,Contusion,17
SYMBICORT,Drug ineffective,17
SYMBICORT,Nasal congestion,16
SYMBICORT,Forced expiratory volume decreased,15
SYMBICORT,Lower respiratory tract infection,14
SYMBICORT,Oropharyngeal pain,14
SYMBICORT,Middle insomnia,14
SYMBICORT,Gait disturbance,13
SYMBICORT,Asthenia,13
SYMBICORT,Heart rate increased,13
SYMBICORT,Feeling abnormal,13
SYMBICORT,Insurance issue,13
SYMBICORT,Injection site pain,13
SYNTHROID,Fatigue,69
SYNTHROID,Off label use,64
SYNTHROID,COVID-19,58
SYNTHROID,Pain,56
SYNTHROID,Headache,48
SYNTHROID,Sinusitis,45
SYNTHROID,Product dose omission issue,42
SYNTHROID,Inappropriate schedule of product administration,40
SYNTHROID,Malaise,39
SYNTHROID,Nausea,38
SYNTHROID,Urinary tract infection,37
SYNTHROID,Drug ineffective,36
SYNTHROID,Arthralgia,35
SYNTHROID,Fall,30
SYNTHROID,Diarrhoea,29
SYNTHROID,Pain in extremity,28
SYNTHROID,Weight decreased,27
SYNTHROID,Pneumonia,27
SYNTHROID,Dizziness,27
SYNTHROID,Pruritus,26
SYNTHROID,Condition aggravated,25
SYNTHROID,Asthenia,25
SYNTHROID,Illness,23
SYNTHROID,Nasopharyngitis,23
SYNTHROID,Dyspnoea,23
SYNTHROID,Anxiety,23
SYNTHROID,Feeling abnormal,22
SYNTHROID,Back pain,22
SYNTHROID,Vomiting,21
SYNTHROID,Contusion,20
SYNTHROID,Gait disturbance,20
SYNTHROID,Hypertension,20
SYNTHROID,Blood pressure increased,20
SYNTHROID,Product use issue,20
SYNTHROID,Alopecia,18
SYNTHROID,Peripheral swelling,18
SYNTHROID,Pyrexia,18
SYNTHROID,Rash,18
SYNTHROID,Cough,18
SYNTHROID,Influenza,18
SYNTHROID,Asthma,17
SYNTHROID,Infection,16
SYNTHROID,Abdominal pain upper,16
SYNTHROID,Drug hypersensitivity,16
SYNTHROID,Depression,15
SYNTHROID,Weight increased,15
SYNTHROID,Oropharyngeal pain,15
SYNTHROID,Abdominal discomfort,13
SYNTHROID,Dehydration,13
SYNTHROID,Constipation,13
TACROLIMUS,Off label use,17
TACROLIMUS,Pruritus,17
TACROLIMUS,Pyrexia,14
TACROLIMUS,Diarrhoea,12
TACROLIMUS,Product dose omission issue,12
TACROLIMUS,Pain,12
TACROLIMUS,Headache,12
TACROLIMUS,Hypertension,12
TACROLIMUS,Acute kidney injury,10
TACROLIMUS,Dermatitis atopic,10
TACROLIMUS,Drug ineffective,9
TACROLIMUS,Urinary tract infection,9
TACROLIMUS,Product use in unapproved indication,9
TACROLIMUS,Rash,9
TACROLIMUS,Arthralgia,9
TACROLIMUS,Erythema,9
TACROLIMUS,Neuropathy peripheral,8
TACROLIMUS,Toxicity to various agents,8
TACROLIMUS,Drug interaction,7
TACROLIMUS,Chronic kidney disease,7
TACROLIMUS,Dry skin,7
TACROLIMUS,Nausea,7
TACROLIMUS,Anxiety,6
TACROLIMUS,Inappropriate schedule of product administration,6
TACROLIMUS,Anaemia,6
TACROLIMUS,Weight decreased,6
TACROLIMUS,Hypotension,6
TACROLIMUS,Dizziness,6
TACROLIMUS,COVID-19,6
TACROLIMUS,Skin exfoliation,6
TACROLIMUS,Neutropenia,5
TACROLIMUS,Condition aggravated,5
TACROLIMUS,Malaise,5
TACROLIMUS,Back pain,5
TACROLIMUS,Renal impairment,5
TACROLIMUS,Cytomegalovirus infection,5
TACROLIMUS,Septic shock,5
TACROLIMUS,Localised infection,5
TACROLIMUS,Abdominal pain,5
TACROLIMUS,Feeling abnormal,5
TACROLIMUS,Mouth ulceration,5
TACROLIMUS,Skin haemorrhage,5
TACROLIMUS,Accidental exposure to product,4
TACROLIMUS,Contusion,4
TACROLIMUS,Infection,4
TACROLIMUS,Emotional distress,4
TACROLIMUS,Anhedonia,4
TACROLIMUS,End stage renal disease,4
TACROLIMUS,Influenza,4
TACROLIMUS,Blood pressure increased,4
TADALAFIL,Headache,82
TADALAFIL,Dyspnoea,68
TADALAFIL,Diarrhoea,67
TADALAFIL,Nausea,64
TADALAFIL,Fatigue,49
TADALAFIL,Cough,42
TADALAFIL,Dizziness,35
TADALAFIL,Vomiting,32
TADALAFIL,Pain in jaw,30
TADALAFIL,Oxygen saturation decreased,27
TADALAFIL,Malaise,26
TADALAFIL,Nasopharyngitis,25
TADALAFIL,Pain in extremity,24
TADALAFIL,Pain,24
TADALAFIL,Pneumonia,21
TADALAFIL,Dyspnoea exertional,21
TADALAFIL,Hypotension,21
TADALAFIL,Myalgia,21
TADALAFIL,Flushing,20
TADALAFIL,Infusion site pain,20
TADALAFIL,Feeling abnormal,18
TADALAFIL,Arthralgia,18
TADALAFIL,Palpitations,17
TADALAFIL,Abdominal pain upper,17
TADALAFIL,Off label use,17
TADALAFIL,Pyrexia,15
TADALAFIL,Asthenia,15
TADALAFIL,Infusion site erythema,15
TADALAFIL,Weight decreased,15
TADALAFIL,Abdominal pain,15
TADALAFIL,Chest pain,14
TADALAFIL,Pulmonary arterial hypertension,14
TADALAFIL,Product dose omission issue,14
TADALAFIL,COVID-19,13
TADALAFIL,Oedema peripheral,13
TADALAFIL,Loss of consciousness,13
TADALAFIL,Vascular device infection,12
TADALAFIL,Abdominal discomfort,12
TADALAFIL,Injection site pain,11
TADALAFIL,Throat irritation,11
TADALAFIL,Anxiety,11
TADALAFIL,Chest discomfort,11
TADALAFIL,Anaemia,11
TADALAFIL,Epistaxis,11
TADALAFIL,Illness,10
TADALAFIL,Chills,10
TADALAFIL,Nasal congestion,10
TADALAFIL,Somnolence,10
TADALAFIL,Pulmonary hypertension,10
TADALAFIL,Hyperhidrosis,9
TAHOR,Hypotension,8
TAHOR,Hypocalcaemia,7
TAHOR,Pruritus,7
TAHOR,Electrocardiogram QT prolonged,7
TAHOR,Eosinophilia,6
TAHOR,Septic shock,6
TAHOR,Diarrhoea,6
TAHOR,General physical health deterioration,6
TAHOR,Cardiogenic shock,5
TAHOR,Xerosis,5
TAHOR,Dermatitis atopic,5
TAHOR,Toxic skin eruption,5
TAHOR,Rash maculo-papular,5
TAHOR,COVID-19 pneumonia,4
TAHOR,Heart transplant rejection,4
TAHOR,Candida infection,4
TAHOR,Enterobacter bacteraemia,4
TAHOR,Proteus infection,4
TAHOR,Fungaemia,4
TAHOR,Chronic kidney disease,4
TAHOR,Drug ineffective for unapproved indication,4
TAHOR,Neuropathy peripheral,4
TAHOR,Malnutrition,4
TAHOR,Respiratory disorder,4
TAHOR,Cytomegalovirus infection,4
TAHOR,Localised infection,4
TAHOR,Off label use,4
TAHOR,Acute kidney injury,4
TAHOR,Pyrexia,3
TAHOR,Anaemia,3
TAHOR,Coma,3
TAHOR,Thrombocytopenia,3
TAHOR,COVID-19,3
TAHOR,Brief psychotic disorder with marked stressors,3
TAHOR,Poisoning deliberate,3
TAHOR,Dysuria,2
TAHOR,Neutropenia,2
TAHOR,Bronchitis,2
TAHOR,Asthenia,2
TAHOR,Vaccination failure,2
TAHOR,Acute generalised exanthematous pustulosis,2
TAHOR,Gastrointestinal haemorrhage,2
TAHOR,Febrile neutropenia,2
TAHOR,Hypokalaemia,2
TAHOR,Acute respiratory distress syndrome,2
TAHOR,Tinnitus,1
TAHOR,Pyelonephritis acute,1
TAHOR,Photophobia,1
TAHOR,Hepatitis acute,1
TAHOR,Nausea,1
TAKHZYRO,Hereditary angioedema,50
TAKHZYRO,Pain,19
TAKHZYRO,Headache,18
TAKHZYRO,Malaise,18
TAKHZYRO,Weight increased,15
TAKHZYRO,Weight decreased,13
TAKHZYRO,Inappropriate schedule of product administration,12
TAKHZYRO,Dizziness,12
TAKHZYRO,Oropharyngeal pain,10
TAKHZYRO,Diarrhoea,9
TAKHZYRO,Fatigue,9
TAKHZYRO,Nausea,9
TAKHZYRO,Pyrexia,9
TAKHZYRO,Product availability issue,8
TAKHZYRO,Influenza,8
TAKHZYRO,Cough,8
TAKHZYRO,Nasal congestion,7
TAKHZYRO,Arthralgia,7
TAKHZYRO,Dysphonia,7
TAKHZYRO,Product dose omission issue,7
TAKHZYRO,Depression,7
TAKHZYRO,Anxiety,6
TAKHZYRO,Gait disturbance,6
TAKHZYRO,Vomiting,6
TAKHZYRO,COVID-19,6
TAKHZYRO,Pruritus,6
TAKHZYRO,Chest pain,6
TAKHZYRO,Condition aggravated,6
TAKHZYRO,Stress,6
TAKHZYRO,Illness,6
TAKHZYRO,Influenza like illness,6
TAKHZYRO,Fall,6
TAKHZYRO,Product use issue,6
TAKHZYRO,Product prescribing error,6
TAKHZYRO,Discouragement,6
TAKHZYRO,Abdominal pain,6
TAKHZYRO,Crying,5
TAKHZYRO,Dyspnoea,5
TAKHZYRO,Blood pressure increased,5
TAKHZYRO,Body height decreased,5
TAKHZYRO,Asthenia,5
TAKHZYRO,Decreased appetite,5
TAKHZYRO,Somnolence,5
TAKHZYRO,Off label use,5
TAKHZYRO,Anosmia,4
TAKHZYRO,Ageusia,4
TAKHZYRO,Pregnancy,4
TAKHZYRO,Erythema,4
TAKHZYRO,Urticaria,4
TAKHZYRO,Back pain,4
TAMSULOSIN,Pain,30
TAMSULOSIN,Off label use,30
TAMSULOSIN,Fatigue,26
TAMSULOSIN,Arthralgia,24
TAMSULOSIN,Anxiety,24
TAMSULOSIN,Anhedonia,20
TAMSULOSIN,Emotional distress,20
TAMSULOSIN,Diarrhoea,20
TAMSULOSIN,Product dose omission issue,18
TAMSULOSIN,Death,17
TAMSULOSIN,Dizziness,17
TAMSULOSIN,COVID-19,17
TAMSULOSIN,Pyrexia,16
TAMSULOSIN,Pneumonia,15
TAMSULOSIN,Rash,14
TAMSULOSIN,Nausea,14
TAMSULOSIN,Pruritus,14
TAMSULOSIN,Vomiting,13
TAMSULOSIN,Chronic kidney disease,12
TAMSULOSIN,Headache,11
TAMSULOSIN,Back pain,11
TAMSULOSIN,Dyspnoea,11
TAMSULOSIN,Drug ineffective,11
TAMSULOSIN,Malaise,10
TAMSULOSIN,Pain in extremity,10
TAMSULOSIN,Osteoporosis,10
TAMSULOSIN,Urinary tract infection,10
TAMSULOSIN,Weight decreased,10
TAMSULOSIN,Asthenia,10
TAMSULOSIN,Condition aggravated,10
TAMSULOSIN,Bone density decreased,9
TAMSULOSIN,Fall,9
TAMSULOSIN,Peripheral swelling,9
TAMSULOSIN,Skin mass,9
TAMSULOSIN,Hypersensitivity,9
TAMSULOSIN,Neck pain,8
TAMSULOSIN,Blood pressure decreased,8
TAMSULOSIN,Intentional product use issue,8
TAMSULOSIN,Visual impairment,8
TAMSULOSIN,Abdominal pain upper,8
TAMSULOSIN,Abdominal discomfort,8
TAMSULOSIN,Blood creatinine increased,7
TAMSULOSIN,Depression,7
TAMSULOSIN,Cough,7
TAMSULOSIN,Gait disturbance,7
TAMSULOSIN,Oedema peripheral,7
TAMSULOSIN,Decreased appetite,7
TAMSULOSIN,Septic shock,7
TAMSULOSIN,Insomnia,7
TAMSULOSIN,Inappropriate schedule of product administration,7
TAMSULOSIN HYDROCHLORIDE,Off label use,30
TAMSULOSIN HYDROCHLORIDE,COVID-19,28
TAMSULOSIN HYDROCHLORIDE,Product dose omission issue,16
TAMSULOSIN HYDROCHLORIDE,Condition aggravated,16
TAMSULOSIN HYDROCHLORIDE,Arthralgia,15
TAMSULOSIN HYDROCHLORIDE,Nausea,14
TAMSULOSIN HYDROCHLORIDE,Asthenia,11
TAMSULOSIN HYDROCHLORIDE,Back pain,11
TAMSULOSIN HYDROCHLORIDE,Hypoaesthesia,11
TAMSULOSIN HYDROCHLORIDE,Fatigue,11
TAMSULOSIN HYDROCHLORIDE,Rash,11
TAMSULOSIN HYDROCHLORIDE,Arthropathy,11
TAMSULOSIN HYDROCHLORIDE,Headache,10
TAMSULOSIN HYDROCHLORIDE,Malaise,10
TAMSULOSIN HYDROCHLORIDE,Dizziness,10
TAMSULOSIN HYDROCHLORIDE,Product use issue,10
TAMSULOSIN HYDROCHLORIDE,Vision blurred,10
TAMSULOSIN HYDROCHLORIDE,Pain in extremity,10
TAMSULOSIN HYDROCHLORIDE,Abdominal discomfort,10
TAMSULOSIN HYDROCHLORIDE,Lower respiratory tract infection,10
TAMSULOSIN HYDROCHLORIDE,Intentional product misuse,10
TAMSULOSIN HYDROCHLORIDE,Inflammation,10
TAMSULOSIN HYDROCHLORIDE,Knee arthroplasty,10
TAMSULOSIN HYDROCHLORIDE,Lung neoplasm malignant,10
TAMSULOSIN HYDROCHLORIDE,Radiation inflammation,10
TAMSULOSIN HYDROCHLORIDE,Diarrhoea,9
TAMSULOSIN HYDROCHLORIDE,Fall,9
TAMSULOSIN HYDROCHLORIDE,Peripheral swelling,9
TAMSULOSIN HYDROCHLORIDE,Urinary retention,9
TAMSULOSIN HYDROCHLORIDE,Schizophrenia,9
TAMSULOSIN HYDROCHLORIDE,Pulmonary pain,9
TAMSULOSIN HYDROCHLORIDE,Drug abuse,9
TAMSULOSIN HYDROCHLORIDE,Overdose,9
TAMSULOSIN HYDROCHLORIDE,Anaemia,8
TAMSULOSIN HYDROCHLORIDE,Pneumonia,8
TAMSULOSIN HYDROCHLORIDE,Diplopia,8
TAMSULOSIN HYDROCHLORIDE,Urinary tract infection,7
TAMSULOSIN HYDROCHLORIDE,Hypokalaemia,7
TAMSULOSIN HYDROCHLORIDE,Dyspnoea,7
TAMSULOSIN HYDROCHLORIDE,Weight decreased,7
TAMSULOSIN HYDROCHLORIDE,Haematochezia,7
TAMSULOSIN HYDROCHLORIDE,Prescribed overdose,7
TAMSULOSIN HYDROCHLORIDE,Maternal exposure before pregnancy,7
TAMSULOSIN HYDROCHLORIDE,Neutrophilia,7
TAMSULOSIN HYDROCHLORIDE,Decreased vibratory sense,7
TAMSULOSIN HYDROCHLORIDE,Somnolence,7
TAMSULOSIN HYDROCHLORIDE,Urinary incontinence,7
TAMSULOSIN HYDROCHLORIDE,Musculoskeletal stiffness,7
TAMSULOSIN HYDROCHLORIDE,Micturition urgency,7
TAMSULOSIN HYDROCHLORIDE,Pruritus,7
TASIGNA,Inappropriate schedule of product administration,18
TASIGNA,Dizziness,13
TASIGNA,Pruritus,12
TASIGNA,Headache,11
TASIGNA,Pain,11
TASIGNA,Influenza,11
TASIGNA,Fatigue,11
TASIGNA,Arthralgia,10
TASIGNA,Weight decreased,10
TASIGNA,Malaise,9
TASIGNA,Pain in extremity,9
TASIGNA,Feeling abnormal,9
TASIGNA,Asthenia,9
TASIGNA,Illness,9
TASIGNA,Pyrexia,8
TASIGNA,Blood cholesterol increased,8
TASIGNA,Discomfort,8
TASIGNA,Nausea,7
TASIGNA,Chest pain,7
TASIGNA,Diarrhoea,7
TASIGNA,Constipation,7
TASIGNA,Abdominal discomfort,7
TASIGNA,Death,7
TASIGNA,Gait disturbance,6
TASIGNA,Platelet count decreased,6
TASIGNA,Haemoglobin decreased,6
TASIGNA,Abdominal pain,6
TASIGNA,Incorrect dose administered,6
TASIGNA,Weight increased,6
TASIGNA,Visual impairment,5
TASIGNA,Dyspepsia,5
TASIGNA,Dry skin,5
TASIGNA,Cough,5
TASIGNA,Nasopharyngitis,5
TASIGNA,Blood glucose increased,5
TASIGNA,Anxiety,5
TASIGNA,Gastritis,5
TASIGNA,Vomiting,4
TASIGNA,Arthropathy,4
TASIGNA,Stress,4
TASIGNA,Syncope,4
TASIGNA,Head discomfort,4
TASIGNA,Dyspnoea,4
TASIGNA,Abdominal pain upper,4
TASIGNA,Anaemia,4
TASIGNA,Inflammation,4
TASIGNA,Oropharyngeal pain,4
TASIGNA,Somnolence,4
TASIGNA,Respiratory disorder,3
TASIGNA,Ear pain,3
TAVALISSE,Diarrhoea,24
TAVALISSE,Fatigue,12
TAVALISSE,Off label use,11
TAVALISSE,Platelet count decreased,11
TAVALISSE,Product dose omission issue,9
TAVALISSE,Blood pressure increased,8
TAVALISSE,Platelet count,7
TAVALISSE,Hypertension,7
TAVALISSE,Dizziness,7
TAVALISSE,Headache,6
TAVALISSE,Contusion,6
TAVALISSE,Drug ineffective,6
TAVALISSE,Death,5
TAVALISSE,Platelet count increased,5
TAVALISSE,Abdominal pain,4
TAVALISSE,COVID-19,4
TAVALISSE,Cough,4
TAVALISSE,Nausea,4
TAVALISSE,Weight increased,4
TAVALISSE,Abdominal pain upper,3
TAVALISSE,Fall,3
TAVALISSE,Constipation,3
TAVALISSE,Rash,3
TAVALISSE,Peripheral swelling,3
TAVALISSE,Pain in extremity,3
TAVALISSE,Dyspnoea,2
TAVALISSE,Erythema,2
TAVALISSE,Abdominal discomfort,2
TAVALISSE,Gastrointestinal disorder,2
TAVALISSE,Blood pressure systolic increased,2
TAVALISSE,Faeces discoloured,2
TAVALISSE,Asthenia,2
TAVALISSE,Flatulence,2
TAVALISSE,Adverse event,2
TAVALISSE,Haemorrhage,2
TAVALISSE,Hypoaesthesia,2
TAVALISSE,Hypersensitivity,2
TAVALISSE,Blood glucose decreased,2
TAVALISSE,Vomiting,2
TAVALISSE,Back pain,2
TAVALISSE,Muscular weakness,2
TAVALISSE,Fluid retention,2
TAVALISSE,Product physical issue,1
TAVALISSE,Colitis,1
TAVALISSE,Haemoglobin decreased,1
TAVALISSE,Gastrointestinal haemorrhage,1
TAVALISSE,Peripheral vascular disorder,1
TAVALISSE,Mouth haemorrhage,1
TAVALISSE,Epistaxis,1
TAVALISSE,Renal impairment,1
TECENTRIQ,Off label use,10
TECENTRIQ,Interstitial lung disease,6
TECENTRIQ,Renal impairment,4
TECENTRIQ,Adrenal insufficiency,4
TECENTRIQ,Hypopituitarism,3
TECENTRIQ,Peripheral sensory neuropathy,3
TECENTRIQ,Erythema multiforme,3
TECENTRIQ,Pyrexia,3
TECENTRIQ,Proteinuria,3
TECENTRIQ,Lung disorder,3
TECENTRIQ,Hepatitis,3
TECENTRIQ,Spinal compression fracture,2
TECENTRIQ,Liver disorder,2
TECENTRIQ,Tubulointerstitial nephritis,2
TECENTRIQ,Hypothyroidism,2
TECENTRIQ,Septic shock,2
TECENTRIQ,Renal failure,2
TECENTRIQ,Diarrhoea,2
TECENTRIQ,Hepatic function abnormal,2
TECENTRIQ,Haemophagocytic lymphohistiocytosis,2
TECENTRIQ,Guillain-Barre syndrome,2
TECENTRIQ,Pulmonary toxicity,2
TECENTRIQ,Cardiac failure,2
TECENTRIQ,Pneumonia,2
TECENTRIQ,Depressed level of consciousness,2
TECENTRIQ,Disseminated intravascular coagulation,2
TECENTRIQ,Immune-mediated hepatic disorder,2
TECENTRIQ,Neutropenia,2
TECENTRIQ,Aspartate aminotransferase increased,2
TECENTRIQ,Alanine aminotransferase increased,2
TECENTRIQ,Pain,2
TECENTRIQ,Myositis,2
TECENTRIQ,Febrile neutropenia,2
TECENTRIQ,Neutrophil count decreased,1
TECENTRIQ,Cholangitis sclerosing,1
TECENTRIQ,Protein urine,1
TECENTRIQ,Pemphigoid,1
TECENTRIQ,Dermatitis exfoliative generalised,1
TECENTRIQ,Small cell lung cancer,1
TECENTRIQ,Organising pneumonia,1
TECENTRIQ,Purpura,1
TECENTRIQ,Eosinophil count increased,1
TECENTRIQ,Product dose omission in error,1
TECENTRIQ,Dyspnoea,1
TECENTRIQ,Ejection fraction decreased,1
TECENTRIQ,Blood pressure systolic decreased,1
TECENTRIQ,Appendicitis,1
TECENTRIQ,Toxic skin eruption,1
TECENTRIQ,Pruritus,1
TECENTRIQ,Anaphylactic shock,1
TECFIDERA,Multiple sclerosis relapse,24
TECFIDERA,Multiple sclerosis,9
TECFIDERA,Treatment failure,8
TECFIDERA,Drug ineffective,8
TECFIDERA,Diarrhoea,7
TECFIDERA,Maternal exposure during pregnancy,6
TECFIDERA,Fatigue,6
TECFIDERA,Flushing,5
TECFIDERA,Dyspnoea,3
TECFIDERA,Headache,3
TECFIDERA,Dizziness,3
TECFIDERA,Fall,3
TECFIDERA,Abdominal pain upper,3
TECFIDERA,Central nervous system lesion,3
TECFIDERA,Vomiting,3
TECFIDERA,Asthenia,2
TECFIDERA,Alopecia,2
TECFIDERA,Muscle spasms,2
TECFIDERA,Pruritus,2
TECFIDERA,Paraesthesia,2
TECFIDERA,Gastrointestinal disorder,2
TECFIDERA,Back pain,2
TECFIDERA,Reactive gastropathy,2
TECFIDERA,Duodenitis,2
TECFIDERA,Gastroduodenal ulcer,2
TECFIDERA,Weight decreased,2
TECFIDERA,Constipation,2
TECFIDERA,Large intestinal stenosis,2
TECFIDERA,Colitis,2
TECFIDERA,Large intestine polyp,2
TECFIDERA,Faecaloma,2
TECFIDERA,Gastric ulcer,2
TECFIDERA,Memory impairment,2
TECFIDERA,Stress,2
TECFIDERA,Lymphopenia,2
TECFIDERA,Therapeutic product effect incomplete,2
TECFIDERA,Abdominal discomfort,2
TECFIDERA,Product dose omission issue,2
TECFIDERA,Nausea,2
TECFIDERA,Pyrexia,2
TECFIDERA,Seizure,2
TECFIDERA,Hand deformity,1
TECFIDERA,Rheumatoid factor positive,1
TECFIDERA,Impaired healing,1
TECFIDERA,Rheumatoid arthritis,1
TECFIDERA,Hypersensitivity,1
TECFIDERA,"Sleep disorder due to general medical condition, insomnia type",1
TECFIDERA,Helicobacter infection,1
TECFIDERA,Hip arthroplasty,1
TECFIDERA,Lower respiratory tract infection,1
TECLISTAMAB,Cytokine release syndrome,13
TECLISTAMAB,COVID-19,10
TECLISTAMAB,Pneumonia,8
TECLISTAMAB,Febrile neutropenia,7
TECLISTAMAB,Sepsis,7
TECLISTAMAB,Plasma cell myeloma,7
TECLISTAMAB,Immune effector cell-associated neurotoxicity syndrome,4
TECLISTAMAB,Dyspnoea,3
TECLISTAMAB,Influenza,3
TECLISTAMAB,Pneumonia bacterial,2
TECLISTAMAB,Hypokalaemia,2
TECLISTAMAB,COVID-19 pneumonia,2
TECLISTAMAB,Myocarditis,2
TECLISTAMAB,Escherichia sepsis,2
TECLISTAMAB,Cytomegalovirus infection reactivation,2
TECLISTAMAB,Neutropenia,2
TECLISTAMAB,Pyrexia,2
TECLISTAMAB,Adenoviral upper respiratory infection,1
TECLISTAMAB,Prostate cancer,1
TECLISTAMAB,Pyramidal tract syndrome,1
TECLISTAMAB,Gastrointestinal disorder,1
TECLISTAMAB,Femoral neck fracture,1
TECLISTAMAB,Diarrhoea,1
TECLISTAMAB,Haemophilus infection,1
TECLISTAMAB,Respiratory tract infection,1
TECLISTAMAB,Hypertension,1
TECLISTAMAB,Ischaemic stroke,1
TECLISTAMAB,Hypoglycaemic coma,1
TECLISTAMAB,Acute myocardial infarction,1
TECLISTAMAB,Overdose,1
TECLISTAMAB,Product preparation error,1
TECLISTAMAB,Incorrect dose administered,1
TECLISTAMAB,Product label confusion,1
TECLISTAMAB,Neutrophil count decreased,1
TECLISTAMAB,Pneumonia klebsiella,1
TECLISTAMAB,Tumour lysis syndrome,1
TECLISTAMAB,Hepatic failure,1
TECLISTAMAB,Hepatorenal syndrome,1
TECLISTAMAB,Hepatitis B reactivation,1
TECLISTAMAB,Paraesthesia oral,1
TECLISTAMAB,CSF protein increased,1
TECLISTAMAB,Arthralgia,1
TECLISTAMAB,Cholecystitis acute,1
TECLISTAMAB,Acute myeloid leukaemia,1
TECLISTAMAB,Lower respiratory tract infection,1
TECLISTAMAB,Staphylococcal sepsis,1
TECLISTAMAB,Haemophagocytic lymphohistiocytosis,1
TECLISTAMAB,Organising pneumonia,1
TECLISTAMAB,Pneumocystis jirovecii pneumonia,1
TECLISTAMAB,Gastroenteritis astroviral,1
TEDUGLUTIDE,Weight decreased,70
TEDUGLUTIDE,Diarrhoea,64
TEDUGLUTIDE,Abdominal pain,56
TEDUGLUTIDE,Vascular device infection,54
TEDUGLUTIDE,Weight increased,48
TEDUGLUTIDE,Product dose omission issue,43
TEDUGLUTIDE,Vomiting,39
TEDUGLUTIDE,Dehydration,39
TEDUGLUTIDE,Nausea,33
TEDUGLUTIDE,Abdominal distension,30
TEDUGLUTIDE,Flatulence,29
TEDUGLUTIDE,COVID-19,28
TEDUGLUTIDE,Decreased appetite,28
TEDUGLUTIDE,Inappropriate schedule of product administration,28
TEDUGLUTIDE,Pyrexia,27
TEDUGLUTIDE,Abdominal discomfort,25
TEDUGLUTIDE,Fatigue,25
TEDUGLUTIDE,Device related sepsis,25
TEDUGLUTIDE,Product use issue,24
TEDUGLUTIDE,Device related infection,24
TEDUGLUTIDE,Abnormal faeces,24
TEDUGLUTIDE,Abdominal pain upper,23
TEDUGLUTIDE,Malaise,21
TEDUGLUTIDE,Constipation,21
TEDUGLUTIDE,Urinary tract infection,20
TEDUGLUTIDE,Illness,20
TEDUGLUTIDE,Asthenia,19
TEDUGLUTIDE,Sepsis,19
TEDUGLUTIDE,Muscle spasms,19
TEDUGLUTIDE,Stoma complication,18
TEDUGLUTIDE,Pain,17
TEDUGLUTIDE,Headache,15
TEDUGLUTIDE,Peripheral swelling,14
TEDUGLUTIDE,Intestinal obstruction,13
TEDUGLUTIDE,Infection,13
TEDUGLUTIDE,Gastrointestinal stoma output increased,13
TEDUGLUTIDE,Arthralgia,13
TEDUGLUTIDE,Nasopharyngitis,13
TEDUGLUTIDE,Small intestinal obstruction,13
TEDUGLUTIDE,Product availability issue,13
TEDUGLUTIDE,Fistula,12
TEDUGLUTIDE,Weight fluctuation,12
TEDUGLUTIDE,Faeces hard,12
TEDUGLUTIDE,Hypokalaemia,11
TEDUGLUTIDE,Back pain,11
TEDUGLUTIDE,Incorrect dose administered,11
TEDUGLUTIDE,Drug ineffective,11
TEDUGLUTIDE,Fall,10
TEDUGLUTIDE,Blood magnesium decreased,10
TEDUGLUTIDE,Pneumonia,10
TEGRETOL,Nausea,6
TEGRETOL,Pyrexia,5
TEGRETOL,Fatigue,5
TEGRETOL,Product use in unapproved indication,5
TEGRETOL,Hepatic cytolysis,5
TEGRETOL,Off label use,5
TEGRETOL,Lymphocyte count decreased,4
TEGRETOL,Somnolence,4
TEGRETOL,Infection,3
TEGRETOL,Urinary tract infection,3
TEGRETOL,Inappropriate schedule of product administration,3
TEGRETOL,White blood cell count decreased,3
TEGRETOL,Seizure,3
TEGRETOL,Headache,3
TEGRETOL,Agranulocytosis,3
TEGRETOL,Drug eruption,3
TEGRETOL,Drug reaction with eosinophilia and systemic symptoms,3
TEGRETOL,Respiratory tract infection,2
TEGRETOL,Tonsillitis,2
TEGRETOL,Gamma-glutamyltransferase increased,2
TEGRETOL,Body temperature abnormal,2
TEGRETOL,Illness,2
TEGRETOL,Upper respiratory tract infection,2
TEGRETOL,Bronchitis,2
TEGRETOL,Sinusitis,2
TEGRETOL,Hernia,2
TEGRETOL,Migraine,2
TEGRETOL,Gastrointestinal infection,2
TEGRETOL,Anaphylactic reaction,2
TEGRETOL,Meningitis,2
TEGRETOL,Sepsis,2
TEGRETOL,Food allergy,2
TEGRETOL,Dyspnoea,2
TEGRETOL,Pruritus,2
TEGRETOL,Vomiting,2
TEGRETOL,Herpes zoster,2
TEGRETOL,Breast cancer,2
TEGRETOL,Fall,2
TEGRETOL,Pancytopenia,2
TEGRETOL,Weight decreased,2
TEGRETOL,Diarrhoea,2
TEGRETOL,Rash maculo-papular,2
TEGRETOL,Dyspepsia,2
TEGRETOL,Confusional state,2
TEGRETOL,Toxicity to various agents,2
TEGRETOL,Hepatic function abnormal,2
TEGRETOL,Erythema,2
TEGRETOL,Skin erosion,2
TEGRETOL,Hypoaesthesia,2
TEGRETOL,Cerebral disorder,2
TELMISARTAN,Fatigue,17
TELMISARTAN,Oedema peripheral,16
TELMISARTAN,Hypotension,15
TELMISARTAN,Off label use,15
TELMISARTAN,Asthenia,12
TELMISARTAN,Palpitations,12
TELMISARTAN,Syncope,12
TELMISARTAN,Acute kidney injury,12
TELMISARTAN,Cardiac failure,12
TELMISARTAN,Mitral valve incompetence,11
TELMISARTAN,Acute myocardial infarction,11
TELMISARTAN,Pyrexia,10
TELMISARTAN,Ventricular hypokinesia,10
TELMISARTAN,Ill-defined disorder,10
TELMISARTAN,Dyspnoea at rest,10
TELMISARTAN,Pericardial disease,10
TELMISARTAN,Anaemia macrocytic,10
TELMISARTAN,Tricuspid valve incompetence,10
TELMISARTAN,Bundle branch block left,10
TELMISARTAN,Ventricular tachycardia,10
TELMISARTAN,Supraventricular tachycardia,10
TELMISARTAN,Intestinal obstruction,10
TELMISARTAN,Left ventricular dysfunction,10
TELMISARTAN,Pulmonary valve disease,10
TELMISARTAN,Diastolic dysfunction,10
TELMISARTAN,Helicobacter gastritis,10
TELMISARTAN,Cardiomegaly,10
TELMISARTAN,Ventricular arrhythmia,10
TELMISARTAN,Pericardial effusion,10
TELMISARTAN,Cardiac discomfort,10
TELMISARTAN,Left ventricular hypertrophy,10
TELMISARTAN,Occult blood,10
TELMISARTAN,Hyperlipidaemia,10
TELMISARTAN,Chronic kidney disease,10
TELMISARTAN,Rales,10
TELMISARTAN,Carotid arteriosclerosis,10
TELMISARTAN,Joint swelling,10
TELMISARTAN,Skin lesion,10
TELMISARTAN,Mitral valve disease,10
TELMISARTAN,Electrocardiogram Q wave abnormal,10
TELMISARTAN,Ejection fraction decreased,10
TELMISARTAN,Coronary artery disease,10
TELMISARTAN,Hepatojugular reflux,10
TELMISARTAN,Electrocardiogram QT prolonged,10
TELMISARTAN,Carotid artery stenosis,10
TELMISARTAN,Systolic dysfunction,10
TELMISARTAN,Aortic valve incompetence,10
TELMISARTAN,Physical examination abnormal,10
TELMISARTAN,Angiopathy,10
TELMISARTAN,Bradycardia,10
TEMAZEPAM,Pain,8
TEMAZEPAM,COVID-19,8
TEMAZEPAM,Headache,7
TEMAZEPAM,Fatigue,7
TEMAZEPAM,Nausea,6
TEMAZEPAM,Product dose omission issue,6
TEMAZEPAM,Diarrhoea,6
TEMAZEPAM,Pneumonia,6
TEMAZEPAM,Off label use,6
TEMAZEPAM,Infusion related reaction,5
TEMAZEPAM,Confusional state,5
TEMAZEPAM,Weight increased,4
TEMAZEPAM,Vomiting,4
TEMAZEPAM,Anxiety,4
TEMAZEPAM,Insomnia,4
TEMAZEPAM,General physical health deterioration,4
TEMAZEPAM,Abdominal pain,4
TEMAZEPAM,C-reactive protein increased,4
TEMAZEPAM,Arthralgia,4
TEMAZEPAM,Toxicity to various agents,4
TEMAZEPAM,Nephrolithiasis,3
TEMAZEPAM,Palpitations,3
TEMAZEPAM,Pyrexia,3
TEMAZEPAM,Osteoporosis,3
TEMAZEPAM,Drug ineffective,3
TEMAZEPAM,Cough,3
TEMAZEPAM,Small intestinal obstruction,3
TEMAZEPAM,Influenza like illness,3
TEMAZEPAM,Illness,3
TEMAZEPAM,Malaise,3
TEMAZEPAM,Decreased appetite,3
TEMAZEPAM,Blood pressure increased,3
TEMAZEPAM,Abdominal distension,3
TEMAZEPAM,Intestinal obstruction,3
TEMAZEPAM,Fall,3
TEMAZEPAM,Overdose,3
TEMAZEPAM,Cardio-respiratory arrest,3
TEMAZEPAM,Drug abuse,3
TEMAZEPAM,Pruritus,3
TEMAZEPAM,Mental disability,2
TEMAZEPAM,Attention deficit hyperactivity disorder,2
TEMAZEPAM,Rib fracture,2
TEMAZEPAM,Asthenia,2
TEMAZEPAM,Chest discomfort,2
TEMAZEPAM,Renal failure,2
TEMAZEPAM,Chronic kidney disease,2
TEMAZEPAM,Emotional distress,2
TEMAZEPAM,Anhedonia,2
TEMAZEPAM,Drug hypersensitivity,2
TEMAZEPAM,Sinusitis,2
TESTOSTERONE,Pain,12
TESTOSTERONE,Anxiety,10
TESTOSTERONE,Emotional distress,10
TESTOSTERONE,Anhedonia,9
TESTOSTERONE,Nausea,8
TESTOSTERONE,Fatigue,7
TESTOSTERONE,Chronic kidney disease,6
TESTOSTERONE,Osteoporosis,6
TESTOSTERONE,Off label use,6
TESTOSTERONE,Bone density decreased,5
TESTOSTERONE,Back pain,5
TESTOSTERONE,Upper respiratory tract infection,5
TESTOSTERONE,Osteopenia,4
TESTOSTERONE,Renal failure,4
TESTOSTERONE,Sinusitis,4
TESTOSTERONE,Product dose omission issue,4
TESTOSTERONE,Gait disturbance,4
TESTOSTERONE,Sleep disorder,4
TESTOSTERONE,Pollakiuria,4
TESTOSTERONE,Vomiting,4
TESTOSTERONE,Headache,4
TESTOSTERONE,Influenza,3
TESTOSTERONE,Multiple fractures,3
TESTOSTERONE,Blood creatinine increased,3
TESTOSTERONE,Drug hypersensitivity,3
TESTOSTERONE,Insomnia,3
TESTOSTERONE,Dyspnoea,3
TESTOSTERONE,Injection site pain,3
TESTOSTERONE,Infusion site swelling,3
TESTOSTERONE,Malaise,3
TESTOSTERONE,Diarrhoea,3
TESTOSTERONE,Inappropriate schedule of product administration,3
TESTOSTERONE,COVID-19,3
TESTOSTERONE,Hyperhidrosis,3
TESTOSTERONE,Chills,3
TESTOSTERONE,Hypertension,2
TESTOSTERONE,Blood iron decreased,2
TESTOSTERONE,Insulin-like growth factor decreased,2
TESTOSTERONE,Hypogonadism,2
TESTOSTERONE,Pituitary tumour,2
TESTOSTERONE,Arterial haemorrhage,2
TESTOSTERONE,Malocclusion,2
TESTOSTERONE,Generalised tonic-clonic seizure,2
TESTOSTERONE,Nephrolithiasis,2
TESTOSTERONE,Proteinuria,2
TESTOSTERONE,Renal impairment,2
TESTOSTERONE,Acute kidney injury,2
TESTOSTERONE,Bone demineralisation,2
TESTOSTERONE,Depression,2
TESTOSTERONE,Ankle fracture,2
TICAGRELOR,Chest pain,8
TICAGRELOR,Arthralgia,8
TICAGRELOR,Pruritus,8
TICAGRELOR,Skin mass,7
TICAGRELOR,Hypersensitivity,7
TICAGRELOR,Gynaecomastia,6
TICAGRELOR,Leukaemia,6
TICAGRELOR,Vertigo,5
TICAGRELOR,Pancreatitis haemorrhagic,5
TICAGRELOR,Hypovolaemia,5
TICAGRELOR,Multiple organ dysfunction syndrome,5
TICAGRELOR,Retroperitoneal haemorrhage,5
TICAGRELOR,Product monitoring error,5
TICAGRELOR,Drug reaction with eosinophilia and systemic symptoms,5
TICAGRELOR,Drug interaction,5
TICAGRELOR,Serotonin syndrome,5
TICAGRELOR,Balance disorder,5
TICAGRELOR,Memory impairment,5
TICAGRELOR,Haematocrit increased,5
TICAGRELOR,Chronic myeloid leukaemia,5
TICAGRELOR,Leukocytosis,5
TICAGRELOR,Performance status decreased,5
TICAGRELOR,Pain in extremity,4
TICAGRELOR,Dyspnoea,4
TICAGRELOR,Abdominal pain,3
TICAGRELOR,Diarrhoea,3
TICAGRELOR,Vascular stent stenosis,3
TICAGRELOR,Blood creatinine increased,2
TICAGRELOR,Tetany,2
TICAGRELOR,Hypocalcaemia,2
TICAGRELOR,Myocardial infarction,2
TICAGRELOR,Asthenia,2
TICAGRELOR,Product dose omission issue,2
TICAGRELOR,Cardiac failure,2
TICAGRELOR,Nausea,2
TICAGRELOR,Palpitations,2
TICAGRELOR,Chest discomfort,2
TICAGRELOR,Melaena,2
TICAGRELOR,Rash pruritic,2
TICAGRELOR,Dysuria,1
TICAGRELOR,Renal tubular necrosis,1
TICAGRELOR,Malaise,1
TICAGRELOR,Hypophagia,1
TICAGRELOR,Blood creatine phosphokinase increased,1
TICAGRELOR,Intracranial aneurysm,1
TICAGRELOR,Renal failure,1
TICAGRELOR,Nephrolithiasis,1
TICAGRELOR,Insomnia,1
TICAGRELOR,Dry skin,1
TICAGRELOR,General physical health deterioration,1
TIVICAY,Pain,109
TIVICAY,Emotional distress,107
TIVICAY,Anhedonia,100
TIVICAY,Anxiety,100
TIVICAY,Chronic kidney disease,62
TIVICAY,Osteoporosis,44
TIVICAY,Renal failure,36
TIVICAY,Osteopenia,29
TIVICAY,Bone density decreased,28
TIVICAY,Blood creatinine increased,27
TIVICAY,Bone demineralisation,27
TIVICAY,Acute kidney injury,23
TIVICAY,Renal impairment,22
TIVICAY,Fatigue,19
TIVICAY,Depression,18
TIVICAY,Gait disturbance,17
TIVICAY,End stage renal disease,15
TIVICAY,Economic problem,12
TIVICAY,Renal injury,11
TIVICAY,Multiple fractures,11
TIVICAY,Asthenia,11
TIVICAY,Foot fracture,10
TIVICAY,Bone loss,9
TIVICAY,Mobility decreased,9
TIVICAY,Decreased activity,9
TIVICAY,Loss of personal independence in daily activities,9
TIVICAY,Vitamin D deficiency,9
TIVICAY,Quality of life decreased,8
TIVICAY,Dysstasia,8
TIVICAY,Back pain,8
TIVICAY,Skeletal injury,7
TIVICAY,Pollakiuria,7
TIVICAY,Nephropathy,6
TIVICAY,Wrist fracture,6
TIVICAY,Ankle fracture,6
TIVICAY,Osteonecrosis,6
TIVICAY,Insomnia,6
TIVICAY,Anaemia,6
TIVICAY,Hip fracture,6
TIVICAY,Nephrolithiasis,5
TIVICAY,Proteinuria,5
TIVICAY,Drug ineffective,5
TIVICAY,Urinary tract infection,4
TIVICAY,Fanconi syndrome acquired,4
TIVICAY,Hypertension,4
TIVICAY,Gout,4
TIVICAY,Foetal exposure during pregnancy,4
TIVICAY,General physical health deterioration,3
TIVICAY,Impaired work ability,3
TIVICAY,Protein urine present,3
TIZANIDINE,Pain,19
TIZANIDINE,Fatigue,15
TIZANIDINE,Anxiety,15
TIZANIDINE,Fall,14
TIZANIDINE,Emotional distress,12
TIZANIDINE,Headache,12
TIZANIDINE,Off label use,12
TIZANIDINE,COVID-19,11
TIZANIDINE,Anhedonia,10
TIZANIDINE,Urinary tract infection,10
TIZANIDINE,Chronic kidney disease,9
TIZANIDINE,Dizziness,9
TIZANIDINE,Drug ineffective,9
TIZANIDINE,Gait disturbance,8
TIZANIDINE,Product dose omission issue,7
TIZANIDINE,Depression,7
TIZANIDINE,Sinusitis,7
TIZANIDINE,Feeling abnormal,7
TIZANIDINE,Malaise,7
TIZANIDINE,Arthralgia,7
TIZANIDINE,Pain in extremity,7
TIZANIDINE,Bone density decreased,6
TIZANIDINE,Contusion,6
TIZANIDINE,Rash,6
TIZANIDINE,Nausea,6
TIZANIDINE,Blood creatinine increased,6
TIZANIDINE,Asthenia,6
TIZANIDINE,Vomiting,5
TIZANIDINE,Diarrhoea,5
TIZANIDINE,Back pain,5
TIZANIDINE,Hypersensitivity,5
TIZANIDINE,Cough,5
TIZANIDINE,Nasopharyngitis,4
TIZANIDINE,Condition aggravated,4
TIZANIDINE,Loss of personal independence in daily activities,4
TIZANIDINE,Dyspnoea,4
TIZANIDINE,Osteoporosis,4
TIZANIDINE,Acute kidney injury,4
TIZANIDINE,Cystitis,4
TIZANIDINE,Constipation,4
TIZANIDINE,Insomnia,4
TIZANIDINE,Osteopenia,4
TIZANIDINE,Mobility decreased,4
TIZANIDINE,Ankle fracture,4
TIZANIDINE,Upper respiratory tract infection,4
TIZANIDINE,Infusion related reaction,4
TIZANIDINE,Weight decreased,4
TIZANIDINE,Hypotension,4
TIZANIDINE,Joint swelling,4
TIZANIDINE,Infection,4
TIZANIDINE HYDROCHLORIDE,Product dose omission issue,15
TIZANIDINE HYDROCHLORIDE,Nausea,14
TIZANIDINE HYDROCHLORIDE,Fatigue,12
TIZANIDINE HYDROCHLORIDE,COVID-19,12
TIZANIDINE HYDROCHLORIDE,Headache,11
TIZANIDINE HYDROCHLORIDE,Pain,11
TIZANIDINE HYDROCHLORIDE,Sinusitis,9
TIZANIDINE HYDROCHLORIDE,Fall,8
TIZANIDINE HYDROCHLORIDE,Anxiety,8
TIZANIDINE HYDROCHLORIDE,Urinary tract infection,8
TIZANIDINE HYDROCHLORIDE,Dyspnoea,7
TIZANIDINE HYDROCHLORIDE,Ear infection,7
TIZANIDINE HYDROCHLORIDE,Weight decreased,7
TIZANIDINE HYDROCHLORIDE,Dizziness,6
TIZANIDINE HYDROCHLORIDE,Influenza,6
TIZANIDINE HYDROCHLORIDE,Malaise,6
TIZANIDINE HYDROCHLORIDE,Diarrhoea,6
TIZANIDINE HYDROCHLORIDE,Pneumonia,6
TIZANIDINE HYDROCHLORIDE,Gait disturbance,5
TIZANIDINE HYDROCHLORIDE,Cystitis,5
TIZANIDINE HYDROCHLORIDE,Upper respiratory tract infection,5
TIZANIDINE HYDROCHLORIDE,Pain in extremity,5
TIZANIDINE HYDROCHLORIDE,Rash,5
TIZANIDINE HYDROCHLORIDE,Pruritus,5
TIZANIDINE HYDROCHLORIDE,Asthenia,5
TIZANIDINE HYDROCHLORIDE,Abdominal discomfort,5
TIZANIDINE HYDROCHLORIDE,Contusion,4
TIZANIDINE HYDROCHLORIDE,Kidney infection,4
TIZANIDINE HYDROCHLORIDE,Infusion related reaction,4
TIZANIDINE HYDROCHLORIDE,Infusion site pain,4
TIZANIDINE HYDROCHLORIDE,Infection,4
TIZANIDINE HYDROCHLORIDE,Burning sensation,4
TIZANIDINE HYDROCHLORIDE,Bronchitis,4
TIZANIDINE HYDROCHLORIDE,Gastroenteritis viral,4
TIZANIDINE HYDROCHLORIDE,Illness,4
TIZANIDINE HYDROCHLORIDE,Multiple sclerosis relapse,4
TIZANIDINE HYDROCHLORIDE,Abdominal pain upper,4
TIZANIDINE HYDROCHLORIDE,Off label use,4
TIZANIDINE HYDROCHLORIDE,Skin burning sensation,3
TIZANIDINE HYDROCHLORIDE,Neck pain,3
TIZANIDINE HYDROCHLORIDE,Hypersomnia,3
TIZANIDINE HYDROCHLORIDE,Insurance issue,3
TIZANIDINE HYDROCHLORIDE,Renal failure,3
TIZANIDINE HYDROCHLORIDE,Limb injury,3
TIZANIDINE HYDROCHLORIDE,Gastric disorder,3
TIZANIDINE HYDROCHLORIDE,Hereditary angioedema,3
TIZANIDINE HYDROCHLORIDE,Infusion site pruritus,3
TIZANIDINE HYDROCHLORIDE,Infusion site discomfort,3
TIZANIDINE HYDROCHLORIDE,Injection site mass,3
TIZANIDINE HYDROCHLORIDE,Paranasal sinus hypersecretion,3
TOCILIZUMAB,Off label use,13
TOCILIZUMAB,Platelet count decreased,11
TOCILIZUMAB,Haemophagocytic lymphohistiocytosis,10
TOCILIZUMAB,Drug ineffective,9
TOCILIZUMAB,Pyrexia,9
TOCILIZUMAB,Condition aggravated,9
TOCILIZUMAB,Arthralgia,9
TOCILIZUMAB,Pneumonia,8
TOCILIZUMAB,Cytokine release syndrome,8
TOCILIZUMAB,Arthropathy,7
TOCILIZUMAB,Synovitis,7
TOCILIZUMAB,Rash,7
TOCILIZUMAB,Drug intolerance,7
TOCILIZUMAB,Vomiting,7
TOCILIZUMAB,Mobility decreased,7
TOCILIZUMAB,Rheumatoid arthritis,7
TOCILIZUMAB,Dyspnoea,7
TOCILIZUMAB,Small intestinal perforation,7
TOCILIZUMAB,Alopecia,6
TOCILIZUMAB,Nausea,6
TOCILIZUMAB,Headache,6
TOCILIZUMAB,Blood cholesterol increased,6
TOCILIZUMAB,Diarrhoea,6
TOCILIZUMAB,Therapeutic product effect decreased,6
TOCILIZUMAB,Abdominal discomfort,6
TOCILIZUMAB,Dizziness,6
TOCILIZUMAB,Intentional product use issue,6
TOCILIZUMAB,Product use issue,6
TOCILIZUMAB,C-reactive protein increased,6
TOCILIZUMAB,Disseminated intravascular coagulation,6
TOCILIZUMAB,White blood cell count decreased,6
TOCILIZUMAB,Immune effector cell-associated neurotoxicity syndrome,6
TOCILIZUMAB,Septic shock,6
TOCILIZUMAB,Respiratory failure,6
TOCILIZUMAB,Hepatic enzyme increased,5
TOCILIZUMAB,Hypersensitivity,5
TOCILIZUMAB,Psoriatic arthropathy,5
TOCILIZUMAB,C-reactive protein abnormal,5
TOCILIZUMAB,Liver disorder,5
TOCILIZUMAB,Fatigue,5
TOCILIZUMAB,Weight decreased,5
TOCILIZUMAB,Musculoskeletal stiffness,5
TOCILIZUMAB,Depression,5
TOCILIZUMAB,Joint swelling,5
TOCILIZUMAB,Gait disturbance,5
TOCILIZUMAB,Hypertension,5
TOCILIZUMAB,Anti-cyclic citrullinated peptide antibody positive,5
TOCILIZUMAB,Malaise,5
TOCILIZUMAB,Live birth,5
TOCILIZUMAB,Maternal exposure during pregnancy,5
TOPAMAX,Nausea,12
TOPAMAX,Sinusitis,12
TOPAMAX,Headache,10
TOPAMAX,Back pain,10
TOPAMAX,Product dose omission issue,10
TOPAMAX,Dizziness,8
TOPAMAX,Malaise,7
TOPAMAX,COVID-19,7
TOPAMAX,Gait disturbance,7
TOPAMAX,Seizure,7
TOPAMAX,Inappropriate schedule of product administration,6
TOPAMAX,Weight decreased,6
TOPAMAX,Migraine,6
TOPAMAX,Fall,6
TOPAMAX,Anxiety,6
TOPAMAX,Illness,6
TOPAMAX,Fatigue,5
TOPAMAX,Upper respiratory tract infection,5
TOPAMAX,Condition aggravated,5
TOPAMAX,Arthralgia,5
TOPAMAX,Feeling abnormal,5
TOPAMAX,Pain,5
TOPAMAX,Depression,4
TOPAMAX,Diarrhoea,4
TOPAMAX,Alopecia,4
TOPAMAX,Dyspepsia,4
TOPAMAX,Insurance issue,4
TOPAMAX,Nasopharyngitis,3
TOPAMAX,Influenza,3
TOPAMAX,Cough,3
TOPAMAX,Anaemia,3
TOPAMAX,Rash,3
TOPAMAX,Vomiting,3
TOPAMAX,Dyspnoea,3
TOPAMAX,Vision blurred,3
TOPAMAX,Syncope,3
TOPAMAX,Bronchitis,3
TOPAMAX,Infusion site pain,3
TOPAMAX,Infusion related reaction,3
TOPAMAX,Abdominal pain upper,3
TOPAMAX,Infusion site pruritus,3
TOPAMAX,Seasonal allergy,3
TOPAMAX,Urinary tract infection,3
TOPAMAX,Hypersensitivity,3
TOPAMAX,Emotional distress,3
TOPAMAX,Anhedonia,3
TOPAMAX,Chest pain,3
TOPAMAX,Ear infection,3
TOPAMAX,Abdominal discomfort,3
TOPAMAX,Memory impairment,3
TOPIRAMATE,Fatigue,22
TOPIRAMATE,Nausea,14
TOPIRAMATE,Pain,13
TOPIRAMATE,Off label use,13
TOPIRAMATE,Headache,13
TOPIRAMATE,Fall,12
TOPIRAMATE,Dizziness,11
TOPIRAMATE,Back pain,10
TOPIRAMATE,Bronchitis,10
TOPIRAMATE,Migraine,9
TOPIRAMATE,COVID-19,9
TOPIRAMATE,Visual impairment,9
TOPIRAMATE,Influenza,8
TOPIRAMATE,Pneumonia,8
TOPIRAMATE,Malaise,8
TOPIRAMATE,Dyspnoea,8
TOPIRAMATE,Product dose omission issue,8
TOPIRAMATE,Weight increased,7
TOPIRAMATE,Vomiting,7
TOPIRAMATE,Somnolence,7
TOPIRAMATE,Oliguria,7
TOPIRAMATE,Cough,6
TOPIRAMATE,Drug ineffective,6
TOPIRAMATE,Diarrhoea,6
TOPIRAMATE,Sinusitis,6
TOPIRAMATE,Balance disorder,6
TOPIRAMATE,Condition aggravated,6
TOPIRAMATE,Asthenia,6
TOPIRAMATE,Weight decreased,5
TOPIRAMATE,Arthralgia,5
TOPIRAMATE,Hypersensitivity,5
TOPIRAMATE,Product use in unapproved indication,5
TOPIRAMATE,Depression,5
TOPIRAMATE,Nasopharyngitis,5
TOPIRAMATE,Inappropriate schedule of product administration,5
TOPIRAMATE,Upper respiratory tract infection,5
TOPIRAMATE,Urinary tract infection,5
TOPIRAMATE,Illness,5
TOPIRAMATE,Paraesthesia,5
TOPIRAMATE,Decreased appetite,5
TOPIRAMATE,Osteoporosis,5
TOPIRAMATE,Agranulocytosis,4
TOPIRAMATE,Alopecia,4
TOPIRAMATE,Anxiety,4
TOPIRAMATE,Ill-defined disorder,4
TOPIRAMATE,Infusion site pain,4
TOPIRAMATE,Infusion site pruritus,4
TOPIRAMATE,Feeling abnormal,4
TOPIRAMATE,Sensitive skin,4
TOPIRAMATE,Pain in extremity,4
TORSEMIDE,Dyspnoea,30
TORSEMIDE,Fatigue,24
TORSEMIDE,Death,22
TORSEMIDE,Anaemia,19
TORSEMIDE,Diarrhoea,19
TORSEMIDE,Pneumonia,19
TORSEMIDE,Dizziness,18
TORSEMIDE,Dehydration,17
TORSEMIDE,General physical health deterioration,17
TORSEMIDE,Pain,15
TORSEMIDE,Atrial fibrillation,15
TORSEMIDE,Cardiac failure,15
TORSEMIDE,Nausea,15
TORSEMIDE,Pyrexia,13
TORSEMIDE,Condition aggravated,13
TORSEMIDE,Urinary tract infection,12
TORSEMIDE,Weight decreased,11
TORSEMIDE,Pleural effusion,10
TORSEMIDE,Acute kidney injury,10
TORSEMIDE,Cough,9
TORSEMIDE,Hypotension,9
TORSEMIDE,Pruritus,9
TORSEMIDE,Asthenia,9
TORSEMIDE,Chest pain,9
TORSEMIDE,Tachycardia,9
TORSEMIDE,Off label use,9
TORSEMIDE,Polyneuropathy,8
TORSEMIDE,Cardiac failure chronic,8
TORSEMIDE,Headache,8
TORSEMIDE,Sepsis,8
TORSEMIDE,Oedema peripheral,8
TORSEMIDE,Haematochezia,8
TORSEMIDE,Vomiting,8
TORSEMIDE,Hyperglycaemia,8
TORSEMIDE,Myocardial infarction,7
TORSEMIDE,Palpitations,7
TORSEMIDE,Constipation,7
TORSEMIDE,Arthralgia,7
TORSEMIDE,Systemic infection,7
TORSEMIDE,Infection,6
TORSEMIDE,Neutropenia,6
TORSEMIDE,Pain in extremity,6
TORSEMIDE,Product dose omission issue,6
TORSEMIDE,Renal impairment,6
TORSEMIDE,Inappropriate schedule of product administration,6
TORSEMIDE,Chronic obstructive pulmonary disease,6
TORSEMIDE,Nasopharyngitis,6
TORSEMIDE,Hepatic cirrhosis,6
TORSEMIDE,Peripheral swelling,6
TORSEMIDE,Labelled drug-drug interaction medication error,6
TRAMADOL,Pain,63
TRAMADOL,Anxiety,51
TRAMADOL,Diarrhoea,37
TRAMADOL,Emotional distress,37
TRAMADOL,Anhedonia,33
TRAMADOL,Nausea,32
TRAMADOL,Fatigue,30
TRAMADOL,Arthralgia,28
TRAMADOL,Vomiting,28
TRAMADOL,Pyrexia,27
TRAMADOL,Off label use,26
TRAMADOL,Drug ineffective,24
TRAMADOL,Dyspnoea,24
TRAMADOL,Depression,23
TRAMADOL,Pain in extremity,22
TRAMADOL,Urinary tract infection,22
TRAMADOL,Chronic kidney disease,22
TRAMADOL,Back pain,22
TRAMADOL,Osteoporosis,21
TRAMADOL,Product dose omission issue,20
TRAMADOL,Fall,19
TRAMADOL,Headache,19
TRAMADOL,Malaise,18
TRAMADOL,Asthenia,18
TRAMADOL,Condition aggravated,16
TRAMADOL,Constipation,16
TRAMADOL,Dizziness,16
TRAMADOL,Gait disturbance,15
TRAMADOL,Rash,15
TRAMADOL,COVID-19,15
TRAMADOL,Pruritus,15
TRAMADOL,Muscle spasms,14
TRAMADOL,Weight decreased,14
TRAMADOL,Confusional state,14
TRAMADOL,Osteopenia,14
TRAMADOL,Bone density decreased,14
TRAMADOL,Cough,13
TRAMADOL,Somnolence,13
TRAMADOL,Blood creatinine increased,13
TRAMADOL,Anaemia,13
TRAMADOL,Decreased appetite,13
TRAMADOL,Poisoning deliberate,13
TRAMADOL,Acute kidney injury,12
TRAMADOL,Renal failure,12
TRAMADOL,Sinusitis,12
TRAMADOL,Pneumonia,12
TRAMADOL,Musculoskeletal stiffness,11
TRAMADOL,Abdominal pain,11
TRAMADOL,Renal impairment,11
TRAMADOL,Illness,11
TRAMADOL HCL,Sinusitis,18
TRAMADOL HCL,Product dose omission issue,16
TRAMADOL HCL,Upper respiratory tract infection,13
TRAMADOL HCL,Fatigue,12
TRAMADOL HCL,COVID-19,11
TRAMADOL HCL,Inappropriate schedule of product administration,9
TRAMADOL HCL,Migraine,9
TRAMADOL HCL,Malaise,9
TRAMADOL HCL,Off label use,9
TRAMADOL HCL,Urinary tract infection,8
TRAMADOL HCL,Pneumonia,7
TRAMADOL HCL,Abdominal pain,7
TRAMADOL HCL,Weight decreased,7
TRAMADOL HCL,Diarrhoea,6
TRAMADOL HCL,Nausea,6
TRAMADOL HCL,Illness,6
TRAMADOL HCL,Fall,6
TRAMADOL HCL,Condition aggravated,5
TRAMADOL HCL,Headache,5
TRAMADOL HCL,Pain,5
TRAMADOL HCL,Bronchitis,5
TRAMADOL HCL,Infusion site pain,5
TRAMADOL HCL,Influenza,5
TRAMADOL HCL,Product use issue,5
TRAMADOL HCL,Pruritus,5
TRAMADOL HCL,Infusion site pruritus,4
TRAMADOL HCL,Small intestinal obstruction,4
TRAMADOL HCL,Insurance issue,4
TRAMADOL HCL,Asthma,4
TRAMADOL HCL,Asthenia,3
TRAMADOL HCL,Pyrexia,3
TRAMADOL HCL,Infusion related reaction,3
TRAMADOL HCL,Oropharyngeal pain,3
TRAMADOL HCL,Feeling abnormal,3
TRAMADOL HCL,Infection,3
TRAMADOL HCL,Hereditary angioedema,3
TRAMADOL HCL,Dyspnoea,3
TRAMADOL HCL,Injection site pruritus,3
TRAMADOL HCL,Injection site erythema,3
TRAMADOL HCL,Hypertension,3
TRAMADOL HCL,Seasonal allergy,3
TRAMADOL HCL,Product availability issue,3
TRAMADOL HCL,Cerebrovascular accident,3
TRAMADOL HCL,Decreased appetite,3
TRAMADOL HCL,Dry eye,3
TRAMADOL HCL,Immunodeficiency,3
TRAMADOL HCL,Abdominal discomfort,3
TRAMADOL HCL,Abdominal pain upper,3
TRAMADOL HCL,Vomiting,3
TRAMADOL HCL,Dizziness,2
TRAMADOL HYDROCHLORIDE,Vomiting,17
TRAMADOL HYDROCHLORIDE,Poisoning deliberate,17
TRAMADOL HYDROCHLORIDE,Pyrexia,16
TRAMADOL HYDROCHLORIDE,Off label use,15
TRAMADOL HYDROCHLORIDE,Headache,15
TRAMADOL HYDROCHLORIDE,Arthralgia,15
TRAMADOL HYDROCHLORIDE,Diarrhoea,15
TRAMADOL HYDROCHLORIDE,Coma,15
TRAMADOL HYDROCHLORIDE,Pruritus,14
TRAMADOL HYDROCHLORIDE,Asthenia,14
TRAMADOL HYDROCHLORIDE,Fatigue,13
TRAMADOL HYDROCHLORIDE,Tachycardia,13
TRAMADOL HYDROCHLORIDE,Confusional state,12
TRAMADOL HYDROCHLORIDE,Dizziness,12
TRAMADOL HYDROCHLORIDE,Muscle spasms,12
TRAMADOL HYDROCHLORIDE,Drug interaction,12
TRAMADOL HYDROCHLORIDE,Acute generalised exanthematous pustulosis,12
TRAMADOL HYDROCHLORIDE,Drug ineffective,11
TRAMADOL HYDROCHLORIDE,Decreased appetite,11
TRAMADOL HYDROCHLORIDE,Dyspnoea,11
TRAMADOL HYDROCHLORIDE,Toxicity to various agents,11
TRAMADOL HYDROCHLORIDE,Seizure,11
TRAMADOL HYDROCHLORIDE,Nausea,10
TRAMADOL HYDROCHLORIDE,Musculoskeletal stiffness,10
TRAMADOL HYDROCHLORIDE,Depression,10
TRAMADOL HYDROCHLORIDE,Maternal exposure during pregnancy,10
TRAMADOL HYDROCHLORIDE,Hypoaesthesia,10
TRAMADOL HYDROCHLORIDE,Hyperhidrosis,10
TRAMADOL HYDROCHLORIDE,Contusion,9
TRAMADOL HYDROCHLORIDE,Neuroleptic malignant syndrome,9
TRAMADOL HYDROCHLORIDE,Urinary retention,9
TRAMADOL HYDROCHLORIDE,Tinnitus,8
TRAMADOL HYDROCHLORIDE,Delirium,8
TRAMADOL HYDROCHLORIDE,Gait disturbance,8
TRAMADOL HYDROCHLORIDE,Condition aggravated,8
TRAMADOL HYDROCHLORIDE,Sleep disorder,8
TRAMADOL HYDROCHLORIDE,Visual impairment,8
TRAMADOL HYDROCHLORIDE,Paraesthesia,8
TRAMADOL HYDROCHLORIDE,Restlessness,8
TRAMADOL HYDROCHLORIDE,Restless legs syndrome,8
TRAMADOL HYDROCHLORIDE,Anxiety,8
TRAMADOL HYDROCHLORIDE,Disorientation,8
TRAMADOL HYDROCHLORIDE,Swelling face,8
TRAMADOL HYDROCHLORIDE,Tremor,8
TRAMADOL HYDROCHLORIDE,Exposure during pregnancy,8
TRAMADOL HYDROCHLORIDE,Illness,8
TRAMADOL HYDROCHLORIDE,Rash,7
TRAMADOL HYDROCHLORIDE,Anaemia,7
TRAMADOL HYDROCHLORIDE,Derealisation,7
TRAMADOL HYDROCHLORIDE,Muscle disorder,7
TRAMETINIB,Pyrexia,18
TRAMETINIB,Fatigue,10
TRAMETINIB,Chills,8
TRAMETINIB,Vomiting,7
TRAMETINIB,Aspartate aminotransferase increased,6
TRAMETINIB,Alanine aminotransferase increased,6
TRAMETINIB,Headache,6
TRAMETINIB,Asthenia,6
TRAMETINIB,Dehydration,6
TRAMETINIB,General physical health deterioration,6
TRAMETINIB,Dyspnoea,5
TRAMETINIB,Acute kidney injury,5
TRAMETINIB,Gamma-glutamyltransferase increased,5
TRAMETINIB,Malignant neoplasm progression,5
TRAMETINIB,Chromaturia,5
TRAMETINIB,Diarrhoea,5
TRAMETINIB,Death,5
TRAMETINIB,Anaemia,5
TRAMETINIB,Thrombocytopenia,5
TRAMETINIB,Rash,4
TRAMETINIB,Confusional state,4
TRAMETINIB,Pain in extremity,4
TRAMETINIB,Decreased appetite,4
TRAMETINIB,Pain,3
TRAMETINIB,Constipation,3
TRAMETINIB,Infection,3
TRAMETINIB,Weight decreased,3
TRAMETINIB,Drug-induced liver injury,3
TRAMETINIB,Blood creatinine increased,3
TRAMETINIB,Leukopenia,3
TRAMETINIB,Sepsis,3
TRAMETINIB,Abdominal pain,3
TRAMETINIB,Off label use,3
TRAMETINIB,Neoplasm progression,3
TRAMETINIB,Fall,3
TRAMETINIB,Nausea,3
TRAMETINIB,Cough,3
TRAMETINIB,C-reactive protein increased,2
TRAMETINIB,Hypotension,2
TRAMETINIB,Ejection fraction decreased,2
TRAMETINIB,Syncope,2
TRAMETINIB,Rash erythematous,2
TRAMETINIB,Skin disorder,2
TRAMETINIB,Renal pain,2
TRAMETINIB,Hypercalcaemia,2
TRAMETINIB,Transaminases increased,2
TRAMETINIB,Neutropenia,2
TRAMETINIB,Respiratory distress,2
TRAMETINIB,Hyponatraemia,2
TRAMETINIB,Haemorrhage,2
TRANEXAMIC ACID,Pain,10
TRANEXAMIC ACID,Malaise,9
TRANEXAMIC ACID,Nausea,8
TRANEXAMIC ACID,Fatigue,7
TRANEXAMIC ACID,Anxiety,7
TRANEXAMIC ACID,Dizziness,7
TRANEXAMIC ACID,Hereditary angioedema,7
TRANEXAMIC ACID,Abdominal pain,7
TRANEXAMIC ACID,Diarrhoea,6
TRANEXAMIC ACID,Weight decreased,6
TRANEXAMIC ACID,Pyrexia,6
TRANEXAMIC ACID,Vomiting,6
TRANEXAMIC ACID,Headache,6
TRANEXAMIC ACID,Weight increased,6
TRANEXAMIC ACID,Depression,5
TRANEXAMIC ACID,Dyspnoea,4
TRANEXAMIC ACID,Cough,4
TRANEXAMIC ACID,Decreased appetite,4
TRANEXAMIC ACID,Discouragement,4
TRANEXAMIC ACID,Dysphonia,4
TRANEXAMIC ACID,Influenza,4
TRANEXAMIC ACID,Off label use,4
TRANEXAMIC ACID,Constipation,4
TRANEXAMIC ACID,Lethargy,4
TRANEXAMIC ACID,Haemorrhage,3
TRANEXAMIC ACID,Pruritus,3
TRANEXAMIC ACID,Chest pain,3
TRANEXAMIC ACID,Drug ineffective,3
TRANEXAMIC ACID,Oropharyngeal pain,3
TRANEXAMIC ACID,Emotional distress,3
TRANEXAMIC ACID,Asthenia,3
TRANEXAMIC ACID,Body height increased,3
TRANEXAMIC ACID,Blood lactate dehydrogenase increased,3
TRANEXAMIC ACID,Abdominal discomfort,3
TRANEXAMIC ACID,Poor venous access,3
TRANEXAMIC ACID,Anaphylactic shock,3
TRANEXAMIC ACID,Hepatic cytolysis,3
TRANEXAMIC ACID,Cholestasis,3
TRANEXAMIC ACID,Leukopenia,3
TRANEXAMIC ACID,Chronic lymphocytic leukaemia,2
TRANEXAMIC ACID,Pallor,2
TRANEXAMIC ACID,Irritability,2
TRANEXAMIC ACID,Tremor,2
TRANEXAMIC ACID,Crying,2
TRANEXAMIC ACID,Loss of consciousness,2
TRANEXAMIC ACID,Fall,2
TRANEXAMIC ACID,Laziness,2
TRANEXAMIC ACID,Thyroid disorder,2
TRANEXAMIC ACID,Abdominal symptom,2
TRANEXAMIC ACID,Injection site bruising,2
TRASTUZUMAB,Diarrhoea,39
TRASTUZUMAB,Fatigue,28
TRASTUZUMAB,Mucosal inflammation,27
TRASTUZUMAB,Alopecia,23
TRASTUZUMAB,Off label use,21
TRASTUZUMAB,Anaemia,20
TRASTUZUMAB,Nausea,19
TRASTUZUMAB,Rash,18
TRASTUZUMAB,Neutropenia,18
TRASTUZUMAB,Neuropathy peripheral,17
TRASTUZUMAB,Ejection fraction decreased,15
TRASTUZUMAB,Gastrooesophageal reflux disease,15
TRASTUZUMAB,Osteonecrosis of jaw,14
TRASTUZUMAB,Influenza like illness,13
TRASTUZUMAB,Lymphoedema,13
TRASTUZUMAB,Vascular device infection,12
TRASTUZUMAB,Gingival swelling,12
TRASTUZUMAB,Epistaxis,12
TRASTUZUMAB,Hot flush,12
TRASTUZUMAB,COVID-19,12
TRASTUZUMAB,Platelet count decreased,11
TRASTUZUMAB,Dyspepsia,11
TRASTUZUMAB,Sepsis,10
TRASTUZUMAB,Overdose,10
TRASTUZUMAB,Seizure,10
TRASTUZUMAB,Disease progression,10
TRASTUZUMAB,Death,10
TRASTUZUMAB,Keratitis,10
TRASTUZUMAB,Visual acuity reduced,10
TRASTUZUMAB,Affective disorder,9
TRASTUZUMAB,Leukopenia,9
TRASTUZUMAB,Neutrophil count increased,9
TRASTUZUMAB,Cellulitis,9
TRASTUZUMAB,Schizophrenia,9
TRASTUZUMAB,Incorrect dose administered,9
TRASTUZUMAB,Psychotic disorder,9
TRASTUZUMAB,Lymphocyte count decreased,9
TRASTUZUMAB,"Hallucination, auditory",9
TRASTUZUMAB,Extrapyramidal disorder,9
TRASTUZUMAB,Delusion of grandeur,9
TRASTUZUMAB,Thrombocytopenia,9
TRASTUZUMAB,Device related infection,8
TRASTUZUMAB,Rhinalgia,8
TRASTUZUMAB,Dyspnoea,7
TRASTUZUMAB,Lymphocyte count abnormal,7
TRASTUZUMAB,Pyrexia,6
TRASTUZUMAB,Asthenia,6
TRASTUZUMAB,Oedema peripheral,6
TRASTUZUMAB,Abdominal pain,6
TRASTUZUMAB,SARS-CoV-2 test positive,6
TRAZODONE,Pain,46
TRAZODONE,Anxiety,43
TRAZODONE,Fatigue,36
TRAZODONE,Emotional distress,33
TRAZODONE,Anhedonia,31
TRAZODONE,Nausea,25
TRAZODONE,Depression,25
TRAZODONE,Diarrhoea,22
TRAZODONE,Chronic kidney disease,21
TRAZODONE,Headache,20
TRAZODONE,Asthenia,19
TRAZODONE,Off label use,18
TRAZODONE,Fall,18
TRAZODONE,Product dose omission issue,17
TRAZODONE,Malaise,15
TRAZODONE,Sinusitis,15
TRAZODONE,Renal failure,14
TRAZODONE,Vomiting,13
TRAZODONE,Osteoporosis,13
TRAZODONE,Condition aggravated,12
TRAZODONE,Weight increased,11
TRAZODONE,Dizziness,11
TRAZODONE,Blood creatinine increased,11
TRAZODONE,Nasopharyngitis,11
TRAZODONE,COVID-19,11
TRAZODONE,Bone density decreased,11
TRAZODONE,Pyrexia,11
TRAZODONE,Weight decreased,10
TRAZODONE,Hypertension,10
TRAZODONE,Illness,10
TRAZODONE,Cough,10
TRAZODONE,Back pain,10
TRAZODONE,Dyspnoea,10
TRAZODONE,Pneumonia,10
TRAZODONE,Bronchitis,9
TRAZODONE,Abdominal pain upper,9
TRAZODONE,Abdominal discomfort,9
TRAZODONE,Acute kidney injury,9
TRAZODONE,Osteopenia,9
TRAZODONE,Pain in extremity,9
TRAZODONE,Myalgia,9
TRAZODONE,Arthralgia,9
TRAZODONE,Suicidal ideation,8
TRAZODONE,End stage renal disease,8
TRAZODONE,Contusion,8
TRAZODONE,Feeling abnormal,8
TRAZODONE,Decreased appetite,8
TRAZODONE,Urinary tract infection,7
TRAZODONE,Blood pressure increased,7
TRAZODONE,Nephrolithiasis,7
TRAZODONE HCL,COVID-19,23
TRAZODONE HCL,Product dose omission issue,21
TRAZODONE HCL,Sinusitis,19
TRAZODONE HCL,Pneumonia,17
TRAZODONE HCL,Fatigue,15
TRAZODONE HCL,Urinary tract infection,12
TRAZODONE HCL,Bronchitis,11
TRAZODONE HCL,Pain,11
TRAZODONE HCL,Malaise,10
TRAZODONE HCL,Headache,10
TRAZODONE HCL,Illness,10
TRAZODONE HCL,Inappropriate schedule of product administration,9
TRAZODONE HCL,Nausea,9
TRAZODONE HCL,Diarrhoea,9
TRAZODONE HCL,Arthralgia,9
TRAZODONE HCL,Seasonal allergy,8
TRAZODONE HCL,Respiratory tract infection,8
TRAZODONE HCL,Infection,8
TRAZODONE HCL,Fall,8
TRAZODONE HCL,Upper respiratory tract infection,7
TRAZODONE HCL,Weight increased,7
TRAZODONE HCL,Weight decreased,7
TRAZODONE HCL,Infusion related reaction,7
TRAZODONE HCL,Multiple allergies,6
TRAZODONE HCL,Dehydration,6
TRAZODONE HCL,Insurance issue,6
TRAZODONE HCL,Pruritus,6
TRAZODONE HCL,Anxiety,5
TRAZODONE HCL,Nasopharyngitis,5
TRAZODONE HCL,Influenza,5
TRAZODONE HCL,Vomiting,5
TRAZODONE HCL,Needle issue,5
TRAZODONE HCL,Sepsis,5
TRAZODONE HCL,Cough,5
TRAZODONE HCL,Muscle spasms,5
TRAZODONE HCL,Blood pressure increased,5
TRAZODONE HCL,Feeling abnormal,5
TRAZODONE HCL,Ear infection,4
TRAZODONE HCL,Staphylococcal infection,4
TRAZODONE HCL,Nephrolithiasis,4
TRAZODONE HCL,Erythema,4
TRAZODONE HCL,Rash,4
TRAZODONE HCL,Small intestinal obstruction,4
TRAZODONE HCL,Infusion site pain,4
TRAZODONE HCL,Renal disorder,4
TRAZODONE HCL,Device issue,4
TRAZODONE HCL,Abdominal distension,4
TRAZODONE HCL,Pyrexia,4
TRAZODONE HCL,Oropharyngeal pain,4
TRAZODONE HCL,Muscle strain,4
TRELEGY ELLIPTA,Product dose omission issue,16
TRELEGY ELLIPTA,COVID-19,15
TRELEGY ELLIPTA,Sinusitis,15
TRELEGY ELLIPTA,Dyspnoea,14
TRELEGY ELLIPTA,Pneumonia,12
TRELEGY ELLIPTA,Asthma,11
TRELEGY ELLIPTA,Headache,11
TRELEGY ELLIPTA,Fall,10
TRELEGY ELLIPTA,Fatigue,10
TRELEGY ELLIPTA,Bronchitis,9
TRELEGY ELLIPTA,Pain,9
TRELEGY ELLIPTA,Insurance issue,8
TRELEGY ELLIPTA,Illness,8
TRELEGY ELLIPTA,Off label use,8
TRELEGY ELLIPTA,Back pain,7
TRELEGY ELLIPTA,Nausea,7
TRELEGY ELLIPTA,Inappropriate schedule of product administration,7
TRELEGY ELLIPTA,Product use issue,6
TRELEGY ELLIPTA,Anxiety,6
TRELEGY ELLIPTA,Seasonal allergy,6
TRELEGY ELLIPTA,Vomiting,6
TRELEGY ELLIPTA,Condition aggravated,6
TRELEGY ELLIPTA,Nasopharyngitis,6
TRELEGY ELLIPTA,Upper respiratory tract infection,6
TRELEGY ELLIPTA,Arthralgia,5
TRELEGY ELLIPTA,Respiratory distress,5
TRELEGY ELLIPTA,Stress,5
TRELEGY ELLIPTA,Cough,5
TRELEGY ELLIPTA,Erythema,4
TRELEGY ELLIPTA,Infusion related reaction,4
TRELEGY ELLIPTA,Limb injury,4
TRELEGY ELLIPTA,Pruritus,4
TRELEGY ELLIPTA,Contusion,4
TRELEGY ELLIPTA,Arthritis,4
TRELEGY ELLIPTA,Sepsis,4
TRELEGY ELLIPTA,Skin laceration,4
TRELEGY ELLIPTA,Somnolence,4
TRELEGY ELLIPTA,Abdominal pain,4
TRELEGY ELLIPTA,Infusion site erythema,4
TRELEGY ELLIPTA,Weight increased,4
TRELEGY ELLIPTA,Influenza,4
TRELEGY ELLIPTA,Dizziness,4
TRELEGY ELLIPTA,Multiple allergies,4
TRELEGY ELLIPTA,COVID-19 pneumonia,3
TRELEGY ELLIPTA,Intervertebral disc protrusion,3
TRELEGY ELLIPTA,Neck pain,3
TRELEGY ELLIPTA,Atrial fibrillation,3
TRELEGY ELLIPTA,Pyrexia,3
TRELEGY ELLIPTA,Respiratory tract congestion,3
TRELEGY ELLIPTA,Upper-airway cough syndrome,3
TREMFYA,Product dose omission issue,98
TREMFYA,Accidental exposure to product,48
TREMFYA,Needle issue,31
TREMFYA,Device issue,23
TREMFYA,Device malfunction,17
TREMFYA,Off label use,15
TREMFYA,Product leakage,15
TREMFYA,Product quality issue,13
TREMFYA,Inappropriate schedule of product administration,8
TREMFYA,Drug delivery system malfunction,7
TREMFYA,Psoriasis,7
TREMFYA,Wrong technique in product usage process,6
TREMFYA,Device leakage,6
TREMFYA,Device defective,6
TREMFYA,Psoriatic arthropathy,5
TREMFYA,Underdose,5
TREMFYA,Pneumonia,5
TREMFYA,Syringe issue,5
TREMFYA,Pain,5
TREMFYA,Injection site haemorrhage,4
TREMFYA,Product complaint,4
TREMFYA,Breast cancer,4
TREMFYA,Product storage error,4
TREMFYA,Drug ineffective,4
TREMFYA,Rash,4
TREMFYA,COVID-19,4
TREMFYA,Product use issue,3
TREMFYA,Liquid product physical issue,3
TREMFYA,Product administration error,3
TREMFYA,Product label issue,3
TREMFYA,Skin disorder,3
TREMFYA,Pruritus,3
TREMFYA,Injury associated with device,2
TREMFYA,Therapeutic product effect incomplete,2
TREMFYA,Illness,2
TREMFYA,Arthralgia,2
TREMFYA,Tuberculosis,2
TREMFYA,Dyspnoea,2
TREMFYA,Skin fissures,2
TREMFYA,Skin exfoliation,2
TREMFYA,Chapped lips,2
TREMFYA,Lip haemorrhage,2
TREMFYA,Skin haemorrhage,2
TREMFYA,Fatigue,2
TREMFYA,Chills,2
TREMFYA,Vomiting,2
TREMFYA,Pyrexia,2
TREMFYA,Poor quality product administered,2
TREMFYA,Hepatic function abnormal,2
TREMFYA,Death,2
TREPROSTINIL,Dyspnoea,75
TREPROSTINIL,Diarrhoea,70
TREPROSTINIL,Headache,61
TREPROSTINIL,Nausea,48
TREPROSTINIL,Fatigue,41
TREPROSTINIL,Malaise,37
TREPROSTINIL,Dizziness,37
TREPROSTINIL,COVID-19,34
TREPROSTINIL,Hypotension,34
TREPROSTINIL,Pain in extremity,33
TREPROSTINIL,Oxygen saturation decreased,32
TREPROSTINIL,Pain,31
TREPROSTINIL,Vomiting,31
TREPROSTINIL,Nasopharyngitis,29
TREPROSTINIL,Cough,26
TREPROSTINIL,Pain in jaw,26
TREPROSTINIL,Infusion site pain,25
TREPROSTINIL,Peripheral swelling,24
TREPROSTINIL,Pyrexia,24
TREPROSTINIL,Injection site erythema,23
TREPROSTINIL,Weight decreased,23
TREPROSTINIL,Pneumonia,22
TREPROSTINIL,Asthenia,21
TREPROSTINIL,Pulmonary hypertension,21
TREPROSTINIL,Injection site pain,20
TREPROSTINIL,Weight increased,20
TREPROSTINIL,Arthralgia,20
TREPROSTINIL,Vascular device infection,19
TREPROSTINIL,Complication associated with device,19
TREPROSTINIL,Chest pain,18
TREPROSTINIL,Nasal congestion,18
TREPROSTINIL,Sinusitis,18
TREPROSTINIL,Syncope,17
TREPROSTINIL,Erythema,17
TREPROSTINIL,Catheter site erythema,16
TREPROSTINIL,Abdominal pain upper,15
TREPROSTINIL,Dyspnoea exertional,15
TREPROSTINIL,Death,15
TREPROSTINIL,Palpitations,14
TREPROSTINIL,Flushing,14
TREPROSTINIL,Feeling abnormal,14
TREPROSTINIL,Loss of consciousness,14
TREPROSTINIL,Abdominal discomfort,14
TREPROSTINIL,Infusion site erythema,14
TREPROSTINIL,Infection,13
TREPROSTINIL,Myalgia,13
TREPROSTINIL,Hypoxia,12
TREPROSTINIL,Chest discomfort,12
TREPROSTINIL,Fall,12
TREPROSTINIL,Decreased appetite,12
TRESIBA,Pain,11
TRESIBA,Off label use,11
TRESIBA,Blood glucose increased,9
TRESIBA,Ascites,9
TRESIBA,Nausea,9
TRESIBA,Condition aggravated,8
TRESIBA,Sepsis,8
TRESIBA,Dyspnoea,8
TRESIBA,Decreased appetite,8
TRESIBA,Stress,7
TRESIBA,Cardiogenic shock,7
TRESIBA,Incorrect route of product administration,7
TRESIBA,Death,7
TRESIBA,Multiple organ dysfunction syndrome,7
TRESIBA,Vomiting,7
TRESIBA,Constipation,7
TRESIBA,Abdominal distension,7
TRESIBA,Anxiety,6
TRESIBA,Bacterial infection,6
TRESIBA,Hyponatraemia,6
TRESIBA,Dry mouth,6
TRESIBA,Somnolence,6
TRESIBA,Neuralgia,6
TRESIBA,Swelling,6
TRESIBA,Weight decreased,6
TRESIBA,Drug ineffective,6
TRESIBA,COVID-19,5
TRESIBA,Fall,5
TRESIBA,Inappropriate schedule of product administration,5
TRESIBA,Drug hypersensitivity,5
TRESIBA,Drug intolerance,5
TRESIBA,Intentional product misuse,5
TRESIBA,General physical health deterioration,5
TRESIBA,Abdominal pain,5
TRESIBA,Sleep disorder,5
TRESIBA,Depression,4
TRESIBA,Chills,4
TRESIBA,Product dose omission issue,4
TRESIBA,Hypertension,4
TRESIBA,Arthralgia,4
TRESIBA,Headache,4
TRESIBA,Product use in unapproved indication,4
TRESIBA,Chronic kidney disease,4
TRESIBA,Anhedonia,4
TRESIBA,Emotional distress,4
TRESIBA,Appendicolith,4
TRESIBA,Ventricular fibrillation,4
TRESIBA,Appendicitis,4
TRESIBA,Fatigue,4
TRESIBA,Anaemia,4
TRIAMCINOLONE,Pain,15
TRIAMCINOLONE,Anxiety,13
TRIAMCINOLONE,Psoriasis,12
TRIAMCINOLONE,Emotional distress,11
TRIAMCINOLONE,Drug ineffective,10
TRIAMCINOLONE,Off label use,9
TRIAMCINOLONE,Anhedonia,9
TRIAMCINOLONE,Diarrhoea,8
TRIAMCINOLONE,Renal failure,7
TRIAMCINOLONE,Osteoporosis,7
TRIAMCINOLONE,Vomiting,7
TRIAMCINOLONE,Arthralgia,7
TRIAMCINOLONE,Nausea,7
TRIAMCINOLONE,Pruritus,7
TRIAMCINOLONE,COVID-19,6
TRIAMCINOLONE,Urinary tract infection,6
TRIAMCINOLONE,Bone density decreased,6
TRIAMCINOLONE,Headache,6
TRIAMCINOLONE,Product dose omission issue,6
TRIAMCINOLONE,Condition aggravated,5
TRIAMCINOLONE,Sinusitis,5
TRIAMCINOLONE,Osteopenia,5
TRIAMCINOLONE,Acute kidney injury,5
TRIAMCINOLONE,Arthritis,5
TRIAMCINOLONE,Fatigue,5
TRIAMCINOLONE,Pyrexia,5
TRIAMCINOLONE,Rash,5
TRIAMCINOLONE,Dizziness,5
TRIAMCINOLONE,Product use in unapproved indication,5
TRIAMCINOLONE,Asthma,4
TRIAMCINOLONE,Renal impairment,4
TRIAMCINOLONE,Gait disturbance,4
TRIAMCINOLONE,Weight decreased,4
TRIAMCINOLONE,Fall,4
TRIAMCINOLONE,Mobility decreased,4
TRIAMCINOLONE,Pneumonia,4
TRIAMCINOLONE,Back pain,4
TRIAMCINOLONE,Product use issue,4
TRIAMCINOLONE,Malaise,4
TRIAMCINOLONE,Muscle spasms,4
TRIAMCINOLONE,Feeling abnormal,4
TRIAMCINOLONE,Abdominal pain upper,4
TRIAMCINOLONE,Hypotension,4
TRIAMCINOLONE,Constipation,4
TRIAMCINOLONE,Bronchitis,3
TRIAMCINOLONE,Upper respiratory tract infection,3
TRIAMCINOLONE,Chronic kidney disease,3
TRIAMCINOLONE,Multiple fractures,3
TRIAMCINOLONE,Hand fracture,3
TRIAMCINOLONE,Skeletal injury,3
TRIAMCINOLONE ACETONIDE,Pruritus,23
TRIAMCINOLONE ACETONIDE,Dry skin,18
TRIAMCINOLONE ACETONIDE,Product dose omission issue,14
TRIAMCINOLONE ACETONIDE,Dermatitis atopic,14
TRIAMCINOLONE ACETONIDE,Headache,12
TRIAMCINOLONE ACETONIDE,Condition aggravated,12
TRIAMCINOLONE ACETONIDE,Skin exfoliation,12
TRIAMCINOLONE ACETONIDE,Arthralgia,11
TRIAMCINOLONE ACETONIDE,Eczema,11
TRIAMCINOLONE ACETONIDE,Insomnia,10
TRIAMCINOLONE ACETONIDE,Product use in unapproved indication,10
TRIAMCINOLONE ACETONIDE,Fatigue,9
TRIAMCINOLONE ACETONIDE,Nausea,9
TRIAMCINOLONE ACETONIDE,COVID-19,9
TRIAMCINOLONE ACETONIDE,Pain,8
TRIAMCINOLONE ACETONIDE,Rash,8
TRIAMCINOLONE ACETONIDE,Dizziness,8
TRIAMCINOLONE ACETONIDE,Skin fissures,8
TRIAMCINOLONE ACETONIDE,Alopecia,7
TRIAMCINOLONE ACETONIDE,Off label use,7
TRIAMCINOLONE ACETONIDE,Drug ineffective,7
TRIAMCINOLONE ACETONIDE,Feeling abnormal,7
TRIAMCINOLONE ACETONIDE,Pyrexia,7
TRIAMCINOLONE ACETONIDE,Asthenia,7
TRIAMCINOLONE ACETONIDE,Psoriasis,7
TRIAMCINOLONE ACETONIDE,Injection site pain,7
TRIAMCINOLONE ACETONIDE,Peripheral swelling,6
TRIAMCINOLONE ACETONIDE,Diarrhoea,6
TRIAMCINOLONE ACETONIDE,Pain in extremity,6
TRIAMCINOLONE ACETONIDE,Sinusitis,6
TRIAMCINOLONE ACETONIDE,Erythema,6
TRIAMCINOLONE ACETONIDE,Rash pruritic,6
TRIAMCINOLONE ACETONIDE,Inappropriate schedule of product administration,6
TRIAMCINOLONE ACETONIDE,Weight decreased,5
TRIAMCINOLONE ACETONIDE,Illness,5
TRIAMCINOLONE ACETONIDE,Asthma,5
TRIAMCINOLONE ACETONIDE,Sleep disorder,5
TRIAMCINOLONE ACETONIDE,Cellulitis,5
TRIAMCINOLONE ACETONIDE,Device related sepsis,5
TRIAMCINOLONE ACETONIDE,Ocular hyperaemia,5
TRIAMCINOLONE ACETONIDE,Contraindicated product administered,4
TRIAMCINOLONE ACETONIDE,Arthropathy,4
TRIAMCINOLONE ACETONIDE,Hypertension,4
TRIAMCINOLONE ACETONIDE,Malaise,4
TRIAMCINOLONE ACETONIDE,Drug intolerance,4
TRIAMCINOLONE ACETONIDE,Vomiting,4
TRIAMCINOLONE ACETONIDE,Therapeutic response decreased,4
TRIAMCINOLONE ACETONIDE,Abdominal pain upper,4
TRIAMCINOLONE ACETONIDE,Therapeutic product effect decreased,4
TRIAMCINOLONE ACETONIDE,Abdominal discomfort,4
TRIMETHOPRIM,Diarrhoea,20
TRIMETHOPRIM,Vomiting,18
TRIMETHOPRIM,Malaise,17
TRIMETHOPRIM,Febrile neutropenia,15
TRIMETHOPRIM,Pain,13
TRIMETHOPRIM,Back pain,12
TRIMETHOPRIM,Abdominal pain,12
TRIMETHOPRIM,Proctalgia,11
TRIMETHOPRIM,Anal inflammation,11
TRIMETHOPRIM,Accident,11
TRIMETHOPRIM,Crohn's disease,11
TRIMETHOPRIM,Body temperature increased,11
TRIMETHOPRIM,Pyrexia,11
TRIMETHOPRIM,Neutropenia,11
TRIMETHOPRIM,Haemorrhoids,11
TRIMETHOPRIM,Chills,10
TRIMETHOPRIM,SARS-CoV-2 test negative,9
TRIMETHOPRIM,Mucosal inflammation,9
TRIMETHOPRIM,Pneumonia,8
TRIMETHOPRIM,Peripheral swelling,8
TRIMETHOPRIM,Fatigue,8
TRIMETHOPRIM,Condition aggravated,8
TRIMETHOPRIM,Illness,7
TRIMETHOPRIM,Contusion,7
TRIMETHOPRIM,Off label use,7
TRIMETHOPRIM,Drug interaction,7
TRIMETHOPRIM,Muscular weakness,7
TRIMETHOPRIM,Myalgia,7
TRIMETHOPRIM,Feeling abnormal,7
TRIMETHOPRIM,Arthralgia,7
TRIMETHOPRIM,Genital ulceration,6
TRIMETHOPRIM,Oral pain,6
TRIMETHOPRIM,Genital pain,6
TRIMETHOPRIM,Atrial fibrillation,6
TRIMETHOPRIM,Product dose omission issue,5
TRIMETHOPRIM,Dyspnoea,5
TRIMETHOPRIM,Rash,5
TRIMETHOPRIM,Blood potassium decreased,5
TRIMETHOPRIM,Gastrointestinal pain,5
TRIMETHOPRIM,Irritable bowel syndrome,5
TRIMETHOPRIM,Food poisoning,5
TRIMETHOPRIM,Abdominal pain upper,5
TRIMETHOPRIM,Nightmare,5
TRIMETHOPRIM,Migraine,5
TRIMETHOPRIM,Neuralgia,5
TRIMETHOPRIM,Hypoaesthesia,5
TRIMETHOPRIM,Tinnitus,5
TRIMETHOPRIM,Arthritis,4
TRIMETHOPRIM,Drug ineffective,4
TRIMETHOPRIM,Orbital haemorrhage,4
TRIUMEQ,Emotional distress,75
TRIUMEQ,Pain,75
TRIUMEQ,Anxiety,72
TRIUMEQ,Anhedonia,71
TRIUMEQ,Chronic kidney disease,43
TRIUMEQ,Renal failure,27
TRIUMEQ,Osteoporosis,26
TRIUMEQ,Depression,22
TRIUMEQ,Renal impairment,22
TRIUMEQ,Acute kidney injury,22
TRIUMEQ,Osteopenia,17
TRIUMEQ,Bone demineralisation,17
TRIUMEQ,Bone density decreased,16
TRIUMEQ,Blood creatinine increased,16
TRIUMEQ,Gait disturbance,15
TRIUMEQ,Back pain,13
TRIUMEQ,Economic problem,12
TRIUMEQ,Renal injury,12
TRIUMEQ,Multiple fractures,11
TRIUMEQ,End stage renal disease,9
TRIUMEQ,Foot fracture,9
TRIUMEQ,Pollakiuria,8
TRIUMEQ,Fatigue,8
TRIUMEQ,Quality of life decreased,7
TRIUMEQ,Bone loss,7
TRIUMEQ,Loss of personal independence in daily activities,7
TRIUMEQ,Asthenia,7
TRIUMEQ,Insomnia,6
TRIUMEQ,Vitamin D deficiency,5
TRIUMEQ,Decreased activity,5
TRIUMEQ,Mobility decreased,5
TRIUMEQ,Tooth loss,5
TRIUMEQ,Proteinuria,5
TRIUMEQ,Dysstasia,5
TRIUMEQ,Rib fracture,4
TRIUMEQ,Osteonecrosis,4
TRIUMEQ,Renal disorder,4
TRIUMEQ,Nephropathy,4
TRIUMEQ,Nausea,4
TRIUMEQ,Anaemia,4
TRIUMEQ,General physical health deterioration,3
TRIUMEQ,Hypertension,3
TRIUMEQ,Ankle fracture,3
TRIUMEQ,Hand fracture,3
TRIUMEQ,Fall,3
TRIUMEQ,Drug ineffective,3
TRIUMEQ,Wrist fracture,3
TRIUMEQ,Renal cyst,3
TRIUMEQ,Pain in extremity,3
TRIUMEQ,Fanconi syndrome acquired,3
TRULICITY,Nausea,9
TRULICITY,Fatigue,8
TRULICITY,Headache,7
TRULICITY,Drug ineffective,6
TRULICITY,Hyponatraemia,6
TRULICITY,Inappropriate antidiuretic hormone secretion,6
TRULICITY,Asthenia,5
TRULICITY,Pain,5
TRULICITY,Product dose omission issue,5
TRULICITY,Anxiety,4
TRULICITY,Pneumonia,4
TRULICITY,Fall,4
TRULICITY,Vomiting,4
TRULICITY,Hepatic cytolysis,4
TRULICITY,Cholestasis,4
TRULICITY,Depression,3
TRULICITY,Dyspnoea,3
TRULICITY,Erythema,3
TRULICITY,Inappropriate schedule of product administration,3
TRULICITY,Hallucination,3
TRULICITY,Psoriasis,3
TRULICITY,Off label use,3
TRULICITY,Cerebrovascular accident,3
TRULICITY,Thrombocytopenia,3
TRULICITY,Arthralgia,3
TRULICITY,Weight decreased,3
TRULICITY,Syncope,3
TRULICITY,Loss of consciousness,3
TRULICITY,Unevaluable event,2
TRULICITY,Obstructive sleep apnoea syndrome,2
TRULICITY,Post procedural complication,2
TRULICITY,Wrong technique in device usage process,2
TRULICITY,Chills,2
TRULICITY,Blindness unilateral,2
TRULICITY,Dysgraphia,2
TRULICITY,Loss of personal independence in daily activities,2
TRULICITY,Tremor,2
TRULICITY,Mobility decreased,2
TRULICITY,Brain neoplasm,2
TRULICITY,Escherichia urinary tract infection,2
TRULICITY,Decreased immune responsiveness,2
TRULICITY,Mutism,2
TRULICITY,Expired device used,2
TRULICITY,Optic nerve disorder,2
TRULICITY,Incorrect route of product administration,2
TRULICITY,Emotional distress,2
TRULICITY,Malaise,2
TRULICITY,COVID-19,2
TRULICITY,Diverticulum,2
TRULICITY,Red blood cell count decreased,2
TRUVADA,Pain,251
TRUVADA,Emotional distress,249
TRUVADA,Anxiety,236
TRUVADA,Anhedonia,232
TRUVADA,Chronic kidney disease,136
TRUVADA,Osteoporosis,102
TRUVADA,Bone density decreased,73
TRUVADA,Osteopenia,73
TRUVADA,Renal failure,72
TRUVADA,Depression,67
TRUVADA,Bone demineralisation,63
TRUVADA,Blood creatinine increased,54
TRUVADA,Renal impairment,53
TRUVADA,Acute kidney injury,48
TRUVADA,Economic problem,43
TRUVADA,Multiple fractures,41
TRUVADA,Fatigue,36
TRUVADA,Gait disturbance,34
TRUVADA,Bone loss,30
TRUVADA,Asthenia,28
TRUVADA,Renal injury,26
TRUVADA,End stage renal disease,24
TRUVADA,Foot fracture,23
TRUVADA,Back pain,23
TRUVADA,Osteonecrosis,23
TRUVADA,Loss of personal independence in daily activities,21
TRUVADA,Decreased activity,17
TRUVADA,Vitamin D deficiency,17
TRUVADA,Insomnia,17
TRUVADA,Quality of life decreased,16
TRUVADA,Nephropathy,15
TRUVADA,Proteinuria,15
TRUVADA,Mobility decreased,15
TRUVADA,Rib fracture,14
TRUVADA,Pollakiuria,14
TRUVADA,Skeletal injury,14
TRUVADA,Dysstasia,14
TRUVADA,Off label use,13
TRUVADA,Drug ineffective,11
TRUVADA,Aspartate aminotransferase increased,11
TRUVADA,Nephrolithiasis,11
TRUVADA,Tooth loss,11
TRUVADA,Anaemia,11
TRUVADA,Hypertension,10
TRUVADA,Intentional product use issue,9
TRUVADA,Maternal exposure during pregnancy,9
TRUVADA,Abortion spontaneous,9
TRUVADA,Hepatic cytolysis,9
TRUVADA,Alanine aminotransferase increased,9
TRUVADA,Hip fracture,9
TYLENOL,Fatigue,66
TYLENOL,COVID-19,65
TYLENOL,Off label use,60
TYLENOL,Pain,60
TYLENOL,Diarrhoea,54
TYLENOL,Nausea,53
TYLENOL,Headache,45
TYLENOL,Arthralgia,40
TYLENOL,Fall,39
TYLENOL,Back pain,36
TYLENOL,Sinusitis,35
TYLENOL,Dyspnoea,35
TYLENOL,Vomiting,34
TYLENOL,Malaise,33
TYLENOL,Asthenia,32
TYLENOL,Nasopharyngitis,30
TYLENOL,Pain in extremity,30
TYLENOL,Inappropriate schedule of product administration,30
TYLENOL,Dizziness,29
TYLENOL,Cough,28
TYLENOL,Weight decreased,27
TYLENOL,Anxiety,27
TYLENOL,Drug ineffective,26
TYLENOL,Pneumonia,25
TYLENOL,Gait disturbance,25
TYLENOL,Urinary tract infection,25
TYLENOL,Product dose omission issue,25
TYLENOL,Pruritus,23
TYLENOL,Rash,23
TYLENOL,Pyrexia,22
TYLENOL,Illness,22
TYLENOL,Peripheral swelling,21
TYLENOL,Condition aggravated,20
TYLENOL,Bronchitis,20
TYLENOL,Somnolence,20
TYLENOL,Infusion related reaction,18
TYLENOL,Emotional distress,18
TYLENOL,Constipation,18
TYLENOL,Decreased appetite,16
TYLENOL,Intentional product use issue,16
TYLENOL,Hypertension,15
TYLENOL,Weight increased,15
TYLENOL,Abdominal discomfort,15
TYLENOL,Anhedonia,15
TYLENOL,Muscle spasms,15
TYLENOL,Influenza,15
TYLENOL,Feeling abnormal,15
TYLENOL,Product use issue,15
TYLENOL,Contusion,14
TYLENOL,Asthma,14
TYLENOL EXTRA STRENGTH,Fatigue,13
TYLENOL EXTRA STRENGTH,Headache,12
TYLENOL EXTRA STRENGTH,Product dose omission issue,12
TYLENOL EXTRA STRENGTH,Sinusitis,11
TYLENOL EXTRA STRENGTH,COVID-19,10
TYLENOL EXTRA STRENGTH,Urinary tract infection,9
TYLENOL EXTRA STRENGTH,Inappropriate schedule of product administration,8
TYLENOL EXTRA STRENGTH,Malaise,7
TYLENOL EXTRA STRENGTH,Pneumonia,7
TYLENOL EXTRA STRENGTH,Back pain,7
TYLENOL EXTRA STRENGTH,Pain in extremity,6
TYLENOL EXTRA STRENGTH,Influenza,6
TYLENOL EXTRA STRENGTH,Foetal exposure during pregnancy,6
TYLENOL EXTRA STRENGTH,Autism spectrum disorder,6
TYLENOL EXTRA STRENGTH,Nausea,5
TYLENOL EXTRA STRENGTH,Nasopharyngitis,5
TYLENOL EXTRA STRENGTH,Diarrhoea,5
TYLENOL EXTRA STRENGTH,Illness,5
TYLENOL EXTRA STRENGTH,Oropharyngeal pain,5
TYLENOL EXTRA STRENGTH,Seasonal allergy,4
TYLENOL EXTRA STRENGTH,Dyspnoea,4
TYLENOL EXTRA STRENGTH,Injection site pain,4
TYLENOL EXTRA STRENGTH,Dizziness,4
TYLENOL EXTRA STRENGTH,Asthma,4
TYLENOL EXTRA STRENGTH,Sputum discoloured,4
TYLENOL EXTRA STRENGTH,Arthralgia,4
TYLENOL EXTRA STRENGTH,Off label use,4
TYLENOL EXTRA STRENGTH,Myocardial infarction,4
TYLENOL EXTRA STRENGTH,Cough,4
TYLENOL EXTRA STRENGTH,Upper respiratory tract infection,4
TYLENOL EXTRA STRENGTH,Weight increased,4
TYLENOL EXTRA STRENGTH,Ear infection,4
TYLENOL EXTRA STRENGTH,Muscle strain,4
TYLENOL EXTRA STRENGTH,Fall,4
TYLENOL EXTRA STRENGTH,Infection,4
TYLENOL EXTRA STRENGTH,Blood pressure increased,3
TYLENOL EXTRA STRENGTH,Peripheral swelling,3
TYLENOL EXTRA STRENGTH,Weight decreased,3
TYLENOL EXTRA STRENGTH,Incorrect dose administered,3
TYLENOL EXTRA STRENGTH,Wheezing,3
TYLENOL EXTRA STRENGTH,Productive cough,3
TYLENOL EXTRA STRENGTH,Cardiac disorder,3
TYLENOL EXTRA STRENGTH,Migraine,3
TYLENOL EXTRA STRENGTH,Infusion related reaction,3
TYLENOL EXTRA STRENGTH,Dysphonia,3
TYLENOL EXTRA STRENGTH,Infusion site pain,3
TYLENOL EXTRA STRENGTH,Infusion site erythema,3
TYLENOL EXTRA STRENGTH,Insurance issue,3
TYLENOL EXTRA STRENGTH,Injection site pruritus,3
TYLENOL EXTRA STRENGTH,Renal disorder,3
TYMLOS,Headache,20
TYMLOS,Nausea,20
TYMLOS,Dizziness,14
TYMLOS,Heart rate increased,12
TYMLOS,Fatigue,11
TYMLOS,Palpitations,8
TYMLOS,Abdominal pain upper,7
TYMLOS,Intentional product misuse,7
TYMLOS,Feeling abnormal,5
TYMLOS,Malaise,5
TYMLOS,Product dose omission issue,4
TYMLOS,Vomiting,4
TYMLOS,COVID-19,4
TYMLOS,Bone pain,4
TYMLOS,Back pain,4
TYMLOS,Decreased appetite,3
TYMLOS,Pain,3
TYMLOS,Product quality issue,3
TYMLOS,Insomnia,3
TYMLOS,Pain in extremity,3
TYMLOS,Arthralgia,3
TYMLOS,Illness,3
TYMLOS,Tachycardia,3
TYMLOS,Blood pressure decreased,3
TYMLOS,Nocturia,2
TYMLOS,Pollakiuria,2
TYMLOS,Weight decreased,2
TYMLOS,Sinusitis,2
TYMLOS,Muscle twitching,2
TYMLOS,Injection site urticaria,2
TYMLOS,Therapeutic response unexpected,2
TYMLOS,Pain in jaw,2
TYMLOS,Asthenia,2
TYMLOS,Flushing,2
TYMLOS,Blood glucose abnormal,2
TYMLOS,Product use in unapproved indication,2
TYMLOS,Product storage error,2
TYMLOS,Diarrhoea,2
TYMLOS,Brain fog,2
TYMLOS,Chest discomfort,2
TYMLOS,Weight increased,2
TYMLOS,Fear of injection,2
TYMLOS,Migraine,2
TYMLOS,Injection site bruising,2
TYMLOS,Neck pain,2
TYMLOS,Atrial fibrillation,2
TYMLOS,Muscle spasms,2
TYMLOS,Musculoskeletal stiffness,2
TYMLOS,Dry mouth,2
TYMLOS,Intentional dose omission,2
TYSABRI,Multiple sclerosis relapse,33
TYSABRI,Progressive multifocal leukoencephalopathy,20
TYSABRI,Prescribed underdose,16
TYSABRI,Immune reconstitution inflammatory syndrome,12
TYSABRI,Fatigue,10
TYSABRI,Headache,9
TYSABRI,Multiple sclerosis,8
TYSABRI,Memory impairment,7
TYSABRI,Maternal exposure during pregnancy,6
TYSABRI,Hypertension,6
TYSABRI,Pain,6
TYSABRI,Dizziness,6
TYSABRI,Peripheral swelling,5
TYSABRI,Invasive ductal breast carcinoma,5
TYSABRI,COVID-19,5
TYSABRI,Nausea,5
TYSABRI,Asthenia,5
TYSABRI,Gait disturbance,5
TYSABRI,Muscular weakness,5
TYSABRI,Vomiting,4
TYSABRI,Hypoaesthesia,4
TYSABRI,Dyspnoea,4
TYSABRI,Vision blurred,4
TYSABRI,Fall,4
TYSABRI,Back pain,4
TYSABRI,Product dose omission issue,4
TYSABRI,Seizure,4
TYSABRI,Contusion,3
TYSABRI,Anxiety,3
TYSABRI,Hypersensitivity,3
TYSABRI,Decreased immune responsiveness,3
TYSABRI,Nervousness,3
TYSABRI,Pain in extremity,3
TYSABRI,Somnolence,3
TYSABRI,Urinary tract infection,3
TYSABRI,Muscle spasticity,3
TYSABRI,Hypothyroidism,3
TYSABRI,Diarrhoea,3
TYSABRI,Balance disorder,3
TYSABRI,Anaemia,3
TYSABRI,Inappropriate schedule of product administration,3
TYSABRI,Cerebellar syndrome,3
TYSABRI,Depression,3
TYSABRI,Paraesthesia,3
TYSABRI,Cerebrovascular accident,3
TYSABRI,Paralysis,3
TYSABRI,Tremor,3
TYSABRI,Drug ineffective,3
TYSABRI,Treatment failure,3
TYSABRI,Premature labour,2
TYVASO,Dyspnoea,57
TYVASO,Cough,49
TYVASO,Oxygen saturation decreased,36
TYVASO,Fatigue,32
TYVASO,Headache,31
TYVASO,Diarrhoea,30
TYVASO,Pneumonia,26
TYVASO,Dizziness,25
TYVASO,Hypotension,19
TYVASO,Asthenia,17
TYVASO,Nausea,16
TYVASO,Off label use,15
TYVASO,Productive cough,15
TYVASO,Death,15
TYVASO,Therapy non-responder,14
TYVASO,Pain,14
TYVASO,Throat irritation,13
TYVASO,Fluid retention,13
TYVASO,Chest pain,13
TYVASO,Dyspnoea exertional,12
TYVASO,Oropharyngeal pain,11
TYVASO,Fall,10
TYVASO,Weight decreased,10
TYVASO,Product dose omission issue,10
TYVASO,Feeling abnormal,9
TYVASO,Vomiting,8
TYVASO,Nasopharyngitis,7
TYVASO,Pulmonary arterial hypertension,7
TYVASO,Syncope,7
TYVASO,Oedema peripheral,7
TYVASO,Gastrooesophageal reflux disease,7
TYVASO,Malaise,7
TYVASO,Peripheral swelling,7
TYVASO,Loss of consciousness,6
TYVASO,Pain in jaw,6
TYVASO,Dysphonia,6
TYVASO,Device malfunction,6
TYVASO,Chills,6
TYVASO,Weight increased,6
TYVASO,Palpitations,6
TYVASO,Device connection issue,6
TYVASO,Lung disorder,6
TYVASO,Drug hypersensitivity,6
TYVASO,Hypertension,6
TYVASO,Condition aggravated,6
TYVASO,Pulmonary oedema,5
TYVASO,Respiratory failure,5
TYVASO,Drug intolerance,5
TYVASO,Abdominal pain upper,5
TYVASO,Somnolence,5
TYVASO DPI,Cough,99
TYVASO DPI,Dyspnoea,80
TYVASO DPI,Headache,67
TYVASO DPI,Dizziness,44
TYVASO DPI,Diarrhoea,41
TYVASO DPI,Fatigue,40
TYVASO DPI,Oxygen saturation decreased,40
TYVASO DPI,Nausea,35
TYVASO DPI,Throat irritation,29
TYVASO DPI,Chest discomfort,22
TYVASO DPI,Asthenia,20
TYVASO DPI,Hypotension,18
TYVASO DPI,Decreased appetite,18
TYVASO DPI,Productive cough,16
TYVASO DPI,Oropharyngeal pain,16
TYVASO DPI,Pneumonia,15
TYVASO DPI,Feeling abnormal,14
TYVASO DPI,Therapy non-responder,14
TYVASO DPI,Chest pain,14
TYVASO DPI,Vomiting,14
TYVASO DPI,Abdominal discomfort,14
TYVASO DPI,Malaise,14
TYVASO DPI,Dyspnoea exertional,13
TYVASO DPI,Epistaxis,13
TYVASO DPI,Peripheral swelling,12
TYVASO DPI,Fluid retention,12
TYVASO DPI,Weight decreased,11
TYVASO DPI,Pain,11
TYVASO DPI,Condition aggravated,11
TYVASO DPI,Flushing,10
TYVASO DPI,Pain in extremity,10
TYVASO DPI,Death,10
TYVASO DPI,Anxiety,10
TYVASO DPI,Inappropriate schedule of product administration,10
TYVASO DPI,Wheezing,10
TYVASO DPI,Product dose omission issue,9
TYVASO DPI,Drug tolerance decreased,9
TYVASO DPI,Nasal congestion,9
TYVASO DPI,Rhinorrhoea,9
TYVASO DPI,Seasonal allergy,8
TYVASO DPI,Chills,8
TYVASO DPI,Heart rate increased,8
TYVASO DPI,COVID-19,7
TYVASO DPI,Arthralgia,7
TYVASO DPI,Sinusitis,7
TYVASO DPI,Drug intolerance,7
TYVASO DPI,Respiratory tract congestion,7
TYVASO DPI,Abdominal pain upper,7
TYVASO DPI,Incorrect dose administered,7
TYVASO DPI,Dysphonia,6
ULTRAVIST,Anaphylactic shock,12
ULTRAVIST,Blood pressure decreased,10
ULTRAVIST,Contrast media allergy,9
ULTRAVIST,Dyspnoea,8
ULTRAVIST,Chills,7
ULTRAVIST,Oxygen saturation decreased,7
ULTRAVIST,Nausea,6
ULTRAVIST,Urticaria,6
ULTRAVIST,Pruritus,6
ULTRAVIST,Erythema,6
ULTRAVIST,Dizziness,6
ULTRAVIST,Loss of consciousness,5
ULTRAVIST,Vision blurred,5
ULTRAVIST,Blood pressure increased,5
ULTRAVIST,Rash,5
ULTRAVIST,Cold sweat,4
ULTRAVIST,Flushing,4
ULTRAVIST,Pallor,4
ULTRAVIST,Incorrect drug administration rate,4
ULTRAVIST,Hyperhidrosis,4
ULTRAVIST,Rash erythematous,4
ULTRAVIST,Chest discomfort,4
ULTRAVIST,Cough,4
ULTRAVIST,Vomiting,4
ULTRAVIST,Unresponsive to stimuli,3
ULTRAVIST,Rash papular,3
ULTRAVIST,Shock,3
ULTRAVIST,Angioedema,3
ULTRAVIST,Dysphonia,3
ULTRAVIST,Confusional state,3
ULTRAVIST,Hypotension,3
ULTRAVIST,Rash pruritic,3
ULTRAVIST,Ocular hyperaemia,3
ULTRAVIST,Eyelid oedema,3
ULTRAVIST,Asthenia,3
ULTRAVIST,Seizure,3
ULTRAVIST,Blood pressure immeasurable,2
ULTRAVIST,Syncope,2
ULTRAVIST,Depressed level of consciousness,2
ULTRAVIST,Heart rate decreased,2
ULTRAVIST,Swelling face,2
ULTRAVIST,Restlessness,2
ULTRAVIST,Cyanosis,2
ULTRAVIST,Heart rate increased,2
ULTRAVIST,Anaphylactic reaction,2
ULTRAVIST,Coma,2
ULTRAVIST,Palpitations,2
ULTRAVIST,Skin warm,2
ULTRAVIST,Respiratory rate increased,2
ULTRAVIST,Dermatitis allergic,2
UNSPECIFIED INGREDIENT,Vomiting,24
UNSPECIFIED INGREDIENT,Nausea,23
UNSPECIFIED INGREDIENT,Off label use,21
UNSPECIFIED INGREDIENT,Diarrhoea,16
UNSPECIFIED INGREDIENT,Constipation,15
UNSPECIFIED INGREDIENT,Headache,14
UNSPECIFIED INGREDIENT,Abdominal distension,14
UNSPECIFIED INGREDIENT,Abdominal pain,13
UNSPECIFIED INGREDIENT,Dyspnoea,13
UNSPECIFIED INGREDIENT,Intentional product use issue,12
UNSPECIFIED INGREDIENT,Somnolence,11
UNSPECIFIED INGREDIENT,General physical health deterioration,11
UNSPECIFIED INGREDIENT,Stress,11
UNSPECIFIED INGREDIENT,Sepsis,11
UNSPECIFIED INGREDIENT,Death,11
UNSPECIFIED INGREDIENT,Rash,10
UNSPECIFIED INGREDIENT,Decreased appetite,10
UNSPECIFIED INGREDIENT,Ascites,10
UNSPECIFIED INGREDIENT,Condition aggravated,10
UNSPECIFIED INGREDIENT,Product dose omission issue,9
UNSPECIFIED INGREDIENT,Dry mouth,9
UNSPECIFIED INGREDIENT,Anaemia,9
UNSPECIFIED INGREDIENT,Cardiogenic shock,9
UNSPECIFIED INGREDIENT,Gait disturbance,9
UNSPECIFIED INGREDIENT,Fatigue,9
UNSPECIFIED INGREDIENT,Swelling,9
UNSPECIFIED INGREDIENT,COVID-19,9
UNSPECIFIED INGREDIENT,Drug ineffective,8
UNSPECIFIED INGREDIENT,Incorrect route of product administration,8
UNSPECIFIED INGREDIENT,Multiple organ dysfunction syndrome,8
UNSPECIFIED INGREDIENT,Nasopharyngitis,8
UNSPECIFIED INGREDIENT,Fall,8
UNSPECIFIED INGREDIENT,Asthenia,8
UNSPECIFIED INGREDIENT,Dehydration,8
UNSPECIFIED INGREDIENT,Pyrexia,7
UNSPECIFIED INGREDIENT,Pruritus,7
UNSPECIFIED INGREDIENT,Intentional product misuse,7
UNSPECIFIED INGREDIENT,Neuralgia,7
UNSPECIFIED INGREDIENT,Neck pain,7
UNSPECIFIED INGREDIENT,Weight decreased,7
UNSPECIFIED INGREDIENT,Oropharyngeal discomfort,6
UNSPECIFIED INGREDIENT,Hypersensitivity,6
UNSPECIFIED INGREDIENT,Pain,6
UNSPECIFIED INGREDIENT,Dizziness,6
UNSPECIFIED INGREDIENT,Drug hypersensitivity,6
UNSPECIFIED INGREDIENT,Bacterial infection,6
UNSPECIFIED INGREDIENT,Product use in unapproved indication,6
UNSPECIFIED INGREDIENT,Upper respiratory tract infection,6
UNSPECIFIED INGREDIENT,Acute kidney injury,6
UNSPECIFIED INGREDIENT,Pneumonia,6
UPTRAVI,Headache,56
UPTRAVI,Diarrhoea,53
UPTRAVI,Pulmonary arterial hypertension,37
UPTRAVI,Nausea,35
UPTRAVI,Hypotension,32
UPTRAVI,Cardiac failure,26
UPTRAVI,Dyspnoea,24
UPTRAVI,Pneumonia,22
UPTRAVI,Off label use,19
UPTRAVI,Vomiting,17
UPTRAVI,Cough,16
UPTRAVI,Anaemia,15
UPTRAVI,Pyrexia,15
UPTRAVI,Dizziness,15
UPTRAVI,Brain natriuretic peptide increased,14
UPTRAVI,Malaise,14
UPTRAVI,Flushing,14
UPTRAVI,Fatigue,14
UPTRAVI,Pain in jaw,14
UPTRAVI,Arthralgia,13
UPTRAVI,Infusion site pain,13
UPTRAVI,Right ventricular failure,11
UPTRAVI,Pain in extremity,11
UPTRAVI,Platelet count decreased,10
UPTRAVI,Pain,10
UPTRAVI,Pleural effusion,9
UPTRAVI,Oedema,9
UPTRAVI,Oedema peripheral,9
UPTRAVI,Fluid retention,8
UPTRAVI,Syncope,8
UPTRAVI,Death,8
UPTRAVI,Pulmonary hypertension,7
UPTRAVI,Rash,7
UPTRAVI,Decreased appetite,7
UPTRAVI,Myalgia,7
UPTRAVI,Infusion site erythema,7
UPTRAVI,Chest pain,7
UPTRAVI,Weight increased,6
UPTRAVI,Renal impairment,6
UPTRAVI,COVID-19,6
UPTRAVI,Asthenia,6
UPTRAVI,Feeling abnormal,6
UPTRAVI,Infusion site swelling,6
UPTRAVI,Oxygen saturation decreased,6
UPTRAVI,Pulmonary congestion,5
UPTRAVI,Abdominal discomfort,5
UPTRAVI,Abdominal pain upper,5
UPTRAVI,Weight decreased,5
UPTRAVI,Rhinorrhoea,5
UPTRAVI,Abdominal pain,5
URAPIDIL,Acute generalised exanthematous pustulosis,8
URAPIDIL,Septic shock,7
URAPIDIL,Multiple organ dysfunction syndrome,7
URAPIDIL,Oedema peripheral,6
URAPIDIL,Pneumonia,4
URAPIDIL,Pneumonia respiratory syncytial viral,4
URAPIDIL,Febrile bone marrow aplasia,4
URAPIDIL,Product use in unapproved indication,4
URAPIDIL,Hepatitis fulminant,4
URAPIDIL,Hepatic cytolysis,4
URAPIDIL,Bone marrow failure,3
URAPIDIL,Hypertension,3
URAPIDIL,Candida infection,3
URAPIDIL,Staphylococcal infection,3
URAPIDIL,Klebsiella infection,3
URAPIDIL,Cardiac failure,2
URAPIDIL,Blood pressure ambulatory increased,2
URAPIDIL,Cardiac autonomic neuropathy,2
URAPIDIL,Back pain,2
URAPIDIL,Supine hypertension,2
URAPIDIL,Off label use,2
URAPIDIL,Anaemia,2
URAPIDIL,Platelet count decreased,2
URAPIDIL,Immune-mediated hepatic disorder,2
URAPIDIL,Cardiac arrest,2
URAPIDIL,Insomnia,2
URAPIDIL,Pancytopenia,2
URAPIDIL,Thrombocytopenia,2
URAPIDIL,Toxic skin eruption,2
URAPIDIL,Infectious pleural effusion,1
URAPIDIL,Aspiration,1
URAPIDIL,Pleural effusion,1
URAPIDIL,Immobilisation syndrome,1
URAPIDIL,Respiratory tract infection,1
URAPIDIL,Pseudomonas test positive,1
URAPIDIL,Bulbospinal muscular atrophy congenital,1
URAPIDIL,Influenza,1
URAPIDIL,Dysphagia,1
URAPIDIL,Pyrexia,1
URAPIDIL,Pneumonia aspiration,1
URAPIDIL,Haemoptysis,1
URAPIDIL,Muscular weakness,1
URAPIDIL,Sputum increased,1
URAPIDIL,Urinary tract infection,1
URAPIDIL,Cardio-respiratory arrest,1
URAPIDIL,Autonomic neuropathy,1
URAPIDIL,Bradycardia,1
URAPIDIL,Renal impairment,1
URAPIDIL,Pemphigoid,1
URAPIDIL,Urogenital haemorrhage,1
URSODIOL,Abdominal pain,12
URSODIOL,Diarrhoea,12
URSODIOL,Decreased appetite,11
URSODIOL,Off label use,9
URSODIOL,Weight increased,8
URSODIOL,Aspartate aminotransferase increased,8
URSODIOL,Hepatic function abnormal,8
URSODIOL,Pain,7
URSODIOL,Dehydration,7
URSODIOL,Weight decreased,7
URSODIOL,Pneumonia,7
URSODIOL,Alanine aminotransferase increased,7
URSODIOL,Asthenia,7
URSODIOL,COVID-19,6
URSODIOL,Liver disorder,6
URSODIOL,Nausea,6
URSODIOL,Oedema peripheral,5
URSODIOL,Herpes zoster,5
URSODIOL,Hypokalaemia,5
URSODIOL,Constipation,5
URSODIOL,Pyrexia,5
URSODIOL,Malaise,5
URSODIOL,Sinusitis,5
URSODIOL,Abdominal pain upper,5
URSODIOL,Fatigue,5
URSODIOL,Abdominal distension,5
URSODIOL,Cough,5
URSODIOL,Drug hypersensitivity,4
URSODIOL,Product dose omission issue,4
URSODIOL,Urinary tract infection,4
URSODIOL,Arthralgia,4
URSODIOL,Flatulence,4
URSODIOL,Tachycardia,4
URSODIOL,Vomiting,4
URSODIOL,Multiple organ dysfunction syndrome,4
URSODIOL,Sepsis,4
URSODIOL,Ascites,4
URSODIOL,Dizziness,4
URSODIOL,Vascular device infection,3
URSODIOL,Malnutrition,3
URSODIOL,Inappropriate schedule of product administration,3
URSODIOL,Poor venous access,3
URSODIOL,Pancreatitis,3
URSODIOL,Haematochezia,3
URSODIOL,Muscle strain,3
URSODIOL,Intentional product use issue,3
URSODIOL,Drug ineffective,3
URSODIOL,Influenza,3
URSODIOL,Confusional state,3
URSODIOL,Acute kidney injury,3
VALACYCLOVIR,Neutropenia,9
VALACYCLOVIR,Pyrexia,9
VALACYCLOVIR,Cytokine release syndrome,9
VALACYCLOVIR,Pain,8
VALACYCLOVIR,Fatigue,8
VALACYCLOVIR,Anxiety,7
VALACYCLOVIR,Off label use,7
VALACYCLOVIR,Dyspnoea,7
VALACYCLOVIR,Headache,7
VALACYCLOVIR,Diarrhoea,7
VALACYCLOVIR,Asthenia,7
VALACYCLOVIR,Drug ineffective,7
VALACYCLOVIR,Emotional distress,6
VALACYCLOVIR,Anhedonia,6
VALACYCLOVIR,Product use in unapproved indication,6
VALACYCLOVIR,Sepsis,6
VALACYCLOVIR,Pneumocystis jirovecii pneumonia,6
VALACYCLOVIR,Weight decreased,5
VALACYCLOVIR,Product dose omission issue,5
VALACYCLOVIR,Nausea,5
VALACYCLOVIR,Urinary tract infection,5
VALACYCLOVIR,Confusional state,5
VALACYCLOVIR,Immune effector cell-associated neurotoxicity syndrome,5
VALACYCLOVIR,Rash,5
VALACYCLOVIR,Tachycardia,4
VALACYCLOVIR,Acute respiratory distress syndrome,4
VALACYCLOVIR,COVID-19,4
VALACYCLOVIR,Febrile neutropenia,4
VALACYCLOVIR,Fall,4
VALACYCLOVIR,Pneumonia,4
VALACYCLOVIR,Hypotension,4
VALACYCLOVIR,Cough,4
VALACYCLOVIR,Hyponatraemia,4
VALACYCLOVIR,Mixed anxiety and depressive disorder,4
VALACYCLOVIR,Depression,3
VALACYCLOVIR,Condition aggravated,3
VALACYCLOVIR,Neuropathy peripheral,3
VALACYCLOVIR,Acute kidney injury,3
VALACYCLOVIR,Chronic kidney disease,3
VALACYCLOVIR,Gait disturbance,3
VALACYCLOVIR,Feeling abnormal,3
VALACYCLOVIR,Abdominal pain upper,3
VALACYCLOVIR,General physical health deterioration,3
VALACYCLOVIR,Infection,3
VALACYCLOVIR,Illness,3
VALACYCLOVIR,Oral herpes,3
VALACYCLOVIR,Thrombocytopenia,3
VALACYCLOVIR,Abdominal pain,3
VALACYCLOVIR,Hot flush,3
VALACYCLOVIR,Vomiting,3
VALACYCLOVIR HYDROCHLORIDE,Neutropenia,47
VALACYCLOVIR HYDROCHLORIDE,Pyrexia,27
VALACYCLOVIR HYDROCHLORIDE,Asthenia,26
VALACYCLOVIR HYDROCHLORIDE,Diarrhoea,26
VALACYCLOVIR HYDROCHLORIDE,Thrombocytopenia,25
VALACYCLOVIR HYDROCHLORIDE,Off label use,24
VALACYCLOVIR HYDROCHLORIDE,Hepatic cytolysis,23
VALACYCLOVIR HYDROCHLORIDE,Anaemia,18
VALACYCLOVIR HYDROCHLORIDE,Acute kidney injury,18
VALACYCLOVIR HYDROCHLORIDE,Lymphopenia,16
VALACYCLOVIR HYDROCHLORIDE,Nausea,16
VALACYCLOVIR HYDROCHLORIDE,COVID-19,16
VALACYCLOVIR HYDROCHLORIDE,Dyspnoea,15
VALACYCLOVIR HYDROCHLORIDE,Pain,14
VALACYCLOVIR HYDROCHLORIDE,Weight decreased,14
VALACYCLOVIR HYDROCHLORIDE,Anxiety,13
VALACYCLOVIR HYDROCHLORIDE,Cytokine release syndrome,13
VALACYCLOVIR HYDROCHLORIDE,Back pain,12
VALACYCLOVIR HYDROCHLORIDE,Lung disorder,12
VALACYCLOVIR HYDROCHLORIDE,Hypocalcaemia,12
VALACYCLOVIR HYDROCHLORIDE,Constipation,12
VALACYCLOVIR HYDROCHLORIDE,Drug reaction with eosinophilia and systemic symptoms,12
VALACYCLOVIR HYDROCHLORIDE,Fatigue,11
VALACYCLOVIR HYDROCHLORIDE,Pneumonia,11
VALACYCLOVIR HYDROCHLORIDE,Cough,10
VALACYCLOVIR HYDROCHLORIDE,Richter's syndrome,10
VALACYCLOVIR HYDROCHLORIDE,Arthralgia,10
VALACYCLOVIR HYDROCHLORIDE,Hyperuricaemia,10
VALACYCLOVIR HYDROCHLORIDE,Hyperkalaemia,10
VALACYCLOVIR HYDROCHLORIDE,Tumour lysis syndrome,9
VALACYCLOVIR HYDROCHLORIDE,Death,9
VALACYCLOVIR HYDROCHLORIDE,Vomiting,9
VALACYCLOVIR HYDROCHLORIDE,Anhedonia,9
VALACYCLOVIR HYDROCHLORIDE,Emotional distress,9
VALACYCLOVIR HYDROCHLORIDE,Epistaxis,9
VALACYCLOVIR HYDROCHLORIDE,Disease progression,9
VALACYCLOVIR HYDROCHLORIDE,Bronchitis,8
VALACYCLOVIR HYDROCHLORIDE,Sepsis,8
VALACYCLOVIR HYDROCHLORIDE,Pancytopenia,8
VALACYCLOVIR HYDROCHLORIDE,Blood bilirubin increased,8
VALACYCLOVIR HYDROCHLORIDE,Hyperthermia,8
VALACYCLOVIR HYDROCHLORIDE,Blood lactate dehydrogenase increased,7
VALACYCLOVIR HYDROCHLORIDE,Leukopenia,7
VALACYCLOVIR HYDROCHLORIDE,Oedema peripheral,7
VALACYCLOVIR HYDROCHLORIDE,Neutrophil count decreased,7
VALACYCLOVIR HYDROCHLORIDE,Agranulocytosis,7
VALACYCLOVIR HYDROCHLORIDE,Chills,7
VALACYCLOVIR HYDROCHLORIDE,Febrile neutropenia,7
VALACYCLOVIR HYDROCHLORIDE,Cholestasis,7
VALACYCLOVIR HYDROCHLORIDE,Eosinophilia,7
VALIUM,Hepatic cytolysis,17
VALIUM,Pain,11
VALIUM,Nausea,8
VALIUM,Hypothermia,8
VALIUM,Sedation,8
VALIUM,Hypoxia,8
VALIUM,Hypoglycaemia,8
VALIUM,Wrong patient received product,8
VALIUM,Anxiety,7
VALIUM,Malaise,6
VALIUM,Fatigue,6
VALIUM,Illness,6
VALIUM,Cholestasis,6
VALIUM,Coma,6
VALIUM,Diarrhoea,5
VALIUM,Headache,5
VALIUM,Weight decreased,5
VALIUM,COVID-19,5
VALIUM,Condition aggravated,5
VALIUM,Constipation,4
VALIUM,Product dose omission issue,4
VALIUM,Pyrexia,4
VALIUM,Cardio-respiratory arrest,4
VALIUM,Hot flush,3
VALIUM,Osteoporosis,3
VALIUM,Muscle spasms,3
VALIUM,Feeling abnormal,3
VALIUM,Anhedonia,3
VALIUM,Emotional distress,3
VALIUM,Renal disorder,3
VALIUM,Pneumonia,3
VALIUM,Inappropriate schedule of product administration,3
VALIUM,Nasopharyngitis,3
VALIUM,Migraine,3
VALIUM,Amnesia,3
VALIUM,Chest pain,3
VALIUM,Dizziness,3
VALIUM,Dyspnoea,3
VALIUM,Heart rate decreased,3
VALIUM,Abdominal pain upper,3
VALIUM,Pruritus,3
VALIUM,Syncope,3
VALIUM,Sudden death,3
VALIUM,Pulmonary oedema,3
VALIUM,Respiratory depression,3
VALIUM,Suicidal ideation,3
VALIUM,Night sweats,2
VALIUM,Drug abuse,2
VALIUM,Peripheral swelling,2
VALIUM,Tremor,2
VALPROATE SODIUM,Off label use,10
VALPROATE SODIUM,Somnolence,9
VALPROATE SODIUM,Wrong patient received product,9
VALPROATE SODIUM,Vomiting,7
VALPROATE SODIUM,Hypotension,6
VALPROATE SODIUM,Malaise,6
VALPROATE SODIUM,Drug interaction,6
VALPROATE SODIUM,Pyrexia,5
VALPROATE SODIUM,Inappropriate schedule of product administration,5
VALPROATE SODIUM,Hypoglycaemia,5
VALPROATE SODIUM,Seizure,5
VALPROATE SODIUM,Gastrointestinal necrosis,5
VALPROATE SODIUM,Megacolon,5
VALPROATE SODIUM,Pancreatitis,5
VALPROATE SODIUM,Thrombocytopenia,4
VALPROATE SODIUM,Intellectual disability,4
VALPROATE SODIUM,Agitation,4
VALPROATE SODIUM,Dyspnoea,4
VALPROATE SODIUM,Sopor,4
VALPROATE SODIUM,Lactic acidosis,4
VALPROATE SODIUM,Hyperlactacidaemia,4
VALPROATE SODIUM,Unresponsive to stimuli,4
VALPROATE SODIUM,Hyporesponsive to stimuli,4
VALPROATE SODIUM,Mobility decreased,4
VALPROATE SODIUM,Oxygen saturation decreased,4
VALPROATE SODIUM,Hypoxia,4
VALPROATE SODIUM,Hepatic cytolysis,3
VALPROATE SODIUM,Diarrhoea,3
VALPROATE SODIUM,Coma,3
VALPROATE SODIUM,Drug ineffective,3
VALPROATE SODIUM,Insomnia,3
VALPROATE SODIUM,Epilepsy,3
VALPROATE SODIUM,Rash vesicular,3
VALPROATE SODIUM,Therapeutic hypothermia,3
VALPROATE SODIUM,Distal intestinal obstruction syndrome,3
VALPROATE SODIUM,Pancreatitis acute,3
VALPROATE SODIUM,Product administration error,3
VALPROATE SODIUM,Hypothermia,3
VALPROATE SODIUM,Oliguria,3
VALPROATE SODIUM,Cardio-respiratory arrest,3
VALPROATE SODIUM,Constipation,2
VALPROATE SODIUM,Fatigue,2
VALPROATE SODIUM,Learning disorder,2
VALPROATE SODIUM,Language disorder,2
VALPROATE SODIUM,Foetal exposure during pregnancy,2
VALPROATE SODIUM,Dysgraphia,2
VALPROATE SODIUM,Bronchitis,2
VALPROATE SODIUM,Speech disorder,2
VALPROATE SODIUM,Asthmatic crisis,2
VALPROATE SODIUM,Inability to afford medication,2
VALSARTAN,Pruritus,14
VALSARTAN,Headache,13
VALSARTAN,Dizziness,13
VALSARTAN,Vomiting,12
VALSARTAN,Diarrhoea,12
VALSARTAN,COVID-19,12
VALSARTAN,Pain,11
VALSARTAN,Nausea,11
VALSARTAN,Dyspnoea,11
VALSARTAN,Fatigue,11
VALSARTAN,Pain in extremity,11
VALSARTAN,Pneumonia,11
VALSARTAN,Abdominal pain,10
VALSARTAN,Asthenia,10
VALSARTAN,Arthralgia,10
VALSARTAN,Neutropenia,10
VALSARTAN,Pyrexia,10
VALSARTAN,Urinary tract infection,9
VALSARTAN,Acute kidney injury,9
VALSARTAN,Off label use,9
VALSARTAN,Hypertension,9
VALSARTAN,Agranulocytosis,9
VALSARTAN,Arrhythmia,8
VALSARTAN,Atrial fibrillation,8
VALSARTAN,Renal cyst,8
VALSARTAN,Cough,8
VALSARTAN,Myalgia,8
VALSARTAN,Back pain,8
VALSARTAN,Muscle spasms,8
VALSARTAN,Product dose omission issue,8
VALSARTAN,Hyperthyroidism,8
VALSARTAN,Interstitial lung disease,8
VALSARTAN,Weight decreased,8
VALSARTAN,Hyponatraemia,8
VALSARTAN,Coma,8
VALSARTAN,Tremor,7
VALSARTAN,Hepatic steatosis,7
VALSARTAN,Hypoaesthesia,7
VALSARTAN,Fall,7
VALSARTAN,Anaemia,7
VALSARTAN,Death,7
VALSARTAN,Blood pressure increased,7
VALSARTAN,Toxicity to various agents,7
VALSARTAN,General physical health deterioration,6
VALSARTAN,Viral infection,6
VALSARTAN,Respiratory failure,6
VALSARTAN,Sepsis,6
VALSARTAN,Decreased appetite,6
VALSARTAN,Weight increased,6
VALSARTAN,Thrombocytopenia,6
VALTREX,Pain,11
VALTREX,Anxiety,11
VALTREX,Emotional distress,10
VALTREX,Anhedonia,9
VALTREX,Fatigue,8
VALTREX,Chronic kidney disease,8
VALTREX,Depression,7
VALTREX,Weight decreased,6
VALTREX,Headache,6
VALTREX,COVID-19,6
VALTREX,Pyrexia,5
VALTREX,Urinary tract infection,5
VALTREX,Off label use,5
VALTREX,Arthritis,5
VALTREX,Nasopharyngitis,5
VALTREX,Dyspnoea,5
VALTREX,Product dose omission issue,5
VALTREX,Blood pressure increased,4
VALTREX,Inappropriate schedule of product administration,4
VALTREX,Malaise,4
VALTREX,Pneumonia,4
VALTREX,Fall,4
VALTREX,Hypertension,4
VALTREX,Dizziness,4
VALTREX,Respiratory tract infection,3
VALTREX,Obstructive sleep apnoea syndrome,3
VALTREX,Nausea,3
VALTREX,Fungal infection,3
VALTREX,Pleural effusion,3
VALTREX,Balance disorder,3
VALTREX,Hypersensitivity,3
VALTREX,Mobility decreased,3
VALTREX,Cough,3
VALTREX,White blood cell count decreased,3
VALTREX,Anaemia,3
VALTREX,Drug ineffective,3
VALTREX,Arthralgia,3
VALTREX,Visual impairment,3
VALTREX,Herpes zoster,3
VALTREX,Condition aggravated,3
VALTREX,Septic shock,3
VALTREX,Chest discomfort,3
VALTREX,Night sweats,3
VALTREX,Stomatitis,3
VALTREX,Thrombocytopenia,2
VALTREX,Post-traumatic stress disorder,2
VALTREX,Victim of sexual abuse,2
VALTREX,Staphylococcal infection,2
VALTREX,Enuresis,2
VALTREX,Abnormal behaviour,2
VANCOMYCIN,Off label use,12
VANCOMYCIN,Diarrhoea,12
VANCOMYCIN,Pyrexia,11
VANCOMYCIN,Pruritus,10
VANCOMYCIN,Febrile neutropenia,10
VANCOMYCIN,Acute kidney injury,9
VANCOMYCIN,Oedema,9
VANCOMYCIN,Neutrophil count decreased,9
VANCOMYCIN,Vascular device infection,9
VANCOMYCIN,Device related sepsis,9
VANCOMYCIN,Agranulocytosis,8
VANCOMYCIN,Eosinophilia,8
VANCOMYCIN,Renal failure,8
VANCOMYCIN,Sepsis,8
VANCOMYCIN,Atrial fibrillation,7
VANCOMYCIN,Rash,7
VANCOMYCIN,Drug reaction with eosinophilia and systemic symptoms,7
VANCOMYCIN,Erythema,7
VANCOMYCIN,Skin exfoliation,6
VANCOMYCIN,Blood albumin decreased,6
VANCOMYCIN,Oedema peripheral,6
VANCOMYCIN,Abdominal distension,6
VANCOMYCIN,Ascites,6
VANCOMYCIN,Thrombocytopenia,6
VANCOMYCIN,Product use in unapproved indication,5
VANCOMYCIN,Tachycardia,5
VANCOMYCIN,Lymphadenopathy,5
VANCOMYCIN,Rash maculo-papular,5
VANCOMYCIN,Venoocclusive liver disease,5
VANCOMYCIN,BK virus infection,5
VANCOMYCIN,Hepatomegaly,5
VANCOMYCIN,Eyelid oedema,5
VANCOMYCIN,Varicella zoster virus infection,5
VANCOMYCIN,Blood potassium decreased,5
VANCOMYCIN,Weight increased,5
VANCOMYCIN,Blood bilirubin increased,5
VANCOMYCIN,Nausea,4
VANCOMYCIN,Blood creatine phosphokinase increased,4
VANCOMYCIN,Heart rate irregular,4
VANCOMYCIN,Infection,4
VANCOMYCIN,Disease progression,4
VANCOMYCIN,Clostridium difficile infection,4
VANCOMYCIN,Chest pain,4
VANCOMYCIN,Headache,4
VANCOMYCIN,Platelet count decreased,4
VANCOMYCIN,Malignant neoplasm progression,4
VANCOMYCIN,Cytokine release syndrome,4
VANCOMYCIN,Arthritis bacterial,4
VANCOMYCIN,Urinary tract infection,4
VANCOMYCIN,Dehydration,4
VEDOLIZUMAB,Diarrhoea,79
VEDOLIZUMAB,Off label use,75
VEDOLIZUMAB,Abdominal pain,75
VEDOLIZUMAB,Colitis ulcerative,65
VEDOLIZUMAB,Weight decreased,54
VEDOLIZUMAB,Headache,53
VEDOLIZUMAB,Malaise,50
VEDOLIZUMAB,Haematochezia,48
VEDOLIZUMAB,Drug ineffective,47
VEDOLIZUMAB,Weight increased,46
VEDOLIZUMAB,COVID-19,43
VEDOLIZUMAB,Crohn's disease,40
VEDOLIZUMAB,Nausea,36
VEDOLIZUMAB,Pyrexia,32
VEDOLIZUMAB,Influenza,31
VEDOLIZUMAB,Pain,31
VEDOLIZUMAB,Cough,31
VEDOLIZUMAB,Frequent bowel movements,30
VEDOLIZUMAB,Vomiting,29
VEDOLIZUMAB,Arthralgia,28
VEDOLIZUMAB,Nasal congestion,27
VEDOLIZUMAB,Fatigue,25
VEDOLIZUMAB,Dizziness,24
VEDOLIZUMAB,Abdominal distension,23
VEDOLIZUMAB,Inappropriate schedule of product administration,21
VEDOLIZUMAB,Product dose omission issue,21
VEDOLIZUMAB,Discouragement,21
VEDOLIZUMAB,Rectal haemorrhage,18
VEDOLIZUMAB,Gastrointestinal inflammation,17
VEDOLIZUMAB,Decreased appetite,17
VEDOLIZUMAB,Rhinorrhoea,16
VEDOLIZUMAB,Chills,15
VEDOLIZUMAB,Constipation,15
VEDOLIZUMAB,Oropharyngeal pain,15
VEDOLIZUMAB,Asthenia,15
VEDOLIZUMAB,Productive cough,15
VEDOLIZUMAB,Pregnancy,14
VEDOLIZUMAB,Diarrhoea haemorrhagic,13
VEDOLIZUMAB,Mucous stools,13
VEDOLIZUMAB,Pruritus,12
VEDOLIZUMAB,Influenza like illness,12
VEDOLIZUMAB,Dyspnoea,12
VEDOLIZUMAB,Insomnia,12
VEDOLIZUMAB,Anxiety,12
VEDOLIZUMAB,Abdominal pain upper,12
VEDOLIZUMAB,Back pain,11
VEDOLIZUMAB,Pain in extremity,11
VEDOLIZUMAB,Therapeutic reaction time decreased,10
VEDOLIZUMAB,Abdominal discomfort,10
VEDOLIZUMAB,Product availability issue,10
VELAGLUCERASE ALFA,Inappropriate schedule of product administration,19
VELAGLUCERASE ALFA,Fall,17
VELAGLUCERASE ALFA,COVID-19,17
VELAGLUCERASE ALFA,Weight increased,16
VELAGLUCERASE ALFA,Product dose omission issue,16
VELAGLUCERASE ALFA,Weight decreased,15
VELAGLUCERASE ALFA,Fatigue,11
VELAGLUCERASE ALFA,Abdominal pain,11
VELAGLUCERASE ALFA,Headache,10
VELAGLUCERASE ALFA,Nausea,10
VELAGLUCERASE ALFA,Bone pain,10
VELAGLUCERASE ALFA,Malaise,10
VELAGLUCERASE ALFA,Vomiting,8
VELAGLUCERASE ALFA,Diarrhoea,8
VELAGLUCERASE ALFA,Pain,8
VELAGLUCERASE ALFA,Incorrect dose administered,7
VELAGLUCERASE ALFA,Product availability issue,7
VELAGLUCERASE ALFA,Influenza,6
VELAGLUCERASE ALFA,Blood pressure increased,6
VELAGLUCERASE ALFA,Pyrexia,6
VELAGLUCERASE ALFA,Weight fluctuation,6
VELAGLUCERASE ALFA,Arthralgia,6
VELAGLUCERASE ALFA,Asthenia,6
VELAGLUCERASE ALFA,Pain in extremity,5
VELAGLUCERASE ALFA,Muscular weakness,5
VELAGLUCERASE ALFA,Dizziness,5
VELAGLUCERASE ALFA,Back pain,5
VELAGLUCERASE ALFA,Product prescribing issue,5
VELAGLUCERASE ALFA,Blood pressure decreased,5
VELAGLUCERASE ALFA,Cough,5
VELAGLUCERASE ALFA,Abdominal pain upper,5
VELAGLUCERASE ALFA,Product prescribing error,5
VELAGLUCERASE ALFA,Urinary tract infection,5
VELAGLUCERASE ALFA,Wrist fracture,4
VELAGLUCERASE ALFA,Osteoporosis,4
VELAGLUCERASE ALFA,Parkinson's disease,4
VELAGLUCERASE ALFA,Epistaxis,4
VELAGLUCERASE ALFA,Poor venous access,4
VELAGLUCERASE ALFA,Body height decreased,3
VELAGLUCERASE ALFA,Seizure,3
VELAGLUCERASE ALFA,Limb injury,3
VELAGLUCERASE ALFA,Sinusitis,3
VELAGLUCERASE ALFA,Chest pain,3
VELAGLUCERASE ALFA,Muscle atrophy,3
VELAGLUCERASE ALFA,Frustration tolerance decreased,3
VELAGLUCERASE ALFA,General physical health deterioration,3
VELAGLUCERASE ALFA,Multiple allergies,3
VELAGLUCERASE ALFA,Mobility decreased,3
VELAGLUCERASE ALFA,Illness,3
VELAGLUCERASE ALFA,Syncope,3
VELCADE,Off label use,25
VELCADE,Plasma cell myeloma,9
VELCADE,Neuropathy peripheral,8
VELCADE,Rash,8
VELCADE,Febrile neutropenia,7
VELCADE,Diarrhoea,7
VELCADE,Acute kidney injury,6
VELCADE,Emotional distress,6
VELCADE,Pneumonia,5
VELCADE,Fatigue,5
VELCADE,Drug abuse,5
VELCADE,Medication error,5
VELCADE,Abnormal behaviour,5
VELCADE,Intentional product misuse,5
VELCADE,Paranoia,5
VELCADE,Hallucination,5
VELCADE,Agitation,5
VELCADE,Disturbance in social behaviour,5
VELCADE,Incorrect route of product administration,5
VELCADE,Disorientation,5
VELCADE,Confusional state,5
VELCADE,Engraftment syndrome,4
VELCADE,Intentional product use issue,4
VELCADE,Pancytopenia,4
VELCADE,Anaemia,4
VELCADE,Back pain,4
VELCADE,Product use in unapproved indication,4
VELCADE,Drug ineffective,3
VELCADE,Pain,3
VELCADE,Platelet count decreased,3
VELCADE,Therapeutic product effect incomplete,3
VELCADE,Atrial fibrillation,3
VELCADE,Asthenia,3
VELCADE,White blood cell count decreased,3
VELCADE,Weight decreased,3
VELCADE,Constipation,3
VELCADE,Hyperpyrexia,3
VELCADE,Hypotension,2
VELCADE,Infusion related reaction,2
VELCADE,Tachycardia,2
VELCADE,Chest discomfort,2
VELCADE,Ileus paralytic,2
VELCADE,Hypovolaemic shock,2
VELCADE,Blood pressure decreased,2
VELCADE,Herpes zoster,2
VELCADE,Clostridium difficile colitis,2
VELCADE,Acute graft versus host disease,2
VELCADE,Pneumonia aspiration,2
VELCADE,Progressive multifocal leukoencephalopathy,2
VELCADE,Vomiting,2
VENCLEXTA,Myelosuppression,24
VENCLEXTA,Neutrophil count decreased,23
VENCLEXTA,Platelet count decreased,21
VENCLEXTA,Acute myeloid leukaemia,21
VENCLEXTA,Pneumonia,20
VENCLEXTA,White blood cell count decreased,19
VENCLEXTA,Pyrexia,18
VENCLEXTA,Febrile neutropenia,18
VENCLEXTA,Off label use,17
VENCLEXTA,Death,13
VENCLEXTA,Neutropenia,12
VENCLEXTA,Anaemia,10
VENCLEXTA,COVID-19,10
VENCLEXTA,Haemoglobin decreased,9
VENCLEXTA,Diarrhoea,9
VENCLEXTA,Infection,8
VENCLEXTA,Tumour lysis syndrome,7
VENCLEXTA,Nausea,7
VENCLEXTA,Sepsis,6
VENCLEXTA,Acute myeloid leukaemia recurrent,6
VENCLEXTA,Dyspnoea,5
VENCLEXTA,Immunodeficiency,5
VENCLEXTA,Fatigue,5
VENCLEXTA,General physical health deterioration,5
VENCLEXTA,Vomiting,4
VENCLEXTA,Asthenia,4
VENCLEXTA,Decreased appetite,4
VENCLEXTA,Constipation,4
VENCLEXTA,Disseminated intravascular coagulation,4
VENCLEXTA,Cerebral haemorrhage,4
VENCLEXTA,Thrombocytopenia,4
VENCLEXTA,Unevaluable event,4
VENCLEXTA,Full blood count abnormal,4
VENCLEXTA,Weight decreased,4
VENCLEXTA,Laboratory test abnormal,4
VENCLEXTA,Pancytopenia,4
VENCLEXTA,Rash,3
VENCLEXTA,Blood bilirubin increased,3
VENCLEXTA,Cellulitis,3
VENCLEXTA,Septic shock,3
VENCLEXTA,Influenza,3
VENCLEXTA,Transfusion,3
VENCLEXTA,Arthralgia,3
VENCLEXTA,Subdural haematoma,3
VENCLEXTA,Dizziness,3
VENCLEXTA,Malaise,3
VENCLEXTA,Drug ineffective,3
VENCLEXTA,Hospitalisation,3
VENCLEXTA,Leukopenia,3
VENCLEXTA,COVID-19 pneumonia,3
VENETOCLAX,Neutropenia,85
VENETOCLAX,Diarrhoea,41
VENETOCLAX,Thrombocytopenia,39
VENETOCLAX,Pyrexia,38
VENETOCLAX,Anaemia,32
VENETOCLAX,Febrile neutropenia,31
VENETOCLAX,COVID-19,28
VENETOCLAX,Asthenia,24
VENETOCLAX,Death,20
VENETOCLAX,Weight decreased,18
VENETOCLAX,Hypocalcaemia,17
VENETOCLAX,Back pain,17
VENETOCLAX,Fatigue,16
VENETOCLAX,Lymphopenia,16
VENETOCLAX,Vomiting,16
VENETOCLAX,Hyperuricaemia,16
VENETOCLAX,Pneumonia,16
VENETOCLAX,Disease progression,16
VENETOCLAX,Dyspnoea,14
VENETOCLAX,Pain,14
VENETOCLAX,Malaise,14
VENETOCLAX,Richter's syndrome,13
VENETOCLAX,Epistaxis,13
VENETOCLAX,Hyperkalaemia,13
VENETOCLAX,Nausea,13
VENETOCLAX,Septic shock,13
VENETOCLAX,Bronchitis,12
VENETOCLAX,Off label use,12
VENETOCLAX,Leukopenia,12
VENETOCLAX,Chills,12
VENETOCLAX,Proctalgia,12
VENETOCLAX,Haemorrhoids,12
VENETOCLAX,Tumour lysis syndrome,11
VENETOCLAX,Anal inflammation,11
VENETOCLAX,Accident,11
VENETOCLAX,Crohn's disease,11
VENETOCLAX,Body temperature increased,11
VENETOCLAX,Acute kidney injury,10
VENETOCLAX,Blood lactate dehydrogenase increased,10
VENETOCLAX,Sepsis,10
VENETOCLAX,Lung disorder,9
VENETOCLAX,Chronic lymphocytic leukaemia,9
VENETOCLAX,Oedema peripheral,9
VENETOCLAX,Constipation,9
VENETOCLAX,Neutrophil count decreased,9
VENETOCLAX,General physical health deterioration,9
VENETOCLAX,SARS-CoV-2 test negative,9
VENETOCLAX,Hyperphosphataemia,8
VENETOCLAX,Cough,8
VENETOCLAX,Arthralgia,8
VENLAFAXINE,Nausea,26
VENLAFAXINE,Off label use,23
VENLAFAXINE,Diarrhoea,22
VENLAFAXINE,Vomiting,19
VENLAFAXINE,Abdominal discomfort,18
VENLAFAXINE,Fatigue,17
VENLAFAXINE,Intentional product misuse,17
VENLAFAXINE,Gait disturbance,17
VENLAFAXINE,Dyspnoea,16
VENLAFAXINE,Product dose omission issue,16
VENLAFAXINE,Dizziness,14
VENLAFAXINE,Drug abuse,13
VENLAFAXINE,Overdose,13
VENLAFAXINE,Depression,13
VENLAFAXINE,Headache,13
VENLAFAXINE,Product use in unapproved indication,13
VENLAFAXINE,Coma,12
VENLAFAXINE,Pulmonary pain,12
VENLAFAXINE,Lower respiratory tract infection,12
VENLAFAXINE,Rash,12
VENLAFAXINE,Mucosal inflammation,12
VENLAFAXINE,Somnolence,11
VENLAFAXINE,Pain,11
VENLAFAXINE,Fall,11
VENLAFAXINE,Productive cough,11
VENLAFAXINE,Arthropathy,11
VENLAFAXINE,Condition aggravated,11
VENLAFAXINE,Asthenia,11
VENLAFAXINE,Knee arthroplasty,10
VENLAFAXINE,Dysphagia,10
VENLAFAXINE,Anaemia,10
VENLAFAXINE,Constipation,10
VENLAFAXINE,Drug ineffective,10
VENLAFAXINE,COVID-19,9
VENLAFAXINE,Obesity,9
VENLAFAXINE,Anxiety,9
VENLAFAXINE,Drug interaction,9
VENLAFAXINE,Hypokalaemia,9
VENLAFAXINE,Decreased appetite,9
VENLAFAXINE,Neutrophil count decreased,9
VENLAFAXINE,Death,9
VENLAFAXINE,Hypomagnesaemia,9
VENLAFAXINE,Feeling abnormal,9
VENLAFAXINE,Arthralgia,8
VENLAFAXINE,Toxicity to various agents,8
VENLAFAXINE,Amyloid arthropathy,8
VENLAFAXINE,Nervous system disorder,8
VENLAFAXINE,Balance disorder,8
VENLAFAXINE,Dehydration,8
VENLAFAXINE,Mouth ulceration,8
VENLAFAXINE HYDROCHLORIDE,Off label use,25
VENLAFAXINE HYDROCHLORIDE,Product dose omission issue,24
VENLAFAXINE HYDROCHLORIDE,Abdominal discomfort,24
VENLAFAXINE HYDROCHLORIDE,Overdose,24
VENLAFAXINE HYDROCHLORIDE,Intentional product misuse,23
VENLAFAXINE HYDROCHLORIDE,Pulmonary pain,23
VENLAFAXINE HYDROCHLORIDE,Lower respiratory tract infection,23
VENLAFAXINE HYDROCHLORIDE,Rash,23
VENLAFAXINE HYDROCHLORIDE,Drug abuse,23
VENLAFAXINE HYDROCHLORIDE,Arthropathy,22
VENLAFAXINE HYDROCHLORIDE,Knee arthroplasty,21
VENLAFAXINE HYDROCHLORIDE,Condition aggravated,14
VENLAFAXINE HYDROCHLORIDE,Lung neoplasm malignant,12
VENLAFAXINE HYDROCHLORIDE,COVID-19,12
VENLAFAXINE HYDROCHLORIDE,Radiation inflammation,12
VENLAFAXINE HYDROCHLORIDE,Inflammation,12
VENLAFAXINE HYDROCHLORIDE,Obesity,11
VENLAFAXINE HYDROCHLORIDE,Schizophrenia,11
VENLAFAXINE HYDROCHLORIDE,Amyloid arthropathy,10
VENLAFAXINE HYDROCHLORIDE,Drug interaction,7
VENLAFAXINE HYDROCHLORIDE,Depression,6
VENLAFAXINE HYDROCHLORIDE,Diarrhoea,6
VENLAFAXINE HYDROCHLORIDE,Somnolence,6
VENLAFAXINE HYDROCHLORIDE,Malaise,6
VENLAFAXINE HYDROCHLORIDE,Food poisoning,6
VENLAFAXINE HYDROCHLORIDE,Headache,4
VENLAFAXINE HYDROCHLORIDE,Dizziness,4
VENLAFAXINE HYDROCHLORIDE,Muscle haemorrhage,4
VENLAFAXINE HYDROCHLORIDE,Tendon rupture,4
VENLAFAXINE HYDROCHLORIDE,Feeling abnormal,4
VENLAFAXINE HYDROCHLORIDE,Vomiting,4
VENLAFAXINE HYDROCHLORIDE,Oral pain,4
VENLAFAXINE HYDROCHLORIDE,Mucosal inflammation,4
VENLAFAXINE HYDROCHLORIDE,Gastrointestinal pain,4
VENLAFAXINE HYDROCHLORIDE,Illness,4
VENLAFAXINE HYDROCHLORIDE,Dementia,4
VENLAFAXINE HYDROCHLORIDE,Genital pain,4
VENLAFAXINE HYDROCHLORIDE,Anxiety,3
VENLAFAXINE HYDROCHLORIDE,Pain,3
VENLAFAXINE HYDROCHLORIDE,Fatigue,3
VENLAFAXINE HYDROCHLORIDE,Tremor,3
VENLAFAXINE HYDROCHLORIDE,Cognitive disorder,3
VENLAFAXINE HYDROCHLORIDE,Contusion,3
VENLAFAXINE HYDROCHLORIDE,Irritable bowel syndrome,3
VENLAFAXINE HYDROCHLORIDE,Abdominal pain,3
VENLAFAXINE HYDROCHLORIDE,Genital ulceration,3
VENLAFAXINE HYDROCHLORIDE,Abdominal pain upper,3
VENLAFAXINE HYDROCHLORIDE,Nightmare,3
VENLAFAXINE HYDROCHLORIDE,Blood potassium decreased,3
VENLAFAXINE HYDROCHLORIDE,Peripheral swelling,3
VENOFER,Drug hypersensitivity,40
VENOFER,Nausea,15
VENOFER,Dyspnoea,15
VENOFER,Flushing,11
VENOFER,Cerebrovascular accident,10
VENOFER,Vomiting,10
VENOFER,Feeling hot,10
VENOFER,Malaise,9
VENOFER,Off label use,9
VENOFER,Erythema,9
VENOFER,Diarrhoea,7
VENOFER,Cough,6
VENOFER,Hyperhidrosis,6
VENOFER,Chest pain,6
VENOFER,Unresponsive to stimuli,6
VENOFER,Loss of employment,5
VENOFER,Cardiac failure,5
VENOFER,Rash,5
VENOFER,Abdominal pain upper,5
VENOFER,Blood pressure increased,5
VENOFER,Dizziness,5
VENOFER,Abdominal pain,4
VENOFER,Headache,4
VENOFER,Abdominal discomfort,4
VENOFER,Drug intolerance,4
VENOFER,Liver disorder,4
VENOFER,Arthralgia,4
VENOFER,Product use issue,4
VENOFER,Gastric disorder,4
VENOFER,Hepatic steatosis,4
VENOFER,Cardiac failure congestive,4
VENOFER,Drug ineffective,4
VENOFER,Hypertension,4
VENOFER,Contraindicated product administered,4
VENOFER,Therapeutic product effect decreased,4
VENOFER,Pruritus,4
VENOFER,Hypotension,4
VENOFER,COVID-19,3
VENOFER,Hepatic enzyme increased,3
VENOFER,Fall,3
VENOFER,Urticaria,3
VENOFER,Seizure,3
VENOFER,Feeling abnormal,3
VENOFER,Blood pressure abnormal,3
VENOFER,Fatigue,2
VENOFER,Loss of personal independence in daily activities,2
VENOFER,Disease recurrence,2
VENOFER,Peripheral swelling,2
VENOFER,Chest discomfort,2
VENOFER,Paraesthesia,2
VENTOLIN,Dyspnoea,46
VENTOLIN,Asthma,41
VENTOLIN,Fatigue,39
VENTOLIN,Pain,39
VENTOLIN,Headache,37
VENTOLIN,Nasopharyngitis,34
VENTOLIN,Cough,34
VENTOLIN,Weight decreased,32
VENTOLIN,Pneumonia,32
VENTOLIN,Blood pressure increased,30
VENTOLIN,Product dose omission issue,30
VENTOLIN,Weight increased,29
VENTOLIN,Pyrexia,28
VENTOLIN,Malaise,25
VENTOLIN,Diarrhoea,25
VENTOLIN,Arthralgia,25
VENTOLIN,Anxiety,24
VENTOLIN,Influenza,23
VENTOLIN,Vomiting,23
VENTOLIN,Wheezing,22
VENTOLIN,Fall,22
VENTOLIN,Sinusitis,22
VENTOLIN,Nausea,20
VENTOLIN,Dizziness,19
VENTOLIN,Bronchitis,19
VENTOLIN,Productive cough,18
VENTOLIN,Joint swelling,18
VENTOLIN,Forced expiratory volume decreased,17
VENTOLIN,Hypersensitivity,17
VENTOLIN,Heart rate increased,17
VENTOLIN,Lower respiratory tract infection,17
VENTOLIN,Off label use,17
VENTOLIN,Inappropriate schedule of product administration,17
VENTOLIN,Incorrect dose administered,16
VENTOLIN,Drug hypersensitivity,16
VENTOLIN,COVID-19,16
VENTOLIN,Oropharyngeal pain,15
VENTOLIN,Middle insomnia,14
VENTOLIN,Gait disturbance,14
VENTOLIN,Feeling abnormal,14
VENTOLIN,Illness,13
VENTOLIN,Blood pressure systolic increased,13
VENTOLIN,Arthritis,13
VENTOLIN,Chest discomfort,12
VENTOLIN,Peripheral swelling,12
VENTOLIN,Asthenia,12
VENTOLIN,Drug ineffective,12
VENTOLIN,Chronic obstructive pulmonary disease,11
VENTOLIN,Respiratory disorder,11
VENTOLIN,Pruritus,11
VENTOLIN HFA,Pain,14
VENTOLIN HFA,COVID-19,14
VENTOLIN HFA,Product dose omission issue,11
VENTOLIN HFA,Fall,9
VENTOLIN HFA,Headache,8
VENTOLIN HFA,Asthenia,8
VENTOLIN HFA,Illness,8
VENTOLIN HFA,Weight increased,8
VENTOLIN HFA,Anxiety,7
VENTOLIN HFA,Sinusitis,7
VENTOLIN HFA,Cough,7
VENTOLIN HFA,Pyrexia,7
VENTOLIN HFA,Fatigue,7
VENTOLIN HFA,Emotional distress,6
VENTOLIN HFA,Anhedonia,6
VENTOLIN HFA,Dyspnoea,6
VENTOLIN HFA,Pneumonia,6
VENTOLIN HFA,Upper respiratory tract infection,6
VENTOLIN HFA,Weight decreased,6
VENTOLIN HFA,Infusion related reaction,6
VENTOLIN HFA,Nasopharyngitis,6
VENTOLIN HFA,Pruritus,6
VENTOLIN HFA,Depression,5
VENTOLIN HFA,Asthma,5
VENTOLIN HFA,Infection,5
VENTOLIN HFA,Infusion site pain,5
VENTOLIN HFA,Urinary tract infection,5
VENTOLIN HFA,Nausea,5
VENTOLIN HFA,Osteopenia,4
VENTOLIN HFA,Respiratory tract infection,4
VENTOLIN HFA,Infusion site erythema,4
VENTOLIN HFA,Bronchitis,4
VENTOLIN HFA,Joint swelling,4
VENTOLIN HFA,Pain in extremity,4
VENTOLIN HFA,Chronic kidney disease,4
VENTOLIN HFA,Poor venous access,4
VENTOLIN HFA,Infusion site extravasation,4
VENTOLIN HFA,Cellulitis,4
VENTOLIN HFA,Back pain,4
VENTOLIN HFA,Intervertebral disc protrusion,4
VENTOLIN HFA,Drug ineffective,4
VENTOLIN HFA,Thermal burn,4
VENTOLIN HFA,Urticaria,4
VENTOLIN HFA,Diarrhoea,4
VENTOLIN HFA,Economic problem,3
VENTOLIN HFA,Osteoporosis,3
VENTOLIN HFA,Seasonal allergy,3
VENTOLIN HFA,Chest pain,3
VENTOLIN HFA,Wheezing,3
VENTOLIN HFA,Malaise,3
VERAPAMIL,Product dose omission issue,7
VERAPAMIL,Cough,7
VERAPAMIL,Pneumonia,7
VERAPAMIL,Malaise,6
VERAPAMIL,Constipation,6
VERAPAMIL,COVID-19,5
VERAPAMIL,Pain,5
VERAPAMIL,Hypertension,5
VERAPAMIL,Back pain,5
VERAPAMIL,Infusion related reaction,4
VERAPAMIL,Fall,4
VERAPAMIL,Inappropriate schedule of product administration,4
VERAPAMIL,Anxiety,4
VERAPAMIL,Weight decreased,4
VERAPAMIL,Migraine,4
VERAPAMIL,Sinusitis,4
VERAPAMIL,Illness,4
VERAPAMIL,Musculoskeletal stiffness,4
VERAPAMIL,Psoriatic arthropathy,4
VERAPAMIL,Diarrhoea,4
VERAPAMIL,Pollakiuria,4
VERAPAMIL,Pain in extremity,4
VERAPAMIL,Dysuria,4
VERAPAMIL,Chronic obstructive pulmonary disease,4
VERAPAMIL,Dyspnoea,4
VERAPAMIL,Memory impairment,3
VERAPAMIL,Fatigue,3
VERAPAMIL,Depression,3
VERAPAMIL,Pelvic fracture,3
VERAPAMIL,Vomiting,3
VERAPAMIL,Nausea,3
VERAPAMIL,Hereditary angioedema,3
VERAPAMIL,Headache,3
VERAPAMIL,Mobility decreased,3
VERAPAMIL,Gait disturbance,3
VERAPAMIL,Death,3
VERAPAMIL,Feeling abnormal,3
VERAPAMIL,Exostosis,3
VERAPAMIL,Cataract,3
VERAPAMIL,Spondylitis,3
VERAPAMIL,Blood uric acid increased,3
VERAPAMIL,Scoliosis,3
VERAPAMIL,Pyelonephritis,3
VERAPAMIL,Spinal osteoarthritis,3
VERAPAMIL,Flatulence,3
VERAPAMIL,Carpal tunnel syndrome,3
VERAPAMIL,Interspinous osteoarthritis,3
VERAPAMIL,Psoriasis,3
VERAPAMIL,Hepatitis A antibody abnormal,3
VERAPAMIL,Facet joint syndrome,3
VIMPAT,Seizure,13
VIMPAT,Off label use,7
VIMPAT,Visual impairment,6
VIMPAT,Sinusitis,5
VIMPAT,Product dose omission issue,5
VIMPAT,Vomiting,4
VIMPAT,Rash,4
VIMPAT,Muscle rigidity,4
VIMPAT,Product dispensing error,4
VIMPAT,Tremor,4
VIMPAT,Cognitive disorder,4
VIMPAT,Maternal exposure during pregnancy,3
VIMPAT,Anxiety,3
VIMPAT,COVID-19,3
VIMPAT,Upper respiratory tract infection,3
VIMPAT,Therapeutic product effect incomplete,3
VIMPAT,Infection,3
VIMPAT,Hyponatraemia,3
VIMPAT,Urinary tract infection,3
VIMPAT,Pneumonia,3
VIMPAT,Product administration interrupted,3
VIMPAT,Leukopenia,3
VIMPAT,Thrombocytopenia,3
VIMPAT,Pyrexia,2
VIMPAT,Premature delivery,2
VIMPAT,Pain,2
VIMPAT,Dizziness,2
VIMPAT,Headache,2
VIMPAT,Dehydration,2
VIMPAT,Herpes zoster,2
VIMPAT,Injection site erythema,2
VIMPAT,Eye abrasion,2
VIMPAT,Bronchitis,2
VIMPAT,Malaise,2
VIMPAT,Weight decreased,2
VIMPAT,Decreased appetite,2
VIMPAT,Epilepsy,2
VIMPAT,Cough,2
VIMPAT,Blood pressure fluctuation,2
VIMPAT,Maternal exposure before pregnancy,2
VIMPAT,Encephalopathy,2
VIMPAT,Rash maculo-papular,2
VIMPAT,Hypoglycaemia,2
VIMPAT,Shock,2
VIMPAT,Anaemia,2
VIMPAT,Cytokine release syndrome,2
VIMPAT,Renal impairment,2
VIMPAT,Hepatic cytolysis,2
VIMPAT,Dyspnoea,2
VIMPAT,Diarrhoea,2
VINCRISTINE,Febrile neutropenia,37
VINCRISTINE,Neutropenia,29
VINCRISTINE,Pyrexia,22
VINCRISTINE,Pancytopenia,21
VINCRISTINE,Anaemia,18
VINCRISTINE,Mucosal inflammation,17
VINCRISTINE,Off label use,14
VINCRISTINE,Pneumonia,13
VINCRISTINE,Vomiting,13
VINCRISTINE,Cough,12
VINCRISTINE,Nausea,12
VINCRISTINE,Sepsis,11
VINCRISTINE,Disease progression,11
VINCRISTINE,Thrombocytopenia,11
VINCRISTINE,Fatigue,10
VINCRISTINE,Stomatitis,9
VINCRISTINE,Headache,9
VINCRISTINE,Respiratory failure,9
VINCRISTINE,Tachycardia,9
VINCRISTINE,Dehydration,8
VINCRISTINE,Product use in unapproved indication,8
VINCRISTINE,White blood cell count decreased,8
VINCRISTINE,Hypotension,8
VINCRISTINE,Diarrhoea,8
VINCRISTINE,Pruritus,8
VINCRISTINE,Dysarthria,7
VINCRISTINE,Abdominal pain,7
VINCRISTINE,Decreased appetite,7
VINCRISTINE,Neutrophil count decreased,7
VINCRISTINE,Urinary tract infection,7
VINCRISTINE,General physical health deterioration,7
VINCRISTINE,Back pain,7
VINCRISTINE,Malignant neoplasm progression,7
VINCRISTINE,Drug hypersensitivity,6
VINCRISTINE,Platelet count decreased,6
VINCRISTINE,Dyspnoea,6
VINCRISTINE,Fall,6
VINCRISTINE,Myalgia,6
VINCRISTINE,Lymphadenopathy,6
VINCRISTINE,Pain in extremity,6
VINCRISTINE,Hypothyroidism,6
VINCRISTINE,Arthralgia,6
VINCRISTINE,Hypokalaemia,6
VINCRISTINE,Electrocardiogram QT prolonged,6
VINCRISTINE,Inflammation,5
VINCRISTINE,Pain,5
VINCRISTINE,Device malfunction,5
VINCRISTINE,Acute respiratory distress syndrome,5
VINCRISTINE,Haemoglobin decreased,5
VINCRISTINE,Myelodysplastic syndrome,5
VINCRISTINE SULFATE,Febrile neutropenia,28
VINCRISTINE SULFATE,Myelosuppression,25
VINCRISTINE SULFATE,Off label use,12
VINCRISTINE SULFATE,Pancytopenia,11
VINCRISTINE SULFATE,Neutropenia,10
VINCRISTINE SULFATE,Sepsis,9
VINCRISTINE SULFATE,Pyrexia,9
VINCRISTINE SULFATE,Dysphagia,8
VINCRISTINE SULFATE,Vomiting,7
VINCRISTINE SULFATE,Nausea,7
VINCRISTINE SULFATE,COVID-19 pneumonia,6
VINCRISTINE SULFATE,Vaccination failure,6
VINCRISTINE SULFATE,Hepatic cytolysis,6
VINCRISTINE SULFATE,COVID-19,6
VINCRISTINE SULFATE,Neoplasm progression,5
VINCRISTINE SULFATE,Pneumonia,5
VINCRISTINE SULFATE,Stomatitis,5
VINCRISTINE SULFATE,Cytokine release syndrome,5
VINCRISTINE SULFATE,White blood cell count decreased,5
VINCRISTINE SULFATE,Drug reaction with eosinophilia and systemic symptoms,5
VINCRISTINE SULFATE,Drug ineffective,4
VINCRISTINE SULFATE,Headache,4
VINCRISTINE SULFATE,Urinary tract infection,4
VINCRISTINE SULFATE,Acute kidney injury,4
VINCRISTINE SULFATE,Inappropriate antidiuretic hormone secretion,4
VINCRISTINE SULFATE,Subdural haematoma,4
VINCRISTINE SULFATE,Pneumonia necrotising,4
VINCRISTINE SULFATE,Corynebacterium infection,4
VINCRISTINE SULFATE,Mucosal inflammation,4
VINCRISTINE SULFATE,Anaemia,4
VINCRISTINE SULFATE,Treatment failure,3
VINCRISTINE SULFATE,Blood HIV RNA increased,3
VINCRISTINE SULFATE,Pathogen resistance,3
VINCRISTINE SULFATE,Oesophageal carcinoma,3
VINCRISTINE SULFATE,Virologic failure,3
VINCRISTINE SULFATE,Second primary malignancy,3
VINCRISTINE SULFATE,Dehydration,3
VINCRISTINE SULFATE,Neutrophil count decreased,3
VINCRISTINE SULFATE,Neuropathy peripheral,3
VINCRISTINE SULFATE,Platelet count decreased,3
VINCRISTINE SULFATE,Acute respiratory distress syndrome,3
VINCRISTINE SULFATE,Fatigue,3
VINCRISTINE SULFATE,Atrial fibrillation,3
VINCRISTINE SULFATE,Granulocyte count decreased,3
VINCRISTINE SULFATE,Pneumonitis,3
VINCRISTINE SULFATE,Alanine aminotransferase increased,3
VINCRISTINE SULFATE,Hypertension,3
VINCRISTINE SULFATE,Diarrhoea,3
VINCRISTINE SULFATE,Cellulitis,3
VINCRISTINE SULFATE,Product use in unapproved indication,2
VIREAD,Pain,128
VIREAD,Emotional distress,126
VIREAD,Anxiety,124
VIREAD,Anhedonia,121
VIREAD,Chronic kidney disease,69
VIREAD,Osteoporosis,62
VIREAD,Bone density decreased,46
VIREAD,Osteopenia,44
VIREAD,Renal failure,41
VIREAD,Blood creatinine increased,32
VIREAD,Depression,31
VIREAD,Bone demineralisation,31
VIREAD,Acute kidney injury,27
VIREAD,Multiple fractures,26
VIREAD,Gait disturbance,22
VIREAD,Fatigue,21
VIREAD,Economic problem,19
VIREAD,Bone loss,17
VIREAD,End stage renal disease,16
VIREAD,Renal injury,16
VIREAD,Asthenia,16
VIREAD,Osteonecrosis,15
VIREAD,Renal impairment,15
VIREAD,Foot fracture,14
VIREAD,Vitamin D deficiency,13
VIREAD,Skeletal injury,11
VIREAD,Back pain,11
VIREAD,Ankle fracture,9
VIREAD,Proteinuria,9
VIREAD,Decreased activity,9
VIREAD,Dysstasia,9
VIREAD,Nephropathy,9
VIREAD,Rib fracture,8
VIREAD,Mobility decreased,8
VIREAD,Hypertension,8
VIREAD,Anaemia,8
VIREAD,Drug ineffective,7
VIREAD,Quality of life decreased,7
VIREAD,Hip fracture,7
VIREAD,Volvulus,6
VIREAD,Foetal exposure during pregnancy,6
VIREAD,Wrist fracture,6
VIREAD,Fanconi syndrome acquired,6
VIREAD,Loss of personal independence in daily activities,6
VIREAD,Insomnia,6
VIREAD,Fall,6
VIREAD,Pollakiuria,6
VIREAD,Renal disorder,5
VIREAD,Femur fracture,5
VIREAD,Virologic failure,4
VITAMIN B,Headache,21
VITAMIN B,COVID-19,19
VITAMIN B,Fatigue,17
VITAMIN B,Product dose omission issue,17
VITAMIN B,Nasopharyngitis,14
VITAMIN B,Nausea,12
VITAMIN B,Infusion site pain,12
VITAMIN B,Infection,12
VITAMIN B,Sinusitis,12
VITAMIN B,Dyspnoea,11
VITAMIN B,Urinary tract infection,10
VITAMIN B,Dizziness,10
VITAMIN B,Fall,9
VITAMIN B,Upper respiratory tract infection,9
VITAMIN B,Pain,9
VITAMIN B,Pyrexia,9
VITAMIN B,Blood pressure increased,9
VITAMIN B,Pneumonia,8
VITAMIN B,Malaise,7
VITAMIN B,Infusion site swelling,7
VITAMIN B,Feeling abnormal,7
VITAMIN B,Inappropriate schedule of product administration,6
VITAMIN B,Limb injury,6
VITAMIN B,Arthralgia,6
VITAMIN B,Insurance issue,6
VITAMIN B,Decreased appetite,6
VITAMIN B,Vertigo,6
VITAMIN B,Infusion site pruritus,5
VITAMIN B,Cystitis,5
VITAMIN B,Respiratory tract infection,5
VITAMIN B,Influenza,5
VITAMIN B,Infusion related reaction,5
VITAMIN B,Oropharyngeal pain,5
VITAMIN B,Migraine,5
VITAMIN B,Asthenia,5
VITAMIN B,Infusion site extravasation,4
VITAMIN B,Sepsis,4
VITAMIN B,Gastrointestinal disorder,4
VITAMIN B,Fungal infection,4
VITAMIN B,Ear infection,4
VITAMIN B,Bronchitis,4
VITAMIN B,Contusion,4
VITAMIN B,Off label use,4
VITAMIN B,Diarrhoea,4
VITAMIN B,Rash,4
VITAMIN B,Incorrect product administration duration,4
VITAMIN B,Kidney infection,4
VITAMIN B,Back pain,4
VITAMIN B,Weight increased,4
VITAMIN B,Pseudomonas infection,4
VITAMIN B COMPLEX,Fatigue,19
VITAMIN B COMPLEX,Headache,13
VITAMIN B COMPLEX,COVID-19,13
VITAMIN B COMPLEX,Pain,12
VITAMIN B COMPLEX,Product dose omission issue,12
VITAMIN B COMPLEX,Diarrhoea,12
VITAMIN B COMPLEX,Sinusitis,11
VITAMIN B COMPLEX,Nasopharyngitis,10
VITAMIN B COMPLEX,Urinary tract infection,10
VITAMIN B COMPLEX,Pruritus,9
VITAMIN B COMPLEX,Anaemia,9
VITAMIN B COMPLEX,Nausea,9
VITAMIN B COMPLEX,Weight decreased,9
VITAMIN B COMPLEX,Decreased appetite,9
VITAMIN B COMPLEX,Off label use,9
VITAMIN B COMPLEX,Asthenia,8
VITAMIN B COMPLEX,Pain in extremity,7
VITAMIN B COMPLEX,Inappropriate schedule of product administration,7
VITAMIN B COMPLEX,Illness,7
VITAMIN B COMPLEX,Rash,7
VITAMIN B COMPLEX,Dyspnoea,7
VITAMIN B COMPLEX,Thrombocytopenia,7
VITAMIN B COMPLEX,Malaise,6
VITAMIN B COMPLEX,Cough,6
VITAMIN B COMPLEX,Weight increased,6
VITAMIN B COMPLEX,Ear infection,6
VITAMIN B COMPLEX,Fall,6
VITAMIN B COMPLEX,Neutropenia,6
VITAMIN B COMPLEX,Hypertension,5
VITAMIN B COMPLEX,Memory impairment,5
VITAMIN B COMPLEX,Anxiety,5
VITAMIN B COMPLEX,Blood pressure increased,5
VITAMIN B COMPLEX,Migraine,5
VITAMIN B COMPLEX,Influenza,5
VITAMIN B COMPLEX,Chest discomfort,5
VITAMIN B COMPLEX,Upper respiratory tract infection,5
VITAMIN B COMPLEX,Pyrexia,5
VITAMIN B COMPLEX,Alopecia,5
VITAMIN B COMPLEX,Insomnia,5
VITAMIN B COMPLEX,Vomiting,5
VITAMIN B COMPLEX,Arthralgia,5
VITAMIN B COMPLEX,Pneumonia,5
VITAMIN B COMPLEX,Oropharyngeal discomfort,4
VITAMIN B COMPLEX,Osteopenia,4
VITAMIN B COMPLEX,Infusion site extravasation,4
VITAMIN B COMPLEX,Infusion site pruritus,4
VITAMIN B COMPLEX,Limb injury,4
VITAMIN B COMPLEX,Abdominal pain,4
VITAMIN B COMPLEX,Dermatitis contact,4
VITAMIN B COMPLEX,Infection,4
VITAMIN B12,Off label use,59
VITAMIN B12,COVID-19,54
VITAMIN B12,Fatigue,48
VITAMIN B12,Diarrhoea,43
VITAMIN B12,Nausea,41
VITAMIN B12,Product dose omission issue,40
VITAMIN B12,Pain,38
VITAMIN B12,Headache,35
VITAMIN B12,Weight decreased,33
VITAMIN B12,Vomiting,33
VITAMIN B12,Weight increased,31
VITAMIN B12,Malaise,30
VITAMIN B12,Urinary tract infection,30
VITAMIN B12,Fall,30
VITAMIN B12,Asthenia,30
VITAMIN B12,Dizziness,29
VITAMIN B12,Nasopharyngitis,26
VITAMIN B12,Arthralgia,26
VITAMIN B12,Abdominal pain,24
VITAMIN B12,Sinusitis,23
VITAMIN B12,Cough,22
VITAMIN B12,Blood pressure increased,22
VITAMIN B12,Pneumonia,21
VITAMIN B12,Inappropriate schedule of product administration,20
VITAMIN B12,Illness,20
VITAMIN B12,Back pain,19
VITAMIN B12,Dyspnoea,19
VITAMIN B12,Pyrexia,19
VITAMIN B12,Anxiety,18
VITAMIN B12,Asthma,17
VITAMIN B12,Pain in extremity,17
VITAMIN B12,Decreased appetite,17
VITAMIN B12,Pruritus,17
VITAMIN B12,Insomnia,16
VITAMIN B12,Abdominal discomfort,16
VITAMIN B12,Bronchitis,15
VITAMIN B12,Infection,15
VITAMIN B12,Condition aggravated,13
VITAMIN B12,Platelet count decreased,13
VITAMIN B12,Rash,13
VITAMIN B12,Abdominal pain upper,13
VITAMIN B12,Anaemia,13
VITAMIN B12,Drug ineffective,12
VITAMIN B12,Intentional product use issue,12
VITAMIN B12,Aspartate aminotransferase increased,12
VITAMIN B12,Gait disturbance,12
VITAMIN B12,Death,12
VITAMIN B12,Dehydration,12
VITAMIN B12,Muscle spasms,12
VITAMIN B12,White blood cell count decreased,12
VITAMIN B6,Nausea,12
VITAMIN B6,Off label use,11
VITAMIN B6,Vomiting,10
VITAMIN B6,Death,8
VITAMIN B6,Constipation,8
VITAMIN B6,Abdominal distension,8
VITAMIN B6,Stress,7
VITAMIN B6,Cardiogenic shock,7
VITAMIN B6,Sepsis,7
VITAMIN B6,Incorrect route of product administration,7
VITAMIN B6,Multiple organ dysfunction syndrome,7
VITAMIN B6,Ascites,7
VITAMIN B6,Condition aggravated,7
VITAMIN B6,Dyspnoea,7
VITAMIN B6,Swelling,7
VITAMIN B6,Product dose omission issue,6
VITAMIN B6,Dry mouth,6
VITAMIN B6,Somnolence,6
VITAMIN B6,Abdominal pain upper,5
VITAMIN B6,Bacterial infection,5
VITAMIN B6,Abdominal pain,5
VITAMIN B6,Neuralgia,5
VITAMIN B6,Illness,4
VITAMIN B6,Cough,4
VITAMIN B6,Drug hypersensitivity,4
VITAMIN B6,Drug intolerance,4
VITAMIN B6,Intentional product misuse,4
VITAMIN B6,Appendicolith,4
VITAMIN B6,Hyponatraemia,4
VITAMIN B6,General physical health deterioration,4
VITAMIN B6,Ventricular fibrillation,4
VITAMIN B6,Appendicitis,4
VITAMIN B6,Pyrexia,4
VITAMIN B6,Sleep disorder,4
VITAMIN B6,COVID-19,3
VITAMIN B6,Alopecia,3
VITAMIN B6,Product use in unapproved indication,3
VITAMIN B6,Blood cholesterol increased,3
VITAMIN B6,Blood phosphorus increased,3
VITAMIN B6,Myasthenia gravis,3
VITAMIN B6,Blood uric acid increased,3
VITAMIN B6,Anaemia,3
VITAMIN B6,Neutrophil count decreased,3
VITAMIN B6,Bronchitis,3
VITAMIN B6,Sinusitis,3
VITAMIN B6,Insomnia,3
VITAMIN B6,Diarrhoea,3
VITAMIN B6,Rash,3
VITAMIN B6,Seizure,3
VITAMIN B6,Nasopharyngitis,2
VITAMIN C,Fatigue,55
VITAMIN C,COVID-19,54
VITAMIN C,Pain,44
VITAMIN C,Off label use,42
VITAMIN C,Product dose omission issue,39
VITAMIN C,Headache,37
VITAMIN C,Dyspnoea,36
VITAMIN C,Diarrhoea,35
VITAMIN C,Nausea,35
VITAMIN C,Sinusitis,34
VITAMIN C,Illness,33
VITAMIN C,Nasopharyngitis,32
VITAMIN C,Arthralgia,27
VITAMIN C,Cough,27
VITAMIN C,Weight decreased,26
VITAMIN C,Drug ineffective,25
VITAMIN C,Condition aggravated,25
VITAMIN C,Asthenia,24
VITAMIN C,Pruritus,24
VITAMIN C,Rash,24
VITAMIN C,Pyrexia,24
VITAMIN C,Vomiting,24
VITAMIN C,Weight increased,23
VITAMIN C,Dizziness,23
VITAMIN C,Urinary tract infection,23
VITAMIN C,Fall,23
VITAMIN C,Pneumonia,22
VITAMIN C,Malaise,22
VITAMIN C,Constipation,20
VITAMIN C,Pain in extremity,19
VITAMIN C,Inappropriate schedule of product administration,17
VITAMIN C,Decreased appetite,16
VITAMIN C,Abdominal pain,16
VITAMIN C,Swelling,16
VITAMIN C,Anxiety,15
VITAMIN C,Joint swelling,15
VITAMIN C,Gait disturbance,15
VITAMIN C,Migraine,15
VITAMIN C,Abdominal discomfort,15
VITAMIN C,Abdominal distension,15
VITAMIN C,Back pain,14
VITAMIN C,Insomnia,14
VITAMIN C,Blood pressure increased,14
VITAMIN C,Influenza,14
VITAMIN C,Death,14
VITAMIN C,Stress,13
VITAMIN C,Rheumatoid arthritis,13
VITAMIN C,Drug hypersensitivity,13
VITAMIN C,Ear infection,13
VITAMIN C,Product use in unapproved indication,13
VITAMIN D,Fatigue,47
VITAMIN D,COVID-19,41
VITAMIN D,Off label use,41
VITAMIN D,Pain,37
VITAMIN D,Fall,34
VITAMIN D,Product dose omission issue,33
VITAMIN D,Diarrhoea,31
VITAMIN D,Sinusitis,30
VITAMIN D,Nausea,29
VITAMIN D,Dyspnoea,28
VITAMIN D,Headache,28
VITAMIN D,Weight decreased,28
VITAMIN D,Asthenia,27
VITAMIN D,Arthralgia,27
VITAMIN D,Back pain,26
VITAMIN D,Cough,26
VITAMIN D,Weight increased,26
VITAMIN D,Pyrexia,25
VITAMIN D,Pain in extremity,25
VITAMIN D,Inappropriate schedule of product administration,24
VITAMIN D,Nasopharyngitis,24
VITAMIN D,Pneumonia,20
VITAMIN D,Dizziness,20
VITAMIN D,Drug hypersensitivity,19
VITAMIN D,Drug ineffective,19
VITAMIN D,Peripheral swelling,19
VITAMIN D,Decreased appetite,18
VITAMIN D,Illness,18
VITAMIN D,Blood pressure increased,18
VITAMIN D,Abdominal pain,18
VITAMIN D,Vomiting,18
VITAMIN D,Urinary tract infection,18
VITAMIN D,Condition aggravated,17
VITAMIN D,Influenza,17
VITAMIN D,Pruritus,17
VITAMIN D,Malaise,17
VITAMIN D,Rash,16
VITAMIN D,Somnolence,16
VITAMIN D,Gait disturbance,16
VITAMIN D,Hypoaesthesia,15
VITAMIN D,Constipation,15
VITAMIN D,Abdominal distension,14
VITAMIN D,Bronchitis,13
VITAMIN D,Anxiety,13
VITAMIN D,Asthma,13
VITAMIN D,Rhinorrhoea,12
VITAMIN D,Stress,12
VITAMIN D,Mobility decreased,12
VITAMIN D,Herpes zoster,12
VITAMIN D,Hypertension,11
VITAMIN D NOS,Pain,43
VITAMIN D NOS,Anxiety,42
VITAMIN D NOS,Emotional distress,37
VITAMIN D NOS,Anhedonia,33
VITAMIN D NOS,Fatigue,27
VITAMIN D NOS,Chronic kidney disease,23
VITAMIN D NOS,Off label use,22
VITAMIN D NOS,Depression,17
VITAMIN D NOS,Headache,15
VITAMIN D NOS,Osteoporosis,15
VITAMIN D NOS,Osteopenia,15
VITAMIN D NOS,Bone density decreased,14
VITAMIN D NOS,Nausea,14
VITAMIN D NOS,Diarrhoea,13
VITAMIN D NOS,COVID-19,13
VITAMIN D NOS,Renal failure,12
VITAMIN D NOS,Asthenia,11
VITAMIN D NOS,Vomiting,11
VITAMIN D NOS,Dizziness,10
VITAMIN D NOS,Drug ineffective,10
VITAMIN D NOS,Blood creatinine increased,10
VITAMIN D NOS,Acute kidney injury,10
VITAMIN D NOS,Condition aggravated,10
VITAMIN D NOS,Product dose omission issue,10
VITAMIN D NOS,Product use in unapproved indication,10
VITAMIN D NOS,Economic problem,9
VITAMIN D NOS,Renal impairment,9
VITAMIN D NOS,Dyspnoea,9
VITAMIN D NOS,Pain in extremity,9
VITAMIN D NOS,Weight decreased,9
VITAMIN D NOS,Pneumonia,9
VITAMIN D NOS,Weight increased,9
VITAMIN D NOS,Fall,8
VITAMIN D NOS,Intentional product use issue,8
VITAMIN D NOS,Tremor,8
VITAMIN D NOS,Muscular weakness,8
VITAMIN D NOS,Inappropriate schedule of product administration,8
VITAMIN D NOS,Pruritus,8
VITAMIN D NOS,Feeling abnormal,7
VITAMIN D NOS,Back pain,7
VITAMIN D NOS,Anaemia,7
VITAMIN D NOS,Gait disturbance,7
VITAMIN D NOS,Illness,6
VITAMIN D NOS,Abdominal discomfort,6
VITAMIN D NOS,Cough,6
VITAMIN D NOS,Heart rate increased,6
VITAMIN D NOS,Incorrect dose administered,6
VITAMIN D NOS,Tachycardia,6
VITAMIN D NOS,Hypertension,5
VITAMIN D NOS,Dry mouth,5
VITAMIN D2,Pain,27
VITAMIN D2,Fatigue,23
VITAMIN D2,Product dose omission issue,23
VITAMIN D2,Sinusitis,23
VITAMIN D2,COVID-19,21
VITAMIN D2,Anxiety,18
VITAMIN D2,Pruritus,16
VITAMIN D2,Emotional distress,14
VITAMIN D2,Anhedonia,14
VITAMIN D2,Headache,14
VITAMIN D2,Nausea,14
VITAMIN D2,Cough,14
VITAMIN D2,Fall,14
VITAMIN D2,Arthralgia,14
VITAMIN D2,Inappropriate schedule of product administration,12
VITAMIN D2,Malaise,12
VITAMIN D2,Back pain,11
VITAMIN D2,Depression,11
VITAMIN D2,Chronic kidney disease,11
VITAMIN D2,Peripheral swelling,11
VITAMIN D2,Upper respiratory tract infection,11
VITAMIN D2,Bronchitis,11
VITAMIN D2,Nasopharyngitis,10
VITAMIN D2,Renal failure,9
VITAMIN D2,Contusion,9
VITAMIN D2,Product use issue,9
VITAMIN D2,Weight increased,9
VITAMIN D2,Dizziness,9
VITAMIN D2,Hypersensitivity,9
VITAMIN D2,Dyspnoea,8
VITAMIN D2,Weight decreased,8
VITAMIN D2,Condition aggravated,8
VITAMIN D2,Pneumonia,8
VITAMIN D2,Illness,8
VITAMIN D2,Asthma,8
VITAMIN D2,Osteopenia,7
VITAMIN D2,Urinary tract infection,7
VITAMIN D2,Vomiting,7
VITAMIN D2,Insurance issue,7
VITAMIN D2,Acute kidney injury,6
VITAMIN D2,Drug hypersensitivity,6
VITAMIN D2,Asthenia,6
VITAMIN D2,Viral infection,6
VITAMIN D2,Diarrhoea,6
VITAMIN D2,Off label use,6
VITAMIN D2,Osteoporosis,5
VITAMIN D2,Influenza,5
VITAMIN D2,Rhinorrhoea,5
VITAMIN D2,Gastrointestinal disorder,5
VITAMIN D2,Seasonal allergy,5
VITAMIN D3,Fatigue,138
VITAMIN D3,Headache,113
VITAMIN D3,COVID-19,113
VITAMIN D3,Product dose omission issue,112
VITAMIN D3,Pain,108
VITAMIN D3,Nausea,98
VITAMIN D3,Fall,85
VITAMIN D3,Diarrhoea,82
VITAMIN D3,Sinusitis,78
VITAMIN D3,Malaise,74
VITAMIN D3,Pneumonia,65
VITAMIN D3,Arthralgia,64
VITAMIN D3,Off label use,63
VITAMIN D3,Dizziness,62
VITAMIN D3,Nasopharyngitis,61
VITAMIN D3,Urinary tract infection,60
VITAMIN D3,Illness,56
VITAMIN D3,Vomiting,55
VITAMIN D3,Pain in extremity,53
VITAMIN D3,Weight decreased,52
VITAMIN D3,Inappropriate schedule of product administration,50
VITAMIN D3,Dyspnoea,49
VITAMIN D3,Asthenia,47
VITAMIN D3,Rash,46
VITAMIN D3,Weight increased,46
VITAMIN D3,Cough,45
VITAMIN D3,Pyrexia,44
VITAMIN D3,Anxiety,42
VITAMIN D3,Pruritus,42
VITAMIN D3,Back pain,42
VITAMIN D3,Upper respiratory tract infection,40
VITAMIN D3,Decreased appetite,37
VITAMIN D3,Infection,37
VITAMIN D3,Drug ineffective,36
VITAMIN D3,Bronchitis,35
VITAMIN D3,Condition aggravated,33
VITAMIN D3,Contusion,32
VITAMIN D3,Gait disturbance,32
VITAMIN D3,Influenza,32
VITAMIN D3,Insurance issue,32
VITAMIN D3,Peripheral swelling,31
VITAMIN D3,Migraine,31
VITAMIN D3,Product use issue,30
VITAMIN D3,Blood pressure increased,30
VITAMIN D3,Abdominal pain upper,29
VITAMIN D3,Depression,29
VITAMIN D3,Abdominal pain,29
VITAMIN D3,Asthma,28
VITAMIN D3,Infusion related reaction,26
VITAMIN D3,Muscle spasms,26
VITAMIN E,Fatigue,16
VITAMIN E,Headache,12
VITAMIN E,Fall,12
VITAMIN E,COVID-19,12
VITAMIN E,Off label use,10
VITAMIN E,Sinusitis,10
VITAMIN E,Product dose omission issue,10
VITAMIN E,Nausea,10
VITAMIN E,Alopecia,9
VITAMIN E,Illness,9
VITAMIN E,Weight decreased,9
VITAMIN E,Asthenia,8
VITAMIN E,Dyspnoea,8
VITAMIN E,Nasopharyngitis,8
VITAMIN E,Pain,8
VITAMIN E,Diarrhoea,7
VITAMIN E,Back pain,7
VITAMIN E,Contusion,7
VITAMIN E,Arthralgia,7
VITAMIN E,Vomiting,6
VITAMIN E,Peripheral swelling,6
VITAMIN E,Pain in extremity,6
VITAMIN E,Influenza,6
VITAMIN E,Anaemia,6
VITAMIN E,Hypersensitivity,5
VITAMIN E,Pruritus,5
VITAMIN E,Somnolence,5
VITAMIN E,Upper respiratory tract infection,5
VITAMIN E,Inappropriate schedule of product administration,5
VITAMIN E,Condition aggravated,5
VITAMIN E,Drug ineffective,5
VITAMIN E,Rheumatoid arthritis,4
VITAMIN E,Discomfort,4
VITAMIN E,Drug hypersensitivity,4
VITAMIN E,Viral infection,4
VITAMIN E,Productive cough,4
VITAMIN E,Dehydration,4
VITAMIN E,Cellulitis,4
VITAMIN E,Asthma,4
VITAMIN E,Product use issue,4
VITAMIN E,Constipation,4
VITAMIN E,Abdominal pain,4
VITAMIN E,Malaise,4
VITAMIN E,Cough,4
VITAMIN E,Death,4
VITAMIN E,Hip fracture,4
VITAMIN E,Tremor,4
VITAMIN E,Hypertension,3
VITAMIN E,Muscle spasms,3
VITAMIN E,Musculoskeletal stiffness,3
VITAMINS,Diarrhoea,36
VITAMINS,Pain,34
VITAMINS,Off label use,30
VITAMINS,Headache,26
VITAMINS,Fatigue,24
VITAMINS,Nausea,23
VITAMINS,Dyspnoea,20
VITAMINS,Anxiety,19
VITAMINS,Product dose omission issue,18
VITAMINS,Pain in extremity,18
VITAMINS,Back pain,16
VITAMINS,Dizziness,16
VITAMINS,Pyrexia,16
VITAMINS,Drug ineffective,15
VITAMINS,Vomiting,15
VITAMINS,Asthenia,14
VITAMINS,Urinary tract infection,14
VITAMINS,Arthralgia,14
VITAMINS,Weight decreased,13
VITAMINS,Emotional distress,12
VITAMINS,Pruritus,12
VITAMINS,Decreased appetite,12
VITAMINS,Blood pressure increased,11
VITAMINS,Anhedonia,11
VITAMINS,Osteoporosis,11
VITAMINS,Fall,11
VITAMINS,Rash,11
VITAMINS,Gait disturbance,11
VITAMINS,Sinusitis,10
VITAMINS,Cough,10
VITAMINS,Weight increased,10
VITAMINS,Abdominal pain upper,10
VITAMINS,COVID-19,9
VITAMINS,Inappropriate schedule of product administration,9
VITAMINS,Pneumonia,9
VITAMINS,Peripheral swelling,9
VITAMINS,Contusion,9
VITAMINS,Abdominal pain,9
VITAMINS,Constipation,9
VITAMINS,White blood cell count decreased,9
VITAMINS,Product use issue,9
VITAMINS,Chills,8
VITAMINS,Wrong technique in product usage process,8
VITAMINS,Influenza,8
VITAMINS,Nasopharyngitis,8
VITAMINS,Condition aggravated,7
VITAMINS,Abdominal discomfort,7
VITAMINS,Osteopenia,7
VITAMINS,Neuropathy peripheral,7
VITAMINS,Muscular weakness,7
VITAMINS NOS,Off label use,14
VITAMINS NOS,Pruritus,14
VITAMINS NOS,Nausea,12
VITAMINS NOS,Dizziness,12
VITAMINS NOS,Dyspnoea,11
VITAMINS NOS,Fatigue,11
VITAMINS NOS,Pain,10
VITAMINS NOS,Dermatitis atopic,10
VITAMINS NOS,Inappropriate schedule of product administration,9
VITAMINS NOS,Headache,9
VITAMINS NOS,Condition aggravated,9
VITAMINS NOS,Product dose omission issue,8
VITAMINS NOS,Weight decreased,8
VITAMINS NOS,Injection site pain,8
VITAMINS NOS,Vomiting,8
VITAMINS NOS,Anxiety,7
VITAMINS NOS,Diarrhoea,7
VITAMINS NOS,Dry skin,7
VITAMINS NOS,Pyrexia,6
VITAMINS NOS,Constipation,6
VITAMINS NOS,Emotional distress,6
VITAMINS NOS,Anhedonia,6
VITAMINS NOS,Drug ineffective,6
VITAMINS NOS,Alopecia,6
VITAMINS NOS,Skin fissures,6
VITAMINS NOS,Asthenia,6
VITAMINS NOS,Rash,6
VITAMINS NOS,Dyspepsia,5
VITAMINS NOS,Chest discomfort,5
VITAMINS NOS,Depression,5
VITAMINS NOS,Product use in unapproved indication,5
VITAMINS NOS,Urinary tract infection,5
VITAMINS NOS,Stress,5
VITAMINS NOS,Malaise,5
VITAMINS NOS,Feeling abnormal,5
VITAMINS NOS,Arthralgia,5
VITAMINS NOS,Peripheral swelling,5
VITAMINS NOS,COVID-19,5
VITAMINS NOS,Thrombosis,4
VITAMINS NOS,Pneumonia,4
VITAMINS NOS,Abdominal discomfort,4
VITAMINS NOS,Back pain,4
VITAMINS NOS,Gait disturbance,4
VITAMINS NOS,Abdominal pain upper,4
VITAMINS NOS,Palpitations,4
VITAMINS NOS,Confusional state,4
VITAMINS NOS,Anaemia,4
VITAMINS NOS,Eye pruritus,4
VITAMINS NOS,Injection site swelling,4
VITAMINS NOS,Eczema,4
VONOPRAZAN FUMARATE,Pyrexia,10
VONOPRAZAN FUMARATE,Diarrhoea,10
VONOPRAZAN FUMARATE,Nausea,9
VONOPRAZAN FUMARATE,Interstitial lung disease,9
VONOPRAZAN FUMARATE,Pneumonia,8
VONOPRAZAN FUMARATE,Decreased appetite,8
VONOPRAZAN FUMARATE,Hypertension,8
VONOPRAZAN FUMARATE,Anaemia,7
VONOPRAZAN FUMARATE,Malaise,7
VONOPRAZAN FUMARATE,Hepatic function abnormal,5
VONOPRAZAN FUMARATE,Lymphocyte count decreased,5
VONOPRAZAN FUMARATE,Dehydration,5
VONOPRAZAN FUMARATE,Headache,5
VONOPRAZAN FUMARATE,Hyponatraemia,4
VONOPRAZAN FUMARATE,Hyperkalaemia,4
VONOPRAZAN FUMARATE,Bacteraemia,4
VONOPRAZAN FUMARATE,Diabetes mellitus,4
VONOPRAZAN FUMARATE,Meningitis,4
VONOPRAZAN FUMARATE,Drug eruption,4
VONOPRAZAN FUMARATE,Pancytopenia,4
VONOPRAZAN FUMARATE,Blood creatine phosphokinase increased,4
VONOPRAZAN FUMARATE,Disease progression,3
VONOPRAZAN FUMARATE,Liver disorder,3
VONOPRAZAN FUMARATE,Off label use,3
VONOPRAZAN FUMARATE,Upper gastrointestinal haemorrhage,3
VONOPRAZAN FUMARATE,Chronic obstructive pulmonary disease,3
VONOPRAZAN FUMARATE,Melaena,3
VONOPRAZAN FUMARATE,Myelosuppression,3
VONOPRAZAN FUMARATE,White blood cell count decreased,3
VONOPRAZAN FUMARATE,Inappropriate schedule of product administration,3
VONOPRAZAN FUMARATE,Neutrophil count decreased,3
VONOPRAZAN FUMARATE,Tumour lysis syndrome,3
VONOPRAZAN FUMARATE,Altered state of consciousness,3
VONOPRAZAN FUMARATE,Pulmonary toxicity,3
VONOPRAZAN FUMARATE,Blood glucose increased,3
VONOPRAZAN FUMARATE,Diabetic ketoacidosis,3
VONOPRAZAN FUMARATE,Myasthenia gravis,3
VONOPRAZAN FUMARATE,Abdominal pain,3
VONOPRAZAN FUMARATE,Renal impairment,3
VONOPRAZAN FUMARATE,Iron deficiency anaemia,3
VONOPRAZAN FUMARATE,Steroid diabetes,3
VONOPRAZAN FUMARATE,Non-small cell lung cancer,3
VONOPRAZAN FUMARATE,Hypoglycaemia,2
VONOPRAZAN FUMARATE,Fulminant type 1 diabetes mellitus,2
VONOPRAZAN FUMARATE,Acute kidney injury,2
VONOPRAZAN FUMARATE,Septic shock,2
VONOPRAZAN FUMARATE,Cerebral infarction,2
VONOPRAZAN FUMARATE,Sepsis,2
VONOPRAZAN FUMARATE,Lung neoplasm malignant,2
VONOPRAZAN FUMARATE,Hypotension,2
VORICONAZOLE,Diarrhoea,18
VORICONAZOLE,Anaemia,13
VORICONAZOLE,Depression,13
VORICONAZOLE,Death,12
VORICONAZOLE,Off label use,12
VORICONAZOLE,Constipation,11
VORICONAZOLE,Dysphagia,11
VORICONAZOLE,Vomiting,11
VORICONAZOLE,Neutrophil count decreased,11
VORICONAZOLE,Hypokalaemia,10
VORICONAZOLE,Headache,10
VORICONAZOLE,Liver injury,10
VORICONAZOLE,Decreased appetite,9
VORICONAZOLE,Mouth ulceration,9
VORICONAZOLE,Dyspnoea,9
VORICONAZOLE,Asthenia,9
VORICONAZOLE,Mucosal inflammation,9
VORICONAZOLE,Productive cough,9
VORICONAZOLE,Product use in unapproved indication,9
VORICONAZOLE,Nausea,9
VORICONAZOLE,Hypomagnesaemia,9
VORICONAZOLE,Fatigue,8
VORICONAZOLE,Nervous system disorder,8
VORICONAZOLE,Dehydration,8
VORICONAZOLE,Neutropenic sepsis,8
VORICONAZOLE,Skin candida,8
VORICONAZOLE,Platelet count decreased,8
VORICONAZOLE,Gait disturbance,7
VORICONAZOLE,Balance disorder,7
VORICONAZOLE,Infection,7
VORICONAZOLE,Hypersensitivity pneumonitis,6
VORICONAZOLE,Immune-mediated lung disease,6
VORICONAZOLE,Mental disorder,6
VORICONAZOLE,Candida infection,5
VORICONAZOLE,Myelosuppression,5
VORICONAZOLE,Hepatic function abnormal,5
VORICONAZOLE,Pain,5
VORICONAZOLE,"Hallucination, visual",5
VORICONAZOLE,Febrile neutropenia,5
VORICONAZOLE,Agranulocytosis,5
VORICONAZOLE,Pancytopenia,5
VORICONAZOLE,Cholestasis,5
VORICONAZOLE,Delirium,5
VORICONAZOLE,Arthralgia,5
VORICONAZOLE,Lupus-like syndrome,5
VORICONAZOLE,Respiratory failure,5
VORICONAZOLE,Ovarian failure,5
VORICONAZOLE,Oedema peripheral,4
VORICONAZOLE,Thrombocytopenia,4
VORICONAZOLE,Insomnia,4
VYNDAMAX,Off label use,63
VYNDAMAX,Death,34
VYNDAMAX,Dyspnoea,23
VYNDAMAX,Weight decreased,21
VYNDAMAX,COVID-19,21
VYNDAMAX,Fall,18
VYNDAMAX,Fatigue,16
VYNDAMAX,Body height decreased,16
VYNDAMAX,Atrial fibrillation,15
VYNDAMAX,Product dose omission issue,15
VYNDAMAX,Condition aggravated,14
VYNDAMAX,Asthenia,14
VYNDAMAX,Cardiac failure congestive,12
VYNDAMAX,Malaise,12
VYNDAMAX,Illness,12
VYNDAMAX,Cardiac disorder,11
VYNDAMAX,Gait disturbance,11
VYNDAMAX,Dizziness,10
VYNDAMAX,Pain,10
VYNDAMAX,Peripheral swelling,9
VYNDAMAX,Hypoacusis,8
VYNDAMAX,Fluid retention,8
VYNDAMAX,Cardiac failure,8
VYNDAMAX,Diarrhoea,6
VYNDAMAX,Drug ineffective,6
VYNDAMAX,Pneumonia,6
VYNDAMAX,Dehydration,6
VYNDAMAX,Poor quality product administered,6
VYNDAMAX,Cerebrovascular accident,6
VYNDAMAX,Hip fracture,6
VYNDAMAX,Feeling abnormal,6
VYNDAMAX,Hypertension,6
VYNDAMAX,Hypotension,6
VYNDAMAX,Balance disorder,5
VYNDAMAX,Abdominal pain upper,5
VYNDAMAX,Heart rate decreased,5
VYNDAMAX,Heart rate increased,5
VYNDAMAX,Cough,5
VYNDAMAX,Haemorrhage,5
VYNDAMAX,Dysstasia,5
VYNDAMAX,Anxiety,5
VYNDAMAX,Urinary tract infection,5
VYNDAMAX,Loss of consciousness,5
VYNDAMAX,Dysphagia,5
VYNDAMAX,Pruritus,4
VYNDAMAX,Somnolence,4
VYNDAMAX,Headache,4
VYNDAMAX,Abdominal distension,4
VYNDAMAX,Vision blurred,4
VYNDAMAX,Pain in extremity,4
VYVANSE,Sinusitis,10
VYVANSE,Product dose omission issue,9
VYVANSE,Off label use,9
VYVANSE,COVID-19,8
VYVANSE,Drug ineffective,7
VYVANSE,Weight decreased,6
VYVANSE,Hypoaesthesia,6
VYVANSE,Nausea,6
VYVANSE,Fatigue,6
VYVANSE,Pneumonia,5
VYVANSE,Pruritus,5
VYVANSE,Gait disturbance,5
VYVANSE,Inappropriate schedule of product administration,5
VYVANSE,Condition aggravated,5
VYVANSE,Erythema,4
VYVANSE,Viral infection,4
VYVANSE,Paraesthesia,4
VYVANSE,Asthma,4
VYVANSE,Feeling abnormal,4
VYVANSE,Product availability issue,4
VYVANSE,Fall,4
VYVANSE,Anxiety,4
VYVANSE,Suicidal ideation,4
VYVANSE,Product use issue,4
VYVANSE,Nasal congestion,3
VYVANSE,Nephrolithiasis,3
VYVANSE,Sinus congestion,3
VYVANSE,Nasopharyngitis,3
VYVANSE,Peripheral swelling,3
VYVANSE,Urinary tract infection,3
VYVANSE,Cholelithiasis,3
VYVANSE,Cerebral disorder,3
VYVANSE,Weight increased,3
VYVANSE,Dehydration,3
VYVANSE,Vomiting,3
VYVANSE,Headache,3
VYVANSE,Dermatitis atopic,3
VYVANSE,Burning sensation,3
VYVANSE,Back pain,3
VYVANSE,Influenza,3
VYVANSE,Cellulitis,2
VYVANSE,White blood cell count increased,2
VYVANSE,Upper respiratory tract infection,2
VYVANSE,Rash pruritic,2
VYVANSE,Insurance issue,2
VYVANSE,Ligament sprain,2
VYVANSE,Gluten sensitivity,2
VYVANSE,Road traffic accident,2
VYVANSE,Respiratory tract infection,2
VYVANSE,Cough,2
VYVGART,Dyspnoea,20
VYVGART,Myasthenia gravis crisis,16
VYVGART,Symptom recurrence,13
VYVGART,Headache,13
VYVGART,Fatigue,12
VYVGART,Asthenia,11
VYVGART,COVID-19,10
VYVGART,Myasthenia gravis,9
VYVGART,Urinary tract infection,8
VYVGART,Hospitalisation,8
VYVGART,Malaise,8
VYVGART,Condition aggravated,8
VYVGART,Dysphagia,7
VYVGART,Muscular weakness,7
VYVGART,Death,6
VYVGART,Fall,6
VYVGART,Peripheral swelling,6
VYVGART,Dizziness,5
VYVGART,Eyelid ptosis,5
VYVGART,Diplopia,5
VYVGART,Sinusitis,4
VYVGART,Pyrexia,4
VYVGART,Pain in extremity,4
VYVGART,Mechanical ventilation,4
VYVGART,Pneumonia,4
VYVGART,Cough,4
VYVGART,Diarrhoea,4
VYVGART,Pain,4
VYVGART,Somnolence,3
VYVGART,Arthralgia,3
VYVGART,Sepsis,3
VYVGART,Blood pressure decreased,3
VYVGART,Respiratory failure,3
VYVGART,Back pain,3
VYVGART,Dysarthria,3
VYVGART,Influenza,3
VYVGART,White blood cell count increased,3
VYVGART,Gait disturbance,3
VYVGART,Therapeutic product effect incomplete,3
VYVGART,Therapy interrupted,3
VYVGART,Therapy cessation,3
VYVGART,Anaemia,3
VYVGART,Abdominal pain upper,3
VYVGART,Atrial fibrillation,3
VYVGART,Herpes zoster,3
VYVGART,Anxiety,3
VYVGART,Chromaturia,2
VYVGART,Dehydration,2
VYVGART,Cellulitis,2
VYVGART,Joint swelling,2
WARFARIN,Dyspnoea,25
WARFARIN,Pain,22
WARFARIN,Hypotension,21
WARFARIN,Off label use,20
WARFARIN,Headache,20
WARFARIN,Diarrhoea,18
WARFARIN,Fatigue,16
WARFARIN,Nausea,14
WARFARIN,Death,14
WARFARIN,COVID-19,13
WARFARIN,Pain in extremity,13
WARFARIN,Pyrexia,12
WARFARIN,Pneumonia,12
WARFARIN,Haemorrhage,12
WARFARIN,Weight decreased,12
WARFARIN,Condition aggravated,10
WARFARIN,Acute kidney injury,10
WARFARIN,Overdose,10
WARFARIN,Malaise,10
WARFARIN,Palpitations,10
WARFARIN,Anaemia,10
WARFARIN,International normalised ratio abnormal,9
WARFARIN,Medication error,9
WARFARIN,Chest pain,9
WARFARIN,Dizziness,9
WARFARIN,Vomiting,9
WARFARIN,Polyuria,8
WARFARIN,Abdominal distension,8
WARFARIN,Infection,8
WARFARIN,Peripheral swelling,8
WARFARIN,Drug ineffective,8
WARFARIN,Atrial fibrillation,8
WARFARIN,Respiratory failure,8
WARFARIN,Decreased appetite,8
WARFARIN,Drug hypersensitivity,7
WARFARIN,Feeling abnormal,7
WARFARIN,Catheter site erythema,7
WARFARIN,Back pain,7
WARFARIN,Infusion site pain,7
WARFARIN,Product dose omission issue,7
WARFARIN,Sepsis,7
WARFARIN,Arthralgia,7
WARFARIN,Asthenia,7
WARFARIN,Diabetes mellitus,7
WARFARIN,Dialysis,6
WARFARIN,Injection site erythema,6
WARFARIN,Pain in jaw,6
WARFARIN,Thrombosis,6
WARFARIN,Rash,6
WARFARIN,Cardiac failure,6
WARFARIN SODIUM,Dyspnoea,22
WARFARIN SODIUM,Nausea,14
WARFARIN SODIUM,Fatigue,13
WARFARIN SODIUM,Diarrhoea,12
WARFARIN SODIUM,Pain,12
WARFARIN SODIUM,Cardiogenic shock,12
WARFARIN SODIUM,Sepsis,11
WARFARIN SODIUM,Vomiting,11
WARFARIN SODIUM,Dry mouth,11
WARFARIN SODIUM,Headache,11
WARFARIN SODIUM,Death,10
WARFARIN SODIUM,Insomnia,9
WARFARIN SODIUM,Abdominal distension,9
WARFARIN SODIUM,Off label use,9
WARFARIN SODIUM,Condition aggravated,9
WARFARIN SODIUM,Neuralgia,9
WARFARIN SODIUM,Product dose omission issue,8
WARFARIN SODIUM,Cardiac failure,8
WARFARIN SODIUM,Cough,8
WARFARIN SODIUM,Arthralgia,8
WARFARIN SODIUM,Stress,7
WARFARIN SODIUM,Incorrect route of product administration,7
WARFARIN SODIUM,Multiple organ dysfunction syndrome,7
WARFARIN SODIUM,Ascites,7
WARFARIN SODIUM,Constipation,7
WARFARIN SODIUM,Abdominal pain,7
WARFARIN SODIUM,Pneumonia,7
WARFARIN SODIUM,Acute kidney injury,7
WARFARIN SODIUM,Back pain,6
WARFARIN SODIUM,Depression,6
WARFARIN SODIUM,Weight decreased,6
WARFARIN SODIUM,Somnolence,6
WARFARIN SODIUM,Infusion site pain,6
WARFARIN SODIUM,Rash,6
WARFARIN SODIUM,Anaemia,6
WARFARIN SODIUM,Pain in extremity,6
WARFARIN SODIUM,Asthenia,6
WARFARIN SODIUM,Decreased appetite,5
WARFARIN SODIUM,Inappropriate schedule of product administration,5
WARFARIN SODIUM,Urinary tract infection,5
WARFARIN SODIUM,Thrombosis,5
WARFARIN SODIUM,Drug hypersensitivity,5
WARFARIN SODIUM,Bacterial infection,5
WARFARIN SODIUM,Drug intolerance,5
WARFARIN SODIUM,Sleep disorder,5
WARFARIN SODIUM,Swelling,5
WARFARIN SODIUM,Memory impairment,5
WARFARIN SODIUM,Fall,5
WARFARIN SODIUM,Fluid retention,5
WARFARIN SODIUM,Palpitations,5
WELLBUTRIN,Pain,21
WELLBUTRIN,Anxiety,17
WELLBUTRIN,Fatigue,13
WELLBUTRIN,Nausea,13
WELLBUTRIN,COVID-19,13
WELLBUTRIN,Dizziness,13
WELLBUTRIN,Product dose omission issue,12
WELLBUTRIN,Malaise,11
WELLBUTRIN,Headache,11
WELLBUTRIN,Feeling abnormal,11
WELLBUTRIN,Pneumonia,11
WELLBUTRIN,Depression,11
WELLBUTRIN,Weight decreased,10
WELLBUTRIN,Nasopharyngitis,9
WELLBUTRIN,Sinusitis,9
WELLBUTRIN,Emotional distress,9
WELLBUTRIN,Fall,9
WELLBUTRIN,Illness,9
WELLBUTRIN,Drug ineffective,9
WELLBUTRIN,Weight increased,8
WELLBUTRIN,Arthralgia,8
WELLBUTRIN,Peripheral swelling,8
WELLBUTRIN,Bronchitis,8
WELLBUTRIN,Anhedonia,8
WELLBUTRIN,Off label use,8
WELLBUTRIN,Blood pressure increased,7
WELLBUTRIN,Pyrexia,7
WELLBUTRIN,Pain in extremity,7
WELLBUTRIN,Cough,7
WELLBUTRIN,Back pain,7
WELLBUTRIN,Asthenia,7
WELLBUTRIN,Abdominal discomfort,6
WELLBUTRIN,Urinary tract infection,6
WELLBUTRIN,Suicidal ideation,6
WELLBUTRIN,Vomiting,6
WELLBUTRIN,Abdominal pain,5
WELLBUTRIN,Obstructive sleep apnoea syndrome,5
WELLBUTRIN,Head injury,5
WELLBUTRIN,Infection,5
WELLBUTRIN,Fibromyalgia,5
WELLBUTRIN,Pruritus,5
WELLBUTRIN,Diarrhoea,5
WELLBUTRIN,Migraine,5
WELLBUTRIN,Condition aggravated,5
WELLBUTRIN,Dyspnoea,4
WELLBUTRIN,Abdominal distension,4
WELLBUTRIN,Infusion related reaction,4
WELLBUTRIN,Stress,4
WELLBUTRIN,Mobility decreased,4
WELLBUTRIN,Asthma,4
XANAX,Fatigue,28
XANAX,Anxiety,26
XANAX,Pain,24
XANAX,Product dose omission issue,22
XANAX,Fall,20
XANAX,Nausea,20
XANAX,Headache,20
XANAX,COVID-19,19
XANAX,Diarrhoea,18
XANAX,Sinusitis,18
XANAX,Asthenia,16
XANAX,Back pain,14
XANAX,Illness,14
XANAX,Depression,14
XANAX,Arthralgia,14
XANAX,Vomiting,14
XANAX,Weight decreased,14
XANAX,Dyspnoea,13
XANAX,Infection,12
XANAX,Malaise,12
XANAX,Urinary tract infection,12
XANAX,Insomnia,11
XANAX,Feeling abnormal,11
XANAX,Anhedonia,11
XANAX,Emotional distress,11
XANAX,Infusion site pain,11
XANAX,Migraine,11
XANAX,Inappropriate schedule of product administration,10
XANAX,Alopecia,10
XANAX,Dizziness,10
XANAX,Coma,10
XANAX,Pyrexia,9
XANAX,Pneumonia,9
XANAX,Tachycardia,9
XANAX,Suicide attempt,9
XANAX,Decreased appetite,8
XANAX,Gait disturbance,8
XANAX,Infusion related reaction,8
XANAX,Off label use,8
XANAX,Atrial fibrillation,8
XANAX,Drug ineffective,7
XANAX,Pain in extremity,7
XANAX,Weight increased,7
XANAX,Chronic kidney disease,7
XANAX,Hypertension,7
XANAX,Myalgia,7
XANAX,Constipation,7
XANAX,Bronchitis,7
XANAX,Confusional state,7
XANAX,Cough,7
XARELTO,Fatigue,38
XARELTO,Diarrhoea,38
XARELTO,Nausea,36
XARELTO,Dyspnoea,35
XARELTO,Dizziness,33
XARELTO,Vomiting,28
XARELTO,Headache,28
XARELTO,Off label use,26
XARELTO,Malaise,26
XARELTO,Decreased appetite,23
XARELTO,Cough,21
XARELTO,Fall,21
XARELTO,Pain,20
XARELTO,Weight decreased,20
XARELTO,Asthenia,20
XARELTO,Death,18
XARELTO,Product dose omission issue,18
XARELTO,Hypotension,18
XARELTO,COVID-19,17
XARELTO,Pneumonia,15
XARELTO,Gastrointestinal haemorrhage,15
XARELTO,Arthralgia,15
XARELTO,Rash,14
XARELTO,Pain in extremity,14
XARELTO,Constipation,14
XARELTO,Abdominal pain,14
XARELTO,Pyrexia,14
XARELTO,Infusion related reaction,14
XARELTO,Peripheral swelling,14
XARELTO,Haemoglobin decreased,14
XARELTO,Acute kidney injury,14
XARELTO,Nasopharyngitis,13
XARELTO,Inappropriate schedule of product administration,13
XARELTO,Palpitations,12
XARELTO,Atrial fibrillation,11
XARELTO,Weight increased,11
XARELTO,Abdominal discomfort,11
XARELTO,Illness,11
XARELTO,Back pain,11
XARELTO,Chest pain,11
XARELTO,Dyspnoea exertional,11
XARELTO,Incorrect dose administered,10
XARELTO,Condition aggravated,10
XARELTO,Erythema,10
XARELTO,Sinusitis,10
XARELTO,Oxygen saturation decreased,10
XARELTO,Blood pressure decreased,10
XARELTO,Anxiety,9
XARELTO,Haematochezia,9
XARELTO,Dehydration,9
XELJANZ,Off label use,90
XELJANZ,Pain,82
XELJANZ,Condition aggravated,81
XELJANZ,Drug ineffective,57
XELJANZ,Arthralgia,51
XELJANZ,Malaise,47
XELJANZ,Fatigue,41
XELJANZ,COVID-19,40
XELJANZ,Illness,39
XELJANZ,Diarrhoea,38
XELJANZ,Intentional product misuse,33
XELJANZ,Nasopharyngitis,32
XELJANZ,Pain in extremity,32
XELJANZ,Headache,29
XELJANZ,Drug hypersensitivity,29
XELJANZ,Product dose omission issue,29
XELJANZ,Infection,28
XELJANZ,Weight increased,27
XELJANZ,Dyspnoea,27
XELJANZ,Musculoskeletal stiffness,26
XELJANZ,Sinusitis,26
XELJANZ,Back pain,26
XELJANZ,Feeling abnormal,26
XELJANZ,Joint swelling,25
XELJANZ,Rash,25
XELJANZ,Cough,25
XELJANZ,Influenza,24
XELJANZ,Pneumonia,24
XELJANZ,Product use issue,23
XELJANZ,Peripheral swelling,23
XELJANZ,Gait disturbance,23
XELJANZ,Muscle spasms,22
XELJANZ,Blood cholesterol increased,21
XELJANZ,Fall,21
XELJANZ,Nausea,21
XELJANZ,Rheumatoid arthritis,20
XELJANZ,Herpes zoster,20
XELJANZ,Alopecia,19
XELJANZ,Memory impairment,19
XELJANZ,Hypertension,18
XELJANZ,Visual impairment,17
XELJANZ,Weight decreased,17
XELJANZ,Therapeutic product effect incomplete,17
XELJANZ,Arthropathy,16
XELJANZ,Hepatic enzyme increased,16
XELJANZ,Therapeutic product effect decreased,16
XELJANZ,Urinary tract infection,15
XELJANZ,Drug intolerance,15
XELJANZ,Inflammation,15
XELJANZ,Dizziness,15
XELJANZ XR,Pain,98
XELJANZ XR,Condition aggravated,63
XELJANZ XR,Illness,58
XELJANZ XR,Arthralgia,54
XELJANZ XR,Off label use,47
XELJANZ XR,Malaise,46
XELJANZ XR,Pain in extremity,45
XELJANZ XR,Nasopharyngitis,37
XELJANZ XR,COVID-19,36
XELJANZ XR,Memory impairment,35
XELJANZ XR,Gait disturbance,35
XELJANZ XR,Headache,34
XELJANZ XR,Drug ineffective,33
XELJANZ XR,Peripheral swelling,30
XELJANZ XR,Fatigue,29
XELJANZ XR,Therapeutic product effect incomplete,29
XELJANZ XR,Hypoacusis,29
XELJANZ XR,Fall,27
XELJANZ XR,Product dose omission issue,26
XELJANZ XR,Feeling abnormal,25
XELJANZ XR,Herpes zoster,25
XELJANZ XR,Intentional product misuse,24
XELJANZ XR,Cough,24
XELJANZ XR,Back pain,23
XELJANZ XR,Influenza,21
XELJANZ XR,Urinary tract infection,21
XELJANZ XR,Knee arthroplasty,20
XELJANZ XR,Oropharyngeal pain,19
XELJANZ XR,Sinusitis,19
XELJANZ XR,Rheumatoid arthritis,18
XELJANZ XR,Confusional state,17
XELJANZ XR,Weight increased,17
XELJANZ XR,Dyspnoea,17
XELJANZ XR,Infection,16
XELJANZ XR,Nausea,16
XELJANZ XR,Blood cholesterol increased,16
XELJANZ XR,Diarrhoea,16
XELJANZ XR,Musculoskeletal stiffness,15
XELJANZ XR,Cataract,15
XELJANZ XR,Pneumonia,15
XELJANZ XR,Hypersensitivity,15
XELJANZ XR,Spinal operation,15
XELJANZ XR,Hypertension,14
XELJANZ XR,Loss of personal independence in daily activities,14
XELJANZ XR,Arthritis,14
XELJANZ XR,Pyrexia,14
XELJANZ XR,Visual impairment,13
XELJANZ XR,Body height decreased,13
XELJANZ XR,Bronchitis,12
XELJANZ XR,Anxiety,12
XGEVA,Diarrhoea,23
XGEVA,Fatigue,22
XGEVA,Anaemia,20
XGEVA,Off label use,17
XGEVA,Alopecia,16
XGEVA,Osteonecrosis of jaw,14
XGEVA,Rash,13
XGEVA,Hot flush,12
XGEVA,Mucosal inflammation,12
XGEVA,Neutropenia,11
XGEVA,Gastrooesophageal reflux disease,10
XGEVA,Asthenia,10
XGEVA,White blood cell count decreased,9
XGEVA,Influenza like illness,9
XGEVA,Ejection fraction decreased,9
XGEVA,Epistaxis,9
XGEVA,COVID-19,9
XGEVA,Pain,8
XGEVA,Vascular device infection,8
XGEVA,Gingival swelling,8
XGEVA,Lymphoedema,8
XGEVA,Neoplasm progression,8
XGEVA,Nausea,8
XGEVA,Arthralgia,8
XGEVA,Thrombocytopenia,7
XGEVA,Leukopenia,7
XGEVA,Platelet count decreased,7
XGEVA,Stomatitis,6
XGEVA,Malaise,6
XGEVA,Cough,6
XGEVA,Sepsis,6
XGEVA,Pancytopenia,6
XGEVA,Constipation,6
XGEVA,Neuropathy peripheral,6
XGEVA,Lymphocyte count decreased,6
XGEVA,Rhinorrhoea,5
XGEVA,Device related infection,5
XGEVA,Back pain,5
XGEVA,Oedema peripheral,5
XGEVA,Full blood count decreased,4
XGEVA,Dyspnoea,4
XGEVA,Urinary tract infection,4
XGEVA,Pyrexia,4
XGEVA,Illness,4
XGEVA,Dry skin,4
XGEVA,Death,4
XGEVA,Pruritus,4
XGEVA,Weight decreased,4
XGEVA,Hypocalcaemia,4
XGEVA,Haemoglobin decreased,4
XIFAXAN,Product use issue,28
XIFAXAN,Insurance issue,14
XIFAXAN,Hospitalisation,8
XIFAXAN,Product use in unapproved indication,8
XIFAXAN,Intentional product use issue,7
XIFAXAN,Inability to afford medication,7
XIFAXAN,Nausea,6
XIFAXAN,Memory impairment,5
XIFAXAN,Fatigue,5
XIFAXAN,Confusional state,5
XIFAXAN,Diarrhoea,4
XIFAXAN,Asthenia,4
XIFAXAN,Headache,4
XIFAXAN,Ammonia increased,4
XIFAXAN,Vomiting,4
XIFAXAN,Anaemia,3
XIFAXAN,Renal disorder,3
XIFAXAN,Abdominal pain upper,3
XIFAXAN,Weight decreased,3
XIFAXAN,Malaise,3
XIFAXAN,Dizziness,3
XIFAXAN,Condition aggravated,3
XIFAXAN,Ill-defined disorder,3
XIFAXAN,Fall,3
XIFAXAN,Ammonia abnormal,3
XIFAXAN,Dyspnoea,3
XIFAXAN,Death,3
XIFAXAN,Feeling abnormal,3
XIFAXAN,Hepatic encephalopathy,3
XIFAXAN,Dehydration,2
XIFAXAN,Stress,2
XIFAXAN,Off label use,2
XIFAXAN,COVID-19,2
XIFAXAN,Product prescribing issue,2
XIFAXAN,Varices oesophageal,2
XIFAXAN,Poor quality sleep,2
XIFAXAN,Delusion,2
XIFAXAN,Contusion,2
XIFAXAN,Treatment noncompliance,2
XIFAXAN,Hepatic lesion,2
XIFAXAN,Pain in extremity,2
XIFAXAN,Pericarditis,2
XIFAXAN,Palpitations,2
XIFAXAN,Abdominal distension,2
XIFAXAN,Urinary tract infection,2
XIFAXAN,Back pain,2
XIFAXAN,Device related bacteraemia,2
XIFAXAN,Injection site irritation,1
XIFAXAN,Pneumonia,1
XIFAXAN,Hypersensitivity,1
XOLAIR,Weight decreased,73
XOLAIR,Asthma,70
XOLAIR,Dyspnoea,63
XOLAIR,Nasopharyngitis,60
XOLAIR,Cough,58
XOLAIR,Headache,54
XOLAIR,Urticaria,53
XOLAIR,Malaise,52
XOLAIR,Weight increased,49
XOLAIR,Influenza,48
XOLAIR,Fatigue,47
XOLAIR,Blood pressure increased,45
XOLAIR,Hypersensitivity,41
XOLAIR,Illness,41
XOLAIR,Pruritus,41
XOLAIR,Wheezing,37
XOLAIR,Inappropriate schedule of product administration,36
XOLAIR,Pyrexia,34
XOLAIR,Pneumonia,34
XOLAIR,Drug hypersensitivity,33
XOLAIR,Product dose omission issue,33
XOLAIR,Productive cough,32
XOLAIR,Oropharyngeal pain,32
XOLAIR,Pain,28
XOLAIR,Forced expiratory volume decreased,25
XOLAIR,Arthralgia,25
XOLAIR,Blood pressure systolic increased,25
XOLAIR,Rash,25
XOLAIR,Incorrect dose administered,24
XOLAIR,Chest discomfort,23
XOLAIR,Bronchitis,23
XOLAIR,Drug ineffective,23
XOLAIR,Off label use,23
XOLAIR,Middle insomnia,22
XOLAIR,Dizziness,22
XOLAIR,Vomiting,22
XOLAIR,Diarrhoea,22
XOLAIR,Asthmatic crisis,22
XOLAIR,Heart rate increased,21
XOLAIR,Feeling abnormal,21
XOLAIR,Nasal congestion,20
XOLAIR,Erythema,20
XOLAIR,Nausea,19
XOLAIR,Anaphylactic reaction,19
XOLAIR,Sputum discoloured,19
XOLAIR,Chest pain,19
XOLAIR,Fall,19
XOLAIR,Asthenia,19
XOLAIR,Swelling,18
XOLAIR,Gait disturbance,18
XYREM,Nausea,11
XYREM,Weight decreased,10
XYREM,Depression,9
XYREM,Somnolence,8
XYREM,Hypertension,8
XYREM,Weight increased,8
XYREM,Obstructive sleep apnoea syndrome,8
XYREM,Product administration interrupted,8
XYREM,Blood pressure increased,7
XYREM,Obesity,6
XYREM,Migraine,6
XYREM,Condition aggravated,5
XYREM,Arthritis,5
XYREM,Headache,5
XYREM,Paraesthesia,4
XYREM,Urinary tract infection,4
XYREM,Fall,4
XYREM,Abdominal discomfort,4
XYREM,Road traffic accident,4
XYREM,Nephrolithiasis,4
XYREM,Memory impairment,4
XYREM,Anxiety,4
XYREM,Back pain,4
XYREM,Adverse drug reaction,4
XYREM,COVID-19,4
XYREM,Gastrooesophageal reflux disease,4
XYREM,Neuropathy peripheral,4
XYREM,Diarrhoea,4
XYREM,Pain in extremity,3
XYREM,Chronic kidney disease,3
XYREM,Hypoaesthesia,3
XYREM,Complex regional pain syndrome,3
XYREM,Spinal osteoarthritis,3
XYREM,Restless legs syndrome,3
XYREM,Nerve compression,3
XYREM,Intentional product use issue,3
XYREM,Feeling abnormal,3
XYREM,Stress,3
XYREM,Insomnia,3
XYREM,Vertigo,3
XYREM,Knee arthroplasty,3
XYREM,Enuresis,3
XYREM,Osteoporosis,3
XYREM,Staphylococcal infection,3
XYREM,Attention deficit hyperactivity disorder,3
XYREM,Pre-existing condition improved,3
XYREM,Dyspnoea,3
XYREM,Suicidal ideation,3
XYREM,Sleep apnoea syndrome,3
XYREM,Illness,3
XYZAL,Headache,17
XYZAL,Pain,14
XYZAL,Pruritus,13
XYZAL,COVID-19,13
XYZAL,Malaise,12
XYZAL,Sinusitis,12
XYZAL,Fatigue,10
XYZAL,Rash,10
XYZAL,Product dose omission issue,10
XYZAL,Pyrexia,9
XYZAL,Fall,8
XYZAL,Nausea,8
XYZAL,Weight increased,7
XYZAL,Anxiety,7
XYZAL,Back pain,7
XYZAL,Dyspnoea,7
XYZAL,Ear infection,6
XYZAL,Pneumonia,6
XYZAL,Cough,6
XYZAL,Nasopharyngitis,6
XYZAL,Urticaria,5
XYZAL,Sleep disorder,5
XYZAL,Contusion,5
XYZAL,Arthralgia,5
XYZAL,Bronchitis,5
XYZAL,Infusion related reaction,5
XYZAL,Productive cough,5
XYZAL,Infection,5
XYZAL,Arthritis,5
XYZAL,Illness,5
XYZAL,Infusion site erythema,5
XYZAL,Urinary tract infection,5
XYZAL,Drug hypersensitivity,4
XYZAL,Myalgia,4
XYZAL,Viral infection,4
XYZAL,Abdominal distension,4
XYZAL,Seasonal allergy,4
XYZAL,Upper respiratory tract infection,4
XYZAL,Migraine,4
XYZAL,Blood pressure decreased,4
XYZAL,Diarrhoea,4
XYZAL,Dehydration,4
XYZAL,Drug ineffective,4
XYZAL,Incorrect dose administered,4
XYZAL,Infusion site pruritus,4
XYZAL,Inappropriate schedule of product administration,4
XYZAL,Vision blurred,3
XYZAL,Sepsis,3
XYZAL,Condition aggravated,3
XYZAL,Photosensitivity reaction,3
YERVOY,Off label use,26
YERVOY,Rash,20
YERVOY,Non-small cell lung cancer,20
YERVOY,Pyrexia,18
YERVOY,Malignant neoplasm progression,17
YERVOY,Hypothyroidism,16
YERVOY,Decreased appetite,15
YERVOY,Prescribed overdose,15
YERVOY,Secondary adrenocortical insufficiency,14
YERVOY,Immune-mediated enterocolitis,13
YERVOY,Hepatic function abnormal,12
YERVOY,Diarrhoea,11
YERVOY,Pulmonary toxicity,11
YERVOY,Interstitial lung disease,10
YERVOY,Malaise,9
YERVOY,Liver disorder,9
YERVOY,Nausea,9
YERVOY,Death,9
YERVOY,Fulminant type 1 diabetes mellitus,8
YERVOY,Adrenocorticotropic hormone deficiency,8
YERVOY,Headache,8
YERVOY,Hypopituitarism,8
YERVOY,Drug-induced liver injury,7
YERVOY,Hyperthyroidism,7
YERVOY,Pruritus,7
YERVOY,Dehydration,7
YERVOY,Cytokine release syndrome,7
YERVOY,Adrenal insufficiency,7
YERVOY,Arthralgia,7
YERVOY,Intentional product use issue,7
YERVOY,Haemophagocytic lymphohistiocytosis,6
YERVOY,Immune-mediated hypothyroidism,6
YERVOY,Adrenal disorder,6
YERVOY,Hepatic cytolysis,6
YERVOY,Blood pressure decreased,5
YERVOY,Disseminated intravascular coagulation,5
YERVOY,Immune-mediated lung disease,5
YERVOY,Altered state of consciousness,5
YERVOY,White blood cell count decreased,5
YERVOY,Condition aggravated,5
YERVOY,Type 1 diabetes mellitus,5
YERVOY,Acute kidney injury,5
YERVOY,Pancreatitis,5
YERVOY,Platelet count decreased,5
YERVOY,Eosinophilia,4
YERVOY,Diabetic ketoacidosis,4
YERVOY,Hypophysitis,4
YERVOY,Immune-mediated uveitis,4
YERVOY,Drug reaction with eosinophilia and systemic symptoms,4
YERVOY,Fall,4
ZANTAC,Pain,12
ZANTAC,Urticaria,11
ZANTAC,Fatigue,10
ZANTAC,Product dose omission issue,10
ZANTAC,Rash,10
ZANTAC,Pruritus,10
ZANTAC,COVID-19,10
ZANTAC,Headache,9
ZANTAC,Weight decreased,9
ZANTAC,Arthralgia,8
ZANTAC,Nasopharyngitis,7
ZANTAC,Swelling,7
ZANTAC,Drug ineffective,7
ZANTAC,Pneumonia,7
ZANTAC,Anaphylactic reaction,6
ZANTAC,Inappropriate schedule of product administration,6
ZANTAC,Hypersensitivity,6
ZANTAC,Bronchitis,6
ZANTAC,Diarrhoea,6
ZANTAC,Weight increased,6
ZANTAC,Myalgia,6
ZANTAC,Drug hypersensitivity,5
ZANTAC,Nausea,5
ZANTAC,Illness,5
ZANTAC,Off label use,5
ZANTAC,Muscle spasms,5
ZANTAC,Asthenia,5
ZANTAC,Malaise,5
ZANTAC,Abdominal pain,4
ZANTAC,Sleep disorder,4
ZANTAC,Peripheral swelling,4
ZANTAC,Product availability issue,4
ZANTAC,Blood pressure systolic increased,4
ZANTAC,Abscess,4
ZANTAC,Sinusitis,4
ZANTAC,Joint swelling,4
ZANTAC,Pyrexia,4
ZANTAC,Migraine,4
ZANTAC,Dizziness,4
ZANTAC,Anxiety,3
ZANTAC,Pain in extremity,3
ZANTAC,Heart rate increased,3
ZANTAC,Back pain,3
ZANTAC,Injection site pain,3
ZANTAC,Chronic spontaneous urticaria,3
ZANTAC,Candida infection,3
ZANTAC,Emotional distress,3
ZANTAC,Infusion site pruritus,3
ZANTAC,Cardiac failure congestive,3
ZANTAC,Ear infection,3
ZEJULA,Fatigue,27
ZEJULA,Nausea,25
ZEJULA,Blood pressure increased,19
ZEJULA,Constipation,18
ZEJULA,Off label use,18
ZEJULA,Platelet count decreased,16
ZEJULA,Headache,15
ZEJULA,Product dose omission issue,15
ZEJULA,Insomnia,14
ZEJULA,Pain,11
ZEJULA,Arthralgia,10
ZEJULA,Vomiting,10
ZEJULA,Abdominal discomfort,9
ZEJULA,Red blood cell count decreased,8
ZEJULA,Asthenia,7
ZEJULA,Thrombocytopenia,7
ZEJULA,Diarrhoea,7
ZEJULA,Cough,7
ZEJULA,Dyspnoea,7
ZEJULA,Nasopharyngitis,6
ZEJULA,White blood cell count decreased,6
ZEJULA,Heart rate increased,6
ZEJULA,Back pain,6
ZEJULA,Decreased activity,6
ZEJULA,Illness,6
ZEJULA,Malaise,5
ZEJULA,Dizziness,5
ZEJULA,Oropharyngeal pain,5
ZEJULA,Decreased appetite,5
ZEJULA,Condition aggravated,5
ZEJULA,Haemoglobin decreased,5
ZEJULA,Anaemia,5
ZEJULA,Sleep disorder,5
ZEJULA,Protein urine present,5
ZEJULA,Pain in extremity,5
ZEJULA,Full blood count abnormal,5
ZEJULA,Pruritus,5
ZEJULA,Abdominal pain upper,5
ZEJULA,Sinusitis,4
ZEJULA,Dysphonia,4
ZEJULA,Myalgia,4
ZEJULA,Laboratory test abnormal,4
ZEJULA,Gastroenteritis viral,4
ZEJULA,Photosensitivity reaction,4
ZEJULA,Dysgeusia,4
ZEJULA,Hypertension,4
ZEJULA,Neutrophil count decreased,4
ZEJULA,Product dose omission in error,4
ZEJULA,Feeling abnormal,4
ZEJULA,Pyrexia,3
ZETIA,Pain,6
ZETIA,Off label use,6
ZETIA,Product dose omission issue,5
ZETIA,Emotional distress,5
ZETIA,Chronic kidney disease,4
ZETIA,Anhedonia,4
ZETIA,Anxiety,4
ZETIA,Fatigue,4
ZETIA,Nausea,4
ZETIA,Myocardial infarction,4
ZETIA,Feeling abnormal,3
ZETIA,Confusional state,3
ZETIA,Pruritus,3
ZETIA,Pain in extremity,3
ZETIA,Condition aggravated,3
ZETIA,Hypertension,3
ZETIA,Accidental exposure to product,3
ZETIA,Fall,3
ZETIA,Pneumonia,3
ZETIA,Abdominal pain upper,3
ZETIA,Pyrexia,3
ZETIA,Poor quality product administered,2
ZETIA,Malaise,2
ZETIA,Product quality issue,2
ZETIA,Anaemia,2
ZETIA,Stress,2
ZETIA,Intervertebral disc protrusion,2
ZETIA,Alopecia,2
ZETIA,Renal failure,2
ZETIA,Back pain,2
ZETIA,Insomnia,2
ZETIA,Blood creatinine increased,2
ZETIA,Skeletal injury,2
ZETIA,Depression,2
ZETIA,Renal impairment,2
ZETIA,Dyspnoea,2
ZETIA,COVID-19,2
ZETIA,Nasopharyngitis,2
ZETIA,Pallor,2
ZETIA,Chills,2
ZETIA,Death,2
ZETIA,Weight decreased,2
ZETIA,Asthma,2
ZETIA,Irritable bowel syndrome,2
ZETIA,Vomiting,2
ZETIA,Arthralgia,2
ZETIA,Diabetes mellitus,2
ZETIA,Discomfort,2
ZETIA,Visual impairment,1
ZETIA,Cognitive disorder,1
ZINC,COVID-19,33
ZINC,Off label use,30
ZINC,Product dose omission issue,26
ZINC,Abdominal discomfort,22
ZINC,Rash,21
ZINC,Intentional product misuse,18
ZINC,Lower respiratory tract infection,18
ZINC,Pulmonary pain,17
ZINC,Overdose,17
ZINC,Drug abuse,17
ZINC,Arthropathy,16
ZINC,Knee arthroplasty,16
ZINC,Malaise,15
ZINC,Fatigue,14
ZINC,Condition aggravated,14
ZINC,Headache,12
ZINC,Sinusitis,11
ZINC,Diarrhoea,11
ZINC,Illness,11
ZINC,Back pain,10
ZINC,Obesity,10
ZINC,Nasopharyngitis,9
ZINC,Nausea,9
ZINC,Pneumonia,9
ZINC,Urinary tract infection,9
ZINC,Weight decreased,9
ZINC,Pruritus,9
ZINC,Feeling abnormal,8
ZINC,Arthralgia,8
ZINC,Amyloid arthropathy,8
ZINC,Lung neoplasm malignant,8
ZINC,Schizophrenia,8
ZINC,Radiation inflammation,8
ZINC,Inflammation,8
ZINC,Fall,7
ZINC,Blood pressure increased,7
ZINC,Weight increased,7
ZINC,Swelling,6
ZINC,Joint swelling,6
ZINC,Pain in extremity,6
ZINC,Injection site pain,6
ZINC,Abdominal pain,6
ZINC,Confusional state,6
ZINC,Drug ineffective,6
ZINC,Dizziness,6
ZINC,Hypersensitivity pneumonitis,6
ZINC,Immune-mediated lung disease,6
ZINC,Asthenia,6
ZINC,Cough,6
ZINC,Dyspnoea,6
ZITHROMAX,Off label use,14
ZITHROMAX,COVID-19,9
ZITHROMAX,Rash erythematous,9
ZITHROMAX,Pruritus,9
ZITHROMAX,Asthma,7
ZITHROMAX,Fatigue,7
ZITHROMAX,Nausea,6
ZITHROMAX,Cough,5
ZITHROMAX,Diarrhoea,5
ZITHROMAX,Rash,5
ZITHROMAX,Dyspnoea,4
ZITHROMAX,Pain,4
ZITHROMAX,Urinary tract infection,4
ZITHROMAX,Headache,4
ZITHROMAX,Bronchitis,4
ZITHROMAX,Pyrexia,4
ZITHROMAX,Malaise,4
ZITHROMAX,Drug hypersensitivity,3
ZITHROMAX,Asthenia,3
ZITHROMAX,Fall,3
ZITHROMAX,Anxiety,3
ZITHROMAX,Illness,3
ZITHROMAX,Product use issue,3
ZITHROMAX,Vomiting,3
ZITHROMAX,Pneumonia,3
ZITHROMAX,Product dose omission issue,3
ZITHROMAX,Upper respiratory tract infection,3
ZITHROMAX,Sinusitis,3
ZITHROMAX,Inappropriate schedule of product administration,3
ZITHROMAX,Rash papular,2
ZITHROMAX,Viral infection,2
ZITHROMAX,Lower respiratory tract infection,2
ZITHROMAX,Hypertension,2
ZITHROMAX,Respiratory disorder,2
ZITHROMAX,Oropharyngeal pain,2
ZITHROMAX,Swelling face,2
ZITHROMAX,Crying,2
ZITHROMAX,Sudden death,2
ZITHROMAX,Seizure,2
ZITHROMAX,Hepatomegaly,2
ZITHROMAX,Prescribed overdose,2
ZITHROMAX,Emotional distress,2
ZITHROMAX,Chronic kidney disease,2
ZITHROMAX,Anhedonia,2
ZITHROMAX,Economic problem,2
ZITHROMAX,Respiratory tract infection viral,2
ZITHROMAX,Respiratory tract infection,2
ZITHROMAX,Ill-defined disorder,2
ZITHROMAX,Oesophageal ulcer,2
ZITHROMAX,Needle issue,2
ZOFRAN,Nausea,48
ZOFRAN,COVID-19,38
ZOFRAN,Fatigue,30
ZOFRAN,Vomiting,30
ZOFRAN,Pain,27
ZOFRAN,Product dose omission issue,25
ZOFRAN,Headache,21
ZOFRAN,Dyspnoea,21
ZOFRAN,Off label use,21
ZOFRAN,Illness,20
ZOFRAN,Diarrhoea,20
ZOFRAN,Pyrexia,19
ZOFRAN,Sinusitis,19
ZOFRAN,Weight decreased,18
ZOFRAN,Anaemia,18
ZOFRAN,Pneumonia,17
ZOFRAN,Dehydration,17
ZOFRAN,Asthenia,17
ZOFRAN,Malaise,16
ZOFRAN,Urinary tract infection,16
ZOFRAN,Anxiety,15
ZOFRAN,Constipation,14
ZOFRAN,Insurance issue,14
ZOFRAN,Fall,13
ZOFRAN,Back pain,13
ZOFRAN,Migraine,13
ZOFRAN,Upper respiratory tract infection,13
ZOFRAN,Inappropriate schedule of product administration,12
ZOFRAN,Nasopharyngitis,12
ZOFRAN,Peripheral swelling,12
ZOFRAN,Pain in extremity,12
ZOFRAN,Cough,11
ZOFRAN,Infusion related reaction,11
ZOFRAN,Arthralgia,11
ZOFRAN,Product use issue,10
ZOFRAN,Acute kidney injury,10
ZOFRAN,Influenza,10
ZOFRAN,Infusion site pain,9
ZOFRAN,Erythema,9
ZOFRAN,Bronchitis,9
ZOFRAN,Abdominal pain,9
ZOFRAN,Decreased appetite,9
ZOFRAN,Neutropenia,9
ZOFRAN,Insomnia,8
ZOFRAN,COVID-19 pneumonia,8
ZOFRAN,Anhedonia,8
ZOFRAN,Emotional distress,8
ZOFRAN,Hypoaesthesia,8
ZOFRAN,Infection,8
ZOFRAN,Rash,8
ZOLEDRONIC ACID,Vomiting,24
ZOLEDRONIC ACID,Pyrexia,24
ZOLEDRONIC ACID,Pain,23
ZOLEDRONIC ACID,Headache,21
ZOLEDRONIC ACID,Arthralgia,21
ZOLEDRONIC ACID,White blood cell count decreased,20
ZOLEDRONIC ACID,Diarrhoea,19
ZOLEDRONIC ACID,Back pain,17
ZOLEDRONIC ACID,Dizziness,16
ZOLEDRONIC ACID,Asthenia,16
ZOLEDRONIC ACID,Anaemia,15
ZOLEDRONIC ACID,Influenza like illness,14
ZOLEDRONIC ACID,Nausea,14
ZOLEDRONIC ACID,Haemoglobin decreased,14
ZOLEDRONIC ACID,Myalgia,13
ZOLEDRONIC ACID,Constipation,13
ZOLEDRONIC ACID,Off label use,13
ZOLEDRONIC ACID,Pneumonia,12
ZOLEDRONIC ACID,Weight decreased,10
ZOLEDRONIC ACID,Pain in extremity,10
ZOLEDRONIC ACID,Dyspnoea,10
ZOLEDRONIC ACID,Fatigue,9
ZOLEDRONIC ACID,Hypertension,9
ZOLEDRONIC ACID,Hypokalaemia,9
ZOLEDRONIC ACID,Decreased appetite,8
ZOLEDRONIC ACID,Nasopharyngitis,8
ZOLEDRONIC ACID,Blood pressure increased,8
ZOLEDRONIC ACID,Anxiety,8
ZOLEDRONIC ACID,Platelet count decreased,8
ZOLEDRONIC ACID,Febrile neutropenia,8
ZOLEDRONIC ACID,Malaise,7
ZOLEDRONIC ACID,Eye swelling,7
ZOLEDRONIC ACID,Cough,7
ZOLEDRONIC ACID,Peripheral swelling,7
ZOLEDRONIC ACID,Death,7
ZOLEDRONIC ACID,Neutrophil count decreased,7
ZOLEDRONIC ACID,Hepatic steatosis,7
ZOLEDRONIC ACID,Lymphadenopathy,7
ZOLEDRONIC ACID,Depressed mood,7
ZOLEDRONIC ACID,Hyponatraemia,7
ZOLEDRONIC ACID,Bone pain,7
ZOLEDRONIC ACID,Paraesthesia,7
ZOLEDRONIC ACID,Palpitations,7
ZOLEDRONIC ACID,Fall,6
ZOLEDRONIC ACID,Gait disturbance,6
ZOLEDRONIC ACID,Rash,6
ZOLEDRONIC ACID,Lymphocyte count decreased,6
ZOLEDRONIC ACID,Burning sensation,6
ZOLEDRONIC ACID,Hypersensitivity,6
ZOLEDRONIC ACID,Weight increased,6
ZOLGENSMA,Pyrexia,40
ZOLGENSMA,Aspartate aminotransferase increased,39
ZOLGENSMA,Alanine aminotransferase increased,37
ZOLGENSMA,Vomiting,24
ZOLGENSMA,Decreased appetite,19
ZOLGENSMA,Platelet count decreased,17
ZOLGENSMA,Troponin I increased,16
ZOLGENSMA,Thrombotic microangiopathy,14
ZOLGENSMA,Thrombocytopenia,13
ZOLGENSMA,Blood lactate dehydrogenase increased,12
ZOLGENSMA,Hypertension,12
ZOLGENSMA,Bradycardia,12
ZOLGENSMA,Hepatic enzyme increased,11
ZOLGENSMA,Haematuria,11
ZOLGENSMA,Hepatic function abnormal,11
ZOLGENSMA,Hyperkalaemia,10
ZOLGENSMA,Pneumonia aspiration,10
ZOLGENSMA,Renal impairment,10
ZOLGENSMA,Generalised oedema,9
ZOLGENSMA,Proteinuria,9
ZOLGENSMA,Tremor,9
ZOLGENSMA,Pneumonia,8
ZOLGENSMA,Transaminases increased,8
ZOLGENSMA,Oliguria,8
ZOLGENSMA,Anaemia,8
ZOLGENSMA,Dyspnoea,8
ZOLGENSMA,Blood creatine phosphokinase increased,7
ZOLGENSMA,Weight increased,7
ZOLGENSMA,Faecaloma,7
ZOLGENSMA,Respiratory disorder,7
ZOLGENSMA,Hypoxia,6
ZOLGENSMA,Cough,6
ZOLGENSMA,Tachycardia,6
ZOLGENSMA,Nausea,6
ZOLGENSMA,Medical device site haemorrhage,6
ZOLGENSMA,Drug withdrawal syndrome,6
ZOLGENSMA,Cerebral atrophy,6
ZOLGENSMA,Disseminated intravascular coagulation,6
ZOLGENSMA,Abdominal distension,6
ZOLGENSMA,Atypical haemolytic uraemic syndrome,6
ZOLGENSMA,Thrombosis,6
ZOLGENSMA,Serratia infection,6
ZOLGENSMA,Ascites,6
ZOLGENSMA,Hypotonia,6
ZOLGENSMA,Acute kidney injury,5
ZOLGENSMA,Upper respiratory tract infection,5
ZOLGENSMA,Respiratory failure,5
ZOLGENSMA,COVID-19,5
ZOLGENSMA,Constipation,5
ZOLGENSMA,Scoliosis,5
ZOLOFT,Anxiety,24
ZOLOFT,Pain,23
ZOLOFT,Fatigue,17
ZOLOFT,Emotional distress,16
ZOLOFT,Anhedonia,16
ZOLOFT,Product dose omission issue,14
ZOLOFT,Sinusitis,12
ZOLOFT,Pneumonia,11
ZOLOFT,COVID-19,11
ZOLOFT,Headache,10
ZOLOFT,Off label use,10
ZOLOFT,Diarrhoea,9
ZOLOFT,Depression,9
ZOLOFT,Chronic kidney disease,9
ZOLOFT,Weight decreased,8
ZOLOFT,Asthenia,8
ZOLOFT,Fall,8
ZOLOFT,Weight increased,7
ZOLOFT,Nausea,7
ZOLOFT,Upper respiratory tract infection,7
ZOLOFT,Osteoporosis,7
ZOLOFT,Urinary tract infection,7
ZOLOFT,Arthralgia,6
ZOLOFT,Pyrexia,6
ZOLOFT,Influenza,6
ZOLOFT,Malaise,6
ZOLOFT,Dizziness,6
ZOLOFT,Blood creatinine increased,6
ZOLOFT,Inappropriate schedule of product administration,6
ZOLOFT,Drug ineffective,6
ZOLOFT,Back pain,6
ZOLOFT,Abdominal pain,6
ZOLOFT,Dyspnoea,5
ZOLOFT,Renal impairment,5
ZOLOFT,Bone density decreased,5
ZOLOFT,Illness,5
ZOLOFT,Tachycardia,5
ZOLOFT,Acute kidney injury,4
ZOLOFT,Nasopharyngitis,4
ZOLOFT,Renal failure,4
ZOLOFT,Osteopenia,4
ZOLOFT,Limb injury,4
ZOLOFT,Confusional state,4
ZOLOFT,Drug hypersensitivity,3
ZOLOFT,Rash,3
ZOLOFT,Vomiting,3
ZOLOFT,Nephrolithiasis,3
ZOLOFT,Attention deficit hyperactivity disorder,3
ZOLOFT,Gastroenteritis viral,3
ZOLOFT,Pain in extremity,3
ZOLPIDEM,Pain,17
ZOLPIDEM,Anxiety,16
ZOLPIDEM,Off label use,13
ZOLPIDEM,Emotional distress,11
ZOLPIDEM,Anhedonia,10
ZOLPIDEM,Fatigue,10
ZOLPIDEM,Pneumonia,10
ZOLPIDEM,Fall,9
ZOLPIDEM,Depression,8
ZOLPIDEM,Hallucination,7
ZOLPIDEM,Diarrhoea,7
ZOLPIDEM,Dyspnoea,7
ZOLPIDEM,Arthralgia,7
ZOLPIDEM,Osteoporosis,7
ZOLPIDEM,Infusion related reaction,7
ZOLPIDEM,Suicide attempt,7
ZOLPIDEM,Product dose omission issue,6
ZOLPIDEM,Chronic kidney disease,6
ZOLPIDEM,Peripheral swelling,6
ZOLPIDEM,Acute kidney injury,6
ZOLPIDEM,Osteopenia,6
ZOLPIDEM,Pain in extremity,6
ZOLPIDEM,Somnolence,6
ZOLPIDEM,COVID-19,6
ZOLPIDEM,Dizziness,6
ZOLPIDEM,Febrile neutropenia,6
ZOLPIDEM,Toxicity to various agents,6
ZOLPIDEM,Gait disturbance,5
ZOLPIDEM,Nausea,5
ZOLPIDEM,Illness,5
ZOLPIDEM,Condition aggravated,5
ZOLPIDEM,Malaise,5
ZOLPIDEM,Decreased appetite,5
ZOLPIDEM,Headache,5
ZOLPIDEM,Renal failure,5
ZOLPIDEM,Bone density decreased,5
ZOLPIDEM,Insomnia,5
ZOLPIDEM,Sepsis,5
ZOLPIDEM,Blood creatinine increased,5
ZOLPIDEM,Hypertension,5
ZOLPIDEM,Constipation,5
ZOLPIDEM,Drug ineffective,5
ZOLPIDEM,Poisoning deliberate,5
ZOLPIDEM,Contusion,4
ZOLPIDEM,Asthenia,4
ZOLPIDEM,Urinary tract infection,4
ZOLPIDEM,Memory impairment,4
ZOLPIDEM,Inappropriate schedule of product administration,4
ZOLPIDEM,Feeling abnormal,4
ZOLPIDEM,Hypothyroidism,4
ZOLPIDEM TARTRATE,Headache,8
ZOLPIDEM TARTRATE,Dizziness,8
ZOLPIDEM TARTRATE,Intentional overdose,8
ZOLPIDEM TARTRATE,Fall,6
ZOLPIDEM TARTRATE,Anxiety,6
ZOLPIDEM TARTRATE,Oxygen saturation decreased,6
ZOLPIDEM TARTRATE,Suicide attempt,6
ZOLPIDEM TARTRATE,Insomnia,5
ZOLPIDEM TARTRATE,Constipation,5
ZOLPIDEM TARTRATE,Nausea,5
ZOLPIDEM TARTRATE,Product dose omission issue,5
ZOLPIDEM TARTRATE,Pneumonia,5
ZOLPIDEM TARTRATE,Fatigue,5
ZOLPIDEM TARTRATE,Inappropriate schedule of product administration,5
ZOLPIDEM TARTRATE,Pruritus,5
ZOLPIDEM TARTRATE,Contusion,4
ZOLPIDEM TARTRATE,Drug ineffective,4
ZOLPIDEM TARTRATE,Muscular weakness,4
ZOLPIDEM TARTRATE,COVID-19,4
ZOLPIDEM TARTRATE,Diarrhoea,4
ZOLPIDEM TARTRATE,Vomiting,4
ZOLPIDEM TARTRATE,Drug-induced liver injury,4
ZOLPIDEM TARTRATE,Malaise,4
ZOLPIDEM TARTRATE,Atrial fibrillation,4
ZOLPIDEM TARTRATE,Pain,3
ZOLPIDEM TARTRATE,Illness,3
ZOLPIDEM TARTRATE,Weight decreased,3
ZOLPIDEM TARTRATE,Dyspnoea,3
ZOLPIDEM TARTRATE,Feeding disorder,3
ZOLPIDEM TARTRATE,Product use complaint,3
ZOLPIDEM TARTRATE,Osteoporosis,3
ZOLPIDEM TARTRATE,Bronchitis,3
ZOLPIDEM TARTRATE,Urinary tract infection,3
ZOLPIDEM TARTRATE,Oedema,3
ZOLPIDEM TARTRATE,Dry skin,3
ZOLPIDEM TARTRATE,Delirium,3
ZOLPIDEM TARTRATE,Urinary retention,3
ZOLPIDEM TARTRATE,Platelet count decreased,3
ZOLPIDEM TARTRATE,Aspartate aminotransferase increased,3
ZOLPIDEM TARTRATE,Hepatic function abnormal,3
ZOLPIDEM TARTRATE,Pulmonary fibrosis,3
ZOLPIDEM TARTRATE,Erythema,3
ZOLPIDEM TARTRATE,Septic shock,3
ZOLPIDEM TARTRATE,Asthma,3
ZOLPIDEM TARTRATE,Sinusitis,2
ZOLPIDEM TARTRATE,Blood potassium decreased,2
ZOLPIDEM TARTRATE,Restlessness,2
ZOLPIDEM TARTRATE,Seasonal allergy,2
ZOLPIDEM TARTRATE,Confusional state,2
ZOLPIDEM TARTRATE,Pleurisy,2
ZOMETA,Fatigue,18
ZOMETA,Dyspepsia,11
ZOMETA,Alopecia,11
ZOMETA,White blood cell count decreased,11
ZOMETA,Vomiting,11
ZOMETA,Nausea,11
ZOMETA,Diarrhoea,10
ZOMETA,Headache,10
ZOMETA,Constipation,9
ZOMETA,Gait disturbance,9
ZOMETA,Dry skin,8
ZOMETA,Fall,8
ZOMETA,Neutropenia,8
ZOMETA,Asthenia,8
ZOMETA,Back pain,7
ZOMETA,Off label use,7
ZOMETA,Stomatitis,7
ZOMETA,Rash,7
ZOMETA,Cough,7
ZOMETA,Pyrexia,7
ZOMETA,Nasopharyngitis,6
ZOMETA,Weight decreased,6
ZOMETA,Anxiety,6
ZOMETA,Aspartate aminotransferase increased,6
ZOMETA,Dysuria,6
ZOMETA,Alanine aminotransferase increased,6
ZOMETA,Full blood count abnormal,6
ZOMETA,Vitamin B complex deficiency,5
ZOMETA,Musculoskeletal stiffness,5
ZOMETA,Influenza like illness,5
ZOMETA,Coronavirus infection,5
ZOMETA,Libido decreased,5
ZOMETA,Mucosal inflammation,5
ZOMETA,Rash pustular,5
ZOMETA,Amenorrhoea,5
ZOMETA,Spinal pain,5
ZOMETA,Disturbance in attention,5
ZOMETA,Pathological fracture,5
ZOMETA,Selenium deficiency,5
ZOMETA,Myalgia,5
ZOMETA,Product dose omission issue,5
ZOMETA,Malaise,5
ZOMETA,Decreased appetite,5
ZOMETA,Metastases to bone,5
ZOMETA,Feeling abnormal,5
ZOMETA,COVID-19,5
ZOMETA,Illness,5
ZOMETA,Abdominal discomfort,5
ZOMETA,Dyspnoea,5
ZOMETA,Pain,5
ZOPICLONE,Diarrhoea,23
ZOPICLONE,Headache,20
ZOPICLONE,Nausea,20
ZOPICLONE,Fatigue,19
ZOPICLONE,Vomiting,19
ZOPICLONE,Constipation,19
ZOPICLONE,Dyspnoea,16
ZOPICLONE,Death,15
ZOPICLONE,Asthenia,14
ZOPICLONE,Off label use,14
ZOPICLONE,Depression,14
ZOPICLONE,Anaemia,13
ZOPICLONE,Coma,13
ZOPICLONE,Decreased appetite,12
ZOPICLONE,Dehydration,12
ZOPICLONE,Confusional state,11
ZOPICLONE,Gait disturbance,11
ZOPICLONE,Dysphagia,11
ZOPICLONE,Product use in unapproved indication,11
ZOPICLONE,Hyponatraemia,10
ZOPICLONE,Hypomagnesaemia,10
ZOPICLONE,Neutropenia,10
ZOPICLONE,Hepatic cytolysis,10
ZOPICLONE,Pain,9
ZOPICLONE,Pyrexia,9
ZOPICLONE,Arthralgia,9
ZOPICLONE,Hypokalaemia,9
ZOPICLONE,Mouth ulceration,9
ZOPICLONE,Suicidal ideation,9
ZOPICLONE,Pneumonia,8
ZOPICLONE,Fall,8
ZOPICLONE,Mucosal inflammation,8
ZOPICLONE,Productive cough,8
ZOPICLONE,Neutropenic sepsis,8
ZOPICLONE,Balance disorder,8
ZOPICLONE,Skin candida,8
ZOPICLONE,Acute kidney injury,8
ZOPICLONE,Lower respiratory tract infection,7
ZOPICLONE,Infusion related reaction,7
ZOPICLONE,Nasopharyngitis,7
ZOPICLONE,Dizziness,7
ZOPICLONE,Nervous system disorder,7
ZOPICLONE,Neutrophil count decreased,7
ZOPICLONE,Hypotension,7
ZOPICLONE,Pruritus,6
ZOPICLONE,Condition aggravated,6
ZOPICLONE,Abdominal pain,6
ZOPICLONE,C-reactive protein increased,6
ZOPICLONE,Myalgia,6
ZOPICLONE,COVID-19,6
ZYRTEC,COVID-19,50
ZYRTEC,Product dose omission issue,47
ZYRTEC,Sinusitis,46
ZYRTEC,Headache,38
ZYRTEC,Fatigue,34
ZYRTEC,Pain,33
ZYRTEC,Pruritus,28
ZYRTEC,Inappropriate schedule of product administration,25
ZYRTEC,Pneumonia,23
ZYRTEC,Nasopharyngitis,23
ZYRTEC,Rash,22
ZYRTEC,Pyrexia,21
ZYRTEC,Nausea,21
ZYRTEC,Arthralgia,21
ZYRTEC,Dyspnoea,21
ZYRTEC,Urinary tract infection,20
ZYRTEC,Dizziness,19
ZYRTEC,Malaise,18
ZYRTEC,Migraine,18
ZYRTEC,Pain in extremity,18
ZYRTEC,Cough,18
ZYRTEC,Injection site pain,17
ZYRTEC,Infusion related reaction,16
ZYRTEC,Infection,16
ZYRTEC,Weight increased,16
ZYRTEC,Bronchitis,16
ZYRTEC,Influenza,16
ZYRTEC,Drug ineffective,15
ZYRTEC,Diarrhoea,15
ZYRTEC,Fall,15
ZYRTEC,Asthenia,14
ZYRTEC,Ear infection,14
ZYRTEC,Hypersensitivity,13
ZYRTEC,Peripheral swelling,13
ZYRTEC,Back pain,13
ZYRTEC,Oropharyngeal pain,13
ZYRTEC,Weight decreased,12
ZYRTEC,Vomiting,12
ZYRTEC,Asthma,12
ZYRTEC,Multiple allergies,12
ZYRTEC,Respiratory tract infection,11
ZYRTEC,Seasonal allergy,11
ZYRTEC,Upper respiratory tract infection,11
ZYRTEC,Infusion site pain,11
ZYRTEC,Illness,10
ZYRTEC,Dermatitis atopic,10
ZYRTEC,Condition aggravated,9
ZYRTEC,Drug hypersensitivity,9
ZYRTEC,Anxiety,9
ZYRTEC,Dehydration,9
